<SEC-DOCUMENT>0001628280-21-010528.txt : 20210517
<SEC-HEADER>0001628280-21-010528.hdr.sgml : 20210517
<ACCEPTANCE-DATETIME>20210517161712
ACCESSION NUMBER:		0001628280-21-010528
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		97
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210517
DATE AS OF CHANGE:		20210517

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Hims & Hers Health, Inc.
		CENTRAL INDEX KEY:			0001773751
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38986
		FILM NUMBER:		21930904

	BUSINESS ADDRESS:	
		STREET 1:		2269 CHESTNUT ST
		STREET 2:		#523
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94123
		BUSINESS PHONE:		415-851-0195

	MAIL ADDRESS:	
		STREET 1:		2269 CHESTNUT ST
		STREET 2:		#523
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94123

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oaktree Acquisition Corp.
		DATE OF NAME CHANGE:	20190412
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>hims-20210331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:38d399d4-426b-4053-8eef-3989252869db,g:a068c89f-8498-4134-8237-732dcbe50228,d:412093a93f204328a33c4602202f8375--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:hims="http://forhims.com/20210331" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hims-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMjYyL2ZyYWc6MGRmOTQyZWU0MDE4NDg0MTljYWE5MmUwMWEzMDcyZTUvdGFibGU6YWM3MGMzY2EyNTFmNDZmNTg1Y2Q1ZWE2MmE3ZWNjNDEvdGFibGVyYW5nZTphYzcwYzNjYTI1MWY0NmY1ODVjZDVlYTYyYTdlY2M0MV8zLTEtMS0xLTI3NzI_20478b59-4a79-487b-8845-c66d81ad99e5">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMjYyL2ZyYWc6MGRmOTQyZWU0MDE4NDg0MTljYWE5MmUwMWEzMDcyZTUvdGFibGU6YWM3MGMzY2EyNTFmNDZmNTg1Y2Q1ZWE2MmE3ZWNjNDEvdGFibGVyYW5nZTphYzcwYzNjYTI1MWY0NmY1ODVjZDVlYTYyYTdlY2M0MV80LTEtMS0xLTI3NzI_f1d4b597-e310-45fb-ac9d-0229ec443fb9">2021</ix:nonNumeric><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMjYyL2ZyYWc6MGRmOTQyZWU0MDE4NDg0MTljYWE5MmUwMWEzMDcyZTUvdGFibGU6YWM3MGMzY2EyNTFmNDZmNTg1Y2Q1ZWE2MmE3ZWNjNDEvdGFibGVyYW5nZTphYzcwYzNjYTI1MWY0NmY1ODVjZDVlYTYyYTdlY2M0MV81LTEtMS0xLTI3NzI_41f2bdfb-ba60-41a5-a305-b46adc494835">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMjYyL2ZyYWc6MGRmOTQyZWU0MDE4NDg0MTljYWE5MmUwMWEzMDcyZTUvdGFibGU6YWM3MGMzY2EyNTFmNDZmNTg1Y2Q1ZWE2MmE3ZWNjNDEvdGFibGVyYW5nZTphYzcwYzNjYTI1MWY0NmY1ODVjZDVlYTYyYTdlY2M0MV82LTEtMS0xLTI3NzI_69a88403-c746-4cb4-b758-7cab550eb51c">0001773751</ix:nonNumeric><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMjYyL2ZyYWc6MGRmOTQyZWU0MDE4NDg0MTljYWE5MmUwMWEzMDcyZTUvdGFibGU6YWM3MGMzY2EyNTFmNDZmNTg1Y2Q1ZWE2MmE3ZWNjNDEvdGFibGVyYW5nZTphYzcwYzNjYTI1MWY0NmY1ODVjZDVlYTYyYTdlY2M0MV83LTEtMS0xLTI3NzI_ca9a14b2-a55e-4cfb-b1d1-4e6d63bd0eca">12/31</ix:nonNumeric><ix:nonNumeric contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" name="hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjExMQ_0328a105-577b-490b-8bab-4760962a29c8">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i5675e635aac644dca3d94839ad1ea8dd_D20200101-20200131" name="hims:LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ2Nw_b7a72c41-6787-457a-a407-941a4bba5358">P3M</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="ia971f9ce30c04ca082f9fb3fa86a9e3a_D20210101-20210331" decimals="5" name="hims:ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNzAxL2ZyYWc6YjFkMjc3MTgxYjg0NDRjZWIwNzlmNDcyNjAwNzVhMjIvdGV4dHJlZ2lvbjpiMWQyNzcxODFiODQ0NGNlYjA3OWY0NzI2MDA3NWEyMl82MDQ3MzEzOTUyODkx_bf904728-4925-4853-8e3f-51d1ebf8390e">2.083</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ibc84ee6d825b47e9b4399d92dea27b78_D20210101-20210331" decimals="5" name="hims:ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNzAxL2ZyYWc6YjFkMjc3MTgxYjg0NDRjZWIwNzlmNDcyNjAwNzVhMjIvdGV4dHJlZ2lvbjpiMWQyNzcxODFiODQ0NGNlYjA3OWY0NzI2MDA3NWEyMl82MDQ3MzEzOTUyOTAz_83b04c4c-17cd-480b-b047-96f25e3f4fc9">2.083</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hims-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2194548550b7484685726895d99493c1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2edfec64c15947d89d7391ae34a7c55c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1b1cf446284148a4ab9d5ea405db014a_I20210514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida06d917140d461e83e2c6831d4ef512_I20210514"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="iae89e874aad64f008fc6334367e88e92_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i739ad782f5ac49639074bf72004c4e5f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad3d9f1d28194144988117c8661db3c7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="if163a4f44b68493db66e067e3b8486e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64997c5f30d84597aaf8c79404b17e9f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43c7f88bdd024bed8ed820a0bbf53b11_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7fedba8f2404efe9b39de971e70cf0f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassFMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i792d7143c7e54d839bf9f447a23d5618_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f47e3f1375b4282b2f716b16c7f63c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib87290b070ee4c958c8ad766257920b6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6ed049ade5b4240a293550a94b55de3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fe00541b18143fba9a548d496dfb366_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec13139dbbe74ce284027b71cc7aab9c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie22663228da14a50972ddb2d671033c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cb115824ec34508bcd4a4a5cdc3f9da_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i417d0d1092d44ad0861530bdff9221e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60ca4e5da0f14565ac395c1f2874530c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i066ff8ea972a49dd9ad1c4f332e6c655_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i735114ee932b44528649a12d298232eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ffa9196bf234ff0ade6790ed45d90db_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffd6f90426014cc5a2a7167bb4a3601e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbecfcc087fd493a80b3a69f6a762834_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72a366adb8ae4f1aa5df0ef732686620_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41f7b9d6eea64578809c722be8aea527_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30ada711d000420db9e5a73ad2e2418d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ClassACommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5ab3e0ebc1e499ea3db5fa26f8b9bc4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ClassACommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie89592b066544281a07fa0169e98833d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ClassACommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4af486b04aad4f14ba113a2fa6b2ee94_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3078188fe78241078c8c9e6b9eed4bc6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7de8dcbf04c4bb6929b04fe9ef68802_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70660543ef984629a669e4c2774e2da9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i791a884a65994079a567da0a06e4cbec_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91a3849afa9e4008b0e42c13bed395ca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6afd3e44df984fe7827f7001bb384073_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia261e8ec32d348948aa7c247ea90ba34_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9806e71b0929497bb5027bab7cf4a37a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib85fb22f79d9475787326d65ff2089e0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i576de665f4e84b76bc7bb8d9ec493671_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f3746a65e7d4ed994c942a878cb3d7d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib224229727c244f7ae39e55c0c9df44d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3eb3a4c78e24298b72949d4acd6af55_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i313e801028b74041921b6b37ca22f649_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fe027cba4b74bb3b95477816832e680_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idba21161446c43ccbb9debeea82200bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47c21ce80c1947b39ed2fbaafbb5bb80_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i373d7d08dbe04fb9940eabc42c50f83a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01b2ce787a3a4bc9884c22437e0f804e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14063932285a47baaf67a27317285b57_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d1aa65fad4a4c2088e713c20737e7ce_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95f1f52b2b1b4200bc65210a3f67c839_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i498b99b9de474e2f9144406648261412_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c79493c43ec4a598105cec06fd2dc82_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f0a47c2a80f4fe0b4cdc6aa3b46a0f0_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb00a578313e4482a66c59493f18d456_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65862cdd601d4522a8afad352086cb6a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b4a0fdda9fc43a19cad6464963b6377_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e26fbeb5863440e9e721a1313cd6a22_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib46889ae15794ea6a849b7097df17e70_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebaa49281ce34f088dcc3e920092930e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93e3fc5bb5ed483ebb7e411c2c1b86a3_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i859fee6b0b4d4ef1bf57cc579f3ad5c1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c64c701476f4358a5a5c9d9ea2fdf8a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c4f929ec7804d5ba080985386fb1710_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa8987c19e604874ab033feedad56d43_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f815b2e739d41ebafd5da94bf4c8d6a_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1681a4a94614a62ad87dae150f2220d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie87d3610f2c94903a4a299c11f9d0cc2_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i541d26427048423291dfa7496890fbfa_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i2c9f921c782846e594e898a25a3e7e57_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bdb1af208e14b2ea352fb5361c65042_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i533a6c1123d5402bb7487743cb056ecc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i932569e05a89431ebc34c4b51b14c702_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23ddbd3a57cb47d2b34bef8d1093c90f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ce0c2a663404279ad0d0d1d6271d369_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c3a9475a70b4c2db3d6e0010a374a0e_I20210119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hims:HimsIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35a4fb924db24a85a1196789003372ba_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ee826f19c8f474091f7807831d1a4a2_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if23c020d049c42f8a21888c7cd351bf5_I20210119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hims:HimsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5182198da4045b7a12388e80e2263ab_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ffc7b3d75784438b282649862e9f57e_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassAAndVMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ad8096dc8594c04b77015e5c84c1bfd_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hims:HimsStockholdersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ParentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if85b92e8012f4f1593f4f90ae859fd82_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hims:HimsWarrantHoldersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ParentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16335511aa6245258d50e49bba22ab99_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hims:HimsOptionAndRSUHoldersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ParentWarrantRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:context id="ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16bc3ab7ee094ed08651067218f9050a_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35fc17d5154d40cda4ba3221e9dcffb6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd8ae28174c74bcbafe8e1b9e1296cad_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b386e439e1545bb8595dd4c08d832e1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d5c88b35bfb47219cf7c806d06b403f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib82714ac40bb439a93d73928f1f21331_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6806d600b8f3488bb1c3fd3461c854a1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i110e767e14c549139091e08b11477a77_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hims:AffiliatedMedicalGroupsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib74f24447d164fde8a5bd9a5c8151c3d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e0a54203ace4daf8d031a96662b2a6a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f396a9dac504e31a6c12e06a6f5e451_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2df3bb0701545b6bfc7f10a7ab86773_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d3aa17ad4214d73ac617595f9b25c56_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17f7c6fe28314265a7171dccf5d0b1e1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1261279d3aa492883efe6f3cd396cb3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3f6c0cccb1747fab4662fd836029d53_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0da6465d5cfd441a8e436e127aad5c7e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice63ea8cf53844e0864c120028d72122_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib363310ebb4645b0a3c4dd9026e8460b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9857a89a397463b9c65163424b97b37_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie581b89d86bb4b27a922377f19e8768c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibaf57a370dcb4f3194869f3b6b0cc8ef_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccc37ed1bbc44e95b445c711db6f3652_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3447faea2aa041928f7c8b0073fbfa56_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e36e9ea2b4a410389a76edfd4bc808c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id21bfa4e61b64d21b588aa675df6b00e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5551c8f434cf4e9996e3e103dd9851e3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dd0cb9d9b154483976882a2f8f17dae_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d5316cfa402448b974312f0f0bc26ca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i77245f278ab24e148fb7d4fc5d3b59fc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5921abd0287d42bca47601e3138ee2b7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e49409a01d64ff5bfdd179b67b5738c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id215004884234f36b4e29d5e5c970035_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i951242edbea04ed9a606420d62e43d5a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i331c1c09758e4c69a36701bae87d7d62_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5563144fb5ca4783b8c91e836f518044_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie21b17ce9282470780a4cb69a30b093f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabbb558f9a6046f6a6d5d46c8153d18b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccdf1b1af9d34e62a5785c63d9ca448c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66b86854e56b4e96a87ecc1cda0a4203_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44535c1c0c1942a59dc7b0356127e67b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie21c138cee4747ccb68c72561e6a795b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i412599e663c246f58192d84fe4e5c1b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ad3e5023fd84a749114f9e9c5d8fe3a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31da51b8ef1b4471a68135a9ca41a2d6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfd5ade4260a4169b2a95d7bff1b3555_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id759fafd0df14ae7b07a52edb22e1ca9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c4a1baeea1040a6bfbcedb38a9692e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e6e3cda27214222b2b0bfe2a6683419_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ed5940103494fb785ddb8f61a51b123_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifda94c6105694420b4c8f321805f5ce1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5013ddd007d4531aa596bb95e66ae50_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5e442e5c43548c4948861619534ee83_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia16cd32451554ee58bc61ba0bd167f4d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33b128102f77412aae3acc936185d672_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99e1a4138a1e4cb69b365d76305514e5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c40d2b1b9bf422baf436e98c75a1c04_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f48df72d4d24ae497a675ff9cf956e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7308d4762634cee8d9041732b9af184_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eca143c66bf4203b6157bcac25d255b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25ea3f8831144795bc21e4c954d3d744_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fe48b31f8c34e88b6668252c5babd68_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1c7658a139f475181f2d9be70639547_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16613643ae1546028149b3da23f7a029_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bd82762a6b54ce086b7a833cdd8431c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic900949695af4a3f8a0e43ab44a1d546_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf3e680104bd40d0a6d893fc9d407cbe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16c0164539c14d3c8ffaafa97bcfab89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e62e51bd26b485eb7df23994a15198e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i987f47d6dcfe4bbcac41361b3f772407_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3283d5498c749f187e436d50e1f4646_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PrivatePlacementWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f384c5987114c539e4c3c37fe1f66ab_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fe856ce18a44b73b24c2b3b20e78100_I20191127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b82495f9a7d49a191625811b12a3abe_I20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02b56d69d02b40c8bb34acbef31e8a91_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a251b644bc0446c8e735717fbf04f53_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a8d0ab00fc54564bf744ee2cdb48474_I20191127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:BusinessCreditCardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68341f8644ea4e029489cb67df2b60c9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:BusinessCreditCardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0973a5a47b37445789cae6d5c00e8ead_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:BusinessCreditCardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a1bd4b3c5cf421eb59bc006d40c812b_I20191127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:CapitalAgreement2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d494bd599bc4c71829076ebfffdde40_I20191127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:CapitalAgreement2019TrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36b5c8248a21411787d87df95d270d0a_I20191127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:CapitalAgreement2019TrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b388341898d4c259124f7ad120acc5c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:CapitalAgreement2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i75207e8547a1486e92e7339599496592_I20191127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:SeriesCPreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85017d290ffd4ccda16318d642b40261_I20200312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:SeriesDPreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9325ba192ff34fe4a7eec3cc7c4f7351_I20200312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:SeriesCPreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5675e635aac644dca3d94839ad1ea8dd_D20200101-20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="i4d3f4663a5ae4f998ff2c4ed33cc4b76_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hims:NewAlbanyOhioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icea812223fa644ce962e9076a86b988e_I20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d8a878dc739415b9ef43d3cafdddb47_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bc5c0ad0d79476dae92187902b6a0c6_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:StockPlan2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia94de2a141c34d8faee9c47c63a6c366_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i413bd17d5b324a2dad4f4ea75d1247df_I20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:StockPlan2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1fd5fc3dab941e482cf5873aed90062_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48ef13256a85415e97d20a62c058228a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:StockPlan2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d283ed598c04971b9439dd96804192f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020And2017StockPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee0a496af430479f9dfecc7ffbe8ba33_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020And2017StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8906c1a545c9405d8f6cc203bc4d9e99_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020And2017StockPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia971f9ce30c04ca082f9fb3fa86a9e3a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementNewEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i576248ed4b664370b9a1e90f22918f91_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementNewEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc84ee6d825b47e9b4399d92dea27b78_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementCurrentEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2adc14d58e77476fbc6512ca96906059_D20200617-20200617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">hims:June172020GrantOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-17</xbrli:startDate><xbrli:endDate>2020-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06c257b7b4f84b529f577d3f4aa15ac5_D20200617-20200617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">hims:June172020GrantTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-17</xbrli:startDate><xbrli:endDate>2020-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32f3c2ba40fa476fa312666156c0f69b_I20200617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">hims:June172020GrantOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11c5ad145e504aa281087775310908bf_I20200617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">hims:June172020GrantTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b379b532e70492d8cd6c9d96f11613d_I20200617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia49cabd9f3a84ee39cb1386e25c9b760_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafad2c662fba4af0b34bd67db2d592d9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">hims:June172020GrantOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84f2f42c202744b7b7bd251ae54caaf7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3fd0dc602f14c74816bb2d095c72cfd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia619e550a49a42d88028da0bc367d495_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07699e94c1ff4e72b8336fc2d39e4b76_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56db4fe025c047fd8e6046a280f8d46d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3569cba9a27b411f87207bfe4f13c768_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icae0610134ea412ca26835b3d027983b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0764a9f39d15480ea6a5fd912a15958e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8154d378681848c08666cc454aeba717_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange006To040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i296427d49b16444e90fd07050ceb45e7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange006To040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07019c3dea37410ca1b9e81a814fc572_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange155To233Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91a56879fe24414495c14c13ef54b061_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange155To233Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i962be1bcc7954ffd848d65b2af00d37f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange243To365Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia020c048cca142b09ded25121b0ecf0f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange243To365Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0109a582058c4a30962735b0ef17b42f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange890To1335Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia30281f381f44828904e830e15c11803_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange890To1335Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f39e7f28aa44acd97c7381291e6f1ac_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange1517To2276Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85a98bf3e25f496e9e070d45dc8dbe79_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange1517To2276Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id23bf3f94c8841a693c2abb9dbea49c4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>hims:day</xbrli:measure></xbrli:unit><xbrli:context id="i6a9e72571629466e95f463c7efbcbd98_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a6191f600fe4f5bba54740cfed54748_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20ea7b45ce3547e9a8128fa8a07b9245_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e017683d1224a57bcb05400dca67f22_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0fd3b92233841f09e31e1c59722c266_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:EarnOutRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f37e4e1d6084fe096e662b5ab77aecd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:ParentWarrantRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i618a5b5ebba449e4bbe23551147cf295_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:EarnOutRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac9c5c2612043669180344154fb064a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:ParentWarrantRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42057812c3884143b23614f4764c8109_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fce2bdf00214d74b06a4e34ca921b88_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:EarnOutRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51fbf31cd21a496f8b77b769104642ea_D20210101-20210131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:ParentWarrantRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05f1d9f417c54e328597f093403d6e89_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i881daecfe2934b7cafec114097e28cd3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfb2bd7ccded4f77ae1362ca9d0a545a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14f486b4660647f98f37f78e924341b0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2886207377754f8d893c27f2490298a6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98bfbbb5e3e147e3889c062c610a6917_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:EarnOutAndParentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a91c65f7eb54a3c989d98b6cb6a18a8_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hims:MarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b7f6544633643809b6705cd0e2ede0d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hims:MarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie769ad9b07ed4265a9edfbcfccff5ae1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ad7aa6b76124ad6ae3961610c692d73_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesSeedPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00d3c217869a498ea1da4262db18091c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesSeedPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id285b35ca96643e8a5dd6301ca706b17_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dab5dbc93cf444c956b2f47e4145d28_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i973de7d14a4c409cb16e8a6b8963bff5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie241c9b58b1b41c5adc333a98cfa439d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesA1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c496814f30146d2a8fffa0636e6175d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec02bacd134949c3a43d4169ef4a503f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea410e7929fb4ea4866693138775bce3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesB1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i310c211669824a0ebd4e0cbbfecbee8c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesB1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia620070bccea49e8ae67e495e7cd6630_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesB2PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36e32a096ad44dfab36246420544e57d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesB2PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbd0e86a85204fc19e2e004fc1ddae21_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90721555cbdb4b9e88888fbf57039262_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01d6bc7c49f14a5ba7fec5954dbe1334_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30440e6cee814b0795a79b39d6cc3d7f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i482412508e5048348a66e153dca18c8a_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07ad18420cfc4998888024c661da561a_D20200301-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie64d700f04004ca28cce3f10ce2c702e_I20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:SeriesCPreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia535ce992e724f86a62e762541499dca_D20200201-20200229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-01</xbrli:startDate><xbrli:endDate>2020-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c24e39c91df42cbaed7932bf65e2d02_I20200301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0f34e27b5684e27b0de10fc97914074_I20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:SeriesCPreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="common_stock_class"><xbrli:measure>hims:common_stock_class</xbrli:measure></xbrli:unit><xbrli:context id="i8d64fe4256a5495dac515af8a61e6773_I20210119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i080dafd9e34b47e7937c78d08d32b686_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41048193847540548f3ba7ae46d9623e_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2089a56369e04eacb54344b55b8e03a8_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:RepurchaseOfStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hims:FormerExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26bd1b4cf75e452991194f1a1a3d5cac_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46d371e52a99410f95f88ff85bac410c_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cc1f5f00f854fd696092abbe8e5eb52_D20200701-20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18d3dd2a0dd54782ac27fc6a98050d65_I20200731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56a3708962c641f6884526a28a764d6b_D20201101-20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsGroupOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70b4853509034ba8ac52e45689f9837d_D20201101-20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-01</xbrli:startDate><xbrli:endDate>2020-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5454149a7fff446f86e9e1f46fc3ecb0_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsGroupOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iead7fc49159344e09cc08f0243c9f687_I20201130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7096ecca3bf42abb946e3f881384b0a_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsGroupTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6fee565f9384a378a7733102fb1daf9_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ff37ff4f4e94c939d22f573f503c48b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsGroupTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d5d169b09da40e69a931bb98ac54af4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8f09575a6074fbbbea2128ab741a987_D20210104-20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-04</xbrli:startDate><xbrli:endDate>2021-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i069f663c8a004fdfbd4a509b3f54b8d3_I20210104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i342bdc4fd0584aca99f4b91a317c0acb_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib55d8e031f574c38bb95ca3aec87d1bd_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6ac477b8fba4a68abf0f1384d4e9f3e_I20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ParentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab13a99ae40f48409e0e1f3fd36fa413_I20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c70da65b2cb41f68da444e9a69d66ae_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PrivatePlacementWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79825d4c5b744870999e9bde3e8537f5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7376dfd331f74bd0b77f3b369c1c6b2a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:DebtWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i843814f57f6e400fa68052b3160a60fe_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cc2663250444268a356d3527951ceb6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ParentWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0929992266364d4095e65e0383a160d6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54b4437d5bc64dd09ecb5bab58c279ad_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsWarrantRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2867394843aa406ea9a5eb734f9b7751_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsWarrantRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65b1285ccd8544e6ab3ef4189e9e2fa5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsCashRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98e637f1336e44e5af203fddfc5974c1_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsCashRedemptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i771a07ec099545b09a6b92170d11d935_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d14d0c90a8548aa962fa7748b3135a9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb1c06dc151e466aa6cc22295c17a714_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:OperationalSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1a302a5f05545f79eca24d49954e1cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:OperationalSupportMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i312fd18031e24c0390d9be5de157fa4e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:IdentityVerificationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i638236725896454da1131afdbb4606ed_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:IdentityVerificationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i922947682b4841668dfbfe65e252e019_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:IdentityVerificationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if227b428e44f45d982ddcf68a4372138_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:IdentityVerificationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02a8feb03ad34f34b5b703765d4c44c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:NonrecourseRelatedPartyPromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if04cc3c5ee874113863826cf1cba7153_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:NonrecourseRelatedPartyPromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadf5123ee59348dda3e8699ab30bad2c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:NonrecourseRelatedPartyPromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6b30bf8b001432a828df2ce3d0da827_D20210120-20210120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:NonrecourseRelatedPartyPromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-20</xbrli:startDate><xbrli:endDate>2021-01-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic59ae3ede9fb4cc19a25f9ae9330b9c1_D20190923-20190923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hims:ChiefExecutiveOfficerAndDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hims:SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-23</xbrli:startDate><xbrli:endDate>2019-09-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a589e0752164dc492e454a20349d082_I20190923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hims:ChiefExecutiveOfficerAndDirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hims:SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic37899a64fdb4b35b8953afb27a19de6_D20190923-20190923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hims:RedeemableCommonStockTransactionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-23</xbrli:startDate><xbrli:endDate>2019-09-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aabfe45198043d3a411876caa90f87c_D20190923-20190923"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:RedeemableCommonStockTransactionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hims:CEOAndDirectorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-23</xbrli:startDate><xbrli:endDate>2019-09-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassVMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i757faef54662457b89e18e28fb99922d_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6168af5421b947c983b702984f8157bc_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassFMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i442b98b30a99440cabcf9c2a33258c44_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hims:StockOptionsSubjectToNonrecoursePromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib288e8afaab1439aa8563d67d92545a5_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hims:StockOptionsSubjectToNonrecoursePromissoryNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie88ff03799b74ad5965527925463ef9a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hims:EarlyExerciseOfStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a72b9ac461b4533a1192dda838f4fe4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hims:EarlyExerciseOfStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06d6c621d2034e6dafae9bcb378bdff9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92de8792f23848c58e1d809553528fd6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecae2ba52ea34c6892d78a05a039922b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c000d18bcbb4f6281442b9c9affe5d1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie90befcd560f42a9bf949f5bd7f3347d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eb6f513a1aa4980bc4049b422e1e15b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44f09386b1fe4221a24a4ffa57406c7b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c9d172982e54c3dbf74e0a823776639_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7772b0e6965c459ead748797e372c5a3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8196ddc57e7a4bfab7217e738f15cb7a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001773751</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i412093a93f204328a33c4602202f8375_1"></div><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:174%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTE2_c65aff8c-9bf8-4cde-9f73-2543f6a09214">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTIz_d11a62f1-eb7f-416c-839f-14bae9545d11">&#9746;</ix:nonNumeric>     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">For the Quarterly Period Ended <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF8xMjA5NDYyNzkwNzk1OA_ba8c119e-49e4-4508-b932-5ea2b23930fd">March&#160;31, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">OR</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTI0_f6dde443-4b61-44ae-aa6b-b339ae2c2d36">&#9744;</ix:nonNumeric>     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to ____________</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTI1_57887616-e9f5-47b0-9869-cf2f24effe30">HIMS &amp; HERS HEALTH, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;(Exact name of registrant as specified in its charter)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"><tr><td style="width:1.0%"></td><td style="width:28.482%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.525%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.030%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.556%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6OTAzMmNhM2EyMGE1NDQ4NWEyZTJiY2U5NWI3OTIzYjUvdGFibGVyYW5nZTo5MDMyY2EzYTIwYTU0NDg1YTJlMmJjZTk1Yjc5MjNiNV8wLTAtMS0xLTI2NjE_01474a30-950d-43a4-b313-eee64b794e6f">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6OTAzMmNhM2EyMGE1NDQ4NWEyZTJiY2U5NWI3OTIzYjUvdGFibGVyYW5nZTo5MDMyY2EzYTIwYTU0NDg1YTJlMmJjZTk1Yjc5MjNiNV8wLTItMS0xLTcyNzE_91202bb5-1c91-40ad-b22d-a9014bc29c8e">001-38986</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6OTAzMmNhM2EyMGE1NDQ4NWEyZTJiY2U5NWI3OTIzYjUvdGFibGVyYW5nZTo5MDMyY2EzYTIwYTU0NDg1YTJlMmJjZTk1Yjc5MjNiNV8wLTMtMS0xLTI2NjM_f2a3034d-1655-4ead-b955-00d9bbf65a14">98-1482650</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.886%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6YjY5ZDcxNDY4YTcyNGQxNjk4ZjNjOWYzNDU3YTYyMjUvdGFibGVyYW5nZTpiNjlkNzE0NjhhNzI0ZDE2OThmM2M5ZjM0NTdhNjIyNV8wLTAtMS0xLTI2NjU_a6119a99-6731-4e9d-81fb-48305b66a982">2269 Chestnut Street, #523</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6YjY5ZDcxNDY4YTcyNGQxNjk4ZjNjOWYzNDU3YTYyMjUvdGFibGVyYW5nZTpiNjlkNzE0NjhhNzI0ZDE2OThmM2M5ZjM0NTdhNjIyNV8wLTItMS0xLTI2Njc_ec99c5d9-f1bc-41bc-9816-f4d55ec603ce">San Francisco</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6YjY5ZDcxNDY4YTcyNGQxNjk4ZjNjOWYzNDU3YTYyMjUvdGFibGVyYW5nZTpiNjlkNzE0NjhhNzI0ZDE2OThmM2M5ZjM0NTdhNjIyNV8wLTQtMS0xLTI2Njk_f0c3ec3d-9698-49fb-b552-cb9e714bb008">California</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6YjY5ZDcxNDY4YTcyNGQxNjk4ZjNjOWYzNDU3YTYyMjUvdGFibGVyYW5nZTpiNjlkNzE0NjhhNzI0ZDE2OThmM2M5ZjM0NTdhNjIyNV8wLTYtMS0xLTI2NzE_88de16d1-1208-4d14-9b52-54d1a96b542a">94123</ix:nonNumeric></span></td></tr><tr><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive office)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(ZIP Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTI3_85fac8d1-32a5-4b55-8f02-7451c34b9738">415</ix:nonNumeric>) <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTMx_24037ea5-463a-49ef-8b34-d9c4c339cd1d">851-0195</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:35.649%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18xLTAtMS0xLTI2OTQ_528b2d90-e9f0-4f17-8396-ffcb962ba484">Class A common stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18xLTEtMS0xLTI2OTY_c6a65eca-cf23-4a7d-bcce-f2ee2debda30">HIMS</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18xLTItMS0xLTI2OTg_fc67d1fe-908b-4b11-bcaa-906d80f82e77">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2edfec64c15947d89d7391ae34a7c55c_D20210101-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18yLTAtMS0xLTcyNzM_3fd44c7a-ad8b-4b75-935c-f2889b43175f">Redeemable warrants, each whole warrant exercisable for one share of Class A common stock</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2edfec64c15947d89d7391ae34a7c55c_D20210101-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18yLTEtMS0xLTcyNzM_a55ac6de-043c-435e-b9bb-2c543c2d8c56">HIMS WS</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i2edfec64c15947d89d7391ae34a7c55c_D20210101-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18yLTItMS0xLTcyNzM_51c1fe5c-3062-4a40-8b6d-ada8cab6dad6">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTgx_99fed404-1a7f-435d-b082-d0cecbca21ee">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">  No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTgy_ab869d57-cc27-47d9-af16-00f1abcc5d5b">Yes</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer", "smaller reporting company", and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Large accelerated filer  &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated filer&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTg1_cac148a1-f7c0-4208-a2fc-ee78bb06a08a">Non-accelerated filer</ix:nonNumeric>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Smaller reporting company&#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTgz_c67cfc0d-4189-41fd-a60c-ec9aa9454a35">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTg0_3f3d0e54-5100-4ba1-9d11-c63af23a6f94">&#9746;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1Njc5_703683dc-a51d-4e74-bc52-962c2ad9249e">&#9744;</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Yes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" format="ixt:booleanfalse" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU2MTIx_129f49e5-0df2-4495-ada0-81a151703a74">&#9746;</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of May 14, 2021, <ix:nonFraction unitRef="shares" contextRef="i1b1cf446284148a4ab9d5ea405db014a_I20210514" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU2MzI2_dc1d9809-66e8-4b0e-b8b5-5b2090d61403">183,424,155</ix:nonFraction> shares of Class A common stock, par value $0.0001, and <ix:nonFraction unitRef="shares" contextRef="ida06d917140d461e83e2c6831d4ef512_I20210514" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1NjY3_2fb2db8f-aeb1-42de-811c-b0785c39fe46">8,377,623</ix:nonFraction> shares of Class V common stock, par value $0.0001, were issued and outstanding.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i412093a93f204328a33c4602202f8375_4"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:93.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.757%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_7">PART I - FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_10">ITEM 1. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_10">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_13">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt;text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_13">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_16">Condensed Consolidated Statements of Operations and Comprehensive Loss</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_19">Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Deficit</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_22">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_22">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_79">ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_79">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_106">ITEM 3. QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_106">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_109">ITEM 4. CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_109">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_112">PART II - OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_115">ITEM 1. LEGAL PROCEEDINGS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_115">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_118">ITEM 1A. RISK FACTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_118">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_121">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_121">76</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_124">ITEM 3. DEFAULTS UPON SENIOR SECURITIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_124">76</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_127">ITEM 4. MINE SAFETY DISCLOSURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_127">76</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_130">ITEM 5. OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_130">76</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_133">ITEM 6. EXHIBITS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_133">77</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_136">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_136">78</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_1712"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This quarterly report on Form 10-Q, including, without limitation, statements under the headings "Management's Discussion and Analysis of Financial Condition and Results of Operations," includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended, (the "Exchange Act"). These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes," "estimates," "anticipates," "expects," "intends," "plans," "may," "will," "potential," "projects," "predicts," "continue," or "should," or, in each case, their negative or other variations or comparable terminology. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not limited to, any statements relating to our financial and business performance, implementation, market acceptance and success of our business model, our ability to expand the scope of our offerings, and our ability to comply with the extensive, complex and evolving regulatory requirements applicable to the healthcare industry. These statements are based on management's current expectations, but actual results may differ materially due to various factors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements contained in this quarterly report on Form 10-Q are based on our current expectations and beliefs concerning future developments and their potential effects on us. Future developments affecting us may not be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under Part II, Item 1A: "Risk Factors." Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. These risks and others described under Part II, Item 1A: "Risk Factors" may not be exhaustive. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and developments in the industry in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in this quarterly report on Form 10-Q. In addition, even if our results or operations, financial condition and liquidity, and developments in the industry in which we operate are consistent with the forward-looking statements contained in this quarterly report on Form 10-Q, those results or developments may not be indicative of results or developments in subsequent periods. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="i412093a93f204328a33c4602202f8375_10"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div id="i412093a93f204328a33c4602202f8375_13"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In&#160;Thousands, Except Share and Per Share Data)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNC0xLTEtMS0w_a390ad34-194e-4fc9-a1a9-004a75e2e160">88,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNC0zLTEtMS0w_26b0ce6b-98b8-463e-87d0-631b046ac207">27,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNS0xLTEtMS0w_b0609661-eded-4a9a-8b6f-37fab63f4757">235,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNS0zLTEtMS0w_f3846d72-15bb-4317-96db-61db74685569">72,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNi0xLTEtMS0w_f17e983c-6a03-4917-b9e7-d9bed100d0bb">4,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNi0zLTEtMS0w_e5358291-d3da-463a-bbb3-52c9f739ae91">3,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNy0xLTEtMS0w_029a5dd3-4a95-4889-ba1e-73a3e7b610f6">12,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNy0zLTEtMS0w_496f6421-5ef6-4b2f-b23d-cde4fd5647dc">5,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred transaction costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DeferredCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfOC0xLTEtMS0w_b691da16-223b-4daf-8935-90bd9f2e2ae0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfOC0zLTEtMS0w_731b6b04-5fbf-431d-8039-a80a457a7b0b">3,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfOS0xLTEtMS0w_5417c964-cec7-4af2-aa4f-40fa16006235">340,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfOS0zLTEtMS0w_6411d817-e81d-4d1e-b3ba-11e98147a54e">113,084</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash, noncurrent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTAtMS0xLTEtMA_e8b7419d-9198-4088-928c-24b30f703ddc">856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTAtMy0xLTEtMA_ba9687bb-44d1-4a7a-91e2-80a8eba72982">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTItMS0xLTEtMA_4c56657e-8947-490b-83fc-bbe719f50905">4,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTItMy0xLTEtMA_1f0c3724-ac66-42f2-a9b0-382c386c98e8">4,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTMtMS0xLTEtMA_092002e9-f0c5-4709-ab5f-02824699e7fe">345,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTMtMy0xLTEtMA_d743235d-e48c-4a92-9d92-698106f8f27b">118,697</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities, mezzanine equity, and stockholders' equity (deficit)</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTYtMS0xLTEtMA_9d2de76f-1e32-430e-ab1e-dca343b77be3">13,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTYtMy0xLTEtMA_dcd8fa3a-4bd8-4043-9f10-d1ffb3dc4217">8,066</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTctMS0xLTEtMA_ba244550-e003-4fc9-a254-3291debdb92a">5,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTctMy0xLTEtMA_ab666d1b-0ff4-4cd0-88b5-fa677e80af7b">4,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTgtMS0xLTEtMA_b8dee365-de24-417f-9164-2c1963ce1f0e">624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTgtMy0xLTEtMA_77b18838-26d7-4d39-88a7-4d9f07127bfe">1,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3d9f1d28194144988117c8661db3c7_I20200331" decimals="-3" format="ixt:zerodash" name="hims:WarrantsAndRightsOutstandingCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjAtMS0xLTEtMA_7dbb9f98-c34d-44cc-9dfe-cdf2f0d41eb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="hims:WarrantsAndRightsOutstandingCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjAtMy0xLTEtMA_173c0e0e-8db1-4638-9fe8-ab5c1df246ee">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjEtMS0xLTEtMA_3b86675b-cdc4-49a0-b164-4708c4a2dd91">19,680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjEtMy0xLTEtMA_41714eb4-d28d-42ef-9d13-147578b5b78b">15,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjAtMS0xLTEtMjA2NzQ_17f029e7-d0a7-4558-a743-3250e20cdbfd">33,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:WarrantsAndRightsOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjAtMy0xLTEtMjA2NzQ_bc1c0416-4afa-4ca7-a0f2-ef202e1ab535">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred rent, noncurrent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="us-gaap:DeferredRentCreditNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjItMS0xLTEtMA_653e787e-79d5-46fb-b456-1b2821cf0ad5">384</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="us-gaap:DeferredRentCreditNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjItMy0xLTEtMA_e60ac8a2-d1f7-4183-950d-a666771aa2ee">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjMtMS0xLTEtMA_a031d5ec-dfa5-442b-8289-6dc35cd027b5">53,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjMtMy0xLTEtMA_7a045a39-59ab-4db4-ab48-bc2d687fe7b0">15,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note&#160;11)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjQtMS0xLTEtNTQ4Nw_41e35655-c986-4914-9e2b-1b5c3712ad16"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjQtMy0xLTEtNTQ4OQ_a39d27ec-56b1-4205-88b6-ce0194dab6b6"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mezzanine equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:26.64pt;text-indent:-8.64pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock&#160;par value $<ix:nonFraction unitRef="usdPerShare" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzI3NDg3NzkwNjk2Nzg_1b09cc17-9252-490e-9739-06bdce5b23da"><ix:nonFraction unitRef="usdPerShare" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="INF" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzI3NDg3NzkwNjk2Nzg_52dbb9ac-d66f-44e3-8fbf-ea1f632abb16">0.0001</ix:nonFraction></ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzI3NDg3NzkwNjk2ODY_717f8f3a-aebf-462d-b85a-f4c01e106f8a">275,000,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzU1_1f900fd6-195f-47f0-86a9-e8c0d8937827">95,997,674</ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzYwNDczMTM5NTMwNzk_17949646-a662-4e5b-9561-d4bd5f41c4a2"><ix:nonFraction unitRef="shares" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzYwNDczMTM5NTMwNzk_78f20977-fafb-48d1-825f-a6b242a5ad82">nil</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4Xzg3_0f1aaa1c-7411-49d2-be9a-501e5b1e8fa4"><ix:nonFraction unitRef="shares" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4Xzg3_bfdddda2-9ee6-4340-b747-a3a96cf7d830">93,328,118</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2021 and December&#160;31, 2020, respectively; liquidation preference of <ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzU0OTc1NTgxMzkxNzU_1538c5db-48e5-4a1b-ab43-15e60b70bed6">nil</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzE4NA_749dc0b4-3c49-48c7-aaa6-2dcb3ad15a6c">268,452</ix:nonFraction> as of March&#160;31, 2021 and December&#160;31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMS0xLTEtMA_fbb430a9-a2da-4cac-88c5-3abf32ff6250">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMy0xLTEtMA_97536cdb-f18f-4044-b329-08a5d5488aee">249,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total mezzanine equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjgtMS0xLTEtMA_7c2b70d4-1953-40c3-b1da-4f1846d8d227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjgtMy0xLTEtMA_a5c29f35-1d63-48ac-9c6d-df3177bfa95e">249,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' equity (deficit):</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:26.64pt;text-indent:-8.64pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock&#160;&#8211; Class&#160;A shares, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="if163a4f44b68493db66e067e3b8486e6_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk2ODk_c4eae99a-0fb0-48a3-af0e-7f2ff1cf46b6"><ix:nonFraction unitRef="usdPerShare" contextRef="i64997c5f30d84597aaf8c79404b17e9f_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk2ODk_d3810aa0-0476-4519-88ab-25c871854f8e">0.0001</ix:nonFraction></ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i64997c5f30d84597aaf8c79404b17e9f_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzQ5_4b31c3f2-0b60-41bc-b131-9cd36c93d194">2,750,000,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if163a4f44b68493db66e067e3b8486e6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzU2_6830f3c0-47e7-49a4-b42e-ac33f9c4d22b">166,696,759</ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="i64997c5f30d84597aaf8c79404b17e9f_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzgx_6561dd21-a4c2-4f96-be04-a4ba0eb92105"><ix:nonFraction unitRef="shares" contextRef="i64997c5f30d84597aaf8c79404b17e9f_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzgx_b02ed279-b88e-4caa-9a46-ee233b90f8e4">182,973,780</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if163a4f44b68493db66e067e3b8486e6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzg4_2af8836d-619a-45bb-bdd8-8bd2334f0bac"><ix:nonFraction unitRef="shares" contextRef="if163a4f44b68493db66e067e3b8486e6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzg4_be3ba1c3-aa0f-46aa-84f6-25fe09aa7783">46,025,754</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2021 and December&#160;31, 2020, respectively; Class&#160;V shares, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i43c7f88bdd024bed8ed820a0bbf53b11_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk4MzA_c2086ed5-0de3-44af-9692-cef4d34bf6e6">0.0001</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i43c7f88bdd024bed8ed820a0bbf53b11_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzE4Mg_80122822-9dcc-49c5-aa69-1e6f16e9b6b5">10,000,000</ix:nonFraction> shares authorized and <ix:nonFraction unitRef="shares" contextRef="i43c7f88bdd024bed8ed820a0bbf53b11_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk4MTY_1b7ae545-bc3d-4e0f-a4d3-b12867f60719"><ix:nonFraction unitRef="shares" contextRef="i43c7f88bdd024bed8ed820a0bbf53b11_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk4MTY_ae7d7089-00d0-45a1-a0bc-070f685cd87c">8,377,623</ix:nonFraction></ix:nonFraction> shares issued, and outstanding as of March&#160;31, 2021; Class&#160;F shares, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ib7fedba8f2404efe9b39de971e70cf0f_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk3OTI_4a1603bb-acc2-408b-9cb8-f466286295af">0.0001</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="ib7fedba8f2404efe9b39de971e70cf0f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk3OTY_6abe3664-4d40-447a-8c97-3bb69f27e7c4"><ix:nonFraction unitRef="shares" contextRef="ib7fedba8f2404efe9b39de971e70cf0f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk3OTY_9c8701a9-d085-47de-bdee-f1fadae4d279"><ix:nonFraction unitRef="shares" contextRef="ib7fedba8f2404efe9b39de971e70cf0f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk3OTY_e5707362-5ab8-495b-a078-8d91028d4da9">6,941,352</ix:nonFraction></ix:nonFraction></ix:nonFraction> shares authorized, issued, and outstanding as of December&#160;31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMS0xLTEtMA_7c18229e-74a0-4efa-a791-2d00868e5fb0">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMy0xLTEtMA_38a7127e-4cf4-4220-b467-1268bb5e86bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzEtMS0xLTEtMA_31a75e02-6e1f-43f3-9e01-94683793b8c3">515,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzEtMy0xLTEtMA_4b73d495-3dda-408f-834b-3cdcf3298f04">24,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzItMS0xLTEtMA_d77b17c6-2468-44fa-968c-7ec02d8739a3">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzItMy0xLTEtMA_e8828ded-4397-41da-8109-18ad15b29428">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzMtMS0xLTEtMA_eddc1482-fc75-48cd-a314-34a9d757ae7f">222,696</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzMtMy0xLTEtMA_1b183392-e6ee-4791-b2cf-75e2a71c93c7">171,292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity (deficit)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzQtMS0xLTEtMA_bc526cd2-e51a-45d7-b7b5-aa0dab5608d2">292,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzQtMy0xLTEtMA_b909a948-a84e-4bdb-a9ab-61c72605f700">146,874</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities, mezzanine equity, and stockholders' equity (deficit)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzUtMS0xLTEtMA_238dad0e-7490-4524-8455-17d9f60e69b5">345,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzUtMy0xLTEtMA_7964f4b4-e5ad-4318-a8cc-a72307075c68">118,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operations and Comprehensive Loss (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In&#160;Thousands, Except Share and Per Share Data)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMi0xLTEtMS0w_0ac469aa-e162-4868-a4a6-689000431bdd">52,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMi0zLTEtMS0w_9e8cb811-3278-4e15-9315-84165e55fe40">30,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMy0xLTEtMS0w_42d6e1ad-229d-48fe-b850-c8823d3b0218">12,067</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMy0zLTEtMS0w_ae2c7b92-c18e-4f58-9c6c-720c37501ed1">9,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNC0xLTEtMS0w_9138f1a2-5d8e-4046-a7e6-8c16b276e8ac">40,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNC0zLTEtMS0w_5bcb6194-8d0a-4327-8125-27da293ac1f1">20,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNi0xLTEtMS0w_943109f3-0323-4240-a5b8-e4884d5b64ff">26,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:MarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNi0zLTEtMS0w_4fe625e9-6a65-4a15-ba07-4cb85a26f809">12,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNy0xLTEtMS0w_691ab159-6b8e-4b4b-848d-fe56cb58a564">61,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNy0zLTEtMS0w_94376419-49a6-4030-b488-d88f3bb7e85d">14,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfOC0xLTEtMS0w_f06e54d6-c0e7-4a4e-a2f8-c50f6eb03537">88,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfOC0zLTEtMS0w_2468ea41-edf0-44e2-8a12-406faf90d49c">26,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfOS0xLTEtMS0w_30b638dd-2c7a-47cc-9ad2-aaed48e6fab5">48,409</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfOS0zLTEtMS0w_66ed8991-f75a-42a2-8b13-05ed6b76d16e">6,218</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTEtMS0xLTEtMA_0442778e-76c2-4002-b02b-96f5ebdff28d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTEtMy0xLTEtMA_ead93521-72ca-44e4-89a9-c55026427f69">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTItMS0xLTEtMA_e2c90ef2-7442-4f8e-8e4b-579b06d77832">2,905</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTItMy0xLTEtMA_f6249fb2-e1d9-4b48-bcbe-75a34389d692">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTMtMS0xLTEtMA_f91ab45c-5d13-4768-abae-1f1e3488afa4">51,314</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTMtMy0xLTEtMA_50fb9f5f-c0b7-4ddb-8804-a44f12f763da">5,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTQtMS0xLTEtMA_2155c69f-275a-46a2-b941-05f363516ee1">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTQtMy0xLTEtMA_100474db-a139-4a7d-8bc8-0edae8411a19">35</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTUtMS0xLTEtMA_0d173d55-1e52-43ff-ab7e-1d98c066bb46">51,404</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTUtMy0xLTEtMA_2bcced5d-9c1e-4e9b-ba28-3ac0de144697">6,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTYtMS0xLTEtMA_001eced4-53c4-426d-b850-5051758f3931">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTYtMy0xLTEtMA_10ab1f5c-3b54-49f2-bfc9-b138475174d3">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total comprehensive loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTctMS0xLTEtMA_6dd570a6-07bb-49ea-abb2-e2cd315adc73">51,465</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTctMy0xLTEtMA_399a0d62-f4b5-447c-9d3f-b18e552a69aa">6,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share attributable to common stockholders:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTktMS0xLTEtMA_9754af05-5da3-4f45-819c-faddf96e564a"><ix:nonFraction unitRef="usdPerShare" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTktMS0xLTEtMA_bf11ef28-3db6-465b-989d-dcf2cba04f28">0.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTktMy0xLTEtMA_8ae377b7-1e12-4227-8431-4cbc6bf12912"><ix:nonFraction unitRef="usdPerShare" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTktMy0xLTEtMA_b040bcba-27cc-4b11-aea9-5b5fec689081">0.17</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMjEtMS0xLTEtMA_c47b4536-3e18-4e8c-aebd-a45fea1f5bc7"><ix:nonFraction unitRef="shares" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMjEtMS0xLTEtMA_f52394e3-e639-473f-86eb-425243dbfde4">153,080,538</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMjEtMy0xLTEtMA_8ce36ee0-4ecd-462f-a4bc-baa4907b6a0b"><ix:nonFraction unitRef="shares" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMjEtMy0xLTEtMA_d99efc90-ec26-4c87-b76e-b5dc455e8a40">34,610,061</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Deficit) (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In&#160;Thousands, Except Share Data)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.086%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.640%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.593%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable<br/>Class&#160;A<br/>Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>&#160;Equity (Deficit)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i792d7143c7e54d839bf9f447a23d5618_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xLTEtMS00NTE3_9cc57cc4-1946-4915-b5bb-9b0a41433532">206,031,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i792d7143c7e54d839bf9f447a23d5618_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0zLTEtMS00NTU5_2e3bfca8-6c1e-4c87-ac71-1ef0ee362a84">249,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f47e3f1375b4282b2f716b16c7f63c1_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi01LTEtMS05ODY3_2e346305-ac0a-401b-8c41-c081cea47c27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f47e3f1375b4282b2f716b16c7f63c1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi03LTEtMS05ODY3_a84a9c4b-2cc5-4251-a1fd-9fb11b0b3ae3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib87290b070ee4c958c8ad766257920b6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi01LTEtMS00NTU0_563a30a4-8b8f-4b63-8a5f-4b120f34f325">116,930,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib87290b070ee4c958c8ad766257920b6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi03LTEtMS00NTU0_03b711f4-244c-436d-ae8c-64e4c967c6be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6ed049ade5b4240a293550a94b55de3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xMC0xLTEtNDU1MA_ed585789-f6b3-4c82-b77f-13739124faa6">24,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7fe00541b18143fba9a548d496dfb366_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xMi0xLTEtNDU1MA_7351b198-e3ea-4c82-9487-d8b6b2f26386">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec13139dbbe74ce284027b71cc7aab9c_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xNC0xLTEtNDU0MA_6d7c8142-7691-4066-94b3-743dab0d5359">171,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie22663228da14a50972ddb2d671033c3_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xNi0xLTEtNDU0MA_3dc525cf-fecb-4c9b-bfb5-fa239ce50485">146,874</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;Recapitalization </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9cb115824ec34508bcd4a4a5cdc3f9da_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0xLTEtMS00NTE3_c53e1a20-4620-41f1-85c1-cd4190210407">112,703,172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i417d0d1092d44ad0861530bdff9221e6_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy01LTEtMS00NTU0_99ab2f2e-fcdb-4115-85b0-fbe2bfd7778b">63,963,496</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i417d0d1092d44ad0861530bdff9221e6_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy03LTEtMS00NTU0_c0626e15-daac-4cf4-b5c3-190f1132d445">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i60ca4e5da0f14565ac395c1f2874530c_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0xMC0xLTEtNDU1MA_b9f62c82-3d4c-411f-8697-f080d35149e8">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i066ff8ea972a49dd9ad1c4f332e6c655_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xLTEtMS00Mjc5_5a721872-9dfd-4a51-96af-a8b84a0e19e4">93,328,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i066ff8ea972a49dd9ad1c4f332e6c655_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0zLTEtMS00Mjg4_6d3a50fc-fd19-4b20-b24b-ce3c356bd730">249,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i735114ee932b44528649a12d298232eb_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC01LTEtMS05ODY3_ded4a007-ec5f-46e4-8f6f-79da45d825da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735114ee932b44528649a12d298232eb_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC03LTEtMS05ODY3_7d44398c-34bf-4b42-979a-627f95445892">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ffa9196bf234ff0ade6790ed45d90db_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi01LTEtMS00Mjkx_67258e0a-e69a-4916-9e51-48661d90c23a">52,967,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ffa9196bf234ff0ade6790ed45d90db_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi03LTEtMS00Mjkx_5eca88af-243a-4477-aed3-1c416a0fa7e1">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffd6f90426014cc5a2a7167bb4a3601e_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xMC0xLTEtNDI5Nw_5e7322d6-30a3-4c81-a660-048b90a2aa7d">24,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibbecfcc087fd493a80b3a69f6a762834_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xMi0xLTEtNDI5Nw_35ecb0a5-391e-4a5f-819c-3aafa7d98353">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72a366adb8ae4f1aa5df0ef732686620_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xNC0xLTEtNDMwMA_9a6c469a-c153-4fd1-b59f-4c98a803dd0c">171,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xNi0xLTEtNDMwMA_5df5b95c-2bd7-445c-8d83-2f5afb0f7b4c">146,874</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pre-closing stock repurchase, net of exercise of vested options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i41f7b9d6eea64578809c722be8aea527_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="hims:TemporaryEquityStockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0xLTEtMS00Mjc5_75e87c53-cd4e-4c6a-ba38-d2ca1409731e">206,511</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41f7b9d6eea64578809c722be8aea527_D20210101-20210331" decimals="-3" name="hims:TemporaryEquityStockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0zLTEtMS00Mjg4_f90e6bad-65e8-48f4-b905-549ac1a8f3bd">125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy01LTEtMS00Mjkx_f6f1f9a4-15c2-4cef-86db-0d5e5bab8e68">1,817,519</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0xMC0xLTEtNDI5Nw_bbfe4fa8-33f4-40c4-888c-ca767eaa6da5">21,902</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0xNi0xLTEtNDMwMA_31e1c246-fd29-42e1-9d9f-5a388bc673b6">21,902</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of preferred stock to common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i41f7b9d6eea64578809c722be8aea527_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="hims:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC0xLTEtMS00Mjc5_f72600d5-bced-4e4d-a08d-a611d54c961c">93,121,607</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41f7b9d6eea64578809c722be8aea527_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="hims:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC0zLTEtMS00Mjg4_32b79513-239c-4d23-9ada-bdef5abf7e2a">249,837</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC01LTEtMS00Mjkx_7028fb73-282b-4f1a-a95e-52acfc2c0011">93,121,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC03LTEtMS00Mjkx_6f0cf9e9-3827-42a8-8a22-f31db3051e38">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC0xMC0xLTEtNDI5Nw_d18cfdcc-3d88-44d2-b7d0-48ab0042e566">249,828</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC0xNi0xLTEtNDMwMA_f62dee0c-a91c-4de2-b6d4-3e2aab7cdc49">249,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of related-party promissory notes associated with vested shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331" decimals="-3" name="hims:AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNS0xMC0xLTEtNDI5Nw_78b4d526-70ed-4aa1-b756-b34ca8835d10">854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="hims:AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNS0xNi0xLTEtNDMwMA_210aa4e0-0fea-4d73-a8cc-88965ce965fd">854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Forfeiture of related-party promissory notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="hims:StockForfeitedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNi01LTEtMS00Mjkx_6641c0f5-6103-48ab-a574-a4bfac9debaa">370,734</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Conversion of Series D preferred stock warrants to Class A common warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:AdjustmentsToAdditionalPaidInCapitalWarrantConversion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNy0xMC0xLTEtNDI5Nw_de2a7b1e-7342-469f-9c11-c27fa0a929f6">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:AdjustmentsToAdditionalPaidInCapitalWarrantConversion" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNy0xNi0xLTEtNDMwMA_ced45a11-75b1-4be2-9270-6bf9066e5764">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of Class A common stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i30ada711d000420db9e5a73ad2e2418d_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOC01LTEtMS00Mjkx_37371422-756b-44f6-84b8-1a0df99441c1">1,867,292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5ab3e0ebc1e499ea3db5fa26f8b9bc4_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOC0xMC0xLTEtNDI5Nw_ce8d8c42-a542-4d10-9cbb-18230c12579c">21,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie89592b066544281a07fa0169e98833d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOC0xNi0xLTEtNDMwMA_ed686c34-d650-4dd8-a269-bbeedf8900b9">21,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock upon Merger, net of transaction costs and Merger warrants liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="hims:StockIssuedDuringPeriodSharesReverseRecapitalization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOS01LTEtMS00Mjkx_e7522f6f-0e89-41f9-bc5e-ccb11980fc9d">23,892,244</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331" decimals="-3" name="hims:StockIssuedDuringPeriodValueReverseRecapitalization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOS03LTEtMS00MzI4_e6d9b8a3-f94e-45e0-bdb5-268444cbb8cb">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:StockIssuedDuringPeriodValueReverseRecapitalization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOS0xMC0xLTEtNDI5Nw_c8fa021d-60d1-4f71-878c-203220641ea9">129,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:StockIssuedDuringPeriodValueReverseRecapitalization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOS0xNi0xLTEtNDMwMA_2924c522-6619-4b6b-9dc6-106b780d5d26">129,659</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of PIPE shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4af486b04aad4f14ba113a2fa6b2ee94_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTAtNS0xLTEtNDI5MQ_f5378c28-e12b-480e-a1e4-c9e4430ff289">7,500,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4af486b04aad4f14ba113a2fa6b2ee94_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTAtNy0xLTEtNDI5MQ_b7309d14-5960-43aa-8459-49c6be0bb92a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3078188fe78241078c8c9e6b9eed4bc6_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTAtMTAtMS0xLTQyOTc_37c16152-dab5-4ec3-a431-fdfdc0df70b3">74,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7de8dcbf04c4bb6929b04fe9ef68802_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTAtMTYtMS0xLTQzMDA_af7ecb16-4c3a-44f5-9c36-56cb7594294a">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of earn-out shares to common stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="hims:StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTEtNS0xLTEtNDI5MQ_cc87acc7-edf7-4883-840d-7f99a650d3b9">14,153,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331" decimals="-3" name="hims:StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTEtNy0xLTEtNDMyOA_0454ca03-6931-4a03-a0eb-f4d1ec9ee061">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="hims:StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTEtMTYtMS0xLTQzMDg_8640599a-3081-447e-b3b1-f8fd8d72c8e3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of vested stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTItNS0xLTEtNDI5MQ_b142071d-11f8-4527-9d7c-eaf58bf602c9">37,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTItMTAtMS0xLTQyOTc_c85a8b82-49a7-42ec-8546-204dd89b0f80">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTItMTYtMS0xLTQzMDA_d3f23bd6-8130-4240-b845-36528e449955">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of early exercised stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331" decimals="-3" name="hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTMtMTAtMS0xLTQyOTc_b722c3d6-6c8a-48cf-966c-45249d8ed5b3">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTMtMTYtMS0xLTQzMDA_1f5b9d56-ca56-4482-84b5-fb4373324e07">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Warrant expense in connection with Merger</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331" decimals="-3" sign="-" name="hims:AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTYtMTAtMS0xLTU3MDc_292b4166-6b66-442b-b79d-906ed0eeae3c">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" name="hims:AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTYtMTYtMS0xLTU3MDc_dc8e762d-b2de-4a31-b85b-967408dfe147">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTQtMTAtMS0xLTQyOTc_c8b0794a-4afe-45e0-b9de-2c6fa997549c">34,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTQtMTYtMS0xLTQzMDA_ae733a4b-28a6-4323-acc6-70d77f171ba4">34,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i70660543ef984629a669e4c2774e2da9_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTUtMTItMS0xLTQyOTc_b371f275-b197-43cf-b10a-931084dc18fb">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTUtMTYtMS0xLTQzMDA_c951ec19-611e-48e0-890d-59b3d7d5204a">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i791a884a65994079a567da0a06e4cbec_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTYtMTQtMS0xLTQzMDA_580433a0-40c1-4bf9-938c-25488572ad32">51,404</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTYtMTYtMS0xLTQzMDA_44c1d636-3d1c-4cf4-8b33-46e049d8eb0a">51,404</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance as of March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91a3849afa9e4008b0e42c13bed395ca_I20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMS0xLTEtNDI3OQ_006af231-2c2b-4d9a-ac65-2bbfc1eb6436">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91a3849afa9e4008b0e42c13bed395ca_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMy0xLTEtNDI4OA_cceddc77-2835-4e47-978c-4a9dbd5be258">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6afd3e44df984fe7827f7001bb384073_I20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMjEtNS0xLTEtOTg2Nw_7e7971f7-9566-451f-a74f-6ba25af16193">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6afd3e44df984fe7827f7001bb384073_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMjEtNy0xLTEtOTg2Nw_f6285880-151f-4b09-83e6-d55ddf2e0c46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia261e8ec32d348948aa7c247ea90ba34_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtNS0xLTEtNDI5MQ_69dee4ea-2c5f-4677-8ec0-05e4a542fa1e">191,351,403</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia261e8ec32d348948aa7c247ea90ba34_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtNy0xLTEtNDI5MQ_34d7c6ef-b08a-445d-8856-6fa18b0741b7">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9806e71b0929497bb5027bab7cf4a37a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMTAtMS0xLTQyOTc_9228ec81-4c9b-43f2-8732-47aa5311f61f">515,216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib85fb22f79d9475787326d65ff2089e0_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMTItMS0xLTQyOTc_44f853ad-69c0-4f51-a577-750bf6a9577e">72</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i576de665f4e84b76bc7bb8d9ec493671_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMTQtMS0xLTQzMDA_dd8f598e-3fcd-4cfc-9aa5-f9a3cd3fc8f2">222,696</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMTYtMS0xLTQzMDA_f663df44-23ef-48a5-b61f-34095e1f052e">292,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.449%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.285%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.393%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.558%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.367%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.589%"></td><td style="width:0.1%"></td></tr><tr style="height:27pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Convertible Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable<br/>Class&#160;A<br/>Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders'<br/>&#160;Equity (Deficit)</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7f3746a65e7d4ed994c942a878cb3d7d_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xLTEtMS00NTgy_2efc3d72-ee66-49d4-bae0-ca5097c0ef61">186,573,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f3746a65e7d4ed994c942a878cb3d7d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0zLTEtMS00NTg2_0c688db3-5d43-4abd-9021-bfb1f502e8dc">186,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib224229727c244f7ae39e55c0c9df44d_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi01LTEtMS00NTkx_2e29b52b-da1b-4471-8b28-f77c6b596705">1,627,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib224229727c244f7ae39e55c0c9df44d_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi03LTEtMS00NTkx_5a081796-0d16-4c9b-b326-f431e5c38a49">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id3eb3a4c78e24298b72949d4acd6af55_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xMC0xLTEtNDU5NA_516b1bf7-8336-4782-8b94-2e5ab215ce1d">113,887,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3eb3a4c78e24298b72949d4acd6af55_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xMi0xLTEtNDU5NA_c9cca56b-cfa7-493c-a81e-c0d346047044">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i313e801028b74041921b6b37ca22f649_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xNC0xLTEtNDU5Nw_9d85b916-94f6-46cf-a39d-8ba1a82ba7ec">13,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe027cba4b74bb3b95477816832e680_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xNi0xLTEtNDU5Nw_23a08c80-32a5-4685-bbf6-bfa37b85fc2b">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idba21161446c43ccbb9debeea82200bb_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xOC0xLTEtNDYwNg_6321534c-fb61-4b5d-b678-f87c0db7314d">153,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47c21ce80c1947b39ed2fbaafbb5bb80_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0yMC0xLTEtNDYwNg_5054839a-5fe1-4d09-b08f-7fdbe8ecfb69">139,793</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i373d7d08dbe04fb9940eabc42c50f83a_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0xLTEtMS00NTgy_5a9d2c37-5fd2-428e-a488-3266a26e6189">102,059,460</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i01b2ce787a3a4bc9884c22437e0f804e_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy01LTEtMS00NTkx_e9192a84-2873-4792-bba7-5d34267030f1">890,074</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i14063932285a47baaf67a27317285b57_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0xMC0xLTEtNDU5NA_f5a413ba-6574-423c-b617-01adf356dc6c">62,298,481</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d1aa65fad4a4c2088e713c20737e7ce_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0yMC0xLTEtNDYwNg_8a73af7b-509a-4fda-803c-e835f00636de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 9.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i95f1f52b2b1b4200bc65210a3f67c839_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xLTEtMS0w_b29827ef-4fad-43a7-9b74-55e96d360fbe">84,514,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95f1f52b2b1b4200bc65210a3f67c839_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0zLTEtMS0w_f2293e0d-a301-4b40-bb58-5ddd3cdf7583">186,741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i498b99b9de474e2f9144406648261412_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi01LTEtMS0w_8f75c8f8-781b-4716-a3a9-2c16df09c5df">737,058</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i498b99b9de474e2f9144406648261412_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi03LTEtMS0w_9d318f6a-985a-449a-8227-7198c07244f9">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c79493c43ec4a598105cec06fd2dc82_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xMC0xLTEtMA_31df3059-f94e-472f-8405-a7cac6f9da35">51,588,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c79493c43ec4a598105cec06fd2dc82_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xMi0xLTEtMA_2f16216a-6c66-4c20-af7f-82184a2208cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f0a47c2a80f4fe0b4cdc6aa3b46a0f0_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xNC0xLTEtMA_bdb3e808-6125-4a68-aecf-81c1e5744844">13,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb00a578313e4482a66c59493f18d456_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xNi0xLTEtMA_5370f7c3-14f5-471f-94ec-9842a9f80226">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i65862cdd601d4522a8afad352086cb6a_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xOC0xLTEtMA_41cefa2d-0776-41cc-8749-714ad8a0ca6c">153,178</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b4a0fdda9fc43a19cad6464963b6377_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0yMC0xLTEtMA_507cea37-28a2-47f3-a54c-71930ddae16d">139,793</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:26.64pt;text-indent:-8.64pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of Series D convertible preferred stock, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0wLTEtMS00MzQ5L3RleHRyZWdpb246YjlmYzg1MmIxZDgzNDNmNjllYWUzMjI3NWZmN2UwMzJfNTQ5NzU1ODEzOTA0MA_b534d08f-9f6a-458b-b9dd-e59ddcaa8ef8">0.1</ix:nonFraction> million</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6e26fbeb5863440e9e721a1313cd6a22_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="hims:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0xLTEtMS0w_e3f9bb39-4996-4ffa-bbe6-b928af436f9f">4,537,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e26fbeb5863440e9e721a1313cd6a22_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0zLTEtMS0w_1e746bff-42e9-4395-a9c0-17666c98f75d">31,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of vested stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib46889ae15794ea6a849b7097df17e70_D20200101-20200331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfNC0xMC0xLTEtMA_0175d95c-a464-4aef-926d-401434f252fb">226</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Early exercise of unvested stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib46889ae15794ea6a849b7097df17e70_D20200101-20200331" decimals="INF" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfNS0xMC0xLTEtMA_ee50d5fb-ce19-40a3-90ca-ed818525d189">226</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of early exercised stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebaa49281ce34f088dcc3e920092930e_D20200101-20200331" decimals="-3" name="hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfNi0xNC0xLTEtMA_31e79bc1-02f5-4051-8899-a5b358b26e4a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfNi0yMC0xLTEtMA_71ad361c-59d4-4142-b298-a44aa438f13a">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeiture of unvested early exercised shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ib46889ae15794ea6a849b7097df17e70_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfNy0xMC0xLTEtMA_d558fb1f-448e-4b29-bcfd-d53058141ddd">46,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebaa49281ce34f088dcc3e920092930e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOC0xNC0xLTEtMA_44b8afea-6eae-411a-84ff-2c6e4cdb1c98">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOC0yMC0xLTEtMA_46dae843-0fbd-47d3-ade3-3393064906ed">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expiration of the Class A common stock redemption right</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i93e3fc5bb5ed483ebb7e411c2c1b86a3_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="hims:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOS01LTEtMS0w_6aea31ab-b225-4679-a2e7-905805d6eb55">737,058</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i93e3fc5bb5ed483ebb7e411c2c1b86a3_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="hims:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOS03LTEtMS0w_b48ec1f7-cce7-43e2-b928-2b7a2a4dc707">4,500</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib46889ae15794ea6a849b7097df17e70_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOS0xMC0xLTEtMA_a437ba90-14ad-479d-8794-0bdb13536259">737,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iebaa49281ce34f088dcc3e920092930e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOS0xNC0xLTEtMA_bc69175a-d876-4b9c-90d9-42832849bac3">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOS0yMC0xLTEtMA_9c04487d-3f27-4f96-b96e-9a736635676d">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i859fee6b0b4d4ef1bf57cc579f3ad5c1_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTAtMTYtMS0xLTA_d77520ac-18a0-47c6-9d22-2d562feeac74">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTAtMjAtMS0xLTA_9ed9d6ca-0041-41b0-b23a-6d846ee5e9ae">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c64c701476f4358a5a5c9d9ea2fdf8a_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTEtMTgtMS0xLTA_faa6e1e7-dad9-4d34-a84c-b37d8bf10b2a">6,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTEtMjAtMS0xLTA_8aac526e-b6e3-4231-a84d-f65c49e7e115">6,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 27.64pt;text-align:left;text-indent:-8.64pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c4f929ec7804d5ba080985386fb1710_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMS0xLTEtMA_6d22fede-f3d1-417a-ab87-6b9d75bfe290">89,051,891</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c4f929ec7804d5ba080985386fb1710_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMy0xLTEtMA_19e298ff-d44d-4ebd-b26d-feed092f7ba4">218,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa8987c19e604874ab033feedad56d43_I20200331" decimals="INF" format="ixt:zerodash" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtNS0xLTEtMA_e6c8e430-4ac7-4c20-b264-b315195addbc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa8987c19e604874ab033feedad56d43_I20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtNy0xLTEtMA_2a5261a7-6313-4dc4-88d8-fcfcc8817e4e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f815b2e739d41ebafd5da94bf4c8d6a_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMTAtMS0xLTA_3fd31664-1200-44d1-8f2c-d23b3b07fd3f">52,279,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f815b2e739d41ebafd5da94bf4c8d6a_I20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMTItMS0xLTA_e3abbdeb-c4d0-436f-bfa8-2432fb504b86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1681a4a94614a62ad87dae150f2220d_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMTQtMS0xLTA_8fc2e180-dbfe-4f3d-a684-231ec4690559">19,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie87d3610f2c94903a4a299c11f9d0cc2_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMTYtMS0xLTA_405e7496-e215-4b88-889b-40e3ca429b1e">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i541d26427048423291dfa7496890fbfa_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMTgtMS0xLTA_31373b00-f337-4d9f-a436-542f3b8f8b42">159,211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad3d9f1d28194144988117c8661db3c7_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMjAtMS0xLTA_cc53a5b0-5303-453d-b5d2-1339dcaa5359">139,953</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows (Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In&#160;Thousands)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.250%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.130%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMy0xLTEtMS0w_2a8d2e9b-9d21-465f-925b-89c425c11637">51,404</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMy0zLTEtMS0w_2eac0ce4-6c24-4961-94b7-d87e690b0b3e">6,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNS0xLTEtMS0w_407add5f-4512-4af1-b7e8-74ebb7e16a98">394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNS0zLTEtMS0w_135a03b0-9f40-4fd8-ae85-78118c9e082c">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNi0xLTEtMS0w_c536910d-ddb5-41b7-8196-7301e35b8adb">34,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNi0zLTEtMS0w_e159c571-c952-44d2-8067-868225ed37b0">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Change in fair value of warrant liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNy0xLTEtMS0w_5824e222-c9a6-44c9-826e-b19a14832c70">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:FairValueAdjustmentOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNy0zLTEtMS0w_c4139c7b-6167-427f-bbf1-3fe6d839d1e0">71</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Warrant expense in connection with Merger</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="hims:NoncashWarrantExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfOC0xLTEtMS0w_36ae7337-59ce-40c6-b0d6-7a9e2b3b7be8">154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="hims:NoncashWarrantExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfOC0zLTEtMS0w_67e256a5-d73a-466a-a94f-744f6c514b86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTEtMS0xLTEtMA_71436ddf-0848-4180-94f5-05baadbfc760">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTEtMy0xLTEtMA_2ac954ae-4d3e-4b09-8b93-a773a1e14da8">84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Noncash other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTItMS0xLTEtMA_97609234-f3bc-42cf-8d2b-3f5c5a639d10">452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTItMy0xLTEtMA_b60749de-2eb4-4cb3-8e19-a9d63cf5eb66">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTQtMS0xLTEtMA_d36f0eb2-d0e3-4f2e-aa41-f7b603a299c3">980</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTQtMy0xLTEtMA_6d58239e-f028-4877-b5be-4710aeb1f55c">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTUtMS0xLTEtMA_5777b3cb-2fa1-445a-a59a-e916121fdd12">7,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTUtMy0xLTEtMA_79a9e9e3-3eef-4493-8314-659dac43045f">471</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTYtMS0xLTEtMA_7ebe64f0-4101-4fa0-8aca-ce968ff65b64">58</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTYtMy0xLTEtMA_122520dd-38f8-4f02-ab13-b7713cf1fdb1">733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTctMS0xLTEtMA_2c6e95c9-7f1c-4e01-8d50-3ddb65037fef">5,117</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTctMy0xLTEtMA_fc4364b2-0474-441d-be34-ea6697361f53">674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTgtMS0xLTEtMA_d85bd9d1-12e2-471c-a756-7238bafeedcb">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTgtMy0xLTEtMA_2740a1a7-2e2e-4970-8ddd-08c9db8ed534">199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTktMS0xLTEtODM5Ng_6e2ad5f9-11ef-4eda-beb7-b54cc7525ece">648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTktMy0xLTEtODM5Ng_ca99eb68-ef75-4474-9fec-4208f9b41512">126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Deferred rent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="hims:IncreaseDecreaseInDeferredRent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjAtMS0xLTEtMA_a2906735-dbac-42a5-8165-ff8f46938da1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="hims:IncreaseDecreaseInDeferredRent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjAtMy0xLTEtMA_51c5640c-f80c-42db-b27f-3ab416cb8f65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjEtMS0xLTEtMA_ecc9c00b-42ee-4827-8032-545ddfd0ab97">15,948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjEtMy0xLTEtMA_8a684246-7eb0-4539-aa94-337633b6a677">5,191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjMtMS0xLTEtMA_fa6d5f00-0c8b-4fb2-9ad2-e10b63a059c6">172,021</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjMtMy0xLTEtMA_9294ff32-9793-474c-89c8-887763115043">17,642</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Maturities of  investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjQtMS0xLTEtMA_1b920430-e107-4d51-a0f2-afacc3983ecc">9,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjQtMy0xLTEtMA_8b96a0f1-0f5c-409c-9d68-6cc4c02b817b">19,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Proceeds from sales of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjUtMS0xLTEtMA_61a931c0-7310-4bb8-b835-76654db82ba0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjUtMy0xLTEtMA_a485528e-ea61-44b2-96d7-71b9e491d1a5">6,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Investment in website development and internal-use software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsForSoftware" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjYtMS0xLTEtODM5Ng_f24377b9-2eb6-4785-8bc4-acf464299fc9">740</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsForSoftware" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjYtMy0xLTEtODM5Ng_6ca952ae-2f7c-4ec3-8543-ecee43108c35">452</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Purchases of property, equipment, and intangible assets </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjctMS0xLTEtMA_c4b9d21a-f372-4bde-a610-79e81b687748">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjctMy0xLTEtMA_8c8dfc07-78bd-447f-844d-39734dfe6051">273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Net cash (used in)/provided by investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjgtMS0xLTEtMA_b11812e4-6520-420f-a995-d7dd0ca53aff">163,324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjgtMy0xLTEtMA_c87b2636-a018-4fe9-9109-a4161dfe36a2">7,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Proceeds from issuance of redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzEtMS0xLTEtMA_6e1b1ea9-bf68-45bb-a8ba-9ac8b3863af1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzEtMy0xLTEtMA_794dcdd5-3c59-4bc9-b032-9621dba8b95c">31,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Payments for issuance costs of convertible preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzItMy0xLTEtMA_c2664e05-4285-44b1-b2dc-da1e5343b05b">89</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Pre-closing stock repurchase</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzEtMS0xLTEtMTUwMDQ_b7559184-8726-45e6-891f-c1ebfa36f99c">22,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzEtMy0xLTEtMTUwMDQ_97ed69a3-a4a7-4baa-a91f-b69b6ca3ce40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock upon Merger</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:ProceedsFromIssuanceOfCommonStockRecapitalization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzMtMS0xLTEtMA_6a6e689b-202e-40b0-8e57-6bd0615e6ff0">197,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="hims:ProceedsFromIssuanceOfCommonStockRecapitalization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzMtMy0xLTEtMA_452b8920-406f-427c-9807-985a91466d97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Proceeds from PIPE</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzQtMS0xLTEtMA_5f9ec8ca-50a1-4b51-a680-028d8cb22dbd">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzQtMy0xLTEtMA_fab48b11-4287-45a0-a362-6a76469514b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Payments for transaction costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzUtMS0xLTEtMA_0f4c14d2-a3de-4c7a-9adb-6945b0d5dc64">12,794</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Repayment of promissory notes associated with vested and unvested shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzYtMS0xLTEtMA_27c68755-dc75-478b-a83a-e857ebee51f8">1,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzYtMy0xLTEtMA_c9ac96eb-d0a3-46f0-8356-b84a1e5309a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Proceeds from exercise of Class A common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzgtMS0xLTEtMA_b035551c-416b-4aa9-b555-484100d0b6e5">807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzgtMy0xLTEtMA_92d5d9e6-956e-4a62-9493-a4ce399d2b19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Proceeds from exercise of vested and unvested stock options, net of repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="hims:ProceedsFromStockOptionsExercisedNetOfRepurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzktMS0xLTEtMA_41d091ca-a2c5-4916-be58-ab437b0e8767">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" name="hims:ProceedsFromStockOptionsExercisedNetOfRepurchases" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzktMy0xLTEtMA_f483471d-7e6c-46b4-b337-6f84adf7263e">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Repayments of principal on term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDAtMS0xLTEtODM5Ng_d694bc4d-e7cf-4587-bd87-0c050cf8ad4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDAtMy0xLTEtODM5Ng_e34d1473-467f-406b-b52a-85c25708ffe3">1,158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDEtMS0xLTEtMA_b937ecd4-362e-4aa2-acae-a9bdcdbc8eca">239,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDEtMy0xLTEtMA_5fc4a0fc-ff0c-428e-9dc8-63f7aae7993e">30,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Foreign currency effect on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDItMS0xLTEtMA_a0fe8356-992f-4239-b917-8580c4203e75">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDItMy0xLTEtMA_2feb3e08-ed44-4695-abe0-22d48bc02dfc">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Increase in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDMtMS0xLTEtMA_ab33715b-a3d3-4756-99c7-3116c3d70c2b">60,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDMtMy0xLTEtMA_8452066c-c76c-47bb-b6c9-07dee6419b73">32,368</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at beginning of the year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDQtMS0xLTEtMA_9ab2af00-71eb-4791-a8c6-e97857be3d35">28,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b4a0fdda9fc43a19cad6464963b6377_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDQtMy0xLTEtMA_3753122d-61d9-420a-9ce9-b2d82fd31c1a">22,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash at end of the three-month period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDUtMS0xLTEtMA_709fbbf4-33df-4dbc-9733-9e1e7a77971c">89,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad3d9f1d28194144988117c8661db3c7_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDUtMy0xLTEtMA_dc057c73-0d2d-4108-afb9-f9092868fcba">55,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cash paid for taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDctMS0xLTEtODM5Ng_25c90aab-2191-4139-8b46-db5326975a16">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDctMy0xLTEtODM5Ng_d41d5d22-8ee1-4d61-9d39-30b72f392661">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDgtMS0xLTEtODM5Ng_fc62f8a7-390a-4cba-a2b8-6c4bc921b83b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDgtMy0xLTEtODM5Ng_30d576c4-25f5-4335-abad-8c89cb809a5f">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Noncash investing and financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Recapitalization of redeemable convertible preferred stock from pre-closing stock repurchase</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="us-gaap:RecapitalizationCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTAtMS0xLTEtODM5Ng_618bda9a-a28b-433c-8763-a354f5ee0cbd">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:RecapitalizationCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTAtMy0xLTEtODM5Ng_bace26e5-3acb-4924-97bc-be380c4fbed1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Conversion of redeemable convertible preferred stock to common stock</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConversionOfStockAmountConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTEtMS0xLTEtODM5Ng_fe11812b-0dbe-4a21-a7db-d052cf12e26e">249,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:ConversionOfStockAmountConverted1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTEtMy0xLTEtODM5Ng_03060e63-a050-4306-8f1c-1b68008f482b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Assumption of Merger warrants liability</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:WarrantsAssumed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDktMS0xLTEtMjA2OTQ_cfa9efa7-a9dc-4504-a980-ee8f2685ed21">51,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="hims:WarrantsAssumed" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDktMy0xLTEtMjA2OTQ_40b0a066-f041-4a2a-85e4-dc37107b1ae6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Exercise of Private Placement Warrants and Public Warrants</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:WarrantsIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTAtMS0xLTEtMjA2OTQ_e68e7385-70df-4112-b1c5-d9e8918e9fa2">20,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="hims:WarrantsIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTAtMy0xLTEtMjA2OTQ_2330938a-1373-42bd-b735-6f504cf16482">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Reclassification of deferred transaction costs</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:ReclassificationOfDeferredTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDktMS0xLTEtMTQ5MDA_b17ba17b-331b-4eb0-9500-c92011355647">3,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="hims:ReclassificationOfDeferredTransactionCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDktMy0xLTEtMTQ5MDA_639e0529-72fd-4a7b-8f2b-1ddf095a8b1f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Conversion of Series D preferred stock warrants to Class A common warrants</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:ConversionOfPreferredStockWarrantsAmountConverted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTItMS0xLTEtODM5Ng_f8bfc7a9-efc6-44c6-8092-a46e13fc9654">1,160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="hims:ConversionOfPreferredStockWarrantsAmountConverted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTItMy0xLTEtODM5Ng_29e04814-2a76-4f84-bb55-61439143cc16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Change in transaction costs payable</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="hims:TransactionCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTQtMS0xLTEtODM5Ng_df21bd73-33f5-45e5-9d90-a178dec29720">511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="hims:TransactionCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTQtMy0xLTEtODM5Ng_42634f68-5b47-42e3-afb9-767a3f9830c5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Vesting of early exercised stock options</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" name="hims:VestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTUtMS0xLTEtODM5Ng_7f852412-bcc9-4d06-8ef6-ea1f9de1409d">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" name="hims:VestingOfEarlyExercisedStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTUtMy0xLTEtODM5Ng_510ac77a-3e06-467e-a8fe-ef4870c54692">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">Expiration of Class A common stock redemption right</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTYtMS0xLTEtODM5Ng_6519e0cf-1247-4769-b83d-c2c0c5e76e86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssued1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTYtMy0xLTEtODM5Ng_653fe2d5-b50b-4ee8-8e3a-e3e17484cf44">4,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">See accompanying notes to unaudited condensed consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></div></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_28"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yOC9mcmFnOjIwYjQzMGE3Zjg5NzRlZTRiYjg4ZmZmYmRkMGM1NmUxL3RleHRyZWdpb246MjBiNDMwYTdmODk3NGVlNGJiODhmZmZiZGQwYzU2ZTFfMTIwOTQ2Mjc5MTMyNjk_afdfce33-f929-4403-8f09-449b96ae41d6" continuedAt="i9f178eb848134ce0aa32a9ffb87aa07f" escape="true">Organization</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i9f178eb848134ce0aa32a9ffb87aa07f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hims &amp; Hers Health, Inc. (the "Company"), formerly known as Oaktree Acquisition Corp. ("OAC"), is a direct-to-customer telehealth company incorporated in Delaware. The Company's mission is to make healthcare accessible, affordable, and convenient for everyone. The Company designed and built a digitally native, cloud-based technology centered around the consumer, and designed everything with the consumer in mind. The Company's proprietary websites, telehealth platform, electronic medical records system, pharmacy integration, and mobile accessibility combine to provide customers with a seamless, easy-to-use, mobile-first experience. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a range of health and wellness products and services available for purchase directly by customers on the Company's websites and through wholesale partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021 (the "Closing Date"), OAC completed the acquisition of Hims, Inc. ("Hims") pursuant to the Agreement and Plan of Merger dated as of September 30, 2020 (the "Merger Agreement") by and among OAC, Hims, and Rx Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of OAC ("Merger Sub"). The Merger Agreement provided for, among other things, the combination of Hims and OAC pursuant to the merger of Merger Sub with and into Hims, with Hims continuing as the surviving entity and as a wholly-owned subsidiary of OAC (the "Merger").</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for as a reverse recapitalization with Hims as the accounting acquirer and OAC as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Hims and its wholly owned subsidiaries as if Hims is the predecessor to the Company. The shares and net loss per common share, prior to the Merger, have been retroactively restated as shares reflecting the exchange ratio established in the Merger (<ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yOC9mcmFnOjIwYjQzMGE3Zjg5NzRlZTRiYjg4ZmZmYmRkMGM1NmUxL3RleHRyZWdpb246MjBiNDMwYTdmODk3NGVlNGJiODhmZmZiZGQwYzU2ZTFfNjA0NzMxMzk2NTg5MA_060204b3-241b-4a68-9c7a-5743d713df4c">0.4530</ix:nonFraction> shares of Company Class A common stock for 1 share of Hims Class A common stock). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger, OAC ordinary shares and warrants were traded on the New York Stock Exchange ("NYSE") under the ticker symbols "OAC" and "OAC WS", respectively. On the Closing Date, the Company's Class A common stock and warrants began trading on the NYSE under the ticker symbols "HIMS" and "HIMS WS", respectively. One of the primary purposes of the Merger was to provide a platform for Hims to gain access to the U.S. capital markets. See Note 3 &#8211; Recapitalization for additional details.</span></div></ix:continuation><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_31"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzE_71d2d6f7-d592-4b3c-bcf2-638ff2a53aa3" continuedAt="i1dce6875a77545949bbf1cc9c8d075a5" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i1dce6875a77545949bbf1cc9c8d075a5" continuedAt="i25c3d8a2170e480da7bd60e0966e29db"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfNjA0NzMxNDIzMzg3Nw_dfc062e0-ee8e-4442-ad89-534d5706b24f" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to accounting principles generally accepted in the United States of America ("U.S. GAAP").</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements as of March&#160;31, 2021 are unaudited. The condensed consolidated balance sheet as of December&#160;31, 2020, included herein was derived from the audited consolidated financial statements as of that date. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. As such, the information included herein should be read in conjunction with the consolidated financial statements and accompanying notes as of and for the year ended December&#160;31, 2020 (the "audited consolidated financial statements").</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and reflect, in management's opinion, all adjustments of a normal, recurring nature that are necessary for the fair statement of the Company's balance sheet, results of operations, and cash flows for the three-month periods, but are not necessarily indicative of the results expected for the full fiscal year or any other period.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfNjA0NzMxNDI2NjY0Nw_006ba222-75d7-4c1d-81ec-4e92957469d8" escape="true">The unaudited condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, and variable interest entities in which it holds a controlling financial interest. All intercompany transactions and balances have been eliminated in these condensed consolidated financial statements.</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i25c3d8a2170e480da7bd60e0966e29db" continuedAt="i2211712ea06f47a283e84c5741da8ee1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2021 and 2020, the Company had operations primarily in the United States and immaterial operations in the United Kingdom.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to the Company's significant accounting policies described in the audited consolidated financial statements for the year ended December&#160;31, 2020, that have had a material impact on these condensed consolidated financial statements and related notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzI_99188d7c-9fe7-477f-bbe5-b86f3caea384" escape="true">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The more significant estimates and assumptions by management include, among others, valuation of inventory, valuation and recognition of stock-based compensation expense, valuation and recognition of warrants, and estimates in capitalization of website development and internal-use software costs. Management believes that the estimates and judgments upon which it relies, are reasonable based upon information available to it at the time that these estimates and judgments were made. Actual results experienced by the Company may differ from management's estimates. To the extent that there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzM_2b55581a-5b1c-4a94-8aef-348747b75be7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt instruments with original maturities at the date of purchase greater than three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with original maturities at the date of purchase and remaining maturities of greater than one year are classified as long-term investments. The Company intends to sell such investments at or close to maturity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The investments, if any, are designated as available-for-sale and are reported at fair value, with unrealized gains and losses, net of tax, recorded in other comprehensive income on the consolidated statements of operations and comprehensive loss, except as noted in the Other-Than-Temporary Impairment section that follows. The Company determines the cost of the investment sold based on specific identification at the individual security level. The Company records the interest income and realized gains and losses on the sale of these instruments within other (expense) income, net on the condensed consolidated statements of operations and comprehensive loss.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other-Than-Temporary Impairment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="hims:OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzQ_528b4329-8f4a-485d-82b9-8bc2802eb85e" escape="true">The Company's investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment's adjusted cost basis. This would occur for marketable debt instruments when the fair value is below amortized cost and the Company intends to sell the instrument, when it is more likely than not that the Company will be required to sell the instrument before recovery of its amortized cost basis, or when the Company does not expect to recover the entire amortized cost basis of the instrument (a credit loss exists). When the Company does not expect to recover the entire amortized cost basis of the instrument, it separates other-than-temporary impairments into amounts representing credit losses, which are recognized in other (expense) income, net, and amounts related to all other factors, which are recognized in other comprehensive (loss) income on the condensed consolidated statements of operations and comprehensive loss.</ix:nonNumeric> The Company incurred <ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyODI_90c83407-28bc-4fc7-85e9-0700a8e32101"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ImpairmentOfInvestments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyODI_9d9d752a-c0e2-48d0-9d5a-5cfb4304a296">no</ix:nonFraction></ix:nonFraction> other-than-temporary impairments on investments for the three months ended March 31, 2021 or 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzU_2d3f1e35-8790-4180-ab89-a191fd301aec" escape="true">Inventory primarily consists of finished goods and raw materials that are located at Company-managed and third-party fulfillment warehouses. Inventory is stated at the lower of cost and net realizable value and inventory cost is determined by the weighted average cost method. The Company reserves for expired, slow-moving, and excess inventory by estimating the net realizable value based on the potential future use of such inventory. Management monitors inventory to identify events that would require impairment due to slow-moving, expired, or obsolete inventory and reduces the value of inventory when required. Obsolete inventory balances are written off against the inventory allowance when management determines that the inventory cannot be sold.</ix:nonNumeric> The Company recorded write-offs of less than $<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTUzOTMxNjMxMDczOTY_445fcae4-e0f4-4c2d-b03e-2c108df6f1f9">0.1</ix:nonFraction>&#160;million for the three months ended March 31, 2021 and $<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMjc0ODc3OTM3OTI2MA_4d43e5d8-0870-4a9b-9f88-8fc9c042923d">0.1</ix:nonFraction> million for the three months ended March 31, 2020.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i2211712ea06f47a283e84c5741da8ee1" continuedAt="i9f0e6f2fc1ae4ddb8b585a51d6519562"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzY_a66eca0e-d9c3-403f-a407-bb0a6e6efa3c" continuedAt="i8536fee1b9ce42f98ef325c21e6623b4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification Topic ("ASC") 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8536fee1b9ce42f98ef325c21e6623b4" continuedAt="if24aa308b93640b8b4aca0324fa820cf">The Company's consolidated revenue primarily comprises of online sales of health and wellness products through the Company's website, including prescription and nonprescription products. In contracts that contain prescription products, revenue also includes medical consultation services.</ix:continuation> Additionally, starting in March&#160;2020, the Company began selling its products to a new wholesale partner.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzc_7189ada3-617b-46e8-85cc-2cc6a80d34da" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue consists of the following (in&#160;thousands): </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended<br/>March 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Online</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bdb1af208e14b2ea352fb5361c65042_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfMi0xLTEtMS0w_956c971e-a635-4af6-85dd-89d617390107">50,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i533a6c1123d5402bb7487743cb056ecc_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfMi0zLTEtMS0w_6822c0bd-7427-40d6-822f-45805f7e6361">28,524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wholesale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i932569e05a89431ebc34c4b51b14c702_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfMy0xLTEtMS0w_b05e2f30-b0ff-4b3f-9228-63e724bacee5">1,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23ddbd3a57cb47d2b34bef8d1093c90f_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfMy0zLTEtMS0w_b79521ff-1035-4c34-8bb1-b72892340f00">1,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfNC0xLTEtMS0w_094e6feb-8aeb-4ffe-93fd-40c2d70570e5">52,314</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfNC0zLTEtMS0w_3329f7ac-b633-4712-81dc-f7e7377787eb">30,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if24aa308b93640b8b4aca0324fa820cf" continuedAt="i31330df5a68642d5821fc2a78f7e3ef6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For online revenue, the Company defines its customer as an individual who purchases products or services through the website. For wholesale revenue, Company defines its customer as a wholesale partner. The transaction price in the Company's contracts with customers is the total amount of consideration to which the Company expects to be entitled in exchange for transferring products or services to the customer.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts that contain prescription products include two performance obligations: access to (i)&#160;products and (ii)&#160;consultation services. The Company's contracts that do not contain prescription products have a single performance obligation. Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised product to the customer and, in contracts that contain services, by the provision of consultation services to the customer. The Company satisfies its performance obligation for products at a point in time, which is upon delivery of the products to a third-party carrier. The Company satisfies its performance obligation for services over the period of the consultation service, which is typically a few days. The customer obtains control of the products and services upon the Company's completion of its performance obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts with multiple performance obligations, the transaction price is allocated to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling price is based on the prices at which the Company separately sells the products and services, as well as market and cost plus margin-based estimates. For each of the three months ended March 31, 2021 and 2020, service revenue represented less than 10% of consolidated revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To fulfill its promise to customers for contracts that include professional medical consultations, the Company maintains relationships with various "Affiliated Medical Groups", which are professional corporations or other professional entities owned by licensed physicians and other professional entities that engage licensed healthcare professionals (medical doctors, physician assistants, nurse practitioners, and mental health providers; collectively referred to as "Providers" or individually, a "Provider") to provide consultation services. Refer to Note 8 &#8211; Variable Interest Entities. The Company accounts for service revenue as a principal in the arrangement with its customers. This conclusion is reached because (i) the Company determines which Affiliated Medical Group and Provider provides the consultation to the customer; (ii) the Company is primarily responsible for the satisfactory fulfillment and acceptability of the services; (iii) the Company incurs costs for consultation services even for visits that do not result in a prescription and the sale of products; and (iv) the Company, at its sole discretion, sets all listed prices charged on its websites for products and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, to fulfill its promise to customers for contracts that include professional medical consultations, the Company maintains relationships with affiliated and third-party pharmacies ("Partner Pharmacies" or individually, a "Partner Pharmacy") to fill prescriptions that are ordered by the Company's customers. The Company accounts for prescription product revenue as a principal in the arrangement with its customers. This conclusion is reached because (i) the Company has sole discretion in determining which Partner Pharmacy fills a customer's prescription; (ii) Partner Pharmacies fill the prescription based on fulfillment instructions provided by the Company, including using the Company's branded packaging for generic products; (iii) the Company is primarily responsible to the customer for the satisfactory fulfillment and acceptability of the order; (iv) the </span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i9f0e6f2fc1ae4ddb8b585a51d6519562" continuedAt="i9577adbd05fc41c882f563cd5bed5429"><ix:continuation id="i31330df5a68642d5821fc2a78f7e3ef6"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is responsible for refunds of the prescription medication after transfer of control to the customer; and (v) the Company, at its sole discretion, sets all listed prices charged on its website for products and services.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates refunds using the expected value method based on historical refunds granted to customers. The Company updates its estimate at the end of each reporting period and recognizes the estimated amount as contra-revenue with a corresponding refund liability. Sales, value-added, and other taxes are excluded from the transaction price and, therefore, from revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made an accounting policy election to account for shipping and handling activities performed after the control of a product has been transferred to the customer as fulfillment costs, with direct costs to ship products to customers included in cost of revenue. The Company's contracts with customers do not contain costs to obtain or costs to fulfill contracts with customers in accordance with ASC 340-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs&#8212;Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For online sales, payment for prescription medication and nonprescription products is typically collected from the customer a few days in advance of product shipment. Contract liabilities are recorded when payments have been received from the customer for undelivered products or services and are recognized as revenue when the performance obligations are later satisfied. Contract liabilities consisting of balances related to customer prepayments are recognized as current deferred revenue on the condensed consolidated balance sheets since the associated revenue will be primarily recognized within the following period. For wholesale arrangements, payments are collected in accordance with contract terms.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzk_32bfd86b-d50a-42c4-b8e1-b6a44924d16e" escape="true">The fair value of stock options, equity-classified warrants issued to vendors, and restricted stock units ("RSUs"), are measured at the grant date fair value. The fair value of employee stock options and vendor warrants are generally determined using the Black-Scholes Merton ("BSM") option-pricing model using various inputs, including estimates of expected volatility, term, risk-free rate, and future dividends. Stock options that were granted to the Company's Chief Executive Officer ("CEO") with performance and market conditions and earn-out RSUs were valued using the Monte Carlo simulation model. The Company recognizes compensation costs on a straight-line basis over the requisite service period of the employee and vendor, which is generally the option vesting term of <ix:nonNumeric contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfNjA0NzMxNDI3MTUzOQ_8183db76-6801-4829-b0b1-20fd568c7908">four years</ix:nonNumeric> for options and warrants that do not have performance or market conditions. Stock options and RSUs with performance conditions are recognized when it is probable that performance criteria will be achieved and compensation cost is recognized using the accelerated attribution method. The Company accounts for forfeitures as they occur.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warrant Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="hims:WarrantLiabilityPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfNjA0NzMxNDI2NjY1NA_2ed6c969-d836-437c-8b1b-39980e6bcf83" escape="true">The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 14 &#8211; Common Stock) as liabilities in addition to warrants to purchase preferred stock. At the end of each reporting period, changes in fair value during the period are recognized as a component of other (expense) income, net within the consolidated statements of operations and comprehensive loss. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.</ix:nonNumeric> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyODA_b0ea783a-1d87-43ef-a352-6e556833ea1c" escape="true">The Company currently leases a warehouse facility and previously leased office space under noncancelable lease agreements that are accounted for as operating leases. Rent expense is recorded on a straight-line basis over the lease term. For rent abatement and rent escalation provisions, the Company recognizes the related rent expense on a straight-line basis over the lease term. The difference between cash rent payments and the recognition of straight-line rent expense is recorded as deferred rent and amortized over the lease term.</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyODE_fb612585-9669-4e7e-868b-b2071aaa2c2a" continuedAt="i53fba8cb190f4baa9db119d228ec1d88" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board ("FASB") issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU modifies the disclosure requirements for fair value measurements by removing, modifying, or adding certain disclosures. The standard is effective for public companies for annual periods beginning after December 15, 2019, with early adoption permitted </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i9577adbd05fc41c882f563cd5bed5429"><ix:continuation id="i53fba8cb190f4baa9db119d228ec1d88"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for removed disclosures and delayed adoption until fiscal year 2020 permitted for the new disclosures. The Company adopted this disclosure requirement for the year ended December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February&#160;2016, the FASB issued ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires lessees to recognize leases on their balance sheets and disclose key information about leasing arrangements. The ASU establishes a right-of-use ("ROU") model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition on the income statement. The standard is effective for smaller reporting companies for annual periods beginning after December&#160;15, 2021 and for interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. In July&#160;2018, the FASB approved an amendment to the new guidance that allows companies the option of using the effective date of the new standard as the initial application (at the beginning of the period in which it is adopted, rather than at the beginning of the earliest comparative period) and to recognize the effects of applying the new ASU as a cumulative effect adjustment to the opening balance sheet or retained earnings. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to require the measurement of expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance also amended the impairment model for available-for-sale debt securities and requires entities to determine whether all or a portion of the unrealized loss on such debt security is a credit loss. In November 2018, ASU 2018-19 was issued which aligns the implementation date for nonpublic entities' annual financial statements with the implementation date for their interim financial statements and clarifies the scope of the guidance in the amendments in ASU 2016-13 to clarify that receivables arising from operating leases are not within the scope of Credit Losses (Topic 326) and should be accounted for in accordance with Leases (Topic 842). In April 2019, the FASB issued ASU 2019-04 which, among other amendments, allows for certain policy elections and practical expedients related to accrued interest on financial instruments. In November 2019, the FASB issued ASU 2019-10 and ASU 2019-11, which addressed certain aspects of the guidance related to effective dates, expected recoveries, troubled debt restructurings, accrued interest receivables, and financial assets secured by collateral. In February and March 2020, the FASB also issued ASU 2020-02 and ASU 2020-03, respectively, which provide certain amendments and improvements to sections of ASU 2016-13. These standards are effective for smaller reporting companies for annual and interim periods beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which is intended to improve consistency and simplify several areas of existing guidance. ASU 2019-12 removes certain exceptions to the general principles related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 is effective for annual periods beginning after December 15, 2020 for public entities, including interim periods within those fiscal years. The standard is effective for nonpublic companies for annual periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and as an emerging growth company ("EGC"), has elected to adopt the pronouncement following the effective date for nonpublic companies. The Company does not expect adoption will have a material impact on the Company's consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance includes amendments to improve the codification by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to the financial statements is codified in the disclosure section of the codification and to clarify guidance so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public entities, including interim periods within those fiscal years. The standard is effective for nonpublic companies for annual periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and as an EGC, has elected to adopt the pronouncement following the effective date for nonpublic companies.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_1198"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="hims:ReverseRecapitalizationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl82MDQ3MzEzOTYzMzk1_e610f182-06df-4332-9a4e-4b873fd222c9" continuedAt="i8593f4ae239243fcbc0c0b4810878127" escape="true">Recapitalization</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i8593f4ae239243fcbc0c0b4810878127"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1 &#8211; Organization, on the Closing Date, OAC completed the acquisition of Hims and acquired <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNTk5OA_0a6e0831-f98b-490a-8fbd-88a107688cf0">100</ix:nonFraction>% of  Hims' shares and Hims received gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" decimals="-5" format="ixt:numdotdecimal" name="hims:ProceedsFromIssuanceOfCommonStockRecapitalization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAwMg_b6d266e2-9003-4d71-990c-2dcdb8aa1cec">197.7</ix:nonFraction> million. Transaction costs of $<ix:nonFraction unitRef="usd" contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" decimals="-5" format="ixt:numdotdecimal" name="hims:ReverseRecapitalizationTransactionCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8yNzQ4Nzc5MDgwMDc1_0b54535a-a614-4000-be6d-cd14b02050b6">16.2</ix:nonFraction> million, which consist of legal, accounting, and other professional services directly related to the Merger, are included in additional paid-in capital in the condensed consolidated balance sheet as of March 31, 2021. On the Closing Date, each Hims stockholder received approximately <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAwOA_4b09c42d-8749-41b3-badc-9954fd6e378c">0.4530</ix:nonFraction> shares of the Company's Class A common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i2ce0c2a663404279ad0d0d1d6271d369_I20210120" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAxMw_49408859-2e03-4796-af21-208589d14ee2">0.0001</ix:nonFraction> per share, for each share of Hims Class A common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i5c3a9475a70b4c2db3d6e0010a374a0e_I20210119" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAxOA_dfaad308-2aa2-4334-ad1f-2d230d8696b4">0.000001</ix:nonFraction> per share, that such stockholder owned (with the CEO receiving <ix:nonFraction unitRef="number" contextRef="i35a4fb924db24a85a1196789003372ba_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAyMw_29f367e5-7545-4ceb-94a1-5e13093603ee">0.4530</ix:nonFraction> shares of Hims &amp; Hers Class V common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i3ee826f19c8f474091f7807831d1a4a2_I20210120" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAyOA_63e5d582-456b-4a76-8e50-f88e741a47ff">0.0001</ix:nonFraction> per share, for each share of Hims Class V common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="if23c020d049c42f8a21888c7cd351bf5_I20210119" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAzMw_5cffb237-6683-40d7-a721-37bd5ffd338d">0.000001</ix:nonFraction> per share, that the CEO owned). Each Hims stockholder also received <ix:nonFraction unitRef="shares" contextRef="ie5182198da4045b7a12388e80e2263ab_I20210120" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl84MjQ2MzM3MjI0MDU0_f22c3979-898f-4119-b822-081b222c16d5">0.0028</ix:nonFraction> warrants exercisable for the Company's Class A common stock, for each share of Hims Class A or Class V common stock owned by such stockholder prior to the Merger and earn-out shares at an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i2ffc7b3d75784438b282649862e9f57e_D20210120-20210120" decimals="INF" name="hims:RecapitalizationContingentConsiderationEquityExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl84MjQ2MzM3MjI0Mjcz_d34f708f-061c-40f7-8d04-0ae7d4be7f0c">0.0443</ix:nonFraction>. See Note 13 &#8211; Redeemable Convertible</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 14 &#8211; Common Stock for additional details of the Company's stockholders' equity prior to and subsequent to the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As additional consideration, OAC also granted <ix:nonFraction unitRef="shares" contextRef="i7ad8096dc8594c04b77015e5c84c1bfd_I20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAzNw_cec2210b-c22b-47e8-b5e2-3dc89479aadc">888,143</ix:nonFraction> OAC Class A common stock warrants ("Parent Warrants") to Hims' stockholders, <ix:nonFraction unitRef="shares" contextRef="if85b92e8012f4f1593f4f90ae859fd82_I20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA0MQ_a456ab46-084a-4155-9328-44c5dc771e9f">3,443</ix:nonFraction> Parent Warrants to warrant holders, and approximately <ix:nonFraction unitRef="shares" contextRef="i16335511aa6245258d50e49bba22ab99_I20210120" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA0NQ_23494d68-169a-4204-a0b3-eba935a9c972">35,000</ix:nonFraction> RSUs to Hims' option and RSU holders ("Parent Warrant RSUs").</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All equity awards of Hims were assumed by OAC and converted into comparable equity awards that are settled or exercisable for shares of the Company's Class A common stock. As a result, each stock option was converted into an option to purchase shares of the Company's Class A common stock based on an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA0OQ_ff952146-9bca-4721-8d04-55d1ecc5af8b">0.4530</ix:nonFraction>. Each award of the Hims' RSUs was converted into RSUs of the Company based on an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA1NQ_fca8156a-a910-4f8a-8f0d-79bab50a095b">0.4530</ix:nonFraction>. Similarly, all outstanding Hims warrants were converted at an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA1OQ_e82831e4-cf8d-4cf0-9727-846893cbafbd">0.4530</ix:nonFraction>.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for as a reverse recapitalization with Hims as the accounting acquirer and OAC as the acquired company for accounting purposes. Hims was determined to be the accounting acquirer since Hims' shareholders prior to the Merger had the greatest voting interest in the combined entity, Hims' shareholders appointed the initial directors of the combined Board of Directors and control future appointments, Hims comprises all of the ongoing operations, and Hims' senior management directs operations of the combined entity. Accordingly, all historical financial information presented in these unaudited condensed consolidated financial statements represents the accounts of Hims and its wholly owned subsidiaries as if Hims, rather than OAC, is the predecessor to the Company. No step-up basis of intangible assets or goodwill was recorded and net assets were stated at historical cost consistent with the treatment of the transaction as a reverse recapitalization of Hims. The shares and net loss per common share prior to the Merger have been retroactively restated as shares reflecting the exchange ratio established in the Merger (<ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA2Mw_bf2cc7bb-3e3b-49a0-8275-c27b3c5ce060">0.4530</ix:nonFraction> Company shares for 1 Hims share). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earn-Out Shares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the closing of the Merger, holders of Hims' common stock and outstanding equity awards (including warrant, stock option and RSU holders) had the right to receive up to an aggregate amount of <ix:nonFraction unitRef="shares" contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" decimals="INF" format="ixt:numdotdecimal" name="hims:ReverseCapitalizationContingentConsiderationEquityShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA2OQ_08e98247-5af7-4a2b-9d1b-ee79609347aa">16,000,000</ix:nonFraction> shares of Company Class A common stock (or equivalent equity award) that would vest (in part) in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA4MQ_07208523-3e62-469d-9993-e4c3d1e61cbc">15.00</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA4Ng_e15e205b-f256-49a6-8c36-f2e102edb8b3">17.50</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA5MQ_6993de5c-ad40-4e79-a2e0-0c6931af6c7b">20.00</ix:nonFraction> for any <ix:nonFraction unitRef="d" contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA5Ng_5321bd64-ec2d-4e4c-bc1f-583fbea27e87">10</ix:nonFraction> trading days within any <ix:nonFraction unitRef="d" contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjEwMQ_7164f5d4-4f84-4936-b858-65f177bb0ae8">20</ix:nonFraction>-trading day period on or prior to the date that is <ix:nonNumeric contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" format="ixt-sec:durwordsen" name="hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjEwNg_8f559933-1fc0-4a4d-befd-6b9a248398f0">five years</ix:nonNumeric> following the Closing Date. These shares of restricted Class A common stock and equivalent equity awards would also vest in connection with an acquisition of the Company if the applicable thresholds were met in any sale (as defined in the Merger Agreement) but subject to the same <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjExMQ_0328a105-577b-490b-8bab-4760962a29c8">five</span>-year deadline. In February 2021, all earn-out thresholds were met. In the first quarter of 2021, earn-out awards related to option holders received final approval by the Board of Directors. The earn-out shares are equity classified since they do not meet the liability classification criteria outlined in ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are both (i) indexed to the Company's own shares and (ii) meet the criteria for equity classification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PIPE Investment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the execution of the Merger Agreement, OAC entered into subscription agreements on September 30, 2020 with certain investors (the "PIPE Investors") pursuant to which such investors collectively subscribed for <ix:nonFraction unitRef="shares" contextRef="ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjEyMQ_0bfc6172-67e5-4e5a-b752-d6e60d677a14">7,500,000</ix:nonFraction> shares of the Company's Class A common stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="i16bc3ab7ee094ed08651067218f9050a_I20210120" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjEyNg_386982fd-279a-4127-818e-590c17fa529b">10.00</ix:nonFraction> per share for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjEzMQ_25b2a777-edb1-48d1-83cd-70f1450cb5db">75.0</ix:nonFraction> million (the "PIPE Investment"). The PIPE Investment was consummated substantially concurrently with the closing of the Merger.</span></div></ix:continuation><div id="i412093a93f204328a33c4602202f8375_34"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RleHRyZWdpb246OWRiMjU3NjZiZGY5NGI4OWE2ZTU5NzNjZWQxZmFjOWZfMTIwOTQ2Mjc5MDYwMjA_e2fdf46b-2fe4-4cad-b472-a776b97e47d1" continuedAt="i7b8491caa6d94c17bddef256d28db1e0" escape="true">Investments</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i7b8491caa6d94c17bddef256d28db1e0"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RleHRyZWdpb246OWRiMjU3NjZiZGY5NGI4OWE2ZTU5NzNjZWQxZmFjOWZfMTIwOTQ2Mjc5MDYwMjE_4051c466-b8e9-42ca-ad91-d0d78b5982c7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments as of March&#160;31, 2021, consist of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35fc17d5154d40cda4ba3221e9dcffb6_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMS0xLTEtMS0w_1f7db32a-997a-433f-a8ae-c645b7e59ec6">177,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35fc17d5154d40cda4ba3221e9dcffb6_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMS0zLTEtMS0w_e1b45f41-ed20-4fcd-bea4-b4db830785c7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35fc17d5154d40cda4ba3221e9dcffb6_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMS01LTEtMS0w_072cc57f-5249-4ecd-af6b-eb4d7a98a64f">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35fc17d5154d40cda4ba3221e9dcffb6_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMS03LTEtMS0w_1acbdde1-b190-4258-b46f-070e40ecdbd9">177,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8ae28174c74bcbafe8e1b9e1296cad_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMi0xLTEtMS0w_beabcd34-1913-408c-b74d-619d61c9ae10">40,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8ae28174c74bcbafe8e1b9e1296cad_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMi0zLTEtMS0w_487570b6-7815-4118-aa8a-be53169a2177">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifd8ae28174c74bcbafe8e1b9e1296cad_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMi01LTEtMS0w_eb08909a-55ce-418e-8ecf-39cc12284a71">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd8ae28174c74bcbafe8e1b9e1296cad_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMi03LTEtMS0w_e7be091d-6c28-4813-bf9a-f924bc396b77">40,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b386e439e1545bb8595dd4c08d832e1_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMy0xLTEtMS0w_5c0c4352-1ecd-40aa-b09b-c609a97c772b">16,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b386e439e1545bb8595dd4c08d832e1_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMy0zLTEtMS0w_1ffd9fd9-25f5-4160-932b-53220f5bea7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b386e439e1545bb8595dd4c08d832e1_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMy01LTEtMS0w_49dbb47a-c1f9-4422-aa4a-5d3209c04c7c">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b386e439e1545bb8595dd4c08d832e1_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMy03LTEtMS0w_8902953b-ec05-4eb6-aa88-33b60d8d9d37">16,924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfNC0xLTEtMS0w_60a78dce-8f64-4af5-9c11-3e94dd48773b">235,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfNC0zLTEtMS0w_0c2007a0-8520-47a3-a160-1e5391630e3c">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfNC01LTEtMS0w_d65812ba-d46e-434b-878a-3d7d2b8a4090">62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfNC03LTEtMS0w_d4e30c7c-4f7b-4910-8426-4872ef954adf">235,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments as of December&#160;31, 2020, consist of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d5c88b35bfb47219cf7c806d06b403f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMS0xLTEtMS0yMDg4_c7121b23-0a88-4a21-9d25-d07f8bf22ff3">55,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d5c88b35bfb47219cf7c806d06b403f_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMS0zLTEtMS0yMDg4_d2866127-2aff-4e48-9eca-003f842614bd">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0d5c88b35bfb47219cf7c806d06b403f_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMS01LTEtMS0yMDg4_75d32758-3d2e-493e-a7d4-8fb8962f43d0">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d5c88b35bfb47219cf7c806d06b403f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMS03LTEtMS0yMDg4_3bc5784f-ccee-4c49-bb90-59de9bafc2be">55,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82714ac40bb439a93d73928f1f21331_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMi0xLTEtMS0yMDg4_7ffe58ee-ee95-4182-83c7-ca3c0068a32f">14,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82714ac40bb439a93d73928f1f21331_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMi0zLTEtMS0yMDg4_0ed9f8df-8633-4198-990a-8c8330536841">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82714ac40bb439a93d73928f1f21331_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMi01LTEtMS0yMDg4_dadcd0f6-1c3a-4842-b495-7fe922c78b5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib82714ac40bb439a93d73928f1f21331_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMi03LTEtMS0yMDg4_17910327-bbe8-4d76-8ebb-9604973463c5">14,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6806d600b8f3488bb1c3fd3461c854a1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMy0xLTEtMS0yMDg4_9bda648e-3bcc-4fc9-84f9-eca1589683bf">3,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6806d600b8f3488bb1c3fd3461c854a1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMy0zLTEtMS0yMDg4_97ff7b61-4ab4-4fdb-925a-100a3cff36a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6806d600b8f3488bb1c3fd3461c854a1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMy01LTEtMS0yMDg4_4ff6d2b9-d16b-45de-8f7f-e6edf08a637a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6806d600b8f3488bb1c3fd3461c854a1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMy03LTEtMS0yMDg4_1721d11c-56fa-43dd-96fe-632da2e979e2">3,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfNC0xLTEtMS0yMDg4_423f7931-c592-4043-8dc4-1381de4d325a">72,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfNC0zLTEtMS0yMDg4_2b399eb8-74d9-4ff9-b5f8-c4fd7c4731a3">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfNC01LTEtMS0yMDg4_861bfbf5-dd28-47c2-921c-8c8b7ee931b8">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfNC03LTEtMS0yMDg4_552bfd28-7551-4a34-842c-c9ad375e2c71">72,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments mature within one year.</span></div></ix:continuation><div id="i412093a93f204328a33c4602202f8375_37"></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RleHRyZWdpb246NDFkNzc4ZjhmMzgxNDQyNzliNjk3ZjIyZDQzOGQ5ZWFfMTIwOTQ2Mjc5MDU2NTY_dfbed23a-9f7f-422f-9914-6a1daac484ed" continuedAt="i3bd2ec1d1c734f24bb67977f10ce460b" escape="true">Inventory</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i3bd2ec1d1c734f24bb67977f10ce460b"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RleHRyZWdpb246NDFkNzc4ZjhmMzgxNDQyNzliNjk3ZjIyZDQzOGQ5ZWFfNjA0NzMxMzk1Mjg4OQ_1f66ecdd-8e47-401c-bd97-35744b539961" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfMS0xLTEtMS0w_3b71d93c-4b53-4085-b493-95fb20341833">3,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfMS0zLTEtMS0w_c6737108-09c5-454e-8e7f-8d4bf89c8e0b">2,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfMi0xLTEtMS0w_58fff967-590f-45c6-a4f7-c0b01d235b5b">977</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfMi0zLTEtMS0w_b5583cb4-4ab1-4c50-8200-3a9d94700f08">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfNC0xLTEtMS0w_8c354f2d-2b34-45de-9183-c9b6b349c2dd">4,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfNC0zLTEtMS0w_a53db20e-d14e-443a-a5b9-89fee157af21">3,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:5pt"><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:OtherCurrentAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RleHRyZWdpb246NDY4Y2JkOTE4MjU3NDhmMmEwZjQ4MzE3ODU5MjQ0NjVfNjA0NzMxMzk1MzAwOA_417b6511-d11d-473e-a657-025ca25ad63d" continuedAt="i4d83e92e5e59440dbf7033b15c6d1480" escape="true">Prepaid Expenses and Other Current Assets</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i4d83e92e5e59440dbf7033b15c6d1480"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RleHRyZWdpb246NDY4Y2JkOTE4MjU3NDhmMmEwZjQ4MzE3ODU5MjQ0NjVfNjA0NzMxMzk1MzAwOQ_8b5b228b-6c03-43b3-a602-637e7f8d95ef" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="hims:TradeAndOtherReceivablesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMS0xLTEtMS0w_5f1d738b-c10c-448d-a290-171cb9829f8c">942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:TradeAndOtherReceivablesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMS0zLTEtMS0w_523e692b-f8ae-486b-8b32-81840b9e9523">1,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMi0xLTEtMS0w_de1aaa94-41dc-4092-bbb4-bfb0adade141">8,650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMi0zLTEtMS0w_cbef7b90-7e0e-4385-a15c-e833953ddf0e">2,691</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:VendorDepositsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMy0xLTEtMS0w_f7f23a57-db11-4999-b943-93e13e72e6e4">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:VendorDepositsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMy0zLTEtMS0w_19ef33e3-f0ce-4142-95ef-2b755bc0c27a">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfNC0xLTEtMS0w_a483fc4f-9c4a-4185-8afb-1a0dbb19d15e">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="us-gaap:OtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfNC0zLTEtMS0w_5834829f-3a7e-42fc-a899-cd37a2d9cf7e">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfNS0xLTEtMS0w_a09a0ba8-2030-4c16-a461-a2515b5cf306">12,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfNS0zLTEtMS0w_7001dd31-c282-4411-9382-d4ac6152c265">5,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_43"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RleHRyZWdpb246NzliMDVhYzM3M2NhNDVjYWJhMWM5MDI3YjQ1MTE1NGVfNjA0NzMxMzk1MjkyMg_594c138f-58e5-49db-b607-cce6136da412" continuedAt="i8c312ea718cc4ff1a16dba532b9da186" escape="true">Accrued Liabilities</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i8c312ea718cc4ff1a16dba532b9da186"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RleHRyZWdpb246NzliMDVhYzM3M2NhNDVjYWJhMWM5MDI3YjQ1MTE1NGVfNjA0NzMxMzk1MjkyMw_37acd6f2-9ba7-4f79-a340-f44a237fb342" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in&#160;thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedMarketingCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMS0xLTEtMS0w_df517494-4014-451b-8310-69b482f579f5">1,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedMarketingCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMS0zLTEtMS0w_d8bcb2b6-cef2-41a8-8bf4-0da3529be21f">1,122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMy0xLTEtMS0w_df1008f6-6f73-4abf-9a32-b04e13daa483">1,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMy0zLTEtMS0w_242e214a-6a6e-41cb-a373-4528a80eb3c1">1,241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:AccruedPayrollCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMy0xLTEtMS05Mzk5_3ea64b50-41fa-40a9-92d7-67e9380adac0">1,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="hims:AccruedPayrollCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMy0zLTEtMS05Mzk5_9981dba6-e21c-4254-8f2b-cfac59b3ffef">919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNC0xLTEtMS0w_535513fe-4d05-49d5-8ccf-4299f42cbfdf">729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNC0zLTEtMS0w_07e80196-4176-4a27-a46a-bea8c2223d20">651</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant exercise deposit liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DepositLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNS0xLTEtMS0w_8a7e59fc-b4b7-4bab-9816-2319ee59b829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="us-gaap:DepositLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNS0zLTEtMS0w_a6d8b548-c561-4aa3-9a57-428f1899e83b">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNy0xLTEtMS0w_4938b4c5-b218-4d52-90b4-7e44c9af34bf">850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNy0zLTEtMS0w_90a142aa-956c-4c9e-a376-ae49e0c36d42">387</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total accrued liabilities </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMTAtMS0xLTEtODQ3OA_4ed5668c-6044-4718-a923-e90a038aeaf5">5,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMTAtMy0xLTEtODQ3OA_2dbca642-f4a4-4f96-9644-b146355c9953">4,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:VariableInterestEntityDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNjA0NzMxMzk1ODk2Mg_bf5d9807-a6f8-4745-a79d-22b99ca5b5b0" continuedAt="if98d90c7792d4f95913030b50c7c148e" escape="true">Variable Interest Entities</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if98d90c7792d4f95913030b50c7c148e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order for customers to obtain a prescription product, customers must complete a consultation with a Provider on the Company's website through one of the Affiliated Medical Groups and receive a written prescription by the applicable Provider. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Affiliated Medical Groups and the Company do not have any shareholders in common. The Affiliated Medical Groups are <ix:nonFraction unitRef="number" contextRef="i110e767e14c549139091e08b11477a77_D20210101-20210331" decimals="INF" name="hims:PercentageOwnedByLicensedPhysicians" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfMTUzOTMxNjI4MDEyNzE_e98f8c70-2274-4a9c-9b9c-8e1ee4c02285">100</ix:nonFraction>% owned by licensed physicians. The Company is party to service agreements with the Affiliated Medical Groups pursuant to which the Company provides management and administrative services and collects the medical consultation fees from customers on behalf of the Affiliated Medical Groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company also entered into service agreements with XeCare LLC ("XeCare"), a licensed mail order pharmacy affiliated with the Company which is expected to provide prescription fulfillment services solely to the Company's customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Affiliated Medical Groups and XeCare are legal entities that the Company has determined qualify as variable interest entities ("VIEs"). The Company determined that it is the primary beneficiary of these entities for accounting purposes because it has the ability to direct the activities that most significantly affect the entities' economic performance and has the obligation to absorb the losses. Under the VIE model, the Company presents the results of operations and the financial position of the Affiliated Medical Groups and XeCare as part of the consolidated financial statements of the Company as if the consolidated group were a single economic entity. There is no noncontrolling interest upon consolidation of the entities. The results of operations and cash flows of the Affiliated Medical Groups and XeCare are also included in the Company's condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, the Company's condensed consolidated balance sheets included Affiliated Medical Groups and XeCare's combined current and total assets of $<ix:nonFraction unitRef="usd" contextRef="ib74f24447d164fde8a5bd9a5c8151c3d_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0ODU4NA_2c7e1af2-0f39-4366-a8c6-07d283e43ce7"><ix:nonFraction unitRef="usd" contextRef="i9e0a54203ace4daf8d031a96662b2a6a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0ODU4NA_94acaf6a-024f-41aa-801f-d20dfcab9830">0.5</ix:nonFraction></ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib74f24447d164fde8a5bd9a5c8151c3d_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0ODU5MA_b40e8c80-6026-462a-9472-2e90fd1a0715"><ix:nonFraction unitRef="usd" contextRef="i9e0a54203ace4daf8d031a96662b2a6a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0ODU5MA_f66aafd3-0b0a-4a0a-91a1-e20dc8831420">1.4</ix:nonFraction></ix:nonFraction> million. As of March&#160;31, 2021 and December&#160;31, 2020, current liabilities were $<ix:nonFraction unitRef="usd" contextRef="ib74f24447d164fde8a5bd9a5c8151c3d_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0NjE3Nw_09093811-fb99-416b-8dbd-9f50445099cc">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9e0a54203ace4daf8d031a96662b2a6a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0NjE4OA_c20eca9b-a6e2-41c5-bedc-7b0514234400">0.8</ix:nonFraction> million and total liabilities were $<ix:nonFraction unitRef="usd" contextRef="ib74f24447d164fde8a5bd9a5c8151c3d_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfODI0NjMzNzIxOTk4OQ_cea623c8-e512-4459-a98f-4f2496f29087">1.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9e0a54203ace4daf8d031a96662b2a6a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfODI0NjMzNzIxOTk0Nw_d7ff3926-d879-4c64-8ff0-0fabb93369a4">1.2</ix:nonFraction> million. All amounts are after elimination of intercompany transactions and balances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations and cash flows of the Affiliated Medical Groups and XeCare are included in the Company's condensed consolidated financial statements. For the three months ended March 31, 2021 and 2020, the Affiliated Medical Groups and XeCare combined charged the Company $<ix:nonFraction unitRef="usd" contextRef="i1f396a9dac504e31a6c12e06a6f5e451_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfMjIzNA_581b6376-841c-4a73-b765-82e0857a2041">3.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic2df3bb0701545b6bfc7f10a7ab86773_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfMjI0MQ_e322c371-d7f2-4598-be27-ee7aa9b8ef6f">0.3</ix:nonFraction> million for services rendered. For the three months ended March 31, 2021 and 2020, the net losses generated by the Affiliated Medical Groups and XeCare combined were $<ix:nonFraction unitRef="usd" contextRef="i7d3aa17ad4214d73ac617595f9b25c56_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfMTY0OTI2NzQ0ODI3OA_c4ee493f-3710-43f0-9782-bdd1ebeee256">1.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i17f7c6fe28314265a7171dccf5d0b1e1_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfODI0NjMzNzIxNDE5Mg_e3755b5e-ac37-4592-83ee-064ffd772c17">2.5</ix:nonFraction> million after elimination of intercompany transactions and balances.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_49"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfNjA0NzMxMzk2MTg2NQ_ded14445-d3ca-46b2-8489-94fd8dc21189" continuedAt="i88229bac6bfc4975bd743d8ed29397d3" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i88229bac6bfc4975bd743d8ed29397d3" continuedAt="id5aafd069ece43adb0ab165e18a9b73f"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfNjA0NzMxMzk2MTg2Ng_23b1e2f7-8cee-468c-8ad4-0facd271415c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis as of March&#160;31, 2021, is as follows (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1261279d3aa492883efe6f3cd396cb3_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMy0xLTEtMS0w_2fea1d65-12bc-4bcc-9a79-a609aedbd899">74,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3f6c0cccb1747fab4662fd836029d53_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMy0zLTEtMS0w_1a87eeca-f743-4276-bb96-bcf57707772c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0da6465d5cfd441a8e436e127aad5c7e_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMy01LTEtMS0w_a80821d7-c390-4f0f-84cd-ab4967cd65ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice63ea8cf53844e0864c120028d72122_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMy03LTEtMS0w_f7ea469a-f353-486b-a2a6-73fc4a3a4a6c">74,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib363310ebb4645b0a3c4dd9026e8460b_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNC0xLTEtMS0w_858f4e4b-d37e-43d4-91d9-e5f049573ea7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9857a89a397463b9c65163424b97b37_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNC0zLTEtMS0w_70af430a-1066-4146-a337-641ede034daf">11,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie581b89d86bb4b27a922377f19e8768c_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNC01LTEtMS0w_69b6e426-5b49-4a87-a867-bb52437bbc12">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaf57a370dcb4f3194869f3b6b0cc8ef_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNC03LTEtMS0w_b1c28e12-58cd-428c-9896-6f4646caaaf3">11,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccc37ed1bbc44e95b445c711db6f3652_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNi0xLTEtMS0w_5aa0f47b-ce0d-437d-bc92-409879254d19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3447faea2aa041928f7c8b0073fbfa56_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNi0zLTEtMS0w_04d8c2c8-51f9-449f-9111-33b7d23facc8">177,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e36e9ea2b4a410389a76edfd4bc808c_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNi01LTEtMS0w_9bf5eb3b-3aef-4b7d-a42a-5c3f0e912966">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21bfa4e61b64d21b588aa675df6b00e_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNi03LTEtMS0w_7cbf9e31-6de3-4d76-919f-2f04f83eefee">177,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5551c8f434cf4e9996e3e103dd9851e3_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNy0xLTEtMS0w_46e562f6-f3ee-494c-ba8c-1e8a95ec74e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dd0cb9d9b154483976882a2f8f17dae_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNy0zLTEtMS0w_8b3ec4ea-c99f-4445-9cf9-f71015ad392a">40,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d5316cfa402448b974312f0f0bc26ca_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNy01LTEtMS0w_9c0dfeed-2174-41b1-b582-efbda122f5ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77245f278ab24e148fb7d4fc5d3b59fc_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNy03LTEtMS0w_8d7a3570-ed4a-4d0c-8d56-3c2376d1a10f">40,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5921abd0287d42bca47601e3138ee2b7_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfOC0xLTEtMS0w_2d606808-2e43-4d91-936d-9567e04286d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e49409a01d64ff5bfdd179b67b5738c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfOC0zLTEtMS0w_c02f8100-0b90-41aa-92cf-40df6eef54f9">16,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id215004884234f36b4e29d5e5c970035_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfOC01LTEtMS0w_62dd7f65-8f63-4537-a720-4f653ca0ea6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i951242edbea04ed9a606420d62e43d5a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfOC03LTEtMS0w_cfe1baf2-d85e-45cb-b5fb-4a4e4527124f">16,924</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i331c1c09758e4c69a36701bae87d7d62_I20210331" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTAtMS0xLTEtMA_f15526a2-8cec-4c48-8e91-7473eb4c356d">856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5563144fb5ca4783b8c91e836f518044_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTAtMy0xLTEtMA_8ea2b54d-9dd3-4211-a1ba-c244edca3b0c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21b17ce9282470780a4cb69a30b093f_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTAtNS0xLTEtMA_e433f173-87b4-4ff7-b2b9-512845230c5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabbb558f9a6046f6a6d5d46c8153d18b_I20210331" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTAtNy0xLTEtMA_9012eda5-6fd1-4a58-914f-7f2dcafad7da">856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccdf1b1af9d34e62a5785c63d9ca448c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTMtMS0xLTEtMA_6a72b41c-98fe-40c6-aa76-f2cd80e2550b">75,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66b86854e56b4e96a87ecc1cda0a4203_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTMtMy0xLTEtMA_244a3ed3-84ab-4c8b-b261-50db46aa4dcf">246,179</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44535c1c0c1942a59dc7b0356127e67b_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTMtNS0xLTEtMA_9a81596f-5aa3-4b7c-b70c-c2f26b8b27ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21c138cee4747ccb68c72561e6a795b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTMtNy0xLTEtMA_4884e387-22c4-4b84-ab1e-051d3112b2d2">321,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccdf1b1af9d34e62a5785c63d9ca448c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTUtMS0xLTEtMA_1b33734b-717d-4668-b1df-d73315a960f0">33,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66b86854e56b4e96a87ecc1cda0a4203_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTUtMy0xLTEtMA_c5bb3ce6-f1c5-4e31-af7b-911af90b3d9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44535c1c0c1942a59dc7b0356127e67b_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTUtNS0xLTEtMA_d4212fea-4b78-4b08-a32d-70204bc4df68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21c138cee4747ccb68c72561e6a795b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTUtNy0xLTEtMA_320c8cd5-dfc5-4b45-899a-89e83206fb9c">33,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iccdf1b1af9d34e62a5785c63d9ca448c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTYtMS0xLTEtMA_cc2c3c27-2043-4c3d-a2f5-8e7e18d17f6b">33,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66b86854e56b4e96a87ecc1cda0a4203_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTYtMy0xLTEtMA_a4b2847f-eb2b-4d4e-a10f-f5d45b130b79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44535c1c0c1942a59dc7b0356127e67b_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTYtNS0xLTEtMA_97940320-2aff-45f2-923a-0df20565feb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie21c138cee4747ccb68c72561e6a795b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTYtNy0xLTEtMA_ebdde3f0-4453-4617-82dc-51fe03fe9fa2">33,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2020, is as follows (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i412599e663c246f58192d84fe4e5c1b9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMy0xLTEtMS0w_66f8ea8c-6477-472e-b7b1-fa0e77d73b0e">12,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ad3e5023fd84a749114f9e9c5d8fe3a_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMy0zLTEtMS0w_17c6ef63-6caf-4771-bae4-a0395723e25a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31da51b8ef1b4471a68135a9ca41a2d6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMy01LTEtMS0w_2e2bdc9d-a521-4010-8b3c-deedb96ab2dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icfd5ade4260a4169b2a95d7bff1b3555_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMy03LTEtMS0w_3911bcb3-0a67-4c3c-a740-eea9a605bd1c">12,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id759fafd0df14ae7b07a52edb22e1ca9_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNC0xLTEtMS0w_e6c6e97b-0bab-42fa-953f-e38bf6b877b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4a1baeea1040a6bfbcedb38a9692e8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNC0zLTEtMS0w_6da5c166-7535-45c2-9f12-f09290669380">12,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e6e3cda27214222b2b0bfe2a6683419_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNC01LTEtMS0w_0c8d2975-2407-4318-86c7-10ebfcc0d61e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ed5940103494fb785ddb8f61a51b123_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNC03LTEtMS0w_38890e05-7185-4df2-8bc3-d1e45f79e4c5">12,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifda94c6105694420b4c8f321805f5ce1_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNi0xLTEtMS0w_16e3233e-f6cf-47e9-8d24-8d687a161d8c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5013ddd007d4531aa596bb95e66ae50_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNi0zLTEtMS0w_bf2d1e5b-4157-4c72-a102-815a3a0e8de3">55,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5e442e5c43548c4948861619534ee83_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNi01LTEtMS0w_3d245899-c11f-41ce-a079-bf75162d4ae1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia16cd32451554ee58bc61ba0bd167f4d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNi03LTEtMS0w_00c0af6b-1496-423b-be88-377fefb33dbf">55,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b128102f77412aae3acc936185d672_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNy0xLTEtMS0w_a816819e-5578-4086-870a-64093452deac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99e1a4138a1e4cb69b365d76305514e5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNy0zLTEtMS0w_448af092-19c7-4fcb-8571-229d28dae6c4">14,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c40d2b1b9bf422baf436e98c75a1c04_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNy01LTEtMS0w_81accbde-413d-4dd2-aa8d-befda80413ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f48df72d4d24ae497a675ff9cf956e3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNy03LTEtMS0w_00fcc1ee-131e-43af-9fff-c0fefb01e65b">14,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7308d4762634cee8d9041732b9af184_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfOC0xLTEtMS0w_de8194a4-285d-443a-a3ef-3d6c4929d920">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7eca143c66bf4203b6157bcac25d255b_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfOC0zLTEtMS0w_a12231ab-2bd8-467a-9489-805df3cb1000">3,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25ea3f8831144795bc21e4c954d3d744_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfOC01LTEtMS0w_dc0396d0-f376-4366-8e26-4c532ddb01c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fe48b31f8c34e88b6668252c5babd68_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfOC03LTEtMS0w_55c044c6-e7ba-43e0-bee0-54e7d2fe5fc3">3,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1c7658a139f475181f2d9be70639547_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTAtMS0xLTEtMA_439693c1-28ca-4238-b131-e9a2187f8569">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16613643ae1546028149b3da23f7a029_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTAtMy0xLTEtMA_220b1a9c-80b0-4e87-ae35-0e2503d56015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bd82762a6b54ce086b7a833cdd8431c_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTAtNS0xLTEtMA_b5018d8b-20f2-4c94-8014-0e0641878f74">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic900949695af4a3f8a0e43ab44a1d546_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTAtNy0xLTEtMA_35473df6-d6b7-4531-889a-dcad5581b19c">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf3e680104bd40d0a6d893fc9d407cbe_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTMtMS0xLTEtMA_afd4ae0b-99be-4433-a1f4-71b14f1dc557">13,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16c0164539c14d3c8ffaafa97bcfab89_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTMtMy0xLTEtMA_404bedcf-7f54-4583-9e20-1e77d9991864">85,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e62e51bd26b485eb7df23994a15198e_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTMtNS0xLTEtMA_ca1593ac-c1ae-4749-921e-a8c136313ddc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987f47d6dcfe4bbcac41361b3f772407_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTMtNy0xLTEtMA_389f9505-6bcf-4a95-a533-d871e98e94a0">98,726</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf3e680104bd40d0a6d893fc9d407cbe_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTUtMS0xLTEtMA_b180f3bf-d74e-4858-8c91-dc40081a638f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16c0164539c14d3c8ffaafa97bcfab89_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTUtMy0xLTEtMA_cc060cb2-f3ac-45a4-abf1-c5f729b0cdee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e62e51bd26b485eb7df23994a15198e_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTUtNS0xLTEtMA_74d35d8b-f44c-4203-bd24-276d31133eb0">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987f47d6dcfe4bbcac41361b3f772407_I20201231" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTUtNy0xLTEtMA_64fc728d-8592-432c-955e-daafa6438ca7">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf3e680104bd40d0a6d893fc9d407cbe_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTYtMS0xLTEtMA_2aa0bc7d-21e0-4852-8abe-f3768a5ec4f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16c0164539c14d3c8ffaafa97bcfab89_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTYtMy0xLTEtMA_d15b6d01-c14c-4f07-9097-346ae31dc4ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e62e51bd26b485eb7df23994a15198e_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTYtNS0xLTEtMA_cf661fd7-83e6-4a71-9c5c-369633fba012">906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i987f47d6dcfe4bbcac41361b3f772407_I20201231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTYtNy0xLTEtMA_8953ddd9-91aa-4625-9cd1-b87be182cd67">906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of cash, accounts receivable, accounts payable, and accrued liabilities approximated their carrying values as of March&#160;31, 2021 and December&#160;31, 2020, due to their short-term nature. All other financial instruments except for warrant liabilities related to the preferred stock warrants and Private Placement Warrants are valued either based on recent trades of securities in active markets or based on quoted market prices of similar instruments and other significant inputs derived from or corroborated by observable market data. The warrant liabilities related to the preferred stock warrants and Private Placement Warrants contain significant unobservable inputs including the expected term and with respect to the preferred stock warrants, the share exchange ratio in evaluating the fair value of underlying common stock, and exercise price. Therefore, these warrant liabilities were evaluated to be a Level 3 fair value measurement.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="id5aafd069ece43adb0ab165e18a9b73f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In prior periods, the fair value of the preferred stock warrant liability had been measured using the BSM option-pricing model and Monte Carlo simulation. During 2020, the Company changed its valuation method as a result of increased probability that the Company's common shares would be publicly listed in the near-term and began using a probability weighted expected returns methodology. As of December 31, 2020, the Company reverted to using a BSM option-pricing model to determine the value of the outstanding Series D preferred stock warrants (that replaced the Series C preferred stock warrants as discussed in Note 10 &#8211; Borrowing Arrangements). Subsequent to the Merger, the Series D preferred stock warrants were converted to Class A common stock warrants. As a result, the Series D preferred stock warrants were adjusted to fair value prior to the conversion resulting in a change in fair value of $<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfMTUzOTMxNjI4MDUyOTI_1eac80bf-f096-4122-83a8-e85050f3e858">0.3</ix:nonFraction> million recognized as a component of other income (expense), net within the consolidated statements of operations and comprehensive loss, and then settled in additional paid-in capital as a result of the conversion to equity-classified Class A common stock warrants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2021, changes in warrant liabilities also related to changes in liabilities for warrants assumed as part of the recapitalization, including Private Placement Warrants and Public Warrants (defined and discussed in Note 14 &#8211; Common Stock). The Company valued the Private Placement Warrants using a Monte Carlo valuation simulation. Inherent in a Monte Carlo simulation are assumptions related to expected term, volatility, risk-free interest rate and dividend yield. The expected term of the warrants was determined to be equivalent to their remaining contractual term and includes consideration of the redemption features that were incorporated into the Monte Carlo model. The Company derived the volatility of its Class A common stock based on average historical stock volatilities of a peer group of public companies that the Company considers to be comparable to its business over a period equivalent to the expected term of the Private Placement Warrants. The risk-free interest rate is based on the U.S. Treasury's rates of U.S. Treasury zero-coupon bonds with a maturity similar to the expected term of the Private Placement Warrants. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="hims:ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfNjA0NzMxMzk2ODQ0NQ_5da9278e-7e7d-4469-ba33-d497f4be5dae" continuedAt="ied98e1d1b8474820aaf0f987c8faa05c" escape="true">The following assumptions were used for the valuation of the Private Placement Warrants on the settlement date:</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ied98e1d1b8474820aaf0f987c8faa05c" continuedAt="i5f912d538a074d2f93aabbc7d163ba91"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic3283d5498c749f187e436d50e1f4646_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjE3Mjk5NmJmZTgwNjQwOTg4MTI2YTRkNzFhMzU3NmFjL3RhYmxlcmFuZ2U6MTcyOTk2YmZlODA2NDA5ODgxMjZhNGQ3MWEzNTc2YWNfMC0xLTEtMS0xOTQ2NA_6b8f2c43-9d40-46b2-94f0-ff1774142657">0.16</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3283d5498c749f187e436d50e1f4646_D20210101-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjE3Mjk5NmJmZTgwNjQwOTg4MTI2YTRkNzFhMzU3NmFjL3RhYmxlcmFuZ2U6MTcyOTk2YmZlODA2NDA5ODgxMjZhNGQ3MWEzNTc2YWNfMS0xLTEtMS0xOTQ2NA_bab846ad-c82d-4a54-9e2e-b409bc933a37">65.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3283d5498c749f187e436d50e1f4646_D20210101-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjE3Mjk5NmJmZTgwNjQwOTg4MTI2YTRkNzFhMzU3NmFjL3RhYmxlcmFuZ2U6MTcyOTk2YmZlODA2NDA5ODgxMjZhNGQ3MWEzNTc2YWNfMi0xLTEtMS0xOTQ2NA_f91cd32a-b755-4549-9876-c15977a0da14">0.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic3283d5498c749f187e436d50e1f4646_D20210101-20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-8" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjE3Mjk5NmJmZTgwNjQwOTg4MTI2YTRkNzFhMzU3NmFjL3RhYmxlcmFuZ2U6MTcyOTk2YmZlODA2NDA5ODgxMjZhNGQ3MWEzNTc2YWNfMy0xLTEtMS0xOTQ2NA_f186a6ba-5b4e-4acf-bfa7-b0097d48e31a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants were valued as of March&#160;31, 2021 using the listed trading price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2f384c5987114c539e4c3c37fe1f66ab_I20210331" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfMTUzOTMxNjI4MDUzMTQ_0c3b79e5-a4ea-447c-a014-9a5357fb1e72">4.40</ix:nonFraction> per Public Warrant.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfNjA0NzMxMzk2NjA5Mg_7197b8e8-a398-4cb2-90de-3de26480abef" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of warrant liabilities is as follows (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMC0xLTEtMS05NTI1_5c96e9a0-d7e4-44d6-8f22-65d14837c287">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of Series D preferred stock warrants to Class A common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMS0xLTEtMS05NTI1_fd64b55c-47b1-49aa-af63-a600cc998bf6">1,160</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants and Public Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMi0xLTEtMS05NTQ5_4f94266e-9c4e-49c2-92d7-8c0894e19124">51,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMy0xLTEtMS05NTQ5_206c1d6a-3ca6-4084-bfa0-7ab2f9163931">20,871</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value of warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMi0xLTEtMS05NTI1_0ab572dc-58f1-4299-9b67-e7bbeeda0892">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMy0xLTEtMS05NTI1_8974c034-b7df-425a-9ffb-bd8e765c160c">33,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had no transfers between levels of the fair value hierarchy of its assets or liabilities measured at fair value. Due to the exercise and conversion to Class A common stock warrants of all preferred stock warrants and exercise of all of the Private Placement Warrants during the period, there were no longer any Level 3 warrant liabilities.</span></div></ix:continuation><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2MzM3OQ_ac5e8101-2b69-4e7c-bc2d-690ca0140154" continuedAt="ib434c7573221439f99c7cf98d693c238" escape="true">Borrowing Arrangements</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib434c7573221439f99c7cf98d693c238" continuedAt="i09f1da1f09b34521ba37277c8410d5cb"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Silicon Valley Bank</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Second Amended and Restated Loan Agreement dated November 27, 2019, between Hims and Silicon Valley Bank ("SVB"), upon Hims' request, SVB would issue letters of credit (the "Letters of Credit") in an aggregate amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="i3fe856ce18a44b73b24c2b3b20e78100_I20191127" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2MTY_b2944d40-fcdd-4d27-af45-a6500a8696e6">2.0</ix:nonFraction> million. This amount is reduced by the amount otherwise available with respect to the cash management services, which may include merchant services, direct deposit of payroll, business credit card, and check cashing services identified in SVB's various agreements. On September 30, 2020, Hims entered into the First Loan Modification Agreement ("Loan Modification </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i09f1da1f09b34521ba37277c8410d5cb"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement") and the aggregate amount of the Letters of Credit was amended to $<ix:nonFraction unitRef="usd" contextRef="i5b82495f9a7d49a191625811b12a3abe_I20200930" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2MjM_31b0a5cf-c7fa-4de9-925c-39ece79e1101">3.5</ix:nonFraction> million. As of March&#160;31, 2021, SVB issued on the Company's behalf, a letter of credit in the amount of $<ix:nonFraction unitRef="usd" contextRef="i02b56d69d02b40c8bb34acbef31e8a91_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfODI0NjMzNzIxNzA2NA_64ea8a2b-62cf-400e-9372-0499f48b9a16">0.8</ix:nonFraction> million as a security deposit for a warehouse space in New Albany, Ohio. SVB required  $<ix:nonFraction unitRef="usd" contextRef="i3a251b644bc0446c8e735717fbf04f53_I20210331" decimals="-5" format="ixt:numdotdecimal" name="hims:DebtInstrumentCovenantRequiredCollateralAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2Mjk_6a07165d-af1a-432b-bd92-6ad8cfd56d5e">0.8</ix:nonFraction> million to be maintained as collateral for the outstanding letter of credit. The Company expects to continue to renew the letter of credit through the duration of the lease. As this is for longer than one year, the Company presents the $<ix:nonFraction unitRef="usd" contextRef="i3a251b644bc0446c8e735717fbf04f53_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2MzU_eb8cb420-5140-4075-a66b-3c5e2d248830">0.8</ix:nonFraction> million within restricted cash, noncurrent on the consolidated condensed balance sheet. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a business credit card as part of the cash management services offered by SVB with an initial limit of $<ix:nonFraction unitRef="usd" contextRef="i5a8d0ab00fc54564bf744ee2cdb48474_I20191127" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NDE_2d7f830f-097f-4d92-815a-b0806f35d722">2.0</ix:nonFraction> million which is reduced by the amount utilized for any issuances of Letters of Credit. This amount was increased to $<ix:nonFraction unitRef="usd" contextRef="i68341f8644ea4e029489cb67df2b60c9_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NDc_c31235e0-8f8a-4ed2-b5e6-972f017a6cc9">3.5</ix:nonFraction> million by the Loan Modification Agreement. To continue to use the credit card, SVB required $<ix:nonFraction unitRef="usd" contextRef="i68341f8644ea4e029489cb67df2b60c9_I20210331" decimals="-5" format="ixt:numdotdecimal" name="hims:DebtInstrumentCovenantRequiredCollateralAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NTM_80f49c1a-66d9-43e6-a24f-52fd8e8a780c">0.2</ix:nonFraction> million to be maintained in a collateralized money market account and this was reflected within restricted cash on the consolidated balance sheet as of December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company terminated the Second Amended and Restated Loan Agreement with SVB resulting in the release of restricted cash of $<ix:nonFraction unitRef="usd" contextRef="i0973a5a47b37445789cae6d5c00e8ead_I20210131" decimals="-5" format="ixt:numdotdecimal" name="hims:DebtInstrumentCovenantRequiredCollateralAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NjY_0aefcfe4-e528-4df4-9ef7-5c6ed8b96e53">0.2</ix:nonFraction> million under the arrangement. The outstanding letter of credit for the warehouse was not included as part of this termination. In addition, the Company continues to use SVB's cash management services and increased its credit card limit to $<ix:nonFraction unitRef="usd" contextRef="i0973a5a47b37445789cae6d5c00e8ead_I20210131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NTk_3fbac71f-1596-4075-b4db-1b6a92b1906d">5.0</ix:nonFraction> million in January 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TriplePoint Venture Growth</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;27, 2019, Hims entered into a Plain English Capital Growth and Security Agreement (the "2019 Capital Agreement") with TriplePoint Venture Growth ("TPC") consisting of a term loan in the aggregate principal amount of up to $<ix:nonFraction unitRef="usd" contextRef="i5a1bd4b3c5cf421eb59bc006d40c812b_I20191127" decimals="INF" format="ixt:numdotdecimal" name="hims:DebtInstrumentMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NzI_f0bc48f4-4f01-47cf-b1f9-2964ce499e8f">50.0</ix:nonFraction> million, with $<ix:nonFraction unitRef="usd" contextRef="i9d494bd599bc4c71829076ebfffdde40_I20191127" decimals="INF" format="ixt:numdotdecimal" name="hims:DebtInstrumentMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2Nzg_eea51e28-dd2b-44b5-9ac7-b062f8959377">25.0</ix:nonFraction> million being available immediately through December&#160;31, 2020 (the "Part 1 Commitment Amount"), and an additional $<ix:nonFraction unitRef="usd" contextRef="i36b5c8248a21411787d87df95d270d0a_I20191127" decimals="INF" format="ixt:numdotdecimal" name="hims:DebtInstrumentMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2ODQ_e7175e6c-37ae-4aae-a136-675891b4a0f6">25.0</ix:nonFraction> million becoming available upon utilization of the Part 1 Commitment Amount through December&#160;31, 2020. There was no minimum advance amount. As collateral, the Company provided a second lien security interest to TPC of substantially all its assets. As of December 31, 2020, the Company had <ix:nonFraction unitRef="usd" contextRef="i7b388341898d4c259124f7ad120acc5c_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DebtLongtermAndShorttermCombinedAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2OTY2Mw_7d291cb0-72fa-46cf-9dfd-ecfc42519a44">no</ix:nonFraction>t drawn down from this term loan and the facility expired.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2019 Capital Agreement, the Company issued to TPC a warrant granting TPC the right to purchase <ix:nonFraction unitRef="shares" contextRef="i75207e8547a1486e92e7339599496592_I20191127" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2MzMxMg_3b81fff9-b2f2-485d-9e2f-3ec7fbefe2c2">89,747</ix:nonFraction> shares of Hims' Series C preferred stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i75207e8547a1486e92e7339599496592_I20191127" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfODI0NjMzNzIyMzAzOQ_b163cee0-8c26-4f87-8c64-1c35000e5cd3">7.67</ix:nonFraction> per share, subject to adjustment in regard to the preferred stock series, number of shares and exercise price if the per share price of subsequent preferred stock rounds less than $<ix:nonFraction unitRef="usdPerShare" contextRef="i75207e8547a1486e92e7339599496592_I20191127" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfODI0NjMzNzIyMzA0Nw_b163cee0-8c26-4f87-8c64-1c35000e5cd3">7.67</ix:nonFraction>. On March&#160;12, 2020, Hims sold Series D preferred stock at an issuance price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i85017d290ffd4ccda16318d642b40261_I20200312" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2MzMzOA_ec39e5f6-efa9-44f0-8147-180f0621d0ce">6.96</ix:nonFraction>, which triggered an adjustment to the TPC warrant terms per the original agreement, resulting in conversion of the previously issued <ix:nonFraction unitRef="shares" contextRef="i9325ba192ff34fe4a7eec3cc7c4f7351_I20200312" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2NzcxOQ_ce592ad8-9ee7-4da7-a90d-fba1150c9afe">89,747</ix:nonFraction> Series C preferred stock warrants at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9325ba192ff34fe4a7eec3cc7c4f7351_I20200312" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2NzczNQ_26709edc-90af-4c1c-9154-fc7a04051d2b">7.67</ix:nonFraction> into <ix:nonFraction unitRef="shares" contextRef="i85017d290ffd4ccda16318d642b40261_I20200312" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2MzM2Mg_9a71f51b-a3af-4252-b3ff-ab7900de1b13">98,723</ix:nonFraction> Series D preferred stock warrants at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i85017d290ffd4ccda16318d642b40261_I20200312" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfODI0NjMzNzIyMzA5OQ_ec39e5f6-efa9-44f0-8147-180f0621d0ce">6.96</ix:nonFraction>. Subsequent to the Merger, the Series D preferred stock warrants were converted to Class A common stock warrants. Refer to Note 13 &#8211; Redeemable Convertible</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Preferred Stock</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further discussion of the conversion into Class A common stock warrants.</span></div></ix:continuation><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk1ODk4MA_47969d28-6fab-42e8-991a-e29025b9a330" continuedAt="i97db2471ebb14c538257c176855b329e" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i97db2471ebb14c538257c176855b329e" continuedAt="i76c3c895bce44cdbbb9fd5a348cad70f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total rent expense for the three months ended March 31, 2021 and 2020, was $<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LeaseAndRentalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNzMx_85bf5338-5408-44df-ad16-dcf36ac64e8a">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LeaseAndRentalExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNzM4_7e7ec076-213b-411a-adcb-0dc4ea77c9aa">0.7</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Company entered into a <ix:nonNumeric contextRef="i5675e635aac644dca3d94839ad1ea8dd_D20200101-20200131" format="ixt-sec:durmonth" name="hims:OperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQzNg_59cc7e21-8b67-46fc-b82b-0572295364da">63</ix:nonNumeric>-month noncancelable lease for <ix:nonFraction unitRef="sqft" contextRef="i4d3f4663a5ae4f998ff2c4ed33cc4b76_I20200131" decimals="-1" format="ixt:numdotdecimal" name="us-gaap:AreaOfRealEstateProperty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ0NQ_266ac656-c251-4f85-9f8f-0adf539ef1ae">302,880</ix:nonFraction> square feet of warehouse space in New Albany, Ohio. The lease commenced on June 1, 2020. Total minimum lease payments are $<ix:nonFraction unitRef="usd" contextRef="icea812223fa644ce962e9076a86b988e_I20200131" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ1NA_55bde4f5-a8d5-47d0-bc58-204e72be031e">7.9</ix:nonFraction>&#160;million, net of rent abatement for an initial <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ2Nw_b7a72c41-6787-457a-a407-941a4bba5358">three</span>-month period and with annual escalation of <ix:nonFraction unitRef="number" contextRef="i5675e635aac644dca3d94839ad1ea8dd_D20200101-20200131" decimals="3" name="hims:OperatingLeaseRentExpenseAnnualEscalationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ3OA_179c823b-ca55-4ab8-bbb5-c1f153a12547">2.5</ix:nonFraction>%. The Company has the option to extend the lease term for a period of <ix:nonNumeric contextRef="i5675e635aac644dca3d94839ad1ea8dd_D20200101-20200131" format="ixt-sec:durwordsen" name="hims:OperatingLeaseRenewalTerm" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ4Mw_7720c843-c43a-49c9-81af-d7beff1e1190">five years</ix:nonNumeric>.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i76c3c895bce44cdbbb9fd5a348cad70f"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQzMw_c5f7cfd1-5d28-4d12-8ad0-8c2423398c25" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease commitments subsequent to March 31, 2021 are as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.335%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfMC0xLTEtMS0xMDE0Ng_fd76a7e0-3242-4c79-9013-921b19b5654a">1,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfMS0xLTEtMS0xMDE0Ng_4debf356-7123-415b-b74e-0fefff25dfeb">1,559</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfMi0xLTEtMS0xMDE0Ng_fbb5fa4d-4958-4fcb-991c-f91252a61377">1,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfMy0xLTEtMS0xMDE0Ng_52e4fece-761c-4665-9479-1c8d9e8847fc">1,638</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfNC0xLTEtMS0xMDE0Ng_13689866-caa5-4ff1-9990-cb6b23bc4369">1,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasesFutureMinimumPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfNS0xLTEtMS0xMDE0Ng_f2df4f65-6c1f-46d6-bcfd-28b7ad0495de">7,055</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchase Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had contractual obligations to make $<ix:nonFraction unitRef="usd" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PurchaseObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfMjA0OQ_d2fcd7b9-0779-41bd-985e-e547fd9d1cee">1.0</ix:nonFraction> million in purchases related to cloud-based software contracts used in operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is a party to various litigation, claims, and other legal and administrative proceedings arising in the ordinary course of business. Some of these claims, lawsuits, and other proceedings may involve highly complex issues that are subject to substantial uncertainties, and could result in damages, fines, penalties, nonmonetary sanctions, or relief. Management is not currently aware of any matters that are reasonably likely to have a material adverse impact on the Company's business, financial position, results of operations, or cash flows.</span></div></ix:continuation><div id="i412093a93f204328a33c4602202f8375_58"></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzA0Mw_e8a763f0-29f6-4b9a-aff8-444cc12c2283" continuedAt="ib623e4b25d644f04a337846e50e18652" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib623e4b25d644f04a337846e50e18652" continuedAt="i26577b4f858f4554b596b29f70b281e1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2017 Stock Plan and 2020 Equity Incentive Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company adopted the 2017 Stock Plan (the "2017 Plan"). Under the 2017 Plan, the Board of Directors could grant awards, including incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, RSU awards, and other stock awards to employees, directors, and consultants. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the Merger, the Board of Directors adopted the 2020 Equity Incentive Plan (the "2020 Plan") and reserved <ix:nonFraction unitRef="shares" contextRef="i5d8a878dc739415b9ef43d3cafdddb47_I20210131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTA5OTUxMTY2MjI1NQ_e2a514f8-e3b4-4f04-a657-42ac296ef77c">21,000,000</ix:nonFraction> authorized shares of Class A common stock the Company could issue. In addition, up to <ix:nonFraction unitRef="shares" contextRef="i5bc5c0ad0d79476dae92187902b6a0c6_D20210101-20210131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTA5OTUxMTY2MjI1OQ_f41ee52e-2653-4adb-83e4-95f12eb9cec7">19,000,000</ix:nonFraction> shares of Hims Class A common stock subject to awards granted under the 2017 Plan that were forfeited, expired or lapsed unexercised or unsettled could be added to the 2020 Plan reserve. Beginning on January 1, 2022 and ending on January 1, 2031, the number of authorized shares of common stock under the 2020 Plan will automatically increase by <ix:nonFraction unitRef="number" contextRef="ia94de2a141c34d8faee9c47c63a6c366_D20210101-20210131" decimals="INF" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTA5OTUxMTY2MjI2Mw_8f8e4735-4fb0-4ac6-8dcd-943a31fc6de7">5</ix:nonFraction>% of the total number of Class A and Class V common stock issued and outstanding on the last day of the preceding fiscal year unless the Board of Directors approves a lesser number. As of the effective date of the 2020 Plan, no further stock awards have been or will be granted under the 2017 Plan. During the period, <ix:nonFraction unitRef="shares" contextRef="i413bd17d5b324a2dad4f4ea75d1247df_I20210131" decimals="INF" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwOTM4NQ_236e65b9-f05a-4064-996b-70fc08d4c059">55,645</ix:nonFraction> shares of Class A common stock subject to awards granted under the 2017 Plan that were outstanding on the Merger date and forfeited after the adoption of the 2020 Plan were added to the 2020 Plan reserve. Therefore, as of March&#160;31, 2021, there were <ix:nonFraction unitRef="shares" contextRef="ic1fd5fc3dab941e482cf5873aed90062_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTA5OTUxMTY2MjI2Nw_2e094728-d42f-44ff-9bd8-1b6b915c193a">21,055,645</ix:nonFraction> shares of Class A common stock reserved and <ix:nonFraction unitRef="shares" contextRef="ic1fd5fc3dab941e482cf5873aed90062_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzE4Nw_8cf10de9-e073-46f3-b538-6be42f996308">18,581,886</ix:nonFraction> shares of Class A common stock available for the Company to grant under the 2020 Stock Plan; there were <ix:nonFraction unitRef="shares" contextRef="i48ef13256a85415e97d20a62c058228a_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzA4NA_b44f78c2-cf1f-41b7-83c5-85fca49b32fc">no</ix:nonFraction> more shares available for grant under the 2017 Plan (since the 2017 Plan was replaced by the 2020 Plan).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under both the 2017 Plan and 2020 Plan, stock options and stock appreciation rights are granted at exercise prices determined by the Board of Directors which cannot be less than <ix:nonFraction unitRef="number" contextRef="i0d283ed598c04971b9439dd96804192f_D20210101-20210331" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODU3Mw_20a44135-2095-4039-89dc-80407644b144">100</ix:nonFraction>% of the estimated fair market value of the common stock on the grant date. Incentive stock options granted to any stockholders holding <ix:nonFraction unitRef="number" contextRef="iee0a496af430479f9dfecc7ffbe8ba33_D20210101-20210331" decimals="2" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODU3OQ_88ed8997-eece-4b8a-a3c4-6fd121a3a618">10</ix:nonFraction>% or more of the Company's equity cannot be granted with an exercise price of less than <ix:nonFraction unitRef="number" contextRef="iee0a496af430479f9dfecc7ffbe8ba33_D20210101-20210331" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODU4NA_c6768f1a-84d1-49e7-ba05-a0191ea38b8d">110</ix:nonFraction>% of the estimated fair market value of the common stock on the grant date and such options are not exercisable after <ix:nonNumeric contextRef="i8906c1a545c9405d8f6cc203bc4d9e99_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAxMDc2NQ_77eaa91a-b4eb-4a8a-8440-7f31e895353a">five years</ix:nonNumeric> from the grant date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options for new employees generally vest over <ix:nonNumeric contextRef="ia971f9ce30c04ca082f9fb3fa86a9e3a_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzA5Mg_0f4b38db-ab5e-4145-aa4c-b5c14bee78cf">four years</ix:nonNumeric>, with <ix:nonFraction unitRef="number" contextRef="i576248ed4b664370b9a1e90f22918f91_D20210101-20210331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzEwOQ_e9c61889-0b60-428b-91fc-91a01aed1923">25</ix:nonFraction>% vesting <ix:nonNumeric contextRef="i576248ed4b664370b9a1e90f22918f91_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODYzMQ_0dac51d3-3a5a-4343-acce-3bbd473623bb">one year</ix:nonNumeric> after the vesting commencement date and then 1/48th of the total grant vesting monthly thereafter. Options granted to current employees generally vest 1/48th of the total grant monthly over <ix:nonNumeric contextRef="ibc84ee6d825b47e9b4399d92dea27b78_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTg1Nw_64e7e74c-6bef-40d1-a557-a631c0949eb6">four years</ix:nonNumeric>. Options granted are exercisable within a period not exceeding <ix:nonNumeric contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODYwMw_892dfe1a-73f6-4712-b1e2-903c7998c239">ten years</ix:nonNumeric> from the grant date. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i26577b4f858f4554b596b29f70b281e1" continuedAt="id2b16cf1c95e4839bcf8382371b0bfd5"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;17, 2020, the Board of Directors granted <ix:nonFraction unitRef="shares" contextRef="i2adc14d58e77476fbc6512ca96906059_D20200617-20200617" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzExNA_fb00f098-8364-4347-9170-b03a4f7c3614">3,246,139</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i06c257b7b4f84b529f577d3f4aa15ac5_D20200617-20200617" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzEyNQ_49f92c36-7b80-451e-a21e-8c6133664173">1,623,070</ix:nonFraction> stock options to the CEO with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2adc14d58e77476fbc6512ca96906059_D20200617-20200617" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzEzNg_28456fea-1847-46f8-a8ac-24873a826cb4"><ix:nonFraction unitRef="usdPerShare" contextRef="i06c257b7b4f84b529f577d3f4aa15ac5_D20200617-20200617" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzEzNg_7aafe83e-284f-49fd-8cb4-ed8ad898a9c2">2.43</ix:nonFraction></ix:nonFraction> to vest upon either (i)&#160;an acquisition of the Company with per share consideration equal to at least $<ix:nonFraction unitRef="usdPerShare" contextRef="i32f3c2ba40fa476fa312666156c0f69b_I20200617" decimals="INF" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNzQwMg_58b4946b-0846-4860-a24d-3f016f284887">22.99</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i11c5ad145e504aa281087775310908bf_I20200617" decimals="INF" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNzQxNw_a2a11bd9-72b9-43b7-a134-90ff9fd4e2c5">38.31</ix:nonFraction>, respectively, or (ii)&#160;a per share price on a public stock exchange that is at least equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i32f3c2ba40fa476fa312666156c0f69b_I20200617" decimals="INF" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNzQyNg_58b4946b-0846-4860-a24d-3f016f284887">22.99</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i11c5ad145e504aa281087775310908bf_I20200617" decimals="INF" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNzQzMA_a2a11bd9-72b9-43b7-a134-90ff9fd4e2c5">38.31</ix:nonFraction>, respectively. The CEO is required to be employed at the time the per share consideration/price is achieved in order to receive the awards, but the awards are not subject to any other service condition. The Company recognizes expense related to these awards based on the fair value and derived service term as measured using a Monte Carlo simulation model, but only upon achieving the requirements outlined in (i) and (ii) above. The grant-date fair value was $<ix:nonFraction unitRef="usd" contextRef="i1b379b532e70492d8cd6c9d96f11613d_I20200617" decimals="-5" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzE3NQ_d16c1f40-fe5c-4b08-96c9-0d9a80501cbc">16.6</ix:nonFraction>&#160;million for these awards. The $<ix:nonFraction unitRef="usdPerShare" contextRef="i32f3c2ba40fa476fa312666156c0f69b_I20200617" decimals="INF" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNzQzNA_58b4946b-0846-4860-a24d-3f016f284887">22.99</ix:nonFraction> per share price threshold related to award for the <ix:nonFraction unitRef="shares" contextRef="ia49cabd9f3a84ee39cb1386e25c9b760_D20210201-20210228" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODcyOQ_3de7ecc2-fec6-44ed-a31c-fe0a9304409b">3,246,139</ix:nonFraction> stock options was achieved in February 2021 subsequent to the Merger and, therefore, the Company recognized all $<ix:nonFraction unitRef="usd" contextRef="iafad2c662fba4af0b34bd67db2d592d9_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTY0OTI2NzQ3NTQ1Nw_4863f295-d6f2-4a54-8f7a-b5716f9a23bb">11.3</ix:nonFraction> million of expense related to the grant during the three months ended March 31, 2021 due to achievement of the market condition. As of March&#160;31, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i84f2f42c202744b7b7bd251ae54caaf7_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTY0OTI2NzQ3NTQ2Ng_21903ee9-2363-4737-a34e-4ff4c315dd5c">4.2</ix:nonFraction> million of remaining compensation expense to be recognized for the remaining <ix:nonFraction unitRef="shares" contextRef="i84f2f42c202744b7b7bd251ae54caaf7_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODY5Nw_c4822d39-1d43-4b63-8150-ceacb5a72f82">1,623,070</ix:nonFraction> stock options over a period of <ix:nonNumeric contextRef="ic3fd0dc602f14c74816bb2d095c72cfd_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTY0OTI2NzQ3NTQ3NQ_a2337ef8-077b-4161-9b59-115f7118baae">3.04</ix:nonNumeric> years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, all Hims option holders received an equivalent award at an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MDQyOA_14869440-a5fd-4049-b880-5b366becf639">0.4530</ix:nonFraction> that vest in accordance with the original terms of the award. The Company determined this to be a Type I modification but did not record any incremental stock-based compensation expense since the fair value of the modified awards immediately after the modification was not greater than the fair value of the original awards immediately before the modification.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzE5Nw_00114458-4013-4528-bcac-f19e7a32ee64" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of the Company's stock options granted was estimated using the following weighted average assumptions for the three months ended March 31, 2021:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmRkYTZiNThlM2ZhZTQ3ZjVhMjc1MmJjM2FlZGY2NWRmL3RhYmxlcmFuZ2U6ZGRhNmI1OGUzZmFlNDdmNWEyNzUyYmMzYWVkZjY1ZGZfMC0xLTEtMS0w_2fea1cb2-973c-4b73-844b-52ee5931f90e">5.77</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmRkYTZiNThlM2ZhZTQ3ZjVhMjc1MmJjM2FlZGY2NWRmL3RhYmxlcmFuZ2U6ZGRhNmI1OGUzZmFlNDdmNWEyNzUyYmMzYWVkZjY1ZGZfMS0xLTEtMS0w_bb0c30ae-4ff8-4cfc-8b9a-51fe49c161d6">58.87</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmRkYTZiNThlM2ZhZTQ3ZjVhMjc1MmJjM2FlZGY2NWRmL3RhYmxlcmFuZ2U6ZGRhNmI1OGUzZmFlNDdmNWEyNzUyYmMzYWVkZjY1ZGZfMi0xLTEtMS0w_0dcf8ed7-7f87-4494-855c-00f9d0c4c1e9">0.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmRkYTZiNThlM2ZhZTQ3ZjVhMjc1MmJjM2FlZGY2NWRmL3RhYmxlcmFuZ2U6ZGRhNmI1OGUzZmFlNDdmNWEyNzUyYmMzYWVkZjY1ZGZfMy0xLTEtMS0w_e6fc5b5b-cbca-4fea-8f0b-0b11840f0e40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTIwOTQ2Mjc5Mzk5NjY_11446a1b-f147-4ef0-b0a4-479fbcd9bd17" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Option activity (excluding the stock options granted to the CEO outlined above) is as follows (in&#160;thousands, except for weighted average exercise price and weighted average contractual term in years):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Contractual<br/>Period<br/>(in&#160;Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia619e550a49a42d88028da0bc367d495_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMS0xLTEtMS0w_8b022c04-a7b5-4e8c-bdc5-ec2a0845009d">26,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia619e550a49a42d88028da0bc367d495_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMS0zLTEtMS0w_c2eb1108-d55c-4dfc-9800-7d11800ee87c">1.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07699e94c1ff4e72b8336fc2d39e4b76_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMS01LTEtMS0w_8cb0f81a-2dc6-4e26-9829-0eb31d001a87">8.50</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56db4fe025c047fd8e6046a280f8d46d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMS03LTEtMS0w_1c8dbbc6-ecdf-4aab-a9e1-361bf84592e8">131,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i3569cba9a27b411f87207bfe4f13c768_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMi0xLTEtMS00NjIz_b6821ae3-9dc2-49f0-a7d8-446d64466bb0">14,474</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i3569cba9a27b411f87207bfe4f13c768_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMi0zLTEtMS00NjIz_1d2403cc-895e-4060-a39a-032ac4d6c519">1.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i56db4fe025c047fd8e6046a280f8d46d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy0xLTEtMS00NjIz_5a7632be-3d45-41ed-84e9-f27e9550b85a">11,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i56db4fe025c047fd8e6046a280f8d46d_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy0zLTEtMS00NjIz_5e3988b0-3f2f-4015-9bcc-9dd877da02db">2.57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07699e94c1ff4e72b8336fc2d39e4b76_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy01LTEtMS02MzE2_3cada0c4-f142-4c96-96ae-e06de887c835">8.50</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56db4fe025c047fd8e6046a280f8d46d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy03LTEtMS0xMDAxMg_6d7f6a57-8143-4ed7-9f80-91b920a7145a">131,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMi0xLTEtMS0w_082f74a7-c927-40c0-a6f0-fe3613b73c8e">423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMi0zLTEtMS0w_14e40ed8-12d0-4c5d-9de3-acc05ee9b3e5">13.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised (including early exercised options vested during the period)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy0xLTEtMS0w_4530f9ed-38d7-4dee-b929-2f887ebbd9dc">384</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy0zLTEtMS0w_eab7671d-2b02-45d3-98ab-ce44a04f38d1">0.90</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited and expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNC0xLTEtMS0w_a285f8b2-e7dc-4ec2-94c2-f065f3da2a89">56</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNC0zLTEtMS0w_a6b07030-3180-498d-a52c-9966cdcc7e0b">1.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNS0xLTEtMS0w_3f89c023-f6a0-48d2-b5d5-4f96c1e9e651">11,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNS0zLTEtMS0w_c4ddb2aa-e48d-476c-9d9a-4df2f133ec7e">3.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNy01LTEtMS01NTgx_9691505a-fc11-4449-bab6-6120cdb26ec5">8.37</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNy03LTEtMS01NTgx_e890aa79-be3c-4365-9b82-28dfe7438a12">122,556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNi0xLTEtMS0w_ee116ae7-6675-45ba-8fc2-2ec91e03521b">11,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNi0zLTEtMS0w_8b7ed86c-745c-4643-b0ee-b6b47578138a">3.02</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNi01LTEtMS0w_632b245b-7b4e-45c4-b9e2-1b92237cbcdc">8.37</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNi03LTEtMS0w_1204aea4-018f-433b-ae74-a263bc00c028">122,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfOC0xLTEtMS0w_5488e8b9-fbd7-4bf2-bfd2-1d569c571237">11,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfOC0zLTEtMS0w_5052fdee-0818-453e-9266-f93f7400625a">2.64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfOC01LTEtMS0w_f7f1d0eb-c3a4-4f6d-b05d-ecad6c70ad84">8.37</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfOC03LTEtMS0w_690c2806-07fe-4ab5-9678-4bd5b3097b83">118,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant-date fair value of options granted for the three months ended March 31, 2021 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjI4Ng_4fe26d7f-9059-415d-a54f-5f7ca5553d01">7.34</ix:nonFraction> per share and the intrinsic value of vested options exercised was $<ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjM2NQ_5b38ea1f-c4cf-4d8a-841b-ed752661225c">2.0</ix:nonFraction> million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="icae0610134ea412ca26835b3d027983b_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjQzMA_3aaa1700-8457-4f61-a043-31ca41105668">20.5</ix:nonFraction> million of unrecognized stock-based compensation related to unvested stock options excluding the CEO stock options, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i0764a9f39d15480ea6a5fd912a15958e_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjU4MA_2923415f-4b9c-4fd6-af7f-296d82afdf1d">3.33</ix:nonNumeric> years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows resulting from the tax benefits for tax deductions resulting from the exercise of stock options in excess of the compensation expense recorded for those options (excess tax benefits) are classified as a cash flow from financing activities. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="id2b16cf1c95e4839bcf8382371b0bfd5" continuedAt="i9b3f80162232442b98c592d6b58d7ac4"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to a full valuation allowance on deferred tax assets, the Company did <ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjk0NA_69539c66-8488-4e8a-8853-455ceca6be97">no</ix:nonFraction>t recognize any tax benefit from stock option exercises for the three months ended March 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Exercise of Common Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#8211; The Company issues shares upon the early exercise of common stock options. The unvested shares are subject to the Company's repurchase right at the lower of the fair market value of the shares of common stock on the date of repurchase or their original purchase price. The proceeds from cash exercises prior to vesting are initially recorded as a deposit liability from the early exercise of stock options and recorded within accrued liabilities on the consolidated balance sheets and reclassified to additional paid-in capital as the Company's repurchase right lapses. Unvested early exercised options are considered outstanding options and also excluded from shares exercisable since the options have been early exercised. These options are included in the option activity as exercised when the options vest. The number of unvested early exercised options were <ix:nonFraction unitRef="shares" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="INF" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMzY3NQ_82f1f92f-0349-4663-a8e3-e7db6a3204f0">301,893</ix:nonFraction> as of March&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzIwOA_29d11a35-3018-4210-a937-2ed4a4ff2717" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The options outstanding and exercisable as of March&#160;31, 2021 (excluding CEO stock options) have been aggregated into ranges for additional disclosure as follows (in&#160;thousands, except weighted average remaining contractual life and exercise price):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.316%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life&#160;(in<br/>Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life&#160;(in<br/>Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ <ix:nonFraction unitRef="usdPerShare" contextRef="i8154d378681848c08666cc454aeba717_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi0wLTEtMS0wL3RleHRyZWdpb246MjdiNWIzY2M5ODg4NDM5OGFhOGMxOWI2NGIyMTc5YmNfMTIwOTQ2Mjc5MDU1NTc_fc5014bc-1d35-4d91-a195-a19cea859cea">0.06</ix:nonFraction> &#8211; <ix:nonFraction unitRef="usdPerShare" contextRef="i8154d378681848c08666cc454aeba717_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi0wLTEtMS0wL3RleHRyZWdpb246MjdiNWIzY2M5ODg4NDM5OGFhOGMxOWI2NGIyMTc5YmNfMTIwOTQ2Mjc5MDU1NjU_4897fb1d-9a37-443a-a911-b3b20dcb7cd4">0.40</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i296427d49b16444e90fd07050ceb45e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi0yLTEtMS0w_2a5fabd8-a7a5-48cc-9d90-267ada0974c9">3,236</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8154d378681848c08666cc454aeba717_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi00LTEtMS0w_6e79c30c-83cc-493e-a9c1-9c0d62e75d9d">6.92</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i296427d49b16444e90fd07050ceb45e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi02LTEtMS0w_f6008746-e865-4884-930f-f449fd7d18ff">3,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8154d378681848c08666cc454aeba717_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi04LTEtMS0w_ba873b01-32e1-4155-b670-fa7c92992ea6">6.92</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i07019c3dea37410ca1b9e81a814fc572_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy0wLTEtMS0wL3RleHRyZWdpb246YzRlM2Y0MmEyZDExNDI2OTlhNGFiODhhYjhmODQzMjJfMTIwOTQ2Mjc5MDU1NTU_70baeb24-e7eb-4ad6-9e72-d52ad63ef372">1.55</ix:nonFraction> &#8211; <ix:nonFraction unitRef="usdPerShare" contextRef="i07019c3dea37410ca1b9e81a814fc572_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy0wLTEtMS0wL3RleHRyZWdpb246YzRlM2Y0MmEyZDExNDI2OTlhNGFiODhhYjhmODQzMjJfMTIwOTQ2Mjc5MDU1NjI_03dae13d-5ee4-426b-8983-5e2432e2f2de">2.33</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91a56879fe24414495c14c13ef54b061_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy0yLTEtMS0w_eca9960f-3e0e-4728-a2cb-4689bb077d72">3,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07019c3dea37410ca1b9e81a814fc572_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy00LTEtMS0w_56ebcea2-0283-4a7c-b0e2-2197e652065f">8.07</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i91a56879fe24414495c14c13ef54b061_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy02LTEtMS0w_f05235be-7808-425e-ac2b-7c3e2e75e3a9">3,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i07019c3dea37410ca1b9e81a814fc572_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy04LTEtMS0w_e1628901-94f2-4795-befd-83a2d7fcfe32">8.07</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i962be1bcc7954ffd848d65b2af00d37f_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC0wLTEtMS0wL3RleHRyZWdpb246MzZkOGIwNDE0ODQ4NDVhMGIxODM1MzE1Y2FmZWNkOTVfMTIwOTQ2Mjc5MDU1NTU_6e70652e-0310-4829-8ed7-6b2a3c2d73e8">2.43</ix:nonFraction> &#8211; <ix:nonFraction unitRef="usdPerShare" contextRef="i962be1bcc7954ffd848d65b2af00d37f_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC0wLTEtMS0wL3RleHRyZWdpb246MzZkOGIwNDE0ODQ4NDVhMGIxODM1MzE1Y2FmZWNkOTVfMTIwOTQ2Mjc5MDU1NjI_921eaf92-ec85-40f3-9bff-45a2daaec70a">3.65</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia020c048cca142b09ded25121b0ecf0f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC0yLTEtMS0w_43c044cb-1423-462e-9d1b-38d69c07d891">3,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i962be1bcc7954ffd848d65b2af00d37f_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC00LTEtMS0w_567af197-78b1-415e-82cb-8e386e0db44e">9.17</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia020c048cca142b09ded25121b0ecf0f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC02LTEtMS0w_099c6c1a-5e21-4e69-824d-8731230eaa09">3,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i962be1bcc7954ffd848d65b2af00d37f_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC04LTEtMS0w_61e40721-e269-4fbe-8b63-69bd26548b69">9.17</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0109a582058c4a30962735b0ef17b42f_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS0wLTEtMS0wL3RleHRyZWdpb246N2JmMjE3MDI5MjJjNGE0NGIxMGEyMWVkODQ0YWM3OGFfMTIwOTQ2Mjc5MDU1NTY_6b508624-ff52-4745-81b0-e720ce1d4195">8.90</ix:nonFraction> &#8211; <ix:nonFraction unitRef="usdPerShare" contextRef="i0109a582058c4a30962735b0ef17b42f_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS0wLTEtMS0wL3RleHRyZWdpb246N2JmMjE3MDI5MjJjNGE0NGIxMGEyMWVkODQ0YWM3OGFfMTIwOTQ2Mjc5MDU1NjQ_697877bb-ddc0-4242-84ee-948261260cc2">13.35</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia30281f381f44828904e830e15c11803_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS0yLTEtMS0w_36c266a7-b90c-4925-bc02-c23e1bdb5e92">1,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0109a582058c4a30962735b0ef17b42f_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS00LTEtMS0w_f1e39861-2736-4854-9068-f86a54a347d6">9.76</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia30281f381f44828904e830e15c11803_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS02LTEtMS0w_27642a2c-ab2c-4071-a2c5-87b6ea00f932">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0109a582058c4a30962735b0ef17b42f_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS04LTEtMS0w_5b9ffd1b-dc0c-440f-9857-119a83fb4941">9.75</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4f39e7f28aa44acd97c7381291e6f1ac_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi0wLTEtMS0wL3RleHRyZWdpb246NWYxNGEwMjVhM2M4NGVhNWI4ZGYzNDZiNjhkYjdhNzFfMTIwOTQ2Mjc5MDU1NTU_acfece67-4846-4e71-9ddf-3dd5a13c260f">15.17</ix:nonFraction> &#8211; <ix:nonFraction unitRef="usdPerShare" contextRef="i4f39e7f28aa44acd97c7381291e6f1ac_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi0wLTEtMS0wL3RleHRyZWdpb246NWYxNGEwMjVhM2M4NGVhNWI4ZGYzNDZiNjhkYjdhNzFfMTIwOTQ2Mjc5MDU1NjI_807b8145-9964-4e96-994f-c23917035228">22.76</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85a98bf3e25f496e9e070d45dc8dbe79_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi0yLTEtMS0w_d163134b-c284-4f13-ae00-5af551c4c435">178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4f39e7f28aa44acd97c7381291e6f1ac_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi00LTEtMS0w_5af5e0a2-196f-41d1-b82a-7ce639ea31c9">9.79</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i85a98bf3e25f496e9e070d45dc8dbe79_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi02LTEtMS0w_0a14799f-a350-4345-be46-b191a0c13754">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4f39e7f28aa44acd97c7381291e6f1ac_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi04LTEtMS0w_649735e9-2ed8-4e55-b269-0d14999f0fb7">9.78</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNy0yLTEtMS0w_d4afda17-ae15-486d-9eb4-e2557617a618">11,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iae89e874aad64f008fc6334367e88e92_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNy02LTEtMS0w_abd30d22-cb9b-473e-89b0-17782993f127">11,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSUs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All RSUs granted prior to the Merger were subject to achievement of a liquidity event which included (i) an initial public offering, (ii) a business combination transaction, or (iii) a sale event as defined by the 2017 Plan. On January 20, 2021, the liquidity event was achieved with the closing of the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs for new employees generally vest over <ix:nonNumeric contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTIwOTQ2Mjc5Mzk5Nzc_10c6c58a-3981-42e2-b1ab-4eda0b821fa0">four years</ix:nonNumeric>, with <ix:nonFraction unitRef="number" contextRef="id23bf3f94c8841a693c2abb9dbea49c4_D20210101-20210331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTIwOTQ2Mjc5Mzk5Nzk_bb792186-53ac-4259-b2c8-ac597afb29ae">25</ix:nonFraction>% vesting <ix:nonNumeric contextRef="id23bf3f94c8841a693c2abb9dbea49c4_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODc1MA_c78061c2-1a60-4aeb-83fa-7f6d670f0fa2">one year</ix:nonNumeric> after the vesting commencement date on the first Company Quarterly Vesting Date (defined below) and the remaining grant vesting quarterly thereafter on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date" or collectively, "Company Quarterly Vesting Dates"). Additional RSUs granted to current employees generally vest quarterly on Company Quarterly Vesting Dates over <ix:nonNumeric contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzIyOQ_087c6126-d17d-422a-baa0-4d2589a112f6">four years</ix:nonNumeric>.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, all Hims RSU holders received an equivalent award at an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTg3Mw_40e6cf1a-05e6-4d82-8456-f8f87c4b6e6a">0.4530</ix:nonFraction> that vest in accordance with the original terms of the award. The Company determined this to be a Type I modification but did not record any incremental stock-based compensation expense since the fair value of the modified awards immediately after the modification was not greater than the fair value of the original awards immediately before the modification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, all Hims RSU and option holders received (a) earn-out RSUs that would vest in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTg4MQ_a8837969-7c7c-4501-a4fa-fde13e88c06c">15.00</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTg4OQ_4bdfb4a2-6f0b-4e11-9865-bcf0b71b3b92">17.50</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTg5Nw_44cff45a-4ce5-4b5d-b54c-ec72504c905a">20.00</ix:nonFraction> for any <ix:nonFraction unitRef="day" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTkwNQ_82a41e22-3cc6-42e1-bb2f-bb164d6a1905">10</ix:nonFraction> trading days within any <ix:nonFraction unitRef="day" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTkwOQ_a724067b-c07e-49ce-8a13-b9838a87996f">20</ix:nonFraction>-trading day period, or a Company sale (as defined in the Merger Agreement) occurs and the thresholds are met on or prior to the date that is <ix:nonNumeric contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" format="ixt-sec:durwordsen" name="hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODgxMg_570e02eb-ca2e-41d5-8046-7a73314b4592">five years</ix:nonNumeric> following the Closing Date; and (b) an allocation of Parent Warrant RSUs. All of these RSUs vest in accordance with the terms of the initial RSU and option award, in addition to any of the aforementioned requirements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The earn-out thresholds for earn-out RSUs were all met in February 2021. The earn-out awards are equity classified since they do not meet the liability classification criteria outlined in ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and are both (i) indexed to the Company's own shares and (ii) meet criteria for equity classification. The Company determined the fair value of the earn-out RSUs using a Monte Carlo simulation model. <ix:continuation id="i5f912d538a074d2f93aabbc7d163ba91" continuedAt="i77507fb7ea734cc78170b78644cdc4ff">The following assumptions were used in this valuation: </ix:continuation></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i9b3f80162232442b98c592d6b58d7ac4" continuedAt="i9c56a6d30cae43e7be3fc4d340a8ff54"><div style="text-align:justify"><ix:continuation id="i77507fb7ea734cc78170b78644cdc4ff"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"></td><td style="width:56.042%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.389%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.169%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjY1OGM1YTQ0YTFlODQ5NGY4MzE1M2VkNmM4MTQzYTM3L3RhYmxlcmFuZ2U6NjU4YzVhNDRhMWU4NDk0ZjgzMTUzZWQ2YzgxNDNhMzdfMC0yLTEtMS0xMTY3Mw_fed4acbb-f74b-4997-af09-d6058c47fd46">5.00</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjY1OGM1YTQ0YTFlODQ5NGY4MzE1M2VkNmM4MTQzYTM3L3RhYmxlcmFuZ2U6NjU4YzVhNDRhMWU4NDk0ZjgzMTUzZWQ2YzgxNDNhMzdfMS0yLTEtMS0xMTY3Mw_2864a11c-1850-4e9b-bf8b-2535e7662602">60.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjY1OGM1YTQ0YTFlODQ5NGY4MzE1M2VkNmM4MTQzYTM3L3RhYmxlcmFuZ2U6NjU4YzVhNDRhMWU4NDk0ZjgzMTUzZWQ2YzgxNDNhMzdfMi0yLTEtMS0xMTY3Mw_0100889f-1907-4cb3-bf70-9bd1c00f82e1">0.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjY1OGM1YTQ0YTFlODQ5NGY4MzE1M2VkNmM4MTQzYTM3L3RhYmxlcmFuZ2U6NjU4YzVhNDRhMWU4NDk0ZjgzMTUzZWQ2YzgxNDNhMzdfMy0yLTEtMS0xMTY3Mw_3f2d9bcd-f19c-4e26-a4fc-d1d9b9027cb5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the Company's equity was also an input into the model and was determined based on the closing trading price of the Company's Class A common stock on the Closing Date of $<ix:nonFraction unitRef="usdPerShare" contextRef="i6a9e72571629466e95f463c7efbcbd98_I20210331" decimals="INF" name="us-gaap:SharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyMjkwOQ_9b5077a0-9452-426a-996e-a7ec3c2a11c7">16.38</ix:nonFraction>.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzI0NA_45cf6b21-082a-45a1-8d5a-5b6ef89345a1" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity including RSUs outstanding prior to the Merger, earn-out RSUs, and Parent Warrant RSUs is as follows (in thousands, except for weighted average grant date fair value):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.660%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.148%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7a6191f600fe4f5bba54740cfed54748_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMS0yLTEtMS0xNjAx_82674e67-01a8-43de-baaa-acd7ba93b739">3,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a6191f600fe4f5bba54740cfed54748_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMS00LTEtMS0xNjAx_b2b519fd-3863-4fb9-8404-f48dfe421d0e">5.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i20ea7b45ce3547e9a8128fa8a07b9245_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMi0yLTEtMS0xNjEx_b6a26f86-9426-473f-96c3-9f375bbebc59">1,904</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i20ea7b45ce3547e9a8128fa8a07b9245_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMi00LTEtMS0xNjEx_92ef4c7e-805b-4bb4-be38-a3b16b0d72ff">5.99</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0e017683d1224a57bcb05400dca67f22_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMy0yLTEtMS0xNjMy_b025f74a-f9b1-4ad5-b567-6abc9503ad97">1,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0e017683d1224a57bcb05400dca67f22_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMy00LTEtMS0xNjMy_69787208-0ab0-4e41-952e-3a92f83e19e1">11.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNC0yLTEtMS0xNjE3_98dd2de9-d7d0-462b-a5c0-fa7d45d544b0">2,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNC00LTEtMS0xNjE3_81faa096-e5ed-4c50-a7b2-1952fad74818">14.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNS0yLTEtMS0xNjIw_7282e61e-72d4-4797-ba7f-3d22b57ff387">790</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNS00LTEtMS0xNjIw_db36badf-e6e7-4d32-8515-1300643065d7">15.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a9e72571629466e95f463c7efbcbd98_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNy0yLTEtMS0xNjMy_3012d598-e6ad-401b-b91f-8ebd4127a156">3,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i6a9e72571629466e95f463c7efbcbd98_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNy00LTEtMS0xNjMy_2dd92b56-dcd4-47b4-8306-adfe3c379a5c">13.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the above activity are <ix:nonFraction unitRef="shares" contextRef="ic0fd3b92233841f09e31e1c59722c266_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzA2MA_8e5b9b6b-3b79-4e60-aaaa-fc4b86b77786">476,308</ix:nonFraction> earn-out RSUs and <ix:nonFraction unitRef="shares" contextRef="i4f37e4e1d6084fe096e662b5ab77aecd_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzA2OA_26644adc-f71d-4318-9e52-1832226845e6">9,478</ix:nonFraction> Parent Warrant RSUs issued to the CEO as part of the Merger that vest in accordance with the same market conditions as the CEO stock options, of which <ix:nonFraction unitRef="shares" contextRef="i618a5b5ebba449e4bbe23551147cf295_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwODUxOQ_c97126d3-ebd8-4698-bcee-fe20a7f70d4d">317,539</ix:nonFraction> earn-out RSUs and <ix:nonFraction unitRef="shares" contextRef="ifac9c5c2612043669180344154fb064a_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwODUyNw_7314fb2c-e0f1-4e18-9445-f806269627ac">6,319</ix:nonFraction> Parent Warrant RSUs vested in the period. In addition, the Company granted <ix:nonFraction unitRef="shares" contextRef="i42057812c3884143b23614f4764c8109_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTk2Nw_235cad44-006b-47d7-8a76-fdd7e99593fe">45,297</ix:nonFraction> RSUs in 2020 and <ix:nonFraction unitRef="shares" contextRef="i0fce2bdf00214d74b06a4e34ca921b88_D20210101-20210131" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzA3Nw_8e466d6c-0198-4f8a-a852-edbf0693cf09">4,431</ix:nonFraction> earn-out RSUs and <ix:nonFraction unitRef="shares" contextRef="i51fbf31cd21a496f8b77b769104642ea_D20210101-20210131" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzA4NQ_4e29f85e-7445-45cc-92e8-1ee1637a6f8b">88</ix:nonFraction> Parent Warrant RSUs as part of the Merger in January 2021 to a non-executive officer that vest in accordance with the achievement of revenue targets upon meeting certain revenue targets from the sale of specific products. None of the awards vested in the period. These grants are also included in the above activity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, there was unrecognized stock-based compensation related to unvested RSUs of $<ix:nonFraction unitRef="usd" contextRef="i6a9e72571629466e95f463c7efbcbd98_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNTIzNA_a0b27f56-f340-48b4-a43c-24f9afeec988">40.1</ix:nonFraction> million, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNTI0Mg_5d782eea-c905-43e2-a8cb-4042295cc6c5">3.61</ix:nonNumeric> years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vendor Warrants</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in stock-based compensation expense is expense for issuance of Class A common stock warrants to nonemployees in connection with vendor service arrangements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, warrant holders received (a) an equivalent warrant at an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTkyNw_eaa2f3b1-5e93-430d-8469-5451fcf050fd">0.4530</ix:nonFraction> (which was determined not to result in incremental stock-based compensation expense similar to the evaluations for stock options and RSUs above); (b) the right to receive, upon exercise, earn-out shares that vest in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTkzNQ_34cb33ef-917f-4a6e-b740-c38eab783093">15.00</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTk0Mw_31545311-1500-495d-a497-60d59c2b1c1c">17.50</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTk1MQ_dc9d0336-9002-42fe-9aa2-e10ca360a711">20.00</ix:nonFraction> for any <ix:nonFraction unitRef="day" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTk1OQ_8b4a1b46-ff92-4cde-b378-1aefcd23b6ab">10</ix:nonFraction> trading days within any <ix:nonFraction unitRef="day" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTk2Mw_73b45ad2-8ed3-40da-a31e-a5d652fead92">20</ix:nonFraction>-trading day period, or a Company sale (as defined in the Merger Agreement) occurs and the thresholds are met on or prior to the date that is <ix:nonNumeric contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" format="ixt-sec:durwordsen" name="hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODg0Mw_d83620d7-10e2-41eb-bfe4-979bc57f028e">five years</ix:nonNumeric> following the Closing Date; and (c) the right to receive, upon exercise, an allocation of Parent Warrants. All of these instruments vest in accordance with the terms of the initial warrant in addition to any of the aforementioned requirements. The earn-out thresholds were all met in February 2021. The earn-out shares and Parent Warrants are equity classified since they do not meet the liability classification criteria.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i9c56a6d30cae43e7be3fc4d340a8ff54"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MDQxNQ_73a17923-3716-42a2-bb63-abe7bab0d9aa" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor warrant activity, excluding any right to receive Merger considerations, is as follows (in thousands, except for weighted average exercise price and weighted average contractual term in years): </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted Average Contractual Term (in Years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="i05f1d9f417c54e328597f093403d6e89_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMS0yLTEtMS0yNDQx_2d0b3d9e-16fb-4300-bcec-48748ae53504">1,861</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="i05f1d9f417c54e328597f093403d6e89_I20201231" decimals="2" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMS00LTEtMS0yNDQx_75a10f3c-b146-4faa-84dc-5e6b50b7e27e">0.79</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i881daecfe2934b7cafec114097e28cd3_D20200101-20201231" format="ixt-sec:duryear" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMS02LTEtMS0yNDQx_682d3925-390b-457e-a243-27ab9ef5382b">7.01</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i05f1d9f417c54e328597f093403d6e89_I20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMS04LTEtMS0yNDQx_b3b51251-d366-4c74-9c08-0bc0303fc0b4">9,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Recapitalization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="idfb2bd7ccded4f77ae1362ca9d0a545a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMi0yLTEtMS0yNDQx_d09ebe37-3a4e-4974-8613-3c0322a505a6">1,018</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="idfb2bd7ccded4f77ae1362ca9d0a545a_I20201231" decimals="2" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMi00LTEtMS0yNDQx_f7e6dff3-661d-459a-8b37-10bd07b9c7a1">0.96</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="i14f486b4660647f98f37f78e924341b0_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMy0yLTEtMS0yNDQx_4ad4d10a-5127-492f-a7d8-769bb360b56f">843</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="i14f486b4660647f98f37f78e924341b0_I20201231" decimals="2" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMy00LTEtMS0yNDQx_577f4287-58d5-4869-8145-1d8193616897">1.75</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i2886207377754f8d893c27f2490298a6_D20200101-20201231" format="ixt-sec:duryear" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMy02LTEtMS0yNDQx_75c2ef8c-4360-4488-aded-8b64e7c83965">7.01</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i14f486b4660647f98f37f78e924341b0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMy04LTEtMS0yNDQx_3431cce4-6c8b-467b-8907-88a457212d13">9,957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNC0yLTEtMS0yNDQx_5b2a4378-b2b4-4c8f-8a71-7fe5e4eeca0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331" decimals="2" format="ixt:zerodash" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNC00LTEtMS0yNDQx_d2c357ff-32e2-4daf-837c-714c813b5e33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(<ix:nonFraction unitRef="shares" contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNS0yLTEtMS0yNDQx_16390810-0139-4f9d-ac87-9555393e3ee6">381</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331" decimals="2" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNS00LTEtMS0yNDQx_f3653e8d-8747-4174-904a-f1a346be017f">1.75</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt;text-indent:9.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited and expired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi0yLTEtMS04NDY2_09ad5d5b-ed46-45b0-90b4-edfec0c720be">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331" decimals="2" format="ixt:zerodash" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi00LTEtMS04NDY2_32307d8c-7851-49b1-b080-18aabffa9020">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi0yLTEtMS0yNDQx_4edbcef8-513e-4392-af7c-7d19a59a2b17">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331" decimals="2" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi00LTEtMS0yNDQx_1eafef77-adb6-40d8-97e8-694897065bb4">1.75</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331" format="ixt-sec:duryear" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi02LTEtMS0yNDQx_9f7841a9-fba3-42ee-9358-2c9a0ed8436d">7.01</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi04LTEtMS0yNDQx_7a859d23-68dd-47fe-8d29-6693e25119c2">5,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Vested and expected to vest as of March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331" decimals="-3" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNy0yLTEtMS0yNDQx_bd42cd0d-68ec-47e1-8ec6-932feb86b2e1">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331" decimals="2" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNy00LTEtMS0yNDQx_7fb1636b-20e5-4795-adb2-ecc5c65ad6aa">1.75</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331" format="ixt-sec:duryear" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNy02LTEtMS0yNDQx_393008a6-e41a-411d-803d-ff8b6a5b3be0">7.01</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNy04LTEtMS0yNDQx_1fc53876-9a25-4649-bb51-ea7e7f0f58f3">5,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercisable as of March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="shares" contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331" decimals="-3" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfOC0yLTEtMS0yNDQx_a50773c2-aa14-4fd7-a643-a21dbf0fb252">185</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331" decimals="2" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfOC00LTEtMS0yNDQx_7ccdb025-35b4-4833-9467-7662c290a613">1.75</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonNumeric contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331" format="ixt-sec:duryear" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfOC02LTEtMS0yNDQx_41004eae-775f-40bf-b13c-59819c6c5fd8">7.01</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:nonFraction unitRef="usd" contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331" decimals="-3" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfOC04LTEtMS0yNDQx_788b0b3c-61c2-4a0b-8d0c-1afe003c9267">2,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the exercise of outstanding warrants above, vendors also have the right to receive <ix:nonFraction unitRef="shares" contextRef="i98bfbbb5e3e147e3889c062c610a6917_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODc3OQ_80123a17-9e05-46d6-9aea-a50016c0c2e8">48,062</ix:nonFraction> shares of Merger consideration, consisting of the holders' allocation of earn-out and Parent Warrant considerations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, there was $<ix:nonFraction unitRef="usd" contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTY0OTI2NzQ3NTc5NQ_6343f0ea-fae5-4df9-8cea-97c53df360d8">0.5</ix:nonFraction> million of unrecognized stock-based compensation expense related to unvested vendor warrants and associated earn-out shares and Parent Warrants, which is expected to be recognized over a weighted average period of <ix:nonNumeric contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzAyMg_2c9d7d7d-16d6-48f1-bc8e-004f39caff67">0.48</ix:nonNumeric> years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzI3OA_154d1ec8-ee6d-49e8-b27b-8dcae9206478" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense for employees and nonemployees, by category, on the condensed consolidated statements of operations and comprehensive loss for three months ended March 31, 2021 and March&#160;31, 2020 (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.547%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a91c65f7eb54a3c989d98b6cb6a18a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMC0xLTEtMS0w_725d3930-7de9-40d7-a2ea-d63853ea45ac">1,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b7f6544633643809b6705cd0e2ede0d_D20200101-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMC0zLTEtMS0w_092afd89-0fa5-4cee-b9c5-352ada9bd1f9">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie769ad9b07ed4265a9edfbcfccff5ae1_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMS0xLTEtMS0w_5918bbe0-202d-4ae6-8397-174a415612b5">32,384</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ad7aa6b76124ad6ae3961610c692d73_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMS0zLTEtMS0w_3f2f3c48-5e1c-4d80-9cc0-c9f6fd3dfc19">1,113</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMi0xLTEtMS0w_159603df-e6ac-4dc6-b2f1-a11e8c24180c">34,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMi0zLTEtMS0w_1f1286f1-9d7f-49c9-89ea-e51d995f9b91">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="hims:TemporaryEquityTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjQ5Mw_2a654f18-5dbc-426e-aaa4-195b22b9c7fc" continuedAt="i203d198f138d4f11b01b08492052fe85" escape="true">Redeemable Convertible</ix:nonNumeric></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:continuation id="i203d198f138d4f11b01b08492052fe85" continuedAt="i5a0c6d2e47614731b0ef00d77b27e840"> Preferred Stock</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5a0c6d2e47614731b0ef00d77b27e840" continuedAt="i9acb5b65f3d249338fa5c57706171910">As of December&#160;31, 2020 the Company had authorized <ix:nonFraction unitRef="shares" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfMjc0ODc3OTA3ODg0MA_ad63c81c-e5f4-4c3b-b2ee-3f181b046e63">95,997,674</ix:nonFraction> shares of Hims' convertible preferred stock, designated in series, with the rights and preferences of each designated series to be determined by the Board of Directors.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i9acb5b65f3d249338fa5c57706171910" continuedAt="ic505ce38768d4cbbbba5512c13f6e49c"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:TemporaryEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjYzMQ_f50634c5-a19b-499b-8966-475b2d8ce090" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of Hims' redeemable convertible preferred stock as of December&#160;31, 2020 (in&#160;thousands, except for share data):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.648%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.626%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Series</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Liquidation<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Proceeds,<br/>Net of<br/>Issuance&#160;Costs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue&#160;Price<br/>per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series Seed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS0yLTEtMS0w_d453ab65-6728-43fc-bf40-beb4b58ce3a9">4,987,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS00LTEtMS0w_898b0366-40a0-4b7c-acb6-0fb26aafa85d"><ix:nonFraction unitRef="shares" contextRef="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS00LTEtMS0w_ec259054-9d65-4e07-83e0-52ec2a9b06dd">4,987,477</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS02LTEtMS0w_21cc612a-2cac-48b0-8262-82e0397f7b55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i00d3c217869a498ea1da4262db18091c_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="hims:ProceedsFromIssuanceOfTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS04LTEtMS0w_f720bccd-ab75-43a8-9c17-5fb2211f0dae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231" decimals="INF" name="hims:TemporaryEquityIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS0xMC0xLTEtMA_140ac7bd-8ff0-41d1-9459-c00540963a6e">0.0001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id285b35ca96643e8a5dd6301ca706b17_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi0yLTEtMS0w_2ba02c4b-8ba5-4ed4-9acf-7f8084d0a972">23,822,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id285b35ca96643e8a5dd6301ca706b17_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi00LTEtMS0w_793b6e74-331a-4b6b-90aa-5c42f70f0e6f"><ix:nonFraction unitRef="shares" contextRef="id285b35ca96643e8a5dd6301ca706b17_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi00LTEtMS0w_c9af821f-5506-43d7-b564-90fb7a025f0d">23,822,492</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id285b35ca96643e8a5dd6301ca706b17_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi02LTEtMS0w_f6fe7980-4c1b-4f38-a9a4-1b321308c6c6">6,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dab5dbc93cf444c956b2f47e4145d28_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:ProceedsFromIssuanceOfTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi04LTEtMS0w_a473a958-f460-4449-acc5-654eb4c67f0b">5,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id285b35ca96643e8a5dd6301ca706b17_I20201231" decimals="INF" name="hims:TemporaryEquityIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi0xMC0xLTEtMA_98db5359-5d92-4a1d-ac00-11d85f63ddde">0.2780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A-1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i973de7d14a4c409cb16e8a6b8963bff5_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy0yLTEtMS0w_3eba7223-1054-4a53-b916-4ce26b4c5c5d">5,742,012</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i973de7d14a4c409cb16e8a6b8963bff5_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy00LTEtMS0w_05eee865-d648-4018-8ebe-01b1186b77e0"><ix:nonFraction unitRef="shares" contextRef="i973de7d14a4c409cb16e8a6b8963bff5_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy00LTEtMS0w_57cb1a1d-45ac-4095-926a-970843e23c1b">5,742,012</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i973de7d14a4c409cb16e8a6b8963bff5_I20201231" decimals="-3" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy02LTEtMS0w_5476d945-d799-4cf4-b122-65170dd779af">753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie241c9b58b1b41c5adc333a98cfa439d_D20200101-20201231" decimals="-3" name="hims:ProceedsFromIssuanceOfTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy04LTEtMS0w_d136fcf5-05d4-4ebe-9f01-c6bccefa532b">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i973de7d14a4c409cb16e8a6b8963bff5_I20201231" decimals="INF" name="hims:TemporaryEquityIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy0xMC0xLTEtMA_5610b9f0-695c-45a9-b9c6-2c3f3e5c14c2">0.1312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c496814f30146d2a8fffa0636e6175d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC0yLTEtMS0w_2829e175-b04d-46b0-8bc6-016c1b5d8cbd">13,270,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2c496814f30146d2a8fffa0636e6175d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC00LTEtMS0w_41790841-0134-49ed-9547-a017349ac5a2"><ix:nonFraction unitRef="shares" contextRef="i2c496814f30146d2a8fffa0636e6175d_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC00LTEtMS0w_7c8b36e4-3956-4dc8-a960-c37b0adf9d8f">13,270,590</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c496814f30146d2a8fffa0636e6175d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC02LTEtMS0w_48c26773-28be-43c6-b729-bcc124e78db2">24,600</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec02bacd134949c3a43d4169ef4a503f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:ProceedsFromIssuanceOfTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC04LTEtMS0w_9fb21c97-b909-42a5-a27b-900d7493f692">23,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2c496814f30146d2a8fffa0636e6175d_I20201231" decimals="INF" name="hims:TemporaryEquityIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC0xMC0xLTEtMA_f8a2ca61-f503-49bc-a406-0a89bc4eec98">1.8538</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B-1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea410e7929fb4ea4866693138775bce3_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS0yLTEtMS0w_f8fccdb2-e501-4dea-bd9b-e1dde43ef729">9,807,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea410e7929fb4ea4866693138775bce3_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS00LTEtMS0w_6629ba83-c526-4881-8293-a27f61e90710"><ix:nonFraction unitRef="shares" contextRef="iea410e7929fb4ea4866693138775bce3_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS00LTEtMS0w_8fafa0c3-b999-4590-92ce-af936e0fa09c">9,807,952</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea410e7929fb4ea4866693138775bce3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS02LTEtMS0w_08cbe338-2e0e-419c-b335-18e6c833af25">20,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i310c211669824a0ebd4e0cbbfecbee8c_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:ProceedsFromIssuanceOfTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS04LTEtMS0w_3d9fbc24-9786-4961-b70e-b4911d0e10f5">14,965</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iea410e7929fb4ea4866693138775bce3_I20201231" decimals="INF" name="hims:TemporaryEquityIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS0xMC0xLTEtMA_1f77ca16-bb8c-4905-8259-76f580db8981">2.0392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B-2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia620070bccea49e8ae67e495e7cd6630_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi0yLTEtMS0w_3f00e695-0495-4b67-bd36-e08c6520d51c">13,464,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia620070bccea49e8ae67e495e7cd6630_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi00LTEtMS0w_74e215d8-e3fa-4183-a202-e18a02eb704d"><ix:nonFraction unitRef="shares" contextRef="ia620070bccea49e8ae67e495e7cd6630_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi00LTEtMS0w_f5404591-751d-40a4-aaea-2f606a2910ff">13,464,939</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia620070bccea49e8ae67e495e7cd6630_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi02LTEtMS0w_a629fb83-83a5-4a21-8df1-f862d4ebb0c4">51,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36e32a096ad44dfab36246420544e57d_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:ProceedsFromIssuanceOfTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi04LTEtMS0w_c849c801-d9cd-4d31-8c93-b57008c8af21">49,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia620070bccea49e8ae67e495e7cd6630_I20201231" decimals="INF" name="hims:TemporaryEquityIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi0xMC0xLTEtMA_c882bec3-ea84-4657-ad4e-db45d09d0c79">3.8152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbd0e86a85204fc19e2e004fc1ddae21_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy0yLTEtMS0w_66910fe0-0fd2-4905-ac97-79abb3a7d394">14,850,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbd0e86a85204fc19e2e004fc1ddae21_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy00LTEtMS0w_0e160783-ab69-4841-a0e4-35a95b647582"><ix:nonFraction unitRef="shares" contextRef="icbd0e86a85204fc19e2e004fc1ddae21_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy00LTEtMS0w_7f598153-d4e4-43cb-8755-ff0da48172bf">14,760,594</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbd0e86a85204fc19e2e004fc1ddae21_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy02LTEtMS0w_0f9d6085-6cdc-4b3b-beac-2da20b08e305">113,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90721555cbdb4b9e88888fbf57039262_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:ProceedsFromIssuanceOfTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy04LTEtMS0w_90b14704-db77-4370-b48e-f36f0581536b">92,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icbd0e86a85204fc19e2e004fc1ddae21_I20201231" decimals="INF" name="hims:TemporaryEquityIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy0xMC0xLTEtMA_6c16d4fd-c0ce-4dab-99c3-65343d914e55">7.6604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC0yLTEtMS01MzI3_34869200-05bc-497f-b5d7-3a60495f648b">10,051,872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC00LTEtMS01MzQx_22312d95-01c3-4786-94ff-d9141aa05cd7"><ix:nonFraction unitRef="shares" contextRef="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC00LTEtMS01MzQx_ca7ab4b0-9b06-44b0-96d9-cbc75a74009a">7,472,062</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC02LTEtMS01MzQ2_f791e886-2314-4a76-b806-786d56f8bbe5">52,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d6bc7c49f14a5ba7fec5954dbe1334_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:ProceedsFromIssuanceOfTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC04LTEtMS01MzUx_967e3960-eba2-428d-9922-f3bf5011ccd8">51,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231" decimals="INF" name="hims:TemporaryEquityIssuedPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC0xMC0xLTEtNTM1Ng_bb9b9643-a8d6-403a-a645-092fb67261fe">6.9639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC0yLTEtMS0w_8a2f8f56-3b04-4711-9d6f-97e419b77ec8">95,997,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC00LTEtMS0w_8954e53d-5015-4cb3-8ab3-f57caa1503c4"><ix:nonFraction unitRef="shares" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC00LTEtMS0w_c8d238b3-5ded-4910-8f22-0eddcae3d274">93,328,118</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquityLiquidationPreference" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC02LTEtMS0w_2cf5303f-9613-4ddc-89c8-7156a493869f">268,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30440e6cee814b0795a79b39d6cc3d7f_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="hims:ProceedsFromIssuanceOfTemporaryEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC04LTEtMS0w_08c508d4-3ca8-4360-ad1c-134601b1ad24">238,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transactions Related to Convertible Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From March&#160;to July&#160;2020, a group of investors purchased <ix:nonFraction unitRef="shares" contextRef="i482412508e5048348a66e153dca18c8a_I20200731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TemporaryEquitySharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2Mjg3Mg_d4868c85-9f7b-496e-861f-ec7c8227e763">7,472,062</ix:nonFraction> shares of Hims Series D redeemable convertible preferred stock and the Company received $<ix:nonFraction unitRef="usd" contextRef="i07ad18420cfc4998888024c661da561a_D20200301-20200731" decimals="-5" format="ixt:numdotdecimal" name="hims:ProceedsFromIssuanceOfTemporaryEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjUwNw_a10048b3-b27e-4bfa-b260-9b08adfc5b4c">51.9</ix:nonFraction>&#160;million in net proceeds.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, all series of Hims redeemable convertible preferred stock were converted into Hims' Class A common stock on a <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" format="ixt-sec:numwordsen" name="hims:RecapitalizationExchangeConversionBasis" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2NzIxMQ_3f2feac3-e868-4439-988e-468a17489579">one</ix:nonFraction>-for-one basis and then converted to the Company's Class A common stock at an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjUyMg_95cf7cce-ab2c-44d7-869f-6f863dd91ea4">0.4530</ix:nonFraction>.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warrants for Redeemable Convertible Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, in accordance with the terms outlined in March 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="ie64d700f04004ca28cce3f10ce2c702e_I20200229" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjkxNw_52295729-c2e7-4d77-a8a4-05c0b4c1ee27">1,341,865</ix:nonFraction> Hims Series C convertible preferred stock warrants based on 2019 revenue. The fair market value of the Hims Series C convertible preferred stock warrants was estimated using the BSM option-pricing model, and at the issuance date, fair value of the liability was $<ix:nonFraction unitRef="usd" contextRef="ie64d700f04004ca28cce3f10ce2c702e_I20200229" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjU0MQ_9438e25c-5e2c-491c-a3c5-737995713c97">10.0</ix:nonFraction>&#160;million. The original liability was recorded as an issuance cost for the Hims Series C preferred stock, reducing the value of the Hims Series C proceeds within mezzanine equity on the consolidated balance sheets. Subsequent adjustments to the fair value of the Hims Series C convertible preferred stock warrants were recorded within other income (expense), net on the consolidated statements of operations and comprehensive loss. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the Hims Series C convertible preferred stock exercised all their warrants and purchased <ix:nonFraction unitRef="shares" contextRef="ia535ce992e724f86a62e762541499dca_D20200201-20200229" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2NzIzNg_eec6189e-b3f0-4848-9353-71a917bab652">1,341,865</ix:nonFraction> shares of Hims Series C convertible preferred stock from the Company in 2020 resulting in settlement of the Hims Series C convertible preferred stock warrant liability. The Company received less than $<ix:nonFraction unitRef="usd" contextRef="ia535ce992e724f86a62e762541499dca_D20200201-20200229" decimals="-5" format="ixt:numdotdecimal" name="hims:ProceedsFromConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjU2Nw_10b87520-9a12-4ce1-b052-a8f4b0c0c4c2">0.1</ix:nonFraction>&#160;million in net proceeds. Upon exercise, the warrant liability at an estimated fair market value of $<ix:nonFraction unitRef="usd" contextRef="i5c24e39c91df42cbaed7932bf65e2d02_I20200301" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WarrantsAndRightsOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjU4MQ_7cd17f33-b0f2-4302-bc0b-dd38bb8d07c1">11.3</ix:nonFraction>&#160;million was reclassified into convertible preferred stock on the consolidated balance sheet.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic505ce38768d4cbbbba5512c13f6e49c">In November 2019, the Company issued <ix:nonFraction unitRef="shares" contextRef="ia0f34e27b5684e27b0de10fc97914074_I20191130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2NzE3OQ_62aeb27c-bf16-4795-b573-9403a7c2bdd6">89,747</ix:nonFraction> Hims Series C preferred stock warrants to TPC in connection with the 2019 Capital Agreement. The fair value of the warrants was considered debt issuance cost and recorded within prepaid and other current assets on the consolidated balance sheet. On March 12, 2020, the Company sold Hims Series D redeemable convertible preferred stock at an issuance price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i85017d290ffd4ccda16318d642b40261_I20200312" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2NzE5OQ_4e96178a-4caf-443e-9fdc-2c44b504d442">6.96</ix:nonFraction>, which triggered an adjustment to the TPC warrant terms per the original agreement, resulting in conversion of the previously issued <ix:nonFraction unitRef="shares" contextRef="i9325ba192ff34fe4a7eec3cc7c4f7351_I20200312" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2NzE4Nw_e5caf1c1-e12e-4956-aa28-60317b33ec47">89,747</ix:nonFraction> Hims Series C preferred stock warrants into <ix:nonFraction unitRef="shares" contextRef="i85017d290ffd4ccda16318d642b40261_I20200312" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfODI0NjMzNzIyMjM1Mw_9a71f51b-a3af-4252-b3ff-ab7900de1b13">98,723</ix:nonFraction> Hims Series D preferred stock warrants. Refer to Note 10 &#8211; Borrowing Arrangements for further discussion. Subsequent to the Merger, the Hims Series D preferred stock warrants were converted to Class A common stock warrants. As a result, the Hims Series D preferred stock warrants were adjusted to fair value prior to the conversion, and then settled in additional paid-in capital as a result of the conversion to equity-classified Class A common stock warrants.</ix:continuation> </span></div><div id="i412093a93f204328a33c4602202f8375_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3Njk5OQ_bc2a2250-1f7b-4aec-b858-d2edcfea1bad" continuedAt="icaf97c6d962445078c22e4e1edebabea" escape="true">Common Stock</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icaf97c6d962445078c22e4e1edebabea" continuedAt="i0ef5df49d4a1466fadfac71869ecb73b">Prior to the Merger, the Company had <ix:nonFraction unitRef="common_stock_class" contextRef="i8d64fe4256a5495dac515af8a61e6773_I20210119" decimals="INF" format="ixt-sec:numwordsen" name="hims:NumberOfClassesOfCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODc1Mw_6761f4ab-4e54-4e8b-b4f4-d2cfe2e4980a">two</ix:nonFraction> classes of authorized common stock, Hims Class A common stock and Hims Class F common stock. Shares issued on early exercise are not considered outstanding for accounting purposes because the employees holding these awards are not entitled to the rewards of stock ownership.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i0ef5df49d4a1466fadfac71869ecb73b" continuedAt="ibaf5a45023874ce4854c2ebb2184f271"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights of the holders of Hims Class A and Hims Class F common stock were identical, except with respect to (i) electing members of the Board of Directors and (ii) voting rights. The outstanding shares of Hims Class A and Hims Class F common stock presented on the consolidated balance sheet and on the consolidated statement of mezzanine equity and stockholders' equity (deficit) for the year ended December 31, 2020 were legally outstanding shares, including shares issued in exchange for related-party promissory notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i080dafd9e34b47e7937c78d08d32b686_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODY5NA_8a1a05ae-dba1-4b68-b69b-0c0993a4c6c2">85,594</ix:nonFraction> of unvested shares of Hims Class A common stock for a cash payment of less than $<ix:nonFraction unitRef="usd" contextRef="i080dafd9e34b47e7937c78d08d32b686_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzA1Mg_17a0b12e-0c1c-4087-a36b-da7fb9524017">0.1</ix:nonFraction>&#160;million, which resulted in a reduction of deposit liability from the early exercise of stock options. In addition, in May 2020, an executive officer departed the Company, which resulted in the repurchase of <ix:nonFraction unitRef="shares" contextRef="i41048193847540548f3ba7ae46d9623e_D20200501-20200531" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODcwMg_dec26d1e-486b-4ca2-bb9f-c522991fe9ff">509,602</ix:nonFraction> unvested shares of Hims Class A common stock in exchange for the cancellation of the principal payable of $<ix:nonFraction unitRef="usd" contextRef="i2089a56369e04eacb54344b55b8e03a8_D20200501-20200531" decimals="-5" format="ixt:numdotdecimal" name="hims:NotesReceivableAmountOfPrincipalPaymentCanceled" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzA3Nw_d4fefdac-2c05-4d6c-9ac2-70ba9912b80a">0.9</ix:nonFraction>&#160;million under an associated promissory note. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-Closing Stock Repurchase</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, the Company repurchased from its stockholders and cancelled <ix:nonFraction unitRef="shares" contextRef="i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTU1OA_4858af90-e0e9-42e3-8563-37eb14d784e7">2,207,580</ix:nonFraction> shares of Hims Class A common stock, including certain stockholders who exercised outstanding stock options, for aggregate payment of $<ix:nonFraction unitRef="usd" contextRef="i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzEwMg_b4dd62b4-c06c-4f40-b773-34a9c5b81371">22.0</ix:nonFraction>&#160;million. Included within the shares repurchased was <ix:nonFraction unitRef="shares" contextRef="i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTU2OQ_70109032-4389-4199-9e5e-1bec19762b4f">183,548</ix:nonFraction> shares of Hims Class&#160;A common stock from the net exercise of stock options as part of the pre-closing stock repurchase for $<ix:nonFraction unitRef="usd" contextRef="i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTU3OA_85a97d1c-4531-46c0-ab14-36eb6873452c">1.8</ix:nonFraction>&#160;million. The repurchase was recognized as a reduction of additional paid-in capital and redeemable convertible preferred stock. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merger Transaction</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to the Merger, each outstanding share of Hims' Class F common stock and preferred stock converted into Hims Class A common stock at the then-effective conversion rate. As a result of the Merger, each outstanding share of the Hims capital stock was converted into the right to receive newly issued shares of the Company's Class A common stock and certain other securities, other than the shares of Hims Class V common stock issued to its CEO immediately prior to the Closing, which were converted into the right to receive newly issued shares of the Company's Class V common stock and certain other securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Closing Date, each Hims stockholder received approximately <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTgzMA_ac60078a-fe02-436f-bef7-c39c414db05b">0.4530</ix:nonFraction> shares of the Company's Class A common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i26bd1b4cf75e452991194f1a1a3d5cac_I20210120" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTgzNA_f13a3241-102b-424c-9650-59eb5a58d997">0.0001</ix:nonFraction> per share, for each share of Hims Class A common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i5c3a9475a70b4c2db3d6e0010a374a0e_I20210119" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTgzOA_0e74e815-6c5d-4cb1-8546-54643f439396">0.000001</ix:nonFraction> per share, that such stockholder owned (with the CEO receiving <ix:nonFraction unitRef="number" contextRef="i35a4fb924db24a85a1196789003372ba_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTg0Ng_b97f57d3-25c7-4ce6-89c8-d7a53ecc4c4f">0.4530</ix:nonFraction> shares of the Company's Class V common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i3ee826f19c8f474091f7807831d1a4a2_I20210120" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTg0Mg_fec313f5-199b-4187-ac01-5b454c10242e">0.0001</ix:nonFraction> per share, for each share of Hims Class V common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="if23c020d049c42f8a21888c7cd351bf5_I20210119" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTg1MA_1dcbb6ca-0019-4797-8e64-2dff5fa11c13">0.000001</ix:nonFraction> per share, that the CEO owned). Each stockholder also received <ix:nonFraction unitRef="shares" contextRef="ie5182198da4045b7a12388e80e2263ab_I20210120" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzE3Mw_f22c3979-898f-4119-b822-081b222c16d5">0.0028</ix:nonFraction> warrants exercisable for the Company's Class A common stock, for each share of Hims Class A or Class V common stock owned by such stockholder prior to the Merger and earn-out shares at an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i2ffc7b3d75784438b282649862e9f57e_D20210120-20210120" decimals="INF" name="hims:RecapitalizationContingentConsiderationEquityExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzE4MQ_d34f708f-061c-40f7-8d04-0ae7d4be7f0c">0.0443</ix:nonFraction>. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Settlement of Nonrecourse Related-Party Promissory Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, the obligations due under all nonrecourse related-party promissory notes were satisfied through the payment of $<ix:nonFraction unitRef="usd" contextRef="i46d371e52a99410f95f88ff85bac410c_D20210120-20210120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzE4OQ_efc4a332-595f-4db2-8f55-77641cdb4589">1.2</ix:nonFraction>&#160;million and the forfeiture of <ix:nonFraction unitRef="shares" contextRef="i46d371e52a99410f95f88ff85bac410c_D20210120-20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzIwMw_be98b34e-d69b-435e-a883-68d719a892a0">370,734</ix:nonFraction> shares of the Company's Class A common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PIPE Investment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the execution of the Merger Agreement, certain investors collectively subscribed for <ix:nonFraction unitRef="shares" contextRef="ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzIxMg_d807be87-5033-4be8-b6d3-2e17836b5749">7,500,000</ix:nonFraction> shares of the Company's Class A common stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="i16bc3ab7ee094ed08651067218f9050a_I20210120" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzIyMw_4724dcff-05a9-4d88-a7a0-9815c79b2a0f">10.00</ix:nonFraction> per share for aggregate gross proceeds of $<ix:nonFraction unitRef="usd" contextRef="ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzIzMQ_64611e43-3246-48b4-b8d1-d93f0960dfca">75.0</ix:nonFraction>&#160;million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class&#160;A Common Stock Warrants</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, Class A common stock warrants have been issued in connection with debt agreements (Note 10 &#8211; Borrowing Arrangements), vendor service agreements (Note 12 &#8211; Stock-Based Compensation), issuance of preferred stock (Note 13 &#8211; Redeemable Convertible</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and to all common stockholders and warrant holders as part of the Merger.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="ibaf5a45023874ce4854c2ebb2184f271" continuedAt="i61687eded7184e8fb9eae783ca18fd83"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior to Merger</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, Hims Class A common stock warrants were exercised to purchase <ix:nonFraction unitRef="shares" contextRef="i0cc1f5f00f854fd696092abbe8e5eb52_D20200701-20200731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMDgwOA_6697f48f-0cfa-49ac-b781-98a6d6afe20e">143,452</ix:nonFraction> shares of Hims Class A common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i18d3dd2a0dd54782ac27fc6a98050d65_I20200731" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMDg2Nw_c1ce4bd4-5586-45c3-9162-bf8285a6048f">0.06</ix:nonFraction> per share. In November 2020, Hims Class A common stock warrants were exercised to purchase <ix:nonFraction unitRef="shares" contextRef="i56a3708962c641f6884526a28a764d6b_D20201101-20201130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMDk3NA_9cd8a674-de9d-45ca-94d3-48aa74b396ed">425,146</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i70b4853509034ba8ac52e45689f9837d_D20201101-20201130" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMDk4Mg_bea19e46-f2f7-4f63-9806-2c150fafa5e0">37,244</ix:nonFraction> shares of Hims Class A common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5454149a7fff446f86e9e1f46fc3ecb0_I20201130" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODc3NA_2661b12a-05c4-4eeb-8199-0d83a465e65c">0.06</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="iead7fc49159344e09cc08f0243c9f687_I20201130" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMTA0OQ_a6d1cf7e-b3c2-4676-8fbf-0a99871d0a2d">1.75</ix:nonFraction> per share, respectively. In December 2020, Class A common stock warrants were exercised to purchase <ix:nonFraction unitRef="shares" contextRef="ia7096ecca3bf42abb946e3f881384b0a_D20201201-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMTE3MA_6b83bacb-2820-45d7-ad91-94504ef9e6f5">178,840</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if6fee565f9384a378a7733102fb1daf9_D20201201-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMTE3OA_da496e49-19ec-499e-b98a-1f41bc93715a">266,522</ix:nonFraction> shares of Hims Class A common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i4ff37ff4f4e94c939d22f573f503c48b_I20201231" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODc4Nw_0ba22404-8461-4501-9b86-4b1b07738914">0.06</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i9d5d169b09da40e69a931bb98ac54af4_I20201231" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODgwMA_9a3ba8bc-b9ec-4412-a7f4-78e5752171bd">1.75</ix:nonFraction> per share, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, holders of Hims Class A common stock vendor warrants exercised their warrants and purchased <ix:nonFraction unitRef="shares" contextRef="ic8f09575a6074fbbbea2128ab741a987_D20210104-20210104" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMTM5OQ_fe46cde1-f1c5-4164-9c2a-1357b8b71340">380,746</ix:nonFraction> shares of Hims Class A common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i069f663c8a004fdfbd4a509b3f54b8d3_I20210104" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMTQ1OA_d6261491-ad67-40ed-acb5-acc72c170899">1.75</ix:nonFraction> per share. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent to Merger</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the accounting acquirer, Hims was deemed to assume <ix:nonFraction unitRef="shares" contextRef="i342bdc4fd0584aca99f4b91a317c0acb_I20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI0Ng_6332a88c-6a5f-4393-ac59-ee2889769dd8">3,012,500</ix:nonFraction> Class A common stock warrants that were held by Oaktree Acquisition Holdings, L.P. ("Sponsor") at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i342bdc4fd0584aca99f4b91a317c0acb_I20210120" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI1Nw_902649ff-1dec-45fc-886f-800890b7eb95">11.50</ix:nonFraction> ("Private Placement Warrants") and <ix:nonFraction unitRef="shares" contextRef="ib55d8e031f574c38bb95ca3aec87d1bd_I20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI2NQ_36ab7cca-c85d-4431-b19c-368a9efe4d76">6,708,333</ix:nonFraction> Class A common stock warrants held by OAC's shareholders at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib55d8e031f574c38bb95ca3aec87d1bd_I20210120" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI3Ng_3a7c81d8-8822-489f-8322-1c52ce1f57e8">11.50</ix:nonFraction> ("Public Warrants") as well as <ix:nonFraction unitRef="shares" contextRef="if6ac477b8fba4a68abf0f1384d4e9f3e_I20210120" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI4NA_ea5726bd-1afc-4039-9815-f73550872e36">888,143</ix:nonFraction> Class A common stock warrants that were granted to Hims' equity holders as part of the Merger. Subsequent to the Merger, the Private Placement Warrants, Public Warrants, and Parent Warrants for shares of Class&#160;A common stock meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement Warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the Private Placement Warrants from being considered indexed to the entity's own stock. Therefore, these warrants are classified as liabilities on the condensed consolidated balance sheets.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each warrant held by Hims' stockholders that was unexercised at the time of the Merger was assumed by the Company and represents the right to receive (a) an equivalent warrant at an exchange ratio of <ix:nonFraction unitRef="number" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI5Mw_b39ee2d0-1c1e-46f7-bf82-f3df984a1c53">0.4530</ix:nonFraction> (which was determined not to result in incremental expense); (b) the right to receive, upon exercise, earn-out shares that vest in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzMwMQ_8e146fba-9cb4-4e61-b0c3-a4982e25b94a">15.00</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzMwOQ_ed471daf-ad58-498f-9807-5440e3cfeb1b">17.50</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzMxNw_9309ddc8-bb05-4569-b392-0165fdbd5329">20.00</ix:nonFraction> for any <ix:nonFraction unitRef="day" contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODQ5MQ_e35ee3e7-5130-4ecd-a482-d453b65b6eec">10</ix:nonFraction> trading days within any <ix:nonFraction unitRef="day" contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" decimals="INF" name="hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODQ5NQ_e6c60a8a-a2f9-4449-afe9-80ae2ca41ab6">20</ix:nonFraction>-trading day period, or a Company sale (as defined in the Merger Agreement) occurs and the thresholds are met on or prior to the date that is <ix:nonNumeric contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120" format="ixt-sec:durwordsen" name="hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODgxMw_bdd2fa1f-58a1-4b40-a632-edfac0fa73e7">five years</ix:nonNumeric> following the Closing Date; and (c) the right to receive, upon exercise, an allocation of Parent Warrants. All of these instruments vest in accordance with the terms of the initial warrant in addition to any of the aforementioned requirements. The earn-out thresholds were all met in February 2021. The earn-out shares are equity classified since they do not meet the liability classification criteria outlined in ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are both (i) indexed to the Company's own shares and (ii) meet criteria for equity classification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, all of the outstanding <ix:nonFraction unitRef="shares" contextRef="iab13a99ae40f48409e0e1f3fd36fa413_I20210228" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMjg4Mw_a0c1520b-788e-4974-9bfd-62306a11d5e3">3,012,500</ix:nonFraction> Private Placement Warrants were net exercised for <ix:nonFraction unitRef="shares" contextRef="i2c70da65b2cb41f68da444e9a69d66ae_D20210201-20210228" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMjkzNw_550c3439-9630-4b66-aecc-aa6e33f892b2">1,474,145</ix:nonFraction> shares of Class A common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzQ3NA_4110584e-d27b-4b6d-81a3-27b108ed9a8a" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had the following warrants outstanding to purchase shares of Class&#160;A common stock (in&#160;thousands, except for share and per share amounts):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.203%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant Type</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issued</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i79825d4c5b744870999e9bde3e8537f5_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMS0wLTEtMS0w_5255a961-2234-4666-b8f7-b3c1ca9c1341">462,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i79825d4c5b744870999e9bde3e8537f5_I20210331" decimals="4" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMS0yLTEtMS0w_3d762ba9-7fc5-4188-baba-e58a00b5e62e">1.75</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 23, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 23, 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7376dfd331f74bd0b77f3b369c1c6b2a_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMi0wLTEtMS0w_a36dc433-76a9-4cbe-9c07-b03b45549de0">98,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7376dfd331f74bd0b77f3b369c1c6b2a_I20210331" decimals="4" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMi0yLTEtMS0w_b4f5c9ec-b484-4e7c-9ef2-886a082d4a62">6.96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 26, 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i843814f57f6e400fa68052b3160a60fe_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMy0wLTEtMS0w_43a74bd9-e899-4aa1-98f7-8071d04523a2">6,695,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i843814f57f6e400fa68052b3160a60fe_I20210331" decimals="4" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMy0yLTEtMS0w_bba74038-9163-4a29-aa27-0140c1734930">11.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 22, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 20, 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1cc2663250444268a356d3527951ceb6_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfNC0wLTEtMS0w_dd25a4e4-8f4e-496c-bd29-74ed7e8b135a">888,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1cc2663250444268a356d3527951ceb6_I20210331" decimals="4" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfNC0yLTEtMS0w_239b29da-e6d2-433f-99d0-ae01f47f23cd">11.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 22, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 20, 2026</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Public Warrants Terms</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants became exercisable into shares of Class A common stock upon <ix:nonNumeric contextRef="i0929992266364d4095e65e0383a160d6_D20210101-20210331" format="ixt-sec:durday" name="hims:ClassOfWarrantOrRightExercisablePeriodAfterClosingDate" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODg0Mw_38d108b7-4089-4436-8c44-3787e85f05cc">30</ix:nonNumeric> days after the Closing Date. The Public Warrants will expire at the later of <ix:nonNumeric contextRef="i0929992266364d4095e65e0383a160d6_D20210101-20210331" format="ixt-sec:durwordsen" name="hims:ClassOfWarrantOrRightExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODg1Nw_b327383b-9b2b-43e1-a56f-73892fcce9b8">five years</ix:nonNumeric> after the completion of a business combination or upon redemption or liquidation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing <ix:nonNumeric contextRef="i0929992266364d4095e65e0383a160d6_D20210101-20210331" format="ixt-sec:durday" name="hims:ClassOfWarrantOrRightRedemptionPeriodAfterExercisable" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODQ5OA_6daa3bc0-f579-447f-a36b-aaaf7bb713f8">90</ix:nonNumeric> days after the Public Warrants become exercisable, the Company may redeem all and only all of the Public Warrants:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at $<ix:nonFraction unitRef="usdPerShare" contextRef="i54b4437d5bc64dd09ecb5bab58c279ad_I20210331" decimals="INF" name="hims:ClassOfWarrantOrRightRedemptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzQ0NQ_f2cb79af-5145-47e2-8a6b-d8a485240f8a">0.10</ix:nonFraction> per warrant upon a minimum of <ix:nonNumeric contextRef="i2867394843aa406ea9a5eb734f9b7751_D20210101-20210331" format="ixt-sec:durday" name="hims:ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODUxMQ_3aa912bc-af6f-40c6-90a1-513830038886">30</ix:nonNumeric> days' prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i61687eded7184e8fb9eae783ca18fd83" continuedAt="i5ba49d12a55a4a5ea4e3502e9e74dbe5"><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the redemption date at a price equal to the average last reported sale price of the Class A common stock for the <ix:nonFraction unitRef="day" contextRef="i2867394843aa406ea9a5eb734f9b7751_D20210101-20210331" decimals="INF" name="hims:ClassOfWarrantOrRightThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODUyNA_9d5d485c-a0a2-4674-b3b5-358cb510c2e2">10</ix:nonFraction> trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants;                     </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the last reported closing price of the Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="i54b4437d5bc64dd09ecb5bab58c279ad_I20210331" decimals="INF" name="hims:ClassOfWarrantOrRightSalePriceRedemptionThreshold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzQ1Mg_d1d638e9-66d2-4f8b-a9f3-828f9515c910">10.00</ix:nonFraction> per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if there is an effective registration statement covering the Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the <ix:nonNumeric contextRef="i2867394843aa406ea9a5eb734f9b7751_D20210101-20210331" format="ixt-sec:durday" name="hims:ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODUyOA_06e3ebe4-0241-40d8-8b00-53e2a93da6b0">30</ix:nonNumeric>-day period after written notice of redemption is given, or an exemption from registration is available.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company may redeem all and only all of the Public Warrants for cash:      </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i65b1285ccd8544e6ab3ef4189e9e2fa5_I20210331" decimals="INF" name="hims:ClassOfWarrantOrRightRedemptionPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzQ2MA_5ce23432-a3f5-4aff-ab47-30b8c290cd0e">0.01</ix:nonFraction> per warrant;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of <ix:nonNumeric contextRef="i98e637f1336e44e5af203fddfc5974c1_D20210101-20210331" format="ixt-sec:durday" name="hims:ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODUzNA_ce8b668a-fc64-459f-a2b7-5b6fb4677fc0">30</ix:nonNumeric> days' prior written notice of redemption; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the last reported closing price of the Class A common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="i65b1285ccd8544e6ab3ef4189e9e2fa5_I20210331" decimals="INF" name="hims:ClassOfWarrantOrRightSalePriceRedemptionThreshold" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzQ2Nw_f92051c4-f1fe-4f08-b67b-bfd5e404d5d5">18.00</ix:nonFraction> per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) for any <ix:nonFraction unitRef="day" contextRef="i98e637f1336e44e5af203fddfc5974c1_D20210101-20210331" decimals="INF" name="hims:ClassOfWarrantOrRightThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODU0Nw_80c3c603-9793-4381-a43a-7f65f615ef22">20</ix:nonFraction> trading days within a <ix:nonFraction unitRef="day" contextRef="i98e637f1336e44e5af203fddfc5974c1_D20210101-20210331" decimals="INF" name="hims:ClassOfWarrantOrRightThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODU1MQ_f9a6284a-ef1b-48fa-ac64-5f2e10db677d">30</ix:nonFraction>-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i5ba49d12a55a4a5ea4e3502e9e74dbe5">If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a cashless basis, as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle.</ix:continuation> </span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1ODk2NA_68b3a66f-4d18-4a5c-97c6-586f2a39bda2" continuedAt="i075d47b2962d4db48ed064850f55dfee" escape="true">Related-Party Transactions</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i075d47b2962d4db48ed064850f55dfee" continuedAt="i372c62b8fbcf4039b1823532d7c15f13"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Atomic Labs, LLC ("Atomic Labs") is a related-party venture capital startup studio that launched the Company, providing initial capital and governance.  During the initial years of operation, the Company utilized operational support from Atomic Labs, primarily consisting of providing office space, conducting back-office professional services, and administering operating expenses. Additionally, an affiliated company of Atomic Labs provides professional services to the Company, primarily to support engineering and operations functions. All services were provided at cost. For both the three months ended March 31, 2021 and 2020, the Company recorded a total of $<ix:nonFraction unitRef="usd" contextRef="i771a07ec099545b09a6b92170d11d935_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjIy_799ca941-a586-47ef-9a1a-08290ccbd00c"><ix:nonFraction unitRef="usd" contextRef="i8d14d0c90a8548aa962fa7748b3135a9_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjIy_8648c20a-b557-4623-94d7-04163c5637ed">0.8</ix:nonFraction></ix:nonFraction> million to Atomic Labs and its affiliated company for services performed and costs incurred on behalf of the Company. There was <ix:nonFraction unitRef="usd" contextRef="ibb1c06dc151e466aa6cc22295c17a714_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA4MTY3MA_70357ea1-3d92-49f8-8a9e-8edc86bbfffe"><ix:nonFraction unitRef="usd" contextRef="ie1a302a5f05545f79eca24d49954e1cb_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA4MTY3MA_8e02743c-48f9-4433-b478-2a1aa75728ef">no</ix:nonFraction></ix:nonFraction> accounts payable balance owed to Atomic Labs and its affiliated company as of March&#160;31, 2021 or December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, for the three months ended March 31, 2021 and 2020, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i312fd18031e24c0390d9be5de157fa4e_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA3ODU0Ng_2d5e76b6-09ec-4572-a6f0-ac36c922e7d8">0.1</ix:nonFraction> million and less than $<ix:nonFraction unitRef="usd" contextRef="i638236725896454da1131afdbb4606ed_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA3ODU1NA_6610987e-c731-41fb-be34-9777ae4aee07">0.1</ix:nonFraction> million for payments made to Vouched, a related-party company that provides identity verification services. These expenses were recognized as selling, general, and administrative expenses. There was $<ix:nonFraction unitRef="usd" contextRef="i922947682b4841668dfbfe65e252e019_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA3ODU3NA_71708082-27fe-4e26-8ffd-1b851c365eb8">0.1</ix:nonFraction> million and less than $<ix:nonFraction unitRef="usd" contextRef="if227b428e44f45d982ddcf68a4372138_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA4MTcyOA_fbaad0f2-b7dd-4bc7-adde-f02906b12c92">0.1</ix:nonFraction> million of payables owed to Vouched as of March&#160;31, 2021 and December&#160;31, 2020. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nonrecourse Related-Party Promissory Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had promissory notes from certain of the Company's executive officers, as well as a founding employee and an executive chairman. The promissory notes, which were issued to the Company by the related parties as consideration for the exercise of stock options, are considered nonrecourse notes for accounting purposes. The loans are secured by the shares of Hims Class&#160;A common stock held by the individuals. There were <ix:nonFraction unitRef="shares" contextRef="i02a8feb03ad34f34b5b703765d4c44c3_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA3NTQxMg_b0d275d5-ea45-47e2-bbc0-d2d199b05715">16,345,627</ix:nonFraction> shares of Hims Class A common stock securing the related-party promissory notes as of December&#160;31, 2020. The related-party promissory notes bore interest between <ix:nonFraction unitRef="number" contextRef="if04cc3c5ee874113863826cf1cba7153_D20200101-20201231" decimals="INF" name="us-gaap:RelatedPartyTransactionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMTU1NA_2b328ece-2be3-40a8-b814-2fe3c45c8fce">2.21</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="iadf5123ee59348dda3e8699ab30bad2c_D20200101-20201231" decimals="INF" name="us-gaap:RelatedPartyTransactionRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMTU2MQ_45d9a163-ba93-4295-9964-17f3929ed440">3.02</ix:nonFraction>% per annum. The loans were due upon the earliest of (1)&#160;ten years from the debt issuance date, (2)&#160;a liquidation of the Company, or (3)&#160;six months following an initial public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended. Prepayment of principal and interest may be made at any time without penalty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nonrecourse related-party promissory notes are not given accounting effect until the notes are repaid in full as the underlying stock options are not considered exercised for accounting purposes. As of December&#160;31, 2020, the total outstanding balance under these promissory notes was $<ix:nonFraction unitRef="usd" contextRef="i02a8feb03ad34f34b5b703765d4c44c3_I20201231" decimals="-5" format="ixt:numdotdecimal" name="hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA3NTM4Nw_3fd8ebe2-c961-4ce5-8eb2-ad12a3545f34">7.2</ix:nonFraction> million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i372c62b8fbcf4039b1823532d7c15f13" continuedAt="i6b3a697109df4463a98bf6c0f50e3452"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, the obligations due under all nonrecourse related-party promissory notes were satisfied through the payment of $<ix:nonFraction unitRef="usd" contextRef="ie6b30bf8b001432a828df2ce3d0da827_D20210120-20210120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRelatedPartyDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfODI0NjMzNzIxNjM1MQ_8f5f901e-c6c5-4e46-bd9b-df443483e94b">1.2</ix:nonFraction>&#160;million and the forfeiture of <ix:nonFraction unitRef="shares" contextRef="ie6b30bf8b001432a828df2ce3d0da827_D20210120-20210120" decimals="INF" format="ixt:numdotdecimal" name="hims:StockForfeitedDuringPeriodShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfODI0NjMzNzIxNjM3Nw_752ea17a-4795-471e-8a54-b2d443df939a">370,734</ix:nonFraction> shares of Hims Class A common stock. The related-party promissory notes were settled within additional paid-in capital on the condensed consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redeemable Common Stock Transaction</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6b3a697109df4463a98bf6c0f50e3452">On September&#160;23, 2019, the Company's&#160;CEO and a member of its Board of Directors, sold <ix:nonFraction unitRef="shares" contextRef="ic59ae3ede9fb4cc19a25f9ae9330b9c1_D20190923-20190923" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1ODk2Ng_1475f29d-4218-4e0f-833f-3b8d052f087a">737,058</ix:nonFraction> shares of Hims Class&#160;A common stock to third party purchasers at $<ix:nonFraction unitRef="usdPerShare" contextRef="i8a589e0752164dc492e454a20349d082_I20190923" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfODI0NjMzNzIxNTg2NQ_0737a4b8-9121-42a8-b4f7-9184b9b41673">6.11</ix:nonFraction> per share for aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="ic59ae3ede9fb4cc19a25f9ae9330b9c1_D20190923-20190923" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1ODk4Ng_8f15a882-58d7-4c7c-ba58-f9ab6151fa04">4.5</ix:nonFraction>&#160;million&#160;pursuant to Hims Class&#160;A Common Stock Purchase Agreements. Under the terms of the vendor service agreement with the third party, the purchasers were granted a put right entitling them to sell the shares to the Company at $<ix:nonFraction unitRef="usdPerShare" contextRef="i8a589e0752164dc492e454a20349d082_I20190923" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfODI0NjMzNzIxNTg3Mw_0737a4b8-9121-42a8-b4f7-9184b9b41673">6.11</ix:nonFraction> per share for a period of <ix:nonNumeric contextRef="ic37899a64fdb4b35b8953afb27a19de6_D20190923-20190923" format="ixt-sec:durwordsen" name="hims:SaleOfStockPutRightPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1OTAwOA_36f51c8c-b804-4c9d-9392-86acb1d2d18e">six months</ix:nonNumeric>. The put right expired on March&#160;23, 2020 without the purchasers exercising their rights to sell the shares to the Company. The Company recorded stock-based compensation expense associated with the transaction of $<ix:nonFraction unitRef="usd" contextRef="i6aabfe45198043d3a411876caa90f87c_D20190923-20190923" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1ODc0Nw_108ae4a5-6694-4c7d-992c-50dd0577879c">3.0</ix:nonFraction> million. Upon expiration of the redemption right, the Company reclassified the aggregate consideration of $<ix:nonFraction unitRef="usd" contextRef="i93e3fc5bb5ed483ebb7e411c2c1b86a3_D20200101-20200331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="hims:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1OTAyNQ_ee6c631f-5010-4632-aeaa-b10219bd02be">4.5</ix:nonFraction>&#160;million that was subject to redemption from mezzanine equity to stockholders' equity on the condensed consolidated balance sheet as of March&#160;31, 2020.</ix:continuation> </span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NTk4Mw_c84d0a89-e24f-4709-bcce-7c47d7503a33" continuedAt="iac9de6d09c684cd6a9e68253a0bd5b58" escape="true">Basic and Diluted Net Loss per Share</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="iac9de6d09c684cd6a9e68253a0bd5b58" continuedAt="i5e612f2dea3e40339406791057d51383"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger and prior to effecting the recapitalization, the Company had two classes of common stock: Hims Class A and Hims Class F common stock. The rights of the holders of Hims Class&#160;A and Hims Class&#160;F common stock were identical, including the liquidation and dividend rights, except with respect to electing members of the Board of Directors and voting rights. As the liquidation and dividend rights were identical, undistributed earnings and losses were allocated on a proportionate basis and the resulting net loss per share attributable to common stockholders was the same for both Hims Class&#160;A and Hims Class&#160;F common stock on an individual and combined basis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Merger, the Company continues to have two classes of common stock: Class A and Class V common stock. Similar to the previous structure, the rights are identical, including liquidation and dividend rights, except Class V common stock has additional voting rights. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the two-class method to calculate net loss per share. <ix:nonFraction unitRef="usd" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DividendsCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NjIxOA_83e26aa0-b907-4787-90d3-374b9e2c697e"><ix:nonFraction unitRef="usd" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:DividendsCommonStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NjIxOA_c837f3ab-5c7f-4697-8887-e6a50b021bbd">No</ix:nonFraction></ix:nonFraction> dividends were declared or paid for the three months ended March 31, 2021 or 2020. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. As there is no contractual obligation for the redeemable convertible preferred stock to share in losses, the Company's basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average shares of common stock outstanding during periods with undistributed losses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NTk4NA_f79c7f99-4686-4fa8-afc9-9eaad302dfdb" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of the Company's basic and diluted net loss per share attributable to common stockholders for the three months ended March 31 (in&#160;thousands, except share and per share amounts):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class&#160;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class V</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class&#160;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class&#160;F</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfMy0xLTEtMS0w_d1bcad5f-ea6e-4723-9946-b9fbd522138e">49,185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfMy0zLTEtMS0w_24d453f6-a2f7-4f02-b9ae-f38216ae6eb2">2,219</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfMy01LTEtMS0w_b558ee96-c9b5-4312-b334-2b5f4774b800">4,823</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6168af5421b947c983b702984f8157bc_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfMy03LTEtMS0w_6f5a6e4e-0388-457e-aad8-fb77890d524a">1,210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS0xLTEtMS0w_1d23534e-9ab3-458c-9035-eaf5f780daa2"><ix:nonFraction unitRef="shares" contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS0xLTEtMS0w_31a5d9d6-5428-4f66-b83f-2af984d3112b">146,471,524</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS0zLTEtMS0w_615b027b-6e35-430f-b1cc-1ed4c20927c0"><ix:nonFraction unitRef="shares" contextRef="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS0zLTEtMS0w_cb04f94b-0fa5-4ed3-bd3c-578c0551e926">6,609,014</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS01LTEtMS0w_12500e18-73de-4b0c-a5a7-da41e7361a5b"><ix:nonFraction unitRef="shares" contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS01LTEtMS0w_77c82c30-8c3b-4a76-937c-3dc20450219f">27,668,709</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6168af5421b947c983b702984f8157bc_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS03LTEtMS0w_ae3587bd-c0a5-42c7-b701-7021851c864f"><ix:nonFraction unitRef="shares" contextRef="i6168af5421b947c983b702984f8157bc_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS03LTEtMS0w_e3e34767-c617-4286-a353-147a10710969">6,941,352</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi0xLTEtMS0w_303a9d3c-3b30-40d3-8635-321b17fec242"><ix:nonFraction unitRef="usdPerShare" contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi0xLTEtMS0w_8e38cfa7-30a2-46da-aacd-6f4c960e106f">0.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi0zLTEtMS0w_15891837-2683-47d0-8df0-8744e42fbbe0"><ix:nonFraction unitRef="usdPerShare" contextRef="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi0zLTEtMS0w_7194fb47-544c-4b24-ab47-c50c6652ae19">0.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi01LTEtMS0w_1a62be30-5701-4814-bafe-12716393db34"><ix:nonFraction unitRef="usdPerShare" contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi01LTEtMS0w_f699bce3-6951-46d0-ad6b-67f67f7a1dff">0.17</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i6168af5421b947c983b702984f8157bc_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi03LTEtMS0w_0c448d5c-3380-4c31-b1be-d1574d46d822"><ix:nonFraction unitRef="usdPerShare" contextRef="i6168af5421b947c983b702984f8157bc_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi03LTEtMS0w_a4c643ce-f894-49b9-8007-c2d3194c1f54">0.17</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share attributable to common stockholders is the same for the three months ended March 31, 2021 and 2020, because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented. There were <ix:nonFraction unitRef="shares" contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331" decimals="0" format="ixt-sec:numwordsen" name="hims:NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NTk4NQ_5e5cec45-6dd9-4d53-b063-14af84adfc73">no</ix:nonFraction> redeemable shares during the three months ended March&#160;31, 2021. During the three months ended March 31, 2020, weighted average Hims Class A common shares presented excludes <ix:nonFraction unitRef="shares" contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="hims:NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NzQ0MA_f4c5befd-9710-4260-98fe-27a3ff6d9d8e">664,162</ix:nonFraction> shares subject to redemption. These shares do not absorb losses.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_31">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hims &amp; Hers Health, Inc.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements (Unaudited) (continued)</span></div></div><ix:continuation id="i5e612f2dea3e40339406791057d51383"><ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NTk5Mw_679e0376-0771-47cf-b425-d1649177812b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses securities that could potentially dilute basic net loss per share in the future that were not included in the computation of diluted net loss per share:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for exercise of stock options subject to nonrecourse promissory notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i442b98b30a99440cabcf9c2a33258c44_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfMi0xLTEtMS0w_41b54450-c31b-4c31-81a0-45068ae3bff4">3,545,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib288e8afaab1439aa8563d67d92545a5_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfMi0zLTEtMS0w_0c9a0fd9-a1f4-44d8-876c-8c39051a7904">16,855,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for early exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie88ff03799b74ad5965527925463ef9a_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfMy0xLTEtMS0w_ab3663b3-3578-4d77-99f3-145cc977214c">388,839</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a72b9ac461b4533a1192dda838f4fe4_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfMy0zLTEtMS0w_07800eca-d66e-40c4-b429-41d3f4223b28">154,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i06d6c621d2034e6dafae9bcb378bdff9_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNC0xLTEtMS0w_efe24ff8-3a6a-4516-9455-bcc60dcc60de">19,702,603</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i92de8792f23848c58e1d809553528fd6_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNC0zLTEtMS0w_78dcd096-cb39-4041-8404-6a259285b7c2">85,510,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iecae2ba52ea34c6892d78a05a039922b_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNS0xLTEtMS00MDY3_ae14e307-605f-4104-a03e-b92d39f49521">16,361,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6c000d18bcbb4f6281442b9c9affe5d1_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNS0zLTEtMS00MDY3_21c539ae-acbd-4f14-9360-8e7829278cbe">6,969,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie90befcd560f42a9bf949f5bd7f3347d_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNS0xLTEtMS0w_a36bf8db-ff96-4b50-b0c9-ebcd747ca9b2">3,347,300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6eb6f513a1aa4980bc4049b422e1e15b_D20200101-20200331" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNS0zLTEtMS0w_aff7a0c1-361a-4456-ad73-78c2467559ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase Class&#160;A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i44f09386b1fe4221a24a4ffa57406c7b_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNi0xLTEtMS0w_29eff669-a279-4006-bf94-40c2fe0b95cc">7,733,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4c9d172982e54c3dbf74e0a823776639_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNi0zLTEtMS0w_826de66d-17e2-4cef-9d8b-f78deaa86566">1,895,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7772b0e6965c459ead748797e372c5a3_D20210101-20210331" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNy0xLTEtMS0w_0c7749a1-5530-4da7-8146-db31f0f50aee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8196ddc57e7a4bfab7217e738f15cb7a_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNy0zLTEtMS0w_0c1767d9-6471-4d32-beb9-02978f499f67">1,433,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_76"></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17. <ix:nonNumeric contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83Ni9mcmFnOjYyMzdlODU0YjJiYzQ5MmQ4MjVhYzU2ZGQ2YmM1MGIyL3RleHRyZWdpb246NjIzN2U4NTRiMmJjNDkyZDgyNWFjNTZkZDZiYzUwYjJfNjA0NzMxMzk3MjMyMw_b4e7fcff-1923-4dcd-ad11-1b7e8ede1122" continuedAt="i515f5ca27d4345ff9945474c52aa9651" escape="true">Income Tax</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="i515f5ca27d4345ff9945474c52aa9651"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was -<ix:nonFraction unitRef="number" contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83Ni9mcmFnOjYyMzdlODU0YjJiYzQ5MmQ4MjVhYzU2ZGQ2YmM1MGIyL3RleHRyZWdpb246NjIzN2U4NTRiMmJjNDkyZDgyNWFjNTZkZDZiYzUwYjJfMjc0ODc3OTA4ODk1Mg_043c70eb-4f87-4531-94b1-e48071cb8d4c">0.2</ix:nonFraction>% and -<ix:nonFraction unitRef="number" contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83Ni9mcmFnOjYyMzdlODU0YjJiYzQ5MmQ4MjVhYzU2ZGQ2YmM1MGIyL3RleHRyZWdpb246NjIzN2U4NTRiMmJjNDkyZDgyNWFjNTZkZDZiYzUwYjJfMjc0ODc3OTA4ODk2Mg_b8cdf36f-1ebc-4225-be94-997a86cebbb4">0.6</ix:nonFraction>% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended March 31, 2021 and 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The effective tax rate differs from the U.S. federal rate primarily due to the impacts of the valuation allowance placed on the Company's deferred tax assets and state minimum taxes.</span></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our Amendment No. 2 on Form 10-K/A for the year ended December 31, 2020 (our "2020 Annual Report"), including "Management's Discussion and Analysis of Financial Condition and Results of Operations" included in ITEM 7 of Part II of our 2020 Annual Report, Amendment No. 1 to our Current Report on Form 8-K filed on March 22, 2021, including the audited consolidated financial statements of Hims as of December 31, 2020 and 2019 and "Management's Discussion and Analysis of Financial Condition and Results of Operations of Hims, Inc." filed as Exhibits 99.1 and 99.2, respectively, and the accompanying unaudited condensed consolidated financial statements and notes thereto included in this quarterly report on Form 10-Q. Our actual results may differ materially from those contained in any forward-looking statements. The events and circumstances reflected in the forward-looking statements may not be achieved or occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Except as required by law, we do not intend to update any of these forward-looking statements after the date hereof or to conform these statements to actual results or revised expectations. Forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) and other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, those factors described under "Risk Factors" in ITEM 1A of Part I of this quarterly report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Unless otherwise indicated or the context otherwise requires, references in this discussion and analysis to "we," "us," "our," the "Company," and "Hims &amp; Hers" refer to Hims &amp; Hers Health, Inc., and references to "Hims" refer to Hims, Inc. and its subsidiaries.</span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hims &amp; Hers, formerly known as Oaktree Acquisition Corp. ("OAC"), is a direct-to-customer telehealth company incorporated in Delaware. Our mission is to make healthcare accessible, affordable, and convenient for everyone. Our proprietary websites, telehealth platform, electronic medical records system, pharmacy integration, and mobile accessibility combine to provide customers with a seamless, easy-to-use, mobile-first experience. We are leading the transformation in healthcare by becoming the digital front door for healthcare consumers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe&#160;the future of healthcare will be driven by consumer brands that empower people and give them full control over their healthcare. We have endeavored to build a healthcare model that squarely focuses on the needs of the healthcare </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consumer.&#160;To further our mission,&#160;we offer a range of health and wellness products and services available for purchase directly by customers on the Company's websites and through wholesale partners.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_1472"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Developments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merger Transaction</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021 (the "Closing Date"), OAC completed the acquisition of Hims, Inc. ("Hims") pursuant to the Agreement and Plan of Merger dated as of September 30, 2020 (the "Merger Agreement") by and among OAC, Hims, and Rx Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of OAC ("Merger Sub"). The Merger Agreement provided for, among other things, the combination of Hims and OAC pursuant to the merger of Merger Sub with and into Hims, with Hims continuing as the surviving entity and as a wholly-owned subsidiary of OAC (the "Merger").</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for as a reverse recapitalization with Hims as the accounting acquirer and OAC as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Hims and its wholly owned subsidiaries as if Hims is the predecessor to the Company. The shares and net loss per common share, prior to the Merger, have been retroactively restated as shares reflecting the exchange ratio established in the Merger (0.4530 shares of Company Class A common stock for 1 share of Hims Class A common stock). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger, OAC ordinary shares and warrants were traded on the New York Stock Exchange ("NYSE") under the ticker symbols "OAC" and "OAC WS", respectively. On the Closing Date, the Company's Class A common stock and warrants began trading on the NYSE under the ticker symbols "HIMS" and "HIMS WS", respectively. One of the primary purposes of the Merger was to provide a platform for Hims to gain access to the U.S. capital markets.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earn-Out Shares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the closing of the Merger, holders of Hims' common stock and outstanding equity awards (including warrant, stock option and RSU holders) had the right to receive up to an aggregate amount of 16,000,000 shares of Company Class A common stock (or equivalent equity award) that would vest (in part) in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $15.00, $17.50 and $20.00 for any 10 trading days within any 20-trading day period on or prior to the date that is five years following the Closing Date. These shares of restricted Class A common stock and equivalent equity awards would also vest in connection with an acquisition of the Company if the applicable thresholds were met in any sale (as defined in the Merger Agreement) but subject to the same five-year deadline. In February 2021, all earn-out thresholds were met. In the first quarter of 2021, earn-out awards related to option holders received final approval by the Board of Directors. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PIPE Investment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the execution of the Merger Agreement, OAC entered into subscription agreements on September 30, 2020 with certain investors (the "PIPE Investors") pursuant to which such investors collectively subscribed for 7,500,000 shares of the Company's Class A common stock at $10.00 per share for aggregate gross proceeds of $75.0 million (the "PIPE Investment"). The PIPE Investment was consummated substantially concurrently with the closing of the Merger.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_1499"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue and Key Business Metrics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management monitors two financial results, Online Revenue and Wholesale Revenue (both defined below), to track our total revenue generation.  "Online Revenue" represents the sales of products and services on our platform, net of refunds, credits, chargebacks and includes revenue recognition adjustments recorded pursuant to accounting principles generally accepted in the United States of America ("U.S. GAAP"), primarily relating to deferred revenue and returns reserve. Online Revenue is generated by selling directly to consumers through our websites, including for both the Hims and Hers brands. Our Online Revenue consists of products and services purchased by customers directly through our online platform. The majority of our Online Revenue is subscription-based, where customers agree to be billed on a recurring basis to have products automatically delivered to them. Subscription billing is preferred by many of our customers because most of our products treat chronic conditions and these product offerings are most effective when taken consistently and continuously. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Wholesale Revenue" represents non-prescription product sales to retailers through wholesale purchasing agreements. We sell only nonprescription products to wholesale partners. In addition to being revenue generative and profitable, wholesale partnerships have the added benefit of generating brand awareness with new customers in physical environments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the following key metrics to help us evaluate our business, identify trends affecting our business, formulate business plans and make strategic decisions. We believe the following metrics are useful in evaluating our business. The table below provides a breakdown of total revenue between Online Revenue and Wholesale Revenue, as well as two key metrics that drive Online Revenue (Net Orders and Average Order Value or "AOV", both defined below) for the three months ended March 31, 2021 and 2020, and the dollar and percentage change between such periods (dollars&#160;in&#160;thousands, except for AOV and Net Orders):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.150%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.382%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.526%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.771%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Online Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wholesale Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,063&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,251&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Orders</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AOV</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Net Orders" are defined as the number of online customer orders minus transactions related to refunds, credits, chargebacks and other negative adjustments. Net Orders represent transactions made on our platform during a defined period of time and exclude revenue recognition adjustments recorded pursuant to U.S. GAAP. AOV is defined as Online Revenue divided by Net Orders. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated $50.7 million in Online Revenue for the three months ended March 31, 2021, an increase of 78% as compared to $28.5 million for the three months ended March 31, 2020. Growth in Online Revenue was driven by growth in AOV and Net Orders. For the three months ended March 31, 2021, AOV was $74, an increase of 42% compared to $52 for the three months ended March 31, 2020.  AOV has grown on a period-over-period basis for nine consecutive fiscal quarters. AOV growth for the three months ended March 31, 2021 was driven by an increase of Net Orders along with higher price points from larger product bundles and multi-month subscriptions (which allow customers to receive two to twelve months of product in one order). For the three months ended March 31, 2021, we generated approximately 687,000 Net Orders, an increase of 26% as compared to approximately 546,000 Net Orders for the three months ended March 31, 2020. Growth in Net Orders was primarily driven by growth in subscriptions (i.e., number of customer agreements where the customer has agreed to be automatically billed on a recurring basis at a defined cadence), which grew to approximately 391,000 as of March&#160;31, 2021. This was an increase of 79% as compared to approximately 218,000 subscriptions as of March&#160;31, 2020. Growth in subscriptions was driven by increased customer conversion rates from improved onsite and customer onboarding experiences, increased customer engagement with our marketing campaigns, increased retention rates of existing subscribers, and increased new customer acquisition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated $1.6 million in Wholesale Revenue for the three months ended March 31, 2021, an increase of 6% as compared to $1.5 million for the three months ended March 31, 2020. During the three months ended March 31, 2020 we began selling to a large new retailer, who continues to be a wholesale partner today. We have not signed any new meaningful wholesale agreements in the last 12 months. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_88"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Factors Affecting Results of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our performance and future success depend on several factors that present significant opportunities for us but also pose risks and challenges.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Customer Acquisition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract new customers is a key factor for our future growth. To date we have successfully acquired new customers through marketing and the development of our brands. As a result, revenue has increased each year since our launch. If we are unable to acquire enough new customers in the future, revenue might decline. New customer acquisition could be negatively impacted if our marketing efforts are less effective in the future. Increases in advertising rates could also negatively impact our ability to acquire new customers. Consumer tastes, preferences, and sentiment for our brands may also change and result in decreased demand for our products and services. Changes in law or regulatory enforcement could also negatively impact our ability to acquire new customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Retention of Customers</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to retain customers is a key factor in our ability to generate revenue. Most of our customers purchase products through subscription-based plans, where customers are billed and sent products on a recurring basis. The recurring nature of this revenue provides us with a certain amount of predictability for future revenue if past customer behavior stays consistent in the future. If customer behavior changes, and customer retention decreases in the future, then future revenue will be negatively impacted. The ability of our customers to continue to pay for our products and services will impact the future results of our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investments in Growth</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to focus on long-term growth through investments in product offerings and customer experience. We are working to enhance our offerings and expand the breadth of products and services offered on our websites. This includes near term investments in the ability to accept insurance on our platform and the development of native mobile phone applications. We expect to make significant investments in marketing to acquire new customers. Additionally, we intend to continue to invest in our fulfillment and operating capabilities, including by opening our own affiliated pharmacy dedicated to our operations. In the short term, we expect these investments to increase our operating expenses; however, in the long term, we anticipate that these investments will positively impact our results of operations. If we are unsuccessful at improving our offerings or are unable to generate additional demand for our offerings, we may not recover the financial investments we make into the business and revenue may not increase in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expansion into New Categories</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to expand into new categories with our offerings. Category expansion allows us to increase the number of customers for whom we can provide products and services. It also allows us to offer access to treatment of additional conditions that may already affect our current customers. Expanding into new categories will require financial investments in additional headcount, marketing and customer acquisition expenses, additional operational capabilities and may require the purchase of new inventory. If we are unable to generate sufficient demand in new categories, we may not recover the financial investments we make into new categories and revenue may not increase in the future.</span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_94"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our financial results determined in accordance with U.S. GAAP, we present Adjusted EBITDA (as defined below), a non-GAAP financial measure. We use Adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that Adjusted EBITDA, when taken together with the corresponding U.S. GAAP financial measure, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations, or outlook. We consider Adjusted EBITDA to be an important measure because it helps illustrate underlying trends in our business and our historical operating performance on a more consistent basis. We believe that the use of Adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool and should not be considered in isolation or as a substitute for financial information presented in accordance with U.S. GAAP. In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP financial measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of Adjusted EBITDA as a tool for comparison. A reconciliation is provided below for Adjusted EBITDA to net loss, the most directly comparable financial measure stated in accordance with U.S. GAAP. Investors are encouraged to review Adjusted EBITDA and the reconciliation of Adjusted EBITDA to net loss, and not to rely on any single financial measure to evaluate our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a key performance measure that our management uses to assess our operating performance. Because Adjusted EBITDA facilitates internal comparisons of our historical operating performance on a more consistent basis, we use this measure for business planning purposes. "Adjusted EBITDA" is defined as net loss before depreciation and amortization, provision for income taxes, interest income, interest expense, amortization of debt issuance costs, stock-based compensation, change in fair value of warrant liability, and one-time Merger bonuses and warrant expense.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles net loss to Adjusted EBITDA for the three months ended March 31, 2021 and 2020 (in thousands):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:72.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,404)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(82)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of warrant liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Merger bonuses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant expense in connection with Merger</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,574)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,633)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the limitations of Adjusted EBITDA include (i)&#160;Adjusted EBITDA does not properly reflect capital commitments to be paid in the future, and (ii)&#160;although depreciation and amortization are non-cash charges, the underlying assets may need to be replaced and Adjusted EBITDA does not reflect these capital expenditures. In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses similar to the adjustments in this presentation. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by these expenses or any unusual or non-recurring items. We compensate for these limitations by providing specific information regarding the U.S. GAAP items excluded from Adjusted EBITDA. When evaluating our performance, you should consider Adjusted EBITDA in addition to, and not a substitute for, other financial performance measures, including our net loss and other U.S. GAAP results.</span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_85"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of the COVID-19 Pandemic</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March&#160;2020, the World Health Organization declared the 2019 novel coronavirus ("COVID-19") a global pandemic. We are closely monitoring the impact of the COVID-19 pandemic on all aspects of our business. We have taken measures in response to the ongoing COVID-19 pandemic, including closing our offices and implementing a work from home policy for our worldwide workforce; implementing additional safety policies and procedures for employees working in our warehouse; suspending employee travel and in-person meetings; and actively managing our fulfillment operations and inventory levels. We may take further actions that alter our business operations as may be required by federal, state, or local authorities or that we determine are in the best interests of our employees, customers, and stockholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial condition and results of operations to date have not been adversely impacted by the COVID-19 pandemic. However, it is possible that the COVID-19 pandemic, the measures taken by the federal, state, or local authorities and businesses affected, and the resulting economic impact may materially and adversely affect our business, results of operations, cash flows and financial positions as well as our customers, suppliers, and partners.  We will continue to monitor the status of the COVID-19 pandemic and adjust our strategy accordingly.</span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, we conduct business through one operating segment. Substantially all our long-lived assets are maintained in, and our losses are attributable to, the United States of America. The consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, and variable interest entities in which it holds a controlling financial interest. The variable interest entities are: (i) professional corporations or other professional entities owned by licensed physicians that engage licensed medical professionals to provide consultation services ("Affiliated Medical Groups"); and (ii) XeCare, LLC ("XeCare"), which is a licensed mail order pharmacy providing prescription fulfillment services solely to our customers. We determined that the Company is the primary beneficiary of the Affiliated Medical Groups and XeCare for accounting purposes because it has the ability to direct the activities that most significantly affect these entities' economic performance and has the obligation to absorb the entities' losses. Under the variable interest entity model, the Company presents the results of operations and the financial position of the entities as part of the Company's consolidated financial statements as if the consolidated group were a single economic entity. </span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_100"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue in accordance with ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when we transfer promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated revenue primarily comprises of online sales of health and wellness products through our websites, including prescription and nonprescription products. In contracts that contain prescription products, revenue also includes fees related to medical consultation services. Additionally, revenue is generated through wholesale arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information on our significant accounting policies, see Note 2 to our accompanying unaudited condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists of costs directly attributable to the products shipped and services rendered, including product costs, packaging materials, shipping costs, and labor costs directly related to revenue generating activities. Costs related to free products, where there is no expectation of future purchases from a customer, are considered to be SG&amp;A (as defined below) and are excluded from cost of revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross profit and gross margin</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our gross profit represents total revenue less our total cost of revenue, and our gross margin is our gross profit expressed as a percentage of our total revenue. Our gross profit and gross margin have been and will continue to be affected by a number of factors, including the prices we charge for our products and services, the costs we incur from our vendors for certain components of our cost of revenues, the mix of the various products and services we sell in a period, the mix of Online Revenue and Wholesale Revenue in a period, and our ability to sell our inventory. We expect our gross margin to increase over the long term, although gross margins may fluctuate from period to period depending on these and other factors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The largest component of our marketing expenses consists of our discretionary customer acquisition expenses. Customer acquisition expenses are the advertising and media costs associated with our efforts to acquire new customers, promote our brands, and build awareness for our products and services. Customer acquisition expenses include advertising in digital media, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">social media, television, radio, out-of-home media and various other media outlets. Marketing expenses also include overhead expenses, including salaries, benefits, taxes and stock-based compensation for personnel; agency, contractor and consulting expenses; content production, software and other marketing operating costs. Marketing is an important driver of growth and we intend to continue to make significant investments in customer acquisition and our marketing organization. As a result, we expect our marketing expenses to increase in absolute dollars for the foreseeable future. However, we expect our marketing expenses to decrease as a percentage of revenue over the long term, although our marketing expenses may fluctuate as a percentage of revenue from period to period due to the timing and amount of these expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general, and administrative expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general, and administrative expenses ("SG&amp;A") include the salaries, benefits, taxes and stock-based compensation for personnel for our executive, engineering, finance, operations and other administrative functions. SG&amp;A also includes general operating expenses for professional services, third-party software and hosting, facilities, warehousing and fulfillment, customer service, payment processing, and depreciation and amortization. We expect SG&amp;A to increase for the foreseeable future as we increase headcount with the growth of our business. We also expect SG&amp;A to increase in the near term as a result of operating as a public company, including expenses associated with compliance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"); and an increase in legal, audit, insurance, investor relations, professional services and other administrative expenses. However, we anticipate SG&amp;A to decrease as a percentage of revenue over the long term, although it may fluctuate as a percentage of total revenue from period to period due to the timing and amount of these expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense primarily included expense related to our past borrowing arrangements with a leading financial institution, which have been paid in full.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (expense) income, net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (expense) income, net primarily consists of change in fair value of warrant liabilities. Other income primarily consists of interest income from investments and our cash and cash equivalents. Other expense includes non-operating expenses and one-time charges classified outside of operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for income taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax provision is primarily due to state taxes. Deferred tax assets are reduced by a valuation allowance to the extent management believes it is not more likely than not to be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income. Management makes estimates and judgments about future taxable income based on assumptions that are consistent with our plans and estimates.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_103"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparisons for three months ended March&#160;31, 2021 and 2020</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our unaudited condensed consolidated statement of operations for the three months ended March 31, 2021 and 2020, and the dollar and percentage change between the two periods (dollars&#160;in&#160;thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:45.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.641%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,063&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,067&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,247&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,619&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,628&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:(1)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,958&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,185&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,837&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(48,409)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,218)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,191)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,905)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,135)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1363)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,314)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,998)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,316)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,404)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,033)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,371)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:26.68pt">Includes stock-based compensation expense as follows (in thousands):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,384&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our results of operations as a percentage of our total revenue for the periods presented:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue was $52.3&#160;million for the three months ended March 31, 2021, compared to $30.1 million for three months ended March 31, 2020, representing an increase of $22.3 million, or 74% primarily attributable to an increase in Online Revenue. Online Revenue was $50.7 million for the three months ended March 31, 2021, compared to $28.5 million&#160;for three months ended March 31, 2020, representing an increase of $22.2 million, or 78%. Growth in Online Revenue was driven by growth in AOV and Net Orders. For the three months ended March 31, 2021, AOV was $74, an increase of 42% compared to $52 for the three months ended March 31, 2020.  AOV has grown on a period-over-period basis for nine consecutive fiscal quarters. AOV growth for the three months ended March 31, 2021 was driven by an increase of Net Orders along with higher price points from larger product bundles and multi-month subscriptions. For the three months ended March 31, 2021, we generated approximately 687,000 Net Orders, an increase of 26% as compared to approximately 546,000 Net Orders for the three months ended March 31, 2020. Growth in Net Orders was primarily driven by growth in subscription, which grew to approximately 391,000 as of March&#160;31, 2021. This was an increase of 79% as compared to approximately 218,000 subscriptions as of March&#160;31, 2020. Growth in subscriptions was driven by increased customer conversion rates from improved onsite and customer onboarding experiences, increased customer engagement with our marketing campaigns, increased retention rates of existing subscribers, and increased new customer acquisition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of revenue and gross profit</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue was $12.1 million for three months ended March 31, 2021, compared to $9.4 million for three months ended March 31, 2020, representing an increase of $2.6 million, or 28%. Gross profit was $40.2 million for the three months ended March 31, 2021, compared to $20.6 million for the three months ended March 31, 2020, representing an increase of $19.6 million, or 95%. Correspondingly, gross margin was 77% for the three months ended March 31, 2021, compared to 69% for the three months ended March 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in cost of revenue for the three months ended March 31, 2021 consisted of increased product and packaging costs of approximately 42%, increased costs associated with medical consultation services of 11%, and increased shipping costs of 23% compared to the three months ended March 31, 2020.&#160;The increase in gross margin for the three months ended March 31, 2021, compared to the three months ended March 31, 2020, was primarily the result of a proportionately lower increase in cost of revenue than the increase in revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing expenses were $27.0 million for the three months ended March 31, 2021, compared to $12.8 million for the three months ended March 31, 2020, representing an increase of $14.2 million or 111%. The most significant component of marketing expenses is customer acquisition costs which increased to $20.3&#160;million in the three months ended March 31, 2021, compared to $8.8&#160;million for the three months ended March 31, 2020, an increase of 131%. The increase in customer acquisition costs was a result of management's decision to increase investment in display and search marketing as it identified opportunities to drive new customer growth.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expenses</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses were $61.7 million for the three months ended March 31, 2021, compared to $14.1 million for the three months ended March 31, 2020, representing an increase of $47.6 million or 339%. The increase in SG&amp;A was primarily driven by an increase in stock-based compensation expense to $32.4 million for the three months ended March 31, 2021, from $1.1 million for the three months ended March 31, 2020 which represents an increase of $31.3 million. The increase in stock-based compensation was a result of expenses related to the earn-out consideration issued as part of the Merger as well as the recognition of expense related to stock options granted to the Chief Executive Officer and vesting of restricted stock units ("RSUs"), which were both contingent upon the achievement of a liquidity event that was satisfied upon the closing of the Merger. All of these resulted in either one-time expenses or cumulative catch-up expense as a result of the Merger. In the three months ended March 31, 2021, we also incurred $5.1 million of bonus expense almost entirely as a result of the transaction bonus described in our SEC filings related to the Merger. Excluding stock-based compensation and Merger bonuses, employee compensation expense (comprised of salaries and wages, benefits, taxes and performance bonuses) was $7.8 million for the three months ended March 31, 2021, compared to $4.1 million for the three months ended March 31, 2020, representing an increase of $3.7 million.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the increase in SG&amp;A was due to $3.8 million increase from professional services costs and $1.5 million increase in higher director and officer insurance liability premiums as a result of becoming a public entity, a $1.3 million increase in order fulfillment and processing costs, and a $1.1 million increase in depreciation and amortization and software and hosting costs as a result of overall increased business activity from Company growth.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had no interest expense for three months ended March 31, 2021 and had less than $0.1 million for the three months ended March 31, 2020. The decrease in the interest expense was attributable to the repayment of all outstanding debt in the second quarter of 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (expense) income, net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net, was $2.9&#160;million for the three months ended March 31, 2021, compared to other income, net, of $0.2&#160;million for the three months ended March 31, 2020, representing a change of $3.1&#160;million. The change to other expense, net for the three months ended March 31, 2021 from other income, net for the three months ended March 31, 2020 was driven primarily by the change in fair value of the warrant liability in each period. Additionally, for the three months ended March 31, 2021, we incurred a one-time $0.2 million warrant expense in connection with the Merger. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for income taxes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes was less than $0.1 million for each of the three months ended March 31, 2021 and 2020.</span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_1530"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception through the Merger, we have financed our operations primarily from the sales of redeemable convertible preferred stock. We received gross proceeds of  $197.7 million from the Merger and $75.0 million from private investors. As of March&#160;31, 2021, our principal sources of liquidity were cash and cash equivalents in the amount of $88.2 million, which were primarily invested in money market funds; and investments in the amount of $235.1 million, which were primarily invested in corporate, government and asset backed bonds.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically incurred negative cash flows from operating activities and significant losses from operations in the past. We expect to continue to incur operating losses at least for the next 12 months due to the investments that we intend to make in our business. We believe our existing cash resources and funds raised from the closing of the Merger in January 2021 are sufficient to support planned operations for the next 12&#160;months. As a result, management believes that its current financial resources are sufficient to continue operating activities for at least one year past the issuance date of the unaudited condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including the number of orders we receive, the size of our customer base, the timing and extent of spend to support the expansion of sales, marketing and development activities, and the impact of the COVID-19 pandemic. We may in the future enter into arrangements to acquire or invest in complementary businesses, services and technologies, including intellectual property rights. We have based this estimate on assumptions that may prove to be wrong, and we could use our available capital resources sooner than we currently expect. We may be required to seek additional equity or debt financing. In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. If we are unable to raise additional capital when desired, our business, financial condition and results of operations would be harmed. In order to support the growth of our business, we may need to incur additional indebtedness or seek capital through new equity or debt financings, which sources of additional capital may not be available to us on acceptable terms or at all.</span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_1556"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a summary of cash flow data (in thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.786%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,948)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in)/provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our largest source of operating cash flows is cash collections from our customers. Our primary use of cash from operating activities includes marketing expenses and personnel-related expenditures to support the growth of our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $15.9 million for the three months ended March 31, 2021. The most significant component of our cash used was a net loss of $51.4 million. This included non-cash expense related to stock-based compensation of $34.2 million, change in fair value of our warrants totaling $2.7 million, depreciation and amortization totaling $0.4 million, and non-cash other loss of $0.5 million. In addition, a cash outflow totaling $2.6 million was attributable to changes in operating assets and liabilities, primarily as a result of an increase in prepaid expenses and other current assets of $7.1 million, an increase in inventory of $1.0 million, and a decrease in deferred revenue of $0.6 million. This outflow was partially offset by an increase in accounts payable and accrued liabilities of $6.2 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $5.2 million for the three months ended March 31, 2020. The most significant component of our cash used was a net loss of $6.0 million. This included non-cash expense related to stock-based compensation of $1.4 million, and depreciation and amortization totaling $0.2 million. In addition, a cash outflow totaling $0.7 million was attributable to changes in operating assets and liabilities, primarily as a result of an increase in inventory of $2.0 million, and an increase in prepaid expenses and other current assets of $0.5 million. This outflow was partially offset by an increase in accounts payable and accrued liabilities of $0.9 million, a decrease in other long-term assets of $0.7 million, and an increase in deferred revenue of $0.1 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows from investing activities primarily relate to our treasury operations of investing in available-for-sale investments, investment in website development and internal-use software, as well as purchase of property and equipment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities for the three months ended March 31, 2021 was $163.3 million, which was primarily due to net investment cash outflows of $162.5 million, as well as investment in website development and internal-use software of $0.7 million, and purchases of property and equipment of $0.1 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities for the three months ended March 31, 2020 was $7.2 million, which was primarily due to net investment cash inflows of $8.0 million. This inflow was partially offset by investment in website development and internal-use software of $0.5 million, and purchases of property and equipment of $0.3 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the three months ended March 31, 2021 was $239.9 million, which was primarily due to the proceeds from the issuance of Class A common stock as a result of the Merger of $197.7 million, proceeds from the PIPE Investment of $75.0 million, proceeds received from employee repayment of promissory notes of $1.2 million, and proceeds from the exercise of warrants and stock options of $0.9 million. This cash inflow was partially offset by payments for transaction costs of $12.8 million and payments related to pre-closing stock repurchases of $22.0 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the three months ended March 31, 2020 was $30.3 million, which was primarily due to the net proceeds from the issuance of convertible preferred stock of $31.5 million. This cash inflow was partially offset by repayments of principal on term loan of $1.2 million.</span></div><div id="i412093a93f204328a33c4602202f8375_1608"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indebtedness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Silicon Valley Bank</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Second Amended and Restated Loan Agreement dated November 27, 2019, between Hims and Silicon Valley Bank ("SVB"), upon Hims' request, SVB would issue letters of credit (the "Letters of Credit") in an aggregate amount not to exceed $2.0 million. This amount is reduced by the amount otherwise available with respect to the cash management services, which may include merchant services, direct deposit of payroll, business credit card, and check cashing services identified in SVB's various agreements. On September 30, 2020, Hims entered into the First Loan Modification Agreement ("Loan Modification Agreement") and the aggregate amount of the Letters of Credit was amended to $3.5 million. As of March&#160;31, 2021, SVB issued on the Company's behalf, a letter of credit in the amount of $0.8 million as a security deposit for a warehouse space in New Albany, Ohio. SVB required  $0.8 million to be maintained as collateral for the outstanding letter of credit. The Company expects to continue to renew the letter of credit through the duration of the lease. As this is for longer than one year, the Company presents the $0.8 million within restricted cash, noncurrent on the consolidated condensed balance sheet. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a business credit card as part of the cash management services offered by SVB with an initial limit of $2.0 million which is reduced by the amount utilized for any issuances of Letters of Credit. This amount was increased to $3.5 million by the Loan Modification Agreement. To continue to use the credit card, SVB required $0.2 million to be maintained in a collateralized money market account and this was reflected within restricted cash on the consolidated balance sheet as of December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company terminated the Second Amended and Restated Loan Agreement with SVB resulting in the release of restricted cash of $0.2 million under the arrangement. The outstanding letter of credit for the warehouse was not included as part of this termination. In addition, the Company continues to use SVB's cash management services and increased its credit card limit to $5.0 million in January 2021.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TriplePoint Venture Growth</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;27, 2019, Hims entered into a Plain English Capital Growth and Security Agreement (the "2019 Capital Agreement") with TriplePoint Venture Growth ("TPC") consisting of a term loan in the aggregate principal amount of up to $50.0 million, with $25.0 million being available immediately through December&#160;31, 2020 (the "Part 1 Commitment Amount"), and an additional $25.0 million becoming available upon utilization of the Part 1 Commitment Amount through December&#160;31, 2020. As of December 31, 2020, the Company had not drawn down from this term loan and the facility expired.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total rent expense for the three months ended March 31, 2021 and 2020, was $0.4 million and $0.7 million.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Company entered into a 63-month noncancelable lease for 302,880 square feet of warehouse space in New Albany, Ohio. The lease commenced on June 1, 2020. Total minimum lease payments are $7.9&#160;million, net of rent abatement for an initial three-month period and with annual escalation of 2.5%. The Company has the option to extend the lease term for a period of five years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease commitments subsequent to March 31, 2021 are as follows (in thousands):</span></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:76.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.335%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,055&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had contractual obligations to make $1.0 million in purchases related to cloud-based software contracts used in operations. These obligations are associated with multi-year agreements that are enforceable and legally binding and that specify all significant terms, including fixed or minimum services to be used, fixed, minimum or variable price provisions and the approximate timing of the services. Obligations under contracts that we can cancel without a significant penalty or agreements with a term of one year or less are not considered.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our critical accounting policies and estimates, please refer to ITEM 7 under Part II, "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2020 Annual Report for the year ended December&#160;31, 2020. There have been no material changes to the critical accounting policies and estimates in 2021 as outlined in our 2020 Annual Report.</span></div><div id="i412093a93f204328a33c4602202f8375_1634"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company Status</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company ("EGC"), as defined in the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"). The JOBS Act permits companies with EGC status to take advantage of an extended transition period to comply with new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies. We have elected to use this extended transition period to enable the Company to comply with new or revised accounting standards that have different effective dates for public and private companies until the earlier of the date we (i)&#160;are no longer an EGC or (ii)&#160;affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our condensed consolidated financial statements for the three months ended March 31, 2021 may not be comparable to companies that comply with the new or revised accounting standards as of public company effective dates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we intend to rely on the other exemptions and reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an EGC, we intend to rely on such exemptions, we are not required to, among other things: (i)&#160;provide an auditor's attestation report on our system of internal controls over financial reporting pursuant to Section&#160;404(b) of the Sarbanes-Oxley Act; (ii)&#160;provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act; (iii)&#160;comply with any requirement that may be adopted by the Public Company Accounting Oversight Board; and (iv)&#160;disclose certain executive compensation-related items such as the correlation between executive compensation and performance and comparisons of the CEO's compensation to median employee compensation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will remain an EGC under the JOBS Act until the earliest of (i)&#160;the last day of our first fiscal year following the fifth anniversary of the closing of the Merger, (ii)&#160;the last date of our fiscal year in which we have total annual gross revenue of at least $1.07&#160;billion, (iii)&#160;the date on which we are deemed to be a "large accelerated filer" under the rules of the SEC with at least </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$700.0&#160;million of outstanding securities held by non-affiliates, or (iv)&#160;the date on which we have issued more than $1.0&#160;billion in non-convertible debt securities during the previous three-years.</span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_106"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. QUALITATIVE AND QUANTITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and are not required to provide the information otherwise required under this item.</span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, as required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon their evaluation, and as a result of the material weakness described below, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective at the reasonable assurance level as of such date. Notwithstanding the identified material weakness, management has concluded that the condensed consolidated financial statements included in this quarterly report on Form 10-Q present fairly, in all material respects, the Company's financial position, results of operations and cash flows for the periods disclosed in accordance with U.S. GAAP.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remediation Efforts to Address the Previously Disclosed Material Weakness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed in Part I, ITEM 9A of our 2020 Annual Report, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that the Company did not maintain effective internal control over financial reporting as of December 31, 2020, due to a material weakness. The material weakness related to not having adequate controls over accounting for complex transactions and, in particular, related to errors in the accounting for warrants issued in connection with OAC's initial public offering and recorded in its pre-merger, historical consolidated financial statements through December 31, 2020. In response to this material weakness, our management has expended, and will continue to expend, a substantial amount of effort and resources for the remediation and improvement of our internal control over financial reporting. While we have processes to identify and evaluate the appropriate accounting technical pronouncements and other literature for all significant or unusual transactions, we are improving these processes to ensure that the nuances of such transactions are effectively evaluated in the context of the increasingly complex accounting standards. As previously disclosed, our remediation plan at this time includes continuing to enhance our internal and external technical accounting resources by hiring additional personnel and increasing communication with third-party professionals with whom we consult regarding the application of complex accounting transactions. Our remediation plan can only be accomplished over time and will be continually reviewed to determine that it is achieving its objectives. We can offer no assurance that these initiatives will ultimately have the intended effects.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal quarter ended March 31, 2021, we completed the Merger and the internal controls of Hims became our internal controls. We are engaged in the process of design and implementation of our internal control over financial reporting in a manner commensurate with the scale of our operations subsequent to the Merger, including the enhancement of our internal and external technical accounting resources.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_112"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_115"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are party to litigation and subject to claims incident to the ordinary course of business. As our growth continues, we may become party to an increasing number of litigation matters and claims. The outcome of litigation and claims cannot be predicted with certainty, and the resolution of these matters could materially affect our future results of operations, cash flows, or financial position. We are not presently party to any legal proceedings that, in the opinion of management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows. </span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A description of the risks and uncertainties associated with our business and ownership of our Class A common stock is set forth below. You should carefully consider the risks described below, as well as the other information in this quarterly report on Form 10-Q, including our condensed consolidated financial statements and the related notes and "Management's Discussion and Analysis of Financial Condition and Results of Operations." The occurrence of any of the events or developments described below could materially and adversely affect our business, financial condition, results of operations, and growth prospects. In such an event, the market price of our Class A common stock could decline. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations. This quarterly report on Form 10-Q also contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of a number of factors, including the risks described below. See "Cautionary Note Regarding Forward-Looking Statements."</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Summary of Principal Risk Factors </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our limited operating history and evolving business make it difficult to evaluate our current business and future prospects and increases the risk of your investment.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our quarterly results of operations, as well as our key metrics, may fluctuate on a quarterly and annual basis, which may result in us failing to meet the expectations of industry and securities analysts or our investors.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We identified a material weakness in our internal control over financial reporting. If we do not adequately address this material weakness or if other material weaknesses or significant deficiencies in our internal control over financial reporting are discovered, this could adversely affect our business and if we fail to maintain effective internal control over financial reporting, the market price of our Class A common stock may be adversely affected.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to expand the scope of our offerings, including the number and type of products and services that we offer, the number and quality of healthcare providers serving our customers and the number and types of conditions capable of being treated through our platform, our business, financial condition and results of operations may be materially and adversely affected.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to successfully market to new customers and retain existing customers, or if evolving privacy, healthcare or other laws prevent or limit our marketing activities, our business, financial condition, and results of operations could be harmed.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We operate in highly competitive markets and face competition from large, well-established healthcare providers and more traditional retailers and pharmaceutical providers with significant resources, and, as a result, we may not be able to compete effectively.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our brand is integral to our success. If we fail to effectively maintain, promote, and enhance our brand in a cost-effective manner, our business and competitive advantage may be harmed.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to attract and retain high quality healthcare providers for our customers, our business, financial condition and results of operations may be materially and adversely affected.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic has increased interest in and customer use of telehealth solutions, including our platform, and we cannot guarantee that this increased interest will continue after the pandemic.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our pharmacy business launched during the fiscal quarter ending March 31, 2021 subjects us to additional healthcare laws and regulations beyond those we face with our core telehealth business, and increases the complexity and extent of our compliance and regulatory obligations.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Government regulation of healthcare creates risks and challenges with respect to our compliance efforts and our business strategies.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to comply with applicable healthcare and other governmental regulations, we could face substantial penalties, our business, financial condition and results of operations could be adversely affected, and we may be required to restructure our operations. </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Evolving government regulations and enforcement activities may require increased costs or adversely affect our results of operations.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Security breaches, loss of data and other disruptions could compromise sensitive information related to our business or customers, or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to legal proceedings and litigation, including intellectual property disputes, which are costly to defend and could materially harm our business and results of operations.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our dual class common stock structure will have the effect of concentrating voting power with our Chief Executive Officer and Co-Founder, Andrew Dudum, which will limit an investor's ability to influence the outcome of important transactions, including a change in control.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The price of our Class A common stock and warrants may be volatile.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A significant portion of our total outstanding shares are restricted from immediate resale but may be sold into the market in the near future. This could cause the market price of our Class A common stock to drop significantly, even if our business is doing well.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Related to Hims &amp; Hers' Business</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our limited operating history and evolving business make it difficult to evaluate our current business and future prospects and increases the risk of your investment.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our limited operating history and evolving business make it difficult to evaluate our current business and future prospects and plan for our future growth. We began offering products and services in 2017. Since that time, our business has expanded and we have increased the ways that we can address customer needs. We have encountered and will continue to encounter significant risks and uncertainties frequently experienced by new and growing companies in rapidly changing and heavily regulated industries, such as attracting new customers and healthcare providers (sometimes referred to herein as "providers"), to our platform, retaining our customers and encouraging them to utilize new offerings we make available, increasing the number of conditions that can be treated by providers through our platform, operating a licensed pharmacy, competition from other companies, whether online healthcare providers or traditional healthcare providers, hiring, integrating, training and retaining skilled personnel, verifying the identity of customers and credentials of providers serving our customers, developing new solutions, determining prices for our solutions, unforeseen expenses, challenges in forecasting accuracy, and new or adverse regulatory developments affecting the use of telehealth, pharmaceutical products, or other aspects of the healthcare industry. Additional risks include our ability to effectively manage growth and process, store, protect, and use personal data in compliance with governmental regulation, contractual obligations, and other legal obligations related to privacy and security. If our assumptions regarding these and other similar risks and uncertainties that relate to our business, which we use to plan our business, are incorrect or change as we gain more experience operating our platform or expand into the treatment of new conditions, or if we do not address these challenges successfully, our operating and financial results could differ materially from our expectations and our business could suffer.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We may not be successful in our women's health and wellness initiatives.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our offerings originally catered towards men seeking treatment for conditions specifically affecting the male population, such as hair loss and erectile dysfunction. A substantial majority of our annual revenue to date has come from male customers. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we recently began offering products and services for women as well, this part of our business is new and still developing. We have less experience marketing our platform and its capabilities to women as compared to men. As a result, our efforts to attract new female customers and to retain existing customers may not be as successful.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">If we are unable to expand the scope of our offerings, including the number and type of products and services that we offer, the number and quality of healthcare providers serving our customers and the number and types of conditions capable of being treated through our platform, our business, financial condition, and results of operations may be materially and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customers with access to non-prescription products, telehealth-based medical consultations with providers, and applicable pharmaceutical products prescribed by the providers for specific medical conditions. In order for our business to continue growing and expanding, we need to continue expanding the scope of products and services we offer our customers, including telehealth consultations and prescription and non-prescription medication for additional conditions. The introduction of new products, services, or technologies by market participants, including us, can quickly make existing products and services offered by us obsolete and unmarketable. Additionally, changes in laws and regulations (or enforcement thereof) could impact the usefulness of our platform and could necessitate changes or modifications to our platform or offerings to accommodate such changes. We invest substantial resources in researching and developing new offerings and enhancing our solutions by incorporating additional features, improving functionality, and adding other improvements to meet our customers' evolving demands. The success of any enhancements or improvements to our services or any new offerings depends on a number of factors, including timely completion, competitive pricing, adequate quality testing, integration with new and existing technologies and overall market acceptance. We may not succeed in developing, marketing, and delivering on a timely and cost-effective basis enhancements or improvements to our services or any new offerings that respond to continued changes in market demands or new customer requirements, and any enhancements or improvements to our services or any new offerings may not achieve market acceptance. Since developing enhancements to our services and the launch of new offerings can be complex, the timetable for the release of new offerings and enhancements to our existing services is difficult to predict, and we may not launch new offerings and updates as rapidly as our current or prospective customers require or expect. Any new offerings or service enhancements that we develop may not be introduced in a timely or cost-effective manner, may contain errors or defects, or may not achieve the broad market acceptance necessary to generate sufficient revenue. Moreover, even if we introduce new offerings, we may experience a decline in revenue of our existing offerings that is not offset by revenue from the new offerings. In addition, we may lose existing customers who choose a competitor's products and services. This could result in a temporary or permanent revenue shortfall and adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">If we are unable to successfully market to new customers and retain existing customers, or if evolving privacy, healthcare, or other laws prevent or limit our marketing activities, our business, financial condition, and results of operations could be harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate revenue from our platform by selling non-prescription health and personal care products to consumers and offering consumers access to telehealth consultations with providers and certain prescription medications that may be prescribed by the providers in connection with the telehealth consultations. We also rely on selling our products through wholesale partnerships. Unless we are able to attract new customers, retain existing customers, and maintain our wholesale partnerships, our business, financial condition, and results of operations may be harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to attract new customers and incentivize existing customers to purchase more of our offerings, we use social media, emails, text messages, celebrity influencers, and other marketing strategies to reach new and existing customers. State and federal laws and regulations governing the privacy and security of personal information, including healthcare data, are evolving rapidly and could impact our ability to identify and market to potential and existing customers. Similarly, certain federal and state laws regulate, and in some cases limit, the use of discounts, promotions, and other marketing strategies in the healthcare industry. If federal, state, or local laws governing our marketing activities become more restrictive or are interpreted by governmental authorities to prohibit or limit these activities, our ability to attract new customers and retain customers would be affected and our business could be materially harmed. In addition, any failure, or perceived failure, by us, to comply with any federal, state, or local laws or regulations governing our marketing activities could adversely affect our reputation, brand, and business, and may result in claims, proceedings, or actions against us by governmental entities, consumers, suppliers or others or other liabilities or may require us to change our operations and/or cease using certain marketing strategies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes to social networking, advertising platforms' or mobile device or other operating systems' terms of use; terms of service or traffic algorithms that limit promotional communications, impose restrictions that would limit our ability or our customers' </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ability to send communications through their platforms; disruptions or downtime experienced by these platforms; or reductions in the use of or engagement with social networking or advertising platforms by customers and potential customers could also harm our business. As laws and regulations rapidly evolve to govern the use of these channels, the failure by us, our employees or third parties acting at our direction to abide by applicable laws and regulations in the use of these channels could adversely affect our reputation or subject us to fines or other penalties. In addition, our employees or third parties acting at our direction may knowingly or inadvertently make use of social media in ways that could lead to the loss or infringement of intellectual property, as well as the public disclosure of proprietary, confidential, or sensitive personal information of our business, employees, consumers or others. Any such inappropriate use of social media, emails and text messages could also cause reputational damage and adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we use emails and text messages to communicate with customers and we collect consumer data, including email addresses and phone numbers, to further our marketing efforts with such consenting consumers. If we fail to adequately or accurately collect such data or if our data collection systems are breached or information therein is misused, our business, financial condition, and results of operations could be harmed. Further, any failure, or perceived failure, by us, or any third parties processing such data, to comply with privacy policies or with any federal or state healthcare, privacy or consumer protection-related laws, regulations, industry self-regulatory principles, industry standards or codes of conduct, regulatory guidance, orders to which we may be subject or other legal obligations relating to privacy or consumer protection could adversely affect our reputation, brand, and business, and may result in claims, proceedings or actions against us by governmental entities, consumers, suppliers or others or other liabilities or may require us to change our operations and/or cease using certain data sets.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">If we are unable to expand our marketing infrastructure, we may fail to increase the usage of our platform to meet our forecasts.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We first launched our services in 2017. As a result, we have only limited experience marketing our offerings and engaging customers at our current scale. We derive a substantial majority of our revenue from customers' subscription-based purchases of prescription products made available through our platform. We expect to expand the conditions for which customers can seek treatment from providers through our platform, including fulfillment of prescription medication and, as a result, new customer acquisition is integral to our business. Our financial condition and results of operations are and will continue to be highly dependent on the ability of our marketing function to adequately promote, market, and attract customers to our platform and offerings in a manner that complies with applicable laws and regulations and at a cost that does not exceed our current budget allocated to marketing.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A key element of our business strategy is the continued expansion of our marketing infrastructure to drive customer enrollment. As we increase our marketing efforts in connection with the expansion of our platform offerings, we will need to further expand the reach of our marketing networks. Our future success will depend largely on our ability to continue to hire, train, retain, and motivate a skilled marketing workforce with significant industry-specific knowledge in various areas, including direct-to-consumer business models, ecommerce, technology, healthcare, and the regulatory restrictions related thereto, as well as the competitive landscape for our solutions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to expand our marketing capabilities, we may not be able to effectively expand the scope of our platform to attract new customers and give our existing customers additional treatment options. Relatedly, if any of our marketing platforms significantly increase their advertising fees, our ability to expand our marketing reach will be greatly impeded. Any such failure could adversely affect our reputation, revenue, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">The failure of our offerings to achieve and maintain market acceptance could result in us achieving revenue below our expectations, which could cause our business, financial condition, and results of operation to be materially and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current business strategy is highly dependent on our platform and offerings achieving and maintaining market acceptance. Market acceptance and adoption of our model and the products and services we make available depend on educating potential customers who may find our services and these products and services useful, as well as potential partners, suppliers, and providers, as to the distinct features, ease-of-use, positive lifestyle impact, cost savings, and other perceived benefits of our offerings as compared to those of competitors. If we are not successful in demonstrating to existing and potential customers the benefits of our services, our revenue may decline or we may fail to increase our revenue in line with our forecasts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Achieving and maintaining market acceptance of our model and our services could be negatively impacted by many factors, including, to the extent they arise:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perceived risks associated with the use of our platform, telehealth or similar technologies generally, including those related to privacy and customer data;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to expand into new conditions and to attract providers qualified to treat those conditions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory developments that affect our business, including in healthcare, data privacy and security, and consumer protection;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitors offering telehealth options or technologies for customers and the rate of acceptable of those solutions as compared to our platform;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perceived difficulty or complexity of obtaining a medical consultation or prescription on our platform; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative reviews of providers treating our customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our business model and the services and products we make available may be perceived by potential customers, providers, suppliers, and partners to be less trustworthy or effective than traditional medical care or competitive telehealth options, and people may be unwilling to change their current health regimens or adopt our offerings. Consumers who have healthcare insurance coverage may not wish to use the platform to access healthcare services or products for which insurance reimbursement is not available. Moreover, we believe that providers can be slow to change their treatment practices or approaches because of perceived liability risks or distrust of departures from traditional practice. Accordingly, we may face resistance to our offerings from brick-and-mortar providers until there is overwhelming evidence to convince them to alter their current approach.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">The market for our model and services is new, rapidly evolving, and increasingly competitive, as the healthcare industry in the United States is undergoing significant structural change and consolidation, which makes it difficult to forecast demand for our solutions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for our model is new and rapidly evolving and we are expanding our business by offering access to consultation and treatment options for new conditions, and it is uncertain whether our offerings will achieve and sustain high levels of demand and market adoption. Our future financial performance depends in part on growth in this market, our ability to market effectively and in a cost-efficient manner, and our ability to adapt to emerging demands of our customers. It is difficult to predict the future growth rate and size of our target market. Negative publicity concerning telehealth generally, our offerings, customer success on our platform, or our market as a whole could limit market acceptance of our business model and services. If our customers do not perceive the benefits of our offerings, or if our offerings do not drive customer use and enrollment, then our market and our customer base may not continue to develop, or they may develop more slowly than we expect. Our success depends in part on the willingness of providers and healthcare organizations to partner with us, increase their use of telehealth, and our ability to demonstrate the value of our technology to providers, as well as our existing and potential customers. If providers, healthcare organizations or regulators work in opposition to us or if we are unable to reduce healthcare costs or drive positive health outcomes for our customers, then the market for our services may not continue to develop, or it might develop more slowly than we expect. Similarly, negative publicity regarding customer confidentiality and privacy in the context of telehealth could limit market acceptance of our business model and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry in the United States is continually undergoing or threatened with significant structural change and is rapidly evolving. We believe demand for our offerings has been driven in part by rapidly growing costs in the traditional healthcare system, difficulties accessing the healthcare system, patient stigma associated with sensitive medical conditions, the movement toward patient-centricity and personalized healthcare, and advances in technology. Widespread acceptance of personalized healthcare enabled by technology is critical to our future growth and success. A reduction in the growth of technology-enabled personalized healthcare could reduce the demand for our services and result in a lower revenue growth rate or decreased revenue. Additionally, the majority of our revenue is driven by products and services offered through our platform on a subscription basis, and the adoption of subscription business models is still relatively new, especially in the healthcare industry. If customers do not shift to subscription business models and subscription health management tools do not achieve widespread adoption, or if there is a reduction in demand for subscription products and services or subscription health management tools, our business, financial condition, and results of operations could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, if healthcare or healthcare benefits trends shift or entirely new technologies are developed that replace existing offerings, our existing or future services could be rendered obsolete and require that we materially change our technology or business model. If we are unable to do so, our business could be adversely affected. In addition, we may experience difficulties with software development, industry standards, design or marketing that could delay or prevent our development, introduction, or implementation of new options on our platform and any enhancements thereto. Any such difficulties may have an adverse effect on our business, financial condition, and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Competitive platforms or other technological breakthroughs for the monitoring, treatment or prevention of medical conditions may adversely affect demand for our offerings.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to achieve our strategic objectives will depend, among other things, on our ability to enable fast and efficient telehealth consultations, maintain comprehensive and affordable offerings, ensure the successful operation of our affiliated pharmacy, and deliver an accessible and reliable platform that is more appealing and user-friendly than available alternatives. Our competitors, as well as a number of other companies and providers, within and outside the healthcare industry, are pursuing new devices, delivery technologies, sensing technologies, procedures, treatments, drugs, and other therapies for the monitoring and treatment of medical conditions. Any technological breakthroughs in monitoring, treatment, or prevention of medical conditions that we could not similarly leverage could reduce the potential market for our offerings, which could significantly reduce our revenue and our potential to grow certain aspects of our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The introduction by competitors of solutions or offerings that are or claim to be superior to our platform or offerings may create market confusion, which may make it difficult for potential customers to differentiate between the benefits of our offerings and competitive solutions. In addition, the entry of multiple new products may lead some of our competitors to employ pricing strategies that could adversely affect the pricing of products and services we make available. If a competitor develops a product or business that competes with or is perceived to be superior to our offerings, or if a competitor employs strategies that place downward pressure on pricing within our industry, our revenue may decline significantly or may not increase in line with our forecasts, either of which could adversely affect our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We operate in highly competitive markets and face competition from large, well-established healthcare providers and more traditional retailers and pharmaceutical providers with significant resources, and, as a result, we may not be able to compete effectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The markets for healthcare are intensely competitive, subject to rapid change and significantly affected by new product and technological introductions and other market activities of industry participants. We compete directly not only with other established telehealth providers but also traditional healthcare providers, pharmacies, and large retailers that sell non-prescription products, including, for example, nutritional supplements, vitamins, and hair care treatments. Our current competitors include traditional healthcare providers expanding into the telehealth market, incumbent telehealth providers, as well as new entrants into our market that are focused on direct-to-consumer healthcare. Our competitors include enterprise-focused companies who may enter the direct-to-consumer healthcare industry, as well as direct-to-consumer healthcare providers. Many of our current and potential competitors may have greater name and brand recognition, longer operating histories, significantly greater resources than we do and may be able to offer products and services similar to those offered on our platform at more attractive prices than we can. Further, our current or potential competitors may be acquired by third parties with greater available resources, which has recently occurred in our industry. As a result, our competitors may be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards, or customer requirements and may have the ability to initiate or withstand substantial price competition. In addition, our competitors have established, and may in the future establish, cooperative relationships with vendors of complementary products, technologies, or services to increase the availability of their solutions in the marketplace.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New competitors or alliances may emerge that have greater market share, a larger customer base, more widely adopted proprietary technologies, greater marketing expertise, and greater financial resources, which could put us at a competitive disadvantage. For example, some state and federal regulatory authorities lowered certain barriers to the practice of telehealth in order to make remote healthcare services more accessible in response to the COVID-19 pandemic. Although it is unclear whether these regulatory changes will be permanent or that they will have a long-term impact on the adoption of telehealth services by the general public or legislative and regulatory authorities, these changes may result in greater competition for our business. The lower barriers to entry may allow various new competitors to enter the market more quickly and cost effectively than before the COVID-19 pandemic. Additionally, we believe that the COVID-19 pandemic has introduced many new users to telehealth and further reinforced its benefits to potential competitors. We believe this may drive additional industry </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidation or collaboration involving competitors that may create competitors with greater resources and access to potential customers. The COVID-19 pandemic may also cause various traditional healthcare providers to evaluate and eventually pursue telehealth options that can be paired with their in-person capabilities. These industry changes could better position our competitors to serve certain segments of our current or future markets, which could create additional price pressure. In light of these factors, even if our offerings are more effective than those of our competitors, current or potential customers may accept competitive solutions in lieu of purchasing from us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to compete effectively depends on our ability to distinguish our company and our offerings from our competitors and their products, and includes factors such as:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accessibility, ease of use and convenience;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price and affordability;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">personalization;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">brand recognition;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term outcomes;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">breadth and efficacy of offerings;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market penetration;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">marketing resources and effectiveness;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">partnerships and alliances;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">relationships with providers, suppliers and partners; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory compliance recourses.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to successfully compete with existing and potential competitors, our business, financial condition, and results of operations could be adversely affected. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We have experienced rapid growth in recent fiscal years and expect to continue to invest in our growth for the foreseeable future. If we fail to manage our growth effectively, we may be unable to execute our business plan, maintain high levels of service, or adequately address competitive challenges.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recently experienced a period of rapid growth in our headcount and operations. The historical revenue of Hims &amp; Hers grew from $26.7 million for the year ended December 31, 2018, to $82.6 million for the year ended December 31, 2019, to $148.8 million for the year ended December 31, 2020. Our number of full-time employees has increased significantly over the last few years, from 41 employees as of December 31, 2018 to 181 employees as of December 31, 2020. During this period, we also established operations in the United Kingdom, launched our affiliated pharmacy, and significantly increased the size of our customer base.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to significantly expand our operations and headcount in the near term, including internationally. This growth has placed, and future growth will place, a significant strain on our management, administrative, operational, and financial infrastructure. Our success will depend in part on our ability to manage this growth effectively and execute our business plan. To manage the expected growth of our operations and personnel, we will need to continue to improve our operational, financial, and management controls and our reporting systems and procedures, and we will need to ensure that we maintain high levels of customer support. Failure to effectively manage growth and execute our business plan could result in difficulty or delays in increasing the size of our customer base, declines in quality of customer support or customer satisfaction, increases in costs, difficulties in introducing new products or features, or other operational difficulties, and any of these difficulties could adversely affect our business performance and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our brand is integral to our success. If we fail to effectively maintain, promote, and enhance our brand in a cost-effective manner, our business and competitive advantage may be harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that maintaining and enhancing our reputation and brand recognition is critical to our relationships with existing customers, providers, strategic partners, and partner pharmacies, and to our ability to attract new customers, providers, strategic partners, and partner pharmacies. The promotion of our brand may require us to make substantial investments, and we </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">anticipate that, given the highly competitive nature of our market, these marketing initiatives may become increasingly difficult and expensive. Brand promotion and marketing activities may not be successful or yield increased revenue, and to the extent that these activities yield increased revenue, the increased revenue may not offset the expenses we incur and our results of operations could be harmed. In addition, any factor that diminishes our reputation or that of our management, including failing to meet the expectations of our customers, providers, or partners, could harm our reputation and brand and make it substantially more difficult for us to attract new customers, providers, and partners. If we do not successfully maintain and enhance our reputation and brand recognition in a cost-effective manner, our business may not grow and we could lose our relationships with customers, providers, and partners, which could harm our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We are dependent on our relationships with the Affiliated Medical Groups, which we do not own, to provide healthcare consultation services, and our business could be adversely affected if those relationships were disrupted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In certain jurisdictions, the corporate practice of medicine doctrine generally prohibits non-physicians from practicing medicine, including by employing physicians to provide clinical services, directing the clinical practice of physicians, or holding an ownership interest in an entity that employs or contracts with physicians. Some states have similar doctrines with respect to other professional licensure categories, including behavioral health services and providers, Other practices, such as professionals splitting their professional fees with a non-professional, are also prohibited in some jurisdictions. Many states also limit the extent to which nurse practitioners and physician assistants can practice independently and require that they practice under the supervision of or in collaboration with a supervising physician.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our platform, our customers gain access to one or more licensed providers, including medical doctors, physician assistants, nurse practitioners, and behavioral health providers for telehealth consultations conducted by video, phone, and/or store-and-forward technology. These providers are employed by or contracted with Affiliated Medical Groups to provide telehealth consultations and related services, including applicable physician supervision of nurse practitioners and physician assistants. We enter into certain contractual arrangements with the Affiliated Medical Groups and their physician owners, including an administrative services agreement with each Affiliated Medical Group for the exclusive provision by us of non-clinical services and support for the Affiliated Medical Groups. While we expect that these relationships with the Affiliated Medical Groups will continue, we cannot guarantee that they will. We believe that our arrangements with the Affiliated Medical Groups have been structured to comply with applicable law and allow the healthcare providers the ability to maintain exclusive authority regarding the provision of clinical healthcare services (including consults that may lead to the writing of prescriptions), but there can be no assurance that government entities or courts would find our approach to be consistent with their interpretation of, and enforcement activities or initiatives related to, these laws and the corporate practice of medicine doctrine. If our arrangements are deemed to be inconsistent with any applicable government entity's interpretation of a law or regulation prohibiting the corporate practice of medicine or a fee-splitting law, we would need to restructure the arrangements with the Affiliated Medical Groups to create a compliant arrangement or terminate the arrangement. A material change in our relationships with the Affiliated Medical Groups, whether resulting from a dispute, a change in government regulation or enforcement patterns, a determination of non-compliance, or the loss of these agreements or business relationships, could impair our ability to provide products and services to our customers and could have a material adverse effect our business, financial condition and results of operations. Violations of the prohibition on corporate practice of medicine doctrine and fee-splitting may impose penalties (e.g., fines or license suspension) on healthcare providers, which could discourage professionals from entering into arrangements with the Affiliated Medical Groups and using our platform and could result in lawsuits by providers against the Affiliated Medical Groups and us. These laws and regulations are subject to change and enforcement based upon political, regulatory, and other influences. More restrictive treatment of healthcare professionals' relationships with non-professionals such as our company in the healthcare services delivery context could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">If we are unable to attract and retain high quality healthcare providers for our customers, our business, financial condition, and results of operations may be materially and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our continued ability to maintain customer access to a network of qualified healthcare providers, which includes medical doctors, physician assistants, nurse practitioners, and licensed behavioral health providers. If the Affiliated Medical Groups are unable to recruit and retain licensed physicians and other qualified providers to perform services on our platform, it could have a material adverse effect on our business and ability to grow and could adversely affect our results of operations. In any particular market, providers could demand higher payments from the Affiliated Medical Groups or take other actions that could result in higher medical costs, less attractive service for our customers, or difficulty meeting regulatory requirements. Our ability to develop and maintain satisfactory relationships with providers and the Affiliated Medical Groups </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">also may be negatively impacted by other factors not associated with us, such as pressures on healthcare providers, consolidation activity among hospitals, physician groups, and other healthcare providers, changes in the patterns of delivery and payment for healthcare services, and any perceived liability risks associated with the use of telehealth. The failure to maintain or to secure new cost-effective arrangements with the Affiliated Medical Groups that engage the providers on our platform may result in a loss of, or inability to grow, our customer base, higher costs, less attractive service for our customers and/or difficulty in meeting regulatory requirements, any of which could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">The activities and quality of healthcare providers treating our customers, including potentially unethical or illegal practices, could damage our brand, subject us to liability, and harm our business and financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business entails the risk of professional liability claims against the Affiliated Medical Groups, the providers, and us. Although we carry insurance covering medical malpractice claims in amounts that we believe are appropriate in light of the risks attendant to our business, successful professional liability or other claims could result in substantial damage awards that exceed the limits of our insurance coverage. In addition, professional liability insurance is expensive and insurance premiums may increase significantly in the future, particularly as we expand the scope of our services and the number of conditions for which we provide access to treatment. As a result, adequate professional liability insurance may not be available to the Affiliated Medical Groups, the providers, our partner pharmacies, or to us in the future at acceptable costs or at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any claims made against us that are not fully covered by insurance could be costly to defend against, result in substantial damage awards against us, and divert the attention of our management, Affiliated Medical Groups, and/or providers from our operations, which could have a material adverse effect on our business, financial condition, and results of operations. In addition, claims against us, even if covered by insurance, may adversely affect our business, brand, or reputation, and divert the attention of our management, Affiliated Medical Groups, affiliated pharmacy, and/or providers from our operations. If our customers have negative experiences on our platform as a result of the activities or quality of providers, including any allegations of potentially unethical or illegal practices, such negative experiences could subject us to liability and negatively affect our brand, our ability to attract new customers, and our ability to retain existing customers. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Any failure to offer high-quality support may adversely affect our relationships with customers and healthcare providers, and in turn our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In using our platform, our customers depend on our customer support to resolve issues in a timely manner. We may be unable to respond quickly enough to accommodate short-term increases in demand for customer support. We also may be unable to modify the nature, scope, and delivery of our offerings or customer support to compete with changes in solutions provided by our competitors. Increased customer demand for support could increase costs and adversely affect our business, financial condition, and results of operations. Our revenue is highly dependent on our reputation and on positive recommendations from our customers, providers, and partners. Any failure to maintain high-quality customer support, or a market perception that we do not maintain high-quality customer support, could adversely affect our reputation, our ability to sell the offerings on our platform, and in turn our business, financial conditions, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our business could be adversely affected if healthcare providers were classified as employees of the Affiliated Medical Groups instead of independent contractors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Affiliated Medical Groups with which we have relationships typically engage providers that perform services through our platform as independent contractors. The Affiliated Medical Groups believe that the providers are independent contractors because, among other things, they can choose whether, when, and where to provide services on our platform and are free to provide services on our competitors' platforms. Nevertheless, recent legislative and judicial activity have in some jurisdictions created more restrictive standards or enforcement uncertainty with respect to the classification of workers within certain industries. The Affiliated Medical Groups may not be successful in defending the independent contractor status of providers in some or all jurisdictions in which we and/or they operate. Furthermore, the costs associated with defending, settling, or resolving pending and future lawsuits (including demands for arbitration) relating to the independent contractor status of providers could be material to the Affiliated Medical Groups. Foreign, state, and local laws governing the definition or classification of independent contractors, or changes thereto, or judicial decisions regarding independent contractor classification, could require classification of providers as employees (or workers or quasi-employees where those statuses exist) of the Affiliated Medical Groups. If the Affiliated Medical Groups are required to classify providers as employees (or as workers or quasi-employees where applicable), it could result in significant additional expenses, potentially including expenses </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">associated with the application of wage and hour laws (including minimum wage, overtime, and meal and rest period requirements), employee benefits, social security contributions, taxes, and penalties. Further, any such reclassification could add significant complexity to our business model and could force us to have to modify or renegotiate our relationships with the Affiliated Medical Groups, which may not be possible on mutually agreeable terms, and could have an adverse effect on our business, financial condition, and results of operations. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Acquisitions and investments could result in operating difficulties, dilution and other harmful consequences that may adversely impact our business, financial condition, and results of operations. Additionally, if we are not able to identify and successfully acquire suitable businesses, our results of operations and prospects could be harmed.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may, in the future, make acquisitions to add employees, complementary companies, products, solutions, technologies, or revenue. These transactions could be material to our results of operations and financial condition. We also expect to continue to evaluate and enter into discussions regarding a wide array of potential strategic transactions. The identification of suitable acquisition candidates can be difficult, time-consuming, and costly, and we may not be able to complete acquisitions on favorable terms, if at all. The process of integrating an acquired company, business, or technology has created, and will continue to create unforeseen operating difficulties and expenditures. The related areas where we face risks include, but are not limited to:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management time and focus from operating our business to addressing acquisition integration challenges;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of key employees of the acquired company and other challenges associated with integrating new employees into our culture, as well as reputational harm if integration is not successful;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in integrating and managing the combined operations, technologies, technology platforms and products of the acquired companies, and realizing the anticipated economic, operational and other benefits in a timely manner, which could result in substantial costs and delays or other operational, technical, or financial problems;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory complexities of integrating or managing the combined operations or expanding into other industries or parts of the healthcare industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assumption of contractual obligations that contain terms that are not beneficial to us, require us to license or waive intellectual property rights, or increase our risk for liabilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to successfully further develop the acquired technology or realize our intended business strategy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainty of entry into markets in which we have limited or no prior experience or in which competitors have stronger market positions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated costs associated with pursuing acquisitions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to find commercial success with the products or services of the acquired company;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulty of transitioning the acquired technology onto our existing platforms and maintaining the security standards for such technology consistent with our other solutions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to successfully onboard customers or maintain brand quality of acquired companies;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">responsibility for the liabilities of acquired businesses, including those that were not disclosed to us or exceed our estimates, as well as, without limitation, liabilities arising out of their failure to maintain effective data protection and privacy controls and comply with applicable regulations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to generate the expected financial results related to an acquisition on a timely manner or at all; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential accounting charges to the extent intangibles recorded in connection with an acquisition, such as goodwill, trademarks, client relationships, or intellectual property, are later determined to be impaired and written down in value.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future acquisitions could also result in expenditures of significant cash, dilutive issuances of our equity securities, the incurrence of debt, restrictions on our business, contingent liabilities, amortization expenses, or write-offs of goodwill, any of which could harm our financial condition. In addition, any acquisitions we announce could be viewed negatively by customers, providers, partners, suppliers, or investors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, competition within our industry for acquisitions of business, technologies and assets may become intense. Even if we are able to identify an acquisition that we would like to consummate, we may not be able to complete the acquisition on </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">commercially reasonable terms or the target may be acquired by another company. We may enter into negotiations for acquisitions that are not ultimately consummated. Those negotiations could result in diversion of management time and significant out-of-pocket costs. If we fail to evaluate and execute acquisitions successfully, we may not be able to realize the benefits of these acquisitions, and our results of operations could be harmed. If we are unable to successfully address any of these risks, our business, financial condition, or results of operations could be harmed.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Expansion into international markets is important for our long-term growth, and as we expand internationally, we will face additional business, political, legal, regulatory, operational, financial, and economic risks, any of which could increase our costs and hinder such growth.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expanding our business to attract customers, providers, and suppliers in countries other than the United States is an element of our long-term business strategy. An important part of targeting international markets is increasing our brand awareness and establishing relationships with partners internationally. Doing business internationally involves a number of risks, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertain legal and regulatory requirements applicable to telehealth and prescription medication;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our inability to replicate our domestic business structure consistently outside of the United States, especially as it relates to our contractual arrangement with affiliated professional entities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">multiple, conflicting and changing laws and regulations such as tax laws, privacy and data protection laws and regulations, export and import restrictions, employment laws, regulatory requirements and other governmental approvals, permits and licenses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtaining regulatory approvals or clearances where required for the sale of our offerings, products, devices, and services in various countries;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">requirements to maintain data and the processing of that data on servers located within the United States or in such countries;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">protecting and enforcing our intellectual property rights;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">logistics and regulations associated with prescribing medicine online and engaging with partner pharmacies to ship the prescribed medication;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural disasters, political and economic instability, including wars, terrorism, social or political unrest, including civil unrest, protests, and other public demonstrations, outbreaks of disease, pandemics or epidemics, boycotts, curtailment of trade, and other market restrictions; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory and compliance risks that relate to maintaining accurate information and control over activities subject to regulation under the U.S. Foreign Corrupt Practices Act (the "FCPA"), and comparable laws and regulations in other countries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to continue to expand our business and to attract talented employees, customers, providers, partners, and suppliers in various international markets will require considerable management attention and resources and is subject to the particular challenges of supporting a rapidly growing business in an environment of multiple languages, cultures, customs, legal systems, alternative dispute resolution systems, regulatory systems, and commercial infrastructures. Entering new international markets will be expensive, our ability to successfully gain market acceptance in any particular market is uncertain, and the distraction of our senior management team could harm our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Economic uncertainty or downturns, particularly as it impacts particular industries, could adversely affect our business and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, the United States and other significant markets have experienced cyclical downturns and worldwide economic conditions remain uncertain. This was especially the case in 2020 as a result of the COVID-19 pandemic. Economic uncertainty and associated macroeconomic conditions make it extremely difficult for our partners, suppliers, and us to accurately forecast and plan future business activities, and could cause our customers to slow spending on our offerings, and could limit the ability of our pharmacy partners to purchase sufficient quantities of pharmaceutical products from suppliers, which could adversely affect our ability to fulfill customer orders and attract new providers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant downturn in the domestic or global economy may cause our customers to pause, delay, or cancel spending on our platform or seek to lower their costs by exploring alternative providers or our competitors. To the extent purchases of our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">offerings are perceived by customers and potential customers as discretionary, our revenue may be disproportionately affected by delays or reductions in general healthcare spending. Also, competitors may respond to challenging market conditions by lowering prices and attempting to lure away our customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the timing, strength, or duration of any economic slowdown or any subsequent recovery generally, or any industry in particular. If the conditions in the general economy and the markets in which we operate worsen from present levels, our business, financial condition, and results of operations could be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">The COVID-19 pandemic has increased interest in and customer use of telehealth solutions, including our platform, and we cannot guarantee that this increased interest will continue after the pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, COVID-19 surfaced in Wuhan, China. The World Health Organization declared a global emergency on January 30, 2020 with respect to the outbreak and then characterized it as a pandemic on March 11, 2020. The outbreak has spread globally, causing companies and various local, state, federal, and international jurisdictions to impose restrictions, such as quarantines, closures, cancellations, and travel restrictions. The duration of the business disruptions, travel restrictions and related financial impact cannot be reasonably estimated at this time. As the COVID-19 pandemic is ongoing, the complete impact of the pandemic is still unknown and rapidly evolving.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to COVID-19, telehealth has seen a steep increase in use across the industry, in part due to governmental waivers of statutory and regulatory restrictions that have historically limited how telehealth may be used in delivering care in certain jurisdictions. We do not know if this relaxation of regulatory barriers resulting from COVID-19 will remain or for how long. There is renewed focus on telehealth among legislatures and regulators due to COVID-19 and the expanded use of telehealth that could result in regulatory changes inconsistent with or that place additional restrictions on our current business model or operations in certain jurisdictions. If customer adoption of telehealth generally or our platform in particular materially decreases as the COVID-19 restrictions are lifted, or if COVID-19 results in regulatory changes that limit our current activities, our industry, business, and results of operations could be adversely affected.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our business depends on continued and unimpeded access to the internet and mobile networks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to deliver our internet-based and mobile-application based services depends on the development and maintenance of the infrastructure of the internet by third parties. This includes maintenance of a reliable network backbone with the necessary speed, data capacity, bandwidth capacity, and security. Our services are designed to operate without interruption. However, we may experience future interruptions and delays in services and availability from time to time. In the event of a catastrophic event with respect to one or more of our systems or those of our service providers, we may experience an extended period of system unavailability, which could negatively impact our relationship with customers, providers, partners, and suppliers. To operate without interruption, both we and our service providers must guard against:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">damage from fire, power loss, natural disasters, and other force majeure events outside our control;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">communications failures;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">software and hardware errors, failures, and crashes;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">security breaches, computer viruses, hacking, denial-of-service attacks, and similar disruptive problems; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other potential interruptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on software licensed from third parties in order to offer our services. These licenses are generally commercially available on varying terms. However, it is possible that this software may not continue to be available on commercially reasonable terms, or at all. Any loss of the right to use any of this software could result in delays in the provisioning of our services until equivalent technology is either developed by us, or, if available, is identified, obtained and integrated. Furthermore, our use of additional or alternative third-party software would require us to enter into license agreements with third parties, and integration of our software with new third-party software may require significant work and require substantial investment of our time and resources. Also, any undetected errors or defects in third-party software could prevent the deployment or impair the functionality of our software, delay new updates or enhancements to our solution, result in a failure of our solution, and injure our reputation. The occurrence of any of the foregoing events could have an adverse impact on our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Any disruption of service at Amazon Web Services, partner pharmacies or other third-party service providers could interrupt access to our platform or delay our customers&#8217; ability to seek treatment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently host our platform, serve our customers and support our operations in the United States using Amazon Web Services ("AWS"), a provider of cloud infrastructure services, and through partner pharmacies and other third-party service providers, including shipping providers and contract manufacturers. We do not have control over the operations of the facilities of partner pharmacies, AWS, or other third-party service providers. Such facilities are vulnerable to damage or interruption from earthquakes, hurricanes, floods, fires, cyber security attacks, terrorist attacks, power losses, telecommunications failures, and similar events. The occurrence of a natural disaster or an act of terrorism, a decision to close the facilities without adequate notice, or other unanticipated problems could result in lengthy interruptions in our ability to generate revenue through customer purchases on the platform. The facilities also could be subject to break-ins, computer viruses, sabotage, intentional acts of vandalism, and other misconduct. Our platform's continuing and uninterrupted performance is critical to our success. Because our platform is used by our customers to engage with providers who can diagnose, manage, and treat medical conditions, and pharmacies who can fulfill and ship prescription medication, it is critical that our platform be accessible without interruption or degradation of performance. Customers may become dissatisfied by any system failure that interrupts our ability to provide our platform or access to the products and services offered through our platform to them. Outages and partner pharmacy closures could lead to claims of damages from our customers, providers, partners, suppliers, and others. We may not be able to easily switch our AWS operations to another cloud provider if there are disruptions or interference with our use of AWS. Sustained or repeated system failures could reduce the attractiveness of our offerings to customers and result in contract terminations, thereby reducing revenue. Moreover, negative publicity arising from these types of disruptions could damage our reputation and may adversely impact use of our platform. We may not carry sufficient business interruption insurance to compensate us for losses that may occur as a result of any events that cause interruptions in our platform. Thus, any such disruptions could have an adverse effect on our business and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our call centers, partner pharmacies, shipping providers, contract manufacturers, nor AWS have an obligation to renew their agreements with us on commercially reasonable terms, or at all. If we are unable to renew our agreements with these third-party service providers on commercially reasonable terms, if our agreements with these providers are prematurely terminated, or if in the future we add additional data, call center, or pharmacy providers, we may experience costs or downtime in connection with the transfer to, or the addition of, such new providers. If these third-party service providers were to increase the cost of their services, we may have to increase the price of our offerings, and our results of operations may be adversely impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We depend on a number of other companies to perform functions critical to our ability to operate our platform, generate revenue from customers, and to perform many of the related functions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on the Affiliated Medical Groups and their providers to deliver quality healthcare consultations and services through our platform. Through our platform, providers are able to prescribe medication fulfilled by a partner pharmacy. Any interruption in the availability of a sufficient number of providers or supply from our partner pharmacies could materially and adversely affect our ability to satisfy our customers and ensure they receive consultation services and any medication that they have been prescribed. If we were to lose our relationship with one of the Affiliated Medical Groups, we cannot guarantee that we will be able to ensure access to a sufficient network of providers. Similarly, if we were to lose our relationship with one of our partner pharmacies in the near term before our own affiliated pharmacy is operational at scale and able to service all geographies, we cannot guarantee that we will be able to find, perform due diligence on, and engage with a replacement partner in a timely manner. Our ability to service customer requirements could be materially impaired or interrupted in the event that our relationship with an Affiliated Medical Group or partner pharmacy is terminated. We also depend on cloud infrastructure providers, payment processors, suppliers of non-prescription products and packaging, and various others that allow our platform to function effectively and serve the needs of our customers. Difficulties with our significant partners and suppliers, regardless of the reason, could have a material adverse effect on our business. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our pharmacy business will subject us to regulations in addition to those we face with our core telehealth business.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XeCare LLC ("XeCare"), our affiliated pharmacy dedicated to our operations, launched in Ohio during the fiscal quarter ended March 31, 2021, and is in the process of obtaining licensure in additional geographies. The operation of XeCare will subject us to extensive federal, state, and local regulation. Pharmacies, pharmacists, and pharmacy technicians are subject to a variety of federal and state statutes and regulations governing various aspects of the pharmacy business, including the distribution of drugs; operation of mail order pharmacies; licensure of facilities and professionals, including pharmacists, technicians, and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other healthcare professionals; packaging, storing, distributing, shipping, and tracking of pharmaceuticals; repackaging of drug products; labeling, medication guides, and other consumer disclosures; interactions with prescribing professionals; compounding of prescription medications; counseling of patients; prescription transfers; advertisement of prescription products and pharmacy services; security; controlled substance inventory control and recordkeeping; and reporting to the U.S. Drug Enforcement Agency, the U.S. Food and Drug Administration (the "FDA"), state boards of pharmacy, the U.S. Consumer Product Safety Commission, and other state enforcement or regulatory agencies. Many states have laws and regulations requiring out-of-state mail-order pharmacies to register with that state's board of pharmacy. In addition, the FDA inspects facilities in connection with procedures to effect recalls of prescription drugs. The Federal Trade Commission also has requirements for mail-order sellers of goods. The U.S. Postal Service (the "USPS") has statutory authority to restrict the transmission of drugs and medicines through the mail to a degree that may have an adverse effect on our mail-order operations. The USPS historically has exercised this statutory authority only with respect to controlled substances. If the USPS restricts our ability to deliver drugs through the mail, alternative means of delivery are available to us. However, alternative means of delivery could be significantly more expensive. The U.S. Department of Transportation has regulatory authority to impose restrictions on drugs inserted into the stream of commerce. These regulations generally do not apply to the USPS and its operations. Failure to successfully expand XeCare's capabilities or any failure or perceived failure by us or XeCare to comply with any applicable federal, state, and local laws and regulations could have a material adverse effect on our business, financial condition, and results of operations and may expose us to civil and criminal penalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our payments system depends on third party service providers and is subject to evolving laws and regulations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have engaged third-party service providers to perform underlying card processing and currency exchange. If these service providers do not perform adequately or if our relationships with these service providers were to terminate, our ability to accept orders through the platform could be adversely affected and our business could be harmed. In addition, if these service providers increase the fees they charge us, our operating expenses could increase and if we respond by increasing the fees we charge to our customers, we could lose some of our customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and regulations related to payments are complex and vary across different jurisdictions in the United States and globally. As a result, we are required to spend significant time and effort to comply with those laws and regulations. Any failure or claim of our failure to comply, or any failure by our third-party service providers to comply, could cost us substantial resources, could result in liabilities, or could force us to stop offering third-party payment systems. As we expand the availability of payments via third parties or offer new payment methods to our customers in the future, we may become subject to additional regulations and compliance requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, through our agreement with our third-party credit card processor, we are indirectly subject to payment card association operating rules and certification requirements, including the Payment Card Industry Data Security Standard. We are also subject to rules governing electronic funds transfers. Any change in these rules and requirements could make it difficult or impossible for us to comply. Any such difficulties or failures with respect to the payment systems we utilize may have an adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our pricing decisions may adversely affect our ability to attract new customers, healthcare providers, and other partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have limited experience determining the optimal prices for our offerings. As competitors introduce new solutions that compete with our offerings, especially in the telehealth market where we face significant competition, we may be unable to attract new customers, providers, or other partners at the same price or based on the same pricing models as we have used historically. Pricing decisions may also impact the mix of adoption among our services and products and negatively impact our overall revenue. As a result, in the future we may be required to reduce our prices, which could adversely affect our revenue, gross profit, profitability, financial position, and cash flows.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our success depends on the continuing and collaborative efforts of our management team, and our business may be severely disrupted if we lose their services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends largely upon the continued services of our key executive officers. These executive officers are at-will employees and therefore they may terminate employment with us at any time with no advance notice. We rely on our leadership team in the areas of marketing, legal and regulatory compliance, telehealth, operations, finance, public policy and government relations, and other general and administrative functions. From time to time, there may be changes in our executive management team resulting from the hiring or departure of executives, which could disrupt our business. The replacement of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">one or more of our executive officers or other key employees would likely involve significant time and costs and may significantly delay or prevent the achievement of our business objectives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We depend on our talent to grow and operate our business, and if we are unable to hire, integrate, develop, motivate, and retain our personnel, we may not be able to grow effectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part on our ability to attract and retain high-quality management in marketing, engineering, operations, healthcare, regulatory, legal, finance, and support functions. Competition for qualified employees is intense in our industry, and the loss of even a few qualified employees, or an inability to attract, retain, and motivate additional highly skilled employees required for the planned expansion of our business could harm our results of operations and impair our ability to grow. To attract and retain key personnel, we use various measures, including an equity incentive program for key executive officers and other employees. These measures may not be enough to attract and retain the personnel we require to operate our business effectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to grow, we may be unable to continue to attract or retain the personnel we need to maintain our competitive position. In addition to hiring new employees, we must continue to focus on retaining our best talent. Competition for these resources, particularly for engineers, is intense. We may need to invest significant amounts of cash and equity for new and existing employees and we may never realize returns on these investments. If we are not able to effectively increase and retain our talent, our ability to achieve our strategic objectives will be adversely impacted, and our business will be harmed. The loss of one or more of our key employees, and any failure to have in place and execute an effective succession plan for key employees, could seriously harm our business. Employees may be more likely to leave us if the shares of our capital stock they own or the shares of our capital stock underlying their equity incentive awards have significantly reduced in value, or the vested shares of our capital stock they own or vested shares of our capital stock underlying their equity incentive awards have significantly appreciated. Many of our employees may receive significant proceeds from sales of our equity in the public markets once the applicable lock-up restrictions expire, which may reduce their motivation to continue to work for us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a remote-first policy that permits most of our employees to work remotely should their particular positions allow. While we believe that most of our operations can be performed remotely, there is no guarantee that we will be as effective while working remotely because our team is dispersed and many employees may have additional personal needs to attend to or distractions in their remote work environment. To the extent our current or future remote work policies result in decreased productivity, harm our company culture, or otherwise negatively affect our business, our financial condition and results of operations could be adversely affected. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">A significant portion of our non-prescription inventory is stored in our Ohio facility and any damage or disruption at this facility may harm our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our non-prescription inventory is located at a facility in Ohio. A natural disaster, fire, power interruption, work stoppage, or other calamity at this facility would significantly disrupt our ability to deliver our products and operate our business. If any material amount of our facility, machinery, or inventory were damaged or unusable, we would be unable to meet our obligations to customers and wholesale partners, which could materially adversely affect our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Risks Related to Governmental Regulation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Government regulation of healthcare creates risks and challenges with respect to our compliance efforts and our business strategies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is subject to changing political, economic and regulatory influences that may affect companies like ours. During the past several years, the healthcare industry has been subject to an increase in governmental regulation and subject to potential disruption due to legislative initiatives and government regulation, as well as judicial interpretations thereof. While these regulations may not directly impact us or our offerings in every instance, they will affect the healthcare industry as a whole and may impact customer use of our services. We currently accept payments only from our customers&#8212;not any third-party payors, such as government healthcare programs or health insurers. Because of this approach, we are not subject to many of the laws and regulations that impact many other participants in healthcare industry. If the government asserts broader regulatory control over companies like us or if we determine that we will facilitate payment from and/or participate in third-party payor programs, the complexity of our operations and our compliance obligations will materially increase.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">If we fail to comply with applicable healthcare and other governmental regulations, we could face substantial penalties, our business, financial condition, and results of operations could be adversely affected, and we may be required to restructure our operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry in general is subject to numerous federal, state, and local laws and regulations that carry substantial criminal and civil fines and penalties. Under our current business model, we currently accept payments only from our customers, and not from any third-party payors, such as government healthcare programs or health insurers. Because of this approach, we are not subject to many of the laws and regulations that impact many other participants in healthcare industry. If the government asserts broader regulatory control over companies like ours or if we determine that we will change our business model and accept payment from and/or participate in third-party payor programs, the complexity of our operations and our compliance obligations will materially increase. Failure to comply with any applicable federal, state and local laws and regulations could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even within the narrowed band of applicable healthcare laws and regulations, because of the breadth of these laws and the narrowness of available statutory and regulatory exemptions, it is possible that some of our activities could be subject to challenge under one or more of such laws. Any action brought against us for violations of these laws or regulations, even if successfully defended, could cause us to incur significant legal expenses and divert our management's attention from the operation of our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have adopted policies and procedures designed to comply with these laws and regulations and conduct internal reviews of our compliance with these laws, our compliance is also subject to governmental review. The growth of our business and sales organization and our future expansion outside of the United States may increase the potential of violating these laws or our internal policies and procedures. The risk of our being found in violation of these or other laws and regulations is further increased by the fact that many have not been fully interpreted by the regulatory authorities or the courts, and their provisions are open to a variety of interpretations. Any action brought against us for violation of these or other laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management's attention from the operation of our business. If our operations are found to be in violation of any of the federal, state, and foreign laws described above or any other current or future fraud and abuse or other healthcare laws and regulations that apply to us, we may be subject to penalties, including significant criminal, civil and administrative penalties, damages and fines, disgorgement, additional reporting requirements and oversight, imprisonment for individuals, and exclusion from participation in government healthcare programs, such as Medicare and Medicaid, as well as contractual damages and reputational harm. We could also be required to curtail or cease our operations. Any of the foregoing consequences could seriously harm our business and our financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to offer access to telehealth services internationally is subject to the applicable laws governing remote care and the practice of medicine in the applicable jurisdiction. Each country's interpretation and enforcement of these laws is evolving and could vary significantly. We cannot provide assurance that we have accurately interpreted each such law and regulation. Moreover, these laws and regulations may change significantly as this manner of providing services and products evolves. New or revised laws and regulations (or interpretations thereof) could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">If our business practices are found to violate federal or state anti-kickback, physician self-referral, or false claims laws, we may incur significant penalties and reputations damage that could adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is subject to extensive federal and state regulation with respect to kickbacks, physician self-referral arrangements, false claims, and other fraud and abuse issues. For example, the federal anti-kickback law (the "Anti-Kickback Law") prohibits, among other things, knowingly and willfully offering, paying, soliciting, receiving, or providing remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual, or the furnishing, arranging for, or recommending of an item or service that is reimbursable, in whole or in part, by a federal healthcare program. "Remuneration" is broadly defined under the Anti-Kickback Law to include anything of value, such as, for example, cash payments, gifts or gift certificates, discounts, or the furnishing of services, supplies, or equipment. The Anti-Kickback Law is broad, and it prohibits many arrangements and practices that are lawful in businesses outside of the healthcare industry.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The penalties for violating the Anti-Kickback Law can be severe. These sanctions include criminal and civil penalties, imprisonment, and possible exclusion from the federal healthcare programs. Many states have adopted laws similar to the Anti-Kickback Law, and some apply to items and services reimbursable by any payor, including private insurers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the federal ban on physician self-referrals, commonly known as the "Stark Law," prohibits, subject to certain exceptions, physician referrals of Medicare patients to an entity providing certain "designated health services" if the physician or an immediate family member of the physician has any financial relationship with the entity. A "financial relationship" is created by an investment interest or a compensation arrangement. Penalties for violating the Stark Law include the return of funds received for all prohibited referrals, fines, civil monetary penalties, and possible exclusion from the federal healthcare programs. In addition to the Stark Law, many states have their own self-referral bans, which may extend to all self-referrals, regardless of the payor.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given our current operations and the current state of this federal law, the Anti-Kickback Law and False Claim Act should not apply to our business. If the scope of the Anti-Kickback Law, the Stark Law, or the False Claims Act changes or a state analog of the Anti-Kickback Law, the Stark Law, or the False Claims Act includes a broader spectrum of activities than the federal statutes, or if we change our business model to accept payments from third-party payors such as a government program, our failure to comply with such laws, or an allegation that we have not complied, could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State-based laws governing kickbacks and physician self-referrals can apply in some cases regardless of whether it is a third-party payor or the customer paying. The interpretation, application, and enforcement of these laws by governmental authorities is a developing area, and there is little precedent to determine how these laws would be applied to companies like ours. Moreover, the safe harbors and exceptions to these laws are often not as well developed as they are at the federal level. Our business practices and marketing activities include certain components that are common among e-commerce and other technology companies, such as the use of social media influencers. While we have structured our business practices and marketing activities in ways that we believe comply with state laws governing kickbacks and physician self-referrals and the policies behind those laws, given the lack of healthcare regulatory precedent specific to these practices, a governmental authority could disagree with our position. If a governmental authority alleged or determined we are not in compliance with these laws, or if new laws or changes to these laws created additional limits on our business practices or marketing activities, we could face fines or other penalties or damages and we may need to modify or terminate certain arrangements, any of which could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">State legislative and regulatory changes specific to the area of telehealth law may present the Affiliated Medical Groups on our platform with additional requirements and state compliance costs, which may create additional operational complexity and increase costs.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Affiliated Medical Groups and their providers' ability to provide telehealth services to patients in a particular jurisdiction is dependent upon the laws that govern the provision of remote care, professional practice standards, and healthcare delivery in general in that jurisdiction. Laws and regulations governing the provision of telehealth services are evolving at a rapid pace and are subject to changing political, regulatory, and other influences. Some states' regulatory agencies or medical boards may have established rules or interpreted existing rules in a manner that limits or restricts providers' ability to provide telehealth services or for physicians to supervise nurse practitioners and physician assistants remotely. Additionally, there may be limitations placed on the modality through which telehealth services are delivered. For example, some states specifically require synchronous (or "live") communications and restrict or exclude the use of asynchronous telehealth modalities, which is also known as "store-and-forward" telehealth. However, other states do not distinguish between synchronous and asynchronous telehealth services. Because this is a developing area of law and regulation, we continually monitor our compliance in every jurisdiction in which we operate. However, we cannot be assured that our or the Affiliated Medical Groups' or providers' activities and arrangements, if challenged, will be found to be in compliance with the law or that a new or existing law will not be implemented, enforced, or changed in manner that is unfavorable to our business model. We cannot predict the regulatory landscape for those jurisdictions in which we operate and any significant changes in law, policies, or standards, or the interpretation or enforcement thereof, could occur with little or no notice. The majority of the consultations provided through our platform are asynchronous consultations for customers located in jurisdictions that permit the use of asynchronous telehealth. If there is a change in laws or regulations related to our business, or the interpretation or enforcement thereof, that adversely affects our structure or operations, including greater restrictions on the use of asynchronous telehealth or remote supervision of nurse practitioners or physician assistants, it could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Evolving government regulations and enforcement activities may require increased costs or adversely affect our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a regulatory climate that is uncertain, our operations may be subject to direct and indirect adoption, expansion or reinterpretation of various laws and regulations. This risk is especially acute in the healthcare industry given the level of government spending, oversight, and control over the industry as a whole. Compliance with these evolving laws, regulations, and interpretations may require us to change our practices at an undeterminable and possibly significant initial monetary and annual expense. These additional monetary expenditures may increase future overhead, which could have a material adverse effect on our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There could be laws and regulations applicable to our business that we have not identified or that, if changed, may be costly to us, and we cannot predict all the ways in which implementation of such laws and regulations may affect us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the states in which we operate, we believe we are in material compliance with all applicable material regulations, but, due to the uncertain regulatory environment, certain states may determine that we are in violation of their laws and regulations. If we must remedy such violations, we may be required to modify our business and services in such states in a manner that undermines our platform's attractiveness to customers, we may become subject to fines or other penalties or, if we determine that the requirements to operate in compliance in such states are overly burdensome, we may elect to terminate our operations in such states. In each case, our revenue may decline and our business, financial condition, and results of operations could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the introduction of new products, services or solutions to our platform may require us to comply with additional, yet undetermined, laws and regulations. Compliance may require obtaining appropriate federal, state, or local licenses or certificates, increasing our security measures and expending additional resources to monitor developments in applicable rules and ensure compliance. The failure to adequately comply with these future laws and regulations may delay or possibly prevent our products or services from being offered to customers, which could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Changes in public policy that mandate or enhance healthcare coverage could have a material adverse effect on our business, operations, and/or results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission is to make healthcare accessible, affordable, and convenient for everyone. It is reasonably possible that our business operations and results of operations could be materially adversely affected by public policy changes at the federal, state, or local level, which include mandatory or enhanced healthcare coverage. Such changes may present us with new marketing and other challenges, which may, for example, cause use of our products and services to decrease or make doing business in particular states less attractive. If we fail to adequately respond to such changes, including by implementing effective operational and strategic initiatives, or do not do so as effectively as our competitors, our business, operations, and results of operations may be materially adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the enactment or content of new legislation and regulations or changes to existing laws or regulations or their enforcement, interpretation or application, or the effect they will have on our business or results of operations, which could be materially adverse. Even if we could predict such matters, we may not be able to reduce or eliminate the potential adverse impact of public policy changes that could fundamentally change the dynamics of our industry.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Changes in insurance and healthcare laws, as well as the potential for further healthcare reform legislation and regulation, have created uncertainty in the healthcare industry and could materially affect our business, financial condition, and result of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act as amended by the Health Care and Education Reconciliation Act, each enacted in March 2010, generally known as the "Health Care Reform Law," significantly expanded health insurance coverage to uninsured Americans and changed the way healthcare is financed by both governmental and private payers. Since then, the Health Care Reform Law has prompted legislative efforts to significantly modify or repeal the Health Care Reform Law, which may impact how the federal government responds to lawsuits challenging the Health Care Reform Law. We cannot predict what further reform proposals, if any, will be adopted, when they may be adopted, or what impact they may have on our business. While we currently only accept payments from customers&#8212;not any third parties or insurance providers&#8212;and our business </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">model may not be directly impacted by healthcare reform, healthcare reform will impact the healthcare industry in which we operate. If we are required to comply with the Health Care Reform Law and fail to comply or are unable to effectively manage such risks and uncertainties, our financial condition and results of operations could be adversely affected.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">The products we sell and our third-party suppliers are subject to FDA regulations and other state and local requirements and if we or our third-party suppliers fail to comply with federal, state, and local requirements, our ability to fulfill customers' orders through our platform could be impaired.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products available through our platform, and the third-party suppliers and manufacturers of these products, are subject to extensive regulation by the FDA and state and local authorities, including pharmaceuticals, over-the-counter drugs, over-the-counter devices, cosmetics, and dietary supplements. These authorities can enforce regulations related to methods and documentation of the testing, production, compounding, control, quality assurance, labeling, packaging, sterilization, storage, and shipping of products. Government regulations specific to pharmaceuticals are wide ranging and govern, among other things: the ability to bring a pharmaceutical to market, the conditions under which it can be sold, the conditions under which it must be manufactured, and permissible claims that may be made for such product. Failure to meet&#8212;or significant changes to&#8212;any federal, state, or local requirements attendant to the sales and marketing of a regulated product could result in enforcement actions, impede our ability to provide access to affected products, and have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We may be subject to fines, penalties, and injunctions if we are determined to be promoting the use of products for unapproved uses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the products available through our platform require approval by the FDA and are subject to the limitations placed by FDA on the approved uses in the product prescribing information. Some of these products are prescribed by providers on the platform for "off-label" uses (i.e., for a use other than that specifically authorized by the FDA for the medication in question). While providers are legally permitted to prescribe medications for off-label uses, and although we believe our product promotion is conducted in material compliance with FDA and other regulations, if the FDA determines that our product promotion constitutes promotion of an unapproved use of an approved product or of an unapproved product, the FDA could request that we modify our product promotion or subject us to regulatory and/or legal enforcement actions, including the issuance of a warning letter, injunction, seizure, civil fine, and criminal penalties. It is also possible that other federal, state, or foreign enforcement authorities might take action if they consider the product promotion to constitute promotion of an unapproved use of an approved product or of an unapproved product, which could result in significant fines or penalties under other statutes, such as laws prohibiting false claims for reimbursement. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">The information that we provide to healthcare providers, customers, and our partners could be inaccurate or incomplete, which could harm our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect and transmit healthcare-related information to and from our customers, providers and partner pharmacies in connection with the telehealth consultations conducted by the providers and prescription medication fulfillment by our partner pharmacies. If the data that we provide to our customers, providers, or partner pharmacies are incorrect or incomplete or if we make mistakes in the capture or input of these data, our reputation may suffer and we could be subject to claims of liability for resulting damages. While we maintain insurance coverage, this coverage may prove to be inadequate or could cease to be available to us on acceptable terms, if at all. Even unsuccessful claims could result in substantial costs and the diversion of management resources. A claim brought against us that is uninsured or under-insured could harm our business, financial condition, and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our use, disclosure, and other processing of personally identifiable information, including health information, is subject to federal, state, and foreign privacy and security regulations, and our failure to comply with those regulations or to adequately secure the information we hold could result in significant liability or reputational harm and, in turn, a material adverse effect on our customers, providers, and revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous state and federal laws and regulations govern the collection, dissemination, use, privacy, confidentiality, security, availability, integrity, and other processing of health information and other types of personal data or personally identifiable information ("PII"). We believe that, because of our operating processes, we are not a covered entity or a business associate under the Health Insurance Portability and Accountability Act ("HIPAA"), which establishes a set of national privacy and security standards for the protection of protected health information by health plans, healthcare clearinghouses, and certain </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">healthcare providers, referred to as covered entities, and the business associates with whom such covered entities contract for services. Notwithstanding that we do not believe that we meet the definition of a covered entity or business associate under HIPAA, we have executed business associate agreements with certain other parties and have assumed obligations that are based upon HIPAA-related requirements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed and maintained policies and procedures with respect to health information and personal information that we use or disclose in connection with our operations, including the adoption of administrative, physical, and technical safeguards to protect such information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to HIPAA, numerous other federal, state, and foreign laws and regulations protect the confidentiality, privacy, availability, integrity, and security of health information and other types of PII, including the California Confidentiality of Medical Information Act. These laws and regulations in many cases are more restrictive than, and may not be preempted by, HIPAA and its implementing rules. These laws and regulations are often uncertain, contradictory, and subject to changed or differing interpretations, and we expect new laws, rules and regulations regarding privacy, data protection, and information security to be proposed and enacted in the future. This complex, dynamic legal landscape regarding privacy, data protection, and information security creates significant compliance issues for us, the Affiliated Medical Groups, and the providers, and potentially exposes us to additional expense, adverse publicity, and liability. While we have implemented data privacy and security measures in an effort to comply with applicable laws and regulations relating to privacy and data protection, some health information and other PII or confidential information is transmitted to us by third parties, who may not implement adequate security and privacy measures, and it is possible that laws, rules, and regulations relating to privacy, data protection, or information security may be interpreted and applied in a manner that is inconsistent with our practices or those of third parties who transmit health information and other PII or confidential information to us. If we or these third parties are found to have violated such laws, rules, or regulations, it could result in government-imposed fines, orders requiring that we or these third parties change our or their practices, or criminal charges, which could adversely affect our business. Complying with these various laws and regulations could cause us to incur substantial costs or require us to change our business practices, systems, and compliance procedures in a manner adverse to our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also publish statements to our customers through our privacy policy that describe how we handle health information or other PII. If federal or state regulatory authorities or private litigants consider any portion of these statements to be untrue, we may be subject to claims of deceptive practices, which could lead to significant liabilities and consequences, including, without limitation, costs of responding to investigations, defending against litigation, settling claims, and complying with regulatory or court orders. Any of the foregoing consequences could seriously harm our business and our financial results. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations, and policies that are applicable to us may limit customers' use and adoption of, and reduce the overall demand for, our platform. Any of the foregoing consequences could have a material adverse impact on our business and our financial results.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Public scrutiny of internet privacy and security issues may result in increased regulation and different industry standards, which could deter or prevent us from providing services to our customers, thereby harming our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory framework for privacy and security issues worldwide is evolving and is likely to remain in flux for the foreseeable future. Various government and consumer agencies have also called for new regulation and changes in industry practices. Practices regarding the registration, collection, processing, storage, sharing, disclosure, use, and security of personal and other information by companies offering an online service like our platform have recently come under increased public scrutiny.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, the California Consumer Privacy Act ("CCPA"), which went into effect on January 1, 2020, requires, among other things, covered companies to provide new disclosures to California consumers and afford such consumers new abilities to opt-out of certain sales of personal information. Similar legislation has been proposed or adopted in other states. Aspects of the CCPA and these other state laws and regulations, as well as their enforcement, remain unclear, and we may be required to modify our practices in an effort to comply with them. Additionally, a new privacy law, the California Privacy Rights Act ("CPRA"), was approved by California voters in November 2020, and significantly modifies the CCPA, requiring us to incur additional costs and expenses and modify certain of our privacy practices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business, including our ability to operate and to expand internationally, could be adversely affected if legislation or regulations are adopted, interpreted, or implemented in a manner that is inconsistent with our current business practices and that require changes to these practices, the design of our websites, mobile applications, solutions, features, or our privacy policies. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, the success of our business has been, and we expect will continue to be, driven by our ability to responsibly gather and use data from data subjects. Therefore, our business could be harmed by any significant change to applicable laws, regulations, or industry standards or practices regarding the storage, use, or disclosure of data our customers or providers share with us, or regarding the manner in which the express or implied consent of customers or providers for such collection, analysis, and disclosure is obtained. Such changes may require us to modify our platform, possibly in a material manner, and may limit our ability to develop new offerings, functionality, or features.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Security breaches, loss of data, and other disruptions could compromise sensitive information related to our business or customers, or prevent us from accessing critical information and expose us to liability, which could adversely affect our business and our reputation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect, store, use and disclose sensitive data, including health information and other types of PII. We also process and store, and use additional third parties to process and store, confidential and proprietary information such as intellectual property and other proprietary business information, including that of our customers, providers, and partners. Our customer information is encrypted but not always de-identified. We manage and maintain our platform and data utilizing a combination of managed data center systems and cloud-based computing center systems.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are highly dependent on information technology networks and systems, including the internet, to securely process, transmit, and store this critical information. Security breaches of this infrastructure, including physical or electronic break-ins, computer viruses, attacks by hackers and similar breaches, and employee or contractor error, negligence or malfeasance, can create system disruptions, shutdowns, or unauthorized disclosure or modifications of information, causing sensitive, confidential or proprietary information to be accessed or acquired without authorization, or to become publicly available. We utilize third-party service providers for important aspects of the collection, storage, transmission, and verification of customer information and other confidential, and sensitive information, and therefore rely on third parties to manage functions that have material cybersecurity risks. Because of the nature of the sensitive, confidential, and proprietary information that we and our service providers collect, store, transmit, and otherwise process, the security of our technology platform and other aspects of our services, including those provided or facilitated by our third-party service providers, are important to our operations and business strategy. We take certain administrative, physical, and technological safeguards to address these risks, such as requiring outsourcing subcontractors who handle customer, user, and patient information for us to enter into agreements that contractually obligate those subcontractors to use reasonable efforts to safeguard sensitive, confidential, and proprietary information. Measures taken to protect our systems, those of our third-party service providers, or sensitive, confidential, and proprietary information that we or our third-party service providers process or maintain, may not adequately protect us from the risks associated with the collection, storage, and transmission of such information. Although we take steps to help protect sensitive, confidential, and proprietary information from unauthorized access or disclosure, our information technology and infrastructure may be vulnerable to attacks by hackers or viruses, failures or breaches due to third-party action, employee negligence or error, malfeasance, or other disruptions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A security breach or privacy violation that leads to disclosure or unauthorized use or modification of, or that prevents access to or otherwise impacts the confidentiality, security, or integrity of, sensitive, confidential, or proprietary information we or our third-party service providers maintain or otherwise process, could harm our reputation, compel us to comply with breach notification laws, and cause us to incur significant costs for remediation, fines, penalties, notification to individuals and governmental authorities, implementation of measures intended to repair or replace systems or technology, and to prevent future occurrences, potential increases in insurance premiums, and forensic security audits or investigations. As a result, a security breach or privacy violation could result in increased costs or loss of revenue. If we are unable to prevent such security breaches or privacy violations or implement satisfactory remedial measures, or if it is perceived that we have been unable to do so, our operations could be disrupted, we may be unable to provide access to our platform, and could suffer a loss of customers or providers or a decrease in the use of our platform, and we may suffer loss of reputation, adverse impacts on customer, provider, and partner confidence, financial loss, governmental investigations or other actions, regulatory or contractual penalties, and other claims and liability. In addition, security breaches and other inappropriate access to, or acquisition or processing of, information can be difficult to detect, and any delay in identifying such incidents or in providing any notification of such incidents may lead to increased harm.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any such breach or interruption of our systems or any of our third-party information technology partners, could compromise our networks or data security processes and sensitive, confidential, or proprietary information could be inaccessible or could be accessed by unauthorized parties, publicly disclosed, lost, or stolen. Any such interruption in access, improper access, disclosure or other loss of such information could result in legal claims or proceedings, liability under laws and regulations that </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">protect the privacy of customer information or other personal information, such as the California Consumer Privacy Act or the General Data Protection Regulation, and regulatory penalties. Unauthorized access, loss or dissemination could also disrupt our operations, including our ability to perform operate our platform and perform our services, provide customer assistance services, conduct research and development activities, collect, process, and prepare company financial information, provide information about our current and future offerings, and engage in other user and clinician education and outreach efforts. Any such breach could also result in the compromise of our trade secrets and other proprietary information, which could adversely affect our business and competitive position. While we maintain insurance covering certain security and privacy damages and claim expenses, we may not carry insurance or maintain coverage sufficient to compensate for all liability and in any event, insurance coverage would not address the reputational damage that could result from a security incident.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Failure to comply with anti-bribery, anti-corruption, and anti-money laundering laws could subject us to penalties and other adverse consequences.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the FCPA and other anti-corruption, anti-bribery, and anti-money laundering laws in the jurisdictions in which we do business, both domestic and abroad. These laws generally prohibit us and our employees from improperly influencing government officials or commercial parties in order to obtain or retain business, direct business to any person, or gain any improper advantage. The FCPA and similar applicable anti-bribery and anti-corruption laws also prohibit our third-party business partners, representatives, and agents from engaging in corruption and bribery. We and our third-party business partners, representatives, and agents may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities. We may be held liable for the corrupt or other illegal activities of these third-party business partners and intermediaries, our employees, representatives, contractors, channel partners, and agents, even if we do not explicitly authorize such activities. These laws also require that we keep accurate books and records and maintain internal controls and compliance procedures designed to prevent any such actions. While we have policies and procedures to address compliance with such laws, we cannot assure that our employees and agents will not take actions in violation of our policies or applicable law, for which we may be ultimately held responsible. Our exposure for violating these laws will increase as we expand internationally and as we commence sales and operations in foreign jurisdictions. Any violation of the FCPA or other applicable anti-bribery, anti-corruption, and anti-money laundering laws could result in whistleblower complaints, adverse media coverage, investigations, imposition of significant legal fees, loss of export privileges, severe criminal or civil sanctions, or suspension or debarment from U.S. government contracts, substantial diversion of management's attention, drop in stock price, or overall adverse consequences to our business, all of which may have an adverse effect on our reputation, business, financial condition, and results of operations. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property and Legal Proceedings</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Failure to protect or enforce our intellectual property rights could harm our business and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intellectual property includes the content of our website, our application, our software code, our electronic medical record system, our unregistered copyrights, and our trademarks. We believe that our intellectual property is an essential asset of our business. If we do not adequately protect our intellectual property, our brand and reputation could be harmed and competitors may be able to use our technologies and erode or negate any competitive advantage we may have, which could materially harm our business, negatively affect our position in the marketplace, limit our ability to commercialize our technology, and delay or render impossible our achievement of profitability. A failure to protect our intellectual property in a cost-effective and meaningful manner could have a material adverse effect on our ability to compete. We regard the protection of our trade secrets, copyrights, trademarks, trade dress, databases, and domain names as critical to our success. We strive to protect our intellectual property rights by relying on federal, state, and common law rights and other rights provided under foreign laws. These laws are subject to change at any time and could further restrict our ability to protect or enforce our intellectual property rights. In addition, the existing laws of certain foreign countries in which we operate may not protect our intellectual property rights to the same extent as do the laws of the United States. We also have a practice of entering into confidentiality and invention assignment agreements with our employees and contractors, and often enter into confidentiality agreements with parties with whom we conduct business in order to limit access to, and disclosure and use of, our proprietary information. In addition, from time to time we make our technology and other intellectual property available to others under license agreements, including open-source license agreements and trademark licenses under agreements with our partners for the purpose of co-branding or co-marketing our products or services. However, these contractual arrangements and the other steps we have taken to protect our intellectual property rights may not prevent the misappropriation of our proprietary information, infringement of our intellectual property rights, disclosure of trade secrets, and other proprietary information, or deter </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">independent development of similar or competing technologies or duplication of our technologies, and may not provide an adequate remedy in the event of such misappropriation or infringement.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Obtaining and maintaining effective intellectual property rights is expensive, as is the costs of defending our rights. We make business decisions about when to file applications or registrations to protect our intellectual property and rely upon trade secret protection, and the approach we select may ultimately prove to be inadequate. We are seeking or may seek to protect certain of our intellectual property rights through filing applications for copyrights, trademarks, and domain names in a number of jurisdictions, a process that is expensive and may not be successful in all jurisdictions. Even where we have intellectual property rights, they may later be found to be unenforceable or have a limited scope of enforceability. In addition, we may not seek to pursue such protection in every jurisdiction. In particular, we believe it is important to maintain, protect, and enhance our brand.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, we pursue the registration of domain names and our trademarks and service marks in the United States and in some jurisdictions outside of the United States. We may, over time, increase our investment in protecting innovations through investments in filings, registrations or similar steps to protect our intellectual property, and these processes are expensive and time-consuming.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to protect our intellectual property rights, we may be required to spend significant resources to monitor and protect these rights. We may not always detect infringement of our intellectual property rights, and defending or enforcing our intellectual property rights, even if successfully detected, prosecuted, enjoined, or remedied, could result in the expenditure of significant financial and managerial resources. Litigation may be necessary to enforce our intellectual property rights, protect our proprietary rights, or determine the validity and scope of proprietary rights claimed by others. Any litigation of this nature, regardless of outcome or merit, could result in substantial costs and diversion of management and technical resources, any of which could adversely affect our business and results of operations. We may also incur significant costs in enforcing our trademarks against those who attempt to imitate our brand and other valuable trademarks and service marks. Furthermore, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims, countersuits, and adversarial proceedings such as oppositions, inter partes review, post-grant review, re-examination, or other post-issuance proceedings, that attack the validity and enforceability of our intellectual property rights. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential or sensitive information could be compromised by disclosure in the event of litigation. In addition, during the course of litigation, there could be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to maintain, protect, and enhance our intellectual property rights, our business, financial condition, and results of operations may be harmed.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We may in the future be subject to claims that we violated intellectual property rights of others, which are extremely costly to defend and could require us to pay significant damages and limit our ability to operate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies in our industry, and other intellectual property rights holders seeking to profit from royalties in connection with grants of licenses, own large numbers of patents, copyrights, trademarks, and trade secrets, and frequently enter into litigation based on allegations of infringement or other violations of intellectual property rights. Our future success depends in part on not infringing upon the intellectual property rights of others. We have in the past and may in the future receive notices that claim we have misappropriated, infringed, or otherwise misused other parties' intellectual property rights. We may be unaware of the intellectual property rights of others that may cover some or all of our technology. Because patent applications can take years to issue and are often afforded confidentiality for some period of time, there may currently be pending applications, unknown to us, that later result in issued patents that could cover our technology.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any intellectual property claim against us or parties indemnified by us, regardless of merit, could be time consuming and expensive to settle or litigate and could divert our management's attention and other resources. These claims also could subject us to significant liability for damages and could result in our having to stop using technology, content, branding or business methods found to be in violation of another party's rights. We might be required or may opt to seek a license for rights to intellectual property held by others, which may not be available on commercially reasonable terms, or at all. Even if a license is available, we could be required to pay significant royalties, which would increase our operating expenses. We may also be required to develop alternative non-infringing technology, content, branding or business methods, which could require </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significant effort and expense, be infeasible, or make us less competitive in the market. Such disputes could also disrupt our business, which would adversely impact our customer satisfaction and ability to attract customers. Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. If we cannot license or develop technology, content, branding or business methods for any allegedly infringing aspect of our business, we may be unable to compete effectively. Additionally, we may be obligated to indemnify our customers in connection with litigation and to obtain licenses or refund subscription fees, which could further exhaust our resources. In the case of infringement or misappropriation caused by technology that we obtain from third parties, any indemnification or other contractual protections we obtain from such third parties, if any, may be insufficient to cover the liabilities we incur as a result of such infringement or misappropriation. Any of these results could harm our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We may be subject to legal proceedings and litigation, including intellectual property disputes, which are costly to defend and could materially harm our business and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be party to lawsuits and legal proceedings in the normal course of business. These matters are often expensive and disruptive to normal business operations. We may face allegations, lawsuits, and regulatory inquiries, audits, and investigations regarding data privacy, security, labor, and employment, consumer protection, practice of medicine, and intellectual property infringement, including claims related to privacy, patents, publicity, trademarks, copyrights, and other rights. A portion of the technologies we use incorporates open-source software, and we may face claims claiming ownership of open-source software or patents related to that software, rights to our intellectual property, or breach of open-source license terms, including a demand to release material portions of our source code or otherwise seeking to enforce the terms of the applicable open-source license. We may also face allegations or litigation related to our acquisitions, securities issuances, or business practices, including public disclosures about our business. Litigation and regulatory proceedings, and particularly the healthcare regulatory and class action matters we could face, may be protracted and expensive, and the results are difficult to predict. Certain of these matters may include speculative claims for substantial or indeterminate amounts of damages and include claims for injunctive relief. Additionally, our litigation costs could be significant. Adverse outcomes with respect to litigation or any of these legal proceedings may result in significant settlement costs or judgments, penalties and fines, or require us to modify our solution or require us to stop offering certain features, all of which could negatively impact our acquisition of customers and revenue growth. We may also become subject to periodic audits, which could likely increase our regulatory compliance costs and may require us to change our business practices, which could negatively impact our revenue growth. Managing legal proceedings, litigation and audits, even if we achieve favorable outcomes, is time-consuming and diverts management's attention from our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of regulatory proceedings, litigation, claims, and audits cannot be predicted with certainty, and determining reserves for pending litigation and other legal, regulatory, and audit matters requires significant judgment. There can be no assurance that our expectations will prove correct, and even if these matters are resolved in our favor or without significant cash settlements. These matters, and the time and resources necessary to litigate or resolve them, could harm our reputation, business, financial condition, and results of operations.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We may face litigation and other risks as a result of the material weakness in our internal control over financial reporting and the restatement of our financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2021, the Staff of the SEC issued a public statement entitled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies ("SPACs")</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (the "Staff Statement"). In the Staff Statement, the Staff of the SEC expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC's balance sheet as opposed to equity. Following the issuance of the Staff Statement, our Board of Directors, after considering the recommendations of management and the audit committee, determined that it was appropriate to restate our previously filed financial statements for the Non-Reliance Periods. See "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Our Warrants are being accounted for as a warrant liability and are being recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our Class A common stock."</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As part of this restatement, we identified a material weakness in our internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of such material weakness, such restatement, the change in accounting for the Warrants, and other matters raised or that may in the future be raised by the SEC, we face potential for litigation or other disputes which may include, among others, claims invoking the federal and state securities laws, contractual claims or other claims arising from the restatement and material weaknesses in our internal control over financial reporting and the preparation of our financial statements. As of the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">date of this quarterly report on Form 10-Q, we have no knowledge of any such litigation or dispute. However, we can provide no assurance that such litigation or dispute will not arise in the future. Any such litigation or dispute, whether successful or not, could have a material adverse effect on our business, results of operations and financial condition.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We face the risk of product liability claims and may not be able to maintain or obtain insurance.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business involves third-party medical providers performing medical consultations and, if warranted, prescribing medication to our customers, as well as the fulfillment and distribution of pharmaceuticals by our affiliated pharmacy. This activity, as well as the sale of other products on our platform, exposes us to the risk of product liability claims. We may be subject to product liability claims if products obtained or prescribed through our platform cause, or merely appear to have caused, an injury. Claims may be made by customers, third-party service providers or manufacturers of products and services we make available. Although we have product liability insurance that we believe is appropriate, this insurance is subject to deductibles and coverage limitations. Our current product liability insurance may not continue to be available to us on acceptable terms, if at all, and, if available, the coverages may not be adequate to protect us against any future product liability claims. If we are unable to obtain insurance at an acceptable cost or on acceptable terms with adequate coverage or otherwise protect against potential product liability claims, we will be exposed to significant liabilities, which may harm our business. A product liability claim, recall or other claim with respect to uninsured liabilities or for amounts in excess of insured liabilities could result in significant costs and significant harm to our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to claims against us even if the apparent injury is due to the actions of others or misuse of the prescribed medication or other product. These liabilities could prevent or interfere with our growth and expansion efforts. Defending a suit, regardless of merit, could be costly, could divert management attention, and may result in adverse publicity or result in reduced acceptance of our platform and offerings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our business could be disrupted by catastrophic events and man-made problems, such as power disruptions, data security breaches, and terrorism.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our systems are vulnerable to damage or interruption from the occurrence of any catastrophic event, including earthquake, fire, flood, tsunami, or other weather event, power loss, telecommunications failure, software or hardware malfunction, cyber-attack, war, terrorist attack, or incident of mass violence, which could result in lengthy interruptions in access to our platform. In addition, acts of terrorism, including malicious internet-based activity, could cause disruptions to the internet or the economy as a whole. Even with our disaster recovery arrangements, access to our platform could be interrupted. If our systems were to fail or be negatively impacted as a result of a natural disaster or other event, our ability to deliver our platform and solution to our customers would be impaired or we could lose critical data. If we are unable to develop adequate plans to ensure that our business functions continue to operate during and after a disaster, and successfully execute on those plans in the event of a disaster or emergency, our business, financial condition, and results of operations could be harmed. We have implemented a disaster recovery program that allows us to move website traffic to a backup data center in the event of a catastrophe. This allows us the ability to move traffic in the event of a problem, and the ability to recover in a short period of time. However, to the extent our disaster recovery program does not effectively support the movement of traffic in a timely or complete manner in the event of a catastrophe, our business and results of operations may be harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not carry business interruption insurance sufficient to compensate us for the potentially significant losses, including the potential harm to our business, financial condition and results of operations that may result from interruptions in access to our platform as a result of system failures.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Results of Operations and Additional Capital Requirements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We have a history of net losses, we anticipate increasing expenses in the future, and we may not be able to achieve or maintain profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hims &amp; Hers has incurred net losses on an annual basis since its inception. Hims &amp; Hers incurred net losses of $75.2 million, $72.1 million, and $18.1 million in the years ended December 31, 2018, 2019, and 2020, respectively. Hims &amp; Hers had an accumulated deficit of $171.3 million as of December 31, 2020. We expect our costs will increase substantially in the foreseeable future and we expect our losses will continue as we expect to invest significant additional funds towards growing our platform, growing our provider network, growing the capabilities of our affiliated pharmacy and enhancing our pharmacy fulfillment system, operating as a public company, and as we continue to invest in increasing our customer base, hiring </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional employees, and developing new products and technological capabilities to enhance our customers' experience on our platform. These efforts may prove more expensive than we currently anticipate, and we may not succeed in increasing our revenue sufficiently to offset these higher expenses. To date, we have financed our operations principally from the sale of our equity, revenue from our platform, and the incurrence of indebtedness. Hims &amp; Hers' historical cash flows from operations were negative for the years ended December 31, 2018, 2019, and 2020. We may not generate positive cash flows from operations or achieve profitability in any given period, and our limited operating history may make it difficult to evaluate our current business and our future prospects.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have encountered and will continue to encounter risks and difficulties frequently experienced by growing companies in rapidly changing and highly regulated industries, including increasing expenses as we continue to grow our business. If we are not able to achieve or maintain positive cash flow in the long term, we may require additional financing, which may not be available on favorable terms or at all and/or which would be dilutive to our stockholders. If we are unable to successfully address these risks and challenges as we encounter them, our business, results of operations, and financial condition would be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our quarterly results of operations, as well as our key metrics, may fluctuate on a quarterly and annual basis, which may result in us failing to meet the expectations of industry and securities analysts or our investors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations have in the past, and could in the future, vary significantly from quarter-to-quarter and year-to-year and may fail to match the expectations of securities analysts because of a variety of factors, many of which are outside of our control and, as a result, should not be relied upon as an indicator of future performance. As a result, we may not be able to accurately forecast our results of operations and growth rate. Any of these events could cause the market price of our common stock to fluctuate. Factors that may contribute to the variability of our results of operations include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new developments on our platform or in our product offerings;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain providers to our platform;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our pricing policies and those of our competitors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to execute our plans to add treatment options and provider expertise for additional medical conditions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term treatment outcomes of customers on our platform;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">medical, technological, or other innovations in our industry or in connection with specific products that we make available on our platform;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain relationships with customers, partners, and suppliers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to retain key members of our executive leadership team;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successful expansion of licensure and capabilities of our affiliated pharmacy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">breaches of security or privacy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the amount and timing of operating costs and capital expenditures related to the expansion of our business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs related to litigation, investigations, regulatory enforcement actions, or settlements;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the legislative or regulatory environment, including with respect to practice of medicine, telehealth, privacy or data protection, or enforcement by government regulators, including fines, orders, or consent decrees;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by competitors or other third parties of significant new products or acquisitions or entrance into certain markets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to make accurate accounting estimates and appropriately recognize revenue for our platform and offerings for which there are no relevant comparable products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">instability in the financial markets;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">global economic conditions;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the duration and extent of the COVID-19 pandemic; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">political, economic, and social instability, including terrorist activities, and any disruption these events may cause to the global economy.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The impact of one or more of the foregoing and other factors may cause our results of operations to vary significantly. As such, we believe that quarter-to-quarter comparisons of our results of operations may not be meaningful and should not be relied upon as an indication of future performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We rely significantly on revenue from customers purchasing subscription-based prescription products and may not be successful in expanding our offerings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the vast majority of our revenue has been, and we expect it to continue to be, derived from customers who purchase subscription-based prescription products through the platform. In our subscription arrangements, customers select a cadence at which they wish to receive product shipments. These customers generate a substantial majority of our revenue. The introduction of competing offerings with lower prices for consumers, fluctuations in prescription prices, changes in consumer purchasing habits, including an increase in the use of mail-order prescriptions, changes in the regulatory landscape, and other factors could result in changes to our contracts or a decline in our revenue, which may have an adverse effect on our business, financial condition, and results of operations. Because we derive a vast majority of our revenue from customers who purchase subscription-based prescription products, any material decline in the use of such offerings could have a pronounced impact on our future revenue and results of operations, particularly if we are unable to expand our offerings overall.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We will incur increased costs and demands upon management as a result of complying with the laws and regulations affecting public companies, which could adversely affect our business, results of operations, and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the reporting requirements of the Exchange Act, the listing standards of NYSE, and other applicable securities rules and regulations. We expect that the requirements of these rules and regulations will continue to increase our legal, accounting, and financial compliance costs, make some activities more difficult, time-consuming, and costly, and place significant strain on our personnel, systems, and resources. For example, the Exchange Act requires, among other things, that we file annual, quarterly, and current reports with respect to our business and results of operations. As a result of the complexity involved in complying with the rules and regulations applicable to public companies, our management's attention may be diverted from other business concerns, which could harm our business, results of operations, and financial condition. Although we have already hired additional employees to assist us in complying with these requirements, we may need to hire more employees in the future or engage outside consultants, which will increase our operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, changing laws, regulations, and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs, and making some activities more time-consuming. These laws, regulations, and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to invest substantial resources to comply with evolving laws, regulations, and standards, and this investment may result in increased general and administrative expenses and a diversion of management's time and attention from business operations to compliance activities. If our efforts to comply with new laws, regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be harmed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The new rules and regulations applicable to public companies has made it more expensive for us to obtain director and officer liability insurance, and we may be required to incur substantially higher costs to maintain the same or similar coverage. These factors could also make it more difficult for us to attract and retain qualified members of our Board of Directors, particularly to serve on our audit committee and compensation committee, and qualified executive officers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of disclosure of information in filings required of a public company, our business and financial condition will become more visible than they have been in the past, which may result in an increased risk of threatened or actual litigation, including by competitors and other third parties. If such claims are successful, our business and results of operations could be harmed, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and harm our business, results of operations, and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We may require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges, including the need to develop new products or services, or enhance our existing platform and associated offerings, enhance our operating infrastructure and acquire complementary businesses and technologies. In order to achieve these objectives, we may make future commitments of capital resources. Accordingly, we may need to engage in equity or debt financings to secure additional funds. If we raise additional funds through further issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences, and privileges superior to those of holders of our common stock. Any debt financing secured by us in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters. In addition, we may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us, when we require it, our ability to continue to support our business growth and to respond to business challenges could be significantly limited.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">If our estimates or judgments relating to our critical accounting policies prove to be incorrect, our results of operations could be adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("U.S. GAAP") and our key metrics require management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes and amounts reported in our key metrics. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets, liabilities, and equity and the amount of revenue and expenses that are not readily apparent from other sources. Significant assumptions and estimates used in preparing our consolidated financial statements include those related to revenue recognition, valuation of warrant liability, fair value of stock-based compensation, and consolidation of variable interest entities. Our results of operations may be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our results of operations to fall below the expectations of securities analysts and investors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our Warrants are being accounted for as a warrant liability and are being recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our Class A common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under U.S. GAAP, we are required to evaluate the Warrants to determine whether they should be accounted for as a warrant liability or as equity. We have concluded that the Warrants contain provisions requiring liability classification. Therefore, as described in our financial statements included in Part I, ITEM 2, of this quarterly report on Form 10-Q, we are accounting for the Warrants as a warrant liability and are recording that liability at fair value. We record any changes in fair value in earnings. The impact of changes in fair value on earnings may have an adverse effect on the market price of our Class A common stock and may cause fluctuations in our results of operations based on factors that are outside of our control.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We identified a material weakness in our internal control over financial reporting. If we do not adequately address this material weakness or if other material weaknesses or significant deficiencies in our internal control over financial reporting are discovered, this could adversely affect our business and the market price of our Class A common stock.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified a material weakness in our internal control over financial reporting as of December 31, 2020, the disclosure of which may have an adverse impact on the price of our Class A common stock (please refer to Part I, ITEM 4 of this quarterly report on Form 10-Q for further discussion). A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our financial statements will not be prevented or detected on a timely basis. As a result of this material weakness, our management concluded that our internal control over financial reporting was not effective as of December 31, 2020, and our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level as of December 31, 2020. The material weakness led to incorrect presentation of our Warrants in prior periods, which has resulted in the restatement of (i) the Company's audited financial statements as of December 31, 2020 and 2019, for the year ended December 31, 2020 and for the period from April 9, 2019 (inception) through December 31, 2019 and (ii) the condensed consolidated unaudited financial statements included in the Company's quarterly reports on Form 10-Q for (a) the three months ended March 31, 2020, (b) the three and six months ended June 30, 2020, and (c) the three and nine months ended </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">September 30, 2020, the three months ended September 30, 2019 and the period from April 9, 2019 (inception) through September 30, 2019. See Note 9 of the Notes to the consolidated financial statements included herein for additional information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although no material misstatement of Hims' historical financial statements was identified, we were required to restate the consolidated financial statements of the Company. We have taken, and intend to continue to take, certain remedial actions intended to address the identified material weakness in our internal control over financial reporting. However, we can give no assurance that such measures will remediate the material weakness identified or that any additional material weaknesses or restatements of financial results will not arise in the future. Additionally, significant costs and resources may be needed to remediate any material weakness (including the material weakness identified) or any internal control deficiencies that may arise in the future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we cannot produce reliable and timely financial reports, investors may lose confidence in our financial reporting and we could be subject to sanctions or investigations by the SEC or other regulatory authorities. Moreover, if we are unable to remediate, evaluate, and test our internal controls on a timely basis in the future, management will be unable to conclude that our internal controls are effective and our independent registered public accounting firm will be unable to express an unqualified opinion on the effectiveness of our internal control over financial reporting.  Any actual or perceived weaknesses or deficiencies that need to be addressed in our internal control over financial reporting, or disclosure of management's assessment of our internal control over financial reporting, could have an adverse impact on our business and the market price of our Class A common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We may not be able to timely and effectively implement controls and procedures required by Section 404(a) and/or 404(b) of the Sarbanes-Oxley Act.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to provide management's attestation on internal controls pursuant to Section 404 of the Sarbanes-Oxley Act. The standards required for a public company under Section 404(a) of the Sarbanes-Oxley Act are significantly more stringent than those previously required of us as a privately-held company. If our Class A common stock held by non-affiliates exceeds $700 million as of June 30 in the upcoming five years, we will also be subject to auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act and the relevant increased disclosure obligations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management may not be able to effectively and timely implement controls and procedures that adequately respond to the increased regulatory compliance and reporting requirements. If we are not able to implement the additional requirements of Section 404(a) and/or 404(b) in a timely manner or with adequate compliance, we may not be able to assess whether our internal controls over financial reporting are effective, which may subject us to adverse regulatory consequences and could harm investor confidence and the market price of our Class A common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Adverse tax laws or regulations could be enacted or existing laws could be applied to us or our customers, which could subject us to additional tax liability and related interest and penalties, increase the costs of our solution, and adversely impact our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The application of federal, state, local, and international tax laws to services provided electronically is evolving. New income, sales, use, value-added, or other tax laws, statutes, rules, regulations, or ordinances could be enacted at any time (possibly with retroactive effect) and could be applied solely or disproportionately to services provided over the internet or could otherwise materially affect our financial position and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, state, local, and foreign tax jurisdictions have differing rules and regulations governing sales, use, value-added, and other taxes, and these rules and regulations can be complex and are subject to varying interpretations that may change over time. Existing tax laws, statutes, rules, regulations, or ordinances could be interpreted, changed, modified, or applied adversely to us (possibly with retroactive effect). If we are required to collect and pay back taxes and associated interest and penalties, and if the amount we are required to collect and pay exceeds our estimates and reserves, or if we are unsuccessful in collecting such amounts from our customers, we could incur potentially substantial unplanned expenses, thereby adversely impacting our results of operations and cash flows. Imposition of such taxes on our services going forward or collection of sales tax from our customers in respect of prior sales could also adversely affect our sales activity and have a negative impact on our results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One or more states may seek to impose incremental or new sales, use, value added, or other tax collection obligations on us, including for past sales by us or our resellers and other partners. A successful assertion by a state, country, or other jurisdiction that we should have been or should be collecting additional sales, use, value added, or other taxes on our solutions could, among other things, result in substantial tax liabilities for past sales, create significant administrative burdens for us, discourage users from utilizing our solutions, or otherwise harm our business, results of operations, and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Certain U.S. state tax authorities may assert that we have a state nexus and seek to impose state and local income taxes which could harm our results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a risk that certain state tax authorities where we do not currently file a state income tax return could assert that we are liable for state and local income taxes based upon income or gross receipts allocable to such states. States are becoming increasingly aggressive in asserting a nexus for state income tax purposes. If a state tax authority successfully asserts that our activities give rise to a nexus, we could be subject to state and local taxation, including penalties and interest attributable to prior periods. Such tax assessments, penalties, and interest may adversely impact our results of operations. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of our Securities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our dual class common stock structure will have the effect of concentrating voting power with our Chief Executive Officer and Co-Founder, Andrew Dudum, which will limit an investor's ability to influence the outcome of important transactions, including a change in control.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares of our Class V common stock have 175 votes per share, while shares of our Class A common stock have one vote per share. Mr. Dudum, our Chief Executive Officer, Co-Founder and a member of our Board of Directors, including his affiliates and permitted transferees, hold all of the issued and outstanding shares of Class V common stock. Accordingly, Mr. Dudum holds, directly or indirectly, approximately 90% of the outstanding voting power and will be able to control matters submitted to our stockholders for approval, including the election of directors, amendments of our organizational documents and any merger, consolidation, sale of all or substantially all of our assets or other major corporate transactions. Mr. Dudum may have interests that differ from yours and may vote in a way with which you disagree and which may be adverse to your interests. This concentrated control may have the effect of delaying, preventing or deterring a change in control, could deprive our stockholders of an opportunity to receive a premium for their capital stock as part of a sale, and might ultimately affect the market price of shares of Class A common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We cannot predict the impact our dual class structure will have on the price of our Class A common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict whether our dual class common stock structure will result in a lower or more volatile market price of Class A common stock or in adverse publicity or other adverse consequences. For example, certain index providers have announced restrictions on including companies with multiple-class share structures in certain of their indices. In July 2017, FTSE Russell and S&amp;P Dow Jones announced that they would cease to allow most newly public companies utilizing dual or multi-class capital structures to be included in their indices. Affected indices include the Russell 2000 and the S&amp;P 500, S&amp;P MidCap 400 and S&amp;P SmallCap 600, which together make up the S&amp;P Composite 1500. Beginning in 2017, MSCI, a leading stock index provider, opened public consultations on their treatment of no-vote and multi-class structures and temporarily barred new multi-class listings from certain of its indices; however, in October 2018, MSCI announced its decision to include equity securities "with unequal voting structures" in its indices and to launch a new index that specifically includes voting rights in its eligibility criteria. Under the announced policies, our dual class capital structure would make us ineligible for inclusion in certain indices, and as a result, mutual funds, exchange-traded funds, and other investment vehicles that attempt to passively track those indices will not be investing in our Class A common stock. These policies are still fairly new and it is as of yet unclear what effect, if any, they will have on the valuations of publicly traded companies excluded from the indices, but it is possible that they may depress these valuations compared to those of other similar companies that are included. Because of our dual class structure, we will likely be excluded from certain of these indices and we cannot assure you that other stock indices will not take similar actions. Given the sustained flow of investment funds into passive strategies that seek to track certain indices, exclusion from stock indices would likely preclude investment by many of these funds and could make shares of our Class A common stock less attractive to other investors. As a result, the market price of shares of our Class A common stock could be adversely affected. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">As a "controlled company" within the meaning of NYSE listing standards, we qualify for exemptions from certain corporate governance requirements. We have the opportunity to elect any of the exemptions afforded a controlled company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because Mr. Dudum controls more than a majority of the total voting power following the consummation of the Merger, we are a "controlled company" within the meaning of NYSE listing standards. Under NYSE Listing Rules, a company of which more than 50% of the voting power is held by another person or group of persons acting together is a "controlled company" and may elect not to comply with the following NYSE rules regarding corporate governance:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the requirement that a majority of its board of directors consist of independent directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the requirement to have a nominating and corporate governance committee composed entirely of independent directors and a written charter addressing the committee's purpose and responsibilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the requirement to have a compensation committee composed entirely of independent directors and a written charter addressing the committee's purpose and responsibilities; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the requirement of an annual performance evaluation of the nominating, corporate governance and compensation committees. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, eight of our nine directors have been determined by our Board of Directors to be independent. We also have an independent compensation committee in addition to an independent audit committee. We do not have a nominating committee. The typical functions of this committee are addressed by our full Board of Directors. For as long as the "controlled company" exemption is available, our Board of Directors in the future may not consist of a majority of independent directors and may not have an independent nominating committee or compensation committee. As a result, you may not have the same protections afforded to stockholders of companies that are subject to all of the NYSE rules regarding corporate governance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Delaware law and our certificate of incorporation and bylaws contain certain provisions, including anti-takeover provisions, that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation, bylaws and the Delaware General Corporation Law (the "DGCL") contain provisions that could have the effect of rendering more difficult, delaying, or preventing an acquisition deemed undesirable by our Board of Directors and therefore depress the trading price of our Class A common stock. These provisions could also make it difficult for stockholders to take certain actions, including electing directors who are not nominated by the current members of our Board of Directors or taking other corporate actions, including effecting changes in our management. Among other things, our certificate of incorporation and/or bylaws include provisions regarding: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Class V common stock that is entitled to 175 votes per share;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our stockholders to take action by written consent in lieu of a meeting for so long as Mr. Dudum and his affiliates and permitted transferees beneficially own a majority of the voting power of the then-outstanding shares of our capital stock;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our Board of Directors to issue shares of preferred stock, including "blank check" preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the limitation of the liability of, and the indemnification of, our directors and officers;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the requirement that a special meeting of stockholders may be called only by a majority of the entire Board of Directors, the chairperson of the Board of Directors or the Chief Executive Officer which could delay the ability of stockholders to force consideration of a proposal or to take action, including the removal of directors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">controlling the procedures for the conduct and scheduling of Board of Directors and stockholder meetings;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of our Board of Directors to amend the bylaws, which may allow our Board of Directors to take additional actions to prevent an unsolicited takeover and inhibit the ability of an acquirer to amend the bylaws to facilitate an unsolicited takeover attempt; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance notice procedures with which stockholders must comply to nominate candidates to our Board of Directors or to propose matters to be acted upon at a stockholders' meeting, which could preclude stockholders from bringing matters before annual or special meetings of stockholders and delay changes in our Board of Directors, and also may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer's own slate of directors or otherwise attempting to obtain control of us.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, alone or together, could delay or prevent hostile takeovers and changes in control or changes in our Board of Directors or management.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our certificate of incorporation includes a provision substantially similar to Section 203 of the DGCL, which may prohibit certain stockholders holding 15% or more of our outstanding capital stock from engaging in certain business combinations with us for a specified period of time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our certificate of incorporation designates a state or federal court located within the State of Delaware as the sole and exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders' ability to obtain a favorable judicial forum for disputes with us or our directors, officers, stockholders, employees, or agents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation provides that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any current or former director, officer, employee, agent, or stockholder, (iii) any action arising pursuant to any provision of the DGCL or our certificate of incorporation or bylaws (as either may be amended from time to time), or (iv) any action asserting a claim against us governed by the internal affairs doctrine. The forgoing provisions will not apply to any claims arising under the Securities Act of 1933, as amended (the "Securities Act"), and, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States will be the sole and exclusive forum for resolving any action asserting a claim arising under the Securities Act. Notwithstanding the foregoing, the provisions of Article XII of our certificate of incorporation will not apply to suits brought to enforce any liability or duty created by the Exchange Act, or any other claim for which the federal district courts of the United States of America shall be the sole and exclusive forum.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These choice of forum provisions in our certificate of incorporation may limit a stockholder's ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits with respect to such claims. There is uncertainty as to whether a court would enforce such provisions, and the enforceability of similar choice of forum provisions in other companies' charter documents has been challenged in legal proceedings. It is possible that a court could find these types of provisions to be inapplicable or unenforceable, and if a court were to find the choice of forum provision contained in our certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations and financial condition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Our warrant agreement designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants, which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with our company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our warrant agreement provides that, subject to applicable law, (i) any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement, including under the Securities Act, will be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and (ii) that we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. We will waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, these provisions of the warrant agreement do not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in any of our warrants will be deemed to have notice of and to have consented to the forum provisions in our warrant agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any action, the subject matter of which is within the scope of the forum provisions of the warrant agreement, is filed in a court other than a court of the State of New York or the United States District Court for the Southern District of New York (a "foreign action") in the name of any holder of our warrants, such holder will be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located in the State of New York in connection with any action brought in any such court to enforce the forum provisions (an "enforcement action"), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder's counsel in the foreign action as agent for such warrant holder.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This choice-of-forum provision may limit a warrant holder's ability to bring a claim in a judicial forum that it finds favorable for disputes with our company, which may discourage such lawsuits. Alternatively, if a court were to find this provision of our warrant agreement inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could materially and adversely affect our business, financial condition and results of operations and result in a diversion of the time and resources of our management and Board of Directors.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We are an emerging growth company and a smaller reporting company within the meaning of the Securities Act, and we have chosen to take advantage of certain exemptions from disclosure requirements available to "emerging growth companies" or "smaller reporting companies," which could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an "emerging growth company" within the meaning of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the "JOBS Act"), and we have chosen to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not "emerging growth companies" including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. As a result, our stockholders may not have access to certain information they may deem important. We could be an emerging growth company for up to five years from OAC's initial public offering, although circumstances could cause us to lose that status earlier, including if the market value of our Class A common stock held by non-affiliates exceeds $700 million as of any June 30 before that time, in which case we would no longer be an emerging growth company as of the following December 31. We cannot predict whether investors will find our securities less attractive because we will rely on these exemptions. If some investors find our securities less attractive as a result of our reliance on these exemptions, the trading prices of our securities may be lower than they otherwise would be, there may be a less active trading market for our securities and the trading prices of our securities may be more volatile.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. We have elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of our financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are a "smaller reporting company" as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (i) the market value of our Class A common stock held by non-affiliates exceeds $250 million as of the prior June 30, or (ii) our annual revenues exceeded $100 million during such completed fiscal year and the market value of our Class A common stock held by non-affiliates exceeds $700 million as of the prior June 30. To the extent we take advantage of such reduced disclosure obligations, it may also make comparison of our financial statements with other public companies difficult or impossible.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">The price of our Class A common stock and warrants may be volatile.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price of our Class A common stock and warrants may fluctuate due to a variety of factors, including:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the industries in which we operate;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variations in our operating performance and the performance of our competitors in general;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">material and adverse impact of the COVID-19 pandemic on the markets and the broader global economy;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated fluctuations in our quarterly or annual results of operation;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">publication of research reports by securities analysts about us or our competitors or our industry;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the public's reaction to our press releases, our other public announcements and our filings with the SEC;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure or the failure of our competitors to meet analysts' projections or guidance that we or our competitors may give to the market;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">additions and departures of key personnel;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in laws and regulations affecting its business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">commencement of, or involvement in, litigation involving us;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our capital structure, such as future issuances of securities or the incurrence of additional debt;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the volume of shares of our Class A common stock available for public sale;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of shares of Class A common stock by the PIPE Investors;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the recent restatement our of previously filed financial statements for the Non-Reliance Periods; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and political conditions such as recessions, interest rates, fuel prices, foreign currency fluctuations, international tariffs, social, political and economic risks and acts of war or terrorism.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These market and industry factors may materially reduce the market price of our Class A common stock and warrants regardless of our operating performance.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">A significant portion of our total outstanding shares are restricted from immediate resale but may be sold into the market in the near future. This could cause the market price of our Class A common stock to drop significantly, even if our business is doing well.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our Class A common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our Class A common stock or warrants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately following the completion of the Merger, the former Hims stockholders owned approximately 83.5% of the total outstanding shares of Class A common stock and Class V common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Sponsor and the holders of more than 75% of the Class A common stock held by former Hims stockholders are subject to certain lock-up restrictions regarding the transfer of shares of Class A common stock, these shares may be sold after the expiration of the respective applicable lock-ups under the Sponsor Agreement, dated as of September 30, 2020, and the Amended and Restated Investors' Rights Agreement, dated September 30, 2020, respectively, along with certain other lock-up agreements signed by Hims stockholder that contain lock-up restrictions substantially similar to those in the Amended and Restated Investors' Rights Agreement. The PIPE Investors are not subject to lock-up restrictions. We have filed a resale shelf registration statement on Form S-1 (No. 333-252814) that relates to the offer and sale from time to time by the selling securityholders named in that prospectus of up to 174,516,077 shares of Class A common stock and up to 3,904,086 warrants. As restrictions on resale end and that prospectus is available for use, the market price of our Class A common stock or warrants could decline if the holders of currently restricted shares sell them or are perceived by the market as intending to sell them.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Warrants are exercisable for our Class A common stock, which could increase the number of shares eligible for future resale in the public market and result in dilution to our stockholders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants to purchase an aggregate of 10,608,958 shares of our Class A common stock became exercisable in accordance with the terms of the warrant agreement governing those securities. These warrants became exercisable 30 days after the completion of the Merger, subject to certain registration and other requirements in the warrant agreement. The exercise price of these warrants is $11.50 per share. To the extent such warrants are exercised, additional shares of our Class A common stock will be issued, which will result in dilution to the holders of our Class A common stock and increase the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market or the fact that such warrants may be exercised could adversely affect the prevailing market price of our Class A common stock. However, there is no guarantee that the Public Warrants will be in the money at a given time prior to their expiration, and as such, the warrants may expire </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">worthless. See "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;The Public Warrants may not be in the money at a given time, and they may expire worthless and the terms of the warrants may be amended in a manner adverse to a holder if holders of at least 50% of the then outstanding Public Warrants approve of such amendment."</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">The Public Warrants may not be in the money at a given time, and they may expire worthless and the terms of the warrants may be amended in a manner adverse to a holder if holders of at least 50% of the then outstanding Public Warrants approve of such amendment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants were issued in registered form under a warrant agreement between Continental, as warrant agent, and OAC prior to the Merger. The warrant agreement provides that the terms of the Public Warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision or correct any mistake, but requires the approval by the holders of at least 50% of the then-outstanding Public Warrants to make any change that adversely affects the interests of the registered holders of Public Warrants. Accordingly, we may amend the terms of the Public Warrants in a manner adverse to a holder if holders of at least 50% of the then outstanding Public Warrants approve of such amendment. Although our ability to amend the terms of the Public Warrants with the consent of at least 50% of the then-outstanding Public Warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash, shorten the exercise period or decrease the number of shares of our Class A common stock purchasable upon exercise of a warrant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the ability to redeem outstanding warrants at any time prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of our Class A common stock equals or exceeds $18.00 per share (as adjusted for share subdivisions, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading-day period ending on the third trading day prior to the date we send the notice of redemption to the warrant holders. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of the outstanding warrants could force you to: (i) exercise your warrants and pay the exercise price therefor at a time when it may be disadvantageous for you to do so; (ii) sell your warrants at the then-current market price when you might otherwise wish to hold your warrants; or (iii) accept the nominal redemption price which, at the time the outstanding warrants are called for redemption, is likely to be substantially less than the market value of your warrants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may redeem your warrants at any time after they become exercisable and prior to their expiration at a price of $0.10 per warrant upon a minimum of 30 days' prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption for a number of shares of Class A common stock determined based on the redemption date and the fair market value of our Class A common stock. The value received upon exercise of the warrants (1) may be less than the value the holders would have received if they had exercised their warrants at a later time where the underlying share price is higher and (2) may not compensate the holders for the value of the warrants. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Reports published by analysts, including projections in those reports that differ from our actual results, could adversely affect the price and trading volume of our Class A common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities research analysts may establish and publish their own periodic projections for us. These projections may vary widely and may not accurately predict the results we actually achieve. Our share price may decline if our actual results do not match the projections of these securities research analysts. Similarly, if one or more of the analysts who write reports on us downgrades our stock or publishes inaccurate or unfavorable research about our business, our stock price could decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, the market price and volume for shares of our Class A common stock could be adversely affected.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">We are subject to changing law and regulations regarding regulatory matters, corporate governance and public disclosure that will increase our costs and the risk of non-compliance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to rules and regulations by various governing bodies, including, for example, the SEC, which are charged with the protection of investors and the oversight of companies whose securities are publicly traded, and to new and evolving </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory measures under applicable law. Our efforts to comply with new and changing laws and regulations will result in increased general and administrative expenses and a diversion of management time and attention.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, because these laws, regulations and standards are subject to varying interpretations, their application in practice may evolve over time as new guidance becomes available. This evolution may result in continuing uncertainty regarding compliance matters and additional costs necessitated by ongoing revisions to our disclosure and governance practices. If we fail to address and comply with these regulations and any subsequent changes, we may be subject to penalty and our business may be harmed.</span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item 2 is contained in our Current Report on Form 8-K, as originally filed with the SEC on January 26, 2021 and as subsequently amended on March 22, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_124"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. DEFAULTS UPON SENIOR SECURITIES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_127"></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_130"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. OTHER INFORMATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i412093a93f204328a33c4602202f8375_133"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS</span></div><div style="margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:9.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001773751/000119312520260568/d74354dex21.htm">Agreement and Plan of Merger dated as of September 30, 2020, by and among Oaktree Acquisition Corp., Rx Merger Sub, Inc. and Hims, Inc. (incorporated by reference to Exhibit 2.1 to the Registrant's Current Report on Form 8-K (File No. 001-38986), filed with the SEC on October 1, 2020).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1773751/000119312521017838/d108056dex31.htm">Certificate of Incorporation of Hims &amp; Hers Health, Inc. (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K (File No. 001-38986), filed with the SEC on January 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1773751/000119312521017838/d108056dex32.htm">Bylaws of Hims &amp; Hers Health, Inc. (incorporated by reference to Exhibit 3.2 to the Company's Current Report on Form 8-K (File No. 001-38986), filed with the SEC on January 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1773751/000119312519190949/d883240dex43.htm">Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to Oaktree Acquisition Corp.'s Registration Statement on Form S-1/A (Registration No.  333-232444), filed with the SEC on July 16, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1773751/000119312519200134/d671484dex41.htm">Warrant Agreement, dated as of July 22, 2019, between Continental Stock Transfer &amp; Trust Company and Oaktree Acquisition Corp. (incorporated by reference to Exhibit 4.1 to Oaktree Acquisition Corp.'s Current Report on Form 8-K (File No. 001-38986), filed with the SEC on July 23, 2019).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1773751/000119312521017838/d108056dex43.htm">Certificate of Corporate Domestication of Oaktree Acquisition Corp. (incorporated by reference to Exhibit 4.3 to the Company's Current Report on Form 8-K (File No. 001-38986), filed with the SEC on January 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1773751/000119312521017838/d108056dex104.htm">Registration Rights Agreement, dated as of January 20, 2021, by and among Hims &amp; Hers Health, Inc. and Oaktree Acquisition Holdings, L.P. (incorporated by reference to Exhibit 10.4 to the Company's Current Report on Form 8-K (File No. 001-38986), filed with the SEC on January 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1773751/000119312521017838/d108056dex106.htm">Hims &amp; Hers Health, Inc. 2020 Equity Incentive Plan and forms of agreement thereunder (incorporated by reference to Exhibit 10.6 to the Company's Current Report on Form 8-K (File No. 001-38986), filed with the SEC on January 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1773751/000119312521017838/d108056dex107.htm">Form of Hims &amp; Hers Health, Inc. 2020 Employee Stock Purchase Plan (incorporated by reference to Exhibit 10.7 to the Company's Current Report on Form 8-K (File No. 001-38986), filed with the SEC on January 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1773751/000119312521017838/d108056dex1016.htm">Employment Agreement, dated as of January 14, 2021, by and between Hims, Inc. and Melissa Baird (incorporated by reference to Exhibit 10.16 to the Company's Current Report on Form 8-K (File No. 001-38986), filed with the SEC on January 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1773751/000119312521017838/d108056dex1017.htm">Share Exchange Agreement, dated as of January 20, 2021, by and among Hims, Inc., Oaktree Acquisition Corp., Andrew Dudum and the Andrew Dudum 2015 Trust, Date July 2, 2015 (incorporated by reference to Exhibit 10.17 to the Company's Current Report on Form 8-K (File No. 001-38986), filed with the SEC on January 26, 2021).</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hims-20210331x10qxex311.htm">Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i412093a93f204328a33c4602202f8375_4">Table of Contents</a></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:9.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.824%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hims-20210331x10qxex312.htm">Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a).*</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hims-20210331x10qxex321.htm">Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350**</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hims-20210331x10qxex322.htm">Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350**</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase</span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furnished herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(2) of Regulation S-K. A copy of any omitted schedule and/or exhibit will be furnished to the SEC upon request.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denotes management compensatory plan, contract or arrangement.</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div id="i412093a93f204328a33c4602202f8375_136"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 17, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:51.462%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.482%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hims &amp; Hers Health, Inc.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Spencer Lee</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name: Spencer Lee</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title: Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</span></td></tr></table></div><div style="margin-top:12pt;text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>hims-20210331x10qxex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic30a1c9a3eb946f985ae68b725b0096c_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULE 13a-14 AND 15d-14</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Andrew Dudum, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2021 of Hims &#38; Hers Health, Inc.&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the period presented in this report&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c. Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d. Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.317%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May 17, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Andrew Dudum</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Andrew Dudum</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>hims-20210331x10qxex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i83831438cb44487f90d5d0e41abb4248_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO RULE 13a-14 AND 15d-14</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Spencer Lee, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2021 of Hims &#38; Hers Health, Inc.&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the period presented in this report&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c. Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d. Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal controls over financial reporting.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.351%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">Date&#58; May 17, 2021</td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Spencer Lee</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Spencer Lee</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>hims-20210331x10qxex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic88660060e5e484d966d2e62587fc3ed_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. 1350</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)</font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the quarterly report of Hims &#38; Hers Health, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.988%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.166%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May 17, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Andrew Dudum</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; Andrew Dudum</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Executive Officer)</font></td></tr></table><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8195;</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>hims-20210331x10qxex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i813b29b246fd4d4ebed62b0cb18249a3_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div><div><font><br></font></div></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">EXHIBIT 32.2</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. 1350</font></div><div style="text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002)</font></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the quarterly report of Hims &#38; Hers Health, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="text-indent:36pt"><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.585%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May 17, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Spencer Lee</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Name&#58; Spencer Lee</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Title&#58; Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>hims-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:38d399d4-426b-4053-8eef-3989252869db,g:a068c89f-8498-4134-8237-732dcbe50228-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hims="http://forhims.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://forhims.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hims-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hims-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hims-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hims-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://forhims.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://forhims.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited" roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Deficit) (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofMezzanineEquityandStockholdersDeficitUnauditedParenthetical" roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersDeficitUnauditedParenthetical">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Deficit (Unaudited) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlowsUnaudited" roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Organization" roleURI="http://forhims.com/role/Organization">
        <link:definition>2101101 - Disclosure - Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationDetails" roleURI="http://forhims.com/role/OrganizationDetails">
        <link:definition>2402401 - Disclosure - Organization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://forhims.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://forhims.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" roleURI="http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" roleURI="http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Recapitalization" roleURI="http://forhims.com/role/Recapitalization">
        <link:definition>2108103 - Disclosure - Recapitalization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RecapitalizationDetails" roleURI="http://forhims.com/role/RecapitalizationDetails">
        <link:definition>2409404 - Disclosure - Recapitalization (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://forhims.com/role/Investments">
        <link:definition>2110104 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://forhims.com/role/InvestmentsTables">
        <link:definition>2311302 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsShorttermInvestmentsDetails" roleURI="http://forhims.com/role/InvestmentsShorttermInvestmentsDetails">
        <link:definition>2412405 - Disclosure - Investments - Short-term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://forhims.com/role/Inventory">
        <link:definition>2113105 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://forhims.com/role/InventoryTables">
        <link:definition>2314303 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryDetails" roleURI="http://forhims.com/role/InventoryDetails">
        <link:definition>2415406 - Disclosure - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesandOtherCurrentAssets" roleURI="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssets">
        <link:definition>2116106 - Disclosure - Prepaid Expenses and Other Current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesandOtherCurrentAssetsTables" roleURI="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsTables">
        <link:definition>2317304 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PrepaidExpensesandOtherCurrentAssetsDetails" roleURI="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails">
        <link:definition>2418407 - Disclosure - Prepaid Expenses and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilities" roleURI="http://forhims.com/role/AccruedLiabilities">
        <link:definition>2119107 - Disclosure - Accrued Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesTables" roleURI="http://forhims.com/role/AccruedLiabilitiesTables">
        <link:definition>2320305 - Disclosure - Accrued Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedLiabilitiesDetails" roleURI="http://forhims.com/role/AccruedLiabilitiesDetails">
        <link:definition>2421408 - Disclosure - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntities" roleURI="http://forhims.com/role/VariableInterestEntities">
        <link:definition>2122108 - Disclosure - Variable Interest Entities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="VariableInterestEntitiesDetails" roleURI="http://forhims.com/role/VariableInterestEntitiesDetails">
        <link:definition>2423409 - Disclosure - Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://forhims.com/role/FairValueMeasurements">
        <link:definition>2124109 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://forhims.com/role/FairValueMeasurementsTables">
        <link:definition>2325306 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails" roleURI="http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails">
        <link:definition>2426410 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetails" roleURI="http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails">
        <link:definition>2427411 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails" roleURI="http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails">
        <link:definition>2428412 - Disclosure - Fair Value Measurements - Fair Value Assumptions of Private Placement Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails" roleURI="http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails">
        <link:definition>2429413 - Disclosure - Fair Value Measurements - Change in the Fair Value of Warrant Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingArrangements" roleURI="http://forhims.com/role/BorrowingArrangements">
        <link:definition>2130110 - Disclosure - Borrowing Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingArrangementsDetails" roleURI="http://forhims.com/role/BorrowingArrangementsDetails">
        <link:definition>2431414 - Disclosure - Borrowing Arrangements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://forhims.com/role/CommitmentsandContingencies">
        <link:definition>2132111 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesTables" roleURI="http://forhims.com/role/CommitmentandContingenciesTables">
        <link:definition>2333307 - Disclosure - Commitment and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://forhims.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2434415 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails" roleURI="http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails">
        <link:definition>2435416 - Disclosure - Commitment and Contingencies - Future Minimum Lease Commitments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://forhims.com/role/StockBasedCompensation">
        <link:definition>2136112 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://forhims.com/role/StockBasedCompensationTables">
        <link:definition>2337308 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails" roleURI="http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails">
        <link:definition>2438417 - Disclosure - Stock-Based Compensation - 2017 Stock Plan and 2020 Equity Incentive Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockOptionsNarrativeDetails" roleURI="http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails">
        <link:definition>2439418 - Disclosure - Stock-Based Compensation - Stock Options Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationWeightedAverageFairValueAssumptionsDetails" roleURI="http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails">
        <link:definition>2440419 - Disclosure - Stock-Based Compensation - Weighted Average Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationOptionActivityDetails" roleURI="http://forhims.com/role/StockBasedCompensationOptionActivityDetails">
        <link:definition>2441420 - Disclosure - Stock-Based Compensation - Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails" roleURI="http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails">
        <link:definition>2442421 - Disclosure - Stock-Based Compensation - Exercise Price Range of Options Outstanding and Exercisable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRSUsNarrativeDetails" roleURI="http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails">
        <link:definition>2443422 - Disclosure - Stock-Based Compensation - RSUs Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails" roleURI="http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails">
        <link:definition>2444423 - Disclosure - Stock-Based Compensation - RSUs Weighted Average Fair Value Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationRSUsActivityDetails" roleURI="http://forhims.com/role/StockBasedCompensationRSUsActivityDetails">
        <link:definition>2445424 - Disclosure - Stock-Based Compensation - RSUs Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationVendorWarrantsNarrativeDetails" roleURI="http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails">
        <link:definition>2446425 - Disclosure - Stock-Based Compensation - Vendor Warrants Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationVendorWarrantActivityDetails" roleURI="http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails">
        <link:definition>2447426 - Disclosure - Stock-Based Compensation - Vendor Warrant Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails" roleURI="http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails">
        <link:definition>2448427 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Employees and Nonemployees (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStock" roleURI="http://forhims.com/role/RedeemableConvertiblePreferredStock">
        <link:definition>2149113 - Disclosure - Redeemable Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockTables" roleURI="http://forhims.com/role/RedeemableConvertiblePreferredStockTables">
        <link:definition>2350309 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockAdditionalInformationDetails" roleURI="http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails">
        <link:definition>2451428 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails" roleURI="http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails">
        <link:definition>2452429 - Disclosure - Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStock" roleURI="http://forhims.com/role/CommonStock">
        <link:definition>2153114 - Disclosure - Common Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockTables" roleURI="http://forhims.com/role/CommonStockTables">
        <link:definition>2354310 - Disclosure - Common Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockAdditionalInformationDetails" roleURI="http://forhims.com/role/CommonStockAdditionalInformationDetails">
        <link:definition>2455430 - Disclosure - Common Stock - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockPreClosingStockRepurchaseDetails" roleURI="http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails">
        <link:definition>2456431 - Disclosure - Common Stock - Pre-Closing Stock Repurchase (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockMergerTransactionDetails" roleURI="http://forhims.com/role/CommonStockMergerTransactionDetails">
        <link:definition>2457432 - Disclosure - Common Stock - Merger Transaction (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails" roleURI="http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails">
        <link:definition>2458433 - Disclosure - Common Stock - Settlement of Nonrecourse Related-Party Promissory Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockPIPEInvestmentDetails" roleURI="http://forhims.com/role/CommonStockPIPEInvestmentDetails">
        <link:definition>2459434 - Disclosure - Common Stock - PIPE Investment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockPriortoMergerDetails" roleURI="http://forhims.com/role/CommonStockPriortoMergerDetails">
        <link:definition>2460435 - Disclosure - Common Stock - Prior to Merger (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockSubsequenttoMergerDetails" roleURI="http://forhims.com/role/CommonStockSubsequenttoMergerDetails">
        <link:definition>2461436 - Disclosure - Common Stock - Subsequent to Merger (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockScheduleofWarrantsOutstandingDetails" roleURI="http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails">
        <link:definition>2462437 - Disclosure - Common Stock - Schedule of Warrants Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommonStockPublicWarrantTermsDetails" roleURI="http://forhims.com/role/CommonStockPublicWarrantTermsDetails">
        <link:definition>2463438 - Disclosure - Common Stock - Public Warrant Terms (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://forhims.com/role/RelatedPartyTransactions">
        <link:definition>2164115 - Disclosure - Related-Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsDetails" roleURI="http://forhims.com/role/RelatedPartyTransactionsDetails">
        <link:definition>2465439 - Disclosure - Related-Party Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShare" roleURI="http://forhims.com/role/BasicandDilutedNetLossperShare">
        <link:definition>2166116 - Disclosure - Basic and Diluted Net Loss per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShareTables" roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareTables">
        <link:definition>2367311 - Disclosure - Basic and Diluted Net Loss per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShareAdditionalInformationDetails" roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails">
        <link:definition>2468440 - Disclosure - Basic and Diluted Net Loss per Share - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails" roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails">
        <link:definition>2469441 - Disclosure - Basic and Diluted Net Loss per Share - Computation of Basic and Diluted Net Loss per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails" roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails">
        <link:definition>2470442 - Disclosure - Basic and Diluted Net Loss per Share - Schedule of Excluded Antidilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTax" roleURI="http://forhims.com/role/IncomeTax">
        <link:definition>2171117 - Disclosure - Income Tax</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://forhims.com/role/IncomeTaxesDetails">
        <link:definition>2472443 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="hims_CommonStockWarrantsGroupTwoMember" abstract="true" name="CommonStockWarrantsGroupTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_CapitalAgreement2019TrancheTwoMember" abstract="true" name="CapitalAgreement2019TrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_TradeAndOtherReceivablesCurrent" abstract="false" name="TradeAndOtherReceivablesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold" abstract="false" name="ClassOfWarrantOrRightSalePriceRedemptionThreshold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage" abstract="false" name="ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hims_TemporaryEquityStockRepurchasedDuringPeriodShares" abstract="false" name="TemporaryEquityStockRepurchasedDuringPeriodShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_WarrantsAndRightsOutstandingCurrent" abstract="false" name="WarrantsAndRightsOutstandingCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption" abstract="false" name="ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_RedeemableWarrantsMember" abstract="true" name="RedeemableWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement" abstract="false" name="LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hims_BusinessCreditCardMember" abstract="true" name="BusinessCreditCardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_CapitalAgreement2019Member" abstract="true" name="CapitalAgreement2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization" abstract="false" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum" abstract="false" name="ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_HimsOptionAndRSUHoldersMember" abstract="true" name="HimsOptionAndRSUHoldersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_DebtWarrantsMember" abstract="true" name="DebtWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_PublicWarrantsCashRedemptionMember" abstract="true" name="PublicWarrantsCashRedemptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_SeriesSeedPreferredStockMember" abstract="true" name="SeriesSeedPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_DebtInstrumentMaximumBorrowingCapacity" abstract="false" name="DebtInstrumentMaximumBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ChiefExecutiveOfficerAndDirectorMember" abstract="true" name="ChiefExecutiveOfficerAndDirectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_ProceedsFromIssuanceOfTemporaryEquity" abstract="false" name="ProceedsFromIssuanceOfTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_CommonClassFMember" abstract="true" name="CommonClassFMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_CommonClassAAndVMember" abstract="true" name="CommonClassAAndVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_StockIssuedDuringPeriodSharesReverseRecapitalization" abstract="false" name="StockIssuedDuringPeriodSharesReverseRecapitalization" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract" abstract="true" name="ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_MarketingExpenseMember" abstract="true" name="MarketingExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember" abstract="true" name="StockOptionsSubjectToNonrecoursePromissoryNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ExercisePriceRange890To1335Member" abstract="true" name="ExercisePriceRange890To1335Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_NotesReceivableAmountOfPrincipalPaymentCanceled" abstract="false" name="NotesReceivableAmountOfPrincipalPaymentCanceled" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ClassOfWarrantOrRightThresholdTradingDays" abstract="false" name="ClassOfWarrantOrRightThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hims_AffiliatedMedicalGroupsMember" abstract="true" name="AffiliatedMedicalGroupsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_NoncashWarrantExpense" abstract="false" name="NoncashWarrantExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" abstract="false" name="ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_EquityIncentivePlan2020And2017StockPlanMember" abstract="true" name="EquityIncentivePlan2020And2017StockPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hims_ExercisePriceRange1517To2276Member" abstract="true" name="ExercisePriceRange1517To2276Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_CEOAndDirectorMember" abstract="true" name="CEOAndDirectorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ReverseRecapitalizationTransactionCosts" abstract="false" name="ReverseRecapitalizationTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_NumberOfClassesOfCommonStock" abstract="false" name="NumberOfClassesOfCommonStock" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hims_SeriesB1PreferredStockMember" abstract="true" name="SeriesB1PreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_StockIssuedDuringPeriodValueReverseRecapitalization" abstract="false" name="StockIssuedDuringPeriodValueReverseRecapitalization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_RepurchaseOfStockMember" abstract="true" name="RepurchaseOfStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization" abstract="false" name="StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare" abstract="false" name="NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_OperatingLeaseTermOfContract" abstract="false" name="OperatingLeaseTermOfContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_ClassACommonStockWarrantsMember" abstract="true" name="ClassACommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_PublicWarrantsWarrantRedemptionMember" abstract="true" name="PublicWarrantsWarrantRedemptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_CapitalAgreement2019TrancheOneMember" abstract="true" name="CapitalAgreement2019TrancheOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_CommonStockWarrantsGroupOneMember" abstract="true" name="CommonStockWarrantsGroupOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_IncreaseDecreaseInDeferredRent" abstract="false" name="IncreaseDecreaseInDeferredRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_HimsWarrantHoldersMember" abstract="true" name="HimsWarrantHoldersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_SeriesA1PreferredStockMember" abstract="true" name="SeriesA1PreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ClassOfWarrantOrRightExpirationPeriod" abstract="false" name="ClassOfWarrantOrRightExpirationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_WarrantsAssumed" abstract="false" name="WarrantsAssumed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_StockPlan2017Member" abstract="true" name="StockPlan2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" abstract="false" name="ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_TransactionCostsIncurredButNotYetPaid" abstract="false" name="TransactionCostsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_EarnOutAndParentWarrantsMember" abstract="true" name="EarnOutAndParentWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract" abstract="true" name="ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_DebtInstrumentCovenantRequiredCollateralAmount" abstract="false" name="DebtInstrumentCovenantRequiredCollateralAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_June172020GrantTwoMember" abstract="true" name="June172020GrantTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ExercisePriceRange155To233Member" abstract="true" name="ExercisePriceRange155To233Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ScheduleOfReverseRecapitaliztionTable" abstract="true" name="ScheduleOfReverseRecapitaliztionTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="hims_OperatingLeaseRentExpenseAnnualEscalationPercent" abstract="false" name="OperatingLeaseRentExpenseAnnualEscalationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_June172020GrantOneMember" abstract="true" name="June172020GrantOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_RedeemableClassACommonStockMember" abstract="true" name="RedeemableClassACommonStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_NonrecourseRelatedPartyPromissoryNotesMember" abstract="true" name="NonrecourseRelatedPartyPromissoryNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_CommonClassVMember" abstract="true" name="CommonClassVMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_SaleOfStockPutRightPeriod" abstract="false" name="SaleOfStockPutRightPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_HimsIncMember" abstract="true" name="HimsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock" abstract="false" name="OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" abstract="false" name="ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_ClassOfWarrantOrRightRedemptionPricePerShare" abstract="false" name="ClassOfWarrantOrRightRedemptionPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" abstract="false" name="ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization" abstract="false" name="StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_FormerExecutiveOfficerMember" abstract="true" name="FormerExecutiveOfficerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod" abstract="false" name="ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hims_TemporaryEquityIssuedPricePerShare" abstract="false" name="TemporaryEquityIssuedPricePerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired" abstract="false" name="ReverseRecapitalizationPercentageOfVotingInterestsAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hims_ReverseRecapitalizationAbstract" abstract="true" name="ReverseRecapitalizationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" abstract="false" name="ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_RecapitalizationExchangeRatio" abstract="false" name="RecapitalizationExchangeRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="hims_OperationalSupportMember" abstract="true" name="OperationalSupportMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_RecapitalizationContingentConsiderationEquityExchangeRatio" abstract="false" name="RecapitalizationContingentConsiderationEquityExchangeRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalWarrantConversion" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ProceedsFromIssuanceOfCommonStockRecapitalization" abstract="false" name="ProceedsFromIssuanceOfCommonStockRecapitalization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ProceedsFromConversionOfConvertibleSecurities" abstract="false" name="ProceedsFromConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ShareBasedPaymentArrangementNewEmployeeMember" abstract="true" name="ShareBasedPaymentArrangementNewEmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ExercisePriceRange243To365Member" abstract="true" name="ExercisePriceRange243To365Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_SeriesCPreferredStockWarrantsMember" abstract="true" name="SeriesCPreferredStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_VestingOfEarlyExercisedStockOptions" abstract="false" name="VestingOfEarlyExercisedStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_OperatingLeaseRenewalTerm" abstract="false" name="OperatingLeaseRenewalTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" abstract="false" name="ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember" abstract="true" name="ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ReverseRecapitalizationDisclosureTextBlock" abstract="false" name="ReverseRecapitalizationDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="hims_VendorDepositsCurrent" abstract="false" name="VendorDepositsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_VendorWarrantsMember" abstract="true" name="VendorWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_WarrantsIssued" abstract="false" name="WarrantsIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ShareBasedPaymentArrangementCurrentEmployeeMember" abstract="true" name="ShareBasedPaymentArrangementCurrentEmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_PercentageOwnedByLicensedPhysicians" abstract="false" name="PercentageOwnedByLicensedPhysicians" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock" abstract="false" name="ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="hims_ReverseRecapitalizationLineItems" abstract="true" name="ReverseRecapitalizationLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember" abstract="true" name="SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_IdentityVerificationServicesMember" abstract="true" name="IdentityVerificationServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_EarnOutRestrictedStockUnitsMember" abstract="true" name="EarnOutRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_WarrantLiabilityPolicyPolicyTextBlock" abstract="false" name="WarrantLiabilityPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_HimsStockholdersMember" abstract="true" name="HimsStockholdersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_TemporaryEquityTextBlock" abstract="false" name="TemporaryEquityTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_ReclassificationOfDeferredTransactionCosts" abstract="false" name="ReclassificationOfDeferredTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_SeriesB2PreferredStockMember" abstract="true" name="SeriesB2PreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hims_StockForfeitedDuringPeriodShares" abstract="false" name="StockForfeitedDuringPeriodShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_TemporaryEquityStockRepurchasedDuringPeriodValue" abstract="false" name="TemporaryEquityStockRepurchasedDuringPeriodValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_SeriesDPreferredStockWarrantsMember" abstract="true" name="SeriesDPreferredStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays" abstract="false" name="ClassOfWarrantOrRightThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember" abstract="true" name="ShareBasedPaymentArrangementEmployeeExcludingCEOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ReverseCapitalizationContingentConsiderationEquityShares" abstract="false" name="ReverseCapitalizationContingentConsiderationEquityShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hims_EquityIncentivePlan2020Member" abstract="true" name="EquityIncentivePlan2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_PrivatePlacementWarrantsMember" abstract="true" name="PrivatePlacementWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable" abstract="false" name="ClassOfWarrantOrRightRedemptionPeriodAfterExercisable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_RecapitalizationExchangeConversionBasis" abstract="false" name="RecapitalizationExchangeConversionBasis" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="hims_ParentWarrantRestrictedStockUnitsMember" abstract="true" name="ParentWarrantRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ProceedsFromStockOptionsExercisedNetOfRepurchases" abstract="false" name="ProceedsFromStockOptionsExercisedNetOfRepurchases" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_AccruedPayrollCostsCurrent" abstract="false" name="AccruedPayrollCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_EarlyExerciseOfStockOptionsMember" abstract="true" name="EarlyExerciseOfStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ParentWarrantsMember" abstract="true" name="ParentWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate" abstract="false" name="ClassOfWarrantOrRightExercisablePeriodAfterClosingDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hims_PublicWarrantsMember" abstract="true" name="PublicWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_NewAlbanyOhioMember" abstract="true" name="NewAlbanyOhioMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_ConversionOfPreferredStockWarrantsAmountConverted" abstract="false" name="ConversionOfPreferredStockWarrantsAmountConverted" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hims_ExercisePriceRange006To040Member" abstract="true" name="ExercisePriceRange006To040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_RedeemableCommonStockTransactionMember" abstract="true" name="RedeemableCommonStockTransactionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="hims_CommonStockWarrantsMember" abstract="true" name="CommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>hims-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:38d399d4-426b-4053-8eef-3989252869db,g:a068c89f-8498-4134-8237-732dcbe50228-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://forhims.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2f4b01c6-0acd-41b0-9845-e49e46a46766" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ab04ee6b-db24-4e49-bb30-1c0cd251e7bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2f4b01c6-0acd-41b0-9845-e49e46a46766" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ab04ee6b-db24-4e49-bb30-1c0cd251e7bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_096c99ba-b81f-445a-b4e2-0bed784a7d28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2f4b01c6-0acd-41b0-9845-e49e46a46766" xlink:to="loc_us-gaap_InventoryNet_096c99ba-b81f-445a-b4e2-0bed784a7d28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent_d99eddc7-80b4-47fa-b0a3-631431154d9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2f4b01c6-0acd-41b0-9845-e49e46a46766" xlink:to="loc_us-gaap_DeferredCostsCurrent_d99eddc7-80b4-47fa-b0a3-631431154d9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c5697331-ca32-40f8-829e-82b900bb440c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2f4b01c6-0acd-41b0-9845-e49e46a46766" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c5697331-ca32-40f8-829e-82b900bb440c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e7f15778-c089-436c-864a-08d297d3c51a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2f4b01c6-0acd-41b0-9845-e49e46a46766" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_e7f15778-c089-436c-864a-08d297d3c51a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ec80af64-501a-4398-a6e1-88ed8f2c0c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3e20519d-91bb-4962-8cc6-a589afa16d41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ec80af64-501a-4398-a6e1-88ed8f2c0c29" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3e20519d-91bb-4962-8cc6-a589afa16d41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ee2318c9-5f14-4ce4-b9f7-4b6d5e08835d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ec80af64-501a-4398-a6e1-88ed8f2c0c29" xlink:to="loc_us-gaap_CommonStockValue_ee2318c9-5f14-4ce4-b9f7-4b6d5e08835d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a9d4bedd-e44f-42e2-9d3a-65c398eeb304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ec80af64-501a-4398-a6e1-88ed8f2c0c29" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a9d4bedd-e44f-42e2-9d3a-65c398eeb304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1618aa0a-c05e-4559-a43f-6b54fe40aa5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ec80af64-501a-4398-a6e1-88ed8f2c0c29" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1618aa0a-c05e-4559-a43f-6b54fe40aa5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cf6fd642-32c4-48c7-a75d-4f3ab44b6c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1865cb39-e5e8-4953-a390-194bd4d13991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_cf6fd642-32c4-48c7-a75d-4f3ab44b6c6a" xlink:to="loc_us-gaap_AssetsCurrent_1865cb39-e5e8-4953-a390-194bd4d13991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_6c24404b-9a6c-4e49-b2e4-0c32a4adad2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_cf6fd642-32c4-48c7-a75d-4f3ab44b6c6a" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_6c24404b-9a6c-4e49-b2e4-0c32a4adad2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_034a55ea-847a-4739-9a6f-ad103f3d3fbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_cf6fd642-32c4-48c7-a75d-4f3ab44b6c6a" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_034a55ea-847a-4739-9a6f-ad103f3d3fbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d6802352-7407-4676-881e-3d204430483d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_1192d5d5-c06b-41ba-8952-bbe9cd4da4a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d6802352-7407-4676-881e-3d204430483d" xlink:to="loc_us-gaap_AccountsPayableCurrent_1192d5d5-c06b-41ba-8952-bbe9cd4da4a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_503de0d6-1302-4d71-b899-adc790b87727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d6802352-7407-4676-881e-3d204430483d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_503de0d6-1302-4d71-b899-adc790b87727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_391edd91-6747-475c-a516-c5eb0fa2491d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d6802352-7407-4676-881e-3d204430483d" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_391edd91-6747-475c-a516-c5eb0fa2491d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_WarrantsAndRightsOutstandingCurrent_83ed412c-cab2-4d04-9422-0b8df5d7daff" xlink:href="hims-20210331.xsd#hims_WarrantsAndRightsOutstandingCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_d6802352-7407-4676-881e-3d204430483d" xlink:to="loc_hims_WarrantsAndRightsOutstandingCurrent_83ed412c-cab2-4d04-9422-0b8df5d7daff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_164ee145-0e1a-44e0-8c8a-80f3c88cafe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_530aeadb-097f-40fc-8b81-e5c665d6f6f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_164ee145-0e1a-44e0-8c8a-80f3c88cafe9" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_530aeadb-097f-40fc-8b81-e5c665d6f6f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_42b7fa83-ac92-4239-94b6-2119e596093c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_164ee145-0e1a-44e0-8c8a-80f3c88cafe9" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_42b7fa83-ac92-4239-94b6-2119e596093c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d1bb3d31-521d-4417-91a0-d2d709999f85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_164ee145-0e1a-44e0-8c8a-80f3c88cafe9" xlink:to="loc_us-gaap_LiabilitiesCurrent_d1bb3d31-521d-4417-91a0-d2d709999f85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_c27804aa-2d3f-41e1-ae60-c82752b65284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e36c128c-cc0d-4cf6-996e-cde90605b326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c27804aa-2d3f-41e1-ae60-c82752b65284" xlink:to="loc_us-gaap_StockholdersEquity_e36c128c-cc0d-4cf6-996e-cde90605b326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_9d921878-dbd5-4c8b-920f-c5cbbfd010d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c27804aa-2d3f-41e1-ae60-c82752b65284" xlink:to="loc_us-gaap_CommitmentsAndContingencies_9d921878-dbd5-4c8b-920f-c5cbbfd010d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_cb3aa870-de74-4f87-a72e-739a90149691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c27804aa-2d3f-41e1-ae60-c82752b65284" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_cb3aa870-de74-4f87-a72e-739a90149691" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_14a15157-83b4-4703-a475-18d4e852c6a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_c27804aa-2d3f-41e1-ae60-c82752b65284" xlink:to="loc_us-gaap_Liabilities_14a15157-83b4-4703-a475-18d4e852c6a0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"/>
  <link:calculationLink xlink:role="http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_0e02b57a-38e4-4e3f-b65b-62727d1e1841" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_614f8f0f-d238-4011-85e8-a0d0cf61a130" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0e02b57a-38e4-4e3f-b65b-62727d1e1841" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_614f8f0f-d238-4011-85e8-a0d0cf61a130" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_d7d18cf2-1271-40e3-8567-2caef9be006b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_0e02b57a-38e4-4e3f-b65b-62727d1e1841" xlink:to="loc_us-gaap_CostOfRevenue_d7d18cf2-1271-40e3-8567-2caef9be006b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a22c9562-d1e9-4732-9741-c4d97df9f21f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_754aedfa-4330-4f52-a96e-06c4bef54401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a22c9562-d1e9-4732-9741-c4d97df9f21f" xlink:to="loc_us-gaap_NetIncomeLoss_754aedfa-4330-4f52-a96e-06c4bef54401" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ffe177d4-e73f-495e-bfc6-8e4cfb65753e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a22c9562-d1e9-4732-9741-c4d97df9f21f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ffe177d4-e73f-495e-bfc6-8e4cfb65753e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_01386d91-0044-44e6-a53b-d691b658c5b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c575b008-6316-44c9-ba7b-739ca96448ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01386d91-0044-44e6-a53b-d691b658c5b5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c575b008-6316-44c9-ba7b-739ca96448ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3acb8e77-9102-4ce0-a848-74c34b27c011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_01386d91-0044-44e6-a53b-d691b658c5b5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3acb8e77-9102-4ce0-a848-74c34b27c011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8f31eda3-66f1-4a0f-ab1b-23c17873d6e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingExpense_3349f84a-ccc3-4109-a9fa-4c47ce52a63c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8f31eda3-66f1-4a0f-ab1b-23c17873d6e8" xlink:to="loc_us-gaap_MarketingExpense_3349f84a-ccc3-4109-a9fa-4c47ce52a63c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d2ad001d-75ee-4a25-b503-fd9053e83835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8f31eda3-66f1-4a0f-ab1b-23c17873d6e8" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_d2ad001d-75ee-4a25-b503-fd9053e83835" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_623431b4-165a-4f31-9e12-7b8ddee1db8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_8f0a22dc-64e4-442d-9ab8-1f33095e119a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_623431b4-165a-4f31-9e12-7b8ddee1db8a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_8f0a22dc-64e4-442d-9ab8-1f33095e119a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_aba5c259-4692-4f4a-ac6a-a09e16fb4865" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_623431b4-165a-4f31-9e12-7b8ddee1db8a" xlink:to="loc_us-gaap_OperatingIncomeLoss_aba5c259-4692-4f4a-ac6a-a09e16fb4865" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_036d9154-7ac9-4436-9406-1403915b4361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_623431b4-165a-4f31-9e12-7b8ddee1db8a" xlink:to="loc_us-gaap_InterestExpense_036d9154-7ac9-4436-9406-1403915b4361" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:calculationLink xlink:role="http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_df837aab-756f-4fef-8970-e85d5fb32cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1a547a3f-941b-4ffb-986e-10110e311294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_df837aab-756f-4fef-8970-e85d5fb32cca" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1a547a3f-941b-4ffb-986e-10110e311294" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware_e9a4bf1b-a4bc-4ad0-bd62-b75c83c8dc18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForSoftware"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_df837aab-756f-4fef-8970-e85d5fb32cca" xlink:to="loc_us-gaap_PaymentsForSoftware_e9a4bf1b-a4bc-4ad0-bd62-b75c83c8dc18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_16b76150-031f-4e01-9152-09488286f026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_df837aab-756f-4fef-8970-e85d5fb32cca" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_16b76150-031f-4e01-9152-09488286f026" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_78cc50b8-1258-44dd-a197-77ddba33f326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_df837aab-756f-4fef-8970-e85d5fb32cca" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_78cc50b8-1258-44dd-a197-77ddba33f326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_fc67ee56-b44f-4cba-8ef1-e2a0980a21d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_df837aab-756f-4fef-8970-e85d5fb32cca" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_fc67ee56-b44f-4cba-8ef1-e2a0980a21d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d91866b2-41d6-4e30-ad95-5f3733423bda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_NetIncomeLoss_d91866b2-41d6-4e30-ad95-5f3733423bda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_014b7e43-c608-4c47-ae4f-43bfb1b16afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_014b7e43-c608-4c47-ae4f-43bfb1b16afb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_75c2ddab-eaaf-4b45-8e9c-8b588a372608" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_75c2ddab-eaaf-4b45-8e9c-8b588a372608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2fd812d4-9909-4ace-a53e-69ea3e2f73a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2fd812d4-9909-4ace-a53e-69ea3e2f73a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_067973c7-5dd0-4473-bb3a-15ea28282c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_067973c7-5dd0-4473-bb3a-15ea28282c9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NoncashWarrantExpense_2761c4d2-1e18-4d2f-b1e3-651767581bb5" xlink:href="hims-20210331.xsd#hims_NoncashWarrantExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_hims_NoncashWarrantExpense_2761c4d2-1e18-4d2f-b1e3-651767581bb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_IncreaseDecreaseInDeferredRent_735fb16f-e716-4c95-a712-bddafb440c49" xlink:href="hims-20210331.xsd#hims_IncreaseDecreaseInDeferredRent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_hims_IncreaseDecreaseInDeferredRent_735fb16f-e716-4c95-a712-bddafb440c49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_aea0a78f-fc9c-474f-a723-4ffc2b089469" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_aea0a78f-fc9c-474f-a723-4ffc2b089469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_810483aa-342b-4e83-84d4-188dfd9c0791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_810483aa-342b-4e83-84d4-188dfd9c0791" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_197077e5-5099-4289-9fb3-f0c462e4f997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_197077e5-5099-4289-9fb3-f0c462e4f997" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_88caba15-bfca-4bfd-a43f-249413444c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_ShareBasedCompensation_88caba15-bfca-4bfd-a43f-249413444c03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8eafe2eb-d021-4dfe-adaf-ce242fa94fa8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8eafe2eb-d021-4dfe-adaf-ce242fa94fa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b9ef2a41-8655-4810-a52b-51676b8b0193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b9ef2a41-8655-4810-a52b-51676b8b0193" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_e39b755d-5250-4a01-a646-f39b1653f964" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_16be1102-8437-42a2-8db5-52a979f540c3" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_e39b755d-5250-4a01-a646-f39b1653f964" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5085eb75-daf8-4bcc-9cc1-bd888a857d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e72ef360-7af1-4119-b359-729833f29c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5085eb75-daf8-4bcc-9cc1-bd888a857d21" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_e72ef360-7af1-4119-b359-729833f29c60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e265054-cffa-4e8b-bf7d-9911254b4a40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5085eb75-daf8-4bcc-9cc1-bd888a857d21" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0e265054-cffa-4e8b-bf7d-9911254b4a40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9a4f8d2b-b2f8-40e6-aa4a-6384188a6f46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5085eb75-daf8-4bcc-9cc1-bd888a857d21" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9a4f8d2b-b2f8-40e6-aa4a-6384188a6f46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_235e1aa8-ebac-450c-86f4-1965e7c209c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_5085eb75-daf8-4bcc-9cc1-bd888a857d21" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_235e1aa8-ebac-450c-86f4-1965e7c209c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_402fb743-95bd-496c-b154-67c8d257fab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_fe04b14d-37e5-4e2a-adf3-45d8b5c82701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_402fb743-95bd-496c-b154-67c8d257fab2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_fe04b14d-37e5-4e2a-adf3-45d8b5c82701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_ce89b1f1-adac-4ccf-af05-20163aae5e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_402fb743-95bd-496c-b154-67c8d257fab2" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_ce89b1f1-adac-4ccf-af05-20163aae5e3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2d51ebc4-e48c-4b1e-b411-de50d4dd46f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_402fb743-95bd-496c-b154-67c8d257fab2" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_2d51ebc4-e48c-4b1e-b411-de50d4dd46f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_59b11490-793f-4695-b9ea-f300d1772a59" xlink:href="hims-20210331.xsd#hims_ProceedsFromIssuanceOfCommonStockRecapitalization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_402fb743-95bd-496c-b154-67c8d257fab2" xlink:to="loc_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_59b11490-793f-4695-b9ea-f300d1772a59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_12b28266-6e3f-4855-8e83-290a908ae9fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_402fb743-95bd-496c-b154-67c8d257fab2" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_12b28266-6e3f-4855-8e83-290a908ae9fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_6808dfcd-c847-45c1-b924-c88183849703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_402fb743-95bd-496c-b154-67c8d257fab2" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_6808dfcd-c847-45c1-b924-c88183849703" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_08df159f-0e04-4c0b-b1f3-5ff708950474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_402fb743-95bd-496c-b154-67c8d257fab2" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_08df159f-0e04-4c0b-b1f3-5ff708950474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases_8261c71a-fefe-43e3-8193-2312e7b5f148" xlink:href="hims-20210331.xsd#hims_ProceedsFromStockOptionsExercisedNetOfRepurchases"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_402fb743-95bd-496c-b154-67c8d257fab2" xlink:to="loc_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases_8261c71a-fefe-43e3-8193-2312e7b5f148" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_5ec6f373-359f-4bc8-9827-72f9cb5efc02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_402fb743-95bd-496c-b154-67c8d257fab2" xlink:to="loc_us-gaap_RepaymentsOfDebt_5ec6f373-359f-4bc8-9827-72f9cb5efc02" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://forhims.com/role/InvestmentsShorttermInvestmentsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#InvestmentsShorttermInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://forhims.com/role/InvestmentsShorttermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4cb8aa07-48bd-4527-a4b8-27c00594ffb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5b01fb86-4718-42aa-95d1-79553b5ad277" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4cb8aa07-48bd-4527-a4b8-27c00594ffb8" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5b01fb86-4718-42aa-95d1-79553b5ad277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2ab81293-7db2-45d6-9926-bccd88dba573" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4cb8aa07-48bd-4527-a4b8-27c00594ffb8" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2ab81293-7db2-45d6-9926-bccd88dba573" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_473eb5d7-4d33-4975-a610-52449f90607a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4cb8aa07-48bd-4527-a4b8-27c00594ffb8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_473eb5d7-4d33-4975-a610-52449f90607a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://forhims.com/role/InventoryDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#InventoryDetails"/>
  <link:calculationLink xlink:role="http://forhims.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c9f2741f-5833-45cb-a410-a3bc50416db3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_6ca6c34d-7794-4391-823e-1c7509421b39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c9f2741f-5833-45cb-a410-a3bc50416db3" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_6ca6c34d-7794-4391-823e-1c7509421b39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_cd2e1c61-3841-4af5-9565-1fdc70a1c25d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_c9f2741f-5833-45cb-a410-a3bc50416db3" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_cd2e1c61-3841-4af5-9565-1fdc70a1c25d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#PrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_69d8132f-da00-46a6-b45a-d2c33ff2c33a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TradeAndOtherReceivablesCurrent_3f039810-69ac-41f8-852d-e8265514c745" xlink:href="hims-20210331.xsd#hims_TradeAndOtherReceivablesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_69d8132f-da00-46a6-b45a-d2c33ff2c33a" xlink:to="loc_hims_TradeAndOtherReceivablesCurrent_3f039810-69ac-41f8-852d-e8265514c745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_c40ad200-568e-4ebd-9549-69b975d6de75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_69d8132f-da00-46a6-b45a-d2c33ff2c33a" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_c40ad200-568e-4ebd-9549-69b975d6de75" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorDepositsCurrent_448c05b6-d460-41d3-8fd3-59ebf5dc08b1" xlink:href="hims-20210331.xsd#hims_VendorDepositsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_69d8132f-da00-46a6-b45a-d2c33ff2c33a" xlink:to="loc_hims_VendorDepositsCurrent_448c05b6-d460-41d3-8fd3-59ebf5dc08b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b6cd9002-ddb7-402d-9f8f-d5312a144978" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_69d8132f-da00-46a6-b45a-d2c33ff2c33a" xlink:to="loc_us-gaap_OtherAssetsCurrent_b6cd9002-ddb7-402d-9f8f-d5312a144978" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://forhims.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://forhims.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_cabfdeb8-beac-4608-b04a-15a3d7b71206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositLiabilityCurrent_8973d02d-47aa-4ce7-85ad-7a7817d55a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_cabfdeb8-beac-4608-b04a-15a3d7b71206" xlink:to="loc_us-gaap_DepositLiabilityCurrent_8973d02d-47aa-4ce7-85ad-7a7817d55a41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_816d8fdb-cb44-407b-a02f-9fff475ab856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_cabfdeb8-beac-4608-b04a-15a3d7b71206" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_816d8fdb-cb44-407b-a02f-9fff475ab856" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_80fd1a96-2229-4679-a4c1-6b68daa441a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_cabfdeb8-beac-4608-b04a-15a3d7b71206" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_80fd1a96-2229-4679-a4c1-6b68daa441a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AccruedPayrollCostsCurrent_309be3a1-bae5-48dc-95e2-aaa4ad4a10b2" xlink:href="hims-20210331.xsd#hims_AccruedPayrollCostsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_cabfdeb8-beac-4608-b04a-15a3d7b71206" xlink:to="loc_hims_AccruedPayrollCostsCurrent_309be3a1-bae5-48dc-95e2-aaa4ad4a10b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_cd7653c4-b88c-403f-a725-4deccd8ab3a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_cabfdeb8-beac-4608-b04a-15a3d7b71206" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_cd7653c4-b88c-403f-a725-4deccd8ab3a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_8adbbb76-ae95-4045-ba9b-fd293f7974d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_cabfdeb8-beac-4608-b04a-15a3d7b71206" xlink:to="loc_us-gaap_TaxesPayableCurrent_8adbbb76-ae95-4045-ba9b-fd293f7974d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7f6070a2-99d2-4d46-bdb3-cb2911b0c0bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_23b95c6e-e188-4247-b9d5-6a30fab8615e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_7f6070a2-99d2-4d46-bdb3-cb2911b0c0bd" xlink:to="loc_us-gaap_ShortTermInvestments_23b95c6e-e188-4247-b9d5-6a30fab8615e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_8906efa7-3611-497e-b7bc-9817e698cd7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_7f6070a2-99d2-4d46-bdb3-cb2911b0c0bd" xlink:to="loc_us-gaap_RestrictedCash_8906efa7-3611-497e-b7bc-9817e698cd7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6a35ceb7-bb50-4b96-933e-7d835c360357" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_7f6070a2-99d2-4d46-bdb3-cb2911b0c0bd" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_6a35ceb7-bb50-4b96-933e-7d835c360357" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_75e0b363-fdd2-4632-aa56-1b4d623df651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_bf8d6953-3aee-41dd-bfbc-78f99c140ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_75e0b363-fdd2-4632-aa56-1b4d623df651" xlink:to="loc_us-gaap_DerivativeLiabilities_bf8d6953-3aee-41dd-bfbc-78f99c140ae8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails"/>
  <link:calculationLink xlink:role="http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_70fe51b5-e911-4fe8-8b82-37ad18853597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_6953b513-738c-4a44-af8c-cb813faa9d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_70fe51b5-e911-4fe8-8b82-37ad18853597" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_6953b513-738c-4a44-af8c-cb813faa9d3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_e67e3d2d-972a-462a-b736-11ab821c0948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_70fe51b5-e911-4fe8-8b82-37ad18853597" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_e67e3d2d-972a-462a-b736-11ab821c0948" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_bbfa3766-0202-42a0-bcfc-43257b1106c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_70fe51b5-e911-4fe8-8b82-37ad18853597" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_bbfa3766-0202-42a0-bcfc-43257b1106c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_c03323f0-ef4f-4187-8fb1-5835a574d0bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_70fe51b5-e911-4fe8-8b82-37ad18853597" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_c03323f0-ef4f-4187-8fb1-5835a574d0bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_5f45ad03-3da5-4b5d-a70c-975367f90eff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_70fe51b5-e911-4fe8-8b82-37ad18853597" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_5f45ad03-3da5-4b5d-a70c-975367f90eff" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>hims-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:38d399d4-426b-4053-8eef-3989252869db,g:a068c89f-8498-4134-8237-732dcbe50228-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://forhims.com/role/Cover" xlink:type="simple" xlink:href="hims-20210331.xsd#Cover"/>
  <link:definitionLink xlink:role="http://forhims.com/role/Cover" xlink:type="extended" id="i136c8278406340bcb885ae9d6d3d0c97_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6abb3818-f456-4fc2-b557-8d956c726ab6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentType_6abb3818-f456-4fc2-b557-8d956c726ab6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_be7f184d-94e7-477f-933e-aeaade501bfc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentQuarterlyReport_be7f184d-94e7-477f-933e-aeaade501bfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_07e0a2da-52df-4dd3-a7dd-4ab0a2412bc8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentPeriodEndDate_07e0a2da-52df-4dd3-a7dd-4ab0a2412bc8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5aba434f-2798-449a-b57f-61628f6feb15" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentTransitionReport_5aba434f-2798-449a-b57f-61628f6feb15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2d903863-3bfc-405c-8178-7e1c8c35ba16" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityRegistrantName_2d903863-3bfc-405c-8178-7e1c8c35ba16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6bc8b721-d02a-4a22-91a4-49f0a5beb572" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6bc8b721-d02a-4a22-91a4-49f0a5beb572" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_709d9040-9c38-4b60-97ed-5411ba1e5dec" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityFileNumber_709d9040-9c38-4b60-97ed-5411ba1e5dec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b3b0c6d5-95e4-4ee0-89ac-05ad6dc36276" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityTaxIdentificationNumber_b3b0c6d5-95e4-4ee0-89ac-05ad6dc36276" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a551a587-6b0a-4df6-a358-db2ff418684c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityAddressAddressLine1_a551a587-6b0a-4df6-a358-db2ff418684c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_907f716b-c2bd-4419-9d60-334aac6774f7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityAddressCityOrTown_907f716b-c2bd-4419-9d60-334aac6774f7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_86356569-5b4b-4789-8547-2950605550aa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityAddressStateOrProvince_86356569-5b4b-4789-8547-2950605550aa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_22a194ea-092e-45cc-809e-949d727cfdab" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityAddressPostalZipCode_22a194ea-092e-45cc-809e-949d727cfdab" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e120d096-7012-4be7-95ab-5bf3141d88b4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_CityAreaCode_e120d096-7012-4be7-95ab-5bf3141d88b4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_bc9bd5e3-44ce-4900-b630-ad7fd3436133" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_LocalPhoneNumber_bc9bd5e3-44ce-4900-b630-ad7fd3436133" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f7f97493-8b60-4889-a7a3-b44aa30ea6be" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_Security12bTitle_f7f97493-8b60-4889-a7a3-b44aa30ea6be" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_77eb457b-cbc4-4ab4-b518-c2348e972141" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_TradingSymbol_77eb457b-cbc4-4ab4-b518-c2348e972141" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9c3537a2-9c68-4dd6-bb24-cf98c60cef18" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_SecurityExchangeName_9c3537a2-9c68-4dd6-bb24-cf98c60cef18" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b7519347-0138-4e3c-8ccb-016c4e8656f7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityCurrentReportingStatus_b7519347-0138-4e3c-8ccb-016c4e8656f7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7a13feb1-8ff9-4bf6-ac60-26f14d0ec3b9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityInteractiveDataCurrent_7a13feb1-8ff9-4bf6-ac60-26f14d0ec3b9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6ab41910-ba70-4131-9f60-c5f1dba91e5c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityFilerCategory_6ab41910-ba70-4131-9f60-c5f1dba91e5c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_5f1b6f25-1ecb-4def-8c46-d63bcd6e3f16" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntitySmallBusiness_5f1b6f25-1ecb-4def-8c46-d63bcd6e3f16" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_640a5222-176d-4236-9d1d-60351fd2d154" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityEmergingGrowthCompany_640a5222-176d-4236-9d1d-60351fd2d154" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_7890d472-2494-4cfc-8a5b-98f75fb61930" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityExTransitionPeriod_7890d472-2494-4cfc-8a5b-98f75fb61930" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8af4d932-d9d2-477a-9ed8-a664c0468c72" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityShellCompany_8af4d932-d9d2-477a-9ed8-a664c0468c72" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b2e90bb6-eb47-44b3-9923-1aeefaded63c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b2e90bb6-eb47-44b3-9923-1aeefaded63c" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4b43bf8f-ca4b-4421-bb84-2ecc67dc2800" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_AmendmentFlag_4b43bf8f-ca4b-4421-bb84-2ecc67dc2800" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d812c793-333d-45fc-a8cf-82698965f561" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentFiscalYearFocus_d812c793-333d-45fc-a8cf-82698965f561" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_69701fde-7b6c-4d88-ba08-8f684cb7e5b9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_69701fde-7b6c-4d88-ba08-8f684cb7e5b9" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2db69062-62b9-43e7-8daa-9742f89463e6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityCentralIndexKey_2db69062-62b9-43e7-8daa-9742f89463e6" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_abab3bc6-4d44-4d3b-8e8d-15394f20e76d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_CurrentFiscalYearEndDate_abab3bc6-4d44-4d3b-8e8d-15394f20e76d" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_5b9fa430-c032-4694-ac5c-4f47a583fd01" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentInformationTable_5b9fa430-c032-4694-ac5c-4f47a583fd01" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7d09313e-9524-4a2c-8fae-d125c9ca34a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_5b9fa430-c032-4694-ac5c-4f47a583fd01" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7d09313e-9524-4a2c-8fae-d125c9ca34a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7d09313e-9524-4a2c-8fae-d125c9ca34a2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7d09313e-9524-4a2c-8fae-d125c9ca34a2" xlink:to="loc_us-gaap_ClassOfStockDomain_7d09313e-9524-4a2c-8fae-d125c9ca34a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2f9f0faa-88fe-4299-af34-3136f79cc7e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7d09313e-9524-4a2c-8fae-d125c9ca34a2" xlink:to="loc_us-gaap_ClassOfStockDomain_2f9f0faa-88fe-4299-af34-3136f79cc7e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_5cd585a5-d9c0-4b23-9f51-6e7b1fbd83c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2f9f0faa-88fe-4299-af34-3136f79cc7e6" xlink:to="loc_us-gaap_CommonClassAMember_5cd585a5-d9c0-4b23-9f51-6e7b1fbd83c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableWarrantsMember_0aa57ea1-5987-450c-8c84-25c00039180f" xlink:href="hims-20210331.xsd#hims_RedeemableWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2f9f0faa-88fe-4299-af34-3136f79cc7e6" xlink:to="loc_hims_RedeemableWarrantsMember_0aa57ea1-5987-450c-8c84-25c00039180f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember_c0199615-172b-4f50-ad18-f6047ac62974" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_2f9f0faa-88fe-4299-af34-3136f79cc7e6" xlink:to="loc_hims_CommonClassVMember_c0199615-172b-4f50-ad18-f6047ac62974" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="ie190727840234c1e9eee1405a72c092a_CondensedConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c4dd6a15-e6e2-4bf5-8460-9338dc51e3eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c4dd6a15-e6e2-4bf5-8460-9338dc51e3eb" xlink:to="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_e753d47e-6754-4416-b0a6-37eb379cae5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_e753d47e-6754-4416-b0a6-37eb379cae5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_b4a860f1-66d7-41cc-bb48-f763054f591b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_b4a860f1-66d7-41cc-bb48-f763054f591b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_a6a999b7-85af-4c6a-ad9d-1a58c3a4d870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_a6a999b7-85af-4c6a-ad9d-1a58c3a4d870" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_b2c6129e-4107-4966-8607-081e02678337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_b2c6129e-4107-4966-8607-081e02678337" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_cb62c856-90ac-469a-aab8-dd6888f8f08b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_cb62c856-90ac-469a-aab8-dd6888f8f08b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_c4dd6a15-e6e2-4bf5-8460-9338dc51e3eb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_893ef703-a721-4b45-9826-6d41f7c4fa28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_893ef703-a721-4b45-9826-6d41f7c4fa28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_339f38f7-0e13-4f5e-8b3d-deed2dc41118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_339f38f7-0e13-4f5e-8b3d-deed2dc41118" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f61a1d32-e594-41ae-bd8e-e7f4170c928c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:to="loc_us-gaap_CommonStockSharesIssued_f61a1d32-e594-41ae-bd8e-e7f4170c928c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6071fb4a-b93f-46a4-8aa6-3a7614e34bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6071fb4a-b93f-46a4-8aa6-3a7614e34bcc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_220d7f71-1343-4eee-9fbc-21f9c07e36c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_c4dd6a15-e6e2-4bf5-8460-9338dc51e3eb" xlink:to="loc_us-gaap_StatementTable_220d7f71-1343-4eee-9fbc-21f9c07e36c0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_de6e6261-e98b-4875-b625-363f29ddaa0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_220d7f71-1343-4eee-9fbc-21f9c07e36c0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_de6e6261-e98b-4875-b625-363f29ddaa0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_de6e6261-e98b-4875-b625-363f29ddaa0d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_de6e6261-e98b-4875-b625-363f29ddaa0d" xlink:to="loc_us-gaap_ClassOfStockDomain_de6e6261-e98b-4875-b625-363f29ddaa0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b61602bd-016f-4b42-ada1-bc8ace341a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_de6e6261-e98b-4875-b625-363f29ddaa0d" xlink:to="loc_us-gaap_ClassOfStockDomain_b61602bd-016f-4b42-ada1-bc8ace341a0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_1a26f026-49db-41c0-8d35-16f928bc3574" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b61602bd-016f-4b42-ada1-bc8ace341a0e" xlink:to="loc_us-gaap_CommonClassAMember_1a26f026-49db-41c0-8d35-16f928bc3574" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember_83781898-c411-4eac-9693-d4250b966061" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b61602bd-016f-4b42-ada1-bc8ace341a0e" xlink:to="loc_hims_CommonClassVMember_83781898-c411-4eac-9693-d4250b966061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassFMember_5e2b3781-6a6a-4501-b114-c6295f1445e5" xlink:href="hims-20210331.xsd#hims_CommonClassFMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b61602bd-016f-4b42-ada1-bc8ace341a0e" xlink:to="loc_hims_CommonClassFMember_5e2b3781-6a6a-4501-b114-c6295f1445e5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited" xlink:type="extended" id="i03f67e9eb52a423ba40ffe224adad01b_CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b943b7ab-1985-437f-8bf9-4bbc9ad2e9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b943b7ab-1985-437f-8bf9-4bbc9ad2e9b2" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2cfee623-cab5-4bc0-95df-19b988cd2af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2cfee623-cab5-4bc0-95df-19b988cd2af3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_933fc064-c0f7-4ab1-9930-859b89355455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_933fc064-c0f7-4ab1-9930-859b89355455" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodShares_f2f6bf8c-cdac-43af-afba-dcf9fedc8def" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodShares_f2f6bf8c-cdac-43af-afba-dcf9fedc8def" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodValue_e978b341-5ec2-4e0d-833a-4e3269770cd8" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodValue_e978b341-5ec2-4e0d-833a-4e3269770cd8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_df91cd3d-2972-4d93-8d8d-d3f446f78795" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_df91cd3d-2972-4d93-8d8d-d3f446f78795" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_aeefa45e-59d7-4a83-9edc-c6740ebadb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_aeefa45e-59d7-4a83-9edc-c6740ebadb5d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4c177e1b-8a3b-40b0-8301-0b7325a5994a" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4c177e1b-8a3b-40b0-8301-0b7325a5994a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_4fe59916-80c9-4dc3-a99c-510d3754d482" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_4fe59916-80c9-4dc3-a99c-510d3754d482" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_371fa9e6-bcb4-4705-9a10-393745eadc28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1b2ba55c-1a57-4f10-8b62-57f0605d7bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_b943b7ab-1985-437f-8bf9-4bbc9ad2e9b2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2404a7f6-ffa9-4ed3-a609-0c888a546d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_SharesOutstanding_2404a7f6-ffa9-4ed3-a609-0c888a546d7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c4a849dc-b570-411c-a12b-d51aacb04934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockholdersEquity_c4a849dc-b570-411c-a12b-d51aacb04934" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_6914510f-ea6f-4a61-8db1-72db553d2877" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_6914510f-ea6f-4a61-8db1-72db553d2877" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_4a6cb6cc-f234-45cc-ac2f-57981f0cab88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_4a6cb6cc-f234-45cc-ac2f-57981f0cab88" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_0f796fe3-f5c6-4a54-a6e1-8ab1cf5f8059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_0f796fe3-f5c6-4a54-a6e1-8ab1cf5f8059" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_98154cb8-fd47-4ffb-a8c5-692f9b24c616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_98154cb8-fd47-4ffb-a8c5-692f9b24c616" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment_9e18db4c-78ea-4eba-85d0-190692e039dc" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment_9e18db4c-78ea-4eba-85d0-190692e039dc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockForfeitedDuringPeriodShares_f8da6808-479e-4d77-a971-b7b624e0a1b5" xlink:href="hims-20210331.xsd#hims_StockForfeitedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_StockForfeitedDuringPeriodShares_f8da6808-479e-4d77-a971-b7b624e0a1b5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion_c0d49b94-cb02-40f7-a5aa-f57d4fe216f6" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion_c0d49b94-cb02-40f7-a5aa-f57d4fe216f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodSharesReverseRecapitalization_c00da11a-c93c-4ca1-b058-953fb13d06fa" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodSharesReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_StockIssuedDuringPeriodSharesReverseRecapitalization_c00da11a-c93c-4ca1-b058-953fb13d06fa" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodValueReverseRecapitalization_53db7047-4b17-4ff5-97db-7ff686544937" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodValueReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_StockIssuedDuringPeriodValueReverseRecapitalization_53db7047-4b17-4ff5-97db-7ff686544937" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_997e1280-ca10-4b4a-bd66-4f5e60831cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_997e1280-ca10-4b4a-bd66-4f5e60831cdd" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_18d85dc5-f398-4a4e-a8fe-fa6b5fb5d5ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_18d85dc5-f398-4a4e-a8fe-fa6b5fb5d5ba" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization_d0f70d35-a618-495b-9ae3-99764ccf2385" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization_d0f70d35-a618-495b-9ae3-99764ccf2385" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization_df731353-44f6-456c-837c-dad28f76016b" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization_df731353-44f6-456c-837c-dad28f76016b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b6c9a5c6-6357-4c6e-83eb-b6199ebe5b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b6c9a5c6-6357-4c6e-83eb-b6199ebe5b84" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_82110587-1376-406e-8f00-470f25354cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_82110587-1376-406e-8f00-470f25354cbe" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod_c494bb9e-7fd1-41f0-aa9d-62f60d621522" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod_c494bb9e-7fd1-41f0-aa9d-62f60d621522" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested_7811a199-25ee-4fda-85cb-859641c03c40" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested_7811a199-25ee-4fda-85cb-859641c03c40" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c317debd-21be-42af-be15-9922a8ec5bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c317debd-21be-42af-be15-9922a8ec5bc9" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense_ded88227-6d2d-4f26-ae87-1038899533b4" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense_ded88227-6d2d-4f26-ae87-1038899533b4" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3fb0dbca-a16c-4a06-8d9f-14256c03e84f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3fb0dbca-a16c-4a06-8d9f-14256c03e84f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3db1cee4-e54f-4a1e-b1d5-24f8c7c26690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3db1cee4-e54f-4a1e-b1d5-24f8c7c26690" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_834a6dec-7905-4379-bc86-6ce0a7b4c209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_NetIncomeLoss_834a6dec-7905-4379-bc86-6ce0a7b4c209" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_104935bc-c9ab-4866-a5f5-40d01e471686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b4632ed7-5a16-4c00-a520-4bcf5cd4417a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_b943b7ab-1985-437f-8bf9-4bbc9ad2e9b2" xlink:to="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_1109aff2-10e1-4755-b198-c867fc00cb3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_srt_RestatementAxis_1109aff2-10e1-4755-b198-c867fc00cb3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_1109aff2-10e1-4755-b198-c867fc00cb3b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_1109aff2-10e1-4755-b198-c867fc00cb3b" xlink:to="loc_srt_RestatementDomain_1109aff2-10e1-4755-b198-c867fc00cb3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_4469ddb4-1828-4229-b333-d70e3f60b03b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_1109aff2-10e1-4755-b198-c867fc00cb3b" xlink:to="loc_srt_RestatementDomain_4469ddb4-1828-4229-b333-d70e3f60b03b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_b43af271-a8d4-47f1-a8c1-a46bd74b6228" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_4469ddb4-1828-4229-b333-d70e3f60b03b" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_b43af271-a8d4-47f1-a8c1-a46bd74b6228" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_a1ce46a9-cb2e-4d87-8122-b2d53b306639" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_4469ddb4-1828-4229-b333-d70e3f60b03b" xlink:to="loc_srt_RestatementAdjustmentMember_a1ce46a9-cb2e-4d87-8122-b2d53b306639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a3602a40-d98c-4bbb-9430-4ae81b4ee993" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a3602a40-d98c-4bbb-9430-4ae81b4ee993" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a3602a40-d98c-4bbb-9430-4ae81b4ee993_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a3602a40-d98c-4bbb-9430-4ae81b4ee993" xlink:to="loc_us-gaap_ClassOfStockDomain_a3602a40-d98c-4bbb-9430-4ae81b4ee993_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e8e06daa-42b5-4e89-b075-fc4b1e5c70d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a3602a40-d98c-4bbb-9430-4ae81b4ee993" xlink:to="loc_us-gaap_ClassOfStockDomain_e8e06daa-42b5-4e89-b075-fc4b1e5c70d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_d91d9bf2-741a-4339-a2fd-0fa399e2ce33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e8e06daa-42b5-4e89-b075-fc4b1e5c70d2" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_d91d9bf2-741a-4339-a2fd-0fa399e2ce33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableClassACommonStockMember_56469c35-a819-4e42-a38c-15980d3a267a" xlink:href="hims-20210331.xsd#hims_RedeemableClassACommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e8e06daa-42b5-4e89-b075-fc4b1e5c70d2" xlink:to="loc_hims_RedeemableClassACommonStockMember_56469c35-a819-4e42-a38c-15980d3a267a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3437dd3f-1cbb-4890-b6c7-d1795fa23592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3437dd3f-1cbb-4890-b6c7-d1795fa23592" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3437dd3f-1cbb-4890-b6c7-d1795fa23592_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3437dd3f-1cbb-4890-b6c7-d1795fa23592" xlink:to="loc_us-gaap_EquityComponentDomain_3437dd3f-1cbb-4890-b6c7-d1795fa23592_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3437dd3f-1cbb-4890-b6c7-d1795fa23592" xlink:to="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ccbe85bb-f410-49e8-b3cd-0bd9673f1fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:to="loc_us-gaap_CommonStockMember_ccbe85bb-f410-49e8-b3cd-0bd9673f1fd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_04ca97d7-e806-4a77-89c1-5768389536dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_04ca97d7-e806-4a77-89c1-5768389536dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3d5319b4-63fc-4619-bbb0-a03cd2e0f245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3d5319b4-63fc-4619-bbb0-a03cd2e0f245" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c33847d6-e95c-4b3e-9cad-fe0933c27eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:to="loc_us-gaap_RetainedEarningsMember_c33847d6-e95c-4b3e-9cad-fe0933c27eed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_a45f28bc-e026-4e1a-a305-89df98369985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_a45f28bc-e026-4e1a-a305-89df98369985" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a45f28bc-e026-4e1a-a305-89df98369985_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_a45f28bc-e026-4e1a-a305-89df98369985" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a45f28bc-e026-4e1a-a305-89df98369985_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_169f9bc4-d8a6-444b-8a8e-1755902f81f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_a45f28bc-e026-4e1a-a305-89df98369985" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_169f9bc4-d8a6-444b-8a8e-1755902f81f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassACommonStockWarrantsMember_23e10d86-9573-4de0-bfa2-e52be2e68b06" xlink:href="hims-20210331.xsd#hims_ClassACommonStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_169f9bc4-d8a6-444b-8a8e-1755902f81f1" xlink:to="loc_hims_ClassACommonStockWarrantsMember_23e10d86-9573-4de0-bfa2-e52be2e68b06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_32364e89-f8dc-4e62-88bd-6b4d35f5e29a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_32364e89-f8dc-4e62-88bd-6b4d35f5e29a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_32364e89-f8dc-4e62-88bd-6b4d35f5e29a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_32364e89-f8dc-4e62-88bd-6b4d35f5e29a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_32364e89-f8dc-4e62-88bd-6b4d35f5e29a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b34fbcd7-e11a-4e1d-9e32-eaf9ea49e04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_32364e89-f8dc-4e62-88bd-6b4d35f5e29a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b34fbcd7-e11a-4e1d-9e32-eaf9ea49e04b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_062c8c20-a729-4e83-a10d-46b6d63049c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b34fbcd7-e11a-4e1d-9e32-eaf9ea49e04b" xlink:to="loc_us-gaap_PrivatePlacementMember_062c8c20-a729-4e83-a10d-46b6d63049c8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended" id="id9d2be07f0da41948bfcf6be1bd5a61e_SummaryofSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aea24d9f-0d75-454c-b9a6-1202cd7973b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_86b7e18e-4b8a-4b23-a6a3-c37c615718eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aea24d9f-0d75-454c-b9a6-1202cd7973b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_86b7e18e-4b8a-4b23-a6a3-c37c615718eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f718d7a-3b76-4aec-b948-d9c05a6e5504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aea24d9f-0d75-454c-b9a6-1202cd7973b5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f718d7a-3b76-4aec-b948-d9c05a6e5504" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_96526f52-255b-4ad3-b890-913d29730da5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f718d7a-3b76-4aec-b948-d9c05a6e5504" xlink:to="loc_us-gaap_AwardTypeAxis_96526f52-255b-4ad3-b890-913d29730da5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96526f52-255b-4ad3-b890-913d29730da5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_96526f52-255b-4ad3-b890-913d29730da5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_96526f52-255b-4ad3-b890-913d29730da5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f410530e-5947-451c-a37d-f4eabc57a096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_96526f52-255b-4ad3-b890-913d29730da5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f410530e-5947-451c-a37d-f4eabc57a096" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_635e2b31-547c-4063-abfa-1114a20ebbf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f410530e-5947-451c-a37d-f4eabc57a096" xlink:to="loc_us-gaap_EmployeeStockOptionMember_635e2b31-547c-4063-abfa-1114a20ebbf7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended" id="i866cc1838ac6443fa02ac942afd3160d_SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c35bbbfe-3b89-4749-a045-f0743e4609b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_70c2c4c0-9571-4cc8-8863-14a6c65b0330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c35bbbfe-3b89-4749-a045-f0743e4609b7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_70c2c4c0-9571-4cc8-8863-14a6c65b0330" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_19139673-8eea-4f35-898d-137a774bb580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c35bbbfe-3b89-4749-a045-f0743e4609b7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_19139673-8eea-4f35-898d-137a774bb580" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f03dc47e-e5ed-48e7-97ab-66b40f07ea97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19139673-8eea-4f35-898d-137a774bb580" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f03dc47e-e5ed-48e7-97ab-66b40f07ea97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_f03dc47e-e5ed-48e7-97ab-66b40f07ea97_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f03dc47e-e5ed-48e7-97ab-66b40f07ea97" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_f03dc47e-e5ed-48e7-97ab-66b40f07ea97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e81d8bee-4c0c-4d75-947f-b1af6f2ef434" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f03dc47e-e5ed-48e7-97ab-66b40f07ea97" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e81d8bee-4c0c-4d75-947f-b1af6f2ef434" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_f9e29541-cfb6-4735-98b7-642859c5aee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e81d8bee-4c0c-4d75-947f-b1af6f2ef434" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_f9e29541-cfb6-4735-98b7-642859c5aee2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_e1900b0f-f242-4391-ac38-b973dadc6a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e81d8bee-4c0c-4d75-947f-b1af6f2ef434" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_e1900b0f-f242-4391-ac38-b973dadc6a44" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/RecapitalizationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#RecapitalizationDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/RecapitalizationDetails" xlink:type="extended" id="i0188b7d5c73f4b579bf6976571fb5d89_RecapitalizationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired_522e8e8e-f2c8-433c-bfd3-c7465a5b8052" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired_522e8e8e-f2c8-433c-bfd3-c7465a5b8052" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_8a9ee670-2896-4d3d-b847-5ccde390dab9" xlink:href="hims-20210331.xsd#hims_ProceedsFromIssuanceOfCommonStockRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_8a9ee670-2896-4d3d-b847-5ccde390dab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationTransactionCosts_6c9844cc-89a4-48e6-8e77-7f015e6956f6" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationTransactionCosts_6c9844cc-89a4-48e6-8e77-7f015e6956f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_5bba1fb6-0ab6-43c0-a66c-a45e3cd9e4b7" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_RecapitalizationExchangeRatio_5bba1fb6-0ab6-43c0-a66c-a45e3cd9e4b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_57a3dc88-b183-4d8d-aca1-56a7263ef70a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_57a3dc88-b183-4d8d-aca1-56a7263ef70a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_38fa5476-45ca-4e26-83c5-a261e422682a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_38fa5476-45ca-4e26-83c5-a261e422682a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_3abc7b77-e0a8-43eb-956e-336d63aeb428" xlink:href="hims-20210331.xsd#hims_RecapitalizationContingentConsiderationEquityExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_3abc7b77-e0a8-43eb-956e-336d63aeb428" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_48d345f4-4384-4f79-88fa-3eecc53fe870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_48d345f4-4384-4f79-88fa-3eecc53fe870" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityShares_7d5eca43-4f4d-4c37-933a-58dbca496761" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseCapitalizationContingentConsiderationEquityShares_7d5eca43-4f4d-4c37-933a-58dbca496761" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_ac065241-b019-47a1-84cb-55f9d7607b79" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_ac065241-b019-47a1-84cb-55f9d7607b79" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_b6c1b3cb-74b8-4f53-8737-79f8c44d6a2a" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_b6c1b3cb-74b8-4f53-8737-79f8c44d6a2a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_f7db2328-7b8b-411f-9c5e-a350ae49cbe5" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_f7db2328-7b8b-411f-9c5e-a350ae49cbe5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_fec6fef0-3eec-4db7-bc54-3d49377973c9" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_fec6fef0-3eec-4db7-bc54-3d49377973c9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod_ff2e316f-2b9c-4f89-8add-2ec4290e88f6" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod_ff2e316f-2b9c-4f89-8add-2ec4290e88f6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_17133d18-ae89-4f92-b62e-9a6e3e4a2200" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_17133d18-ae89-4f92-b62e-9a6e3e4a2200" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ddf34724-8d09-4fe7-bca5-bd1673c874f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ddf34724-8d09-4fe7-bca5-bd1673c874f4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_380cc132-60e8-47e3-a227-1df27516ec34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_380cc132-60e8-47e3-a227-1df27516ec34" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e1c627dd-e3dd-449c-8700-6818e6e52840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e1c627dd-e3dd-449c-8700-6818e6e52840" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:href="hims-20210331.xsd#hims_ScheduleOfReverseRecapitaliztionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_17147dcc-9f26-4668-bd4e-70817e66b424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_17147dcc-9f26-4668-bd4e-70817e66b424" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_17147dcc-9f26-4668-bd4e-70817e66b424_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_17147dcc-9f26-4668-bd4e-70817e66b424" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_17147dcc-9f26-4668-bd4e-70817e66b424_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_71ca69ef-4e0c-41c7-be08-941cb8f67902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_17147dcc-9f26-4668-bd4e-70817e66b424" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_71ca69ef-4e0c-41c7-be08-941cb8f67902" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_2cd9d2d0-a0f7-4a08-95f9-70a20bed9fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_71ca69ef-4e0c-41c7-be08-941cb8f67902" xlink:to="loc_us-gaap_PrivatePlacementMember_2cd9d2d0-a0f7-4a08-95f9-70a20bed9fb7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b0118506-a5e3-4fa5-9c9a-0947107d9ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b0118506-a5e3-4fa5-9c9a-0947107d9ade" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b0118506-a5e3-4fa5-9c9a-0947107d9ade_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b0118506-a5e3-4fa5-9c9a-0947107d9ade" xlink:to="loc_us-gaap_ClassOfStockDomain_b0118506-a5e3-4fa5-9c9a-0947107d9ade_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8c09caa0-ba2d-47fb-9119-774140422d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b0118506-a5e3-4fa5-9c9a-0947107d9ade" xlink:to="loc_us-gaap_ClassOfStockDomain_8c09caa0-ba2d-47fb-9119-774140422d2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassAAndVMember_ce5f676e-a418-425b-97d0-98ecda645e0c" xlink:href="hims-20210331.xsd#hims_CommonClassAAndVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8c09caa0-ba2d-47fb-9119-774140422d2c" xlink:to="loc_hims_CommonClassAAndVMember_ce5f676e-a418-425b-97d0-98ecda645e0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_303c8cbc-2953-449b-970d-009ccea4767c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_CommonClassAAndVMember_ce5f676e-a418-425b-97d0-98ecda645e0c" xlink:to="loc_us-gaap_CommonClassAMember_303c8cbc-2953-449b-970d-009ccea4767c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember_1f95a0b7-185d-42a4-b17e-53b702b14c77" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_CommonClassAAndVMember_ce5f676e-a418-425b-97d0-98ecda645e0c" xlink:to="loc_hims_CommonClassVMember_1f95a0b7-185d-42a4-b17e-53b702b14c77" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_2634779b-6030-4672-8cb1-282bf08638c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_2634779b-6030-4672-8cb1-282bf08638c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2634779b-6030-4672-8cb1-282bf08638c1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_2634779b-6030-4672-8cb1-282bf08638c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2634779b-6030-4672-8cb1-282bf08638c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c99b3391-810d-40a3-b17e-e6101698debe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_2634779b-6030-4672-8cb1-282bf08638c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c99b3391-810d-40a3-b17e-e6101698debe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_7f46f5fb-d1ec-4963-8303-e538151aa67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c99b3391-810d-40a3-b17e-e6101698debe" xlink:to="loc_us-gaap_CommonClassAMember_7f46f5fb-d1ec-4963-8303-e538151aa67a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantsMember_d065e2f9-64f1-4f81-bf38-79cb68224b53" xlink:href="hims-20210331.xsd#hims_ParentWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c99b3391-810d-40a3-b17e-e6101698debe" xlink:to="loc_hims_ParentWarrantsMember_d065e2f9-64f1-4f81-bf38-79cb68224b53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantRestrictedStockUnitsMember_1d04d9b0-dcde-4875-ba80-29de60b2a20c" xlink:href="hims-20210331.xsd#hims_ParentWarrantRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c99b3391-810d-40a3-b17e-e6101698debe" xlink:to="loc_hims_ParentWarrantRestrictedStockUnitsMember_1d04d9b0-dcde-4875-ba80-29de60b2a20c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7c319581-1bf6-42f1-a835-747e92e1b264" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_dei_LegalEntityAxis_7c319581-1bf6-42f1-a835-747e92e1b264" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_7c319581-1bf6-42f1-a835-747e92e1b264_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_7c319581-1bf6-42f1-a835-747e92e1b264" xlink:to="loc_dei_EntityDomain_7c319581-1bf6-42f1-a835-747e92e1b264_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5b2666c6-d34e-4d1b-a1aa-01057adb2520" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_7c319581-1bf6-42f1-a835-747e92e1b264" xlink:to="loc_dei_EntityDomain_5b2666c6-d34e-4d1b-a1aa-01057adb2520" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsIncMember_bd1a6f33-641d-4cd0-b634-ec3e684f8f7f" xlink:href="hims-20210331.xsd#hims_HimsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_5b2666c6-d34e-4d1b-a1aa-01057adb2520" xlink:to="loc_hims_HimsIncMember_bd1a6f33-641d-4cd0-b634-ec3e684f8f7f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_aea6ae20-6353-4bc8-83a4-3a36184b6632" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_srt_TitleOfIndividualAxis_aea6ae20-6353-4bc8-83a4-3a36184b6632" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aea6ae20-6353-4bc8-83a4-3a36184b6632_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_aea6ae20-6353-4bc8-83a4-3a36184b6632" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aea6ae20-6353-4bc8-83a4-3a36184b6632_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_814a667d-a30b-4ace-b8ab-76248b1204e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_aea6ae20-6353-4bc8-83a4-3a36184b6632" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_814a667d-a30b-4ace-b8ab-76248b1204e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_363310f1-7b7b-462b-9a33-d6b1d759280d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_814a667d-a30b-4ace-b8ab-76248b1204e9" xlink:to="loc_srt_ChiefExecutiveOfficerMember_363310f1-7b7b-462b-9a33-d6b1d759280d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c3550c04-3752-41ef-8142-4560c9ec8f45" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_srt_CounterpartyNameAxis_c3550c04-3752-41ef-8142-4560c9ec8f45" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c3550c04-3752-41ef-8142-4560c9ec8f45_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_c3550c04-3752-41ef-8142-4560c9ec8f45" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c3550c04-3752-41ef-8142-4560c9ec8f45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_17db68f4-50df-43ce-8ba9-def39a268881" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_c3550c04-3752-41ef-8142-4560c9ec8f45" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_17db68f4-50df-43ce-8ba9-def39a268881" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsStockholdersMember_a202394e-1a87-4e83-9ab2-fcf6290b1c10" xlink:href="hims-20210331.xsd#hims_HimsStockholdersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_17db68f4-50df-43ce-8ba9-def39a268881" xlink:to="loc_hims_HimsStockholdersMember_a202394e-1a87-4e83-9ab2-fcf6290b1c10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsWarrantHoldersMember_97fac3a5-c1a9-440c-b06c-cffed8f753df" xlink:href="hims-20210331.xsd#hims_HimsWarrantHoldersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_17db68f4-50df-43ce-8ba9-def39a268881" xlink:to="loc_hims_HimsWarrantHoldersMember_97fac3a5-c1a9-440c-b06c-cffed8f753df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsOptionAndRSUHoldersMember_9f8cd1df-7559-4aff-acaa-3f01963f0a4f" xlink:href="hims-20210331.xsd#hims_HimsOptionAndRSUHoldersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_17db68f4-50df-43ce-8ba9-def39a268881" xlink:to="loc_hims_HimsOptionAndRSUHoldersMember_9f8cd1df-7559-4aff-acaa-3f01963f0a4f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4e2b459d-0440-4a4a-89c8-a8752fc6486e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4e2b459d-0440-4a4a-89c8-a8752fc6486e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4e2b459d-0440-4a4a-89c8-a8752fc6486e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4e2b459d-0440-4a4a-89c8-a8752fc6486e" xlink:to="loc_us-gaap_EquityComponentDomain_4e2b459d-0440-4a4a-89c8-a8752fc6486e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6d5f0ccb-5ed8-4e27-9368-df60b6191216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4e2b459d-0440-4a4a-89c8-a8752fc6486e" xlink:to="loc_us-gaap_EquityComponentDomain_6d5f0ccb-5ed8-4e27-9368-df60b6191216" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8b5352bd-acf7-4140-85d3-10b4724acb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6d5f0ccb-5ed8-4e27-9368-df60b6191216" xlink:to="loc_us-gaap_CommonStockMember_8b5352bd-acf7-4140-85d3-10b4724acb2e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/InvestmentsShorttermInvestmentsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#InvestmentsShorttermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/InvestmentsShorttermInvestmentsDetails" xlink:type="extended" id="ib8816a8e07614eddad1dfd575b43416f_InvestmentsShorttermInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_757a200d-3ed9-4510-a526-12db6bbacb9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_757a200d-3ed9-4510-a526-12db6bbacb9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7e5cec56-a58e-4d62-8491-da083f9ba0ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7e5cec56-a58e-4d62-8491-da083f9ba0ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_377615a0-2454-433b-a43f-fd43b2ff4a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_377615a0-2454-433b-a43f-fd43b2ff4a99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6cbdab59-2fd7-45b2-957d-bcd1b45a3556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6cbdab59-2fd7-45b2-957d-bcd1b45a3556" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_0a4aa812-ef1c-4efb-9998-5f3f6dae25c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:to="loc_us-gaap_MarketableSecuritiesTable_0a4aa812-ef1c-4efb-9998-5f3f6dae25c9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e8d00378-72ba-49a9-b8c0-32d75b454d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_MarketableSecuritiesTable_0a4aa812-ef1c-4efb-9998-5f3f6dae25c9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e8d00378-72ba-49a9-b8c0-32d75b454d44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e8d00378-72ba-49a9-b8c0-32d75b454d44_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e8d00378-72ba-49a9-b8c0-32d75b454d44" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_e8d00378-72ba-49a9-b8c0-32d75b454d44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c902576-a15d-490f-a2c2-ee5c71204d01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e8d00378-72ba-49a9-b8c0-32d75b454d44" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c902576-a15d-490f-a2c2-ee5c71204d01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_bc94684b-2bc7-4bfb-8f27-ee122a9764c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c902576-a15d-490f-a2c2-ee5c71204d01" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_bc94684b-2bc7-4bfb-8f27-ee122a9764c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c7604516-e118-4ee4-b4e2-81ef2af4e861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c902576-a15d-490f-a2c2-ee5c71204d01" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c7604516-e118-4ee4-b4e2-81ef2af4e861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_53a4842e-f9ac-4841-96f2-cca1b633b56f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c902576-a15d-490f-a2c2-ee5c71204d01" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_53a4842e-f9ac-4841-96f2-cca1b633b56f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#VariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/VariableInterestEntitiesDetails" xlink:type="extended" id="iba5809c1f9ba485bb5c2244b0ef5303a_VariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PercentageOwnedByLicensedPhysicians_04597409-affe-4e7d-9f87-b501828072f1" xlink:href="hims-20210331.xsd#hims_PercentageOwnedByLicensedPhysicians"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_hims_PercentageOwnedByLicensedPhysicians_04597409-affe-4e7d-9f87-b501828072f1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4b70b79c-417e-4863-83c9-03533ce1ca4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_AssetsCurrent_4b70b79c-417e-4863-83c9-03533ce1ca4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9875e407-9eef-4a11-b89b-c1b5e94d8580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_Assets_9875e407-9eef-4a11-b89b-c1b5e94d8580" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ab18e710-e69d-4879-a0cd-e48c1471e98e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_LiabilitiesCurrent_ab18e710-e69d-4879-a0cd-e48c1471e98e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f20340e2-53d9-484f-b3a2-3906d69f458b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_Liabilities_f20340e2-53d9-484f-b3a2-3906d69f458b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliers_20566b4f-ba7e-4b63-bd8e-aa2d91bc4ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_PaymentsToSuppliers_20566b4f-ba7e-4b63-bd8e-aa2d91bc4ac4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_493bf0d3-8bf9-42c1-9674-89cfeef66e14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_NetIncomeLoss_493bf0d3-8bf9-42c1-9674-89cfeef66e14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0b990c22-e261-40a1-8483-bcc0d68306c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0b990c22-e261-40a1-8483-bcc0d68306c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_0b990c22-e261-40a1-8483-bcc0d68306c4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0b990c22-e261-40a1-8483-bcc0d68306c4" xlink:to="loc_srt_ConsolidatedEntitiesDomain_0b990c22-e261-40a1-8483-bcc0d68306c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e3bff126-d055-4418-b861-7330d06d736f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0b990c22-e261-40a1-8483-bcc0d68306c4" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e3bff126-d055-4418-b861-7330d06d736f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b245d4f8-4ad8-4a23-9e45-2e2a9d097810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e3bff126-d055-4418-b861-7330d06d736f" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b245d4f8-4ad8-4a23-9e45-2e2a9d097810" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_63152dea-7c4c-492b-b7e6-ceb29a4e2e7f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:to="loc_dei_LegalEntityAxis_63152dea-7c4c-492b-b7e6-ceb29a4e2e7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_63152dea-7c4c-492b-b7e6-ceb29a4e2e7f_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_63152dea-7c4c-492b-b7e6-ceb29a4e2e7f" xlink:to="loc_dei_EntityDomain_63152dea-7c4c-492b-b7e6-ceb29a4e2e7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_44ce8ec7-0111-497b-b562-7f07957a80f9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_63152dea-7c4c-492b-b7e6-ceb29a4e2e7f" xlink:to="loc_dei_EntityDomain_44ce8ec7-0111-497b-b562-7f07957a80f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AffiliatedMedicalGroupsMember_701a69bd-d6a5-4047-be9e-534c0ab22e0c" xlink:href="hims-20210331.xsd#hims_AffiliatedMedicalGroupsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_44ce8ec7-0111-497b-b562-7f07957a80f9" xlink:to="loc_hims_AffiliatedMedicalGroupsMember_701a69bd-d6a5-4047-be9e-534c0ab22e0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6230be1b-d54f-4bd9-bb52-e9f4a755f80e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:to="loc_srt_ConsolidationItemsAxis_6230be1b-d54f-4bd9-bb52-e9f4a755f80e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_6230be1b-d54f-4bd9-bb52-e9f4a755f80e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_6230be1b-d54f-4bd9-bb52-e9f4a755f80e" xlink:to="loc_srt_ConsolidationItemsDomain_6230be1b-d54f-4bd9-bb52-e9f4a755f80e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3c4c5529-80b2-4212-98c5-0cd08e06fd78" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_6230be1b-d54f-4bd9-bb52-e9f4a755f80e" xlink:to="loc_srt_ConsolidationItemsDomain_3c4c5529-80b2-4212-98c5-0cd08e06fd78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationEliminationsMember_e881193c-4c8b-4c64-ba66-a2c7309d361a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_3c4c5529-80b2-4212-98c5-0cd08e06fd78" xlink:to="loc_srt_ConsolidationEliminationsMember_e881193c-4c8b-4c64-ba66-a2c7309d361a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails" xlink:type="extended" id="i37002040a71b4dc3b8aff69e0468b665_FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_71419c5f-81d9-4fd3-ac42-d56840f442a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_71419c5f-81d9-4fd3-ac42-d56840f442a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_7369e8d3-a8ba-4596-907b-245aa9801609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_ShortTermInvestments_7369e8d3-a8ba-4596-907b-245aa9801609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_b69e3fdf-e0e7-4ff0-87c1-26e0ab79f68b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_RestrictedCash_b69e3fdf-e0e7-4ff0-87c1-26e0ab79f68b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c0ad4119-8888-44f9-a4d1-c28a9dea62b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c0ad4119-8888-44f9-a4d1-c28a9dea62b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ffd96963-1f40-4c5b-b206-9880fb944bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_DerivativeLiabilities_ffd96963-1f40-4c5b-b206-9880fb944bf4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_f209d0d0-0aa7-4654-b159-eb5d7c28e64d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_f209d0d0-0aa7-4654-b159-eb5d7c28e64d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d647e9d-ca3d-4147-b28c-950a6aaea7de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d647e9d-ca3d-4147-b28c-950a6aaea7de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3d647e9d-ca3d-4147-b28c-950a6aaea7de_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d647e9d-ca3d-4147-b28c-950a6aaea7de" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_3d647e9d-ca3d-4147-b28c-950a6aaea7de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c23e787f-0fd6-45e6-9a31-e7ecb5e34230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d647e9d-ca3d-4147-b28c-950a6aaea7de" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c23e787f-0fd6-45e6-9a31-e7ecb5e34230" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_463774c4-4689-46a3-aa40-f1f974dd4f65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c23e787f-0fd6-45e6-9a31-e7ecb5e34230" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_463774c4-4689-46a3-aa40-f1f974dd4f65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f6361baf-a1d2-46d5-9cff-91ef72c43ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c23e787f-0fd6-45e6-9a31-e7ecb5e34230" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f6361baf-a1d2-46d5-9cff-91ef72c43ba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7d6828c7-abef-498a-8b9c-a26ed381e1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c23e787f-0fd6-45e6-9a31-e7ecb5e34230" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7d6828c7-abef-498a-8b9c-a26ed381e1b6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c1347181-15d6-4de4-a39b-46e03baa65fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c1347181-15d6-4de4-a39b-46e03baa65fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_c1347181-15d6-4de4-a39b-46e03baa65fb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c1347181-15d6-4de4-a39b-46e03baa65fb" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_c1347181-15d6-4de4-a39b-46e03baa65fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_272c0185-5717-4af8-9ce3-6a807949b467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c1347181-15d6-4de4-a39b-46e03baa65fb" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_272c0185-5717-4af8-9ce3-6a807949b467" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6849aaa9-0ec3-4a00-9a8c-5b58b758f329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_272c0185-5717-4af8-9ce3-6a807949b467" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6849aaa9-0ec3-4a00-9a8c-5b58b758f329" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_00a10bf6-47aa-46ae-b4ac-3ae668625f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_00a10bf6-47aa-46ae-b4ac-3ae668625f42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_00a10bf6-47aa-46ae-b4ac-3ae668625f42_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_00a10bf6-47aa-46ae-b4ac-3ae668625f42" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_00a10bf6-47aa-46ae-b4ac-3ae668625f42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdb94384-50f9-459f-95de-6c566f4d835d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_00a10bf6-47aa-46ae-b4ac-3ae668625f42" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdb94384-50f9-459f-95de-6c566f4d835d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_e27505f1-fedc-4a9a-9aeb-628b5cc372ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdb94384-50f9-459f-95de-6c566f4d835d" xlink:to="loc_us-gaap_MoneyMarketFundsMember_e27505f1-fedc-4a9a-9aeb-628b5cc372ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_0098e20d-1980-4f86-820c-56181c1c7ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdb94384-50f9-459f-95de-6c566f4d835d" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_0098e20d-1980-4f86-820c-56181c1c7ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d278c2de-1e9b-47c8-a23a-1a10a888fdbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d278c2de-1e9b-47c8-a23a-1a10a888fdbd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d278c2de-1e9b-47c8-a23a-1a10a888fdbd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d278c2de-1e9b-47c8-a23a-1a10a888fdbd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d278c2de-1e9b-47c8-a23a-1a10a888fdbd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9132cb03-eba2-421e-806f-47be171448f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d278c2de-1e9b-47c8-a23a-1a10a888fdbd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9132cb03-eba2-421e-806f-47be171448f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_e59366a6-2cde-43fd-a155-809ad99993c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9132cb03-eba2-421e-806f-47be171448f4" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_e59366a6-2cde-43fd-a155-809ad99993c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_375eb182-51e1-4bfb-947a-f42435f89a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9132cb03-eba2-421e-806f-47be171448f4" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_375eb182-51e1-4bfb-947a-f42435f89a4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_1faf74da-0b39-4c83-b7d1-c90f1464571e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9132cb03-eba2-421e-806f-47be171448f4" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_1faf74da-0b39-4c83-b7d1-c90f1464571e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_d1b7d458-e4c6-4ee1-8531-2281e173a4ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_d1b7d458-e4c6-4ee1-8531-2281e173a4ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d1b7d458-e4c6-4ee1-8531-2281e173a4ed_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_d1b7d458-e4c6-4ee1-8531-2281e173a4ed" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d1b7d458-e4c6-4ee1-8531-2281e173a4ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_4b844f6b-a7ef-4adc-a08f-53739b46ba02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_d1b7d458-e4c6-4ee1-8531-2281e173a4ed" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_4b844f6b-a7ef-4adc-a08f-53739b46ba02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_3e34bd1b-6e46-465d-95a2-48ebc6340b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended" id="i8f11753e44384b839b982f3b4eafc3f4_FairValueMeasurementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f4dc4fe4-ac7a-48b3-97a8-6232bff55aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_d63c3b62-162a-4cb6-bc77-71caa59c3ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f4dc4fe4-ac7a-48b3-97a8-6232bff55aa3" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_d63c3b62-162a-4cb6-bc77-71caa59c3ca0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_05251785-843b-495e-b310-d85e3eaf48e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f4dc4fe4-ac7a-48b3-97a8-6232bff55aa3" xlink:to="loc_us-gaap_SharePrice_05251785-843b-495e-b310-d85e3eaf48e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1e772a8-ef40-470a-8b5f-f0cdebcf0e57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f4dc4fe4-ac7a-48b3-97a8-6232bff55aa3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1e772a8-ef40-470a-8b5f-f0cdebcf0e57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_e0c24304-f3e8-47fc-8302-11555e3fa359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1e772a8-ef40-470a-8b5f-f0cdebcf0e57" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_e0c24304-f3e8-47fc-8302-11555e3fa359" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_e0c24304-f3e8-47fc-8302-11555e3fa359_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_e0c24304-f3e8-47fc-8302-11555e3fa359" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_e0c24304-f3e8-47fc-8302-11555e3fa359_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_ce322fb3-ab77-464e-b5b2-ca9669f6c915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_e0c24304-f3e8-47fc-8302-11555e3fa359" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_ce322fb3-ab77-464e-b5b2-ca9669f6c915" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsMember_4101bc47-79fd-44bd-8afd-f974ab0518e0" xlink:href="hims-20210331.xsd#hims_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_ce322fb3-ab77-464e-b5b2-ca9669f6c915" xlink:to="loc_hims_PublicWarrantsMember_4101bc47-79fd-44bd-8afd-f974ab0518e0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails" xlink:type="extended" id="ia72ef14d6f4047bfac3336b4e1ca0707_FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3b86ab8c-e42b-4004-b79f-20deea0dbc18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3b86ab8c-e42b-4004-b79f-20deea0dbc18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_e16ce805-3cce-421c-8256-d673c4049f06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_e16ce805-3cce-421c-8256-d673c4049f06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ee285490-2897-41e7-8eb4-10cf83c293ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ee285490-2897-41e7-8eb4-10cf83c293ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ecf73c26-50c5-4f5e-b2f7-77c5b2447c02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ecf73c26-50c5-4f5e-b2f7-77c5b2447c02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd5c3373-de8c-44b8-b94f-44b5965169d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd5c3373-de8c-44b8-b94f-44b5965169d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f6cb4d31-0ed6-4f80-a7c7-c8875693ed15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd5c3373-de8c-44b8-b94f-44b5965169d8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f6cb4d31-0ed6-4f80-a7c7-c8875693ed15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_f6cb4d31-0ed6-4f80-a7c7-c8875693ed15_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f6cb4d31-0ed6-4f80-a7c7-c8875693ed15" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_f6cb4d31-0ed6-4f80-a7c7-c8875693ed15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_33714563-0364-4a8e-967f-78385e37226e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f6cb4d31-0ed6-4f80-a7c7-c8875693ed15" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_33714563-0364-4a8e-967f-78385e37226e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PrivatePlacementWarrantsMember_951e439d-cfb5-4915-bab0-5970935ea12e" xlink:href="hims-20210331.xsd#hims_PrivatePlacementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_33714563-0364-4a8e-967f-78385e37226e" xlink:to="loc_hims_PrivatePlacementWarrantsMember_951e439d-cfb5-4915-bab0-5970935ea12e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/BorrowingArrangementsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#BorrowingArrangementsDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/BorrowingArrangementsDetails" xlink:type="extended" id="iead960f86c864c73954c068ea238b48d_BorrowingArrangementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_34aaabcf-64f0-4625-b8eb-e4312a6699d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_34aaabcf-64f0-4625-b8eb-e4312a6699d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_a906a083-9665-4bc6-9039-43b5d278d9bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_a906a083-9665-4bc6-9039-43b5d278d9bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_DebtInstrumentCovenantRequiredCollateralAmount_16dffab4-e4e7-4dae-841b-d06d576f9f95" xlink:href="hims-20210331.xsd#hims_DebtInstrumentCovenantRequiredCollateralAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_hims_DebtInstrumentCovenantRequiredCollateralAmount_16dffab4-e4e7-4dae-841b-d06d576f9f95" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_edd00eec-90ea-40a5-ba80-0e6b2a26cf91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_edd00eec-90ea-40a5-ba80-0e6b2a26cf91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_DebtInstrumentMaximumBorrowingCapacity_246c1393-5116-4d3f-8b9a-c921866979ea" xlink:href="hims-20210331.xsd#hims_DebtInstrumentMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_hims_DebtInstrumentMaximumBorrowingCapacity_246c1393-5116-4d3f-8b9a-c921866979ea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_3c196ce7-b394-4b11-b463-15cc6c2d2d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_3c196ce7-b394-4b11-b463-15cc6c2d2d9c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9479a4bc-1c24-458d-8cc0-f042a57943eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9479a4bc-1c24-458d-8cc0-f042a57943eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5ada2fd9-fad0-4f90-b083-e854b1706bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5ada2fd9-fad0-4f90-b083-e854b1706bfd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_86ffc4eb-60bc-4d4d-84b9-2780f52e081f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:to="loc_us-gaap_CreditFacilityAxis_86ffc4eb-60bc-4d4d-84b9-2780f52e081f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_86ffc4eb-60bc-4d4d-84b9-2780f52e081f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_86ffc4eb-60bc-4d4d-84b9-2780f52e081f" xlink:to="loc_us-gaap_CreditFacilityDomain_86ffc4eb-60bc-4d4d-84b9-2780f52e081f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_97e670bc-5e2d-4615-a506-fbbc24bca4e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_86ffc4eb-60bc-4d4d-84b9-2780f52e081f" xlink:to="loc_us-gaap_CreditFacilityDomain_97e670bc-5e2d-4615-a506-fbbc24bca4e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_9eb447f4-7c01-42db-8c32-f398fe34bafa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_97e670bc-5e2d-4615-a506-fbbc24bca4e1" xlink:to="loc_us-gaap_LetterOfCreditMember_9eb447f4-7c01-42db-8c32-f398fe34bafa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6ee15437-5ae0-4add-91c6-d59257a2f595" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:to="loc_us-gaap_DebtInstrumentAxis_6ee15437-5ae0-4add-91c6-d59257a2f595" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6ee15437-5ae0-4add-91c6-d59257a2f595_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6ee15437-5ae0-4add-91c6-d59257a2f595" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6ee15437-5ae0-4add-91c6-d59257a2f595_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9daebe0f-4dee-4a98-ad98-9cbac6d30628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6ee15437-5ae0-4add-91c6-d59257a2f595" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9daebe0f-4dee-4a98-ad98-9cbac6d30628" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_BusinessCreditCardMember_b80b6691-5ec7-4597-ac17-3823e3cfd943" xlink:href="hims-20210331.xsd#hims_BusinessCreditCardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9daebe0f-4dee-4a98-ad98-9cbac6d30628" xlink:to="loc_hims_BusinessCreditCardMember_b80b6691-5ec7-4597-ac17-3823e3cfd943" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CapitalAgreement2019Member_4b181e24-8034-4d80-ab0f-25bf1d3fa780" xlink:href="hims-20210331.xsd#hims_CapitalAgreement2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9daebe0f-4dee-4a98-ad98-9cbac6d30628" xlink:to="loc_hims_CapitalAgreement2019Member_4b181e24-8034-4d80-ab0f-25bf1d3fa780" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CapitalAgreement2019TrancheOneMember_e3539b87-8a98-4a97-a733-f62db7cc323f" xlink:href="hims-20210331.xsd#hims_CapitalAgreement2019TrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_CapitalAgreement2019Member_4b181e24-8034-4d80-ab0f-25bf1d3fa780" xlink:to="loc_hims_CapitalAgreement2019TrancheOneMember_e3539b87-8a98-4a97-a733-f62db7cc323f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CapitalAgreement2019TrancheTwoMember_2d144a17-6119-4b62-bd7a-dc61d753e68b" xlink:href="hims-20210331.xsd#hims_CapitalAgreement2019TrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_CapitalAgreement2019Member_4b181e24-8034-4d80-ab0f-25bf1d3fa780" xlink:to="loc_hims_CapitalAgreement2019TrancheTwoMember_2d144a17-6119-4b62-bd7a-dc61d753e68b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dcd6296b-85a8-4fab-ab4f-6b61b3a4a5da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dcd6296b-85a8-4fab-ab4f-6b61b3a4a5da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dcd6296b-85a8-4fab-ab4f-6b61b3a4a5da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dcd6296b-85a8-4fab-ab4f-6b61b3a4a5da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dcd6296b-85a8-4fab-ab4f-6b61b3a4a5da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bb74915c-b803-48d5-a27f-c9640e078a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dcd6296b-85a8-4fab-ab4f-6b61b3a4a5da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bb74915c-b803-48d5-a27f-c9640e078a41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7a063153-e207-4c50-bd92-dc4dc398ff33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bb74915c-b803-48d5-a27f-c9640e078a41" xlink:to="loc_us-gaap_LineOfCreditMember_7a063153-e207-4c50-bd92-dc4dc398ff33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_5221860a-fe7e-4b51-a33d-3a7f32741679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bb74915c-b803-48d5-a27f-c9640e078a41" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_5221860a-fe7e-4b51-a33d-3a7f32741679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_5a79a03c-c59d-4702-8c52-5356ea5469c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_5a79a03c-c59d-4702-8c52-5356ea5469c1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5a79a03c-c59d-4702-8c52-5356ea5469c1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5a79a03c-c59d-4702-8c52-5356ea5469c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5a79a03c-c59d-4702-8c52-5356ea5469c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_e5339e2e-7587-4c33-8dc6-97d504b2044c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5a79a03c-c59d-4702-8c52-5356ea5469c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_e5339e2e-7587-4c33-8dc6-97d504b2044c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesCPreferredStockWarrantsMember_da852806-6d0e-48ed-b09a-e7d4a117c171" xlink:href="hims-20210331.xsd#hims_SeriesCPreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e5339e2e-7587-4c33-8dc6-97d504b2044c" xlink:to="loc_hims_SeriesCPreferredStockWarrantsMember_da852806-6d0e-48ed-b09a-e7d4a117c171" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesDPreferredStockWarrantsMember_658a70a0-ec56-4a10-8cff-2d6cafb13886" xlink:href="hims-20210331.xsd#hims_SeriesDPreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e5339e2e-7587-4c33-8dc6-97d504b2044c" xlink:to="loc_hims_SeriesDPreferredStockWarrantsMember_658a70a0-ec56-4a10-8cff-2d6cafb13886" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="i7991647dd80448ce9f9d5d29b16e3dbc_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense_8ff6dd0a-5961-41b1-89d4-a37c04296ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_us-gaap_LeaseAndRentalExpense_8ff6dd0a-5961-41b1-89d4-a37c04296ea0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperatingLeaseTermOfContract_8e7fb4c8-c701-430f-9aea-2c34ce590827" xlink:href="hims-20210331.xsd#hims_OperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_hims_OperatingLeaseTermOfContract_8e7fb4c8-c701-430f-9aea-2c34ce590827" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_7377dad1-c446-4d50-8d27-293aecbb925d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_7377dad1-c446-4d50-8d27-293aecbb925d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2ba53ca2-ab09-4ac6-927f-cc8e942c90a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2ba53ca2-ab09-4ac6-927f-cc8e942c90a0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement_d69bc283-234c-431c-b6d6-d4980cd20350" xlink:href="hims-20210331.xsd#hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement_d69bc283-234c-431c-b6d6-d4980cd20350" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperatingLeaseRentExpenseAnnualEscalationPercent_5c8a72a4-5b4c-4522-be6c-df81b30ae95f" xlink:href="hims-20210331.xsd#hims_OperatingLeaseRentExpenseAnnualEscalationPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_hims_OperatingLeaseRentExpenseAnnualEscalationPercent_5c8a72a4-5b4c-4522-be6c-df81b30ae95f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperatingLeaseRenewalTerm_337bb35a-71fe-4e4a-9bd6-0514523f9705" xlink:href="hims-20210331.xsd#hims_OperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_hims_OperatingLeaseRenewalTerm_337bb35a-71fe-4e4a-9bd6-0514523f9705" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_7dbd7a04-f2ae-4ef7-9b7d-e31dd7e53a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_us-gaap_PurchaseObligation_7dbd7a04-f2ae-4ef7-9b7d-e31dd7e53a7e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_9f273358-16d4-483c-a17a-fac20eeb24d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_us-gaap_OtherCommitmentsTable_9f273358-16d4-483c-a17a-fac20eeb24d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ffe38dcf-8b7b-4022-b414-e57ac1d67cc6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_9f273358-16d4-483c-a17a-fac20eeb24d3" xlink:to="loc_srt_StatementGeographicalAxis_ffe38dcf-8b7b-4022-b414-e57ac1d67cc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ffe38dcf-8b7b-4022-b414-e57ac1d67cc6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ffe38dcf-8b7b-4022-b414-e57ac1d67cc6" xlink:to="loc_srt_SegmentGeographicalDomain_ffe38dcf-8b7b-4022-b414-e57ac1d67cc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_05def646-7ba2-456a-8d78-252724146851" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ffe38dcf-8b7b-4022-b414-e57ac1d67cc6" xlink:to="loc_srt_SegmentGeographicalDomain_05def646-7ba2-456a-8d78-252724146851" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NewAlbanyOhioMember_1a66a7e3-9cf0-4712-a99b-35cd8c804863" xlink:href="hims-20210331.xsd#hims_NewAlbanyOhioMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_05def646-7ba2-456a-8d78-252724146851" xlink:to="loc_hims_NewAlbanyOhioMember_1a66a7e3-9cf0-4712-a99b-35cd8c804863" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails" xlink:type="extended" id="i66175383af4243a7bc01712111b43fd7_StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_4d2ec28f-dd3d-4777-aa92-2cbd79eb4470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_4d2ec28f-dd3d-4777-aa92-2cbd79eb4470" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_bd8fa874-963c-4740-ab00-5366f93effa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_bd8fa874-963c-4740-ab00-5366f93effa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock_68b007dd-4203-43cf-804c-6e02de21737f" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock_68b007dd-4203-43cf-804c-6e02de21737f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans_7c4d8fc5-2015-468f-bccb-553e53733122" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans_7c4d8fc5-2015-468f-bccb-553e53733122" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_64ee041a-a400-4e1e-b0fd-17992daf8f67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_64ee041a-a400-4e1e-b0fd-17992daf8f67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c45ecb7c-34f6-4b59-986c-758cf2817532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c45ecb7c-34f6-4b59-986c-758cf2817532" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent_4ed8c032-1e7b-4f58-ab6c-416402411448" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent_4ed8c032-1e7b-4f58-ab6c-416402411448" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7b32fa3d-1f9c-4431-b975-cb139f1306b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7b32fa3d-1f9c-4431-b975-cb139f1306b2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_902a6427-bfb3-42dd-9138-71ab119137ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:to="loc_us-gaap_PlanNameAxis_902a6427-bfb3-42dd-9138-71ab119137ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_902a6427-bfb3-42dd-9138-71ab119137ca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_902a6427-bfb3-42dd-9138-71ab119137ca" xlink:to="loc_us-gaap_PlanNameDomain_902a6427-bfb3-42dd-9138-71ab119137ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7f6a742b-f6e2-4f37-af0d-9ff650e0e412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_902a6427-bfb3-42dd-9138-71ab119137ca" xlink:to="loc_us-gaap_PlanNameDomain_7f6a742b-f6e2-4f37-af0d-9ff650e0e412" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EquityIncentivePlan2020And2017StockPlanMember_d88b9235-d648-445d-bcd7-3f2e3b6f7e1b" xlink:href="hims-20210331.xsd#hims_EquityIncentivePlan2020And2017StockPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7f6a742b-f6e2-4f37-af0d-9ff650e0e412" xlink:to="loc_hims_EquityIncentivePlan2020And2017StockPlanMember_d88b9235-d648-445d-bcd7-3f2e3b6f7e1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EquityIncentivePlan2020Member_dcc0412e-9d96-44db-a637-8cc0c0551aff" xlink:href="hims-20210331.xsd#hims_EquityIncentivePlan2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_EquityIncentivePlan2020And2017StockPlanMember_d88b9235-d648-445d-bcd7-3f2e3b6f7e1b" xlink:to="loc_hims_EquityIncentivePlan2020Member_dcc0412e-9d96-44db-a637-8cc0c0551aff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockPlan2017Member_5f5ec40d-9f6a-4151-b8f6-0e5086c48ee2" xlink:href="hims-20210331.xsd#hims_StockPlan2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_EquityIncentivePlan2020And2017StockPlanMember_d88b9235-d648-445d-bcd7-3f2e3b6f7e1b" xlink:to="loc_hims_StockPlan2017Member_5f5ec40d-9f6a-4151-b8f6-0e5086c48ee2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5b54ace5-480d-4a04-8a7d-dc364b4ce833" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:to="loc_srt_RangeAxis_5b54ace5-480d-4a04-8a7d-dc364b4ce833" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_5b54ace5-480d-4a04-8a7d-dc364b4ce833_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_5b54ace5-480d-4a04-8a7d-dc364b4ce833" xlink:to="loc_srt_RangeMember_5b54ace5-480d-4a04-8a7d-dc364b4ce833_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_de8956dd-8e5a-4e60-8fc9-2f69c2f633aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_5b54ace5-480d-4a04-8a7d-dc364b4ce833" xlink:to="loc_srt_RangeMember_de8956dd-8e5a-4e60-8fc9-2f69c2f633aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_72517aab-debb-4d50-867a-fcff67688769" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_de8956dd-8e5a-4e60-8fc9-2f69c2f633aa" xlink:to="loc_srt_MinimumMember_72517aab-debb-4d50-867a-fcff67688769" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_caab15d8-171d-484c-8276-0f477b3884dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:to="loc_us-gaap_AwardTypeAxis_caab15d8-171d-484c-8276-0f477b3884dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_caab15d8-171d-484c-8276-0f477b3884dd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_caab15d8-171d-484c-8276-0f477b3884dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_caab15d8-171d-484c-8276-0f477b3884dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_33f447e2-5dff-403d-bb52-d04e93479603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_caab15d8-171d-484c-8276-0f477b3884dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_33f447e2-5dff-403d-bb52-d04e93479603" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d2f85369-5a3c-4306-8750-5c803f0053a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_33f447e2-5dff-403d-bb52-d04e93479603" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d2f85369-5a3c-4306-8750-5c803f0053a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember_82d30258-14b3-4188-bcea-390b23333a10" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_33f447e2-5dff-403d-bb52-d04e93479603" xlink:to="loc_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember_82d30258-14b3-4188-bcea-390b23333a10" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationStockOptionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails" xlink:type="extended" id="i3c97e9cc71c74e388ef2f903d372cf2e_StockBasedCompensationStockOptionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_69061775-29fe-4285-a7cd-86885075e36f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_69061775-29fe-4285-a7cd-86885075e36f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5f4dadef-0b30-444c-8104-fd4baff9aa12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5f4dadef-0b30-444c-8104-fd4baff9aa12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage_5f599400-885d-43fb-b94e-92bfa63675cb" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage_5f599400-885d-43fb-b94e-92bfa63675cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40bf6147-1eba-4610-a23a-c22873bf0cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40bf6147-1eba-4610-a23a-c22873bf0cb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00cfb5df-1d52-4b81-89a0-0bdfd02bde39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00cfb5df-1d52-4b81-89a0-0bdfd02bde39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a81062ce-609e-4a76-8d59-7efdfe5705d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a81062ce-609e-4a76-8d59-7efdfe5705d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold_fada8f31-928c-4b33-9b70-c0c508696cb6" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold_fada8f31-928c-4b33-9b70-c0c508696cb6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_329aa67b-3e9b-42d0-a2f7-24765bba660f" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_329aa67b-3e9b-42d0-a2f7-24765bba660f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e318b225-89ea-426d-aea3-146df3733ac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e318b225-89ea-426d-aea3-146df3733ac9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5a005922-ec0e-427f-b8e9-11730ba79a3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5a005922-ec0e-427f-b8e9-11730ba79a3b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ee6de546-4de1-4cd6-993d-de68b3097b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ee6de546-4de1-4cd6-993d-de68b3097b22" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_66c790ba-d547-4bdd-92e0-504c730642bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_66c790ba-d547-4bdd-92e0-504c730642bc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fa43f069-abcd-4e94-8fcb-e61da4484124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fa43f069-abcd-4e94-8fcb-e61da4484124" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_65884996-abbd-4ccf-9ed0-ac99afc8d0a1" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_hims_RecapitalizationExchangeRatio_65884996-abbd-4ccf-9ed0-ac99afc8d0a1" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c4c80e4c-36b8-4c19-8623-7c9f277ebbc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c4c80e4c-36b8-4c19-8623-7c9f277ebbc9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_778cdc6f-282e-4b6a-80c9-60807a673f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_778cdc6f-282e-4b6a-80c9-60807a673f2b" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_17c88d68-fadf-405e-a97f-165315ac2417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_17c88d68-fadf-405e-a97f-165315ac2417" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares_5d013b9c-98f7-4ca1-8100-ab7bc2ff6373" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares_5d013b9c-98f7-4ca1-8100-ab7bc2ff6373" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6f3499da-150d-4c99-8118-3f3402158d04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_us-gaap_AwardTypeAxis_6f3499da-150d-4c99-8118-3f3402158d04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f3499da-150d-4c99-8118-3f3402158d04_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6f3499da-150d-4c99-8118-3f3402158d04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6f3499da-150d-4c99-8118-3f3402158d04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dbbeb075-7de0-471e-b917-1e6fa59504c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6f3499da-150d-4c99-8118-3f3402158d04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dbbeb075-7de0-471e-b917-1e6fa59504c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2752fbaa-ffac-47e5-a99f-ef48feaecd8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dbbeb075-7de0-471e-b917-1e6fa59504c0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2752fbaa-ffac-47e5-a99f-ef48feaecd8a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_960a7625-e399-4246-bd1c-832d33bc97a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_us-gaap_GranteeStatusAxis_960a7625-e399-4246-bd1c-832d33bc97a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_960a7625-e399-4246-bd1c-832d33bc97a8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_960a7625-e399-4246-bd1c-832d33bc97a8" xlink:to="loc_us-gaap_GranteeStatusDomain_960a7625-e399-4246-bd1c-832d33bc97a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_58207df2-bf3d-4585-a5b4-02d8ec947d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_960a7625-e399-4246-bd1c-832d33bc97a8" xlink:to="loc_us-gaap_GranteeStatusDomain_58207df2-bf3d-4585-a5b4-02d8ec947d2c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementNewEmployeeMember_54433875-c6b4-402f-9873-fd38d32f4c66" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementNewEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_58207df2-bf3d-4585-a5b4-02d8ec947d2c" xlink:to="loc_hims_ShareBasedPaymentArrangementNewEmployeeMember_54433875-c6b4-402f-9873-fd38d32f4c66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementCurrentEmployeeMember_1cfbee47-42a4-4a59-8279-91f74a34283a" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementCurrentEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_58207df2-bf3d-4585-a5b4-02d8ec947d2c" xlink:to="loc_hims_ShareBasedPaymentArrangementCurrentEmployeeMember_1cfbee47-42a4-4a59-8279-91f74a34283a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_8fc6d004-4416-4c03-a218-9837d000ea78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_58207df2-bf3d-4585-a5b4-02d8ec947d2c" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_8fc6d004-4416-4c03-a218-9837d000ea78" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_07d6cdda-d4db-404d-ace3-a025260e3551" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_us-gaap_VestingAxis_07d6cdda-d4db-404d-ace3-a025260e3551" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_07d6cdda-d4db-404d-ace3-a025260e3551_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_07d6cdda-d4db-404d-ace3-a025260e3551" xlink:to="loc_us-gaap_VestingDomain_07d6cdda-d4db-404d-ace3-a025260e3551_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_55698005-a187-40d0-893a-83091e15c2cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_07d6cdda-d4db-404d-ace3-a025260e3551" xlink:to="loc_us-gaap_VestingDomain_55698005-a187-40d0-893a-83091e15c2cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_55865599-3473-4f84-935d-757f658c534f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_55698005-a187-40d0-893a-83091e15c2cc" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_55865599-3473-4f84-935d-757f658c534f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_facbeecd-f049-4aba-83f2-e26e9a06c5a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_srt_TitleOfIndividualAxis_facbeecd-f049-4aba-83f2-e26e9a06c5a1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_facbeecd-f049-4aba-83f2-e26e9a06c5a1_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_facbeecd-f049-4aba-83f2-e26e9a06c5a1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_facbeecd-f049-4aba-83f2-e26e9a06c5a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_195c9a0b-a1d3-4132-9c7c-f3b565351395" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_facbeecd-f049-4aba-83f2-e26e9a06c5a1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_195c9a0b-a1d3-4132-9c7c-f3b565351395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_37008f7f-e57a-426f-a273-5cb499eef997" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_195c9a0b-a1d3-4132-9c7c-f3b565351395" xlink:to="loc_srt_ChiefExecutiveOfficerMember_37008f7f-e57a-426f-a273-5cb499eef997" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_0e02645f-5bf9-43f3-a0a9-f30452eba523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_us-gaap_AwardDateAxis_0e02645f-5bf9-43f3-a0a9-f30452eba523" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_0e02645f-5bf9-43f3-a0a9-f30452eba523_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_0e02645f-5bf9-43f3-a0a9-f30452eba523" xlink:to="loc_us-gaap_AwardDateDomain_0e02645f-5bf9-43f3-a0a9-f30452eba523_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_e54e9c61-c5f7-4156-a4a4-1ac20a8c873b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_0e02645f-5bf9-43f3-a0a9-f30452eba523" xlink:to="loc_us-gaap_AwardDateDomain_e54e9c61-c5f7-4156-a4a4-1ac20a8c873b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_June172020GrantOneMember_2164c71f-c119-4767-b8d6-840ad0d9ca3a" xlink:href="hims-20210331.xsd#hims_June172020GrantOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_e54e9c61-c5f7-4156-a4a4-1ac20a8c873b" xlink:to="loc_hims_June172020GrantOneMember_2164c71f-c119-4767-b8d6-840ad0d9ca3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_June172020GrantTwoMember_73293dc4-0229-4f27-8432-63134c942586" xlink:href="hims-20210331.xsd#hims_June172020GrantTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_e54e9c61-c5f7-4156-a4a4-1ac20a8c873b" xlink:to="loc_hims_June172020GrantTwoMember_73293dc4-0229-4f27-8432-63134c942586" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationWeightedAverageFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails" xlink:type="extended" id="ia9bccdcaeb9f400ca748e2536553d59f_StockBasedCompensationWeightedAverageFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_890495ee-2906-41ee-94d0-2249685dfa9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_890495ee-2906-41ee-94d0-2249685dfa9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_e9f77d4a-74df-415a-8453-8ca2454023bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_e9f77d4a-74df-415a-8453-8ca2454023bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6b0abcf4-edc9-47f1-abd0-941dac40b70e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6b0abcf4-edc9-47f1-abd0-941dac40b70e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e8bcf5d1-9d42-4b03-b323-7ebe227b6f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e8bcf5d1-9d42-4b03-b323-7ebe227b6f63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d163a2fd-9147-4b6b-a470-765b5fba41a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d163a2fd-9147-4b6b-a470-765b5fba41a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_45351d26-5977-4539-9d7b-3eee410c08be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d163a2fd-9147-4b6b-a470-765b5fba41a5" xlink:to="loc_us-gaap_AwardTypeAxis_45351d26-5977-4539-9d7b-3eee410c08be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_45351d26-5977-4539-9d7b-3eee410c08be_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_45351d26-5977-4539-9d7b-3eee410c08be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_45351d26-5977-4539-9d7b-3eee410c08be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a08e59b-1310-4c68-9d4f-ce474a6e0a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_45351d26-5977-4539-9d7b-3eee410c08be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a08e59b-1310-4c68-9d4f-ce474a6e0a53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e7be099e-8d9d-4df8-9472-33d40e6a7d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a08e59b-1310-4c68-9d4f-ce474a6e0a53" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e7be099e-8d9d-4df8-9472-33d40e6a7d21" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationOptionActivityDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensationOptionActivityDetails" xlink:type="extended" id="ibfcb518de9f548e9a1d11a6d45415735_StockBasedCompensationOptionActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bbbf8fa1-8ec1-47c8-9219-65455670e254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bbbf8fa1-8ec1-47c8-9219-65455670e254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9be0203f-68ab-47b7-b2bc-8180e43bcb62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9be0203f-68ab-47b7-b2bc-8180e43bcb62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5c88a11c-0de0-4130-a8c5-2bbdebfecfdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5c88a11c-0de0-4130-a8c5-2bbdebfecfdb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_fe5af64f-2158-4dfc-88fe-6da8a0c9009f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_fe5af64f-2158-4dfc-88fe-6da8a0c9009f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8682c12c-7b01-4500-b63f-199469af0d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9318eb0b-d10d-4c45-a8ad-9295d1b053cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9318eb0b-d10d-4c45-a8ad-9295d1b053cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b674879e-db05-434c-8238-88aff72fb8f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b674879e-db05-434c-8238-88aff72fb8f5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c86e8d78-b99f-4df5-b795-96c2dff0e249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c86e8d78-b99f-4df5-b795-96c2dff0e249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ea99ca5f-67c3-4f6f-998b-e8270147f3c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ea99ca5f-67c3-4f6f-998b-e8270147f3c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0f7935d0-e67e-4c17-81f2-29f1a04ff267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0f7935d0-e67e-4c17-81f2-29f1a04ff267" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_af6c63b0-a946-44d1-ae64-5a9970874625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_af6c63b0-a946-44d1-ae64-5a9970874625" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a6abdbad-7995-4d4d-bcbf-8a2d185b9236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_959f27c5-1bd0-490d-90b9-05c8deb07806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_959f27c5-1bd0-490d-90b9-05c8deb07806" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8813a2be-da95-452b-972a-aa6d1e80290e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8813a2be-da95-452b-972a-aa6d1e80290e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f8172c7-9192-415d-b6f8-e59da294e555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f8172c7-9192-415d-b6f8-e59da294e555" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51e5fb91-a42a-4ebd-b6a1-f5bce5e88a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f8172c7-9192-415d-b6f8-e59da294e555" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51e5fb91-a42a-4ebd-b6a1-f5bce5e88a68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ee945898-ad50-4d1f-84d8-09ad2f80d67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f8172c7-9192-415d-b6f8-e59da294e555" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ee945898-ad50-4d1f-84d8-09ad2f80d67a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c7a82a35-8830-4a80-aa5d-b5da799e808f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f8172c7-9192-415d-b6f8-e59da294e555" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c7a82a35-8830-4a80-aa5d-b5da799e808f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_ef03e314-f17b-4108-9632-6a06af63788f" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_ef03e314-f17b-4108-9632-6a06af63788f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4fce3473-afcd-4efa-970c-a57736d45e65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_ef03e314-f17b-4108-9632-6a06af63788f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4fce3473-afcd-4efa-970c-a57736d45e65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_51081dbd-77f9-4349-8361-500dd0b5b6e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_ef03e314-f17b-4108-9632-6a06af63788f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_51081dbd-77f9-4349-8361-500dd0b5b6e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6632d6e9-c663-42b6-b002-89d027bfc601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_ef03e314-f17b-4108-9632-6a06af63788f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6632d6e9-c663-42b6-b002-89d027bfc601" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a3479f25-cda4-4418-bf7a-a12e17767687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a3479f25-cda4-4418-bf7a-a12e17767687" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_51be124e-c6f7-49c2-ab22-fcf52374de18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a3479f25-cda4-4418-bf7a-a12e17767687" xlink:to="loc_us-gaap_GranteeStatusAxis_51be124e-c6f7-49c2-ab22-fcf52374de18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_51be124e-c6f7-49c2-ab22-fcf52374de18_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_51be124e-c6f7-49c2-ab22-fcf52374de18" xlink:to="loc_us-gaap_GranteeStatusDomain_51be124e-c6f7-49c2-ab22-fcf52374de18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_00801861-b947-4e74-a144-f5b64f1882a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_51be124e-c6f7-49c2-ab22-fcf52374de18" xlink:to="loc_us-gaap_GranteeStatusDomain_00801861-b947-4e74-a144-f5b64f1882a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember_e00cd62a-6d49-42f4-bb0d-0704ba3a5418" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_00801861-b947-4e74-a144-f5b64f1882a3" xlink:to="loc_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember_e00cd62a-6d49-42f4-bb0d-0704ba3a5418" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_2a11f45b-e9b0-460a-b0c7-ed5e5b1f6b58" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a3479f25-cda4-4418-bf7a-a12e17767687" xlink:to="loc_srt_RestatementAxis_2a11f45b-e9b0-460a-b0c7-ed5e5b1f6b58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_2a11f45b-e9b0-460a-b0c7-ed5e5b1f6b58_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_2a11f45b-e9b0-460a-b0c7-ed5e5b1f6b58" xlink:to="loc_srt_RestatementDomain_2a11f45b-e9b0-460a-b0c7-ed5e5b1f6b58_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f421587b-782a-41e4-b296-065f0774ec3a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_2a11f45b-e9b0-460a-b0c7-ed5e5b1f6b58" xlink:to="loc_srt_RestatementDomain_f421587b-782a-41e4-b296-065f0774ec3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_2b61beb6-2bbf-4de3-8b39-42fc3f8b383b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_f421587b-782a-41e4-b296-065f0774ec3a" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_2b61beb6-2bbf-4de3-8b39-42fc3f8b383b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_c22b1c9d-6044-4a73-9320-a004453176f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_f421587b-782a-41e4-b296-065f0774ec3a" xlink:to="loc_srt_RestatementAdjustmentMember_c22b1c9d-6044-4a73-9320-a004453176f8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails" xlink:type="extended" id="i2588f96cf8b84e8485b479f741b5a076_StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_4d218fc2-2b5f-415d-956b-8d153128b065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_4d218fc2-2b5f-415d-956b-8d153128b065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_52e2b6a1-28aa-4768-9e20-6f0072e49347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_52e2b6a1-28aa-4768-9e20-6f0072e49347" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_6d48b607-bd7f-4200-991d-fd17b756d439" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:to="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_6d48b607-bd7f-4200-991d-fd17b756d439" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_69a7738f-d908-4f9c-bfe4-af9d362e2d48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_6d48b607-bd7f-4200-991d-fd17b756d439" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_69a7738f-d908-4f9c-bfe4-af9d362e2d48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_0b9c2e86-c854-4be6-adea-c18250824536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_6d48b607-bd7f-4200-991d-fd17b756d439" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_0b9c2e86-c854-4be6-adea-c18250824536" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_30a081ea-139d-451a-aa92-330cb3532379" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:to="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_30a081ea-139d-451a-aa92-330cb3532379" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_294c6c83-9932-4595-9397-47dc1c2de45a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_30a081ea-139d-451a-aa92-330cb3532379" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_294c6c83-9932-4595-9397-47dc1c2de45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_581bdc90-c3dd-4884-b3da-bccdf184260d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_30a081ea-139d-451a-aa92-330cb3532379" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_581bdc90-c3dd-4884-b3da-bccdf184260d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_57758bfe-1b51-4a17-9ce3-05e684be75ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_57758bfe-1b51-4a17-9ce3-05e684be75ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_038042d8-1a3e-4adf-a629-fa55a4f390d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_57758bfe-1b51-4a17-9ce3-05e684be75ac" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_038042d8-1a3e-4adf-a629-fa55a4f390d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_038042d8-1a3e-4adf-a629-fa55a4f390d9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_038042d8-1a3e-4adf-a629-fa55a4f390d9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_038042d8-1a3e-4adf-a629-fa55a4f390d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_038042d8-1a3e-4adf-a629-fa55a4f390d9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange006To040Member_db2f590e-3d18-453f-8589-3daf3b576540" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange006To040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:to="loc_hims_ExercisePriceRange006To040Member_db2f590e-3d18-453f-8589-3daf3b576540" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange155To233Member_f7bf6c1a-2216-4b25-8f6d-8a13ab01f8c4" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange155To233Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:to="loc_hims_ExercisePriceRange155To233Member_f7bf6c1a-2216-4b25-8f6d-8a13ab01f8c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange243To365Member_a4b39951-29e3-467e-b2fe-0c93489ddb5c" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange243To365Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:to="loc_hims_ExercisePriceRange243To365Member_a4b39951-29e3-467e-b2fe-0c93489ddb5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange890To1335Member_cfa3d85b-fe14-40ef-a063-d1c05eeb87e0" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange890To1335Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:to="loc_hims_ExercisePriceRange890To1335Member_cfa3d85b-fe14-40ef-a063-d1c05eeb87e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange1517To2276Member_f5cfbd38-9353-45e6-87ee-558abd01f407" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange1517To2276Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:to="loc_hims_ExercisePriceRange1517To2276Member_f5cfbd38-9353-45e6-87ee-558abd01f407" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationRSUsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails" xlink:type="extended" id="i6a1d3475ad0b4b85be792e9acec05e76_StockBasedCompensationRSUsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_795bf96d-8100-424d-94ff-2d59c88128f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_795bf96d-8100-424d-94ff-2d59c88128f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_fa183af3-97be-4457-a534-db18bff84ba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_fa183af3-97be-4457-a534-db18bff84ba3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_61e40c9e-8af7-4e5d-a159-728ef704e263" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_RecapitalizationExchangeRatio_61e40c9e-8af7-4e5d-a159-728ef704e263" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_9d55b25e-0c3c-4406-9d52-d018df3bd6c8" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_9d55b25e-0c3c-4406-9d52-d018df3bd6c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_78a1f16a-9dc4-4294-963b-52a55c880903" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_78a1f16a-9dc4-4294-963b-52a55c880903" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_4a542a79-c103-4442-91dd-0a69c0bbf9db" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_4a542a79-c103-4442-91dd-0a69c0bbf9db" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_98adebf3-135b-4296-bd49-b44e703299f6" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_98adebf3-135b-4296-bd49-b44e703299f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_6223cf20-bc5b-4f8c-8dcd-060d1f5a2d59" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_6223cf20-bc5b-4f8c-8dcd-060d1f5a2d59" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_38c4d162-b489-4463-9026-4b42f0d8dd14" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_38c4d162-b489-4463-9026-4b42f0d8dd14" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_02eee665-b629-429c-a209-10c4d4f7dcfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_SharePrice_02eee665-b629-429c-a209-10c4d4f7dcfe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ae9f609-7312-4c3e-8de0-b22b8c1c2384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ae9f609-7312-4c3e-8de0-b22b8c1c2384" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77fd5201-cead-48a7-b2aa-78d1518d9283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77fd5201-cead-48a7-b2aa-78d1518d9283" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_7285f314-1ecb-4bf7-878e-c214d5859aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_7285f314-1ecb-4bf7-878e-c214d5859aa4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5d1afe49-a5dc-451a-97d3-b69154fe60a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5d1afe49-a5dc-451a-97d3-b69154fe60a5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5705e066-32c9-4972-96aa-a4b497b8d80b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:to="loc_us-gaap_AwardTypeAxis_5705e066-32c9-4972-96aa-a4b497b8d80b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5705e066-32c9-4972-96aa-a4b497b8d80b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5705e066-32c9-4972-96aa-a4b497b8d80b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5705e066-32c9-4972-96aa-a4b497b8d80b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd85f254-072b-4b1c-9c3b-3b532004c951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5705e066-32c9-4972-96aa-a4b497b8d80b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd85f254-072b-4b1c-9c3b-3b532004c951" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_625ae9ee-34a5-482d-ae3e-8250ab1ee66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd85f254-072b-4b1c-9c3b-3b532004c951" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_625ae9ee-34a5-482d-ae3e-8250ab1ee66c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EarnOutRestrictedStockUnitsMember_c67389b2-fba3-4b70-a7c6-7d525b52747f" xlink:href="hims-20210331.xsd#hims_EarnOutRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd85f254-072b-4b1c-9c3b-3b532004c951" xlink:to="loc_hims_EarnOutRestrictedStockUnitsMember_c67389b2-fba3-4b70-a7c6-7d525b52747f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantRestrictedStockUnitsMember_35c1c2d6-e03a-410e-9f41-5dcb578ee767" xlink:href="hims-20210331.xsd#hims_ParentWarrantRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd85f254-072b-4b1c-9c3b-3b532004c951" xlink:to="loc_hims_ParentWarrantRestrictedStockUnitsMember_35c1c2d6-e03a-410e-9f41-5dcb578ee767" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_ec8daf28-ad0a-4da1-94a5-78740851e5a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:to="loc_srt_TitleOfIndividualAxis_ec8daf28-ad0a-4da1-94a5-78740851e5a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ec8daf28-ad0a-4da1-94a5-78740851e5a2_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_ec8daf28-ad0a-4da1-94a5-78740851e5a2" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ec8daf28-ad0a-4da1-94a5-78740851e5a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_63e5860a-9fab-4dd7-b1be-926e67b3423f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_ec8daf28-ad0a-4da1-94a5-78740851e5a2" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_63e5860a-9fab-4dd7-b1be-926e67b3423f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_7924bdf5-c6e1-4161-a1b9-460113b566ad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_63e5860a-9fab-4dd7-b1be-926e67b3423f" xlink:to="loc_srt_ChiefExecutiveOfficerMember_7924bdf5-c6e1-4161-a1b9-460113b566ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember_3ddc5e41-dd4d-4e69-989a-0d8baaf7010e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_63e5860a-9fab-4dd7-b1be-926e67b3423f" xlink:to="loc_srt_OfficerMember_3ddc5e41-dd4d-4e69-989a-0d8baaf7010e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_52fea6a8-44e5-47b2-823f-2402878ad020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:to="loc_us-gaap_VestingAxis_52fea6a8-44e5-47b2-823f-2402878ad020" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_52fea6a8-44e5-47b2-823f-2402878ad020_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_52fea6a8-44e5-47b2-823f-2402878ad020" xlink:to="loc_us-gaap_VestingDomain_52fea6a8-44e5-47b2-823f-2402878ad020_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_07cbf01a-841d-4e42-9167-7b3a14c70201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_52fea6a8-44e5-47b2-823f-2402878ad020" xlink:to="loc_us-gaap_VestingDomain_07cbf01a-841d-4e42-9167-7b3a14c70201" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_11f39630-f3e8-4434-90b5-bb27bb08b57d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_07cbf01a-841d-4e42-9167-7b3a14c70201" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_11f39630-f3e8-4434-90b5-bb27bb08b57d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails" xlink:type="extended" id="id499b2b942244f6180c8d479916cda6c_StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5299888f-7ea4-4a83-9b8e-0f698d58b962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5299888f-7ea4-4a83-9b8e-0f698d58b962" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54dfa372-fd99-48ec-808c-589597b6cb22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54dfa372-fd99-48ec-808c-589597b6cb22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0af5f7c3-0206-4683-9e04-71577ba41aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0af5f7c3-0206-4683-9e04-71577ba41aa2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_08d55d19-a624-4eb4-b72f-2ce79585a2b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_08d55d19-a624-4eb4-b72f-2ce79585a2b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1589f7c9-2960-436c-b4b5-8818d70f4889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1589f7c9-2960-436c-b4b5-8818d70f4889" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_14ade6a4-728d-48d4-b194-b98a48b0efca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1589f7c9-2960-436c-b4b5-8818d70f4889" xlink:to="loc_us-gaap_AwardTypeAxis_14ade6a4-728d-48d4-b194-b98a48b0efca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_14ade6a4-728d-48d4-b194-b98a48b0efca_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_14ade6a4-728d-48d4-b194-b98a48b0efca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_14ade6a4-728d-48d4-b194-b98a48b0efca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75b29970-d1b5-4095-b52d-d16fe33c451b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_14ade6a4-728d-48d4-b194-b98a48b0efca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75b29970-d1b5-4095-b52d-d16fe33c451b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_84e604ef-ec22-4054-843f-eba4a637e57c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75b29970-d1b5-4095-b52d-d16fe33c451b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_84e604ef-ec22-4054-843f-eba4a637e57c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationRSUsActivityDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationRSUsActivityDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensationRSUsActivityDetails" xlink:type="extended" id="id549f388d3d64ce4b2b53eb0f5ac36f3_StockBasedCompensationRSUsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6d43366-b9f1-4129-8f9f-7a13bf07448f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6d43366-b9f1-4129-8f9f-7a13bf07448f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ab204419-007a-4833-9701-31191131093d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ab204419-007a-4833-9701-31191131093d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a17a9d08-d534-4be7-9ffd-6e125e84c1b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a17a9d08-d534-4be7-9ffd-6e125e84c1b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3c2bd097-be42-497c-9b73-dd7d4e59281a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3c2bd097-be42-497c-9b73-dd7d4e59281a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_03b4de0c-4e27-4b34-a019-e56afd3ad8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6d43366-b9f1-4129-8f9f-7a13bf07448f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f93ba00e-d768-4200-927e-b911aa3a4cdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f93ba00e-d768-4200-927e-b911aa3a4cdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_62bdf2a1-b411-4a9b-a2c3-d9274cbd363b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_62bdf2a1-b411-4a9b-a2c3-d9274cbd363b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2b5068f1-911f-44c3-966b-f1fd177144fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2b5068f1-911f-44c3-966b-f1fd177144fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e2fc4fee-0b19-4fda-93ed-35df1c9f8e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_764b3f91-a989-402a-98c0-c088d8d79022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6d43366-b9f1-4129-8f9f-7a13bf07448f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_764b3f91-a989-402a-98c0-c088d8d79022" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_6bc6a5a3-8acd-4513-87be-ab6271d0d6d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_764b3f91-a989-402a-98c0-c088d8d79022" xlink:to="loc_srt_RestatementAxis_6bc6a5a3-8acd-4513-87be-ab6271d0d6d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_6bc6a5a3-8acd-4513-87be-ab6271d0d6d4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_6bc6a5a3-8acd-4513-87be-ab6271d0d6d4" xlink:to="loc_srt_RestatementDomain_6bc6a5a3-8acd-4513-87be-ab6271d0d6d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_eae91b25-f6ec-44e2-b0f6-bb88653519ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_6bc6a5a3-8acd-4513-87be-ab6271d0d6d4" xlink:to="loc_srt_RestatementDomain_eae91b25-f6ec-44e2-b0f6-bb88653519ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_ab0273c3-af4b-4346-afcd-8911fa743b93" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_eae91b25-f6ec-44e2-b0f6-bb88653519ff" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_ab0273c3-af4b-4346-afcd-8911fa743b93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_58a09648-b5f9-4c2a-bedf-993e25399645" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_eae91b25-f6ec-44e2-b0f6-bb88653519ff" xlink:to="loc_srt_RestatementAdjustmentMember_58a09648-b5f9-4c2a-bedf-993e25399645" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_776984ce-c4ae-4979-bc59-0de429de8d8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_764b3f91-a989-402a-98c0-c088d8d79022" xlink:to="loc_us-gaap_AwardTypeAxis_776984ce-c4ae-4979-bc59-0de429de8d8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_776984ce-c4ae-4979-bc59-0de429de8d8e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_776984ce-c4ae-4979-bc59-0de429de8d8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_776984ce-c4ae-4979-bc59-0de429de8d8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f835af2-31c7-4e01-97bd-acc93c8c4255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_776984ce-c4ae-4979-bc59-0de429de8d8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f835af2-31c7-4e01-97bd-acc93c8c4255" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_827911e0-c40f-45a2-87ad-1c98b1ff61a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f835af2-31c7-4e01-97bd-acc93c8c4255" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_827911e0-c40f-45a2-87ad-1c98b1ff61a4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationVendorWarrantsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails" xlink:type="extended" id="i852aa7ff093b4cb0bf7c401ee098c039_StockBasedCompensationVendorWarrantsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_1ba73c3f-f58a-4925-8cb9-62ae8ae5bac5" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_RecapitalizationExchangeRatio_1ba73c3f-f58a-4925-8cb9-62ae8ae5bac5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_04c41091-5167-4cc4-be69-35eabde2aad8" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_04c41091-5167-4cc4-be69-35eabde2aad8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_fb2b983a-5727-4703-b19b-802b422f219c" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_fb2b983a-5727-4703-b19b-802b422f219c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_75aaf1da-6b2c-4fab-afd1-2bc8254c80fb" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_75aaf1da-6b2c-4fab-afd1-2bc8254c80fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_43d28b18-bd54-4601-b0a0-aa986df8e8df" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_43d28b18-bd54-4601-b0a0-aa986df8e8df" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_0a259d54-7b66-4468-b74e-9f60fdb3826d" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_0a259d54-7b66-4468-b74e-9f60fdb3826d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_35639c21-1391-4740-aa77-c731bac61b3b" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_35639c21-1391-4740-aa77-c731bac61b3b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8903b753-6af3-483c-aeb6-52e5d906d15d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8903b753-6af3-483c-aeb6-52e5d906d15d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a721b744-0d52-452c-acec-338ba037b58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a721b744-0d52-452c-acec-338ba037b58e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9d90ec0c-69a5-4948-bc75-c81e21511746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9d90ec0c-69a5-4948-bc75-c81e21511746" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6a3737f-8596-4aaf-8f7b-109b9eb3fe48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6a3737f-8596-4aaf-8f7b-109b9eb3fe48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a5d43e97-0b90-403d-8a65-43db95bdb80e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6a3737f-8596-4aaf-8f7b-109b9eb3fe48" xlink:to="loc_us-gaap_AwardTypeAxis_a5d43e97-0b90-403d-8a65-43db95bdb80e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5d43e97-0b90-403d-8a65-43db95bdb80e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a5d43e97-0b90-403d-8a65-43db95bdb80e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5d43e97-0b90-403d-8a65-43db95bdb80e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42207a00-bf8a-4bde-a35e-4e124e5bcc41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a5d43e97-0b90-403d-8a65-43db95bdb80e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42207a00-bf8a-4bde-a35e-4e124e5bcc41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorWarrantsMember_1095b1f7-4ae6-46d2-9796-90bebee1adf0" xlink:href="hims-20210331.xsd#hims_VendorWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42207a00-bf8a-4bde-a35e-4e124e5bcc41" xlink:to="loc_hims_VendorWarrantsMember_1095b1f7-4ae6-46d2-9796-90bebee1adf0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_eae8823e-d627-4ac3-8d48-d9f9de1c0973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6a3737f-8596-4aaf-8f7b-109b9eb3fe48" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_eae8823e-d627-4ac3-8d48-d9f9de1c0973" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_eae8823e-d627-4ac3-8d48-d9f9de1c0973_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eae8823e-d627-4ac3-8d48-d9f9de1c0973" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_eae8823e-d627-4ac3-8d48-d9f9de1c0973_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1c768efb-1cd7-4c60-a09b-c97c9a67854c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eae8823e-d627-4ac3-8d48-d9f9de1c0973" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1c768efb-1cd7-4c60-a09b-c97c9a67854c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EarnOutAndParentWarrantsMember_697133d0-df28-4809-af9d-fbb7dacf305d" xlink:href="hims-20210331.xsd#hims_EarnOutAndParentWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1c768efb-1cd7-4c60-a09b-c97c9a67854c" xlink:to="loc_hims_EarnOutAndParentWarrantsMember_697133d0-df28-4809-af9d-fbb7dacf305d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationVendorWarrantActivityDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails" xlink:type="extended" id="i026a39e2515349acba779c4147a3bdf8_StockBasedCompensationVendorWarrantActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_7b1a7337-55c2-4f7e-a55c-893f43b36d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_7b1a7337-55c2-4f7e-a55c-893f43b36d87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c9a30ca6-82d4-4482-a787-cd09e315114d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c9a30ca6-82d4-4482-a787-cd09e315114d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_edea1fe5-6e87-4928-89cc-32812c44c8be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_edea1fe5-6e87-4928-89cc-32812c44c8be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_0b5652d0-2449-4967-bcd6-05313d82e9d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_0b5652d0-2449-4967-bcd6-05313d82e9d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_21997c1b-c477-4fcf-a636-7fe1347c21c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_38c329ef-1fc4-431f-9026-b9758c3fbac1" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_38c329ef-1fc4-431f-9026-b9758c3fbac1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_f9f0cff8-d432-4a1c-91e6-6005194bf9a2" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_f9f0cff8-d432-4a1c-91e6-6005194bf9a2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6438abf2-4440-41d4-a5e9-68a8094af421" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6438abf2-4440-41d4-a5e9-68a8094af421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_602d389a-b275-4414-94fc-064940893c88" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_602d389a-b275-4414-94fc-064940893c88" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_2802da92-e4f0-4612-bcff-0ccb066ea0d0" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_2802da92-e4f0-4612-bcff-0ccb066ea0d0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3b48d500-fdf7-4f6d-b529-21220f5f580c" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3b48d500-fdf7-4f6d-b529-21220f5f580c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_e141c69f-fc0d-4760-bc22-3c603a2bceb8" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_3581bd80-bfe2-428e-9ad5-a45a6b255b83" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_3581bd80-bfe2-428e-9ad5-a45a6b255b83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_c3c193b0-d384-4912-b603-aff98906ff3d" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_c3c193b0-d384-4912-b603-aff98906ff3d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract_67ff7a1d-4199-4046-bbbe-04048650f28a" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract_67ff7a1d-4199-4046-bbbe-04048650f28a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_d4907857-114c-4991-a1b0-605b77086cbb" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract_67ff7a1d-4199-4046-bbbe-04048650f28a" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_d4907857-114c-4991-a1b0-605b77086cbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms_c2198b8e-c0cc-4a9d-90bb-1ccc79c6c06c" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms_c2198b8e-c0cc-4a9d-90bb-1ccc79c6c06c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms_6e69f365-4726-4dc7-9f81-43d7b706dea8" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms_6e69f365-4726-4dc7-9f81-43d7b706dea8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract_c3457ab3-35c7-4d54-832b-11cd1d1f824b" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract_c3457ab3-35c7-4d54-832b-11cd1d1f824b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_b03aee7b-d48a-4baf-9a22-a58d1b36a4a4" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract_c3457ab3-35c7-4d54-832b-11cd1d1f824b" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_b03aee7b-d48a-4baf-9a22-a58d1b36a4a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_be8f95b1-7be7-4db5-a812-dd7e0a78e08c" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_be8f95b1-7be7-4db5-a812-dd7e0a78e08c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_2a3fa71f-3e01-4803-8b70-32b4a2efc797" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_2a3fa71f-3e01-4803-8b70-32b4a2efc797" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7cf59c0e-e54b-4794-b6a6-54927bdf0399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7cf59c0e-e54b-4794-b6a6-54927bdf0399" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c6619368-3a53-427f-8518-8213c16ed67d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7cf59c0e-e54b-4794-b6a6-54927bdf0399" xlink:to="loc_us-gaap_AwardTypeAxis_c6619368-3a53-427f-8518-8213c16ed67d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c6619368-3a53-427f-8518-8213c16ed67d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c6619368-3a53-427f-8518-8213c16ed67d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c6619368-3a53-427f-8518-8213c16ed67d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_773394f0-4949-4315-ac8d-91e4ebcbbe68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c6619368-3a53-427f-8518-8213c16ed67d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_773394f0-4949-4315-ac8d-91e4ebcbbe68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorWarrantsMember_e099e691-ac56-4d20-804c-19524f8a426a" xlink:href="hims-20210331.xsd#hims_VendorWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_773394f0-4949-4315-ac8d-91e4ebcbbe68" xlink:to="loc_hims_VendorWarrantsMember_e099e691-ac56-4d20-804c-19524f8a426a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_7cd84c83-84d1-49b0-a265-7d865644a6a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7cf59c0e-e54b-4794-b6a6-54927bdf0399" xlink:to="loc_srt_RestatementAxis_7cd84c83-84d1-49b0-a265-7d865644a6a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7cd84c83-84d1-49b0-a265-7d865644a6a6_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_7cd84c83-84d1-49b0-a265-7d865644a6a6" xlink:to="loc_srt_RestatementDomain_7cd84c83-84d1-49b0-a265-7d865644a6a6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_9458d6b6-7a56-442a-999c-919549867617" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_7cd84c83-84d1-49b0-a265-7d865644a6a6" xlink:to="loc_srt_RestatementDomain_9458d6b6-7a56-442a-999c-919549867617" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_c903f2d8-2c75-479f-8aee-fbb9c5456ada" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_9458d6b6-7a56-442a-999c-919549867617" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_c903f2d8-2c75-479f-8aee-fbb9c5456ada" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_01cfc62f-9120-4e59-b82a-f99cd37897cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_9458d6b6-7a56-442a-999c-919549867617" xlink:to="loc_srt_RestatementAdjustmentMember_01cfc62f-9120-4e59-b82a-f99cd37897cd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails" xlink:type="extended" id="if6f3d676923b4701a65007036421a063_StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f3b45237-07f2-4b60-a0b2-392a9b249d60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_dbdf08b1-9be0-4ad6-bf35-a7ff7d2e99e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f3b45237-07f2-4b60-a0b2-392a9b249d60" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_dbdf08b1-9be0-4ad6-bf35-a7ff7d2e99e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e02dc7d1-5c7c-45b8-a986-25b5ca9d3e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f3b45237-07f2-4b60-a0b2-392a9b249d60" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e02dc7d1-5c7c-45b8-a986-25b5ca9d3e1c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_cfd79168-7bbb-4cd7-bcd2-adf4538e2934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e02dc7d1-5c7c-45b8-a986-25b5ca9d3e1c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_cfd79168-7bbb-4cd7-bcd2-adf4538e2934" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cfd79168-7bbb-4cd7-bcd2-adf4538e2934_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_cfd79168-7bbb-4cd7-bcd2-adf4538e2934" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cfd79168-7bbb-4cd7-bcd2-adf4538e2934_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0d46020a-59b8-4c42-b388-fa538ad91ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_cfd79168-7bbb-4cd7-bcd2-adf4538e2934" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0d46020a-59b8-4c42-b388-fa538ad91ba4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_MarketingExpenseMember_da4db995-a2db-4fc3-ba07-744f7861e786" xlink:href="hims-20210331.xsd#hims_MarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0d46020a-59b8-4c42-b388-fa538ad91ba4" xlink:to="loc_hims_MarketingExpenseMember_da4db995-a2db-4fc3-ba07-744f7861e786" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2bddef8e-47b8-43c7-a549-74a30fdb5677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0d46020a-59b8-4c42-b388-fa538ad91ba4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2bddef8e-47b8-43c7-a549-74a30fdb5677" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#RedeemableConvertiblePreferredStockAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:type="extended" id="ie107fe3d1b884a2d9e4df6124eee9e70_RedeemableConvertiblePreferredStockAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_fac04435-a664-44ae-9965-1782f3f70681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_fac04435-a664-44ae-9965-1782f3f70681" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_8e6f0300-3969-44f9-a106-47f9438c0c04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_8e6f0300-3969-44f9-a106-47f9438c0c04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromIssuanceOfTemporaryEquity_baee93ea-90a6-4bd1-9b6a-f1cb99b1e1b9" xlink:href="hims-20210331.xsd#hims_ProceedsFromIssuanceOfTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_hims_ProceedsFromIssuanceOfTemporaryEquity_baee93ea-90a6-4bd1-9b6a-f1cb99b1e1b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeConversionBasis_1b0a733e-a51a-443f-a5bc-d871c32068c8" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeConversionBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_hims_RecapitalizationExchangeConversionBasis_1b0a733e-a51a-443f-a5bc-d871c32068c8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_6572a15d-470f-41d4-8b92-f1fe2f671fc1" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_hims_RecapitalizationExchangeRatio_6572a15d-470f-41d4-8b92-f1fe2f671fc1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_25c579cf-8e77-4100-95d3-5a33dde7edd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_25c579cf-8e77-4100-95d3-5a33dde7edd6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1b537a29-3922-4960-9087-38c0e4075b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_1b537a29-3922-4960-9087-38c0e4075b24" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70161df6-66f4-4fbd-8a20-345058114619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70161df6-66f4-4fbd-8a20-345058114619" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromConversionOfConvertibleSecurities_eb31b34a-7666-4b8c-9f77-b932fd6c5ec7" xlink:href="hims-20210331.xsd#hims_ProceedsFromConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_hims_ProceedsFromConversionOfConvertibleSecurities_eb31b34a-7666-4b8c-9f77-b932fd6c5ec7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_93d49ccc-46d5-4ebb-bc9b-d04c91db2303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_93d49ccc-46d5-4ebb-bc9b-d04c91db2303" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_4baec37b-09d9-4e16-be1a-a5da77248103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_4baec37b-09d9-4e16-be1a-a5da77248103" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8d94372c-ce2d-48b1-9071-3b92fba54988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4baec37b-09d9-4e16-be1a-a5da77248103" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8d94372c-ce2d-48b1-9071-3b92fba54988" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8d94372c-ce2d-48b1-9071-3b92fba54988_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8d94372c-ce2d-48b1-9071-3b92fba54988" xlink:to="loc_us-gaap_ClassOfStockDomain_8d94372c-ce2d-48b1-9071-3b92fba54988_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d837157d-becc-43a2-afc4-f08a233ad83f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8d94372c-ce2d-48b1-9071-3b92fba54988" xlink:to="loc_us-gaap_ClassOfStockDomain_d837157d-becc-43a2-afc4-f08a233ad83f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_535740aa-ac0c-4f06-96ad-a4aa443141d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d837157d-becc-43a2-afc4-f08a233ad83f" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_535740aa-ac0c-4f06-96ad-a4aa443141d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_bdac9a81-b724-480f-9834-08dc921d2f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d837157d-becc-43a2-afc4-f08a233ad83f" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_bdac9a81-b724-480f-9834-08dc921d2f91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1943f61a-bdf2-4501-8cba-f67e60ef0b70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4baec37b-09d9-4e16-be1a-a5da77248103" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1943f61a-bdf2-4501-8cba-f67e60ef0b70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1943f61a-bdf2-4501-8cba-f67e60ef0b70_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1943f61a-bdf2-4501-8cba-f67e60ef0b70" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1943f61a-bdf2-4501-8cba-f67e60ef0b70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_945fa7a9-b412-4fd8-8ef0-90575ad35862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1943f61a-bdf2-4501-8cba-f67e60ef0b70" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_945fa7a9-b412-4fd8-8ef0-90575ad35862" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesCPreferredStockWarrantsMember_87011ac5-c064-4c59-bb95-8631fd0f0efb" xlink:href="hims-20210331.xsd#hims_SeriesCPreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_945fa7a9-b412-4fd8-8ef0-90575ad35862" xlink:to="loc_hims_SeriesCPreferredStockWarrantsMember_87011ac5-c064-4c59-bb95-8631fd0f0efb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesDPreferredStockWarrantsMember_7bc2c37b-e402-4904-a6ce-acfc7b63d627" xlink:href="hims-20210331.xsd#hims_SeriesDPreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_945fa7a9-b412-4fd8-8ef0-90575ad35862" xlink:to="loc_hims_SeriesDPreferredStockWarrantsMember_7bc2c37b-e402-4904-a6ce-acfc7b63d627" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails" xlink:type="extended" id="ie54fecf5283e4573b32c24671979ccc4_RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_a736e999-6603-4e51-aa76-087109b9a06a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_a736e999-6603-4e51-aa76-087109b9a06a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_8d6420da-1761-4d28-b029-975c444d67fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_8d6420da-1761-4d28-b029-975c444d67fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2ecd5bf5-cfb1-4e13-a2e7-0544c682e289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2ecd5bf5-cfb1-4e13-a2e7-0544c682e289" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_04e38c7e-11d1-4d07-98cb-1aaaebb18682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_04e38c7e-11d1-4d07-98cb-1aaaebb18682" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromIssuanceOfTemporaryEquity_813e0609-581e-4113-b0d5-347d5b415ca7" xlink:href="hims-20210331.xsd#hims_ProceedsFromIssuanceOfTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_hims_ProceedsFromIssuanceOfTemporaryEquity_813e0609-581e-4113-b0d5-347d5b415ca7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityIssuedPricePerShare_697125b3-0d5f-4485-bb9e-8d98b220f688" xlink:href="hims-20210331.xsd#hims_TemporaryEquityIssuedPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_hims_TemporaryEquityIssuedPricePerShare_697125b3-0d5f-4485-bb9e-8d98b220f688" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_8a13d8a8-f900-4f00-bc3d-b424d80fb60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_8a13d8a8-f900-4f00-bc3d-b424d80fb60c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cae41ade-7caa-4881-b9b4-417951a1e9d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_8a13d8a8-f900-4f00-bc3d-b424d80fb60c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cae41ade-7caa-4881-b9b4-417951a1e9d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cae41ade-7caa-4881-b9b4-417951a1e9d5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cae41ade-7caa-4881-b9b4-417951a1e9d5" xlink:to="loc_us-gaap_ClassOfStockDomain_cae41ade-7caa-4881-b9b4-417951a1e9d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cae41ade-7caa-4881-b9b4-417951a1e9d5" xlink:to="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesSeedPreferredStockMember_c20ea6ca-337c-4aab-8586-660d3a37ee9b" xlink:href="hims-20210331.xsd#hims_SeriesSeedPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_hims_SeriesSeedPreferredStockMember_c20ea6ca-337c-4aab-8586-660d3a37ee9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_9a82bb54-e157-475d-9318-4c1ad881a462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_9a82bb54-e157-475d-9318-4c1ad881a462" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesA1PreferredStockMember_afe2c6d0-0863-47d8-a481-7dd7a8cd7e0f" xlink:href="hims-20210331.xsd#hims_SeriesA1PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_hims_SeriesA1PreferredStockMember_afe2c6d0-0863-47d8-a481-7dd7a8cd7e0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_e1987dba-1dac-4895-a894-8cd27ee7f0e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_e1987dba-1dac-4895-a894-8cd27ee7f0e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesB1PreferredStockMember_c6d29b42-6e35-4181-ac08-41f1452994c5" xlink:href="hims-20210331.xsd#hims_SeriesB1PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_hims_SeriesB1PreferredStockMember_c6d29b42-6e35-4181-ac08-41f1452994c5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesB2PreferredStockMember_77a5b704-6bdf-441b-8cb7-01344510d960" xlink:href="hims-20210331.xsd#hims_SeriesB2PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_hims_SeriesB2PreferredStockMember_77a5b704-6bdf-441b-8cb7-01344510d960" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_7acac814-b86b-4b55-b483-bdb51345c6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_7acac814-b86b-4b55-b483-bdb51345c6e2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_979b8f28-bc67-4f0e-89c9-e7c54110d752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_979b8f28-bc67-4f0e-89c9-e7c54110d752" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockAdditionalInformationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CommonStockAdditionalInformationDetails" xlink:type="extended" id="ie2a31c87d3a74a8d852cde00f1952d18_CommonStockAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NumberOfClassesOfCommonStock_8c4ee1c1-560b-4b59-87b3-89b14c06fb16" xlink:href="hims-20210331.xsd#hims_NumberOfClassesOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:to="loc_hims_NumberOfClassesOfCommonStock_8c4ee1c1-560b-4b59-87b3-89b14c06fb16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_d9136862-822a-4818-ab25-99a1adaaf96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_d9136862-822a-4818-ab25-99a1adaaf96e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d54926ad-e46c-4921-9dae-427f94fd0a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d54926ad-e46c-4921-9dae-427f94fd0a2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NotesReceivableAmountOfPrincipalPaymentCanceled_ee54ece1-bd55-47a7-9055-87c4f94bdf84" xlink:href="hims-20210331.xsd#hims_NotesReceivableAmountOfPrincipalPaymentCanceled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:to="loc_hims_NotesReceivableAmountOfPrincipalPaymentCanceled_ee54ece1-bd55-47a7-9055-87c4f94bdf84" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7bb5ff5b-3cc7-4f0a-b727-ad943f26ac87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7bb5ff5b-3cc7-4f0a-b727-ad943f26ac87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7bb5ff5b-3cc7-4f0a-b727-ad943f26ac87_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7bb5ff5b-3cc7-4f0a-b727-ad943f26ac87" xlink:to="loc_us-gaap_ClassOfStockDomain_7bb5ff5b-3cc7-4f0a-b727-ad943f26ac87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7d68f51c-ec0c-4ef8-8411-8f258295c925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7bb5ff5b-3cc7-4f0a-b727-ad943f26ac87" xlink:to="loc_us-gaap_ClassOfStockDomain_7d68f51c-ec0c-4ef8-8411-8f258295c925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_91ac3acf-e253-47e6-9a52-aff51cac57c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_7d68f51c-ec0c-4ef8-8411-8f258295c925" xlink:to="loc_us-gaap_CommonClassAMember_91ac3acf-e253-47e6-9a52-aff51cac57c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2dac8fcf-f3e0-46c7-8da0-defeae11048d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2dac8fcf-f3e0-46c7-8da0-defeae11048d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_2dac8fcf-f3e0-46c7-8da0-defeae11048d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2dac8fcf-f3e0-46c7-8da0-defeae11048d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_2dac8fcf-f3e0-46c7-8da0-defeae11048d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_97dab0f4-ed28-493f-b7b0-de3da41bab57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2dac8fcf-f3e0-46c7-8da0-defeae11048d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_97dab0f4-ed28-493f-b7b0-de3da41bab57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RepurchaseOfStockMember_b9d4240f-340a-4846-9c4d-77c6c238df2d" xlink:href="hims-20210331.xsd#hims_RepurchaseOfStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97dab0f4-ed28-493f-b7b0-de3da41bab57" xlink:to="loc_hims_RepurchaseOfStockMember_b9d4240f-340a-4846-9c4d-77c6c238df2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f9e1188-dd2a-468f-8310-a496e4a4acb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f9e1188-dd2a-468f-8310-a496e4a4acb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_1f9e1188-dd2a-468f-8310-a496e4a4acb9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f9e1188-dd2a-468f-8310-a496e4a4acb9" xlink:to="loc_us-gaap_RelatedPartyDomain_1f9e1188-dd2a-468f-8310-a496e4a4acb9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_720455c6-ae18-49fe-981e-fb03c078f756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f9e1188-dd2a-468f-8310-a496e4a4acb9" xlink:to="loc_us-gaap_RelatedPartyDomain_720455c6-ae18-49fe-981e-fb03c078f756" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_FormerExecutiveOfficerMember_3610248d-303e-4247-8d31-73373a4e4351" xlink:href="hims-20210331.xsd#hims_FormerExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_720455c6-ae18-49fe-981e-fb03c078f756" xlink:to="loc_hims_FormerExecutiveOfficerMember_3610248d-303e-4247-8d31-73373a4e4351" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockPreClosingStockRepurchaseDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails" xlink:type="extended" id="i9e9b79f16f004f44b9fe722d969da405_CommonStockPreClosingStockRepurchaseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_54aa9310-3ab6-47c3-8236-7c04e77fab77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_54aa9310-3ab6-47c3-8236-7c04e77fab77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_30147ca8-fd91-494b-8966-46b2932376b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_30147ca8-fd91-494b-8966-46b2932376b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_66bfeffe-7a0f-4779-98c8-9ed7c36bd4fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_66bfeffe-7a0f-4779-98c8-9ed7c36bd4fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_3246c6d2-b532-4fae-a20f-effcb38e341e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_3246c6d2-b532-4fae-a20f-effcb38e341e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_4f121960-0137-487d-84db-515e18c2301e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_4f121960-0137-487d-84db-515e18c2301e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_92c3c821-4d4b-4993-adea-e517c8e14748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4f121960-0137-487d-84db-515e18c2301e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_92c3c821-4d4b-4993-adea-e517c8e14748" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_92c3c821-4d4b-4993-adea-e517c8e14748_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92c3c821-4d4b-4993-adea-e517c8e14748" xlink:to="loc_us-gaap_ClassOfStockDomain_92c3c821-4d4b-4993-adea-e517c8e14748_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_80c68e19-41a4-473c-9627-016f2155bc47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92c3c821-4d4b-4993-adea-e517c8e14748" xlink:to="loc_us-gaap_ClassOfStockDomain_80c68e19-41a4-473c-9627-016f2155bc47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_36f46d70-9029-4f6b-b13a-7e5505365aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_80c68e19-41a4-473c-9627-016f2155bc47" xlink:to="loc_us-gaap_CommonClassAMember_36f46d70-9029-4f6b-b13a-7e5505365aae" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockMergerTransactionDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockMergerTransactionDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CommonStockMergerTransactionDetails" xlink:type="extended" id="i8fa83c425d9f486c97df6370369f896a_CommonStockMergerTransactionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_a48c6b20-52bc-4b2e-ac62-1e22f2da194e" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:to="loc_hims_RecapitalizationExchangeRatio_a48c6b20-52bc-4b2e-ac62-1e22f2da194e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_89e05d35-f59e-44a3-8e9f-a6f3bccb8744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_89e05d35-f59e-44a3-8e9f-a6f3bccb8744" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_973875c5-2757-4faa-8d49-551796b2eca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_973875c5-2757-4faa-8d49-551796b2eca5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_153fe080-df62-40b7-9e79-5157afa42842" xlink:href="hims-20210331.xsd#hims_RecapitalizationContingentConsiderationEquityExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:to="loc_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_153fe080-df62-40b7-9e79-5157afa42842" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cdb31462-2713-4694-8944-a030dc689e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cdb31462-2713-4694-8944-a030dc689e51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cdb31462-2713-4694-8944-a030dc689e51_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cdb31462-2713-4694-8944-a030dc689e51" xlink:to="loc_us-gaap_ClassOfStockDomain_cdb31462-2713-4694-8944-a030dc689e51_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b1ee53f4-87ac-410e-9901-717af765ec52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cdb31462-2713-4694-8944-a030dc689e51" xlink:to="loc_us-gaap_ClassOfStockDomain_b1ee53f4-87ac-410e-9901-717af765ec52" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassAAndVMember_2eff1f25-859d-4afb-b202-95dbd3afac79" xlink:href="hims-20210331.xsd#hims_CommonClassAAndVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_b1ee53f4-87ac-410e-9901-717af765ec52" xlink:to="loc_hims_CommonClassAAndVMember_2eff1f25-859d-4afb-b202-95dbd3afac79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_cd180499-49f5-4016-a27b-d293b29fee40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_CommonClassAAndVMember_2eff1f25-859d-4afb-b202-95dbd3afac79" xlink:to="loc_us-gaap_CommonClassAMember_cd180499-49f5-4016-a27b-d293b29fee40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember_0e1c991f-6ec1-46f5-bab3-29d0710bc142" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hims_CommonClassAAndVMember_2eff1f25-859d-4afb-b202-95dbd3afac79" xlink:to="loc_hims_CommonClassVMember_0e1c991f-6ec1-46f5-bab3-29d0710bc142" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d8932c83-fb4c-47d7-93d1-e8e53a1d0b39" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_dei_LegalEntityAxis_d8932c83-fb4c-47d7-93d1-e8e53a1d0b39" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_d8932c83-fb4c-47d7-93d1-e8e53a1d0b39_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_d8932c83-fb4c-47d7-93d1-e8e53a1d0b39" xlink:to="loc_dei_EntityDomain_d8932c83-fb4c-47d7-93d1-e8e53a1d0b39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_00cd36a1-67bc-4c85-aded-fb8fb940616d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_d8932c83-fb4c-47d7-93d1-e8e53a1d0b39" xlink:to="loc_dei_EntityDomain_00cd36a1-67bc-4c85-aded-fb8fb940616d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsIncMember_aca11a80-e719-492d-9d5c-768005170388" xlink:href="hims-20210331.xsd#hims_HimsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_00cd36a1-67bc-4c85-aded-fb8fb940616d" xlink:to="loc_hims_HimsIncMember_aca11a80-e719-492d-9d5c-768005170388" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_3f9ac9c4-2004-4e6a-8dc9-5cab671212e4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_srt_TitleOfIndividualAxis_3f9ac9c4-2004-4e6a-8dc9-5cab671212e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3f9ac9c4-2004-4e6a-8dc9-5cab671212e4_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_3f9ac9c4-2004-4e6a-8dc9-5cab671212e4" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_3f9ac9c4-2004-4e6a-8dc9-5cab671212e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_cfaa1abb-d2c4-4267-b2f7-ef2c3ce26ad7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_3f9ac9c4-2004-4e6a-8dc9-5cab671212e4" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_cfaa1abb-d2c4-4267-b2f7-ef2c3ce26ad7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_c6f2a389-e09c-4abb-afd3-a2082663c77c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_cfaa1abb-d2c4-4267-b2f7-ef2c3ce26ad7" xlink:to="loc_srt_ChiefExecutiveOfficerMember_c6f2a389-e09c-4abb-afd3-a2082663c77c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_72ee228d-c585-494a-b7d8-a71f41bceab1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_72ee228d-c585-494a-b7d8-a71f41bceab1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_72ee228d-c585-494a-b7d8-a71f41bceab1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_72ee228d-c585-494a-b7d8-a71f41bceab1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_72ee228d-c585-494a-b7d8-a71f41bceab1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_9f7b2c04-42ba-43c3-a4f5-ebf188aac61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_72ee228d-c585-494a-b7d8-a71f41bceab1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_9f7b2c04-42ba-43c3-a4f5-ebf188aac61b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_a48586f4-9c72-45a5-8c06-74b2f0c55f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_9f7b2c04-42ba-43c3-a4f5-ebf188aac61b" xlink:to="loc_us-gaap_CommonClassAMember_a48586f4-9c72-45a5-8c06-74b2f0c55f2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ca58549e-1bd7-49b7-b028-6b803f27d638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ca58549e-1bd7-49b7-b028-6b803f27d638" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ca58549e-1bd7-49b7-b028-6b803f27d638_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ca58549e-1bd7-49b7-b028-6b803f27d638" xlink:to="loc_us-gaap_EquityComponentDomain_ca58549e-1bd7-49b7-b028-6b803f27d638_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4406bd98-304c-4f42-a109-4e47ae0befcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ca58549e-1bd7-49b7-b028-6b803f27d638" xlink:to="loc_us-gaap_EquityComponentDomain_4406bd98-304c-4f42-a109-4e47ae0befcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7ff2c436-8aac-4b95-977e-2c974e42bbd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_4406bd98-304c-4f42-a109-4e47ae0befcb" xlink:to="loc_us-gaap_CommonStockMember_7ff2c436-8aac-4b95-977e-2c974e42bbd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails" xlink:type="extended" id="if2e8768ac2454d709d4ba133da69a727_CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_eee2ad97-a172-4013-9643-21641463e747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_ad388e6a-fddc-45dc-af1b-5f3ea856b8f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_eee2ad97-a172-4013-9643-21641463e747" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_ad388e6a-fddc-45dc-af1b-5f3ea856b8f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_559d2600-a979-44da-b05b-69bb7571bb45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_eee2ad97-a172-4013-9643-21641463e747" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_559d2600-a979-44da-b05b-69bb7571bb45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_db2c2d62-d31f-442b-973c-1921eea8ede3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_eee2ad97-a172-4013-9643-21641463e747" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_db2c2d62-d31f-442b-973c-1921eea8ede3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8e85ec0e-635a-4a52-96ba-2b3cc0d3cfaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_db2c2d62-d31f-442b-973c-1921eea8ede3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8e85ec0e-635a-4a52-96ba-2b3cc0d3cfaf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8e85ec0e-635a-4a52-96ba-2b3cc0d3cfaf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8e85ec0e-635a-4a52-96ba-2b3cc0d3cfaf" xlink:to="loc_us-gaap_ClassOfStockDomain_8e85ec0e-635a-4a52-96ba-2b3cc0d3cfaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d7f79ed5-12a6-4a7a-9219-8ed210c102fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8e85ec0e-635a-4a52-96ba-2b3cc0d3cfaf" xlink:to="loc_us-gaap_ClassOfStockDomain_d7f79ed5-12a6-4a7a-9219-8ed210c102fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_478e3ff7-a2c9-49f7-a628-ee391004d8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d7f79ed5-12a6-4a7a-9219-8ed210c102fc" xlink:to="loc_us-gaap_CommonClassAMember_478e3ff7-a2c9-49f7-a628-ee391004d8d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0041d719-2f37-4c5e-9174-d66ea6b418a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_db2c2d62-d31f-442b-973c-1921eea8ede3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0041d719-2f37-4c5e-9174-d66ea6b418a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0041d719-2f37-4c5e-9174-d66ea6b418a9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0041d719-2f37-4c5e-9174-d66ea6b418a9" xlink:to="loc_us-gaap_EquityComponentDomain_0041d719-2f37-4c5e-9174-d66ea6b418a9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3ac64340-a796-4ff2-848f-85171c18585e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0041d719-2f37-4c5e-9174-d66ea6b418a9" xlink:to="loc_us-gaap_EquityComponentDomain_3ac64340-a796-4ff2-848f-85171c18585e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1bff4856-864e-43d6-9bfe-0d8028eff14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_3ac64340-a796-4ff2-848f-85171c18585e" xlink:to="loc_us-gaap_CommonStockMember_1bff4856-864e-43d6-9bfe-0d8028eff14c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockPIPEInvestmentDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockPIPEInvestmentDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CommonStockPIPEInvestmentDetails" xlink:type="extended" id="i1f43a45acdd1489ca5e30bacdb1e20c2_CommonStockPIPEInvestmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_d849919b-5839-47e1-83ab-c8122c5d9afd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f9b50d17-9086-46c4-8058-45ab99ef90e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_d849919b-5839-47e1-83ab-c8122c5d9afd" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f9b50d17-9086-46c4-8058-45ab99ef90e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_1ddc5df0-4931-49fe-a840-c6a6cde2dc4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_d849919b-5839-47e1-83ab-c8122c5d9afd" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_1ddc5df0-4931-49fe-a840-c6a6cde2dc4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6e9b12c5-2b6a-4cf2-be91-22010c77fe23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_d849919b-5839-47e1-83ab-c8122c5d9afd" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6e9b12c5-2b6a-4cf2-be91-22010c77fe23" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_517cd00e-6b01-4d63-8aba-1273448f20e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_d849919b-5839-47e1-83ab-c8122c5d9afd" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_517cd00e-6b01-4d63-8aba-1273448f20e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9b2cf686-dfbf-40c8-b5ac-886639c1192c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_517cd00e-6b01-4d63-8aba-1273448f20e0" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9b2cf686-dfbf-40c8-b5ac-886639c1192c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9b2cf686-dfbf-40c8-b5ac-886639c1192c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9b2cf686-dfbf-40c8-b5ac-886639c1192c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9b2cf686-dfbf-40c8-b5ac-886639c1192c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9563ad3d-e593-490f-b5e7-c68a6d299409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9b2cf686-dfbf-40c8-b5ac-886639c1192c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9563ad3d-e593-490f-b5e7-c68a6d299409" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_09b638ed-4bbd-44bd-9b57-7830e859446a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9563ad3d-e593-490f-b5e7-c68a6d299409" xlink:to="loc_us-gaap_PrivatePlacementMember_09b638ed-4bbd-44bd-9b57-7830e859446a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockPriortoMergerDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockPriortoMergerDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CommonStockPriortoMergerDetails" xlink:type="extended" id="i2c3b6ccc53024138a95180f0dec8bf7b_CommonStockPriortoMergerDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_77486cd6-44c7-43b5-bab4-d3022fd8f8ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_13b07782-131a-445e-bed9-3373bd0092dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_77486cd6-44c7-43b5-bab4-d3022fd8f8ef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_13b07782-131a-445e-bed9-3373bd0092dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7a01ca3a-fdcf-473f-9a06-9df14003c3c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_77486cd6-44c7-43b5-bab4-d3022fd8f8ef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7a01ca3a-fdcf-473f-9a06-9df14003c3c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_41c52e24-5986-4e84-908a-0b8e449541d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_77486cd6-44c7-43b5-bab4-d3022fd8f8ef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_41c52e24-5986-4e84-908a-0b8e449541d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_b151662c-1833-4ff1-97fa-45a3021ba18f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_41c52e24-5986-4e84-908a-0b8e449541d6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_b151662c-1833-4ff1-97fa-45a3021ba18f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_b151662c-1833-4ff1-97fa-45a3021ba18f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_b151662c-1833-4ff1-97fa-45a3021ba18f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_b151662c-1833-4ff1-97fa-45a3021ba18f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_b151662c-1833-4ff1-97fa-45a3021ba18f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonStockWarrantsMember_d9b32a85-22ae-4665-a181-0fa0499e3379" xlink:href="hims-20210331.xsd#hims_CommonStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:to="loc_hims_CommonStockWarrantsMember_d9b32a85-22ae-4665-a181-0fa0499e3379" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonStockWarrantsGroupOneMember_393ea08c-3825-4622-85c9-aeb7ae4ed978" xlink:href="hims-20210331.xsd#hims_CommonStockWarrantsGroupOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:to="loc_hims_CommonStockWarrantsGroupOneMember_393ea08c-3825-4622-85c9-aeb7ae4ed978" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorWarrantsMember_6ec5dbf2-9b6e-4672-9fb1-16b29761d38e" xlink:href="hims-20210331.xsd#hims_VendorWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:to="loc_hims_VendorWarrantsMember_6ec5dbf2-9b6e-4672-9fb1-16b29761d38e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonStockWarrantsGroupTwoMember_3ce12950-40c3-4f1c-a20d-2135847268d2" xlink:href="hims-20210331.xsd#hims_CommonStockWarrantsGroupTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:to="loc_hims_CommonStockWarrantsGroupTwoMember_3ce12950-40c3-4f1c-a20d-2135847268d2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_669d0c5a-6b45-4738-beba-b6e79e6469d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_41c52e24-5986-4e84-908a-0b8e449541d6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_669d0c5a-6b45-4738-beba-b6e79e6469d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_669d0c5a-6b45-4738-beba-b6e79e6469d6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_669d0c5a-6b45-4738-beba-b6e79e6469d6" xlink:to="loc_us-gaap_ClassOfStockDomain_669d0c5a-6b45-4738-beba-b6e79e6469d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ef0498c4-132e-4144-9d86-891469eaf70f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_669d0c5a-6b45-4738-beba-b6e79e6469d6" xlink:to="loc_us-gaap_ClassOfStockDomain_ef0498c4-132e-4144-9d86-891469eaf70f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_17206782-c45e-4092-8b8d-920d6de791fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_ef0498c4-132e-4144-9d86-891469eaf70f" xlink:to="loc_us-gaap_CommonClassAMember_17206782-c45e-4092-8b8d-920d6de791fc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockSubsequenttoMergerDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockSubsequenttoMergerDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CommonStockSubsequenttoMergerDetails" xlink:type="extended" id="i07d5ea40c8bb4241b852e5d3bb3841bb_CommonStockSubsequenttoMergerDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_070013ea-4688-4a8d-b180-fe448f3646ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_070013ea-4688-4a8d-b180-fe448f3646ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c213d5b6-185a-489a-9ec2-9b56b7c0ebeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c213d5b6-185a-489a-9ec2-9b56b7c0ebeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_8ba76419-615f-42cd-be7a-f694be4a8cba" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_RecapitalizationExchangeRatio_8ba76419-615f-42cd-be7a-f694be4a8cba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_9f67296e-8c75-465f-82fb-8728426029b6" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_9f67296e-8c75-465f-82fb-8728426029b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_a34b6c4e-1692-40ce-9b56-b3c3a039b011" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_a34b6c4e-1692-40ce-9b56-b3c3a039b011" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_4fdcd18a-8c84-4dfa-8b39-a7bcd558b24d" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_4fdcd18a-8c84-4dfa-8b39-a7bcd558b24d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_aa3d20ca-1543-464b-b96e-d5247678527b" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_aa3d20ca-1543-464b-b96e-d5247678527b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_4a8a42df-f06f-4e6e-920e-07cbb84fc150" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_4a8a42df-f06f-4e6e-920e-07cbb84fc150" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_204c4a54-d4c4-466f-84d2-82722ecb99d4" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_204c4a54-d4c4-466f-84d2-82722ecb99d4" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_48b02309-d440-4e26-81d2-0eabef659fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_48b02309-d440-4e26-81d2-0eabef659fbf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_a51762bb-709b-42bb-b41d-1a6a2e7f3336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_a51762bb-709b-42bb-b41d-1a6a2e7f3336" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_ec491574-af29-4365-b5c3-fcd30f4f039d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_a51762bb-709b-42bb-b41d-1a6a2e7f3336" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_ec491574-af29-4365-b5c3-fcd30f4f039d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_ec491574-af29-4365-b5c3-fcd30f4f039d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ec491574-af29-4365-b5c3-fcd30f4f039d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_ec491574-af29-4365-b5c3-fcd30f4f039d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_29a78d2c-2099-43a5-af66-73acbf09f453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ec491574-af29-4365-b5c3-fcd30f4f039d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_29a78d2c-2099-43a5-af66-73acbf09f453" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PrivatePlacementWarrantsMember_d8fcdd14-0915-464a-b5f7-7a3108577d56" xlink:href="hims-20210331.xsd#hims_PrivatePlacementWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_29a78d2c-2099-43a5-af66-73acbf09f453" xlink:to="loc_hims_PrivatePlacementWarrantsMember_d8fcdd14-0915-464a-b5f7-7a3108577d56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsMember_5b8e7f8f-3b77-41d8-9bb8-df4fb23bc4a8" xlink:href="hims-20210331.xsd#hims_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_29a78d2c-2099-43a5-af66-73acbf09f453" xlink:to="loc_hims_PublicWarrantsMember_5b8e7f8f-3b77-41d8-9bb8-df4fb23bc4a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantsMember_d05d306e-f1fb-49a2-9557-1d0eb6c610f4" xlink:href="hims-20210331.xsd#hims_ParentWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_29a78d2c-2099-43a5-af66-73acbf09f453" xlink:to="loc_hims_ParentWarrantsMember_d05d306e-f1fb-49a2-9557-1d0eb6c610f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_af7a2771-74ca-4fdf-8bc9-aff1c95dcfcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_a51762bb-709b-42bb-b41d-1a6a2e7f3336" xlink:to="loc_us-gaap_StatementClassOfStockAxis_af7a2771-74ca-4fdf-8bc9-aff1c95dcfcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_af7a2771-74ca-4fdf-8bc9-aff1c95dcfcb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_af7a2771-74ca-4fdf-8bc9-aff1c95dcfcb" xlink:to="loc_us-gaap_ClassOfStockDomain_af7a2771-74ca-4fdf-8bc9-aff1c95dcfcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_744172a5-6e6c-419e-a7bc-92b8c3fc0cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_af7a2771-74ca-4fdf-8bc9-aff1c95dcfcb" xlink:to="loc_us-gaap_ClassOfStockDomain_744172a5-6e6c-419e-a7bc-92b8c3fc0cea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_aa4f30bf-0e19-4383-8b70-38c3c3b3a2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_744172a5-6e6c-419e-a7bc-92b8c3fc0cea" xlink:to="loc_us-gaap_CommonClassAMember_aa4f30bf-0e19-4383-8b70-38c3c3b3a2fd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockScheduleofWarrantsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails" xlink:type="extended" id="ia9842a3d5bc74472bd938f2d7bc43413_CommonStockScheduleofWarrantsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_e9e78ad4-ad6e-4ff7-a1c5-e7ecb490acaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2db0880c-a7f3-42b0-bcf3-1747f5d18980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e9e78ad4-ad6e-4ff7-a1c5-e7ecb490acaf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2db0880c-a7f3-42b0-bcf3-1747f5d18980" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_d86ec093-3965-48e6-9820-93ba55b039e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e9e78ad4-ad6e-4ff7-a1c5-e7ecb490acaf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_d86ec093-3965-48e6-9820-93ba55b039e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_d9f64b97-4db9-477b-8cf6-bf1b8fa47fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e9e78ad4-ad6e-4ff7-a1c5-e7ecb490acaf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_d9f64b97-4db9-477b-8cf6-bf1b8fa47fa3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0d52072e-a7a7-4cf7-8f2f-83e91c48d008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d9f64b97-4db9-477b-8cf6-bf1b8fa47fa3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0d52072e-a7a7-4cf7-8f2f-83e91c48d008" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0d52072e-a7a7-4cf7-8f2f-83e91c48d008_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0d52072e-a7a7-4cf7-8f2f-83e91c48d008" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0d52072e-a7a7-4cf7-8f2f-83e91c48d008_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0d52072e-a7a7-4cf7-8f2f-83e91c48d008" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorWarrantsMember_59c7fb70-c561-46e5-8743-4ec56d4302c6" xlink:href="hims-20210331.xsd#hims_VendorWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:to="loc_hims_VendorWarrantsMember_59c7fb70-c561-46e5-8743-4ec56d4302c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_DebtWarrantsMember_c04269d3-304a-4bc3-b85f-2d8906249895" xlink:href="hims-20210331.xsd#hims_DebtWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:to="loc_hims_DebtWarrantsMember_c04269d3-304a-4bc3-b85f-2d8906249895" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsMember_8c9ac398-9549-4404-8686-c9a739aebd66" xlink:href="hims-20210331.xsd#hims_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:to="loc_hims_PublicWarrantsMember_8c9ac398-9549-4404-8686-c9a739aebd66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantsMember_70a835d8-9297-4b56-857b-c6fe86b6fb51" xlink:href="hims-20210331.xsd#hims_ParentWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:to="loc_hims_ParentWarrantsMember_70a835d8-9297-4b56-857b-c6fe86b6fb51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b5c59061-e8f5-41fb-9e7d-770ba95311ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d9f64b97-4db9-477b-8cf6-bf1b8fa47fa3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b5c59061-e8f5-41fb-9e7d-770ba95311ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b5c59061-e8f5-41fb-9e7d-770ba95311ff_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b5c59061-e8f5-41fb-9e7d-770ba95311ff" xlink:to="loc_us-gaap_ClassOfStockDomain_b5c59061-e8f5-41fb-9e7d-770ba95311ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f99114b6-b1d5-4ab3-894b-08de0532478e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b5c59061-e8f5-41fb-9e7d-770ba95311ff" xlink:to="loc_us-gaap_ClassOfStockDomain_f99114b6-b1d5-4ab3-894b-08de0532478e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_5ee6b8c6-74a9-40fe-85a8-d4b3e0a94cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_f99114b6-b1d5-4ab3-894b-08de0532478e" xlink:to="loc_us-gaap_CommonClassAMember_5ee6b8c6-74a9-40fe-85a8-d4b3e0a94cbd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockPublicWarrantTermsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockPublicWarrantTermsDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/CommonStockPublicWarrantTermsDetails" xlink:type="extended" id="i8d941134b6594935a624a8b252184748_CommonStockPublicWarrantTermsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate_0e69c1ea-3051-4f00-ac3f-721cedfb340b" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate_0e69c1ea-3051-4f00-ac3f-721cedfb340b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightExpirationPeriod_ec887d8d-927c-4b6d-a3f1-6a26b197a0a3" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightExpirationPeriod_ec887d8d-927c-4b6d-a3f1-6a26b197a0a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable_8103ba99-790d-4ba5-aaee-2d42b4d01709" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable_8103ba99-790d-4ba5-aaee-2d42b4d01709" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightRedemptionPricePerShare_da313cad-5fe1-4227-9e35-21f30d980913" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightRedemptionPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightRedemptionPricePerShare_da313cad-5fe1-4227-9e35-21f30d980913" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum_9c54484e-6e50-4437-8623-60037a6be804" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum_9c54484e-6e50-4437-8623-60037a6be804" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightThresholdTradingDays_daa8270d-6fe1-430a-8757-67bf0255b9d0" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightThresholdTradingDays_daa8270d-6fe1-430a-8757-67bf0255b9d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold_559631e1-8332-4d81-82b4-544e9ae70c33" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold_559631e1-8332-4d81-82b4-544e9ae70c33" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption_49407ee9-18b1-4a77-915f-cd32a1224cb3" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption_49407ee9-18b1-4a77-915f-cd32a1224cb3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays_9379c6a5-9c89-4a12-a3ae-b137e93478d9" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays_9379c6a5-9c89-4a12-a3ae-b137e93478d9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_b6d727e3-6165-4833-9e2a-f7ee6bf1204f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_b6d727e3-6165-4833-9e2a-f7ee6bf1204f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_6a36cb7e-28db-4ea5-822e-4cd066df4da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b6d727e3-6165-4833-9e2a-f7ee6bf1204f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_6a36cb7e-28db-4ea5-822e-4cd066df4da2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_6a36cb7e-28db-4ea5-822e-4cd066df4da2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6a36cb7e-28db-4ea5-822e-4cd066df4da2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_6a36cb7e-28db-4ea5-822e-4cd066df4da2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5b8fbd95-762c-4952-b7d6-13f4a46fe843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6a36cb7e-28db-4ea5-822e-4cd066df4da2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5b8fbd95-762c-4952-b7d6-13f4a46fe843" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsMember_adc21b5d-b723-43dd-8c85-928a90d3488e" xlink:href="hims-20210331.xsd#hims_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5b8fbd95-762c-4952-b7d6-13f4a46fe843" xlink:to="loc_hims_PublicWarrantsMember_adc21b5d-b723-43dd-8c85-928a90d3488e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsWarrantRedemptionMember_f3778ebe-201c-4a65-8ff1-7018cd2fce3f" xlink:href="hims-20210331.xsd#hims_PublicWarrantsWarrantRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5b8fbd95-762c-4952-b7d6-13f4a46fe843" xlink:to="loc_hims_PublicWarrantsWarrantRedemptionMember_f3778ebe-201c-4a65-8ff1-7018cd2fce3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsCashRedemptionMember_9567b203-4899-46be-905e-93588fac2ef0" xlink:href="hims-20210331.xsd#hims_PublicWarrantsCashRedemptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5b8fbd95-762c-4952-b7d6-13f4a46fe843" xlink:to="loc_hims_PublicWarrantsCashRedemptionMember_9567b203-4899-46be-905e-93588fac2ef0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6d629311-0027-444f-a93c-aaf24968898a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b6d727e3-6165-4833-9e2a-f7ee6bf1204f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6d629311-0027-444f-a93c-aaf24968898a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6d629311-0027-444f-a93c-aaf24968898a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6d629311-0027-444f-a93c-aaf24968898a" xlink:to="loc_us-gaap_ClassOfStockDomain_6d629311-0027-444f-a93c-aaf24968898a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_55821fe5-d6b2-416e-aaa9-fcfe6761d33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6d629311-0027-444f-a93c-aaf24968898a" xlink:to="loc_us-gaap_ClassOfStockDomain_55821fe5-d6b2-416e-aaa9-fcfe6761d33b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_bbbc3677-1856-489a-8f8b-9b9795dd1dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_55821fe5-d6b2-416e-aaa9-fcfe6761d33b" xlink:to="loc_us-gaap_CommonClassAMember_bbbc3677-1856-489a-8f8b-9b9795dd1dbc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#RelatedPartyTransactionsDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/RelatedPartyTransactionsDetails" xlink:type="extended" id="i6cf3eb89d8704378a8eb3e6836a72aed_RelatedPartyTransactionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_cbbe66b0-1df2-49c4-9bf9-ffa6b3fd89aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_cbbe66b0-1df2-49c4-9bf9-ffa6b3fd89aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_635b624f-7c0e-4d27-8ee0-4a7985008d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_635b624f-7c0e-4d27-8ee0-4a7985008d0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_262f3782-d3a3-4e6f-a82c-6d857855ca55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_262f3782-d3a3-4e6f-a82c-6d857855ca55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dc673109-3808-4f79-b166-85b501337e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dc673109-3808-4f79-b166-85b501337e4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_65b79ea3-0146-4ace-b7fe-38a6102210fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_65b79ea3-0146-4ace-b7fe-38a6102210fd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue_7cece89b-c1f8-4307-b947-dd56b72ce1d0" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue_7cece89b-c1f8-4307-b947-dd56b72ce1d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_77c2c1ef-2174-4d0a-b62a-506bc9dff64d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_77c2c1ef-2174-4d0a-b62a-506bc9dff64d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockForfeitedDuringPeriodShares_0034d629-d8e6-4c17-b80c-a545da2ccff4" xlink:href="hims-20210331.xsd#hims_StockForfeitedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_hims_StockForfeitedDuringPeriodShares_0034d629-d8e6-4c17-b80c-a545da2ccff4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d805b024-2159-4220-9ffe-01bef204993d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d805b024-2159-4220-9ffe-01bef204993d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_efff71b0-79fd-4bc5-b8d4-6c6163be9e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_efff71b0-79fd-4bc5-b8d4-6c6163be9e5a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e6960133-8d6b-4392-8e5c-53b0d182fba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e6960133-8d6b-4392-8e5c-53b0d182fba0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SaleOfStockPutRightPeriod_c762ce9c-749d-4f61-a45b-a3eb7b5b93ed" xlink:href="hims-20210331.xsd#hims_SaleOfStockPutRightPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_hims_SaleOfStockPutRightPeriod_c762ce9c-749d-4f61-a45b-a3eb7b5b93ed" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_790a0ec4-005a-4241-9d32-51d3ddf7827c" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_790a0ec4-005a-4241-9d32-51d3ddf7827c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bafc8778-e5d3-4c5a-afed-7699c08d77e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bafc8778-e5d3-4c5a-afed-7699c08d77e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_bafc8778-e5d3-4c5a-afed-7699c08d77e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bafc8778-e5d3-4c5a-afed-7699c08d77e1" xlink:to="loc_us-gaap_RelatedPartyDomain_bafc8778-e5d3-4c5a-afed-7699c08d77e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bafc8778-e5d3-4c5a-afed-7699c08d77e1" xlink:to="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_a0bb9a5a-bf5b-455d-a667-2e2398082b02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:to="loc_srt_AffiliatedEntityMember_a0bb9a5a-bf5b-455d-a667-2e2398082b02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ManagementMember_662bb594-3550-462e-8a10-6a25d9dfbce5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ManagementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:to="loc_srt_ManagementMember_662bb594-3550-462e-8a10-6a25d9dfbce5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ChiefExecutiveOfficerAndDirectorMember_e73f9284-9c4e-4769-adff-57ea686e75f2" xlink:href="hims-20210331.xsd#hims_ChiefExecutiveOfficerAndDirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:to="loc_hims_ChiefExecutiveOfficerAndDirectorMember_e73f9284-9c4e-4769-adff-57ea686e75f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CEOAndDirectorMember_adc592bf-acba-402d-9657-de78522ef5b8" xlink:href="hims-20210331.xsd#hims_CEOAndDirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:to="loc_hims_CEOAndDirectorMember_adc592bf-acba-402d-9657-de78522ef5b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_c2481925-d241-4530-8903-814024758563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_c2481925-d241-4530-8903-814024758563" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_c2481925-d241-4530-8903-814024758563_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_c2481925-d241-4530-8903-814024758563" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_c2481925-d241-4530-8903-814024758563_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_c2481925-d241-4530-8903-814024758563" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperationalSupportMember_2c33c9b3-56de-4372-ad29-b9f9ce0341be" xlink:href="hims-20210331.xsd#hims_OperationalSupportMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:to="loc_hims_OperationalSupportMember_2c33c9b3-56de-4372-ad29-b9f9ce0341be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_IdentityVerificationServicesMember_5c2a03e8-5156-45ae-92b4-c871f46817ae" xlink:href="hims-20210331.xsd#hims_IdentityVerificationServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:to="loc_hims_IdentityVerificationServicesMember_5c2a03e8-5156-45ae-92b4-c871f46817ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NonrecourseRelatedPartyPromissoryNotesMember_2878c79c-13d9-4aae-8561-1eced7b81c21" xlink:href="hims-20210331.xsd#hims_NonrecourseRelatedPartyPromissoryNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:to="loc_hims_NonrecourseRelatedPartyPromissoryNotesMember_2878c79c-13d9-4aae-8561-1eced7b81c21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableCommonStockTransactionMember_e7c07a93-2f2d-42c9-90a9-c75516639423" xlink:href="hims-20210331.xsd#hims_RedeemableCommonStockTransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:to="loc_hims_RedeemableCommonStockTransactionMember_e7c07a93-2f2d-42c9-90a9-c75516639423" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fcd9aff2-e37f-4023-b61b-0df605a33a59" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_srt_RangeAxis_fcd9aff2-e37f-4023-b61b-0df605a33a59" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fcd9aff2-e37f-4023-b61b-0df605a33a59_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fcd9aff2-e37f-4023-b61b-0df605a33a59" xlink:to="loc_srt_RangeMember_fcd9aff2-e37f-4023-b61b-0df605a33a59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fafd25e1-021c-4100-8607-80f7e44608fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fcd9aff2-e37f-4023-b61b-0df605a33a59" xlink:to="loc_srt_RangeMember_fafd25e1-021c-4100-8607-80f7e44608fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ae7317ec-86bc-4f34-9d0b-7acbcfb25d58" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fafd25e1-021c-4100-8607-80f7e44608fc" xlink:to="loc_srt_MinimumMember_ae7317ec-86bc-4f34-9d0b-7acbcfb25d58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_182f184b-e979-4c3b-8ead-361dacd119c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fafd25e1-021c-4100-8607-80f7e44608fc" xlink:to="loc_srt_MaximumMember_182f184b-e979-4c3b-8ead-361dacd119c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ac8c0825-c9c6-4cd8-897b-8fca3c7d1a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ac8c0825-c9c6-4cd8-897b-8fca3c7d1a7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ac8c0825-c9c6-4cd8-897b-8fca3c7d1a7f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ac8c0825-c9c6-4cd8-897b-8fca3c7d1a7f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ac8c0825-c9c6-4cd8-897b-8fca3c7d1a7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_952132b8-da9d-4e7a-9870-b056fa7ba01d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ac8c0825-c9c6-4cd8-897b-8fca3c7d1a7f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_952132b8-da9d-4e7a-9870-b056fa7ba01d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember_044fafe7-c101-49b8-941c-d838c9b8db6f" xlink:href="hims-20210331.xsd#hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_952132b8-da9d-4e7a-9870-b056fa7ba01d" xlink:to="loc_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember_044fafe7-c101-49b8-941c-d838c9b8db6f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableCommonStockTransactionMember_3cd10dc5-4a42-4465-a4da-a0591cd406b0" xlink:href="hims-20210331.xsd#hims_RedeemableCommonStockTransactionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_952132b8-da9d-4e7a-9870-b056fa7ba01d" xlink:to="loc_hims_RedeemableCommonStockTransactionMember_3cd10dc5-4a42-4465-a4da-a0591cd406b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1909ed30-dc2c-474b-b827-bd0e16525f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1909ed30-dc2c-474b-b827-bd0e16525f01" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1909ed30-dc2c-474b-b827-bd0e16525f01_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1909ed30-dc2c-474b-b827-bd0e16525f01" xlink:to="loc_us-gaap_ClassOfStockDomain_1909ed30-dc2c-474b-b827-bd0e16525f01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e0a3e584-40d4-4065-9751-10542ceee9fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1909ed30-dc2c-474b-b827-bd0e16525f01" xlink:to="loc_us-gaap_ClassOfStockDomain_e0a3e584-40d4-4065-9751-10542ceee9fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableClassACommonStockMember_f33af340-45a0-4e6f-8ad4-d74a95ea1639" xlink:href="hims-20210331.xsd#hims_RedeemableClassACommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e0a3e584-40d4-4065-9751-10542ceee9fb" xlink:to="loc_hims_RedeemableClassACommonStockMember_f33af340-45a0-4e6f-8ad4-d74a95ea1639" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#BasicandDilutedNetLossperShareAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails" xlink:type="extended" id="i3a79d05183b44a04be0a3ef71eb28b99_BasicandDilutedNetLossperShareAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_3248e1cc-51ac-45aa-a839-a1b3d1d1fd37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_b6de495a-b464-4e83-9334-5c48b66bcacf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_3248e1cc-51ac-45aa-a839-a1b3d1d1fd37" xlink:to="loc_us-gaap_DividendsCommonStock_b6de495a-b464-4e83-9334-5c48b66bcacf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare_72150d5b-60f9-4740-8954-569b501a43cf" xlink:href="hims-20210331.xsd#hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_3248e1cc-51ac-45aa-a839-a1b3d1d1fd37" xlink:to="loc_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare_72150d5b-60f9-4740-8954-569b501a43cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_066f7e0b-5172-4139-bc3a-5f22034ce2b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_3248e1cc-51ac-45aa-a839-a1b3d1d1fd37" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_066f7e0b-5172-4139-bc3a-5f22034ce2b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fe585c31-13c5-4224-9d2d-34552372992b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_066f7e0b-5172-4139-bc3a-5f22034ce2b8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fe585c31-13c5-4224-9d2d-34552372992b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fe585c31-13c5-4224-9d2d-34552372992b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fe585c31-13c5-4224-9d2d-34552372992b" xlink:to="loc_us-gaap_ClassOfStockDomain_fe585c31-13c5-4224-9d2d-34552372992b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1bce28df-2c6f-43d0-b688-7a9ac448b2b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fe585c31-13c5-4224-9d2d-34552372992b" xlink:to="loc_us-gaap_ClassOfStockDomain_1bce28df-2c6f-43d0-b688-7a9ac448b2b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_4e303921-da32-442e-a4ee-cf54dd7e31fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_1bce28df-2c6f-43d0-b688-7a9ac448b2b3" xlink:to="loc_us-gaap_CommonClassAMember_4e303921-da32-442e-a4ee-cf54dd7e31fe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails" xlink:type="extended" id="i5385a983b41745e8a68fe5f325228e2e_BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_13f7042c-2c8e-496c-a6ce-6c5697c2f9e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_835ead5f-13f7-44e2-a967-69bd0788d473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_13f7042c-2c8e-496c-a6ce-6c5697c2f9e8" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_835ead5f-13f7-44e2-a967-69bd0788d473" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fab8ad4b-6bf5-41d4-8ee8-b4fd52747ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_835ead5f-13f7-44e2-a967-69bd0788d473" xlink:to="loc_us-gaap_NetIncomeLoss_fab8ad4b-6bf5-41d4-8ee8-b4fd52747ab4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_13f7042c-2c8e-496c-a6ce-6c5697c2f9e8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a17868ce-33f0-4d5c-b231-17db4dfa6f2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a17868ce-33f0-4d5c-b231-17db4dfa6f2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01928dac-ef0b-469b-8283-512ca6c60d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01928dac-ef0b-469b-8283-512ca6c60d4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c7632c7a-0032-4054-a4ec-e1bd0ff8310d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:to="loc_us-gaap_EarningsPerShareBasic_c7632c7a-0032-4054-a4ec-e1bd0ff8310d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7e0de6c4-706d-446a-9d8d-19f6a7c6db42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7e0de6c4-706d-446a-9d8d-19f6a7c6db42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cedfde09-a621-4137-a3f6-711cd7f1bc77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_13f7042c-2c8e-496c-a6ce-6c5697c2f9e8" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cedfde09-a621-4137-a3f6-711cd7f1bc77" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_477f260e-533a-41a0-b1f5-4510d204b411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cedfde09-a621-4137-a3f6-711cd7f1bc77" xlink:to="loc_us-gaap_StatementClassOfStockAxis_477f260e-533a-41a0-b1f5-4510d204b411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_477f260e-533a-41a0-b1f5-4510d204b411_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_477f260e-533a-41a0-b1f5-4510d204b411" xlink:to="loc_us-gaap_ClassOfStockDomain_477f260e-533a-41a0-b1f5-4510d204b411_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_64c3850d-a6c7-4cb9-92c1-6da62fe58757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_477f260e-533a-41a0-b1f5-4510d204b411" xlink:to="loc_us-gaap_ClassOfStockDomain_64c3850d-a6c7-4cb9-92c1-6da62fe58757" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_0f282761-5dad-46d1-af6c-fc49482723db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_64c3850d-a6c7-4cb9-92c1-6da62fe58757" xlink:to="loc_us-gaap_CommonClassAMember_0f282761-5dad-46d1-af6c-fc49482723db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember_c4fd89a3-6f8e-40e1-b196-b99b527c59b5" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_64c3850d-a6c7-4cb9-92c1-6da62fe58757" xlink:to="loc_hims_CommonClassVMember_c4fd89a3-6f8e-40e1-b196-b99b527c59b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassFMember_f470e840-52cf-4f15-9bb5-f8a6dbb50b47" xlink:href="hims-20210331.xsd#hims_CommonClassFMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_64c3850d-a6c7-4cb9-92c1-6da62fe58757" xlink:to="loc_hims_CommonClassFMember_f470e840-52cf-4f15-9bb5-f8a6dbb50b47" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails" xlink:type="extended" id="idbeaa81d0f1f4503b84f04372b68943e_BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7cf74ab4-3c53-4215-b8e5-7b67a488d658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_efbe8440-69e0-46a6-ae3c-ef9dbd9e4fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7cf74ab4-3c53-4215-b8e5-7b67a488d658" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_efbe8440-69e0-46a6-ae3c-ef9dbd9e4fcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_569c6b8a-1053-45ec-9c2b-47a001ae5545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7cf74ab4-3c53-4215-b8e5-7b67a488d658" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_569c6b8a-1053-45ec-9c2b-47a001ae5545" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cab43547-08f2-4320-8f10-b5d67515e873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_569c6b8a-1053-45ec-9c2b-47a001ae5545" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cab43547-08f2-4320-8f10-b5d67515e873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab43547-08f2-4320-8f10-b5d67515e873_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cab43547-08f2-4320-8f10-b5d67515e873" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_cab43547-08f2-4320-8f10-b5d67515e873_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cab43547-08f2-4320-8f10-b5d67515e873" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember_ca4b0ace-374d-4fbc-bafa-7c65b74ecaad" xlink:href="hims-20210331.xsd#hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember_ca4b0ace-374d-4fbc-bafa-7c65b74ecaad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EarlyExerciseOfStockOptionsMember_2d0f7895-6d22-4914-a8ea-4dd8d5b23654" xlink:href="hims-20210331.xsd#hims_EarlyExerciseOfStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_hims_EarlyExerciseOfStockOptionsMember_2d0f7895-6d22-4914-a8ea-4dd8d5b23654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_e851f5ec-c952-4d52-b98e-f22e61a6d66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_e851f5ec-c952-4d52-b98e-f22e61a6d66c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3fac8bca-3b94-4024-9d78-d67bc0161214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3fac8bca-3b94-4024-9d78-d67bc0161214" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_91a5e3ee-51a6-4ab1-a827-98b0c8fc324b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_91a5e3ee-51a6-4ab1-a827-98b0c8fc324b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_05fdee0c-9200-4d2a-b383-474f6b4c4295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_us-gaap_WarrantMember_05fdee0c-9200-4d2a-b383-474f6b4c4295" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_3981ee3c-ed8f-4d06-b5ab-fae83778c1a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_569c6b8a-1053-45ec-9c2b-47a001ae5545" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_3981ee3c-ed8f-4d06-b5ab-fae83778c1a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3981ee3c-ed8f-4d06-b5ab-fae83778c1a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_3981ee3c-ed8f-4d06-b5ab-fae83778c1a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3981ee3c-ed8f-4d06-b5ab-fae83778c1a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4765afbf-c295-4ce7-9fa4-cfed45312975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_3981ee3c-ed8f-4d06-b5ab-fae83778c1a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4765afbf-c295-4ce7-9fa4-cfed45312975" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_19377c0d-5cb4-41c9-9be7-457baf08cafe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4765afbf-c295-4ce7-9fa4-cfed45312975" xlink:to="loc_us-gaap_CommonClassAMember_19377c0d-5cb4-41c9-9be7-457baf08cafe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_676cc5d1-0b93-4c31-9941-bc562188d27d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4765afbf-c295-4ce7-9fa4-cfed45312975" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_676cc5d1-0b93-4c31-9941-bc562188d27d" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hims-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:38d399d4-426b-4053-8eef-3989252869db,g:a068c89f-8498-4134-8237-732dcbe50228-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_1a57f16d-1b49-46ec-8233-edd529e3a8ee_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of real estate property</link:label>
    <link:label id="lab_us-gaap_AreaOfRealEstateProperty_label_en-US" xlink:label="lab_us-gaap_AreaOfRealEstateProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of Real Estate Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfRealEstateProperty" xlink:to="lab_us-gaap_AreaOfRealEstateProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_22920a1c-970a-42f2-a0f9-f31cff813f05_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_cb592bdb-f029-484a-8ff2-9acbd84dd94c_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_7bc55889-c320-4d3d-9de4-e5c0362110ab_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ExercisePriceRange006To040Member_499e7eb8-ac59-45ac-930a-350ecf3b8945_terseLabel_en-US" xlink:label="lab_hims_ExercisePriceRange006To040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $0.06 to $0.40</link:label>
    <link:label id="lab_hims_ExercisePriceRange006To040Member_label_en-US" xlink:label="lab_hims_ExercisePriceRange006To040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $0.06 to $0.40 [Member]</link:label>
    <link:label id="lab_hims_ExercisePriceRange006To040Member_documentation_en-US" xlink:label="lab_hims_ExercisePriceRange006To040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $0.06 to $0.40</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange006To040Member" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange006To040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ExercisePriceRange006To040Member" xlink:to="lab_hims_ExercisePriceRange006To040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_fd310735-8f80-4c32-b837-ad8fa0e18fae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding balance</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_OperatingLeaseRenewalTerm_03f6b5a2-9eec-44d0-bb3d-d671ed09c38d_terseLabel_en-US" xlink:label="lab_hims_OperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, renewal term</link:label>
    <link:label id="lab_hims_OperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_hims_OperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Renewal Term</link:label>
    <link:label id="lab_hims_OperatingLeaseRenewalTerm_documentation_en-US" xlink:label="lab_hims_OperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperatingLeaseRenewalTerm" xlink:href="hims-20210331.xsd#hims_OperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_OperatingLeaseRenewalTerm" xlink:to="lab_hims_OperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_5867245e-95a6-4ec7-89bd-9323b2ee5b14_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised warrants</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9e466238-124e-44f7-af08-98feb961ead7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d69577ce-4ab1-428e-a000-50ffc25b50be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_6e6ee624-54cb-4990-9b5c-7600a79ad328_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c6e9b46d-862b-4130-808e-b74a9d14a8c6_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_6abade27-247d-491f-ac04-d2f81f1f5a75_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_4a9625b3-2d28-4949-a5b7-64d021572aa5_terseLabel_en-US" xlink:label="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Series D convertible preferred stock, net of issuance costs (in shares)</link:label>
    <link:label id="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_685f501a-f8ab-4816-890f-7f12b3f4dfa8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_DebtWarrantsMember_aa3a0ad1-9a8f-401e-95fc-8723d68f7788_terseLabel_en-US" xlink:label="lab_hims_DebtWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Warrants</link:label>
    <link:label id="lab_hims_DebtWarrantsMember_label_en-US" xlink:label="lab_hims_DebtWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Warrants [Member]</link:label>
    <link:label id="lab_hims_DebtWarrantsMember_documentation_en-US" xlink:label="lab_hims_DebtWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_DebtWarrantsMember" xlink:href="hims-20210331.xsd#hims_DebtWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_DebtWarrantsMember" xlink:to="lab_hims_DebtWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_PercentageOwnedByLicensedPhysicians_8e68e10f-bd69-4dac-b75a-696bd5b7ce62_terseLabel_en-US" xlink:label="lab_hims_PercentageOwnedByLicensedPhysicians" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage owned by licensed physicians</link:label>
    <link:label id="lab_hims_PercentageOwnedByLicensedPhysicians_label_en-US" xlink:label="lab_hims_PercentageOwnedByLicensedPhysicians" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Owned By Licensed Physicians</link:label>
    <link:label id="lab_hims_PercentageOwnedByLicensedPhysicians_documentation_en-US" xlink:label="lab_hims_PercentageOwnedByLicensedPhysicians" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Owned By Licensed Physicians</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PercentageOwnedByLicensedPhysicians" xlink:href="hims-20210331.xsd#hims_PercentageOwnedByLicensedPhysicians"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_PercentageOwnedByLicensedPhysicians" xlink:to="lab_hims_PercentageOwnedByLicensedPhysicians" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_0b99e533-7be3-43fb-8550-0cd0cb1c1da3_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity, par or stated value per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_dd9ad54a-3d04-4d81-9cc6-ffb22cf3743b_terseLabel_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger one (in dollars per share)</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, One</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" xlink:to="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_29a8dd6d-bb54-4647-a0b8-8810de8b019c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_425c9a0d-4bf9-4693-a5d1-f32397c39f67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_WarrantsIssued_42926d01-3d85-451a-b956-0a504a0d43fa_terseLabel_en-US" xlink:label="lab_hims_WarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of Private Placement Warrants and Public Warrants</link:label>
    <link:label id="lab_hims_WarrantsIssued_label_en-US" xlink:label="lab_hims_WarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Issued</link:label>
    <link:label id="lab_hims_WarrantsIssued_documentation_en-US" xlink:label="lab_hims_WarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_WarrantsIssued" xlink:href="hims-20210331.xsd#hims_WarrantsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_WarrantsIssued" xlink:to="lab_hims_WarrantsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a70cab54-d9d3-45e6-b3a3-83b2ba57ac2f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_6d484c21-2ef7-4392-a763-65a28e970d77_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_d5d9e31e-fb56-4454-9259-8fbc5d40e81a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_318feb70-07b0-4dec-84c0-00cb6ca97b19_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-closing stock repurchase, net of exercise of vested options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_887af150-866d-4ac4-bbd6-655952d891be_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-closing stock repurchase, net of exercise of vested options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1e9a56ca-c380-4c81-ad35-7867074b7562_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ConversionOfPreferredStockWarrantsAmountConverted_31cc2230-acfe-478a-8255-16786f9826f0_terseLabel_en-US" xlink:label="lab_hims_ConversionOfPreferredStockWarrantsAmountConverted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Series D preferred stock warrants to Class A common warrants</link:label>
    <link:label id="lab_hims_ConversionOfPreferredStockWarrantsAmountConverted_label_en-US" xlink:label="lab_hims_ConversionOfPreferredStockWarrantsAmountConverted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Of Preferred Stock Warrants, Amount Converted</link:label>
    <link:label id="lab_hims_ConversionOfPreferredStockWarrantsAmountConverted_documentation_en-US" xlink:label="lab_hims_ConversionOfPreferredStockWarrantsAmountConverted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Of Preferred Stock Warrants, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ConversionOfPreferredStockWarrantsAmountConverted" xlink:href="hims-20210331.xsd#hims_ConversionOfPreferredStockWarrantsAmountConverted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ConversionOfPreferredStockWarrantsAmountConverted" xlink:to="lab_hims_ConversionOfPreferredStockWarrantsAmountConverted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_92e85408-669e-4a33-abc3-d6cb042f2d44_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_06527405-f01e-4e73-9f83-ab8bb5fa14ef_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of Class A common stock warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_baea5078-ab59-4b12-83c7-fc77d5974736_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_e0f33795-a6e5-4b97-9908-b2dc1bc44305_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, mezzanine equity, and stockholders' equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_e0f88e8f-c5ee-4eed-8aad-a5746c2ea0b3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_162a6738-e775-43bd-9787-295404597002_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_f309e9cf-66d9-4e42-81d1-938109dd9e90_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_4a3a73ef-9ab4-419f-9ed7-a0067484d706_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_4b5da244-1410-4be6-83d3-b6c0510d4db9_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_EarnOutAndParentWarrantsMember_3ccb0bad-cb81-47e4-b72e-2eb2583308db_terseLabel_en-US" xlink:label="lab_hims_EarnOutAndParentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-Out And Parent Warrants</link:label>
    <link:label id="lab_hims_EarnOutAndParentWarrantsMember_label_en-US" xlink:label="lab_hims_EarnOutAndParentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-Out And Parent Warrants [Member]</link:label>
    <link:label id="lab_hims_EarnOutAndParentWarrantsMember_documentation_en-US" xlink:label="lab_hims_EarnOutAndParentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn-Out And Parent Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EarnOutAndParentWarrantsMember" xlink:href="hims-20210331.xsd#hims_EarnOutAndParentWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_EarnOutAndParentWarrantsMember" xlink:to="lab_hims_EarnOutAndParentWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_95dbee17-38d3-49a1-bc88-814793b99c34_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_fc154b1b-1b22-4ec9-b27e-0a8e1bbe1d20_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_HimsStockholdersMember_b1b85df2-f05c-4ad5-9f0f-8111d6e63dba_terseLabel_en-US" xlink:label="lab_hims_HimsStockholdersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims' Stockholders</link:label>
    <link:label id="lab_hims_HimsStockholdersMember_label_en-US" xlink:label="lab_hims_HimsStockholdersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims' Stockholders [Member]</link:label>
    <link:label id="lab_hims_HimsStockholdersMember_documentation_en-US" xlink:label="lab_hims_HimsStockholdersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims' Stockholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsStockholdersMember" xlink:href="hims-20210331.xsd#hims_HimsStockholdersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_HimsStockholdersMember" xlink:to="lab_hims_HimsStockholdersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms_6a3a5841-370c-47ad-be68-83b6af78fc68_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of period (in years)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Terms</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_WarrantsAndRightsOutstandingCurrent_37b90c9d-c980-41fe-bf61-09943f462863_terseLabel_en-US" xlink:label="lab_hims_WarrantsAndRightsOutstandingCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant liabilities</link:label>
    <link:label id="lab_hims_WarrantsAndRightsOutstandingCurrent_label_en-US" xlink:label="lab_hims_WarrantsAndRightsOutstandingCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Current</link:label>
    <link:label id="lab_hims_WarrantsAndRightsOutstandingCurrent_documentation_en-US" xlink:label="lab_hims_WarrantsAndRightsOutstandingCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_WarrantsAndRightsOutstandingCurrent" xlink:href="hims-20210331.xsd#hims_WarrantsAndRightsOutstandingCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_WarrantsAndRightsOutstandingCurrent" xlink:to="lab_hims_WarrantsAndRightsOutstandingCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_RedeemableWarrantsMember_7be1828a-e421-4383-890d-b720062a6c38_terseLabel_en-US" xlink:label="lab_hims_RedeemableWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable warrants, each whole warrant exercisable for one share of Class A common stock</link:label>
    <link:label id="lab_hims_RedeemableWarrantsMember_label_en-US" xlink:label="lab_hims_RedeemableWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Warrants [Member]</link:label>
    <link:label id="lab_hims_RedeemableWarrantsMember_documentation_en-US" xlink:label="lab_hims_RedeemableWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableWarrantsMember" xlink:href="hims-20210331.xsd#hims_RedeemableWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_RedeemableWarrantsMember" xlink:to="lab_hims_RedeemableWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_58b69bc5-b6b3-409b-8f84-6174ccb472f7_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_625da27f-f9c7-4c84-bd1e-9810a38189da_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a6f3e1bd-fa8d-492f-8000-60a8aa99c7aa_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3723f242-55b5-4312-ace4-acc1e8232a81_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_8d4ca1e9-c891-4710-a16f-e8e7640e129a_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_539833cb-60ad-4fcb-a0b1-47545323d429_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note&#160;11)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_09378c98-c06f-45dc-9a72-7132ba4da403_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-closing stock repurchase</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_5e70fb10-bfe7-414b-a0c1-9c2238e9e497_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_1c7c2633-19e4-4e5c-946f-3338674b4e97_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d94b013d-2031-46e8-aba2-d80496441d98_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_ddcd50a1-24d8-4bf7-83d3-5accd07213ea_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax payables</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_eb7aac31-8ae1-464b-9acb-1848b2ca72b5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_503353ad-aa19-40ec-adf5-98ce0afa9489_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_67385cfb-ab21-45d3-af10-5b6d3bcda1da_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_e1181be7-cdfd-49a1-9bc7-960949c9274a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_b7fa27e0-5621-4ef5-8e4c-27bd1c60fc80_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract_e8a296d1-ea4f-46f4-bdc6-504727ce603c_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Intrinsic Value, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Intrinsic Value, Additional Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_SeriesSeedPreferredStockMember_70d9304a-8464-47ae-bbc7-6070587aa503_terseLabel_en-US" xlink:label="lab_hims_SeriesSeedPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Seed</link:label>
    <link:label id="lab_hims_SeriesSeedPreferredStockMember_label_en-US" xlink:label="lab_hims_SeriesSeedPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Seed Preferred Stock [Member]</link:label>
    <link:label id="lab_hims_SeriesSeedPreferredStockMember_documentation_en-US" xlink:label="lab_hims_SeriesSeedPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series Seed Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesSeedPreferredStockMember" xlink:href="hims-20210331.xsd#hims_SeriesSeedPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_SeriesSeedPreferredStockMember" xlink:to="lab_hims_SeriesSeedPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_84ff3906-da76-4d42-bf36-3bb9ec0684f0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_d0eef9d3-9fef-4bb3-9cdc-af598b641112_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_360b77f6-fd07-4133-9743-ab2fe72c97c0_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_f4be4151-c017-4a90-8e01-ce0dc80d00f2_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_7d0d8eb2-db0d-406a-a664-b6336d22885d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_bb3ac929-f5fd-4ac0-87fc-219444ccd354_periodStartLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_b2292e12-5fd6-435d-ad68-9432b3eb2d5f_periodEndLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_SeriesB2PreferredStockMember_204633f4-d27d-4f81-ac1c-7f4b5d12ce49_terseLabel_en-US" xlink:label="lab_hims_SeriesB2PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-2</link:label>
    <link:label id="lab_hims_SeriesB2PreferredStockMember_label_en-US" xlink:label="lab_hims_SeriesB2PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-2 Preferred Stock [Member]</link:label>
    <link:label id="lab_hims_SeriesB2PreferredStockMember_documentation_en-US" xlink:label="lab_hims_SeriesB2PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-2 Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesB2PreferredStockMember" xlink:href="hims-20210331.xsd#hims_SeriesB2PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_SeriesB2PreferredStockMember" xlink:to="lab_hims_SeriesB2PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold_ebbd0178-1c3b-4923-9fbc-79958051b6a1_terseLabel_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale price redemption threshold (in dollars per share)</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold_label_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Sale Price Redemption Threshold</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold_documentation_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Sale Price Redemption Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold" xlink:to="lab_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_PublicWarrantsMember_5d8ee93c-aebf-41a4-a676-c8f1a7ca2e2a_terseLabel_en-US" xlink:label="lab_hims_PublicWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants</link:label>
    <link:label id="lab_hims_PublicWarrantsMember_label_en-US" xlink:label="lab_hims_PublicWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants [Member]</link:label>
    <link:label id="lab_hims_PublicWarrantsMember_documentation_en-US" xlink:label="lab_hims_PublicWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsMember" xlink:href="hims-20210331.xsd#hims_PublicWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_PublicWarrantsMember" xlink:to="lab_hims_PublicWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ExercisePriceRange890To1335Member_e58e2ffd-af3f-406e-aaca-c48ec3c6fc80_terseLabel_en-US" xlink:label="lab_hims_ExercisePriceRange890To1335Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $8.90 to $13.35</link:label>
    <link:label id="lab_hims_ExercisePriceRange890To1335Member_label_en-US" xlink:label="lab_hims_ExercisePriceRange890To1335Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $8.90 to $13.35 [Member]</link:label>
    <link:label id="lab_hims_ExercisePriceRange890To1335Member_documentation_en-US" xlink:label="lab_hims_ExercisePriceRange890To1335Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $8.90 to $13.35</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange890To1335Member" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange890To1335Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ExercisePriceRange890To1335Member" xlink:to="lab_hims_ExercisePriceRange890To1335Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_5cf1d008-7bb6-4bde-a571-ef7c3f59f7a2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5fae3f01-262e-453f-a734-8d99cbe3e631_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1d5c38e3-57f4-489b-8d4d-6ca4264feeda_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_86045067-9aed-4e15-9202-646251f3dc6a_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_08a6f4c9-3948-4772-b873-833a763060b6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity (deficit):</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_2f6d2958-9a8e-48d6-b045-edb2d69375eb_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, purchases from related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Purchases from Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_4532b56d-0f08-4743-b8ad-a8b3cf76d252_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, Forfeited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_746a99dc-c997-4e9b-aefa-1fde99565d90_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ba0390b9-7911-40ae-89b6-2280352dc275_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment arrangement, nonvested award, cost not yet recognized, amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRelatedPartyDebt_40680228-382e-4dfd-b1e8-39efe6772bce_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of promissory notes associated with vested and unvested shares</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRelatedPartyDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Related Party Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRelatedPartyDebt" xlink:to="lab_us-gaap_ProceedsFromRelatedPartyDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans_51c8b536-c78e-404d-b623-07d748438def_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of authorized shares transferred between plans (in shares)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Authorized Shares Transferred Between Plans</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Authorized Shares Transferred Between Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_RedeemableCommonStockTransactionMember_0f48347b-83cf-44e1-bcdb-22e14c4a43e5_terseLabel_en-US" xlink:label="lab_hims_RedeemableCommonStockTransactionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Common Stock Transaction</link:label>
    <link:label id="lab_hims_RedeemableCommonStockTransactionMember_label_en-US" xlink:label="lab_hims_RedeemableCommonStockTransactionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Common Stock Transaction [Member]</link:label>
    <link:label id="lab_hims_RedeemableCommonStockTransactionMember_documentation_en-US" xlink:label="lab_hims_RedeemableCommonStockTransactionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Common Stock Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableCommonStockTransactionMember" xlink:href="hims-20210331.xsd#hims_RedeemableCommonStockTransactionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_RedeemableCommonStockTransactionMember" xlink:to="lab_hims_RedeemableCommonStockTransactionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_f7fdf0ec-0166-4340-8790-1b4689da287e_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_8a3585f5-cfa5-479e-9542-295ce10f5bef_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_2d75e8ba-b1b7-4acc-a4d1-ed9023911957_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payments arrangement, option, exercise price range, lower range limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_f1e4b883-b482-475e-badf-8ccd49c27302_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c34ee4ad-cff7-40b4-abba-ac909efa1d4a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_5c6204ac-2434-43de-9586-31a5504c2696_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_VestingOfEarlyExercisedStockOptions_13454f30-8440-4897-b56f-fde41c25fa94_terseLabel_en-US" xlink:label="lab_hims_VestingOfEarlyExercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of early exercised stock options</link:label>
    <link:label id="lab_hims_VestingOfEarlyExercisedStockOptions_label_en-US" xlink:label="lab_hims_VestingOfEarlyExercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Of Early Exercised Stock Options</link:label>
    <link:label id="lab_hims_VestingOfEarlyExercisedStockOptions_documentation_en-US" xlink:label="lab_hims_VestingOfEarlyExercisedStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting Of Early Exercised Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VestingOfEarlyExercisedStockOptions" xlink:href="hims-20210331.xsd#hims_VestingOfEarlyExercisedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_VestingOfEarlyExercisedStockOptions" xlink:to="lab_hims_VestingOfEarlyExercisedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare_732f418f-4def-4979-a094-533af40e76f0_terseLabel_en-US" xlink:label="lab_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of redeemable shares excluded from calculation of net income (loss) per share (in shares)</link:label>
    <link:label id="lab_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare_label_en-US" xlink:label="lab_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Redeemable Shares Excluded From Calculation Of Net Income (Loss) Per Share</link:label>
    <link:label id="lab_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare_documentation_en-US" xlink:label="lab_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Redeemable Shares Excluded From Calculation Of Net Income (Loss) Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare" xlink:href="hims-20210331.xsd#hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare" xlink:to="lab_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_6d2dfa13-6070-4586-a5ba-82c394f8e921_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited and expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ChiefExecutiveOfficerAndDirectorMember_6da11060-bcac-4b0e-9de3-f69b3819bbf3_terseLabel_en-US" xlink:label="lab_hims_ChiefExecutiveOfficerAndDirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer And Director</link:label>
    <link:label id="lab_hims_ChiefExecutiveOfficerAndDirectorMember_label_en-US" xlink:label="lab_hims_ChiefExecutiveOfficerAndDirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer And Director [Member]</link:label>
    <link:label id="lab_hims_ChiefExecutiveOfficerAndDirectorMember_documentation_en-US" xlink:label="lab_hims_ChiefExecutiveOfficerAndDirectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer And Director</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ChiefExecutiveOfficerAndDirectorMember" xlink:href="hims-20210331.xsd#hims_ChiefExecutiveOfficerAndDirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ChiefExecutiveOfficerAndDirectorMember" xlink:to="lab_hims_ChiefExecutiveOfficerAndDirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_fe4d9015-8d65-4bda-b7c9-d43f4bbad721_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_22100b12-f3db-4949-9898-29ed85647fb6_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_00fe5138-cd39-44a4-9c55-4dcd72307488_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in fair value of warrants</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_03a411c7-57a4-4b24-b268-ff556571a610_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wholesale</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_WarrantLiabilityPolicyPolicyTextBlock_18cdbd16-d746-4c82-9e5c-5e8a596ae9be_terseLabel_en-US" xlink:label="lab_hims_WarrantLiabilityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Liabilities</link:label>
    <link:label id="lab_hims_WarrantLiabilityPolicyPolicyTextBlock_label_en-US" xlink:label="lab_hims_WarrantLiabilityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Liability, Policy [Policy Text Block]</link:label>
    <link:label id="lab_hims_WarrantLiabilityPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_hims_WarrantLiabilityPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant Liability, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_WarrantLiabilityPolicyPolicyTextBlock" xlink:href="hims-20210331.xsd#hims_WarrantLiabilityPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_WarrantLiabilityPolicyPolicyTextBlock" xlink:to="lab_hims_WarrantLiabilityPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_a1539ff0-6dc1-476b-9b2c-54b6e0a8f393_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited and expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_4735f19a-e72d-426c-8a15-fd85e792e290_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_92f0ef72-5ad2-4120-b4ab-dd09dc812679_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_eef3e21a-222a-424d-a00b-c631c18c9d5a_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d5ef7892-18d5-4286-a91f-740fcf71ec60_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_67324295-d967-46c8-8034-a4e0a306aa6a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_a601640e-bd24-43db-9762-441743eff841_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_04b1dfc5-9207-4a61-bd68-9ca469315cce_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_c94bc572-1bf7-4a53-b345-d7636e205acf_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_NewAlbanyOhioMember_098c3cbc-e21e-4935-afbd-8837d4951a51_terseLabel_en-US" xlink:label="lab_hims_NewAlbanyOhioMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Albany, Ohio</link:label>
    <link:label id="lab_hims_NewAlbanyOhioMember_label_en-US" xlink:label="lab_hims_NewAlbanyOhioMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Albany, Ohio [Member]</link:label>
    <link:label id="lab_hims_NewAlbanyOhioMember_documentation_en-US" xlink:label="lab_hims_NewAlbanyOhioMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Albany, Ohio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NewAlbanyOhioMember" xlink:href="hims-20210331.xsd#hims_NewAlbanyOhioMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_NewAlbanyOhioMember" xlink:to="lab_hims_NewAlbanyOhioMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseCapitalizationContingentConsiderationEquityShares_5b547678-3f43-4616-bc1c-9bb50289f8d5_terseLabel_en-US" xlink:label="lab_hims_ReverseCapitalizationContingentConsiderationEquityShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, contingent consideration, equity (in shares)</link:label>
    <link:label id="lab_hims_ReverseCapitalizationContingentConsiderationEquityShares_label_en-US" xlink:label="lab_hims_ReverseCapitalizationContingentConsiderationEquityShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Capitalization, Contingent Consideration, Equity, Shares</link:label>
    <link:label id="lab_hims_ReverseCapitalizationContingentConsiderationEquityShares_documentation_en-US" xlink:label="lab_hims_ReverseCapitalizationContingentConsiderationEquityShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Capitalization, Contingent Consideration, Equity, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityShares" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseCapitalizationContingentConsiderationEquityShares" xlink:to="lab_hims_ReverseCapitalizationContingentConsiderationEquityShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_fe836f34-deb5-4c3d-90bc-1304898ee172_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity, liquidation preference</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_3b0f5f67-4eae-4caa-ad32-c49a4823c9a0_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Liquidation Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Liquidation Preference</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLiquidationPreference" xlink:to="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember_087d18f6-05b8-47b8-855b-8e16c375ea82_terseLabel_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee, excluding CEO</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember_label_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Employee, Excluding CEO [Member]</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember_documentation_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Employee, Excluding CEO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember" xlink:to="lab_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_OperatingLeaseRentExpenseAnnualEscalationPercent_8f74048a-a2aa-47d4-96d5-c01c237aaaab_terseLabel_en-US" xlink:label="lab_hims_OperatingLeaseRentExpenseAnnualEscalationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent expense, annual escalation, percent</link:label>
    <link:label id="lab_hims_OperatingLeaseRentExpenseAnnualEscalationPercent_label_en-US" xlink:label="lab_hims_OperatingLeaseRentExpenseAnnualEscalationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Rent Expense, Annual Escalation, Percent</link:label>
    <link:label id="lab_hims_OperatingLeaseRentExpenseAnnualEscalationPercent_documentation_en-US" xlink:label="lab_hims_OperatingLeaseRentExpenseAnnualEscalationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Rent Expense, Annual Escalation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperatingLeaseRentExpenseAnnualEscalationPercent" xlink:href="hims-20210331.xsd#hims_OperatingLeaseRentExpenseAnnualEscalationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_OperatingLeaseRentExpenseAnnualEscalationPercent" xlink:to="lab_hims_OperatingLeaseRentExpenseAnnualEscalationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_OperationalSupportMember_ac619d35-92c0-40ac-82f2-a19beb0be348_terseLabel_en-US" xlink:label="lab_hims_OperationalSupportMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operational Support</link:label>
    <link:label id="lab_hims_OperationalSupportMember_label_en-US" xlink:label="lab_hims_OperationalSupportMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operational Support [Member]</link:label>
    <link:label id="lab_hims_OperationalSupportMember_documentation_en-US" xlink:label="lab_hims_OperationalSupportMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operational Support</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperationalSupportMember" xlink:href="hims-20210331.xsd#hims_OperationalSupportMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_OperationalSupportMember" xlink:to="lab_hims_OperationalSupportMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_0117fcab-fde2-4bd1-a23a-234d9b6b5c6d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_91d62a54-21cf-4716-a4e2-7ed2d8040828_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_0daafa54-48b6-411b-becc-22809ecc1833_terseLabel_en-US" xlink:label="lab_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible securities</link:label>
    <link:label id="lab_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</link:label>
    <link:label id="lab_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue_13f8234d-53d9-42dc-8c29-7180dd4ae86a_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation arrangement by share-based payment award, options, outstanding, value</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Value</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ba985cc3-9aa9-4db1-b3e5-087971ac5e53_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_854304e5-0df5-4895-8fae-410b2466b2f7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_356361c1-a610-408d-a624-fc0282c7e16d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_04540229-fce5-4693-a346-aa17cc4e6ab5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share attributable to common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption_3a45e59a-9c81-4655-9c99-6faa95096ab5_terseLabel_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period after written notice of redemption</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption_label_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Period After Written Notice Of Redemption</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption_documentation_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Period After Written Notice Of Redemption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption" xlink:to="lab_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_639d3bc8-76ee-4cfe-b5d6-228dd3aa7681_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_24f78bbd-b960-42f5-bc75-62c57dfb60ff_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_08ae6c2e-c5fe-44bd-aa89-9535aa6fa0f1_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_66f8ecbe-ddbb-4085-b020-571c6c7a9253_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government bonds</link:label>
    <link:label id="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Agencies Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentAgenciesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_af6e77e2-a444-4f10-bbef-29929a356afd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited and expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_ae98af7b-eebe-4a6d-8faf-5227cf59ff55_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_753407f0-2adf-42e3-a9ff-f3ab2318cf8c_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_d69d8435-dbca-4089-94b4-3700eec86e51_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_934435ae-d39d-4b29-b7cb-7325ad1ec8c9_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ScheduleOfReverseRecapitaliztionTable_9d048fbb-2148-435d-97d8-b9eca926895b_terseLabel_en-US" xlink:label="lab_hims_ScheduleOfReverseRecapitaliztionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitaliztion [Table]</link:label>
    <link:label id="lab_hims_ScheduleOfReverseRecapitaliztionTable_label_en-US" xlink:label="lab_hims_ScheduleOfReverseRecapitaliztionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitaliztion [Table]</link:label>
    <link:label id="lab_hims_ScheduleOfReverseRecapitaliztionTable_documentation_en-US" xlink:label="lab_hims_ScheduleOfReverseRecapitaliztionTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Reverse Recapitaliztion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ScheduleOfReverseRecapitaliztionTable" xlink:href="hims-20210331.xsd#hims_ScheduleOfReverseRecapitaliztionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable" xlink:to="lab_hims_ScheduleOfReverseRecapitaliztionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_9b750a1d-f381-4971-8524-244d3936a82b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_e9376596-22ba-445f-8791-fabcee36b33c_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_41de2ad6-0b71-423b-8020-9b7a84905387_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b5b45b86-e8db-481c-8713-32982a89232b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum_6a89a1f7-e431-4676-9be7-b24201182f58_terseLabel_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum period of prior notice for share redemption</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum_label_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Share Redemption Notice Period, Minimum</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum_documentation_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Share Redemption Notice Period, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum" xlink:to="lab_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_87c6d93d-3c72-459e-96f4-a994ee9242f0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of the period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_019fc897-f867-48a7-8498-c3ec2611e7de_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_96db5aed-4ac0-40a2-b354-048db1aa60e5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_8d639be2-9361-4720-98f9-2bc8571c619c_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a6bdd647-14f9-450e-ba88-4c2e28bb5de0_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_f33e73e6-8392-46af-a4bf-b8655442f04c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_20286a20-5822-41ef-8a51-166117c10274_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, future minimum payments due</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_91bb5a83-b412-40a6-ae81-b046da1e6848_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_c5e858d0-a035-417f-9bba-59590cc0677e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_70b28003-788e-40a2-ac09-26303822b3dd_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31, 2020</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_7e5b94e2-05b0-4efb-b2c8-aea353ce330d_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at March 31, 2021</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_1d3b38b3-056b-45eb-b564-22191231bf99_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares available for grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_6affa734-abf8-41cb-9c01-dca62498c5d6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_fe5d3264-9958-489d-b8f0-8b0127119076_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of principal on term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_bf2b5d08-0af9-4edf-9931-9098c3c87851_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from PIPE</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b3818e2b-3670-492a-baa9-85c57bc86b3b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_29df4bf2-c4f0-4a55-b648-58ada3c92f04_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_CommonClassVMember_865aedd7-312b-423b-b4b0-89c9a998139d_terseLabel_en-US" xlink:label="lab_hims_CommonClassVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class V</link:label>
    <link:label id="lab_hims_CommonClassVMember_label_en-US" xlink:label="lab_hims_CommonClassVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class V [Member]</link:label>
    <link:label id="lab_hims_CommonClassVMember_documentation_en-US" xlink:label="lab_hims_CommonClassVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class V</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_CommonClassVMember" xlink:to="lab_hims_CommonClassVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_3faea461-3158-46a9-981b-4546f408adce_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ExercisePriceRange1517To2276Member_42efba61-6f1a-496c-a0ca-21ff9706f4e3_terseLabel_en-US" xlink:label="lab_hims_ExercisePriceRange1517To2276Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $15.17 to $22.76</link:label>
    <link:label id="lab_hims_ExercisePriceRange1517To2276Member_label_en-US" xlink:label="lab_hims_ExercisePriceRange1517To2276Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $15.17 to $22.76 [Member]</link:label>
    <link:label id="lab_hims_ExercisePriceRange1517To2276Member_documentation_en-US" xlink:label="lab_hims_ExercisePriceRange1517To2276Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $15.17 to $22.76</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange1517To2276Member" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange1517To2276Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ExercisePriceRange1517To2276Member" xlink:to="lab_hims_ExercisePriceRange1517To2276Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_74fbdcb4-f62b-47da-a8c8-ba0a43047fe7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_09bb1775-f38a-4f17-91ed-2e5a157a179d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_9e0e4d2e-dec2-4b18-8cfa-eb1045ce384f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_3696b7db-b55c-4d8f-8150-0162e9e162c9_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d9e78ada-23d5-4bd9-be59-b7cc245ad501_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember_1a7c00cf-f563-4d59-9d70-692c9bba7f16_terseLabel_en-US" xlink:label="lab_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for exercise of stock options subject to nonrecourse promissory notes</link:label>
    <link:label id="lab_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember_label_en-US" xlink:label="lab_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Subject To Nonrecourse Promissory Notes [Member]</link:label>
    <link:label id="lab_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember_documentation_en-US" xlink:label="lab_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Subject To Nonrecourse Promissory Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember" xlink:href="hims-20210331.xsd#hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember" xlink:to="lab_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_EquityIncentivePlan2020Member_5c75b3b3-ab55-432e-b055-c00da02bc265_terseLabel_en-US" xlink:label="lab_hims_EquityIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Equity Incentive Plan</link:label>
    <link:label id="lab_hims_EquityIncentivePlan2020Member_label_en-US" xlink:label="lab_hims_EquityIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan, 2020 [Member]</link:label>
    <link:label id="lab_hims_EquityIncentivePlan2020Member_documentation_en-US" xlink:label="lab_hims_EquityIncentivePlan2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EquityIncentivePlan2020Member" xlink:href="hims-20210331.xsd#hims_EquityIncentivePlan2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_EquityIncentivePlan2020Member" xlink:to="lab_hims_EquityIncentivePlan2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_c35a62b4-7147-43a0-9d18-593bc2c0ded3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ManagementMember_6363481a-7c66-41e7-8295-9d960f9a1061_terseLabel_en-US" xlink:label="lab_srt_ManagementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management</link:label>
    <link:label id="lab_srt_ManagementMember_label_en-US" xlink:label="lab_srt_ManagementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ManagementMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ManagementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ManagementMember" xlink:to="lab_srt_ManagementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_ced28d13-c7d6-4d70-87b6-ffc50cdd8014_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_TradeAndOtherReceivablesCurrent_0be36987-46e8-4931-acf7-63cb95a15d7b_terseLabel_en-US" xlink:label="lab_hims_TradeAndOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade and other receivables, net</link:label>
    <link:label id="lab_hims_TradeAndOtherReceivablesCurrent_label_en-US" xlink:label="lab_hims_TradeAndOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade And Other Receivables, Current</link:label>
    <link:label id="lab_hims_TradeAndOtherReceivablesCurrent_documentation_en-US" xlink:label="lab_hims_TradeAndOtherReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade And Other Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TradeAndOtherReceivablesCurrent" xlink:href="hims-20210331.xsd#hims_TradeAndOtherReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_TradeAndOtherReceivablesCurrent" xlink:to="lab_hims_TradeAndOtherReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_02d5df64-2b56-4ce2-82b1-be1487f7cf8c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_1a4cbfda-fcb4-4159-acab-86316a9b0767_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_82c39541-011b-4f59-9ef8-645c8e49888d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payments arrangement, nonvested award, option, cost not yet recognized, amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_420738a7-cfc1-4321-9b6c-fb8563c0339f_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems" xlink:to="lab_us-gaap_MarketableSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_248d3f32-f0e7-44cc-8471-0b39b2756b2d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_e4ede56c-0017-4b73-90a7-3aabf0bff811_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_CommonStockWarrantsGroupTwoMember_60be8d11-c232-4e01-9139-c570fbf5db09_terseLabel_en-US" xlink:label="lab_hims_CommonStockWarrantsGroupTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants, Group Two</link:label>
    <link:label id="lab_hims_CommonStockWarrantsGroupTwoMember_label_en-US" xlink:label="lab_hims_CommonStockWarrantsGroupTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants, Group Two [Member]</link:label>
    <link:label id="lab_hims_CommonStockWarrantsGroupTwoMember_documentation_en-US" xlink:label="lab_hims_CommonStockWarrantsGroupTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants, Group Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonStockWarrantsGroupTwoMember" xlink:href="hims-20210331.xsd#hims_CommonStockWarrantsGroupTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_CommonStockWarrantsGroupTwoMember" xlink:to="lab_hims_CommonStockWarrantsGroupTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_8422f7f6-9ab3-428e-a59c-0c38c3909a40_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock to common stock</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCurrent_ad78c4ff-b9fa-4861-bc91-4ffd3bbcf8cf_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred transaction costs</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCurrent" xlink:to="lab_us-gaap_DeferredCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense_82987f1a-414e-4503-b4be-214e5dc72460_negatedTerseLabel_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant expense in connection with Merger</link:label>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense_label_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Recapitalization, Warrant Expense</link:label>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense_documentation_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Recapitalization, Warrant Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense" xlink:to="lab_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_93b00470-55c4-42af-a905-90ec1ac96377_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency effect on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_1b7d2b5e-3389-47d2-8133-f4ebb28d5220_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_46bbf73f-fd82-4e1c-91f8-e30a08457081_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_aaec61f0-5d3e-4f15-ac84-3f9939a1c759_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_6f110bb6-4aa6-4a34-9604-79a0028282b1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_5cf8c112-1289-4a7c-97ec-23e6f3972283_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_CommonStockWarrantsMember_799968d7-8d82-48ad-b655-f82a6ea2f63a_terseLabel_en-US" xlink:label="lab_hims_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:label id="lab_hims_CommonStockWarrantsMember_label_en-US" xlink:label="lab_hims_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
    <link:label id="lab_hims_CommonStockWarrantsMember_documentation_en-US" xlink:label="lab_hims_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonStockWarrantsMember" xlink:href="hims-20210331.xsd#hims_CommonStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_CommonStockWarrantsMember" xlink:to="lab_hims_CommonStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ca2e40a9-d728-41e8-8e60-46362cd6e831_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_52120ab7-bbe3-4a15-b988-85f5749676c8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing expenses</link:label>
    <link:label id="lab_us-gaap_AccruedMarketingCostsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Marketing Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedMarketingCostsCurrent" xlink:to="lab_us-gaap_AccruedMarketingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_4db4c0eb-8432-4e3c-ba4f-dfde280a4561_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general, and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_7eab6a82-b9d1-450f-9901-67326a26fbd3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_OperatingLeaseTermOfContract_d7f46659-17b6-4df0-a52b-3ae284097ea7_terseLabel_en-US" xlink:label="lab_hims_OperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_hims_OperatingLeaseTermOfContract_label_en-US" xlink:label="lab_hims_OperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Term Of Contract</link:label>
    <link:label id="lab_hims_OperatingLeaseTermOfContract_documentation_en-US" xlink:label="lab_hims_OperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Term Of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperatingLeaseTermOfContract" xlink:href="hims-20210331.xsd#hims_OperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_OperatingLeaseTermOfContract" xlink:to="lab_hims_OperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_5ffcbc10-7c3a-411e-b1e1-26c90809798a_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired_4976314a-1ec8-458d-94b2-6e70242fb182_terseLabel_en-US" xlink:label="lab_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, percentage of voting interests acquired</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Percentage Of Voting Interests Acquired</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Percentage Of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired" xlink:to="lab_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_14e6a54f-c267-4741-aec3-1f678ecd48fa_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_f50fb087-2118-4f37-a714-6465d7702948_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest and the end of period</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_1be09096-a419-4b6c-8a87-5568670d7689_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_7b985819-0519-4d51-b638-6cb92a134b02_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_84d51e0b-38b3-4764-bf6c-41b5a6618c8c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of PIPE shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_5299c5c1-a0a3-4d68-8cde-234273f07ee0_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_dca5c00e-34e3-4970-a966-f8bda758f5ff_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f1d01338-4d25-4ad2-840d-dc7180555434_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_2883ebc0-b958-4791-bdbd-b6dc20cc7388_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_7011555f-77e1-4520-a18d-8a86fcb60b93_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_ea914713-990b-4a7d-a8d3-61eaae169c7a_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_2833b991-50da-431f-b792-97ae79aa7ee2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related-Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_4e61e1c9-0ba4-413c-98f4-a7eceae3c1cb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement Warrants and Public Warrants</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_5ce493ae-6851-4218-b9dd-23ca0215769b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bbaa8883-cf20-409f-aefd-c2275a8bb0e1_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_33b68383-66f6-4a48-a08f-38e7b2ab6de9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_99a77d27-e508-45a5-a301-962887214ce9_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_5d1b2aa3-3e74-44c7-ac8a-ae4326731872_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_BusinessCreditCardMember_090cae49-54e7-4514-9ca7-63acbc976c98_terseLabel_en-US" xlink:label="lab_hims_BusinessCreditCardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Credit Card</link:label>
    <link:label id="lab_hims_BusinessCreditCardMember_label_en-US" xlink:label="lab_hims_BusinessCreditCardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Credit Card [Member]</link:label>
    <link:label id="lab_hims_BusinessCreditCardMember_documentation_en-US" xlink:label="lab_hims_BusinessCreditCardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Credit Card</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_BusinessCreditCardMember" xlink:href="hims-20210331.xsd#hims_BusinessCreditCardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_BusinessCreditCardMember" xlink:to="lab_hims_BusinessCreditCardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_6ae107ea-1d69-4490-9cdb-84314586b9f2_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_VendorWarrantsMember_ed1da869-97c3-49b0-a2b1-77b98e0b53ec_terseLabel_en-US" xlink:label="lab_hims_VendorWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Warrants</link:label>
    <link:label id="lab_hims_VendorWarrantsMember_label_en-US" xlink:label="lab_hims_VendorWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Warrants [Member]</link:label>
    <link:label id="lab_hims_VendorWarrantsMember_documentation_en-US" xlink:label="lab_hims_VendorWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorWarrantsMember" xlink:href="hims-20210331.xsd#hims_VendorWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_VendorWarrantsMember" xlink:to="lab_hims_VendorWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a870ff4b-25e6-4bfa-b2f3-acfffe06a157_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_d4466e8c-52b1-4503-8c2d-7c094d10043f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, related parties</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_b88dcc80-f92f-48f2-9a55-c8c4f417c05a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_DebtInstrumentCovenantRequiredCollateralAmount_db906de9-4737-410c-9fd7-7416b2c46115_terseLabel_en-US" xlink:label="lab_hims_DebtInstrumentCovenantRequiredCollateralAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, covenant, required collateral amount</link:label>
    <link:label id="lab_hims_DebtInstrumentCovenantRequiredCollateralAmount_label_en-US" xlink:label="lab_hims_DebtInstrumentCovenantRequiredCollateralAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Required Collateral Amount</link:label>
    <link:label id="lab_hims_DebtInstrumentCovenantRequiredCollateralAmount_documentation_en-US" xlink:label="lab_hims_DebtInstrumentCovenantRequiredCollateralAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Required Collateral Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_DebtInstrumentCovenantRequiredCollateralAmount" xlink:href="hims-20210331.xsd#hims_DebtInstrumentCovenantRequiredCollateralAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_DebtInstrumentCovenantRequiredCollateralAmount" xlink:to="lab_hims_DebtInstrumentCovenantRequiredCollateralAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_3c260c95-9044-4e21-b9c9-291ae7323c66_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_8908e97f-c41d-42d8-9a87-5e5b2272fea3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_3d63428f-d40e-4c36-833f-a47c09e35313_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_0b4a387d-4335-486a-ade4-8f8cf57d1c2d_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_67221e94-e6f7-44f9-950f-3e51afa4f9a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_1dbcddfd-e6d1-4c6f-9212-c388c8586552_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a596ff11-e3c5-467c-8de9-0858d58c5c97_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketingExpense_20f06668-864e-46ab-b3c0-2f853208439a_terseLabel_en-US" xlink:label="lab_us-gaap_MarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing</link:label>
    <link:label id="lab_us-gaap_MarketingExpense_label_en-US" xlink:label="lab_us-gaap_MarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingExpense" xlink:to="lab_us-gaap_MarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_72c58003-a26e-4d31-9655-87bc24fc510a_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_3ecf02f6-02c7-4435-834e-1a4ecacd5349_terseLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_NotesReceivableAmountOfPrincipalPaymentCanceled_f87eb286-c682-44f8-ac0e-2911b64a6a5b_terseLabel_en-US" xlink:label="lab_hims_NotesReceivableAmountOfPrincipalPaymentCanceled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, amount of principal payment canceled</link:label>
    <link:label id="lab_hims_NotesReceivableAmountOfPrincipalPaymentCanceled_label_en-US" xlink:label="lab_hims_NotesReceivableAmountOfPrincipalPaymentCanceled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Amount Of Principal Payment Canceled</link:label>
    <link:label id="lab_hims_NotesReceivableAmountOfPrincipalPaymentCanceled_documentation_en-US" xlink:label="lab_hims_NotesReceivableAmountOfPrincipalPaymentCanceled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Amount Of Principal Payment Canceled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NotesReceivableAmountOfPrincipalPaymentCanceled" xlink:href="hims-20210331.xsd#hims_NotesReceivableAmountOfPrincipalPaymentCanceled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_NotesReceivableAmountOfPrincipalPaymentCanceled" xlink:to="lab_hims_NotesReceivableAmountOfPrincipalPaymentCanceled" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent_905133d3-efe9-498e-bad9-a03590a2ad5b_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders equity ownership, percent</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Stockholders Equity Ownership, Percent</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Stockholders Equity Ownership, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_HimsWarrantHoldersMember_378124ba-6739-4969-b93f-1becf43b858b_terseLabel_en-US" xlink:label="lab_hims_HimsWarrantHoldersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims' Warrant Holders</link:label>
    <link:label id="lab_hims_HimsWarrantHoldersMember_label_en-US" xlink:label="lab_hims_HimsWarrantHoldersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims' Warrant Holders [Member]</link:label>
    <link:label id="lab_hims_HimsWarrantHoldersMember_documentation_en-US" xlink:label="lab_hims_HimsWarrantHoldersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims' Warrant Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsWarrantHoldersMember" xlink:href="hims-20210331.xsd#hims_HimsWarrantHoldersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_HimsWarrantHoldersMember" xlink:to="lab_hims_HimsWarrantHoldersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_4903e76d-bb59-44e5-9007-2138ffc39603_terseLabel_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, contingent consideration, equity, earnout period, threshold trading days</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Days</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" xlink:to="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_e7c7d5ca-5afd-44ce-ab07-92d6f5a7f326_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_c3b21376-8998-4aaf-aa45-ba6d3b571705_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_a1838b15-4be8-4236-bcd1-e240fc6ad367_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vested at the end of the period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion_4513f782-8190-41f0-a0eb-fc1c19cc2dc4_terseLabel_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Series D preferred stock warrants to Class A common warrants</link:label>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion_label_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Warrant Conversion</link:label>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion_documentation_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Warrant Conversion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion" xlink:to="lab_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_643c2c2b-b5a6-4a16-87fb-de42355bd924_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_db1ea496-a3bd-4bb3-8e5f-5bb52b4b47d6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_638cf1e9-fecf-4647-a963-e7af507780cb_terseLabel_en-US" xlink:label="lab_hims_RecapitalizationContingentConsiderationEquityExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization, contingent consideration, equity, exchange ratio</link:label>
    <link:label id="lab_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_label_en-US" xlink:label="lab_hims_RecapitalizationContingentConsiderationEquityExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization, Contingent Consideration, Equity, Exchange Ratio</link:label>
    <link:label id="lab_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_documentation_en-US" xlink:label="lab_hims_RecapitalizationContingentConsiderationEquityExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization, Contingent Consideration, Equity, Exchange Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationContingentConsiderationEquityExchangeRatio" xlink:href="hims-20210331.xsd#hims_RecapitalizationContingentConsiderationEquityExchangeRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_RecapitalizationContingentConsiderationEquityExchangeRatio" xlink:to="lab_hims_RecapitalizationContingentConsiderationEquityExchangeRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_ccc8d28e-758d-4a86-bbff-eb81d8d6d9f3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_3b5fa230-6742-4fad-840a-3feb94a12169_negatedTerseLabel_en-US" xlink:label="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible securities (in shares)</link:label>
    <link:label id="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</link:label>
    <link:label id="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_cc842dc3-865f-415d-b3ac-c31589541eb3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodShares_728415c5-c32b-489f-a607-cfc3c6bc2f4e_terseLabel_en-US" xlink:label="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-closing stock repurchase, net of exercise of vested options (in shares)</link:label>
    <link:label id="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Repurchased During Period, Shares</link:label>
    <link:label id="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodShares_documentation_en-US" xlink:label="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:to="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_f8908a69-34f0-4c87-b238-90cb1f123523_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6b099de3-4ee4-4524-b264-a9e157a4572e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_1c528f3f-255c-493e-97e6-ae7355799e76_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_27d2c56c-2cb0-4349-a11a-5d8581dcc1b3_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Online</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodValue_c994b6f5-2792-41e6-b5dc-3fa127358935_terseLabel_en-US" xlink:label="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-closing stock repurchase, net of exercise of vested options</link:label>
    <link:label id="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Repurchased During Period, Value</link:label>
    <link:label id="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodValue_documentation_en-US" xlink:label="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:to="lab_hims_TemporaryEquityStockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_5f961c1a-fe9c-422d-89ad-58ad74f2e900_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_df0e09a4-99ef-453f-9b58-74429efb3239_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_2d71637d-05fb-4287-a294-3bf771f827ef_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_3a8a7013-94ca-4c6d-9040-33408a09e94e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_88757848-db97-4460-93d7-1bce4acd37c8_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_895884d9-5803-4da5-822b-a4e2e80c0e0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_4cf800de-916e-456e-bfcb-871d4c510e1a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b6fcab70-40e2-49a9-8502-0aa43148a85c_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_185b1b52-cf27-44b8-9e30-b7be19b6b6cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_CapitalAgreement2019TrancheOneMember_b5b57d7c-c979-4057-977d-620768cef1d9_terseLabel_en-US" xlink:label="lab_hims_CapitalAgreement2019TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Agreement, 2019, Tranche One</link:label>
    <link:label id="lab_hims_CapitalAgreement2019TrancheOneMember_label_en-US" xlink:label="lab_hims_CapitalAgreement2019TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Agreement, 2019, Tranche One [Member]</link:label>
    <link:label id="lab_hims_CapitalAgreement2019TrancheOneMember_documentation_en-US" xlink:label="lab_hims_CapitalAgreement2019TrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Agreement, 2019, Tranche One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CapitalAgreement2019TrancheOneMember" xlink:href="hims-20210331.xsd#hims_CapitalAgreement2019TrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_CapitalAgreement2019TrancheOneMember" xlink:to="lab_hims_CapitalAgreement2019TrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_ef743e10-8307-4fab-b759-ffc38046c254_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding (in years)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3f4997b6-02b5-4342-9dc7-0a31fba85399_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_03b5e553-f681-4221-8a91-0d99c7ffe446_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsTextBlock" xlink:to="lab_us-gaap_OtherCurrentAssetsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_c1ccdd0b-edb5-4491-ba48-74a5ef5559be_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_ab273c52-f133-46e4-85a7-3e61db63f0b0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:to="lab_us-gaap_VariableInterestEntityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6e956e0d-cfa4-4d36-b0df-b1041fbfd3be_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_d967487c-295d-4c33-9e14-56e76c263827_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of period</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_CommonClassAAndVMember_6e1002c0-09e0-48c1-a0df-d06f6894c5a2_terseLabel_en-US" xlink:label="lab_hims_CommonClassAAndVMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A and V</link:label>
    <link:label id="lab_hims_CommonClassAAndVMember_label_en-US" xlink:label="lab_hims_CommonClassAAndVMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A And V [Member]</link:label>
    <link:label id="lab_hims_CommonClassAAndVMember_documentation_en-US" xlink:label="lab_hims_CommonClassAAndVMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A And V</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassAAndVMember" xlink:href="hims-20210331.xsd#hims_CommonClassAAndVMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_CommonClassAAndVMember" xlink:to="lab_hims_CommonClassAAndVMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_35fbcf01-4a39-4ded-90c4-714b369e93dd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a9dfc9df-4c7f-4caa-af24-9b0214204859_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_dfe8a36d-dd2d-45d5-a05c-a6ead531e7b6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_79a089b8-aa55-43e2-aee3-f3a7defce1c1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_0cb1bd92-f13e-4ef5-9fbb-5f81c10eb174_terseLabel_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, long-term and short-term, combined amount</link:label>
    <link:label id="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount_label_en-US" xlink:label="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Long-term and Short-term, Combined Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:to="lab_us-gaap_DebtLongtermAndShorttermCombinedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_d2708b12-10d1-4fd0-a632-c8fffa7cf446_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_SaleOfStockPutRightPeriod_482d6d84-d6cd-47ba-87b5-cbac66a75678_terseLabel_en-US" xlink:label="lab_hims_SaleOfStockPutRightPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, put right period</link:label>
    <link:label id="lab_hims_SaleOfStockPutRightPeriod_label_en-US" xlink:label="lab_hims_SaleOfStockPutRightPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Put Right Period</link:label>
    <link:label id="lab_hims_SaleOfStockPutRightPeriod_documentation_en-US" xlink:label="lab_hims_SaleOfStockPutRightPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Put Right Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SaleOfStockPutRightPeriod" xlink:href="hims-20210331.xsd#hims_SaleOfStockPutRightPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_SaleOfStockPutRightPeriod" xlink:to="lab_hims_SaleOfStockPutRightPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_StockForfeitedDuringPeriodShares_1f0228a9-0396-47ce-a96d-ffc1d8d3a0a4_negatedTerseLabel_en-US" xlink:label="lab_hims_StockForfeitedDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of related-party promissory notes (in shares)</link:label>
    <link:label id="lab_hims_StockForfeitedDuringPeriodShares_e865d9bc-998f-4d6d-a027-4046941cd9ec_terseLabel_en-US" xlink:label="lab_hims_StockForfeitedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of related-party promissory notes (in shares)</link:label>
    <link:label id="lab_hims_StockForfeitedDuringPeriodShares_label_en-US" xlink:label="lab_hims_StockForfeitedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Forfeited During Period, Shares</link:label>
    <link:label id="lab_hims_StockForfeitedDuringPeriodShares_documentation_en-US" xlink:label="lab_hims_StockForfeitedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Forfeited During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockForfeitedDuringPeriodShares" xlink:href="hims-20210331.xsd#hims_StockForfeitedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_StockForfeitedDuringPeriodShares" xlink:to="lab_hims_StockForfeitedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_def92de6-15e4-4ad1-861a-93c0632d6dbf_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government bonds</link:label>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ClassOfWarrantOrRightThresholdTradingDays_417a73ca-f391-4054-a64a-e39b60abb2a7_terseLabel_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold trading days</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightThresholdTradingDays_label_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Threshold Trading Days</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightThresholdTradingDays_documentation_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightThresholdTradingDays" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ClassOfWarrantOrRightThresholdTradingDays" xlink:to="lab_hims_ClassOfWarrantOrRightThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_51a82fdb-ec32-42be-b00a-9b37316968ff_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party transaction, rate</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionRate_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionRate" xlink:to="lab_us-gaap_RelatedPartyTransactionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_67ea112c-d1ad-4b84-b4c8-a9d217e612a0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod_34137a29-6577-4093-bd5e-388e2dfd94da_terseLabel_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, contingent consideration, equity, earnout period, threshold trading day period</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Day Period</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Day Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod" xlink:to="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_33c5d2b8-2391-4dac-b822-6f4d538fb51b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_SeriesA1PreferredStockMember_cf4c4358-2c10-405e-9f3b-b768ff2d503f_terseLabel_en-US" xlink:label="lab_hims_SeriesA1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A-1</link:label>
    <link:label id="lab_hims_SeriesA1PreferredStockMember_label_en-US" xlink:label="lab_hims_SeriesA1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A-1 Preferred Stock [Member]</link:label>
    <link:label id="lab_hims_SeriesA1PreferredStockMember_documentation_en-US" xlink:label="lab_hims_SeriesA1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A-1 Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesA1PreferredStockMember" xlink:href="hims-20210331.xsd#hims_SeriesA1PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_SeriesA1PreferredStockMember" xlink:to="lab_hims_SeriesA1PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_cc6ac392-83ff-43fb-a114-8b8a60c523ce_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases, rent expense</link:label>
    <link:label id="lab_us-gaap_LeaseAndRentalExpense_label_en-US" xlink:label="lab_us-gaap_LeaseAndRentalExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Rent Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseAndRentalExpense" xlink:to="lab_us-gaap_LeaseAndRentalExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization_42af61cc-5f48-40da-8e96-3a4ce11c0d6f_negatedTerseLabel_en-US" xlink:label="lab_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Series D preferred stock warrants to Class A common stock warrants</link:label>
    <link:label id="lab_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization_label_en-US" xlink:label="lab_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reverse Recapitalization</link:label>
    <link:label id="lab_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization_documentation_en-US" xlink:label="lab_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization" xlink:href="hims-20210331.xsd#hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization" xlink:to="lab_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_c4dc5bda-3518-4aa7-97b0-c4ae8e8b55d6_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRentCreditNoncurrent_047c8e8c-46c8-4961-bbcc-5dda197cad72_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRentCreditNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred rent, noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredRentCreditNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRentCreditNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Rent Credit, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRentCreditNoncurrent" xlink:to="lab_us-gaap_DeferredRentCreditNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_e1735a66-6b5f-4db6-87e4-dd520a625da0_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_NoncashWarrantExpense_26692fc5-6b66-42df-a43e-353c67c6008b_terseLabel_en-US" xlink:label="lab_hims_NoncashWarrantExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant expense in connection with Merger</link:label>
    <link:label id="lab_hims_NoncashWarrantExpense_label_en-US" xlink:label="lab_hims_NoncashWarrantExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Warrant Expense</link:label>
    <link:label id="lab_hims_NoncashWarrantExpense_documentation_en-US" xlink:label="lab_hims_NoncashWarrantExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Warrant Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NoncashWarrantExpense" xlink:href="hims-20210331.xsd#hims_NoncashWarrantExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_NoncashWarrantExpense" xlink:to="lab_hims_NoncashWarrantExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_d7a2a073-dcea-446e-a1d6-c4d0f61420fe_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment_7a50c466-649c-45a1-9317-3dc24b5d1f17_terseLabel_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of related-party promissory notes associated with vested shares</link:label>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment_label_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Related Party Receivable Repayment</link:label>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment_documentation_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Related Party Receivable Repayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment" xlink:to="lab_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OfficerMember_69c53dcd-f032-46b9-b67d-21ea31d59d06_terseLabel_en-US" xlink:label="lab_srt_OfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer</link:label>
    <link:label id="lab_srt_OfficerMember_label_en-US" xlink:label="lab_srt_OfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficerMember" xlink:to="lab_srt_OfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_RedeemableClassACommonStockMember_575a9001-b1ea-481c-89f5-44ebd0e75ebc_terseLabel_en-US" xlink:label="lab_hims_RedeemableClassACommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Class&#160;A Common&#160;Stock</link:label>
    <link:label id="lab_hims_RedeemableClassACommonStockMember_label_en-US" xlink:label="lab_hims_RedeemableClassACommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Class A Common Stock [Member]</link:label>
    <link:label id="lab_hims_RedeemableClassACommonStockMember_documentation_en-US" xlink:label="lab_hims_RedeemableClassACommonStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Class A Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableClassACommonStockMember" xlink:href="hims-20210331.xsd#hims_RedeemableClassACommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_RedeemableClassACommonStockMember" xlink:to="lab_hims_RedeemableClassACommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ParentWarrantRestrictedStockUnitsMember_519cd935-e385-4890-95d4-ea438f47404e_terseLabel_en-US" xlink:label="lab_hims_ParentWarrantRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Warrant Restricted Stock Units</link:label>
    <link:label id="lab_hims_ParentWarrantRestrictedStockUnitsMember_label_en-US" xlink:label="lab_hims_ParentWarrantRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Warrant Restricted Stock Units [Member]</link:label>
    <link:label id="lab_hims_ParentWarrantRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_hims_ParentWarrantRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Warrant Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantRestrictedStockUnitsMember" xlink:href="hims-20210331.xsd#hims_ParentWarrantRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ParentWarrantRestrictedStockUnitsMember" xlink:to="lab_hims_ParentWarrantRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_ee200068-d325-4205-9ea1-b07c79ec229c_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited and expired (in dollars per share)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures And Expirations In Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures And Expirations In Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_27418058-b268-4fce-834d-e18c42920b12_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e9fdfd90-1b63-484b-99dc-219ed212e35e_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_StockPlan2017Member_db20a949-05bc-4fb0-a7e8-0a0928f138c7_terseLabel_en-US" xlink:label="lab_hims_StockPlan2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Plan, 2017</link:label>
    <link:label id="lab_hims_StockPlan2017Member_label_en-US" xlink:label="lab_hims_StockPlan2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Plan, 2017 [Member]</link:label>
    <link:label id="lab_hims_StockPlan2017Member_documentation_en-US" xlink:label="lab_hims_StockPlan2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Plan, 2017</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockPlan2017Member" xlink:href="hims-20210331.xsd#hims_StockPlan2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_StockPlan2017Member" xlink:to="lab_hims_StockPlan2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ebb43e24-b46b-4812-8c6e-2c6c949727ae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_4766b087-c8c1-4faf-885f-3b2fc0938bac_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_9993b39b-1eec-463f-8fe0-e380675802ba_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForSoftware_e1a4a205-4285-4c92-b0dc-5f6eba88b0ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in website development and internal-use software</link:label>
    <link:label id="lab_us-gaap_PaymentsForSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsForSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForSoftware" xlink:to="lab_us-gaap_PaymentsForSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_96697d86-9b9e-4275-a2b8-cf5aac7c3486_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_dd223ec2-59b6-45c3-856b-f73bb32ce842_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_11fabe6e-26ee-4cc8-91a6-8eaa3107bc28_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a810227e-4303-4bda-8b51-4ea26e22ae9c_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e0a4ec4f-ab6a-49fb-8c37-a4d10e41fe93_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, capital shares reserved for future issuance</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_b77d84a2-842a-4594-9e49-c54641efdc7e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_CapitalAgreement2019TrancheTwoMember_1c6d2f56-f7e7-4b49-a686-884df6ed8ef3_terseLabel_en-US" xlink:label="lab_hims_CapitalAgreement2019TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Agreement, 2019, Tranche Two</link:label>
    <link:label id="lab_hims_CapitalAgreement2019TrancheTwoMember_label_en-US" xlink:label="lab_hims_CapitalAgreement2019TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Agreement, 2019, Tranche Two [Member]</link:label>
    <link:label id="lab_hims_CapitalAgreement2019TrancheTwoMember_documentation_en-US" xlink:label="lab_hims_CapitalAgreement2019TrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Agreement, 2019, Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CapitalAgreement2019TrancheTwoMember" xlink:href="hims-20210331.xsd#hims_CapitalAgreement2019TrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_CapitalAgreement2019TrancheTwoMember" xlink:to="lab_hims_CapitalAgreement2019TrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_19b19264-76de-4f9a-8b7f-8ead4b5f18ea_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_b21bc69c-d12a-488a-b259-7bc71e7b2e7a_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_f65db62a-2ee7-498a-8b8b-447115e86b0b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_eef8332a-0f49-415d-971a-315abd6085e2_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_e128dfc1-2936-453d-a811-f92ec9d0e0ff_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_9c72e01f-baab-4d88-9753-aa10721f2dea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-closing stock repurchase, net of exercise of vested options</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_6689aa50-16c4-4616-820e-3fb953ba364e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-closing stock repurchase, net of exercise of vested options</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_CEOAndDirectorMember_4a3bb04f-5a65-4a8d-a88a-0801ef568cd0_terseLabel_en-US" xlink:label="lab_hims_CEOAndDirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CEO And Director</link:label>
    <link:label id="lab_hims_CEOAndDirectorMember_label_en-US" xlink:label="lab_hims_CEOAndDirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CEO And Director [Member]</link:label>
    <link:label id="lab_hims_CEOAndDirectorMember_documentation_en-US" xlink:label="lab_hims_CEOAndDirectorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CEO And Director</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CEOAndDirectorMember" xlink:href="hims-20210331.xsd#hims_CEOAndDirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_CEOAndDirectorMember" xlink:to="lab_hims_CEOAndDirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_0856d89b-fc9d-4f1b-9126-e8715fa7a41b_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_d4265a73-91fd-44b2-9112-fd78b24c4f93_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of period (in shares)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ExercisePriceRange243To365Member_1b31df4f-7fe8-4255-9e60-488a9b842b47_terseLabel_en-US" xlink:label="lab_hims_ExercisePriceRange243To365Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $2.43 to $3.65</link:label>
    <link:label id="lab_hims_ExercisePriceRange243To365Member_label_en-US" xlink:label="lab_hims_ExercisePriceRange243To365Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $2.43 to $3.65 [Member]</link:label>
    <link:label id="lab_hims_ExercisePriceRange243To365Member_documentation_en-US" xlink:label="lab_hims_ExercisePriceRange243To365Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $2.43 to $3.65</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange243To365Member" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange243To365Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ExercisePriceRange243To365Member" xlink:to="lab_hims_ExercisePriceRange243To365Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_89a9493f-422b-47a7-a953-17896a864e91_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTable" xlink:to="lab_us-gaap_MarketableSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_a7925751-bff4-431e-a462-7818cce6130e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchased and retired during period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_c806be9f-a856-44f4-85eb-b5b2144c3363_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_AffiliatedMedicalGroupsMember_70695566-c22e-47af-a506-944629be5961_terseLabel_en-US" xlink:label="lab_hims_AffiliatedMedicalGroupsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Medical Groups</link:label>
    <link:label id="lab_hims_AffiliatedMedicalGroupsMember_label_en-US" xlink:label="lab_hims_AffiliatedMedicalGroupsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Medical Groups [Member]</link:label>
    <link:label id="lab_hims_AffiliatedMedicalGroupsMember_documentation_en-US" xlink:label="lab_hims_AffiliatedMedicalGroupsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Medical Groups</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AffiliatedMedicalGroupsMember" xlink:href="hims-20210331.xsd#hims_AffiliatedMedicalGroupsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_AffiliatedMedicalGroupsMember" xlink:to="lab_hims_AffiliatedMedicalGroupsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationAbstract_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization [Abstract]</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationAbstract_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationAbstract" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationAbstract" xlink:to="lab_hims_ReverseRecapitalizationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_a0566ba5-1f73-4d1a-b726-42de965edc0b_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_1b5bc1aa-47c3-4d7f-a946-b26a991d27ef_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_f09c38e4-f425-47c9-84fa-9c5bf6f8bc0c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_StockIssuedDuringPeriodSharesReverseRecapitalization_a36ec3e8-92b4-4299-a2a6-14d15b383475_terseLabel_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon Merger, net of transaction costs and merger warrant liability (in shares)</link:label>
    <link:label id="lab_hims_StockIssuedDuringPeriodSharesReverseRecapitalization_label_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Reverse Recapitalization</link:label>
    <link:label id="lab_hims_StockIssuedDuringPeriodSharesReverseRecapitalization_documentation_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodSharesReverseRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:to="lab_hims_StockIssuedDuringPeriodSharesReverseRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToSuppliers_ef25c7fe-1662-4405-97db-4cd82e764b6a_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to suppliers</link:label>
    <link:label id="lab_us-gaap_PaymentsToSuppliers_label_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Suppliers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliers" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToSuppliers" xlink:to="lab_us-gaap_PaymentsToSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_PrivatePlacementWarrantsMember_2c6c1e5e-0062-404b-bb5b-3ea4c893cbc5_terseLabel_en-US" xlink:label="lab_hims_PrivatePlacementWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement Warrants</link:label>
    <link:label id="lab_hims_PrivatePlacementWarrantsMember_label_en-US" xlink:label="lab_hims_PrivatePlacementWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement Warrants [Member]</link:label>
    <link:label id="lab_hims_PrivatePlacementWarrantsMember_documentation_en-US" xlink:label="lab_hims_PrivatePlacementWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PrivatePlacementWarrantsMember" xlink:href="hims-20210331.xsd#hims_PrivatePlacementWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_PrivatePlacementWarrantsMember" xlink:to="lab_hims_PrivatePlacementWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_ead82547-2b16-43ac-91bd-a3561875daec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_b200d16c-9fad-44a4-857f-7dd164c616c8_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of period (in dollars per share)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_PublicWarrantsCashRedemptionMember_3b724e6f-4c89-46ce-9ec7-372aaf366546_terseLabel_en-US" xlink:label="lab_hims_PublicWarrantsCashRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants, Cash Redemption</link:label>
    <link:label id="lab_hims_PublicWarrantsCashRedemptionMember_label_en-US" xlink:label="lab_hims_PublicWarrantsCashRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants, Cash Redemption [Member]</link:label>
    <link:label id="lab_hims_PublicWarrantsCashRedemptionMember_documentation_en-US" xlink:label="lab_hims_PublicWarrantsCashRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants, Cash Redemption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsCashRedemptionMember" xlink:href="hims-20210331.xsd#hims_PublicWarrantsCashRedemptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_PublicWarrantsCashRedemptionMember" xlink:to="lab_hims_PublicWarrantsCashRedemptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_ec0243a2-ef35-4157-87fe-0be7a4dbab6d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76369828-e972-4046-bfeb-79d310859a15_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_e70bb77b-c042-4d88-970d-2380e04dc54d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_c93a9e3d-fa6a-48e7-a0d5-70be35aa368d_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_741efedc-96b8-48f0-b992-80574d46d9a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7fbbafc3-07f3-4039-aead-89a42821865b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_MarketingExpenseMember_26c15f5b-0a22-4e79-a6a3-64402602d8da_terseLabel_en-US" xlink:label="lab_hims_MarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing</link:label>
    <link:label id="lab_hims_MarketingExpenseMember_label_en-US" xlink:label="lab_hims_MarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Expense [Member]</link:label>
    <link:label id="lab_hims_MarketingExpenseMember_documentation_en-US" xlink:label="lab_hims_MarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_MarketingExpenseMember" xlink:href="hims-20210331.xsd#hims_MarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_MarketingExpenseMember" xlink:to="lab_hims_MarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_f73ed0d2-4802-464c-a7c2-9ec223e6a74a_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_69a36d52-e719-4275-a4df-0de5e9f2cb9b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_7c069101-2a61-44fb-9201-9f02f3dbc1d1_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_6d065532-9fa1-4ff8-9360-9dd9e651ff15_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate_187f795a-4769-4584-b7df-9189995bc414_terseLabel_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable period after closing date</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate_label_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercisable Period After Closing Date</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate_documentation_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercisable Period After Closing Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate" xlink:to="lab_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage_419b3940-5d58-4be0-a159-724c1acf34fd_terseLabel_en-US" xlink:label="lab_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting rights, monthly percentage</link:label>
    <link:label id="lab_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage_label_en-US" xlink:label="lab_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Award, Award Vesting Rights, Monthly Percentage</link:label>
    <link:label id="lab_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage_documentation_en-US" xlink:label="lab_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Award, Award Vesting Rights, Monthly Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage" xlink:to="lab_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_51502385-7994-409e-a16d-12a3a3ae9f22_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_428dd8f7-9323-44b8-b63f-c0d92ccce7b5_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_6627d9f0-c55e-46db-945d-84ea2862a541_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment arrangement, nonvested award, excluding option, cost not yet recognized, amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_AccruedPayrollCostsCurrent_c82cf9ed-06ce-445d-a460-87009eb02392_terseLabel_en-US" xlink:label="lab_hims_AccruedPayrollCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll costs</link:label>
    <link:label id="lab_hims_AccruedPayrollCostsCurrent_label_en-US" xlink:label="lab_hims_AccruedPayrollCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Payroll Costs, Current</link:label>
    <link:label id="lab_hims_AccruedPayrollCostsCurrent_documentation_en-US" xlink:label="lab_hims_AccruedPayrollCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Payroll Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AccruedPayrollCostsCurrent" xlink:href="hims-20210331.xsd#hims_AccruedPayrollCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_AccruedPayrollCostsCurrent" xlink:to="lab_hims_AccruedPayrollCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_ae54633f-1d4a-4547-bf99-62d69e60fbd7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeiture of unvested early exercised shares (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_SeriesCPreferredStockWarrantsMember_ad2131c3-cca3-423e-8932-3510cf7689c4_terseLabel_en-US" xlink:label="lab_hims_SeriesCPreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock Warrants</link:label>
    <link:label id="lab_hims_SeriesCPreferredStockWarrantsMember_label_en-US" xlink:label="lab_hims_SeriesCPreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock Warrants [Member]</link:label>
    <link:label id="lab_hims_SeriesCPreferredStockWarrantsMember_documentation_en-US" xlink:label="lab_hims_SeriesCPreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesCPreferredStockWarrantsMember" xlink:href="hims-20210331.xsd#hims_SeriesCPreferredStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_SeriesCPreferredStockWarrantsMember" xlink:to="lab_hims_SeriesCPreferredStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ParentWarrantsMember_f69594d5-17d2-4ab0-9e1e-4bc1b7581eb8_terseLabel_en-US" xlink:label="lab_hims_ParentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Warrants</link:label>
    <link:label id="lab_hims_ParentWarrantsMember_label_en-US" xlink:label="lab_hims_ParentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Warrants [Member]</link:label>
    <link:label id="lab_hims_ParentWarrantsMember_documentation_en-US" xlink:label="lab_hims_ParentWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantsMember" xlink:href="hims-20210331.xsd#hims_ParentWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ParentWarrantsMember" xlink:to="lab_hims_ParentWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_81df920a-ccbf-4d4d-b10b-84e1dad0fac7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_52954ea2-41bb-499a-bb0b-9605b0b45ac8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_c4283097-28e5-4b89-bec8-f21054d88262_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_250ea256-0397-415e-81bc-c727cd4aac2a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed bonds</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_a6c47ab4-c948-470b-889f-6ce16ddadfc8_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_02e42b4d-9d9f-4ed0-ac18-bbbe7b47189d_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateBondSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateBondSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Bond Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateBondSecuritiesMember" xlink:to="lab_us-gaap_CorporateBondSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_8fcfc357-f884-42a9-bc67-b47d770afd35_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_be4c21a1-e908-44ff-b9ab-0648957bbaea_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_95a69352-82f4-473c-bc53-dfe0a7645250_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3430601c-940f-49fe-86fb-09bbd31edd26_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_929951af-dad3-4c53-be52-88638090a2c8_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligation</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_EarnOutRestrictedStockUnitsMember_3f7088b0-eb90-4c8b-a4f0-a516f4fbe1cc_terseLabel_en-US" xlink:label="lab_hims_EarnOutRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Out Restricted Stock Units</link:label>
    <link:label id="lab_hims_EarnOutRestrictedStockUnitsMember_label_en-US" xlink:label="lab_hims_EarnOutRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Out Restricted Stock Units [Member]</link:label>
    <link:label id="lab_hims_EarnOutRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_hims_EarnOutRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earn Out Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EarnOutRestrictedStockUnitsMember" xlink:href="hims-20210331.xsd#hims_EarnOutRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_EarnOutRestrictedStockUnitsMember" xlink:to="lab_hims_EarnOutRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_478f2004-4cce-4c2a-aa31-95cd48343bc1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_HimsOptionAndRSUHoldersMember_bf6d50a4-c3e2-4004-9207-d73a451e70a6_terseLabel_en-US" xlink:label="lab_hims_HimsOptionAndRSUHoldersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims' Option And RSU Holders</link:label>
    <link:label id="lab_hims_HimsOptionAndRSUHoldersMember_label_en-US" xlink:label="lab_hims_HimsOptionAndRSUHoldersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims' Option And RSU Holders [Member]</link:label>
    <link:label id="lab_hims_HimsOptionAndRSUHoldersMember_documentation_en-US" xlink:label="lab_hims_HimsOptionAndRSUHoldersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims' Option And RSU Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsOptionAndRSUHoldersMember" xlink:href="hims-20210331.xsd#hims_HimsOptionAndRSUHoldersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_HimsOptionAndRSUHoldersMember" xlink:to="lab_hims_HimsOptionAndRSUHoldersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_aa8f88ff-caca-4a6d-9096-a8bc681e0007_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_e11d2754-0df6-4061-8fe3-1c631df209f0_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ClassOfWarrantOrRightExpirationPeriod_d380f7f4-d0c7-4cdb-81b6-b1209e32238b_terseLabel_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant expiration period</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightExpirationPeriod_label_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Expiration Period</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightExpirationPeriod_documentation_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightExpirationPeriod" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ClassOfWarrantOrRightExpirationPeriod" xlink:to="lab_hims_ClassOfWarrantOrRightExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f820ca2d-4934-4109-ae22-8443a21d3b8c_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_TemporaryEquityTextBlock_53667fdb-f1de-42c5-8fec-be373f40e8cd_terseLabel_en-US" xlink:label="lab_hims_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_hims_TemporaryEquityTextBlock_label_en-US" xlink:label="lab_hims_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Text Block]</link:label>
    <link:label id="lab_hims_TemporaryEquityTextBlock_documentation_en-US" xlink:label="lab_hims_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityTextBlock" xlink:href="hims-20210331.xsd#hims_TemporaryEquityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_TemporaryEquityTextBlock" xlink:to="lab_hims_TemporaryEquityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_NonrecourseRelatedPartyPromissoryNotesMember_732273a7-94df-4463-8370-685deb95cc7e_terseLabel_en-US" xlink:label="lab_hims_NonrecourseRelatedPartyPromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecourse Related-Party Promissory Notes</link:label>
    <link:label id="lab_hims_NonrecourseRelatedPartyPromissoryNotesMember_label_en-US" xlink:label="lab_hims_NonrecourseRelatedPartyPromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecourse Related-Party Promissory Notes [Member]</link:label>
    <link:label id="lab_hims_NonrecourseRelatedPartyPromissoryNotesMember_documentation_en-US" xlink:label="lab_hims_NonrecourseRelatedPartyPromissoryNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonrecourse Related-Party Promissory Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NonrecourseRelatedPartyPromissoryNotesMember" xlink:href="hims-20210331.xsd#hims_NonrecourseRelatedPartyPromissoryNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_NonrecourseRelatedPartyPromissoryNotesMember" xlink:to="lab_hims_NonrecourseRelatedPartyPromissoryNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_b4559a0c-aefe-4397-8463-f2e12e04dd7c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_IdentityVerificationServicesMember_2e1ce378-81c9-432b-aa73-627de70b45bc_terseLabel_en-US" xlink:label="lab_hims_IdentityVerificationServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identity Verification Services</link:label>
    <link:label id="lab_hims_IdentityVerificationServicesMember_label_en-US" xlink:label="lab_hims_IdentityVerificationServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identity Verification Services [Member]</link:label>
    <link:label id="lab_hims_IdentityVerificationServicesMember_documentation_en-US" xlink:label="lab_hims_IdentityVerificationServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identity Verification Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_IdentityVerificationServicesMember" xlink:href="hims-20210331.xsd#hims_IdentityVerificationServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_IdentityVerificationServicesMember" xlink:to="lab_hims_IdentityVerificationServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_02204471-450c-415f-bea7-2a2f8c4e74eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e9e3806f-0fb3-42ea-93de-d7469846ac2f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_3783c7c7-f4f3-4fdc-9b4d-e78a0560d01a_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Intrinsic Value</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Intrinsic Value, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Intrinsic Value, Additional Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_226f0d8b-ded4-47bc-ad3e-6c1f43053494_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Series D convertible preferred stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_21a58433-c1f7-40e4-b924-1d16e8ec8dbe_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_e3a87ffb-fca1-46f5-95d7-1846b008f5a9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares_05d9d732-f60f-4357-b787-414a86117371_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early exercises of nonvested options (in shares)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Early Exercises, Number Of Shares</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Early Exercises, Number Of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock_3228b4c0-abb4-4408-be75-6edc54f4f69c_terseLabel_en-US" xlink:label="lab_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-Than-Temporary Impairment</link:label>
    <link:label id="lab_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-Than-Temporary Impairment On Investments, Policy [Policy Text Block]</link:label>
    <link:label id="lab_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-Than-Temporary Impairment On Investments, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock" xlink:href="hims-20210331.xsd#hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock" xlink:to="lab_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization_30e4b083-8c7e-4e35-9e1a-8cf19ee8f891_terseLabel_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of earn-out shares to common stockholders</link:label>
    <link:label id="lab_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization_label_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Contingent Consideration, Reverse Recapitalization</link:label>
    <link:label id="lab_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization_documentation_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Contingent Consideration, Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization" xlink:to="lab_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_a5ec8d1c-a12d-48f5-81bc-4b83069493ae_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ClassOfWarrantOrRightRedemptionPricePerShare_f960c6f2-bef5-4dee-b017-540c7a81f5b1_terseLabel_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightRedemptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of warrant or right, redemption price per share (in dollars per share)</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightRedemptionPricePerShare_label_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightRedemptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Redemption Price Per Share</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightRedemptionPricePerShare_documentation_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightRedemptionPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Redemption Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightRedemptionPricePerShare" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightRedemptionPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ClassOfWarrantOrRightRedemptionPricePerShare" xlink:to="lab_hims_ClassOfWarrantOrRightRedemptionPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_IncreaseDecreaseInDeferredRent_686f397f-0fb6-4607-aa1e-5311dd86c974_terseLabel_en-US" xlink:label="lab_hims_IncreaseDecreaseInDeferredRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred rent</link:label>
    <link:label id="lab_hims_IncreaseDecreaseInDeferredRent_label_en-US" xlink:label="lab_hims_IncreaseDecreaseInDeferredRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Deferred Rent</link:label>
    <link:label id="lab_hims_IncreaseDecreaseInDeferredRent_documentation_en-US" xlink:label="lab_hims_IncreaseDecreaseInDeferredRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Deferred Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_IncreaseDecreaseInDeferredRent" xlink:href="hims-20210331.xsd#hims_IncreaseDecreaseInDeferredRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_IncreaseDecreaseInDeferredRent" xlink:to="lab_hims_IncreaseDecreaseInDeferredRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d9c90665-0d92-4e98-b83b-21c364274df4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible securities</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8c78951a-5ac0-4600-b767-2dcd35e2c377_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_RecapitalizationExchangeConversionBasis_5ae194fd-a1b8-4ec6-a579-430013519c5a_terseLabel_en-US" xlink:label="lab_hims_RecapitalizationExchangeConversionBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization exchange conversion basis</link:label>
    <link:label id="lab_hims_RecapitalizationExchangeConversionBasis_label_en-US" xlink:label="lab_hims_RecapitalizationExchangeConversionBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Conversion Basis</link:label>
    <link:label id="lab_hims_RecapitalizationExchangeConversionBasis_documentation_en-US" xlink:label="lab_hims_RecapitalizationExchangeConversionBasis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Conversion Basis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeConversionBasis" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeConversionBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_RecapitalizationExchangeConversionBasis" xlink:to="lab_hims_RecapitalizationExchangeConversionBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_HimsIncMember_a9304cfd-3ced-42c3-b78a-c5b40d19534f_terseLabel_en-US" xlink:label="lab_hims_HimsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims, Inc.</link:label>
    <link:label id="lab_hims_HimsIncMember_label_en-US" xlink:label="lab_hims_HimsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims, Inc. [Member]</link:label>
    <link:label id="lab_hims_HimsIncMember_documentation_en-US" xlink:label="lab_hims_HimsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hims, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsIncMember" xlink:href="hims-20210331.xsd#hims_HimsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_HimsIncMember" xlink:to="lab_hims_HimsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_d519a80f-f19a-46ce-a179-29d3e4b4dba4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash, noncurrent</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_53289b51-8f03-4611-9b5e-a0f49710dc9e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_StockIssuedDuringPeriodValueReverseRecapitalization_8aa63488-ac76-4aaa-b03f-14d82c49264f_terseLabel_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon Merger, net of transaction costs and Merger warrants liability</link:label>
    <link:label id="lab_hims_StockIssuedDuringPeriodValueReverseRecapitalization_label_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Reverse Recapitalization</link:label>
    <link:label id="lab_hims_StockIssuedDuringPeriodValueReverseRecapitalization_documentation_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodValueReverseRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:to="lab_hims_StockIssuedDuringPeriodValueReverseRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_8697bf15-9a68-43d4-bbbd-0b5dc107c328_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity:</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAbstract" xlink:to="lab_us-gaap_TemporaryEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_d008ef21-d799-461d-9125-6c9263f02953_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_371a8acc-4dd3-4447-b6d7-fa096e3e8448_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_39043479-a8c3-4dbe-ac88-192f2f724ed8_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at the end of period (in shares)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_9e170a65-2eb1-4691-b4de-bae88decf5f2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock, percent</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_215908a6-20e7-4e18-8b06-c62d85b21720_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_169ee34e-fcf3-4515-93bd-1c73e89170cd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested_a14a2ee7-828a-4515-bbfa-62d4717f4d1c_terseLabel_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of early exercised stock options</link:label>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested_label_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Early Exercised Options, Vested</link:label>
    <link:label id="lab_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested_documentation_en-US" xlink:label="lab_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Early Exercised Options, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" xlink:to="lab_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_3f038ad5-a9dd-4284-af75-f8e4d40b64de_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_12a7b50b-e70a-4602-a38c-f4afcb8dc0a8_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_6b4a06e1-715c-4f37-ac46-e0bee991ccfb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payment arrangement, exercise of option, tax benefit</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Exercise of Option, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_45be6e6b-0fb7-4188-8f9c-0aa499975880_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_442d0522-5342-43bc-95e6-69c94d11c18a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_7939eecd-2bdf-418d-9276-f65d0c1fe08c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of warrant or right, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_d79249fa-6698-4d79-bf14-716b47258e83_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ClassACommonStockWarrantsMember_9aeab919-00e9-4029-9d56-2f4f3545c999_terseLabel_en-US" xlink:label="lab_hims_ClassACommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common Stock Warrants</link:label>
    <link:label id="lab_hims_ClassACommonStockWarrantsMember_label_en-US" xlink:label="lab_hims_ClassACommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common Stock Warrants [Member]</link:label>
    <link:label id="lab_hims_ClassACommonStockWarrantsMember_documentation_en-US" xlink:label="lab_hims_ClassACommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassACommonStockWarrantsMember" xlink:href="hims-20210331.xsd#hims_ClassACommonStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ClassACommonStockWarrantsMember" xlink:to="lab_hims_ClassACommonStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationTransactionCosts_7aa88be3-a43b-4e21-b132-349a9e98d4d7_terseLabel_en-US" xlink:label="lab_hims_ReverseRecapitalizationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, deferred transaction costs</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationTransactionCosts_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Transaction Costs</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationTransactionCosts_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationTransactionCosts" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationTransactionCosts" xlink:to="lab_hims_ReverseRecapitalizationTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_364de202-9e8a-481a-bfb6-fb1d2167476c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_FormerExecutiveOfficerMember_a278b660-c69f-4f1b-b6f0-fdbfd4f6852e_terseLabel_en-US" xlink:label="lab_hims_FormerExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Executive Officer</link:label>
    <link:label id="lab_hims_FormerExecutiveOfficerMember_label_en-US" xlink:label="lab_hims_FormerExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Executive Officer [Member]</link:label>
    <link:label id="lab_hims_FormerExecutiveOfficerMember_documentation_en-US" xlink:label="lab_hims_FormerExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Executive Officer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_FormerExecutiveOfficerMember" xlink:href="hims-20210331.xsd#hims_FormerExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_FormerExecutiveOfficerMember" xlink:to="lab_hims_FormerExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_NumberOfClassesOfCommonStock_98560ca2-9fb5-4c4a-b9f3-cf0160067297_terseLabel_en-US" xlink:label="lab_hims_NumberOfClassesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of classes of common stock</link:label>
    <link:label id="lab_hims_NumberOfClassesOfCommonStock_label_en-US" xlink:label="lab_hims_NumberOfClassesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Classes Of Common Stock</link:label>
    <link:label id="lab_hims_NumberOfClassesOfCommonStock_documentation_en-US" xlink:label="lab_hims_NumberOfClassesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Classes Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NumberOfClassesOfCommonStock" xlink:href="hims-20210331.xsd#hims_NumberOfClassesOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_NumberOfClassesOfCommonStock" xlink:to="lab_hims_NumberOfClassesOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_TransactionCostsIncurredButNotYetPaid_d7a3d62e-2132-46b3-bc2f-0488eb166d7f_terseLabel_en-US" xlink:label="lab_hims_TransactionCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in transaction costs payable</link:label>
    <link:label id="lab_hims_TransactionCostsIncurredButNotYetPaid_label_en-US" xlink:label="lab_hims_TransactionCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Costs Incurred But Not Yet Paid</link:label>
    <link:label id="lab_hims_TransactionCostsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_hims_TransactionCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction Costs Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TransactionCostsIncurredButNotYetPaid" xlink:href="hims-20210331.xsd#hims_TransactionCostsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_TransactionCostsIncurredButNotYetPaid" xlink:to="lab_hims_TransactionCostsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_dbd92dc9-2d69-4047-809e-430be4fef396_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_bddfe60f-6350-4b23-a9c2-1263b49eb4fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_June172020GrantOneMember_8901057f-95b7-4c86-b9cb-cc45a2011a8c_terseLabel_en-US" xlink:label="lab_hims_June172020GrantOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 17, 2020 Grant One</link:label>
    <link:label id="lab_hims_June172020GrantOneMember_label_en-US" xlink:label="lab_hims_June172020GrantOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 17, 2020 Grant One [Member]</link:label>
    <link:label id="lab_hims_June172020GrantOneMember_documentation_en-US" xlink:label="lab_hims_June172020GrantOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 17, 2020 Grant One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_June172020GrantOneMember" xlink:href="hims-20210331.xsd#hims_June172020GrantOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_June172020GrantOneMember" xlink:to="lab_hims_June172020GrantOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_2871b722-157f-4dd7-8f6f-d745f33908f3_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_fc7ed764-2a0e-488e-8cf9-bcd39437d05f_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_b5fac66e-98a4-48e7-a61e-51551e5768b6_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_b41a8c80-36fa-4805-9844-80f58a7f7808_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_81a5c18b-594c-49db-8269-90c0a8c11627_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold_f62f8a29-aef2-4431-9837-bed3421fcdd6_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition with shares consideration threshold (in dollars per share)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Acquisition With Share Consideration Threshold</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Acquisition With Share Consideration Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1daed7b5-8f1f-40c7-a65e-112df0edcb81_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1d795062-fccf-4bfe-9c6a-32fa421f3203_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_8d7735bf-205f-4426-99eb-be814574b1f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedPaymentArrangementNewEmployeeMember_5353b221-0370-4a6c-a7da-deaa4d78dac6_terseLabel_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementNewEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Employee</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementNewEmployeeMember_label_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementNewEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, New Employee [Member]</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementNewEmployeeMember_documentation_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementNewEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, New Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementNewEmployeeMember" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementNewEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedPaymentArrangementNewEmployeeMember" xlink:to="lab_hims_ShareBasedPaymentArrangementNewEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b581c803-e167-4a0a-b2d3-dca63b0f42e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at the end of the period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_d5f6d00c-7a4e-4e2c-896d-856a427d6b07_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8b968a1a-9367-43da-ad3e-4d7963b5cb7a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_c5b34c6d-5cfa-4c77-99ea-f51ba59b1bb9_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_19574ecc-7cb0-4140-858c-9653cca3ced3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4e6a870a-8e0a-4573-b4ec-28f8c54a1bfd_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c360a1f7-fbcd-4102-ab4d-5719793e6d31_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_TemporaryEquityIssuedPricePerShare_c29d5a79-ce97-4ae9-b3b3-c4cdfe91d244_verboseLabel_en-US" xlink:label="lab_hims_TemporaryEquityIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issue Price per Share (in dollars per share)</link:label>
    <link:label id="lab_hims_TemporaryEquityIssuedPricePerShare_label_en-US" xlink:label="lab_hims_TemporaryEquityIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Issued, Price Per Share</link:label>
    <link:label id="lab_hims_TemporaryEquityIssuedPricePerShare_documentation_en-US" xlink:label="lab_hims_TemporaryEquityIssuedPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Issued, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityIssuedPricePerShare" xlink:href="hims-20210331.xsd#hims_TemporaryEquityIssuedPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_TemporaryEquityIssuedPricePerShare" xlink:to="lab_hims_TemporaryEquityIssuedPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms_36a98b7b-040b-4c84-b7ca-707e9c2a50bc_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at the end of period (in years)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Remaining Contractual Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_e5433b99-0ab8-4d8a-89f6-c2a8b1ad0206_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationDisclosureTextBlock_b88c7a8d-580f-43ca-8591-793f6c3d9be5_terseLabel_en-US" xlink:label="lab_hims_ReverseRecapitalizationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationDisclosureTextBlock_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization Disclosure [Text Block]</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationDisclosureTextBlock_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationDisclosureTextBlock" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationDisclosureTextBlock" xlink:to="lab_hims_ReverseRecapitalizationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_ec0a25c5-6581-49ea-bbe1-442db7efd2ad_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStock_eed886ad-69e7-42e2-9bc5-009d39a3820d_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, common stock</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStock" xlink:to="lab_us-gaap_DividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_78c3b153-7217-4b43-a357-13cdb145990f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b7ec7198-b65f-4189-bfac-17e75c94cf43_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember_e45367ab-8914-41bb-83f6-a442c8626a60_terseLabel_en-US" xlink:label="lab_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock from CEO and Member Of Board of Directors</link:label>
    <link:label id="lab_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember_label_en-US" xlink:label="lab_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock From CEO And Member Of Board Of Directors [Member]</link:label>
    <link:label id="lab_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember_documentation_en-US" xlink:label="lab_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock From CEO And Member Of Board Of Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember" xlink:href="hims-20210331.xsd#hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember" xlink:to="lab_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_6e19bd05-a195-4e87-a8f0-292d78574a5a_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_b07b4292-70d7-457b-9361-3283ca4b6c37_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock&#160;&#8211; Class&#160;A shares, par value $0.0001, 2,750,000,000 and 166,696,759 shares authorized and 182,973,780 and 46,025,754 shares issued and outstanding as of March&#160;31, 2021 and December&#160;31, 2020, respectively; Class&#160;V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued, and outstanding as of March&#160;31, 2021; Class&#160;F shares, par value $0.0001, 6,941,352 shares authorized, issued, and outstanding as of December&#160;31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_e1e55c16-b4ab-400c-aa35-fc9746baff8b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_8998e859-a1f5-4fff-903a-62b5826376ba_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of the period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_3b9feedc-34cf-4203-9cf7-43a6d101ad6d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_73b300c5-de2d-4943-9e15-1d5ac5efa6d8_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_cab6d2fe-b1fa-4493-859b-05c6341637ff_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_e3b3e476-b632-4f63-b8af-33efa7b349a8_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in fair value of warrants</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_CapitalAgreement2019Member_61fb2de6-74f4-46e2-9885-d108c356e69b_terseLabel_en-US" xlink:label="lab_hims_CapitalAgreement2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Agreement, 2019</link:label>
    <link:label id="lab_hims_CapitalAgreement2019Member_label_en-US" xlink:label="lab_hims_CapitalAgreement2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Agreement, 2019 [Member]</link:label>
    <link:label id="lab_hims_CapitalAgreement2019Member_documentation_en-US" xlink:label="lab_hims_CapitalAgreement2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Agreement, 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CapitalAgreement2019Member" xlink:href="hims-20210331.xsd#hims_CapitalAgreement2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_CapitalAgreement2019Member" xlink:to="lab_hims_CapitalAgreement2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_d7324b26-d155-46ff-8d75-18c4cbd90d86_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_eee744d9-3d3a-42b4-8d03-3a4a6422ebb7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement_6107560c-1045-4d7e-90e3-e2f9812aed5b_terseLabel_en-US" xlink:label="lab_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, operating lease, period for payments net of rent abatement</link:label>
    <link:label id="lab_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement_label_en-US" xlink:label="lab_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Period For Payments Net Of Rent Abatement</link:label>
    <link:label id="lab_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement_documentation_en-US" xlink:label="lab_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Period For Payments Net Of Rent Abatement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement" xlink:href="hims-20210331.xsd#hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement" xlink:to="lab_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6a244401-4322-4ed9-9b64-65d63d1a4580_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_RepurchaseOfStockMember_01260e8f-07b8-42c6-b6f5-b8c9afed3032_terseLabel_en-US" xlink:label="lab_hims_RepurchaseOfStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of Stock</link:label>
    <link:label id="lab_hims_RepurchaseOfStockMember_label_en-US" xlink:label="lab_hims_RepurchaseOfStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Of Stock [Member]</link:label>
    <link:label id="lab_hims_RepurchaseOfStockMember_documentation_en-US" xlink:label="lab_hims_RepurchaseOfStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase Of Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RepurchaseOfStockMember" xlink:href="hims-20210331.xsd#hims_RepurchaseOfStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_RepurchaseOfStockMember" xlink:to="lab_hims_RepurchaseOfStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_c3dc7fca-1bd4-4098-b21b-878421986e00_terseLabel_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger three (in dollars per share)</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Three</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" xlink:to="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_e45f1540-78f4-42b0-942f-5e5e5db9b078_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards vesting rights, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7a3386f7-586f-4a8a-9f76-967a36cc30b5_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c8003e31-4d89-4f50-a756-3cf11c18a5ce_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8d6aa680-ec7d-4bf0-848f-3648f0f5d0c7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_03b6df1a-19d0-489a-b518-0545163efe57_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_7f812f57-5940-4d6f-abad-afac6e1de553_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesDPreferredStockMember_64a5fed2-a37f-4fee-945f-9fd04e617a85_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesDPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D</link:label>
    <link:label id="lab_us-gaap_SeriesDPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesDPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesDPreferredStockMember" xlink:to="lab_us-gaap_SeriesDPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_80e2b27d-ef3c-4397-ac10-a86b52d56bd5_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total mezzanine equity</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d16e9a41-3eca-4562-bfd5-9417a2843db0_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_48f99ff5-f399-4c55-9ca4-7d4d784700a8_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_589ff95d-e20b-446b-8df4-19c89e82eb9a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity (deficit)</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5700c777-3caf-4d0e-b753-6808efb362e6_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_06c7da65-9723-4569-830b-897accadbc78_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_acaf41c5-609d-4e1c-b84c-78a76f8187bc_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of stock issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_8e023be5-61a9-4f13-b3e2-e84a91ee5b71_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of stock issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_5d2b200c-078f-4ee2-a451-355e4a0599dd_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, mezzanine equity, and stockholders' equity (deficit)</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7efa997b-a352-4dbc-9d36-0c34c7a71170_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_da199887-937c-499c-aced-470bca1dc308_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d1857e92-d299-4a9c-81d5-cdabbb18057b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_5896c192-176b-4cb5-b5c4-f9e2c334ea4e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_EarlyExerciseOfStockOptionsMember_fc211aa7-0285-4e99-825b-75569fc014d5_terseLabel_en-US" xlink:label="lab_hims_EarlyExerciseOfStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for early exercise of stock options</link:label>
    <link:label id="lab_hims_EarlyExerciseOfStockOptionsMember_label_en-US" xlink:label="lab_hims_EarlyExerciseOfStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Exercise Of Stock Options [Member]</link:label>
    <link:label id="lab_hims_EarlyExerciseOfStockOptionsMember_documentation_en-US" xlink:label="lab_hims_EarlyExerciseOfStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Exercise Of Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EarlyExerciseOfStockOptionsMember" xlink:href="hims-20210331.xsd#hims_EarlyExerciseOfStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_EarlyExerciseOfStockOptionsMember" xlink:to="lab_hims_EarlyExerciseOfStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_be905aaf-87ba-4fe6-9f53-6cd9f410c68b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_01f4b904-cdfd-485f-9572-cb9072b879d8_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_3a111683-ca8d-4513-9822-012785ea9afb_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock</link:label>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_6a61cc12-d02b-402a-bd0f-91b5de162985_verboseLabel_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C</link:label>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesCPreferredStockMember" xlink:to="lab_us-gaap_SeriesCPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_70fcbfc5-2d2e-4f65-bcf0-4407cdd3831b_terseLabel_en-US" xlink:label="lab_hims_ProceedsFromIssuanceOfCommonStockRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock, recapitalization</link:label>
    <link:label id="lab_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_label_en-US" xlink:label="lab_hims_ProceedsFromIssuanceOfCommonStockRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock, Recapitalization</link:label>
    <link:label id="lab_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_documentation_en-US" xlink:label="lab_hims_ProceedsFromIssuanceOfCommonStockRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Common Stock, Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromIssuanceOfCommonStockRecapitalization" xlink:href="hims-20210331.xsd#hims_ProceedsFromIssuanceOfCommonStockRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ProceedsFromIssuanceOfCommonStockRecapitalization" xlink:to="lab_hims_ProceedsFromIssuanceOfCommonStockRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_530c6f0f-c219-4827-8d00-7e29e6dc9d59_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_4b08aba3-227e-4087-a58e-ffcd41e372f2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Four Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_dbd54ca7-d2c1-4ecf-b188-02f647add64b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ProceedsFromIssuanceOfTemporaryEquity_9eba3c30-d0d0-4662-8003-704d72f317fe_terseLabel_en-US" xlink:label="lab_hims_ProceedsFromIssuanceOfTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of temporary equity</link:label>
    <link:label id="lab_hims_ProceedsFromIssuanceOfTemporaryEquity_7252c52a-5399-4131-a974-7ef15c4ac696_verboseLabel_en-US" xlink:label="lab_hims_ProceedsFromIssuanceOfTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Net of Issuance Costs</link:label>
    <link:label id="lab_hims_ProceedsFromIssuanceOfTemporaryEquity_label_en-US" xlink:label="lab_hims_ProceedsFromIssuanceOfTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Temporary Equity</link:label>
    <link:label id="lab_hims_ProceedsFromIssuanceOfTemporaryEquity_documentation_en-US" xlink:label="lab_hims_ProceedsFromIssuanceOfTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Issuance Of Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromIssuanceOfTemporaryEquity" xlink:href="hims-20210331.xsd#hims_ProceedsFromIssuanceOfTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ProceedsFromIssuanceOfTemporaryEquity" xlink:to="lab_hims_ProceedsFromIssuanceOfTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_6dbddbb3-5c9f-44d4-92dd-de0ae3ecf80a_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_393d33ed-13b4-4664-b508-e3e245183006_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_bbdcf99f-9091-409e-8347-2a67b9ff9795_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_2d9c1bf0-e351-4364-bf0f-f05841058c1e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_0e7f0a2f-2c9f-46ad-98bf-d0be56474211_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b1a7f59a-1b08-4db6-9b41-3e4bc35b8014_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_d142f217-41b3-4a2d-9ebe-0d946110584f_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_743a385a-b190-4030-8011-932e6e62e217_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_7776fe46-500b-411e-9b96-f91fa31272d7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f0180114-cb94-4f52-8ec0-80bf66ef5bcf_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_e2fa165e-e6d5-494c-86f5-cfcb888dc01a_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_00e6d699-34d5-4314-91c0-9f0ddd89e8d1_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_3c71b90d-e00d-4377-91bd-ed3268af9563_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c91a5b06-61a7-4a70-94d2-0718263b2eea_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_bf760400-d48d-438b-8cdf-9ccaad62a5bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_WarrantsAssumed_c1cb2bb9-88d8-473a-a79a-68e84b7dc8a7_terseLabel_en-US" xlink:label="lab_hims_WarrantsAssumed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assumption of Merger warrants liability</link:label>
    <link:label id="lab_hims_WarrantsAssumed_label_en-US" xlink:label="lab_hims_WarrantsAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Assumed</link:label>
    <link:label id="lab_hims_WarrantsAssumed_documentation_en-US" xlink:label="lab_hims_WarrantsAssumed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_WarrantsAssumed" xlink:href="hims-20210331.xsd#hims_WarrantsAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_WarrantsAssumed" xlink:to="lab_hims_WarrantsAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_80076d6d-8647-4f5a-95f0-5d40d5812885_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Grants In Period, Weighted Average Exercise Price</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Grants In Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_f9ffb97b-17b2-468f-a73e-a5479a8e9e50_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays_a9a642ea-8410-419e-8131-8e1737e29d90_terseLabel_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold consecutive trading days</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays" xlink:to="lab_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_22b6e9eb-fac1-47e6-8e4c-9f8f4674ddc5_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_68049804-9a28-46a6-b027-c081ce4a8efb_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_36a8b074-967a-440e-8631-07561252f8c8_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_310fad7a-6854-4dfc-a3bb-621f4ab5c932_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_dcd6da3c-f151-4cc5-b2d6-b1b815688c77_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_DebtInstrumentMaximumBorrowingCapacity_d14d6cdd-eb9b-4568-9cb0-d2a908494a8f_terseLabel_en-US" xlink:label="lab_hims_DebtInstrumentMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, maximum borrowing capacity</link:label>
    <link:label id="lab_hims_DebtInstrumentMaximumBorrowingCapacity_label_en-US" xlink:label="lab_hims_DebtInstrumentMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Borrowing Capacity</link:label>
    <link:label id="lab_hims_DebtInstrumentMaximumBorrowingCapacity_documentation_en-US" xlink:label="lab_hims_DebtInstrumentMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_DebtInstrumentMaximumBorrowingCapacity" xlink:href="hims-20210331.xsd#hims_DebtInstrumentMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_DebtInstrumentMaximumBorrowingCapacity" xlink:to="lab_hims_DebtInstrumentMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod_74ae4a2b-6767-4abf-97a9-3e5a68c3a9e7_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early exercise of unvested stock options (in shares)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Exercises In Period</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_73836b81-1b3a-4e79-b606-7a82b061b0fe_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock_5f2baa02-49f9-423b-a065-c140ae7304de_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage increase in authorized shares of common stock</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Annual Increase In Authorized Shares Of Common Stock</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Annual Increase In Authorized Shares Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_19c97d8e-cdd2-4156-ae73-befeef57b5a4_terseLabel_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outstanding</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_label_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding [Abstract]</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_documentation_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract" xlink:to="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember_a2688679-c931-45e0-bf99-31aa84de1f24_terseLabel_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options and Stock Appreciation Rights</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option And Stock Appreciation Rights (SARS) [Member]</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember_documentation_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option And Stock Appreciation Rights (SARS)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember" xlink:to="lab_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_a139efe7-ba1a-4745-a5fe-3556d8796445_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of warrant or right, number securities called by warrants or rights (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_f68bbab6-f5f2-4ce1-b37a-d352ba364f05_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_786e7df3-08bf-4659-b17f-1a70268e6412_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_0cf53f08-eb8b-48ee-9b67-3a2b01425082_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_SeriesB1PreferredStockMember_aedbbad9-7b1d-4ff3-82b1-04379bbbe04d_terseLabel_en-US" xlink:label="lab_hims_SeriesB1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-1</link:label>
    <link:label id="lab_hims_SeriesB1PreferredStockMember_label_en-US" xlink:label="lab_hims_SeriesB1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-1 Preferred Stock [Member]</link:label>
    <link:label id="lab_hims_SeriesB1PreferredStockMember_documentation_en-US" xlink:label="lab_hims_SeriesB1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B-1 Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesB1PreferredStockMember" xlink:href="hims-20210331.xsd#hims_SeriesB1PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_SeriesB1PreferredStockMember" xlink:to="lab_hims_SeriesB1PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_PublicWarrantsWarrantRedemptionMember_1b7441db-7a50-48d3-8889-37449b183071_terseLabel_en-US" xlink:label="lab_hims_PublicWarrantsWarrantRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants, Warrant Redemption</link:label>
    <link:label id="lab_hims_PublicWarrantsWarrantRedemptionMember_label_en-US" xlink:label="lab_hims_PublicWarrantsWarrantRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants, Warrant Redemption [Member]</link:label>
    <link:label id="lab_hims_PublicWarrantsWarrantRedemptionMember_documentation_en-US" xlink:label="lab_hims_PublicWarrantsWarrantRedemptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants, Warrant Redemption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsWarrantRedemptionMember" xlink:href="hims-20210331.xsd#hims_PublicWarrantsWarrantRedemptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_PublicWarrantsWarrantRedemptionMember" xlink:to="lab_hims_PublicWarrantsWarrantRedemptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_ff519904-8137-4169-8a83-838103dc49ee_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_VendorDepositsCurrent_15109860-45b2-4f45-9049-64d7158a3e26_terseLabel_en-US" xlink:label="lab_hims_VendorDepositsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor deposits</link:label>
    <link:label id="lab_hims_VendorDepositsCurrent_label_en-US" xlink:label="lab_hims_VendorDepositsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Deposits, Current</link:label>
    <link:label id="lab_hims_VendorDepositsCurrent_documentation_en-US" xlink:label="lab_hims_VendorDepositsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vendor Deposits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorDepositsCurrent" xlink:href="hims-20210331.xsd#hims_VendorDepositsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_VendorDepositsCurrent" xlink:to="lab_hims_VendorDepositsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_75c9a140-4de2-4bc8-8c31-92d923f4261f_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_ae2d392a-a57d-4372-ad74-dc528a147324_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_1ee9a183-b70c-4754-b9ae-76221e434d3f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecapitalizationCosts_cb4f1064-f185-4c13-8c28-40bbe4eddd04_terseLabel_en-US" xlink:label="lab_us-gaap_RecapitalizationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization of redeemable convertible preferred stock from pre-closing stock repurchase</link:label>
    <link:label id="lab_us-gaap_RecapitalizationCosts_label_en-US" xlink:label="lab_us-gaap_RecapitalizationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecapitalizationCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecapitalizationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecapitalizationCosts" xlink:to="lab_us-gaap_RecapitalizationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_aa5c533d-98cd-4795-ba93-6e8d4f423b3a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_c8c8dd00-597a-4519-ba15-8402001493c4_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Grant Date Fair Value</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedPaymentArrangementCurrentEmployeeMember_1188bd70-1a40-48e0-b248-fe9ec91cdb4c_terseLabel_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementCurrentEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Employee</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementCurrentEmployeeMember_label_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementCurrentEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Current Employee [Member]</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementCurrentEmployeeMember_documentation_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementCurrentEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Current Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementCurrentEmployeeMember" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementCurrentEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedPaymentArrangementCurrentEmployeeMember" xlink:to="lab_hims_ShareBasedPaymentArrangementCurrentEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_CommonClassFMember_7aef7858-097f-467d-9d67-e4fce967149d_terseLabel_en-US" xlink:label="lab_hims_CommonClassFMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class F</link:label>
    <link:label id="lab_hims_CommonClassFMember_label_en-US" xlink:label="lab_hims_CommonClassFMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class F [Member]</link:label>
    <link:label id="lab_hims_CommonClassFMember_documentation_en-US" xlink:label="lab_hims_CommonClassFMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class F</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassFMember" xlink:href="hims-20210331.xsd#hims_CommonClassFMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_CommonClassFMember" xlink:to="lab_hims_CommonClassFMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_4b19a952-bdb1-41d6-8eb5-17fe8a5a6d2d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of PIPE shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_52c65e02-fccb-4dac-8b56-383da7e4655d_terseLabel_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, contingent consideration, equity, earnout period, threshold consecutive trading days</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" xlink:to="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_8f8e803b-f6b9-4e4e-a054-b11893d16e15_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ad8775ac-e7f8-472c-a13c-efda0abc0f28_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of convertible securities (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_7a66e214-c939-4361-ae68-93619a7844f6_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_SeriesDPreferredStockWarrantsMember_08080bd8-d30b-42e0-8738-2d3d84e23c22_terseLabel_en-US" xlink:label="lab_hims_SeriesDPreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Preferred Stock Warrants</link:label>
    <link:label id="lab_hims_SeriesDPreferredStockWarrantsMember_label_en-US" xlink:label="lab_hims_SeriesDPreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Preferred Stock Warrants [Member]</link:label>
    <link:label id="lab_hims_SeriesDPreferredStockWarrantsMember_documentation_en-US" xlink:label="lab_hims_SeriesDPreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series D Preferred Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesDPreferredStockWarrantsMember" xlink:href="hims-20210331.xsd#hims_SeriesDPreferredStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_SeriesDPreferredStockWarrantsMember" xlink:to="lab_hims_SeriesDPreferredStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_18a33a2e-ef74-4d27-a639-4d813f7d5928_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_RecapitalizationExchangeRatio_b25f4a24-eeff-4498-b433-ed198b2617b1_terseLabel_en-US" xlink:label="lab_hims_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization exchange ratio</link:label>
    <link:label id="lab_hims_RecapitalizationExchangeRatio_label_en-US" xlink:label="lab_hims_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio</link:label>
    <link:label id="lab_hims_RecapitalizationExchangeRatio_documentation_en-US" xlink:label="lab_hims_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_RecapitalizationExchangeRatio" xlink:to="lab_hims_RecapitalizationExchangeRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization_2d3d1447-0898-421c-92b7-322d49225b56_terseLabel_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of earn-out shares to common stockholders (in shares)</link:label>
    <link:label id="lab_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization_label_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Contingent Consideration, Reverse Recapitalization</link:label>
    <link:label id="lab_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization_documentation_en-US" xlink:label="lab_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Contingent Consideration, Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization" xlink:to="lab_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_d245d1f4-9952-432d-a481-1cd46b87bf67_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at the end of the period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_a3f2ac2b-2cc0-49f4-a608-7b142d14f05f_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash investing and financing activities</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7bfb523b-0712-45ed-af27-2f8973790cce_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of vested stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2d44ae4c-8bf0-484d-b9fb-0cc3a96a2c03_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fc3a9b5a-94c7-449e-b8c2-fac58d2b1323_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_01ec3a40-4a97-43fb-9c05-5ff9a07977dc_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_ade821c1-1a6b-4ce5-bab0-caa4a7b8b7e6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_c2e8a8d5-e8ec-4e85-ae8e-da39504c634a_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_ba851992-bdef-4dd5-a0b5-db46b62d3aee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssued1_4394c2f3-2c94-4962-9aed-60cec22d247c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration of Class A common stock redemption right</link:label>
    <link:label id="lab_us-gaap_StockIssued1_label_en-US" xlink:label="lab_us-gaap_StockIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssued1" xlink:to="lab_us-gaap_StockIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2eed29c2-982c-4130-b4ee-867727f98237_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_bd9e02c3-9340-4d61-9d39-379d678efb9e_terseLabel_en-US" xlink:label="lab_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, contingent consideration, equity, earnout period</link:label>
    <link:label id="lab_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_label_en-US" xlink:label="lab_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Capitalization, Contingent Consideration, Equity, Earnout Period</link:label>
    <link:label id="lab_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_documentation_en-US" xlink:label="lab_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Capitalization, Contingent Consideration, Equity, Earnout Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" xlink:to="lab_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_837ca589-a4b4-4164-b67a-36b397b8e48c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_d2a49583-78fe-413f-b81b-abf25f34154b_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_95ffb55e-dbf0-4a5f-a4e2-01ce6a8f9e6d_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_09576795-c7e1-46ac-8469-d9cfa05df57e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationLineItems_22860fbb-b22b-4d92-a8de-f9d00835ca66_terseLabel_en-US" xlink:label="lab_hims_ReverseRecapitalizationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization [Line Items]</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationLineItems_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization [Line Items]</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationLineItems_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationLineItems" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationLineItems" xlink:to="lab_hims_ReverseRecapitalizationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ProceedsFromConversionOfConvertibleSecurities_c3428a64-8ac8-4fa6-a256-b0b482deedd0_terseLabel_en-US" xlink:label="lab_hims_ProceedsFromConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from conversion of convertible securities</link:label>
    <link:label id="lab_hims_ProceedsFromConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_hims_ProceedsFromConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Conversion Of Convertible Securities</link:label>
    <link:label id="lab_hims_ProceedsFromConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_hims_ProceedsFromConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromConversionOfConvertibleSecurities" xlink:href="hims-20210331.xsd#hims_ProceedsFromConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ProceedsFromConversionOfConvertibleSecurities" xlink:to="lab_hims_ProceedsFromConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_68f06306-e5ac-4ca3-b077-af881067f8ce_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than temporary impairment losses, investments</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfInvestments_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment Losses, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfInvestments" xlink:to="lab_us-gaap_ImpairmentOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_2b7c3ddc-1e8a-4c7b-a87f-d422b1ca98b0_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_f50e5bbc-d5fc-411f-8930-11025c805fe4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_2f261715-039f-49c4-9968-a58e619856d2_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_b8ca7f69-c26b-4ad8-bd0e-d5e1597d44e3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of warrant or right, number of securities called by each warrant or right (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Each Warrant or Right</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_2a215423-f233-4c59-b34a-6bf411693f88_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_b318bc7c-ae65-4733-a197-5e947cfce391_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of redeemable convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Redeemable Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_f2df7d8c-9eaa-453e-9b27-4d95c1206acf_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ExercisePriceRange155To233Member_58949a0f-99d9-4a63-b2c5-c118c67cc6cd_terseLabel_en-US" xlink:label="lab_hims_ExercisePriceRange155To233Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $1.55 to $2.33</link:label>
    <link:label id="lab_hims_ExercisePriceRange155To233Member_label_en-US" xlink:label="lab_hims_ExercisePriceRange155To233Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $1.55 to $2.33 [Member]</link:label>
    <link:label id="lab_hims_ExercisePriceRange155To233Member_documentation_en-US" xlink:label="lab_hims_ExercisePriceRange155To233Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price Range $1.55 to $2.33</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange155To233Member" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange155To233Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ExercisePriceRange155To233Member" xlink:to="lab_hims_ExercisePriceRange155To233Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_CommonStockWarrantsGroupOneMember_8920b27e-67b5-4d99-afaa-8e34602bb7eb_terseLabel_en-US" xlink:label="lab_hims_CommonStockWarrantsGroupOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants, Group One</link:label>
    <link:label id="lab_hims_CommonStockWarrantsGroupOneMember_label_en-US" xlink:label="lab_hims_CommonStockWarrantsGroupOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants, Group One [Member]</link:label>
    <link:label id="lab_hims_CommonStockWarrantsGroupOneMember_documentation_en-US" xlink:label="lab_hims_CommonStockWarrantsGroupOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Warrants, Group One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonStockWarrantsGroupOneMember" xlink:href="hims-20210331.xsd#hims_CommonStockWarrantsGroupOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_CommonStockWarrantsGroupOneMember" xlink:to="lab_hims_CommonStockWarrantsGroupOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_374d5aeb-ac10-4338-897d-911cc18516b6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Three Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_5517ba11-3180-4c2b-b62c-50deb1117ec9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_a0396390-09fd-4e87-9af5-db9da0ef0586_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_9427b72f-f87e-4fea-8b2e-a33ceb8bf551_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property, equipment, and intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_05511760-a656-4b0f-82a3-e93b21ad0fa8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_6dd6c1ed-8630-42c0-96d9-634b0c7fbabf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Five Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0d332dfb-2467-4aa4-99b6-bbd92057a531_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at beginning of the year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_74794df2-887b-4aca-bc31-e27918062456_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash at end of the three-month period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_5c0335b9-aca0-4432-8876-f24558c0bc28_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_b842ebcc-47d9-4bfd-b0d8-e6354569d9f4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_6037e330-cd5a-4050-a420-80fec98883ae_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_5784e7ac-7243-43fe-a7ae-ecbddd3c7cea_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_f753bf2c-8c92-488f-a8d7-51450d7b5b51_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_f530d956-57eb-4455-9e0a-f335d883980a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_b1ba2d40-5e2b-4d48-ac35-3f8e63d1a81d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases, Future Minimum Payments, Due in Two Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:to="lab_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_1f1c095b-43ce-437f-85d7-3b5c093db3b2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_62677da1-68c3-42a1-8b5c-c7648e2d2d17_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8ecebae1-6d4d-4cc1-af09-f7cb8eb40d1f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_June172020GrantTwoMember_d4e4d29b-35b6-4ae6-a545-844eece57cb8_terseLabel_en-US" xlink:label="lab_hims_June172020GrantTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 17, 2020 Grant Two</link:label>
    <link:label id="lab_hims_June172020GrantTwoMember_label_en-US" xlink:label="lab_hims_June172020GrantTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 17, 2020 Grant Two [Member]</link:label>
    <link:label id="lab_hims_June172020GrantTwoMember_documentation_en-US" xlink:label="lab_hims_June172020GrantTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">June 17, 2020 Grant Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_June172020GrantTwoMember" xlink:href="hims-20210331.xsd#hims_June172020GrantTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_June172020GrantTwoMember" xlink:to="lab_hims_June172020GrantTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_ed1ef93b-770b-4292-92af-73dc92ce3ec1_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_3ce872f8-eda3-400e-a56b-f7a279e5800c_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_132fe417-c37e-405f-8bd5-f8574740e56f_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine equity, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_9ece0b5a-c806-431c-af95-fa05c41d81a1_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_d3e92228-9a61-41af-bf37-cc2340be6d0b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_c389afd9-d932-41a5-87ad-5df4ab1e5bca_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3676b181-bb80-4f37-addf-e1e26ea64e99_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of exercises during period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_d28d60be-667f-4ee9-9d21-42e931707cee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_427b9e93-ec30-4e2c-9fd0-67f7bca53a55_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_3a1ab003-211a-4c8b-a8fc-a074290203a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payments arrangement, option, exercise price range, upper range limit (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:to="lab_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_2a7f8ea6-c5ed-4d9a-b8db-60700f3b1d17_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Contractual Life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_9a04d721-fc3c-479e-af15-4574e6d39ddf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationEliminationsMember_274ff200-bf69-4467-91cc-411a03a2ca23_terseLabel_en-US" xlink:label="lab_srt_ConsolidationEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Eliminations</link:label>
    <link:label id="lab_srt_ConsolidationEliminationsMember_label_en-US" xlink:label="lab_srt_ConsolidationEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationEliminationsMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationEliminationsMember" xlink:to="lab_srt_ConsolidationEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4ad5d546-e2ea-4ca9-9efd-e0c1ba5b17af_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_f1936803-3582-4018-81eb-ce54f36c070b_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at the end of period (in dollars per share)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_a86e2d65-c4c6-4e6d-902a-027a775bb758_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_8bb87fcc-9a46-4c1a-87b8-f6bd3e48735d_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ded66be2-fb23-4e7a-ab87-f82d89479057_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of vested stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_EquityIncentivePlan2020And2017StockPlanMember_61f57621-b8b0-4904-9fd8-499ae0e8e34e_terseLabel_en-US" xlink:label="lab_hims_EquityIncentivePlan2020And2017StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Equity Incentive Plan and 2017 Stock Plan</link:label>
    <link:label id="lab_hims_EquityIncentivePlan2020And2017StockPlanMember_label_en-US" xlink:label="lab_hims_EquityIncentivePlan2020And2017StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan, 2020 And 2017 Stock Plan [Member]</link:label>
    <link:label id="lab_hims_EquityIncentivePlan2020And2017StockPlanMember_documentation_en-US" xlink:label="lab_hims_EquityIncentivePlan2020And2017StockPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan, 2020 And 2017 Stock Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EquityIncentivePlan2020And2017StockPlanMember" xlink:href="hims-20210331.xsd#hims_EquityIncentivePlan2020And2017StockPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_EquityIncentivePlan2020And2017StockPlanMember" xlink:to="lab_hims_EquityIncentivePlan2020And2017StockPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_702a05ab-7bb9-4a5b-a1e0-4580b3b5fe5c_terseLabel_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Exercisable</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_label_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable [Abstract]</link:label>
    <link:label id="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_documentation_en-US" xlink:label="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract" xlink:to="lab_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_65d289c6-93b7-4a7d-9aad-99f52a646c3d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit facility, maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_2e11fb5c-f8de-4212-9bf7-831ca57dafbd_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_94b4ccbd-3694-4255-9ecd-7f57c2695607_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_42875020-7720-4a2b-8420-5145c91937f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_d6c0098e-1386-4ea8-9f3d-bb6b461e89bf_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_afc5ab0d-6746-499a-85ef-609822489811_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_3f7492b8-0d91-46aa-8b0a-eb7919d0ad70_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_41c8a5a2-0df6-418f-9a58-ec462833df41_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases_1b5c7f6f-7fc6-4983-9368-a6ad40b3e24d_terseLabel_en-US" xlink:label="lab_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of vested and unvested stock options, net of repurchases</link:label>
    <link:label id="lab_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases_label_en-US" xlink:label="lab_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Stock Options Exercised, Net Of Repurchases</link:label>
    <link:label id="lab_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases_documentation_en-US" xlink:label="lab_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Stock Options Exercised, Net Of Repurchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases" xlink:href="hims-20210331.xsd#hims_ProceedsFromStockOptionsExercisedNetOfRepurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases" xlink:to="lab_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_cf16e13b-82fa-4a42-b07f-fff3a30896eb_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_c4ef151f-6de5-4abb-8046-ab49b4674dd0_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate reconciliation, percent</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_59f314f3-b90b-479d-a2ad-c26572b1f579_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_119a1732-47b4-4372-919c-e3b95021f9cf_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2f6dfed9-3a3e-4d45-aaaa-a75e4d00d8b7_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in)/provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_61f58c8b-9b2a-4a32-875d-e4f0e7fd98cc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Contractual Period (in&#160;Years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_ccc2e5aa-d0bd-408a-b458-cdb25bb9729b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding balance (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_532d6049-961b-4086-a9cf-96631025e7aa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_d69bf8be-f1fa-44ab-827a-a2eb00d3cc03_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant liabilities</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_6e239073-24e1-4e94-9c1c-aad78c6c037e_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and rights outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_044b8872-c110-4588-a535-b7efe23a5db6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_ba495b9b-4e2f-47d3-b698-0018e7482d2f_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_cb4aabeb-0086-4a78-aae0-9b51c2e1c6ae_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_0f2f026a-7aa0-4534-9af2-75b7eaa7dd3e_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable_23d39331-ad98-4d42-a3dd-6fdeaef2d6fa_terseLabel_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period after warrants become exercisable for warrant redemption commencement</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable_label_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Redemption Period After Exercisable</link:label>
    <link:label id="lab_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable_documentation_en-US" xlink:label="lab_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Redemption Period After Exercisable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable" xlink:to="lab_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_a0e6b0ca-09fd-4a21-b7f3-8eb17c76fc2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock_ff7ab497-5bd6-4bd2-aad6-778bd992f4d3_terseLabel_en-US" xlink:label="lab_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions</link:label>
    <link:label id="lab_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label id="lab_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock_documentation_en-US" xlink:label="lab_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:href="hims-20210331.xsd#hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositLiabilityCurrent_b27629c3-3756-4c9b-828e-1ed389719119_terseLabel_en-US" xlink:label="lab_us-gaap_DepositLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant exercise deposit liability</link:label>
    <link:label id="lab_us-gaap_DepositLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_DepositLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositLiabilityCurrent" xlink:to="lab_us-gaap_DepositLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrivatePlacementMember_9f6932c5-28fb-41bd-abec-8955387d8252_terseLabel_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PIPE Investment</link:label>
    <link:label id="lab_us-gaap_PrivatePlacementMember_label_en-US" xlink:label="lab_us-gaap_PrivatePlacementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Placement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrivatePlacementMember" xlink:to="lab_us-gaap_PrivatePlacementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_4508a09c-912b-4dd1-8f59-0e43186f9073_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and Diluted Net Loss per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_86e8ada7-4e6d-42a8-bbac-d2eaf9a0dade_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_26365fcd-c785-408c-af53-192160f4c339_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract_afb9b720-c772-4441-b2dc-f9b14289a0a2_terseLabel_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Contractual Term (in Years)</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract_documentation_en-US" xlink:label="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Additional Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract" xlink:to="lab_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_4d0280c7-f778-49f6-93d1-0aaba1f1176d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_b90f2dd7-5ca5-4e27-82cb-38648f11e07f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest at the end of the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReclassificationOfDeferredTransactionCosts_1f842d20-873b-4c51-b53e-af40ff78860a_terseLabel_en-US" xlink:label="lab_hims_ReclassificationOfDeferredTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of deferred transaction costs</link:label>
    <link:label id="lab_hims_ReclassificationOfDeferredTransactionCosts_label_en-US" xlink:label="lab_hims_ReclassificationOfDeferredTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Of Deferred Transaction Costs</link:label>
    <link:label id="lab_hims_ReclassificationOfDeferredTransactionCosts_documentation_en-US" xlink:label="lab_hims_ReclassificationOfDeferredTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Of Deferred Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReclassificationOfDeferredTransactionCosts" xlink:href="hims-20210331.xsd#hims_ReclassificationOfDeferredTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReclassificationOfDeferredTransactionCosts" xlink:to="lab_hims_ReclassificationOfDeferredTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_d2e7cf45-4b13-4619-8a4d-9d9e2af28ac4_terseLabel_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger two (in dollars per share)</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_label_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Two</link:label>
    <link:label id="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_documentation_en-US" xlink:label="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" xlink:to="lab_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_346d3ea9-6ed2-4a71-8550-cb413e97bd69_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_da9cb341-eea9-4aea-bd24-7960b49b9e28_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hims-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:38d399d4-426b-4053-8eef-3989252869db,g:a068c89f-8498-4134-8237-732dcbe50228-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://forhims.com/role/Cover" xlink:type="simple" xlink:href="hims-20210331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://forhims.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9e15db1f-66e9-4835-94c9-3da229cdfabb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_5b9fa430-c032-4694-ac5c-4f47a583fd01" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9e15db1f-66e9-4835-94c9-3da229cdfabb" xlink:to="loc_dei_DocumentInformationTable_5b9fa430-c032-4694-ac5c-4f47a583fd01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7d09313e-9524-4a2c-8fae-d125c9ca34a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_5b9fa430-c032-4694-ac5c-4f47a583fd01" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7d09313e-9524-4a2c-8fae-d125c9ca34a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_2f9f0faa-88fe-4299-af34-3136f79cc7e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7d09313e-9524-4a2c-8fae-d125c9ca34a2" xlink:to="loc_us-gaap_ClassOfStockDomain_2f9f0faa-88fe-4299-af34-3136f79cc7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_5cd585a5-d9c0-4b23-9f51-6e7b1fbd83c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2f9f0faa-88fe-4299-af34-3136f79cc7e6" xlink:to="loc_us-gaap_CommonClassAMember_5cd585a5-d9c0-4b23-9f51-6e7b1fbd83c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableWarrantsMember_0aa57ea1-5987-450c-8c84-25c00039180f" xlink:href="hims-20210331.xsd#hims_RedeemableWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2f9f0faa-88fe-4299-af34-3136f79cc7e6" xlink:to="loc_hims_RedeemableWarrantsMember_0aa57ea1-5987-450c-8c84-25c00039180f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember_c0199615-172b-4f50-ad18-f6047ac62974" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_2f9f0faa-88fe-4299-af34-3136f79cc7e6" xlink:to="loc_hims_CommonClassVMember_c0199615-172b-4f50-ad18-f6047ac62974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_5b9fa430-c032-4694-ac5c-4f47a583fd01" xlink:to="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_6abb3818-f456-4fc2-b557-8d956c726ab6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentType_6abb3818-f456-4fc2-b557-8d956c726ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_be7f184d-94e7-477f-933e-aeaade501bfc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentQuarterlyReport_be7f184d-94e7-477f-933e-aeaade501bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_07e0a2da-52df-4dd3-a7dd-4ab0a2412bc8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentPeriodEndDate_07e0a2da-52df-4dd3-a7dd-4ab0a2412bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5aba434f-2798-449a-b57f-61628f6feb15" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentTransitionReport_5aba434f-2798-449a-b57f-61628f6feb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2d903863-3bfc-405c-8178-7e1c8c35ba16" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityRegistrantName_2d903863-3bfc-405c-8178-7e1c8c35ba16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6bc8b721-d02a-4a22-91a4-49f0a5beb572" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6bc8b721-d02a-4a22-91a4-49f0a5beb572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_709d9040-9c38-4b60-97ed-5411ba1e5dec" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityFileNumber_709d9040-9c38-4b60-97ed-5411ba1e5dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b3b0c6d5-95e4-4ee0-89ac-05ad6dc36276" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityTaxIdentificationNumber_b3b0c6d5-95e4-4ee0-89ac-05ad6dc36276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_a551a587-6b0a-4df6-a358-db2ff418684c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityAddressAddressLine1_a551a587-6b0a-4df6-a358-db2ff418684c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_907f716b-c2bd-4419-9d60-334aac6774f7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityAddressCityOrTown_907f716b-c2bd-4419-9d60-334aac6774f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_86356569-5b4b-4789-8547-2950605550aa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityAddressStateOrProvince_86356569-5b4b-4789-8547-2950605550aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_22a194ea-092e-45cc-809e-949d727cfdab" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityAddressPostalZipCode_22a194ea-092e-45cc-809e-949d727cfdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e120d096-7012-4be7-95ab-5bf3141d88b4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_CityAreaCode_e120d096-7012-4be7-95ab-5bf3141d88b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_bc9bd5e3-44ce-4900-b630-ad7fd3436133" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_LocalPhoneNumber_bc9bd5e3-44ce-4900-b630-ad7fd3436133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f7f97493-8b60-4889-a7a3-b44aa30ea6be" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_Security12bTitle_f7f97493-8b60-4889-a7a3-b44aa30ea6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_77eb457b-cbc4-4ab4-b518-c2348e972141" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_TradingSymbol_77eb457b-cbc4-4ab4-b518-c2348e972141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_9c3537a2-9c68-4dd6-bb24-cf98c60cef18" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_SecurityExchangeName_9c3537a2-9c68-4dd6-bb24-cf98c60cef18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b7519347-0138-4e3c-8ccb-016c4e8656f7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityCurrentReportingStatus_b7519347-0138-4e3c-8ccb-016c4e8656f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_7a13feb1-8ff9-4bf6-ac60-26f14d0ec3b9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityInteractiveDataCurrent_7a13feb1-8ff9-4bf6-ac60-26f14d0ec3b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6ab41910-ba70-4131-9f60-c5f1dba91e5c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityFilerCategory_6ab41910-ba70-4131-9f60-c5f1dba91e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_5f1b6f25-1ecb-4def-8c46-d63bcd6e3f16" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntitySmallBusiness_5f1b6f25-1ecb-4def-8c46-d63bcd6e3f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_640a5222-176d-4236-9d1d-60351fd2d154" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityEmergingGrowthCompany_640a5222-176d-4236-9d1d-60351fd2d154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_7890d472-2494-4cfc-8a5b-98f75fb61930" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityExTransitionPeriod_7890d472-2494-4cfc-8a5b-98f75fb61930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_8af4d932-d9d2-477a-9ed8-a664c0468c72" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityShellCompany_8af4d932-d9d2-477a-9ed8-a664c0468c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b2e90bb6-eb47-44b3-9923-1aeefaded63c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b2e90bb6-eb47-44b3-9923-1aeefaded63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4b43bf8f-ca4b-4421-bb84-2ecc67dc2800" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_AmendmentFlag_4b43bf8f-ca4b-4421-bb84-2ecc67dc2800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d812c793-333d-45fc-a8cf-82698965f561" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentFiscalYearFocus_d812c793-333d-45fc-a8cf-82698965f561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_69701fde-7b6c-4d88-ba08-8f684cb7e5b9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_DocumentFiscalPeriodFocus_69701fde-7b6c-4d88-ba08-8f684cb7e5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2db69062-62b9-43e7-8daa-9742f89463e6" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_EntityCentralIndexKey_2db69062-62b9-43e7-8daa-9742f89463e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_abab3bc6-4d44-4d3b-8e8d-15394f20e76d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_ba39e43a-6ad4-48c6-a0d1-d02d400e28c4" xlink:to="loc_dei_CurrentFiscalYearEndDate_abab3bc6-4d44-4d3b-8e8d-15394f20e76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_cc40951f-b24c-4da3-b7eb-08b240dd1ce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0e0cbb79-402b-4fbe-b08e-4507a946b3de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cc40951f-b24c-4da3-b7eb-08b240dd1ce8" xlink:to="loc_us-gaap_AssetsAbstract_0e0cbb79-402b-4fbe-b08e-4507a946b3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_13f84611-8f55-457f-a830-570c9c82e4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0e0cbb79-402b-4fbe-b08e-4507a946b3de" xlink:to="loc_us-gaap_AssetsCurrentAbstract_13f84611-8f55-457f-a830-570c9c82e4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f1974aac-4f59-4380-a5bf-cad41b1096f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13f84611-8f55-457f-a830-570c9c82e4ad" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f1974aac-4f59-4380-a5bf-cad41b1096f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_799f6fc9-f8b2-413d-bfa7-8dd392523007" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13f84611-8f55-457f-a830-570c9c82e4ad" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_799f6fc9-f8b2-413d-bfa7-8dd392523007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9066e57d-adb8-4bca-bdc9-51ec28da0868" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13f84611-8f55-457f-a830-570c9c82e4ad" xlink:to="loc_us-gaap_InventoryNet_9066e57d-adb8-4bca-bdc9-51ec28da0868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eda67bf8-b88f-4d80-9200-6096df71360b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13f84611-8f55-457f-a830-570c9c82e4ad" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eda67bf8-b88f-4d80-9200-6096df71360b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent_f4d1c90c-cfed-4962-b14b-19e0a055b2eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13f84611-8f55-457f-a830-570c9c82e4ad" xlink:to="loc_us-gaap_DeferredCostsCurrent_f4d1c90c-cfed-4962-b14b-19e0a055b2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8696efc4-1a72-4be7-9af0-756fac6d7690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_13f84611-8f55-457f-a830-570c9c82e4ad" xlink:to="loc_us-gaap_AssetsCurrent_8696efc4-1a72-4be7-9af0-756fac6d7690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_e2619546-7d11-4fb6-99cb-a25a75a08ce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0e0cbb79-402b-4fbe-b08e-4507a946b3de" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_e2619546-7d11-4fb6-99cb-a25a75a08ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_29e0fa08-3018-4353-9609-1c63bc70a280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0e0cbb79-402b-4fbe-b08e-4507a946b3de" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_29e0fa08-3018-4353-9609-1c63bc70a280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_7f2c6ab7-cab1-4507-b1c1-fb7eab25b676" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0e0cbb79-402b-4fbe-b08e-4507a946b3de" xlink:to="loc_us-gaap_Assets_7f2c6ab7-cab1-4507-b1c1-fb7eab25b676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1df72484-d4e1-4d24-9031-6e167fb444df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_cc40951f-b24c-4da3-b7eb-08b240dd1ce8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1df72484-d4e1-4d24-9031-6e167fb444df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3993a81e-6e16-45d8-83d9-eed45b9263e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1df72484-d4e1-4d24-9031-6e167fb444df" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3993a81e-6e16-45d8-83d9-eed45b9263e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f2b69961-90eb-4e81-a995-a4bce6f94853" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3993a81e-6e16-45d8-83d9-eed45b9263e4" xlink:to="loc_us-gaap_AccountsPayableCurrent_f2b69961-90eb-4e81-a995-a4bce6f94853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_aca93773-3286-410f-a439-5da589e18b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3993a81e-6e16-45d8-83d9-eed45b9263e4" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_aca93773-3286-410f-a439-5da589e18b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c2d62f61-13bb-4fdc-a0de-f04d764deccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3993a81e-6e16-45d8-83d9-eed45b9263e4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_c2d62f61-13bb-4fdc-a0de-f04d764deccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_WarrantsAndRightsOutstandingCurrent_2d1e1cc4-8458-447e-88b6-3c16de0be32e" xlink:href="hims-20210331.xsd#hims_WarrantsAndRightsOutstandingCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3993a81e-6e16-45d8-83d9-eed45b9263e4" xlink:to="loc_hims_WarrantsAndRightsOutstandingCurrent_2d1e1cc4-8458-447e-88b6-3c16de0be32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_169a029b-bb80-41f6-8ef9-5318283f0d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3993a81e-6e16-45d8-83d9-eed45b9263e4" xlink:to="loc_us-gaap_LiabilitiesCurrent_169a029b-bb80-41f6-8ef9-5318283f0d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_fe90787d-43c2-43dd-a5c2-d5db43e4aa3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1df72484-d4e1-4d24-9031-6e167fb444df" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_fe90787d-43c2-43dd-a5c2-d5db43e4aa3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRentCreditNoncurrent_fe3dce3b-6688-4f90-944b-6bc2aa1606bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1df72484-d4e1-4d24-9031-6e167fb444df" xlink:to="loc_us-gaap_DeferredRentCreditNoncurrent_fe3dce3b-6688-4f90-944b-6bc2aa1606bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_bb40ae28-e5c9-464e-8038-9c352537cceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1df72484-d4e1-4d24-9031-6e167fb444df" xlink:to="loc_us-gaap_Liabilities_bb40ae28-e5c9-464e-8038-9c352537cceb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_69a66ec8-ba62-43a8-a127-c4a318e51a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1df72484-d4e1-4d24-9031-6e167fb444df" xlink:to="loc_us-gaap_CommitmentsAndContingencies_69a66ec8-ba62-43a8-a127-c4a318e51a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_84bff5d0-fdbf-4f9b-8e1f-935b7ad73032" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1df72484-d4e1-4d24-9031-6e167fb444df" xlink:to="loc_us-gaap_TemporaryEquityAbstract_84bff5d0-fdbf-4f9b-8e1f-935b7ad73032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_b27036ae-abb8-487b-ad56-5d2ce792606a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_84bff5d0-fdbf-4f9b-8e1f-935b7ad73032" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_b27036ae-abb8-487b-ad56-5d2ce792606a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5cd450d7-5874-48f3-908a-f9438b2f691c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1df72484-d4e1-4d24-9031-6e167fb444df" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5cd450d7-5874-48f3-908a-f9438b2f691c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_88d685f3-64f4-41b0-abdf-c1274d7d6c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5cd450d7-5874-48f3-908a-f9438b2f691c" xlink:to="loc_us-gaap_CommonStockValue_88d685f3-64f4-41b0-abdf-c1274d7d6c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7d5a7c24-fedc-4c06-b77f-98b00c6b1206" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5cd450d7-5874-48f3-908a-f9438b2f691c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7d5a7c24-fedc-4c06-b77f-98b00c6b1206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9a75c257-4b7a-4695-8938-ddee2d643b3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5cd450d7-5874-48f3-908a-f9438b2f691c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_9a75c257-4b7a-4695-8938-ddee2d643b3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4094ff3b-d21e-4379-836d-81b8e3f9c13d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5cd450d7-5874-48f3-908a-f9438b2f691c" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_4094ff3b-d21e-4379-836d-81b8e3f9c13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7c74a302-fe8d-45be-8315-08699fc3a84f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5cd450d7-5874-48f3-908a-f9438b2f691c" xlink:to="loc_us-gaap_StockholdersEquity_7c74a302-fe8d-45be-8315-08699fc3a84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_02be8cb1-b979-49e9-ad70-a41877d3cab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_1df72484-d4e1-4d24-9031-6e167fb444df" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_02be8cb1-b979-49e9-ad70-a41877d3cab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e40fcf9f-1f16-4abc-980a-6b7b2619910c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_220d7f71-1343-4eee-9fbc-21f9c07e36c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e40fcf9f-1f16-4abc-980a-6b7b2619910c" xlink:to="loc_us-gaap_StatementTable_220d7f71-1343-4eee-9fbc-21f9c07e36c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_de6e6261-e98b-4875-b625-363f29ddaa0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220d7f71-1343-4eee-9fbc-21f9c07e36c0" xlink:to="loc_us-gaap_StatementClassOfStockAxis_de6e6261-e98b-4875-b625-363f29ddaa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b61602bd-016f-4b42-ada1-bc8ace341a0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_de6e6261-e98b-4875-b625-363f29ddaa0d" xlink:to="loc_us-gaap_ClassOfStockDomain_b61602bd-016f-4b42-ada1-bc8ace341a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_1a26f026-49db-41c0-8d35-16f928bc3574" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b61602bd-016f-4b42-ada1-bc8ace341a0e" xlink:to="loc_us-gaap_CommonClassAMember_1a26f026-49db-41c0-8d35-16f928bc3574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember_83781898-c411-4eac-9693-d4250b966061" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b61602bd-016f-4b42-ada1-bc8ace341a0e" xlink:to="loc_hims_CommonClassVMember_83781898-c411-4eac-9693-d4250b966061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassFMember_5e2b3781-6a6a-4501-b114-c6295f1445e5" xlink:href="hims-20210331.xsd#hims_CommonClassFMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b61602bd-016f-4b42-ada1-bc8ace341a0e" xlink:to="loc_hims_CommonClassFMember_5e2b3781-6a6a-4501-b114-c6295f1445e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_c4dd6a15-e6e2-4bf5-8460-9338dc51e3eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_220d7f71-1343-4eee-9fbc-21f9c07e36c0" xlink:to="loc_us-gaap_StatementLineItems_c4dd6a15-e6e2-4bf5-8460-9338dc51e3eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c4dd6a15-e6e2-4bf5-8460-9338dc51e3eb" xlink:to="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_e753d47e-6754-4416-b0a6-37eb379cae5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_e753d47e-6754-4416-b0a6-37eb379cae5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_b4a860f1-66d7-41cc-bb48-f763054f591b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_b4a860f1-66d7-41cc-bb48-f763054f591b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_a6a999b7-85af-4c6a-ad9d-1a58c3a4d870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_a6a999b7-85af-4c6a-ad9d-1a58c3a4d870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_b2c6129e-4107-4966-8607-081e02678337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_b2c6129e-4107-4966-8607-081e02678337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_cb62c856-90ac-469a-aab8-dd6888f8f08b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_674d5867-a87d-42fc-a3a4-4094fc56e8f2" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_cb62c856-90ac-469a-aab8-dd6888f8f08b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_c4dd6a15-e6e2-4bf5-8460-9338dc51e3eb" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_893ef703-a721-4b45-9826-6d41f7c4fa28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_893ef703-a721-4b45-9826-6d41f7c4fa28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_339f38f7-0e13-4f5e-8b3d-deed2dc41118" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_339f38f7-0e13-4f5e-8b3d-deed2dc41118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_f61a1d32-e594-41ae-bd8e-e7f4170c928c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:to="loc_us-gaap_CommonStockSharesIssued_f61a1d32-e594-41ae-bd8e-e7f4170c928c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6071fb4a-b93f-46a4-8aa6-3a7614e34bcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_6cee9b52-7cae-4bf9-a451-0aff91f54ce0" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6071fb4a-b93f-46a4-8aa6-3a7614e34bcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_92d84519-c921-4e32-a2b4-8c078eeee649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_92d84519-c921-4e32-a2b4-8c078eeee649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_3cb9f492-79b0-405c-96da-883a8c5110aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_CostOfRevenue_3cb9f492-79b0-405c-96da-883a8c5110aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_aa84c146-0712-4f41-bbcf-8503a21619bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_GrossProfit_aa84c146-0712-4f41-bbcf-8503a21619bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7bb6f8cf-c321-4734-9024-f9a37cae333c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7bb6f8cf-c321-4734-9024-f9a37cae333c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingExpense_62dfd240-555f-43f0-9423-6ca4dbc88179" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7bb6f8cf-c321-4734-9024-f9a37cae333c" xlink:to="loc_us-gaap_MarketingExpense_62dfd240-555f-43f0-9423-6ca4dbc88179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b25506bf-64fd-4d95-8a37-790a692f72e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7bb6f8cf-c321-4734-9024-f9a37cae333c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b25506bf-64fd-4d95-8a37-790a692f72e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_4683f881-2b20-4fe5-bba7-9d6b5ec14542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7bb6f8cf-c321-4734-9024-f9a37cae333c" xlink:to="loc_us-gaap_OperatingExpenses_4683f881-2b20-4fe5-bba7-9d6b5ec14542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_73578149-73b2-4707-8a35-cb8fead7cf79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_OperatingIncomeLoss_73578149-73b2-4707-8a35-cb8fead7cf79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_91a00892-d86c-4bda-b749-b769c19f56d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_91a00892-d86c-4bda-b749-b769c19f56d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b809b837-7d31-4a8f-a690-421c7c797acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_91a00892-d86c-4bda-b749-b769c19f56d6" xlink:to="loc_us-gaap_InterestExpense_b809b837-7d31-4a8f-a690-421c7c797acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b0243155-0974-4137-b7fc-7733bbaeb0a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_91a00892-d86c-4bda-b749-b769c19f56d6" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_b0243155-0974-4137-b7fc-7733bbaeb0a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3eeb414b-802a-4b1b-8cb6-b4875f18498b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3eeb414b-802a-4b1b-8cb6-b4875f18498b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ad0ff12a-11e3-4930-b244-6812a1f51385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ad0ff12a-11e3-4930-b244-6812a1f51385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b19bf5de-4759-42b2-9720-2ff8a2a94ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_NetIncomeLoss_b19bf5de-4759-42b2-9720-2ff8a2a94ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8bf4131a-f484-4625-b6d3-c74b168198f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8bf4131a-f484-4625-b6d3-c74b168198f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_408835d4-be6b-4a5b-b099-f0c47ce7baf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_408835d4-be6b-4a5b-b099-f0c47ce7baf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_114645b3-e031-4e07-b1d5-dd479aa67288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_114645b3-e031-4e07-b1d5-dd479aa67288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a9a45c51-183c-4f03-af94-fdde252f5a1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_114645b3-e031-4e07-b1d5-dd479aa67288" xlink:to="loc_us-gaap_EarningsPerShareBasic_a9a45c51-183c-4f03-af94-fdde252f5a1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_dc4e35a9-a8fb-4a52-ab14-d867018ba816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_114645b3-e031-4e07-b1d5-dd479aa67288" xlink:to="loc_us-gaap_EarningsPerShareDiluted_dc4e35a9-a8fb-4a52-ab14-d867018ba816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_74e3ce02-b884-4409-9c80-b97fc2f36371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_74f77550-8280-4197-95d0-c9e57128820a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_74e3ce02-b884-4409-9c80-b97fc2f36371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6e6a6f4b-3ae3-48e5-b748-6af90fb09540" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_74e3ce02-b884-4409-9c80-b97fc2f36371" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6e6a6f4b-3ae3-48e5-b748-6af90fb09540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4bb14f6d-8398-4d76-9620-013e8c24f41a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_74e3ce02-b884-4409-9c80-b97fc2f36371" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4bb14f6d-8398-4d76-9620-013e8c24f41a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_afd40fba-1c1b-4b12-a45f-e1afb0a98942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_afd40fba-1c1b-4b12-a45f-e1afb0a98942" xlink:to="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_1109aff2-10e1-4755-b198-c867fc00cb3b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_srt_RestatementAxis_1109aff2-10e1-4755-b198-c867fc00cb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_4469ddb4-1828-4229-b333-d70e3f60b03b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_1109aff2-10e1-4755-b198-c867fc00cb3b" xlink:to="loc_srt_RestatementDomain_4469ddb4-1828-4229-b333-d70e3f60b03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_b43af271-a8d4-47f1-a8c1-a46bd74b6228" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_4469ddb4-1828-4229-b333-d70e3f60b03b" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_b43af271-a8d4-47f1-a8c1-a46bd74b6228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_a1ce46a9-cb2e-4d87-8122-b2d53b306639" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_4469ddb4-1828-4229-b333-d70e3f60b03b" xlink:to="loc_srt_RestatementAdjustmentMember_a1ce46a9-cb2e-4d87-8122-b2d53b306639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_a3602a40-d98c-4bbb-9430-4ae81b4ee993" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_us-gaap_StatementClassOfStockAxis_a3602a40-d98c-4bbb-9430-4ae81b4ee993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e8e06daa-42b5-4e89-b075-fc4b1e5c70d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_a3602a40-d98c-4bbb-9430-4ae81b4ee993" xlink:to="loc_us-gaap_ClassOfStockDomain_e8e06daa-42b5-4e89-b075-fc4b1e5c70d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_d91d9bf2-741a-4339-a2fd-0fa399e2ce33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e8e06daa-42b5-4e89-b075-fc4b1e5c70d2" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_d91d9bf2-741a-4339-a2fd-0fa399e2ce33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableClassACommonStockMember_56469c35-a819-4e42-a38c-15980d3a267a" xlink:href="hims-20210331.xsd#hims_RedeemableClassACommonStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e8e06daa-42b5-4e89-b075-fc4b1e5c70d2" xlink:to="loc_hims_RedeemableClassACommonStockMember_56469c35-a819-4e42-a38c-15980d3a267a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_3437dd3f-1cbb-4890-b6c7-d1795fa23592" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_3437dd3f-1cbb-4890-b6c7-d1795fa23592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_3437dd3f-1cbb-4890-b6c7-d1795fa23592" xlink:to="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ccbe85bb-f410-49e8-b3cd-0bd9673f1fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:to="loc_us-gaap_CommonStockMember_ccbe85bb-f410-49e8-b3cd-0bd9673f1fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_04ca97d7-e806-4a77-89c1-5768389536dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_04ca97d7-e806-4a77-89c1-5768389536dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3d5319b4-63fc-4619-bbb0-a03cd2e0f245" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_3d5319b4-63fc-4619-bbb0-a03cd2e0f245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c33847d6-e95c-4b3e-9cad-fe0933c27eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_9e4fc299-b02e-4c84-a2b9-6fe8e547c4b9" xlink:to="loc_us-gaap_RetainedEarningsMember_c33847d6-e95c-4b3e-9cad-fe0933c27eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_a45f28bc-e026-4e1a-a305-89df98369985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_a45f28bc-e026-4e1a-a305-89df98369985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_169f9bc4-d8a6-444b-8a8e-1755902f81f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_a45f28bc-e026-4e1a-a305-89df98369985" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_169f9bc4-d8a6-444b-8a8e-1755902f81f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassACommonStockWarrantsMember_23e10d86-9573-4de0-bfa2-e52be2e68b06" xlink:href="hims-20210331.xsd#hims_ClassACommonStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_169f9bc4-d8a6-444b-8a8e-1755902f81f1" xlink:to="loc_hims_ClassACommonStockWarrantsMember_23e10d86-9573-4de0-bfa2-e52be2e68b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_32364e89-f8dc-4e62-88bd-6b4d35f5e29a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_32364e89-f8dc-4e62-88bd-6b4d35f5e29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b34fbcd7-e11a-4e1d-9e32-eaf9ea49e04b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_32364e89-f8dc-4e62-88bd-6b4d35f5e29a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b34fbcd7-e11a-4e1d-9e32-eaf9ea49e04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_062c8c20-a729-4e83-a10d-46b6d63049c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b34fbcd7-e11a-4e1d-9e32-eaf9ea49e04b" xlink:to="loc_us-gaap_PrivatePlacementMember_062c8c20-a729-4e83-a10d-46b6d63049c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_b943b7ab-1985-437f-8bf9-4bbc9ad2e9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6b7b90bd-1322-455c-8634-04930e25f3be" xlink:to="loc_us-gaap_StatementLineItems_b943b7ab-1985-437f-8bf9-4bbc9ad2e9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b943b7ab-1985-437f-8bf9-4bbc9ad2e9b2" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2cfee623-cab5-4bc0-95df-19b988cd2af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2cfee623-cab5-4bc0-95df-19b988cd2af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_933fc064-c0f7-4ab1-9930-859b89355455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_933fc064-c0f7-4ab1-9930-859b89355455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodShares_f2f6bf8c-cdac-43af-afba-dcf9fedc8def" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodShares_f2f6bf8c-cdac-43af-afba-dcf9fedc8def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodValue_e978b341-5ec2-4e0d-833a-4e3269770cd8" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_hims_TemporaryEquityStockRepurchasedDuringPeriodValue_e978b341-5ec2-4e0d-833a-4e3269770cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_df91cd3d-2972-4d93-8d8d-d3f446f78795" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_df91cd3d-2972-4d93-8d8d-d3f446f78795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_aeefa45e-59d7-4a83-9edc-c6740ebadb5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_aeefa45e-59d7-4a83-9edc-c6740ebadb5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4c177e1b-8a3b-40b0-8301-0b7325a5994a" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4c177e1b-8a3b-40b0-8301-0b7325a5994a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_4fe59916-80c9-4dc3-a99c-510d3754d482" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_4fe59916-80c9-4dc3-a99c-510d3754d482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_371fa9e6-bcb4-4705-9a10-393745eadc28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_371fa9e6-bcb4-4705-9a10-393745eadc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1b2ba55c-1a57-4f10-8b62-57f0605d7bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_d5b5e363-fb80-40b5-83ef-723c540de62c" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_1b2ba55c-1a57-4f10-8b62-57f0605d7bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_b943b7ab-1985-437f-8bf9-4bbc9ad2e9b2" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2404a7f6-ffa9-4ed3-a609-0c888a546d7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_SharesOutstanding_2404a7f6-ffa9-4ed3-a609-0c888a546d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c4a849dc-b570-411c-a12b-d51aacb04934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockholdersEquity_c4a849dc-b570-411c-a12b-d51aacb04934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_6914510f-ea6f-4a61-8db1-72db553d2877" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_6914510f-ea6f-4a61-8db1-72db553d2877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_4a6cb6cc-f234-45cc-ac2f-57981f0cab88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_4a6cb6cc-f234-45cc-ac2f-57981f0cab88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_0f796fe3-f5c6-4a54-a6e1-8ab1cf5f8059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_0f796fe3-f5c6-4a54-a6e1-8ab1cf5f8059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_98154cb8-fd47-4ffb-a8c5-692f9b24c616" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_98154cb8-fd47-4ffb-a8c5-692f9b24c616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment_9e18db4c-78ea-4eba-85d0-190692e039dc" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment_9e18db4c-78ea-4eba-85d0-190692e039dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockForfeitedDuringPeriodShares_f8da6808-479e-4d77-a971-b7b624e0a1b5" xlink:href="hims-20210331.xsd#hims_StockForfeitedDuringPeriodShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_StockForfeitedDuringPeriodShares_f8da6808-479e-4d77-a971-b7b624e0a1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion_c0d49b94-cb02-40f7-a5aa-f57d4fe216f6" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion_c0d49b94-cb02-40f7-a5aa-f57d4fe216f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodSharesReverseRecapitalization_c00da11a-c93c-4ca1-b058-953fb13d06fa" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodSharesReverseRecapitalization"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_StockIssuedDuringPeriodSharesReverseRecapitalization_c00da11a-c93c-4ca1-b058-953fb13d06fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodValueReverseRecapitalization_53db7047-4b17-4ff5-97db-7ff686544937" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodValueReverseRecapitalization"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_StockIssuedDuringPeriodValueReverseRecapitalization_53db7047-4b17-4ff5-97db-7ff686544937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_997e1280-ca10-4b4a-bd66-4f5e60831cdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_997e1280-ca10-4b4a-bd66-4f5e60831cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_18d85dc5-f398-4a4e-a8fe-fa6b5fb5d5ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_18d85dc5-f398-4a4e-a8fe-fa6b5fb5d5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization_d0f70d35-a618-495b-9ae3-99764ccf2385" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization_d0f70d35-a618-495b-9ae3-99764ccf2385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization_df731353-44f6-456c-837c-dad28f76016b" xlink:href="hims-20210331.xsd#hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization_df731353-44f6-456c-837c-dad28f76016b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b6c9a5c6-6357-4c6e-83eb-b6199ebe5b84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b6c9a5c6-6357-4c6e-83eb-b6199ebe5b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_82110587-1376-406e-8f00-470f25354cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_82110587-1376-406e-8f00-470f25354cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod_c494bb9e-7fd1-41f0-aa9d-62f60d621522" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod_c494bb9e-7fd1-41f0-aa9d-62f60d621522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested_7811a199-25ee-4fda-85cb-859641c03c40" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested_7811a199-25ee-4fda-85cb-859641c03c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c317debd-21be-42af-be15-9922a8ec5bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_c317debd-21be-42af-be15-9922a8ec5bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense_ded88227-6d2d-4f26-ae87-1038899533b4" xlink:href="hims-20210331.xsd#hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense_ded88227-6d2d-4f26-ae87-1038899533b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3fb0dbca-a16c-4a06-8d9f-14256c03e84f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3fb0dbca-a16c-4a06-8d9f-14256c03e84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3db1cee4-e54f-4a1e-b1d5-24f8c7c26690" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3db1cee4-e54f-4a1e-b1d5-24f8c7c26690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_834a6dec-7905-4379-bc86-6ce0a7b4c209" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_NetIncomeLoss_834a6dec-7905-4379-bc86-6ce0a7b4c209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_104935bc-c9ab-4866-a5f5-40d01e471686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_SharesOutstanding_104935bc-c9ab-4866-a5f5-40d01e471686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b4632ed7-5a16-4c00-a520-4bcf5cd4417a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2e74b748-025e-4806-9632-685fb9144759" xlink:to="loc_us-gaap_StockholdersEquity_b4632ed7-5a16-4c00-a520-4bcf5cd4417a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersDeficitUnauditedParenthetical" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedStatementsofMezzanineEquityandStockholdersDeficitUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersDeficitUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a19e4d30-4c37-44e9-9cd8-855dee5137e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_2807dc03-766d-4037-b534-b0619f6966cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a19e4d30-4c37-44e9-9cd8-855dee5137e6" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_2807dc03-766d-4037-b534-b0619f6966cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="simple" xlink:href="hims-20210331.xsd#CondensedConsolidatedStatementsofCashFlowsUnaudited"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ede1a324-5da2-4689-9f60-edb5aa829487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f3f0401b-e5a3-4b6b-b99d-4f4f3a226f8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ede1a324-5da2-4689-9f60-edb5aa829487" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f3f0401b-e5a3-4b6b-b99d-4f4f3a226f8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_52a1da5f-7387-471a-9742-7adadbd71240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f3f0401b-e5a3-4b6b-b99d-4f4f3a226f8d" xlink:to="loc_us-gaap_NetIncomeLoss_52a1da5f-7387-471a-9742-7adadbd71240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b53c2085-4943-477d-aeae-0f6c09a7b0c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f3f0401b-e5a3-4b6b-b99d-4f4f3a226f8d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b53c2085-4943-477d-aeae-0f6c09a7b0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8aebecb1-3c61-463b-9b51-d3aea517f874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b53c2085-4943-477d-aeae-0f6c09a7b0c1" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8aebecb1-3c61-463b-9b51-d3aea517f874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_5e801a4f-22c5-4eb7-a906-a10308c36285" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b53c2085-4943-477d-aeae-0f6c09a7b0c1" xlink:to="loc_us-gaap_ShareBasedCompensation_5e801a4f-22c5-4eb7-a906-a10308c36285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_9431d1fa-9d69-4e2e-b316-c5d5e6fa5a98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b53c2085-4943-477d-aeae-0f6c09a7b0c1" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_9431d1fa-9d69-4e2e-b316-c5d5e6fa5a98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NoncashWarrantExpense_bf7d190a-095e-4dbc-b72e-9af7938bae26" xlink:href="hims-20210331.xsd#hims_NoncashWarrantExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b53c2085-4943-477d-aeae-0f6c09a7b0c1" xlink:to="loc_hims_NoncashWarrantExpense_bf7d190a-095e-4dbc-b72e-9af7938bae26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_550992cf-5d62-43e6-93e0-2ba0bbd9b0c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b53c2085-4943-477d-aeae-0f6c09a7b0c1" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_550992cf-5d62-43e6-93e0-2ba0bbd9b0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_f45b32f7-d286-4924-91a2-70532a3ca0a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b53c2085-4943-477d-aeae-0f6c09a7b0c1" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_f45b32f7-d286-4924-91a2-70532a3ca0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b40536b1-8c5c-45a0-a171-5e03287f675b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b53c2085-4943-477d-aeae-0f6c09a7b0c1" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b40536b1-8c5c-45a0-a171-5e03287f675b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_9b42e77e-3675-4f78-8e1e-4cc3c12e8822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b40536b1-8c5c-45a0-a171-5e03287f675b" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_9b42e77e-3675-4f78-8e1e-4cc3c12e8822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2cffd8e2-490d-46e2-817a-a5b988f6e2be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b40536b1-8c5c-45a0-a171-5e03287f675b" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2cffd8e2-490d-46e2-817a-a5b988f6e2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b7333c6e-8daa-4541-b635-7b2762346f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b40536b1-8c5c-45a0-a171-5e03287f675b" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_b7333c6e-8daa-4541-b635-7b2762346f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f3a7dbd4-8415-41a8-967a-727f6379b1cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b40536b1-8c5c-45a0-a171-5e03287f675b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_f3a7dbd4-8415-41a8-967a-727f6379b1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5d08ab93-9a0a-4d92-aca7-e18ac0056125" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b40536b1-8c5c-45a0-a171-5e03287f675b" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_5d08ab93-9a0a-4d92-aca7-e18ac0056125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4826c729-cde8-4796-9d95-6aa446a70280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b40536b1-8c5c-45a0-a171-5e03287f675b" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4826c729-cde8-4796-9d95-6aa446a70280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_IncreaseDecreaseInDeferredRent_14b08c78-7870-4878-a43c-d840b253061b" xlink:href="hims-20210331.xsd#hims_IncreaseDecreaseInDeferredRent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b40536b1-8c5c-45a0-a171-5e03287f675b" xlink:to="loc_hims_IncreaseDecreaseInDeferredRent_14b08c78-7870-4878-a43c-d840b253061b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d1c285af-584e-49ab-933d-d73c58643997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f3f0401b-e5a3-4b6b-b99d-4f4f3a226f8d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d1c285af-584e-49ab-933d-d73c58643997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a993704-fba2-494d-847c-7aaffd2215a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ede1a324-5da2-4689-9f60-edb5aa829487" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a993704-fba2-494d-847c-7aaffd2215a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_7f646712-45f4-4fe4-8152-50a58814736b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a993704-fba2-494d-847c-7aaffd2215a9" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_7f646712-45f4-4fe4-8152-50a58814736b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_47e72588-68eb-44f9-8353-188d4880a96f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a993704-fba2-494d-847c-7aaffd2215a9" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_47e72588-68eb-44f9-8353-188d4880a96f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_9f7ec8d1-6869-4cc0-97cd-516d15774f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a993704-fba2-494d-847c-7aaffd2215a9" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_9f7ec8d1-6869-4cc0-97cd-516d15774f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForSoftware_ac372ca7-4814-4bcf-98f0-5cc9e47a964e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForSoftware"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a993704-fba2-494d-847c-7aaffd2215a9" xlink:to="loc_us-gaap_PaymentsForSoftware_ac372ca7-4814-4bcf-98f0-5cc9e47a964e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_973b783c-a727-484f-8a26-b6d57c2b242b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a993704-fba2-494d-847c-7aaffd2215a9" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_973b783c-a727-484f-8a26-b6d57c2b242b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a1277b90-25b3-4967-bdad-9f11b8cd34d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_3a993704-fba2-494d-847c-7aaffd2215a9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a1277b90-25b3-4967-bdad-9f11b8cd34d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ede1a324-5da2-4689-9f60-edb5aa829487" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_865b65db-3db8-48d3-9d07-8b5b26ff1662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_865b65db-3db8-48d3-9d07-8b5b26ff1662" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_7704f5a5-db20-4ca3-87b6-778a5d24fa36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_7704f5a5-db20-4ca3-87b6-778a5d24fa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d42493f9-3506-405b-ace4-c5c31d76dc15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d42493f9-3506-405b-ace4-c5c31d76dc15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_2dd636e4-05af-40b8-8b5b-90b72b8fdada" xlink:href="hims-20210331.xsd#hims_ProceedsFromIssuanceOfCommonStockRecapitalization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:to="loc_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_2dd636e4-05af-40b8-8b5b-90b72b8fdada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2a78d852-12c0-4e51-8415-f10beb7647ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_2a78d852-12c0-4e51-8415-f10beb7647ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_0909d3f7-bed4-48ad-8ce9-b0f428696667" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_0909d3f7-bed4-48ad-8ce9-b0f428696667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_551c65d4-a84e-4eb2-b3c5-838e80073822" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_551c65d4-a84e-4eb2-b3c5-838e80073822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases_b26a1fdf-1f4f-42a0-b962-d1dd394750f1" xlink:href="hims-20210331.xsd#hims_ProceedsFromStockOptionsExercisedNetOfRepurchases"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:to="loc_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases_b26a1fdf-1f4f-42a0-b962-d1dd394750f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_76886e0e-fa37-490d-a242-e5111af8a37a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:to="loc_us-gaap_RepaymentsOfDebt_76886e0e-fa37-490d-a242-e5111af8a37a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1b10591-fb25-4aca-8005-0e81a12be2c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_442fe564-ed2e-4780-bdc9-82c191547499" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d1b10591-fb25-4aca-8005-0e81a12be2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_a0df23f9-7c03-4a60-866f-fcff87026f1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ede1a324-5da2-4689-9f60-edb5aa829487" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_a0df23f9-7c03-4a60-866f-fcff87026f1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06947cba-ddde-4972-9762-6f76b4e4be9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ede1a324-5da2-4689-9f60-edb5aa829487" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06947cba-ddde-4972-9762-6f76b4e4be9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a32fb59-72be-4718-903f-8bde1adb4705" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ede1a324-5da2-4689-9f60-edb5aa829487" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9a32fb59-72be-4718-903f-8bde1adb4705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ca50818-9003-4baa-a225-7f0394e8909f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ede1a324-5da2-4689-9f60-edb5aa829487" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4ca50818-9003-4baa-a225-7f0394e8909f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_d264c823-8af9-4493-a89e-203d26865d26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ede1a324-5da2-4689-9f60-edb5aa829487" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_d264c823-8af9-4493-a89e-203d26865d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_f1047d0a-b0d9-431e-a505-642412974753" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d264c823-8af9-4493-a89e-203d26865d26" xlink:to="loc_us-gaap_IncomeTaxesPaid_f1047d0a-b0d9-431e-a505-642412974753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_076d3375-6d70-4542-9333-214c4e75103a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_d264c823-8af9-4493-a89e-203d26865d26" xlink:to="loc_us-gaap_InterestPaidNet_076d3375-6d70-4542-9333-214c4e75103a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ede1a324-5da2-4689-9f60-edb5aa829487" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecapitalizationCosts_cac69c53-e356-42e7-8fdd-b433d5cb0d5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RecapitalizationCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:to="loc_us-gaap_RecapitalizationCosts_cac69c53-e356-42e7-8fdd-b433d5cb0d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_c0ba34b5-6524-4033-8f5a-454a127b7d7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_c0ba34b5-6524-4033-8f5a-454a127b7d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_WarrantsAssumed_e62f3d32-3c86-4d37-a5b6-0c0e6560f796" xlink:href="hims-20210331.xsd#hims_WarrantsAssumed"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:to="loc_hims_WarrantsAssumed_e62f3d32-3c86-4d37-a5b6-0c0e6560f796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_WarrantsIssued_631cd405-8d07-4bdb-8947-463aca831f0c" xlink:href="hims-20210331.xsd#hims_WarrantsIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:to="loc_hims_WarrantsIssued_631cd405-8d07-4bdb-8947-463aca831f0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReclassificationOfDeferredTransactionCosts_1923e891-1ae1-4f2e-a2a3-2a290ea17843" xlink:href="hims-20210331.xsd#hims_ReclassificationOfDeferredTransactionCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:to="loc_hims_ReclassificationOfDeferredTransactionCosts_1923e891-1ae1-4f2e-a2a3-2a290ea17843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ConversionOfPreferredStockWarrantsAmountConverted_d418035f-96e4-4f09-a12c-e095f8e30ed9" xlink:href="hims-20210331.xsd#hims_ConversionOfPreferredStockWarrantsAmountConverted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:to="loc_hims_ConversionOfPreferredStockWarrantsAmountConverted_d418035f-96e4-4f09-a12c-e095f8e30ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TransactionCostsIncurredButNotYetPaid_77c691e6-fe9d-4998-8b9c-1e53977caf5a" xlink:href="hims-20210331.xsd#hims_TransactionCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:to="loc_hims_TransactionCostsIncurredButNotYetPaid_77c691e6-fe9d-4998-8b9c-1e53977caf5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VestingOfEarlyExercisedStockOptions_498bf73e-6d89-4c08-90e7-a034ff8c01e5" xlink:href="hims-20210331.xsd#hims_VestingOfEarlyExercisedStockOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:to="loc_hims_VestingOfEarlyExercisedStockOptions_498bf73e-6d89-4c08-90e7-a034ff8c01e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssued1_10fea4ec-71ed-4032-9f36-95499c1ddba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssued1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_fde3069f-4499-43af-ba3c-086fb3e9874e" xlink:to="loc_us-gaap_StockIssued1_10fea4ec-71ed-4032-9f36-95499c1ddba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/Organization" xlink:type="simple" xlink:href="hims-20210331.xsd#Organization"/>
  <link:presentationLink xlink:role="http://forhims.com/role/Organization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f2cdb29b-08c6-4c54-80d3-8ac8cc6540ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7cf59b53-a6ad-4262-9d48-af53bc7e40ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f2cdb29b-08c6-4c54-80d3-8ac8cc6540ed" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_7cf59b53-a6ad-4262-9d48-af53bc7e40ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/OrganizationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#OrganizationDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/OrganizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_44faa0a6-e72e-4a28-b771-2f89bd2f1fda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_f60bcb21-fcd2-4656-a23f-ef34984902d9" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_44faa0a6-e72e-4a28-b771-2f89bd2f1fda" xlink:to="loc_hims_RecapitalizationExchangeRatio_f60bcb21-fcd2-4656-a23f-ef34984902d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="hims-20210331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://forhims.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_46a53792-2cf7-4905-b2ff-6634dbb5fc55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_b5a05ded-22e5-411b-9d63-5642f515186c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_46a53792-2cf7-4905-b2ff-6634dbb5fc55" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_b5a05ded-22e5-411b-9d63-5642f515186c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="hims-20210331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ce1d09ff-0d6a-4780-a11f-7df5fca642fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_ce1d09ff-0d6a-4780-a11f-7df5fca642fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_590c0728-1569-43c5-aa07-cfddd4ac5a6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_590c0728-1569-43c5-aa07-cfddd4ac5a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5c6cdce2-6f6c-409e-b413-1e2401d0f12d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_us-gaap_UseOfEstimates_5c6cdce2-6f6c-409e-b413-1e2401d0f12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_0804e4f0-1555-4ce0-b181-f0bb41e1e792" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_0804e4f0-1555-4ce0-b181-f0bb41e1e792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock_f2b235a3-8739-4491-9437-ae3becb3cb2f" xlink:href="hims-20210331.xsd#hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock_f2b235a3-8739-4491-9437-ae3becb3cb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_5c373a02-02d0-4f20-a3e9-20ea1cd9f564" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_5c373a02-02d0-4f20-a3e9-20ea1cd9f564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_bb2d2e6c-aa9e-4ab2-94f4-33faa8af79e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_bb2d2e6c-aa9e-4ab2-94f4-33faa8af79e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_61f35f21-a3bf-4000-a432-c39a5ee5f24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_61f35f21-a3bf-4000-a432-c39a5ee5f24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_WarrantLiabilityPolicyPolicyTextBlock_d01872d6-fb7f-40b2-bbf2-76fa004eb2c4" xlink:href="hims-20210331.xsd#hims_WarrantLiabilityPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_hims_WarrantLiabilityPolicyPolicyTextBlock_d01872d6-fb7f-40b2-bbf2-76fa004eb2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_6135781d-5967-46e8-a391-e24825047310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_6135781d-5967-46e8-a391-e24825047310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_393b787c-509c-4eb4-91ea-60a0004583b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59e1a517-ecc6-4bbe-ac63-f0663b15e8a9" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_393b787c-509c-4eb4-91ea-60a0004583b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="hims-20210331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_5292686e-3295-4d74-9503-8f3252cbc8e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_555d232b-78e3-4cd9-a748-f812ceb365d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_5292686e-3295-4d74-9503-8f3252cbc8e6" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_555d232b-78e3-4cd9-a748-f812ceb365d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aac24338-6db5-422c-af6c-8959bec10ba8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfInvestments_7342f883-3c88-4c5d-81fc-64eed109da42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aac24338-6db5-422c-af6c-8959bec10ba8" xlink:to="loc_us-gaap_ImpairmentOfInvestments_7342f883-3c88-4c5d-81fc-64eed109da42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_72127d68-9f0c-42ae-8b3f-6bfb7d422a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aac24338-6db5-422c-af6c-8959bec10ba8" xlink:to="loc_us-gaap_InventoryWriteDown_72127d68-9f0c-42ae-8b3f-6bfb7d422a2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f718d7a-3b76-4aec-b948-d9c05a6e5504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aac24338-6db5-422c-af6c-8959bec10ba8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f718d7a-3b76-4aec-b948-d9c05a6e5504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_96526f52-255b-4ad3-b890-913d29730da5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f718d7a-3b76-4aec-b948-d9c05a6e5504" xlink:to="loc_us-gaap_AwardTypeAxis_96526f52-255b-4ad3-b890-913d29730da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f410530e-5947-451c-a37d-f4eabc57a096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_96526f52-255b-4ad3-b890-913d29730da5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f410530e-5947-451c-a37d-f4eabc57a096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_635e2b31-547c-4063-abfa-1114a20ebbf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f410530e-5947-451c-a37d-f4eabc57a096" xlink:to="loc_us-gaap_EmployeeStockOptionMember_635e2b31-547c-4063-abfa-1114a20ebbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aea24d9f-0d75-454c-b9a6-1202cd7973b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7f718d7a-3b76-4aec-b948-d9c05a6e5504" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aea24d9f-0d75-454c-b9a6-1202cd7973b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_86b7e18e-4b8a-4b23-a6a3-c37c615718eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_aea24d9f-0d75-454c-b9a6-1202cd7973b5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_86b7e18e-4b8a-4b23-a6a3-c37c615718eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_95e5f3a9-b032-4fa0-8cb1-106d90910e00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_19139673-8eea-4f35-898d-137a774bb580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_95e5f3a9-b032-4fa0-8cb1-106d90910e00" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_19139673-8eea-4f35-898d-137a774bb580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f03dc47e-e5ed-48e7-97ab-66b40f07ea97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19139673-8eea-4f35-898d-137a774bb580" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f03dc47e-e5ed-48e7-97ab-66b40f07ea97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e81d8bee-4c0c-4d75-947f-b1af6f2ef434" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_f03dc47e-e5ed-48e7-97ab-66b40f07ea97" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e81d8bee-4c0c-4d75-947f-b1af6f2ef434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_f9e29541-cfb6-4735-98b7-642859c5aee2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e81d8bee-4c0c-4d75-947f-b1af6f2ef434" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_f9e29541-cfb6-4735-98b7-642859c5aee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_e1900b0f-f242-4391-ac38-b973dadc6a44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_e81d8bee-4c0c-4d75-947f-b1af6f2ef434" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_e1900b0f-f242-4391-ac38-b973dadc6a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c35bbbfe-3b89-4749-a045-f0743e4609b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19139673-8eea-4f35-898d-137a774bb580" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c35bbbfe-3b89-4749-a045-f0743e4609b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_70c2c4c0-9571-4cc8-8863-14a6c65b0330" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c35bbbfe-3b89-4749-a045-f0743e4609b7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_70c2c4c0-9571-4cc8-8863-14a6c65b0330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/Recapitalization" xlink:type="simple" xlink:href="hims-20210331.xsd#Recapitalization"/>
  <link:presentationLink xlink:role="http://forhims.com/role/Recapitalization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationAbstract_732630a8-0a11-4412-8b93-c97ccb292b69" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationDisclosureTextBlock_25c03acb-4046-4abc-a69a-4e099c0bca53" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationAbstract_732630a8-0a11-4412-8b93-c97ccb292b69" xlink:to="loc_hims_ReverseRecapitalizationDisclosureTextBlock_25c03acb-4046-4abc-a69a-4e099c0bca53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/RecapitalizationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#RecapitalizationDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/RecapitalizationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationAbstract_05c4a2b0-a773-4c20-977c-fca3f22b5ce6" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:href="hims-20210331.xsd#hims_ScheduleOfReverseRecapitaliztionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationAbstract_05c4a2b0-a773-4c20-977c-fca3f22b5ce6" xlink:to="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_17147dcc-9f26-4668-bd4e-70817e66b424" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_17147dcc-9f26-4668-bd4e-70817e66b424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_71ca69ef-4e0c-41c7-be08-941cb8f67902" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_17147dcc-9f26-4668-bd4e-70817e66b424" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_71ca69ef-4e0c-41c7-be08-941cb8f67902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_2cd9d2d0-a0f7-4a08-95f9-70a20bed9fb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_71ca69ef-4e0c-41c7-be08-941cb8f67902" xlink:to="loc_us-gaap_PrivatePlacementMember_2cd9d2d0-a0f7-4a08-95f9-70a20bed9fb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b0118506-a5e3-4fa5-9c9a-0947107d9ade" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b0118506-a5e3-4fa5-9c9a-0947107d9ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8c09caa0-ba2d-47fb-9119-774140422d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b0118506-a5e3-4fa5-9c9a-0947107d9ade" xlink:to="loc_us-gaap_ClassOfStockDomain_8c09caa0-ba2d-47fb-9119-774140422d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassAAndVMember_ce5f676e-a418-425b-97d0-98ecda645e0c" xlink:href="hims-20210331.xsd#hims_CommonClassAAndVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8c09caa0-ba2d-47fb-9119-774140422d2c" xlink:to="loc_hims_CommonClassAAndVMember_ce5f676e-a418-425b-97d0-98ecda645e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_303c8cbc-2953-449b-970d-009ccea4767c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_CommonClassAAndVMember_ce5f676e-a418-425b-97d0-98ecda645e0c" xlink:to="loc_us-gaap_CommonClassAMember_303c8cbc-2953-449b-970d-009ccea4767c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember_1f95a0b7-185d-42a4-b17e-53b702b14c77" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_CommonClassAAndVMember_ce5f676e-a418-425b-97d0-98ecda645e0c" xlink:to="loc_hims_CommonClassVMember_1f95a0b7-185d-42a4-b17e-53b702b14c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_2634779b-6030-4672-8cb1-282bf08638c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_2634779b-6030-4672-8cb1-282bf08638c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c99b3391-810d-40a3-b17e-e6101698debe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_2634779b-6030-4672-8cb1-282bf08638c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c99b3391-810d-40a3-b17e-e6101698debe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_7f46f5fb-d1ec-4963-8303-e538151aa67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c99b3391-810d-40a3-b17e-e6101698debe" xlink:to="loc_us-gaap_CommonClassAMember_7f46f5fb-d1ec-4963-8303-e538151aa67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantsMember_d065e2f9-64f1-4f81-bf38-79cb68224b53" xlink:href="hims-20210331.xsd#hims_ParentWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c99b3391-810d-40a3-b17e-e6101698debe" xlink:to="loc_hims_ParentWarrantsMember_d065e2f9-64f1-4f81-bf38-79cb68224b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantRestrictedStockUnitsMember_1d04d9b0-dcde-4875-ba80-29de60b2a20c" xlink:href="hims-20210331.xsd#hims_ParentWarrantRestrictedStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c99b3391-810d-40a3-b17e-e6101698debe" xlink:to="loc_hims_ParentWarrantRestrictedStockUnitsMember_1d04d9b0-dcde-4875-ba80-29de60b2a20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_7c319581-1bf6-42f1-a835-747e92e1b264" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_dei_LegalEntityAxis_7c319581-1bf6-42f1-a835-747e92e1b264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5b2666c6-d34e-4d1b-a1aa-01057adb2520" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_7c319581-1bf6-42f1-a835-747e92e1b264" xlink:to="loc_dei_EntityDomain_5b2666c6-d34e-4d1b-a1aa-01057adb2520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsIncMember_bd1a6f33-641d-4cd0-b634-ec3e684f8f7f" xlink:href="hims-20210331.xsd#hims_HimsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_5b2666c6-d34e-4d1b-a1aa-01057adb2520" xlink:to="loc_hims_HimsIncMember_bd1a6f33-641d-4cd0-b634-ec3e684f8f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_aea6ae20-6353-4bc8-83a4-3a36184b6632" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_srt_TitleOfIndividualAxis_aea6ae20-6353-4bc8-83a4-3a36184b6632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_814a667d-a30b-4ace-b8ab-76248b1204e9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_aea6ae20-6353-4bc8-83a4-3a36184b6632" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_814a667d-a30b-4ace-b8ab-76248b1204e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_363310f1-7b7b-462b-9a33-d6b1d759280d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_814a667d-a30b-4ace-b8ab-76248b1204e9" xlink:to="loc_srt_ChiefExecutiveOfficerMember_363310f1-7b7b-462b-9a33-d6b1d759280d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c3550c04-3752-41ef-8142-4560c9ec8f45" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_srt_CounterpartyNameAxis_c3550c04-3752-41ef-8142-4560c9ec8f45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_17db68f4-50df-43ce-8ba9-def39a268881" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_c3550c04-3752-41ef-8142-4560c9ec8f45" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_17db68f4-50df-43ce-8ba9-def39a268881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsStockholdersMember_a202394e-1a87-4e83-9ab2-fcf6290b1c10" xlink:href="hims-20210331.xsd#hims_HimsStockholdersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_17db68f4-50df-43ce-8ba9-def39a268881" xlink:to="loc_hims_HimsStockholdersMember_a202394e-1a87-4e83-9ab2-fcf6290b1c10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsWarrantHoldersMember_97fac3a5-c1a9-440c-b06c-cffed8f753df" xlink:href="hims-20210331.xsd#hims_HimsWarrantHoldersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_17db68f4-50df-43ce-8ba9-def39a268881" xlink:to="loc_hims_HimsWarrantHoldersMember_97fac3a5-c1a9-440c-b06c-cffed8f753df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsOptionAndRSUHoldersMember_9f8cd1df-7559-4aff-acaa-3f01963f0a4f" xlink:href="hims-20210331.xsd#hims_HimsOptionAndRSUHoldersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_17db68f4-50df-43ce-8ba9-def39a268881" xlink:to="loc_hims_HimsOptionAndRSUHoldersMember_9f8cd1df-7559-4aff-acaa-3f01963f0a4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4e2b459d-0440-4a4a-89c8-a8752fc6486e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4e2b459d-0440-4a4a-89c8-a8752fc6486e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6d5f0ccb-5ed8-4e27-9368-df60b6191216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4e2b459d-0440-4a4a-89c8-a8752fc6486e" xlink:to="loc_us-gaap_EquityComponentDomain_6d5f0ccb-5ed8-4e27-9368-df60b6191216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8b5352bd-acf7-4140-85d3-10b4724acb2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6d5f0ccb-5ed8-4e27-9368-df60b6191216" xlink:to="loc_us-gaap_CommonStockMember_8b5352bd-acf7-4140-85d3-10b4724acb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ScheduleOfReverseRecapitaliztionTable_32a34ab9-ce13-4576-9418-3cad35ea173c" xlink:to="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired_522e8e8e-f2c8-433c-bfd3-c7465a5b8052" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired_522e8e8e-f2c8-433c-bfd3-c7465a5b8052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_8a9ee670-2896-4d3d-b847-5ccde390dab9" xlink:href="hims-20210331.xsd#hims_ProceedsFromIssuanceOfCommonStockRecapitalization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ProceedsFromIssuanceOfCommonStockRecapitalization_8a9ee670-2896-4d3d-b847-5ccde390dab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationTransactionCosts_6c9844cc-89a4-48e6-8e77-7f015e6956f6" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationTransactionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationTransactionCosts_6c9844cc-89a4-48e6-8e77-7f015e6956f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_5bba1fb6-0ab6-43c0-a66c-a45e3cd9e4b7" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_RecapitalizationExchangeRatio_5bba1fb6-0ab6-43c0-a66c-a45e3cd9e4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_57a3dc88-b183-4d8d-aca1-56a7263ef70a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_57a3dc88-b183-4d8d-aca1-56a7263ef70a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_38fa5476-45ca-4e26-83c5-a261e422682a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_38fa5476-45ca-4e26-83c5-a261e422682a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_3abc7b77-e0a8-43eb-956e-336d63aeb428" xlink:href="hims-20210331.xsd#hims_RecapitalizationContingentConsiderationEquityExchangeRatio"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_3abc7b77-e0a8-43eb-956e-336d63aeb428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_48d345f4-4384-4f79-88fa-3eecc53fe870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_48d345f4-4384-4f79-88fa-3eecc53fe870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityShares_7d5eca43-4f4d-4c37-933a-58dbca496761" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseCapitalizationContingentConsiderationEquityShares_7d5eca43-4f4d-4c37-933a-58dbca496761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_ac065241-b019-47a1-84cb-55f9d7607b79" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_ac065241-b019-47a1-84cb-55f9d7607b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_b6c1b3cb-74b8-4f53-8737-79f8c44d6a2a" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_b6c1b3cb-74b8-4f53-8737-79f8c44d6a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_f7db2328-7b8b-411f-9c5e-a350ae49cbe5" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_f7db2328-7b8b-411f-9c5e-a350ae49cbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_fec6fef0-3eec-4db7-bc54-3d49377973c9" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_fec6fef0-3eec-4db7-bc54-3d49377973c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod_ff2e316f-2b9c-4f89-8add-2ec4290e88f6" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod_ff2e316f-2b9c-4f89-8add-2ec4290e88f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_17133d18-ae89-4f92-b62e-9a6e3e4a2200" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_17133d18-ae89-4f92-b62e-9a6e3e4a2200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ddf34724-8d09-4fe7-bca5-bd1673c874f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_ddf34724-8d09-4fe7-bca5-bd1673c874f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_380cc132-60e8-47e3-a227-1df27516ec34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_380cc132-60e8-47e3-a227-1df27516ec34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e1c627dd-e3dd-449c-8700-6818e6e52840" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ReverseRecapitalizationLineItems_1a6a13c6-8bc2-43da-9865-d7f9b8c30caa" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e1c627dd-e3dd-449c-8700-6818e6e52840" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/Investments" xlink:type="simple" xlink:href="hims-20210331.xsd#Investments"/>
  <link:presentationLink xlink:role="http://forhims.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b5d87d2a-520d-49d5-8382-01f41769ab4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7b488e7e-f3c6-4927-981e-892aa3dc1743" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_b5d87d2a-520d-49d5-8382-01f41769ab4d" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_7b488e7e-f3c6-4927-981e-892aa3dc1743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/InvestmentsTables" xlink:type="simple" xlink:href="hims-20210331.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a0c7a349-b83c-4d03-b197-7405b8a10d8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_eff68ea9-f4f2-46c7-97bb-3a7bf381536f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_a0c7a349-b83c-4d03-b197-7405b8a10d8d" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_eff68ea9-f4f2-46c7-97bb-3a7bf381536f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/InvestmentsShorttermInvestmentsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#InvestmentsShorttermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/InvestmentsShorttermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_73470af3-d368-43f5-bf39-cb24e55a240c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_0a4aa812-ef1c-4efb-9998-5f3f6dae25c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_73470af3-d368-43f5-bf39-cb24e55a240c" xlink:to="loc_us-gaap_MarketableSecuritiesTable_0a4aa812-ef1c-4efb-9998-5f3f6dae25c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_e8d00378-72ba-49a9-b8c0-32d75b454d44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_0a4aa812-ef1c-4efb-9998-5f3f6dae25c9" xlink:to="loc_us-gaap_FinancialInstrumentAxis_e8d00378-72ba-49a9-b8c0-32d75b454d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c902576-a15d-490f-a2c2-ee5c71204d01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_e8d00378-72ba-49a9-b8c0-32d75b454d44" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c902576-a15d-490f-a2c2-ee5c71204d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_bc94684b-2bc7-4bfb-8f27-ee122a9764c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c902576-a15d-490f-a2c2-ee5c71204d01" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_bc94684b-2bc7-4bfb-8f27-ee122a9764c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c7604516-e118-4ee4-b4e2-81ef2af4e861" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentAgenciesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c902576-a15d-490f-a2c2-ee5c71204d01" xlink:to="loc_us-gaap_USGovernmentAgenciesDebtSecuritiesMember_c7604516-e118-4ee4-b4e2-81ef2af4e861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_53a4842e-f9ac-4841-96f2-cca1b633b56f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c902576-a15d-490f-a2c2-ee5c71204d01" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_53a4842e-f9ac-4841-96f2-cca1b633b56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MarketableSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_0a4aa812-ef1c-4efb-9998-5f3f6dae25c9" xlink:to="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_757a200d-3ed9-4510-a526-12db6bbacb9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_757a200d-3ed9-4510-a526-12db6bbacb9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7e5cec56-a58e-4d62-8491-da083f9ba0ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_7e5cec56-a58e-4d62-8491-da083f9ba0ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_377615a0-2454-433b-a43f-fd43b2ff4a99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_377615a0-2454-433b-a43f-fd43b2ff4a99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6cbdab59-2fd7-45b2-957d-bcd1b45a3556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesLineItems_61dfef7d-619f-41e2-8fd9-7d7eede3935d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6cbdab59-2fd7-45b2-957d-bcd1b45a3556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/Inventory" xlink:type="simple" xlink:href="hims-20210331.xsd#Inventory"/>
  <link:presentationLink xlink:role="http://forhims.com/role/Inventory" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_f83db45c-619a-4a4b-a1f3-e8c6c6a792ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_ddf83321-1510-4e97-b8c6-a7afbd357e62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_f83db45c-619a-4a4b-a1f3-e8c6c6a792ff" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_ddf83321-1510-4e97-b8c6-a7afbd357e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/InventoryTables" xlink:type="simple" xlink:href="hims-20210331.xsd#InventoryTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/InventoryTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_1ed308ce-5afa-4bf2-a102-25718e603fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_62320075-0b50-4c96-adc1-908f7d5d9ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_1ed308ce-5afa-4bf2-a102-25718e603fdf" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_62320075-0b50-4c96-adc1-908f7d5d9ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/InventoryDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#InventoryDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_72ddc9af-eea5-450c-b666-837b4bcafdbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5c96dd59-563b-4fc2-bd5a-55a83169bb07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_72ddc9af-eea5-450c-b666-837b4bcafdbb" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5c96dd59-563b-4fc2-bd5a-55a83169bb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_81c75760-87ff-429c-ad10-55097b1a9401" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_72ddc9af-eea5-450c-b666-837b4bcafdbb" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_81c75760-87ff-429c-ad10-55097b1a9401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a4e74da5-293f-45e9-9a10-8123e15e2f0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_72ddc9af-eea5-450c-b666-837b4bcafdbb" xlink:to="loc_us-gaap_InventoryNet_a4e74da5-293f-45e9-9a10-8123e15e2f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssets" xlink:type="simple" xlink:href="hims-20210331.xsd#PrepaidExpensesandOtherCurrentAssets"/>
  <link:presentationLink xlink:role="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_169b6002-525e-41b1-9af3-547f4cc0fef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsTextBlock_06c13172-a800-4f4d-8ceb-57146e07e13e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentAssetsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_169b6002-525e-41b1-9af3-547f4cc0fef1" xlink:to="loc_us-gaap_OtherCurrentAssetsTextBlock_06c13172-a800-4f4d-8ceb-57146e07e13e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsTables" xlink:type="simple" xlink:href="hims-20210331.xsd#PrepaidExpensesandOtherCurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_8b791302-a00e-418e-8034-1c467f408ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_aaf04465-4a60-4dd3-8e2b-3ed28d217a9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_8b791302-a00e-418e-8034-1c467f408ec6" xlink:to="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock_aaf04465-4a60-4dd3-8e2b-3ed28d217a9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#PrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_32c1c9c2-35ce-422f-a541-32a0f485cc63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TradeAndOtherReceivablesCurrent_c008c6d5-f3f8-486b-8fff-873580993d5c" xlink:href="hims-20210331.xsd#hims_TradeAndOtherReceivablesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_32c1c9c2-35ce-422f-a541-32a0f485cc63" xlink:to="loc_hims_TradeAndOtherReceivablesCurrent_c008c6d5-f3f8-486b-8fff-873580993d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_3e001829-6319-4654-a7b3-172864b88b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_32c1c9c2-35ce-422f-a541-32a0f485cc63" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_3e001829-6319-4654-a7b3-172864b88b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorDepositsCurrent_445a8cdd-8682-4e74-8991-8c7791ec5acb" xlink:href="hims-20210331.xsd#hims_VendorDepositsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_32c1c9c2-35ce-422f-a541-32a0f485cc63" xlink:to="loc_hims_VendorDepositsCurrent_445a8cdd-8682-4e74-8991-8c7791ec5acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_c2370a50-51bf-44c5-b244-b72a3007464d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_32c1c9c2-35ce-422f-a541-32a0f485cc63" xlink:to="loc_us-gaap_OtherAssetsCurrent_c2370a50-51bf-44c5-b244-b72a3007464d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00883135-03cf-47c4-ac75-5151c77e13f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_32c1c9c2-35ce-422f-a541-32a0f485cc63" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_00883135-03cf-47c4-ac75-5151c77e13f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/AccruedLiabilities" xlink:type="simple" xlink:href="hims-20210331.xsd#AccruedLiabilities"/>
  <link:presentationLink xlink:role="http://forhims.com/role/AccruedLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_f9264aba-a7d3-41a3-8753-e78697370c8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_d0793a09-3dc5-45c7-83db-b537835e6e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_f9264aba-a7d3-41a3-8753-e78697370c8f" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_d0793a09-3dc5-45c7-83db-b537835e6e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/AccruedLiabilitiesTables" xlink:type="simple" xlink:href="hims-20210331.xsd#AccruedLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/AccruedLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_917aa7ca-0840-40b2-8657-603dc9037f74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_15be1156-f24d-49fb-beb7-3a1fbed33bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_917aa7ca-0840-40b2-8657-603dc9037f74" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_15be1156-f24d-49fb-beb7-3a1fbed33bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#AccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_6514f97f-7c09-4610-b483-b79b3f6f195a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedMarketingCostsCurrent_8bb32248-5683-48b9-8959-5332e7182a7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedMarketingCostsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_6514f97f-7c09-4610-b483-b79b3f6f195a" xlink:to="loc_us-gaap_AccruedMarketingCostsCurrent_8bb32248-5683-48b9-8959-5332e7182a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_df8d5a6e-eb9a-4e51-b037-feff8e77dff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_6514f97f-7c09-4610-b483-b79b3f6f195a" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_df8d5a6e-eb9a-4e51-b037-feff8e77dff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AccruedPayrollCostsCurrent_78b81af9-55cf-4815-ad1b-17bb49c772eb" xlink:href="hims-20210331.xsd#hims_AccruedPayrollCostsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_6514f97f-7c09-4610-b483-b79b3f6f195a" xlink:to="loc_hims_AccruedPayrollCostsCurrent_78b81af9-55cf-4815-ad1b-17bb49c772eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_62e9c851-2e83-4189-b5ef-1916989d5068" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_6514f97f-7c09-4610-b483-b79b3f6f195a" xlink:to="loc_us-gaap_TaxesPayableCurrent_62e9c851-2e83-4189-b5ef-1916989d5068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositLiabilityCurrent_3fa4b05f-7965-422b-a7e9-87cc2bbee029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepositLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_6514f97f-7c09-4610-b483-b79b3f6f195a" xlink:to="loc_us-gaap_DepositLiabilityCurrent_3fa4b05f-7965-422b-a7e9-87cc2bbee029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f36bf97f-b52b-42f9-9cd7-8fa053faab47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_6514f97f-7c09-4610-b483-b79b3f6f195a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_f36bf97f-b52b-42f9-9cd7-8fa053faab47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_372a96b5-6be5-4680-b67c-8ba96a203c5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract_6514f97f-7c09-4610-b483-b79b3f6f195a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_372a96b5-6be5-4680-b67c-8ba96a203c5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/VariableInterestEntities" xlink:type="simple" xlink:href="hims-20210331.xsd#VariableInterestEntities"/>
  <link:presentationLink xlink:role="http://forhims.com/role/VariableInterestEntities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7b741686-035b-4161-841a-c3de275167bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_2f92bc7a-9642-4383-9fc1-e9cc63def885" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7b741686-035b-4161-841a-c3de275167bb" xlink:to="loc_us-gaap_VariableInterestEntityDisclosureTextBlock_2f92bc7a-9642-4383-9fc1-e9cc63def885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/VariableInterestEntitiesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#VariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/VariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_001b0f3d-4362-44e1-a89d-a8f276ae5d4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_001b0f3d-4362-44e1-a89d-a8f276ae5d4f" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_0b990c22-e261-40a1-8483-bcc0d68306c4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_0b990c22-e261-40a1-8483-bcc0d68306c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e3bff126-d055-4418-b861-7330d06d736f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_0b990c22-e261-40a1-8483-bcc0d68306c4" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e3bff126-d055-4418-b861-7330d06d736f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b245d4f8-4ad8-4a23-9e45-2e2a9d097810" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e3bff126-d055-4418-b861-7330d06d736f" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b245d4f8-4ad8-4a23-9e45-2e2a9d097810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_63152dea-7c4c-492b-b7e6-ceb29a4e2e7f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:to="loc_dei_LegalEntityAxis_63152dea-7c4c-492b-b7e6-ceb29a4e2e7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_44ce8ec7-0111-497b-b562-7f07957a80f9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_63152dea-7c4c-492b-b7e6-ceb29a4e2e7f" xlink:to="loc_dei_EntityDomain_44ce8ec7-0111-497b-b562-7f07957a80f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_AffiliatedMedicalGroupsMember_701a69bd-d6a5-4047-be9e-534c0ab22e0c" xlink:href="hims-20210331.xsd#hims_AffiliatedMedicalGroupsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_44ce8ec7-0111-497b-b562-7f07957a80f9" xlink:to="loc_hims_AffiliatedMedicalGroupsMember_701a69bd-d6a5-4047-be9e-534c0ab22e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_6230be1b-d54f-4bd9-bb52-e9f4a755f80e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:to="loc_srt_ConsolidationItemsAxis_6230be1b-d54f-4bd9-bb52-e9f4a755f80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3c4c5529-80b2-4212-98c5-0cd08e06fd78" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_6230be1b-d54f-4bd9-bb52-e9f4a755f80e" xlink:to="loc_srt_ConsolidationItemsDomain_3c4c5529-80b2-4212-98c5-0cd08e06fd78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationEliminationsMember_e881193c-4c8b-4c64-ba66-a2c7309d361a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationEliminationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_3c4c5529-80b2-4212-98c5-0cd08e06fd78" xlink:to="loc_srt_ConsolidationEliminationsMember_e881193c-4c8b-4c64-ba66-a2c7309d361a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_f4232fef-5093-45f1-9179-cee6c536b01f" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PercentageOwnedByLicensedPhysicians_04597409-affe-4e7d-9f87-b501828072f1" xlink:href="hims-20210331.xsd#hims_PercentageOwnedByLicensedPhysicians"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_hims_PercentageOwnedByLicensedPhysicians_04597409-affe-4e7d-9f87-b501828072f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4b70b79c-417e-4863-83c9-03533ce1ca4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_AssetsCurrent_4b70b79c-417e-4863-83c9-03533ce1ca4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9875e407-9eef-4a11-b89b-c1b5e94d8580" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_Assets_9875e407-9eef-4a11-b89b-c1b5e94d8580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ab18e710-e69d-4879-a0cd-e48c1471e98e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_LiabilitiesCurrent_ab18e710-e69d-4879-a0cd-e48c1471e98e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_f20340e2-53d9-484f-b3a2-3906d69f458b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_Liabilities_f20340e2-53d9-484f-b3a2-3906d69f458b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliers_20566b4f-ba7e-4b63-bd8e-aa2d91bc4ac4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliers"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_PaymentsToSuppliers_20566b4f-ba7e-4b63-bd8e-aa2d91bc4ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_493bf0d3-8bf9-42c1-9674-89cfeef66e14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_211b7467-6ef0-4dc4-bcd6-ccc621e20f02" xlink:to="loc_us-gaap_NetIncomeLoss_493bf0d3-8bf9-42c1-9674-89cfeef66e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="hims-20210331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://forhims.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7b71edf1-28f8-4170-9525-e30fb4ce8f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_9a629b8a-18d8-417b-8ae5-21af17e2d251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7b71edf1-28f8-4170-9525-e30fb4ce8f36" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_9a629b8a-18d8-417b-8ae5-21af17e2d251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="hims-20210331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2d7c8337-d8da-4244-80d2-1ca9433ce281" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_a2b719d7-4705-46fd-bc32-5c43f09f94e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2d7c8337-d8da-4244-80d2-1ca9433ce281" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_a2b719d7-4705-46fd-bc32-5c43f09f94e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock_fbaf8300-1b4d-4e83-bcd9-8a6e88442070" xlink:href="hims-20210331.xsd#hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2d7c8337-d8da-4244-80d2-1ca9433ce281" xlink:to="loc_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock_fbaf8300-1b4d-4e83-bcd9-8a6e88442070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_19fc2441-5e29-46e1-9499-dc01f9692da7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2d7c8337-d8da-4244-80d2-1ca9433ce281" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_19fc2441-5e29-46e1-9499-dc01f9692da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bea042e2-3ed1-4e50-84aa-55827257f08e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bea042e2-3ed1-4e50-84aa-55827257f08e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d647e9d-ca3d-4147-b28c-950a6aaea7de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d647e9d-ca3d-4147-b28c-950a6aaea7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c23e787f-0fd6-45e6-9a31-e7ecb5e34230" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_3d647e9d-ca3d-4147-b28c-950a6aaea7de" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c23e787f-0fd6-45e6-9a31-e7ecb5e34230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_463774c4-4689-46a3-aa40-f1f974dd4f65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c23e787f-0fd6-45e6-9a31-e7ecb5e34230" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_463774c4-4689-46a3-aa40-f1f974dd4f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f6361baf-a1d2-46d5-9cff-91ef72c43ba7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c23e787f-0fd6-45e6-9a31-e7ecb5e34230" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f6361baf-a1d2-46d5-9cff-91ef72c43ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_7d6828c7-abef-498a-8b9c-a26ed381e1b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_c23e787f-0fd6-45e6-9a31-e7ecb5e34230" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_7d6828c7-abef-498a-8b9c-a26ed381e1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c1347181-15d6-4de4-a39b-46e03baa65fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c1347181-15d6-4de4-a39b-46e03baa65fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_272c0185-5717-4af8-9ce3-6a807949b467" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_c1347181-15d6-4de4-a39b-46e03baa65fb" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_272c0185-5717-4af8-9ce3-6a807949b467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_6849aaa9-0ec3-4a00-9a8c-5b58b758f329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_272c0185-5717-4af8-9ce3-6a807949b467" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_6849aaa9-0ec3-4a00-9a8c-5b58b758f329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_00a10bf6-47aa-46ae-b4ac-3ae668625f42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_00a10bf6-47aa-46ae-b4ac-3ae668625f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdb94384-50f9-459f-95de-6c566f4d835d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_00a10bf6-47aa-46ae-b4ac-3ae668625f42" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdb94384-50f9-459f-95de-6c566f4d835d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_e27505f1-fedc-4a9a-9aeb-628b5cc372ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdb94384-50f9-459f-95de-6c566f4d835d" xlink:to="loc_us-gaap_MoneyMarketFundsMember_e27505f1-fedc-4a9a-9aeb-628b5cc372ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_0098e20d-1980-4f86-820c-56181c1c7ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fdb94384-50f9-459f-95de-6c566f4d835d" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_0098e20d-1980-4f86-820c-56181c1c7ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_d278c2de-1e9b-47c8-a23a-1a10a888fdbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_FinancialInstrumentAxis_d278c2de-1e9b-47c8-a23a-1a10a888fdbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9132cb03-eba2-421e-806f-47be171448f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_d278c2de-1e9b-47c8-a23a-1a10a888fdbd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9132cb03-eba2-421e-806f-47be171448f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_e59366a6-2cde-43fd-a155-809ad99993c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9132cb03-eba2-421e-806f-47be171448f4" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_e59366a6-2cde-43fd-a155-809ad99993c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateBondSecuritiesMember_375eb182-51e1-4bfb-947a-f42435f89a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateBondSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9132cb03-eba2-421e-806f-47be171448f4" xlink:to="loc_us-gaap_CorporateBondSecuritiesMember_375eb182-51e1-4bfb-947a-f42435f89a4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_1faf74da-0b39-4c83-b7d1-c90f1464571e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9132cb03-eba2-421e-806f-47be171448f4" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_1faf74da-0b39-4c83-b7d1-c90f1464571e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_d1b7d458-e4c6-4ee1-8531-2281e173a4ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_d1b7d458-e4c6-4ee1-8531-2281e173a4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_4b844f6b-a7ef-4adc-a08f-53739b46ba02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis_d1b7d458-e4c6-4ee1-8531-2281e173a4ed" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_4b844f6b-a7ef-4adc-a08f-53739b46ba02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_3e34bd1b-6e46-465d-95a2-48ebc6340b2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e972a197-ac0d-4036-8992-84f2869ed294" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_71419c5f-81d9-4fd3-ac42-d56840f442a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_71419c5f-81d9-4fd3-ac42-d56840f442a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_7369e8d3-a8ba-4596-907b-245aa9801609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_ShortTermInvestments_7369e8d3-a8ba-4596-907b-245aa9801609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_b69e3fdf-e0e7-4ff0-87c1-26e0ab79f68b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_RestrictedCash_b69e3fdf-e0e7-4ff0-87c1-26e0ab79f68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_c0ad4119-8888-44f9-a4d1-c28a9dea62b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_c0ad4119-8888-44f9-a4d1-c28a9dea62b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_ffd96963-1f40-4c5b-b206-9880fb944bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_DerivativeLiabilities_ffd96963-1f40-4c5b-b206-9880fb944bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_f209d0d0-0aa7-4654-b159-eb5d7c28e64d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3f48369f-ffe3-4bf3-a2f8-1540c741d5bf" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_f209d0d0-0aa7-4654-b159-eb5d7c28e64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#FairValueMeasurementsAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_89f82397-f150-4bec-b297-47537338f533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1e772a8-ef40-470a-8b5f-f0cdebcf0e57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_89f82397-f150-4bec-b297-47537338f533" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1e772a8-ef40-470a-8b5f-f0cdebcf0e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_e0c24304-f3e8-47fc-8302-11555e3fa359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1e772a8-ef40-470a-8b5f-f0cdebcf0e57" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_e0c24304-f3e8-47fc-8302-11555e3fa359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_ce322fb3-ab77-464e-b5b2-ca9669f6c915" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_e0c24304-f3e8-47fc-8302-11555e3fa359" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_ce322fb3-ab77-464e-b5b2-ca9669f6c915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsMember_4101bc47-79fd-44bd-8afd-f974ab0518e0" xlink:href="hims-20210331.xsd#hims_PublicWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_ce322fb3-ab77-464e-b5b2-ca9669f6c915" xlink:to="loc_hims_PublicWarrantsMember_4101bc47-79fd-44bd-8afd-f974ab0518e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f4dc4fe4-ac7a-48b3-97a8-6232bff55aa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a1e772a8-ef40-470a-8b5f-f0cdebcf0e57" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f4dc4fe4-ac7a-48b3-97a8-6232bff55aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_d63c3b62-162a-4cb6-bc77-71caa59c3ca0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f4dc4fe4-ac7a-48b3-97a8-6232bff55aa3" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_d63c3b62-162a-4cb6-bc77-71caa59c3ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_05251785-843b-495e-b310-d85e3eaf48e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f4dc4fe4-ac7a-48b3-97a8-6232bff55aa3" xlink:to="loc_us-gaap_SharePrice_05251785-843b-495e-b310-d85e3eaf48e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_80f33b75-3f7e-4dec-825a-a00acc34835d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd5c3373-de8c-44b8-b94f-44b5965169d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_80f33b75-3f7e-4dec-825a-a00acc34835d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd5c3373-de8c-44b8-b94f-44b5965169d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f6cb4d31-0ed6-4f80-a7c7-c8875693ed15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd5c3373-de8c-44b8-b94f-44b5965169d8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f6cb4d31-0ed6-4f80-a7c7-c8875693ed15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_33714563-0364-4a8e-967f-78385e37226e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f6cb4d31-0ed6-4f80-a7c7-c8875693ed15" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_33714563-0364-4a8e-967f-78385e37226e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PrivatePlacementWarrantsMember_951e439d-cfb5-4915-bab0-5970935ea12e" xlink:href="hims-20210331.xsd#hims_PrivatePlacementWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_33714563-0364-4a8e-967f-78385e37226e" xlink:to="loc_hims_PrivatePlacementWarrantsMember_951e439d-cfb5-4915-bab0-5970935ea12e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd5c3373-de8c-44b8-b94f-44b5965169d8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3b86ab8c-e42b-4004-b79f-20deea0dbc18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_3b86ab8c-e42b-4004-b79f-20deea0dbc18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_e16ce805-3cce-421c-8256-d673c4049f06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_e16ce805-3cce-421c-8256-d673c4049f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ee285490-2897-41e7-8eb4-10cf83c293ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_ee285490-2897-41e7-8eb4-10cf83c293ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ecf73c26-50c5-4f5e-b2f7-77c5b2447c02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_140a3687-2b7a-4812-8c36-8e009b8a6685" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ecf73c26-50c5-4f5e-b2f7-77c5b2447c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5cfc994b-f09f-4335-a15a-929dd0bddc6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f262de75-4a09-439e-8f1d-84c476696f67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5cfc994b-f09f-4335-a15a-929dd0bddc6f" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f262de75-4a09-439e-8f1d-84c476696f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_159908cf-38e4-407b-99f8-8612f568cfd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f262de75-4a09-439e-8f1d-84c476696f67" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_159908cf-38e4-407b-99f8-8612f568cfd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization_30808a3b-ebd8-4742-9fef-74edd0371233" xlink:href="hims-20210331.xsd#hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f262de75-4a09-439e-8f1d-84c476696f67" xlink:to="loc_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization_30808a3b-ebd8-4742-9fef-74edd0371233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_374824cd-6765-4642-8737-1d82f6fc2ae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f262de75-4a09-439e-8f1d-84c476696f67" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues_374824cd-6765-4642-8737-1d82f6fc2ae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0f7648f5-829c-4160-8daf-50cbe85dbe6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f262de75-4a09-439e-8f1d-84c476696f67" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_0f7648f5-829c-4160-8daf-50cbe85dbe6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_508ba1ed-330f-4299-9c7c-358bfaae5a12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f262de75-4a09-439e-8f1d-84c476696f67" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_508ba1ed-330f-4299-9c7c-358bfaae5a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_79dfca04-ed9d-4677-8830-b31c2740ac8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_f262de75-4a09-439e-8f1d-84c476696f67" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_79dfca04-ed9d-4677-8830-b31c2740ac8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/BorrowingArrangements" xlink:type="simple" xlink:href="hims-20210331.xsd#BorrowingArrangements"/>
  <link:presentationLink xlink:role="http://forhims.com/role/BorrowingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_86e7c799-82fc-4162-9b91-394c22c44056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_a0d1c9f1-8397-4822-9cea-01332030087c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_86e7c799-82fc-4162-9b91-394c22c44056" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_a0d1c9f1-8397-4822-9cea-01332030087c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/BorrowingArrangementsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#BorrowingArrangementsDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/BorrowingArrangementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_92ca73a8-f6fd-4f91-8bff-9fb309f4d4f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_92ca73a8-f6fd-4f91-8bff-9fb309f4d4f4" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_86ffc4eb-60bc-4d4d-84b9-2780f52e081f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:to="loc_us-gaap_CreditFacilityAxis_86ffc4eb-60bc-4d4d-84b9-2780f52e081f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_97e670bc-5e2d-4615-a506-fbbc24bca4e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_86ffc4eb-60bc-4d4d-84b9-2780f52e081f" xlink:to="loc_us-gaap_CreditFacilityDomain_97e670bc-5e2d-4615-a506-fbbc24bca4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_9eb447f4-7c01-42db-8c32-f398fe34bafa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_97e670bc-5e2d-4615-a506-fbbc24bca4e1" xlink:to="loc_us-gaap_LetterOfCreditMember_9eb447f4-7c01-42db-8c32-f398fe34bafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6ee15437-5ae0-4add-91c6-d59257a2f595" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:to="loc_us-gaap_DebtInstrumentAxis_6ee15437-5ae0-4add-91c6-d59257a2f595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9daebe0f-4dee-4a98-ad98-9cbac6d30628" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6ee15437-5ae0-4add-91c6-d59257a2f595" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9daebe0f-4dee-4a98-ad98-9cbac6d30628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_BusinessCreditCardMember_b80b6691-5ec7-4597-ac17-3823e3cfd943" xlink:href="hims-20210331.xsd#hims_BusinessCreditCardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9daebe0f-4dee-4a98-ad98-9cbac6d30628" xlink:to="loc_hims_BusinessCreditCardMember_b80b6691-5ec7-4597-ac17-3823e3cfd943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CapitalAgreement2019Member_4b181e24-8034-4d80-ab0f-25bf1d3fa780" xlink:href="hims-20210331.xsd#hims_CapitalAgreement2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_9daebe0f-4dee-4a98-ad98-9cbac6d30628" xlink:to="loc_hims_CapitalAgreement2019Member_4b181e24-8034-4d80-ab0f-25bf1d3fa780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CapitalAgreement2019TrancheOneMember_e3539b87-8a98-4a97-a733-f62db7cc323f" xlink:href="hims-20210331.xsd#hims_CapitalAgreement2019TrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_CapitalAgreement2019Member_4b181e24-8034-4d80-ab0f-25bf1d3fa780" xlink:to="loc_hims_CapitalAgreement2019TrancheOneMember_e3539b87-8a98-4a97-a733-f62db7cc323f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CapitalAgreement2019TrancheTwoMember_2d144a17-6119-4b62-bd7a-dc61d753e68b" xlink:href="hims-20210331.xsd#hims_CapitalAgreement2019TrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_CapitalAgreement2019Member_4b181e24-8034-4d80-ab0f-25bf1d3fa780" xlink:to="loc_hims_CapitalAgreement2019TrancheTwoMember_2d144a17-6119-4b62-bd7a-dc61d753e68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dcd6296b-85a8-4fab-ab4f-6b61b3a4a5da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dcd6296b-85a8-4fab-ab4f-6b61b3a4a5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bb74915c-b803-48d5-a27f-c9640e078a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dcd6296b-85a8-4fab-ab4f-6b61b3a4a5da" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bb74915c-b803-48d5-a27f-c9640e078a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7a063153-e207-4c50-bd92-dc4dc398ff33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bb74915c-b803-48d5-a27f-c9640e078a41" xlink:to="loc_us-gaap_LineOfCreditMember_7a063153-e207-4c50-bd92-dc4dc398ff33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_5221860a-fe7e-4b51-a33d-3a7f32741679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_bb74915c-b803-48d5-a27f-c9640e078a41" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_5221860a-fe7e-4b51-a33d-3a7f32741679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_5a79a03c-c59d-4702-8c52-5356ea5469c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_5a79a03c-c59d-4702-8c52-5356ea5469c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_e5339e2e-7587-4c33-8dc6-97d504b2044c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_5a79a03c-c59d-4702-8c52-5356ea5469c1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_e5339e2e-7587-4c33-8dc6-97d504b2044c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesCPreferredStockWarrantsMember_da852806-6d0e-48ed-b09a-e7d4a117c171" xlink:href="hims-20210331.xsd#hims_SeriesCPreferredStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e5339e2e-7587-4c33-8dc6-97d504b2044c" xlink:to="loc_hims_SeriesCPreferredStockWarrantsMember_da852806-6d0e-48ed-b09a-e7d4a117c171" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesDPreferredStockWarrantsMember_658a70a0-ec56-4a10-8cff-2d6cafb13886" xlink:href="hims-20210331.xsd#hims_SeriesDPreferredStockWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_e5339e2e-7587-4c33-8dc6-97d504b2044c" xlink:to="loc_hims_SeriesDPreferredStockWarrantsMember_658a70a0-ec56-4a10-8cff-2d6cafb13886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_6bd866c3-74a5-49ce-8111-3d265fb9450e" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_34aaabcf-64f0-4625-b8eb-e4312a6699d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_34aaabcf-64f0-4625-b8eb-e4312a6699d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_a906a083-9665-4bc6-9039-43b5d278d9bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_a906a083-9665-4bc6-9039-43b5d278d9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_DebtInstrumentCovenantRequiredCollateralAmount_16dffab4-e4e7-4dae-841b-d06d576f9f95" xlink:href="hims-20210331.xsd#hims_DebtInstrumentCovenantRequiredCollateralAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_hims_DebtInstrumentCovenantRequiredCollateralAmount_16dffab4-e4e7-4dae-841b-d06d576f9f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_edd00eec-90ea-40a5-ba80-0e6b2a26cf91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_edd00eec-90ea-40a5-ba80-0e6b2a26cf91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_DebtInstrumentMaximumBorrowingCapacity_246c1393-5116-4d3f-8b9a-c921866979ea" xlink:href="hims-20210331.xsd#hims_DebtInstrumentMaximumBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_hims_DebtInstrumentMaximumBorrowingCapacity_246c1393-5116-4d3f-8b9a-c921866979ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_3c196ce7-b394-4b11-b463-15cc6c2d2d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtLongtermAndShorttermCombinedAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_DebtLongtermAndShorttermCombinedAmount_3c196ce7-b394-4b11-b463-15cc6c2d2d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9479a4bc-1c24-458d-8cc0-f042a57943eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_9479a4bc-1c24-458d-8cc0-f042a57943eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5ada2fd9-fad0-4f90-b083-e854b1706bfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_9671e655-8d58-4f53-98ef-565346da4005" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_5ada2fd9-fad0-4f90-b083-e854b1706bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="hims-20210331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6e8ea49b-ae8c-487f-a2db-d8b43b17925d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_89be7e83-8947-498f-b1ca-4099728ebfb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6e8ea49b-ae8c-487f-a2db-d8b43b17925d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_89be7e83-8947-498f-b1ca-4099728ebfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommitmentandContingenciesTables" xlink:type="simple" xlink:href="hims-20210331.xsd#CommitmentandContingenciesTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommitmentandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6f3bc108-d18e-494d-9bec-c80164149ee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_a090cf29-1d8e-47ff-b060-9aee6b9c1d25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6f3bc108-d18e-494d-9bec-c80164149ee1" xlink:to="loc_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_a090cf29-1d8e-47ff-b060-9aee6b9c1d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ea997389-02f8-43bb-a1c1-9c0794ba7a30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_9f273358-16d4-483c-a17a-fac20eeb24d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ea997389-02f8-43bb-a1c1-9c0794ba7a30" xlink:to="loc_us-gaap_OtherCommitmentsTable_9f273358-16d4-483c-a17a-fac20eeb24d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ffe38dcf-8b7b-4022-b414-e57ac1d67cc6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_9f273358-16d4-483c-a17a-fac20eeb24d3" xlink:to="loc_srt_StatementGeographicalAxis_ffe38dcf-8b7b-4022-b414-e57ac1d67cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_05def646-7ba2-456a-8d78-252724146851" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ffe38dcf-8b7b-4022-b414-e57ac1d67cc6" xlink:to="loc_srt_SegmentGeographicalDomain_05def646-7ba2-456a-8d78-252724146851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NewAlbanyOhioMember_1a66a7e3-9cf0-4712-a99b-35cd8c804863" xlink:href="hims-20210331.xsd#hims_NewAlbanyOhioMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_05def646-7ba2-456a-8d78-252724146851" xlink:to="loc_hims_NewAlbanyOhioMember_1a66a7e3-9cf0-4712-a99b-35cd8c804863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_9f273358-16d4-483c-a17a-fac20eeb24d3" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseAndRentalExpense_8ff6dd0a-5961-41b1-89d4-a37c04296ea0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseAndRentalExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_us-gaap_LeaseAndRentalExpense_8ff6dd0a-5961-41b1-89d4-a37c04296ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperatingLeaseTermOfContract_8e7fb4c8-c701-430f-9aea-2c34ce590827" xlink:href="hims-20210331.xsd#hims_OperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_hims_OperatingLeaseTermOfContract_8e7fb4c8-c701-430f-9aea-2c34ce590827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfRealEstateProperty_7377dad1-c446-4d50-8d27-293aecbb925d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AreaOfRealEstateProperty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_us-gaap_AreaOfRealEstateProperty_7377dad1-c446-4d50-8d27-293aecbb925d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2ba53ca2-ab09-4ac6-927f-cc8e942c90a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_2ba53ca2-ab09-4ac6-927f-cc8e942c90a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement_d69bc283-234c-431c-b6d6-d4980cd20350" xlink:href="hims-20210331.xsd#hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement_d69bc283-234c-431c-b6d6-d4980cd20350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperatingLeaseRentExpenseAnnualEscalationPercent_5c8a72a4-5b4c-4522-be6c-df81b30ae95f" xlink:href="hims-20210331.xsd#hims_OperatingLeaseRentExpenseAnnualEscalationPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_hims_OperatingLeaseRentExpenseAnnualEscalationPercent_5c8a72a4-5b4c-4522-be6c-df81b30ae95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperatingLeaseRenewalTerm_337bb35a-71fe-4e4a-9bd6-0514523f9705" xlink:href="hims-20210331.xsd#hims_OperatingLeaseRenewalTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_hims_OperatingLeaseRenewalTerm_337bb35a-71fe-4e4a-9bd6-0514523f9705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_7dbd7a04-f2ae-4ef7-9b7d-e31dd7e53a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_ef33b118-be82-46c5-bd2c-1aa31aa95c9e" xlink:to="loc_us-gaap_PurchaseObligation_7dbd7a04-f2ae-4ef7-9b7d-e31dd7e53a7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e5baf5fc-ac45-4dc1-9e71-989a5cff9310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_8c24e4fd-14d0-47f5-8cbd-5dfd9f16aff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e5baf5fc-ac45-4dc1-9e71-989a5cff9310" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear_8c24e4fd-14d0-47f5-8cbd-5dfd9f16aff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9621aa2e-4072-408d-a9ca-a4e093e79459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e5baf5fc-ac45-4dc1-9e71-989a5cff9310" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears_9621aa2e-4072-408d-a9ca-a4e093e79459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_7baf8800-9e6b-415a-b7f9-0734ceb83587" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e5baf5fc-ac45-4dc1-9e71-989a5cff9310" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears_7baf8800-9e6b-415a-b7f9-0734ceb83587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_50401dd3-1376-49c8-9ee1-4b8bd9cbdbd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e5baf5fc-ac45-4dc1-9e71-989a5cff9310" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears_50401dd3-1376-49c8-9ee1-4b8bd9cbdbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_e5251cfc-46b5-46d9-a0ec-c15f21f37d9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e5baf5fc-ac45-4dc1-9e71-989a5cff9310" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears_e5251cfc-46b5-46d9-a0ec-c15f21f37d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_e9e52d58-18d8-4383-8ebd-0e68cae4c391" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e5baf5fc-ac45-4dc1-9e71-989a5cff9310" xlink:to="loc_us-gaap_OperatingLeasesFutureMinimumPaymentsDue_e9e52d58-18d8-4383-8ebd-0e68cae4c391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba7b8f4d-f20e-46d5-8b86-223749801ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ae3468cf-c670-4b54-9055-548cbadb063c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ba7b8f4d-f20e-46d5-8b86-223749801ecd" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_ae3468cf-c670-4b54-9055-548cbadb063c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c76abbf-20f3-4299-afce-40f02e3d629f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_741bdd24-88b0-445b-b67d-67a1ed2943e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c76abbf-20f3-4299-afce-40f02e3d629f" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_741bdd24-88b0-445b-b67d-67a1ed2943e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_19e1f6ae-b4a9-4da6-9068-914c674c8617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c76abbf-20f3-4299-afce-40f02e3d629f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_19e1f6ae-b4a9-4da6-9068-914c674c8617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_3ba11ee1-1f84-463d-8f92-159e6f53572e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c76abbf-20f3-4299-afce-40f02e3d629f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock_3ba11ee1-1f84-463d-8f92-159e6f53572e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock_0990d42e-7eba-44c3-b3b3-d19ed02e4ea6" xlink:href="hims-20210331.xsd#hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c76abbf-20f3-4299-afce-40f02e3d629f" xlink:to="loc_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock_0990d42e-7eba-44c3-b3b3-d19ed02e4ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_b9530c28-f1b7-4d6f-9afd-eec76751ea5c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c76abbf-20f3-4299-afce-40f02e3d629f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_b9530c28-f1b7-4d6f-9afd-eec76751ea5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_3e71f4b4-f24d-48f1-bf4f-2c2326debadd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c76abbf-20f3-4299-afce-40f02e3d629f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_3e71f4b4-f24d-48f1-bf4f-2c2326debadd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_8eb6278b-5b33-4476-b8ce-880bcfe3fb57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3c76abbf-20f3-4299-afce-40f02e3d629f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_8eb6278b-5b33-4476-b8ce-880bcfe3fb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_227d2fb1-f330-403e-a420-f5b5df84e28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_227d2fb1-f330-403e-a420-f5b5df84e28a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_902a6427-bfb3-42dd-9138-71ab119137ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:to="loc_us-gaap_PlanNameAxis_902a6427-bfb3-42dd-9138-71ab119137ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7f6a742b-f6e2-4f37-af0d-9ff650e0e412" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_902a6427-bfb3-42dd-9138-71ab119137ca" xlink:to="loc_us-gaap_PlanNameDomain_7f6a742b-f6e2-4f37-af0d-9ff650e0e412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EquityIncentivePlan2020And2017StockPlanMember_d88b9235-d648-445d-bcd7-3f2e3b6f7e1b" xlink:href="hims-20210331.xsd#hims_EquityIncentivePlan2020And2017StockPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7f6a742b-f6e2-4f37-af0d-9ff650e0e412" xlink:to="loc_hims_EquityIncentivePlan2020And2017StockPlanMember_d88b9235-d648-445d-bcd7-3f2e3b6f7e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EquityIncentivePlan2020Member_dcc0412e-9d96-44db-a637-8cc0c0551aff" xlink:href="hims-20210331.xsd#hims_EquityIncentivePlan2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_EquityIncentivePlan2020And2017StockPlanMember_d88b9235-d648-445d-bcd7-3f2e3b6f7e1b" xlink:to="loc_hims_EquityIncentivePlan2020Member_dcc0412e-9d96-44db-a637-8cc0c0551aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockPlan2017Member_5f5ec40d-9f6a-4151-b8f6-0e5086c48ee2" xlink:href="hims-20210331.xsd#hims_StockPlan2017Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_EquityIncentivePlan2020And2017StockPlanMember_d88b9235-d648-445d-bcd7-3f2e3b6f7e1b" xlink:to="loc_hims_StockPlan2017Member_5f5ec40d-9f6a-4151-b8f6-0e5086c48ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_5b54ace5-480d-4a04-8a7d-dc364b4ce833" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:to="loc_srt_RangeAxis_5b54ace5-480d-4a04-8a7d-dc364b4ce833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_de8956dd-8e5a-4e60-8fc9-2f69c2f633aa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_5b54ace5-480d-4a04-8a7d-dc364b4ce833" xlink:to="loc_srt_RangeMember_de8956dd-8e5a-4e60-8fc9-2f69c2f633aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_72517aab-debb-4d50-867a-fcff67688769" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_de8956dd-8e5a-4e60-8fc9-2f69c2f633aa" xlink:to="loc_srt_MinimumMember_72517aab-debb-4d50-867a-fcff67688769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_caab15d8-171d-484c-8276-0f477b3884dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:to="loc_us-gaap_AwardTypeAxis_caab15d8-171d-484c-8276-0f477b3884dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_33f447e2-5dff-403d-bb52-d04e93479603" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_caab15d8-171d-484c-8276-0f477b3884dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_33f447e2-5dff-403d-bb52-d04e93479603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d2f85369-5a3c-4306-8750-5c803f0053a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_33f447e2-5dff-403d-bb52-d04e93479603" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d2f85369-5a3c-4306-8750-5c803f0053a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember_82d30258-14b3-4188-bcea-390b23333a10" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_33f447e2-5dff-403d-bb52-d04e93479603" xlink:to="loc_hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember_82d30258-14b3-4188-bcea-390b23333a10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4f46521f-2749-4eda-bb8c-450ad288f521" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_4d2ec28f-dd3d-4777-aa92-2cbd79eb4470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_4d2ec28f-dd3d-4777-aa92-2cbd79eb4470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_bd8fa874-963c-4740-ab00-5366f93effa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_bd8fa874-963c-4740-ab00-5366f93effa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock_68b007dd-4203-43cf-804c-6e02de21737f" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock_68b007dd-4203-43cf-804c-6e02de21737f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans_7c4d8fc5-2015-468f-bccb-553e53733122" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans_7c4d8fc5-2015-468f-bccb-553e53733122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_64ee041a-a400-4e1e-b0fd-17992daf8f67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_64ee041a-a400-4e1e-b0fd-17992daf8f67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c45ecb7c-34f6-4b59-986c-758cf2817532" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c45ecb7c-34f6-4b59-986c-758cf2817532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent_4ed8c032-1e7b-4f58-ab6c-416402411448" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent_4ed8c032-1e7b-4f58-ab6c-416402411448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7b32fa3d-1f9c-4431-b975-cb139f1306b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0ffd5434-e1b5-482c-bd4e-f76c342c1024" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_7b32fa3d-1f9c-4431-b975-cb139f1306b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationStockOptionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_daf7afe3-e81a-48da-89e9-debf0a4f31d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_daf7afe3-e81a-48da-89e9-debf0a4f31d9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6f3499da-150d-4c99-8118-3f3402158d04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_us-gaap_AwardTypeAxis_6f3499da-150d-4c99-8118-3f3402158d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dbbeb075-7de0-471e-b917-1e6fa59504c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6f3499da-150d-4c99-8118-3f3402158d04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dbbeb075-7de0-471e-b917-1e6fa59504c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2752fbaa-ffac-47e5-a99f-ef48feaecd8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dbbeb075-7de0-471e-b917-1e6fa59504c0" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2752fbaa-ffac-47e5-a99f-ef48feaecd8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_960a7625-e399-4246-bd1c-832d33bc97a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_us-gaap_GranteeStatusAxis_960a7625-e399-4246-bd1c-832d33bc97a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_58207df2-bf3d-4585-a5b4-02d8ec947d2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_960a7625-e399-4246-bd1c-832d33bc97a8" xlink:to="loc_us-gaap_GranteeStatusDomain_58207df2-bf3d-4585-a5b4-02d8ec947d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementNewEmployeeMember_54433875-c6b4-402f-9873-fd38d32f4c66" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementNewEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_58207df2-bf3d-4585-a5b4-02d8ec947d2c" xlink:to="loc_hims_ShareBasedPaymentArrangementNewEmployeeMember_54433875-c6b4-402f-9873-fd38d32f4c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementCurrentEmployeeMember_1cfbee47-42a4-4a59-8279-91f74a34283a" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementCurrentEmployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_58207df2-bf3d-4585-a5b4-02d8ec947d2c" xlink:to="loc_hims_ShareBasedPaymentArrangementCurrentEmployeeMember_1cfbee47-42a4-4a59-8279-91f74a34283a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_8fc6d004-4416-4c03-a218-9837d000ea78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_58207df2-bf3d-4585-a5b4-02d8ec947d2c" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_8fc6d004-4416-4c03-a218-9837d000ea78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_07d6cdda-d4db-404d-ace3-a025260e3551" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_us-gaap_VestingAxis_07d6cdda-d4db-404d-ace3-a025260e3551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_55698005-a187-40d0-893a-83091e15c2cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_07d6cdda-d4db-404d-ace3-a025260e3551" xlink:to="loc_us-gaap_VestingDomain_55698005-a187-40d0-893a-83091e15c2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_55865599-3473-4f84-935d-757f658c534f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_55698005-a187-40d0-893a-83091e15c2cc" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_55865599-3473-4f84-935d-757f658c534f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_facbeecd-f049-4aba-83f2-e26e9a06c5a1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_srt_TitleOfIndividualAxis_facbeecd-f049-4aba-83f2-e26e9a06c5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_195c9a0b-a1d3-4132-9c7c-f3b565351395" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_facbeecd-f049-4aba-83f2-e26e9a06c5a1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_195c9a0b-a1d3-4132-9c7c-f3b565351395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_37008f7f-e57a-426f-a273-5cb499eef997" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_195c9a0b-a1d3-4132-9c7c-f3b565351395" xlink:to="loc_srt_ChiefExecutiveOfficerMember_37008f7f-e57a-426f-a273-5cb499eef997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_0e02645f-5bf9-43f3-a0a9-f30452eba523" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_us-gaap_AwardDateAxis_0e02645f-5bf9-43f3-a0a9-f30452eba523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_e54e9c61-c5f7-4156-a4a4-1ac20a8c873b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_0e02645f-5bf9-43f3-a0a9-f30452eba523" xlink:to="loc_us-gaap_AwardDateDomain_e54e9c61-c5f7-4156-a4a4-1ac20a8c873b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_June172020GrantOneMember_2164c71f-c119-4767-b8d6-840ad0d9ca3a" xlink:href="hims-20210331.xsd#hims_June172020GrantOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_e54e9c61-c5f7-4156-a4a4-1ac20a8c873b" xlink:to="loc_hims_June172020GrantOneMember_2164c71f-c119-4767-b8d6-840ad0d9ca3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_June172020GrantTwoMember_73293dc4-0229-4f27-8432-63134c942586" xlink:href="hims-20210331.xsd#hims_June172020GrantTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_e54e9c61-c5f7-4156-a4a4-1ac20a8c873b" xlink:to="loc_hims_June172020GrantTwoMember_73293dc4-0229-4f27-8432-63134c942586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_006c5a5a-fe9c-47d8-bc38-6e980c805a2e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_69061775-29fe-4285-a7cd-86885075e36f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_69061775-29fe-4285-a7cd-86885075e36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5f4dadef-0b30-444c-8104-fd4baff9aa12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5f4dadef-0b30-444c-8104-fd4baff9aa12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage_5f599400-885d-43fb-b94e-92bfa63675cb" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage_5f599400-885d-43fb-b94e-92bfa63675cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40bf6147-1eba-4610-a23a-c22873bf0cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_40bf6147-1eba-4610-a23a-c22873bf0cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00cfb5df-1d52-4b81-89a0-0bdfd02bde39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_00cfb5df-1d52-4b81-89a0-0bdfd02bde39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a81062ce-609e-4a76-8d59-7efdfe5705d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a81062ce-609e-4a76-8d59-7efdfe5705d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold_fada8f31-928c-4b33-9b70-c0c508696cb6" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold_fada8f31-928c-4b33-9b70-c0c508696cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_329aa67b-3e9b-42d0-a2f7-24765bba660f" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue_329aa67b-3e9b-42d0-a2f7-24765bba660f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e318b225-89ea-426d-aea3-146df3733ac9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e318b225-89ea-426d-aea3-146df3733ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5a005922-ec0e-427f-b8e9-11730ba79a3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5a005922-ec0e-427f-b8e9-11730ba79a3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ee6de546-4de1-4cd6-993d-de68b3097b22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ee6de546-4de1-4cd6-993d-de68b3097b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_66c790ba-d547-4bdd-92e0-504c730642bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_66c790ba-d547-4bdd-92e0-504c730642bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fa43f069-abcd-4e94-8fcb-e61da4484124" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_fa43f069-abcd-4e94-8fcb-e61da4484124" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_65884996-abbd-4ccf-9ed0-ac99afc8d0a1" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_hims_RecapitalizationExchangeRatio_65884996-abbd-4ccf-9ed0-ac99afc8d0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c4c80e4c-36b8-4c19-8623-7c9f277ebbc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c4c80e4c-36b8-4c19-8623-7c9f277ebbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_778cdc6f-282e-4b6a-80c9-60807a673f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_778cdc6f-282e-4b6a-80c9-60807a673f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_17c88d68-fadf-405e-a97f-165315ac2417" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions_17c88d68-fadf-405e-a97f-165315ac2417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares_5d013b9c-98f7-4ca1-8100-ab7bc2ff6373" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ace34f56-2a56-4a32-ada0-4eadfaa630d0" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares_5d013b9c-98f7-4ca1-8100-ab7bc2ff6373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationWeightedAverageFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c383217-2302-459f-9fbc-f041e73b824c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d163a2fd-9147-4b6b-a470-765b5fba41a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6c383217-2302-459f-9fbc-f041e73b824c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d163a2fd-9147-4b6b-a470-765b5fba41a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_45351d26-5977-4539-9d7b-3eee410c08be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d163a2fd-9147-4b6b-a470-765b5fba41a5" xlink:to="loc_us-gaap_AwardTypeAxis_45351d26-5977-4539-9d7b-3eee410c08be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a08e59b-1310-4c68-9d4f-ce474a6e0a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_45351d26-5977-4539-9d7b-3eee410c08be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a08e59b-1310-4c68-9d4f-ce474a6e0a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_e7be099e-8d9d-4df8-9472-33d40e6a7d21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0a08e59b-1310-4c68-9d4f-ce474a6e0a53" xlink:to="loc_us-gaap_EmployeeStockOptionMember_e7be099e-8d9d-4df8-9472-33d40e6a7d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d163a2fd-9147-4b6b-a470-765b5fba41a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_890495ee-2906-41ee-94d0-2249685dfa9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_890495ee-2906-41ee-94d0-2249685dfa9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_e9f77d4a-74df-415a-8453-8ca2454023bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_e9f77d4a-74df-415a-8453-8ca2454023bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6b0abcf4-edc9-47f1-abd0-941dac40b70e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_6b0abcf4-edc9-47f1-abd0-941dac40b70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e8bcf5d1-9d42-4b03-b323-7ebe227b6f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fe81aefb-5a24-4434-a384-227417347117" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_e8bcf5d1-9d42-4b03-b323-7ebe227b6f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationOptionActivityDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4fc727bd-c46b-444f-9d6c-9bdeb6005c97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a3479f25-cda4-4418-bf7a-a12e17767687" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4fc727bd-c46b-444f-9d6c-9bdeb6005c97" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a3479f25-cda4-4418-bf7a-a12e17767687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_51be124e-c6f7-49c2-ab22-fcf52374de18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a3479f25-cda4-4418-bf7a-a12e17767687" xlink:to="loc_us-gaap_GranteeStatusAxis_51be124e-c6f7-49c2-ab22-fcf52374de18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_00801861-b947-4e74-a144-f5b64f1882a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_51be124e-c6f7-49c2-ab22-fcf52374de18" xlink:to="loc_us-gaap_GranteeStatusDomain_00801861-b947-4e74-a144-f5b64f1882a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember_e00cd62a-6d49-42f4-bb0d-0704ba3a5418" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_00801861-b947-4e74-a144-f5b64f1882a3" xlink:to="loc_hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember_e00cd62a-6d49-42f4-bb0d-0704ba3a5418" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_2a11f45b-e9b0-460a-b0c7-ed5e5b1f6b58" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a3479f25-cda4-4418-bf7a-a12e17767687" xlink:to="loc_srt_RestatementAxis_2a11f45b-e9b0-460a-b0c7-ed5e5b1f6b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f421587b-782a-41e4-b296-065f0774ec3a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_2a11f45b-e9b0-460a-b0c7-ed5e5b1f6b58" xlink:to="loc_srt_RestatementDomain_f421587b-782a-41e4-b296-065f0774ec3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_2b61beb6-2bbf-4de3-8b39-42fc3f8b383b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_f421587b-782a-41e4-b296-065f0774ec3a" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_2b61beb6-2bbf-4de3-8b39-42fc3f8b383b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_c22b1c9d-6044-4a73-9320-a004453176f8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_f421587b-782a-41e4-b296-065f0774ec3a" xlink:to="loc_srt_RestatementAdjustmentMember_c22b1c9d-6044-4a73-9320-a004453176f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a3479f25-cda4-4418-bf7a-a12e17767687" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bbbf8fa1-8ec1-47c8-9219-65455670e254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bbbf8fa1-8ec1-47c8-9219-65455670e254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9be0203f-68ab-47b7-b2bc-8180e43bcb62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9be0203f-68ab-47b7-b2bc-8180e43bcb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5c88a11c-0de0-4130-a8c5-2bbdebfecfdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5c88a11c-0de0-4130-a8c5-2bbdebfecfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_fe5af64f-2158-4dfc-88fe-6da8a0c9009f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_fe5af64f-2158-4dfc-88fe-6da8a0c9009f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8682c12c-7b01-4500-b63f-199469af0d74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d18ec4fa-0730-4257-8f0b-016823f48ba6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8682c12c-7b01-4500-b63f-199469af0d74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9318eb0b-d10d-4c45-a8ad-9295d1b053cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_9318eb0b-d10d-4c45-a8ad-9295d1b053cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b674879e-db05-434c-8238-88aff72fb8f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_b674879e-db05-434c-8238-88aff72fb8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c86e8d78-b99f-4df5-b795-96c2dff0e249" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_c86e8d78-b99f-4df5-b795-96c2dff0e249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ea99ca5f-67c3-4f6f-998b-e8270147f3c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_ea99ca5f-67c3-4f6f-998b-e8270147f3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0f7935d0-e67e-4c17-81f2-29f1a04ff267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0f7935d0-e67e-4c17-81f2-29f1a04ff267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_af6c63b0-a946-44d1-ae64-5a9970874625" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_af6c63b0-a946-44d1-ae64-5a9970874625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a6abdbad-7995-4d4d-bcbf-8a2d185b9236" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_df85958d-38eb-4801-afad-d485aba0b688" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a6abdbad-7995-4d4d-bcbf-8a2d185b9236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_959f27c5-1bd0-490d-90b9-05c8deb07806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_959f27c5-1bd0-490d-90b9-05c8deb07806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8813a2be-da95-452b-972a-aa6d1e80290e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_8813a2be-da95-452b-972a-aa6d1e80290e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f8172c7-9192-415d-b6f8-e59da294e555" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f8172c7-9192-415d-b6f8-e59da294e555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51e5fb91-a42a-4ebd-b6a1-f5bce5e88a68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f8172c7-9192-415d-b6f8-e59da294e555" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_51e5fb91-a42a-4ebd-b6a1-f5bce5e88a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ee945898-ad50-4d1f-84d8-09ad2f80d67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f8172c7-9192-415d-b6f8-e59da294e555" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_ee945898-ad50-4d1f-84d8-09ad2f80d67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c7a82a35-8830-4a80-aa5d-b5da799e808f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_3f8172c7-9192-415d-b6f8-e59da294e555" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_c7a82a35-8830-4a80-aa5d-b5da799e808f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_ef03e314-f17b-4108-9632-6a06af63788f" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51882014-4d34-4c45-844a-23c7e1534bd1" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_ef03e314-f17b-4108-9632-6a06af63788f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4fce3473-afcd-4efa-970c-a57736d45e65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_ef03e314-f17b-4108-9632-6a06af63788f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4fce3473-afcd-4efa-970c-a57736d45e65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_51081dbd-77f9-4349-8361-500dd0b5b6e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_ef03e314-f17b-4108-9632-6a06af63788f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_51081dbd-77f9-4349-8361-500dd0b5b6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6632d6e9-c663-42b6-b002-89d027bfc601" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract_ef03e314-f17b-4108-9632-6a06af63788f" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_6632d6e9-c663-42b6-b002-89d027bfc601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_172215b1-5d35-426a-87c1-cacf2cafb34e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_57758bfe-1b51-4a17-9ce3-05e684be75ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_172215b1-5d35-426a-87c1-cacf2cafb34e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_57758bfe-1b51-4a17-9ce3-05e684be75ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_038042d8-1a3e-4adf-a629-fa55a4f390d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_57758bfe-1b51-4a17-9ce3-05e684be75ac" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_038042d8-1a3e-4adf-a629-fa55a4f390d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_038042d8-1a3e-4adf-a629-fa55a4f390d9" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange006To040Member_db2f590e-3d18-453f-8589-3daf3b576540" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange006To040Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:to="loc_hims_ExercisePriceRange006To040Member_db2f590e-3d18-453f-8589-3daf3b576540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange155To233Member_f7bf6c1a-2216-4b25-8f6d-8a13ab01f8c4" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange155To233Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:to="loc_hims_ExercisePriceRange155To233Member_f7bf6c1a-2216-4b25-8f6d-8a13ab01f8c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange243To365Member_a4b39951-29e3-467e-b2fe-0c93489ddb5c" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange243To365Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:to="loc_hims_ExercisePriceRange243To365Member_a4b39951-29e3-467e-b2fe-0c93489ddb5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange890To1335Member_cfa3d85b-fe14-40ef-a063-d1c05eeb87e0" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange890To1335Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:to="loc_hims_ExercisePriceRange890To1335Member_cfa3d85b-fe14-40ef-a063-d1c05eeb87e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ExercisePriceRange1517To2276Member_f5cfbd38-9353-45e6-87ee-558abd01f407" xlink:href="hims-20210331.xsd#hims_ExercisePriceRange1517To2276Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain_cd975361-46ca-4399-be64-be3e23c1a69b" xlink:to="loc_hims_ExercisePriceRange1517To2276Member_f5cfbd38-9353-45e6-87ee-558abd01f407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable_57758bfe-1b51-4a17-9ce3-05e684be75ac" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_4d218fc2-2b5f-415d-956b-8d153128b065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit_4d218fc2-2b5f-415d-956b-8d153128b065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_52e2b6a1-28aa-4768-9e20-6f0072e49347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit_52e2b6a1-28aa-4768-9e20-6f0072e49347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_6d48b607-bd7f-4200-991d-fd17b756d439" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:to="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_6d48b607-bd7f-4200-991d-fd17b756d439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_69a7738f-d908-4f9c-bfe4-af9d362e2d48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_6d48b607-bd7f-4200-991d-fd17b756d439" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions_69a7738f-d908-4f9c-bfe4-af9d362e2d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_0b9c2e86-c854-4be6-adea-c18250824536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract_6d48b607-bd7f-4200-991d-fd17b756d439" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2_0b9c2e86-c854-4be6-adea-c18250824536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_30a081ea-139d-451a-aa92-330cb3532379" xlink:href="hims-20210331.xsd#hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems_157c1469-f24f-43ef-b0f7-4edf2dfc94ae" xlink:to="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_30a081ea-139d-451a-aa92-330cb3532379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_294c6c83-9932-4595-9397-47dc1c2de45a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_30a081ea-139d-451a-aa92-330cb3532379" xlink:to="loc_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions_294c6c83-9932-4595-9397-47dc1c2de45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_581bdc90-c3dd-4884-b3da-bccdf184260d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract_30a081ea-139d-451a-aa92-330cb3532379" xlink:to="loc_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_581bdc90-c3dd-4884-b3da-bccdf184260d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationRSUsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3795592d-ec06-476f-a104-74f6ba91462f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3795592d-ec06-476f-a104-74f6ba91462f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5705e066-32c9-4972-96aa-a4b497b8d80b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:to="loc_us-gaap_AwardTypeAxis_5705e066-32c9-4972-96aa-a4b497b8d80b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd85f254-072b-4b1c-9c3b-3b532004c951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5705e066-32c9-4972-96aa-a4b497b8d80b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd85f254-072b-4b1c-9c3b-3b532004c951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_625ae9ee-34a5-482d-ae3e-8250ab1ee66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd85f254-072b-4b1c-9c3b-3b532004c951" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_625ae9ee-34a5-482d-ae3e-8250ab1ee66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EarnOutRestrictedStockUnitsMember_c67389b2-fba3-4b70-a7c6-7d525b52747f" xlink:href="hims-20210331.xsd#hims_EarnOutRestrictedStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd85f254-072b-4b1c-9c3b-3b532004c951" xlink:to="loc_hims_EarnOutRestrictedStockUnitsMember_c67389b2-fba3-4b70-a7c6-7d525b52747f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantRestrictedStockUnitsMember_35c1c2d6-e03a-410e-9f41-5dcb578ee767" xlink:href="hims-20210331.xsd#hims_ParentWarrantRestrictedStockUnitsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_dd85f254-072b-4b1c-9c3b-3b532004c951" xlink:to="loc_hims_ParentWarrantRestrictedStockUnitsMember_35c1c2d6-e03a-410e-9f41-5dcb578ee767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_ec8daf28-ad0a-4da1-94a5-78740851e5a2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:to="loc_srt_TitleOfIndividualAxis_ec8daf28-ad0a-4da1-94a5-78740851e5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_63e5860a-9fab-4dd7-b1be-926e67b3423f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_ec8daf28-ad0a-4da1-94a5-78740851e5a2" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_63e5860a-9fab-4dd7-b1be-926e67b3423f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_7924bdf5-c6e1-4161-a1b9-460113b566ad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_63e5860a-9fab-4dd7-b1be-926e67b3423f" xlink:to="loc_srt_ChiefExecutiveOfficerMember_7924bdf5-c6e1-4161-a1b9-460113b566ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember_3ddc5e41-dd4d-4e69-989a-0d8baaf7010e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_63e5860a-9fab-4dd7-b1be-926e67b3423f" xlink:to="loc_srt_OfficerMember_3ddc5e41-dd4d-4e69-989a-0d8baaf7010e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_52fea6a8-44e5-47b2-823f-2402878ad020" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:to="loc_us-gaap_VestingAxis_52fea6a8-44e5-47b2-823f-2402878ad020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_07cbf01a-841d-4e42-9167-7b3a14c70201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_52fea6a8-44e5-47b2-823f-2402878ad020" xlink:to="loc_us-gaap_VestingDomain_07cbf01a-841d-4e42-9167-7b3a14c70201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_11f39630-f3e8-4434-90b5-bb27bb08b57d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_07cbf01a-841d-4e42-9167-7b3a14c70201" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_11f39630-f3e8-4434-90b5-bb27bb08b57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5435fd47-d64f-45d7-ba84-350c3488380d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_795bf96d-8100-424d-94ff-2d59c88128f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_795bf96d-8100-424d-94ff-2d59c88128f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_fa183af3-97be-4457-a534-db18bff84ba3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_fa183af3-97be-4457-a534-db18bff84ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_61e40c9e-8af7-4e5d-a159-728ef704e263" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_RecapitalizationExchangeRatio_61e40c9e-8af7-4e5d-a159-728ef704e263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_9d55b25e-0c3c-4406-9d52-d018df3bd6c8" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_9d55b25e-0c3c-4406-9d52-d018df3bd6c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_78a1f16a-9dc4-4294-963b-52a55c880903" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_78a1f16a-9dc4-4294-963b-52a55c880903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_4a542a79-c103-4442-91dd-0a69c0bbf9db" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_4a542a79-c103-4442-91dd-0a69c0bbf9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_98adebf3-135b-4296-bd49-b44e703299f6" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_98adebf3-135b-4296-bd49-b44e703299f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_6223cf20-bc5b-4f8c-8dcd-060d1f5a2d59" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_6223cf20-bc5b-4f8c-8dcd-060d1f5a2d59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_38c4d162-b489-4463-9026-4b42f0d8dd14" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_38c4d162-b489-4463-9026-4b42f0d8dd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_02eee665-b629-429c-a209-10c4d4f7dcfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_SharePrice_02eee665-b629-429c-a209-10c4d4f7dcfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ae9f609-7312-4c3e-8de0-b22b8c1c2384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0ae9f609-7312-4c3e-8de0-b22b8c1c2384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77fd5201-cead-48a7-b2aa-78d1518d9283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_77fd5201-cead-48a7-b2aa-78d1518d9283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_7285f314-1ecb-4bf7-878e-c214d5859aa4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_7285f314-1ecb-4bf7-878e-c214d5859aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5d1afe49-a5dc-451a-97d3-b69154fe60a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f0ea8616-3bf7-458c-a4f0-c049fb25fd76" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5d1afe49-a5dc-451a-97d3-b69154fe60a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31a10941-2b90-44c7-b99c-b22910b1d250" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1589f7c9-2960-436c-b4b5-8818d70f4889" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31a10941-2b90-44c7-b99c-b22910b1d250" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1589f7c9-2960-436c-b4b5-8818d70f4889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_14ade6a4-728d-48d4-b194-b98a48b0efca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1589f7c9-2960-436c-b4b5-8818d70f4889" xlink:to="loc_us-gaap_AwardTypeAxis_14ade6a4-728d-48d4-b194-b98a48b0efca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75b29970-d1b5-4095-b52d-d16fe33c451b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_14ade6a4-728d-48d4-b194-b98a48b0efca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75b29970-d1b5-4095-b52d-d16fe33c451b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_84e604ef-ec22-4054-843f-eba4a637e57c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_75b29970-d1b5-4095-b52d-d16fe33c451b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_84e604ef-ec22-4054-843f-eba4a637e57c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1589f7c9-2960-436c-b4b5-8818d70f4889" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5299888f-7ea4-4a83-9b8e-0f698d58b962" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5299888f-7ea4-4a83-9b8e-0f698d58b962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54dfa372-fd99-48ec-808c-589597b6cb22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_54dfa372-fd99-48ec-808c-589597b6cb22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0af5f7c3-0206-4683-9e04-71577ba41aa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_0af5f7c3-0206-4683-9e04-71577ba41aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_08d55d19-a624-4eb4-b72f-2ce79585a2b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58679f83-2dc3-4b54-813e-4531f91d53e6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_08d55d19-a624-4eb4-b72f-2ce79585a2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationRSUsActivityDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationRSUsActivityDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationRSUsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b383c07-f4ca-458f-9b7e-1c725bfe13b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_764b3f91-a989-402a-98c0-c088d8d79022" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6b383c07-f4ca-458f-9b7e-1c725bfe13b5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_764b3f91-a989-402a-98c0-c088d8d79022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_6bc6a5a3-8acd-4513-87be-ab6271d0d6d4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_764b3f91-a989-402a-98c0-c088d8d79022" xlink:to="loc_srt_RestatementAxis_6bc6a5a3-8acd-4513-87be-ab6271d0d6d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_eae91b25-f6ec-44e2-b0f6-bb88653519ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_6bc6a5a3-8acd-4513-87be-ab6271d0d6d4" xlink:to="loc_srt_RestatementDomain_eae91b25-f6ec-44e2-b0f6-bb88653519ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_ab0273c3-af4b-4346-afcd-8911fa743b93" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_eae91b25-f6ec-44e2-b0f6-bb88653519ff" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_ab0273c3-af4b-4346-afcd-8911fa743b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_58a09648-b5f9-4c2a-bedf-993e25399645" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_eae91b25-f6ec-44e2-b0f6-bb88653519ff" xlink:to="loc_srt_RestatementAdjustmentMember_58a09648-b5f9-4c2a-bedf-993e25399645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_776984ce-c4ae-4979-bc59-0de429de8d8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_764b3f91-a989-402a-98c0-c088d8d79022" xlink:to="loc_us-gaap_AwardTypeAxis_776984ce-c4ae-4979-bc59-0de429de8d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f835af2-31c7-4e01-97bd-acc93c8c4255" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_776984ce-c4ae-4979-bc59-0de429de8d8e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f835af2-31c7-4e01-97bd-acc93c8c4255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_827911e0-c40f-45a2-87ad-1c98b1ff61a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2f835af2-31c7-4e01-97bd-acc93c8c4255" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_827911e0-c40f-45a2-87ad-1c98b1ff61a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6d43366-b9f1-4129-8f9f-7a13bf07448f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_764b3f91-a989-402a-98c0-c088d8d79022" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6d43366-b9f1-4129-8f9f-7a13bf07448f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6d43366-b9f1-4129-8f9f-7a13bf07448f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ab204419-007a-4833-9701-31191131093d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ab204419-007a-4833-9701-31191131093d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a17a9d08-d534-4be7-9ffd-6e125e84c1b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a17a9d08-d534-4be7-9ffd-6e125e84c1b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3c2bd097-be42-497c-9b73-dd7d4e59281a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3c2bd097-be42-497c-9b73-dd7d4e59281a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_03b4de0c-4e27-4b34-a019-e56afd3ad8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_da618af8-11a1-4b56-a496-3ace6ffee5db" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_03b4de0c-4e27-4b34-a019-e56afd3ad8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_c6d43366-b9f1-4129-8f9f-7a13bf07448f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f93ba00e-d768-4200-927e-b911aa3a4cdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_f93ba00e-d768-4200-927e-b911aa3a4cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_62bdf2a1-b411-4a9b-a2c3-d9274cbd363b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_62bdf2a1-b411-4a9b-a2c3-d9274cbd363b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2b5068f1-911f-44c3-966b-f1fd177144fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2b5068f1-911f-44c3-966b-f1fd177144fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e2fc4fee-0b19-4fda-93ed-35df1c9f8e43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_069bcaff-c3cd-4358-967e-4dfdb2561f83" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e2fc4fee-0b19-4fda-93ed-35df1c9f8e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationVendorWarrantsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_56c9b4f3-25ec-495e-9c9b-14cfa0116413" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6a3737f-8596-4aaf-8f7b-109b9eb3fe48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_56c9b4f3-25ec-495e-9c9b-14cfa0116413" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6a3737f-8596-4aaf-8f7b-109b9eb3fe48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a5d43e97-0b90-403d-8a65-43db95bdb80e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6a3737f-8596-4aaf-8f7b-109b9eb3fe48" xlink:to="loc_us-gaap_AwardTypeAxis_a5d43e97-0b90-403d-8a65-43db95bdb80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42207a00-bf8a-4bde-a35e-4e124e5bcc41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a5d43e97-0b90-403d-8a65-43db95bdb80e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42207a00-bf8a-4bde-a35e-4e124e5bcc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorWarrantsMember_1095b1f7-4ae6-46d2-9796-90bebee1adf0" xlink:href="hims-20210331.xsd#hims_VendorWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42207a00-bf8a-4bde-a35e-4e124e5bcc41" xlink:to="loc_hims_VendorWarrantsMember_1095b1f7-4ae6-46d2-9796-90bebee1adf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_eae8823e-d627-4ac3-8d48-d9f9de1c0973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6a3737f-8596-4aaf-8f7b-109b9eb3fe48" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_eae8823e-d627-4ac3-8d48-d9f9de1c0973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1c768efb-1cd7-4c60-a09b-c97c9a67854c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_eae8823e-d627-4ac3-8d48-d9f9de1c0973" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1c768efb-1cd7-4c60-a09b-c97c9a67854c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EarnOutAndParentWarrantsMember_697133d0-df28-4809-af9d-fbb7dacf305d" xlink:href="hims-20210331.xsd#hims_EarnOutAndParentWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_1c768efb-1cd7-4c60-a09b-c97c9a67854c" xlink:to="loc_hims_EarnOutAndParentWarrantsMember_697133d0-df28-4809-af9d-fbb7dacf305d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b6a3737f-8596-4aaf-8f7b-109b9eb3fe48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_1ba73c3f-f58a-4925-8cb9-62ae8ae5bac5" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_RecapitalizationExchangeRatio_1ba73c3f-f58a-4925-8cb9-62ae8ae5bac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_04c41091-5167-4cc4-be69-35eabde2aad8" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_04c41091-5167-4cc4-be69-35eabde2aad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_fb2b983a-5727-4703-b19b-802b422f219c" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_fb2b983a-5727-4703-b19b-802b422f219c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_75aaf1da-6b2c-4fab-afd1-2bc8254c80fb" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_75aaf1da-6b2c-4fab-afd1-2bc8254c80fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_43d28b18-bd54-4601-b0a0-aa986df8e8df" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_43d28b18-bd54-4601-b0a0-aa986df8e8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_0a259d54-7b66-4468-b74e-9f60fdb3826d" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_0a259d54-7b66-4468-b74e-9f60fdb3826d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_35639c21-1391-4740-aa77-c731bac61b3b" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_35639c21-1391-4740-aa77-c731bac61b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8903b753-6af3-483c-aeb6-52e5d906d15d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_8903b753-6af3-483c-aeb6-52e5d906d15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a721b744-0d52-452c-acec-338ba037b58e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_a721b744-0d52-452c-acec-338ba037b58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9d90ec0c-69a5-4948-bc75-c81e21511746" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_66ae61d9-5aef-40b0-9bda-ef716bba4074" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_9d90ec0c-69a5-4948-bc75-c81e21511746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationVendorWarrantActivityDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_65da6b4a-d465-40ab-964f-a43f4da26233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7cf59c0e-e54b-4794-b6a6-54927bdf0399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_65da6b4a-d465-40ab-964f-a43f4da26233" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7cf59c0e-e54b-4794-b6a6-54927bdf0399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c6619368-3a53-427f-8518-8213c16ed67d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7cf59c0e-e54b-4794-b6a6-54927bdf0399" xlink:to="loc_us-gaap_AwardTypeAxis_c6619368-3a53-427f-8518-8213c16ed67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_773394f0-4949-4315-ac8d-91e4ebcbbe68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c6619368-3a53-427f-8518-8213c16ed67d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_773394f0-4949-4315-ac8d-91e4ebcbbe68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorWarrantsMember_e099e691-ac56-4d20-804c-19524f8a426a" xlink:href="hims-20210331.xsd#hims_VendorWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_773394f0-4949-4315-ac8d-91e4ebcbbe68" xlink:to="loc_hims_VendorWarrantsMember_e099e691-ac56-4d20-804c-19524f8a426a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_7cd84c83-84d1-49b0-a265-7d865644a6a6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7cf59c0e-e54b-4794-b6a6-54927bdf0399" xlink:to="loc_srt_RestatementAxis_7cd84c83-84d1-49b0-a265-7d865644a6a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_9458d6b6-7a56-442a-999c-919549867617" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_7cd84c83-84d1-49b0-a265-7d865644a6a6" xlink:to="loc_srt_RestatementDomain_9458d6b6-7a56-442a-999c-919549867617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_c903f2d8-2c75-479f-8aee-fbb9c5456ada" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_9458d6b6-7a56-442a-999c-919549867617" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_c903f2d8-2c75-479f-8aee-fbb9c5456ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_01cfc62f-9120-4e59-b82a-f99cd37897cd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_9458d6b6-7a56-442a-999c-919549867617" xlink:to="loc_srt_RestatementAdjustmentMember_01cfc62f-9120-4e59-b82a-f99cd37897cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7cf59c0e-e54b-4794-b6a6-54927bdf0399" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_7b1a7337-55c2-4f7e-a55c-893f43b36d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_7b1a7337-55c2-4f7e-a55c-893f43b36d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c9a30ca6-82d4-4482-a787-cd09e315114d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c9a30ca6-82d4-4482-a787-cd09e315114d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_edea1fe5-6e87-4928-89cc-32812c44c8be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_edea1fe5-6e87-4928-89cc-32812c44c8be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_0b5652d0-2449-4967-bcd6-05313d82e9d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations_0b5652d0-2449-4967-bcd6-05313d82e9d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_21997c1b-c477-4fcf-a636-7fe1347c21c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_5036c4a4-7a9b-492a-bee9-6eb8918da527" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_21997c1b-c477-4fcf-a636-7fe1347c21c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_38c329ef-1fc4-431f-9026-b9758c3fbac1" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber_38c329ef-1fc4-431f-9026-b9758c3fbac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_f9f0cff8-d432-4a1c-91e6-6005194bf9a2" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_f9f0cff8-d432-4a1c-91e6-6005194bf9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6438abf2-4440-41d4-a5e9-68a8094af421" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_6438abf2-4440-41d4-a5e9-68a8094af421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_602d389a-b275-4414-94fc-064940893c88" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice_602d389a-b275-4414-94fc-064940893c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_2802da92-e4f0-4612-bcff-0ccb066ea0d0" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice_2802da92-e4f0-4612-bcff-0ccb066ea0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3b48d500-fdf7-4f6d-b529-21220f5f580c" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3b48d500-fdf7-4f6d-b529-21220f5f580c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_e141c69f-fc0d-4760-bc22-3c603a2bceb8" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract_e15c3bb8-2600-4cbf-8340-2c6f10c2b1b8" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice_e141c69f-fc0d-4760-bc22-3c603a2bceb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_3581bd80-bfe2-428e-9ad5-a45a6b255b83" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_3581bd80-bfe2-428e-9ad5-a45a6b255b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_c3c193b0-d384-4912-b603-aff98906ff3d" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_c3c193b0-d384-4912-b603-aff98906ff3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract_67ff7a1d-4199-4046-bbbe-04048650f28a" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract_67ff7a1d-4199-4046-bbbe-04048650f28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_d4907857-114c-4991-a1b0-605b77086cbb" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract_67ff7a1d-4199-4046-bbbe-04048650f28a" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms_d4907857-114c-4991-a1b0-605b77086cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms_c2198b8e-c0cc-4a9d-90bb-1ccc79c6c06c" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms_c2198b8e-c0cc-4a9d-90bb-1ccc79c6c06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms_6e69f365-4726-4dc7-9f81-43d7b706dea8" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms_6e69f365-4726-4dc7-9f81-43d7b706dea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract_c3457ab3-35c7-4d54-832b-11cd1d1f824b" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract_c3457ab3-35c7-4d54-832b-11cd1d1f824b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_b03aee7b-d48a-4baf-9a22-a58d1b36a4a4" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract_c3457ab3-35c7-4d54-832b-11cd1d1f824b" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue_b03aee7b-d48a-4baf-9a22-a58d1b36a4a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_be8f95b1-7be7-4db5-a812-dd7e0a78e08c" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_be8f95b1-7be7-4db5-a812-dd7e0a78e08c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_2a3fa71f-3e01-4803-8b70-32b4a2efc797" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dcde6f7-b98d-418c-b950-1a22dfb7258e" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue_2a3fa71f-3e01-4803-8b70-32b4a2efc797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_017050c6-576c-4979-b025-7026126cbfb0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e02dc7d1-5c7c-45b8-a986-25b5ca9d3e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_017050c6-576c-4979-b025-7026126cbfb0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e02dc7d1-5c7c-45b8-a986-25b5ca9d3e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_cfd79168-7bbb-4cd7-bcd2-adf4538e2934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e02dc7d1-5c7c-45b8-a986-25b5ca9d3e1c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_cfd79168-7bbb-4cd7-bcd2-adf4538e2934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0d46020a-59b8-4c42-b388-fa538ad91ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_cfd79168-7bbb-4cd7-bcd2-adf4538e2934" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0d46020a-59b8-4c42-b388-fa538ad91ba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_MarketingExpenseMember_da4db995-a2db-4fc3-ba07-744f7861e786" xlink:href="hims-20210331.xsd#hims_MarketingExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0d46020a-59b8-4c42-b388-fa538ad91ba4" xlink:to="loc_hims_MarketingExpenseMember_da4db995-a2db-4fc3-ba07-744f7861e786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2bddef8e-47b8-43c7-a549-74a30fdb5677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0d46020a-59b8-4c42-b388-fa538ad91ba4" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2bddef8e-47b8-43c7-a549-74a30fdb5677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f3b45237-07f2-4b60-a0b2-392a9b249d60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_e02dc7d1-5c7c-45b8-a986-25b5ca9d3e1c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f3b45237-07f2-4b60-a0b2-392a9b249d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_dbdf08b1-9be0-4ad6-bf35-a7ff7d2e99e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_f3b45237-07f2-4b60-a0b2-392a9b249d60" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_dbdf08b1-9be0-4ad6-bf35-a7ff7d2e99e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/RedeemableConvertiblePreferredStock" xlink:type="simple" xlink:href="hims-20210331.xsd#RedeemableConvertiblePreferredStock"/>
  <link:presentationLink xlink:role="http://forhims.com/role/RedeemableConvertiblePreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_62a9506e-a893-4644-a05c-039998b7fcab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityTextBlock_0995d602-5ad4-4c9c-9e6d-ef696e9d0bc6" xlink:href="hims-20210331.xsd#hims_TemporaryEquityTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_62a9506e-a893-4644-a05c-039998b7fcab" xlink:to="loc_hims_TemporaryEquityTextBlock_0995d602-5ad4-4c9c-9e6d-ef696e9d0bc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="simple" xlink:href="hims-20210331.xsd#RedeemableConvertiblePreferredStockTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_265dedd8-3427-4d08-a2b0-c784f1dc3f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_4c4da97e-3490-4040-89fd-42c544682d87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_265dedd8-3427-4d08-a2b0-c784f1dc3f3e" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_4c4da97e-3490-4040-89fd-42c544682d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#RedeemableConvertiblePreferredStockAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_89c4f88d-1e36-4557-9859-3d018039ed5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_4baec37b-09d9-4e16-be1a-a5da77248103" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_89c4f88d-1e36-4557-9859-3d018039ed5b" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_4baec37b-09d9-4e16-be1a-a5da77248103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8d94372c-ce2d-48b1-9071-3b92fba54988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4baec37b-09d9-4e16-be1a-a5da77248103" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8d94372c-ce2d-48b1-9071-3b92fba54988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d837157d-becc-43a2-afc4-f08a233ad83f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8d94372c-ce2d-48b1-9071-3b92fba54988" xlink:to="loc_us-gaap_ClassOfStockDomain_d837157d-becc-43a2-afc4-f08a233ad83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_535740aa-ac0c-4f06-96ad-a4aa443141d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d837157d-becc-43a2-afc4-f08a233ad83f" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_535740aa-ac0c-4f06-96ad-a4aa443141d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_bdac9a81-b724-480f-9834-08dc921d2f91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d837157d-becc-43a2-afc4-f08a233ad83f" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_bdac9a81-b724-480f-9834-08dc921d2f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1943f61a-bdf2-4501-8cba-f67e60ef0b70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4baec37b-09d9-4e16-be1a-a5da77248103" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1943f61a-bdf2-4501-8cba-f67e60ef0b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_945fa7a9-b412-4fd8-8ef0-90575ad35862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1943f61a-bdf2-4501-8cba-f67e60ef0b70" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_945fa7a9-b412-4fd8-8ef0-90575ad35862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesCPreferredStockWarrantsMember_87011ac5-c064-4c59-bb95-8631fd0f0efb" xlink:href="hims-20210331.xsd#hims_SeriesCPreferredStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_945fa7a9-b412-4fd8-8ef0-90575ad35862" xlink:to="loc_hims_SeriesCPreferredStockWarrantsMember_87011ac5-c064-4c59-bb95-8631fd0f0efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesDPreferredStockWarrantsMember_7bc2c37b-e402-4904-a6ce-acfc7b63d627" xlink:href="hims-20210331.xsd#hims_SeriesDPreferredStockWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_945fa7a9-b412-4fd8-8ef0-90575ad35862" xlink:to="loc_hims_SeriesDPreferredStockWarrantsMember_7bc2c37b-e402-4904-a6ce-acfc7b63d627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_4baec37b-09d9-4e16-be1a-a5da77248103" xlink:to="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_fac04435-a664-44ae-9965-1782f3f70681" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_fac04435-a664-44ae-9965-1782f3f70681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_8e6f0300-3969-44f9-a106-47f9438c0c04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_8e6f0300-3969-44f9-a106-47f9438c0c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromIssuanceOfTemporaryEquity_baee93ea-90a6-4bd1-9b6a-f1cb99b1e1b9" xlink:href="hims-20210331.xsd#hims_ProceedsFromIssuanceOfTemporaryEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_hims_ProceedsFromIssuanceOfTemporaryEquity_baee93ea-90a6-4bd1-9b6a-f1cb99b1e1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeConversionBasis_1b0a733e-a51a-443f-a5bc-d871c32068c8" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeConversionBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_hims_RecapitalizationExchangeConversionBasis_1b0a733e-a51a-443f-a5bc-d871c32068c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_6572a15d-470f-41d4-8b92-f1fe2f671fc1" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_hims_RecapitalizationExchangeRatio_6572a15d-470f-41d4-8b92-f1fe2f671fc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_25c579cf-8e77-4100-95d3-5a33dde7edd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_25c579cf-8e77-4100-95d3-5a33dde7edd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_1b537a29-3922-4960-9087-38c0e4075b24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_1b537a29-3922-4960-9087-38c0e4075b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70161df6-66f4-4fbd-8a20-345058114619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_70161df6-66f4-4fbd-8a20-345058114619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromConversionOfConvertibleSecurities_eb31b34a-7666-4b8c-9f77-b932fd6c5ec7" xlink:href="hims-20210331.xsd#hims_ProceedsFromConversionOfConvertibleSecurities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_hims_ProceedsFromConversionOfConvertibleSecurities_eb31b34a-7666-4b8c-9f77-b932fd6c5ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_93d49ccc-46d5-4ebb-bc9b-d04c91db2303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_6b109b0f-e2cf-4de1-a53f-0973f41492a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_93d49ccc-46d5-4ebb-bc9b-d04c91db2303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_8342f680-ed69-4f3b-9c42-f9cdcb04d0e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_8a13d8a8-f900-4f00-bc3d-b424d80fb60c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_8342f680-ed69-4f3b-9c42-f9cdcb04d0e9" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_8a13d8a8-f900-4f00-bc3d-b424d80fb60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cae41ade-7caa-4881-b9b4-417951a1e9d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_8a13d8a8-f900-4f00-bc3d-b424d80fb60c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cae41ade-7caa-4881-b9b4-417951a1e9d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cae41ade-7caa-4881-b9b4-417951a1e9d5" xlink:to="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesSeedPreferredStockMember_c20ea6ca-337c-4aab-8586-660d3a37ee9b" xlink:href="hims-20210331.xsd#hims_SeriesSeedPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_hims_SeriesSeedPreferredStockMember_c20ea6ca-337c-4aab-8586-660d3a37ee9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_9a82bb54-e157-475d-9318-4c1ad881a462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_9a82bb54-e157-475d-9318-4c1ad881a462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesA1PreferredStockMember_afe2c6d0-0863-47d8-a481-7dd7a8cd7e0f" xlink:href="hims-20210331.xsd#hims_SeriesA1PreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_hims_SeriesA1PreferredStockMember_afe2c6d0-0863-47d8-a481-7dd7a8cd7e0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_e1987dba-1dac-4895-a894-8cd27ee7f0e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_e1987dba-1dac-4895-a894-8cd27ee7f0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesB1PreferredStockMember_c6d29b42-6e35-4181-ac08-41f1452994c5" xlink:href="hims-20210331.xsd#hims_SeriesB1PreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_hims_SeriesB1PreferredStockMember_c6d29b42-6e35-4181-ac08-41f1452994c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SeriesB2PreferredStockMember_77a5b704-6bdf-441b-8cb7-01344510d960" xlink:href="hims-20210331.xsd#hims_SeriesB2PreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_hims_SeriesB2PreferredStockMember_77a5b704-6bdf-441b-8cb7-01344510d960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_7acac814-b86b-4b55-b483-bdb51345c6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_7acac814-b86b-4b55-b483-bdb51345c6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesDPreferredStockMember_979b8f28-bc67-4f0e-89c9-e7c54110d752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeriesDPreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3bd33944-70d0-4ee1-8cb6-121c2f3d8696" xlink:to="loc_us-gaap_SeriesDPreferredStockMember_979b8f28-bc67-4f0e-89c9-e7c54110d752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_8a13d8a8-f900-4f00-bc3d-b424d80fb60c" xlink:to="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_a736e999-6603-4e51-aa76-087109b9a06a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_a736e999-6603-4e51-aa76-087109b9a06a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_8d6420da-1761-4d28-b029-975c444d67fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_8d6420da-1761-4d28-b029-975c444d67fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_2ecd5bf5-cfb1-4e13-a2e7-0544c682e289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_2ecd5bf5-cfb1-4e13-a2e7-0544c682e289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_04e38c7e-11d1-4d07-98cb-1aaaebb18682" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_04e38c7e-11d1-4d07-98cb-1aaaebb18682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ProceedsFromIssuanceOfTemporaryEquity_813e0609-581e-4113-b0d5-347d5b415ca7" xlink:href="hims-20210331.xsd#hims_ProceedsFromIssuanceOfTemporaryEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_hims_ProceedsFromIssuanceOfTemporaryEquity_813e0609-581e-4113-b0d5-347d5b415ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityIssuedPricePerShare_697125b3-0d5f-4485-bb9e-8d98b220f688" xlink:href="hims-20210331.xsd#hims_TemporaryEquityIssuedPricePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_c74feab3-07cf-442e-9656-f34105f66e10" xlink:to="loc_hims_TemporaryEquityIssuedPricePerShare_697125b3-0d5f-4485-bb9e-8d98b220f688" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStock" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStock"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_411ed3dd-2cb8-4aa9-9da9-3b7216afa35f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_52866623-c9e0-4f87-b90b-b11d45a2c670" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_411ed3dd-2cb8-4aa9-9da9-3b7216afa35f" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_52866623-c9e0-4f87-b90b-b11d45a2c670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockTables" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fc5df0e3-54e1-49ac-968b-1131586a9232" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_c2ccefaa-197c-4164-8f4f-66f2486bed46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fc5df0e3-54e1-49ac-968b-1131586a9232" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_c2ccefaa-197c-4164-8f4f-66f2486bed46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockAdditionalInformationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStockAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_80d35c4a-edee-46ef-a425-c4f5bdc0f044" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_80d35c4a-edee-46ef-a425-c4f5bdc0f044" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_7bb5ff5b-3cc7-4f0a-b727-ad943f26ac87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:to="loc_us-gaap_StatementClassOfStockAxis_7bb5ff5b-3cc7-4f0a-b727-ad943f26ac87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7d68f51c-ec0c-4ef8-8411-8f258295c925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_7bb5ff5b-3cc7-4f0a-b727-ad943f26ac87" xlink:to="loc_us-gaap_ClassOfStockDomain_7d68f51c-ec0c-4ef8-8411-8f258295c925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_91ac3acf-e253-47e6-9a52-aff51cac57c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7d68f51c-ec0c-4ef8-8411-8f258295c925" xlink:to="loc_us-gaap_CommonClassAMember_91ac3acf-e253-47e6-9a52-aff51cac57c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_2dac8fcf-f3e0-46c7-8da0-defeae11048d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_2dac8fcf-f3e0-46c7-8da0-defeae11048d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_97dab0f4-ed28-493f-b7b0-de3da41bab57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_2dac8fcf-f3e0-46c7-8da0-defeae11048d" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_97dab0f4-ed28-493f-b7b0-de3da41bab57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RepurchaseOfStockMember_b9d4240f-340a-4846-9c4d-77c6c238df2d" xlink:href="hims-20210331.xsd#hims_RepurchaseOfStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97dab0f4-ed28-493f-b7b0-de3da41bab57" xlink:to="loc_hims_RepurchaseOfStockMember_b9d4240f-340a-4846-9c4d-77c6c238df2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f9e1188-dd2a-468f-8310-a496e4a4acb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f9e1188-dd2a-468f-8310-a496e4a4acb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_720455c6-ae18-49fe-981e-fb03c078f756" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_1f9e1188-dd2a-468f-8310-a496e4a4acb9" xlink:to="loc_us-gaap_RelatedPartyDomain_720455c6-ae18-49fe-981e-fb03c078f756" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_FormerExecutiveOfficerMember_3610248d-303e-4247-8d31-73373a4e4351" xlink:href="hims-20210331.xsd#hims_FormerExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_720455c6-ae18-49fe-981e-fb03c078f756" xlink:to="loc_hims_FormerExecutiveOfficerMember_3610248d-303e-4247-8d31-73373a4e4351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_c6c57135-0436-407e-8dd4-9349dc8a79be" xlink:to="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NumberOfClassesOfCommonStock_8c4ee1c1-560b-4b59-87b3-89b14c06fb16" xlink:href="hims-20210331.xsd#hims_NumberOfClassesOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:to="loc_hims_NumberOfClassesOfCommonStock_8c4ee1c1-560b-4b59-87b3-89b14c06fb16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_d9136862-822a-4818-ab25-99a1adaaf96e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_d9136862-822a-4818-ab25-99a1adaaf96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d54926ad-e46c-4921-9dae-427f94fd0a2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_d54926ad-e46c-4921-9dae-427f94fd0a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NotesReceivableAmountOfPrincipalPaymentCanceled_ee54ece1-bd55-47a7-9055-87c4f94bdf84" xlink:href="hims-20210331.xsd#hims_NotesReceivableAmountOfPrincipalPaymentCanceled"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ffa13746-539b-430f-afc1-d1889e103918" xlink:to="loc_hims_NotesReceivableAmountOfPrincipalPaymentCanceled_ee54ece1-bd55-47a7-9055-87c4f94bdf84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockPreClosingStockRepurchaseDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_96c55b94-9c23-44b0-a22b-b55e07900bd7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_4f121960-0137-487d-84db-515e18c2301e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_96c55b94-9c23-44b0-a22b-b55e07900bd7" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_4f121960-0137-487d-84db-515e18c2301e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_92c3c821-4d4b-4993-adea-e517c8e14748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4f121960-0137-487d-84db-515e18c2301e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_92c3c821-4d4b-4993-adea-e517c8e14748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_80c68e19-41a4-473c-9627-016f2155bc47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_92c3c821-4d4b-4993-adea-e517c8e14748" xlink:to="loc_us-gaap_ClassOfStockDomain_80c68e19-41a4-473c-9627-016f2155bc47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_36f46d70-9029-4f6b-b13a-7e5505365aae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_80c68e19-41a4-473c-9627-016f2155bc47" xlink:to="loc_us-gaap_CommonClassAMember_36f46d70-9029-4f6b-b13a-7e5505365aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4f121960-0137-487d-84db-515e18c2301e" xlink:to="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_54aa9310-3ab6-47c3-8236-7c04e77fab77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_54aa9310-3ab6-47c3-8236-7c04e77fab77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_30147ca8-fd91-494b-8966-46b2932376b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_30147ca8-fd91-494b-8966-46b2932376b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_66bfeffe-7a0f-4779-98c8-9ed7c36bd4fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_66bfeffe-7a0f-4779-98c8-9ed7c36bd4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_3246c6d2-b532-4fae-a20f-effcb38e341e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_500e16f9-53f2-4b6a-ab5b-c6be21a0af87" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_3246c6d2-b532-4fae-a20f-effcb38e341e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockMergerTransactionDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockMergerTransactionDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStockMergerTransactionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4daf2be4-d9af-431b-93ba-8f39ef900c24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4daf2be4-d9af-431b-93ba-8f39ef900c24" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_cdb31462-2713-4694-8944-a030dc689e51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_us-gaap_StatementClassOfStockAxis_cdb31462-2713-4694-8944-a030dc689e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b1ee53f4-87ac-410e-9901-717af765ec52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_cdb31462-2713-4694-8944-a030dc689e51" xlink:to="loc_us-gaap_ClassOfStockDomain_b1ee53f4-87ac-410e-9901-717af765ec52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassAAndVMember_2eff1f25-859d-4afb-b202-95dbd3afac79" xlink:href="hims-20210331.xsd#hims_CommonClassAAndVMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_b1ee53f4-87ac-410e-9901-717af765ec52" xlink:to="loc_hims_CommonClassAAndVMember_2eff1f25-859d-4afb-b202-95dbd3afac79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_cd180499-49f5-4016-a27b-d293b29fee40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_CommonClassAAndVMember_2eff1f25-859d-4afb-b202-95dbd3afac79" xlink:to="loc_us-gaap_CommonClassAMember_cd180499-49f5-4016-a27b-d293b29fee40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember_0e1c991f-6ec1-46f5-bab3-29d0710bc142" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hims_CommonClassAAndVMember_2eff1f25-859d-4afb-b202-95dbd3afac79" xlink:to="loc_hims_CommonClassVMember_0e1c991f-6ec1-46f5-bab3-29d0710bc142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_d8932c83-fb4c-47d7-93d1-e8e53a1d0b39" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_dei_LegalEntityAxis_d8932c83-fb4c-47d7-93d1-e8e53a1d0b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_00cd36a1-67bc-4c85-aded-fb8fb940616d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_d8932c83-fb4c-47d7-93d1-e8e53a1d0b39" xlink:to="loc_dei_EntityDomain_00cd36a1-67bc-4c85-aded-fb8fb940616d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_HimsIncMember_aca11a80-e719-492d-9d5c-768005170388" xlink:href="hims-20210331.xsd#hims_HimsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_00cd36a1-67bc-4c85-aded-fb8fb940616d" xlink:to="loc_hims_HimsIncMember_aca11a80-e719-492d-9d5c-768005170388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_3f9ac9c4-2004-4e6a-8dc9-5cab671212e4" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_srt_TitleOfIndividualAxis_3f9ac9c4-2004-4e6a-8dc9-5cab671212e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_cfaa1abb-d2c4-4267-b2f7-ef2c3ce26ad7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_3f9ac9c4-2004-4e6a-8dc9-5cab671212e4" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_cfaa1abb-d2c4-4267-b2f7-ef2c3ce26ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_c6f2a389-e09c-4abb-afd3-a2082663c77c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_cfaa1abb-d2c4-4267-b2f7-ef2c3ce26ad7" xlink:to="loc_srt_ChiefExecutiveOfficerMember_c6f2a389-e09c-4abb-afd3-a2082663c77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_72ee228d-c585-494a-b7d8-a71f41bceab1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_72ee228d-c585-494a-b7d8-a71f41bceab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_9f7b2c04-42ba-43c3-a4f5-ebf188aac61b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_72ee228d-c585-494a-b7d8-a71f41bceab1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_9f7b2c04-42ba-43c3-a4f5-ebf188aac61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_a48586f4-9c72-45a5-8c06-74b2f0c55f2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_9f7b2c04-42ba-43c3-a4f5-ebf188aac61b" xlink:to="loc_us-gaap_CommonClassAMember_a48586f4-9c72-45a5-8c06-74b2f0c55f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ca58549e-1bd7-49b7-b028-6b803f27d638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ca58549e-1bd7-49b7-b028-6b803f27d638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4406bd98-304c-4f42-a109-4e47ae0befcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ca58549e-1bd7-49b7-b028-6b803f27d638" xlink:to="loc_us-gaap_EquityComponentDomain_4406bd98-304c-4f42-a109-4e47ae0befcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7ff2c436-8aac-4b95-977e-2c974e42bbd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_4406bd98-304c-4f42-a109-4e47ae0befcb" xlink:to="loc_us-gaap_CommonStockMember_7ff2c436-8aac-4b95-977e-2c974e42bbd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_9632340c-ca22-480f-8d53-066d19211fc9" xlink:to="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_a48c6b20-52bc-4b2e-ac62-1e22f2da194e" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:to="loc_hims_RecapitalizationExchangeRatio_a48c6b20-52bc-4b2e-ac62-1e22f2da194e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_89e05d35-f59e-44a3-8e9f-a6f3bccb8744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_89e05d35-f59e-44a3-8e9f-a6f3bccb8744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_973875c5-2757-4faa-8d49-551796b2eca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_973875c5-2757-4faa-8d49-551796b2eca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_153fe080-df62-40b7-9e79-5157afa42842" xlink:href="hims-20210331.xsd#hims_RecapitalizationContingentConsiderationEquityExchangeRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_8476741a-0606-4855-ace5-ae1fffa9e890" xlink:to="loc_hims_RecapitalizationContingentConsiderationEquityExchangeRatio_153fe080-df62-40b7-9e79-5157afa42842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6ed6fecc-9284-4442-aa2f-4de7e875e8f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_db2c2d62-d31f-442b-973c-1921eea8ede3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6ed6fecc-9284-4442-aa2f-4de7e875e8f6" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_db2c2d62-d31f-442b-973c-1921eea8ede3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_8e85ec0e-635a-4a52-96ba-2b3cc0d3cfaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_db2c2d62-d31f-442b-973c-1921eea8ede3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_8e85ec0e-635a-4a52-96ba-2b3cc0d3cfaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d7f79ed5-12a6-4a7a-9219-8ed210c102fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_8e85ec0e-635a-4a52-96ba-2b3cc0d3cfaf" xlink:to="loc_us-gaap_ClassOfStockDomain_d7f79ed5-12a6-4a7a-9219-8ed210c102fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_478e3ff7-a2c9-49f7-a628-ee391004d8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d7f79ed5-12a6-4a7a-9219-8ed210c102fc" xlink:to="loc_us-gaap_CommonClassAMember_478e3ff7-a2c9-49f7-a628-ee391004d8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_0041d719-2f37-4c5e-9174-d66ea6b418a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_db2c2d62-d31f-442b-973c-1921eea8ede3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_0041d719-2f37-4c5e-9174-d66ea6b418a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_3ac64340-a796-4ff2-848f-85171c18585e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_0041d719-2f37-4c5e-9174-d66ea6b418a9" xlink:to="loc_us-gaap_EquityComponentDomain_3ac64340-a796-4ff2-848f-85171c18585e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_1bff4856-864e-43d6-9bfe-0d8028eff14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_3ac64340-a796-4ff2-848f-85171c18585e" xlink:to="loc_us-gaap_CommonStockMember_1bff4856-864e-43d6-9bfe-0d8028eff14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_eee2ad97-a172-4013-9643-21641463e747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_db2c2d62-d31f-442b-973c-1921eea8ede3" xlink:to="loc_us-gaap_ClassOfStockLineItems_eee2ad97-a172-4013-9643-21641463e747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_ad388e6a-fddc-45dc-af1b-5f3ea856b8f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_eee2ad97-a172-4013-9643-21641463e747" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_ad388e6a-fddc-45dc-af1b-5f3ea856b8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_559d2600-a979-44da-b05b-69bb7571bb45" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_eee2ad97-a172-4013-9643-21641463e747" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_559d2600-a979-44da-b05b-69bb7571bb45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockPIPEInvestmentDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockPIPEInvestmentDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStockPIPEInvestmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f739e6d9-3245-46f8-8bdb-08743d7f2c01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_517cd00e-6b01-4d63-8aba-1273448f20e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f739e6d9-3245-46f8-8bdb-08743d7f2c01" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_517cd00e-6b01-4d63-8aba-1273448f20e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_9b2cf686-dfbf-40c8-b5ac-886639c1192c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_517cd00e-6b01-4d63-8aba-1273448f20e0" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_9b2cf686-dfbf-40c8-b5ac-886639c1192c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9563ad3d-e593-490f-b5e7-c68a6d299409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_9b2cf686-dfbf-40c8-b5ac-886639c1192c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9563ad3d-e593-490f-b5e7-c68a6d299409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrivatePlacementMember_09b638ed-4bbd-44bd-9b57-7830e859446a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrivatePlacementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_9563ad3d-e593-490f-b5e7-c68a6d299409" xlink:to="loc_us-gaap_PrivatePlacementMember_09b638ed-4bbd-44bd-9b57-7830e859446a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_d849919b-5839-47e1-83ab-c8122c5d9afd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_517cd00e-6b01-4d63-8aba-1273448f20e0" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_d849919b-5839-47e1-83ab-c8122c5d9afd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f9b50d17-9086-46c4-8058-45ab99ef90e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_d849919b-5839-47e1-83ab-c8122c5d9afd" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_f9b50d17-9086-46c4-8058-45ab99ef90e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_1ddc5df0-4931-49fe-a840-c6a6cde2dc4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_d849919b-5839-47e1-83ab-c8122c5d9afd" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_1ddc5df0-4931-49fe-a840-c6a6cde2dc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6e9b12c5-2b6a-4cf2-be91-22010c77fe23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_d849919b-5839-47e1-83ab-c8122c5d9afd" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_6e9b12c5-2b6a-4cf2-be91-22010c77fe23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockPriortoMergerDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockPriortoMergerDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStockPriortoMergerDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_74409e49-32ec-4797-a1ae-790ddc3f3e3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_41c52e24-5986-4e84-908a-0b8e449541d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_74409e49-32ec-4797-a1ae-790ddc3f3e3b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_41c52e24-5986-4e84-908a-0b8e449541d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_b151662c-1833-4ff1-97fa-45a3021ba18f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_41c52e24-5986-4e84-908a-0b8e449541d6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_b151662c-1833-4ff1-97fa-45a3021ba18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_b151662c-1833-4ff1-97fa-45a3021ba18f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonStockWarrantsMember_d9b32a85-22ae-4665-a181-0fa0499e3379" xlink:href="hims-20210331.xsd#hims_CommonStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:to="loc_hims_CommonStockWarrantsMember_d9b32a85-22ae-4665-a181-0fa0499e3379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonStockWarrantsGroupOneMember_393ea08c-3825-4622-85c9-aeb7ae4ed978" xlink:href="hims-20210331.xsd#hims_CommonStockWarrantsGroupOneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:to="loc_hims_CommonStockWarrantsGroupOneMember_393ea08c-3825-4622-85c9-aeb7ae4ed978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorWarrantsMember_6ec5dbf2-9b6e-4672-9fb1-16b29761d38e" xlink:href="hims-20210331.xsd#hims_VendorWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:to="loc_hims_VendorWarrantsMember_6ec5dbf2-9b6e-4672-9fb1-16b29761d38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonStockWarrantsGroupTwoMember_3ce12950-40c3-4f1c-a20d-2135847268d2" xlink:href="hims-20210331.xsd#hims_CommonStockWarrantsGroupTwoMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fa640d1f-82a8-4c31-9355-4ab99d8df4ab" xlink:to="loc_hims_CommonStockWarrantsGroupTwoMember_3ce12950-40c3-4f1c-a20d-2135847268d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_669d0c5a-6b45-4738-beba-b6e79e6469d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_41c52e24-5986-4e84-908a-0b8e449541d6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_669d0c5a-6b45-4738-beba-b6e79e6469d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ef0498c4-132e-4144-9d86-891469eaf70f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_669d0c5a-6b45-4738-beba-b6e79e6469d6" xlink:to="loc_us-gaap_ClassOfStockDomain_ef0498c4-132e-4144-9d86-891469eaf70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_17206782-c45e-4092-8b8d-920d6de791fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_ef0498c4-132e-4144-9d86-891469eaf70f" xlink:to="loc_us-gaap_CommonClassAMember_17206782-c45e-4092-8b8d-920d6de791fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_77486cd6-44c7-43b5-bab4-d3022fd8f8ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_41c52e24-5986-4e84-908a-0b8e449541d6" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_77486cd6-44c7-43b5-bab4-d3022fd8f8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_13b07782-131a-445e-bed9-3373bd0092dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_77486cd6-44c7-43b5-bab4-d3022fd8f8ef" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_13b07782-131a-445e-bed9-3373bd0092dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7a01ca3a-fdcf-473f-9a06-9df14003c3c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_77486cd6-44c7-43b5-bab4-d3022fd8f8ef" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_7a01ca3a-fdcf-473f-9a06-9df14003c3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockSubsequenttoMergerDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockSubsequenttoMergerDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStockSubsequenttoMergerDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6a1f89bd-9b5a-42e2-b2ab-6732cf033135" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_a51762bb-709b-42bb-b41d-1a6a2e7f3336" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6a1f89bd-9b5a-42e2-b2ab-6732cf033135" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_a51762bb-709b-42bb-b41d-1a6a2e7f3336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_ec491574-af29-4365-b5c3-fcd30f4f039d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_a51762bb-709b-42bb-b41d-1a6a2e7f3336" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_ec491574-af29-4365-b5c3-fcd30f4f039d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_29a78d2c-2099-43a5-af66-73acbf09f453" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_ec491574-af29-4365-b5c3-fcd30f4f039d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_29a78d2c-2099-43a5-af66-73acbf09f453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PrivatePlacementWarrantsMember_d8fcdd14-0915-464a-b5f7-7a3108577d56" xlink:href="hims-20210331.xsd#hims_PrivatePlacementWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_29a78d2c-2099-43a5-af66-73acbf09f453" xlink:to="loc_hims_PrivatePlacementWarrantsMember_d8fcdd14-0915-464a-b5f7-7a3108577d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsMember_5b8e7f8f-3b77-41d8-9bb8-df4fb23bc4a8" xlink:href="hims-20210331.xsd#hims_PublicWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_29a78d2c-2099-43a5-af66-73acbf09f453" xlink:to="loc_hims_PublicWarrantsMember_5b8e7f8f-3b77-41d8-9bb8-df4fb23bc4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantsMember_d05d306e-f1fb-49a2-9557-1d0eb6c610f4" xlink:href="hims-20210331.xsd#hims_ParentWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_29a78d2c-2099-43a5-af66-73acbf09f453" xlink:to="loc_hims_ParentWarrantsMember_d05d306e-f1fb-49a2-9557-1d0eb6c610f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_af7a2771-74ca-4fdf-8bc9-aff1c95dcfcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_a51762bb-709b-42bb-b41d-1a6a2e7f3336" xlink:to="loc_us-gaap_StatementClassOfStockAxis_af7a2771-74ca-4fdf-8bc9-aff1c95dcfcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_744172a5-6e6c-419e-a7bc-92b8c3fc0cea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_af7a2771-74ca-4fdf-8bc9-aff1c95dcfcb" xlink:to="loc_us-gaap_ClassOfStockDomain_744172a5-6e6c-419e-a7bc-92b8c3fc0cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_aa4f30bf-0e19-4383-8b70-38c3c3b3a2fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_744172a5-6e6c-419e-a7bc-92b8c3fc0cea" xlink:to="loc_us-gaap_CommonClassAMember_aa4f30bf-0e19-4383-8b70-38c3c3b3a2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_a51762bb-709b-42bb-b41d-1a6a2e7f3336" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_070013ea-4688-4a8d-b180-fe448f3646ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_070013ea-4688-4a8d-b180-fe448f3646ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c213d5b6-185a-489a-9ec2-9b56b7c0ebeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c213d5b6-185a-489a-9ec2-9b56b7c0ebeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RecapitalizationExchangeRatio_8ba76419-615f-42cd-be7a-f694be4a8cba" xlink:href="hims-20210331.xsd#hims_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_RecapitalizationExchangeRatio_8ba76419-615f-42cd-be7a-f694be4a8cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_9f67296e-8c75-465f-82fb-8728426029b6" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne_9f67296e-8c75-465f-82fb-8728426029b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_a34b6c4e-1692-40ce-9b56-b3c3a039b011" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo_a34b6c4e-1692-40ce-9b56-b3c3a039b011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_4fdcd18a-8c84-4dfa-8b39-a7bcd558b24d" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree_4fdcd18a-8c84-4dfa-8b39-a7bcd558b24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_aa3d20ca-1543-464b-b96e-d5247678527b" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays_aa3d20ca-1543-464b-b96e-d5247678527b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_4a8a42df-f06f-4e6e-920e-07cbb84fc150" xlink:href="hims-20210331.xsd#hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays_4a8a42df-f06f-4e6e-920e-07cbb84fc150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_204c4a54-d4c4-466f-84d2-82722ecb99d4" xlink:href="hims-20210331.xsd#hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod_204c4a54-d4c4-466f-84d2-82722ecb99d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_48b02309-d440-4e26-81d2-0eabef659fbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_41a91518-c058-406b-b9bf-9acb5b6d33f3" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_48b02309-d440-4e26-81d2-0eabef659fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockScheduleofWarrantsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_aba7ef28-b841-49ff-bea6-304c03288203" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_d9f64b97-4db9-477b-8cf6-bf1b8fa47fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_aba7ef28-b841-49ff-bea6-304c03288203" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_d9f64b97-4db9-477b-8cf6-bf1b8fa47fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0d52072e-a7a7-4cf7-8f2f-83e91c48d008" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d9f64b97-4db9-477b-8cf6-bf1b8fa47fa3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0d52072e-a7a7-4cf7-8f2f-83e91c48d008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0d52072e-a7a7-4cf7-8f2f-83e91c48d008" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_VendorWarrantsMember_59c7fb70-c561-46e5-8743-4ec56d4302c6" xlink:href="hims-20210331.xsd#hims_VendorWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:to="loc_hims_VendorWarrantsMember_59c7fb70-c561-46e5-8743-4ec56d4302c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_DebtWarrantsMember_c04269d3-304a-4bc3-b85f-2d8906249895" xlink:href="hims-20210331.xsd#hims_DebtWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:to="loc_hims_DebtWarrantsMember_c04269d3-304a-4bc3-b85f-2d8906249895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsMember_8c9ac398-9549-4404-8686-c9a739aebd66" xlink:href="hims-20210331.xsd#hims_PublicWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:to="loc_hims_PublicWarrantsMember_8c9ac398-9549-4404-8686-c9a739aebd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ParentWarrantsMember_70a835d8-9297-4b56-857b-c6fe86b6fb51" xlink:href="hims-20210331.xsd#hims_ParentWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_16ffc4a9-e737-45c7-81c2-282c53516ae8" xlink:to="loc_hims_ParentWarrantsMember_70a835d8-9297-4b56-857b-c6fe86b6fb51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b5c59061-e8f5-41fb-9e7d-770ba95311ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d9f64b97-4db9-477b-8cf6-bf1b8fa47fa3" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b5c59061-e8f5-41fb-9e7d-770ba95311ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_f99114b6-b1d5-4ab3-894b-08de0532478e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b5c59061-e8f5-41fb-9e7d-770ba95311ff" xlink:to="loc_us-gaap_ClassOfStockDomain_f99114b6-b1d5-4ab3-894b-08de0532478e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_5ee6b8c6-74a9-40fe-85a8-d4b3e0a94cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_f99114b6-b1d5-4ab3-894b-08de0532478e" xlink:to="loc_us-gaap_CommonClassAMember_5ee6b8c6-74a9-40fe-85a8-d4b3e0a94cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_e9e78ad4-ad6e-4ff7-a1c5-e7ecb490acaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_d9f64b97-4db9-477b-8cf6-bf1b8fa47fa3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_e9e78ad4-ad6e-4ff7-a1c5-e7ecb490acaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2db0880c-a7f3-42b0-bcf3-1747f5d18980" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e9e78ad4-ad6e-4ff7-a1c5-e7ecb490acaf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_2db0880c-a7f3-42b0-bcf3-1747f5d18980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_d86ec093-3965-48e6-9820-93ba55b039e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_e9e78ad4-ad6e-4ff7-a1c5-e7ecb490acaf" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_d86ec093-3965-48e6-9820-93ba55b039e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/CommonStockPublicWarrantTermsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#CommonStockPublicWarrantTermsDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/CommonStockPublicWarrantTermsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7f2fedb3-a47c-48b8-8570-61ea508e9d2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_b6d727e3-6165-4833-9e2a-f7ee6bf1204f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7f2fedb3-a47c-48b8-8570-61ea508e9d2d" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_b6d727e3-6165-4833-9e2a-f7ee6bf1204f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_6a36cb7e-28db-4ea5-822e-4cd066df4da2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b6d727e3-6165-4833-9e2a-f7ee6bf1204f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_6a36cb7e-28db-4ea5-822e-4cd066df4da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5b8fbd95-762c-4952-b7d6-13f4a46fe843" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6a36cb7e-28db-4ea5-822e-4cd066df4da2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5b8fbd95-762c-4952-b7d6-13f4a46fe843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsMember_adc21b5d-b723-43dd-8c85-928a90d3488e" xlink:href="hims-20210331.xsd#hims_PublicWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5b8fbd95-762c-4952-b7d6-13f4a46fe843" xlink:to="loc_hims_PublicWarrantsMember_adc21b5d-b723-43dd-8c85-928a90d3488e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsWarrantRedemptionMember_f3778ebe-201c-4a65-8ff1-7018cd2fce3f" xlink:href="hims-20210331.xsd#hims_PublicWarrantsWarrantRedemptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5b8fbd95-762c-4952-b7d6-13f4a46fe843" xlink:to="loc_hims_PublicWarrantsWarrantRedemptionMember_f3778ebe-201c-4a65-8ff1-7018cd2fce3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_PublicWarrantsCashRedemptionMember_9567b203-4899-46be-905e-93588fac2ef0" xlink:href="hims-20210331.xsd#hims_PublicWarrantsCashRedemptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5b8fbd95-762c-4952-b7d6-13f4a46fe843" xlink:to="loc_hims_PublicWarrantsCashRedemptionMember_9567b203-4899-46be-905e-93588fac2ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6d629311-0027-444f-a93c-aaf24968898a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b6d727e3-6165-4833-9e2a-f7ee6bf1204f" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6d629311-0027-444f-a93c-aaf24968898a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_55821fe5-d6b2-416e-aaa9-fcfe6761d33b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6d629311-0027-444f-a93c-aaf24968898a" xlink:to="loc_us-gaap_ClassOfStockDomain_55821fe5-d6b2-416e-aaa9-fcfe6761d33b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_bbbc3677-1856-489a-8f8b-9b9795dd1dbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_55821fe5-d6b2-416e-aaa9-fcfe6761d33b" xlink:to="loc_us-gaap_CommonClassAMember_bbbc3677-1856-489a-8f8b-9b9795dd1dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_b6d727e3-6165-4833-9e2a-f7ee6bf1204f" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate_0e69c1ea-3051-4f00-ac3f-721cedfb340b" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate_0e69c1ea-3051-4f00-ac3f-721cedfb340b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightExpirationPeriod_ec887d8d-927c-4b6d-a3f1-6a26b197a0a3" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightExpirationPeriod_ec887d8d-927c-4b6d-a3f1-6a26b197a0a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable_8103ba99-790d-4ba5-aaee-2d42b4d01709" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable_8103ba99-790d-4ba5-aaee-2d42b4d01709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightRedemptionPricePerShare_da313cad-5fe1-4227-9e35-21f30d980913" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightRedemptionPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightRedemptionPricePerShare_da313cad-5fe1-4227-9e35-21f30d980913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum_9c54484e-6e50-4437-8623-60037a6be804" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum_9c54484e-6e50-4437-8623-60037a6be804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightThresholdTradingDays_daa8270d-6fe1-430a-8757-67bf0255b9d0" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightThresholdTradingDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightThresholdTradingDays_daa8270d-6fe1-430a-8757-67bf0255b9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold_559631e1-8332-4d81-82b4-544e9ae70c33" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold_559631e1-8332-4d81-82b4-544e9ae70c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption_49407ee9-18b1-4a77-915f-cd32a1224cb3" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption_49407ee9-18b1-4a77-915f-cd32a1224cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays_9379c6a5-9c89-4a12-a3ae-b137e93478d9" xlink:href="hims-20210331.xsd#hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_a9159c63-ebc6-4964-a999-3e433e97a9ef" xlink:to="loc_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays_9379c6a5-9c89-4a12-a3ae-b137e93478d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="hims-20210331.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://forhims.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_898b0aec-5696-4855-8dd4-e2fd0a7c2163" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b888cdf8-4c57-4483-9fb6-d7173d313503" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_898b0aec-5696-4855-8dd4-e2fd0a7c2163" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_b888cdf8-4c57-4483-9fb6-d7173d313503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/RelatedPartyTransactionsDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#RelatedPartyTransactionsDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/RelatedPartyTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_28ba3d8e-c819-48d1-becf-91128a347589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_28ba3d8e-c819-48d1-becf-91128a347589" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bafc8778-e5d3-4c5a-afed-7699c08d77e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bafc8778-e5d3-4c5a-afed-7699c08d77e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_bafc8778-e5d3-4c5a-afed-7699c08d77e1" xlink:to="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_a0bb9a5a-bf5b-455d-a667-2e2398082b02" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:to="loc_srt_AffiliatedEntityMember_a0bb9a5a-bf5b-455d-a667-2e2398082b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ManagementMember_662bb594-3550-462e-8a10-6a25d9dfbce5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ManagementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:to="loc_srt_ManagementMember_662bb594-3550-462e-8a10-6a25d9dfbce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ChiefExecutiveOfficerAndDirectorMember_e73f9284-9c4e-4769-adff-57ea686e75f2" xlink:href="hims-20210331.xsd#hims_ChiefExecutiveOfficerAndDirectorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:to="loc_hims_ChiefExecutiveOfficerAndDirectorMember_e73f9284-9c4e-4769-adff-57ea686e75f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CEOAndDirectorMember_adc592bf-acba-402d-9657-de78522ef5b8" xlink:href="hims-20210331.xsd#hims_CEOAndDirectorMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_05576df0-bc86-4601-9bfd-07d52bed00c5" xlink:to="loc_hims_CEOAndDirectorMember_adc592bf-acba-402d-9657-de78522ef5b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_c2481925-d241-4530-8903-814024758563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_c2481925-d241-4530-8903-814024758563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_c2481925-d241-4530-8903-814024758563" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_OperationalSupportMember_2c33c9b3-56de-4372-ad29-b9f9ce0341be" xlink:href="hims-20210331.xsd#hims_OperationalSupportMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:to="loc_hims_OperationalSupportMember_2c33c9b3-56de-4372-ad29-b9f9ce0341be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_IdentityVerificationServicesMember_5c2a03e8-5156-45ae-92b4-c871f46817ae" xlink:href="hims-20210331.xsd#hims_IdentityVerificationServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:to="loc_hims_IdentityVerificationServicesMember_5c2a03e8-5156-45ae-92b4-c871f46817ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NonrecourseRelatedPartyPromissoryNotesMember_2878c79c-13d9-4aae-8561-1eced7b81c21" xlink:href="hims-20210331.xsd#hims_NonrecourseRelatedPartyPromissoryNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:to="loc_hims_NonrecourseRelatedPartyPromissoryNotesMember_2878c79c-13d9-4aae-8561-1eced7b81c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableCommonStockTransactionMember_e7c07a93-2f2d-42c9-90a9-c75516639423" xlink:href="hims-20210331.xsd#hims_RedeemableCommonStockTransactionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_97fe3fd6-c9bb-4450-a44d-9882527a3e98" xlink:to="loc_hims_RedeemableCommonStockTransactionMember_e7c07a93-2f2d-42c9-90a9-c75516639423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fcd9aff2-e37f-4023-b61b-0df605a33a59" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_srt_RangeAxis_fcd9aff2-e37f-4023-b61b-0df605a33a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fafd25e1-021c-4100-8607-80f7e44608fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fcd9aff2-e37f-4023-b61b-0df605a33a59" xlink:to="loc_srt_RangeMember_fafd25e1-021c-4100-8607-80f7e44608fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ae7317ec-86bc-4f34-9d0b-7acbcfb25d58" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fafd25e1-021c-4100-8607-80f7e44608fc" xlink:to="loc_srt_MinimumMember_ae7317ec-86bc-4f34-9d0b-7acbcfb25d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_182f184b-e979-4c3b-8ead-361dacd119c1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fafd25e1-021c-4100-8607-80f7e44608fc" xlink:to="loc_srt_MaximumMember_182f184b-e979-4c3b-8ead-361dacd119c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ac8c0825-c9c6-4cd8-897b-8fca3c7d1a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ac8c0825-c9c6-4cd8-897b-8fca3c7d1a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_952132b8-da9d-4e7a-9870-b056fa7ba01d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ac8c0825-c9c6-4cd8-897b-8fca3c7d1a7f" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_952132b8-da9d-4e7a-9870-b056fa7ba01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember_044fafe7-c101-49b8-941c-d838c9b8db6f" xlink:href="hims-20210331.xsd#hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_952132b8-da9d-4e7a-9870-b056fa7ba01d" xlink:to="loc_hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember_044fafe7-c101-49b8-941c-d838c9b8db6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableCommonStockTransactionMember_3cd10dc5-4a42-4465-a4da-a0591cd406b0" xlink:href="hims-20210331.xsd#hims_RedeemableCommonStockTransactionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_952132b8-da9d-4e7a-9870-b056fa7ba01d" xlink:to="loc_hims_RedeemableCommonStockTransactionMember_3cd10dc5-4a42-4465-a4da-a0591cd406b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1909ed30-dc2c-474b-b827-bd0e16525f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1909ed30-dc2c-474b-b827-bd0e16525f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e0a3e584-40d4-4065-9751-10542ceee9fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1909ed30-dc2c-474b-b827-bd0e16525f01" xlink:to="loc_us-gaap_ClassOfStockDomain_e0a3e584-40d4-4065-9751-10542ceee9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_RedeemableClassACommonStockMember_f33af340-45a0-4e6f-8ad4-d74a95ea1639" xlink:href="hims-20210331.xsd#hims_RedeemableClassACommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e0a3e584-40d4-4065-9751-10542ceee9fb" xlink:to="loc_hims_RedeemableClassACommonStockMember_f33af340-45a0-4e6f-8ad4-d74a95ea1639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_22c2c610-c62f-4f4c-869d-e4484c3e3dd9" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_cbbe66b0-1df2-49c4-9bf9-ffa6b3fd89aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_cbbe66b0-1df2-49c4-9bf9-ffa6b3fd89aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_635b624f-7c0e-4d27-8ee0-4a7985008d0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty_635b624f-7c0e-4d27-8ee0-4a7985008d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_262f3782-d3a3-4e6f-a82c-6d857855ca55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_262f3782-d3a3-4e6f-a82c-6d857855ca55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dc673109-3808-4f79-b166-85b501337e4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_dc673109-3808-4f79-b166-85b501337e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionRate_65b79ea3-0146-4ace-b7fe-38a6102210fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_RelatedPartyTransactionRate_65b79ea3-0146-4ace-b7fe-38a6102210fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue_7cece89b-c1f8-4307-b947-dd56b72ce1d0" xlink:href="hims-20210331.xsd#hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue_7cece89b-c1f8-4307-b947-dd56b72ce1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRelatedPartyDebt_77c2c1ef-2174-4d0a-b62a-506bc9dff64d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRelatedPartyDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_ProceedsFromRelatedPartyDebt_77c2c1ef-2174-4d0a-b62a-506bc9dff64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockForfeitedDuringPeriodShares_0034d629-d8e6-4c17-b80c-a545da2ccff4" xlink:href="hims-20210331.xsd#hims_StockForfeitedDuringPeriodShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_hims_StockForfeitedDuringPeriodShares_0034d629-d8e6-4c17-b80c-a545da2ccff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d805b024-2159-4220-9ffe-01bef204993d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d805b024-2159-4220-9ffe-01bef204993d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_efff71b0-79fd-4bc5-b8d4-6c6163be9e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_efff71b0-79fd-4bc5-b8d4-6c6163be9e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e6960133-8d6b-4392-8e5c-53b0d182fba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e6960133-8d6b-4392-8e5c-53b0d182fba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_SaleOfStockPutRightPeriod_c762ce9c-749d-4f61-a45b-a3eb7b5b93ed" xlink:href="hims-20210331.xsd#hims_SaleOfStockPutRightPeriod"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_hims_SaleOfStockPutRightPeriod_c762ce9c-749d-4f61-a45b-a3eb7b5b93ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_790a0ec4-005a-4241-9d32-51d3ddf7827c" xlink:href="hims-20210331.xsd#hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_6da936f2-c3a0-4a5c-816f-c75925915ce7" xlink:to="loc_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_790a0ec4-005a-4241-9d32-51d3ddf7827c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/BasicandDilutedNetLossperShare" xlink:type="simple" xlink:href="hims-20210331.xsd#BasicandDilutedNetLossperShare"/>
  <link:presentationLink xlink:role="http://forhims.com/role/BasicandDilutedNetLossperShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1f69bd5f-2c0b-4f8a-8124-b56177a975f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_48432519-c816-47d6-853e-bfadc02d58da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1f69bd5f-2c0b-4f8a-8124-b56177a975f9" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_48432519-c816-47d6-853e-bfadc02d58da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareTables" xlink:type="simple" xlink:href="hims-20210331.xsd#BasicandDilutedNetLossperShareTables"/>
  <link:presentationLink xlink:role="http://forhims.com/role/BasicandDilutedNetLossperShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d06382a6-bf8b-4bff-a534-ffc4df54f617" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_717336eb-3e50-4228-b893-39ba52c55c64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d06382a6-bf8b-4bff-a534-ffc4df54f617" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_717336eb-3e50-4228-b893-39ba52c55c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ad5a0e07-71ba-42ae-a13b-5dd5e50a6ae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d06382a6-bf8b-4bff-a534-ffc4df54f617" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ad5a0e07-71ba-42ae-a13b-5dd5e50a6ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#BasicandDilutedNetLossperShareAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5dfabd8d-e8c2-4773-bd91-9ac81db8eeb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_066f7e0b-5172-4139-bc3a-5f22034ce2b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5dfabd8d-e8c2-4773-bd91-9ac81db8eeb5" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_066f7e0b-5172-4139-bc3a-5f22034ce2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fe585c31-13c5-4224-9d2d-34552372992b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_066f7e0b-5172-4139-bc3a-5f22034ce2b8" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fe585c31-13c5-4224-9d2d-34552372992b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1bce28df-2c6f-43d0-b688-7a9ac448b2b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fe585c31-13c5-4224-9d2d-34552372992b" xlink:to="loc_us-gaap_ClassOfStockDomain_1bce28df-2c6f-43d0-b688-7a9ac448b2b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_4e303921-da32-442e-a4ee-cf54dd7e31fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_1bce28df-2c6f-43d0-b688-7a9ac448b2b3" xlink:to="loc_us-gaap_CommonClassAMember_4e303921-da32-442e-a4ee-cf54dd7e31fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_3248e1cc-51ac-45aa-a839-a1b3d1d1fd37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_066f7e0b-5172-4139-bc3a-5f22034ce2b8" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_3248e1cc-51ac-45aa-a839-a1b3d1d1fd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStock_b6de495a-b464-4e83-9334-5c48b66bcacf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_3248e1cc-51ac-45aa-a839-a1b3d1d1fd37" xlink:to="loc_us-gaap_DividendsCommonStock_b6de495a-b464-4e83-9334-5c48b66bcacf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare_72150d5b-60f9-4740-8954-569b501a43cf" xlink:href="hims-20210331.xsd#hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_3248e1cc-51ac-45aa-a839-a1b3d1d1fd37" xlink:to="loc_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare_72150d5b-60f9-4740-8954-569b501a43cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ae48e9a0-700e-4446-85b6-6d29827557b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cedfde09-a621-4137-a3f6-711cd7f1bc77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ae48e9a0-700e-4446-85b6-6d29827557b4" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cedfde09-a621-4137-a3f6-711cd7f1bc77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_477f260e-533a-41a0-b1f5-4510d204b411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cedfde09-a621-4137-a3f6-711cd7f1bc77" xlink:to="loc_us-gaap_StatementClassOfStockAxis_477f260e-533a-41a0-b1f5-4510d204b411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_64c3850d-a6c7-4cb9-92c1-6da62fe58757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_477f260e-533a-41a0-b1f5-4510d204b411" xlink:to="loc_us-gaap_ClassOfStockDomain_64c3850d-a6c7-4cb9-92c1-6da62fe58757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_0f282761-5dad-46d1-af6c-fc49482723db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_64c3850d-a6c7-4cb9-92c1-6da62fe58757" xlink:to="loc_us-gaap_CommonClassAMember_0f282761-5dad-46d1-af6c-fc49482723db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassVMember_c4fd89a3-6f8e-40e1-b196-b99b527c59b5" xlink:href="hims-20210331.xsd#hims_CommonClassVMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_64c3850d-a6c7-4cb9-92c1-6da62fe58757" xlink:to="loc_hims_CommonClassVMember_c4fd89a3-6f8e-40e1-b196-b99b527c59b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_CommonClassFMember_f470e840-52cf-4f15-9bb5-f8a6dbb50b47" xlink:href="hims-20210331.xsd#hims_CommonClassFMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_64c3850d-a6c7-4cb9-92c1-6da62fe58757" xlink:to="loc_hims_CommonClassFMember_f470e840-52cf-4f15-9bb5-f8a6dbb50b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_13f7042c-2c8e-496c-a6ce-6c5697c2f9e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_cedfde09-a621-4137-a3f6-711cd7f1bc77" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_13f7042c-2c8e-496c-a6ce-6c5697c2f9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_835ead5f-13f7-44e2-a967-69bd0788d473" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_13f7042c-2c8e-496c-a6ce-6c5697c2f9e8" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_835ead5f-13f7-44e2-a967-69bd0788d473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fab8ad4b-6bf5-41d4-8ee8-b4fd52747ab4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_835ead5f-13f7-44e2-a967-69bd0788d473" xlink:to="loc_us-gaap_NetIncomeLoss_fab8ad4b-6bf5-41d4-8ee8-b4fd52747ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_13f7042c-2c8e-496c-a6ce-6c5697c2f9e8" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a17868ce-33f0-4d5c-b231-17db4dfa6f2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a17868ce-33f0-4d5c-b231-17db4dfa6f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01928dac-ef0b-469b-8283-512ca6c60d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_01928dac-ef0b-469b-8283-512ca6c60d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c7632c7a-0032-4054-a4ec-e1bd0ff8310d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:to="loc_us-gaap_EarningsPerShareBasic_c7632c7a-0032-4054-a4ec-e1bd0ff8310d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_7e0de6c4-706d-446a-9d8d-19f6a7c6db42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_99c4576e-e79c-4d6c-8ed5-4e300459a3b1" xlink:to="loc_us-gaap_EarningsPerShareDiluted_7e0de6c4-706d-446a-9d8d-19f6a7c6db42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2160f845-b399-4832-93ac-efbc32a5c8e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_569c6b8a-1053-45ec-9c2b-47a001ae5545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2160f845-b399-4832-93ac-efbc32a5c8e3" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_569c6b8a-1053-45ec-9c2b-47a001ae5545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cab43547-08f2-4320-8f10-b5d67515e873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_569c6b8a-1053-45ec-9c2b-47a001ae5545" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cab43547-08f2-4320-8f10-b5d67515e873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cab43547-08f2-4320-8f10-b5d67515e873" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember_ca4b0ace-374d-4fbc-bafa-7c65b74ecaad" xlink:href="hims-20210331.xsd#hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember_ca4b0ace-374d-4fbc-bafa-7c65b74ecaad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hims_EarlyExerciseOfStockOptionsMember_2d0f7895-6d22-4914-a8ea-4dd8d5b23654" xlink:href="hims-20210331.xsd#hims_EarlyExerciseOfStockOptionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_hims_EarlyExerciseOfStockOptionsMember_2d0f7895-6d22-4914-a8ea-4dd8d5b23654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_e851f5ec-c952-4d52-b98e-f22e61a6d66c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_e851f5ec-c952-4d52-b98e-f22e61a6d66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_3fac8bca-3b94-4024-9d78-d67bc0161214" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_us-gaap_EmployeeStockOptionMember_3fac8bca-3b94-4024-9d78-d67bc0161214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_91a5e3ee-51a6-4ab1-a827-98b0c8fc324b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_91a5e3ee-51a6-4ab1-a827-98b0c8fc324b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_05fdee0c-9200-4d2a-b383-474f6b4c4295" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_8a115d8b-a1e5-4609-b351-43c185f8ff56" xlink:to="loc_us-gaap_WarrantMember_05fdee0c-9200-4d2a-b383-474f6b4c4295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_3981ee3c-ed8f-4d06-b5ab-fae83778c1a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_569c6b8a-1053-45ec-9c2b-47a001ae5545" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_3981ee3c-ed8f-4d06-b5ab-fae83778c1a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4765afbf-c295-4ce7-9fa4-cfed45312975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_3981ee3c-ed8f-4d06-b5ab-fae83778c1a3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4765afbf-c295-4ce7-9fa4-cfed45312975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_19377c0d-5cb4-41c9-9be7-457baf08cafe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4765afbf-c295-4ce7-9fa4-cfed45312975" xlink:to="loc_us-gaap_CommonClassAMember_19377c0d-5cb4-41c9-9be7-457baf08cafe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_676cc5d1-0b93-4c31-9941-bc562188d27d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_4765afbf-c295-4ce7-9fa4-cfed45312975" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_676cc5d1-0b93-4c31-9941-bc562188d27d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7cf74ab4-3c53-4215-b8e5-7b67a488d658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_569c6b8a-1053-45ec-9c2b-47a001ae5545" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7cf74ab4-3c53-4215-b8e5-7b67a488d658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_efbe8440-69e0-46a6-ae3c-ef9dbd9e4fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7cf74ab4-3c53-4215-b8e5-7b67a488d658" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_efbe8440-69e0-46a6-ae3c-ef9dbd9e4fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/IncomeTax" xlink:type="simple" xlink:href="hims-20210331.xsd#IncomeTax"/>
  <link:presentationLink xlink:role="http://forhims.com/role/IncomeTax" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8c4bd943-a1e7-4012-b899-8ebc16793c5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_5d485945-2fa6-4faa-b6d8-2808cb391c3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8c4bd943-a1e7-4012-b899-8ebc16793c5a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_5d485945-2fa6-4faa-b6d8-2808cb391c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://forhims.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="hims-20210331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://forhims.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2f8bbddd-3aff-431f-9343-0071a0a7c1f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0706b65e-9a37-4531-bb2d-9b5238310bbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2f8bbddd-3aff-431f-9343-0071a0a7c1f2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_0706b65e-9a37-4531-bb2d-9b5238310bbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>hims-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:hims="http://forhims.com/20210331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="hims-20210331.xsd" xlink:type="simple"/>
    <context id="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2194548550b7484685726895d99493c1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2edfec64c15947d89d7391ae34a7c55c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1b1cf446284148a4ab9d5ea405db014a_I20210514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-14</instant>
        </period>
    </context>
    <context id="ida06d917140d461e83e2c6831d4ef512_I20210514">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-14</instant>
        </period>
    </context>
    <context id="iae89e874aad64f008fc6334367e88e92_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i739ad782f5ac49639074bf72004c4e5f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad3d9f1d28194144988117c8661db3c7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if163a4f44b68493db66e067e3b8486e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i64997c5f30d84597aaf8c79404b17e9f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i43c7f88bdd024bed8ed820a0bbf53b11_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib7fedba8f2404efe9b39de971e70cf0f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i792d7143c7e54d839bf9f447a23d5618_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f47e3f1375b4282b2f716b16c7f63c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib87290b070ee4c958c8ad766257920b6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if6ed049ade5b4240a293550a94b55de3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7fe00541b18143fba9a548d496dfb366_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec13139dbbe74ce284027b71cc7aab9c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie22663228da14a50972ddb2d671033c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9cb115824ec34508bcd4a4a5cdc3f9da_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i417d0d1092d44ad0861530bdff9221e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60ca4e5da0f14565ac395c1f2874530c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i066ff8ea972a49dd9ad1c4f332e6c655_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i735114ee932b44528649a12d298232eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4ffa9196bf234ff0ade6790ed45d90db_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iffd6f90426014cc5a2a7167bb4a3601e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibbecfcc087fd493a80b3a69f6a762834_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i72a366adb8ae4f1aa5df0ef732686620_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41f7b9d6eea64578809c722be8aea527_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i30ada711d000420db9e5a73ad2e2418d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie5ab3e0ebc1e499ea3db5fa26f8b9bc4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie89592b066544281a07fa0169e98833d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ClassACommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4af486b04aad4f14ba113a2fa6b2ee94_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3078188fe78241078c8c9e6b9eed4bc6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id7de8dcbf04c4bb6929b04fe9ef68802_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i70660543ef984629a669e4c2774e2da9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i791a884a65994079a567da0a06e4cbec_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i91a3849afa9e4008b0e42c13bed395ca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6afd3e44df984fe7827f7001bb384073_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia261e8ec32d348948aa7c247ea90ba34_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9806e71b0929497bb5027bab7cf4a37a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib85fb22f79d9475787326d65ff2089e0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i576de665f4e84b76bc7bb8d9ec493671_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7f3746a65e7d4ed994c942a878cb3d7d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib224229727c244f7ae39e55c0c9df44d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id3eb3a4c78e24298b72949d4acd6af55_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i313e801028b74041921b6b37ca22f649_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6fe027cba4b74bb3b95477816832e680_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idba21161446c43ccbb9debeea82200bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i47c21ce80c1947b39ed2fbaafbb5bb80_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i373d7d08dbe04fb9940eabc42c50f83a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i01b2ce787a3a4bc9884c22437e0f804e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i14063932285a47baaf67a27317285b57_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2d1aa65fad4a4c2088e713c20737e7ce_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i95f1f52b2b1b4200bc65210a3f67c839_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i498b99b9de474e2f9144406648261412_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8c79493c43ec4a598105cec06fd2dc82_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7f0a47c2a80f4fe0b4cdc6aa3b46a0f0_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="icb00a578313e4482a66c59493f18d456_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i65862cdd601d4522a8afad352086cb6a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6b4a0fdda9fc43a19cad6464963b6377_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i6e26fbeb5863440e9e721a1313cd6a22_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib46889ae15794ea6a849b7097df17e70_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iebaa49281ce34f088dcc3e920092930e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i93e3fc5bb5ed483ebb7e411c2c1b86a3_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i859fee6b0b4d4ef1bf57cc579f3ad5c1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8c64c701476f4358a5a5c9d9ea2fdf8a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2c4f929ec7804d5ba080985386fb1710_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iaa8987c19e604874ab033feedad56d43_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:RedeemableClassACommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0f815b2e739d41ebafd5da94bf4c8d6a_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if1681a4a94614a62ad87dae150f2220d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie87d3610f2c94903a4a299c11f9d0cc2_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i541d26427048423291dfa7496890fbfa_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i2c9f921c782846e594e898a25a3e7e57_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="i0bdb1af208e14b2ea352fb5361c65042_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i533a6c1123d5402bb7487743cb056ecc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i932569e05a89431ebc34c4b51b14c702_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i23ddbd3a57cb47d2b34bef8d1093c90f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib9aae412577446ebbf1adc5652403981_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i2ce0c2a663404279ad0d0d1d6271d369_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="i5c3a9475a70b4c2db3d6e0010a374a0e_I20210119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hims:HimsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-19</instant>
        </period>
    </context>
    <context id="i35a4fb924db24a85a1196789003372ba_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="i3ee826f19c8f474091f7807831d1a4a2_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="if23c020d049c42f8a21888c7cd351bf5_I20210119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hims:HimsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-19</instant>
        </period>
    </context>
    <context id="ie5182198da4045b7a12388e80e2263ab_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="i2ffc7b3d75784438b282649862e9f57e_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassAAndVMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i7ad8096dc8594c04b77015e5c84c1bfd_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hims:HimsStockholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ParentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="if85b92e8012f4f1593f4f90ae859fd82_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hims:HimsWarrantHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ParentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="i16335511aa6245258d50e49bba22ab99_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hims:HimsOptionAndRSUHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ParentWarrantRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i16bc3ab7ee094ed08651067218f9050a_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="i35fc17d5154d40cda4ba3221e9dcffb6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifd8ae28174c74bcbafe8e1b9e1296cad_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9b386e439e1545bb8595dd4c08d832e1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0d5c88b35bfb47219cf7c806d06b403f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib82714ac40bb439a93d73928f1f21331_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentAgenciesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6806d600b8f3488bb1c3fd3461c854a1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i110e767e14c549139091e08b11477a77_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hims:AffiliatedMedicalGroupsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib74f24447d164fde8a5bd9a5c8151c3d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9e0a54203ace4daf8d031a96662b2a6a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f396a9dac504e31a6c12e06a6f5e451_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic2df3bb0701545b6bfc7f10a7ab86773_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">srt:ConsolidationEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7d3aa17ad4214d73ac617595f9b25c56_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i17f7c6fe28314265a7171dccf5d0b1e1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie1261279d3aa492883efe6f3cd396cb3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia3f6c0cccb1747fab4662fd836029d53_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0da6465d5cfd441a8e436e127aad5c7e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ice63ea8cf53844e0864c120028d72122_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib363310ebb4645b0a3c4dd9026e8460b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if9857a89a397463b9c65163424b97b37_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie581b89d86bb4b27a922377f19e8768c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibaf57a370dcb4f3194869f3b6b0cc8ef_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iccc37ed1bbc44e95b445c711db6f3652_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3447faea2aa041928f7c8b0073fbfa56_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4e36e9ea2b4a410389a76edfd4bc808c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id21bfa4e61b64d21b588aa675df6b00e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5551c8f434cf4e9996e3e103dd9851e3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9dd0cb9d9b154483976882a2f8f17dae_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6d5316cfa402448b974312f0f0bc26ca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i77245f278ab24e148fb7d4fc5d3b59fc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5921abd0287d42bca47601e3138ee2b7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1e49409a01d64ff5bfdd179b67b5738c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id215004884234f36b4e29d5e5c970035_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i951242edbea04ed9a606420d62e43d5a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i331c1c09758e4c69a36701bae87d7d62_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5563144fb5ca4783b8c91e836f518044_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie21b17ce9282470780a4cb69a30b093f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iabbb558f9a6046f6a6d5d46c8153d18b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iccdf1b1af9d34e62a5785c63d9ca448c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i66b86854e56b4e96a87ecc1cda0a4203_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i44535c1c0c1942a59dc7b0356127e67b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie21c138cee4747ccb68c72561e6a795b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i412599e663c246f58192d84fe4e5c1b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7ad3e5023fd84a749114f9e9c5d8fe3a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i31da51b8ef1b4471a68135a9ca41a2d6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icfd5ade4260a4169b2a95d7bff1b3555_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id759fafd0df14ae7b07a52edb22e1ca9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5c4a1baeea1040a6bfbcedb38a9692e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3e6e3cda27214222b2b0bfe2a6683419_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ed5940103494fb785ddb8f61a51b123_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifda94c6105694420b4c8f321805f5ce1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie5013ddd007d4531aa596bb95e66ae50_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if5e442e5c43548c4948861619534ee83_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia16cd32451554ee58bc61ba0bd167f4d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateBondSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i33b128102f77412aae3acc936185d672_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99e1a4138a1e4cb69b365d76305514e5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0c40d2b1b9bf422baf436e98c75a1c04_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1f48df72d4d24ae497a675ff9cf956e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia7308d4762634cee8d9041732b9af184_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7eca143c66bf4203b6157bcac25d255b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i25ea3f8831144795bc21e4c954d3d744_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6fe48b31f8c34e88b6668252c5babd68_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1c7658a139f475181f2d9be70639547_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i16613643ae1546028149b3da23f7a029_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0bd82762a6b54ce086b7a833cdd8431c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic900949695af4a3f8a0e43ab44a1d546_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibf3e680104bd40d0a6d893fc9d407cbe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i16c0164539c14d3c8ffaafa97bcfab89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8e62e51bd26b485eb7df23994a15198e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i987f47d6dcfe4bbcac41361b3f772407_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic3283d5498c749f187e436d50e1f4646_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2f384c5987114c539e4c3c37fe1f66ab_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3fe856ce18a44b73b24c2b3b20e78100_I20191127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-27</instant>
        </period>
    </context>
    <context id="i5b82495f9a7d49a191625811b12a3abe_I20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-30</instant>
        </period>
    </context>
    <context id="i02b56d69d02b40c8bb34acbef31e8a91_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3a251b644bc0446c8e735717fbf04f53_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5a8d0ab00fc54564bf744ee2cdb48474_I20191127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:BusinessCreditCardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-27</instant>
        </period>
    </context>
    <context id="i68341f8644ea4e029489cb67df2b60c9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:BusinessCreditCardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0973a5a47b37445789cae6d5c00e8ead_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:BusinessCreditCardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i5a1bd4b3c5cf421eb59bc006d40c812b_I20191127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:CapitalAgreement2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-27</instant>
        </period>
    </context>
    <context id="i9d494bd599bc4c71829076ebfffdde40_I20191127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:CapitalAgreement2019TrancheOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-27</instant>
        </period>
    </context>
    <context id="i36b5c8248a21411787d87df95d270d0a_I20191127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:CapitalAgreement2019TrancheTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-27</instant>
        </period>
    </context>
    <context id="i7b388341898d4c259124f7ad120acc5c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hims:CapitalAgreement2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i75207e8547a1486e92e7339599496592_I20191127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:SeriesCPreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-27</instant>
        </period>
    </context>
    <context id="i85017d290ffd4ccda16318d642b40261_I20200312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:SeriesDPreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-12</instant>
        </period>
    </context>
    <context id="i9325ba192ff34fe4a7eec3cc7c4f7351_I20200312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:SeriesCPreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-12</instant>
        </period>
    </context>
    <context id="i5675e635aac644dca3d94839ad1ea8dd_D20200101-20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="i4d3f4663a5ae4f998ff2c4ed33cc4b76_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hims:NewAlbanyOhioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="icea812223fa644ce962e9076a86b988e_I20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="i5d8a878dc739415b9ef43d3cafdddb47_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="i5bc5c0ad0d79476dae92187902b6a0c6_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:StockPlan2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="ia94de2a141c34d8faee9c47c63a6c366_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i413bd17d5b324a2dad4f4ea75d1247df_I20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:StockPlan2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="ic1fd5fc3dab941e482cf5873aed90062_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i48ef13256a85415e97d20a62c058228a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:StockPlan2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0d283ed598c04971b9439dd96804192f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020And2017StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iee0a496af430479f9dfecc7ffbe8ba33_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020And2017StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8906c1a545c9405d8f6cc203bc4d9e99_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hims:EquityIncentivePlan2020And2017StockPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia971f9ce30c04ca082f9fb3fa86a9e3a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementNewEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i576248ed4b664370b9a1e90f22918f91_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementNewEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibc84ee6d825b47e9b4399d92dea27b78_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementCurrentEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2adc14d58e77476fbc6512ca96906059_D20200617-20200617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">hims:June172020GrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-17</startDate>
            <endDate>2020-06-17</endDate>
        </period>
    </context>
    <context id="i06c257b7b4f84b529f577d3f4aa15ac5_D20200617-20200617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">hims:June172020GrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-17</startDate>
            <endDate>2020-06-17</endDate>
        </period>
    </context>
    <context id="i32f3c2ba40fa476fa312666156c0f69b_I20200617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">hims:June172020GrantOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-17</instant>
        </period>
    </context>
    <context id="i11c5ad145e504aa281087775310908bf_I20200617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">hims:June172020GrantTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-17</instant>
        </period>
    </context>
    <context id="i1b379b532e70492d8cd6c9d96f11613d_I20200617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-17</instant>
        </period>
    </context>
    <context id="ia49cabd9f3a84ee39cb1386e25c9b760_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="iafad2c662fba4af0b34bd67db2d592d9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">hims:June172020GrantOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i84f2f42c202744b7b7bd251ae54caaf7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic3fd0dc602f14c74816bb2d095c72cfd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia619e550a49a42d88028da0bc367d495_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i07699e94c1ff4e72b8336fc2d39e4b76_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56db4fe025c047fd8e6046a280f8d46d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3569cba9a27b411f87207bfe4f13c768_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">hims:ShareBasedPaymentArrangementEmployeeExcludingCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icae0610134ea412ca26835b3d027983b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0764a9f39d15480ea6a5fd912a15958e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8154d378681848c08666cc454aeba717_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange006To040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i296427d49b16444e90fd07050ceb45e7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange006To040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i07019c3dea37410ca1b9e81a814fc572_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange155To233Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i91a56879fe24414495c14c13ef54b061_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange155To233Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i962be1bcc7954ffd848d65b2af00d37f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange243To365Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia020c048cca142b09ded25121b0ecf0f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange243To365Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0109a582058c4a30962735b0ef17b42f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange890To1335Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia30281f381f44828904e830e15c11803_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange890To1335Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4f39e7f28aa44acd97c7381291e6f1ac_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange1517To2276Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i85a98bf3e25f496e9e070d45dc8dbe79_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis">hims:ExercisePriceRange1517To2276Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id23bf3f94c8841a693c2abb9dbea49c4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6a9e72571629466e95f463c7efbcbd98_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7a6191f600fe4f5bba54740cfed54748_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i20ea7b45ce3547e9a8128fa8a07b9245_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0e017683d1224a57bcb05400dca67f22_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic0fd3b92233841f09e31e1c59722c266_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:EarnOutRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4f37e4e1d6084fe096e662b5ab77aecd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:ParentWarrantRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i618a5b5ebba449e4bbe23551147cf295_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:EarnOutRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifac9c5c2612043669180344154fb064a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:ParentWarrantRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i42057812c3884143b23614f4764c8109_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0fce2bdf00214d74b06a4e34ca921b88_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:EarnOutRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i51fbf31cd21a496f8b77b769104642ea_D20210101-20210131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:ParentWarrantRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="i05f1d9f417c54e328597f093403d6e89_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i881daecfe2934b7cafec114097e28cd3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idfb2bd7ccded4f77ae1362ca9d0a545a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14f486b4660647f98f37f78e924341b0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2886207377754f8d893c27f2490298a6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i98bfbbb5e3e147e3889c062c610a6917_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:EarnOutAndParentWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6a91c65f7eb54a3c989d98b6cb6a18a8_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hims:MarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8b7f6544633643809b6705cd0e2ede0d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">hims:MarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie769ad9b07ed4265a9edfbcfccff5ae1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3ad7aa6b76124ad6ae3961610c692d73_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesSeedPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i00d3c217869a498ea1da4262db18091c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesSeedPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id285b35ca96643e8a5dd6301ca706b17_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0dab5dbc93cf444c956b2f47e4145d28_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i973de7d14a4c409cb16e8a6b8963bff5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie241c9b58b1b41c5adc333a98cfa439d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesA1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2c496814f30146d2a8fffa0636e6175d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iec02bacd134949c3a43d4169ef4a503f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea410e7929fb4ea4866693138775bce3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i310c211669824a0ebd4e0cbbfecbee8c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesB1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia620070bccea49e8ae67e495e7cd6630_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesB2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36e32a096ad44dfab36246420544e57d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:SeriesB2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icbd0e86a85204fc19e2e004fc1ddae21_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90721555cbdb4b9e88888fbf57039262_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i01d6bc7c49f14a5ba7fec5954dbe1334_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i30440e6cee814b0795a79b39d6cc3d7f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i482412508e5048348a66e153dca18c8a_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i07ad18420cfc4998888024c661da561a_D20200301-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesDPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="ie64d700f04004ca28cce3f10ce2c702e_I20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:SeriesCPreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-29</instant>
        </period>
    </context>
    <context id="ia535ce992e724f86a62e762541499dca_D20200201-20200229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-01</startDate>
            <endDate>2020-02-29</endDate>
        </period>
    </context>
    <context id="i5c24e39c91df42cbaed7932bf65e2d02_I20200301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-01</instant>
        </period>
    </context>
    <context id="ia0f34e27b5684e27b0de10fc97914074_I20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:SeriesCPreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-30</instant>
        </period>
    </context>
    <context id="i8d64fe4256a5495dac515af8a61e6773_I20210119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
        </entity>
        <period>
            <instant>2021-01-19</instant>
        </period>
    </context>
    <context id="i080dafd9e34b47e7937c78d08d32b686_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i41048193847540548f3ba7ae46d9623e_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i2089a56369e04eacb54344b55b8e03a8_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:RepurchaseOfStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hims:FormerExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i26bd1b4cf75e452991194f1a1a3d5cac_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="i46d371e52a99410f95f88ff85bac410c_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="i0cc1f5f00f854fd696092abbe8e5eb52_D20200701-20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-07-31</endDate>
        </period>
    </context>
    <context id="i18d3dd2a0dd54782ac27fc6a98050d65_I20200731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-31</instant>
        </period>
    </context>
    <context id="i56a3708962c641f6884526a28a764d6b_D20201101-20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsGroupOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="i70b4853509034ba8ac52e45689f9837d_D20201101-20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-01</startDate>
            <endDate>2020-11-30</endDate>
        </period>
    </context>
    <context id="i5454149a7fff446f86e9e1f46fc3ecb0_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsGroupOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="iead7fc49159344e09cc08f0243c9f687_I20201130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-30</instant>
        </period>
    </context>
    <context id="ia7096ecca3bf42abb946e3f881384b0a_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsGroupTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if6fee565f9384a378a7733102fb1daf9_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4ff37ff4f4e94c939d22f573f503c48b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:CommonStockWarrantsGroupTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d5d169b09da40e69a931bb98ac54af4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8f09575a6074fbbbea2128ab741a987_D20210104-20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-04</startDate>
            <endDate>2021-01-04</endDate>
        </period>
    </context>
    <context id="i069f663c8a004fdfbd4a509b3f54b8d3_I20210104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-04</instant>
        </period>
    </context>
    <context id="i342bdc4fd0584aca99f4b91a317c0acb_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="ib55d8e031f574c38bb95ca3aec87d1bd_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="if6ac477b8fba4a68abf0f1384d4e9f3e_I20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ParentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-20</instant>
        </period>
    </context>
    <context id="iab13a99ae40f48409e0e1f3fd36fa413_I20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-28</instant>
        </period>
    </context>
    <context id="i2c70da65b2cb41f68da444e9a69d66ae_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="i79825d4c5b744870999e9bde3e8537f5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:VendorWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7376dfd331f74bd0b77f3b369c1c6b2a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:DebtWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i843814f57f6e400fa68052b3160a60fe_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1cc2663250444268a356d3527951ceb6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:ParentWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0929992266364d4095e65e0383a160d6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i54b4437d5bc64dd09ecb5bab58c279ad_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsWarrantRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2867394843aa406ea9a5eb734f9b7751_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsWarrantRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i65b1285ccd8544e6ab3ef4189e9e2fa5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsCashRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i98e637f1336e44e5af203fddfc5974c1_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">hims:PublicWarrantsCashRedemptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i771a07ec099545b09a6b92170d11d935_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8d14d0c90a8548aa962fa7748b3135a9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibb1c06dc151e466aa6cc22295c17a714_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:OperationalSupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie1a302a5f05545f79eca24d49954e1cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:OperationalSupportMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i312fd18031e24c0390d9be5de157fa4e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:IdentityVerificationServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i638236725896454da1131afdbb4606ed_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:IdentityVerificationServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i922947682b4841668dfbfe65e252e019_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:IdentityVerificationServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if227b428e44f45d982ddcf68a4372138_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:IdentityVerificationServicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i02a8feb03ad34f34b5b703765d4c44c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:NonrecourseRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if04cc3c5ee874113863826cf1cba7153_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:NonrecourseRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iadf5123ee59348dda3e8699ab30bad2c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:NonrecourseRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie6b30bf8b001432a828df2ce3d0da827_D20210120-20210120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:NonrecourseRelatedPartyPromissoryNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:ManagementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-20</startDate>
            <endDate>2021-01-20</endDate>
        </period>
    </context>
    <context id="ic59ae3ede9fb4cc19a25f9ae9330b9c1_D20190923-20190923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hims:ChiefExecutiveOfficerAndDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hims:SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-23</startDate>
            <endDate>2019-09-23</endDate>
        </period>
    </context>
    <context id="i8a589e0752164dc492e454a20349d082_I20190923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hims:ChiefExecutiveOfficerAndDirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hims:SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-23</instant>
        </period>
    </context>
    <context id="ic37899a64fdb4b35b8953afb27a19de6_D20190923-20190923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">hims:RedeemableCommonStockTransactionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-23</startDate>
            <endDate>2019-09-23</endDate>
        </period>
    </context>
    <context id="i6aabfe45198043d3a411876caa90f87c_D20190923-20190923">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">hims:RedeemableCommonStockTransactionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">hims:CEOAndDirectorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-23</startDate>
            <endDate>2019-09-23</endDate>
        </period>
    </context>
    <context id="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i757faef54662457b89e18e28fb99922d_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6168af5421b947c983b702984f8157bc_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">hims:CommonClassFMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i442b98b30a99440cabcf9c2a33258c44_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hims:StockOptionsSubjectToNonrecoursePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib288e8afaab1439aa8563d67d92545a5_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hims:StockOptionsSubjectToNonrecoursePromissoryNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie88ff03799b74ad5965527925463ef9a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hims:EarlyExerciseOfStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3a72b9ac461b4533a1192dda838f4fe4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">hims:EarlyExerciseOfStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i06d6c621d2034e6dafae9bcb378bdff9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i92de8792f23848c58e1d809553528fd6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iecae2ba52ea34c6892d78a05a039922b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6c000d18bcbb4f6281442b9c9affe5d1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie90befcd560f42a9bf949f5bd7f3347d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6eb6f513a1aa4980bc4049b422e1e15b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i44f09386b1fe4221a24a4ffa57406c7b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4c9d172982e54c3dbf74e0a823776639_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7772b0e6965c459ead748797e372c5a3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8196ddc57e7a4bfab7217e738f15cb7a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001773751</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="day">
        <measure>hims:day</measure>
    </unit>
    <unit id="common_stock_class">
        <measure>hims:common_stock_class</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMjYyL2ZyYWc6MGRmOTQyZWU0MDE4NDg0MTljYWE5MmUwMWEzMDcyZTUvdGFibGU6YWM3MGMzY2EyNTFmNDZmNTg1Y2Q1ZWE2MmE3ZWNjNDEvdGFibGVyYW5nZTphYzcwYzNjYTI1MWY0NmY1ODVjZDVlYTYyYTdlY2M0MV8zLTEtMS0xLTI3NzI_20478b59-4a79-487b-8845-c66d81ad99e5">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMjYyL2ZyYWc6MGRmOTQyZWU0MDE4NDg0MTljYWE5MmUwMWEzMDcyZTUvdGFibGU6YWM3MGMzY2EyNTFmNDZmNTg1Y2Q1ZWE2MmE3ZWNjNDEvdGFibGVyYW5nZTphYzcwYzNjYTI1MWY0NmY1ODVjZDVlYTYyYTdlY2M0MV80LTEtMS0xLTI3NzI_f1d4b597-e310-45fb-ac9d-0229ec443fb9">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMjYyL2ZyYWc6MGRmOTQyZWU0MDE4NDg0MTljYWE5MmUwMWEzMDcyZTUvdGFibGU6YWM3MGMzY2EyNTFmNDZmNTg1Y2Q1ZWE2MmE3ZWNjNDEvdGFibGVyYW5nZTphYzcwYzNjYTI1MWY0NmY1ODVjZDVlYTYyYTdlY2M0MV81LTEtMS0xLTI3NzI_41f2bdfb-ba60-41a5-a305-b46adc494835">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMjYyL2ZyYWc6MGRmOTQyZWU0MDE4NDg0MTljYWE5MmUwMWEzMDcyZTUvdGFibGU6YWM3MGMzY2EyNTFmNDZmNTg1Y2Q1ZWE2MmE3ZWNjNDEvdGFibGVyYW5nZTphYzcwYzNjYTI1MWY0NmY1ODVjZDVlYTYyYTdlY2M0MV82LTEtMS0xLTI3NzI_69a88403-c746-4cb4-b758-7cab550eb51c">0001773751</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMjYyL2ZyYWc6MGRmOTQyZWU0MDE4NDg0MTljYWE5MmUwMWEzMDcyZTUvdGFibGU6YWM3MGMzY2EyNTFmNDZmNTg1Y2Q1ZWE2MmE3ZWNjNDEvdGFibGVyYW5nZTphYzcwYzNjYTI1MWY0NmY1ODVjZDVlYTYyYTdlY2M0MV83LTEtMS0xLTI3NzI_ca9a14b2-a55e-4cfb-b1d1-4e6d63bd0eca">--12-31</dei:CurrentFiscalYearEndDate>
    <hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjExMQ_0328a105-577b-490b-8bab-4760962a29c8">P5Y</hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod>
    <hims:LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement
      contextRef="i5675e635aac644dca3d94839ad1ea8dd_D20200101-20200131"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ2Nw_b7a72c41-6787-457a-a407-941a4bba5358">P3M</hims:LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement>
    <hims:ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage
      contextRef="ia971f9ce30c04ca082f9fb3fa86a9e3a_D20210101-20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNzAxL2ZyYWc6YjFkMjc3MTgxYjg0NDRjZWIwNzlmNDcyNjAwNzVhMjIvdGV4dHJlZ2lvbjpiMWQyNzcxODFiODQ0NGNlYjA3OWY0NzI2MDA3NWEyMl82MDQ3MzEzOTUyODkx_bf904728-4925-4853-8e3f-51d1ebf8390e"
      unitRef="number">0.02083</hims:ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage>
    <hims:ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage
      contextRef="ibc84ee6d825b47e9b4399d92dea27b78_D20210101-20210331"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNzAxL2ZyYWc6YjFkMjc3MTgxYjg0NDRjZWIwNzlmNDcyNjAwNzVhMjIvdGV4dHJlZ2lvbjpiMWQyNzcxODFiODQ0NGNlYjA3OWY0NzI2MDA3NWEyMl82MDQ3MzEzOTUyOTAz_83b04c4c-17cd-480b-b047-96f25e3f4fc9"
      unitRef="number">0.02083</hims:ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage>
    <dei:DocumentType
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTE2_c65aff8c-9bf8-4cde-9f73-2543f6a09214">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTIz_d11a62f1-eb7f-416c-839f-14bae9545d11">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF8xMjA5NDYyNzkwNzk1OA_ba8c119e-49e4-4508-b932-5ea2b23930fd">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTI0_f6dde443-4b61-44ae-aa6b-b339ae2c2d36">false</dei:DocumentTransitionReport>
    <dei:EntityRegistrantName
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTI1_57887616-e9f5-47b0-9869-cf2f24effe30">HIMS &amp; HERS HEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6OTAzMmNhM2EyMGE1NDQ4NWEyZTJiY2U5NWI3OTIzYjUvdGFibGVyYW5nZTo5MDMyY2EzYTIwYTU0NDg1YTJlMmJjZTk1Yjc5MjNiNV8wLTAtMS0xLTI2NjE_01474a30-950d-43a4-b313-eee64b794e6f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6OTAzMmNhM2EyMGE1NDQ4NWEyZTJiY2U5NWI3OTIzYjUvdGFibGVyYW5nZTo5MDMyY2EzYTIwYTU0NDg1YTJlMmJjZTk1Yjc5MjNiNV8wLTItMS0xLTcyNzE_91202bb5-1c91-40ad-b22d-a9014bc29c8e">001-38986</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6OTAzMmNhM2EyMGE1NDQ4NWEyZTJiY2U5NWI3OTIzYjUvdGFibGVyYW5nZTo5MDMyY2EzYTIwYTU0NDg1YTJlMmJjZTk1Yjc5MjNiNV8wLTMtMS0xLTI2NjM_f2a3034d-1655-4ead-b955-00d9bbf65a14">98-1482650</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6YjY5ZDcxNDY4YTcyNGQxNjk4ZjNjOWYzNDU3YTYyMjUvdGFibGVyYW5nZTpiNjlkNzE0NjhhNzI0ZDE2OThmM2M5ZjM0NTdhNjIyNV8wLTAtMS0xLTI2NjU_a6119a99-6731-4e9d-81fb-48305b66a982">2269 Chestnut Street, #523</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6YjY5ZDcxNDY4YTcyNGQxNjk4ZjNjOWYzNDU3YTYyMjUvdGFibGVyYW5nZTpiNjlkNzE0NjhhNzI0ZDE2OThmM2M5ZjM0NTdhNjIyNV8wLTItMS0xLTI2Njc_ec99c5d9-f1bc-41bc-9816-f4d55ec603ce">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6YjY5ZDcxNDY4YTcyNGQxNjk4ZjNjOWYzNDU3YTYyMjUvdGFibGVyYW5nZTpiNjlkNzE0NjhhNzI0ZDE2OThmM2M5ZjM0NTdhNjIyNV8wLTQtMS0xLTI2Njk_f0c3ec3d-9698-49fb-b552-cb9e714bb008">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6YjY5ZDcxNDY4YTcyNGQxNjk4ZjNjOWYzNDU3YTYyMjUvdGFibGVyYW5nZTpiNjlkNzE0NjhhNzI0ZDE2OThmM2M5ZjM0NTdhNjIyNV8wLTYtMS0xLTI2NzE_88de16d1-1208-4d14-9b52-54d1a96b542a">94123</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTI3_85fac8d1-32a5-4b55-8f02-7451c34b9738">415</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTMx_24037ea5-463a-49ef-8b34-d9c4c339cd1d">851-0195</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18xLTAtMS0xLTI2OTQ_528b2d90-e9f0-4f17-8396-ffcb962ba484">Class A common stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18xLTEtMS0xLTI2OTY_c6a65eca-cf23-4a7d-bcce-f2ee2debda30">HIMS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18xLTItMS0xLTI2OTg_fc67d1fe-908b-4b11-bcaa-906d80f82e77">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i2edfec64c15947d89d7391ae34a7c55c_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18yLTAtMS0xLTcyNzM_3fd44c7a-ad8b-4b75-935c-f2889b43175f">Redeemable warrants, each whole warrant exercisable for one share of Class A common stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i2edfec64c15947d89d7391ae34a7c55c_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18yLTEtMS0xLTcyNzM_a55ac6de-043c-435e-b9bb-2c543c2d8c56">HIMS WS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i2edfec64c15947d89d7391ae34a7c55c_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGFibGU6ZjU2NGYyODc2ZDE1NDVhZmExMGJmMDY1ZmMzZTU2OTMvdGFibGVyYW5nZTpmNTY0ZjI4NzZkMTU0NWFmYTEwYmYwNjVmYzNlNTY5M18yLTItMS0xLTcyNzM_51c1fe5c-3062-4a40-8b6d-ada8cab6dad6">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTgx_99fed404-1a7f-435d-b082-d0cecbca21ee">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTgy_ab869d57-cc27-47d9-af16-00f1abcc5d5b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTg1_cac148a1-f7c0-4208-a2fc-ee78bb06a08a">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTgz_c67cfc0d-4189-41fd-a60c-ec9aa9454a35">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1MTg0_3f3d0e54-5100-4ba1-9d11-c63af23a6f94">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1Njc5_703683dc-a51d-4e74-bc52-962c2ad9249e">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU2MTIx_129f49e5-0df2-4495-ada0-81a151703a74">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1b1cf446284148a4ab9d5ea405db014a_I20210514"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU2MzI2_dc1d9809-66e8-4b0e-b8b5-5b2090d61403"
      unitRef="shares">183424155</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ida06d917140d461e83e2c6831d4ef512_I20210514"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xL2ZyYWc6YmU1MTliMDE1NmI2NGFjNGEzNDlhYTNjNDkwM2I1ZjAvdGV4dHJlZ2lvbjpiZTUxOWIwMTU2YjY0YWM0YTM0OWFhM2M0OTAzYjVmMF82MDQ3MzEzOTU1NjY3_2fb2db8f-aeb1-42de-811c-b0785c39fe46"
      unitRef="shares">8377623</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNC0xLTEtMS0w_a390ad34-194e-4fc9-a1a9-004a75e2e160"
      unitRef="usd">88169000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNC0zLTEtMS0w_26b0ce6b-98b8-463e-87d0-631b046ac207"
      unitRef="usd">27344000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNS0xLTEtMS0w_b0609661-eded-4a9a-8b6f-37fab63f4757"
      unitRef="usd">235097000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNS0zLTEtMS0w_f3846d72-15bb-4317-96db-61db74685569"
      unitRef="usd">72864000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:InventoryNet
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNi0xLTEtMS0w_f17e983c-6a03-4917-b9e7-d9bed100d0bb"
      unitRef="usd">4523000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNi0zLTEtMS0w_e5358291-d3da-463a-bbb3-52c9f739ae91"
      unitRef="usd">3543000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNy0xLTEtMS0w_029a5dd3-4a95-4889-ba1e-73a3e7b610f6"
      unitRef="usd">12407000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfNy0zLTEtMS0w_496f6421-5ef6-4b2f-b23d-cde4fd5647dc"
      unitRef="usd">5404000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:DeferredCostsCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfOC0xLTEtMS0w_b691da16-223b-4daf-8935-90bd9f2e2ae0"
      unitRef="usd">0</us-gaap:DeferredCostsCurrent>
    <us-gaap:DeferredCostsCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfOC0zLTEtMS0w_731b6b04-5fbf-431d-8039-a80a457a7b0b"
      unitRef="usd">3929000</us-gaap:DeferredCostsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfOS0xLTEtMS0w_5417c964-cec7-4af2-aa4f-40fa16006235"
      unitRef="usd">340196000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfOS0zLTEtMS0w_6411d817-e81d-4d1e-b3ba-11e98147a54e"
      unitRef="usd">113084000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTAtMS0xLTEtMA_e8b7419d-9198-4088-928c-24b30f703ddc"
      unitRef="usd">856000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTAtMy0xLTEtMA_ba9687bb-44d1-4a7a-91e2-80a8eba72982"
      unitRef="usd">1006000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTItMS0xLTEtMA_4c56657e-8947-490b-83fc-bbe719f50905"
      unitRef="usd">4848000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTItMy0xLTEtMA_1f0c3724-ac66-42f2-a9b0-382c386c98e8"
      unitRef="usd">4607000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTMtMS0xLTEtMA_092002e9-f0c5-4709-ab5f-02824699e7fe"
      unitRef="usd">345900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTMtMy0xLTEtMA_d743235d-e48c-4a92-9d92-698106f8f27b"
      unitRef="usd">118697000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTYtMS0xLTEtMA_9d2de76f-1e32-430e-ab1e-dca343b77be3"
      unitRef="usd">13233000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTYtMy0xLTEtMA_dcd8fa3a-4bd8-4043-9f10-d1ffb3dc4217"
      unitRef="usd">8066000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTctMS0xLTEtMA_ba244550-e003-4fc9-a254-3291debdb92a"
      unitRef="usd">5823000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTctMy0xLTEtMA_ab666d1b-0ff4-4cd0-88b5-fa677e80af7b"
      unitRef="usd">4984000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTgtMS0xLTEtMA_b8dee365-de24-417f-9164-2c1963ce1f0e"
      unitRef="usd">624000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMTgtMy0xLTEtMA_77b18838-26d7-4d39-88a7-4d9f07127bfe"
      unitRef="usd">1272000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <hims:WarrantsAndRightsOutstandingCurrent
      contextRef="iad3d9f1d28194144988117c8661db3c7_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjAtMS0xLTEtMA_7dbb9f98-c34d-44cc-9dfe-cdf2f0d41eb2"
      unitRef="usd">0</hims:WarrantsAndRightsOutstandingCurrent>
    <hims:WarrantsAndRightsOutstandingCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjAtMy0xLTEtMA_173c0e0e-8db1-4638-9fe8-ab5c1df246ee"
      unitRef="usd">906000</hims:WarrantsAndRightsOutstandingCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjEtMS0xLTEtMA_3b86675b-cdc4-49a0-b164-4708c4a2dd91"
      unitRef="usd">19680000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjEtMy0xLTEtMA_41714eb4-d28d-42ef-9d13-147578b5b78b"
      unitRef="usd">15228000</us-gaap:LiabilitiesCurrent>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjAtMS0xLTEtMjA2NzQ_17f029e7-d0a7-4558-a743-3250e20cdbfd"
      unitRef="usd">33370000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjAtMy0xLTEtMjA2NzQ_bc1c0416-4afa-4ca7-a0f2-ef202e1ab535"
      unitRef="usd">0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:DeferredRentCreditNoncurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjItMS0xLTEtMA_653e787e-79d5-46fb-b456-1b2821cf0ad5"
      unitRef="usd">384000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:DeferredRentCreditNoncurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjItMy0xLTEtMA_e60ac8a2-d1f7-4183-950d-a666771aa2ee"
      unitRef="usd">381000</us-gaap:DeferredRentCreditNoncurrent>
    <us-gaap:Liabilities
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjMtMS0xLTEtMA_a031d5ec-dfa5-442b-8289-6dc35cd027b5"
      unitRef="usd">53434000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjMtMy0xLTEtMA_7a045a39-59ab-4db4-ab48-bc2d687fe7b0"
      unitRef="usd">15609000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjQtMS0xLTEtNTQ4Nw_41e35655-c986-4914-9e2b-1b5c3712ad16"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjQtMy0xLTEtNTQ4OQ_a39d27ec-56b1-4205-88b6-ce0194dab6b6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzI3NDg3NzkwNjk2Nzg_1b09cc17-9252-490e-9739-06bdce5b23da"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzI3NDg3NzkwNjk2Nzg_52dbb9ac-d66f-44e3-8fbf-ea1f632abb16"
      unitRef="usdPerShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzI3NDg3NzkwNjk2ODY_717f8f3a-aebf-462d-b85a-f4c01e106f8a"
      unitRef="shares">275000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzU1_1f900fd6-195f-47f0-86a9-e8c0d8937827"
      unitRef="shares">95997674</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzYwNDczMTM5NTMwNzk_17949646-a662-4e5b-9561-d4bd5f41c4a2"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzYwNDczMTM5NTMwNzk_78f20977-fafb-48d1-825f-a6b242a5ad82"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4Xzg3_0f1aaa1c-7411-49d2-be9a-501e5b1e8fa4"
      unitRef="shares">93328118</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4Xzg3_bfdddda2-9ee6-4340-b747-a3a96cf7d830"
      unitRef="shares">93328118</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzU0OTc1NTgxMzkxNzU_1538c5db-48e5-4a1b-ab43-15e60b70bed6"
      unitRef="usd">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMC0xLTEtMC90ZXh0cmVnaW9uOjNjZWU5NDgzOGJlMTQxNjZhZDg4MWVkYTcwOWNkMTk4XzE4NA_749dc0b4-3c49-48c7-aaa6-2dcb3ad15a6c"
      unitRef="usd">268452000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMS0xLTEtMA_fbb430a9-a2da-4cac-88c5-3abf32ff6250"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjYtMy0xLTEtMA_97536cdb-f18f-4044-b329-08a5d5488aee"
      unitRef="usd">249962000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjgtMS0xLTEtMA_7c2b70d4-1953-40c3-b1da-4f1846d8d227"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMjgtMy0xLTEtMA_a5c29f35-1d63-48ac-9c6d-df3177bfa95e"
      unitRef="usd">249962000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if163a4f44b68493db66e067e3b8486e6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk2ODk_c4eae99a-0fb0-48a3-af0e-7f2ff1cf46b6"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i64997c5f30d84597aaf8c79404b17e9f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk2ODk_d3810aa0-0476-4519-88ab-25c871854f8e"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i64997c5f30d84597aaf8c79404b17e9f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzQ5_4b31c3f2-0b60-41bc-b131-9cd36c93d194"
      unitRef="shares">2750000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if163a4f44b68493db66e067e3b8486e6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzU2_6830f3c0-47e7-49a4-b42e-ac33f9c4d22b"
      unitRef="shares">166696759</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i64997c5f30d84597aaf8c79404b17e9f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzgx_6561dd21-a4c2-4f96-be04-a4ba0eb92105"
      unitRef="shares">182973780</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i64997c5f30d84597aaf8c79404b17e9f_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzgx_b02ed279-b88e-4caa-9a46-ee233b90f8e4"
      unitRef="shares">182973780</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if163a4f44b68493db66e067e3b8486e6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzg4_2af8836d-619a-45bb-bdd8-8bd2334f0bac"
      unitRef="shares">46025754</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="if163a4f44b68493db66e067e3b8486e6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzg4_be3ba1c3-aa0f-46aa-84f6-25fe09aa7783"
      unitRef="shares">46025754</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i43c7f88bdd024bed8ed820a0bbf53b11_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk4MzA_c2086ed5-0de3-44af-9692-cef4d34bf6e6"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i43c7f88bdd024bed8ed820a0bbf53b11_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzE4Mg_80122822-9dcc-49c5-aa69-1e6f16e9b6b5"
      unitRef="shares">10000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i43c7f88bdd024bed8ed820a0bbf53b11_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk4MTY_1b7ae545-bc3d-4e0f-a4d3-b12867f60719"
      unitRef="shares">8377623</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i43c7f88bdd024bed8ed820a0bbf53b11_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk4MTY_ae7d7089-00d0-45a1-a0bc-070f685cd87c"
      unitRef="shares">8377623</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib7fedba8f2404efe9b39de971e70cf0f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk3OTI_4a1603bb-acc2-408b-9cb8-f466286295af"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib7fedba8f2404efe9b39de971e70cf0f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk3OTY_6abe3664-4d40-447a-8c97-3bb69f27e7c4"
      unitRef="shares">6941352</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib7fedba8f2404efe9b39de971e70cf0f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk3OTY_9c8701a9-d085-47de-bdee-f1fadae4d279"
      unitRef="shares">6941352</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib7fedba8f2404efe9b39de971e70cf0f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOjUyMzBkNWE1MDhiMTRkZGE4NjMwNWFhNjA2ZGFjN2MxXzI3NDg3NzkwNjk3OTY_e5707362-5ab8-495b-a078-8d91028d4da9"
      unitRef="shares">6941352</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMS0xLTEtMA_7c18229e-74a0-4efa-a791-2d00868e5fb0"
      unitRef="usd">18000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzAtMy0xLTEtMA_38a7127e-4cf4-4220-b467-1268bb5e86bd"
      unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzEtMS0xLTEtMA_31a75e02-6e1f-43f3-9e01-94683793b8c3"
      unitRef="usd">515216000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzEtMy0xLTEtMA_4b73d495-3dda-408f-834b-3cdcf3298f04"
      unitRef="usd">24429000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzItMS0xLTEtMA_d77b17c6-2468-44fa-968c-7ec02d8739a3"
      unitRef="usd">-72000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzItMy0xLTEtMA_e8828ded-4397-41da-8109-18ad15b29428"
      unitRef="usd">-11000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzMtMS0xLTEtMA_eddc1482-fc75-48cd-a314-34a9d757ae7f"
      unitRef="usd">-222696000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzMtMy0xLTEtMA_1b183392-e6ee-4791-b2cf-75e2a71c93c7"
      unitRef="usd">-171292000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzQtMS0xLTEtMA_bc526cd2-e51a-45d7-b7b5-aa0dab5608d2"
      unitRef="usd">292466000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzQtMy0xLTEtMA_b909a948-a84e-4bdb-a9ab-61c72605f700"
      unitRef="usd">-146874000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzUtMS0xLTEtMA_238dad0e-7490-4524-8455-17d9f60e69b5"
      unitRef="usd">345900000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMy9mcmFnOjlmNWRhNDQyYTAwNzRkOGViNTY4ODEzZmRhMmFkOTczL3RhYmxlOjFmOTUzNjg0NTg0ZDQyNTVhOGJhZDk5ODc1MTVlZmM0L3RhYmxlcmFuZ2U6MWY5NTM2ODQ1ODRkNDI1NWE4YmFkOTk4NzUxNWVmYzRfMzUtMy0xLTEtMA_7964f4b4-e5ad-4318-a8cc-a72307075c68"
      unitRef="usd">118697000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMi0xLTEtMS0w_0ac469aa-e162-4868-a4a6-689000431bdd"
      unitRef="usd">52314000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMi0zLTEtMS0w_9e8cb811-3278-4e15-9315-84165e55fe40"
      unitRef="usd">30063000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMy0xLTEtMS0w_42d6e1ad-229d-48fe-b850-c8823d3b0218"
      unitRef="usd">12067000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMy0zLTEtMS0w_ae2c7b92-c18e-4f58-9c6c-720c37501ed1"
      unitRef="usd">9444000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNC0xLTEtMS0w_9138f1a2-5d8e-4046-a7e6-8c16b276e8ac"
      unitRef="usd">40247000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNC0zLTEtMS0w_5bcb6194-8d0a-4327-8125-27da293ac1f1"
      unitRef="usd">20619000</us-gaap:GrossProfit>
    <us-gaap:MarketingExpense
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNi0xLTEtMS0w_943109f3-0323-4240-a5b8-e4884d5b64ff"
      unitRef="usd">26958000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNi0zLTEtMS0w_4fe625e9-6a65-4a15-ba07-4cb85a26f809"
      unitRef="usd">12773000</us-gaap:MarketingExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNy0xLTEtMS0w_691ab159-6b8e-4b4b-848d-fe56cb58a564"
      unitRef="usd">61698000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfNy0zLTEtMS0w_94376419-49a6-4030-b488-d88f3bb7e85d"
      unitRef="usd">14064000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfOC0xLTEtMS0w_f06e54d6-c0e7-4a4e-a2f8-c50f6eb03537"
      unitRef="usd">88656000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfOC0zLTEtMS0w_2468ea41-edf0-44e2-8a12-406faf90d49c"
      unitRef="usd">26837000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfOS0xLTEtMS0w_30b638dd-2c7a-47cc-9ad2-aaed48e6fab5"
      unitRef="usd">-48409000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfOS0zLTEtMS0w_66ed8991-f75a-42a2-8b13-05ed6b76d16e"
      unitRef="usd">-6218000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTEtMS0xLTEtMA_0442778e-76c2-4002-b02b-96f5ebdff28d"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTEtMy0xLTEtMA_ead93521-72ca-44e4-89a9-c55026427f69"
      unitRef="usd">10000</us-gaap:InterestExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTItMS0xLTEtMA_e2c90ef2-7442-4f8e-8e4b-579b06d77832"
      unitRef="usd">-2905000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTItMy0xLTEtMA_f6249fb2-e1d9-4b48-bcbe-75a34389d692"
      unitRef="usd">230000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTMtMS0xLTEtMA_f91ab45c-5d13-4768-abae-1f1e3488afa4"
      unitRef="usd">-51314000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTMtMy0xLTEtMA_50fb9f5f-c0b7-4ddb-8804-a44f12f763da"
      unitRef="usd">-5998000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTQtMS0xLTEtMA_2155c69f-275a-46a2-b941-05f363516ee1"
      unitRef="usd">90000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTQtMy0xLTEtMA_100474db-a139-4a7d-8bc8-0edae8411a19"
      unitRef="usd">35000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTUtMS0xLTEtMA_0d173d55-1e52-43ff-ab7e-1d98c066bb46"
      unitRef="usd">-51404000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTUtMy0xLTEtMA_2bcced5d-9c1e-4e9b-ba28-3ac0de144697"
      unitRef="usd">-6033000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTYtMS0xLTEtMA_001eced4-53c4-426d-b850-5051758f3931"
      unitRef="usd">-61000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTYtMy0xLTEtMA_10ab1f5c-3b54-49f2-bfc9-b138475174d3"
      unitRef="usd">-42000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTctMS0xLTEtMA_6dd570a6-07bb-49ea-abb2-e2cd315adc73"
      unitRef="usd">-51465000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTctMy0xLTEtMA_399a0d62-f4b5-447c-9d3f-b18e552a69aa"
      unitRef="usd">-6075000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTktMS0xLTEtMA_9754af05-5da3-4f45-819c-faddf96e564a"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTktMS0xLTEtMA_bf11ef28-3db6-465b-989d-dcf2cba04f28"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTktMy0xLTEtMA_8ae377b7-1e12-4227-8431-4cbc6bf12912"
      unitRef="usdPerShare">-0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMTktMy0xLTEtMA_b040bcba-27cc-4b11-aea9-5b5fec689081"
      unitRef="usdPerShare">-0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMjEtMS0xLTEtMA_c47b4536-3e18-4e8c-aebd-a45fea1f5bc7"
      unitRef="shares">153080538</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMjEtMS0xLTEtMA_f52394e3-e639-473f-86eb-425243dbfde4"
      unitRef="shares">153080538</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMjEtMy0xLTEtMA_8ce36ee0-4ecd-462f-a4bc-baa4907b6a0b"
      unitRef="shares">34610061</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xNi9mcmFnOjBmNzY1Y2E4M2M4OTQ4M2NhNWY4Nzg3MDAxZTJiZTMwL3RhYmxlOjM0YTA3YWFlODQxMDRiNTM5Mzk4NzY2NmQ5NDU2NThmL3RhYmxlcmFuZ2U6MzRhMDdhYWU4NDEwNGI1MzkzOTg3NjY2ZDk0NTY1OGZfMjEtMy0xLTEtMA_d99efc90-ec26-4c87-b76e-b5dc455e8a40"
      unitRef="shares">34610061</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i792d7143c7e54d839bf9f447a23d5618_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xLTEtMS00NTE3_9cc57cc4-1946-4915-b5bb-9b0a41433532"
      unitRef="shares">206031290</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i792d7143c7e54d839bf9f447a23d5618_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0zLTEtMS00NTU5_2e3bfca8-6c1e-4c87-ac71-1ef0ee362a84"
      unitRef="usd">249962000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1f47e3f1375b4282b2f716b16c7f63c1_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi01LTEtMS05ODY3_2e346305-ac0a-401b-8c41-c081cea47c27"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i1f47e3f1375b4282b2f716b16c7f63c1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi03LTEtMS05ODY3_a84a9c4b-2cc5-4251-a1fd-9fb11b0b3ae3"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ib87290b070ee4c958c8ad766257920b6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi01LTEtMS00NTU0_563a30a4-8b8f-4b63-8a5f-4b120f34f325"
      unitRef="shares">116930602</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ib87290b070ee4c958c8ad766257920b6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi03LTEtMS00NTU0_03b711f4-244c-436d-ae8c-64e4c967c6be"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if6ed049ade5b4240a293550a94b55de3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xMC0xLTEtNDU1MA_ed585789-f6b3-4c82-b77f-13739124faa6"
      unitRef="usd">24429000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7fe00541b18143fba9a548d496dfb366_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xMi0xLTEtNDU1MA_7351b198-e3ea-4c82-9487-d8b6b2f26386"
      unitRef="usd">-11000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec13139dbbe74ce284027b71cc7aab9c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xNC0xLTEtNDU0MA_6d7c8142-7691-4066-94b3-743dab0d5359"
      unitRef="usd">-171292000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie22663228da14a50972ddb2d671033c3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xNi0xLTEtNDU0MA_3dc525cf-fecb-4c9b-bfb5-fa239ce50485"
      unitRef="usd">-146874000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i9cb115824ec34508bcd4a4a5cdc3f9da_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0xLTEtMS00NTE3_c53e1a20-4620-41f1-85c1-cd4190210407"
      unitRef="shares">112703172</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i417d0d1092d44ad0861530bdff9221e6_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy01LTEtMS00NTU0_99ab2f2e-fcdb-4115-85b0-fbe2bfd7778b"
      unitRef="shares">63963496</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i417d0d1092d44ad0861530bdff9221e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy03LTEtMS00NTU0_c0626e15-daac-4cf4-b5c3-190f1132d445"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i60ca4e5da0f14565ac395c1f2874530c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0xMC0xLTEtNDU1MA_b9f62c82-3d4c-411f-8697-f080d35149e8"
      unitRef="usd">-5000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i066ff8ea972a49dd9ad1c4f332e6c655_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xLTEtMS00Mjc5_5a721872-9dfd-4a51-96af-a8b84a0e19e4"
      unitRef="shares">93328118</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i066ff8ea972a49dd9ad1c4f332e6c655_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0zLTEtMS00Mjg4_6d3a50fc-fd19-4b20-b24b-ce3c356bd730"
      unitRef="usd">249962000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i735114ee932b44528649a12d298232eb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC01LTEtMS05ODY3_ded4a007-ec5f-46e4-8f6f-79da45d825da"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i735114ee932b44528649a12d298232eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC03LTEtMS05ODY3_7d44398c-34bf-4b42-979a-627f95445892"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i4ffa9196bf234ff0ade6790ed45d90db_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi01LTEtMS00Mjkx_67258e0a-e69a-4916-9e51-48661d90c23a"
      unitRef="shares">52967106</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i4ffa9196bf234ff0ade6790ed45d90db_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi03LTEtMS00Mjkx_5eca88af-243a-4477-aed3-1c416a0fa7e1"
      unitRef="usd">5000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iffd6f90426014cc5a2a7167bb4a3601e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xMC0xLTEtNDI5Nw_5e7322d6-30a3-4c81-a660-048b90a2aa7d"
      unitRef="usd">24424000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibbecfcc087fd493a80b3a69f6a762834_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xMi0xLTEtNDI5Nw_35ecb0a5-391e-4a5f-819c-3aafa7d98353"
      unitRef="usd">-11000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i72a366adb8ae4f1aa5df0ef732686620_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xNC0xLTEtNDMwMA_9a6c469a-c153-4fd1-b59f-4c98a803dd0c"
      unitRef="usd">-171292000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMi0xNi0xLTEtNDMwMA_5df5b95c-2bd7-445c-8d83-2f5afb0f7b4c"
      unitRef="usd">-146874000</us-gaap:StockholdersEquity>
    <hims:TemporaryEquityStockRepurchasedDuringPeriodShares
      contextRef="i41f7b9d6eea64578809c722be8aea527_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0xLTEtMS00Mjc5_75e87c53-cd4e-4c6a-ba38-d2ca1409731e"
      unitRef="shares">206511</hims:TemporaryEquityStockRepurchasedDuringPeriodShares>
    <hims:TemporaryEquityStockRepurchasedDuringPeriodValue
      contextRef="i41f7b9d6eea64578809c722be8aea527_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0zLTEtMS00Mjg4_f90e6bad-65e8-48f4-b905-549ac1a8f3bd"
      unitRef="usd">125000</hims:TemporaryEquityStockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy01LTEtMS00Mjkx_f6f1f9a4-15c2-4cef-86db-0d5e5bab8e68"
      unitRef="shares">1817519</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0xMC0xLTEtNDI5Nw_bbfe4fa8-33f4-40c4-888c-ca767eaa6da5"
      unitRef="usd">21902000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMy0xNi0xLTEtNDMwMA_31e1c246-fd29-42e1-9d9f-5a388bc673b6"
      unitRef="usd">21902000</us-gaap:StockRepurchasedDuringPeriodValue>
    <hims:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i41f7b9d6eea64578809c722be8aea527_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC0xLTEtMS00Mjc5_f72600d5-bced-4e4d-a08d-a611d54c961c"
      unitRef="shares">93121607</hims:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <hims:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i41f7b9d6eea64578809c722be8aea527_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC0zLTEtMS00Mjg4_32b79513-239c-4d23-9ada-bdef5abf7e2a"
      unitRef="usd">-249837000</hims:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC01LTEtMS00Mjkx_7028fb73-282b-4f1a-a95e-52acfc2c0011"
      unitRef="shares">93121607</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC03LTEtMS00Mjkx_6f0cf9e9-3827-42a8-8a22-f31db3051e38"
      unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC0xMC0xLTEtNDI5Nw_d18cfdcc-3d88-44d2-b7d0-48ab0042e566"
      unitRef="usd">249828000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNC0xNi0xLTEtNDMwMA_f62dee0c-a91c-4de2-b6d4-3e2aab7cdc49"
      unitRef="usd">249837000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <hims:AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment
      contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNS0xMC0xLTEtNDI5Nw_78b4d526-70ed-4aa1-b756-b34ca8835d10"
      unitRef="usd">854000</hims:AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment>
    <hims:AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNS0xNi0xLTEtNDMwMA_210aa4e0-0fea-4d73-a8cc-88965ce965fd"
      unitRef="usd">854000</hims:AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment>
    <hims:StockForfeitedDuringPeriodShares
      contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNi01LTEtMS00Mjkx_6641c0f5-6103-48ab-a574-a4bfac9debaa"
      unitRef="shares">370734</hims:StockForfeitedDuringPeriodShares>
    <hims:AdjustmentsToAdditionalPaidInCapitalWarrantConversion
      contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNy0xMC0xLTEtNDI5Nw_de2a7b1e-7342-469f-9c11-c27fa0a929f6"
      unitRef="usd">1160000</hims:AdjustmentsToAdditionalPaidInCapitalWarrantConversion>
    <hims:AdjustmentsToAdditionalPaidInCapitalWarrantConversion
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfNy0xNi0xLTEtNDMwMA_ced45a11-75b1-4be2-9270-6bf9066e5764"
      unitRef="usd">1160000</hims:AdjustmentsToAdditionalPaidInCapitalWarrantConversion>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i30ada711d000420db9e5a73ad2e2418d_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOC01LTEtMS00Mjkx_37371422-756b-44f6-84b8-1a0df99441c1"
      unitRef="shares">1867292</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ie5ab3e0ebc1e499ea3db5fa26f8b9bc4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOC0xMC0xLTEtNDI5Nw_ce8d8c42-a542-4d10-9cbb-18230c12579c"
      unitRef="usd">21678000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ie89592b066544281a07fa0169e98833d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOC0xNi0xLTEtNDMwMA_ed686c34-d650-4dd8-a269-bbeedf8900b9"
      unitRef="usd">21678000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <hims:StockIssuedDuringPeriodSharesReverseRecapitalization
      contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOS01LTEtMS00Mjkx_e7522f6f-0e89-41f9-bc5e-ccb11980fc9d"
      unitRef="shares">23892244</hims:StockIssuedDuringPeriodSharesReverseRecapitalization>
    <hims:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOS03LTEtMS00MzI4_e6d9b8a3-f94e-45e0-bdb5-268444cbb8cb"
      unitRef="usd">2000</hims:StockIssuedDuringPeriodValueReverseRecapitalization>
    <hims:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOS0xMC0xLTEtNDI5Nw_c8fa021d-60d1-4f71-878c-203220641ea9"
      unitRef="usd">129657000</hims:StockIssuedDuringPeriodValueReverseRecapitalization>
    <hims:StockIssuedDuringPeriodValueReverseRecapitalization
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfOS0xNi0xLTEtNDMwMA_2924c522-6619-4b6b-9dc6-106b780d5d26"
      unitRef="usd">129659000</hims:StockIssuedDuringPeriodValueReverseRecapitalization>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i4af486b04aad4f14ba113a2fa6b2ee94_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTAtNS0xLTEtNDI5MQ_f5378c28-e12b-480e-a1e4-c9e4430ff289"
      unitRef="shares">7500000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4af486b04aad4f14ba113a2fa6b2ee94_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTAtNy0xLTEtNDI5MQ_b7309d14-5960-43aa-8459-49c6be0bb92a"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i3078188fe78241078c8c9e6b9eed4bc6_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTAtMTAtMS0xLTQyOTc_37c16152-dab5-4ec3-a431-fdfdc0df70b3"
      unitRef="usd">74999000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id7de8dcbf04c4bb6929b04fe9ef68802_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTAtMTYtMS0xLTQzMDA_af7ecb16-4c3a-44f5-9c36-56cb7594294a"
      unitRef="usd">75000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <hims:StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization
      contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTEtNS0xLTEtNDI5MQ_cc87acc7-edf7-4883-840d-7f99a650d3b9"
      unitRef="shares">14153520</hims:StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization>
    <hims:StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization
      contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTEtNy0xLTEtNDMyOA_0454ca03-6931-4a03-a0eb-f4d1ec9ee061"
      unitRef="usd">1000</hims:StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization>
    <hims:StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTEtMTYtMS0xLTQzMDg_8640599a-3081-447e-b3b1-f8fd8d72c8e3"
      unitRef="usd">1000</hims:StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i5a1e34b0f7834df997f80b94ae24385b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTItNS0xLTEtNDI5MQ_b142071d-11f8-4527-9d7c-eaf58bf602c9"
      unitRef="shares">37887</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTItMTAtMS0xLTQyOTc_c85a8b82-49a7-42ec-8546-204dd89b0f80"
      unitRef="usd">80000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTItMTYtMS0xLTQzMDA_d3f23bd6-8130-4240-b845-36528e449955"
      unitRef="usd">80000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
      contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTMtMTAtMS0xLTQyOTc_b722c3d6-6c8a-48cf-966c-45249d8ed5b3"
      unitRef="usd">54000</hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested>
    <hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTMtMTYtMS0xLTQzMDA_1f5b9d56-ca56-4482-84b5-fb4373324e07"
      unitRef="usd">54000</hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested>
    <hims:AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense
      contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTYtMTAtMS0xLTU3MDc_292b4166-6b66-442b-b79d-906ed0eeae3c"
      unitRef="usd">-154000</hims:AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense>
    <hims:AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTYtMTYtMS0xLTU3MDc_dc8e762d-b2de-4a31-b85b-967408dfe147"
      unitRef="usd">-154000</hims:AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaaf173b9907f42a4983dd923fd5f864d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTQtMTAtMS0xLTQyOTc_c8b0794a-4afe-45e0-b9de-2c6fa997549c"
      unitRef="usd">34230000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTQtMTYtMS0xLTQzMDA_ae733a4b-28a6-4323-acc6-70d77f171ba4"
      unitRef="usd">34230000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i70660543ef984629a669e4c2774e2da9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTUtMTItMS0xLTQyOTc_b371f275-b197-43cf-b10a-931084dc18fb"
      unitRef="usd">-61000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTUtMTYtMS0xLTQzMDA_c951ec19-611e-48e0-890d-59b3d7d5204a"
      unitRef="usd">-61000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i791a884a65994079a567da0a06e4cbec_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTYtMTQtMS0xLTQzMDA_580433a0-40c1-4bf9-938c-25488572ad32"
      unitRef="usd">-51404000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTYtMTYtMS0xLTQzMDA_44c1d636-3d1c-4cf4-8b33-46e049d8eb0a"
      unitRef="usd">-51404000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i91a3849afa9e4008b0e42c13bed395ca_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMS0xLTEtNDI3OQ_006af231-2c2b-4d9a-ac65-2bbfc1eb6436"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i91a3849afa9e4008b0e42c13bed395ca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMy0xLTEtNDI4OA_cceddc77-2835-4e47-978c-4a9dbd5be258"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i6afd3e44df984fe7827f7001bb384073_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMjEtNS0xLTEtOTg2Nw_7e7971f7-9566-451f-a74f-6ba25af16193"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i6afd3e44df984fe7827f7001bb384073_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMjEtNy0xLTEtOTg2Nw_f6285880-151f-4b09-83e6-d55ddf2e0c46"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ia261e8ec32d348948aa7c247ea90ba34_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtNS0xLTEtNDI5MQ_69dee4ea-2c5f-4677-8ec0-05e4a542fa1e"
      unitRef="shares">191351403</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia261e8ec32d348948aa7c247ea90ba34_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtNy0xLTEtNDI5MQ_34d7c6ef-b08a-445d-8856-6fa18b0741b7"
      unitRef="usd">18000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9806e71b0929497bb5027bab7cf4a37a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMTAtMS0xLTQyOTc_9228ec81-4c9b-43f2-8732-47aa5311f61f"
      unitRef="usd">515216000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib85fb22f79d9475787326d65ff2089e0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMTItMS0xLTQyOTc_44f853ad-69c0-4f51-a577-750bf6a9577e"
      unitRef="usd">-72000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i576de665f4e84b76bc7bb8d9ec493671_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMTQtMS0xLTQzMDA_dd8f598e-3fcd-4cfc-9aa5-f9a3cd3fc8f2"
      unitRef="usd">-222696000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjY1ZjQ0NjkxNzgxMzQxMTViZWNkNDg5ODg2MjhlMjU1L3RhYmxlcmFuZ2U6NjVmNDQ2OTE3ODEzNDExNWJlY2Q0ODk4ODYyOGUyNTVfMTgtMTYtMS0xLTQzMDA_f663df44-23ef-48a5-b61f-34095e1f052e"
      unitRef="usd">292466000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i7f3746a65e7d4ed994c942a878cb3d7d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xLTEtMS00NTgy_2efc3d72-ee66-49d4-bae0-ca5097c0ef61"
      unitRef="shares">186573651</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i7f3746a65e7d4ed994c942a878cb3d7d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0zLTEtMS00NTg2_0c688db3-5d43-4abd-9021-bfb1f502e8dc"
      unitRef="usd">186741000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ib224229727c244f7ae39e55c0c9df44d_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi01LTEtMS00NTkx_2e29b52b-da1b-4471-8b28-f77c6b596705"
      unitRef="shares">1627132</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ib224229727c244f7ae39e55c0c9df44d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi03LTEtMS00NTkx_5a081796-0d16-4c9b-b326-f431e5c38a49"
      unitRef="usd">4500000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="id3eb3a4c78e24298b72949d4acd6af55_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xMC0xLTEtNDU5NA_516b1bf7-8336-4782-8b94-2e5ab215ce1d"
      unitRef="shares">113887093</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id3eb3a4c78e24298b72949d4acd6af55_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xMi0xLTEtNDU5NA_c9cca56b-cfa7-493c-a81e-c0d346047044"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i313e801028b74041921b6b37ca22f649_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xNC0xLTEtNDU5Nw_9d85b916-94f6-46cf-a39d-8ba1a82ba7ec"
      unitRef="usd">13383000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6fe027cba4b74bb3b95477816832e680_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xNi0xLTEtNDU5Nw_23a08c80-32a5-4685-bbf6-bfa37b85fc2b"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idba21161446c43ccbb9debeea82200bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xOC0xLTEtNDYwNg_6321534c-fb61-4b5d-b678-f87c0db7314d"
      unitRef="usd">-153178000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i47c21ce80c1947b39ed2fbaafbb5bb80_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0yMC0xLTEtNDYwNg_5054839a-5fe1-4d09-b08f-7fdbe8ecfb69"
      unitRef="usd">-139793000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i373d7d08dbe04fb9940eabc42c50f83a_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0xLTEtMS00NTgy_5a9d2c37-5fd2-428e-a488-3266a26e6189"
      unitRef="shares">102059460</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i01b2ce787a3a4bc9884c22437e0f804e_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy01LTEtMS00NTkx_e9192a84-2873-4792-bba7-5d34267030f1"
      unitRef="shares">890074</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="i14063932285a47baaf67a27317285b57_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0xMC0xLTEtNDU5NA_f5a413ba-6574-423c-b617-01adf356dc6c"
      unitRef="shares">62298481</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i2d1aa65fad4a4c2088e713c20737e7ce_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0yMC0xLTEtNDYwNg_8a73af7b-509a-4fda-803c-e835f00636de"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i95f1f52b2b1b4200bc65210a3f67c839_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xLTEtMS0w_b29827ef-4fad-43a7-9b74-55e96d360fbe"
      unitRef="shares">84514191</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i95f1f52b2b1b4200bc65210a3f67c839_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0zLTEtMS0w_f2293e0d-a301-4b40-bb58-5ddd3cdf7583"
      unitRef="usd">186741000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i498b99b9de474e2f9144406648261412_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi01LTEtMS0w_8f75c8f8-781b-4716-a3a9-2c16df09c5df"
      unitRef="shares">737058</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i498b99b9de474e2f9144406648261412_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi03LTEtMS0w_9d318f6a-985a-449a-8227-7198c07244f9"
      unitRef="usd">4500000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i8c79493c43ec4a598105cec06fd2dc82_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xMC0xLTEtMA_31df3059-f94e-472f-8405-a7cac6f9da35"
      unitRef="shares">51588612</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8c79493c43ec4a598105cec06fd2dc82_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xMi0xLTEtMA_2f16216a-6c66-4c20-af7f-82184a2208cc"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7f0a47c2a80f4fe0b4cdc6aa3b46a0f0_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xNC0xLTEtMA_bdb3e808-6125-4a68-aecf-81c1e5744844"
      unitRef="usd">13383000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icb00a578313e4482a66c59493f18d456_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xNi0xLTEtMA_5370f7c3-14f5-471f-94ec-9842a9f80226"
      unitRef="usd">2000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i65862cdd601d4522a8afad352086cb6a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0xOC0xLTEtMA_41cefa2d-0776-41cc-8749-714ad8a0ca6c"
      unitRef="usd">-153178000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6b4a0fdda9fc43a19cad6464963b6377_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMi0yMC0xLTEtMA_507cea37-28a2-47f3-a54c-71930ddae16d"
      unitRef="usd">-139793000</us-gaap:StockholdersEquity>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0wLTEtMS00MzQ5L3RleHRyZWdpb246YjlmYzg1MmIxZDgzNDNmNjllYWUzMjI3NWZmN2UwMzJfNTQ5NzU1ODEzOTA0MA_b534d08f-9f6a-458b-b9dd-e59ddcaa8ef8"
      unitRef="usd">100000</us-gaap:PaymentsOfStockIssuanceCosts>
    <hims:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="i6e26fbeb5863440e9e721a1313cd6a22_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0xLTEtMS0w_e3f9bb39-4996-4ffa-bbe6-b928af436f9f"
      unitRef="shares">4537700</hims:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="i6e26fbeb5863440e9e721a1313cd6a22_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMy0zLTEtMS0w_1e746bff-42e9-4395-a9c0-17666c98f75d"
      unitRef="usd">31511000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ib46889ae15794ea6a849b7097df17e70_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfNC0xMC0xLTEtMA_0175d95c-a464-4aef-926d-401434f252fb"
      unitRef="shares">226</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod
      contextRef="ib46889ae15794ea6a849b7097df17e70_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfNS0xMC0xLTEtMA_ee50d5fb-ce19-40a3-90ca-ed818525d189"
      unitRef="shares">226</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod>
    <hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
      contextRef="iebaa49281ce34f088dcc3e920092930e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfNi0xNC0xLTEtMA_31e79bc1-02f5-4051-8899-a5b358b26e4a"
      unitRef="usd">11000</hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested>
    <hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfNi0yMC0xLTEtMA_71ad361c-59d4-4142-b298-a44aa438f13a"
      unitRef="usd">11000</hims:AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
      contextRef="ib46889ae15794ea6a849b7097df17e70_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfNy0xMC0xLTEtMA_d558fb1f-448e-4b29-bcfd-d53058141ddd"
      unitRef="shares">46242</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iebaa49281ce34f088dcc3e920092930e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOC0xNC0xLTEtMA_44b8afea-6eae-411a-84ff-2c6e4cdb1c98"
      unitRef="usd">1404000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOC0yMC0xLTEtMA_46dae843-0fbd-47d3-ade3-3393064906ed"
      unitRef="usd">1404000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <hims:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i93e3fc5bb5ed483ebb7e411c2c1b86a3_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOS01LTEtMS0w_6aea31ab-b225-4679-a2e7-905805d6eb55"
      unitRef="shares">737058</hims:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <hims:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i93e3fc5bb5ed483ebb7e411c2c1b86a3_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOS03LTEtMS0w_b48ec1f7-cce7-43e2-b928-2b7a2a4dc707"
      unitRef="usd">-4500000</hims:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ib46889ae15794ea6a849b7097df17e70_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOS0xMC0xLTEtMA_a437ba90-14ad-479d-8794-0bdb13536259"
      unitRef="shares">737058</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="iebaa49281ce34f088dcc3e920092930e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOS0xNC0xLTEtMA_bc69175a-d876-4b9c-90d9-42832849bac3"
      unitRef="usd">4500000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfOS0yMC0xLTEtMA_9c04487d-3f27-4f96-b96e-9a736635676d"
      unitRef="usd">4500000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i859fee6b0b4d4ef1bf57cc579f3ad5c1_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTAtMTYtMS0xLTA_d77520ac-18a0-47c6-9d22-2d562feeac74"
      unitRef="usd">-42000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTAtMjAtMS0xLTA_9ed9d6ca-0041-41b0-b23a-6d846ee5e9ae"
      unitRef="usd">-42000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i8c64c701476f4358a5a5c9d9ea2fdf8a_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTEtMTgtMS0xLTA_faa6e1e7-dad9-4d34-a84c-b37d8bf10b2a"
      unitRef="usd">-6033000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTEtMjAtMS0xLTA_8aac526e-b6e3-4231-a84d-f65c49e7e115"
      unitRef="usd">-6033000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i2c4f929ec7804d5ba080985386fb1710_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMS0xLTEtMA_6d22fede-f3d1-417a-ab87-6b9d75bfe290"
      unitRef="shares">89051891</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i2c4f929ec7804d5ba080985386fb1710_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMy0xLTEtMA_19e298ff-d44d-4ebd-b26d-feed092f7ba4"
      unitRef="usd">218252000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iaa8987c19e604874ab033feedad56d43_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtNS0xLTEtMA_e6c8e430-4ac7-4c20-b264-b315195addbc"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="iaa8987c19e604874ab033feedad56d43_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtNy0xLTEtMA_2a5261a7-6313-4dc4-88d8-fcfcc8817e4e"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i0f815b2e739d41ebafd5da94bf4c8d6a_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMTAtMS0xLTA_3fd31664-1200-44d1-8f2c-d23b3b07fd3f"
      unitRef="shares">52279880</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i0f815b2e739d41ebafd5da94bf4c8d6a_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMTItMS0xLTA_e3abbdeb-c4d0-436f-bfa8-2432fb504b86"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if1681a4a94614a62ad87dae150f2220d_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMTQtMS0xLTA_8fc2e180-dbfe-4f3d-a684-231ec4690559"
      unitRef="usd">19298000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie87d3610f2c94903a4a299c11f9d0cc2_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMTYtMS0xLTA_405e7496-e215-4b88-889b-40e3ca429b1e"
      unitRef="usd">-40000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i541d26427048423291dfa7496890fbfa_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMTgtMS0xLTA_31373b00-f337-4d9f-a436-542f3b8f8b42"
      unitRef="usd">-159211000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iad3d9f1d28194144988117c8661db3c7_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xOS9mcmFnOjkzMmEzYTc5ZmIyMDQ4MzI4ZDkwZmU3MmNjOWFmYWM3L3RhYmxlOjljZDJmYjM5YTRhMDRjNjVhM2M2NmQ0MmYwOThhM2NiL3RhYmxlcmFuZ2U6OWNkMmZiMzlhNGEwNGM2NWEzYzY2ZDQyZjA5OGEzY2JfMTQtMjAtMS0xLTA_cc53a5b0-5303-453d-b5d2-1339dcaa5359"
      unitRef="usd">-139953000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMy0xLTEtMS0w_2a8d2e9b-9d21-465f-925b-89c425c11637"
      unitRef="usd">-51404000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMy0zLTEtMS0w_2eac0ce4-6c24-4961-94b7-d87e690b0b3e"
      unitRef="usd">-6033000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNS0xLTEtMS0w_407add5f-4512-4af1-b7e8-74ebb7e16a98"
      unitRef="usd">394000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNS0zLTEtMS0w_135a03b0-9f40-4fd8-ae85-78118c9e082c"
      unitRef="usd">180000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNi0xLTEtMS0w_c536910d-ddb5-41b7-8196-7301e35b8adb"
      unitRef="usd">34230000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNi0zLTEtMS0w_e159c571-c952-44d2-8067-868225ed37b0"
      unitRef="usd">1404000</us-gaap:ShareBasedCompensation>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNy0xLTEtMS0w_5824e222-c9a6-44c9-826e-b19a14832c70"
      unitRef="usd">2681000</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNy0zLTEtMS0w_c4139c7b-6167-427f-bbf1-3fe6d839d1e0"
      unitRef="usd">-71000</us-gaap:FairValueAdjustmentOfWarrants>
    <hims:NoncashWarrantExpense
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfOC0xLTEtMS0w_36ae7337-59ce-40c6-b0d6-7a9e2b3b7be8"
      unitRef="usd">154000</hims:NoncashWarrantExpense>
    <hims:NoncashWarrantExpense
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfOC0zLTEtMS0w_67e256a5-d73a-466a-a94f-744f6c514b86"
      unitRef="usd">0</hims:NoncashWarrantExpense>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTEtMS0xLTEtMA_71436ddf-0848-4180-94f5-05baadbfc760"
      unitRef="usd">144000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTEtMy0xLTEtMA_2ac954ae-4d3e-4b09-8b93-a773a1e14da8"
      unitRef="usd">84000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTItMS0xLTEtMA_97609234-f3bc-42cf-8d2b-3f5c5a639d10"
      unitRef="usd">-452000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTItMy0xLTEtMA_b60749de-2eb4-4cb3-8e19-a9d63cf5eb66"
      unitRef="usd">16000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTQtMS0xLTEtMA_d36f0eb2-d0e3-4f2e-aa41-f7b603a299c3"
      unitRef="usd">980000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTQtMy0xLTEtMA_6d58239e-f028-4877-b5be-4710aeb1f55c"
      unitRef="usd">2000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTUtMS0xLTEtMA_5777b3cb-2fa1-445a-a59a-e916121fdd12"
      unitRef="usd">7147000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTUtMy0xLTEtMA_79a9e9e3-3eef-4493-8314-659dac43045f"
      unitRef="usd">471000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTYtMS0xLTEtMA_7ebe64f0-4101-4fa0-8aca-ce968ff65b64"
      unitRef="usd">58000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTYtMy0xLTEtMA_122520dd-38f8-4f02-ab13-b7713cf1fdb1"
      unitRef="usd">-733000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTctMS0xLTEtMA_2c6e95c9-7f1c-4e01-8d50-3ddb65037fef"
      unitRef="usd">5117000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTctMy0xLTEtMA_fc4364b2-0474-441d-be34-ea6697361f53"
      unitRef="usd">674000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTgtMS0xLTEtMA_d85bd9d1-12e2-471c-a756-7238bafeedcb"
      unitRef="usd">1114000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTgtMy0xLTEtMA_2740a1a7-2e2e-4970-8ddd-08c9db8ed534"
      unitRef="usd">199000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTktMS0xLTEtODM5Ng_6e2ad5f9-11ef-4eda-beb7-b54cc7525ece"
      unitRef="usd">-648000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMTktMy0xLTEtODM5Ng_ca99eb68-ef75-4474-9fec-4208f9b41512"
      unitRef="usd">126000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <hims:IncreaseDecreaseInDeferredRent
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjAtMS0xLTEtMA_a2906735-dbac-42a5-8165-ff8f46938da1"
      unitRef="usd">3000</hims:IncreaseDecreaseInDeferredRent>
    <hims:IncreaseDecreaseInDeferredRent
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjAtMy0xLTEtMA_51c5640c-f80c-42db-b27f-3ab416cb8f65"
      unitRef="usd">0</hims:IncreaseDecreaseInDeferredRent>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjEtMS0xLTEtMA_ecc9c00b-42ee-4827-8032-545ddfd0ab97"
      unitRef="usd">-15948000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjEtMy0xLTEtMA_8a684246-7eb0-4539-aa94-337633b6a677"
      unitRef="usd">-5191000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjMtMS0xLTEtMA_fa6d5f00-0c8b-4fb2-9ad2-e10b63a059c6"
      unitRef="usd">172021000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjMtMy0xLTEtMA_9294ff32-9793-474c-89c8-887763115043"
      unitRef="usd">17642000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjQtMS0xLTEtMA_1b920430-e107-4d51-a0f2-afacc3983ecc"
      unitRef="usd">9500000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjQtMy0xLTEtMA_8b96a0f1-0f5c-409c-9d68-6cc4c02b817b"
      unitRef="usd">19200000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjUtMS0xLTEtMA_61a931c0-7310-4bb8-b835-76654db82ba0"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjUtMy0xLTEtMA_a485528e-ea61-44b2-96d7-71b9e491d1a5"
      unitRef="usd">6400000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsForSoftware
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjYtMS0xLTEtODM5Ng_f24377b9-2eb6-4785-8bc4-acf464299fc9"
      unitRef="usd">740000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsForSoftware
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjYtMy0xLTEtODM5Ng_6ca952ae-2f7c-4ec3-8543-ecee43108c35"
      unitRef="usd">452000</us-gaap:PaymentsForSoftware>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjctMS0xLTEtMA_c4b9d21a-f372-4bde-a610-79e81b687748"
      unitRef="usd">63000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjctMy0xLTEtMA_8c8dfc07-78bd-447f-844d-39734dfe6051"
      unitRef="usd">273000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjgtMS0xLTEtMA_b11812e4-6520-420f-a995-d7dd0ca53aff"
      unitRef="usd">-163324000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMjgtMy0xLTEtMA_c87b2636-a018-4fe9-9109-a4161dfe36a2"
      unitRef="usd">7233000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzEtMS0xLTEtMA_6e1b1ea9-bf68-45bb-a8ba-9ac8b3863af1"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzEtMy0xLTEtMA_794dcdd5-3c59-4bc9-b032-9621dba8b95c"
      unitRef="usd">31600000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzItMy0xLTEtMA_c2664e05-4285-44b1-b2dc-da1e5343b05b"
      unitRef="usd">89000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzEtMS0xLTEtMTUwMDQ_b7559184-8726-45e6-891f-c1ebfa36f99c"
      unitRef="usd">22027000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzEtMy0xLTEtMTUwMDQ_97ed69a3-a4a7-4baa-a91f-b69b6ca3ce40"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <hims:ProceedsFromIssuanceOfCommonStockRecapitalization
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzMtMS0xLTEtMA_6a6e689b-202e-40b0-8e57-6bd0615e6ff0"
      unitRef="usd">197686000</hims:ProceedsFromIssuanceOfCommonStockRecapitalization>
    <hims:ProceedsFromIssuanceOfCommonStockRecapitalization
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzMtMy0xLTEtMA_452b8920-406f-427c-9807-985a91466d97"
      unitRef="usd">0</hims:ProceedsFromIssuanceOfCommonStockRecapitalization>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzQtMS0xLTEtMA_5f9ec8ca-50a1-4b51-a680-028d8cb22dbd"
      unitRef="usd">75000000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzQtMy0xLTEtMA_fab48b11-4287-45a0-a362-6a76469514b6"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzUtMS0xLTEtMA_0f4c14d2-a3de-4c7a-9adb-6945b0d5dc64"
      unitRef="usd">12794000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzYtMS0xLTEtMA_27c68755-dc75-478b-a83a-e857ebee51f8"
      unitRef="usd">1193000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzYtMy0xLTEtMA_c9ac96eb-d0a3-46f0-8356-b84a1e5309a2"
      unitRef="usd">0</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzgtMS0xLTEtMA_b035551c-416b-4aa9-b555-484100d0b6e5"
      unitRef="usd">807000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzgtMy0xLTEtMA_92d5d9e6-956e-4a62-9493-a4ce399d2b19"
      unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <hims:ProceedsFromStockOptionsExercisedNetOfRepurchases
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzktMS0xLTEtMA_41d091ca-a2c5-4916-be58-ab437b0e8767"
      unitRef="usd">80000</hims:ProceedsFromStockOptionsExercisedNetOfRepurchases>
    <hims:ProceedsFromStockOptionsExercisedNetOfRepurchases
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfMzktMy0xLTEtMA_f483471d-7e6c-46b4-b337-6f84adf7263e"
      unitRef="usd">-18000</hims:ProceedsFromStockOptionsExercisedNetOfRepurchases>
    <us-gaap:RepaymentsOfDebt
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDAtMS0xLTEtODM5Ng_d694bc4d-e7cf-4587-bd87-0c050cf8ad4c"
      unitRef="usd">0</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDAtMy0xLTEtODM5Ng_e34d1473-467f-406b-b52a-85c25708ffe3"
      unitRef="usd">1158000</us-gaap:RepaymentsOfDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDEtMS0xLTEtMA_b937ecd4-362e-4aa2-acae-a9bdcdbc8eca"
      unitRef="usd">239945000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDEtMy0xLTEtMA_5fc4a0fc-ff0c-428e-9dc8-63f7aae7993e"
      unitRef="usd">30335000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDItMS0xLTEtMA_a0fe8356-992f-4239-b917-8580c4203e75"
      unitRef="usd">2000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDItMy0xLTEtMA_2feb3e08-ed44-4695-abe0-22d48bc02dfc"
      unitRef="usd">-9000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDMtMS0xLTEtMA_ab33715b-a3d3-4756-99c7-3116c3d70c2b"
      unitRef="usd">60675000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDMtMy0xLTEtMA_8452066c-c76c-47bb-b6c9-07dee6419b73"
      unitRef="usd">32368000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDQtMS0xLTEtMA_9ab2af00-71eb-4791-a8c6-e97857be3d35"
      unitRef="usd">28350000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6b4a0fdda9fc43a19cad6464963b6377_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDQtMy0xLTEtMA_3753122d-61d9-420a-9ce9-b2d82fd31c1a"
      unitRef="usd">22797000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDUtMS0xLTEtMA_709fbbf4-33df-4dbc-9733-9e1e7a77971c"
      unitRef="usd">89025000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iad3d9f1d28194144988117c8661db3c7_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDUtMy0xLTEtMA_dc057c73-0d2d-4108-afb9-f9092868fcba"
      unitRef="usd">55165000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDctMS0xLTEtODM5Ng_25c90aab-2191-4139-8b46-db5326975a16"
      unitRef="usd">59000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDctMy0xLTEtODM5Ng_d41d5d22-8ee1-4d61-9d39-30b72f392661"
      unitRef="usd">69000</us-gaap:IncomeTaxesPaid>
    <us-gaap:InterestPaidNet
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDgtMS0xLTEtODM5Ng_fc62f8a7-390a-4cba-a2b8-6c4bc921b83b"
      unitRef="usd">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDgtMy0xLTEtODM5Ng_30d576c4-25f5-4335-abad-8c89cb809a5f"
      unitRef="usd">8000</us-gaap:InterestPaidNet>
    <us-gaap:RecapitalizationCosts
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTAtMS0xLTEtODM5Ng_618bda9a-a28b-433c-8763-a354f5ee0cbd"
      unitRef="usd">125000</us-gaap:RecapitalizationCosts>
    <us-gaap:RecapitalizationCosts
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTAtMy0xLTEtODM5Ng_bace26e5-3acb-4924-97bc-be380c4fbed1"
      unitRef="usd">0</us-gaap:RecapitalizationCosts>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTEtMS0xLTEtODM5Ng_fe11812b-0dbe-4a21-a7db-d052cf12e26e"
      unitRef="usd">249837000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTEtMy0xLTEtODM5Ng_03060e63-a050-4306-8f1c-1b68008f482b"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <hims:WarrantsAssumed
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDktMS0xLTEtMjA2OTQ_cfa9efa7-a9dc-4504-a980-ee8f2685ed21"
      unitRef="usd">51814000</hims:WarrantsAssumed>
    <hims:WarrantsAssumed
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDktMy0xLTEtMjA2OTQ_40b0a066-f041-4a2a-85e4-dc37107b1ae6"
      unitRef="usd">0</hims:WarrantsAssumed>
    <hims:WarrantsIssued
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTAtMS0xLTEtMjA2OTQ_e68e7385-70df-4112-b1c5-d9e8918e9fa2"
      unitRef="usd">20871000</hims:WarrantsIssued>
    <hims:WarrantsIssued
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTAtMy0xLTEtMjA2OTQ_2330938a-1373-42bd-b735-6f504cf16482"
      unitRef="usd">0</hims:WarrantsIssued>
    <hims:ReclassificationOfDeferredTransactionCosts
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDktMS0xLTEtMTQ5MDA_b17ba17b-331b-4eb0-9500-c92011355647"
      unitRef="usd">3929000</hims:ReclassificationOfDeferredTransactionCosts>
    <hims:ReclassificationOfDeferredTransactionCosts
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNDktMy0xLTEtMTQ5MDA_639e0529-72fd-4a7b-8f2b-1ddf095a8b1f"
      unitRef="usd">0</hims:ReclassificationOfDeferredTransactionCosts>
    <hims:ConversionOfPreferredStockWarrantsAmountConverted
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTItMS0xLTEtODM5Ng_f8bfc7a9-efc6-44c6-8092-a46e13fc9654"
      unitRef="usd">1160000</hims:ConversionOfPreferredStockWarrantsAmountConverted>
    <hims:ConversionOfPreferredStockWarrantsAmountConverted
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTItMy0xLTEtODM5Ng_29e04814-2a76-4f84-bb55-61439143cc16"
      unitRef="usd">0</hims:ConversionOfPreferredStockWarrantsAmountConverted>
    <hims:TransactionCostsIncurredButNotYetPaid
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTQtMS0xLTEtODM5Ng_df21bd73-33f5-45e5-9d90-a178dec29720"
      unitRef="usd">511000</hims:TransactionCostsIncurredButNotYetPaid>
    <hims:TransactionCostsIncurredButNotYetPaid
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTQtMy0xLTEtODM5Ng_42634f68-5b47-42e3-afb9-767a3f9830c5"
      unitRef="usd">0</hims:TransactionCostsIncurredButNotYetPaid>
    <hims:VestingOfEarlyExercisedStockOptions
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTUtMS0xLTEtODM5Ng_7f852412-bcc9-4d06-8ef6-ea1f9de1409d"
      unitRef="usd">54000</hims:VestingOfEarlyExercisedStockOptions>
    <hims:VestingOfEarlyExercisedStockOptions
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTUtMy0xLTEtODM5Ng_510ac77a-3e06-467e-a8fe-ef4870c54692"
      unitRef="usd">11000</hims:VestingOfEarlyExercisedStockOptions>
    <us-gaap:StockIssued1
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTYtMS0xLTEtODM5Ng_6519e0cf-1247-4769-b83d-c2c0c5e76e86"
      unitRef="usd">0</us-gaap:StockIssued1>
    <us-gaap:StockIssued1
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yMi9mcmFnOjgyYzliZmYxYmEzNzQ5MjRhMDFhMDE0YzA4NTQ3Y2RhL3RhYmxlOjNmMzgyNTQzY2EwZjQ1YzA5NTM0M2JhZDIzZjc4MmYxL3RhYmxlcmFuZ2U6M2YzODI1NDNjYTBmNDVjMDk1MzQzYmFkMjNmNzgyZjFfNTYtMy0xLTEtODM5Ng_653fe2d5-b50b-4ee8-8e3a-e3e17484cf44"
      unitRef="usd">4500000</us-gaap:StockIssued1>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yOC9mcmFnOjIwYjQzMGE3Zjg5NzRlZTRiYjg4ZmZmYmRkMGM1NmUxL3RleHRyZWdpb246MjBiNDMwYTdmODk3NGVlNGJiODhmZmZiZGQwYzU2ZTFfMTIwOTQ2Mjc5MTMyNjk_afdfce33-f929-4403-8f09-449b96ae41d6">Organization&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Hims &amp;amp; Hers Health, Inc. (the "Company"), formerly known as Oaktree Acquisition Corp. ("OAC"), is a direct-to-customer telehealth company incorporated in Delaware. The Company's mission is to make healthcare accessible, affordable, and convenient for everyone. The Company designed and built a digitally native, cloud-based technology centered around the consumer, and designed everything with the consumer in mind. The Company's proprietary websites, telehealth platform, electronic medical records system, pharmacy integration, and mobile accessibility combine to provide customers with a seamless, easy-to-use, mobile-first experience. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company offers a range of health and wellness products and services available for purchase directly by customers on the Company's websites and through wholesale partners.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2021 (the "Closing Date"), OAC completed the acquisition of Hims, Inc. ("Hims") pursuant to the Agreement and Plan of Merger dated as of September 30, 2020 (the "Merger Agreement") by and among OAC, Hims, and Rx Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of OAC ("Merger Sub"). The Merger Agreement provided for, among other things, the combination of Hims and OAC pursuant to the merger of Merger Sub with and into Hims, with Hims continuing as the surviving entity and as a wholly-owned subsidiary of OAC (the "Merger").&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Merger was accounted for as a reverse recapitalization with Hims as the accounting acquirer and OAC as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Hims and its wholly owned subsidiaries as if Hims is the predecessor to the Company. The shares and net loss per common share, prior to the Merger, have been retroactively restated as shares reflecting the exchange ratio established in the Merger (0.4530 shares of Company Class A common stock for 1 share of Hims Class A common stock). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Merger, OAC ordinary shares and warrants were traded on the New York Stock Exchange ("NYSE") under the ticker symbols "OAC" and "OAC WS", respectively. On the Closing Date, the Company's Class A common stock and warrants began trading on the NYSE under the ticker symbols "HIMS" and "HIMS WS", respectively. One of the primary purposes of the Merger was to provide a platform for Hims to gain access to the U.S. capital markets. See Note 3 &#x2013; Recapitalization for additional details.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8yOC9mcmFnOjIwYjQzMGE3Zjg5NzRlZTRiYjg4ZmZmYmRkMGM1NmUxL3RleHRyZWdpb246MjBiNDMwYTdmODk3NGVlNGJiODhmZmZiZGQwYzU2ZTFfNjA0NzMxMzk2NTg5MA_060204b3-241b-4a68-9c7a-5743d713df4c"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzE_71d2d6f7-d592-4b3c-bcf2-638ff2a53aa3">Summary of Significant Accounting Policies&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to accounting principles generally accepted in the United States of America ("U.S. GAAP").&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements as of March&#160;31, 2021 are unaudited. The condensed consolidated balance sheet as of December&#160;31, 2020, included herein was derived from the audited consolidated financial statements as of that date. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. As such, the information included herein should be read in conjunction with the consolidated financial statements and accompanying notes as of and for the year ended December&#160;31, 2020 (the "audited consolidated financial statements").&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and reflect, in management's opinion, all adjustments of a normal, recurring nature that are necessary for the fair statement of the Company's balance sheet, results of operations, and cash flows for the three-month periods, but are not necessarily indicative of the results expected for the full fiscal year or any other period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, and variable interest entities in which it holds a controlling financial interest. All intercompany transactions and balances have been eliminated in these condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2021 and 2020, the Company had operations primarily in the United States and immaterial operations in the United Kingdom.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no changes to the Company's significant accounting policies described in the audited consolidated financial statements for the year ended December&#160;31, 2020, that have had a material impact on these condensed consolidated financial statements and related notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The more significant estimates and assumptions by management include, among others, valuation of inventory, valuation and recognition of stock-based compensation expense, valuation and recognition of warrants, and estimates in capitalization of website development and internal-use software costs. Management believes that the estimates and judgments upon which it relies, are reasonable based upon information available to it at the time that these estimates and judgments were made. Actual results experienced by the Company may differ from management's estimates. To the extent that there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt instruments with original maturities at the date of purchase greater than three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with original maturities at the date of purchase and remaining maturities of greater than one year are classified as long-term investments. The Company intends to sell such investments at or close to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The investments, if any, are designated as available-for-sale and are reported at fair value, with unrealized gains and losses, net of tax, recorded in other comprehensive income on the consolidated statements of operations and comprehensive loss, except as noted in the Other-Than-Temporary Impairment section that follows. The Company determines the cost of the investment sold based on specific identification at the individual security level. The Company records the interest income and realized gains and losses on the sale of these instruments within other (expense) income, net on the condensed consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other-Than-Temporary Impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment's adjusted cost basis. This would occur for marketable debt instruments when the fair value is below amortized cost and the Company intends to sell the instrument, when it is more likely than not that the Company will be required to sell the instrument before recovery of its amortized cost basis, or when the Company does not expect to recover the entire amortized cost basis of the instrument (a credit loss exists). When the Company does not expect to recover the entire amortized cost basis of the instrument, it separates other-than-temporary impairments into amounts representing credit losses, which are recognized in other (expense) income, net, and amounts related to all other factors, which are recognized in other comprehensive (loss) income on the condensed consolidated statements of operations and comprehensive loss. The Company incurred no other-than-temporary impairments on investments for the three months ended March 31, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory primarily consists of finished goods and raw materials that are located at Company-managed and third-party fulfillment warehouses. Inventory is stated at the lower of cost and net realizable value and inventory cost is determined by the weighted average cost method. The Company reserves for expired, slow-moving, and excess inventory by estimating the net realizable value based on the potential future use of such inventory. Management monitors inventory to identify events that would require impairment due to slow-moving, expired, or obsolete inventory and reduces the value of inventory when required. Obsolete inventory balances are written off against the inventory allowance when management determines that the inventory cannot be sold. The Company recorded write-offs of less than $0.1&#160;million for the three months ended March 31, 2021 and $0.1 million for the three months ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with Accounting Standards Codification Topic ("ASC") 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's consolidated revenue primarily comprises of online sales of health and wellness products through the Company's website, including prescription and nonprescription products. In contracts that contain prescription products, revenue also includes medical consultation services. Additionally, starting in March&#160;2020, the Company began selling its products to a new wholesale partner.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue consists of the following (in&#160;thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Online&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wholesale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For online revenue, the Company defines its customer as an individual who purchases products or services through the website. For wholesale revenue, Company defines its customer as a wholesale partner. The transaction price in the Company's contracts with customers is the total amount of consideration to which the Company expects to be entitled in exchange for transferring products or services to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's contracts that contain prescription products include two performance obligations: access to (i)&#160;products and (ii)&#160;consultation services. The Company's contracts that do not contain prescription products have a single performance obligation. Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised product to the customer and, in contracts that contain services, by the provision of consultation services to the customer. The Company satisfies its performance obligation for products at a point in time, which is upon delivery of the products to a third-party carrier. The Company satisfies its performance obligation for services over the period of the consultation service, which is typically a few days. The customer obtains control of the products and services upon the Company's completion of its performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts with multiple performance obligations, the transaction price is allocated to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling price is based on the prices at which the Company separately sells the products and services, as well as market and cost plus margin-based estimates. For each of the three months ended March 31, 2021 and 2020, service revenue represented less than 10% of consolidated revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To fulfill its promise to customers for contracts that include professional medical consultations, the Company maintains relationships with various "Affiliated Medical Groups", which are professional corporations or other professional entities owned by licensed physicians and other professional entities that engage licensed healthcare professionals (medical doctors, physician assistants, nurse practitioners, and mental health providers; collectively referred to as "Providers" or individually, a "Provider") to provide consultation services. Refer to Note 8 &#x2013; Variable Interest Entities. The Company accounts for service revenue as a principal in the arrangement with its customers. This conclusion is reached because (i) the Company determines which Affiliated Medical Group and Provider provides the consultation to the customer; (ii) the Company is primarily responsible for the satisfactory fulfillment and acceptability of the services; (iii) the Company incurs costs for consultation services even for visits that do not result in a prescription and the sale of products; and (iv) the Company, at its sole discretion, sets all listed prices charged on its websites for products and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, to fulfill its promise to customers for contracts that include professional medical consultations, the Company maintains relationships with affiliated and third-party pharmacies ("Partner Pharmacies" or individually, a "Partner Pharmacy") to fill prescriptions that are ordered by the Company's customers. The Company accounts for prescription product revenue as a principal in the arrangement with its customers. This conclusion is reached because (i) the Company has sole discretion in determining which Partner Pharmacy fills a customer's prescription; (ii) Partner Pharmacies fill the prescription based on fulfillment instructions provided by the Company, including using the Company's branded packaging for generic products; (iii) the Company is primarily responsible to the customer for the satisfactory fulfillment and acceptability of the order; (iv) the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company is responsible for refunds of the prescription medication after transfer of control to the customer; and (v) the Company, at its sole discretion, sets all listed prices charged on its website for products and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates refunds using the expected value method based on historical refunds granted to customers. The Company updates its estimate at the end of each reporting period and recognizes the estimated amount as contra-revenue with a corresponding refund liability. Sales, value-added, and other taxes are excluded from the transaction price and, therefore, from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has made an accounting policy election to account for shipping and handling activities performed after the control of a product has been transferred to the customer as fulfillment costs, with direct costs to ship products to customers included in cost of revenue. The Company's contracts with customers do not contain costs to obtain or costs to fulfill contracts with customers in accordance with ASC 340-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs&#x2014;Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For online sales, payment for prescription medication and nonprescription products is typically collected from the customer a few days in advance of product shipment. Contract liabilities are recorded when payments have been received from the customer for undelivered products or services and are recognized as revenue when the performance obligations are later satisfied. Contract liabilities consisting of balances related to customer prepayments are recognized as current deferred revenue on the condensed consolidated balance sheets since the associated revenue will be primarily recognized within the following period. For wholesale arrangements, payments are collected in accordance with contract terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock options, equity-classified warrants issued to vendors, and restricted stock units ("RSUs"), are measured at the grant date fair value. The fair value of employee stock options and vendor warrants are generally determined using the Black-Scholes Merton ("BSM") option-pricing model using various inputs, including estimates of expected volatility, term, risk-free rate, and future dividends. Stock options that were granted to the Company's Chief Executive Officer ("CEO") with performance and market conditions and earn-out RSUs were valued using the Monte Carlo simulation model. The Company recognizes compensation costs on a straight-line basis over the requisite service period of the employee and vendor, which is generally the option vesting term of four years for options and warrants that do not have performance or market conditions. Stock options and RSUs with performance conditions are recognized when it is probable that performance criteria will be achieved and compensation cost is recognized using the accelerated attribution method. The Company accounts for forfeitures as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Warrant Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 14 &#x2013; Common Stock) as liabilities in addition to warrants to purchase preferred stock. At the end of each reporting period, changes in fair value during the period are recognized as a component of other (expense) income, net within the consolidated statements of operations and comprehensive loss. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company currently leases a warehouse facility and previously leased office space under noncancelable lease agreements that are accounted for as operating leases. Rent expense is recorded on a straight-line basis over the lease term. For rent abatement and rent escalation provisions, the Company recognizes the related rent expense on a straight-line basis over the lease term. The difference between cash rent payments and the recognition of straight-line rent expense is recorded as deferred rent and amortized over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the Financial Accounting Standards Board ("FASB") issued ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure Framework &#x2013; Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which amends ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This ASU modifies the disclosure requirements for fair value measurements by removing, modifying, or adding certain disclosures. The standard is effective for public companies for annual periods beginning after December 15, 2019, with early adoption permitted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for removed disclosures and delayed adoption until fiscal year 2020 permitted for the new disclosures. The Company adopted this disclosure requirement for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February&#160;2016, the FASB issued ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires lessees to recognize leases on their balance sheets and disclose key information about leasing arrangements. The ASU establishes a right-of-use ("ROU") model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition on the income statement. The standard is effective for smaller reporting companies for annual periods beginning after December&#160;15, 2021 and for interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. In July&#160;2018, the FASB approved an amendment to the new guidance that allows companies the option of using the effective date of the new standard as the initial application (at the beginning of the period in which it is adopted, rather than at the beginning of the earliest comparative period) and to recognize the effects of applying the new ASU as a cumulative effect adjustment to the opening balance sheet or retained earnings. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to require the measurement of expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance also amended the impairment model for available-for-sale debt securities and requires entities to determine whether all or a portion of the unrealized loss on such debt security is a credit loss. In November 2018, ASU 2018-19 was issued which aligns the implementation date for nonpublic entities' annual financial statements with the implementation date for their interim financial statements and clarifies the scope of the guidance in the amendments in ASU 2016-13 to clarify that receivables arising from operating leases are not within the scope of Credit Losses (Topic 326) and should be accounted for in accordance with Leases (Topic 842). In April 2019, the FASB issued ASU 2019-04 which, among other amendments, allows for certain policy elections and practical expedients related to accrued interest on financial instruments. In November 2019, the FASB issued ASU 2019-10 and ASU 2019-11, which addressed certain aspects of the guidance related to effective dates, expected recoveries, troubled debt restructurings, accrued interest receivables, and financial assets secured by collateral. In February and March 2020, the FASB also issued ASU 2020-02 and ASU 2020-03, respectively, which provide certain amendments and improvements to sections of ASU 2016-13. These standards are effective for smaller reporting companies for annual and interim periods beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which is intended to improve consistency and simplify several areas of existing guidance. ASU 2019-12 removes certain exceptions to the general principles related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 is effective for annual periods beginning after December 15, 2020 for public entities, including interim periods within those fiscal years. The standard is effective for nonpublic companies for annual periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and as an emerging growth company ("EGC"), has elected to adopt the pronouncement following the effective date for nonpublic companies. The Company does not expect adoption will have a material impact on the Company's consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASU 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The guidance includes amendments to improve the codification by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to the financial statements is codified in the disclosure section of the codification and to clarify guidance so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public entities, including interim periods within those fiscal years. The standard is effective for nonpublic companies for annual periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and as an EGC, has elected to adopt the pronouncement following the effective date for nonpublic companies.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfNjA0NzMxNDIzMzg3Nw_dfc062e0-ee8e-4442-ad89-534d5706b24f">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to accounting principles generally accepted in the United States of America ("U.S. GAAP").&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements as of March&#160;31, 2021 are unaudited. The condensed consolidated balance sheet as of December&#160;31, 2020, included herein was derived from the audited consolidated financial statements as of that date. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. As such, the information included herein should be read in conjunction with the consolidated financial statements and accompanying notes as of and for the year ended December&#160;31, 2020 (the "audited consolidated financial statements").&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and reflect, in management's opinion, all adjustments of a normal, recurring nature that are necessary for the fair statement of the Company's balance sheet, results of operations, and cash flows for the three-month periods, but are not necessarily indicative of the results expected for the full fiscal year or any other period.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfNjA0NzMxNDI2NjY0Nw_006ba222-75d7-4c1d-81ec-4e92957469d8">The unaudited condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, and variable interest entities in which it holds a controlling financial interest. All intercompany transactions and balances have been eliminated in these condensed consolidated financial statements.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzI_99188d7c-9fe7-477f-bbe5-b86f3caea384">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The more significant estimates and assumptions by management include, among others, valuation of inventory, valuation and recognition of stock-based compensation expense, valuation and recognition of warrants, and estimates in capitalization of website development and internal-use software costs. Management believes that the estimates and judgments upon which it relies, are reasonable based upon information available to it at the time that these estimates and judgments were made. Actual results experienced by the Company may differ from management's estimates. To the extent that there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected.</us-gaap:UseOfEstimates>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzM_2b55581a-5b1c-4a94-8aef-348747b75be7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt instruments with original maturities at the date of purchase greater than three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with original maturities at the date of purchase and remaining maturities of greater than one year are classified as long-term investments. The Company intends to sell such investments at or close to maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The investments, if any, are designated as available-for-sale and are reported at fair value, with unrealized gains and losses, net of tax, recorded in other comprehensive income on the consolidated statements of operations and comprehensive loss, except as noted in the Other-Than-Temporary Impairment section that follows. The Company determines the cost of the investment sold based on specific identification at the individual security level. The Company records the interest income and realized gains and losses on the sale of these instruments within other (expense) income, net on the condensed consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <hims:OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzQ_528b4329-8f4a-485d-82b9-8bc2802eb85e">The Company's investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment's adjusted cost basis. This would occur for marketable debt instruments when the fair value is below amortized cost and the Company intends to sell the instrument, when it is more likely than not that the Company will be required to sell the instrument before recovery of its amortized cost basis, or when the Company does not expect to recover the entire amortized cost basis of the instrument (a credit loss exists). When the Company does not expect to recover the entire amortized cost basis of the instrument, it separates other-than-temporary impairments into amounts representing credit losses, which are recognized in other (expense) income, net, and amounts related to all other factors, which are recognized in other comprehensive (loss) income on the condensed consolidated statements of operations and comprehensive loss.</hims:OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock>
    <us-gaap:ImpairmentOfInvestments
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyODI_90c83407-28bc-4fc7-85e9-0700a8e32101"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:ImpairmentOfInvestments
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyODI_9d9d752a-c0e2-48d0-9d5a-5cfb4304a296"
      unitRef="usd">0</us-gaap:ImpairmentOfInvestments>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzU_2d3f1e35-8790-4180-ab89-a191fd301aec">Inventory primarily consists of finished goods and raw materials that are located at Company-managed and third-party fulfillment warehouses. Inventory is stated at the lower of cost and net realizable value and inventory cost is determined by the weighted average cost method. The Company reserves for expired, slow-moving, and excess inventory by estimating the net realizable value based on the potential future use of such inventory. Management monitors inventory to identify events that would require impairment due to slow-moving, expired, or obsolete inventory and reduces the value of inventory when required. Obsolete inventory balances are written off against the inventory allowance when management determines that the inventory cannot be sold.</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryWriteDown
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTUzOTMxNjMxMDczOTY_445fcae4-e0f4-4c2d-b03e-2c108df6f1f9"
      unitRef="usd">100000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMjc0ODc3OTM3OTI2MA_4d43e5d8-0870-4a9b-9f88-8fc9c042923d"
      unitRef="usd">100000</us-gaap:InventoryWriteDown>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzY_a66eca0e-d9c3-403f-a407-bb0a6e6efa3c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue in accordance with Accounting Standards Codification Topic ("ASC") 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.&lt;/span&gt;The Company's consolidated revenue primarily comprises of online sales of health and wellness products through the Company's website, including prescription and nonprescription products. In contracts that contain prescription products, revenue also includes medical consultation services.&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For online revenue, the Company defines its customer as an individual who purchases products or services through the website. For wholesale revenue, Company defines its customer as a wholesale partner. The transaction price in the Company's contracts with customers is the total amount of consideration to which the Company expects to be entitled in exchange for transferring products or services to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's contracts that contain prescription products include two performance obligations: access to (i)&#160;products and (ii)&#160;consultation services. The Company's contracts that do not contain prescription products have a single performance obligation. Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised product to the customer and, in contracts that contain services, by the provision of consultation services to the customer. The Company satisfies its performance obligation for products at a point in time, which is upon delivery of the products to a third-party carrier. The Company satisfies its performance obligation for services over the period of the consultation service, which is typically a few days. The customer obtains control of the products and services upon the Company's completion of its performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For contracts with multiple performance obligations, the transaction price is allocated to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling price is based on the prices at which the Company separately sells the products and services, as well as market and cost plus margin-based estimates. For each of the three months ended March 31, 2021 and 2020, service revenue represented less than 10% of consolidated revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To fulfill its promise to customers for contracts that include professional medical consultations, the Company maintains relationships with various "Affiliated Medical Groups", which are professional corporations or other professional entities owned by licensed physicians and other professional entities that engage licensed healthcare professionals (medical doctors, physician assistants, nurse practitioners, and mental health providers; collectively referred to as "Providers" or individually, a "Provider") to provide consultation services. Refer to Note 8 &#x2013; Variable Interest Entities. The Company accounts for service revenue as a principal in the arrangement with its customers. This conclusion is reached because (i) the Company determines which Affiliated Medical Group and Provider provides the consultation to the customer; (ii) the Company is primarily responsible for the satisfactory fulfillment and acceptability of the services; (iii) the Company incurs costs for consultation services even for visits that do not result in a prescription and the sale of products; and (iv) the Company, at its sole discretion, sets all listed prices charged on its websites for products and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additionally, to fulfill its promise to customers for contracts that include professional medical consultations, the Company maintains relationships with affiliated and third-party pharmacies ("Partner Pharmacies" or individually, a "Partner Pharmacy") to fill prescriptions that are ordered by the Company's customers. The Company accounts for prescription product revenue as a principal in the arrangement with its customers. This conclusion is reached because (i) the Company has sole discretion in determining which Partner Pharmacy fills a customer's prescription; (ii) Partner Pharmacies fill the prescription based on fulfillment instructions provided by the Company, including using the Company's branded packaging for generic products; (iii) the Company is primarily responsible to the customer for the satisfactory fulfillment and acceptability of the order; (iv) the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Company is responsible for refunds of the prescription medication after transfer of control to the customer; and (v) the Company, at its sole discretion, sets all listed prices charged on its website for products and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates refunds using the expected value method based on historical refunds granted to customers. The Company updates its estimate at the end of each reporting period and recognizes the estimated amount as contra-revenue with a corresponding refund liability. Sales, value-added, and other taxes are excluded from the transaction price and, therefore, from revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has made an accounting policy election to account for shipping and handling activities performed after the control of a product has been transferred to the customer as fulfillment costs, with direct costs to ship products to customers included in cost of revenue. The Company's contracts with customers do not contain costs to obtain or costs to fulfill contracts with customers in accordance with ASC 340-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs&#x2014;Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For online sales, payment for prescription medication and nonprescription products is typically collected from the customer a few days in advance of product shipment. Contract liabilities are recorded when payments have been received from the customer for undelivered products or services and are recognized as revenue when the performance obligations are later satisfied. Contract liabilities consisting of balances related to customer prepayments are recognized as current deferred revenue on the condensed consolidated balance sheets since the associated revenue will be primarily recognized within the following period. For wholesale arrangements, payments are collected in accordance with contract terms.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzc_7189ada3-617b-46e8-85cc-2cc6a80d34da">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue consists of the following (in&#160;thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Online&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Wholesale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0bdb1af208e14b2ea352fb5361c65042_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfMi0xLTEtMS0w_956c971e-a635-4af6-85dd-89d617390107"
      unitRef="usd">50680000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i533a6c1123d5402bb7487743cb056ecc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfMi0zLTEtMS0w_6822c0bd-7427-40d6-822f-45805f7e6361"
      unitRef="usd">28524000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i932569e05a89431ebc34c4b51b14c702_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfMy0xLTEtMS0w_b05e2f30-b0ff-4b3f-9228-63e724bacee5"
      unitRef="usd">1634000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23ddbd3a57cb47d2b34bef8d1093c90f_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfMy0zLTEtMS0w_b79521ff-1035-4c34-8bb1-b72892340f00"
      unitRef="usd">1539000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfNC0xLTEtMS0w_094e6feb-8aeb-4ffe-93fd-40c2d70570e5"
      unitRef="usd">52314000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RhYmxlOjFlNjY1ODg2YTNiNTRlYjE4NTAyNGQzOGIzNmFhZWNlL3RhYmxlcmFuZ2U6MWU2NjU4ODZhM2I1NGViMTg1MDI0ZDM4YjM2YWFlY2VfNC0zLTEtMS0w_3329f7ac-b633-4712-81dc-f7e7377787eb"
      unitRef="usd">30063000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyNzk_32bfd86b-d50a-42c4-b8e1-b6a44924d16e">The fair value of stock options, equity-classified warrants issued to vendors, and restricted stock units ("RSUs"), are measured at the grant date fair value. The fair value of employee stock options and vendor warrants are generally determined using the Black-Scholes Merton ("BSM") option-pricing model using various inputs, including estimates of expected volatility, term, risk-free rate, and future dividends. Stock options that were granted to the Company's Chief Executive Officer ("CEO") with performance and market conditions and earn-out RSUs were valued using the Monte Carlo simulation model. The Company recognizes compensation costs on a straight-line basis over the requisite service period of the employee and vendor, which is generally the option vesting term of four years for options and warrants that do not have performance or market conditions. Stock options and RSUs with performance conditions are recognized when it is probable that performance criteria will be achieved and compensation cost is recognized using the accelerated attribution method. The Company accounts for forfeitures as they occur.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfNjA0NzMxNDI3MTUzOQ_8183db76-6801-4829-b0b1-20fd568c7908">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hims:WarrantLiabilityPolicyPolicyTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfNjA0NzMxNDI2NjY1NA_2ed6c969-d836-437c-8b1b-39980e6bcf83">The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 14 &#x2013; Common Stock) as liabilities in addition to warrants to purchase preferred stock. At the end of each reporting period, changes in fair value during the period are recognized as a component of other (expense) income, net within the consolidated statements of operations and comprehensive loss. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.</hims:WarrantLiabilityPolicyPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyODA_b0ea783a-1d87-43ef-a352-6e556833ea1c">The Company currently leases a warehouse facility and previously leased office space under noncancelable lease agreements that are accounted for as operating leases. Rent expense is recorded on a straight-line basis over the lease term. For rent abatement and rent escalation provisions, the Company recognizes the related rent expense on a straight-line basis over the lease term. The difference between cash rent payments and the recognition of straight-line rent expense is recorded as deferred rent and amortized over the lease term.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zMS9mcmFnOjA3NDU1ODIyYzI4YTQ5ZGJiZmQwM2QwYTUyMTVhNzBlL3RleHRyZWdpb246MDc0NTU4MjJjMjhhNDlkYmJmZDAzZDBhNTIxNWE3MGVfMTIwOTQ2MjgxODEyODE_fb612585-9669-4e7e-868b-b2071aaa2c2a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the Financial Accounting Standards Board ("FASB") issued ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure Framework &#x2013; Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which amends ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This ASU modifies the disclosure requirements for fair value measurements by removing, modifying, or adding certain disclosures. The standard is effective for public companies for annual periods beginning after December 15, 2019, with early adoption permitted &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for removed disclosures and delayed adoption until fiscal year 2020 permitted for the new disclosures. The Company adopted this disclosure requirement for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February&#160;2016, the FASB issued ASU 2016-02, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires lessees to recognize leases on their balance sheets and disclose key information about leasing arrangements. The ASU establishes a right-of-use ("ROU") model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition on the income statement. The standard is effective for smaller reporting companies for annual periods beginning after December&#160;15, 2021 and for interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. In July&#160;2018, the FASB approved an amendment to the new guidance that allows companies the option of using the effective date of the new standard as the initial application (at the beginning of the period in which it is adopted, rather than at the beginning of the earliest comparative period) and to recognize the effects of applying the new ASU as a cumulative effect adjustment to the opening balance sheet or retained earnings. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to require the measurement of expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance also amended the impairment model for available-for-sale debt securities and requires entities to determine whether all or a portion of the unrealized loss on such debt security is a credit loss. In November 2018, ASU 2018-19 was issued which aligns the implementation date for nonpublic entities' annual financial statements with the implementation date for their interim financial statements and clarifies the scope of the guidance in the amendments in ASU 2016-13 to clarify that receivables arising from operating leases are not within the scope of Credit Losses (Topic 326) and should be accounted for in accordance with Leases (Topic 842). In April 2019, the FASB issued ASU 2019-04 which, among other amendments, allows for certain policy elections and practical expedients related to accrued interest on financial instruments. In November 2019, the FASB issued ASU 2019-10 and ASU 2019-11, which addressed certain aspects of the guidance related to effective dates, expected recoveries, troubled debt restructurings, accrued interest receivables, and financial assets secured by collateral. In February and March 2020, the FASB also issued ASU 2020-02 and ASU 2020-03, respectively, which provide certain amendments and improvements to sections of ASU 2016-13. These standards are effective for smaller reporting companies for annual and interim periods beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which is intended to improve consistency and simplify several areas of existing guidance. ASU 2019-12 removes certain exceptions to the general principles related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 is effective for annual periods beginning after December 15, 2020 for public entities, including interim periods within those fiscal years. The standard is effective for nonpublic companies for annual periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and as an emerging growth company ("EGC"), has elected to adopt the pronouncement following the effective date for nonpublic companies. The Company does not expect adoption will have a material impact on the Company's consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the FASB issued ASU 2020-10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Codification Improvements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The guidance includes amendments to improve the codification by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to the financial statements is codified in the disclosure section of the codification and to clarify guidance so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public entities, including interim periods within those fiscal years. The standard is effective for nonpublic companies for annual periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and as an EGC, has elected to adopt the pronouncement following the effective date for nonpublic companies.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <hims:ReverseRecapitalizationDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl82MDQ3MzEzOTYzMzk1_e610f182-06df-4332-9a4e-4b873fd222c9">Recapitalization&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed in Note 1 &#x2013; Organization, on the Closing Date, OAC completed the acquisition of Hims and acquired 100% of  Hims' shares and Hims received gross proceeds of $197.7 million. Transaction costs of $16.2 million, which consist of legal, accounting, and other professional services directly related to the Merger, are included in additional paid-in capital in the condensed consolidated balance sheet as of March 31, 2021. On the Closing Date, each Hims stockholder received approximately 0.4530 shares of the Company's Class A common stock, par value $0.0001 per share, for each share of Hims Class A common stock, par value $0.000001 per share, that such stockholder owned (with the CEO receiving 0.4530 shares of Hims &amp;amp; Hers Class V common stock, par value $0.0001 per share, for each share of Hims Class V common stock, par value $0.000001 per share, that the CEO owned). Each Hims stockholder also received 0.0028 warrants exercisable for the Company's Class A common stock, for each share of Hims Class A or Class V common stock owned by such stockholder prior to the Merger and earn-out shares at an exchange ratio of 0.0443. See Note 13 &#x2013; Redeemable Convertible&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Preferred Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and Note 14 &#x2013; Common Stock for additional details of the Company's stockholders' equity prior to and subsequent to the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As additional consideration, OAC also granted 888,143 OAC Class A common stock warrants ("Parent Warrants") to Hims' stockholders, 3,443 Parent Warrants to warrant holders, and approximately 35,000 RSUs to Hims' option and RSU holders ("Parent Warrant RSUs").&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All equity awards of Hims were assumed by OAC and converted into comparable equity awards that are settled or exercisable for shares of the Company's Class A common stock. As a result, each stock option was converted into an option to purchase shares of the Company's Class A common stock based on an exchange ratio of 0.4530. Each award of the Hims' RSUs was converted into RSUs of the Company based on an exchange ratio of 0.4530. Similarly, all outstanding Hims warrants were converted at an exchange ratio of 0.4530.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Merger was accounted for as a reverse recapitalization with Hims as the accounting acquirer and OAC as the acquired company for accounting purposes. Hims was determined to be the accounting acquirer since Hims' shareholders prior to the Merger had the greatest voting interest in the combined entity, Hims' shareholders appointed the initial directors of the combined Board of Directors and control future appointments, Hims comprises all of the ongoing operations, and Hims' senior management directs operations of the combined entity. Accordingly, all historical financial information presented in these unaudited condensed consolidated financial statements represents the accounts of Hims and its wholly owned subsidiaries as if Hims, rather than OAC, is the predecessor to the Company. No step-up basis of intangible assets or goodwill was recorded and net assets were stated at historical cost consistent with the treatment of the transaction as a reverse recapitalization of Hims. The shares and net loss per common share prior to the Merger have been retroactively restated as shares reflecting the exchange ratio established in the Merger (0.4530 Company shares for 1 Hims share). &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Earn-Out Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the closing of the Merger, holders of Hims' common stock and outstanding equity awards (including warrant, stock option and RSU holders) had the right to receive up to an aggregate amount of 16,000,000 shares of Company Class A common stock (or equivalent equity award) that would vest (in part) in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $15.00, $17.50 and $20.00 for any 10 trading days within any 20-trading day period on or prior to the date that is five years following the Closing Date. These shares of restricted Class A common stock and equivalent equity awards would also vest in connection with an acquisition of the Company if the applicable thresholds were met in any sale (as defined in the Merger Agreement) but subject to the same &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjExMQ_0328a105-577b-490b-8bab-4760962a29c8"&gt;five&lt;/span&gt;-year deadline. In February 2021, all earn-out thresholds were met. In the first quarter of 2021, earn-out awards related to option holders received final approval by the Board of Directors. The earn-out shares are equity classified since they do not meet the liability classification criteria outlined in ASC 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and are both (i) indexed to the Company's own shares and (ii) meet the criteria for equity classification.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PIPE Investment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the execution of the Merger Agreement, OAC entered into subscription agreements on September 30, 2020 with certain investors (the "PIPE Investors") pursuant to which such investors collectively subscribed for 7,500,000 shares of the Company's Class A common stock at $10.00 per share for aggregate gross proceeds of $75.0 million (the "PIPE Investment"). The PIPE Investment was consummated substantially concurrently with the closing of the Merger.&lt;/span&gt;&lt;/div&gt;</hims:ReverseRecapitalizationDisclosureTextBlock>
    <hims:ReverseRecapitalizationPercentageOfVotingInterestsAcquired
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNTk5OA_0a6e0831-f98b-490a-8fbd-88a107688cf0"
      unitRef="number">1</hims:ReverseRecapitalizationPercentageOfVotingInterestsAcquired>
    <hims:ProceedsFromIssuanceOfCommonStockRecapitalization
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAwMg_b6d266e2-9003-4d71-990c-2dcdb8aa1cec"
      unitRef="usd">197700000</hims:ProceedsFromIssuanceOfCommonStockRecapitalization>
    <hims:ReverseRecapitalizationTransactionCosts
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8yNzQ4Nzc5MDgwMDc1_0b54535a-a614-4000-be6d-cd14b02050b6"
      unitRef="usd">16200000</hims:ReverseRecapitalizationTransactionCosts>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAwOA_4b09c42d-8749-41b3-badc-9954fd6e378c"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2ce0c2a663404279ad0d0d1d6271d369_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAxMw_49408859-2e03-4796-af21-208589d14ee2"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5c3a9475a70b4c2db3d6e0010a374a0e_I20210119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAxOA_dfaad308-2aa2-4334-ad1f-2d230d8696b4"
      unitRef="usdPerShare">0.000001</us-gaap:CommonStockParOrStatedValuePerShare>
    <hims:RecapitalizationExchangeRatio
      contextRef="i35a4fb924db24a85a1196789003372ba_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAyMw_29f367e5-7545-4ceb-94a1-5e13093603ee"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3ee826f19c8f474091f7807831d1a4a2_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAyOA_63e5d582-456b-4a76-8e50-f88e741a47ff"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if23c020d049c42f8a21888c7cd351bf5_I20210119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAzMw_5cffb237-6683-40d7-a721-37bd5ffd338d"
      unitRef="usdPerShare">0.000001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="ie5182198da4045b7a12388e80e2263ab_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl84MjQ2MzM3MjI0MDU0_f22c3979-898f-4119-b822-081b222c16d5"
      unitRef="shares">0.0028</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <hims:RecapitalizationContingentConsiderationEquityExchangeRatio
      contextRef="i2ffc7b3d75784438b282649862e9f57e_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl84MjQ2MzM3MjI0Mjcz_d34f708f-061c-40f7-8d04-0ae7d4be7f0c"
      unitRef="number">0.0443</hims:RecapitalizationContingentConsiderationEquityExchangeRatio>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i7ad8096dc8594c04b77015e5c84c1bfd_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjAzNw_cec2210b-c22b-47e8-b5e2-3dc89479aadc"
      unitRef="shares">888143</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="if85b92e8012f4f1593f4f90ae859fd82_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA0MQ_a456ab46-084a-4155-9328-44c5dc771e9f"
      unitRef="shares">3443</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i16335511aa6245258d50e49bba22ab99_I20210120"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA0NQ_23494d68-169a-4204-a0b3-eba935a9c972"
      unitRef="shares">35000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA0OQ_ff952146-9bca-4721-8d04-55d1ecc5af8b"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA1NQ_fca8156a-a910-4f8a-8f0d-79bab50a095b"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA1OQ_e82831e4-cf8d-4cf0-9727-846893cbafbd"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA2Mw_bf2cc7bb-3e3b-49a0-8275-c27b3c5ce060"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <hims:ReverseCapitalizationContingentConsiderationEquityShares
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA2OQ_08e98247-5af7-4a2b-9d1b-ee79609347aa"
      unitRef="shares">16000000</hims:ReverseCapitalizationContingentConsiderationEquityShares>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA4MQ_07208523-3e62-469d-9993-e4c3d1e61cbc"
      unitRef="usdPerShare">15.00</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA4Ng_e15e205b-f256-49a6-8c36-f2e102edb8b3"
      unitRef="usdPerShare">17.50</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA5MQ_6993de5c-ad40-4e79-a2e0-0c6931af6c7b"
      unitRef="usdPerShare">20.00</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjA5Ng_5321bd64-ec2d-4e4c-bc1f-583fbea27e87"
      unitRef="d">10</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjEwMQ_7164f5d4-4f84-4936-b858-65f177bb0ae8"
      unitRef="d">20</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod>
    <hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjEwNg_8f559933-1fc0-4a4d-befd-6b9a248398f0">P5Y</hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjEyMQ_0bfc6172-67e5-4e5a-b752-d6e60d677a14"
      unitRef="shares">7500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i16bc3ab7ee094ed08651067218f9050a_I20210120"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjEyNg_386982fd-279a-4127-818e-590c17fa529b"
      unitRef="usdPerShare">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjEzMQ_25b2a777-edb1-48d1-83cd-70f1450cb5db"
      unitRef="usd">75000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RleHRyZWdpb246OWRiMjU3NjZiZGY5NGI4OWE2ZTU5NzNjZWQxZmFjOWZfMTIwOTQ2Mjc5MDYwMjA_e2fdf46b-2fe4-4cad-b472-a776b97e47d1">Investments&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments as of March&#160;31, 2021, consist of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjusted&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments as of December&#160;31, 2020, consist of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjusted&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments mature within one year.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RleHRyZWdpb246OWRiMjU3NjZiZGY5NGI4OWE2ZTU5NzNjZWQxZmFjOWZfMTIwOTQ2Mjc5MDYwMjE_4051c466-b8e9-42ca-ad91-d0d78b5982c7">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments as of March&#160;31, 2021, consist of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjusted&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,156&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments as of December&#160;31, 2020, consist of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjusted&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i35fc17d5154d40cda4ba3221e9dcffb6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMS0xLTEtMS0w_1f7db32a-997a-433f-a8ae-c645b7e59ec6"
      unitRef="usd">177273000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i35fc17d5154d40cda4ba3221e9dcffb6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMS0zLTEtMS0w_e1b45f41-ed20-4fcd-bea4-b4db830785c7"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i35fc17d5154d40cda4ba3221e9dcffb6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMS01LTEtMS0w_072cc57f-5249-4ecd-af6b-eb4d7a98a64f"
      unitRef="usd">53000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i35fc17d5154d40cda4ba3221e9dcffb6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMS03LTEtMS0w_1acbdde1-b190-4258-b46f-070e40ecdbd9"
      unitRef="usd">177221000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifd8ae28174c74bcbafe8e1b9e1296cad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMi0xLTEtMS0w_beabcd34-1913-408c-b74d-619d61c9ae10"
      unitRef="usd">40955000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifd8ae28174c74bcbafe8e1b9e1296cad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMi0zLTEtMS0w_487570b6-7815-4118-aa8a-be53169a2177"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifd8ae28174c74bcbafe8e1b9e1296cad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMi01LTEtMS0w_eb08909a-55ce-418e-8ecf-39cc12284a71"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd8ae28174c74bcbafe8e1b9e1296cad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMi03LTEtMS0w_e7be091d-6c28-4813-bf9a-f924bc396b77"
      unitRef="usd">40952000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9b386e439e1545bb8595dd4c08d832e1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMy0xLTEtMS0w_5c0c4352-1ecd-40aa-b09b-c609a97c772b"
      unitRef="usd">16928000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9b386e439e1545bb8595dd4c08d832e1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMy0zLTEtMS0w_1ffd9fd9-25f5-4160-932b-53220f5bea7b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9b386e439e1545bb8595dd4c08d832e1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMy01LTEtMS0w_49dbb47a-c1f9-4422-aa4a-5d3209c04c7c"
      unitRef="usd">4000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9b386e439e1545bb8595dd4c08d832e1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfMy03LTEtMS0w_8902953b-ec05-4eb6-aa88-33b60d8d9d37"
      unitRef="usd">16924000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfNC0xLTEtMS0w_60a78dce-8f64-4af5-9c11-3e94dd48773b"
      unitRef="usd">235156000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfNC0zLTEtMS0w_0c2007a0-8520-47a3-a160-1e5391630e3c"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfNC01LTEtMS0w_d65812ba-d46e-434b-878a-3d7d2b8a4090"
      unitRef="usd">62000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjYxNDk2YTA4OWRiZDQ2MmU4ZGRmZWFlZGM5NDE5MDVhL3RhYmxlcmFuZ2U6NjE0OTZhMDg5ZGJkNDYyZThkZGZlYWVkYzk0MTkwNWFfNC03LTEtMS0w_d4e30c7c-4f7b-4910-8426-4872ef954adf"
      unitRef="usd">235097000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0d5c88b35bfb47219cf7c806d06b403f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMS0xLTEtMS0yMDg4_c7121b23-0a88-4a21-9d25-d07f8bf22ff3"
      unitRef="usd">55224000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0d5c88b35bfb47219cf7c806d06b403f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMS0zLTEtMS0yMDg4_d2866127-2aff-4e48-9eca-003f842614bd"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0d5c88b35bfb47219cf7c806d06b403f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMS01LTEtMS0yMDg4_75d32758-3d2e-493e-a7d4-8fb8962f43d0"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0d5c88b35bfb47219cf7c806d06b403f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMS03LTEtMS0yMDg4_3bc5784f-ccee-4c49-bb90-59de9bafc2be"
      unitRef="usd">55227000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib82714ac40bb439a93d73928f1f21331_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMi0xLTEtMS0yMDg4_7ffe58ee-ee95-4182-83c7-ca3c0068a32f"
      unitRef="usd">14121000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib82714ac40bb439a93d73928f1f21331_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMi0zLTEtMS0yMDg4_0ed9f8df-8633-4198-990a-8c8330536841"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib82714ac40bb439a93d73928f1f21331_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMi01LTEtMS0yMDg4_dadcd0f6-1c3a-4842-b495-7fe922c78b5c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib82714ac40bb439a93d73928f1f21331_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMi03LTEtMS0yMDg4_17910327-bbe8-4d76-8ebb-9604973463c5"
      unitRef="usd">14123000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6806d600b8f3488bb1c3fd3461c854a1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMy0xLTEtMS0yMDg4_9bda648e-3bcc-4fc9-84f9-eca1589683bf"
      unitRef="usd">3514000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6806d600b8f3488bb1c3fd3461c854a1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMy0zLTEtMS0yMDg4_97ff7b61-4ab4-4fdb-925a-100a3cff36a2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6806d600b8f3488bb1c3fd3461c854a1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMy01LTEtMS0yMDg4_4ff6d2b9-d16b-45de-8f7f-e6edf08a637a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6806d600b8f3488bb1c3fd3461c854a1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfMy03LTEtMS0yMDg4_1721d11c-56fa-43dd-96fe-632da2e979e2"
      unitRef="usd">3514000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfNC0xLTEtMS0yMDg4_423f7931-c592-4043-8dc4-1381de4d325a"
      unitRef="usd">72859000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfNC0zLTEtMS0yMDg4_2b399eb8-74d9-4ff9-b5f8-c4fd7c4731a3"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfNC01LTEtMS0yMDg4_861bfbf5-dd28-47c2-921c-8c8b7ee931b8"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNC9mcmFnOjlkYjI1NzY2YmRmOTRiODlhNmU1OTczY2VkMWZhYzlmL3RhYmxlOjRjM2M4ODk1MDllYzQ0OTRiNTZmNWI0YTFiNmZkOTBmL3RhYmxlcmFuZ2U6NGMzYzg4OTUwOWVjNDQ5NGI1NmY1YjRhMWI2ZmQ5MGZfNC03LTEtMS0yMDg4_552bfd28-7551-4a34-842c-c9ad375e2c71"
      unitRef="usd">72864000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RleHRyZWdpb246NDFkNzc4ZjhmMzgxNDQyNzliNjk3ZjIyZDQzOGQ5ZWFfMTIwOTQ2Mjc5MDU2NTY_dfbed23a-9f7f-422f-9914-6a1daac484ed">Inventory&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consists of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RleHRyZWdpb246NDFkNzc4ZjhmMzgxNDQyNzliNjk3ZjIyZDQzOGQ5ZWFfNjA0NzMxMzk1Mjg4OQ_1f66ecdd-8e47-401c-bd97-35744b539961">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consists of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;977&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfMS0xLTEtMS0w_3b71d93c-4b53-4085-b493-95fb20341833"
      unitRef="usd">3546000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfMS0zLTEtMS0w_c6737108-09c5-454e-8e7f-8d4bf89c8e0b"
      unitRef="usd">2856000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfMi0xLTEtMS0w_58fff967-590f-45c6-a4f7-c0b01d235b5b"
      unitRef="usd">977000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfMi0zLTEtMS0w_b5583cb4-4ab1-4c50-8200-3a9d94700f08"
      unitRef="usd">687000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfNC0xLTEtMS0w_8c354f2d-2b34-45de-9183-c9b6b349c2dd"
      unitRef="usd">4523000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8zNy9mcmFnOjQxZDc3OGY4ZjM4MTQ0Mjc5YjY5N2YyMmQ0MzhkOWVhL3RhYmxlOjMzZWM3YWZlNmQyYzQyNGNhMzI0MGM4ZDBhMWZkYWIwL3RhYmxlcmFuZ2U6MzNlYzdhZmU2ZDJjNDI0Y2EzMjQwYzhkMGExZmRhYjBfNC0zLTEtMS0w_a53db20e-d14e-443a-a5b9-89fee157af21"
      unitRef="usd">3543000</us-gaap:InventoryNet>
    <us-gaap:OtherCurrentAssetsTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RleHRyZWdpb246NDY4Y2JkOTE4MjU3NDhmMmEwZjQ4MzE3ODU5MjQ0NjVfNjA0NzMxMzk1MzAwOA_417b6511-d11d-473e-a657-025ca25ad63d">Prepaid Expenses and Other Current Assets&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade and other receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentAssetsTextBlock>
    <us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RleHRyZWdpb246NDY4Y2JkOTE4MjU3NDhmMmEwZjQ4MzE3ODU5MjQ0NjVfNjA0NzMxMzk1MzAwOQ_8b5b228b-6c03-43b3-a602-637e7f8d95ef">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses and other current assets consist of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade and other receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock>
    <hims:TradeAndOtherReceivablesCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMS0xLTEtMS0w_5f1d738b-c10c-448d-a290-171cb9829f8c"
      unitRef="usd">942000</hims:TradeAndOtherReceivablesCurrent>
    <hims:TradeAndOtherReceivablesCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMS0zLTEtMS0w_523e692b-f8ae-486b-8b32-81840b9e9523"
      unitRef="usd">1147000</hims:TradeAndOtherReceivablesCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMi0xLTEtMS0w_de1aaa94-41dc-4092-bbb4-bfb0adade141"
      unitRef="usd">8650000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMi0zLTEtMS0w_cbef7b90-7e0e-4385-a15c-e833953ddf0e"
      unitRef="usd">2691000</us-gaap:PrepaidExpenseCurrent>
    <hims:VendorDepositsCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMy0xLTEtMS0w_f7f23a57-db11-4999-b943-93e13e72e6e4"
      unitRef="usd">2810000</hims:VendorDepositsCurrent>
    <hims:VendorDepositsCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfMy0zLTEtMS0w_19ef33e3-f0ce-4142-95ef-2b755bc0c27a"
      unitRef="usd">1395000</hims:VendorDepositsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfNC0xLTEtMS0w_a483fc4f-9c4a-4185-8afb-1a0dbb19d15e"
      unitRef="usd">5000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfNC0zLTEtMS0w_5834829f-3a7e-42fc-a899-cd37a2d9cf7e"
      unitRef="usd">171000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfNS0xLTEtMS0w_a09a0ba8-2030-4c16-a461-a2515b5cf306"
      unitRef="usd">12407000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80MC9mcmFnOjQ2OGNiZDkxODI1NzQ4ZjJhMGY0ODMxNzg1OTI0NDY1L3RhYmxlOjJkOGM5ZmM2NTM5OTQ2M2VhYjA5YmU1OGRiZTRhYTJmL3RhYmxlcmFuZ2U6MmQ4YzlmYzY1Mzk5NDYzZWFiMDliZTU4ZGJlNGFhMmZfNS0zLTEtMS0w_7001dd31-c282-4411-9382-d4ac6152c265"
      unitRef="usd">5404000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RleHRyZWdpb246NzliMDVhYzM3M2NhNDVjYWJhMWM5MDI3YjQ1MTE1NGVfNjA0NzMxMzk1MjkyMg_594c138f-58e5-49db-b607-cce6136da412">Accrued Liabilities&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant exercise deposit liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RleHRyZWdpb246NzliMDVhYzM3M2NhNDVjYWJhMWM5MDI3YjQ1MTE1NGVfNjA0NzMxMzk1MjkyMw_37acd6f2-9ba7-4f79-a340-f44a237fb342">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consist of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax payables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant exercise deposit liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Total accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,823&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMS0xLTEtMS0w_df517494-4014-451b-8310-69b482f579f5"
      unitRef="usd">1514000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedMarketingCostsCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMS0zLTEtMS0w_d8bcb2b6-cef2-41a8-8bf4-0da3529be21f"
      unitRef="usd">1122000</us-gaap:AccruedMarketingCostsCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMy0xLTEtMS0w_df1008f6-6f73-4abf-9a32-b04e13daa483"
      unitRef="usd">1480000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMy0zLTEtMS0w_242e214a-6a6e-41cb-a373-4528a80eb3c1"
      unitRef="usd">1241000</us-gaap:AccruedProfessionalFeesCurrent>
    <hims:AccruedPayrollCostsCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMy0xLTEtMS05Mzk5_3ea64b50-41fa-40a9-92d7-67e9380adac0"
      unitRef="usd">1250000</hims:AccruedPayrollCostsCurrent>
    <hims:AccruedPayrollCostsCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMy0zLTEtMS05Mzk5_9981dba6-e21c-4254-8f2b-cfac59b3ffef"
      unitRef="usd">919000</hims:AccruedPayrollCostsCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNC0xLTEtMS0w_535513fe-4d05-49d5-8ccf-4299f42cbfdf"
      unitRef="usd">729000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNC0zLTEtMS0w_07e80196-4176-4a27-a46a-bea8c2223d20"
      unitRef="usd">651000</us-gaap:TaxesPayableCurrent>
    <us-gaap:DepositLiabilityCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNS0xLTEtMS0w_8a7e59fc-b4b7-4bab-9816-2319ee59b829"
      unitRef="usd">0</us-gaap:DepositLiabilityCurrent>
    <us-gaap:DepositLiabilityCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNS0zLTEtMS0w_a6d8b548-c561-4aa3-9a57-428f1899e83b"
      unitRef="usd">664000</us-gaap:DepositLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNy0xLTEtMS0w_4938b4c5-b218-4d52-90b4-7e44c9af34bf"
      unitRef="usd">850000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfNy0zLTEtMS0w_90a142aa-956c-4c9e-a376-ae49e0c36d42"
      unitRef="usd">387000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMTAtMS0xLTEtODQ3OA_4ed5668c-6044-4718-a923-e90a038aeaf5"
      unitRef="usd">5823000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80My9mcmFnOjc5YjA1YWMzNzNjYTQ1Y2FiYTFjOTAyN2I0NTExNTRlL3RhYmxlOjljMDY5ZWQ2YzgwMDQyMjU4Njc4NzIwYzYyZDYzOTU0L3RhYmxlcmFuZ2U6OWMwNjllZDZjODAwNDIyNTg2Nzg3MjBjNjJkNjM5NTRfMTAtMy0xLTEtODQ3OA_2dbca642-f4a4-4f96-9644-b146355c9953"
      unitRef="usd">4984000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:VariableInterestEntityDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNjA0NzMxMzk1ODk2Mg_bf5d9807-a6f8-4745-a79d-22b99ca5b5b0">Variable Interest Entities&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In order for customers to obtain a prescription product, customers must complete a consultation with a Provider on the Company's website through one of the Affiliated Medical Groups and receive a written prescription by the applicable Provider. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Affiliated Medical Groups and the Company do not have any shareholders in common. The Affiliated Medical Groups are 100% owned by licensed physicians. The Company is party to service agreements with the Affiliated Medical Groups pursuant to which the Company provides management and administrative services and collects the medical consultation fees from customers on behalf of the Affiliated Medical Groups.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company also entered into service agreements with XeCare LLC ("XeCare"), a licensed mail order pharmacy affiliated with the Company which is expected to provide prescription fulfillment services solely to the Company's customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Affiliated Medical Groups and XeCare are legal entities that the Company has determined qualify as variable interest entities ("VIEs"). The Company determined that it is the primary beneficiary of these entities for accounting purposes because it has the ability to direct the activities that most significantly affect the entities' economic performance and has the obligation to absorb the losses. Under the VIE model, the Company presents the results of operations and the financial position of the Affiliated Medical Groups and XeCare as part of the consolidated financial statements of the Company as if the consolidated group were a single economic entity. There is no noncontrolling interest upon consolidation of the entities. The results of operations and cash flows of the Affiliated Medical Groups and XeCare are also included in the Company's condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021 and December&#160;31, 2020, the Company's condensed consolidated balance sheets included Affiliated Medical Groups and XeCare's combined current and total assets of $0.5 million and $1.4 million. As of March&#160;31, 2021 and December&#160;31, 2020, current liabilities were $1.1 million and $0.8 million and total liabilities were $1.5 million and $1.2 million. All amounts are after elimination of intercompany transactions and balances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The results of operations and cash flows of the Affiliated Medical Groups and XeCare are included in the Company's condensed consolidated financial statements. For the three months ended March 31, 2021 and 2020, the Affiliated Medical Groups and XeCare combined charged the Company $3.4 million and $0.3 million for services rendered. For the three months ended March 31, 2021 and 2020, the net losses generated by the Affiliated Medical Groups and XeCare combined were $1.8 million and $2.5 million after elimination of intercompany transactions and balances.&lt;/span&gt;&lt;/div&gt;</us-gaap:VariableInterestEntityDisclosureTextBlock>
    <hims:PercentageOwnedByLicensedPhysicians
      contextRef="i110e767e14c549139091e08b11477a77_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfMTUzOTMxNjI4MDEyNzE_e98f8c70-2274-4a9c-9b9c-8e1ee4c02285"
      unitRef="number">1</hims:PercentageOwnedByLicensedPhysicians>
    <us-gaap:AssetsCurrent
      contextRef="ib74f24447d164fde8a5bd9a5c8151c3d_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0ODU4NA_2c7e1af2-0f39-4366-a8c6-07d283e43ce7"
      unitRef="usd">500000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i9e0a54203ace4daf8d031a96662b2a6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0ODU4NA_94acaf6a-024f-41aa-801f-d20dfcab9830"
      unitRef="usd">500000</us-gaap:AssetsCurrent>
    <us-gaap:Assets
      contextRef="ib74f24447d164fde8a5bd9a5c8151c3d_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0ODU5MA_b40e8c80-6026-462a-9472-2e90fd1a0715"
      unitRef="usd">1400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9e0a54203ace4daf8d031a96662b2a6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0ODU5MA_f66aafd3-0b0a-4a0a-91a1-e20dc8831420"
      unitRef="usd">1400000</us-gaap:Assets>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib74f24447d164fde8a5bd9a5c8151c3d_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0NjE3Nw_09093811-fb99-416b-8dbd-9f50445099cc"
      unitRef="usd">1100000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i9e0a54203ace4daf8d031a96662b2a6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfNTQ5NzU1ODE0NjE4OA_c20eca9b-a6e2-41c5-bedc-7b0514234400"
      unitRef="usd">800000</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="ib74f24447d164fde8a5bd9a5c8151c3d_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfODI0NjMzNzIxOTk4OQ_cea623c8-e512-4459-a98f-4f2496f29087"
      unitRef="usd">1500000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i9e0a54203ace4daf8d031a96662b2a6a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfODI0NjMzNzIxOTk0Nw_d7ff3926-d879-4c64-8ff0-0fabb93369a4"
      unitRef="usd">1200000</us-gaap:Liabilities>
    <us-gaap:PaymentsToSuppliers
      contextRef="i1f396a9dac504e31a6c12e06a6f5e451_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfMjIzNA_581b6376-841c-4a73-b765-82e0857a2041"
      unitRef="usd">3400000</us-gaap:PaymentsToSuppliers>
    <us-gaap:PaymentsToSuppliers
      contextRef="ic2df3bb0701545b6bfc7f10a7ab86773_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfMjI0MQ_e322c371-d7f2-4598-be27-ee7aa9b8ef6f"
      unitRef="usd">300000</us-gaap:PaymentsToSuppliers>
    <us-gaap:NetIncomeLoss
      contextRef="i7d3aa17ad4214d73ac617595f9b25c56_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfMTY0OTI2NzQ0ODI3OA_c4ee493f-3710-43f0-9782-bdd1ebeee256"
      unitRef="usd">1800000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i17f7c6fe28314265a7171dccf5d0b1e1_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80Ni9mcmFnOjA5MzA0ZGI0MmQ5NDRjOTdhYzIxMDFhMjY3MDgxMGUzL3RleHRyZWdpb246MDkzMDRkYjQyZDk0NGM5N2FjMjEwMWEyNjcwODEwZTNfODI0NjMzNzIxNDE5Mg_e3755b5e-ac37-4592-83ee-064ffd772c17"
      unitRef="usd">2500000</us-gaap:NetIncomeLoss>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfNjA0NzMxMzk2MTg2NQ_ded14445-d3ca-46b2-8489-94fd8dc21189">Fair Value Measurements&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis as of March&#160;31, 2021, is as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2020, is as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of cash, accounts receivable, accounts payable, and accrued liabilities approximated their carrying values as of March&#160;31, 2021 and December&#160;31, 2020, due to their short-term nature. All other financial instruments except for warrant liabilities related to the preferred stock warrants and Private Placement Warrants are valued either based on recent trades of securities in active markets or based on quoted market prices of similar instruments and other significant inputs derived from or corroborated by observable market data. The warrant liabilities related to the preferred stock warrants and Private Placement Warrants contain significant unobservable inputs including the expected term and with respect to the preferred stock warrants, the share exchange ratio in evaluating the fair value of underlying common stock, and exercise price. Therefore, these warrant liabilities were evaluated to be a Level 3 fair value measurement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In prior periods, the fair value of the preferred stock warrant liability had been measured using the BSM option-pricing model and Monte Carlo simulation. During 2020, the Company changed its valuation method as a result of increased probability that the Company's common shares would be publicly listed in the near-term and began using a probability weighted expected returns methodology. As of December 31, 2020, the Company reverted to using a BSM option-pricing model to determine the value of the outstanding Series D preferred stock warrants (that replaced the Series C preferred stock warrants as discussed in Note 10 &#x2013; Borrowing Arrangements). Subsequent to the Merger, the Series D preferred stock warrants were converted to Class A common stock warrants. As a result, the Series D preferred stock warrants were adjusted to fair value prior to the conversion resulting in a change in fair value of $0.3 million recognized as a component of other income (expense), net within the consolidated statements of operations and comprehensive loss, and then settled in additional paid-in capital as a result of the conversion to equity-classified Class A common stock warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March 31, 2021, changes in warrant liabilities also related to changes in liabilities for warrants assumed as part of the recapitalization, including Private Placement Warrants and Public Warrants (defined and discussed in Note 14 &#x2013; Common Stock). The Company valued the Private Placement Warrants using a Monte Carlo valuation simulation. Inherent in a Monte Carlo simulation are assumptions related to expected term, volatility, risk-free interest rate and dividend yield. The expected term of the warrants was determined to be equivalent to their remaining contractual term and includes consideration of the redemption features that were incorporated into the Monte Carlo model. The Company derived the volatility of its Class A common stock based on average historical stock volatilities of a peer group of public companies that the Company considers to be comparable to its business over a period equivalent to the expected term of the Private Placement Warrants. The risk-free interest rate is based on the U.S. Treasury's rates of U.S. Treasury zero-coupon bonds with a maturity similar to the expected term of the Private Placement Warrants. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The following assumptions were used for the valuation of the Private Placement Warrants on the settlement date:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Public Warrants were valued as of March&#160;31, 2021 using the listed trading price of $4.40 per Public Warrant.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the fair value of warrant liabilities is as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Conversion of Series D preferred stock warrants to Class A common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private Placement Warrants and Public Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in fair value of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company had no transfers between levels of the fair value hierarchy of its assets or liabilities measured at fair value. Due to the exercise and conversion to Class A common stock warrants of all preferred stock warrants and exercise of all of the Private Placement Warrants during the period, there were no longer any Level 3 warrant liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfNjA0NzMxMzk2MTg2Ng_23b1e2f7-8cee-468c-8ad4-0facd271415c">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis as of March&#160;31, 2021, is as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,924&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;246,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;321,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2020, is as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie1261279d3aa492883efe6f3cd396cb3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMy0xLTEtMS0w_2fea1d65-12bc-4bcc-9a79-a609aedbd899"
      unitRef="usd">74930000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia3f6c0cccb1747fab4662fd836029d53_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMy0zLTEtMS0w_1a87eeca-f743-4276-bb96-bcf57707772c"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0da6465d5cfd441a8e436e127aad5c7e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMy01LTEtMS0w_a80821d7-c390-4f0f-84cd-ab4967cd65ed"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ice63ea8cf53844e0864c120028d72122_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMy03LTEtMS0w_f7ea469a-f353-486b-a2a6-73fc4a3a4a6c"
      unitRef="usd">74930000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ib363310ebb4645b0a3c4dd9026e8460b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNC0xLTEtMS0w_858f4e4b-d37e-43d4-91d9-e5f049573ea7"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if9857a89a397463b9c65163424b97b37_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNC0zLTEtMS0w_70af430a-1066-4146-a337-641ede034daf"
      unitRef="usd">11082000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ie581b89d86bb4b27a922377f19e8768c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNC01LTEtMS0w_69b6e426-5b49-4a87-a867-bb52437bbc12"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibaf57a370dcb4f3194869f3b6b0cc8ef_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNC03LTEtMS0w_b1c28e12-58cd-428c-9896-6f4646caaaf3"
      unitRef="usd">11082000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments
      contextRef="iccc37ed1bbc44e95b445c711db6f3652_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNi0xLTEtMS0w_5aa0f47b-ce0d-437d-bc92-409879254d19"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i3447faea2aa041928f7c8b0073fbfa56_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNi0zLTEtMS0w_04d8c2c8-51f9-449f-9111-33b7d23facc8"
      unitRef="usd">177221000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i4e36e9ea2b4a410389a76edfd4bc808c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNi01LTEtMS0w_9bf5eb3b-3aef-4b7d-a42a-5c3f0e912966"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="id21bfa4e61b64d21b588aa675df6b00e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNi03LTEtMS0w_7cbf9e31-6de3-4d76-919f-2f04f83eefee"
      unitRef="usd">177221000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i5551c8f434cf4e9996e3e103dd9851e3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNy0xLTEtMS0w_46e562f6-f3ee-494c-ba8c-1e8a95ec74e4"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i9dd0cb9d9b154483976882a2f8f17dae_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNy0zLTEtMS0w_8b3ec4ea-c99f-4445-9cf9-f71015ad392a"
      unitRef="usd">40952000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i6d5316cfa402448b974312f0f0bc26ca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNy01LTEtMS0w_9c0dfeed-2174-41b1-b582-efbda122f5ec"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i77245f278ab24e148fb7d4fc5d3b59fc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfNy03LTEtMS0w_8d7a3570-ed4a-4d0c-8d56-3c2376d1a10f"
      unitRef="usd">40952000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i5921abd0287d42bca47601e3138ee2b7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfOC0xLTEtMS0w_2d606808-2e43-4d91-936d-9567e04286d8"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i1e49409a01d64ff5bfdd179b67b5738c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfOC0zLTEtMS0w_c02f8100-0b90-41aa-92cf-40df6eef54f9"
      unitRef="usd">16924000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="id215004884234f36b4e29d5e5c970035_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfOC01LTEtMS0w_62dd7f65-8f63-4537-a720-4f653ca0ea6e"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i951242edbea04ed9a606420d62e43d5a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfOC03LTEtMS0w_cfe1baf2-d85e-45cb-b5fb-4a4e4527124f"
      unitRef="usd">16924000</us-gaap:ShortTermInvestments>
    <us-gaap:RestrictedCash
      contextRef="i331c1c09758e4c69a36701bae87d7d62_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTAtMS0xLTEtMA_f15526a2-8cec-4c48-8e91-7473eb4c356d"
      unitRef="usd">856000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i5563144fb5ca4783b8c91e836f518044_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTAtMy0xLTEtMA_8ea2b54d-9dd3-4211-a1ba-c244edca3b0c"
      unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="ie21b17ce9282470780a4cb69a30b093f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTAtNS0xLTEtMA_e433f173-87b4-4ff7-b2b9-512845230c5c"
      unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="iabbb558f9a6046f6a6d5d46c8153d18b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTAtNy0xLTEtMA_9012eda5-6fd1-4a58-914f-7f2dcafad7da"
      unitRef="usd">856000</us-gaap:RestrictedCash>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iccdf1b1af9d34e62a5785c63d9ca448c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTMtMS0xLTEtMA_6a72b41c-98fe-40c6-aa76-f2cd80e2550b"
      unitRef="usd">75786000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i66b86854e56b4e96a87ecc1cda0a4203_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTMtMy0xLTEtMA_244a3ed3-84ab-4c8b-b261-50db46aa4dcf"
      unitRef="usd">246179000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i44535c1c0c1942a59dc7b0356127e67b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTMtNS0xLTEtMA_9a81596f-5aa3-4b7c-b70c-c2f26b8b27ab"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ie21c138cee4747ccb68c72561e6a795b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTMtNy0xLTEtMA_4884e387-22c4-4b84-ab1e-051d3112b2d2"
      unitRef="usd">321965000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="iccdf1b1af9d34e62a5785c63d9ca448c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTUtMS0xLTEtMA_1b33734b-717d-4668-b1df-d73315a960f0"
      unitRef="usd">33370000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i66b86854e56b4e96a87ecc1cda0a4203_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTUtMy0xLTEtMA_c5bb3ce6-f1c5-4e31-af7b-911af90b3d9e"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i44535c1c0c1942a59dc7b0356127e67b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTUtNS0xLTEtMA_d4212fea-4b78-4b08-a32d-70204bc4df68"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ie21c138cee4747ccb68c72561e6a795b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTUtNy0xLTEtMA_320c8cd5-dfc5-4b45-899a-89e83206fb9c"
      unitRef="usd">33370000</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="iccdf1b1af9d34e62a5785c63d9ca448c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTYtMS0xLTEtMA_cc2c3c27-2043-4c3d-a2f5-8e7e18d17f6b"
      unitRef="usd">33370000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i66b86854e56b4e96a87ecc1cda0a4203_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTYtMy0xLTEtMA_a4b2847f-eb2b-4d4e-a10f-f5d45b130b79"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i44535c1c0c1942a59dc7b0356127e67b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTYtNS0xLTEtMA_97940320-2aff-45f2-923a-0df20565feb5"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ie21c138cee4747ccb68c72561e6a795b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmNhMjI3OWNkYTc1MDRlZGRiM2Q3MDgzZjhhNTcxNzIxL3RhYmxlcmFuZ2U6Y2EyMjc5Y2RhNzUwNGVkZGIzZDcwODNmOGE1NzE3MjFfMTYtNy0xLTEtMA_ebdde3f0-4453-4617-82dc-51fe03fe9fa2"
      unitRef="usd">33370000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i412599e663c246f58192d84fe4e5c1b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMy0xLTEtMS0w_66f8ea8c-6477-472e-b7b1-fa0e77d73b0e"
      unitRef="usd">12163000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7ad3e5023fd84a749114f9e9c5d8fe3a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMy0zLTEtMS0w_17c6ef63-6caf-4771-bae4-a0395723e25a"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i31da51b8ef1b4471a68135a9ca41a2d6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMy01LTEtMS0w_2e2bdc9d-a521-4010-8b3c-deedb96ab2dd"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icfd5ade4260a4169b2a95d7bff1b3555_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMy03LTEtMS0w_3911bcb3-0a67-4c3c-a740-eea9a605bd1c"
      unitRef="usd">12163000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id759fafd0df14ae7b07a52edb22e1ca9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNC0xLTEtMS0w_e6c6e97b-0bab-42fa-953f-e38bf6b877b4"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5c4a1baeea1040a6bfbcedb38a9692e8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNC0zLTEtMS0w_6da5c166-7535-45c2-9f12-f09290669380"
      unitRef="usd">12693000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3e6e3cda27214222b2b0bfe2a6683419_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNC01LTEtMS0w_0c8d2975-2407-4318-86c7-10ebfcc0d61e"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9ed5940103494fb785ddb8f61a51b123_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNC03LTEtMS0w_38890e05-7185-4df2-8bc3-d1e45f79e4c5"
      unitRef="usd">12693000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:ShortTermInvestments
      contextRef="ifda94c6105694420b4c8f321805f5ce1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNi0xLTEtMS0w_16e3233e-f6cf-47e9-8d24-8d687a161d8c"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ie5013ddd007d4531aa596bb95e66ae50_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNi0zLTEtMS0w_bf2d1e5b-4157-4c72-a102-815a3a0e8de3"
      unitRef="usd">55227000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="if5e442e5c43548c4948861619534ee83_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNi01LTEtMS0w_3d245899-c11f-41ce-a079-bf75162d4ae1"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ia16cd32451554ee58bc61ba0bd167f4d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNi03LTEtMS0w_00c0af6b-1496-423b-be88-377fefb33dbf"
      unitRef="usd">55227000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i33b128102f77412aae3acc936185d672_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNy0xLTEtMS0w_a816819e-5578-4086-870a-64093452deac"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i99e1a4138a1e4cb69b365d76305514e5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNy0zLTEtMS0w_448af092-19c7-4fcb-8571-229d28dae6c4"
      unitRef="usd">14123000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i0c40d2b1b9bf422baf436e98c75a1c04_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNy01LTEtMS0w_81accbde-413d-4dd2-aa8d-befda80413ad"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i1f48df72d4d24ae497a675ff9cf956e3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfNy03LTEtMS0w_00fcc1ee-131e-43af-9fff-c0fefb01e65b"
      unitRef="usd">14123000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ia7308d4762634cee8d9041732b9af184_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfOC0xLTEtMS0w_de8194a4-285d-443a-a3ef-3d6c4929d920"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i7eca143c66bf4203b6157bcac25d255b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfOC0zLTEtMS0w_a12231ab-2bd8-467a-9489-805df3cb1000"
      unitRef="usd">3514000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i25ea3f8831144795bc21e4c954d3d744_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfOC01LTEtMS0w_dc0396d0-f376-4366-8e26-4c532ddb01c4"
      unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="i6fe48b31f8c34e88b6668252c5babd68_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfOC03LTEtMS0w_55c044c6-e7ba-43e0-bee0-54e7d2fe5fc3"
      unitRef="usd">3514000</us-gaap:ShortTermInvestments>
    <us-gaap:RestrictedCash
      contextRef="ic1c7658a139f475181f2d9be70639547_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTAtMS0xLTEtMA_439693c1-28ca-4238-b131-e9a2187f8569"
      unitRef="usd">1006000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i16613643ae1546028149b3da23f7a029_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTAtMy0xLTEtMA_220b1a9c-80b0-4e87-ae35-0e2503d56015"
      unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i0bd82762a6b54ce086b7a833cdd8431c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTAtNS0xLTEtMA_b5018d8b-20f2-4c94-8014-0e0641878f74"
      unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="ic900949695af4a3f8a0e43ab44a1d546_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTAtNy0xLTEtMA_35473df6-d6b7-4531-889a-dcad5581b19c"
      unitRef="usd">1006000</us-gaap:RestrictedCash>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibf3e680104bd40d0a6d893fc9d407cbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTMtMS0xLTEtMA_afd4ae0b-99be-4433-a1f4-71b14f1dc557"
      unitRef="usd">13169000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i16c0164539c14d3c8ffaafa97bcfab89_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTMtMy0xLTEtMA_404bedcf-7f54-4583-9e20-1e77d9991864"
      unitRef="usd">85557000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i8e62e51bd26b485eb7df23994a15198e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTMtNS0xLTEtMA_ca1593ac-c1ae-4749-921e-a8c136313ddc"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i987f47d6dcfe4bbcac41361b3f772407_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTMtNy0xLTEtMA_389f9505-6bcf-4a95-a533-d871e98e94a0"
      unitRef="usd">98726000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities
      contextRef="ibf3e680104bd40d0a6d893fc9d407cbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTUtMS0xLTEtMA_b180f3bf-d74e-4858-8c91-dc40081a638f"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i16c0164539c14d3c8ffaafa97bcfab89_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTUtMy0xLTEtMA_cc060cb2-f3ac-45a4-abf1-c5f729b0cdee"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i8e62e51bd26b485eb7df23994a15198e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTUtNS0xLTEtMA_74d35d8b-f44c-4203-bd24-276d31133eb0"
      unitRef="usd">906000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i987f47d6dcfe4bbcac41361b3f772407_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTUtNy0xLTEtMA_64fc728d-8592-432c-955e-daafa6438ca7"
      unitRef="usd">906000</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ibf3e680104bd40d0a6d893fc9d407cbe_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTYtMS0xLTEtMA_2aa0bc7d-21e0-4852-8abe-f3768a5ec4f4"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i16c0164539c14d3c8ffaafa97bcfab89_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTYtMy0xLTEtMA_d15b6d01-c14c-4f07-9097-346ae31dc4ba"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i8e62e51bd26b485eb7df23994a15198e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTYtNS0xLTEtMA_cf661fd7-83e6-4a71-9c5c-369633fba012"
      unitRef="usd">906000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i987f47d6dcfe4bbcac41361b3f772407_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjYyNGQxN2E0YTU3MDQxZWJiMzA2MmEwMmVmNzdkNGJjL3RhYmxlcmFuZ2U6NjI0ZDE3YTRhNTcwNDFlYmIzMDYyYTAyZWY3N2Q0YmNfMTYtNy0xLTEtMA_8953ddd9-91aa-4625-9cd1-b87be182cd67"
      unitRef="usd">906000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfMTUzOTMxNjI4MDUyOTI_1eac80bf-f096-4122-83a8-e85050f3e858"
      unitRef="usd">300000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease>
    <hims:ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfNjA0NzMxMzk2ODQ0NQ_5da9278e-7e7d-4469-ba33-d497f4be5dae">The following assumptions were used for the valuation of the Private Placement Warrants on the settlement date:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.16&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;The following assumptions were used in this valuation: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</hims:ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic3283d5498c749f187e436d50e1f4646_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjE3Mjk5NmJmZTgwNjQwOTg4MTI2YTRkNzFhMzU3NmFjL3RhYmxlcmFuZ2U6MTcyOTk2YmZlODA2NDA5ODgxMjZhNGQ3MWEzNTc2YWNfMC0xLTEtMS0xOTQ2NA_6b8f2c43-9d40-46b2-94f0-ff1774142657">P0Y1M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ic3283d5498c749f187e436d50e1f4646_D20210101-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjE3Mjk5NmJmZTgwNjQwOTg4MTI2YTRkNzFhMzU3NmFjL3RhYmxlcmFuZ2U6MTcyOTk2YmZlODA2NDA5ODgxMjZhNGQ3MWEzNTc2YWNfMS0xLTEtMS0xOTQ2NA_bab846ad-c82d-4a54-9e2e-b409bc933a37"
      unitRef="number">0.6500</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic3283d5498c749f187e436d50e1f4646_D20210101-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjE3Mjk5NmJmZTgwNjQwOTg4MTI2YTRkNzFhMzU3NmFjL3RhYmxlcmFuZ2U6MTcyOTk2YmZlODA2NDA5ODgxMjZhNGQ3MWEzNTc2YWNfMi0xLTEtMS0xOTQ2NA_f91cd32a-b755-4549-9876-c15977a0da14"
      unitRef="number">0.0003</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic3283d5498c749f187e436d50e1f4646_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOjE3Mjk5NmJmZTgwNjQwOTg4MTI2YTRkNzFhMzU3NmFjL3RhYmxlcmFuZ2U6MTcyOTk2YmZlODA2NDA5ODgxMjZhNGQ3MWEzNTc2YWNfMy0xLTEtMS0xOTQ2NA_f186a6ba-5b4e-4acf-bfa7-b0097d48e31a"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharePrice
      contextRef="i2f384c5987114c539e4c3c37fe1f66ab_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfMTUzOTMxNjI4MDUzMTQ_0c3b79e5-a4ea-447c-a014-9a5357fb1e72"
      unitRef="usdPerShare">4.40</us-gaap:SharePrice>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RleHRyZWdpb246ODZkZDI3NDIwNTZkNDk5ZDhjN2M2YzRmMGE2Y2Y3YjRfNjA0NzMxMzk2NjA5Mg_7197b8e8-a398-4cb2-90de-3de26480abef">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in the fair value of warrant liabilities is as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Conversion of Series D preferred stock warrants to Class A common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,160)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private Placement Warrants and Public Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,871)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in fair value of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMC0xLTEtMS05NTI1_5c96e9a0-d7e4-44d6-8f22-65d14837c287"
      unitRef="usd">906000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <hims:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMS0xLTEtMS05NTI1_fd64b55c-47b1-49aa-af63-a600cc998bf6"
      unitRef="usd">1160000</hims:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMi0xLTEtMS05NTQ5_4f94266e-9c4e-49c2-92d7-8c0894e19124"
      unitRef="usd">51814000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMy0xLTEtMS05NTQ5_206c1d6a-3ca6-4084-bfa0-7ab2f9163931"
      unitRef="usd">-20871000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMi0xLTEtMS05NTI1_0ab572dc-58f1-4299-9b67-e7bbeeda0892"
      unitRef="usd">2681000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV80OS9mcmFnOjg2ZGQyNzQyMDU2ZDQ5OWQ4YzdjNmM0ZjBhNmNmN2I0L3RhYmxlOmUxN2Q5NDZkNjE4NTQ3NTZhMDVjZGQ2YzcxMDMwOTI3L3RhYmxlcmFuZ2U6ZTE3ZDk0NmQ2MTg1NDc1NmEwNWNkZDZjNzEwMzA5MjdfMy0xLTEtMS05NTI1_8974c034-b7df-425a-9ffb-bd8e765c160c"
      unitRef="usd">33370000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2MzM3OQ_ac5e8101-2b69-4e7c-bc2d-690ca0140154">Borrowing Arrangements&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Silicon Valley Bank&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Second Amended and Restated Loan Agreement dated November 27, 2019, between Hims and Silicon Valley Bank ("SVB"), upon Hims' request, SVB would issue letters of credit (the "Letters of Credit") in an aggregate amount not to exceed $2.0 million. This amount is reduced by the amount otherwise available with respect to the cash management services, which may include merchant services, direct deposit of payroll, business credit card, and check cashing services identified in SVB's various agreements. On September 30, 2020, Hims entered into the First Loan Modification Agreement ("Loan Modification &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Agreement") and the aggregate amount of the Letters of Credit was amended to $3.5 million. As of March&#160;31, 2021, SVB issued on the Company's behalf, a letter of credit in the amount of $0.8 million as a security deposit for a warehouse space in New Albany, Ohio. SVB required  $0.8 million to be maintained as collateral for the outstanding letter of credit. The Company expects to continue to renew the letter of credit through the duration of the lease. As this is for longer than one year, the Company presents the $0.8 million within restricted cash, noncurrent on the consolidated condensed balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There is a business credit card as part of the cash management services offered by SVB with an initial limit of $2.0 million which is reduced by the amount utilized for any issuances of Letters of Credit. This amount was increased to $3.5 million by the Loan Modification Agreement. To continue to use the credit card, SVB required $0.2 million to be maintained in a collateralized money market account and this was reflected within restricted cash on the consolidated balance sheet as of December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company terminated the Second Amended and Restated Loan Agreement with SVB resulting in the release of restricted cash of $0.2 million under the arrangement. The outstanding letter of credit for the warehouse was not included as part of this termination. In addition, the Company continues to use SVB's cash management services and increased its credit card limit to $5.0 million in January 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;TriplePoint Venture Growth&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November&#160;27, 2019, Hims entered into a Plain English Capital Growth and Security Agreement (the "2019 Capital Agreement") with TriplePoint Venture Growth ("TPC") consisting of a term loan in the aggregate principal amount of up to $50.0 million, with $25.0 million being available immediately through December&#160;31, 2020 (the "Part 1 Commitment Amount"), and an additional $25.0 million becoming available upon utilization of the Part 1 Commitment Amount through December&#160;31, 2020. There was no minimum advance amount. As collateral, the Company provided a second lien security interest to TPC of substantially all its assets. As of December 31, 2020, the Company had not drawn down from this term loan and the facility expired.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the 2019 Capital Agreement, the Company issued to TPC a warrant granting TPC the right to purchase 89,747 shares of Hims' Series C preferred stock at an exercise price of $7.67 per share, subject to adjustment in regard to the preferred stock series, number of shares and exercise price if the per share price of subsequent preferred stock rounds less than $7.67. On March&#160;12, 2020, Hims sold Series D preferred stock at an issuance price of $6.96, which triggered an adjustment to the TPC warrant terms per the original agreement, resulting in conversion of the previously issued 89,747 Series C preferred stock warrants at an exercise price of $7.67 into 98,723 Series D preferred stock warrants at an exercise price of $6.96. Subsequent to the Merger, the Series D preferred stock warrants were converted to Class A common stock warrants. Refer to Note 13 &#x2013; Redeemable Convertible&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Preferred Stock&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for further discussion of the conversion into Class A common stock warrants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i3fe856ce18a44b73b24c2b3b20e78100_I20191127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2MTY_b2944d40-fcdd-4d27-af45-a6500a8696e6"
      unitRef="usd">2000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5b82495f9a7d49a191625811b12a3abe_I20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2MjM_31b0a5cf-c7fa-4de9-925c-39ece79e1101"
      unitRef="usd">3500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="i02b56d69d02b40c8bb34acbef31e8a91_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfODI0NjMzNzIxNzA2NA_64ea8a2b-62cf-400e-9372-0499f48b9a16"
      unitRef="usd">800000</us-gaap:ProceedsFromIssuanceOfDebt>
    <hims:DebtInstrumentCovenantRequiredCollateralAmount
      contextRef="i3a251b644bc0446c8e735717fbf04f53_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2Mjk_6a07165d-af1a-432b-bd92-6ad8cfd56d5e"
      unitRef="usd">800000</hims:DebtInstrumentCovenantRequiredCollateralAmount>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i3a251b644bc0446c8e735717fbf04f53_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2MzU_eb8cb420-5140-4075-a66b-3c5e2d248830"
      unitRef="usd">800000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5a8d0ab00fc54564bf744ee2cdb48474_I20191127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NDE_2d7f830f-097f-4d92-815a-b0806f35d722"
      unitRef="usd">2000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i68341f8644ea4e029489cb67df2b60c9_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NDc_c31235e0-8f8a-4ed2-b5e6-972f017a6cc9"
      unitRef="usd">3500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <hims:DebtInstrumentCovenantRequiredCollateralAmount
      contextRef="i68341f8644ea4e029489cb67df2b60c9_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NTM_80f49c1a-66d9-43e6-a24f-52fd8e8a780c"
      unitRef="usd">200000</hims:DebtInstrumentCovenantRequiredCollateralAmount>
    <hims:DebtInstrumentCovenantRequiredCollateralAmount
      contextRef="i0973a5a47b37445789cae6d5c00e8ead_I20210131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NjY_0aefcfe4-e528-4df4-9ef7-5c6ed8b96e53"
      unitRef="usd">200000</hims:DebtInstrumentCovenantRequiredCollateralAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0973a5a47b37445789cae6d5c00e8ead_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NTk_3fbac71f-1596-4075-b4db-1b6a92b1906d"
      unitRef="usd">5000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <hims:DebtInstrumentMaximumBorrowingCapacity
      contextRef="i5a1bd4b3c5cf421eb59bc006d40c812b_I20191127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2NzI_f0bc48f4-4f01-47cf-b1f9-2964ce499e8f"
      unitRef="usd">50000000.0</hims:DebtInstrumentMaximumBorrowingCapacity>
    <hims:DebtInstrumentMaximumBorrowingCapacity
      contextRef="i9d494bd599bc4c71829076ebfffdde40_I20191127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2Nzg_eea51e28-dd2b-44b5-9ac7-b062f8959377"
      unitRef="usd">25000000.0</hims:DebtInstrumentMaximumBorrowingCapacity>
    <hims:DebtInstrumentMaximumBorrowingCapacity
      contextRef="i36b5c8248a21411787d87df95d270d0a_I20191127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfMTUzOTMxNjI4MDQ2ODQ_e7175e6c-37ae-4aae-a136-675891b4a0f6"
      unitRef="usd">25000000.0</hims:DebtInstrumentMaximumBorrowingCapacity>
    <us-gaap:DebtLongtermAndShorttermCombinedAmount
      contextRef="i7b388341898d4c259124f7ad120acc5c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2OTY2Mw_7d291cb0-72fa-46cf-9dfd-ecfc42519a44"
      unitRef="usd">0</us-gaap:DebtLongtermAndShorttermCombinedAmount>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i75207e8547a1486e92e7339599496592_I20191127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2MzMxMg_3b81fff9-b2f2-485d-9e2f-3ec7fbefe2c2"
      unitRef="shares">89747</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i75207e8547a1486e92e7339599496592_I20191127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfODI0NjMzNzIyMzAzOQ_b163cee0-8c26-4f87-8c64-1c35000e5cd3"
      unitRef="usdPerShare">7.67</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i75207e8547a1486e92e7339599496592_I20191127"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfODI0NjMzNzIyMzA0Nw_b163cee0-8c26-4f87-8c64-1c35000e5cd3"
      unitRef="usdPerShare">7.67</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i85017d290ffd4ccda16318d642b40261_I20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2MzMzOA_ec39e5f6-efa9-44f0-8147-180f0621d0ce"
      unitRef="usdPerShare">6.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i9325ba192ff34fe4a7eec3cc7c4f7351_I20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2NzcxOQ_ce592ad8-9ee7-4da7-a90d-fba1150c9afe"
      unitRef="shares">89747</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i9325ba192ff34fe4a7eec3cc7c4f7351_I20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2NzczNQ_26709edc-90af-4c1c-9154-fc7a04051d2b"
      unitRef="usdPerShare">7.67</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i85017d290ffd4ccda16318d642b40261_I20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfNjA0NzMxMzk2MzM2Mg_9a71f51b-a3af-4252-b3ff-ab7900de1b13"
      unitRef="shares">98723</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i85017d290ffd4ccda16318d642b40261_I20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81Mi9mcmFnOjkyZDkzYWY2YmI3YzRjOTZiZGRkNjBkYjk3NzFmZTM1L3RleHRyZWdpb246OTJkOTNhZjZiYjdjNGM5NmJkZGQ2MGRiOTc3MWZlMzVfODI0NjMzNzIyMzA5OQ_ec39e5f6-efa9-44f0-8147-180f0621d0ce"
      unitRef="usdPerShare">6.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk1ODk4MA_47969d28-6fab-42e8-991a-e29025b9a330">Commitments and Contingencies&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Leases &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total rent expense for the three months ended March 31, 2021 and 2020, was $0.4 million and $0.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the Company entered into a 63-month noncancelable lease for 302,880 square feet of warehouse space in New Albany, Ohio. The lease commenced on June 1, 2020. Total minimum lease payments are $7.9&#160;million, net of rent abatement for an initial &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ2Nw_b7a72c41-6787-457a-a407-941a4bba5358"&gt;three&lt;/span&gt;-month period and with annual escalation of 2.5%. The Company has the option to extend the lease term for a period of five years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease commitments subsequent to March 31, 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Purchase Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company had contractual obligations to make $1.0 million in purchases related to cloud-based software contracts used in operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company is a party to various litigation, claims, and other legal and administrative proceedings arising in the ordinary course of business. Some of these claims, lawsuits, and other proceedings may involve highly complex issues that are subject to substantial uncertainties, and could result in damages, fines, penalties, nonmonetary sanctions, or relief. Management is not currently aware of any matters that are reasonably likely to have a material adverse impact on the Company's business, financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LeaseAndRentalExpense
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNzMx_85bf5338-5408-44df-ad16-dcf36ac64e8a"
      unitRef="usd">400000</us-gaap:LeaseAndRentalExpense>
    <us-gaap:LeaseAndRentalExpense
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNzM4_7e7ec076-213b-411a-adcb-0dc4ea77c9aa"
      unitRef="usd">700000</us-gaap:LeaseAndRentalExpense>
    <hims:OperatingLeaseTermOfContract
      contextRef="i5675e635aac644dca3d94839ad1ea8dd_D20200101-20200131"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQzNg_59cc7e21-8b67-46fc-b82b-0572295364da">P63M</hims:OperatingLeaseTermOfContract>
    <us-gaap:AreaOfRealEstateProperty
      contextRef="i4d3f4663a5ae4f998ff2c4ed33cc4b76_I20200131"
      decimals="-1"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ0NQ_266ac656-c251-4f85-9f8f-0adf539ef1ae"
      unitRef="sqft">302880</us-gaap:AreaOfRealEstateProperty>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="icea812223fa644ce962e9076a86b988e_I20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ1NA_55bde4f5-a8d5-47d0-bc58-204e72be031e"
      unitRef="usd">7900000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <hims:OperatingLeaseRentExpenseAnnualEscalationPercent
      contextRef="i5675e635aac644dca3d94839ad1ea8dd_D20200101-20200131"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ3OA_179c823b-ca55-4ab8-bbb5-c1f153a12547"
      unitRef="number">0.025</hims:OperatingLeaseRentExpenseAnnualEscalationPercent>
    <hims:OperatingLeaseRenewalTerm
      contextRef="i5675e635aac644dca3d94839ad1ea8dd_D20200101-20200131"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ4Mw_7720c843-c43a-49c9-81af-d7beff1e1190">P5Y</hims:OperatingLeaseRenewalTerm>
    <us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQzMw_c5f7cfd1-5d28-4d12-8ad0-8c2423398c25">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease commitments subsequent to March 31, 2021 are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.465%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.335%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfMC0xLTEtMS0xMDE0Ng_fd76a7e0-3242-4c79-9013-921b19b5654a"
      unitRef="usd">1146000</us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfMS0xLTEtMS0xMDE0Ng_4debf356-7123-415b-b74e-0fefff25dfeb"
      unitRef="usd">1559000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfMi0xLTEtMS0xMDE0Ng_fbb5fa4d-4958-4fcb-991c-f91252a61377"
      unitRef="usd">1598000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInThreeYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfMy0xLTEtMS0xMDE0Ng_52e4fece-761c-4665-9479-1c8d9e8847fc"
      unitRef="usd">1638000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfNC0xLTEtMS0xMDE0Ng_13689866-caa5-4ff1-9990-cb6b23bc4369"
      unitRef="usd">1114000</us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears>
    <us-gaap:OperatingLeasesFutureMinimumPaymentsDue
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RhYmxlOmZiOGVhZmZlMjc2MTQ2OWY4YWZkOGNkYjhhMjRkMWRkL3RhYmxlcmFuZ2U6ZmI4ZWFmZmUyNzYxNDY5ZjhhZmQ4Y2RiOGEyNGQxZGRfNS0xLTEtMS0xMDE0Ng_f2df4f65-6c1f-46d6-bcfd-28b7ad0495de"
      unitRef="usd">7055000</us-gaap:OperatingLeasesFutureMinimumPaymentsDue>
    <us-gaap:PurchaseObligation
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfMjA0OQ_d2fcd7b9-0779-41bd-985e-e547fd9d1cee"
      unitRef="usd">1000000.0</us-gaap:PurchaseObligation>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzA0Mw_e8a763f0-29f6-4b9a-aff8-444cc12c2283">Stock-Based Compensation&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2017 Stock Plan and 2020 Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2017, the Company adopted the 2017 Stock Plan (the "2017 Plan"). Under the 2017 Plan, the Board of Directors could grant awards, including incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, RSU awards, and other stock awards to employees, directors, and consultants. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, in connection with the Merger, the Board of Directors adopted the 2020 Equity Incentive Plan (the "2020 Plan") and reserved 21,000,000 authorized shares of Class A common stock the Company could issue. In addition, up to 19,000,000 shares of Hims Class A common stock subject to awards granted under the 2017 Plan that were forfeited, expired or lapsed unexercised or unsettled could be added to the 2020 Plan reserve. Beginning on January 1, 2022 and ending on January 1, 2031, the number of authorized shares of common stock under the 2020 Plan will automatically increase by 5% of the total number of Class A and Class V common stock issued and outstanding on the last day of the preceding fiscal year unless the Board of Directors approves a lesser number. As of the effective date of the 2020 Plan, no further stock awards have been or will be granted under the 2017 Plan. During the period, 55,645 shares of Class A common stock subject to awards granted under the 2017 Plan that were outstanding on the Merger date and forfeited after the adoption of the 2020 Plan were added to the 2020 Plan reserve. Therefore, as of March&#160;31, 2021, there were 21,055,645 shares of Class A common stock reserved and 18,581,886 shares of Class A common stock available for the Company to grant under the 2020 Stock Plan; there were no more shares available for grant under the 2017 Plan (since the 2017 Plan was replaced by the 2020 Plan).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under both the 2017 Plan and 2020 Plan, stock options and stock appreciation rights are granted at exercise prices determined by the Board of Directors which cannot be less than 100% of the estimated fair market value of the common stock on the grant date. Incentive stock options granted to any stockholders holding 10% or more of the Company's equity cannot be granted with an exercise price of less than 110% of the estimated fair market value of the common stock on the grant date and such options are not exercisable after five years from the grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options for new employees generally vest over four years, with 25% vesting one year after the vesting commencement date and then 1/48th of the total grant vesting monthly thereafter. Options granted to current employees generally vest 1/48th of the total grant monthly over four years. Options granted are exercisable within a period not exceeding ten years from the grant date. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;17, 2020, the Board of Directors granted 3,246,139 and 1,623,070 stock options to the CEO with an exercise price of $2.43 to vest upon either (i)&#160;an acquisition of the Company with per share consideration equal to at least $22.99 and $38.31, respectively, or (ii)&#160;a per share price on a public stock exchange that is at least equal to $22.99 and $38.31, respectively. The CEO is required to be employed at the time the per share consideration/price is achieved in order to receive the awards, but the awards are not subject to any other service condition. The Company recognizes expense related to these awards based on the fair value and derived service term as measured using a Monte Carlo simulation model, but only upon achieving the requirements outlined in (i) and (ii) above. The grant-date fair value was $16.6&#160;million for these awards. The $22.99 per share price threshold related to award for the 3,246,139 stock options was achieved in February 2021 subsequent to the Merger and, therefore, the Company recognized all $11.3 million of expense related to the grant during the three months ended March 31, 2021 due to achievement of the market condition. As of March&#160;31, 2021, there was $4.2 million of remaining compensation expense to be recognized for the remaining 1,623,070 stock options over a period of 3.04 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, all Hims option holders received an equivalent award at an exchange ratio of 0.4530 that vest in accordance with the original terms of the award. The Company determined this to be a Type I modification but did not record any incremental stock-based compensation expense since the fair value of the modified awards immediately after the modification was not greater than the fair value of the original awards immediately before the modification.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant-date fair value of the Company's stock options granted was estimated using the following weighted average assumptions for the three months ended March 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.77&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Option activity (excluding the stock options granted to the CEO outlined above) is as follows (in&#160;thousands, except for weighted average exercise price and weighted average contractual term in years):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Contractual&lt;br/&gt;Period&lt;br/&gt;(in&#160;Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recapitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised (including early exercised options vested during the period)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited and expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant-date fair value of options granted for the three months ended March 31, 2021 was $7.34 per share and the intrinsic value of vested options exercised was $2.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, there was $20.5 million of unrecognized stock-based compensation related to unvested stock options excluding the CEO stock options, which is expected to be recognized over a weighted average period of 3.33 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cash flows resulting from the tax benefits for tax deductions resulting from the exercise of stock options in excess of the compensation expense recorded for those options (excess tax benefits) are classified as a cash flow from financing activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to a full valuation allowance on deferred tax assets, the Company did not recognize any tax benefit from stock option exercises for the three months ended March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Early Exercise of Common Stock Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#x2013; The Company issues shares upon the early exercise of common stock options. The unvested shares are subject to the Company's repurchase right at the lower of the fair market value of the shares of common stock on the date of repurchase or their original purchase price. The proceeds from cash exercises prior to vesting are initially recorded as a deposit liability from the early exercise of stock options and recorded within accrued liabilities on the consolidated balance sheets and reclassified to additional paid-in capital as the Company's repurchase right lapses. Unvested early exercised options are considered outstanding options and also excluded from shares exercisable since the options have been early exercised. These options are included in the option activity as exercised when the options vest. The number of unvested early exercised options were 301,893 as of March&#160;31, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The options outstanding and exercisable as of March&#160;31, 2021 (excluding CEO stock options) have been aggregated into ranges for additional disclosure as follows (in&#160;thousands, except weighted average remaining contractual life and exercise price):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&#160;(in&lt;br/&gt;Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&#160;(in&lt;br/&gt;Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$ 0.06 &#x2013; 0.40&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.92&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55 &#x2013; 2.33&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.07&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.43 &#x2013; 3.65&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.90 &#x2013; 13.35&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.76&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.17 &#x2013; 22.76&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.78&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;RSUs&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All RSUs granted prior to the Merger were subject to achievement of a liquidity event which included (i) an initial public offering, (ii) a business combination transaction, or (iii) a sale event as defined by the 2017 Plan. On January 20, 2021, the liquidity event was achieved with the closing of the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs for new employees generally vest over four years, with 25% vesting one year after the vesting commencement date on the first Company Quarterly Vesting Date (defined below) and the remaining grant vesting quarterly thereafter on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date" or collectively, "Company Quarterly Vesting Dates"). Additional RSUs granted to current employees generally vest quarterly on Company Quarterly Vesting Dates over four years.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, all Hims RSU holders received an equivalent award at an exchange ratio of 0.4530 that vest in accordance with the original terms of the award. The Company determined this to be a Type I modification but did not record any incremental stock-based compensation expense since the fair value of the modified awards immediately after the modification was not greater than the fair value of the original awards immediately before the modification.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, all Hims RSU and option holders received (a) earn-out RSUs that would vest in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $15.00, $17.50 and $20.00 for any 10 trading days within any 20-trading day period, or a Company sale (as defined in the Merger Agreement) occurs and the thresholds are met on or prior to the date that is five years following the Closing Date; and (b) an allocation of Parent Warrant RSUs. All of these RSUs vest in accordance with the terms of the initial RSU and option award, in addition to any of the aforementioned requirements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The earn-out thresholds for earn-out RSUs were all met in February 2021. The earn-out awards are equity classified since they do not meet the liability classification criteria outlined in ASC 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distinguishing Liabilities from Equity &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and are both (i) indexed to the Company's own shares and (ii) meet criteria for equity classification. The Company determined the fair value of the earn-out RSUs using a Monte Carlo simulation model. The following assumptions were used in this valuation: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.389%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.169%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.00&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The value of the Company's equity was also an input into the model and was determined based on the closing trading price of the Company's Class A common stock on the Closing Date of $16.38.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU activity including RSUs outstanding prior to the Merger, earn-out RSUs, and Parent Warrant RSUs is as follows (in thousands, except for weighted average grant date fair value):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recapitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the above activity are 476,308 earn-out RSUs and 9,478 Parent Warrant RSUs issued to the CEO as part of the Merger that vest in accordance with the same market conditions as the CEO stock options, of which 317,539 earn-out RSUs and 6,319 Parent Warrant RSUs vested in the period. In addition, the Company granted 45,297 RSUs in 2020 and 4,431 earn-out RSUs and 88 Parent Warrant RSUs as part of the Merger in January 2021 to a non-executive officer that vest in accordance with the achievement of revenue targets upon meeting certain revenue targets from the sale of specific products. None of the awards vested in the period. These grants are also included in the above activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, there was unrecognized stock-based compensation related to unvested RSUs of $40.1 million, which is expected to be recognized over a weighted average period of 3.61 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Vendor Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in stock-based compensation expense is expense for issuance of Class A common stock warrants to nonemployees in connection with vendor service arrangements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, warrant holders received (a) an equivalent warrant at an exchange ratio of 0.4530 (which was determined not to result in incremental stock-based compensation expense similar to the evaluations for stock options and RSUs above); (b) the right to receive, upon exercise, earn-out shares that vest in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $15.00, $17.50 and $20.00 for any 10 trading days within any 20-trading day period, or a Company sale (as defined in the Merger Agreement) occurs and the thresholds are met on or prior to the date that is five years following the Closing Date; and (c) the right to receive, upon exercise, an allocation of Parent Warrants. All of these instruments vest in accordance with the terms of the initial warrant in addition to any of the aforementioned requirements. The earn-out thresholds were all met in February 2021. The earn-out shares and Parent Warrants are equity classified since they do not meet the liability classification criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vendor warrant activity, excluding any right to receive Merger considerations, is as follows (in thousands, except for weighted average exercise price and weighted average contractual term in years): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Weighted Average Contractual Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;9,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Recapitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;9,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt;text-indent:9.35pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Forfeited and expired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Vested and expected to vest as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Exercisable as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the exercise of outstanding warrants above, vendors also have the right to receive 48,062 shares of Merger consideration, consisting of the holders' allocation of earn-out and Parent Warrant considerations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, there was $0.5 million of unrecognized stock-based compensation expense related to unvested vendor warrants and associated earn-out shares and Parent Warrants, which is expected to be recognized over a weighted average period of 0.48 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock-based compensation expense for employees and nonemployees, by category, on the condensed consolidated statements of operations and comprehensive loss for three months ended March 31, 2021 and March&#160;31, 2020 (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i5d8a878dc739415b9ef43d3cafdddb47_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTA5OTUxMTY2MjI1NQ_e2a514f8-e3b4-4f04-a657-42ac296ef77c"
      unitRef="shares">21000000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i5bc5c0ad0d79476dae92187902b6a0c6_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTA5OTUxMTY2MjI1OQ_f41ee52e-2653-4adb-83e4-95f12eb9cec7"
      unitRef="shares">19000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock
      contextRef="ia94de2a141c34d8faee9c47c63a6c366_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTA5OTUxMTY2MjI2Mw_8f8e4735-4fb0-4ac6-8dcd-943a31fc6de7"
      unitRef="number">0.05</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans
      contextRef="i413bd17d5b324a2dad4f4ea75d1247df_I20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwOTM4NQ_236e65b9-f05a-4064-996b-70fc08d4c059"
      unitRef="shares">55645</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ic1fd5fc3dab941e482cf5873aed90062_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTA5OTUxMTY2MjI2Nw_2e094728-d42f-44ff-9bd8-1b6b915c193a"
      unitRef="shares">21055645</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ic1fd5fc3dab941e482cf5873aed90062_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzE4Nw_8cf10de9-e073-46f3-b538-6be42f996308"
      unitRef="shares">18581886</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i48ef13256a85415e97d20a62c058228a_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzA4NA_b44f78c2-cf1f-41b7-83c5-85fca49b32fc"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i0d283ed598c04971b9439dd96804192f_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODU3Mw_20a44135-2095-4039-89dc-80407644b144"
      unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent
      contextRef="iee0a496af430479f9dfecc7ffbe8ba33_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODU3OQ_88ed8997-eece-4b8a-a3c4-6fd121a3a618"
      unitRef="number">0.10</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="iee0a496af430479f9dfecc7ffbe8ba33_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODU4NA_c6768f1a-84d1-49e7-ba05-a0191ea38b8d"
      unitRef="number">1.10</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i8906c1a545c9405d8f6cc203bc4d9e99_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAxMDc2NQ_77eaa91a-b4eb-4a8a-8440-7f31e895353a">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia971f9ce30c04ca082f9fb3fa86a9e3a_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzA5Mg_0f4b38db-ab5e-4145-aa4c-b5c14bee78cf">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i576248ed4b664370b9a1e90f22918f91_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzEwOQ_e9c61889-0b60-428b-91fc-91a01aed1923"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i576248ed4b664370b9a1e90f22918f91_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODYzMQ_0dac51d3-3a5a-4343-acce-3bbd473623bb">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ibc84ee6d825b47e9b4399d92dea27b78_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTg1Nw_64e7e74c-6bef-40d1-a557-a631c0949eb6">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODYwMw_892dfe1a-73f6-4712-b1e2-903c7998c239">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2adc14d58e77476fbc6512ca96906059_D20200617-20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzExNA_fb00f098-8364-4347-9170-b03a4f7c3614"
      unitRef="shares">3246139</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i06c257b7b4f84b529f577d3f4aa15ac5_D20200617-20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzEyNQ_49f92c36-7b80-451e-a21e-8c6133664173"
      unitRef="shares">1623070</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i2adc14d58e77476fbc6512ca96906059_D20200617-20200617"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzEzNg_28456fea-1847-46f8-a8ac-24873a826cb4"
      unitRef="usdPerShare">2.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i06c257b7b4f84b529f577d3f4aa15ac5_D20200617-20200617"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzEzNg_7aafe83e-284f-49fd-8cb4-ed8ad898a9c2"
      unitRef="usdPerShare">2.43</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold
      contextRef="i32f3c2ba40fa476fa312666156c0f69b_I20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNzQwMg_58b4946b-0846-4860-a24d-3f016f284887"
      unitRef="usdPerShare">22.99</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold
      contextRef="i11c5ad145e504aa281087775310908bf_I20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNzQxNw_a2a11bd9-72b9-43b7-a134-90ff9fd4e2c5"
      unitRef="usdPerShare">38.31</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold
      contextRef="i32f3c2ba40fa476fa312666156c0f69b_I20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNzQyNg_58b4946b-0846-4860-a24d-3f016f284887"
      unitRef="usdPerShare">22.99</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold
      contextRef="i11c5ad145e504aa281087775310908bf_I20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNzQzMA_a2a11bd9-72b9-43b7-a134-90ff9fd4e2c5"
      unitRef="usdPerShare">38.31</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue
      contextRef="i1b379b532e70492d8cd6c9d96f11613d_I20200617"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzE3NQ_d16c1f40-fe5c-4b08-96c9-0d9a80501cbc"
      unitRef="usd">16600000</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold
      contextRef="i32f3c2ba40fa476fa312666156c0f69b_I20200617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNzQzNA_58b4946b-0846-4860-a24d-3f016f284887"
      unitRef="usdPerShare">22.99</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia49cabd9f3a84ee39cb1386e25c9b760_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODcyOQ_3de7ecc2-fec6-44ed-a31c-fe0a9304409b"
      unitRef="shares">3246139</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iafad2c662fba4af0b34bd67db2d592d9_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTY0OTI2NzQ3NTQ1Nw_4863f295-d6f2-4a54-8f7a-b5716f9a23bb"
      unitRef="usd">11300000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i84f2f42c202744b7b7bd251ae54caaf7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTY0OTI2NzQ3NTQ2Ng_21903ee9-2363-4737-a34e-4ff4c315dd5c"
      unitRef="usd">4200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i84f2f42c202744b7b7bd251ae54caaf7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODY5Nw_c4822d39-1d43-4b63-8150-ceacb5a72f82"
      unitRef="shares">1623070</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ic3fd0dc602f14c74816bb2d095c72cfd_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTY0OTI2NzQ3NTQ3NQ_a2337ef8-077b-4161-9b59-115f7118baae">P3Y14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MDQyOA_14869440-a5fd-4049-b880-5b366becf639"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzE5Nw_00114458-4013-4528-bcac-f19e7a32ee64">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant-date fair value of the Company's stock options granted was estimated using the following weighted average assumptions for the three months ended March 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.77&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58.87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmRkYTZiNThlM2ZhZTQ3ZjVhMjc1MmJjM2FlZGY2NWRmL3RhYmxlcmFuZ2U6ZGRhNmI1OGUzZmFlNDdmNWEyNzUyYmMzYWVkZjY1ZGZfMC0xLTEtMS0w_2fea1cb2-973c-4b73-844b-52ee5931f90e">P5Y9M7D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmRkYTZiNThlM2ZhZTQ3ZjVhMjc1MmJjM2FlZGY2NWRmL3RhYmxlcmFuZ2U6ZGRhNmI1OGUzZmFlNDdmNWEyNzUyYmMzYWVkZjY1ZGZfMS0xLTEtMS0w_bb0c30ae-4ff8-4cfc-8b9a-51fe49c161d6"
      unitRef="number">0.5887</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmRkYTZiNThlM2ZhZTQ3ZjVhMjc1MmJjM2FlZGY2NWRmL3RhYmxlcmFuZ2U6ZGRhNmI1OGUzZmFlNDdmNWEyNzUyYmMzYWVkZjY1ZGZfMi0xLTEtMS0w_0dcf8ed7-7f87-4494-855c-00f9d0c4c1e9"
      unitRef="number">0.0083</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmRkYTZiNThlM2ZhZTQ3ZjVhMjc1MmJjM2FlZGY2NWRmL3RhYmxlcmFuZ2U6ZGRhNmI1OGUzZmFlNDdmNWEyNzUyYmMzYWVkZjY1ZGZfMy0xLTEtMS0w_e6fc5b5b-cbca-4fea-8f0b-0b11840f0e40"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTIwOTQ2Mjc5Mzk5NjY_11446a1b-f147-4ef0-b0a4-479fbcd9bd17">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Option activity (excluding the stock options granted to the CEO outlined above) is as follows (in&#160;thousands, except for weighted average exercise price and weighted average contractual term in years):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Exercise&lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Contractual&lt;br/&gt;Period&lt;br/&gt;(in&#160;Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recapitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,474)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;423&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised (including early exercised options vested during the period)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(384)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited and expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and expected to vest as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia619e550a49a42d88028da0bc367d495_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMS0xLTEtMS0w_8b022c04-a7b5-4e8c-bdc5-ec2a0845009d"
      unitRef="shares">26459000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia619e550a49a42d88028da0bc367d495_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMS0zLTEtMS0w_c2eb1108-d55c-4dfc-9800-7d11800ee87c"
      unitRef="usdPerShare">1.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i07699e94c1ff4e72b8336fc2d39e4b76_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMS01LTEtMS0w_8cb0f81a-2dc6-4e26-9829-0eb31d001a87">P8Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i56db4fe025c047fd8e6046a280f8d46d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMS03LTEtMS0w_1c8dbbc6-ecdf-4aab-a9e1-361bf84592e8"
      unitRef="usd">131770000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i3569cba9a27b411f87207bfe4f13c768_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMi0xLTEtMS00NjIz_b6821ae3-9dc2-49f0-a7d8-446d64466bb0"
      unitRef="shares">14474000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i3569cba9a27b411f87207bfe4f13c768_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMi0zLTEtMS00NjIz_1d2403cc-895e-4060-a39a-032ac4d6c519"
      unitRef="usdPerShare">1.41</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i56db4fe025c047fd8e6046a280f8d46d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy0xLTEtMS00NjIz_5a7632be-3d45-41ed-84e9-f27e9550b85a"
      unitRef="shares">11985000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i56db4fe025c047fd8e6046a280f8d46d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy0zLTEtMS00NjIz_5e3988b0-3f2f-4015-9bcc-9dd877da02db"
      unitRef="usdPerShare">2.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i07699e94c1ff4e72b8336fc2d39e4b76_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy01LTEtMS02MzE2_3cada0c4-f142-4c96-96ae-e06de887c835">P8Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i56db4fe025c047fd8e6046a280f8d46d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy03LTEtMS0xMDAxMg_6d7f6a57-8143-4ed7-9f80-91b920a7145a"
      unitRef="usd">131770000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMi0xLTEtMS0w_082f74a7-c927-40c0-a6f0-fe3613b73c8e"
      unitRef="shares">423000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMi0zLTEtMS0w_14e40ed8-12d0-4c5d-9de3-acc05ee9b3e5"
      unitRef="usdPerShare">13.79</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy0xLTEtMS0w_4530f9ed-38d7-4dee-b929-2f887ebbd9dc"
      unitRef="shares">384000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfMy0zLTEtMS0w_eab7671d-2b02-45d3-98ab-ce44a04f38d1"
      unitRef="usdPerShare">0.90</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNC0xLTEtMS0w_a285f8b2-e7dc-4ec2-94c2-f065f3da2a89"
      unitRef="shares">56000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNC0zLTEtMS0w_a6b07030-3180-498d-a52c-9966cdcc7e0b"
      unitRef="usdPerShare">1.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNS0xLTEtMS0w_3f89c023-f6a0-48d2-b5d5-4f96c1e9e651"
      unitRef="shares">11968000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNS0zLTEtMS0w_c4ddb2aa-e48d-476c-9d9a-4df2f133ec7e"
      unitRef="usdPerShare">3.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNy01LTEtMS01NTgx_9691505a-fc11-4449-bab6-6120cdb26ec5">P8Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNy03LTEtMS01NTgx_e890aa79-be3c-4365-9b82-28dfe7438a12"
      unitRef="usd">122556000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNi0xLTEtMS0w_ee116ae7-6675-45ba-8fc2-2ec91e03521b"
      unitRef="shares">11968000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNi0zLTEtMS0w_8b7ed86c-745c-4643-b0ee-b6b47578138a"
      unitRef="usdPerShare">3.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNi01LTEtMS0w_632b245b-7b4e-45c4-b9e2-1b92237cbcdc">P8Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfNi03LTEtMS0w_1204aea4-018f-433b-ae74-a263bc00c028"
      unitRef="usd">122556000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfOC0xLTEtMS0w_5488e8b9-fbd7-4bf2-bfd2-1d569c571237"
      unitRef="shares">11165000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfOC0zLTEtMS0w_5052fdee-0818-453e-9266-f93f7400625a"
      unitRef="usdPerShare">2.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfOC01LTEtMS0w_f7f1d0eb-c3a4-4f6d-b05d-ecad6c70ad84">P8Y4M13D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i96df6e7fe0a44d26a9a8ef6124809f51_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmZhNDdmMjlhYjk1NTQ3NjdhMjg2YzgwMGUyODQ3MjI0L3RhYmxlcmFuZ2U6ZmE0N2YyOWFiOTU1NDc2N2EyODZjODAwZTI4NDcyMjRfOC03LTEtMS0w_690c2806-07fe-4ab5-9678-4bd5b3097b83"
      unitRef="usd">118231000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjI4Ng_4fe26d7f-9059-415d-a54f-5f7ca5553d01"
      unitRef="usdPerShare">7.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjM2NQ_5b38ea1f-c4cf-4d8a-841b-ed752661225c"
      unitRef="usd">2000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="icae0610134ea412ca26835b3d027983b_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjQzMA_3aaa1700-8457-4f61-a043-31ca41105668"
      unitRef="usd">20500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i0764a9f39d15480ea6a5fd912a15958e_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjU4MA_2923415f-4b9c-4fd6-af7f-296d82afdf1d">P3Y3M29D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjk0NA_69539c66-8488-4e8a-8853-455ceca6be97"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMzY3NQ_82f1f92f-0349-4663-a8e3-e7db6a3204f0"
      unitRef="shares">301893</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares>
    <us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzIwOA_29d11a35-3018-4210-a937-2ed4a4ff2717">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The options outstanding and exercisable as of March&#160;31, 2021 (excluding CEO stock options) have been aggregated into ranges for additional disclosure as follows (in&#160;thousands, except weighted average remaining contractual life and exercise price):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.311%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Options Exercisable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&#160;(in&lt;br/&gt;Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual&lt;br/&gt;Life&#160;(in&lt;br/&gt;Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$ 0.06 &#x2013; 0.40&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.92&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.92&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.55 &#x2013; 2.33&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.07&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.07&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.43 &#x2013; 3.65&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.17&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.90 &#x2013; 13.35&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.76&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.75&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.17 &#x2013; 22.76&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.78&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i8154d378681848c08666cc454aeba717_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi0wLTEtMS0wL3RleHRyZWdpb246MjdiNWIzY2M5ODg4NDM5OGFhOGMxOWI2NGIyMTc5YmNfMTIwOTQ2Mjc5MDU1NTc_fc5014bc-1d35-4d91-a195-a19cea859cea"
      unitRef="usdPerShare">0.06</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i8154d378681848c08666cc454aeba717_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi0wLTEtMS0wL3RleHRyZWdpb246MjdiNWIzY2M5ODg4NDM5OGFhOGMxOWI2NGIyMTc5YmNfMTIwOTQ2Mjc5MDU1NjU_4897fb1d-9a37-443a-a911-b3b20dcb7cd4"
      unitRef="usdPerShare">0.40</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i296427d49b16444e90fd07050ceb45e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi0yLTEtMS0w_2a5fabd8-a7a5-48cc-9d90-267ada0974c9"
      unitRef="shares">3236000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i8154d378681848c08666cc454aeba717_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi00LTEtMS0w_6e79c30c-83cc-493e-a9c1-9c0d62e75d9d">P6Y11M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i296427d49b16444e90fd07050ceb45e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi02LTEtMS0w_f6008746-e865-4884-930f-f449fd7d18ff"
      unitRef="shares">3123000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i8154d378681848c08666cc454aeba717_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMi04LTEtMS0w_ba873b01-32e1-4155-b670-fa7c92992ea6">P6Y11M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i07019c3dea37410ca1b9e81a814fc572_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy0wLTEtMS0wL3RleHRyZWdpb246YzRlM2Y0MmEyZDExNDI2OTlhNGFiODhhYjhmODQzMjJfMTIwOTQ2Mjc5MDU1NTU_70baeb24-e7eb-4ad6-9e72-d52ad63ef372"
      unitRef="usdPerShare">1.55</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i07019c3dea37410ca1b9e81a814fc572_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy0wLTEtMS0wL3RleHRyZWdpb246YzRlM2Y0MmEyZDExNDI2OTlhNGFiODhhYjhmODQzMjJfMTIwOTQ2Mjc5MDU1NjI_03dae13d-5ee4-426b-8983-5e2432e2f2de"
      unitRef="usdPerShare">2.33</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i91a56879fe24414495c14c13ef54b061_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy0yLTEtMS0w_eca9960f-3e0e-4728-a2cb-4689bb077d72"
      unitRef="shares">3368000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i07019c3dea37410ca1b9e81a814fc572_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy00LTEtMS0w_56ebcea2-0283-4a7c-b0e2-2197e652065f">P8Y25D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i91a56879fe24414495c14c13ef54b061_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy02LTEtMS0w_f05235be-7808-425e-ac2b-7c3e2e75e3a9"
      unitRef="shares">3182000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i07019c3dea37410ca1b9e81a814fc572_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfMy04LTEtMS0w_e1628901-94f2-4795-befd-83a2d7fcfe32">P8Y25D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i962be1bcc7954ffd848d65b2af00d37f_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC0wLTEtMS0wL3RleHRyZWdpb246MzZkOGIwNDE0ODQ4NDVhMGIxODM1MzE1Y2FmZWNkOTVfMTIwOTQ2Mjc5MDU1NTU_6e70652e-0310-4829-8ed7-6b2a3c2d73e8"
      unitRef="usdPerShare">2.43</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i962be1bcc7954ffd848d65b2af00d37f_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC0wLTEtMS0wL3RleHRyZWdpb246MzZkOGIwNDE0ODQ4NDVhMGIxODM1MzE1Y2FmZWNkOTVfMTIwOTQ2Mjc5MDU1NjI_921eaf92-ec85-40f3-9bff-45a2daaec70a"
      unitRef="usdPerShare">3.65</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ia020c048cca142b09ded25121b0ecf0f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC0yLTEtMS0w_43c044cb-1423-462e-9d1b-38d69c07d891"
      unitRef="shares">3298000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i962be1bcc7954ffd848d65b2af00d37f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC00LTEtMS0w_567af197-78b1-415e-82cb-8e386e0db44e">P9Y2M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ia020c048cca142b09ded25121b0ecf0f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC02LTEtMS0w_099c6c1a-5e21-4e69-824d-8731230eaa09"
      unitRef="shares">3295000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i962be1bcc7954ffd848d65b2af00d37f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNC04LTEtMS0w_61e40721-e269-4fbe-8b63-69bd26548b69">P9Y2M1D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i0109a582058c4a30962735b0ef17b42f_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS0wLTEtMS0wL3RleHRyZWdpb246N2JmMjE3MDI5MjJjNGE0NGIxMGEyMWVkODQ0YWM3OGFfMTIwOTQ2Mjc5MDU1NTY_6b508624-ff52-4745-81b0-e720ce1d4195"
      unitRef="usdPerShare">8.90</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i0109a582058c4a30962735b0ef17b42f_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS0wLTEtMS0wL3RleHRyZWdpb246N2JmMjE3MDI5MjJjNGE0NGIxMGEyMWVkODQ0YWM3OGFfMTIwOTQ2Mjc5MDU1NjQ_697877bb-ddc0-4242-84ee-948261260cc2"
      unitRef="usdPerShare">13.35</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="ia30281f381f44828904e830e15c11803_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS0yLTEtMS0w_36c266a7-b90c-4925-bc02-c23e1bdb5e92"
      unitRef="shares">1888000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i0109a582058c4a30962735b0ef17b42f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS00LTEtMS0w_f1e39861-2736-4854-9068-f86a54a347d6">P9Y9M3D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="ia30281f381f44828904e830e15c11803_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS02LTEtMS0w_27642a2c-ab2c-4071-a2c5-87b6ea00f932"
      unitRef="shares">1558000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i0109a582058c4a30962735b0ef17b42f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNS04LTEtMS0w_5b9ffd1b-dc0c-440f-9857-119a83fb4941">P9Y9M</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
      contextRef="i4f39e7f28aa44acd97c7381291e6f1ac_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi0wLTEtMS0wL3RleHRyZWdpb246NWYxNGEwMjVhM2M4NGVhNWI4ZGYzNDZiNjhkYjdhNzFfMTIwOTQ2Mjc5MDU1NTU_acfece67-4846-4e71-9ddf-3dd5a13c260f"
      unitRef="usdPerShare">15.17</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
      contextRef="i4f39e7f28aa44acd97c7381291e6f1ac_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi0wLTEtMS0wL3RleHRyZWdpb246NWYxNGEwMjVhM2M4NGVhNWI4ZGYzNDZiNjhkYjdhNzFfMTIwOTQ2Mjc5MDU1NjI_807b8145-9964-4e96-994f-c23917035228"
      unitRef="usdPerShare">22.76</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="i85a98bf3e25f496e9e070d45dc8dbe79_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi0yLTEtMS0w_d163134b-c284-4f13-ae00-5af551c4c435"
      unitRef="shares">178000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i4f39e7f28aa44acd97c7381291e6f1ac_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi00LTEtMS0w_5af5e0a2-196f-41d1-b82a-7ce639ea31c9">P9Y9M14D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="i85a98bf3e25f496e9e070d45dc8dbe79_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi02LTEtMS0w_0a14799f-a350-4345-be46-b191a0c13754"
      unitRef="shares">7000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
      contextRef="i4f39e7f28aa44acd97c7381291e6f1ac_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNi04LTEtMS0w_649735e9-2ed8-4e55-b269-0d14999f0fb7">P9Y9M10D</us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNy0yLTEtMS0w_d4afda17-ae15-486d-9eb4-e2557617a618"
      unitRef="shares">11968000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions>
    <us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
      contextRef="iae89e874aad64f008fc6334367e88e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOmFiOTk3YjY3Y2E2NTQ3MjI5MWRmNGQyZGE4OThjMjMzL3RhYmxlcmFuZ2U6YWI5OTdiNjdjYTY1NDcyMjkxZGY0ZDJkYTg5OGMyMzNfNy02LTEtMS0w_abd30d22-cb9b-473e-89b0-17782993f127"
      unitRef="shares">11165000</us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTIwOTQ2Mjc5Mzk5Nzc_10c6c58a-3981-42e2-b1ab-4eda0b821fa0">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="id23bf3f94c8841a693c2abb9dbea49c4_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTIwOTQ2Mjc5Mzk5Nzk_bb792186-53ac-4259-b2c8-ac597afb29ae"
      unitRef="number">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="id23bf3f94c8841a693c2abb9dbea49c4_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODc1MA_c78061c2-1a60-4aeb-83fa-7f6d670f0fa2">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzIyOQ_087c6126-d17d-422a-baa0-4d2589a112f6">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTg3Mw_40e6cf1a-05e6-4d82-8456-f8f87c4b6e6a"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTg4MQ_a8837969-7c7c-4501-a4fa-fde13e88c06c"
      unitRef="usdPerShare">15.00</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTg4OQ_4bdfb4a2-6f0b-4e11-9865-bcf0b71b3b92"
      unitRef="usdPerShare">17.50</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTg5Nw_44cff45a-4ce5-4b5d-b54c-ec72504c905a"
      unitRef="usdPerShare">20.00</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTkwNQ_82a41e22-3cc6-42e1-bb2f-bb164d6a1905"
      unitRef="day">10</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTkwOQ_a724067b-c07e-49ce-8a13-b9838a87996f"
      unitRef="day">20</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays>
    <hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODgxMg_570e02eb-ca2e-41d5-8046-7a73314b4592">P5Y</hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjY1OGM1YTQ0YTFlODQ5NGY4MzE1M2VkNmM4MTQzYTM3L3RhYmxlcmFuZ2U6NjU4YzVhNDRhMWU4NDk0ZjgzMTUzZWQ2YzgxNDNhMzdfMC0yLTEtMS0xMTY3Mw_fed4acbb-f74b-4997-af09-d6058c47fd46">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjY1OGM1YTQ0YTFlODQ5NGY4MzE1M2VkNmM4MTQzYTM3L3RhYmxlcmFuZ2U6NjU4YzVhNDRhMWU4NDk0ZjgzMTUzZWQ2YzgxNDNhMzdfMS0yLTEtMS0xMTY3Mw_2864a11c-1850-4e9b-bf8b-2535e7662602"
      unitRef="number">0.6000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjY1OGM1YTQ0YTFlODQ5NGY4MzE1M2VkNmM4MTQzYTM3L3RhYmxlcmFuZ2U6NjU4YzVhNDRhMWU4NDk0ZjgzMTUzZWQ2YzgxNDNhMzdfMi0yLTEtMS0xMTY3Mw_0100889f-1907-4cb3-bf70-9bd1c00f82e1"
      unitRef="number">0.0050</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjY1OGM1YTQ0YTFlODQ5NGY4MzE1M2VkNmM4MTQzYTM3L3RhYmxlcmFuZ2U6NjU4YzVhNDRhMWU4NDk0ZjgzMTUzZWQ2YzgxNDNhMzdfMy0yLTEtMS0xMTY3Mw_3f2d9bcd-f19c-4e26-a4fc-d1d9b9027cb5"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:SharePrice
      contextRef="i6a9e72571629466e95f463c7efbcbd98_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyMjkwOQ_9b5077a0-9452-426a-996e-a7ec3c2a11c7"
      unitRef="usdPerShare">16.38</us-gaap:SharePrice>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzI0NA_45cf6b21-082a-45a1-8d5a-5b6ef89345a1">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU activity including RSUs outstanding prior to the Merger, earn-out RSUs, and Parent Warrant RSUs is as follows (in thousands, except for weighted average grant date fair value):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.660%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.578%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.148%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recapitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,904)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(790)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i7a6191f600fe4f5bba54740cfed54748_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMS0yLTEtMS0xNjAx_82674e67-01a8-43de-baaa-acd7ba93b739"
      unitRef="shares">3480000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i7a6191f600fe4f5bba54740cfed54748_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMS00LTEtMS0xNjAx_b2b519fd-3863-4fb9-8404-f48dfe421d0e"
      unitRef="usdPerShare">5.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i20ea7b45ce3547e9a8128fa8a07b9245_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMi0yLTEtMS0xNjEx_b6a26f86-9426-473f-96c3-9f375bbebc59"
      unitRef="shares">1904000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i20ea7b45ce3547e9a8128fa8a07b9245_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMi00LTEtMS0xNjEx_92ef4c7e-805b-4bb4-be38-a3b16b0d72ff"
      unitRef="usdPerShare">5.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i0e017683d1224a57bcb05400dca67f22_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMy0yLTEtMS0xNjMy_b025f74a-f9b1-4ad5-b567-6abc9503ad97"
      unitRef="shares">1576000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i0e017683d1224a57bcb05400dca67f22_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfMy00LTEtMS0xNjMy_69787208-0ab0-4e41-952e-3a92f83e19e1"
      unitRef="usdPerShare">11.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNC0yLTEtMS0xNjE3_98dd2de9-d7d0-462b-a5c0-fa7d45d544b0"
      unitRef="shares">2804000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNC00LTEtMS0xNjE3_81faa096-e5ed-4c50-a7b2-1952fad74818"
      unitRef="usdPerShare">14.95</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNS0yLTEtMS0xNjIw_7282e61e-72d4-4797-ba7f-3d22b57ff387"
      unitRef="shares">790000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNS00LTEtMS0xNjIw_db36badf-e6e7-4d32-8515-1300643065d7"
      unitRef="usdPerShare">15.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i6a9e72571629466e95f463c7efbcbd98_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNy0yLTEtMS0xNjMy_3012d598-e6ad-401b-b91f-8ebd4127a156"
      unitRef="shares">3590000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i6a9e72571629466e95f463c7efbcbd98_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjk5OWIzOGRhNWZkZTQ3NDJiOTQ5YWU2MjU5Y2NjNWRmL3RhYmxlcmFuZ2U6OTk5YjM4ZGE1ZmRlNDc0MmI5NDlhZTYyNTljY2M1ZGZfNy00LTEtMS0xNjMy_2dd92b56-dcd4-47b4-8306-adfe3c379a5c"
      unitRef="usdPerShare">13.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ic0fd3b92233841f09e31e1c59722c266_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzA2MA_8e5b9b6b-3b79-4e60-aaaa-fc4b86b77786"
      unitRef="shares">476308</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i4f37e4e1d6084fe096e662b5ab77aecd_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzA2OA_26644adc-f71d-4318-9e52-1832226845e6"
      unitRef="shares">9478</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i618a5b5ebba449e4bbe23551147cf295_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwODUxOQ_c97126d3-ebd8-4698-bcee-fe20a7f70d4d"
      unitRef="shares">317539</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ifac9c5c2612043669180344154fb064a_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwODUyNw_7314fb2c-e0f1-4e18-9445-f806269627ac"
      unitRef="shares">6319</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i42057812c3884143b23614f4764c8109_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTk2Nw_235cad44-006b-47d7-8a76-fdd7e99593fe"
      unitRef="shares">45297</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0fce2bdf00214d74b06a4e34ca921b88_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzA3Nw_8e466d6c-0198-4f8a-a852-edbf0693cf09"
      unitRef="shares">4431</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i51fbf31cd21a496f8b77b769104642ea_D20210101-20210131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzA4NQ_4e29f85e-7445-45cc-92e8-1ee1637a6f8b"
      unitRef="shares">88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i6a9e72571629466e95f463c7efbcbd98_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNTIzNA_a0b27f56-f340-48b4-a43c-24f9afeec988"
      unitRef="usd">40100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i270ee5ced559409599d7bc96fdfae812_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEyNTI0Mg_5d782eea-c905-43e2-a8cb-4042295cc6c5">P3Y7M9D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTkyNw_eaa2f3b1-5e93-430d-8469-5451fcf050fd"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTkzNQ_34cb33ef-917f-4a6e-b740-c38eab783093"
      unitRef="usdPerShare">15.00</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTk0Mw_31545311-1500-495d-a497-60d59c2b1c1c"
      unitRef="usdPerShare">17.50</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTk1MQ_dc9d0336-9002-42fe-9aa2-e10ca360a711"
      unitRef="usdPerShare">20.00</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTk1OQ_8b4a1b46-ff92-4cde-b378-1aefcd23b6ab"
      unitRef="day">10</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MTk2Mw_73b45ad2-8ed3-40da-a31e-a5d652fead92"
      unitRef="day">20</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays>
    <hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODg0Mw_d83620d7-10e2-41eb-bfe4-979bc57f028e">P5Y</hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk5MDQxNQ_73a17923-3716-42a2-bb63-abe7bab0d9aa">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vendor warrant activity, excluding any right to receive Merger considerations, is as follows (in thousands, except for weighted average exercise price and weighted average contractual term in years): &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.426%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Weighted Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Weighted Average Contractual Term (in Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1,861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;9,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Recapitalization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(1,018)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;0.96&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;9,957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;(381)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:6pt;text-indent:9.35pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Forfeited and expired&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Outstanding at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Vested and expected to vest as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;5,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Exercisable as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;1.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;7.01&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;2,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i05f1d9f417c54e328597f093403d6e89_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMS0yLTEtMS0yNDQx_2d0b3d9e-16fb-4300-bcec-48748ae53504"
      unitRef="shares">1861000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i05f1d9f417c54e328597f093403d6e89_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMS00LTEtMS0yNDQx_75a10f3c-b146-4faa-84dc-5e6b50b7e27e"
      unitRef="usdPerShare">0.79</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i881daecfe2934b7cafec114097e28cd3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMS02LTEtMS0yNDQx_682d3925-390b-457e-a243-27ab9ef5382b">P7Y3D</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
      contextRef="i05f1d9f417c54e328597f093403d6e89_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMS04LTEtMS0yNDQx_b3b51251-d366-4c74-9c08-0bc0303fc0b4"
      unitRef="usd">9957000</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="idfb2bd7ccded4f77ae1362ca9d0a545a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMi0yLTEtMS0yNDQx_d09ebe37-3a4e-4974-8613-3c0322a505a6"
      unitRef="shares">1018000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="idfb2bd7ccded4f77ae1362ca9d0a545a_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMi00LTEtMS0yNDQx_f7e6dff3-661d-459a-8b37-10bd07b9c7a1"
      unitRef="usdPerShare">0.96</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i14f486b4660647f98f37f78e924341b0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMy0yLTEtMS0yNDQx_4ad4d10a-5127-492f-a7d8-769bb360b56f"
      unitRef="shares">843000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i14f486b4660647f98f37f78e924341b0_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMy00LTEtMS0yNDQx_577f4287-58d5-4869-8145-1d8193616897"
      unitRef="usdPerShare">1.75</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i2886207377754f8d893c27f2490298a6_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMy02LTEtMS0yNDQx_75c2ef8c-4360-4488-aded-8b64e7c83965">P7Y3D</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
      contextRef="i14f486b4660647f98f37f78e924341b0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfMy04LTEtMS0yNDQx_3431cce4-6c8b-467b-8907-88a457212d13"
      unitRef="usd">9957000</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNC0yLTEtMS0yNDQx_5b2a4378-b2b4-4c8f-8a71-7fe5e4eeca0b"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNC00LTEtMS0yNDQx_d2c357ff-32e2-4daf-837c-714c813b5e33"
      unitRef="usdPerShare">0</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
      contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNS0yLTEtMS0yNDQx_16390810-0139-4f9d-ac87-9555393e3ee6"
      unitRef="shares">381000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNS00LTEtMS0yNDQx_f3653e8d-8747-4174-904a-f1a346be017f"
      unitRef="usdPerShare">1.75</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
      contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi0yLTEtMS04NDY2_09ad5d5b-ed46-45b0-90b4-edfec0c720be"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi00LTEtMS04NDY2_32307d8c-7851-49b1-b080-18aabffa9020"
      unitRef="usdPerShare">0</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi0yLTEtMS0yNDQx_4edbcef8-513e-4392-af7c-7d19a59a2b17"
      unitRef="shares">462000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice
      contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi00LTEtMS0yNDQx_1eafef77-adb6-40d8-97e8-694897065bb4"
      unitRef="usdPerShare">1.75</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi02LTEtMS0yNDQx_9f7841a9-fba3-42ee-9358-2c9a0ed8436d">P7Y3D</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
      contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNi04LTEtMS0yNDQx_7a859d23-68dd-47fe-8d29-6693e25119c2"
      unitRef="usd">5308000</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber
      contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNy0yLTEtMS0yNDQx_bd42cd0d-68ec-47e1-8ec6-932feb86b2e1"
      unitRef="shares">462000</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNy00LTEtMS0yNDQx_7fb1636b-20e5-4795-adb2-ecc5c65ad6aa"
      unitRef="usdPerShare">1.75</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms
      contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNy02LTEtMS0yNDQx_393008a6-e41a-411d-803d-ff8b6a5b3be0">P7Y3D</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfNy04LTEtMS0yNDQx_1fc53876-9a25-4649-bb51-ea7e7f0f58f3"
      unitRef="usd">5308000</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber
      contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfOC0yLTEtMS0yNDQx_a50773c2-aa14-4fd7-a643-a21dbf0fb252"
      unitRef="shares">185000</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice
      contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfOC00LTEtMS0yNDQx_7ccdb025-35b4-4833-9467-7662c290a613"
      unitRef="usdPerShare">1.75</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms
      contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfOC02LTEtMS0yNDQx_41004eae-775f-40bf-b13c-59819c6c5fd8">P7Y3D</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue
      contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjkyYmI4MjQ5MDIwMTQyYWQ4NDkxMzYzYjE5NTVmMWNiL3RhYmxlcmFuZ2U6OTJiYjgyNDkwMjAxNDJhZDg0OTEzNjNiMTk1NWYxY2JfOC04LTEtMS0yNDQx_788b0b3c-61c2-4a0b-8d0c-1afe003c9267"
      unitRef="usd">2123000</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i98bfbbb5e3e147e3889c062c610a6917_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxNDAwODc3OQ_80123a17-9e05-46d6-9aea-a50016c0c2e8"
      unitRef="shares">48062</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i8e6a617bf8cf4f5aad2833449c6a4135_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMTY0OTI2NzQ3NTc5NQ_6343f0ea-fae5-4df9-8cea-97c53df360d8"
      unitRef="usd">500000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfMjc0ODc3OTEwNzAyMg_2c9d7d7d-16d6-48f1-bc8e-004f39caff67">P0Y5M23D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RleHRyZWdpb246OWQ0NWVmM2JmYzRlNDNhMzljZDlmYzg0NDkzMDI4NWZfNjA0NzMxMzk4NzI3OA_154d1ec8-ee6d-49e8-b27b-8dcae9206478">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock-based compensation expense for employees and nonemployees, by category, on the condensed consolidated statements of operations and comprehensive loss for three months ended March 31, 2021 and March&#160;31, 2020 (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.301%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.381%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.526%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general, and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6a91c65f7eb54a3c989d98b6cb6a18a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMC0xLTEtMS0w_725d3930-7de9-40d7-a2ea-d63853ea45ac"
      unitRef="usd">1846000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8b7f6544633643809b6705cd0e2ede0d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMC0zLTEtMS0w_092afd89-0fa5-4cee-b9c5-352ada9bd1f9"
      unitRef="usd">291000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie769ad9b07ed4265a9edfbcfccff5ae1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMS0xLTEtMS0w_5918bbe0-202d-4ae6-8397-174a415612b5"
      unitRef="usd">32384000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i3ad7aa6b76124ad6ae3961610c692d73_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMS0zLTEtMS0w_3f2f3c48-5e1c-4d80-9cc0-c9f6fd3dfc19"
      unitRef="usd">1113000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMi0xLTEtMS0w_159603df-e6ac-4dc6-b2f1-a11e8c24180c"
      unitRef="usd">34230000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81OC9mcmFnOjlkNDVlZjNiZmM0ZTQzYTM5Y2Q5ZmM4NDQ5MzAyODVmL3RhYmxlOjQ4ZWRlYjljYzk5OTRhNzBhYjYwOTgyOTVkZTg0NzUzL3RhYmxlcmFuZ2U6NDhlZGViOWNjOTk5NGE3MGFiNjA5ODI5NWRlODQ3NTNfMi0zLTEtMS0w_1f1286f1-9d7f-49c9-89ea-e51d995f9b91"
      unitRef="usd">1404000</us-gaap:AllocatedShareBasedCompensationExpense>
    <hims:TemporaryEquityTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjQ5Mw_2a654f18-5dbc-426e-aaa4-195b22b9c7fc">Redeemable Convertible Preferred StockAs of December&#160;31, 2020 the Company had authorized 95,997,674 shares of Hims' convertible preferred stock, designated in series, with the rights and preferences of each designated series to be determined by the Board of Directors.&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of Hims' redeemable convertible preferred stock as of December&#160;31, 2020 (in&#160;thousands, except for share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Series&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Liquidation&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Proceeds,&lt;br/&gt;Net of&lt;br/&gt;Issuance&#160;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue&#160;Price&lt;br/&gt;per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series Seed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,987,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,987,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,822,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,822,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,742,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,742,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,270,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,270,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,807,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,807,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B-2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,464,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,464,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,850,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,760,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,051,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,472,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,997,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,328,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Transactions Related to Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From March&#160;to July&#160;2020, a group of investors purchased 7,472,062 shares of Hims Series D redeemable convertible preferred stock and the Company received $51.9&#160;million in net proceeds.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, all series of Hims redeemable convertible preferred stock were converted into Hims' Class A common stock on a one-for-one basis and then converted to the Company's Class A common stock at an exchange ratio of 0.4530.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Warrants for Redeemable Convertible Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, in accordance with the terms outlined in March 2019, the Company issued 1,341,865 Hims Series C convertible preferred stock warrants based on 2019 revenue. The fair market value of the Hims Series C convertible preferred stock warrants was estimated using the BSM option-pricing model, and at the issuance date, fair value of the liability was $10.0&#160;million. The original liability was recorded as an issuance cost for the Hims Series C preferred stock, reducing the value of the Hims Series C proceeds within mezzanine equity on the consolidated balance sheets. Subsequent adjustments to the fair value of the Hims Series C convertible preferred stock warrants were recorded within other income (expense), net on the consolidated statements of operations and comprehensive loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The holders of the Hims Series C convertible preferred stock exercised all their warrants and purchased 1,341,865 shares of Hims Series C convertible preferred stock from the Company in 2020 resulting in settlement of the Hims Series C convertible preferred stock warrant liability. The Company received less than $0.1&#160;million in net proceeds. Upon exercise, the warrant liability at an estimated fair market value of $11.3&#160;million was reclassified into convertible preferred stock on the consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;In November 2019, the Company issued 89,747 Hims Series C preferred stock warrants to TPC in connection with the 2019 Capital Agreement. The fair value of the warrants was considered debt issuance cost and recorded within prepaid and other current assets on the consolidated balance sheet. On March 12, 2020, the Company sold Hims Series D redeemable convertible preferred stock at an issuance price of $6.96, which triggered an adjustment to the TPC warrant terms per the original agreement, resulting in conversion of the previously issued 89,747 Hims Series C preferred stock warrants into 98,723 Hims Series D preferred stock warrants. Refer to Note 10 &#x2013; Borrowing Arrangements for further discussion. Subsequent to the Merger, the Hims Series D preferred stock warrants were converted to Class A common stock warrants. As a result, the Hims Series D preferred stock warrants were adjusted to fair value prior to the conversion, and then settled in additional paid-in capital as a result of the conversion to equity-classified Class A common stock warrants.</hims:TemporaryEquityTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfMjc0ODc3OTA3ODg0MA_ad63c81c-e5f4-4c3b-b2ee-3f181b046e63"
      unitRef="shares">95997674</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjYzMQ_f50634c5-a19b-499b-8966-475b2d8ce090">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table is a summary of Hims' redeemable convertible preferred stock as of December&#160;31, 2020 (in&#160;thousands, except for share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.626%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Series&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate&lt;br/&gt;Liquidation&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Proceeds,&lt;br/&gt;Net of&lt;br/&gt;Issuance&#160;Costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue&#160;Price&lt;br/&gt;per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series Seed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,987,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,987,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,822,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,822,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series A-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,742,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,742,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,270,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,270,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B-1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,807,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,807,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series B-2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,464,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,464,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,850,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,760,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.6604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Series D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,051,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,472,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.9639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;95,997,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,328,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS0yLTEtMS0w_d453ab65-6728-43fc-bf40-beb4b58ce3a9"
      unitRef="shares">4987477</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS00LTEtMS0w_898b0366-40a0-4b7c-acb6-0fb26aafa85d"
      unitRef="shares">4987477</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS00LTEtMS0w_ec259054-9d65-4e07-83e0-52ec2a9b06dd"
      unitRef="shares">4987477</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS02LTEtMS0w_21cc612a-2cac-48b0-8262-82e0397f7b55"
      unitRef="usd">0</us-gaap:TemporaryEquityLiquidationPreference>
    <hims:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="i00d3c217869a498ea1da4262db18091c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS04LTEtMS0w_f720bccd-ab75-43a8-9c17-5fb2211f0dae"
      unitRef="usd">0</hims:ProceedsFromIssuanceOfTemporaryEquity>
    <hims:TemporaryEquityIssuedPricePerShare
      contextRef="ibcafc3c8a8a6421cb500d0acdd1da778_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMS0xMC0xLTEtMA_140ac7bd-8ff0-41d1-9459-c00540963a6e"
      unitRef="usdPerShare">0.0001</hims:TemporaryEquityIssuedPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="id285b35ca96643e8a5dd6301ca706b17_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi0yLTEtMS0w_2ba02c4b-8ba5-4ed4-9acf-7f8084d0a972"
      unitRef="shares">23822492</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="id285b35ca96643e8a5dd6301ca706b17_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi00LTEtMS0w_793b6e74-331a-4b6b-90aa-5c42f70f0e6f"
      unitRef="shares">23822492</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="id285b35ca96643e8a5dd6301ca706b17_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi00LTEtMS0w_c9af821f-5506-43d7-b564-90fb7a025f0d"
      unitRef="shares">23822492</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="id285b35ca96643e8a5dd6301ca706b17_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi02LTEtMS0w_f6fe7980-4c1b-4f38-a9a4-1b321308c6c6"
      unitRef="usd">6621000</us-gaap:TemporaryEquityLiquidationPreference>
    <hims:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="i0dab5dbc93cf444c956b2f47e4145d28_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi04LTEtMS0w_a473a958-f460-4449-acc5-654eb4c67f0b"
      unitRef="usd">5106000</hims:ProceedsFromIssuanceOfTemporaryEquity>
    <hims:TemporaryEquityIssuedPricePerShare
      contextRef="id285b35ca96643e8a5dd6301ca706b17_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMi0xMC0xLTEtMA_98db5359-5d92-4a1d-ac00-11d85f63ddde"
      unitRef="usdPerShare">0.2780</hims:TemporaryEquityIssuedPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i973de7d14a4c409cb16e8a6b8963bff5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy0yLTEtMS0w_3eba7223-1054-4a53-b916-4ce26b4c5c5d"
      unitRef="shares">5742012</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i973de7d14a4c409cb16e8a6b8963bff5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy00LTEtMS0w_05eee865-d648-4018-8ebe-01b1186b77e0"
      unitRef="shares">5742012</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i973de7d14a4c409cb16e8a6b8963bff5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy00LTEtMS0w_57cb1a1d-45ac-4095-926a-970843e23c1b"
      unitRef="shares">5742012</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i973de7d14a4c409cb16e8a6b8963bff5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy02LTEtMS0w_5476d945-d799-4cf4-b122-65170dd779af"
      unitRef="usd">753000</us-gaap:TemporaryEquityLiquidationPreference>
    <hims:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="ie241c9b58b1b41c5adc333a98cfa439d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy04LTEtMS0w_d136fcf5-05d4-4ebe-9f01-c6bccefa532b"
      unitRef="usd">740000</hims:ProceedsFromIssuanceOfTemporaryEquity>
    <hims:TemporaryEquityIssuedPricePerShare
      contextRef="i973de7d14a4c409cb16e8a6b8963bff5_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfMy0xMC0xLTEtMA_5610b9f0-695c-45a9-b9c6-2c3f3e5c14c2"
      unitRef="usdPerShare">0.1312</hims:TemporaryEquityIssuedPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i2c496814f30146d2a8fffa0636e6175d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC0yLTEtMS0w_2829e175-b04d-46b0-8bc6-016c1b5d8cbd"
      unitRef="shares">13270590</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i2c496814f30146d2a8fffa0636e6175d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC00LTEtMS0w_41790841-0134-49ed-9547-a017349ac5a2"
      unitRef="shares">13270590</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i2c496814f30146d2a8fffa0636e6175d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC00LTEtMS0w_7c8b36e4-3956-4dc8-a960-c37b0adf9d8f"
      unitRef="shares">13270590</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i2c496814f30146d2a8fffa0636e6175d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC02LTEtMS0w_48c26773-28be-43c6-b729-bcc124e78db2"
      unitRef="usd">24600000</us-gaap:TemporaryEquityLiquidationPreference>
    <hims:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="iec02bacd134949c3a43d4169ef4a503f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC04LTEtMS0w_9fb21c97-b909-42a5-a27b-900d7493f692"
      unitRef="usd">23429000</hims:ProceedsFromIssuanceOfTemporaryEquity>
    <hims:TemporaryEquityIssuedPricePerShare
      contextRef="i2c496814f30146d2a8fffa0636e6175d_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNC0xMC0xLTEtMA_f8a2ca61-f503-49bc-a406-0a89bc4eec98"
      unitRef="usdPerShare">1.8538</hims:TemporaryEquityIssuedPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="iea410e7929fb4ea4866693138775bce3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS0yLTEtMS0w_f8fccdb2-e501-4dea-bd9b-e1dde43ef729"
      unitRef="shares">9807952</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="iea410e7929fb4ea4866693138775bce3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS00LTEtMS0w_6629ba83-c526-4881-8293-a27f61e90710"
      unitRef="shares">9807952</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="iea410e7929fb4ea4866693138775bce3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS00LTEtMS0w_8fafa0c3-b999-4590-92ce-af936e0fa09c"
      unitRef="shares">9807952</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="iea410e7929fb4ea4866693138775bce3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS02LTEtMS0w_08cbe338-2e0e-419c-b335-18e6c833af25"
      unitRef="usd">20000000</us-gaap:TemporaryEquityLiquidationPreference>
    <hims:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="i310c211669824a0ebd4e0cbbfecbee8c_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS04LTEtMS0w_3d9fbc24-9786-4961-b70e-b4911d0e10f5"
      unitRef="usd">14965000</hims:ProceedsFromIssuanceOfTemporaryEquity>
    <hims:TemporaryEquityIssuedPricePerShare
      contextRef="iea410e7929fb4ea4866693138775bce3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNS0xMC0xLTEtMA_1f77ca16-bb8c-4905-8259-76f580db8981"
      unitRef="usdPerShare">2.0392</hims:TemporaryEquityIssuedPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ia620070bccea49e8ae67e495e7cd6630_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi0yLTEtMS0w_3f00e695-0495-4b67-bd36-e08c6520d51c"
      unitRef="shares">13464939</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ia620070bccea49e8ae67e495e7cd6630_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi00LTEtMS0w_74e215d8-e3fa-4183-a202-e18a02eb704d"
      unitRef="shares">13464939</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ia620070bccea49e8ae67e495e7cd6630_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi00LTEtMS0w_f5404591-751d-40a4-aaea-2f606a2910ff"
      unitRef="shares">13464939</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="ia620070bccea49e8ae67e495e7cd6630_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi02LTEtMS0w_a629fb83-83a5-4a21-8df1-f862d4ebb0c4"
      unitRef="usd">51371000</us-gaap:TemporaryEquityLiquidationPreference>
    <hims:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="i36e32a096ad44dfab36246420544e57d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi04LTEtMS0w_c849c801-d9cd-4d31-8c93-b57008c8af21"
      unitRef="usd">49911000</hims:ProceedsFromIssuanceOfTemporaryEquity>
    <hims:TemporaryEquityIssuedPricePerShare
      contextRef="ia620070bccea49e8ae67e495e7cd6630_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNi0xMC0xLTEtMA_c882bec3-ea84-4657-ad4e-db45d09d0c79"
      unitRef="usdPerShare">3.8152</hims:TemporaryEquityIssuedPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="icbd0e86a85204fc19e2e004fc1ddae21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy0yLTEtMS0w_66910fe0-0fd2-4905-ac97-79abb3a7d394"
      unitRef="shares">14850340</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="icbd0e86a85204fc19e2e004fc1ddae21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy00LTEtMS0w_0e160783-ab69-4841-a0e4-35a95b647582"
      unitRef="shares">14760594</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="icbd0e86a85204fc19e2e004fc1ddae21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy00LTEtMS0w_7f598153-d4e4-43cb-8755-ff0da48172bf"
      unitRef="shares">14760594</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="icbd0e86a85204fc19e2e004fc1ddae21_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy02LTEtMS0w_0f9d6085-6cdc-4b3b-beac-2da20b08e305"
      unitRef="usd">113072000</us-gaap:TemporaryEquityLiquidationPreference>
    <hims:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="i90721555cbdb4b9e88888fbf57039262_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy04LTEtMS0w_90b14704-db77-4370-b48e-f36f0581536b"
      unitRef="usd">92590000</hims:ProceedsFromIssuanceOfTemporaryEquity>
    <hims:TemporaryEquityIssuedPricePerShare
      contextRef="icbd0e86a85204fc19e2e004fc1ddae21_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfNy0xMC0xLTEtMA_6c16d4fd-c0ce-4dab-99c3-65343d914e55"
      unitRef="usdPerShare">7.6604</hims:TemporaryEquityIssuedPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC0yLTEtMS01MzI3_34869200-05bc-497f-b5d7-3a60495f648b"
      unitRef="shares">10051872</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC00LTEtMS01MzQx_22312d95-01c3-4786-94ff-d9141aa05cd7"
      unitRef="shares">7472062</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC00LTEtMS01MzQx_ca7ab4b0-9b06-44b0-96d9-cbc75a74009a"
      unitRef="shares">7472062</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC02LTEtMS01MzQ2_f791e886-2314-4a76-b806-786d56f8bbe5"
      unitRef="usd">52035000</us-gaap:TemporaryEquityLiquidationPreference>
    <hims:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="i01d6bc7c49f14a5ba7fec5954dbe1334_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC04LTEtMS01MzUx_967e3960-eba2-428d-9922-f3bf5011ccd8"
      unitRef="usd">51900000</hims:ProceedsFromIssuanceOfTemporaryEquity>
    <hims:TemporaryEquityIssuedPricePerShare
      contextRef="idab11dd7dd1f4e9988ad58855a4a30fd_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC0xMC0xLTEtNTM1Ng_bb9b9643-a8d6-403a-a645-092fb67261fe"
      unitRef="usdPerShare">6.9639</hims:TemporaryEquityIssuedPricePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC0yLTEtMS0w_8a2f8f56-3b04-4711-9d6f-97e419b77ec8"
      unitRef="shares">95997674</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC00LTEtMS0w_8954e53d-5015-4cb3-8ab3-f57caa1503c4"
      unitRef="shares">93328118</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC00LTEtMS0w_c8d238b3-5ded-4910-8f22-0eddcae3d274"
      unitRef="shares">93328118</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i739ad782f5ac49639074bf72004c4e5f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC02LTEtMS0w_2cf5303f-9613-4ddc-89c8-7156a493869f"
      unitRef="usd">268452000</us-gaap:TemporaryEquityLiquidationPreference>
    <hims:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="i30440e6cee814b0795a79b39d6cc3d7f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RhYmxlOmIxMGQ4NDJiNzNjYTQzOGViMjM2NjQ0OTc4MTA5NWY4L3RhYmxlcmFuZ2U6YjEwZDg0MmI3M2NhNDM4ZWIyMzY2NDQ5NzgxMDk1ZjhfOC04LTEtMS0w_08c508d4-3ca8-4360-ad1c-134601b1ad24"
      unitRef="usd">238641000</hims:ProceedsFromIssuanceOfTemporaryEquity>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i482412508e5048348a66e153dca18c8a_I20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2Mjg3Mg_d4868c85-9f7b-496e-861f-ec7c8227e763"
      unitRef="shares">7472062</us-gaap:TemporaryEquitySharesIssued>
    <hims:ProceedsFromIssuanceOfTemporaryEquity
      contextRef="i07ad18420cfc4998888024c661da561a_D20200301-20200731"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjUwNw_a10048b3-b27e-4bfa-b260-9b08adfc5b4c"
      unitRef="usd">51900000</hims:ProceedsFromIssuanceOfTemporaryEquity>
    <hims:RecapitalizationExchangeConversionBasis
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2NzIxMQ_3f2feac3-e868-4439-988e-468a17489579"
      unitRef="number">1</hims:RecapitalizationExchangeConversionBasis>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjUyMg_95cf7cce-ab2c-44d7-869f-6f863dd91ea4"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ie64d700f04004ca28cce3f10ce2c702e_I20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjkxNw_52295729-c2e7-4d77-a8a4-05c0b4c1ee27"
      unitRef="shares">1341865</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="ie64d700f04004ca28cce3f10ce2c702e_I20200229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjU0MQ_9438e25c-5e2c-491c-a3c5-737995713c97"
      unitRef="usd">10000000.0</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ia535ce992e724f86a62e762541499dca_D20200201-20200229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2NzIzNg_eec6189e-b3f0-4848-9353-71a917bab652"
      unitRef="shares">1341865</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <hims:ProceedsFromConversionOfConvertibleSecurities
      contextRef="ia535ce992e724f86a62e762541499dca_D20200201-20200229"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjU2Nw_10b87520-9a12-4ce1-b052-a8f4b0c0c4c2"
      unitRef="usd">100000</hims:ProceedsFromConversionOfConvertibleSecurities>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i5c24e39c91df42cbaed7932bf65e2d02_I20200301"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2MjU4MQ_7cd17f33-b0f2-4302-bc0b-dd38bb8d07c1"
      unitRef="usd">11300000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ia0f34e27b5684e27b0de10fc97914074_I20191130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2NzE3OQ_62aeb27c-bf16-4795-b573-9403a7c2bdd6"
      unitRef="shares">89747</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i85017d290ffd4ccda16318d642b40261_I20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2NzE5OQ_4e96178a-4caf-443e-9fdc-2c44b504d442"
      unitRef="usdPerShare">6.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i9325ba192ff34fe4a7eec3cc7c4f7351_I20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfNjA0NzMxMzk2NzE4Nw_e5caf1c1-e12e-4956-aa28-60317b33ec47"
      unitRef="shares">89747</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i85017d290ffd4ccda16318d642b40261_I20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82MS9mcmFnOmI4NGY2MzY1MmQ5ZjQ4NjQ5YjI5NjkyNmEzMjczYWY3L3RleHRyZWdpb246Yjg0ZjYzNjUyZDlmNDg2NDliMjk2OTI2YTMyNzNhZjdfODI0NjMzNzIyMjM1Mw_9a71f51b-a3af-4252-b3ff-ab7900de1b13"
      unitRef="shares">98723</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3Njk5OQ_bc2a2250-1f7b-4aec-b858-d2edcfea1bad">Common StockPrior to the Merger, the Company had two classes of authorized common stock, Hims Class A common stock and Hims Class F common stock. Shares issued on early exercise are not considered outstanding for accounting purposes because the employees holding these awards are not entitled to the rewards of stock ownership.&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights of the holders of Hims Class A and Hims Class F common stock were identical, except with respect to (i) electing members of the Board of Directors and (ii) voting rights. The outstanding shares of Hims Class A and Hims Class F common stock presented on the consolidated balance sheet and on the consolidated statement of mezzanine equity and stockholders' equity (deficit) for the year ended December 31, 2020 were legally outstanding shares, including shares issued in exchange for related-party promissory notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2020, the Company repurchased 85,594 of unvested shares of Hims Class A common stock for a cash payment of less than $0.1&#160;million, which resulted in a reduction of deposit liability from the early exercise of stock options. In addition, in May 2020, an executive officer departed the Company, which resulted in the repurchase of 509,602 unvested shares of Hims Class A common stock in exchange for the cancellation of the principal payable of $0.9&#160;million under an associated promissory note. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Pre-Closing Stock Repurchase&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 20, 2021, the Company repurchased from its stockholders and cancelled 2,207,580 shares of Hims Class A common stock, including certain stockholders who exercised outstanding stock options, for aggregate payment of $22.0&#160;million. Included within the shares repurchased was 183,548 shares of Hims Class&#160;A common stock from the net exercise of stock options as part of the pre-closing stock repurchase for $1.8&#160;million. The repurchase was recognized as a reduction of additional paid-in capital and redeemable convertible preferred stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Merger Transaction&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immediately prior to the Merger, each outstanding share of Hims' Class F common stock and preferred stock converted into Hims Class A common stock at the then-effective conversion rate. As a result of the Merger, each outstanding share of the Hims capital stock was converted into the right to receive newly issued shares of the Company's Class A common stock and certain other securities, other than the shares of Hims Class V common stock issued to its CEO immediately prior to the Closing, which were converted into the right to receive newly issued shares of the Company's Class V common stock and certain other securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On the Closing Date, each Hims stockholder received approximately 0.4530 shares of the Company's Class A common stock, par value $0.0001 per share, for each share of Hims Class A common stock, par value $0.000001 per share, that such stockholder owned (with the CEO receiving 0.4530 shares of the Company's Class V common stock, par value $0.0001 per share, for each share of Hims Class V common stock, par value $0.000001 per share, that the CEO owned). Each stockholder also received 0.0028 warrants exercisable for the Company's Class A common stock, for each share of Hims Class A or Class V common stock owned by such stockholder prior to the Merger and earn-out shares at an exchange ratio of 0.0443. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Settlement of Nonrecourse Related-Party Promissory Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, the obligations due under all nonrecourse related-party promissory notes were satisfied through the payment of $1.2&#160;million and the forfeiture of 370,734 shares of the Company's Class A common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;PIPE Investment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concurrently with the execution of the Merger Agreement, certain investors collectively subscribed for 7,500,000 shares of the Company's Class A common stock at $10.00 per share for aggregate gross proceeds of $75.0&#160;million. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Class&#160;A Common Stock Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed above, Class A common stock warrants have been issued in connection with debt agreements (Note 10 &#x2013; Borrowing Arrangements), vendor service agreements (Note 12 &#x2013; Stock-Based Compensation), issuance of preferred stock (Note 13 &#x2013; Redeemable Convertible&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Preferred Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and to all common stockholders and warrant holders as part of the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prior to Merger&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2020, Hims Class A common stock warrants were exercised to purchase 143,452 shares of Hims Class A common stock at an exercise price of $0.06 per share. In November 2020, Hims Class A common stock warrants were exercised to purchase 425,146 and 37,244 shares of Hims Class A common stock at an exercise price of $0.06 and $1.75 per share, respectively. In December 2020, Class A common stock warrants were exercised to purchase 178,840 and 266,522 shares of Hims Class A common stock at an exercise price of $0.06 and $1.75 per share, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 4, 2021, holders of Hims Class A common stock vendor warrants exercised their warrants and purchased 380,746 shares of Hims Class A common stock at an exercise price of $1.75 per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Subsequent to Merger&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the accounting acquirer, Hims was deemed to assume 3,012,500 Class A common stock warrants that were held by Oaktree Acquisition Holdings, L.P. ("Sponsor") at an exercise price of $11.50 ("Private Placement Warrants") and 6,708,333 Class A common stock warrants held by OAC's shareholders at an exercise price of $11.50 ("Public Warrants") as well as 888,143 Class A common stock warrants that were granted to Hims' equity holders as part of the Merger. Subsequent to the Merger, the Private Placement Warrants, Public Warrants, and Parent Warrants for shares of Class&#160;A common stock meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement Warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the Private Placement Warrants from being considered indexed to the entity's own stock. Therefore, these warrants are classified as liabilities on the condensed consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each warrant held by Hims' stockholders that was unexercised at the time of the Merger was assumed by the Company and represents the right to receive (a) an equivalent warrant at an exchange ratio of 0.4530 (which was determined not to result in incremental expense); (b) the right to receive, upon exercise, earn-out shares that vest in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $15.00, $17.50 and $20.00 for any 10 trading days within any 20-trading day period, or a Company sale (as defined in the Merger Agreement) occurs and the thresholds are met on or prior to the date that is five years following the Closing Date; and (c) the right to receive, upon exercise, an allocation of Parent Warrants. All of these instruments vest in accordance with the terms of the initial warrant in addition to any of the aforementioned requirements. The earn-out thresholds were all met in February 2021. The earn-out shares are equity classified since they do not meet the liability classification criteria outlined in ASC 480, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and are both (i) indexed to the Company's own shares and (ii) meet criteria for equity classification.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2021, all of the outstanding 3,012,500 Private Placement Warrants were net exercised for 1,474,145 shares of Class A common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company had the following warrants outstanding to purchase shares of Class&#160;A common stock (in&#160;thousands, except for share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrant Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 23, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 23, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 12, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 26, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Public&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,695,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 22, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 20, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Parent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 22, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 20, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Public Warrants Terms&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Public Warrants became exercisable into shares of Class A common stock upon 30 days after the Closing Date. The Public Warrants will expire at the later of five years after the completion of a business combination or upon redemption or liquidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commencing 90 days after the Public Warrants become exercisable, the Company may redeem all and only all of the Public Warrants:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;at $0.10 per warrant upon a minimum of 30 days' prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on the redemption date at a price equal to the average last reported sale price of the Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants;                     &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;if the last reported closing price of the Class A common stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;if there is an effective registration statement covering the Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given, or an exemption from registration is available.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company may redeem all and only all of the Public Warrants for cash:      &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;at a price of $0.01 per warrant;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;upon a minimum of 30 days' prior written notice of redemption; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;if the last reported closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/div&gt;If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a cashless basis, as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <hims:NumberOfClassesOfCommonStock
      contextRef="i8d64fe4256a5495dac515af8a61e6773_I20210119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODc1Mw_6761f4ab-4e54-4e8b-b4f4-d2cfe2e4980a"
      unitRef="common_stock_class">2</hims:NumberOfClassesOfCommonStock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i080dafd9e34b47e7937c78d08d32b686_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODY5NA_8a1a05ae-dba1-4b68-b69b-0c0993a4c6c2"
      unitRef="shares">85594</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i080dafd9e34b47e7937c78d08d32b686_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzA1Mg_17a0b12e-0c1c-4087-a36b-da7fb9524017"
      unitRef="usd">100000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i41048193847540548f3ba7ae46d9623e_D20200501-20200531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODcwMg_dec26d1e-486b-4ca2-bb9f-c522991fe9ff"
      unitRef="shares">509602</us-gaap:StockRepurchasedDuringPeriodShares>
    <hims:NotesReceivableAmountOfPrincipalPaymentCanceled
      contextRef="i2089a56369e04eacb54344b55b8e03a8_D20200501-20200531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzA3Nw_d4fefdac-2c05-4d6c-9ac2-70ba9912b80a"
      unitRef="usd">900000</hims:NotesReceivableAmountOfPrincipalPaymentCanceled>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTU1OA_4858af90-e0e9-42e3-8563-37eb14d784e7"
      unitRef="shares">2207580</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzEwMg_b4dd62b4-c06c-4f40-b773-34a9c5b81371"
      unitRef="usd">22000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTU2OQ_70109032-4389-4199-9e5e-1bec19762b4f"
      unitRef="shares">183548</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTU3OA_85a97d1c-4531-46c0-ab14-36eb6873452c"
      unitRef="usd">1800000</us-gaap:StockRepurchasedDuringPeriodValue>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTgzMA_ac60078a-fe02-436f-bef7-c39c414db05b"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i26bd1b4cf75e452991194f1a1a3d5cac_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTgzNA_f13a3241-102b-424c-9650-59eb5a58d997"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5c3a9475a70b4c2db3d6e0010a374a0e_I20210119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTgzOA_0e74e815-6c5d-4cb1-8546-54643f439396"
      unitRef="usdPerShare">0.000001</us-gaap:CommonStockParOrStatedValuePerShare>
    <hims:RecapitalizationExchangeRatio
      contextRef="i35a4fb924db24a85a1196789003372ba_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTg0Ng_b97f57d3-25c7-4ce6-89c8-d7a53ecc4c4f"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i3ee826f19c8f474091f7807831d1a4a2_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTg0Mg_fec313f5-199b-4187-ac01-5b454c10242e"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if23c020d049c42f8a21888c7cd351bf5_I20210119"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxNDAwMTg1MA_1dcbb6ca-0019-4797-8e64-2dff5fa11c13"
      unitRef="usdPerShare">0.000001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="ie5182198da4045b7a12388e80e2263ab_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzE3Mw_f22c3979-898f-4119-b822-081b222c16d5"
      unitRef="shares">0.0028</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <hims:RecapitalizationContingentConsiderationEquityExchangeRatio
      contextRef="i2ffc7b3d75784438b282649862e9f57e_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzE4MQ_d34f708f-061c-40f7-8d04-0ae7d4be7f0c"
      unitRef="number">0.0443</hims:RecapitalizationContingentConsiderationEquityExchangeRatio>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="i46d371e52a99410f95f88ff85bac410c_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzE4OQ_efc4a332-595f-4db2-8f55-77641cdb4589"
      unitRef="usd">1200000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="i46d371e52a99410f95f88ff85bac410c_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzIwMw_be98b34e-d69b-435e-a883-68d719a892a0"
      unitRef="shares">370734</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzIxMg_d807be87-5033-4be8-b6d3-2e17836b5749"
      unitRef="shares">7500000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i16bc3ab7ee094ed08651067218f9050a_I20210120"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzIyMw_4724dcff-05a9-4d88-a7a0-9815c79b2a0f"
      unitRef="usdPerShare">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzIzMQ_64611e43-3246-48b4-b8d1-d93f0960dfca"
      unitRef="usd">75000000.0</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i0cc1f5f00f854fd696092abbe8e5eb52_D20200701-20200731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMDgwOA_6697f48f-0cfa-49ac-b781-98a6d6afe20e"
      unitRef="shares">143452</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i18d3dd2a0dd54782ac27fc6a98050d65_I20200731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMDg2Nw_c1ce4bd4-5586-45c3-9162-bf8285a6048f"
      unitRef="usdPerShare">0.06</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i56a3708962c641f6884526a28a764d6b_D20201101-20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMDk3NA_9cd8a674-de9d-45ca-94d3-48aa74b396ed"
      unitRef="shares">425146</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i70b4853509034ba8ac52e45689f9837d_D20201101-20201130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMDk4Mg_bea19e46-f2f7-4f63-9806-2c150fafa5e0"
      unitRef="shares">37244</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i5454149a7fff446f86e9e1f46fc3ecb0_I20201130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODc3NA_2661b12a-05c4-4eeb-8199-0d83a465e65c"
      unitRef="usdPerShare">0.06</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="iead7fc49159344e09cc08f0243c9f687_I20201130"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMTA0OQ_a6d1cf7e-b3c2-4676-8fbf-0a99871d0a2d"
      unitRef="usdPerShare">1.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ia7096ecca3bf42abb946e3f881384b0a_D20201201-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMTE3MA_6b83bacb-2820-45d7-ad91-94504ef9e6f5"
      unitRef="shares">178840</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="if6fee565f9384a378a7733102fb1daf9_D20201201-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMTE3OA_da496e49-19ec-499e-b98a-1f41bc93715a"
      unitRef="shares">266522</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i4ff37ff4f4e94c939d22f573f503c48b_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODc4Nw_0ba22404-8461-4501-9b86-4b1b07738914"
      unitRef="usdPerShare">0.06</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i9d5d169b09da40e69a931bb98ac54af4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODgwMA_9a3ba8bc-b9ec-4412-a7f4-78e5752171bd"
      unitRef="usdPerShare">1.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="ic8f09575a6074fbbbea2128ab741a987_D20210104-20210104"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMTM5OQ_fe46cde1-f1c5-4164-9c2a-1357b8b71340"
      unitRef="shares">380746</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i069f663c8a004fdfbd4a509b3f54b8d3_I20210104"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMTQ1OA_d6261491-ad67-40ed-acb5-acc72c170899"
      unitRef="usdPerShare">1.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i342bdc4fd0584aca99f4b91a317c0acb_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI0Ng_6332a88c-6a5f-4393-ac59-ee2889769dd8"
      unitRef="shares">3012500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i342bdc4fd0584aca99f4b91a317c0acb_I20210120"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI1Nw_902649ff-1dec-45fc-886f-800890b7eb95"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="ib55d8e031f574c38bb95ca3aec87d1bd_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI2NQ_36ab7cca-c85d-4431-b19c-368a9efe4d76"
      unitRef="shares">6708333</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ib55d8e031f574c38bb95ca3aec87d1bd_I20210120"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI3Ng_3a7c81d8-8822-489f-8322-1c52ce1f57e8"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="if6ac477b8fba4a68abf0f1384d4e9f3e_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI4NA_ea5726bd-1afc-4039-9815-f73550872e36"
      unitRef="shares">888143</us-gaap:ClassOfWarrantOrRightOutstanding>
    <hims:RecapitalizationExchangeRatio
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzI5Mw_b39ee2d0-1c1e-46f7-bf82-f3df984a1c53"
      unitRef="number">0.4530</hims:RecapitalizationExchangeRatio>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzMwMQ_8e146fba-9cb4-4e61-b0c3-a4982e25b94a"
      unitRef="usdPerShare">15.00</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzMwOQ_ed471daf-ad58-498f-9807-5440e3cfeb1b"
      unitRef="usdPerShare">17.50</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree
      contextRef="i2c9f921c782846e594e898a25a3e7e57_I20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzMxNw_9309ddc8-bb05-4569-b392-0165fdbd5329"
      unitRef="usdPerShare">20.00</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODQ5MQ_e35ee3e7-5130-4ecd-a482-d453b65b6eec"
      unitRef="day">10</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays>
    <hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODQ5NQ_e6c60a8a-a2f9-4449-afe9-80ae2ca41ab6"
      unitRef="day">20</hims:ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays>
    <hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod
      contextRef="ib9aae412577446ebbf1adc5652403981_D20210120-20210120"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODgxMw_bdd2fa1f-58a1-4b40-a632-edfac0fa73e7">P5Y</hims:ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="iab13a99ae40f48409e0e1f3fd36fa413_I20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMjg4Mw_a0c1520b-788e-4974-9bfd-62306a11d5e3"
      unitRef="shares">3012500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i2c70da65b2cb41f68da444e9a69d66ae_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfMjc0ODc3OTExMjkzNw_550c3439-9630-4b66-aecc-aa6e33f892b2"
      unitRef="shares">1474145</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzQ3NA_4110584e-d27b-4b6d-81a3-27b108ed9a8a">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company had the following warrants outstanding to purchase shares of Class&#160;A common stock (in&#160;thousands, except for share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrant Type&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise&#160;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vendor&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 23, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 23, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 12, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 26, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Public&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,695,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 22, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 20, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Parent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;888,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 22, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 20, 2026&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i79825d4c5b744870999e9bde3e8537f5_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMS0wLTEtMS0w_5255a961-2234-4666-b8f7-b3c1ca9c1341"
      unitRef="shares">462335</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i79825d4c5b744870999e9bde3e8537f5_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMS0yLTEtMS0w_3d762ba9-7fc5-4188-baba-e58a00b5e62e"
      unitRef="usdPerShare">1.75</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i7376dfd331f74bd0b77f3b369c1c6b2a_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMi0wLTEtMS0w_a36dc433-76a9-4cbe-9c07-b03b45549de0"
      unitRef="shares">98723</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i7376dfd331f74bd0b77f3b369c1c6b2a_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMi0yLTEtMS0w_b4f5c9ec-b484-4e7c-9ef2-886a082d4a62"
      unitRef="usdPerShare">6.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i843814f57f6e400fa68052b3160a60fe_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMy0wLTEtMS0w_43a74bd9-e899-4aa1-98f7-8071d04523a2"
      unitRef="shares">6695915</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i843814f57f6e400fa68052b3160a60fe_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfMy0yLTEtMS0w_bba74038-9163-4a29-aa27-0140c1734930"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i1cc2663250444268a356d3527951ceb6_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfNC0wLTEtMS0w_dd25a4e4-8f4e-496c-bd29-74ed7e8b135a"
      unitRef="shares">888143</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i1cc2663250444268a356d3527951ceb6_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RhYmxlOjdhYzkwYzkyZmQ2ZDQzMjJiYjAzNDdiMTk3YzkyZDEzL3RhYmxlcmFuZ2U6N2FjOTBjOTJmZDZkNDMyMmJiMDM0N2IxOTdjOTJkMTNfNC0yLTEtMS0w_239b29da-e6d2-433f-99d0-ae01f47f23cd"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <hims:ClassOfWarrantOrRightExercisablePeriodAfterClosingDate
      contextRef="i0929992266364d4095e65e0383a160d6_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODg0Mw_38d108b7-4089-4436-8c44-3787e85f05cc">P30D</hims:ClassOfWarrantOrRightExercisablePeriodAfterClosingDate>
    <hims:ClassOfWarrantOrRightExpirationPeriod
      contextRef="i0929992266364d4095e65e0383a160d6_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk5ODg1Nw_b327383b-9b2b-43e1-a56f-73892fcce9b8">P5Y</hims:ClassOfWarrantOrRightExpirationPeriod>
    <hims:ClassOfWarrantOrRightRedemptionPeriodAfterExercisable
      contextRef="i0929992266364d4095e65e0383a160d6_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODQ5OA_6daa3bc0-f579-447f-a36b-aaaf7bb713f8">P90D</hims:ClassOfWarrantOrRightRedemptionPeriodAfterExercisable>
    <hims:ClassOfWarrantOrRightRedemptionPricePerShare
      contextRef="i54b4437d5bc64dd09ecb5bab58c279ad_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzQ0NQ_f2cb79af-5145-47e2-8a6b-d8a485240f8a"
      unitRef="usdPerShare">0.10</hims:ClassOfWarrantOrRightRedemptionPricePerShare>
    <hims:ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum
      contextRef="i2867394843aa406ea9a5eb734f9b7751_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODUxMQ_3aa912bc-af6f-40c6-90a1-513830038886">P30D</hims:ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum>
    <hims:ClassOfWarrantOrRightThresholdTradingDays
      contextRef="i2867394843aa406ea9a5eb734f9b7751_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODUyNA_9d5d485c-a0a2-4674-b3b5-358cb510c2e2"
      unitRef="day">10</hims:ClassOfWarrantOrRightThresholdTradingDays>
    <hims:ClassOfWarrantOrRightSalePriceRedemptionThreshold
      contextRef="i54b4437d5bc64dd09ecb5bab58c279ad_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzQ1Mg_d1d638e9-66d2-4f8b-a9f3-828f9515c910"
      unitRef="usdPerShare">10.00</hims:ClassOfWarrantOrRightSalePriceRedemptionThreshold>
    <hims:ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption
      contextRef="i2867394843aa406ea9a5eb734f9b7751_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODUyOA_06e3ebe4-0241-40d8-8b00-53e2a93da6b0">P30D</hims:ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption>
    <hims:ClassOfWarrantOrRightRedemptionPricePerShare
      contextRef="i65b1285ccd8544e6ab3ef4189e9e2fa5_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzQ2MA_5ce23432-a3f5-4aff-ab47-30b8c290cd0e"
      unitRef="usdPerShare">0.01</hims:ClassOfWarrantOrRightRedemptionPricePerShare>
    <hims:ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum
      contextRef="i98e637f1336e44e5af203fddfc5974c1_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODUzNA_ce8b668a-fc64-459f-a2b7-5b6fb4677fc0">P30D</hims:ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum>
    <hims:ClassOfWarrantOrRightSalePriceRedemptionThreshold
      contextRef="i65b1285ccd8544e6ab3ef4189e9e2fa5_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3NzQ2Nw_f92051c4-f1fe-4f08-b67b-bfd5e404d5d5"
      unitRef="usdPerShare">18.00</hims:ClassOfWarrantOrRightSalePriceRedemptionThreshold>
    <hims:ClassOfWarrantOrRightThresholdTradingDays
      contextRef="i98e637f1336e44e5af203fddfc5974c1_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODU0Nw_80c3c603-9793-4381-a43a-7f65f615ef22"
      unitRef="day">20</hims:ClassOfWarrantOrRightThresholdTradingDays>
    <hims:ClassOfWarrantOrRightThresholdConsecutiveTradingDays
      contextRef="i98e637f1336e44e5af203fddfc5974c1_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82NC9mcmFnOjU3Y2E0NjMzNGQ5OTRlZGZhNGJhMGJmNWI5OGZkY2IxL3RleHRyZWdpb246NTdjYTQ2MzM0ZDk5NGVkZmE0YmEwYmY1Yjk4ZmRjYjFfNjA0NzMxMzk3ODU1MQ_f9a6284a-ef1b-48fa-ac64-5f2e10db677d"
      unitRef="day">30</hims:ClassOfWarrantOrRightThresholdConsecutiveTradingDays>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1ODk2NA_68b3a66f-4d18-4a5c-97c6-586f2a39bda2">Related-Party Transactions&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Atomic Labs, LLC ("Atomic Labs") is a related-party venture capital startup studio that launched the Company, providing initial capital and governance.  During the initial years of operation, the Company utilized operational support from Atomic Labs, primarily consisting of providing office space, conducting back-office professional services, and administering operating expenses. Additionally, an affiliated company of Atomic Labs provides professional services to the Company, primarily to support engineering and operations functions. All services were provided at cost. For both the three months ended March 31, 2021 and 2020, the Company recorded a total of $0.8 million to Atomic Labs and its affiliated company for services performed and costs incurred on behalf of the Company. There was no accounts payable balance owed to Atomic Labs and its affiliated company as of March&#160;31, 2021 or December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, for the three months ended March 31, 2021 and 2020, the Company recorded $0.1 million and less than $0.1 million for payments made to Vouched, a related-party company that provides identity verification services. These expenses were recognized as selling, general, and administrative expenses. There was $0.1 million and less than $0.1 million of payables owed to Vouched as of March&#160;31, 2021 and December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Nonrecourse Related-Party Promissory Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company had promissory notes from certain of the Company's executive officers, as well as a founding employee and an executive chairman. The promissory notes, which were issued to the Company by the related parties as consideration for the exercise of stock options, are considered nonrecourse notes for accounting purposes. The loans are secured by the shares of Hims Class&#160;A common stock held by the individuals. There were 16,345,627 shares of Hims Class A common stock securing the related-party promissory notes as of December&#160;31, 2020. The related-party promissory notes bore interest between 2.21% and 3.02% per annum. The loans were due upon the earliest of (1)&#160;ten years from the debt issuance date, (2)&#160;a liquidation of the Company, or (3)&#160;six months following an initial public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended. Prepayment of principal and interest may be made at any time without penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The nonrecourse related-party promissory notes are not given accounting effect until the notes are repaid in full as the underlying stock options are not considered exercised for accounting purposes. As of December&#160;31, 2020, the total outstanding balance under these promissory notes was $7.2 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Merger, the obligations due under all nonrecourse related-party promissory notes were satisfied through the payment of $1.2&#160;million and the forfeiture of 370,734 shares of Hims Class A common stock. The related-party promissory notes were settled within additional paid-in capital on the condensed consolidated balance sheet.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Redeemable Common Stock Transaction&lt;/span&gt;&lt;/div&gt;On September&#160;23, 2019, the Company's&#160;CEO and a member of its Board of Directors, sold 737,058 shares of Hims Class&#160;A common stock to third party purchasers at $6.11 per share for aggregate consideration of $4.5&#160;million&#160;pursuant to Hims Class&#160;A Common Stock Purchase Agreements. Under the terms of the vendor service agreement with the third party, the purchasers were granted a put right entitling them to sell the shares to the Company at $6.11 per share for a period of six months. The put right expired on March&#160;23, 2020 without the purchasers exercising their rights to sell the shares to the Company. The Company recorded stock-based compensation expense associated with the transaction of $3.0 million. Upon expiration of the redemption right, the Company reclassified the aggregate consideration of $4.5&#160;million that was subject to redemption from mezzanine equity to stockholders' equity on the condensed consolidated balance sheet as of March&#160;31, 2020.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i771a07ec099545b09a6b92170d11d935_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjIy_799ca941-a586-47ef-9a1a-08290ccbd00c"
      unitRef="usd">800000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i8d14d0c90a8548aa962fa7748b3135a9_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjIy_8648c20a-b557-4623-94d7-04163c5637ed"
      unitRef="usd">800000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="ibb1c06dc151e466aa6cc22295c17a714_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA4MTY3MA_70357ea1-3d92-49f8-8a9e-8edc86bbfffe"
      unitRef="usd">0</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="ie1a302a5f05545f79eca24d49954e1cb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA4MTY3MA_8e02743c-48f9-4433-b478-2a1aa75728ef"
      unitRef="usd">0</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i312fd18031e24c0390d9be5de157fa4e_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA3ODU0Ng_2d5e76b6-09ec-4572-a6f0-ac36c922e7d8"
      unitRef="usd">100000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty
      contextRef="i638236725896454da1131afdbb4606ed_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA3ODU1NA_6610987e-c731-41fb-be34-9777ae4aee07"
      unitRef="usd">100000</us-gaap:RelatedPartyTransactionPurchasesFromRelatedParty>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i922947682b4841668dfbfe65e252e019_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA3ODU3NA_71708082-27fe-4e26-8ffd-1b851c365eb8"
      unitRef="usd">100000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="if227b428e44f45d982ddcf68a4372138_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA4MTcyOA_fbaad0f2-b7dd-4bc7-adde-f02906b12c92"
      unitRef="usd">100000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i02a8feb03ad34f34b5b703765d4c44c3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA3NTQxMg_b0d275d5-ea45-47e2-bbc0-d2d199b05715"
      unitRef="shares">16345627</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="if04cc3c5ee874113863826cf1cba7153_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMTU1NA_2b328ece-2be3-40a8-b814-2fe3c45c8fce"
      unitRef="number">0.0221</us-gaap:RelatedPartyTransactionRate>
    <us-gaap:RelatedPartyTransactionRate
      contextRef="iadf5123ee59348dda3e8699ab30bad2c_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMTU2MQ_45d9a163-ba93-4295-9964-17f3929ed440"
      unitRef="number">0.0302</us-gaap:RelatedPartyTransactionRate>
    <hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue
      contextRef="i02a8feb03ad34f34b5b703765d4c44c3_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfMjc0ODc3OTA3NTM4Nw_3fd8ebe2-c961-4ce5-8eb2-ad12a3545f34"
      unitRef="usd">7200000</hims:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="ie6b30bf8b001432a828df2ce3d0da827_D20210120-20210120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfODI0NjMzNzIxNjM1MQ_8f5f901e-c6c5-4e46-bd9b-df443483e94b"
      unitRef="usd">1200000</us-gaap:ProceedsFromRelatedPartyDebt>
    <hims:StockForfeitedDuringPeriodShares
      contextRef="ie6b30bf8b001432a828df2ce3d0da827_D20210120-20210120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfODI0NjMzNzIxNjM3Nw_752ea17a-4795-471e-8a54-b2d443df939a"
      unitRef="shares">370734</hims:StockForfeitedDuringPeriodShares>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ic59ae3ede9fb4cc19a25f9ae9330b9c1_D20190923-20190923"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1ODk2Ng_1475f29d-4218-4e0f-833f-3b8d052f087a"
      unitRef="shares">737058</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i8a589e0752164dc492e454a20349d082_I20190923"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfODI0NjMzNzIxNTg2NQ_0737a4b8-9121-42a8-b4f7-9184b9b41673"
      unitRef="usdPerShare">6.11</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ic59ae3ede9fb4cc19a25f9ae9330b9c1_D20190923-20190923"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1ODk4Ng_8f15a882-58d7-4c7c-ba58-f9ab6151fa04"
      unitRef="usd">4500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i8a589e0752164dc492e454a20349d082_I20190923"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfODI0NjMzNzIxNTg3Mw_0737a4b8-9121-42a8-b4f7-9184b9b41673"
      unitRef="usdPerShare">6.11</us-gaap:SaleOfStockPricePerShare>
    <hims:SaleOfStockPutRightPeriod
      contextRef="ic37899a64fdb4b35b8953afb27a19de6_D20190923-20190923"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1OTAwOA_36f51c8c-b804-4c9d-9392-86acb1d2d18e">P6M</hims:SaleOfStockPutRightPeriod>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i6aabfe45198043d3a411876caa90f87c_D20190923-20190923"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1ODc0Nw_108ae4a5-6694-4c7d-992c-50dd0577879c"
      unitRef="usd">3000000.0</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <hims:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i93e3fc5bb5ed483ebb7e411c2c1b86a3_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV82Ny9mcmFnOjA3M2M5ODY4YjM4MjQwNzU4ZDAyZGI0Mjk5MmIwMjYyL3RleHRyZWdpb246MDczYzk4NjhiMzgyNDA3NThkMDJkYjQyOTkyYjAyNjJfNjA0NzMxMzk1OTAyNQ_ee6c631f-5010-4632-aeaa-b10219bd02be"
      unitRef="usd">-4500000</hims:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NTk4Mw_c84d0a89-e24f-4709-bcce-7c47d7503a33">Basic and Diluted Net Loss per Share&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Merger and prior to effecting the recapitalization, the Company had two classes of common stock: Hims Class A and Hims Class F common stock. The rights of the holders of Hims Class&#160;A and Hims Class&#160;F common stock were identical, including the liquidation and dividend rights, except with respect to electing members of the Board of Directors and voting rights. As the liquidation and dividend rights were identical, undistributed earnings and losses were allocated on a proportionate basis and the resulting net loss per share attributable to common stockholders was the same for both Hims Class&#160;A and Hims Class&#160;F common stock on an individual and combined basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subsequent to the Merger, the Company continues to have two classes of common stock: Class A and Class V common stock. Similar to the previous structure, the rights are identical, including liquidation and dividend rights, except Class V common stock has additional voting rights. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the two-class method to calculate net loss per share. No dividends were declared or paid for the three months ended March 31, 2021 or 2020. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. As there is no contractual obligation for the redeemable convertible preferred stock to share in losses, the Company's basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average shares of common stock outstanding during periods with undistributed losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of the Company's basic and diluted net loss per share attributable to common stockholders for the three months ended March 31 (in&#160;thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Class&#160;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Class V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Class&#160;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Class&#160;F&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,471,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,609,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,668,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,941,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net loss per share attributable to common stockholders is the same for the three months ended March 31, 2021 and 2020, because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented. There were no redeemable shares during the three months ended March&#160;31, 2021. During the three months ended March 31, 2020, weighted average Hims Class A common shares presented excludes 664,162 shares subject to redemption. These shares do not absorb losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table discloses securities that could potentially dilute basic net loss per share in the future that were not included in the computation of diluted net loss per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for exercise of stock options subject to nonrecourse promissory notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,855,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for early exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,702,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,510,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,361,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,969,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,347,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase Class&#160;A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,733,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,895,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,433,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:DividendsCommonStock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NjIxOA_83e26aa0-b907-4787-90d3-374b9e2c697e"
      unitRef="usd">0</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NjIxOA_c837f3ab-5c7f-4697-8887-e6a50b021bbd"
      unitRef="usd">0</us-gaap:DividendsCommonStock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NTk4NA_f79c7f99-4686-4fa8-afc9-9eaad302dfdb">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of the Company's basic and diluted net loss per share attributable to common stockholders for the three months ended March 31 (in&#160;thousands, except share and per share amounts):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Class&#160;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Class V&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Class&#160;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Class&#160;F&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,185)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,219)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;146,471,524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,609,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,668,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,941,352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net loss per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfMy0xLTEtMS0w_d1bcad5f-ea6e-4723-9946-b9fbd522138e"
      unitRef="usd">-49185000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfMy0zLTEtMS0w_24d453f6-a2f7-4f02-b9ae-f38216ae6eb2"
      unitRef="usd">-2219000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfMy01LTEtMS0w_b558ee96-c9b5-4312-b334-2b5f4774b800"
      unitRef="usd">-4823000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i6168af5421b947c983b702984f8157bc_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfMy03LTEtMS0w_6f5a6e4e-0388-457e-aad8-fb77890d524a"
      unitRef="usd">-1210000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS0xLTEtMS0w_1d23534e-9ab3-458c-9035-eaf5f780daa2"
      unitRef="shares">146471524</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS0xLTEtMS0w_31a5d9d6-5428-4f66-b83f-2af984d3112b"
      unitRef="shares">146471524</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS0zLTEtMS0w_615b027b-6e35-430f-b1cc-1ed4c20927c0"
      unitRef="shares">6609014</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS0zLTEtMS0w_cb04f94b-0fa5-4ed3-bd3c-578c0551e926"
      unitRef="shares">6609014</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS01LTEtMS0w_12500e18-73de-4b0c-a5a7-da41e7361a5b"
      unitRef="shares">27668709</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS01LTEtMS0w_77c82c30-8c3b-4a76-937c-3dc20450219f"
      unitRef="shares">27668709</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i6168af5421b947c983b702984f8157bc_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS03LTEtMS0w_ae3587bd-c0a5-42c7-b701-7021851c864f"
      unitRef="shares">6941352</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i6168af5421b947c983b702984f8157bc_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNS03LTEtMS0w_e3e34767-c617-4286-a353-147a10710969"
      unitRef="shares">6941352</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi0xLTEtMS0w_303a9d3c-3b30-40d3-8635-321b17fec242"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi0xLTEtMS0w_8e38cfa7-30a2-46da-aacd-6f4c960e106f"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi0zLTEtMS0w_15891837-2683-47d0-8df0-8744e42fbbe0"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6406a62422a341a89c4ac5b918b34cf7_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi0zLTEtMS0w_7194fb47-544c-4b24-ab47-c50c6652ae19"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi01LTEtMS0w_1a62be30-5701-4814-bafe-12716393db34"
      unitRef="usdPerShare">-0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi01LTEtMS0w_f699bce3-6951-46d0-ad6b-67f67f7a1dff"
      unitRef="usdPerShare">-0.17</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i6168af5421b947c983b702984f8157bc_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi03LTEtMS0w_0c448d5c-3380-4c31-b1be-d1574d46d822"
      unitRef="usdPerShare">-0.17</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i6168af5421b947c983b702984f8157bc_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOjhmMTQ2ZGQ2NzY2YTQ0NmZiMGNkNTdkYWI1YTZkMTQyL3RhYmxlcmFuZ2U6OGYxNDZkZDY3NjZhNDQ2ZmIwY2Q1N2RhYjVhNmQxNDJfNi03LTEtMS0w_a4c643ce-f894-49b9-8007-c2d3194c1f54"
      unitRef="usdPerShare">-0.17</us-gaap:EarningsPerShareDiluted>
    <hims:NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare
      contextRef="i2194548550b7484685726895d99493c1_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NTk4NQ_5e5cec45-6dd9-4d53-b063-14af84adfc73"
      unitRef="shares">0</hims:NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare>
    <hims:NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare
      contextRef="i757faef54662457b89e18e28fb99922d_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NzQ0MA_f4c5befd-9710-4260-98fe-27a3ff6d9d8e"
      unitRef="shares">664162</hims:NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RleHRyZWdpb246Y2U4YjJkM2FjNmRlNDEyYjljMDExYzk3OWQxYmQyYjdfNjA0NzMxMzk1NTk5Mw_679e0376-0771-47cf-b425-d1649177812b">&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table discloses securities that could potentially dilute basic net loss per share in the future that were not included in the computation of diluted net loss per share:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.730%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for exercise of stock options subject to nonrecourse promissory notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,545,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,855,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock issued for early exercise of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;388,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,702,603&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,510,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,361,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,969,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,347,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase Class&#160;A common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,733,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,895,345&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,433,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i442b98b30a99440cabcf9c2a33258c44_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfMi0xLTEtMS0w_41b54450-c31b-4c31-81a0-45068ae3bff4"
      unitRef="shares">3545821</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib288e8afaab1439aa8563d67d92545a5_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfMi0zLTEtMS0w_0c9a0fd9-a1f4-44d8-876c-8c39051a7904"
      unitRef="shares">16855230</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie88ff03799b74ad5965527925463ef9a_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfMy0xLTEtMS0w_ab3663b3-3578-4d77-99f3-145cc977214c"
      unitRef="shares">388839</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3a72b9ac461b4533a1192dda838f4fe4_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfMy0zLTEtMS0w_07800eca-d66e-40c4-b429-41d3f4223b28"
      unitRef="shares">154820</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i06d6c621d2034e6dafae9bcb378bdff9_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNC0xLTEtMS0w_efe24ff8-3a6a-4516-9455-bcc60dcc60de"
      unitRef="shares">19702603</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i92de8792f23848c58e1d809553528fd6_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNC0zLTEtMS0w_78dcd096-cb39-4041-8404-6a259285b7c2"
      unitRef="shares">85510700</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iecae2ba52ea34c6892d78a05a039922b_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNS0xLTEtMS00MDY3_ae14e307-605f-4104-a03e-b92d39f49521"
      unitRef="shares">16361955</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6c000d18bcbb4f6281442b9c9affe5d1_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNS0zLTEtMS00MDY3_21c539ae-acbd-4f14-9360-8e7829278cbe"
      unitRef="shares">6969701</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie90befcd560f42a9bf949f5bd7f3347d_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNS0xLTEtMS0w_a36bf8db-ff96-4b50-b0c9-ebcd747ca9b2"
      unitRef="shares">3347300</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i6eb6f513a1aa4980bc4049b422e1e15b_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNS0zLTEtMS0w_aff7a0c1-361a-4456-ad73-78c2467559ef"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i44f09386b1fe4221a24a4ffa57406c7b_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNi0xLTEtMS0w_29eff669-a279-4006-bf94-40c2fe0b95cc"
      unitRef="shares">7733346</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4c9d172982e54c3dbf74e0a823776639_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNi0zLTEtMS0w_826de66d-17e2-4cef-9d8b-f78deaa86566"
      unitRef="shares">1895345</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7772b0e6965c459ead748797e372c5a3_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNy0xLTEtMS0w_0c7749a1-5530-4da7-8146-db31f0f50aee"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8196ddc57e7a4bfab7217e738f15cb7a_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83MC9mcmFnOmNlOGIyZDNhYzZkZTQxMmI5YzAxMWM5NzlkMWJkMmI3L3RhYmxlOmQwMzMyMmY4OGVlODQ5YzI4YmFkZDdiZmUxYmFmYzNkL3RhYmxlcmFuZ2U6ZDAzMzIyZjg4ZWU4NDljMjhiYWRkN2JmZTFiYWZjM2RfNy0zLTEtMS0w_0c1767d9-6471-4d32-beb9-02978f499f67"
      unitRef="shares">1433585</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83Ni9mcmFnOjYyMzdlODU0YjJiYzQ5MmQ4MjVhYzU2ZGQ2YmM1MGIyL3RleHRyZWdpb246NjIzN2U4NTRiMmJjNDkyZDgyNWFjNTZkZDZiYzUwYjJfNjA0NzMxMzk3MjMyMw_b4e7fcff-1923-4dcd-ad11-1b7e8ede1122">Income Tax&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective income tax rate was -0.2% and -0.6% &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for the three months ended March 31, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The effective tax rate differs from the U.S. federal rate primarily due to the impacts of the valuation allowance placed on the Company's deferred tax assets and state minimum taxes.&lt;/span&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i99867449219c42e3b58d75ee18d746a8_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83Ni9mcmFnOjYyMzdlODU0YjJiYzQ5MmQ4MjVhYzU2ZGQ2YmM1MGIyL3RleHRyZWdpb246NjIzN2U4NTRiMmJjNDkyZDgyNWFjNTZkZDZiYzUwYjJfMjc0ODc3OTA4ODk1Mg_043c70eb-4f87-4531-94b1-e48071cb8d4c"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ifbaa699e25164c4b8ec0a00013f09e46_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV83Ni9mcmFnOjYyMzdlODU0YjJiYzQ5MmQ4MjVhYzU2ZGQ2YmM1MGIyL3RleHRyZWdpb246NjIzN2U4NTRiMmJjNDkyZDgyNWFjNTZkZDZiYzUwYjJfMjc0ODc3OTA4ODk2Mg_b8cdf36f-1ebc-4225-be94-997a86cebbb4"
      unitRef="number">-0.006</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409345372664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>May 14, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HIMS & HERS HEALTH, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1482650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2269 Chestnut Street, #523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">851-0195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001773751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HIMS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">183,424,155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_RedeemableWarrantsMember', window );">Redeemable warrants, each whole warrant exercisable for one share of Class A common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable warrants, each whole warrant exercisable for one share of Class A common stock<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HIMS WS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember', window );">Common Class V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,377,623<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_RedeemableWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_RedeemableWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409345062472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 88,169<span></span>
</td>
<td class="nump">$ 27,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Short-term investments</a></td>
<td class="nump">235,097<span></span>
</td>
<td class="nump">72,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">4,523<span></span>
</td>
<td class="nump">3,543<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">12,407<span></span>
</td>
<td class="nump">5,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCurrent', window );">Deferred transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">340,196<span></span>
</td>
<td class="nump">113,084<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, noncurrent</a></td>
<td class="nump">856<span></span>
</td>
<td class="nump">1,006<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">4,848<span></span>
</td>
<td class="nump">4,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">345,900<span></span>
</td>
<td class="nump">118,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">13,233<span></span>
</td>
<td class="nump">8,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">5,823<span></span>
</td>
<td class="nump">4,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">624<span></span>
</td>
<td class="nump">1,272<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_WarrantsAndRightsOutstandingCurrent', window );">Warrant liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">906<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">19,680<span></span>
</td>
<td class="nump">15,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrant liabilities</a></td>
<td class="nump">33,370<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCreditNoncurrent', window );">Deferred rent, noncurrent</a></td>
<td class="nump">384<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">53,434<span></span>
</td>
<td class="nump">15,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note&#160;11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Mezzanine equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Total mezzanine equity</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">249,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock&#160;&#8211; Class&#160;A shares, par value $0.0001, 2,750,000,000 and 166,696,759 shares authorized and 182,973,780 and 46,025,754 shares issued and outstanding as of March&#160;31, 2021 and December&#160;31, 2020, respectively; Class&#160;V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued, and outstanding as of March&#160;31, 2021; Class&#160;F shares, par value $0.0001, 6,941,352 shares authorized, issued, and outstanding as of December&#160;31, 2020</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">515,216<span></span>
</td>
<td class="nump">24,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(72)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(222,696)<span></span>
</td>
<td class="num">(171,292)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">292,466<span></span>
</td>
<td class="num">(146,874)<span></span>
</td>
<td class="num">$ (139,953)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, mezzanine equity, and stockholders' equity (deficit)</a></td>
<td class="nump">$ 345,900<span></span>
</td>
<td class="nump">$ 118,697<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_WarrantsAndRightsOutstandingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants and Rights Outstanding, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_WarrantsAndRightsOutstandingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCreditNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.26(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549951&amp;loc=d3e39927-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCreditNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409348959768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Mezzanine equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Mezzanine equity, par or stated value per share (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Mezzanine equity, shares authorized (in shares)</a></td>
<td class="nump">275,000,000<span></span>
</td>
<td class="nump">95,997,674<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Mezzanine equity, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">93,328,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Mezzanine equity, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">93,328,118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Mezzanine equity, liquidation preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 268,452,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">2,750,000,000<span></span>
</td>
<td class="nump">166,696,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">182,973,780<span></span>
</td>
<td class="nump">46,025,754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">182,973,780<span></span>
</td>
<td class="nump">46,025,754<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember', window );">Common Class V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">8,377,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">8,377,623<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassFMember', window );">Common Class F</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,941,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,941,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,941,352<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_CommonClassFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409345592408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 52,314<span></span>
</td>
<td class="nump">$ 30,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">12,067<span></span>
</td>
<td class="nump">9,444<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">40,247<span></span>
</td>
<td class="nump">20,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketingExpense', window );">Marketing</a></td>
<td class="nump">26,958<span></span>
</td>
<td class="nump">12,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general, and administrative</a></td>
<td class="nump">61,698<span></span>
</td>
<td class="nump">14,064<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">88,656<span></span>
</td>
<td class="nump">26,837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(48,409)<span></span>
</td>
<td class="num">(6,218)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other (expense) income, net</a></td>
<td class="num">(2,905)<span></span>
</td>
<td class="nump">230<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before provision for income taxes</a></td>
<td class="num">(51,314)<span></span>
</td>
<td class="num">(5,998)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(90)<span></span>
</td>
<td class="num">(35)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(51,404)<span></span>
</td>
<td class="num">(6,033)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Total comprehensive loss</a></td>
<td class="num">$ (51,465)<span></span>
</td>
<td class="num">$ (6,075)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net loss per share attributable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted average shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">153,080,538<span></span>
</td>
<td class="nump">34,610,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">153,080,538<span></span>
</td>
<td class="nump">34,610,061<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409258425160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Deficit) (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>PIPE Investment</div></th>
<th class="th"><div>Class A Common Stock Warrants</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>PIPE Investment</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Class A Common Stock Warrants</div>
</th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>PIPE Investment</div>
</th>
<th class="th">
<div>Additional Paid-In Capital </div>
<div>Class A Common Stock Warrants</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Redeemable Convertible Preferred Stock</div></th>
<th class="th"><div>Redeemable Class&#160;A Common&#160;Stock</div></th>
<th class="th"><div>Previously Reported</div></th>
<th class="th">
<div>Previously Reported </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Previously Reported </div>
<div>Additional Paid-In Capital</div>
</th>
<th class="th">
<div>Previously Reported </div>
<div>Accumulated Other Comprehensive Income (Loss)</div>
</th>
<th class="th">
<div>Previously Reported </div>
<div>Accumulated Deficit</div>
</th>
<th class="th">
<div>Previously Reported </div>
<div>Redeemable Convertible Preferred Stock</div>
</th>
<th class="th">
<div>Previously Reported </div>
<div>Redeemable Class&#160;A Common&#160;Stock</div>
</th>
<th class="th"><div>Revision of Prior Period, Adjustment</div></th>
<th class="th">
<div>Revision of Prior Period, Adjustment </div>
<div>Common Stock</div>
</th>
<th class="th">
<div>Revision of Prior Period, Adjustment </div>
<div>Additional Paid-In Capital</div>
</th>
<th class="th">
<div>Revision of Prior Period, Adjustment </div>
<div>Redeemable Convertible Preferred Stock</div>
</th>
<th class="th">
<div>Revision of Prior Period, Adjustment </div>
<div>Redeemable Class&#160;A Common&#160;Stock</div>
</th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Mezzanine equity, beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,514,191<span></span>
</td>
<td class="nump">737,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,573,651<span></span>
</td>
<td class="nump">1,627,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,059,460<span></span>
</td>
<td class="nump">890,074<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Mezzanine equity, beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,741<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,741<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Series D convertible preferred stock, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,537,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of Series D convertible preferred stock, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(737,058)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Mezzanine equity, ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,051,891<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Mezzanine equity, ending balance at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 218,252<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,588,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,887,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,298,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">$ (139,793)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (153,178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (139,793)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 13,383<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="num">$ (153,178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">737,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible securities</a></td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of vested stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod', window );">Early exercise of unvested stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested', window );">Vesting of early exercised stock options</a></td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares', window );">Forfeiture of unvested early exercised shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,242)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">1,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(6,033)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,033)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,279,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="num">$ (139,953)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="num">(159,211)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Mezzanine equity, beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,514,191<span></span>
</td>
<td class="nump">737,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">186,573,651<span></span>
</td>
<td class="nump">1,627,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,059,460<span></span>
</td>
<td class="nump">890,074<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Mezzanine equity, beginning balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,741<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 186,741<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Mezzanine equity, ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">93,328,118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,328,118<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,031,290<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112,703,172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Mezzanine equity, ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 249,962<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 249,962<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 249,962<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,588,612<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,887,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,298,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="num">(139,793)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(153,178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(139,793)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">13,383<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(153,178)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,967,106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,930,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">63,963,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="num">$ (146,874)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,424<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(171,292)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (146,874)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 24,429<span></span>
</td>
<td class="num">$ (11)<span></span>
</td>
<td class="num">$ (171,292)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="num">$ (5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityStockRepurchasedDuringPeriodShares', window );">Pre-closing stock repurchase, net of exercise of vested options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityStockRepurchasedDuringPeriodValue', window );">Pre-closing stock repurchase, net of exercise of vested options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(93,121,607)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (249,837)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Mezzanine equity, ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Mezzanine equity, ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Pre-closing stock repurchase, net of exercise of vested options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,817,519)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Pre-closing stock repurchase, net of exercise of vested options</a></td>
<td class="num">(21,902)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21,902)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,121,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,867,292<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible securities</a></td>
<td class="nump">249,837<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,678<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,828<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment', window );">Repayment of related-party promissory notes associated with vested shares</a></td>
<td class="nump">854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">854<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_StockForfeitedDuringPeriodShares', window );">Forfeiture of related-party promissory notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(370,734)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion', window );">Conversion of Series D preferred stock warrants to Class A common warrants</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_StockIssuedDuringPeriodSharesReverseRecapitalization', window );">Issuance of common stock upon Merger, net of transaction costs and merger warrant liability (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,892,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_StockIssuedDuringPeriodValueReverseRecapitalization', window );">Issuance of common stock upon Merger, net of transaction costs and Merger warrants liability</a></td>
<td class="nump">129,659<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">129,657<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of PIPE shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of PIPE shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization', window );">Issuance of earn-out shares to common stockholders (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,153,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization', window );">Issuance of earn-out shares to common stockholders</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of vested stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of vested stock options</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested', window );">Vesting of early exercised stock options</a></td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense', window );">Warrant expense in connection with Merger</a></td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">34,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(51,404)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(51,404)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">191,351,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 292,466<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 515,216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (72)<span></span>
</td>
<td class="num">$ (222,696)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Early Exercised Options, Vested</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Recapitalization, Warrant Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Related Party Receivable Repayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Warrant Conversion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_StockForfeitedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Forfeited During Period, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_StockForfeitedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Contingent Consideration, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_StockIssuedDuringPeriodSharesReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_StockIssuedDuringPeriodSharesReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Contingent Consideration, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_StockIssuedDuringPeriodValueReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_StockIssuedDuringPeriodValueReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_TemporaryEquityStockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Repurchased During Period, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_TemporaryEquityStockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_TemporaryEquityStockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Repurchased During Period, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_TemporaryEquityStockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409339696520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Deficit (Unaudited) (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of stock issuance costs</a></td>
<td class="nump">$ 12,794<span></span>
</td>
<td class="nump">$ 89<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409344894360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (51,404)<span></span>
</td>
<td class="num">$ (6,033)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">394<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">34,230<span></span>
</td>
<td class="nump">1,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Change in fair value of warrant liabilities</a></td>
<td class="nump">2,681<span></span>
</td>
<td class="num">(71)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_NoncashWarrantExpense', window );">Warrant expense in connection with Merger</a></td>
<td class="nump">154<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">144<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Noncash other</a></td>
<td class="nump">452<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(980)<span></span>
</td>
<td class="num">(2,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(7,147)<span></span>
</td>
<td class="num">(471)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="num">(58)<span></span>
</td>
<td class="nump">733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">5,117<span></span>
</td>
<td class="nump">674<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="nump">1,114<span></span>
</td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="num">(648)<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_IncreaseDecreaseInDeferredRent', window );">Deferred rent</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(15,948)<span></span>
</td>
<td class="num">(5,191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of investments</a></td>
<td class="num">(172,021)<span></span>
</td>
<td class="num">(17,642)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities of investments</a></td>
<td class="nump">9,500<span></span>
</td>
<td class="nump">19,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales of investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForSoftware', window );">Investment in website development and internal-use software</a></td>
<td class="num">(740)<span></span>
</td>
<td class="num">(452)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Purchases of property, equipment, and intangible assets</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash (used in)/provided by investing activities</a></td>
<td class="num">(163,324)<span></span>
</td>
<td class="nump">7,233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from issuance of redeemable convertible preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">31,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of stock issuance costs</a></td>
<td class="num">(12,794)<span></span>
</td>
<td class="num">(89)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Pre-closing stock repurchase</a></td>
<td class="num">(22,027)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfCommonStockRecapitalization', window );">Proceeds from issuance of common stock, recapitalization</a></td>
<td class="nump">197,686<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from PIPE</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Repayment of promissory notes associated with vested and unvested shares</a></td>
<td class="nump">1,193<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of Class A common stock warrants</a></td>
<td class="nump">807<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases', window );">Proceeds from exercise of vested and unvested stock options, net of repurchases</a></td>
<td class="nump">80<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of principal on term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,158)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">239,945<span></span>
</td>
<td class="nump">30,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Foreign currency effect on cash and cash equivalents</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">60,675<span></span>
</td>
<td class="nump">32,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at beginning of the year</a></td>
<td class="nump">28,350<span></span>
</td>
<td class="nump">22,797<span></span>
</td>
<td class="nump">$ 22,797<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash at end of the three-month period</a></td>
<td class="nump">89,025<span></span>
</td>
<td class="nump">55,165<span></span>
</td>
<td class="nump">$ 28,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for taxes</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Noncash investing and financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RecapitalizationCosts', window );">Recapitalization of redeemable convertible preferred stock from pre-closing stock repurchase</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of redeemable convertible preferred stock to common stock</a></td>
<td class="nump">249,837<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_WarrantsAssumed', window );">Assumption of Merger warrants liability</a></td>
<td class="nump">51,814<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_WarrantsIssued', window );">Exercise of Private Placement Warrants and Public Warrants</a></td>
<td class="nump">20,871<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReclassificationOfDeferredTransactionCosts', window );">Reclassification of deferred transaction costs</a></td>
<td class="nump">3,929<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ConversionOfPreferredStockWarrantsAmountConverted', window );">Conversion of Series D preferred stock warrants to Class A common warrants</a></td>
<td class="nump">1,160<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TransactionCostsIncurredButNotYetPaid', window );">Change in transaction costs payable</a></td>
<td class="nump">511<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_VestingOfEarlyExercisedStockOptions', window );">Vesting of early exercised stock options</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssued1', window );">Expiration of Class A common stock redemption right</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ConversionOfPreferredStockWarrantsAmountConverted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Preferred Stock Warrants, Amount Converted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ConversionOfPreferredStockWarrantsAmountConverted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_IncreaseDecreaseInDeferredRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Deferred Rent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_IncreaseDecreaseInDeferredRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_NoncashWarrantExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Warrant Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_NoncashWarrantExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ProceedsFromIssuanceOfCommonStockRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock, Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ProceedsFromIssuanceOfCommonStockRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ProceedsFromStockOptionsExercisedNetOfRepurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Stock Options Exercised, Net Of Repurchases</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ProceedsFromStockOptionsExercisedNetOfRepurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReclassificationOfDeferredTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification Of Deferred Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReclassificationOfDeferredTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_TransactionCostsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Transaction Costs Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_TransactionCostsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_VestingOfEarlyExercisedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vesting Of Early Exercised Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_VestingOfEarlyExercisedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_WarrantsAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Assumed</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_WarrantsAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_WarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_WarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section 25<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=109262497&amp;loc=d3e20148-110875<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecapitalizationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of recapitalization costs for professional fees associated with restructuring debt and equity mixture that do not qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecapitalizationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of stock issued in noncash financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337284312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization</a></td>
<td class="text">Organization<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hims &amp; Hers Health, Inc. (the "Company"), formerly known as Oaktree Acquisition Corp. ("OAC"), is a direct-to-customer telehealth company incorporated in Delaware. The Company's mission is to make healthcare accessible, affordable, and convenient for everyone. The Company designed and built a digitally native, cloud-based technology centered around the consumer, and designed everything with the consumer in mind. The Company's proprietary websites, telehealth platform, electronic medical records system, pharmacy integration, and mobile accessibility combine to provide customers with a seamless, easy-to-use, mobile-first experience. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company offers a range of health and wellness products and services available for purchase directly by customers on the Company's websites and through wholesale partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021 (the "Closing Date"), OAC completed the acquisition of Hims, Inc. ("Hims") pursuant to the Agreement and Plan of Merger dated as of September 30, 2020 (the "Merger Agreement") by and among OAC, Hims, and Rx Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of OAC ("Merger Sub"). The Merger Agreement provided for, among other things, the combination of Hims and OAC pursuant to the merger of Merger Sub with and into Hims, with Hims continuing as the surviving entity and as a wholly-owned subsidiary of OAC (the "Merger").</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for as a reverse recapitalization with Hims as the accounting acquirer and OAC as the acquired company for accounting purposes. Accordingly, all historical financial information presented in the unaudited condensed consolidated financial statements represents the accounts of Hims and its wholly owned subsidiaries as if Hims is the predecessor to the Company. The shares and net loss per common share, prior to the Merger, have been retroactively restated as shares reflecting the exchange ratio established in the Merger (0.4530 shares of Company Class A common stock for 1 share of Hims Class A common stock). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger, OAC ordinary shares and warrants were traded on the New York Stock Exchange ("NYSE") under the ticker symbols "OAC" and "OAC WS", respectively. On the Closing Date, the Company's Class A common stock and warrants began trading on the NYSE under the ticker symbols "HIMS" and "HIMS WS", respectively. One of the primary purposes of the Merger was to provide a platform for Hims to gain access to the U.S. capital markets. See Note 3 &#8211; Recapitalization for additional details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337524296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to accounting principles generally accepted in the United States of America ("U.S. GAAP").</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements as of March&#160;31, 2021 are unaudited. The condensed consolidated balance sheet as of December&#160;31, 2020, included herein was derived from the audited consolidated financial statements as of that date. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. As such, the information included herein should be read in conjunction with the consolidated financial statements and accompanying notes as of and for the year ended December&#160;31, 2020 (the "audited consolidated financial statements").</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and reflect, in management's opinion, all adjustments of a normal, recurring nature that are necessary for the fair statement of the Company's balance sheet, results of operations, and cash flows for the three-month periods, but are not necessarily indicative of the results expected for the full fiscal year or any other period.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, and variable interest entities in which it holds a controlling financial interest. All intercompany transactions and balances have been eliminated in these condensed consolidated financial statements.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2021 and 2020, the Company had operations primarily in the United States and immaterial operations in the United Kingdom.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to the Company's significant accounting policies described in the audited consolidated financial statements for the year ended December&#160;31, 2020, that have had a material impact on these condensed consolidated financial statements and related notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The more significant estimates and assumptions by management include, among others, valuation of inventory, valuation and recognition of stock-based compensation expense, valuation and recognition of warrants, and estimates in capitalization of website development and internal-use software costs. Management believes that the estimates and judgments upon which it relies, are reasonable based upon information available to it at the time that these estimates and judgments were made. Actual results experienced by the Company may differ from management's estimates. To the extent that there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Investments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt instruments with original maturities at the date of purchase greater than three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with original maturities at the date of purchase and remaining maturities of greater than one year are classified as long-term investments. The Company intends to sell such investments at or close to maturity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The investments, if any, are designated as available-for-sale and are reported at fair value, with unrealized gains and losses, net of tax, recorded in other comprehensive income on the consolidated statements of operations and comprehensive loss, except as noted in the Other-Than-Temporary Impairment section that follows. The Company determines the cost of the investment sold based on specific identification at the individual security level. The Company records the interest income and realized gains and losses on the sale of these instruments within other (expense) income, net on the condensed consolidated statements of operations and comprehensive loss.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other-Than-Temporary Impairment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment's adjusted cost basis. This would occur for marketable debt instruments when the fair value is below amortized cost and the Company intends to sell the instrument, when it is more likely than not that the Company will be required to sell the instrument before recovery of its amortized cost basis, or when the Company does not expect to recover the entire amortized cost basis of the instrument (a credit loss exists). When the Company does not expect to recover the entire amortized cost basis of the instrument, it separates other-than-temporary impairments into amounts representing credit losses, which are recognized in other (expense) income, net, and amounts related to all other factors, which are recognized in other comprehensive (loss) income on the condensed consolidated statements of operations and comprehensive loss. The Company incurred no other-than-temporary impairments on investments for the three months ended March 31, 2021 or 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inventory</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory primarily consists of finished goods and raw materials that are located at Company-managed and third-party fulfillment warehouses. Inventory is stated at the lower of cost and net realizable value and inventory cost is determined by the weighted average cost method. The Company reserves for expired, slow-moving, and excess inventory by estimating the net realizable value based on the potential future use of such inventory. Management monitors inventory to identify events that would require impairment due to slow-moving, expired, or obsolete inventory and reduces the value of inventory when required. Obsolete inventory balances are written off against the inventory allowance when management determines that the inventory cannot be sold. The Company recorded write-offs of less than $0.1&#160;million for the three months ended March 31, 2021 and $0.1 million for the three months ended March 31, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification Topic ("ASC") 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's consolidated revenue primarily comprises of online sales of health and wellness products through the Company's website, including prescription and nonprescription products. In contracts that contain prescription products, revenue also includes medical consultation services. Additionally, starting in March&#160;2020, the Company began selling its products to a new wholesale partner.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue consists of the following (in&#160;thousands): </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended<br/>March 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Online</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wholesale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,314&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For online revenue, the Company defines its customer as an individual who purchases products or services through the website. For wholesale revenue, Company defines its customer as a wholesale partner. The transaction price in the Company's contracts with customers is the total amount of consideration to which the Company expects to be entitled in exchange for transferring products or services to the customer.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts that contain prescription products include two performance obligations: access to (i)&#160;products and (ii)&#160;consultation services. The Company's contracts that do not contain prescription products have a single performance obligation. Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised product to the customer and, in contracts that contain services, by the provision of consultation services to the customer. The Company satisfies its performance obligation for products at a point in time, which is upon delivery of the products to a third-party carrier. The Company satisfies its performance obligation for services over the period of the consultation service, which is typically a few days. The customer obtains control of the products and services upon the Company's completion of its performance obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts with multiple performance obligations, the transaction price is allocated to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling price is based on the prices at which the Company separately sells the products and services, as well as market and cost plus margin-based estimates. For each of the three months ended March 31, 2021 and 2020, service revenue represented less than 10% of consolidated revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To fulfill its promise to customers for contracts that include professional medical consultations, the Company maintains relationships with various "Affiliated Medical Groups", which are professional corporations or other professional entities owned by licensed physicians and other professional entities that engage licensed healthcare professionals (medical doctors, physician assistants, nurse practitioners, and mental health providers; collectively referred to as "Providers" or individually, a "Provider") to provide consultation services. Refer to Note 8 &#8211; Variable Interest Entities. The Company accounts for service revenue as a principal in the arrangement with its customers. This conclusion is reached because (i) the Company determines which Affiliated Medical Group and Provider provides the consultation to the customer; (ii) the Company is primarily responsible for the satisfactory fulfillment and acceptability of the services; (iii) the Company incurs costs for consultation services even for visits that do not result in a prescription and the sale of products; and (iv) the Company, at its sole discretion, sets all listed prices charged on its websites for products and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, to fulfill its promise to customers for contracts that include professional medical consultations, the Company maintains relationships with affiliated and third-party pharmacies ("Partner Pharmacies" or individually, a "Partner Pharmacy") to fill prescriptions that are ordered by the Company's customers. The Company accounts for prescription product revenue as a principal in the arrangement with its customers. This conclusion is reached because (i) the Company has sole discretion in determining which Partner Pharmacy fills a customer's prescription; (ii) Partner Pharmacies fill the prescription based on fulfillment instructions provided by the Company, including using the Company's branded packaging for generic products; (iii) the Company is primarily responsible to the customer for the satisfactory fulfillment and acceptability of the order; (iv) the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is responsible for refunds of the prescription medication after transfer of control to the customer; and (v) the Company, at its sole discretion, sets all listed prices charged on its website for products and services.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates refunds using the expected value method based on historical refunds granted to customers. The Company updates its estimate at the end of each reporting period and recognizes the estimated amount as contra-revenue with a corresponding refund liability. Sales, value-added, and other taxes are excluded from the transaction price and, therefore, from revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made an accounting policy election to account for shipping and handling activities performed after the control of a product has been transferred to the customer as fulfillment costs, with direct costs to ship products to customers included in cost of revenue. The Company's contracts with customers do not contain costs to obtain or costs to fulfill contracts with customers in accordance with ASC 340-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs&#8212;Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For online sales, payment for prescription medication and nonprescription products is typically collected from the customer a few days in advance of product shipment. Contract liabilities are recorded when payments have been received from the customer for undelivered products or services and are recognized as revenue when the performance obligations are later satisfied. Contract liabilities consisting of balances related to customer prepayments are recognized as current deferred revenue on the condensed consolidated balance sheets since the associated revenue will be primarily recognized within the following period. For wholesale arrangements, payments are collected in accordance with contract terms.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options, equity-classified warrants issued to vendors, and restricted stock units ("RSUs"), are measured at the grant date fair value. The fair value of employee stock options and vendor warrants are generally determined using the Black-Scholes Merton ("BSM") option-pricing model using various inputs, including estimates of expected volatility, term, risk-free rate, and future dividends. Stock options that were granted to the Company's Chief Executive Officer ("CEO") with performance and market conditions and earn-out RSUs were valued using the Monte Carlo simulation model. The Company recognizes compensation costs on a straight-line basis over the requisite service period of the employee and vendor, which is generally the option vesting term of four years for options and warrants that do not have performance or market conditions. Stock options and RSUs with performance conditions are recognized when it is probable that performance criteria will be achieved and compensation cost is recognized using the accelerated attribution method. The Company accounts for forfeitures as they occur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warrant Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 14 &#8211; Common Stock) as liabilities in addition to warrants to purchase preferred stock. At the end of each reporting period, changes in fair value during the period are recognized as a component of other (expense) income, net within the consolidated statements of operations and comprehensive loss. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company currently leases a warehouse facility and previously leased office space under noncancelable lease agreements that are accounted for as operating leases. Rent expense is recorded on a straight-line basis over the lease term. For rent abatement and rent escalation provisions, the Company recognizes the related rent expense on a straight-line basis over the lease term. The difference between cash rent payments and the recognition of straight-line rent expense is recorded as deferred rent and amortized over the lease term.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board ("FASB") issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU modifies the disclosure requirements for fair value measurements by removing, modifying, or adding certain disclosures. The standard is effective for public companies for annual periods beginning after December 15, 2019, with early adoption permitted </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for removed disclosures and delayed adoption until fiscal year 2020 permitted for the new disclosures. The Company adopted this disclosure requirement for the year ended December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February&#160;2016, the FASB issued ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires lessees to recognize leases on their balance sheets and disclose key information about leasing arrangements. The ASU establishes a right-of-use ("ROU") model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition on the income statement. The standard is effective for smaller reporting companies for annual periods beginning after December&#160;15, 2021 and for interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. In July&#160;2018, the FASB approved an amendment to the new guidance that allows companies the option of using the effective date of the new standard as the initial application (at the beginning of the period in which it is adopted, rather than at the beginning of the earliest comparative period) and to recognize the effects of applying the new ASU as a cumulative effect adjustment to the opening balance sheet or retained earnings. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to require the measurement of expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance also amended the impairment model for available-for-sale debt securities and requires entities to determine whether all or a portion of the unrealized loss on such debt security is a credit loss. In November 2018, ASU 2018-19 was issued which aligns the implementation date for nonpublic entities' annual financial statements with the implementation date for their interim financial statements and clarifies the scope of the guidance in the amendments in ASU 2016-13 to clarify that receivables arising from operating leases are not within the scope of Credit Losses (Topic 326) and should be accounted for in accordance with Leases (Topic 842). In April 2019, the FASB issued ASU 2019-04 which, among other amendments, allows for certain policy elections and practical expedients related to accrued interest on financial instruments. In November 2019, the FASB issued ASU 2019-10 and ASU 2019-11, which addressed certain aspects of the guidance related to effective dates, expected recoveries, troubled debt restructurings, accrued interest receivables, and financial assets secured by collateral. In February and March 2020, the FASB also issued ASU 2020-02 and ASU 2020-03, respectively, which provide certain amendments and improvements to sections of ASU 2016-13. These standards are effective for smaller reporting companies for annual and interim periods beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which is intended to improve consistency and simplify several areas of existing guidance. ASU 2019-12 removes certain exceptions to the general principles related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 is effective for annual periods beginning after December 15, 2020 for public entities, including interim periods within those fiscal years. The standard is effective for nonpublic companies for annual periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and as an emerging growth company ("EGC"), has elected to adopt the pronouncement following the effective date for nonpublic companies. The Company does not expect adoption will have a material impact on the Company's consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance includes amendments to improve the codification by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to the financial statements is codified in the disclosure section of the codification and to clarify guidance so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public entities, including interim periods within those fiscal years. The standard is effective for nonpublic companies for annual periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and as an EGC, has elected to adopt the pronouncement following the effective date for nonpublic companies.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337286472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recapitalization<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationAbstract', window );"><strong>Reverse Recapitalization [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationDisclosureTextBlock', window );">Recapitalization</a></td>
<td class="text">Recapitalization<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 1 &#8211; Organization, on the Closing Date, OAC completed the acquisition of Hims and acquired 100% of  Hims' shares and Hims received gross proceeds of $197.7 million. Transaction costs of $16.2 million, which consist of legal, accounting, and other professional services directly related to the Merger, are included in additional paid-in capital in the condensed consolidated balance sheet as of March 31, 2021. On the Closing Date, each Hims stockholder received approximately 0.4530 shares of the Company's Class A common stock, par value $0.0001 per share, for each share of Hims Class A common stock, par value $0.000001 per share, that such stockholder owned (with the CEO receiving 0.4530 shares of Hims &amp; Hers Class V common stock, par value $0.0001 per share, for each share of Hims Class V common stock, par value $0.000001 per share, that the CEO owned). Each Hims stockholder also received 0.0028 warrants exercisable for the Company's Class A common stock, for each share of Hims Class A or Class V common stock owned by such stockholder prior to the Merger and earn-out shares at an exchange ratio of 0.0443. See Note 13 &#8211; Redeemable Convertible</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Note 14 &#8211; Common Stock for additional details of the Company's stockholders' equity prior to and subsequent to the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As additional consideration, OAC also granted 888,143 OAC Class A common stock warrants ("Parent Warrants") to Hims' stockholders, 3,443 Parent Warrants to warrant holders, and approximately 35,000 RSUs to Hims' option and RSU holders ("Parent Warrant RSUs").</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All equity awards of Hims were assumed by OAC and converted into comparable equity awards that are settled or exercisable for shares of the Company's Class A common stock. As a result, each stock option was converted into an option to purchase shares of the Company's Class A common stock based on an exchange ratio of 0.4530. Each award of the Hims' RSUs was converted into RSUs of the Company based on an exchange ratio of 0.4530. Similarly, all outstanding Hims warrants were converted at an exchange ratio of 0.4530.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Merger was accounted for as a reverse recapitalization with Hims as the accounting acquirer and OAC as the acquired company for accounting purposes. Hims was determined to be the accounting acquirer since Hims' shareholders prior to the Merger had the greatest voting interest in the combined entity, Hims' shareholders appointed the initial directors of the combined Board of Directors and control future appointments, Hims comprises all of the ongoing operations, and Hims' senior management directs operations of the combined entity. Accordingly, all historical financial information presented in these unaudited condensed consolidated financial statements represents the accounts of Hims and its wholly owned subsidiaries as if Hims, rather than OAC, is the predecessor to the Company. No step-up basis of intangible assets or goodwill was recorded and net assets were stated at historical cost consistent with the treatment of the transaction as a reverse recapitalization of Hims. The shares and net loss per common share prior to the Merger have been retroactively restated as shares reflecting the exchange ratio established in the Merger (0.4530 Company shares for 1 Hims share). </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earn-Out Shares</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the closing of the Merger, holders of Hims' common stock and outstanding equity awards (including warrant, stock option and RSU holders) had the right to receive up to an aggregate amount of 16,000,000 shares of Company Class A common stock (or equivalent equity award) that would vest (in part) in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $15.00, $17.50 and $20.00 for any 10 trading days within any 20-trading day period on or prior to the date that is five years following the Closing Date. These shares of restricted Class A common stock and equivalent equity awards would also vest in connection with an acquisition of the Company if the applicable thresholds were met in any sale (as defined in the Merger Agreement) but subject to the same <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV8xMTk4L2ZyYWc6MjM2ZTcwZDY2ZTYwNDVlYWEzNDllMjkwODQ1MGExY2YvdGV4dHJlZ2lvbjoyMzZlNzBkNjZlNjA0NWVhYTM0OWUyOTA4NDUwYTFjZl8xNTM5MzE2MjgwNjExMQ_0328a105-577b-490b-8bab-4760962a29c8">five</span>-year deadline. In February 2021, all earn-out thresholds were met. In the first quarter of 2021, earn-out awards related to option holders received final approval by the Board of Directors. The earn-out shares are equity classified since they do not meet the liability classification criteria outlined in ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are both (i) indexed to the Company's own shares and (ii) meet the criteria for equity classification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PIPE Investment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the execution of the Merger Agreement, OAC entered into subscription agreements on September 30, 2020 with certain investors (the "PIPE Investors") pursuant to which such investors collectively subscribed for 7,500,000 shares of the Company's Class A common stock at $10.00 per share for aggregate gross proceeds of $75.0 million (the "PIPE Investment"). The PIPE Investment was consummated substantially concurrently with the closing of the Merger.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409338743592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments as of March&#160;31, 2021, consist of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,097&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments as of December&#160;31, 2020, consist of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,859&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,864&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments mature within one year.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337345128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text">Inventory<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,523&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,543&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409338743592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentAssetsTextBlock', window );">Prepaid Expenses and Other Current Assets</a></td>
<td class="text">Prepaid Expenses and Other Current Assets<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,407&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentAssetsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other current assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentAssetsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337518248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Liabilities</a></td>
<td class="text">Accrued Liabilities<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in&#160;thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant exercise deposit liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total accrued liabilities </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337528104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityDisclosureTextBlock', window );">Variable Interest Entities</a></td>
<td class="text">Variable Interest Entities<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order for customers to obtain a prescription product, customers must complete a consultation with a Provider on the Company's website through one of the Affiliated Medical Groups and receive a written prescription by the applicable Provider. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Affiliated Medical Groups and the Company do not have any shareholders in common. The Affiliated Medical Groups are 100% owned by licensed physicians. The Company is party to service agreements with the Affiliated Medical Groups pursuant to which the Company provides management and administrative services and collects the medical consultation fees from customers on behalf of the Affiliated Medical Groups.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company also entered into service agreements with XeCare LLC ("XeCare"), a licensed mail order pharmacy affiliated with the Company which is expected to provide prescription fulfillment services solely to the Company's customers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Affiliated Medical Groups and XeCare are legal entities that the Company has determined qualify as variable interest entities ("VIEs"). The Company determined that it is the primary beneficiary of these entities for accounting purposes because it has the ability to direct the activities that most significantly affect the entities' economic performance and has the obligation to absorb the losses. Under the VIE model, the Company presents the results of operations and the financial position of the Affiliated Medical Groups and XeCare as part of the consolidated financial statements of the Company as if the consolidated group were a single economic entity. There is no noncontrolling interest upon consolidation of the entities. The results of operations and cash flows of the Affiliated Medical Groups and XeCare are also included in the Company's condensed consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, the Company's condensed consolidated balance sheets included Affiliated Medical Groups and XeCare's combined current and total assets of $0.5 million and $1.4 million. As of March&#160;31, 2021 and December&#160;31, 2020, current liabilities were $1.1 million and $0.8 million and total liabilities were $1.5 million and $1.2 million. All amounts are after elimination of intercompany transactions and balances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of operations and cash flows of the Affiliated Medical Groups and XeCare are included in the Company's condensed consolidated financial statements. For the three months ended March 31, 2021 and 2020, the Affiliated Medical Groups and XeCare combined charged the Company $3.4 million and $0.3 million for services rendered. For the three months ended March 31, 2021 and 2020, the net losses generated by the Affiliated Medical Groups and XeCare combined were $1.8 million and $2.5 million after elimination of intercompany transactions and balances.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409338823096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis as of March&#160;31, 2021, is as follows (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,965&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2020, is as follows (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,557&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of cash, accounts receivable, accounts payable, and accrued liabilities approximated their carrying values as of March&#160;31, 2021 and December&#160;31, 2020, due to their short-term nature. All other financial instruments except for warrant liabilities related to the preferred stock warrants and Private Placement Warrants are valued either based on recent trades of securities in active markets or based on quoted market prices of similar instruments and other significant inputs derived from or corroborated by observable market data. The warrant liabilities related to the preferred stock warrants and Private Placement Warrants contain significant unobservable inputs including the expected term and with respect to the preferred stock warrants, the share exchange ratio in evaluating the fair value of underlying common stock, and exercise price. Therefore, these warrant liabilities were evaluated to be a Level 3 fair value measurement.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In prior periods, the fair value of the preferred stock warrant liability had been measured using the BSM option-pricing model and Monte Carlo simulation. During 2020, the Company changed its valuation method as a result of increased probability that the Company's common shares would be publicly listed in the near-term and began using a probability weighted expected returns methodology. As of December 31, 2020, the Company reverted to using a BSM option-pricing model to determine the value of the outstanding Series D preferred stock warrants (that replaced the Series C preferred stock warrants as discussed in Note 10 &#8211; Borrowing Arrangements). Subsequent to the Merger, the Series D preferred stock warrants were converted to Class A common stock warrants. As a result, the Series D preferred stock warrants were adjusted to fair value prior to the conversion resulting in a change in fair value of $0.3 million recognized as a component of other income (expense), net within the consolidated statements of operations and comprehensive loss, and then settled in additional paid-in capital as a result of the conversion to equity-classified Class A common stock warrants.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March 31, 2021, changes in warrant liabilities also related to changes in liabilities for warrants assumed as part of the recapitalization, including Private Placement Warrants and Public Warrants (defined and discussed in Note 14 &#8211; Common Stock). The Company valued the Private Placement Warrants using a Monte Carlo valuation simulation. Inherent in a Monte Carlo simulation are assumptions related to expected term, volatility, risk-free interest rate and dividend yield. The expected term of the warrants was determined to be equivalent to their remaining contractual term and includes consideration of the redemption features that were incorporated into the Monte Carlo model. The Company derived the volatility of its Class A common stock based on average historical stock volatilities of a peer group of public companies that the Company considers to be comparable to its business over a period equivalent to the expected term of the Private Placement Warrants. The risk-free interest rate is based on the U.S. Treasury's rates of U.S. Treasury zero-coupon bonds with a maturity similar to the expected term of the Private Placement Warrants. The dividend rate is based on the historical rate, which the Company anticipates remaining at zero. The following assumptions were used for the valuation of the Private Placement Warrants on the settlement date:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants were valued as of March&#160;31, 2021 using the listed trading price of $4.40 per Public Warrant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of warrant liabilities is as follows (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of Series D preferred stock warrants to Class A common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants and Public Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,871)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value of warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had no transfers between levels of the fair value hierarchy of its assets or liabilities measured at fair value. Due to the exercise and conversion to Class A common stock warrants of all preferred stock warrants and exercise of all of the Private Placement Warrants during the period, there were no longer any Level 3 warrant liabilities.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337473240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowing Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowing Arrangements</a></td>
<td class="text">Borrowing Arrangements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Silicon Valley Bank</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Second Amended and Restated Loan Agreement dated November 27, 2019, between Hims and Silicon Valley Bank ("SVB"), upon Hims' request, SVB would issue letters of credit (the "Letters of Credit") in an aggregate amount not to exceed $2.0 million. This amount is reduced by the amount otherwise available with respect to the cash management services, which may include merchant services, direct deposit of payroll, business credit card, and check cashing services identified in SVB's various agreements. On September 30, 2020, Hims entered into the First Loan Modification Agreement ("Loan Modification </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement") and the aggregate amount of the Letters of Credit was amended to $3.5 million. As of March&#160;31, 2021, SVB issued on the Company's behalf, a letter of credit in the amount of $0.8 million as a security deposit for a warehouse space in New Albany, Ohio. SVB required  $0.8 million to be maintained as collateral for the outstanding letter of credit. The Company expects to continue to renew the letter of credit through the duration of the lease. As this is for longer than one year, the Company presents the $0.8 million within restricted cash, noncurrent on the consolidated condensed balance sheet. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is a business credit card as part of the cash management services offered by SVB with an initial limit of $2.0 million which is reduced by the amount utilized for any issuances of Letters of Credit. This amount was increased to $3.5 million by the Loan Modification Agreement. To continue to use the credit card, SVB required $0.2 million to be maintained in a collateralized money market account and this was reflected within restricted cash on the consolidated balance sheet as of December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company terminated the Second Amended and Restated Loan Agreement with SVB resulting in the release of restricted cash of $0.2 million under the arrangement. The outstanding letter of credit for the warehouse was not included as part of this termination. In addition, the Company continues to use SVB's cash management services and increased its credit card limit to $5.0 million in January 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TriplePoint Venture Growth</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November&#160;27, 2019, Hims entered into a Plain English Capital Growth and Security Agreement (the "2019 Capital Agreement") with TriplePoint Venture Growth ("TPC") consisting of a term loan in the aggregate principal amount of up to $50.0 million, with $25.0 million being available immediately through December&#160;31, 2020 (the "Part 1 Commitment Amount"), and an additional $25.0 million becoming available upon utilization of the Part 1 Commitment Amount through December&#160;31, 2020. There was no minimum advance amount. As collateral, the Company provided a second lien security interest to TPC of substantially all its assets. As of December 31, 2020, the Company had not drawn down from this term loan and the facility expired.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2019 Capital Agreement, the Company issued to TPC a warrant granting TPC the right to purchase 89,747 shares of Hims' Series C preferred stock at an exercise price of $7.67 per share, subject to adjustment in regard to the preferred stock series, number of shares and exercise price if the per share price of subsequent preferred stock rounds less than $7.67. On March&#160;12, 2020, Hims sold Series D preferred stock at an issuance price of $6.96, which triggered an adjustment to the TPC warrant terms per the original agreement, resulting in conversion of the previously issued 89,747 Series C preferred stock warrants at an exercise price of $7.67 into 98,723 Series D preferred stock warrants at an exercise price of $6.96. Subsequent to the Merger, the Series D preferred stock warrants were converted to Class A common stock warrants. Refer to Note 13 &#8211; Redeemable Convertible</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Preferred Stock</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for further discussion of the conversion into Class A common stock warrants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337338424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Leases </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total rent expense for the three months ended March 31, 2021 and 2020, was $0.4 million and $0.7 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the Company entered into a 63-month noncancelable lease for 302,880 square feet of warehouse space in New Albany, Ohio. The lease commenced on June 1, 2020. Total minimum lease payments are $7.9&#160;million, net of rent abatement for an initial <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjQxMjA5M2E5M2YyMDQzMjhhMzNjNDYwMjIwMmY4Mzc1L3NlYzo0MTIwOTNhOTNmMjA0MzI4YTMzYzQ2MDIyMDJmODM3NV81NS9mcmFnOmIwZDA5ZDg1MWE1MjRkODFhNzBmZWNkOTVkOGUyMzBjL3RleHRyZWdpb246YjBkMDlkODUxYTUyNGQ4MWE3MGZlY2Q5NWQ4ZTIzMGNfNjA0NzMxMzk2MTQ2Nw_b7a72c41-6787-457a-a407-941a4bba5358">three</span>-month period and with annual escalation of 2.5%. The Company has the option to extend the lease term for a period of five years.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease commitments subsequent to March 31, 2021 are as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.335%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,055&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Purchase Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had contractual obligations to make $1.0 million in purchases related to cloud-based software contracts used in operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company is a party to various litigation, claims, and other legal and administrative proceedings arising in the ordinary course of business. Some of these claims, lawsuits, and other proceedings may involve highly complex issues that are subject to substantial uncertainties, and could result in damages, fines, penalties, nonmonetary sanctions, or relief. Management is not currently aware of any matters that are reasonably likely to have a material adverse impact on the Company's business, financial position, results of operations, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337281272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2017 Stock Plan and 2020 Equity Incentive Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2017, the Company adopted the 2017 Stock Plan (the "2017 Plan"). Under the 2017 Plan, the Board of Directors could grant awards, including incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock awards, RSU awards, and other stock awards to employees, directors, and consultants. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, in connection with the Merger, the Board of Directors adopted the 2020 Equity Incentive Plan (the "2020 Plan") and reserved 21,000,000 authorized shares of Class A common stock the Company could issue. In addition, up to 19,000,000 shares of Hims Class A common stock subject to awards granted under the 2017 Plan that were forfeited, expired or lapsed unexercised or unsettled could be added to the 2020 Plan reserve. Beginning on January 1, 2022 and ending on January 1, 2031, the number of authorized shares of common stock under the 2020 Plan will automatically increase by 5% of the total number of Class A and Class V common stock issued and outstanding on the last day of the preceding fiscal year unless the Board of Directors approves a lesser number. As of the effective date of the 2020 Plan, no further stock awards have been or will be granted under the 2017 Plan. During the period, 55,645 shares of Class A common stock subject to awards granted under the 2017 Plan that were outstanding on the Merger date and forfeited after the adoption of the 2020 Plan were added to the 2020 Plan reserve. Therefore, as of March&#160;31, 2021, there were 21,055,645 shares of Class A common stock reserved and 18,581,886 shares of Class A common stock available for the Company to grant under the 2020 Stock Plan; there were no more shares available for grant under the 2017 Plan (since the 2017 Plan was replaced by the 2020 Plan).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under both the 2017 Plan and 2020 Plan, stock options and stock appreciation rights are granted at exercise prices determined by the Board of Directors which cannot be less than 100% of the estimated fair market value of the common stock on the grant date. Incentive stock options granted to any stockholders holding 10% or more of the Company's equity cannot be granted with an exercise price of less than 110% of the estimated fair market value of the common stock on the grant date and such options are not exercisable after five years from the grant date. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options for new employees generally vest over four years, with 25% vesting one year after the vesting commencement date and then 1/48th of the total grant vesting monthly thereafter. Options granted to current employees generally vest 1/48th of the total grant monthly over four years. Options granted are exercisable within a period not exceeding ten years from the grant date. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;17, 2020, the Board of Directors granted 3,246,139 and 1,623,070 stock options to the CEO with an exercise price of $2.43 to vest upon either (i)&#160;an acquisition of the Company with per share consideration equal to at least $22.99 and $38.31, respectively, or (ii)&#160;a per share price on a public stock exchange that is at least equal to $22.99 and $38.31, respectively. The CEO is required to be employed at the time the per share consideration/price is achieved in order to receive the awards, but the awards are not subject to any other service condition. The Company recognizes expense related to these awards based on the fair value and derived service term as measured using a Monte Carlo simulation model, but only upon achieving the requirements outlined in (i) and (ii) above. The grant-date fair value was $16.6&#160;million for these awards. The $22.99 per share price threshold related to award for the 3,246,139 stock options was achieved in February 2021 subsequent to the Merger and, therefore, the Company recognized all $11.3 million of expense related to the grant during the three months ended March 31, 2021 due to achievement of the market condition. As of March&#160;31, 2021, there was $4.2 million of remaining compensation expense to be recognized for the remaining 1,623,070 stock options over a period of 3.04 years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, all Hims option holders received an equivalent award at an exchange ratio of 0.4530 that vest in accordance with the original terms of the award. The Company determined this to be a Type I modification but did not record any incremental stock-based compensation expense since the fair value of the modified awards immediately after the modification was not greater than the fair value of the original awards immediately before the modification.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of the Company's stock options granted was estimated using the following weighted average assumptions for the three months ended March 31, 2021:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.77</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Option activity (excluding the stock options granted to the CEO outlined above) is as follows (in&#160;thousands, except for weighted average exercise price and weighted average contractual term in years):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Contractual<br/>Period<br/>(in&#160;Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised (including early exercised options vested during the period)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited and expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,968&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.37</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant-date fair value of options granted for the three months ended March 31, 2021 was $7.34 per share and the intrinsic value of vested options exercised was $2.0 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, there was $20.5 million of unrecognized stock-based compensation related to unvested stock options excluding the CEO stock options, which is expected to be recognized over a weighted average period of 3.33 years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cash flows resulting from the tax benefits for tax deductions resulting from the exercise of stock options in excess of the compensation expense recorded for those options (excess tax benefits) are classified as a cash flow from financing activities. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to a full valuation allowance on deferred tax assets, the Company did not recognize any tax benefit from stock option exercises for the three months ended March 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Early Exercise of Common Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#8211; The Company issues shares upon the early exercise of common stock options. The unvested shares are subject to the Company's repurchase right at the lower of the fair market value of the shares of common stock on the date of repurchase or their original purchase price. The proceeds from cash exercises prior to vesting are initially recorded as a deposit liability from the early exercise of stock options and recorded within accrued liabilities on the consolidated balance sheets and reclassified to additional paid-in capital as the Company's repurchase right lapses. Unvested early exercised options are considered outstanding options and also excluded from shares exercisable since the options have been early exercised. These options are included in the option activity as exercised when the options vest. The number of unvested early exercised options were 301,893 as of March&#160;31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The options outstanding and exercisable as of March&#160;31, 2021 (excluding CEO stock options) have been aggregated into ranges for additional disclosure as follows (in&#160;thousands, except weighted average remaining contractual life and exercise price):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.316%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life&#160;(in<br/>Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life&#160;(in<br/>Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 0.06 &#8211; 0.40</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.92</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.92</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55 &#8211; 2.33</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.07</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.07</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.43 &#8211; 3.65</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.17</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.90 &#8211; 13.35</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.76</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.17 &#8211; 22.76</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.78</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,165&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSUs</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All RSUs granted prior to the Merger were subject to achievement of a liquidity event which included (i) an initial public offering, (ii) a business combination transaction, or (iii) a sale event as defined by the 2017 Plan. On January 20, 2021, the liquidity event was achieved with the closing of the Merger.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs for new employees generally vest over four years, with 25% vesting one year after the vesting commencement date on the first Company Quarterly Vesting Date (defined below) and the remaining grant vesting quarterly thereafter on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date" or collectively, "Company Quarterly Vesting Dates"). Additional RSUs granted to current employees generally vest quarterly on Company Quarterly Vesting Dates over four years.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, all Hims RSU holders received an equivalent award at an exchange ratio of 0.4530 that vest in accordance with the original terms of the award. The Company determined this to be a Type I modification but did not record any incremental stock-based compensation expense since the fair value of the modified awards immediately after the modification was not greater than the fair value of the original awards immediately before the modification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, all Hims RSU and option holders received (a) earn-out RSUs that would vest in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $15.00, $17.50 and $20.00 for any 10 trading days within any 20-trading day period, or a Company sale (as defined in the Merger Agreement) occurs and the thresholds are met on or prior to the date that is five years following the Closing Date; and (b) an allocation of Parent Warrant RSUs. All of these RSUs vest in accordance with the terms of the initial RSU and option award, in addition to any of the aforementioned requirements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The earn-out thresholds for earn-out RSUs were all met in February 2021. The earn-out awards are equity classified since they do not meet the liability classification criteria outlined in ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and are both (i) indexed to the Company's own shares and (ii) meet criteria for equity classification. The Company determined the fair value of the earn-out RSUs using a Monte Carlo simulation model. The following assumptions were used in this valuation: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:56.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.169%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The value of the Company's equity was also an input into the model and was determined based on the closing trading price of the Company's Class A common stock on the Closing Date of $16.38.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity including RSUs outstanding prior to the Merger, earn-out RSUs, and Parent Warrant RSUs is as follows (in thousands, except for weighted average grant date fair value):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,590&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the above activity are 476,308 earn-out RSUs and 9,478 Parent Warrant RSUs issued to the CEO as part of the Merger that vest in accordance with the same market conditions as the CEO stock options, of which 317,539 earn-out RSUs and 6,319 Parent Warrant RSUs vested in the period. In addition, the Company granted 45,297 RSUs in 2020 and 4,431 earn-out RSUs and 88 Parent Warrant RSUs as part of the Merger in January 2021 to a non-executive officer that vest in accordance with the achievement of revenue targets upon meeting certain revenue targets from the sale of specific products. None of the awards vested in the period. These grants are also included in the above activity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, there was unrecognized stock-based compensation related to unvested RSUs of $40.1 million, which is expected to be recognized over a weighted average period of 3.61 years.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vendor Warrants</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in stock-based compensation expense is expense for issuance of Class A common stock warrants to nonemployees in connection with vendor service arrangements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, warrant holders received (a) an equivalent warrant at an exchange ratio of 0.4530 (which was determined not to result in incremental stock-based compensation expense similar to the evaluations for stock options and RSUs above); (b) the right to receive, upon exercise, earn-out shares that vest in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $15.00, $17.50 and $20.00 for any 10 trading days within any 20-trading day period, or a Company sale (as defined in the Merger Agreement) occurs and the thresholds are met on or prior to the date that is five years following the Closing Date; and (c) the right to receive, upon exercise, an allocation of Parent Warrants. All of these instruments vest in accordance with the terms of the initial warrant in addition to any of the aforementioned requirements. The earn-out thresholds were all met in February 2021. The earn-out shares and Parent Warrants are equity classified since they do not meet the liability classification criteria.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor warrant activity, excluding any right to receive Merger considerations, is as follows (in thousands, except for weighted average exercise price and weighted average contractual term in years): </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted Average Contractual Term (in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.01</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Recapitalization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,018)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.96</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.01</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(381)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt;text-indent:9.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited and expired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.01</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Vested and expected to vest as of March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">462&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.01</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercisable as of March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">185&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.01</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the exercise of outstanding warrants above, vendors also have the right to receive 48,062 shares of Merger consideration, consisting of the holders' allocation of earn-out and Parent Warrant considerations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, there was $0.5 million of unrecognized stock-based compensation expense related to unvested vendor warrants and associated earn-out shares and Parent Warrants, which is expected to be recognized over a weighted average period of 0.48 years. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense for employees and nonemployees, by category, on the condensed consolidated statements of operations and comprehensive loss for three months ended March 31, 2021 and March&#160;31, 2020 (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337479144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityTextBlock', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text">Redeemable Convertible Preferred StockAs of December&#160;31, 2020 the Company had authorized 95,997,674 shares of Hims' convertible preferred stock, designated in series, with the rights and preferences of each designated series to be determined by the Board of Directors.<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of Hims' redeemable convertible preferred stock as of December&#160;31, 2020 (in&#160;thousands, except for share data):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.626%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Series</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Liquidation<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Proceeds,<br/>Net of<br/>Issuance&#160;Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue&#160;Price<br/>per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series Seed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,987,477&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,987,477&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0001&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,822,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,822,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A-1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,270,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,270,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B-1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,807,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,807,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B-2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,464,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,464,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,850,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,760,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,051,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,472,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,997,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,328,118&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,452&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,641&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transactions Related to Convertible Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From March&#160;to July&#160;2020, a group of investors purchased 7,472,062 shares of Hims Series D redeemable convertible preferred stock and the Company received $51.9&#160;million in net proceeds.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, all series of Hims redeemable convertible preferred stock were converted into Hims' Class A common stock on a one-for-one basis and then converted to the Company's Class A common stock at an exchange ratio of 0.4530.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warrants for Redeemable Convertible Preferred Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, in accordance with the terms outlined in March 2019, the Company issued 1,341,865 Hims Series C convertible preferred stock warrants based on 2019 revenue. The fair market value of the Hims Series C convertible preferred stock warrants was estimated using the BSM option-pricing model, and at the issuance date, fair value of the liability was $10.0&#160;million. The original liability was recorded as an issuance cost for the Hims Series C preferred stock, reducing the value of the Hims Series C proceeds within mezzanine equity on the consolidated balance sheets. Subsequent adjustments to the fair value of the Hims Series C convertible preferred stock warrants were recorded within other income (expense), net on the consolidated statements of operations and comprehensive loss. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of the Hims Series C convertible preferred stock exercised all their warrants and purchased 1,341,865 shares of Hims Series C convertible preferred stock from the Company in 2020 resulting in settlement of the Hims Series C convertible preferred stock warrant liability. The Company received less than $0.1&#160;million in net proceeds. Upon exercise, the warrant liability at an estimated fair market value of $11.3&#160;million was reclassified into convertible preferred stock on the consolidated balance sheet.</span></div>In November 2019, the Company issued 89,747 Hims Series C preferred stock warrants to TPC in connection with the 2019 Capital Agreement. The fair value of the warrants was considered debt issuance cost and recorded within prepaid and other current assets on the consolidated balance sheet. On March 12, 2020, the Company sold Hims Series D redeemable convertible preferred stock at an issuance price of $6.96, which triggered an adjustment to the TPC warrant terms per the original agreement, resulting in conversion of the previously issued 89,747 Hims Series C preferred stock warrants into 98,723 Hims Series D preferred stock warrants. Refer to Note 10 &#8211; Borrowing Arrangements for further discussion. Subsequent to the Merger, the Hims Series D preferred stock warrants were converted to Class A common stock warrants. As a result, the Hims Series D preferred stock warrants were adjusted to fair value prior to the conversion, and then settled in additional paid-in capital as a result of the conversion to equity-classified Class A common stock warrants.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_TemporaryEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_TemporaryEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409339380744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Common Stock</a></td>
<td class="text">Common StockPrior to the Merger, the Company had two classes of authorized common stock, Hims Class A common stock and Hims Class F common stock. Shares issued on early exercise are not considered outstanding for accounting purposes because the employees holding these awards are not entitled to the rewards of stock ownership.<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights of the holders of Hims Class A and Hims Class F common stock were identical, except with respect to (i) electing members of the Board of Directors and (ii) voting rights. The outstanding shares of Hims Class A and Hims Class F common stock presented on the consolidated balance sheet and on the consolidated statement of mezzanine equity and stockholders' equity (deficit) for the year ended December 31, 2020 were legally outstanding shares, including shares issued in exchange for related-party promissory notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, the Company repurchased 85,594 of unvested shares of Hims Class A common stock for a cash payment of less than $0.1&#160;million, which resulted in a reduction of deposit liability from the early exercise of stock options. In addition, in May 2020, an executive officer departed the Company, which resulted in the repurchase of 509,602 unvested shares of Hims Class A common stock in exchange for the cancellation of the principal payable of $0.9&#160;million under an associated promissory note. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pre-Closing Stock Repurchase</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 20, 2021, the Company repurchased from its stockholders and cancelled 2,207,580 shares of Hims Class A common stock, including certain stockholders who exercised outstanding stock options, for aggregate payment of $22.0&#160;million. Included within the shares repurchased was 183,548 shares of Hims Class&#160;A common stock from the net exercise of stock options as part of the pre-closing stock repurchase for $1.8&#160;million. The repurchase was recognized as a reduction of additional paid-in capital and redeemable convertible preferred stock. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merger Transaction</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to the Merger, each outstanding share of Hims' Class F common stock and preferred stock converted into Hims Class A common stock at the then-effective conversion rate. As a result of the Merger, each outstanding share of the Hims capital stock was converted into the right to receive newly issued shares of the Company's Class A common stock and certain other securities, other than the shares of Hims Class V common stock issued to its CEO immediately prior to the Closing, which were converted into the right to receive newly issued shares of the Company's Class V common stock and certain other securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Closing Date, each Hims stockholder received approximately 0.4530 shares of the Company's Class A common stock, par value $0.0001 per share, for each share of Hims Class A common stock, par value $0.000001 per share, that such stockholder owned (with the CEO receiving 0.4530 shares of the Company's Class V common stock, par value $0.0001 per share, for each share of Hims Class V common stock, par value $0.000001 per share, that the CEO owned). Each stockholder also received 0.0028 warrants exercisable for the Company's Class A common stock, for each share of Hims Class A or Class V common stock owned by such stockholder prior to the Merger and earn-out shares at an exchange ratio of 0.0443. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Settlement of Nonrecourse Related-Party Promissory Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, the obligations due under all nonrecourse related-party promissory notes were satisfied through the payment of $1.2&#160;million and the forfeiture of 370,734 shares of the Company's Class A common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PIPE Investment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concurrently with the execution of the Merger Agreement, certain investors collectively subscribed for 7,500,000 shares of the Company's Class A common stock at $10.00 per share for aggregate gross proceeds of $75.0&#160;million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class&#160;A Common Stock Warrants</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, Class A common stock warrants have been issued in connection with debt agreements (Note 10 &#8211; Borrowing Arrangements), vendor service agreements (Note 12 &#8211; Stock-Based Compensation), issuance of preferred stock (Note 13 &#8211; Redeemable Convertible</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Preferred Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and to all common stockholders and warrant holders as part of the Merger.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior to Merger</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2020, Hims Class A common stock warrants were exercised to purchase 143,452 shares of Hims Class A common stock at an exercise price of $0.06 per share. In November 2020, Hims Class A common stock warrants were exercised to purchase 425,146 and 37,244 shares of Hims Class A common stock at an exercise price of $0.06 and $1.75 per share, respectively. In December 2020, Class A common stock warrants were exercised to purchase 178,840 and 266,522 shares of Hims Class A common stock at an exercise price of $0.06 and $1.75 per share, respectively.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 4, 2021, holders of Hims Class A common stock vendor warrants exercised their warrants and purchased 380,746 shares of Hims Class A common stock at an exercise price of $1.75 per share. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsequent to Merger</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the accounting acquirer, Hims was deemed to assume 3,012,500 Class A common stock warrants that were held by Oaktree Acquisition Holdings, L.P. ("Sponsor") at an exercise price of $11.50 ("Private Placement Warrants") and 6,708,333 Class A common stock warrants held by OAC's shareholders at an exercise price of $11.50 ("Public Warrants") as well as 888,143 Class A common stock warrants that were granted to Hims' equity holders as part of the Merger. Subsequent to the Merger, the Private Placement Warrants, Public Warrants, and Parent Warrants for shares of Class&#160;A common stock meet liability classification requirements since the warrants may be required to be settled in cash under a tender offer. In addition, Private Placement Warrants are potentially subject to a different settlement amount as a result of being held by the Sponsor which precludes the Private Placement Warrants from being considered indexed to the entity's own stock. Therefore, these warrants are classified as liabilities on the condensed consolidated balance sheets.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each warrant held by Hims' stockholders that was unexercised at the time of the Merger was assumed by the Company and represents the right to receive (a) an equivalent warrant at an exchange ratio of 0.4530 (which was determined not to result in incremental expense); (b) the right to receive, upon exercise, earn-out shares that vest in equal thirds if the trading price of the Company's Class A common stock was greater than or equal to $15.00, $17.50 and $20.00 for any 10 trading days within any 20-trading day period, or a Company sale (as defined in the Merger Agreement) occurs and the thresholds are met on or prior to the date that is five years following the Closing Date; and (c) the right to receive, upon exercise, an allocation of Parent Warrants. All of these instruments vest in accordance with the terms of the initial warrant in addition to any of the aforementioned requirements. The earn-out thresholds were all met in February 2021. The earn-out shares are equity classified since they do not meet the liability classification criteria outlined in ASC 480, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Distinguishing Liabilities from Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are both (i) indexed to the Company's own shares and (ii) meet criteria for equity classification.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2021, all of the outstanding 3,012,500 Private Placement Warrants were net exercised for 1,474,145 shares of Class A common stock.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had the following warrants outstanding to purchase shares of Class&#160;A common stock (in&#160;thousands, except for share and per share amounts):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.203%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 23, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 23, 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 26, 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,695,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 22, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 20, 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 22, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 20, 2026</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Public Warrants Terms</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Public Warrants became exercisable into shares of Class A common stock upon 30 days after the Closing Date. The Public Warrants will expire at the later of five years after the completion of a business combination or upon redemption or liquidation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing 90 days after the Public Warrants become exercisable, the Company may redeem all and only all of the Public Warrants:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at $0.10 per warrant upon a minimum of 30 days' prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on the redemption date at a price equal to the average last reported sale price of the Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants;                     </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the last reported closing price of the Class A common stock equals or exceeds $10.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if there is an effective registration statement covering the Class A common stock issuable upon exercise of the warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given, or an exemption from registration is available.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company may redeem all and only all of the Public Warrants for cash:      </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at a price of $0.01 per warrant;</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">upon a minimum of 30 days' prior written notice of redemption; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the last reported closing price of the Class A common stock equals or exceeds $18.00 per share (as adjusted per share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.</span></div>If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a cashless basis, as described in the warrant agreement. Additionally, in no event will the Company be required to net cash settle.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337479144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related-Party Transactions</a></td>
<td class="text">Related-Party Transactions<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Atomic Labs, LLC ("Atomic Labs") is a related-party venture capital startup studio that launched the Company, providing initial capital and governance.  During the initial years of operation, the Company utilized operational support from Atomic Labs, primarily consisting of providing office space, conducting back-office professional services, and administering operating expenses. Additionally, an affiliated company of Atomic Labs provides professional services to the Company, primarily to support engineering and operations functions. All services were provided at cost. For both the three months ended March 31, 2021 and 2020, the Company recorded a total of $0.8 million to Atomic Labs and its affiliated company for services performed and costs incurred on behalf of the Company. There was no accounts payable balance owed to Atomic Labs and its affiliated company as of March&#160;31, 2021 or December&#160;31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, for the three months ended March 31, 2021 and 2020, the Company recorded $0.1 million and less than $0.1 million for payments made to Vouched, a related-party company that provides identity verification services. These expenses were recognized as selling, general, and administrative expenses. There was $0.1 million and less than $0.1 million of payables owed to Vouched as of March&#160;31, 2021 and December&#160;31, 2020. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nonrecourse Related-Party Promissory Notes</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company had promissory notes from certain of the Company's executive officers, as well as a founding employee and an executive chairman. The promissory notes, which were issued to the Company by the related parties as consideration for the exercise of stock options, are considered nonrecourse notes for accounting purposes. The loans are secured by the shares of Hims Class&#160;A common stock held by the individuals. There were 16,345,627 shares of Hims Class A common stock securing the related-party promissory notes as of December&#160;31, 2020. The related-party promissory notes bore interest between 2.21% and 3.02% per annum. The loans were due upon the earliest of (1)&#160;ten years from the debt issuance date, (2)&#160;a liquidation of the Company, or (3)&#160;six months following an initial public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended. Prepayment of principal and interest may be made at any time without penalty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The nonrecourse related-party promissory notes are not given accounting effect until the notes are repaid in full as the underlying stock options are not considered exercised for accounting purposes. As of December&#160;31, 2020, the total outstanding balance under these promissory notes was $7.2 million.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Merger, the obligations due under all nonrecourse related-party promissory notes were satisfied through the payment of $1.2&#160;million and the forfeiture of 370,734 shares of Hims Class A common stock. The related-party promissory notes were settled within additional paid-in capital on the condensed consolidated balance sheet.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redeemable Common Stock Transaction</span></div>On September&#160;23, 2019, the Company's&#160;CEO and a member of its Board of Directors, sold 737,058 shares of Hims Class&#160;A common stock to third party purchasers at $6.11 per share for aggregate consideration of $4.5&#160;million&#160;pursuant to Hims Class&#160;A Common Stock Purchase Agreements. Under the terms of the vendor service agreement with the third party, the purchasers were granted a put right entitling them to sell the shares to the Company at $6.11 per share for a period of six months. The put right expired on March&#160;23, 2020 without the purchasers exercising their rights to sell the shares to the Company. The Company recorded stock-based compensation expense associated with the transaction of $3.0 million. Upon expiration of the redemption right, the Company reclassified the aggregate consideration of $4.5&#160;million that was subject to redemption from mezzanine equity to stockholders' equity on the condensed consolidated balance sheet as of March&#160;31, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409338817560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Basic and Diluted Net Loss per Share</a></td>
<td class="text">Basic and Diluted Net Loss per Share<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Merger and prior to effecting the recapitalization, the Company had two classes of common stock: Hims Class A and Hims Class F common stock. The rights of the holders of Hims Class&#160;A and Hims Class&#160;F common stock were identical, including the liquidation and dividend rights, except with respect to electing members of the Board of Directors and voting rights. As the liquidation and dividend rights were identical, undistributed earnings and losses were allocated on a proportionate basis and the resulting net loss per share attributable to common stockholders was the same for both Hims Class&#160;A and Hims Class&#160;F common stock on an individual and combined basis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the Merger, the Company continues to have two classes of common stock: Class A and Class V common stock. Similar to the previous structure, the rights are identical, including liquidation and dividend rights, except Class V common stock has additional voting rights. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the two-class method to calculate net loss per share. No dividends were declared or paid for the three months ended March 31, 2021 or 2020. Undistributed earnings for each period are allocated to participating securities, including the redeemable convertible preferred stock, based on the contractual participation rights of the security to share in the current earnings as if all current period earnings had been distributed. As there is no contractual obligation for the redeemable convertible preferred stock to share in losses, the Company's basic net loss per share is computed by dividing the net loss attributable to common stockholders by the weighted average shares of common stock outstanding during periods with undistributed losses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of the Company's basic and diluted net loss per share attributable to common stockholders for the three months ended March 31 (in&#160;thousands, except share and per share amounts):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class&#160;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class V</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class&#160;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class&#160;F</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,471,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,609,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,668,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,941,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net loss per share attributable to common stockholders is the same for the three months ended March 31, 2021 and 2020, because the inclusion of potential shares of common stock would have been anti-dilutive for the periods presented. There were no redeemable shares during the three months ended March&#160;31, 2021. During the three months ended March 31, 2020, weighted average Hims Class A common shares presented excludes 664,162 shares subject to redemption. These shares do not absorb losses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses securities that could potentially dilute basic net loss per share in the future that were not included in the computation of diluted net loss per share:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for exercise of stock options subject to nonrecourse promissory notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,855,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for early exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,702,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,510,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,361,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,969,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,347,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase Class&#160;A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,733,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409338815160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Tax</a></td>
<td class="text">Income Tax<span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was -0.2% and -0.6% </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the three months ended March 31, 2021 and 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The effective tax rate differs from the U.S. federal rate primarily due to the impacts of the valuation allowance placed on the Company's deferred tax assets and state minimum taxes.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409345407576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Principles of Consolidation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to accounting principles generally accepted in the United States of America ("U.S. GAAP").</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements as of March&#160;31, 2021 are unaudited. The condensed consolidated balance sheet as of December&#160;31, 2020, included herein was derived from the audited consolidated financial statements as of that date. Certain information and note disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. As such, the information included herein should be read in conjunction with the consolidated financial statements and accompanying notes as of and for the year ended December&#160;31, 2020 (the "audited consolidated financial statements").</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited condensed consolidated financial statements have been prepared on the same basis as the audited consolidated financial statements and reflect, in management's opinion, all adjustments of a normal, recurring nature that are necessary for the fair statement of the Company's balance sheet, results of operations, and cash flows for the three-month periods, but are not necessarily indicative of the results expected for the full fiscal year or any other period.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">The unaudited condensed consolidated financial statements include the accounts of the Company, its wholly owned subsidiaries, and variable interest entities in which it holds a controlling financial interest. All intercompany transactions and balances have been eliminated in these condensed consolidated financial statements.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The more significant estimates and assumptions by management include, among others, valuation of inventory, valuation and recognition of stock-based compensation expense, valuation and recognition of warrants, and estimates in capitalization of website development and internal-use software costs. Management believes that the estimates and judgments upon which it relies, are reasonable based upon information available to it at the time that these estimates and judgments were made. Actual results experienced by the Company may differ from management's estimates. To the extent that there are material differences between these estimates and actual results, the Company's condensed consolidated financial statements will be affected.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt instruments with original maturities at the date of purchase greater than three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with original maturities at the date of purchase and remaining maturities of greater than one year are classified as long-term investments. The Company intends to sell such investments at or close to maturity.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The investments, if any, are designated as available-for-sale and are reported at fair value, with unrealized gains and losses, net of tax, recorded in other comprehensive income on the consolidated statements of operations and comprehensive loss, except as noted in the Other-Than-Temporary Impairment section that follows. The Company determines the cost of the investment sold based on specific identification at the individual security level. The Company records the interest income and realized gains and losses on the sale of these instruments within other (expense) income, net on the condensed consolidated statements of operations and comprehensive loss.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock', window );">Other-Than-Temporary Impairment</a></td>
<td class="text">The Company's investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment's adjusted cost basis. This would occur for marketable debt instruments when the fair value is below amortized cost and the Company intends to sell the instrument, when it is more likely than not that the Company will be required to sell the instrument before recovery of its amortized cost basis, or when the Company does not expect to recover the entire amortized cost basis of the instrument (a credit loss exists). When the Company does not expect to recover the entire amortized cost basis of the instrument, it separates other-than-temporary impairments into amounts representing credit losses, which are recognized in other (expense) income, net, and amounts related to all other factors, which are recognized in other comprehensive (loss) income on the condensed consolidated statements of operations and comprehensive loss.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text">Inventory primarily consists of finished goods and raw materials that are located at Company-managed and third-party fulfillment warehouses. Inventory is stated at the lower of cost and net realizable value and inventory cost is determined by the weighted average cost method. The Company reserves for expired, slow-moving, and excess inventory by estimating the net realizable value based on the potential future use of such inventory. Management monitors inventory to identify events that would require impairment due to slow-moving, expired, or obsolete inventory and reduces the value of inventory when required. Obsolete inventory balances are written off against the inventory allowance when management determines that the inventory cannot be sold.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue in accordance with Accounting Standards Codification Topic ("ASC") 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when it transfers promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.</span>The Company's consolidated revenue primarily comprises of online sales of health and wellness products through the Company's website, including prescription and nonprescription products. In contracts that contain prescription products, revenue also includes medical consultation services.<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For online revenue, the Company defines its customer as an individual who purchases products or services through the website. For wholesale revenue, Company defines its customer as a wholesale partner. The transaction price in the Company's contracts with customers is the total amount of consideration to which the Company expects to be entitled in exchange for transferring products or services to the customer.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts that contain prescription products include two performance obligations: access to (i)&#160;products and (ii)&#160;consultation services. The Company's contracts that do not contain prescription products have a single performance obligation. Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised product to the customer and, in contracts that contain services, by the provision of consultation services to the customer. The Company satisfies its performance obligation for products at a point in time, which is upon delivery of the products to a third-party carrier. The Company satisfies its performance obligation for services over the period of the consultation service, which is typically a few days. The customer obtains control of the products and services upon the Company's completion of its performance obligations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For contracts with multiple performance obligations, the transaction price is allocated to each performance obligation on a relative stand-alone selling price basis. The stand-alone selling price is based on the prices at which the Company separately sells the products and services, as well as market and cost plus margin-based estimates. For each of the three months ended March 31, 2021 and 2020, service revenue represented less than 10% of consolidated revenues.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To fulfill its promise to customers for contracts that include professional medical consultations, the Company maintains relationships with various "Affiliated Medical Groups", which are professional corporations or other professional entities owned by licensed physicians and other professional entities that engage licensed healthcare professionals (medical doctors, physician assistants, nurse practitioners, and mental health providers; collectively referred to as "Providers" or individually, a "Provider") to provide consultation services. Refer to Note 8 &#8211; Variable Interest Entities. The Company accounts for service revenue as a principal in the arrangement with its customers. This conclusion is reached because (i) the Company determines which Affiliated Medical Group and Provider provides the consultation to the customer; (ii) the Company is primarily responsible for the satisfactory fulfillment and acceptability of the services; (iii) the Company incurs costs for consultation services even for visits that do not result in a prescription and the sale of products; and (iv) the Company, at its sole discretion, sets all listed prices charged on its websites for products and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, to fulfill its promise to customers for contracts that include professional medical consultations, the Company maintains relationships with affiliated and third-party pharmacies ("Partner Pharmacies" or individually, a "Partner Pharmacy") to fill prescriptions that are ordered by the Company's customers. The Company accounts for prescription product revenue as a principal in the arrangement with its customers. This conclusion is reached because (i) the Company has sole discretion in determining which Partner Pharmacy fills a customer's prescription; (ii) Partner Pharmacies fill the prescription based on fulfillment instructions provided by the Company, including using the Company's branded packaging for generic products; (iii) the Company is primarily responsible to the customer for the satisfactory fulfillment and acceptability of the order; (iv) the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company is responsible for refunds of the prescription medication after transfer of control to the customer; and (v) the Company, at its sole discretion, sets all listed prices charged on its website for products and services.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates refunds using the expected value method based on historical refunds granted to customers. The Company updates its estimate at the end of each reporting period and recognizes the estimated amount as contra-revenue with a corresponding refund liability. Sales, value-added, and other taxes are excluded from the transaction price and, therefore, from revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has made an accounting policy election to account for shipping and handling activities performed after the control of a product has been transferred to the customer as fulfillment costs, with direct costs to ship products to customers included in cost of revenue. The Company's contracts with customers do not contain costs to obtain or costs to fulfill contracts with customers in accordance with ASC 340-40, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs&#8212;Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For online sales, payment for prescription medication and nonprescription products is typically collected from the customer a few days in advance of product shipment. Contract liabilities are recorded when payments have been received from the customer for undelivered products or services and are recognized as revenue when the performance obligations are later satisfied. Contract liabilities consisting of balances related to customer prepayments are recognized as current deferred revenue on the condensed consolidated balance sheets since the associated revenue will be primarily recognized within the following period. For wholesale arrangements, payments are collected in accordance with contract terms.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-based Compensation</a></td>
<td class="text">The fair value of stock options, equity-classified warrants issued to vendors, and restricted stock units ("RSUs"), are measured at the grant date fair value. The fair value of employee stock options and vendor warrants are generally determined using the Black-Scholes Merton ("BSM") option-pricing model using various inputs, including estimates of expected volatility, term, risk-free rate, and future dividends. Stock options that were granted to the Company's Chief Executive Officer ("CEO") with performance and market conditions and earn-out RSUs were valued using the Monte Carlo simulation model. The Company recognizes compensation costs on a straight-line basis over the requisite service period of the employee and vendor, which is generally the option vesting term of four years for options and warrants that do not have performance or market conditions. Stock options and RSUs with performance conditions are recognized when it is probable that performance criteria will be achieved and compensation cost is recognized using the accelerated attribution method. The Company accounts for forfeitures as they occur.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_WarrantLiabilityPolicyPolicyTextBlock', window );">Warrant Liabilities</a></td>
<td class="text">The Company classifies Private Placement Warrants and Public Warrants (both defined and discussed in Note 14 &#8211; Common Stock) as liabilities in addition to warrants to purchase preferred stock. At the end of each reporting period, changes in fair value during the period are recognized as a component of other (expense) income, net within the consolidated statements of operations and comprehensive loss. The Company will continue to adjust the warrant liability for changes in the fair value until the earlier of a) the exercise or expiration of the warrants or b) the redemption of the warrants, at which time the warrants will be reclassified to additional paid-in capital.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text">The Company currently leases a warehouse facility and previously leased office space under noncancelable lease agreements that are accounted for as operating leases. Rent expense is recorded on a straight-line basis over the lease term. For rent abatement and rent escalation provisions, the Company recognizes the related rent expense on a straight-line basis over the lease term. The difference between cash rent payments and the recognition of straight-line rent expense is recorded as deferred rent and amortized over the lease term.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the Financial Accounting Standards Board ("FASB") issued ASU 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which amends ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU modifies the disclosure requirements for fair value measurements by removing, modifying, or adding certain disclosures. The standard is effective for public companies for annual periods beginning after December 15, 2019, with early adoption permitted </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for removed disclosures and delayed adoption until fiscal year 2020 permitted for the new disclosures. The Company adopted this disclosure requirement for the year ended December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February&#160;2016, the FASB issued ASU 2016-02, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires lessees to recognize leases on their balance sheets and disclose key information about leasing arrangements. The ASU establishes a right-of-use ("ROU") model that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition on the income statement. The standard is effective for smaller reporting companies for annual periods beginning after December&#160;15, 2021 and for interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. In July&#160;2018, the FASB approved an amendment to the new guidance that allows companies the option of using the effective date of the new standard as the initial application (at the beginning of the period in which it is adopted, rather than at the beginning of the earliest comparative period) and to recognize the effects of applying the new ASU as a cumulative effect adjustment to the opening balance sheet or retained earnings. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to require the measurement of expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. The guidance also amended the impairment model for available-for-sale debt securities and requires entities to determine whether all or a portion of the unrealized loss on such debt security is a credit loss. In November 2018, ASU 2018-19 was issued which aligns the implementation date for nonpublic entities' annual financial statements with the implementation date for their interim financial statements and clarifies the scope of the guidance in the amendments in ASU 2016-13 to clarify that receivables arising from operating leases are not within the scope of Credit Losses (Topic 326) and should be accounted for in accordance with Leases (Topic 842). In April 2019, the FASB issued ASU 2019-04 which, among other amendments, allows for certain policy elections and practical expedients related to accrued interest on financial instruments. In November 2019, the FASB issued ASU 2019-10 and ASU 2019-11, which addressed certain aspects of the guidance related to effective dates, expected recoveries, troubled debt restructurings, accrued interest receivables, and financial assets secured by collateral. In February and March 2020, the FASB also issued ASU 2020-02 and ASU 2020-03, respectively, which provide certain amendments and improvements to sections of ASU 2016-13. These standards are effective for smaller reporting companies for annual and interim periods beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which is intended to improve consistency and simplify several areas of existing guidance. ASU 2019-12 removes certain exceptions to the general principles related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. ASU 2019-12 is effective for annual periods beginning after December 15, 2020 for public entities, including interim periods within those fiscal years. The standard is effective for nonpublic companies for annual periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and as an emerging growth company ("EGC"), has elected to adopt the pronouncement following the effective date for nonpublic companies. The Company does not expect adoption will have a material impact on the Company's consolidated financial statements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the FASB issued ASU 2020-10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance includes amendments to improve the codification by ensuring that all guidance that requires or provides an option for an entity to provide information in the notes to the financial statements is codified in the disclosure section of the codification and to clarify guidance so that entities can apply guidance more consistently on codifications that are varied in nature where the original guidance may have been unclear. ASU 2020-10 is effective for annual periods beginning after December 15, 2020 for public entities, including interim periods within those fiscal years. The standard is effective for nonpublic companies for annual periods beginning after December 15, 2021 and interim periods within fiscal years beginning after December 15, 2022, with early adoption permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements and as an EGC, has elected to adopt the pronouncement following the effective date for nonpublic companies.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other-Than-Temporary Impairment On Investments, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_WarrantLiabilityPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrant Liability, Policy</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_WarrantLiabilityPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337436488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue consists of the following (in&#160;thousands): </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended<br/>March 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Online</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,680&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,524&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wholesale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,314&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,063&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337578760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments as of March&#160;31, 2021, consist of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,273&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,221&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,924&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,156&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,097&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments as of December&#160;31, 2020, consist of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjusted<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,224&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,227&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,859&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,864&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409348946504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory, Current</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consists of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,546&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">977&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,523&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,543&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337528664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock', window );">Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets consist of the following (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">942&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,691&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total prepaid expenses and other current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,407&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337523736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consist of the following (in&#160;thousands):</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,122&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,480&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax payables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">729&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant exercise deposit liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">387&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Total accrued liabilities </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,823&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,984&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409355597048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis as of March&#160;31, 2021, is as follows (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,786&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">246,179&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,965&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's fair value hierarchy for its financial assets and liabilities that are measured at fair value on a recurring basis as of December&#160;31, 2020, is as follows (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,557&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,726&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions</a></td>
<td class="text">The following assumptions were used for the valuation of the Private Placement Warrants on the settlement date:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table>The following assumptions were used in this valuation: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:56.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.169%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in the fair value of warrant liabilities is as follows (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of Series D preferred stock warrants to Class A common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,160)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private Placement Warrants and Public Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,814&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,871)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in fair value of warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,370&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409338574952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock', window );">Schedule of Future Minimum Rental Payments for Operating Leases</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease commitments subsequent to March 31, 2021 are as follows (in thousands):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:76.465%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.335%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,559&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,638&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,055&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409340292184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of the Company's stock options granted was estimated using the following weighted average assumptions for the three months ended March 31, 2021:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.77</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58.87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Option activity (excluding the stock options granted to the CEO outlined above) is as follows (in&#160;thousands, except for weighted average exercise price and weighted average contractual term in years):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Exercise<br/>Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Contractual<br/>Period<br/>(in&#160;Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Intrinsic<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,459&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,474)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,985&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.50</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised (including early exercised options vested during the period)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(384)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited and expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding at March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and expected to vest as of March 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,968&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.37</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,556&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,165&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock', window );">Share-based Payment Arrangement, Option, Exercise Price Range</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The options outstanding and exercisable as of March&#160;31, 2021 (excluding CEO stock options) have been aggregated into ranges for additional disclosure as follows (in&#160;thousands, except weighted average remaining contractual life and exercise price):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.316%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Options Exercisable</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life&#160;(in<br/>Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Remaining<br/>Contractual<br/>Life&#160;(in<br/>Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$ 0.06 &#8211; 0.40</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,236&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.92</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.92</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.55 &#8211; 2.33</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,368&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.07</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.07</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.43 &#8211; 3.65</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,298&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.17</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.17</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.90 &#8211; 13.35</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.76</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.75</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.17 &#8211; 22.76</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.78</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,165&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions</a></td>
<td class="text">The following assumptions were used for the valuation of the Private Placement Warrants on the settlement date:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.16</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.00&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table>The following assumptions were used in this valuation: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.269%"><tr><td style="width:1.0%"/><td style="width:56.042%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.169%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.00</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Share-based Payment Arrangement, Restricted Stock Unit, Activity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU activity including RSUs outstanding prior to the Merger, earn-out RSUs, and Parent Warrant RSUs is as follows (in thousands, except for weighted average grant date fair value):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.660%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.578%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.148%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,480&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.30&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recapitalization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,904)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,804&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(790)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,590&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.16&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Share-based Payment Arrangement, Expensed and Capitalized, Amount</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock-based compensation expense for employees and nonemployees, by category, on the condensed consolidated statements of operations and comprehensive loss for three months ended March 31, 2021 and March&#160;31, 2020 (in&#160;thousands):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.545%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.547%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,846&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general, and administrative</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,384&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Share-based Payment Arrangement, Activity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vendor warrant activity, excluding any right to receive Merger considerations, is as follows (in thousands, except for weighted average exercise price and weighted average contractual term in years): </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.028%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Weighted Average Contractual Term (in Years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.79</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.01</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Recapitalization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(1,018)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">0.96</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">843&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.01</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">9,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;text-indent:9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(381)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt;text-indent:9.35pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Forfeited and expired</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Outstanding at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.01</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Vested and expected to vest as of March 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">462&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.75</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.01</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">5,308&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exercisable as of March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">185&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">1.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">7.01</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;text-indent:2.9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">2,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337529784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Temporary Equity</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table is a summary of Hims' redeemable convertible preferred stock as of December&#160;31, 2020 (in&#160;thousands, except for share data):</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.626%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Series</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate<br/>Liquidation<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Proceeds,<br/>Net of<br/>Issuance&#160;Costs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue&#160;Price<br/>per&#160;Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series Seed</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,987,477&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,987,477&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0001&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,822,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,822,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,621&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series A-1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,270,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,270,590&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B-1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,807,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,807,952&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,965&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series B-2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,464,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,464,939&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series C</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,850,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,760,594&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Series D</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,051,872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,472,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,997,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,328,118&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268,452&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238,641&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337265880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company had the following warrants outstanding to purchase shares of Class&#160;A common stock (in&#160;thousands, except for share and per share amounts):</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.203%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant Type</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160;&#160;&#160;&#160; &#160;&#160;&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise&#160;Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issued</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vendor</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 23, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 23, 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 12, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 26, 2026</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,695,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 22, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 20, 2026</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">888,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 22, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 20, 2026</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409338599496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of the Company's basic and diluted net loss per share attributable to common stockholders for the three months ended March 31 (in&#160;thousands, except share and per share amounts):</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class&#160;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class V</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class&#160;A</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class&#160;F</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to common stockholders</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,219)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,823)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">146,471,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,609,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,668,709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,941,352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.34)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.17)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table discloses securities that could potentially dilute basic net loss per share in the future that were not included in the computation of diluted net loss per share:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for exercise of stock options subject to nonrecourse promissory notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,545,821&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,855,230&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock issued for early exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">388,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154,820&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,702,603&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,510,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,361,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,969,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,347,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase Class&#160;A common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,733,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,895,345&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,433,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337461128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Organization (Details)<br></strong></div></th>
<th class="th"><div>Jan. 20, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">0.4530<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409345597240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfInvestments', window );">Other than temporary impairment losses, investments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409344937816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 52,314<span></span>
</td>
<td class="nump">$ 30,063<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Online</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">50,680<span></span>
</td>
<td class="nump">28,524<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Wholesale</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,634<span></span>
</td>
<td class="nump">$ 1,539<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409262234344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Recapitalization (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="6"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 19, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired', window );">Reverse recapitalization, percentage of voting interests acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfCommonStockRecapitalization', window );">Proceeds from issuance of common stock, recapitalization | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 197,686<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationTransactionCosts', window );">Reverse recapitalization, deferred transaction costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseCapitalizationContingentConsiderationEquityShares', window );">Reverse recapitalization, contingent consideration, equity (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger one (in dollars per share)</a></td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger two (in dollars per share)</a></td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger three (in dollars per share)</a></td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays', window );">Reverse recapitalization, contingent consideration, equity, earnout period, threshold trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod', window );">Reverse recapitalization, contingent consideration, equity, earnout period, threshold trading day period | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod', window );">Reverse recapitalization, contingent consideration, equity, earnout period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of warrant or right, number of securities called by each warrant or right (in shares) | shares</a></td>
<td class="nump">0.0028<span></span>
</td>
<td class="nump">0.0028<span></span>
</td>
<td class="nump">0.0028<span></span>
</td>
<td class="nump">0.0028<span></span>
</td>
<td class="nump">0.0028<span></span>
</td>
<td class="nump">0.0028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantRestrictedStockUnitsMember', window );">Parent Warrant Restricted Stock Units | Hims' Option And RSU Holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares) | shares</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassAAndVMember', window );">Common Class A and V | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationContingentConsiderationEquityExchangeRatio', window );">Recapitalization, contingent consideration, equity, exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A | Hims, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.000001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A | Parent Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares) | shares</a></td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A | Parent Warrants | Hims' Stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares) | shares</a></td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A | Parent Warrants | Hims' Warrant Holders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares) | shares</a></td>
<td class="nump">3,443<span></span>
</td>
<td class="nump">3,443<span></span>
</td>
<td class="nump">3,443<span></span>
</td>
<td class="nump">3,443<span></span>
</td>
<td class="nump">3,443<span></span>
</td>
<td class="nump">3,443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember', window );">Common Class V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember', window );">Common Class V | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember', window );">Common Class V | Hims, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.000001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember', window );">PIPE Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationLineItems', window );"><strong>Reverse Recapitalization [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="nump">$ 10.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ProceedsFromIssuanceOfCommonStockRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Common Stock, Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ProceedsFromIssuanceOfCommonStockRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationContingentConsiderationEquityExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization, Contingent Consideration, Equity, Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationContingentConsiderationEquityExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Capitalization, Contingent Consideration, Equity, Earnout Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseCapitalizationContingentConsiderationEquityShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Capitalization, Contingent Consideration, Equity, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseCapitalizationContingentConsiderationEquityShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Day Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Percentage Of Voting Interests Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=hims_HimsOptionAndRSUHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=hims_HimsOptionAndRSUHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassAAndVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_CommonClassAAndVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hims_HimsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hims_HimsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=hims_HimsStockholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=hims_HimsStockholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=hims_HimsWarrantHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=hims_HimsWarrantHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409349391384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Short-term Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">$ 235,156<span></span>
</td>
<td class="nump">$ 72,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">235,097<span></span>
</td>
<td class="nump">72,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">177,273<span></span>
</td>
<td class="nump">55,224<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">177,221<span></span>
</td>
<td class="nump">55,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember', window );">Government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">40,955<span></span>
</td>
<td class="nump">14,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">40,952<span></span>
</td>
<td class="nump">14,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesLineItems', window );"><strong>Marketable Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Adjusted Cost</a></td>
<td class="nump">16,928<span></span>
</td>
<td class="nump">3,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized Losses</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 16,924<span></span>
</td>
<td class="nump">$ 3,514<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentAgenciesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409355457256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Inventory</a></td>
<td class="nump">$ 3,546<span></span>
</td>
<td class="nump">$ 2,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">977<span></span>
</td>
<td class="nump">687<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 4,523<span></span>
</td>
<td class="nump">$ 3,543<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409351429320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Prepaid Expenses and Other Current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TradeAndOtherReceivablesCurrent', window );">Trade and other receivables, net</a></td>
<td class="nump">$ 942<span></span>
</td>
<td class="nump">$ 1,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">8,650<span></span>
</td>
<td class="nump">2,691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_VendorDepositsCurrent', window );">Vendor deposits</a></td>
<td class="nump">2,810<span></span>
</td>
<td class="nump">1,395<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid expenses and other current assets</a></td>
<td class="nump">$ 12,407<span></span>
</td>
<td class="nump">$ 5,404<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_TradeAndOtherReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trade And Other Receivables, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_TradeAndOtherReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_VendorDepositsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Vendor Deposits, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_VendorDepositsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409345072456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract', window );"><strong>Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedMarketingCostsCurrent', window );">Marketing expenses</a></td>
<td class="nump">$ 1,514<span></span>
</td>
<td class="nump">$ 1,122<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional services</a></td>
<td class="nump">1,480<span></span>
</td>
<td class="nump">1,241<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_AccruedPayrollCostsCurrent', window );">Payroll costs</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Tax payables</a></td>
<td class="nump">729<span></span>
</td>
<td class="nump">651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositLiabilityCurrent', window );">Warrant exercise deposit liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">387<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued liabilities</a></td>
<td class="nump">$ 5,823<span></span>
</td>
<td class="nump">$ 4,984<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_AccruedPayrollCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Payroll Costs, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_AccruedPayrollCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedMarketingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedMarketingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion, due within one year or one operating cycle, if longer, of deposits held other than customer deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409351557784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Variable Interest Entities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 340,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,084<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">345,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">118,697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">19,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,228<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">53,434<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (51,404)<span></span>
</td>
<td class="num">$ (6,033)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=hims_AffiliatedMedicalGroupsMember', window );">Affiliated Medical Groups</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_PercentageOwnedByLicensedPhysicians', window );">Percentage owned by licensed physicians</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Assets</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Liabilities</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary | Consolidation, Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliers', window );">Payments to suppliers</a></td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_PercentageOwnedByLicensedPhysicians">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage Owned By Licensed Physicians</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_PercentageOwnedByLicensedPhysicians</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments of cash to suppliers for goods and services during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hims_AffiliatedMedicalGroupsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hims_AffiliatedMedicalGroupsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=srt_ConsolidationEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=srt_ConsolidationEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409339093736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Assets and Liabilities (Details) - Fair Value, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">$ 321,965<span></span>
</td>
<td class="nump">$ 98,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Warrant liabilities</a></td>
<td class="nump">33,370<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">33,370<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">40,952<span></span>
</td>
<td class="nump">14,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">177,221<span></span>
</td>
<td class="nump">55,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Asset-backed bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">16,924<span></span>
</td>
<td class="nump">3,514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">74,930<span></span>
</td>
<td class="nump">12,163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">11,082<span></span>
</td>
<td class="nump">12,693<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">75,786<span></span>
</td>
<td class="nump">13,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Warrant liabilities</a></td>
<td class="nump">33,370<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">33,370<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Asset-backed bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">74,930<span></span>
</td>
<td class="nump">12,163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level&#160;1 | Government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">246,179<span></span>
</td>
<td class="nump">85,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">40,952<span></span>
</td>
<td class="nump">14,123<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">177,221<span></span>
</td>
<td class="nump">55,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Asset-backed bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">16,924<span></span>
</td>
<td class="nump">3,514<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2 | Government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">11,082<span></span>
</td>
<td class="nump">12,693<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Corporate bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Asset-backed bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3 | Government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateBondSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409340162440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease', window );">Increase in fair value of warrants | $</a></td>
<td class="nump">$ 0.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 4.40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409341412072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assumptions of Private Placement Warrants (Details) - Private Placement Warrants<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">1 month 28 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.03%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409337417208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Change in the Fair Value of Warrant Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at December 31, 2020</a></td>
<td class="nump">$ 906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization', window );">Conversion of Series D preferred stock warrants to Class A common stock warrants</a></td>
<td class="num">(1,160)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues', window );">Private Placement Warrants and Public Warrants</a></td>
<td class="nump">51,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Exercised warrants</a></td>
<td class="num">(20,871)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Increase in fair value of warrants</a></td>
<td class="nump">2,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Balance at March 31, 2021</a></td>
<td class="nump">$ 33,370<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reverse Recapitalization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409349679944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowing Arrangements (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Mar. 12, 2020</div></th>
<th class="th"><div>Feb. 29, 2020</div></th>
<th class="th"><div>Nov. 30, 2019</div></th>
<th class="th"><div>Nov. 27, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, noncurrent</a></td>
<td class="nump">$ 856,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,006,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesCPreferredStockWarrantsMember', window );">Series C Preferred Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number securities called by warrants or rights (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,747<span></span>
</td>
<td class="nump">1,341,865<span></span>
</td>
<td class="nump">89,747<span></span>
</td>
<td class="nump">89,747<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesDPreferredStockWarrantsMember', window );">Series D Preferred Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number securities called by warrants or rights (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hims_BusinessCreditCardMember', window );">Business Credit Card | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_DebtInstrumentCovenantRequiredCollateralAmount', window );">Debt instrument, covenant, required collateral amount</a></td>
<td class="nump">200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hims_CapitalAgreement2019Member', window );">Capital Agreement, 2019 | Notes Payable, Other Payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_DebtInstrumentMaximumBorrowingCapacity', window );">Debt instrument, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtLongtermAndShorttermCombinedAmount', window );">Debt, long-term and short-term, combined amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hims_CapitalAgreement2019TrancheOneMember', window );">Capital Agreement, 2019, Tranche One | Notes Payable, Other Payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_DebtInstrumentMaximumBorrowingCapacity', window );">Debt instrument, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hims_CapitalAgreement2019TrancheTwoMember', window );">Capital Agreement, 2019, Tranche Two | Notes Payable, Other Payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_DebtInstrumentMaximumBorrowingCapacity', window );">Debt instrument, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit | Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit facility, maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_DebtInstrumentCovenantRequiredCollateralAmount', window );">Debt instrument, covenant, required collateral amount</a></td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash, noncurrent</a></td>
<td class="nump">$ 800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_DebtInstrumentCovenantRequiredCollateralAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Required Collateral Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_DebtInstrumentCovenantRequiredCollateralAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_DebtInstrumentMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Maximum Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_DebtInstrumentMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtLongtermAndShorttermCombinedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate of total long-term debt, including current maturities and short-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtLongtermAndShorttermCombinedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesCPreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesCPreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesDPreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesDPreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hims_BusinessCreditCardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hims_BusinessCreditCardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hims_CapitalAgreement2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hims_CapitalAgreement2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hims_CapitalAgreement2019TrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hims_CapitalAgreement2019TrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hims_CapitalAgreement2019TrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hims_CapitalAgreement2019TrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409345095288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseAndRentalExpense', window );">Operating leases, rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_OperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">63 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Operating leases, future minimum payments due</a></td>
<td class="nump">$ 7,900<span></span>
</td>
<td class="nump">7,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement', window );">Lessee, operating lease, period for payments net of rent abatement</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_OperatingLeaseRentExpenseAnnualEscalationPercent', window );">Rent expense, annual escalation, percent</a></td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_OperatingLeaseRenewalTerm', window );">Operating lease, renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Purchase obligation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hims_NewAlbanyOhioMember', window );">New Albany, Ohio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfRealEstateProperty', window );">Area of real estate property | ft&#178;</a></td>
<td class="nump">302,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Period For Payments Net Of Rent Abatement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_OperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Renewal Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_OperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_OperatingLeaseRentExpenseAnnualEscalationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Rent Expense, Annual Escalation, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_OperatingLeaseRentExpenseAnnualEscalationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_OperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Term Of Contract</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_OperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfRealEstateProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of a real estate property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfRealEstateProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseAndRentalExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseAndRentalExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hims_NewAlbanyOhioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hims_NewAlbanyOhioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409345589448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitment and Contingencies - Future Minimum Lease Commitments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear', window );">2021</a></td>
<td class="nump">$ 1,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears', window );">2022</a></td>
<td class="nump">1,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears', window );">2023</a></td>
<td class="nump">1,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears', window );">2024</a></td>
<td class="nump">1,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears', window );">2025</a></td>
<td class="nump">1,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue', window );">Total</a></td>
<td class="nump">$ 7,055<span></span>
</td>
<td class="nump">$ 7,900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121573735&amp;loc=d3e41502-112717<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 10<br> -Section 55<br> -Paragraph 40<br> -Subparagraph (Note 3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121580752&amp;loc=d3e38371-112697<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409262233576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - 2017 Stock Plan and 2020 Equity Incentive Plan (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hims_EquityIncentivePlan2020And2017StockPlanMember', window );">2020 Equity Incentive Plan and 2017 Stock Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hims_EquityIncentivePlan2020And2017StockPlanMember', window );">2020 Equity Incentive Plan and 2017 Stock Plan | Minimum | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent', window );">Stockholders equity ownership, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hims_EquityIncentivePlan2020And2017StockPlanMember', window );">2020 Equity Incentive Plan and 2017 Stock Plan | Minimum | Stock Options and Stock Appreciation Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hims_EquityIncentivePlan2020Member', window );">2020 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Common stock, capital shares reserved for future issuance</a></td>
<td class="nump">21,000,000<span></span>
</td>
<td class="nump">21,055,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock', window );">Percentage increase in authorized shares of common stock</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,581,886<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hims_StockPlan2017Member', window );">Stock Plan, 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Number of additional shares authorized (in shares)</a></td>
<td class="nump">19,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans', window );">Number of authorized shares transferred between plans (in shares)</a></td>
<td class="nump">55,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Authorized Shares Transferred Between Plans</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Annual Increase In Authorized Shares Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Stockholders Equity Ownership, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hims_EquityIncentivePlan2020And2017StockPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hims_EquityIncentivePlan2020And2017StockPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hims_EquityIncentivePlan2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hims_EquityIncentivePlan2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hims_StockPlan2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hims_StockPlan2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409258301720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock Options Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 17, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jan. 20, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,230,000<span></span>
</td>
<td class="nump">$ 1,404,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of exercises during period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions', window );">Share-based payment arrangement, exercise of option, tax benefit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares', window );">Early exercises of nonvested options (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">301,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue', window );">Grant date fair value</a></td>
<td class="nump">$ 16,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of vested stock options (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,246,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Share-based payments arrangement, nonvested award, option, cost not yet recognized, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,623,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | June 17, 2020 Grant One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Award granted (in shares) | shares</a></td>
<td class="nump">3,246,139<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Awards granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold', window );">Acquisition with shares consideration threshold (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 22.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | June 17, 2020 Grant Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Award granted (in shares) | shares</a></td>
<td class="nump">1,623,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Awards granted (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold', window );">Acquisition with shares consideration threshold (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 38.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember', window );">Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Share-based payments arrangement, nonvested award, option, cost not yet recognized, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Chief Executive Officer | June 17, 2020 Grant One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | New Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage', window );">Award vesting rights, monthly percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.083%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | New Employee | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Awards vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Current Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage', window );">Award vesting rights, monthly percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.083%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 3 months 29 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Acquisition With Share Consideration Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Early Exercises, Number Of Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Award, Award Vesting Rights, Monthly Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=hims_June172020GrantOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=hims_June172020GrantOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=hims_June172020GrantTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=hims_June172020GrantTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=hims_ShareBasedPaymentArrangementNewEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=hims_ShareBasedPaymentArrangementNewEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=hims_ShareBasedPaymentArrangementCurrentEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=hims_ShareBasedPaymentArrangementCurrentEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409339979592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Weighted Average Fair Value Assumptions (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years 9 months 7 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">58.87%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.83%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409339061640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Option Activity (Details) - Employee, excluding CEO - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">11,985<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">423<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(384)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Forfeited and expired (in shares)</a></td>
<td class="num">(56)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">11,968<span></span>
</td>
<td class="nump">11,985<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at the end of the period (in shares)</a></td>
<td class="nump">11,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at the end of the period (in shares)</a></td>
<td class="nump">11,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 2.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">13.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">0.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited and expired (in dollars per share)</a></td>
<td class="nump">1.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">3.02<span></span>
</td>
<td class="nump">$ 2.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest at the end of the period (in dollars per share)</a></td>
<td class="nump">3.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end of the period (in dollars per share)</a></td>
<td class="nump">$ 2.64<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Contractual Period (in&#160;Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding balance (in years)</a></td>
<td class="text">8 years 4 months 13 days<span></span>
</td>
<td class="text">8 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Vested and expected to vested at the end of the period (in years)</a></td>
<td class="text">8 years 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable at the end of the period (in years)</a></td>
<td class="text">8 years 4 months 13 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding balance</a></td>
<td class="nump">$ 122,556<span></span>
</td>
<td class="nump">$ 131,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest at the end of the period</a></td>
<td class="nump">122,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercisable at the end of the period</a></td>
<td class="nump">$ 118,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">26,459<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 1.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GranteeStatusAxis=hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember', window );">Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">14,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 1.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.41<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Intrinsic Value, Additional Disclosures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409341809000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Exercise Price Range of Options Outstanding and Exercisable (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract', window );"><strong>Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Shares (in shares)</a></td>
<td class="nump">11,968<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract', window );"><strong>Options Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares (in shares)</a></td>
<td class="nump">11,165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange006To040Member', window );">Exercise Price Range $0.06 to $0.40</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based payments arrangement, option, exercise price range, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based payments arrangement, option, exercise price range, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract', window );"><strong>Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Shares (in shares)</a></td>
<td class="nump">3,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">6 years 11 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract', window );"><strong>Options Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares (in shares)</a></td>
<td class="nump">3,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">6 years 11 months 1 day<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange155To233Member', window );">Exercise Price Range $1.55 to $2.33</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based payments arrangement, option, exercise price range, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 1.55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based payments arrangement, option, exercise price range, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract', window );"><strong>Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Shares (in shares)</a></td>
<td class="nump">3,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">8 years 25 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract', window );"><strong>Options Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares (in shares)</a></td>
<td class="nump">3,182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">8 years 25 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange243To365Member', window );">Exercise Price Range $2.43 to $3.65</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based payments arrangement, option, exercise price range, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 2.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based payments arrangement, option, exercise price range, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract', window );"><strong>Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Shares (in shares)</a></td>
<td class="nump">3,298<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">9 years 2 months 1 day<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract', window );"><strong>Options Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares (in shares)</a></td>
<td class="nump">3,295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">9 years 2 months 1 day<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange890To1335Member', window );">Exercise Price Range $8.90 to $13.35</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based payments arrangement, option, exercise price range, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based payments arrangement, option, exercise price range, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 13.35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract', window );"><strong>Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Shares (in shares)</a></td>
<td class="nump">1,888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">9 years 9 months 3 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract', window );"><strong>Options Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares (in shares)</a></td>
<td class="nump">1,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">9 years 9 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange1517To2276Member', window );">Exercise Price Range $15.17 to $22.76</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems', window );"><strong>Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit', window );">Share-based payments arrangement, option, exercise price range, lower range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit', window );">Share-based payments arrangement, option, exercise price range, upper range limit (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 22.76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract', window );"><strong>Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions', window );">Shares (in shares)</a></td>
<td class="nump">178<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">9 years 9 months 14 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract', window );"><strong>Options Exercisable</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions', window );">Shares (in shares)</a></td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2', window );">Weighted Average Remaining Contractual Life (in years)</a></td>
<td class="text">9 years 9 months 10 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange006To040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange006To040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange155To233Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange155To233Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange243To365Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange243To365Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange890To1335Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange890To1335Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange1517To2276Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis=hims_ExercisePriceRange1517To2276Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409349450424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - RSUs Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>d </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>day </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger one (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger two (in dollars per share) | $ / shares</a></td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger three (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays', window );">Reverse recapitalization, contingent consideration, equity, earnout period, threshold trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays', window );">Reverse recapitalization, contingent consideration, equity, earnout period, threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod', window );">Reverse recapitalization, contingent consideration, equity, earnout period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">790,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,804,000<span></span>
</td>
<td class="nump">45,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share-based payment arrangement, nonvested award, excluding option, cost not yet recognized, amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 7 months 9 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Awards vesting rights, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hims_EarnOutRestrictedStockUnitsMember', window );">Earn Out Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">317,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hims_EarnOutRestrictedStockUnitsMember', window );">Earn Out Restricted Stock Units | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hims_EarnOutRestrictedStockUnitsMember', window );">Earn Out Restricted Stock Units | Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hims_ParentWarrantRestrictedStockUnitsMember', window );">Parent Warrant Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,319<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hims_ParentWarrantRestrictedStockUnitsMember', window );">Parent Warrant Restricted Stock Units | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hims_ParentWarrantRestrictedStockUnitsMember', window );">Parent Warrant Restricted Stock Units | Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Capitalization, Contingent Consideration, Equity, Earnout Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hims_EarnOutRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hims_EarnOutRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hims_ParentWarrantRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hims_ParentWarrantRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409338923512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - RSUs Weighted Average Fair Value Assumptions (Details) - RSUs<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409341806680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - RSUs Activity (Details) - RSUs - $ / shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">1,576,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">2,804,000<span></span>
</td>
<td class="nump">45,297<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(790,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">3,590,000<span></span>
</td>
<td class="nump">1,576,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 11.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">14.95<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">15.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 13.16<span></span>
</td>
<td class="nump">$ 11.29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">3,480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,480,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 5.30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">1,904,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,904,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 5.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.99<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409345410312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Vendor Warrants Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>d </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>day </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>day </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger one (in dollars per share)</a></td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger two (in dollars per share)</a></td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger three (in dollars per share)</a></td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays', window );">Reverse recapitalization, contingent consideration, equity, earnout period, threshold trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays', window );">Reverse recapitalization, contingent consideration, equity, earnout period, threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod', window );">Reverse recapitalization, contingent consideration, equity, earnout period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_EarnOutAndParentWarrantsMember', window );">Earn-Out And Parent Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number securities called by warrants or rights (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,062<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hims_VendorWarrantsMember', window );">Vendor Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based payment arrangement, nonvested award, cost not yet recognized, amount | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 months 23 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Capitalization, Contingent Consideration, Equity, Earnout Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_EarnOutAndParentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_EarnOutAndParentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hims_VendorWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hims_VendorWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409341951928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Vendor Warrant Activity (Details) - Vendor Warrants - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">843<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="nump">843<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(381)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations', window );">Forfeited and expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">843<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest at the end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber', window );">Exercisable at the end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited and expired (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested and expected to vest at the end of period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice', window );">Exercisable at the end of period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Contractual Term (in Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms', window );">Outstanding (in years)</a></td>
<td class="text">7 years 3 days<span></span>
</td>
<td class="text">7 years 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms', window );">Vested and expected to vest at the end of period (in years)</a></td>
<td class="text">7 years 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms', window );">Exercisable at the end of period (in years)</a></td>
<td class="text">7 years 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue', window );">Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,308<span></span>
</td>
<td class="nump">$ 9,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Vested and expected to vest and the end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue', window );">Exercisable at the end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hims_VendorWarrantsMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 0.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract', window );"><strong>Weighted Average Contractual Term (in Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms', window );">Outstanding (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract', window );"><strong>Aggregate Intrinsic Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue', window );">Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,957<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hims_VendorWarrantsMember', window );">Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Additional Disclosures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures And Expirations In Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Grants In Period, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Intrinsic Value, Additional Disclosures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Remaining Contractual Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Exercise Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Remaining Contractual Terms</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-option equity instruments exercised by participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were either cancelled or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hims_VendorWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hims_VendorWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409349599192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Employees and Nonemployees (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 34,230<span></span>
</td>
<td class="nump">$ 1,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=hims_MarketingExpenseMember', window );">Marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">1,846<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general, and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 32,384<span></span>
</td>
<td class="nump">$ 1,113<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=hims_MarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=hims_MarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409349452408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 29, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th">
<div>Mar. 12, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 01, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 27, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,328,118<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,328,118<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds from issuance of temporary equity | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238,641<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeConversionBasis', window );">Recapitalization exchange conversion basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 33,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesCPreferredStockWarrantsMember', window );">Series C Preferred Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number securities called by warrants or rights (in shares)</a></td>
<td class="nump">1,341,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,747<span></span>
</td>
<td class="nump">89,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding | $</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.67<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesDPreferredStockWarrantsMember', window );">Series D Preferred Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Class of warrant or right, number securities called by warrants or rights (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,472,062<span></span>
</td>
<td class="nump">7,472,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,472,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds from issuance of temporary equity | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,900<span></span>
</td>
<td class="nump">$ 51,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,760,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,760,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds from issuance of temporary equity | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares)</a></td>
<td class="nump">1,341,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromConversionOfConvertibleSecurities', window );">Proceeds from conversion of convertible securities | $</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ProceedsFromConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ProceedsFromConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ProceedsFromIssuanceOfTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ProceedsFromIssuanceOfTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationExchangeConversionBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Conversion Basis</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationExchangeConversionBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesCPreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesCPreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesDPreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_SeriesDPreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409340495352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,997,674<span></span>
</td>
<td class="nump">275,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,328,118<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,328,118<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Aggregate Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 268,452,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds, Net of Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 238,641,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_SeriesSeedPreferredStockMember', window );">Series Seed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,987,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,987,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,987,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Aggregate Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds, Net of Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityIssuedPricePerShare', window );">Issue Price per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,822,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,822,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,822,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Aggregate Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,621,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds, Net of Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityIssuedPricePerShare', window );">Issue Price per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_SeriesA1PreferredStockMember', window );">Series A-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,742,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,742,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,742,012<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Aggregate Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 753,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds, Net of Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 740,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityIssuedPricePerShare', window );">Issue Price per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,270,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,270,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,270,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Aggregate Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds, Net of Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,429,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityIssuedPricePerShare', window );">Issue Price per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.8538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_SeriesB1PreferredStockMember', window );">Series B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,807,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,807,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,807,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Aggregate Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds, Net of Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,965,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityIssuedPricePerShare', window );">Issue Price per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.0392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_SeriesB2PreferredStockMember', window );">Series B-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,464,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,464,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,464,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Aggregate Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,371,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds, Net of Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49,911,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityIssuedPricePerShare', window );">Issue Price per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.8152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,850,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,760,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,760,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Aggregate Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 113,072,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds, Net of Issuance Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,590,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityIssuedPricePerShare', window );">Issue Price per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.6604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember', window );">Series D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Shares Authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,051,872<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Shares Issued (in shares)</a></td>
<td class="nump">7,472,062<span></span>
</td>
<td class="nump">7,472,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,472,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Aggregate Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 52,035,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ProceedsFromIssuanceOfTemporaryEquity', window );">Proceeds, Net of Issuance Costs</a></td>
<td class="nump">$ 51,900,000<span></span>
</td>
<td class="nump">$ 51,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityIssuedPricePerShare', window );">Issue Price per Share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.9639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ProceedsFromIssuanceOfTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Issuance Of Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ProceedsFromIssuanceOfTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_TemporaryEquityIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Issued, Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_TemporaryEquityIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_SeriesSeedPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_SeriesSeedPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_SeriesA1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_SeriesA1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_SeriesB1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_SeriesB1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_SeriesB2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_SeriesB2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesDPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409262183416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Additional Information (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 19, 2021 </div>
<div>common_stock_class</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_NumberOfClassesOfCommonStock', window );">Number of classes of common stock | common_stock_class</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,027<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=hims_RepurchaseOfStockMember', window );">Repurchase of Stock | Former Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_NotesReceivableAmountOfPrincipalPaymentCanceled', window );">Notes receivable, amount of principal payment canceled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Pre-closing stock repurchase, net of exercise of vested options (in shares) | shares</a></td>
<td class="nump">183,548<span></span>
</td>
<td class="nump">509,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of common stock</a></td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_NotesReceivableAmountOfPrincipalPaymentCanceled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Amount Of Principal Payment Canceled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_NotesReceivableAmountOfPrincipalPaymentCanceled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_NumberOfClassesOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Classes Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_NumberOfClassesOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=hims_RepurchaseOfStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=hims_RepurchaseOfStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hims_FormerExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hims_FormerExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409339822488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Pre-Closing Stock Repurchase (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th"><div>May 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,027<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Pre-closing stock repurchase, net of exercise of vested options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Stock repurchased and retired during period (in shares)</a></td>
<td class="nump">2,207,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Payments for repurchase of common stock</a></td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Pre-closing stock repurchase, net of exercise of vested options (in shares)</a></td>
<td class="nump">183,548<span></span>
</td>
<td class="nump">509,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,594<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Pre-closing stock repurchase, net of exercise of vested options</a></td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409355166472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Merger Transaction (Details)<br></strong></div></th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 19, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">0.4530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight', window );">Class of warrant or right, number of securities called by each warrant or right (in shares) | shares</a></td>
<td class="nump">0.0028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">0.4530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassAAndVMember', window );">Common Class A and V | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationContingentConsiderationEquityExchangeRatio', window );">Recapitalization, contingent consideration, equity, exchange ratio</a></td>
<td class="nump">0.0443<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A | Hims, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.000001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember', window );">Common Class V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember', window );">Common Class V | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember', window );">Common Class V | Hims, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.000001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationContingentConsiderationEquityExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization, Contingent Consideration, Equity, Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationContingentConsiderationEquityExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassAAndVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_CommonClassAAndVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hims_HimsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hims_HimsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409339802392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Settlement of Nonrecourse Related-Party Promissory Notes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Repayment of promissory notes associated with vested and unvested shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,193<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Repayment of promissory notes associated with vested and unvested shares</a></td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited', window );">Common stock, forfeited (in shares)</a></td>
<td class="nump">370,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares (or other type of equity) forfeited during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409351582664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - PIPE Investment (Details) - PIPE Investment<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">7,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction | $</a></td>
<td class="nump">$ 75.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409355169528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Prior to Merger (Details) - Common Class A - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 04, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
<th class="th"><div>Jul. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_CommonStockWarrantsMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_CommonStockWarrantsGroupOneMember', window );">Common Stock Warrants, Group One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_VendorWarrantsMember', window );">Vendor Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares)</a></td>
<td class="nump">380,746<span></span>
</td>
<td class="nump">266,522<span></span>
</td>
<td class="nump">37,244<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_CommonStockWarrantsGroupTwoMember', window );">Common Stock Warrants, Group Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">178,840<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.06<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_CommonStockWarrantsGroupOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_CommonStockWarrantsGroupOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_VendorWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_VendorWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_CommonStockWarrantsGroupTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_CommonStockWarrantsGroupTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409340733848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Subsequent to Merger (Details)<br></strong></div></th>
<th class="th" colspan="3"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 20, 2021 </div>
<div>day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 28, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="nump">0.4530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger one (in dollars per share)</a></td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger two (in dollars per share)</a></td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="nump">17.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree', window );">Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger three (in dollars per share)</a></td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays', window );">Reverse recapitalization, contingent consideration, equity, earnout period, threshold trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays', window );">Reverse recapitalization, contingent consideration, equity, earnout period, threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod', window );">Reverse recapitalization, contingent consideration, equity, earnout period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PrivatePlacementWarrantsMember', window );">Private Placement Warrants | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares) | shares</a></td>
<td class="nump">3,012,500<span></span>
</td>
<td class="nump">3,012,500<span></span>
</td>
<td class="nump">3,012,500<span></span>
</td>
<td class="nump">3,012,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of convertible securities (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,474,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember', window );">Public Warrants | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares) | shares</a></td>
<td class="nump">6,708,333<span></span>
</td>
<td class="nump">6,708,333<span></span>
</td>
<td class="nump">6,708,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,695,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantsMember', window );">Parent Warrants | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares) | shares</a></td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Class of warrant or right, exercise price of warrants or rights (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Capitalization, Contingent Consideration, Equity, Earnout Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, One</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Two</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PrivatePlacementWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_PrivatePlacementWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409349015416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Common Stock - Schedule of Warrants Outstanding (Details) - Common Class A - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th"><div>Jan. 04, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 30, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_VendorWarrantsMember', window );">Vendor Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares (in shares)</a></td>
<td class="nump">462,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_DebtWarrantsMember', window );">Debt Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares (in shares)</a></td>
<td class="nump">98,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 6.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares (in shares)</a></td>
<td class="nump">6,695,915<span></span>
</td>
<td class="nump">6,708,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantsMember', window );">Parent Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares (in shares)</a></td>
<td class="nump">888,143<span></span>
</td>
<td class="nump">888,143<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_VendorWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_VendorWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_DebtWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_DebtWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_ParentWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409339517640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Common Stock - Public Warrant Terms (Details) - Common Class A<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>day </div>
<div>$ / shares</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember', window );">Public Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate', window );">Exercisable period after closing date</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightExpirationPeriod', window );">Warrant expiration period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable', window );">Period after warrants become exercisable for warrant redemption commencement</a></td>
<td class="text">90 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsWarrantRedemptionMember', window );">Public Warrants, Warrant Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightRedemptionPricePerShare', window );">Class of warrant or right, redemption price per share (in dollars per share)</a></td>
<td class="nump">$ 0.10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum', window );">Minimum period of prior notice for share redemption</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold', window );">Sale price redemption threshold (in dollars per share)</a></td>
<td class="nump">$ 10.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption', window );">Period after written notice of redemption</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsCashRedemptionMember', window );">Public Warrants, Cash Redemption</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightRedemptionPricePerShare', window );">Class of warrant or right, redemption price per share (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum', window );">Minimum period of prior notice for share redemption</a></td>
<td class="text">30 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightThresholdTradingDays', window );">Threshold trading days | day</a></td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold', window );">Sale price redemption threshold (in dollars per share)</a></td>
<td class="nump">$ 18.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays', window );">Threshold consecutive trading days | day</a></td>
<td class="nump">30<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercisable Period After Closing Date</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ClassOfWarrantOrRightExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Expiration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ClassOfWarrantOrRightExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Period After Written Notice Of Redemption</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Redemption Period After Exercisable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ClassOfWarrantOrRightRedemptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Redemption Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ClassOfWarrantOrRightRedemptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Sale Price Redemption Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Share Redemption Notice Period, Minimum</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ClassOfWarrantOrRightThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ClassOfWarrantOrRightThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsWarrantRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsWarrantRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsCashRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=hims_PublicWarrantsCashRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409341304888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related-Party Transactions (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 20, 2021</div></th>
<th class="th"><div>Sep. 23, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Repayment of promissory notes associated with vested and unvested shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,193,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_RedeemableClassACommonStockMember', window );">Redeemable Class&#160;A Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party transaction, expenses from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Redeemable Common Stock Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_SaleOfStockPutRightPeriod', window );">Sale of stock, put right period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Operational Support</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable, related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Affiliated Entity | Identity Verification Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty', window );">Related party transaction, purchases from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable, related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ManagementMember', window );">Management | Nonrecourse Related-Party Promissory Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,345,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue', window );">Share-based compensation arrangement by share-based payment award, options, outstanding, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRelatedPartyDebt', window );">Repayment of promissory notes associated with vested and unvested shares</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_StockForfeitedDuringPeriodShares', window );">Forfeiture of related-party promissory notes (in shares)</a></td>
<td class="nump">370,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ManagementMember', window );">Management | Nonrecourse Related-Party Promissory Notes | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related party transaction, rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.21%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ManagementMember', window );">Management | Nonrecourse Related-Party Promissory Notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionRate', window );">Related party transaction, rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.02%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hims_ChiefExecutiveOfficerAndDirectorMember', window );">Chief Executive Officer And Director | Sale of Stock from CEO and Member Of Board of Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">737,058<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hims_CEOAndDirectorMember', window );">CEO And Director | Redeemable Common Stock Transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Related party transaction, expenses from transactions with related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_SaleOfStockPutRightPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Put Right Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_SaleOfStockPutRightPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_StockForfeitedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Forfeited During Period, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_StockForfeitedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRelatedPartyDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRelatedPartyDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_RedeemableClassACommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_RedeemableClassACommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=hims_RedeemableCommonStockTransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=hims_RedeemableCommonStockTransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=hims_OperationalSupportMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=hims_OperationalSupportMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=hims_IdentityVerificationServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=hims_IdentityVerificationServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ManagementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ManagementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=hims_NonrecourseRelatedPartyPromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=hims_NonrecourseRelatedPartyPromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hims_ChiefExecutiveOfficerAndDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hims_ChiefExecutiveOfficerAndDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hims_CEOAndDirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=hims_CEOAndDirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=hims_RedeemableCommonStockTransactionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=hims_RedeemableCommonStockTransactionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409344896344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends, common stock</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare', window );">Number of redeemable shares excluded from calculation of net income (loss) per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">664,162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Redeemable Shares Excluded From Calculation Of Net Income (Loss) Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hims_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409341903768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share - Computation of Basic and Diluted Net Loss per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (51,404)<span></span>
</td>
<td class="num">$ (6,033)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">153,080,538<span></span>
</td>
<td class="nump">34,610,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">153,080,538<span></span>
</td>
<td class="nump">34,610,061<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (49,185)<span></span>
</td>
<td class="num">$ (4,823)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">146,471,524<span></span>
</td>
<td class="nump">27,668,709<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">146,471,524<span></span>
</td>
<td class="nump">27,668,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember', window );">Common Class V</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (2,219)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">6,609,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">6,609,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassFMember', window );">Common Class F</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss attributable to common stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,210)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,941,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,941,352<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_CommonClassVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=hims_CommonClassFMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=hims_CommonClassFMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409341292568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basic and Diluted Net Loss per Share - Schedule of Excluded Antidilutive Securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember', window );">Common stock issued for exercise of stock options subject to nonrecourse promissory notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">3,545,821<span></span>
</td>
<td class="nump">16,855,230<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hims_EarlyExerciseOfStockOptionsMember', window );">Common stock issued for early exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">388,839<span></span>
</td>
<td class="nump">154,820<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">19,702,603<span></span>
</td>
<td class="nump">85,510,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">16,361,955<span></span>
</td>
<td class="nump">6,969,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">3,347,300<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">7,733,346<span></span>
</td>
<td class="nump">1,895,345<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants | Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,433,585<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hims_EarlyExerciseOfStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=hims_EarlyExerciseOfStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409338653448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate reconciliation, percent</a></td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.60%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R9999.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140409344895928">
<tr>
<th class="tl" colspan="1">Label</th>
<th class="tl"><strong>Element</strong></th>
<th class="th" colspan="1">Value</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring [Member] | Money Market Funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">$ 1,006,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">856,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Money Market Funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3 [Member] | Fair Value, Recurring [Member] | Money Market Funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member] | Money Market Funds [Member]</a></td>
<td class="th" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">856,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;">us-gaap_RestrictedCash</td>
<td class="nump">$ 1,006,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>92
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MUWK'%!N?2K$A4C\-:/K ^,98P]O$F9[&N9)P-P8[-9Z(!RY)E^01DSP_[2G
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M[<W_P=%A"$8=BEU[/K'?OVD)#YMF0C[9A(<,PD/LPM-^_&+BVQA"75>FN\@
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MH #P?LNA9NENU/EO_P^"U7]02P,$%     @ (H*Q4ALW/T'A P  A!$  !@
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M750O6M^F19'.JX\S%O)"6 KPO]^E_$!2?RG?W5[_HR&'_P=02P,$%     @
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M81?//OJ-LOI?)12=S"(\ROBL[*U?9NO%=ZR/Z+VSL0[TVE9<W;6? <D(9S'
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M4^A\9H5U_&02&,DVK#XX7S*Q2,T))2Y$+&T4&D53&D(<E%C__&>NBO2+>,,
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M)O6<+9?GA&HSMN#O*WX!RB;T.04FQ8ZEP*)D _(Z"P8.T5&[('"\#BD9"'M
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M.4''YXL9 ],-6&<X78>FWFM'(Q*V);U):'P G>=:NX/A$PROW/854$L#!!0
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MT4;1/_3S"IVXI1,[.O'_%?TJB)W6L:Y8@E./QE&C>D;O$C*<=.),ET@:*VU
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M=EP#2>%Y>G/. 0M G:D[[/.VZ>JSCP5Q03^6Z%>5!9VVA3UB@T:$#5MQ]#]
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M $/S$'7D ISCS60P;Y.-DSPL%O.A1;:LWE"D'INTX_GU6U5]L"E1EA-D%KO
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MY@;2*PTI.0(I9;_65;M1[&U5B&(X_Q*P<J@E%K57R8, ?^5-R-(X8$F4Q _
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MA9*$Y8AMI@LT*H0^J?1LR6H +88<T8Y"0IPN(!<$1^F%\0%*J :(S@T$8SV
M'_@5 ]VQ9 3ZBFSB /Q#]G^0H(WG>XA@GW%I[T7XU659W^'=';4VD6I0,@["
MAEJ@VWJ9T*,,ZRE[^PW#"LH1?>9$FG!_P;)P/N_?WM;H*DO,);-%N)BS/["/
M4GU]LL8%).",#1U4. '*MDCAM9M:R%N(-N A[Z4 Q_7'?ULD<?(,1NC,1/>
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M$1.%VD!//F.WWM2)LI_N020A+@S6HTM [K*P*A4%]X1S:\>-^W[Z<2OU.";
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MB</%T4YV(E&O39L=HCO= RN'\"H/"#_7H%JM-,WUM=-*927/)9J\\@B02C(
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ME 1KM #OKXVIPA<ZH/D][,O_ E!+ P04    "  B@K%2CUME&( &  !U$
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MLT-N"B5SKMWC<$.PX9BFR'EE1<9D *+*9)-W"4GQO1$Y\T2 =G)Q3[)YZSH
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M    >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;)U42T_;0!#^*R-+J)?6=NQ
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MK:SG=8QBR^\?4@A@?V.MWRDAP?BB+IX!4$L#!!0    ( "*"L5)<VD,V7QH
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M?4=Y? 8\2M9RMH,PVY>=)SZ$9M1TV[$Q=OI?O4$KGU0=7>U:?=2%#B2S@?2
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M!+PA&(^Z3&*/G 6?$<0^B2$*+HIH0M:<P4/WE-&.IIE!G1+V A+]+3?->ZT
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MLJ/L$S)LO-%,7"0;/K9<I(K<*8$E%RQ5J?IL &-Q'#<\<H]C<NYH;P9LN;H
M5)NQ!?]^0*]!:4-C7&!2;'$++$HZ0#=]U@0<HJ'VX<#QI4A)0<@"^H2KI/S]
M>Y!5?(=!AI7^."[Z6_UL).\^T06Z;]&\<?A(#V8A#3+E%</7]]12D"7]^3HF
MBZR<42A=@C]C8?$R-1P:7L&J\4R4U&ZDQ!GV=Y83)?&ACS+!-ZFY3,,01VH.
M^=NT,ATB6XJ($W.W@GV=$E#7J4^AP9G:5-CE8_[=UG8I&4]5EP2S@$0!\-Q4
MP;=@AN(Q/90IBOD?7#)/2U,%I._PMH:DJK*7/ Q9L1,??"'^O\@C^^#X\IK:
M@;" K^'DP<%]@4ORKW]"P/+W!"M_EU+*&V!0=. +1RUE2V<W5,+FY4\F+WZ\
MP0(N-KEH*7E3%AO(EO:M+,&0E=3WA$$'CF/T%H'1!>'(( J<Y=I+? M)8,&>
M2TJ?89#>E)UE>S1P'&.?<7DQ'=YT>Y5;_Q'*E18=GWN,S!AQT22;"V]K-CX4
M:#C('(6=$>O:K+T8WYS1QELC>(1\GRUKSQZ^ZHV#-GH/F]BB_2\W\D*?CJ^&
MR')3X2T0\3)*MA.)'@,@C'OPMI 6>$'J)<:G&$JF9^AN?#34*.M4LTRS9U4"
M+,0S<?)"M V]G89"S/""DC2QVF;M-B"G@#_=67ZV_V_+_H_9,K!8?ZV]VE<0
M.<_>W8JVE-Y0BW0#:.'7N,9OXUMPK_G=K^EQ?H7N:[KX@XG5!0R]./OFZPEG
M.,,?G6WI3;!SVW5V31]76E7:X0/P^\*"ELL?N$!\-_"S_P%02P,$%     @
M(H*Q4FMU!BYQ @  )@4  !D   !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL
M?53!;MLP#/T5PMBA!8+:L9TL"Q(#2;MA.Q0+FFX]##LH-FT+E25/4IKN[T?)
MCI<"32XR)?.]1U*D%@>EGTV-:.&U$=(L@]K:=AZ&)J^Q8>9&M2CI3ZETPRQM
M=16:5B,K/*@181Q%T[!A7 ;9PI]M=+90>RNXQ(T&LV\:IO^N4:C#,A@'QX,'
M7M76'839HF45;M'^:#>:=N' 4O &I>%*@L9R&:S&\W7J_+W#3XX'<V*#RV2G
MU+/;?"N60>0"0H&Y=0R,/B]XBT(X(@KC3\\9#)(.>&H?V;_XW"F7'3-XJ\03
M+VR]#&8!%%BRO; /ZO 5^WPFCB]7PO@5#IWO) X@WQNKFAY,$31<=E_VVM?A
M!#"+S@#B'A#[N#LA'^4=LRQ;:'4 [;R)S1D^58^FX+ATE[*UFOYRPMELVUT&
MJ!*VO)*\Y#F3%E9YKO;2<EG!1@F><S1P]<AV LWU(K0D[.!AWHNL.Y'XC$@"
M]TK:VL!G66#Q%A]2P$/4\3'J=7R1\)[I&TC&(XBC>'R!+QFJD'B^Y S?>^G^
M6NV,U=0UOR\(I(- Z@72,P)WW+"JTE@QWXM4[0=\0;G']XIYD<I-Z=RT+,=E
M0&-H4+]@D/5LD"L:%V.-4[ U0JD$C9W+ZXI+.E%[PV1AKN= />T]'FN-^.9^
M?%'=$L%WKPX?8!*-IK.(C'@VFL0I/-6*6H$)A/%HFJ2T3I)/\*@L$S2J72R$
MBD?)."4CB4;1-('W"AF>]&Z#NO(3:L#?1]?&P^GP"*RZWO_OWKT@U!45EP8$
ME@2-;CY. M#=5'8;JUH_"3ME::Z\6=-#AMHYT/]2*7O<.('A:<S^ 5!+ P04
M    "  B@K%2C++E   #  #I!@  &0   'AL+W=O<FMS:&5E=',O<VAE970R
M-RYX;6RM55&/VS8,_BN$5Q0)X)YMV4YRMR1 [J[="JS H=>N#\4>9)N)U;.E
M5&(N[7[]*#OQ4NPN?=E#(I(B/Y*?)6J^-_;!U8@$W]I&NT50$VVOHLB5-;;2
M79@M:MY9&]M*8M5N(K>U**LNJ&TB$<>3J)5*!\MY9[NSR[G94:,TWEEPN[:5
M]OLU-F:_")+@:'BO-C5Y0[2<;^4&[Y$^;N\L:]& 4JD6M5-&@\7U(E@E5]>9
M]^\<_E2X=R<R^$X*8QZ\\K9:!+$O"!LLR2-(7A[Q!IO& W$97P^8P9#2!Y[*
M1_0W7>_<2R$=WICFDZJH7@2S "I<RUU#[\W^=SSTDWN\TC2N^X=][YMSQG+G
MR+2'8-9;I?M5?COP<!(PBY\)$(< T=7=)^JJO)4DEW-K]F"]-Z-YH6NUB^;B
ME/8?Y9XL[RJ.H^5;_8B.F&5R,/H@BP;=>!X1(_O]J#R@7/<HXAF4%-X93;6#
MU[K"ZL?XB"L:RA+'LJ[%6<!WTEY FH0@8I&<P4N'-M,.+_UYFR'<8D$@=06O
MO^X4?8=[+'=6D4('GU>%(\M'Y:\S2;,A:=8ES9YOX@')<WJ2XBERS\+X:WGE
MMK+$1<#WSJ%]Q&!Y7QM+KPAM"^KD$TH'9@V<N*P'^D(H#5\B1WZ+:H2U:?@N
M*KV!D=)L,3O';+CQ%:RJ+WSDL(*/FF]XH_[^47PCE84;8[?&2D(H#$?!"TBF
MTU!,4R_Q;Y2GXZ-1)/";>42K?74'_RP.+_,<!#N.>T7 RCFD5X4L'SA+[Y9,
MPDLQ@Y>_S$0B?H51-NY-&7PP)!MP3Q/P D2:ATD^8<E7-)J(\<$87T[A+&VW
M6&);H#TR%_]_S/UAN$/W'(%YSE1E7O 5=P5WINE_V4NR,&%6Q4!,9TB?8C -
M\R0;_(YK;_T)AU,1SO)++PP%>=,D@Z>N170R?EJTFV[(.N9NIZF?1(-UF..K
M?GS]Z]X_ GQR-TH[:'#-H?'%- _ ]H.U5\ALNV%6&.+1V(DUOT5HO0/OKXVA
MH^(3#*_;\A]02P,$%     @ (H*Q4L,8D1EA @  !04  !D   !X;"]W;W)K
M<VAE971S+W-H965T,C@N>&ULA51+;]LP#/XKA-!#"P1U8N>U( G0M"O6PX"B
M[;;#L(-BT[906?(DN6[__2C9\3*@S2X62?'[^#"I=:O-LRT1';Q64MD-*YVK
M5U%DTQ(K;B]UC8IN<FTJ[D@U161K@SP+H$I&\7@\CRHN%-NN@^W>;->Z<5(H
MO#=@FZKBYFV'4K<;-F$'PX,H2N<-T79=\P(?T7VK[PUIT<"2B0J5%5J!P7S#
MKB:KW=3[!X?O EM[)(.O9*_ULU?NL@T;^X108NH\ Z?C!:]12D]$:?SN.=D0
MT@./Y0/[;:B=:MESB]=:_A"9*S=LR2##G#?2/>CV"_;US#Q?JJ4-7V@[WR1F
MD#;6Z:H'4P:54-W)7_L^' &6XP\ <0^(0]Y=H)#E#7=\NS:Z!>.]B<T+H=2
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M6Q8TI5'9"W2>2VD.AG70S_WY3U!+ P04    "  B@K%23 ]^&]8"  #>!0
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MO^N!JK=)+1A9N@E>2T/[P%TS6L"HK &]IU*:HV #-"M]^A=02P,$%     @
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M^F<]VAA4]5JJ""/G[H4RD8;>.VZ8T0,3E66@]:F49DU8 \V3=?@/4$L#!!0
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M![.AOQ8:[T#[6ZW=9>(%QO_@\G]02P,$%     @ (H*Q4@BKY!;D @  & 8
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M4")';3Y#Z^V[LAC"(].:26M :?!-;]ZJ[\>N%L8YH:)D15>5$&R!0 ]8,7F
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MC.<]OYGQI)TVS[9&)'9II++KJ"9J[SFW>8T-V)EN4;F34IL&R)FFXK8U"$4
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MRAJ8_8V4=)A8!\W#.GD#4$L#!!0    ( "*"L5+-!+&!L (  -L'   9
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M[WRDCUG4-TD]47QEF_$C5[JUVV&I;U\0)D#OYYRKW<0D:._SY!]02P,$%
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ML@*<=S81KN8?]^2@N>=I\O',?=,+YYZRUIE[0%P Q(5 7 3$3;IQ=7]K"O9
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MQ&'5;R&J%X(NRBOLMU0(FI5/YP3+418 ^?F,4O'\HK@5O_I%ROE_4$L#!!0
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MJ:L?N#90[]>,R;>)OEW:/Q/3?U!+ P04    "  B@K%2'&EFT]@#  #D#@
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MDL4T=[H,Q:(TT,\WG*NG3IF@*6QG_P%02P,$%     @ (H*Q4IY/C:PK!@
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MZAS[Q1RPSCN[,NGKRAS8S$?IRAS@S(=R9=YM^[BAK'W[F)?^8]=9F4E?9>8
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M"7Y\8Z.'[&'JV\C::)>]W&JUUB8M2/Z^B2+[XTWZ?';Q//[R/U!+ P04
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M.WY@7,,S$S7"')FI-9+BUL 7F.0Y=\(Q 3,9JN]D/+]'R[@P%W &,9B":33
M)3Q);LTE'=)ZSH4@6Y/&EBBZ0''6T)D&.LD1.GV8*VD+ U]ECOG?_C&EUN:7
M[/.;)B<!YTQWH-^[A*2;])Z6]W!^=O%!_$2 ?BM@WP?H'PFP=$!?W,/(X4Z5
MU"PF"#71FLF-EQ-6[W!HMV#O_GBR8SJ'']\)$F862_/S!*%!2VC@"0V.$)K)
MC+K3H"O$VE5WZZNKUD#1B!(5]S><?5::@-L+4KINWHZ[G7X:;S]A<]6RN3K)
M9E&O!,_@I0E](K_K%O'Z_Q!\V!(:GDS1!X)*\PSAG$3/E1!,&ZA0AV=VX00_
M\N:"\B' S8'P@\[@'^'C@R8O46_\*#.0J5K:T._M:3LM)V%(?)B'44M-L>'2
M@, UN78[0ZJA#N,K;*RJ_,A8*4L#R"\+FOBHG0'=KY6R^XT+T/Z'C/\ 4$L#
M!!0    ( "*"L5)\A,_[E0(  )L&   9    >&PO=V]R:W-H965T<R]S:&5E
M=#0X+GAM;(V5;6O;,!#'O\IA&+2PQH[3)*4D@:0/;+!":%G[8NR%8I]C4<GR
M)#FIO_U.LN-ED)B^L772W5^_.\GGV5[I=Y,C6OB0HC#S(+>VO U#D^0HF1FH
M$@M:R926S)*IMZ$I-;+4!TD1QE$T"27C1;"8^;FU7LQ4904O<*W!5%(R7:]0
MJ/T\& :'B6>^S:V;"!>SDFWQ!>W/<JW)"CN5E$LL#%<%:,SFP7)XNYHZ?^_P
MRG%OCL;@,MDH]>Z,[^D\B!P0"DRL4V#TVN$="N&$".-/JQET6[K X_%!_='G
M3KELF,$[)=YX:O-Y<!- BAFKA'U6^V_8YC-V>HD2QC]AW_I& 225L4JVP40@
M>=&\V4=;AZ. X>1,0-P&Q)Z[V<A3WC/+%C.M]J"=-ZFY@4_51Q,<+]RAO%A-
MJYSB[.*1<0VO3%0(3\A,I9$J;@U<P='*TM"9E:Z*!E0&:\UWS"*L!4N\.[PQ
MK9D+N[A'R[@PER1PWFT66D)W &'28JX:S/@,Y@B>5&%S P]%BNG_\2&EW.4=
M'_)>Q;V"3TP/8#3\"G$4#WOT1ET=1UYO=$;O)6<:K]S]2.%.2?IF#//7;NE2
MWC;Y;VHX]ENSVD\O]TRG\.L'2<)WB]+\[@&Z[H"N/=#U&:"'CY(N/NUB44NX
MX 74R+2Y/%7[?J4A2%=[B&\@9;7I81MW;.//L>V4H"H);NM36/TBD_$@BK[T
MT$PZFDFOT#,W[U>91@1>4+'06-!T;T\1]0M%@VC4!S3M@*:?*T_*=SS%(H6:
MHTA/ ?4+1><J%!XU#(EZZ]NB@415A6UZ1S?;==YETW#^N3=MFSZD+:>^(#"C
MT&@PI5/332ML#*M*WWXVRE(S\\.<_AZHG0.M9TK9@^$VZ/Y'B[]02P,$%
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M;H(H3I"+A>++_'AQRI7B:7ZY !:!T ;X?,91#LU"!RC/\8?_ U!+ P04
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MBOSKC7Q'\67VM<&4*\63;#-D=,:$N4"?GW.NMCOF X;R&YK)?U!+ P04
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MJ4_Y84H?!M0N@/8W2MG3Q!U0?VK&?P!02P,$%     @ (H*Q4GD!+#[6 P
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M5D$<!_%**D.(8X^ ,YDX64J=UZ5-!M=+X1+!W(T=%XZL7?E)',X9.*@Z9V:
M,]?C5/SM%?[VM/[^F;Q2\K5L\;)WL'*W?EVW6-?5KCM_)<P+>/O*[L'*EVA@
MUR_>+Q;O:Q>7ZK\D0>*V% - 7C<!:R?2-PW!H& QT(<@]H_(LX%!GAW.:<R/
M84%RJ"7Y2'@I3K+PRAM!P4X. RR 6!,@U1G0)=@0%M"V*,Z&6C<J%.VN*B]=
MDV3"SR$YB50.7V9E#WH-K$I%S]9JTE/:/\AX37:$R7X(O.<\6+# (QJQLJ%:
M YX@5SX-0\QXXGWF=FU&Y="#LM=7_2:WE1+;R%A1#(D@TU?+5C)NZW6\JB^&
M/#+()!M,(J(DUM9K;+/<&/(R5E];R:_=HK^'XF-(QM5G3=X,M<RJLE:Z;>N%
M^R0U,O)KEJ]LR%AIO-TB\B;29,AP< Q#)?#V\#B9FLH^E<F]U1:'X"=A44KQ
M'R()GNO:5J764*_6?V\%%SC+OP3ZK08Z;X#U0/W,%"#@X[>ZGG[Z"8"J<TKT
MH?W[,U03 ?UJY@ZHB@+U%<4H836$]>CFA%6]@?K6?[):,;+"@H ?,F^#F <>
M>,3A5E=@H:HC4%]'2LE:NTG*K-W2.]E#W<&'OKUFUG#8Z]>_N5#5%:BO*]I<
MDX,'SZ[6@\/B4O&@RDW5%VC4WS>F42T5]R!,T(8-#2Q410/JB\:"D5T@-_[A
M&[@C&\J$?ONMI!T./K?GA$J#H;[+/G;7.86'?;0]<.V/>=<RJ[K55@*.6MKM
M8S8N4U377#>24$*+OJJ[1DH+T==UU^BPN^Y>]8<-;I>^<^B[ZU/[MFF.:\A'
MZ2-R_H_N 2G10WK1,^X>IBU QJ4(*=%#[F\O14CI&-+KF+X4S7-KLR*#E,HA
M?0-[)\4S_6 OI5N^692!12K@%V#B_[OE(B*QT+FG-!#I^]#V3WA*H!R]0!TM
MITZ-1G7MCV6\;5:5K5(R1]_$'2>G.9@A"25U#OPB.764=CEZ[?J,G#IU\C5T
M&]PN?>UM^4QPJISFN"U\K-*92438*CVLXL"CVUADQR?%:'$@-DF/@2PU/3M-
MN\5,1H^#D"REJ91NF0$L.Z#*;@3=I"<PSU0(&J67:X)]PI()\O<EI>+])EF@
M."8<_P)02P,$%     @ (H*Q4F ZF3OO @  W@@  !D   !X;"]W;W)K<VAE
M971S+W-H965T-C,N>&ULS59=;]HP%/TK5M2'5J+-9RFM  EHIU5:)U3:[6':
M@R&7Q"*Q,]N4=K]^UTYP*06TETI] =NY]_C<<QS?=%="+E0.H,ES67#5\W*M
MJRO?5[,<2JK.1 4<G\R%+*G&J<Q\54F@J4TJ"S\*@K9?4L:]?M>NC66_*Y:Z
M8!S&DJAE65+Y,H1"K'I>Z*T7[EF6:[/@][L5S6 "^K$:2YSY#B5E)7#%!"<2
MYCUO$%Z-PL DV(@?#%9J8TQ,*5,A%F9RF_:\P#"" F;:0%#\>X(1%(5!0AY_
M&E#/[6D2-\=K]"^V>"QF2A6,1/&3I3KO>1V/I#"GRT+?B]57: HZ-W@S42C[
M2U9-;."1V5)I43;)R*!DO/ZGSXT0&PF(LSLA:A*B[81D3T+<),2VT)J9+>N:
M:MKO2K$BTD0CFAE8;6PV5L.XL7&B)3YEF*?[$RUFB],A"I&2D2CQ="AJ]3TE
MD]I9(N9D;]3-LQD#P?-$;LJJ$"\ BE">DN^"@ULXO@9-6:%.$/9Q<DV.CT[(
M$6&</.1BJ3!<=7V-U1A._JQA/JR91WN8Q^1.<)TK<L-32-_F^ZB"DR):2S&,
M#@+>47E&XK!%HB *=_ 9_7]Z<(!.[)R)+5Z\SYF<2CB=6LW'] 5?'4T&4E*>
M@1FWUMJG5NX1K9BF!?L+:8L,2K'$Z%_?$)+<:BC5[P.$$D<HL822/80>!&Y
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M9*:TYO*39_-:W\5.'[;H8]YUEJI5X;U/%W+147_IKD?8T6"F3U9SQO#3&;O
MSHZ_;Y.I1] ;#_O8[Q+D+K^2<V?YE;O\.LJ;<N0X&M+,/ZGZ$4N_O^1ZD^7E
MQ+[_MHW5#^^?CWJ$]T')=?&OHS]M^M.J/[7TOUU%N2R\\ZU:97G\GUX<K^+4
M*ZI7NY;#Y:X=J]J5T'HX"UD8"B[HR>RA?9[,@5@PO_K7C-R3S!K)K(_D#T6Q
M/2R7F7()P0%"P4]RS8$6F;R1R?O(_'.K"A6EBSA='M+*^VHU!UJTBD:K<&H]
M7RYSN8R4]#[&>IDMHHKY7Z)D*[N$[IKQ]M3R@#+<GMJ=4G.D16G0* V<2F_R
M;"[EHGCC_:&_=#7LRF40I?,2=84JNM0&IEH2<(JL"S%LM(3N&99YK&?X5CJY
MA7Q O7\4KZ/6EPD:U^UUO_92HV$@J!#=IPYAD(+'<W'=J[\,P"LB([NT;MA?
M"Z 8N5D\T(5UMQ[F0H!6Y&;K,^Q5=^PC ]")W.RL5H6^8(GU!V]D[E6S5$W,
M(DN2*"^J5ZM)ZIZC77O1UC35?D<68<!)Y 9E;?ESEQL!92@XCM\!4.@ H0;[
M/32_M4F ,0UQ]ZG#0#?LCV?XNM< '<! W(N! QR/30@>$ ,4Q&X*#K1\W:WM
M-<ZQ_9L, P>QFX//,'[=L2V&(9_;Q0 (L1N$+[5_W7[?_E@$%EU 1WS@RK-V
M_UO7E3T&RF%^%/]CP!4^@*NA_J_[M9<Z$Q3[R+;2 7;8?>$VS/[!0!E 1-R+
MB$/<;R+1J84 $8F;B /-7W=K^TTP8K4; 2(2-Q&?X?VZXYX6:M_:$0 B<0/Q
MI=:OV^];'Q'K9+7VX0<N%'?>OW#MZ0%PA![%^01017IMDOL[GY@;8$2P\%EH
MFU/@'.FU$^YG?6)N;@_H !J27C0<X'UBXO" &. A<?-PJ/D[=K&4.](4 D@D
M;B0^Q_YAQYZ:XM"JA@(4J1N*+P5 W;X- #0-&+%\^5.@)#UPW5@#P/GE3P%T
M%!\GV -BT5Y;VP'1GKFS#0-?A,P"3]H*&7NEC/T(0#LB1J<,@"+M!<4! * =
M^:%3"T"1NJ$XT/]UMSW'^:XTE0(6J1N+S_ _-7,]1$/.[&J B]3-Q1?[/S#\
MCZ<^L6W5*&"2]DK[+MYBASL9<(X=)^QC "PV<MC'S'TN(I33D(26Q!YHQT9,
M^YB9]AW0 4QD8\=]S(3B 3% 139JWL?,O(\A(NR[?];Z167TV(^9L1\-0^10
M VADQTW_F)G^D6F ;,QF0$K6*_V[=-D30,>.D_XQ(!8;.?UCYE87T8#YA-I^
M"P/<\1'3/VZF?X@*KB^[J44'0)&/G?[Q#BJZQ0 5^:CI'S?3/X2(+[#5<QS
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M-C<N>&ULO59-;]I $/TK*RN'1$KP-Y@(D (4-54KH="TAZJ'C3W@56RON[M
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M9\=6MM6BN5]K[G]DL[Z7Z?Y1INW ];W@,+#)L9EO];M[#5[&?VP6^'[?:\Z
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M;][V=:J_UT 8 [T^YERM!N;Z77X!]OX#4$L#!!0    ( "*"L5*CT>[Y@P0
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MHL9'#5#?UXS)YX6^?\NO@&?_ U!+ P04    "  B@K%2H?KQ9C@#  #=#
M&0   'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6RU5UUOVC 4_2M6M(=6VDB<
M;RI :J'5.NT#%:U]F/9@$@-6G9C9!KI_/]M)$R@AS<-X@=BYY]QCWY,;9[!C
M_%FL,);@):.Y&%HK*==7MBV2%<Z0Z+$USM6=!>,9DFK(E[98<XQ2 \JH[3I.
M:&>(Y-9H8.:F?#1@&TE)CJ<<B$V6(?[W!E.V&UK0>IUX(,N5U!/V:+!&2SS#
M\N=ZRM7(KEA2DN%<$)8#CA=#ZQI>W<%( TS$(\$[L7<-]%+FC#WKP7TZM!RM
M"%.<2$V!U-\6CS&EFDGI^%.26E5.#=R_?F6_,XM7BYDC@<>,/I%4KH96;($4
M+]"&R@>V^XS+!06:+V%4F%^P*V,="R0;(5E6@I6"C.3%/WHI-V(/ /T3 +<$
MN%T!7@GPN@+\$N!W!00E(.@*"$M :/:^V"RSTQ,DT6C V0YP':W8](4IET&K
M#2:Y=M9,<G67*)P<C5F6J0+/)$N>P2<P4\Y--Q0#M@!/B'.42P%^;*20*$])
MO@07$RP1H>)2!9?8,45"@&LU\0'80*P0QV)@2R5.I["34LA-(<0](>0;XCW@
MP8_ =5S8 !^WP[^@O*>@)^&3#G#'/PF_;8=/<%*)=QK@=^WP[VRKX$X3W%;U
MK(KJ5D5U#9]_@N\1YRGC50%;&+V*T3.,WBF;F!K7I@"*WG0A\.NK"@7W$F?B
M=TLBOTKDMTJ?&?N "Y*73KILLE+!$1@.W3NW(S]T/2\8V-N&W$&5.VC-??N"
M>4($!E-.$FPTI(Q2Q 588U[H:913T,9[<F OJL44!NP2=-LEZ.Z=H(.UA]7:
MP]:U3_!<=C%,5/%%YS5,7"6*_X-AXB/#]./(]9KWK%^E[I_'+_VC H:]?M@L
M!CIU)W=:Y4PW<TJ2+D6$>V\'>-XRPKIGP?:FU:V0)<E^)<.P'_3AFX=DW!08
M.;'GG2@ZK%LA],Y3]I+WX,&%O2/A[T0=JJ[[*FQOK%.E*N_TB,.Z7\+@S.ZH
MVQ-L[T\=W1$>%3V.8^A[;_?XW;A#F777@]&9O!%UJ;J]=]#3!W]U:%J27 "*
M%PKFJ+> !7AQEBX&DJW-V6_.I#I)FLN5^O[ 7 >H^PO&Y.M 'R>K+YK1/U!+
M P04    "  B@K%2,:)10;8#   _#@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970W-"YX;6RU5]MNVS@0_15"Z$,+I-'%\:VP#21NBQ9H@"#I;A\6^T!+8XL(
M+UJ2CF-@/WY)2J:4K<4X0/)BB1+GG#,SY+$XVPEYKTH C1X9Y6H>E5I7G^)8
MY24PK,Y%!=R\60O)L#9#N8E5)0$7+HC1.$N24<PPX=%BYI[=R,5,;#4E'&XD
M4EO&L-Q? 16[>91&AP>W9%-J^R!>S"J\@3O0?U0WTHQBCU(0!EP1P9&$]3RZ
M3#]=92[ S?B3P$YU[I%-927$O1U\+^918A4!A5Q;"&PN#[ $2BV2T?%/ QIY
M3AO8O3^@?W7)FV166,%2T%^DT.4\FD2H@#7>4GTK=M^@26AH\7)!E?M%NWKN
M>!RA?*NT8$VP4< (KZ_XL2E$)R#K"\B:@,SIKHF<RL]8X\5,BAV2=K9!LS<N
M51=MQ!%NNW*GI7E+3)Q>+ 5CICAW6N3WZ".ZV:XHR=$O+"7F&OT$R11Z_QDT
M)E1],!.:^4N*E4*7LU@;#18ISAN^JYHOZ^$;H&O!=:G0%UY \30^-MI] MDA
M@:LL"'B-Y3D:I&<H2[*TP/MW*$:JQ!)4 'S@JS-PX!<]X$_+$4*\\(@7#G'0
M5V]7.+'V)182N:V _OIAIJ+O&ICZ.T T]$3#H/0OCR!SHO"* JI $E$@O-8@
M44Z%(GR#"JSA6/_"L(/$!.Y#E1AY@:,@TJ$ \%@1B=T6K74>$Q6&&J(]8!D2
M-?:BQN&&=RNU:]J.5I +!D9I6U+CAX?WQIP*8)7+P,PSEI6#^=''\@BS3Y\M
M[L3G,7G)PCWSR^W6:PVP3#W+]&T7<YJT-I4$$_)4NY9*6JJS;ODK27*WW&L+
M0.\)1X6@U"R.]NF'HZY5TT\<O?TK>U@DY^DL?CBFNF.N:5#U->&$;=EA QKY
M1J%1SH6V0NTBJH7*GK8TXL(LS^_)-&L59T&LGZ5QSE+0 FF)B]HG]@K]:R]'
MI=5PPT[=TJ2G;*WKIF';O</6M%PO.\W57MH+VEH3C4Z1UUIX>O$"DY!$:^"'
MEIH6/]/+,/8)O6S_ =*P5_]F DNLRM,<(&U=/!V]L0>TWIR&[?'-/6!\Q .2
M/A-HK3@->_%KF4"8Y82%T]IZ.GU=$YC^9@)9SR[+6L?/PH[_>B;0$#TQ@4F/
MO-;:L[#IMC7*!5>0;^WIXL1Z-=#=>@W^7Z^X\TW/0&[<R449LBW7]>>]?^I/
M1Y?UF:"=7A^MS"?RAG"%**Q-:'(^-L2R/JW4 RTJ=T)8"6W.&^ZV-"<\D':"
M>;\60A\&EL"?&1?_ 5!+ P04    "  B@K%2,&&\_+T%  "B&0  &0   'AL
M+W=O<FMS:&5E=',O<VAE970W-2YX;6S%65MOVS84_BN$=T$+.+8H^MHE!A([
MP3HL35"OW<.P!T:B8Z*2J))4' /]\3ND%%..93I+9^PAL2B?^SG\SB%]NA+R
MBUHRIM%CFF3JK+74.G_7[:IHR5*J.B)G&7RS$#*E&I;ROJMRR6ALF=*D&P;!
MH)M2GK4FI_;=K9R<BD(G/&.W$JDB3:E<7[!$K,Y:N/7TXB._7VKSHCLYS>D]
MFS/]*;^5L.INI,0\99GB(D.2+<Y:Y_C=%1D;!DOQF;.5JCTCX\J=$%_,XGU\
MU@J,12QAD38B*'P\L"E+$B,)[/A:"6UM=!K&^O.3]"OK/#AS1Q6;BN1/'NOE
M66O40C%;T"+1'\7J5U8YU#?R(I$H^Q^M*MJ@A:)":9%6S&!!RK/RDSY6@:@Q
MX-X>AK!B"%_*0"H&\E*&7L70>RE#OV+HOY1A4#$,;.S+8-E(SZBFDU,I5D@:
M:I!F'FRZ+#<$F&>FLN9:PK<<^/3D(TNH9O')+95ZC?Z0-%/4YERA-S.F*4_4
M6W2"/LUGZ,V/;T^[&G0:SFY4R;\HY8=[Y/]&LPX*@S;\A;B!?>IGG[,<V(EA
MQ^,&]IF?_9K*#B)XK_;+E[,'#>Q7?O89B_:Q=R%-FUR%FUR%5A[QYPKMY K]
M]3N0HO>:I>IOCR*R442LHMY>13E= WQH)!8HER+E2@FY1IG03"$*BXA;2U9<
M+]$#4^:99C$JLFJAEE0RU92P4O/ :C:P]S#!>$R"  +T4,_,+IVCV'*JMW&J
M=\"IF $JWR4,31/PX><?\"#XY1Q-19J*K%S-M8B^> +8W^CJ'S=3@XVB@=>I
MJ8"(2POSD*K(KC0W/BH6%9)KWIB%RU)JOQ;=DUX_".IIV+)GN+%GZ+7G?+'@
M25D;EYGF>NWQ<;21.3IN,,<;1>,#%5(JRJTB[12U$7N$5JZ@^!>P&^I?J7(/
MR#IK4]F/=P(^V@YWF9>#9%N.X<"A?/#O\H*^H?J&L'L V?*O1]@35%SK,/BX
M^<,.(''H=7-.P1G8",HXTD9YH9$THP7*F>0B;NP_?HD#!('12^4SS\$J]N-J
M4Q9NP#1JHD$3-"_R7$CMT^70#O>.''4'=KCO=RN*1)%I!=6_-N74WMH.S0@T
MJV3V&P&^ZJ[]E_8 [/ 2^P&S*07O8U8^?H8J6?#(I@/-F7S@T7/CM]4Z6,3#
M(V?#H24>O1;%\D)&2[J!L8.@56FJYP@WH59%-]A/M^V+ V3L1^375=;XD#55
M>1VDVY[2'-B&?K"]IAD<RNS\] U]$)EDX(54#&T/V[=NL/I@!BO?A.C -CPR
MV(:U:=0/C3=YV0#AO*HT3'\\NT=O>%;-?DUGA:M*XE9!#4BO/PB'>X+NL#7T
M8^O<:#TQA\P8YJ#4M.MR'U,)0:C2<;<NK:OHGJ9<NJ(R;B-1.M2N>]1&#S0I
M6*,SNR/J,/05D,/N\-"H>K3Y^Z)2O57U7JM=&PC];0!.^@O&=2%M"ZXVZDD)
M0SM.^ OE(MSM#F08#$EOCY$._T,__K]R;P+Q-<]X6J2^K>/:07CD=A"Z=A"^
MNAW W-%<V'Z)82?$/_EL<_ >^N'].Y)!'P\D@SBX)L&1C]4.G0G^KY-Q0"+I
M!*$O&<3!.?'#^73)V0)=/L*YT5SVH1N8E"(FT3G@RHQ#:K20$/FG$;L\*]@Y
M8GIY8]'GFJ5WP'"S0!<" -50/3'ZFANI74N0(V?*03#Q0_"SDT166-?,"PM:
M".JQ $L Q6I9/(!JTTIG'=6& &O]43.J$0>]Q ^]S\\]$C)GSCRE,=:L6"0)
ME<J];;:PU#.J63CH8+S'/H>ZQ(^ZS^R+H,ORN#KW0*>(&!0<U,M6,!O-&^PT
M+^^U!7&(3/P7%Z:&GU7Z]YV/B4-H<N3[#>( E_QO-QQ3LCM.DZ I-]W:;;7Y
M]>*:RGL.:A*V ,Z@,X0:E.4/ N5"B]Q>8-\)K45J'Y>,0OT8 OA^(: K5 MS
M)[[Y66;R#U!+ P04    "  B@K%2OD10+\@"   I!P  &0   'AL+W=O<FMS
M:&5E=',O<VAE970W-BYX;6S-54UO&C$0_2NC50]$HEE8"%01(/&1JI&2"(6F
M/50]F/7 6O':U/9"\N\[]BY;D@+JL9==?\Q[?C/C&0]VVCS;#-'!2RZ5'4:9
M<YOK.+9IACFSEWJ#BG96VN3,T=2L8[LQR'@ Y3).6JU>G#.AHM$@K,W-:* +
M)X7"N0%;Y#DSKQ.4>C>,VM%^X5&L,^<7XM%@P]:X0/>TF1N:Q34+%SDJ*[0"
M@ZMA-&Y?3_O>/AA\$[BS!V/PGBRU?O:36SZ,6EX02DR=9V#TV^(4I?1$).-7
MQ1G51WK@X7C/_CGX3KXLF<6IEM\%=]DP^A0!QQ4KI'O4NR]8^7/E^5(M;?C"
MKK)M19 6UNF\ I."7*CRSUZJ.!P B.<X(*D R7M ]P2@4P$ZP=%267!KQAP;
M#8S>@?'6Q.8'(38!3=X(Y;.X<(9V!>'<:,*L2($I#C,A"X<<'NCJW&EK88,&
M%ADS"!]AS+GP86<2;E5Y=WP2&C-T3$A[029/BQDT/EP,8D>R/'F<5A(FI83D
MA(0.W&OE,@LWBB-_BX_)G=JG9._3)#E+>,_,)73:34A:2?N(GNF_PUMGY'3J
M$'<"7^<$WPTS2JBUA?D^H$T(86_"\A6F.L\IDE/)K&U2<%-9<+*&KSM=+L(]
MNDQS^'%'O'#K,+<_SZCJUJJZ057WA*J9V J.BM.A:2F![EKZ?"Q])5$O$/FN
ML!U16+:' 3UG\4;=5:WNZJRZPZC ^(R[O9JP]Q\EH5^KZI]U\Z'(EZ1'KZ@A
M<J3^O)0(UJNS@"]>!17DRN@<4B;30I951^:*BE0H2AQ"0U*Q7H1J#4AH"%5Q
M'"W&4M'5F6S^;='K==N]Y%U*XX.NDZ-9AV9LZ385RI7%6J_6_7X<VMR[]0F]
M V7;_D-3/B)4BFNA+$A<$67KLD^B3-F8RXG3F]#;EMI1IPS#C-XR--Z ]E=:
MN_W$'U"_CJ/?4$L#!!0    ( "*"L5+S<7>;0 0   D4   9    >&PO=V]R
M:W-H965T<R]S:&5E=#<W+GAM;+68VV[C-A"&7X40]B(!=B.1U,$.; .QW$4+
M-(M@TVRO:8NVA$BB2]+Q[MN7.EBT'(EAD?0FUF'F]S]#SF>$LR/CSR*E5(*?
M15Z*N9-*N;]U7;%):4'$#=O34KW9,EX0J6[YSA5[3DE2)Q6YBSPO= N2E<YB
M5C][X(L9.\@\*^D#!^)0%(3_6M*<'><.=$X/OF>[5%8/W,5L3W;TD<JG_0-7
M=VZGDF0%+47&2L#I=N[<P=L8XRJACOB1T:,XNP95*6O&GJN;/Y*YXU6.:$XW
MLI(@ZN.%QC3/*R7EXY]6U.F^LTH\OSZI?ZV+5\6LB: QR__.$IG.G8D#$KHE
MAUQ^9\??:5M04.EM6"[JO^#8QGH.V!R$9$6;K!P46=E\DI]M(\X2E,YP FH3
MT&6"/Y* VX2Z<V[CK"YK1219S#@[ EY%*[7JHNY-G:VJR<IJ&1\E5V\SE2<7
M2R*R#2!E E99?I T =_4WOF3"0'VE(/'E' *OH"8%?N#)'7GV19895VMJ"19
M+JY5_M/C"EQ]N@:?@ M$]5: K 1/92;%9_507?^5LH-0BF+F2E57Y<[=M#4L
MFQK02 T8W+-2I@+\5B8TZ>>[JA]=4]"I*4MD%+PG_ 9@^!D@#\$!/[%]NF>P
M@[LUPK4>'M'[=B@H)Y+Q6X.8WXGYM9@_)J86*J\6BDC)L[5:U'5.@61@PXI"
MK:[:<9OGE.4)Y8-+T:B'M7K%B)?%EP#ZGC]S7\X[-! 6>AAW43WO0><],#9B
M14NF9N"M5H2=7&AL1;.+K]3F:[;D]5"]C41P5@@,L#?Q CRY*/EU)/9#J' *
MAZN..IN1T>9IQ-XP&ED;?1UI-CKIC$XL^YFP/">\@4%M>=!QHS8YWR/>#;[<
M28-1,!JV.NVL3JU[:F=V:F5V,&K,+/0TI#VCW;B9S3@G:G#O#%L?GG$?OA\J
M$&DY]+]BI97O <.?PDEPT>#!N D: 0O4B(5FQEJB!6K,0C-GK>#2:O2&U@_]
M" ;H<F<-A*(H#">1-QVI75,5!A\!F%;%RNSKT#?,:F9#6VC;S6TK]];@#H>-
M3JYF-[2'MZ7AR,[P8-BH8<UP:(9X#S4_3*.@60NG[T<-TC!$9AB^%S6M? \A
M",&1G8DT49&9J)8(09JIR,Q4*X2T&N>C%H;>U(/^2#T:B0A_!!9:%7L#&J'(
M%J%VD]/*C4].WX?F([+GHZ63X#\YT?!#9OCUAO.K:9-I0*'H X93XP.9\?'.
MX8Q;^=YP0@2]D<YI!B$S@RR'$VL*83.%;(8S;C5ZLS'U(0[0<#U8PP;##QC.
MN%6Q-Z#AA&WA9#42<2MG^7N%S_XWMJ>4I1-LY<0].U11([*KSYJ$VL>'4C9'
M"=W3[CSKKC[%N7B^A+=Q<RJE99I#LGO"=UDI0$ZW2M*[B=0Z\>;<J;F1;%\?
MW:R9E*RH+U-*U.Q4 >K]EC%YNJF^H#O]6_P+4$L#!!0    ( "*"L5*^"6B-
M^0,  *41   9    >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;,U8;6_;-A#^
M*X0^M< 6B=2K ]M XG18@78P8G3],/0#+=$V%XG42"I.@/[X'65%\IN$H@,&
M?8E)ZN[XW#U'7H[3O51/>L>802]%+O3,V1E3WKJN3G>LH/I&EDS EXU4!34P
M55M7EXK1K%8J<I=X7N06E MG/JW7EFH^E97)N6!+A715%%2]WK-<[F<.=MX6
M'OEV9^R".Y^6=,M6S'PIEPIF;FLEXP43FDN!%-O,G#M\NR"^5:@E_N1LKX_&
MR+JREO+)3CYF,\>SB%C.4F--4/AY9@N6Y]82X/BG,>JT>UK%X_&;]=]JY\&9
M-=5L(?.O/#.[F9,X*&,;6N7F4>Y_9XU#H;67RES7?]&^D?4<E%;:R*)1!@0%
M%X=?^M($XD@![%Q7((T".5<(>A3\1J&.G'M 5KOU0 V=3Y7<(V6EP9H=U+&I
MM<$;+BR-*Z/@*P<],[^GFJ>(B@P]\+PR+$-_0.Y\DEJCDBFTVE'%T*]H!>F3
M53E#<H,^O*1YE8'DG3 \LUI !%JQM%+<<*;1NP=F*,_U>U#4UH">N@:PVAW=
MM,%U?\!%>G#YZ+,49J?1!P%;G>J[X&/K*'ES])X,&OQ,U0WR\2^(> 1?P;/X
M<75O ([?QMVO[04]]A:R*""+@=_T"7&M*X@G'$K$7IA*N:X#??@H2YOO&@[:
M^F_(?60D$E(HELI*@5RI9 'Z4KW"LCD/]0FVH,46U-C\'FQ]O+;$;V!/!!Z4
ME:'U8;19097@8JO1LDV;OSZ!8?31L$)_&X 5MK#"P9"=P-(=+'8"*SV%Q=Y@
MV6RNDQ&]XZ))R_?7\O( (JQ!V$OP>>Z'09C8I'D^SI=+.1PE84A\KQ4\<3-J
MW8Q^+C.HRE_[\V,@P'&[<SPFWI,65C(&WI-+WI,D\2=GM%^*X3!(2 _ID];'
MR:"/CRQC4)_7<,,NI'AFRG [7D)-8TJ!CRO+]4 PL===^-Z86,9'E0B/@><&
MQ0F#D]@CD>>?47U%$@XX]F*OAVU,.E_)H*^K'SRZN*LGV!\5K5TQP<$H: VN
MW,=^A"=A>$[KI60TB2 %< ^K78'"PQ7J<?5ED,RN!.!H5&1V%0+'HR SOKR,
M_2#VCPY>P^6E8-_9[,H-'JXW7ZE25!B-OJ.F%B]R"O\/WPU%L+OH\61,U)*N
M+A!O#-0V*(X9BV,?V(W.J+TBB)-)Z ?A=8))5VC(<*$Y(O@_UUW27?F$C(KX
MKG*0X5;D_R+>'SBJ#>67(CCP_3 YI]P]:G@+IK;U.X &C)4PAY:P76W?&N[J
M#OML_1[?+@XO!IV9PP,&-'Q;#FU7SC9@TKN) 94ZO D<)D:6=5N]E@::]'JX
M8S1CR@K ]XV$=JR9V W:EYGYOU!+ P04    "  B@K%2[GW"0"@"   P!0
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M)]I'YM-:<^19:G3'C+,F-G?P;^/1E(U0KHI/:.A6$ ZS.Y7K&M@GO@/++M:
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    "  B@K%2L.-L(.L%  "M-   #P
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MNSD/!2)E/DJ_PTS+%H\2195"65$R_\KJ2I:>HV2?><55(1B C!#(J$?(GQ&
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M %!+ 0(4 Q0    ( "*"L5('04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ (H*Q4LF8$9_O    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ (H*Q4IE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    "  B@K%2UD7S(@4&  !)&P  &
M        @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ (H*Q4B?K/-HC!@  +!@  !@              ("!20X  'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( "*"L5(;-S]!X0,  (01   8
M              " @:(4  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    "  B@K%2!^D]F-L$  #Q$0  &               @(&Y&   >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ (H*Q4BH(R&/,"P
M0$0  !@              ("!RAT  'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    ( "*"L5*LA""?;@(  ' %   8              " @<PI
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    "  B@K%20ODJ
MNG()   T*0  &               @(%P+   >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ (H*Q4EL)HA9,!@  5PX  !@
M ("!&#8  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( "*"
ML5+!FA5/Y!H  &M8   8              " @9H\  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    "  B@K%2:,F@Q-T(   #%P  &0
M        @(&T5P  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   ( "*"L5( SNA=\P(  /L&   9              " @<A@  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ (H*Q4DGJ$$1, @  \00
M !D              ("!\F,  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    "  B@K%2F#+59JD"   ,!@  &0              @(%U9@
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( "*"L5*(KN*:
MQP(  -T%   9              " @55I  !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ (H*Q4B4R3/R8!0  H0\  !D
M ("!4VP  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    "  B
M@K%2TM#@!'D)  "8&P  &0              @($B<@  >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( "*"L5(LQ7<0O@<  +(3   9
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M970R,2YX;6Q02P$"% ,4    "  B@K%2CUME&( &  !U$   &0
M    @($UL   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M "*"L5)KF@FYF@8   L2   9              " @>RV  !X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ (H*Q4O.:DUMR @  704  !D
M             ("!O;T  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    "  B@K%27-I#-E\:   G6   &0              @(%FP   >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( "*"L5)K=08N<0(
M "8%   9              " @?S:  !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ (H*Q4HRRY0   P  Z08  !D              ("!
MI-T  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    "  B@K%2
MPQB1&6$"   %!0  &0              @(';X   >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    ( "*"L5)IL&()KP(   ,&   9
M      " @7/C  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ (H*Q4DP/?AO6 @  W@4  !D              ("!6>8  'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    "  B@K%24\BU>4 %  "^#@
M&0              @(%FZ0  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+
M 0(4 Q0    ( "*"L5*,C%3_@ (  %$%   9              " @=WN  !X
M;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ (H*Q4B?.6GN8
M!P  G!8  !D              ("!E/$  'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6Q02P$"% ,4    "  B@K%28U^92VT#   3!P  &0
M@(%C^0  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( "*"
ML5((J^06Y (  !@&   9              " @0?]  !X;"]W;W)K<VAE971S
M+W-H965T,S4N>&UL4$L! A0#%     @ (H*Q4DT-KX1&!   "@H  !D
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M=#0P+GAM;%!+ 0(4 Q0    ( "*"L5* P%20M@,  -$/   9
M  " @=44 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @
M(H*Q4MSAZPTS @  A04  !D              ("!PA@! 'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6Q02P$"% ,4    "  B@K%2R"1@$+<"  !'!P  &0
M            @($L&P$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4
M Q0    ( "*"L5)R*.=&ZP(  %@(   9              " @1H> 0!X;"]W
M;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ (H*Q4AQI9M/8 P
MY X  !D              ("!/"$! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6Q02P$"% ,4    "  B@K%2GD^-K"L&  ";+P  &0              @(%+
M)0$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( "*"L5)I
M4#'RG@(  $\&   9              " @:TK 0!X;"]W;W)K<VAE971S+W-H
M965T-#<N>&UL4$L! A0#%     @ (H*Q4GR$S_N5 @  FP8  !D
M     ("!@BX! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( "*"L5)RFQZT, 0  *P1   9              "
M@6]  0!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ (H*Q
M4E$+']=Q!@  3R,  !D              ("!UD0! 'AL+W=O<FMS:&5E=',O
M<VAE970U-"YX;6Q02P$"% ,4    "  B@K%2A1M0\Y0"  "*!@  &0
M        @(%^2P$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0
M   ( "*"L5+6%BE.4@4  #09   9              " @4E. 0!X;"]W;W)K
M<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ (H*Q4GH7[X4]!0  Z2(
M !D              ("!TE,! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q0
M2P$"% ,4    "  B@K%2QP@ITN,%  "*'P  &0              @(%&60$
M>&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( "*"L5+$<MDC
MA@(  '8&   9              " @6!? 0!X;"]W;W)K<VAE971S+W-H965T
M-3DN>&UL4$L! A0#%     @ (H*Q4GD!+#[6 P  /A   !D
M ("!'6(! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    "  B
M@K%2+4E^^ST$  "B$   &0              @($J9@$ >&PO=V]R:W-H965T
M<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( "*"L5)DR"7A<P4  #(<   9
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M970V-BYX;6Q02P$"% ,4    "  B@K%2X2_9#Q$#   T"@  &0
M    @(&5@P$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    (
M "*"L5*",< AZ ,  /,1   9              " @=V& 0!X;"]W;W)K<VAE
M971S+W-H965T-C@N>&UL4$L! A0#%     @ (H*Q4H/+V$2? @  ,@<  !D
M             ("!_(H! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"
M% ,4    "  B@K%2\^'6VFX"  "5!0  &0              @('2C0$ >&PO
M=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( "*"L5*CDBRA7 ,
M  T.   9              " @7>0 0!X;"]W;W)K<VAE971S+W-H965T-S$N
M>&UL4$L! A0#%     @ (H*Q4J/1[OF#!   #A8  !D              ("!
M"I0! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    "  B@K%2
MH?KQ9C@#  #=#   &0              @('$F $ >&PO=V]R:W-H965T<R]S
M:&5E=#<S+GAM;%!+ 0(4 Q0    ( "*"L5(QHE%!M@,  #\.   9
M      " @3.< 0!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%
M  @ (H*Q4C!AO/R]!0  HAD  !D              ("!(* ! 'AL+W=O<FMS
M:&5E=',O<VAE970W-2YX;6Q02P$"% ,4    "  B@K%2OD10+\@"   I!P
M&0              @($4I@$ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+
M 0(4 Q0    ( "*"L5+S<7>;0 0   D4   9              " @1.I 0!X
M;"]W;W)K<VAE971S+W-H965T-S<N>&UL4$L! A0#%     @ (H*Q4KX):(WY
M P  I1$  !D              ("!BJT! 'AL+W=O<FMS:&5E=',O<VAE970W
M."YX;6Q02P$"% ,4    "  B@K%2[GW"0"@"   P!0  &0
M@(&ZL0$ >&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;%!+ 0(4 Q0    ( "*"
ML5(TYI7!FP(  )H+   9              " @1FT 0!X;"]W;W)K<VAE971S
M+W-H965T.# N>&UL4$L! A0#%     @ (H*Q4F!NDCDV P  '!0   T
M         ( !Z[8! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  B@K%2EXJ[
M',     3 @  "P              @ %,N@$ 7W)E;',O+G)E;'-02P$"% ,4
M    "  B@K%2L.-L(.L%  "M-   #P              @ $UNP$ >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ (H*Q4K3%"JYH @  1R\  !H
M     ( !3<$! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ (H*Q4BP!9SL; @  #BX  !,              ( ![<,! %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     %@ 6  ?&   .<8!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>336</ContextCount>
  <ElementCount>436</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>113</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Deficit) (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Deficit) (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Deficit (Unaudited) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersDeficitUnauditedParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Deficit (Unaudited) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/Organization</Role>
      <ShortName>Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Recapitalization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/Recapitalization</Role>
      <ShortName>Recapitalization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113105 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2116106 - Disclosure - Prepaid Expenses and Other Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/PrepaidExpensesandOtherCurrentAssets</Role>
      <ShortName>Prepaid Expenses and Other Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119107 - Disclosure - Accrued Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/AccruedLiabilities</Role>
      <ShortName>Accrued Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2122108 - Disclosure - Variable Interest Entities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/VariableInterestEntities</Role>
      <ShortName>Variable Interest Entities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2124109 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2130110 - Disclosure - Borrowing Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/BorrowingArrangements</Role>
      <ShortName>Borrowing Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2132111 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2136112 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2149113 - Disclosure - Redeemable Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/RedeemableConvertiblePreferredStock</Role>
      <ShortName>Redeemable Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2153114 - Disclosure - Common Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommonStock</Role>
      <ShortName>Common Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2164115 - Disclosure - Related-Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related-Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2166116 - Disclosure - Basic and Diluted Net Loss per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/BasicandDilutedNetLossperShare</Role>
      <ShortName>Basic and Diluted Net Loss per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2171117 - Disclosure - Income Tax</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/IncomeTax</Role>
      <ShortName>Income Tax</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://forhims.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://forhims.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://forhims.com/role/Investments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://forhims.com/role/Inventory</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsTables</Role>
      <ShortName>Prepaid Expenses and Other Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://forhims.com/role/PrepaidExpensesandOtherCurrentAssets</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2320305 - Disclosure - Accrued Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/AccruedLiabilitiesTables</Role>
      <ShortName>Accrued Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://forhims.com/role/AccruedLiabilities</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2325306 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://forhims.com/role/FairValueMeasurements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2333307 - Disclosure - Commitment and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommitmentandContingenciesTables</Role>
      <ShortName>Commitment and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2337308 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://forhims.com/role/StockBasedCompensation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2350309 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/RedeemableConvertiblePreferredStockTables</Role>
      <ShortName>Redeemable Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://forhims.com/role/RedeemableConvertiblePreferredStock</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2354310 - Disclosure - Common Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommonStockTables</Role>
      <ShortName>Common Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://forhims.com/role/CommonStock</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2367311 - Disclosure - Basic and Diluted Net Loss per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/BasicandDilutedNetLossperShareTables</Role>
      <ShortName>Basic and Diluted Net Loss per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://forhims.com/role/BasicandDilutedNetLossperShare</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Organization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/OrganizationDetails</Role>
      <ShortName>Organization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://forhims.com/role/Organization</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - Recapitalization (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/RecapitalizationDetails</Role>
      <ShortName>Recapitalization (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://forhims.com/role/Recapitalization</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - Investments - Short-term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/InvestmentsShorttermInvestmentsDetails</Role>
      <ShortName>Investments - Short-term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/InventoryDetails</Role>
      <ShortName>Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://forhims.com/role/InventoryTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2418407 - Disclosure - Prepaid Expenses and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails</Role>
      <ShortName>Prepaid Expenses and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2421408 - Disclosure - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/AccruedLiabilitiesDetails</Role>
      <ShortName>Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://forhims.com/role/AccruedLiabilitiesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2423409 - Disclosure - Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/VariableInterestEntitiesDetails</Role>
      <ShortName>Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://forhims.com/role/VariableInterestEntities</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2426410 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2427411 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2428412 - Disclosure - Fair Value Measurements - Fair Value Assumptions of Private Placement Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails</Role>
      <ShortName>Fair Value Measurements - Fair Value Assumptions of Private Placement Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2429413 - Disclosure - Fair Value Measurements - Change in the Fair Value of Warrant Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails</Role>
      <ShortName>Fair Value Measurements - Change in the Fair Value of Warrant Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2431414 - Disclosure - Borrowing Arrangements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/BorrowingArrangementsDetails</Role>
      <ShortName>Borrowing Arrangements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://forhims.com/role/BorrowingArrangements</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2434415 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://forhims.com/role/CommitmentsandContingencies</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2435416 - Disclosure - Commitment and Contingencies - Future Minimum Lease Commitments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails</Role>
      <ShortName>Commitment and Contingencies - Future Minimum Lease Commitments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2438417 - Disclosure - Stock-Based Compensation - 2017 Stock Plan and 2020 Equity Incentive Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails</Role>
      <ShortName>Stock-Based Compensation - 2017 Stock Plan and 2020 Equity Incentive Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2439418 - Disclosure - Stock-Based Compensation - Stock Options Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Stock Options Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2440419 - Disclosure - Stock-Based Compensation - Weighted Average Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails</Role>
      <ShortName>Stock-Based Compensation - Weighted Average Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2441420 - Disclosure - Stock-Based Compensation - Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2442421 - Disclosure - Stock-Based Compensation - Exercise Price Range of Options Outstanding and Exercisable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails</Role>
      <ShortName>Stock-Based Compensation - Exercise Price Range of Options Outstanding and Exercisable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2443422 - Disclosure - Stock-Based Compensation - RSUs Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - RSUs Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2444423 - Disclosure - Stock-Based Compensation - RSUs Weighted Average Fair Value Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails</Role>
      <ShortName>Stock-Based Compensation - RSUs Weighted Average Fair Value Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2445424 - Disclosure - Stock-Based Compensation - RSUs Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationRSUsActivityDetails</Role>
      <ShortName>Stock-Based Compensation - RSUs Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2446425 - Disclosure - Stock-Based Compensation - Vendor Warrants Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails</Role>
      <ShortName>Stock-Based Compensation - Vendor Warrants Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2447426 - Disclosure - Stock-Based Compensation - Vendor Warrant Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Vendor Warrant Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2448427 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Employees and Nonemployees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Employees and Nonemployees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2451428 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2452429 - Disclosure - Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2455430 - Disclosure - Common Stock - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommonStockAdditionalInformationDetails</Role>
      <ShortName>Common Stock - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2456431 - Disclosure - Common Stock - Pre-Closing Stock Repurchase (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails</Role>
      <ShortName>Common Stock - Pre-Closing Stock Repurchase (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2457432 - Disclosure - Common Stock - Merger Transaction (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommonStockMergerTransactionDetails</Role>
      <ShortName>Common Stock - Merger Transaction (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2458433 - Disclosure - Common Stock - Settlement of Nonrecourse Related-Party Promissory Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails</Role>
      <ShortName>Common Stock - Settlement of Nonrecourse Related-Party Promissory Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2459434 - Disclosure - Common Stock - PIPE Investment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommonStockPIPEInvestmentDetails</Role>
      <ShortName>Common Stock - PIPE Investment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2460435 - Disclosure - Common Stock - Prior to Merger (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommonStockPriortoMergerDetails</Role>
      <ShortName>Common Stock - Prior to Merger (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2461436 - Disclosure - Common Stock - Subsequent to Merger (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommonStockSubsequenttoMergerDetails</Role>
      <ShortName>Common Stock - Subsequent to Merger (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2462437 - Disclosure - Common Stock - Schedule of Warrants Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails</Role>
      <ShortName>Common Stock - Schedule of Warrants Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2463438 - Disclosure - Common Stock - Public Warrant Terms (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/CommonStockPublicWarrantTermsDetails</Role>
      <ShortName>Common Stock - Public Warrant Terms (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2465439 - Disclosure - Related-Party Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/RelatedPartyTransactionsDetails</Role>
      <ShortName>Related-Party Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://forhims.com/role/RelatedPartyTransactions</ParentRole>
      <Position>75</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2468440 - Disclosure - Basic and Diluted Net Loss per Share - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails</Role>
      <ShortName>Basic and Diluted Net Loss per Share - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2469441 - Disclosure - Basic and Diluted Net Loss per Share - Computation of Basic and Diluted Net Loss per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails</Role>
      <ShortName>Basic and Diluted Net Loss per Share - Computation of Basic and Diluted Net Loss per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2470442 - Disclosure - Basic and Diluted Net Loss per Share - Schedule of Excluded Antidilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails</Role>
      <ShortName>Basic and Diluted Net Loss per Share - Schedule of Excluded Antidilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2472443 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://forhims.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://forhims.com/role/IncomeTax</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="hims-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9999.htm</HtmlFileName>
      <LongName>Uncategorized Items - hims-20210331.htm</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/role/uncategorizedFacts</Role>
      <ShortName>Uncategorized Items - hims-20210331.htm</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="hims-20210331.htm">hims-20210331.htm</File>
    <File>hims-20210331.xsd</File>
    <File>hims-20210331_cal.xml</File>
    <File>hims-20210331_def.xml</File>
    <File>hims-20210331_lab.xml</File>
    <File>hims-20210331_pre.xml</File>
    <File>hims-20210331x10qxex311.htm</File>
    <File>hims-20210331x10qxex312.htm</File>
    <File>hims-20210331x10qxex321.htm</File>
    <File>hims-20210331x10qxex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>98
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hims-20210331.htm": {
   "axisCustom": 0,
   "axisStandard": 31,
   "contextCount": 336,
   "dts": {
    "calculationLink": {
     "local": [
      "hims-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hims-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "hims-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hims-20210331_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hims-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "hims-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 626,
   "entityCount": 1,
   "hidden": {
    "http://forhims.com/20210331": 4,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 9
   },
   "keyCustom": 93,
   "keyStandard": 343,
   "memberCustom": 61,
   "memberStandard": 42,
   "nsprefix": "hims",
   "nsuri": "http://forhims.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://forhims.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hims:ReverseRecapitalizationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Recapitalization",
     "role": "http://forhims.com/role/Recapitalization",
     "shortName": "Recapitalization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hims:ReverseRecapitalizationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - Investments",
     "role": "http://forhims.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113105 - Disclosure - Inventory",
     "role": "http://forhims.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116106 - Disclosure - Prepaid Expenses and Other Current Assets",
     "role": "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssets",
     "shortName": "Prepaid Expenses and Other Current Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentAssetsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119107 - Disclosure - Accrued Liabilities",
     "role": "http://forhims.com/role/AccruedLiabilities",
     "shortName": "Accrued Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122108 - Disclosure - Variable Interest Entities",
     "role": "http://forhims.com/role/VariableInterestEntities",
     "shortName": "Variable Interest Entities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124109 - Disclosure - Fair Value Measurements",
     "role": "http://forhims.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2130110 - Disclosure - Borrowing Arrangements",
     "role": "http://forhims.com/role/BorrowingArrangements",
     "shortName": "Borrowing Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132111 - Disclosure - Commitments and Contingencies",
     "role": "http://forhims.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136112 - Disclosure - Stock-Based Compensation",
     "role": "http://forhims.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hims:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149113 - Disclosure - Redeemable Convertible Preferred Stock",
     "role": "http://forhims.com/role/RedeemableConvertiblePreferredStock",
     "shortName": "Redeemable Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hims:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153114 - Disclosure - Common Stock",
     "role": "http://forhims.com/role/CommonStock",
     "shortName": "Common Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164115 - Disclosure - Related-Party Transactions",
     "role": "http://forhims.com/role/RelatedPartyTransactions",
     "shortName": "Related-Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2166116 - Disclosure - Basic and Diluted Net Loss per Share",
     "role": "http://forhims.com/role/BasicandDilutedNetLossperShare",
     "shortName": "Basic and Diluted Net Loss per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2171117 - Disclosure - Income Tax",
     "role": "http://forhims.com/role/IncomeTax",
     "shortName": "Income Tax",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://forhims.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - Investments (Tables)",
     "role": "http://forhims.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Inventory (Tables)",
     "role": "http://forhims.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - Prepaid Expenses and Other Current Assets (Tables)",
     "role": "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsTables",
     "shortName": "Prepaid Expenses and Other Current Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "role": "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320305 - Disclosure - Accrued Liabilities (Tables)",
     "role": "http://forhims.com/role/AccruedLiabilitiesTables",
     "shortName": "Accrued Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325306 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://forhims.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333307 - Disclosure - Commitment and Contingencies (Tables)",
     "role": "http://forhims.com/role/CommitmentandContingenciesTables",
     "shortName": "Commitment and Contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337308 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://forhims.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350309 - Disclosure - Redeemable Convertible Preferred Stock (Tables)",
     "role": "http://forhims.com/role/RedeemableConvertiblePreferredStockTables",
     "shortName": "Redeemable Convertible Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354310 - Disclosure - Common Stock (Tables)",
     "role": "http://forhims.com/role/CommonStockTables",
     "shortName": "Common Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2367311 - Disclosure - Basic and Diluted Net Loss per Share (Tables)",
     "role": "http://forhims.com/role/BasicandDilutedNetLossperShareTables",
     "shortName": "Basic and Diluted Net Loss per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i2c9f921c782846e594e898a25a3e7e57_I20210120",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hims:RecapitalizationExchangeRatio",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Organization (Details)",
     "role": "http://forhims.com/role/OrganizationDetails",
     "shortName": "Organization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfInvestments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "role": "http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ImpairmentOfInvestments",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "role": "http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails",
     "shortName": "Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i0bdb1af208e14b2ea352fb5361c65042_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)",
     "role": "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i2c9f921c782846e594e898a25a3e7e57_I20210120",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hims:ReverseRecapitalizationPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - Recapitalization (Details)",
     "role": "http://forhims.com/role/RecapitalizationDetails",
     "shortName": "Recapitalization (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ib9aae412577446ebbf1adc5652403981_D20210120-20210120",
      "decimals": "-5",
      "lang": "en-US",
      "name": "hims:ProceedsFromIssuanceOfCommonStockRecapitalization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - Investments - Short-term Investments (Details)",
     "role": "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails",
     "shortName": "Investments - Short-term Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:MarketableSecuritiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Inventory (Details)",
     "role": "http://forhims.com/role/InventoryDetails",
     "shortName": "Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryFinishedGoodsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hims:TradeAndOtherReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418407 - Disclosure - Prepaid Expenses and Other Current Assets (Details)",
     "role": "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails",
     "shortName": "Prepaid Expenses and Other Current Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "hims:TradeAndOtherReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedMarketingCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421408 - Disclosure - Accrued Liabilities (Details)",
     "role": "http://forhims.com/role/AccruedLiabilitiesDetails",
     "shortName": "Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedMarketingCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423409 - Disclosure - Variable Interest Entities (Details)",
     "role": "http://forhims.com/role/VariableInterestEntitiesDetails",
     "shortName": "Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i110e767e14c549139091e08b11477a77_D20210101-20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "hims:PercentageOwnedByLicensedPhysicians",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ie21c138cee4747ccb68c72561e6a795b_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426410 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities (Details)",
     "role": "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Schedule of Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ie21c138cee4747ccb68c72561e6a795b_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427411 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "role": "http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ic3283d5498c749f187e436d50e1f4646_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428412 - Disclosure - Fair Value Measurements - Fair Value Assumptions of Private Placement Warrants (Details)",
     "role": "http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails",
     "shortName": "Fair Value Measurements - Fair Value Assumptions of Private Placement Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ic3283d5498c749f187e436d50e1f4646_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i739ad782f5ac49639074bf72004c4e5f_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429413 - Disclosure - Fair Value Measurements - Change in the Fair Value of Warrant Liabilities (Details)",
     "role": "http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails",
     "shortName": "Fair Value Measurements - Change in the Fair Value of Warrant Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i739ad782f5ac49639074bf72004c4e5f_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i95f1f52b2b1b4200bc65210a3f67c839_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Deficit) (Unaudited)",
     "role": "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
     "shortName": "Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Deficit) (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i6e26fbeb5863440e9e721a1313cd6a22_D20200101-20200331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "hims:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashNoncurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431414 - Disclosure - Borrowing Arrangements (Details)",
     "role": "http://forhims.com/role/BorrowingArrangementsDetails",
     "shortName": "Borrowing Arrangements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i68341f8644ea4e029489cb67df2b60c9_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434415 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://forhims.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseAndRentalExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435416 - Disclosure - Commitment and Contingencies - Future Minimum Lease Commitments (Details)",
     "role": "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails",
     "shortName": "Commitment and Contingencies - Future Minimum Lease Commitments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438417 - Disclosure - Stock-Based Compensation - 2017 Stock Plan and 2020 Equity Incentive Plan (Details)",
     "role": "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails",
     "shortName": "Stock-Based Compensation - 2017 Stock Plan and 2020 Equity Incentive Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i8906c1a545c9405d8f6cc203bc4d9e99_D20210101-20210331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439418 - Disclosure - Stock-Based Compensation - Stock Options Narrative (Details)",
     "role": "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails",
     "shortName": "Stock-Based Compensation - Stock Options Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440419 - Disclosure - Stock-Based Compensation - Weighted Average Fair Value Assumptions (Details)",
     "role": "http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails",
     "shortName": "Stock-Based Compensation - Weighted Average Fair Value Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ic193587f900c422d99a73e17bc3a8b2f_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i56db4fe025c047fd8e6046a280f8d46d_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441420 - Disclosure - Stock-Based Compensation - Option Activity (Details)",
     "role": "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
     "shortName": "Stock-Based Compensation - Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i913789bdac1345d384ccb19b9e71efd3_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442421 - Disclosure - Stock-Based Compensation - Exercise Price Range of Options Outstanding and Exercisable (Details)",
     "role": "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails",
     "shortName": "Stock-Based Compensation - Exercise Price Range of Options Outstanding and Exercisable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iae89e874aad64f008fc6334367e88e92_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i2c9f921c782846e594e898a25a3e7e57_I20210120",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hims:RecapitalizationExchangeRatio",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443422 - Disclosure - Stock-Based Compensation - RSUs Narrative (Details)",
     "role": "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
     "shortName": "Stock-Based Compensation - RSUs Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i270ee5ced559409599d7bc96fdfae812_D20210101-20210331",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i270ee5ced559409599d7bc96fdfae812_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444423 - Disclosure - Stock-Based Compensation - RSUs Weighted Average Fair Value Assumptions (Details)",
     "role": "http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails",
     "shortName": "Stock-Based Compensation - RSUs Weighted Average Fair Value Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i270ee5ced559409599d7bc96fdfae812_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsOfStockIssuanceCosts",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Deficit (Unaudited) (Parenthetical)",
     "role": "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersDeficitUnauditedParenthetical",
     "shortName": "Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Deficit (Unaudited) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i0e017683d1224a57bcb05400dca67f22_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445424 - Disclosure - Stock-Based Compensation - RSUs Activity (Details)",
     "role": "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
     "shortName": "Stock-Based Compensation - RSUs Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i6a9e72571629466e95f463c7efbcbd98_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i2c9f921c782846e594e898a25a3e7e57_I20210120",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hims:RecapitalizationExchangeRatio",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446425 - Disclosure - Stock-Based Compensation - Vendor Warrants Narrative (Details)",
     "role": "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails",
     "shortName": "Stock-Based Compensation - Vendor Warrants Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i98bfbbb5e3e147e3889c062c610a6917_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i8e6a617bf8cf4f5aad2833449c6a4135_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447426 - Disclosure - Stock-Based Compensation - Vendor Warrant Activity (Details)",
     "role": "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails",
     "shortName": "Stock-Based Compensation - Vendor Warrant Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i71bbcd6c9a8544e19d41c0ad14f6aa7f_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448427 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Employees and Nonemployees (Details)",
     "role": "http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation Expense for Employees and Nonemployees (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i6a91c65f7eb54a3c989d98b6cb6a18a8_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i739ad782f5ac49639074bf72004c4e5f_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451428 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)",
     "role": "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i2c9f921c782846e594e898a25a3e7e57_I20210120",
      "decimals": "INF",
      "lang": "en-US",
      "name": "hims:RecapitalizationExchangeConversionBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i739ad782f5ac49639074bf72004c4e5f_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452429 - Disclosure - Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock (Details)",
     "role": "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ibcafc3c8a8a6421cb500d0acdd1da778_I20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i8d64fe4256a5495dac515af8a61e6773_I20210119",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hims:NumberOfClassesOfCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "common_stock_class",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455430 - Disclosure - Common Stock - Additional Information (Details)",
     "role": "http://forhims.com/role/CommonStockAdditionalInformationDetails",
     "shortName": "Common Stock - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i8d64fe4256a5495dac515af8a61e6773_I20210119",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hims:NumberOfClassesOfCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "common_stock_class",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsForRepurchaseOfCommonStock",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456431 - Disclosure - Common Stock - Pre-Closing Stock Repurchase (Details)",
     "role": "http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails",
     "shortName": "Common Stock - Pre-Closing Stock Repurchase (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i41a0f3e486ea467db3090dce1a65767b_D20210120-20210120",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedAndRetiredDuringPeriodShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i2c9f921c782846e594e898a25a3e7e57_I20210120",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hims:RecapitalizationExchangeRatio",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457432 - Disclosure - Common Stock - Merger Transaction (Details)",
     "role": "http://forhims.com/role/CommonStockMergerTransactionDetails",
     "shortName": "Common Stock - Merger Transaction (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromRelatedPartyDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458433 - Disclosure - Common Stock - Settlement of Nonrecourse Related-Party Promissory Notes (Details)",
     "role": "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails",
     "shortName": "Common Stock - Settlement of Nonrecourse Related-Party Promissory Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i46d371e52a99410f95f88ff85bac410c_D20210120-20210120",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromRelatedPartyDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "role": "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
     "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ie07ffdf9076247ab9a6dbfe66f62c70b_D20210120-20210120",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459434 - Disclosure - Common Stock - PIPE Investment (Details)",
     "role": "http://forhims.com/role/CommonStockPIPEInvestmentDetails",
     "shortName": "Common Stock - PIPE Investment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i0cc1f5f00f854fd696092abbe8e5eb52_D20200701-20200731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460435 - Disclosure - Common Stock - Prior to Merger (Details)",
     "role": "http://forhims.com/role/CommonStockPriortoMergerDetails",
     "shortName": "Common Stock - Prior to Merger (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i0cc1f5f00f854fd696092abbe8e5eb52_D20200701-20200731",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i2c9f921c782846e594e898a25a3e7e57_I20210120",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hims:RecapitalizationExchangeRatio",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461436 - Disclosure - Common Stock - Subsequent to Merger (Details)",
     "role": "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
     "shortName": "Common Stock - Subsequent to Merger (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "iab13a99ae40f48409e0e1f3fd36fa413_I20210228",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i79825d4c5b744870999e9bde3e8537f5_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462437 - Disclosure - Common Stock - Schedule of Warrants Outstanding (Details)",
     "role": "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
     "shortName": "Common Stock - Schedule of Warrants Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i79825d4c5b744870999e9bde3e8537f5_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i0929992266364d4095e65e0383a160d6_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hims:ClassOfWarrantOrRightExercisablePeriodAfterClosingDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463438 - Disclosure - Common Stock - Public Warrant Terms (Details)",
     "role": "http://forhims.com/role/CommonStockPublicWarrantTermsDetails",
     "shortName": "Common Stock - Public Warrant Terms (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i0929992266364d4095e65e0383a160d6_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hims:ClassOfWarrantOrRightExercisablePeriodAfterClosingDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromRelatedPartyDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465439 - Disclosure - Related-Party Transactions (Details)",
     "role": "http://forhims.com/role/RelatedPartyTransactionsDetails",
     "shortName": "Related-Party Transactions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i771a07ec099545b09a6b92170d11d935_D20210101-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468440 - Disclosure - Basic and Diluted Net Loss per Share - Additional Information (Details)",
     "role": "http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails",
     "shortName": "Basic and Diluted Net Loss per Share - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DividendsCommonStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469441 - Disclosure - Basic and Diluted Net Loss per Share - Computation of Basic and Diluted Net Loss per Share (Details)",
     "role": "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
     "shortName": "Basic and Diluted Net Loss per Share - Computation of Basic and Diluted Net Loss per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i2194548550b7484685726895d99493c1_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i442b98b30a99440cabcf9c2a33258c44_D20210101-20210331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470442 - Disclosure - Basic and Diluted Net Loss per Share - Schedule of Excluded Antidilutive Securities (Details)",
     "role": "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails",
     "shortName": "Basic and Diluted Net Loss per Share - Schedule of Excluded Antidilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i442b98b30a99440cabcf9c2a33258c44_D20210101-20210331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472443 - Disclosure - Income Taxes (Details)",
     "role": "http://forhims.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Organization",
     "role": "http://forhims.com/role/Organization",
     "shortName": "Organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://forhims.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "i99867449219c42e3b58d75ee18d746a8_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9999": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hims-20210331.htm",
      "contextRef": "ic900949695af4a3f8a0e43ab44a1d546_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "",
     "isDefault": "false",
     "longName": "Uncategorized Items - hims-20210331.htm",
     "role": "http://xbrl.sec.gov/role/uncategorizedFacts",
     "shortName": "Uncategorized Items - hims-20210331.htm",
     "subGroupType": "",
     "uniqueAnchor": null
    }
   },
   "segmentCount": 113,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r493"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "hims_AccruedPayrollCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/AccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Payroll Costs, Current",
        "label": "Accrued Payroll Costs, Current",
        "terseLabel": "Payroll costs"
       }
      }
     },
     "localname": "AccruedPayrollCostsCurrent",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital, Early Exercised Options, Vested",
        "label": "Adjustments To Additional Paid In Capital, Early Exercised Options, Vested",
        "terseLabel": "Vesting of early exercised stock options"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalEarlyExercisedOptionsVested",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital, Recapitalization, Warrant Expense",
        "label": "Adjustments To Additional Paid In Capital, Recapitalization, Warrant Expense",
        "negatedTerseLabel": "Warrant expense in connection with Merger"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalRecapitalizationWarrantExpense",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital, Related Party Receivable Repayment",
        "label": "Adjustments To Additional Paid In Capital, Related Party Receivable Repayment",
        "terseLabel": "Repayment of related-party promissory notes associated with vested shares"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalRelatedPartyReceivableRepayment",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_AdjustmentsToAdditionalPaidInCapitalWarrantConversion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital, Warrant Conversion",
        "label": "Adjustments To Additional Paid In Capital, Warrant Conversion",
        "terseLabel": "Conversion of Series D preferred stock warrants to Class A common warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantConversion",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_AffiliatedMedicalGroupsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affiliated Medical Groups",
        "label": "Affiliated Medical Groups [Member]",
        "terseLabel": "Affiliated Medical Groups"
       }
      }
     },
     "localname": "AffiliatedMedicalGroupsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_BusinessCreditCardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Credit Card",
        "label": "Business Credit Card [Member]",
        "terseLabel": "Business Credit Card"
       }
      }
     },
     "localname": "BusinessCreditCardMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_CEOAndDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CEO And Director",
        "label": "CEO And Director [Member]",
        "terseLabel": "CEO And Director"
       }
      }
     },
     "localname": "CEOAndDirectorMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_CapitalAgreement2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Agreement, 2019",
        "label": "Capital Agreement, 2019 [Member]",
        "terseLabel": "Capital Agreement, 2019"
       }
      }
     },
     "localname": "CapitalAgreement2019Member",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_CapitalAgreement2019TrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Agreement, 2019, Tranche One",
        "label": "Capital Agreement, 2019, Tranche One [Member]",
        "terseLabel": "Capital Agreement, 2019, Tranche One"
       }
      }
     },
     "localname": "CapitalAgreement2019TrancheOneMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_CapitalAgreement2019TrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Agreement, 2019, Tranche Two",
        "label": "Capital Agreement, 2019, Tranche Two [Member]",
        "terseLabel": "Capital Agreement, 2019, Tranche Two"
       }
      }
     },
     "localname": "CapitalAgreement2019TrancheTwoMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ChiefExecutiveOfficerAndDirectorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Chief Executive Officer And Director",
        "label": "Chief Executive Officer And Director [Member]",
        "terseLabel": "Chief Executive Officer And Director"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerAndDirectorMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ClassACommonStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class A Common Stock Warrants",
        "label": "Class A Common Stock Warrants [Member]",
        "terseLabel": "Class A Common Stock Warrants"
       }
      }
     },
     "localname": "ClassACommonStockWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ClassOfWarrantOrRightExercisablePeriodAfterClosingDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Exercisable Period After Closing Date",
        "label": "Class Of Warrant Or Right, Exercisable Period After Closing Date",
        "terseLabel": "Exercisable period after closing date"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisablePeriodAfterClosingDate",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_ClassOfWarrantOrRightExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Expiration Period",
        "label": "Class Of Warrant Or Right, Expiration Period",
        "terseLabel": "Warrant expiration period"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExpirationPeriod",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Period After Written Notice Of Redemption",
        "label": "Class Of Warrant Or Right, Period After Written Notice Of Redemption",
        "terseLabel": "Period after written notice of redemption"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightPeriodAfterWrittenNoticeOfRedemption",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_ClassOfWarrantOrRightRedemptionPeriodAfterExercisable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Redemption Period After Exercisable",
        "label": "Class Of Warrant Or Right, Redemption Period After Exercisable",
        "terseLabel": "Period after warrants become exercisable for warrant redemption commencement"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionPeriodAfterExercisable",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_ClassOfWarrantOrRightRedemptionPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Redemption Price Per Share",
        "label": "Class Of Warrant Or Right, Redemption Price Per Share",
        "terseLabel": "Class of warrant or right, redemption price per share (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightRedemptionPricePerShare",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ClassOfWarrantOrRightSalePriceRedemptionThreshold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Sale Price Redemption Threshold",
        "label": "Class Of Warrant Or Right, Sale Price Redemption Threshold",
        "terseLabel": "Sale price redemption threshold (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightSalePriceRedemptionThreshold",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Share Redemption Notice Period, Minimum",
        "label": "Class Of Warrant Or Right, Share Redemption Notice Period, Minimum",
        "terseLabel": "Minimum period of prior notice for share redemption"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightShareRedemptionNoticePeriodMinimum",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_ClassOfWarrantOrRightThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Threshold Consecutive Trading Days",
        "label": "Class Of Warrant Or Right, Threshold Consecutive Trading Days",
        "terseLabel": "Threshold consecutive trading days"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightThresholdConsecutiveTradingDays",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hims_ClassOfWarrantOrRightThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Threshold Trading Days",
        "label": "Class Of Warrant Or Right, Threshold Trading Days",
        "terseLabel": "Threshold trading days"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightThresholdTradingDays",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hims_CommonClassAAndVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Class A And V",
        "label": "Common Class A And V [Member]",
        "terseLabel": "Common Class A and V"
       }
      }
     },
     "localname": "CommonClassAAndVMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_CommonClassFMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Class F",
        "label": "Common Class F [Member]",
        "terseLabel": "Common Class F"
       }
      }
     },
     "localname": "CommonClassFMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_CommonClassVMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Class V",
        "label": "Common Class V [Member]",
        "terseLabel": "Common Class V"
       }
      }
     },
     "localname": "CommonClassVMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/Cover",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_CommonStockWarrantsGroupOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrants, Group One",
        "label": "Common Stock Warrants, Group One [Member]",
        "terseLabel": "Common Stock Warrants, Group One"
       }
      }
     },
     "localname": "CommonStockWarrantsGroupOneMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPriortoMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_CommonStockWarrantsGroupTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrants, Group Two",
        "label": "Common Stock Warrants, Group Two [Member]",
        "terseLabel": "Common Stock Warrants, Group Two"
       }
      }
     },
     "localname": "CommonStockWarrantsGroupTwoMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPriortoMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_CommonStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Warrants",
        "label": "Common Stock Warrants [Member]",
        "terseLabel": "Common Stock Warrants"
       }
      }
     },
     "localname": "CommonStockWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPriortoMergerDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ConversionOfPreferredStockWarrantsAmountConverted": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion Of Preferred Stock Warrants, Amount Converted",
        "label": "Conversion Of Preferred Stock Warrants, Amount Converted",
        "terseLabel": "Conversion of Series D preferred stock warrants to Class A common warrants"
       }
      }
     },
     "localname": "ConversionOfPreferredStockWarrantsAmountConverted",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_DebtInstrumentCovenantRequiredCollateralAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Required Collateral Amount",
        "label": "Debt Instrument, Covenant, Required Collateral Amount",
        "terseLabel": "Debt instrument, covenant, required collateral amount"
       }
      }
     },
     "localname": "DebtInstrumentCovenantRequiredCollateralAmount",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_DebtInstrumentMaximumBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Maximum Borrowing Capacity",
        "label": "Debt Instrument, Maximum Borrowing Capacity",
        "terseLabel": "Debt instrument, maximum borrowing capacity"
       }
      }
     },
     "localname": "DebtInstrumentMaximumBorrowingCapacity",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_DebtWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Warrants",
        "label": "Debt Warrants [Member]",
        "terseLabel": "Debt Warrants"
       }
      }
     },
     "localname": "DebtWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_EarlyExerciseOfStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Early Exercise Of Stock Options",
        "label": "Early Exercise Of Stock Options [Member]",
        "terseLabel": "Common stock issued for early exercise of stock options"
       }
      }
     },
     "localname": "EarlyExerciseOfStockOptionsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_EarnOutAndParentWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn-Out And Parent Warrants",
        "label": "Earn-Out And Parent Warrants [Member]",
        "terseLabel": "Earn-Out And Parent Warrants"
       }
      }
     },
     "localname": "EarnOutAndParentWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_EarnOutRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earn Out Restricted Stock Units",
        "label": "Earn Out Restricted Stock Units [Member]",
        "terseLabel": "Earn Out Restricted Stock Units"
       }
      }
     },
     "localname": "EarnOutRestrictedStockUnitsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_EquityIncentivePlan2020And2017StockPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Plan, 2020 And 2017 Stock Plan",
        "label": "Equity Incentive Plan, 2020 And 2017 Stock Plan [Member]",
        "terseLabel": "2020 Equity Incentive Plan and 2017 Stock Plan"
       }
      }
     },
     "localname": "EquityIncentivePlan2020And2017StockPlanMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_EquityIncentivePlan2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Plan, 2020",
        "label": "Equity Incentive Plan, 2020 [Member]",
        "terseLabel": "2020 Equity Incentive Plan"
       }
      }
     },
     "localname": "EquityIncentivePlan2020Member",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ExercisePriceRange006To040Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range $0.06 to $0.40",
        "label": "Exercise Price Range $0.06 to $0.40 [Member]",
        "terseLabel": "Exercise Price Range $0.06 to $0.40"
       }
      }
     },
     "localname": "ExercisePriceRange006To040Member",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ExercisePriceRange1517To2276Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range $15.17 to $22.76",
        "label": "Exercise Price Range $15.17 to $22.76 [Member]",
        "terseLabel": "Exercise Price Range $15.17 to $22.76"
       }
      }
     },
     "localname": "ExercisePriceRange1517To2276Member",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ExercisePriceRange155To233Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range $1.55 to $2.33",
        "label": "Exercise Price Range $1.55 to $2.33 [Member]",
        "terseLabel": "Exercise Price Range $1.55 to $2.33"
       }
      }
     },
     "localname": "ExercisePriceRange155To233Member",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ExercisePriceRange243To365Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range $2.43 to $3.65",
        "label": "Exercise Price Range $2.43 to $3.65 [Member]",
        "terseLabel": "Exercise Price Range $2.43 to $3.65"
       }
      }
     },
     "localname": "ExercisePriceRange243To365Member",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ExercisePriceRange890To1335Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise Price Range $8.90 to $13.35",
        "label": "Exercise Price Range $8.90 to $13.35 [Member]",
        "terseLabel": "Exercise Price Range $8.90 to $13.35"
       }
      }
     },
     "localname": "ExercisePriceRange890To1335Member",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reverse Recapitalization",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Reverse Recapitalization",
        "negatedTerseLabel": "Conversion of Series D preferred stock warrants to Class A common stock warrants"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityReverseRecapitalization",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_FormerExecutiveOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Executive Officer",
        "label": "Former Executive Officer [Member]",
        "terseLabel": "Former Executive Officer"
       }
      }
     },
     "localname": "FormerExecutiveOfficerMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_HimsIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hims, Inc.",
        "label": "Hims, Inc. [Member]",
        "terseLabel": "Hims, Inc."
       }
      }
     },
     "localname": "HimsIncMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_HimsOptionAndRSUHoldersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hims' Option And RSU Holders",
        "label": "Hims' Option And RSU Holders [Member]",
        "terseLabel": "Hims' Option And RSU Holders"
       }
      }
     },
     "localname": "HimsOptionAndRSUHoldersMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_HimsStockholdersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hims' Stockholders",
        "label": "Hims' Stockholders [Member]",
        "terseLabel": "Hims' Stockholders"
       }
      }
     },
     "localname": "HimsStockholdersMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_HimsWarrantHoldersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hims' Warrant Holders",
        "label": "Hims' Warrant Holders [Member]",
        "terseLabel": "Hims' Warrant Holders"
       }
      }
     },
     "localname": "HimsWarrantHoldersMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_IdentityVerificationServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identity Verification Services",
        "label": "Identity Verification Services [Member]",
        "terseLabel": "Identity Verification Services"
       }
      }
     },
     "localname": "IdentityVerificationServicesMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_IncreaseDecreaseInDeferredRent": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Deferred Rent",
        "label": "Increase (Decrease) In Deferred Rent",
        "terseLabel": "Deferred rent"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRent",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_June172020GrantOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 17, 2020 Grant One",
        "label": "June 17, 2020 Grant One [Member]",
        "terseLabel": "June 17, 2020 Grant One"
       }
      }
     },
     "localname": "June172020GrantOneMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_June172020GrantTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "June 17, 2020 Grant Two",
        "label": "June 17, 2020 Grant Two [Member]",
        "terseLabel": "June 17, 2020 Grant Two"
       }
      }
     },
     "localname": "June172020GrantTwoMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Period For Payments Net Of Rent Abatement",
        "label": "Lessee, Operating Lease, Period For Payments Net Of Rent Abatement",
        "terseLabel": "Lessee, operating lease, period for payments net of rent abatement"
       }
      }
     },
     "localname": "LesseeOperatingLeasePeriodForPaymentsNetOfRentAbatement",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_MarketingExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketing Expense",
        "label": "Marketing Expense [Member]",
        "terseLabel": "Marketing"
       }
      }
     },
     "localname": "MarketingExpenseMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_NewAlbanyOhioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "New Albany, Ohio",
        "label": "New Albany, Ohio [Member]",
        "terseLabel": "New Albany, Ohio"
       }
      }
     },
     "localname": "NewAlbanyOhioMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_NoncashWarrantExpense": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Warrant Expense",
        "label": "Noncash Warrant Expense",
        "terseLabel": "Warrant expense in connection with Merger"
       }
      }
     },
     "localname": "NoncashWarrantExpense",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_NonrecourseRelatedPartyPromissoryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonrecourse Related-Party Promissory Notes",
        "label": "Nonrecourse Related-Party Promissory Notes [Member]",
        "terseLabel": "Nonrecourse Related-Party Promissory Notes"
       }
      }
     },
     "localname": "NonrecourseRelatedPartyPromissoryNotesMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_NotesReceivableAmountOfPrincipalPaymentCanceled": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notes Receivable, Amount Of Principal Payment Canceled",
        "label": "Notes Receivable, Amount Of Principal Payment Canceled",
        "terseLabel": "Notes receivable, amount of principal payment canceled"
       }
      }
     },
     "localname": "NotesReceivableAmountOfPrincipalPaymentCanceled",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_NumberOfClassesOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Classes Of Common Stock",
        "label": "Number Of Classes Of Common Stock",
        "terseLabel": "Number of classes of common stock"
       }
      }
     },
     "localname": "NumberOfClassesOfCommonStock",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hims_NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Redeemable Shares Excluded From Calculation Of Net Income (Loss) Per Share",
        "label": "Number Of Redeemable Shares Excluded From Calculation Of Net Income (Loss) Per Share",
        "terseLabel": "Number of redeemable shares excluded from calculation of net income (loss) per share (in shares)"
       }
      }
     },
     "localname": "NumberOfRedeemableSharesExcludedFromCalculationOfNetIncomeLossPerShare",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_OperatingLeaseRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Renewal Term",
        "label": "Operating Lease, Renewal Term",
        "terseLabel": "Operating lease, renewal term"
       }
      }
     },
     "localname": "OperatingLeaseRenewalTerm",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_OperatingLeaseRentExpenseAnnualEscalationPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Rent Expense, Annual Escalation, Percent",
        "label": "Operating Lease, Rent Expense, Annual Escalation, Percent",
        "terseLabel": "Rent expense, annual escalation, percent"
       }
      }
     },
     "localname": "OperatingLeaseRentExpenseAnnualEscalationPercent",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hims_OperatingLeaseTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Term Of Contract",
        "label": "Operating Lease, Term Of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "OperatingLeaseTermOfContract",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_OperationalSupportMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operational Support",
        "label": "Operational Support [Member]",
        "terseLabel": "Operational Support"
       }
      }
     },
     "localname": "OperationalSupportMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other-Than-Temporary Impairment On Investments, Policy",
        "label": "Other-Than-Temporary Impairment On Investments, Policy [Policy Text Block]",
        "terseLabel": "Other-Than-Temporary Impairment"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentOnInvestmentsPolicyPolicyTextBlock",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hims_ParentWarrantRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Parent Warrant Restricted Stock Units",
        "label": "Parent Warrant Restricted Stock Units [Member]",
        "terseLabel": "Parent Warrant Restricted Stock Units"
       }
      }
     },
     "localname": "ParentWarrantRestrictedStockUnitsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ParentWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Parent Warrants",
        "label": "Parent Warrants [Member]",
        "terseLabel": "Parent Warrants"
       }
      }
     },
     "localname": "ParentWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_PercentageOwnedByLicensedPhysicians": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Owned By Licensed Physicians",
        "label": "Percentage Owned By Licensed Physicians",
        "terseLabel": "Percentage owned by licensed physicians"
       }
      }
     },
     "localname": "PercentageOwnedByLicensedPhysicians",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hims_PrivatePlacementWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Placement Warrants",
        "label": "Private Placement Warrants [Member]",
        "terseLabel": "Private Placement Warrants"
       }
      }
     },
     "localname": "PrivatePlacementWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ProceedsFromConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Conversion Of Convertible Securities",
        "label": "Proceeds From Conversion Of Convertible Securities",
        "terseLabel": "Proceeds from conversion of convertible securities"
       }
      }
     },
     "localname": "ProceedsFromConversionOfConvertibleSecurities",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_ProceedsFromIssuanceOfCommonStockRecapitalization": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Issuance Of Common Stock, Recapitalization",
        "label": "Proceeds From Issuance Of Common Stock, Recapitalization",
        "terseLabel": "Proceeds from issuance of common stock, recapitalization"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStockRecapitalization",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_ProceedsFromIssuanceOfTemporaryEquity": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Issuance Of Temporary Equity",
        "label": "Proceeds From Issuance Of Temporary Equity",
        "terseLabel": "Proceeds from issuance of temporary equity",
        "verboseLabel": "Proceeds, Net of Issuance Costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfTemporaryEquity",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_ProceedsFromStockOptionsExercisedNetOfRepurchases": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Stock Options Exercised, Net Of Repurchases",
        "label": "Proceeds From Stock Options Exercised, Net Of Repurchases",
        "terseLabel": "Proceeds from exercise of vested and unvested stock options, net of repurchases"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercisedNetOfRepurchases",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_PublicWarrantsCashRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Warrants, Cash Redemption",
        "label": "Public Warrants, Cash Redemption [Member]",
        "terseLabel": "Public Warrants, Cash Redemption"
       }
      }
     },
     "localname": "PublicWarrantsCashRedemptionMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_PublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Warrants",
        "label": "Public Warrants [Member]",
        "terseLabel": "Public Warrants"
       }
      }
     },
     "localname": "PublicWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails",
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_PublicWarrantsWarrantRedemptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Warrants, Warrant Redemption",
        "label": "Public Warrants, Warrant Redemption [Member]",
        "terseLabel": "Public Warrants, Warrant Redemption"
       }
      }
     },
     "localname": "PublicWarrantsWarrantRedemptionMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_RecapitalizationContingentConsiderationEquityExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recapitalization, Contingent Consideration, Equity, Exchange Ratio",
        "label": "Recapitalization, Contingent Consideration, Equity, Exchange Ratio",
        "terseLabel": "Recapitalization, contingent consideration, equity, exchange ratio"
       }
      }
     },
     "localname": "RecapitalizationContingentConsiderationEquityExchangeRatio",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hims_RecapitalizationExchangeConversionBasis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recapitalization Exchange Conversion Basis",
        "label": "Recapitalization Exchange Conversion Basis",
        "terseLabel": "Recapitalization exchange conversion basis"
       }
      }
     },
     "localname": "RecapitalizationExchangeConversionBasis",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hims_RecapitalizationExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recapitalization Exchange Ratio",
        "label": "Recapitalization Exchange Ratio",
        "terseLabel": "Recapitalization exchange ratio"
       }
      }
     },
     "localname": "RecapitalizationExchangeRatio",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/OrganizationDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "hims_ReclassificationOfDeferredTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification Of Deferred Transaction Costs",
        "label": "Reclassification Of Deferred Transaction Costs",
        "terseLabel": "Reclassification of deferred transaction costs"
       }
      }
     },
     "localname": "ReclassificationOfDeferredTransactionCosts",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_RedeemableClassACommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Class A Common Stock",
        "label": "Redeemable Class A Common Stock [Member]",
        "terseLabel": "Redeemable Class\u00a0A Common\u00a0Stock"
       }
      }
     },
     "localname": "RedeemableClassACommonStockMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_RedeemableCommonStockTransactionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Common Stock Transaction",
        "label": "Redeemable Common Stock Transaction [Member]",
        "terseLabel": "Redeemable Common Stock Transaction"
       }
      }
     },
     "localname": "RedeemableCommonStockTransactionMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_RedeemableWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Warrants",
        "label": "Redeemable Warrants [Member]",
        "terseLabel": "Redeemable warrants, each whole warrant exercisable for one share of Class A common stock"
       }
      }
     },
     "localname": "RedeemableWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_RepurchaseOfStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repurchase Of Stock",
        "label": "Repurchase Of Stock [Member]",
        "terseLabel": "Repurchase of Stock"
       }
      }
     },
     "localname": "RepurchaseOfStockMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Capitalization, Contingent Consideration, Equity, Earnout Period",
        "label": "Reverse Capitalization, Contingent Consideration, Equity, Earnout Period",
        "terseLabel": "Reverse recapitalization, contingent consideration, equity, earnout period"
       }
      }
     },
     "localname": "ReverseCapitalizationContingentConsiderationEquityEarnoutPeriod",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_ReverseCapitalizationContingentConsiderationEquityShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Capitalization, Contingent Consideration, Equity, Shares",
        "label": "Reverse Capitalization, Contingent Consideration, Equity, Shares",
        "terseLabel": "Reverse recapitalization, contingent consideration, equity (in shares)"
       }
      }
     },
     "localname": "ReverseCapitalizationContingentConsiderationEquityShares",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_ReverseRecapitalizationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization",
        "label": "Reverse Recapitalization [Abstract]"
       }
      }
     },
     "localname": "ReverseRecapitalizationAbstract",
     "nsuri": "http://forhims.com/20210331",
     "xbrltype": "stringItemType"
    },
    "hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, One",
        "label": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, One",
        "terseLabel": "Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger one (in dollars per share)"
       }
      }
     },
     "localname": "ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerOne",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Three",
        "label": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Three",
        "terseLabel": "Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger three (in dollars per share)"
       }
      }
     },
     "localname": "ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerThree",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Two",
        "label": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Stock Price Trigger, Two",
        "terseLabel": "Reverse recapitalization, contingent consideration, equity, earnout period, stock price trigger two (in dollars per share)"
       }
      }
     },
     "localname": "ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodStockPriceTriggerTwo",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Consecutive Trading Days",
        "label": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Consecutive Trading Days",
        "terseLabel": "Reverse recapitalization, contingent consideration, equity, earnout period, threshold consecutive trading days"
       }
      }
     },
     "localname": "ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdConsecutiveTradingDays",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Day Period",
        "label": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Day Period",
        "terseLabel": "Reverse recapitalization, contingent consideration, equity, earnout period, threshold trading day period"
       }
      }
     },
     "localname": "ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDayPeriod",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hims_ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Days",
        "label": "Reverse Recapitalization, Contingent Consideration, Equity, Earnout Period, Threshold Trading Days",
        "terseLabel": "Reverse recapitalization, contingent consideration, equity, earnout period, threshold trading days"
       }
      }
     },
     "localname": "ReverseRecapitalizationContingentConsiderationEquityEarnoutPeriodThresholdTradingDays",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hims_ReverseRecapitalizationDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization Disclosure",
        "label": "Reverse Recapitalization Disclosure [Text Block]",
        "terseLabel": "Recapitalization"
       }
      }
     },
     "localname": "ReverseRecapitalizationDisclosureTextBlock",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/Recapitalization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hims_ReverseRecapitalizationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization",
        "label": "Reverse Recapitalization [Line Items]",
        "terseLabel": "Reverse Recapitalization [Line Items]"
       }
      }
     },
     "localname": "ReverseRecapitalizationLineItems",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hims_ReverseRecapitalizationPercentageOfVotingInterestsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization, Percentage Of Voting Interests Acquired",
        "label": "Reverse Recapitalization, Percentage Of Voting Interests Acquired",
        "terseLabel": "Reverse recapitalization, percentage of voting interests acquired"
       }
      }
     },
     "localname": "ReverseRecapitalizationPercentageOfVotingInterestsAcquired",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hims_ReverseRecapitalizationTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reverse Recapitalization, Transaction Costs",
        "label": "Reverse Recapitalization, Transaction Costs",
        "terseLabel": "Reverse recapitalization, deferred transaction costs"
       }
      }
     },
     "localname": "ReverseRecapitalizationTransactionCosts",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock From CEO And Member Of Board Of Directors",
        "label": "Sale Of Stock From CEO And Member Of Board Of Directors [Member]",
        "terseLabel": "Sale of Stock from CEO and Member Of Board of Directors"
       }
      }
     },
     "localname": "SaleOfStockFromCEOAndMemberOfBoardOfDirectorsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_SaleOfStockPutRightPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Put Right Period",
        "label": "Sale Of Stock, Put Right Period",
        "terseLabel": "Sale of stock, put right period"
       }
      }
     },
     "localname": "SaleOfStockPutRightPeriod",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_ScheduleOfReverseRecapitaliztionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Reverse Recapitaliztion",
        "label": "Schedule Of Reverse Recapitaliztion [Table]",
        "terseLabel": "Schedule Of Reverse Recapitaliztion [Table]"
       }
      }
     },
     "localname": "ScheduleOfReverseRecapitaliztionTable",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hims_ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions",
        "label": "Schedule Of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Equity Instrument Other Than Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEquityInstrumentOtherThanOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsTables",
      "http://forhims.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hims_SeriesA1PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A-1 Preferred Stock",
        "label": "Series A-1 Preferred Stock [Member]",
        "terseLabel": "Series A-1"
       }
      }
     },
     "localname": "SeriesA1PreferredStockMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_SeriesB1PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B-1 Preferred Stock",
        "label": "Series B-1 Preferred Stock [Member]",
        "terseLabel": "Series B-1"
       }
      }
     },
     "localname": "SeriesB1PreferredStockMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_SeriesB2PreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B-2 Preferred Stock",
        "label": "Series B-2 Preferred Stock [Member]",
        "terseLabel": "Series B-2"
       }
      }
     },
     "localname": "SeriesB2PreferredStockMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_SeriesCPreferredStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series C Preferred Stock Warrants",
        "label": "Series C Preferred Stock Warrants [Member]",
        "terseLabel": "Series C Preferred Stock Warrants"
       }
      }
     },
     "localname": "SeriesCPreferredStockWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_SeriesDPreferredStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series D Preferred Stock Warrants",
        "label": "Series D Preferred Stock Warrants [Member]",
        "terseLabel": "Series D Preferred Stock Warrants"
       }
      }
     },
     "localname": "SeriesDPreferredStockWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_SeriesSeedPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series Seed Preferred Stock",
        "label": "Series Seed Preferred Stock [Member]",
        "terseLabel": "Series Seed"
       }
      }
     },
     "localname": "SeriesSeedPreferredStockMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Acquisition With Share Consideration Threshold",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Acquisition With Share Consideration Threshold",
        "terseLabel": "Acquisition with shares consideration threshold (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcquisitionWithShareConsiderationThreshold",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Additional Disclosures",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted Average Contractual Term (in Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsAdditionalDisclosuresAbstract",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Exercisable at the end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableAggregateIntrinsicValue",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Non-Option Equity Instruments, Exercisable",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Number",
        "terseLabel": "Exercisable at the end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at the end of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Terms",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercisable, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Exercisable at the end of period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageRemainingContractualTerms",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Exercises In Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures And Expirations In Period, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures And Expirations In Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited and expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Grants In Period, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Grants In Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Intrinsic Value, Additional Disclosures",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Intrinsic Value, Additional Disclosures [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIntrinsicValueAdditionalDisclosuresAbstract",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePriceAbstract",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Remaining Contractual Terms",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Outstanding (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Aggregate Intrinsic Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest and the end of period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest at the end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest at the end of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Remaining Contractual Terms",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Non-Option Equity Instruments, Vested And Expected To Vest, Outstanding, Weighted Average Remaining Contractual Terms",
        "terseLabel": "Vested and expected to vest at the end of period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerms",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Authorized Shares Transferred Between Plans",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Number Of Authorized Shares Transferred Between Plans",
        "terseLabel": "Number of authorized shares transferred between plans (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAuthorizedSharesTransferredBetweenPlans",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Grants In Period, Grant Date Fair Value",
        "terseLabel": "Grant date fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Intrinsic Value, Additional Disclosures",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Intrinsic Value, Additional Disclosures [Abstract]",
        "terseLabel": "Aggregate Intrinsic Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIntrinsicValueAdditionalDisclosuresAbstract",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Early Exercises, Number Of Shares",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Early Exercises, Number Of Shares",
        "terseLabel": "Early exercises of nonvested options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedEarlyExercisesNumberOfShares",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Exercises In Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Exercises In Period",
        "terseLabel": "Early exercise of unvested stock options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedExercisesInPeriod",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Outstanding, Value",
        "terseLabel": "Share-based compensation arrangement by share-based payment award, options, outstanding, value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingValue",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Annual Increase In Authorized Shares Of Common Stock",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Annual Increase In Authorized Shares Of Common Stock",
        "terseLabel": "Percentage increase in authorized shares of common stock"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageAnnualIncreaseInAuthorizedSharesOfCommonStock",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hims_ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Stockholders Equity Ownership, Percent",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Stockholders Equity Ownership, Percent",
        "terseLabel": "Stockholders equity ownership, percent"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardStockholdersEquityOwnershipPercent",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hims_ShareBasedPaymentArrangementCurrentEmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Current Employee",
        "label": "Share-Based Payment Arrangement, Current Employee [Member]",
        "terseLabel": "Current Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementCurrentEmployeeMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ShareBasedPaymentArrangementEmployeeExcludingCEOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Employee, Excluding CEO",
        "label": "Share-Based Payment Arrangement, Employee, Excluding CEO [Member]",
        "terseLabel": "Employee, excluding CEO"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeExcludingCEOMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ShareBasedPaymentArrangementNewEmployeeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, New Employee",
        "label": "Share-Based Payment Arrangement, New Employee [Member]",
        "terseLabel": "New Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNewEmployeeMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Option And Stock Appreciation Rights (SARS)",
        "label": "Share-Based Payment Arrangement, Option And Stock Appreciation Rights (SARS) [Member]",
        "terseLabel": "Stock Options and Stock Appreciation Rights"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionAndStockAppreciationRightsSARSMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable [Abstract]",
        "terseLabel": "Options Exercisable"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionExercisePriceRangeSharesExercisableAbstract",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hims_ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding [Abstract]",
        "terseLabel": "Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementOptionExercisePriceRangeSharesOutstandingAbstract",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hims_ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Payment Award, Award Vesting Rights, Monthly Percentage",
        "label": "Share-Based Payment Award, Award Vesting Rights, Monthly Percentage",
        "terseLabel": "Award vesting rights, monthly percentage"
       }
      }
     },
     "localname": "ShareBasedPaymentAwardAwardVestingRightsMonthlyPercentage",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hims_StockForfeitedDuringPeriodShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Forfeited During Period, Shares",
        "label": "Stock Forfeited During Period, Shares",
        "negatedTerseLabel": "Forfeiture of related-party promissory notes (in shares)",
        "terseLabel": "Forfeiture of related-party promissory notes (in shares)"
       }
      }
     },
     "localname": "StockForfeitedDuringPeriodShares",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Contingent Consideration, Reverse Recapitalization",
        "label": "Stock Issued During Period, Shares, Contingent Consideration, Reverse Recapitalization",
        "terseLabel": "Issuance of earn-out shares to common stockholders (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesContingentConsiderationReverseRecapitalization",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_StockIssuedDuringPeriodSharesReverseRecapitalization": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Shares, Reverse Recapitalization",
        "label": "Stock Issued During Period, Shares, Reverse Recapitalization",
        "terseLabel": "Issuance of common stock upon Merger, net of transaction costs and merger warrant liability (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesReverseRecapitalization",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Contingent Consideration, Reverse Recapitalization",
        "label": "Stock Issued During Period, Value, Contingent Consideration, Reverse Recapitalization",
        "terseLabel": "Issuance of earn-out shares to common stockholders"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueContingentConsiderationReverseRecapitalization",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_StockIssuedDuringPeriodValueReverseRecapitalization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Reverse Recapitalization",
        "label": "Stock Issued During Period, Value, Reverse Recapitalization",
        "terseLabel": "Issuance of common stock upon Merger, net of transaction costs and Merger warrants liability"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueReverseRecapitalization",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_StockOptionsSubjectToNonrecoursePromissoryNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Options Subject To Nonrecourse Promissory Notes",
        "label": "Stock Options Subject To Nonrecourse Promissory Notes [Member]",
        "terseLabel": "Common stock issued for exercise of stock options subject to nonrecourse promissory notes"
       }
      }
     },
     "localname": "StockOptionsSubjectToNonrecoursePromissoryNotesMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_StockPlan2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Plan, 2017",
        "label": "Stock Plan, 2017 [Member]",
        "terseLabel": "Stock Plan, 2017"
       }
      }
     },
     "localname": "StockPlan2017Member",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_TemporaryEquityIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity Issued, Price Per Share",
        "label": "Temporary Equity Issued, Price Per Share",
        "verboseLabel": "Issue Price per Share (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityIssuedPricePerShare",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hims_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities",
        "label": "Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities",
        "negatedTerseLabel": "Conversion of convertible securities (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of Series D convertible preferred stock, net of issuance costs (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities",
        "label": "Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities",
        "terseLabel": "Conversion of convertible securities"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_TemporaryEquityStockRepurchasedDuringPeriodShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Repurchased During Period, Shares",
        "label": "Temporary Equity, Stock Repurchased During Period, Shares",
        "terseLabel": "Pre-closing stock repurchase, net of exercise of vested options (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockRepurchasedDuringPeriodShares",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "hims_TemporaryEquityStockRepurchasedDuringPeriodValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Repurchased During Period, Value",
        "label": "Temporary Equity, Stock Repurchased During Period, Value",
        "terseLabel": "Pre-closing stock repurchase, net of exercise of vested options"
       }
      }
     },
     "localname": "TemporaryEquityStockRepurchasedDuringPeriodValue",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_TemporaryEquityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity",
        "label": "Temporary Equity [Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTextBlock",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hims_TradeAndOtherReceivablesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trade And Other Receivables, Current",
        "label": "Trade And Other Receivables, Current",
        "terseLabel": "Trade and other receivables, net"
       }
      }
     },
     "localname": "TradeAndOtherReceivablesCurrent",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_TransactionCostsIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction Costs Incurred But Not Yet Paid",
        "label": "Transaction Costs Incurred But Not Yet Paid",
        "terseLabel": "Change in transaction costs payable"
       }
      }
     },
     "localname": "TransactionCostsIncurredButNotYetPaid",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_VendorDepositsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor Deposits, Current",
        "label": "Vendor Deposits, Current",
        "terseLabel": "Vendor deposits"
       }
      }
     },
     "localname": "VendorDepositsCurrent",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_VendorWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vendor Warrants",
        "label": "Vendor Warrants [Member]",
        "terseLabel": "Vendor Warrants"
       }
      }
     },
     "localname": "VendorWarrantsMember",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CommonStockPriortoMergerDetails",
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hims_VestingOfEarlyExercisedStockOptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting Of Early Exercised Stock Options",
        "label": "Vesting Of Early Exercised Stock Options",
        "terseLabel": "Vesting of early exercised stock options"
       }
      }
     },
     "localname": "VestingOfEarlyExercisedStockOptions",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_WarrantLiabilityPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrant Liability, Policy",
        "label": "Warrant Liability, Policy [Policy Text Block]",
        "terseLabel": "Warrant Liabilities"
       }
      }
     },
     "localname": "WarrantLiabilityPolicyPolicyTextBlock",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hims_WarrantsAndRightsOutstandingCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants and Rights Outstanding, Current",
        "label": "Warrants and Rights Outstanding, Current",
        "terseLabel": "Warrant liabilities"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingCurrent",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_WarrantsAssumed": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Assumed",
        "label": "Warrants Assumed",
        "terseLabel": "Assumption of Merger warrants liability"
       }
      }
     },
     "localname": "WarrantsAssumed",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hims_WarrantsIssued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants Issued",
        "label": "Warrants Issued",
        "terseLabel": "Exercise of Private Placement Warrants and Public Warrants"
       }
      }
     },
     "localname": "WarrantsIssued",
     "nsuri": "http://forhims.com/20210331",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r266",
      "r379",
      "r380",
      "r383",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Affiliated Entity"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r336",
      "r337",
      "r341",
      "r342",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r336",
      "r337",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation, Eliminations [Member]",
        "terseLabel": "Consolidation, Eliminations"
       }
      }
     },
     "localname": "ConsolidationEliminationsMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r159",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r159",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r58",
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ManagementMember": {
     "auth_ref": [
      "r178",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Management [Member]",
        "terseLabel": "Management"
       }
      }
     },
     "localname": "ManagementMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r268",
      "r269",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r416",
      "r466",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r268",
      "r269",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r416",
      "r466",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails",
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficerMember": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officer [Member]",
        "terseLabel": "Officer"
       }
      }
     },
     "localname": "OfficerMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r258",
      "r268",
      "r269",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r416",
      "r466",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails",
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r258",
      "r268",
      "r269",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r416",
      "r466",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails",
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r126",
      "r127",
      "r129",
      "r130",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Adjustment"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r143",
      "r194",
      "r195",
      "r314",
      "r326",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r126",
      "r127",
      "r128",
      "r129",
      "r130",
      "r143",
      "r194",
      "r195",
      "r314",
      "r326",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r116",
      "r118",
      "r119",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r126",
      "r127",
      "r129",
      "r130",
      "r143",
      "r194",
      "r195",
      "r314",
      "r326",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r175",
      "r176",
      "r248",
      "r251",
      "r467",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r175",
      "r176",
      "r248",
      "r251",
      "r467",
      "r481",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r178",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/AccruedLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r114",
      "r380",
      "r440",
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties.",
        "label": "Accounts Payable, Related Parties",
        "terseLabel": "Accounts payable, related parties"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://forhims.com/role/AccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Total accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/AccruedLiabilitiesDetails",
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedMarketingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/AccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services.   Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Marketing Costs, Current",
        "terseLabel": "Marketing expenses"
       }
      }
     },
     "localname": "AccruedMarketingCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r43"
     ],
     "calculation": {
      "http://forhims.com/role/AccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r25",
      "r60",
      "r61",
      "r62",
      "r455",
      "r474",
      "r478"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r59",
      "r62",
      "r63",
      "r116",
      "r117",
      "r119",
      "r340",
      "r469",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r116",
      "r117",
      "r119",
      "r311",
      "r312",
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r271",
      "r274",
      "r317",
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r274",
      "r307",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r75",
      "r97",
      "r371"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AreaOfRealEstateProperty": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area of a real estate property.",
        "label": "Area of Real Estate Property",
        "terseLabel": "Area of real estate property"
       }
      }
     },
     "localname": "AreaOfRealEstateProperty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r188",
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Asset-backed bonds"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails",
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r109",
      "r163",
      "r166",
      "r172",
      "r192",
      "r336",
      "r341",
      "r362",
      "r433",
      "r453"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r7",
      "r55",
      "r109",
      "r192",
      "r336",
      "r341",
      "r362"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r186"
     ],
     "calculation": {
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r187"
     ],
     "calculation": {
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r184",
      "r201"
     ],
     "calculation": {
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Adjusted Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r180",
      "r185",
      "r201",
      "r439"
     ],
     "calculation": {
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r182",
      "r201"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-sale, Current",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r275",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r275",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Principles of Consolidation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r36",
      "r99"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r92",
      "r99",
      "r104"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of the three-month period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of the year"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r92",
      "r363"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r107",
      "r109",
      "r133",
      "r134",
      "r135",
      "r137",
      "r139",
      "r148",
      "r149",
      "r150",
      "r192",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails",
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails",
      "http://forhims.com/role/CommonStockPriortoMergerDetails",
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails",
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/Cover",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails",
      "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r235",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails",
      "http://forhims.com/role/BorrowingArrangementsDetails",
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockPriortoMergerDetails",
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails",
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails",
      "http://forhims.com/role/BorrowingArrangementsDetails",
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockPriortoMergerDetails",
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails",
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Class of warrant or right, exercise price of warrants or rights (in dollars per share)",
        "verboseLabel": "Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails",
      "http://forhims.com/role/CommonStockPriortoMergerDetails",
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Warrant or Right [Line Items]",
        "terseLabel": "Class of Warrant or Right [Line Items]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPriortoMergerDetails",
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails",
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right",
        "terseLabel": "Class of warrant or right, number of securities called by each warrant or right (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Class of warrant or right, number securities called by warrants or rights (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Class of warrant or right, outstanding (in shares)",
        "verboseLabel": "Shares (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "auth_ref": [
      "r235",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Class of Warrant or Right [Table]",
        "terseLabel": "Class of Warrant or Right [Table]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPriortoMergerDetails",
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails",
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r46",
      "r218",
      "r441",
      "r458"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note\u00a011)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r215",
      "r216",
      "r217",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails",
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails",
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails",
      "http://forhims.com/role/CommonStockPriortoMergerDetails",
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails",
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/Cover",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Common stock, capital shares reserved for future issuance"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r116",
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r22",
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock\u00a0\u2013 Class\u00a0A shares, par value $0.0001, 2,750,000,000 and 166,696,759 shares authorized and 182,973,780 and 46,025,754 shares issued and outstanding as of March\u00a031, 2021 and December\u00a031, 2020, respectively; Class\u00a0V shares, par value $0.0001, 10,000,000 shares authorized and 8,377,623 shares issued, and outstanding as of March\u00a031, 2021; Class\u00a0F shares, par value $0.0001, 6,941,352 shares authorized, issued, and outstanding as of December\u00a031, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r66",
      "r68",
      "r69",
      "r73",
      "r444",
      "r461"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Total comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r105",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r237",
      "r238",
      "r249"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r248",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r248",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r101",
      "r102",
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Conversion of redeemable convertible preferred stock to common stock"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateBondSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).",
        "label": "Corporate Bond Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateBondSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r259",
      "r267",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r77",
      "r109",
      "r192",
      "r362"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowing Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r15",
      "r17",
      "r18",
      "r434",
      "r435",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtLongtermAndShorttermCombinedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.",
        "label": "Debt, Long-term and Short-term, Combined Amount",
        "terseLabel": "Debt, long-term and short-term, combined amount"
       }
      }
     },
     "localname": "DebtLongtermAndShorttermCombinedAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer; the aggregate carrying amount of current assets, not separately presented elsewhere in the balance sheet; and other deferred costs.",
        "label": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]",
        "terseLabel": "Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure"
       }
      }
     },
     "localname": "DeferredCostsCapitalizedPrepaidAndOtherAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredCostsCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.",
        "label": "Deferred Costs, Current",
        "terseLabel": "Deferred transaction costs"
       }
      }
     },
     "localname": "DeferredCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRentCreditNoncurrent": {
     "auth_ref": [
      "r47",
      "r373"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date.",
        "label": "Deferred Rent Credit, Noncurrent",
        "terseLabel": "Deferred rent, noncurrent"
       }
      }
     },
     "localname": "DeferredRentCreditNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositLiabilityCurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://forhims.com/role/AccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current portion, due within one year or one operating cycle, if longer, of deposits held other than customer deposits.",
        "label": "Deposit Liability, Current",
        "terseLabel": "Warrant exercise deposit liability"
       }
      }
     },
     "localname": "DepositLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r97",
      "r161"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r56",
      "r57",
      "r361"
     ],
     "calculation": {
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Warrant liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r248",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r234",
      "r450"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "terseLabel": "Dividends, common stock"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r74",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r131",
      "r133",
      "r137",
      "r138",
      "r139",
      "r143",
      "r144",
      "r445",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net loss per share attributable to common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails",
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r74",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r133",
      "r137",
      "r138",
      "r139",
      "r143",
      "r144",
      "r445",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Basic and Diluted Net Loss per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Foreign currency effect on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate reconciliation, percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized, amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-based payment arrangement, nonvested award, excluding option, cost not yet recognized, amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r308"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Share-based payments arrangement, nonvested award, option, cost not yet recognized, amount"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions": {
     "auth_ref": [
      "r310"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit from exercise of option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Exercise of Option, Tax Benefit",
        "terseLabel": "Share-based payment arrangement, exercise of option, tax benefit"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails",
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r116",
      "r117",
      "r119",
      "r121",
      "r127",
      "r130",
      "r147",
      "r193",
      "r227",
      "r234",
      "r311",
      "r312",
      "r313",
      "r325",
      "r326",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "auth_ref": [
      "r97",
      "r222"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.",
        "label": "Fair Value Adjustment of Warrants",
        "terseLabel": "Change in fair value of warrant liabilities"
       }
      }
     },
     "localname": "FairValueAdjustmentOfWarrants",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r349",
      "r350",
      "r351",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r350",
      "r389",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r349",
      "r350",
      "r352",
      "r353",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r259",
      "r260",
      "r265",
      "r267",
      "r350",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r259",
      "r260",
      "r265",
      "r267",
      "r350",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r350",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r354",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Increase in fair value of warrants"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": {
     "auth_ref": [
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances",
        "terseLabel": "Private Placement Warrants and Public Warrants"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)",
        "terseLabel": "Increase in fair value of warrants"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "terseLabel": "Exercised warrants"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r354"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Balance at March 31, 2021",
        "periodStartLabel": "Balance at December 31, 2020"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsChangeintheFairValueofWarrantLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r267",
      "r389",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r357",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r188",
      "r189",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r202",
      "r203",
      "r204",
      "r205",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails",
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r270",
      "r272",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r76",
      "r109",
      "r163",
      "r165",
      "r168",
      "r171",
      "r173",
      "r192",
      "r362"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfInvestments": {
     "auth_ref": [
      "r183"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount by which the fair value of an investment is less than the amortized cost basis or carrying amount of that investment at the balance sheet date and the decline in fair value is deemed to be other than temporary, before considering whether or not such amount is recognized in earnings or other comprehensive income.",
        "label": "Other than Temporary Impairment Losses, Investments",
        "terseLabel": "Other than temporary impairment losses, investments"
       }
      }
     },
     "localname": "ImpairmentOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r71",
      "r163",
      "r165",
      "r168",
      "r171",
      "r173",
      "r430",
      "r442",
      "r447",
      "r464"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r322",
      "r323",
      "r324",
      "r327",
      "r329",
      "r331",
      "r332",
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Tax"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/IncomeTax"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r110",
      "r129",
      "r130",
      "r162",
      "r320",
      "r328",
      "r330",
      "r465"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r94",
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r70",
      "r160",
      "r370",
      "r371",
      "r446"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r91",
      "r93",
      "r100"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r29",
      "r209"
     ],
     "calculation": {
      "http://forhims.com/role/InventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r52"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://forhims.com/role/InventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r12",
      "r53",
      "r105",
      "r146",
      "r206",
      "r208",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r30",
      "r209"
     ],
     "calculation": {
      "http://forhims.com/role/InventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r191",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r190",
      "r431",
      "r449",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseAndRentalExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "Operating Leases, Rent Expense",
        "terseLabel": "Operating leases, rent expense"
       }
      }
     },
     "localname": "LeaseAndRentalExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r42",
      "r109",
      "r167",
      "r192",
      "r337",
      "r341",
      "r342",
      "r362"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "terseLabel": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r109",
      "r192",
      "r362",
      "r436",
      "r457"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, mezzanine equity, and stockholders' equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, mezzanine equity, and stockholders' equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r44",
      "r109",
      "r192",
      "r337",
      "r341",
      "r342",
      "r362"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r349"
     ],
     "calculation": {
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r40"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit facility, maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r40",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r45"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r45",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Marketable Securities [Line Items]",
        "terseLabel": "Marketable Securities [Line Items]"
       }
      }
     },
     "localname": "MarketableSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in marketable security.",
        "label": "Marketable Securities [Table]",
        "terseLabel": "Marketable Securities [Table]"
       }
      }
     },
     "localname": "MarketableSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MarketingExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.",
        "label": "Marketing Expense",
        "terseLabel": "Marketing"
       }
      }
     },
     "localname": "MarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r92"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash (used in)/provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r92",
      "r95",
      "r98"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r0",
      "r64",
      "r67",
      "r72",
      "r98",
      "r109",
      "r120",
      "r122",
      "r123",
      "r124",
      "r125",
      "r129",
      "r130",
      "r136",
      "r163",
      "r165",
      "r168",
      "r171",
      "r173",
      "r192",
      "r362",
      "r443",
      "r460"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited",
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Noncash investing and financing activities"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other (expense) income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Notes Payable, Other Payables"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r163",
      "r165",
      "r168",
      "r171",
      "r173"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDue": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for leases having an initial or remaining non-cancelable letter-terms in excess of one year.",
        "label": "Operating Leases, Future Minimum Payments Due",
        "terseLabel": "Operating leases, future minimum payments due",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails",
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Five Years",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Four Years",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInFourYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Three Years",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInThreeYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Due in Two Years",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsDueInTwoYears",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeasesFutureMinimumPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Operating Leases, Future Minimum Payments, Remainder of Fiscal Year",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentandContingenciesFutureMinimumLeaseCommitmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r1",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Organization"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/Organization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r43"
     ],
     "calculation": {
      "http://forhims.com/role/AccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r37"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r65",
      "r68",
      "r334",
      "r335",
      "r339"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Other comprehensive loss",
        "verboseLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other current assets.",
        "label": "Other Current Assets [Text Block]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Noncash other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Pre-closing stock repurchase",
        "terseLabel": "Payments for repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForSoftware": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the development, modification or acquisition of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments for Software",
        "negatedTerseLabel": "Investment in website development and internal-use software"
       }
      }
     },
     "localname": "PaymentsForSoftware",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedTerseLabel": "Payments of stock issuance costs",
        "terseLabel": "Payments of stock issuance costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersDeficitUnauditedParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r80",
      "r82",
      "r181"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedTerseLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherProductiveAssets": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.",
        "label": "Payments to Acquire Other Productive Assets",
        "negatedTerseLabel": "Purchases of property, equipment, and intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliers": {
     "auth_ref": [
      "r89",
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments of cash to suppliers for goods and services during the current period.",
        "label": "Payments to Suppliers",
        "terseLabel": "Payments to suppliers"
       }
      }
     },
     "localname": "PaymentsToSuppliers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r275",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r34",
      "r35"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Total prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r4",
      "r6",
      "r211",
      "r212"
     ],
     "calculation": {
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/PrepaidExpensesandOtherCurrentAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrivatePlacementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.",
        "label": "Private Placement [Member]",
        "terseLabel": "PIPE Investment"
       }
      }
     },
     "localname": "PrivatePlacementMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPIPEInvestmentDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Proceeds from issuance of debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.",
        "label": "Proceeds from Issuance of Private Placement",
        "terseLabel": "Proceeds from PIPE"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.",
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuance of redeemable convertible preferred stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r80",
      "r81",
      "r181"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Maturities of investments"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRelatedPartyDebt": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.",
        "label": "Proceeds from Related Party Debt",
        "terseLabel": "Repayment of promissory notes associated with vested and unvested shares"
       }
      }
     },
     "localname": "ProceedsFromRelatedPartyDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r80",
      "r81",
      "r181"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Proceeds from sales of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from exercise of Class A common stock warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PurchaseObligation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.",
        "label": "Purchase Obligation",
        "terseLabel": "Purchase obligation"
       }
      }
     },
     "localname": "PurchaseObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RecapitalizationCosts": {
     "auth_ref": [
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of recapitalization costs for professional fees associated with restructuring debt and equity mixture that do not qualify for capitalization.",
        "label": "Recapitalization Costs",
        "terseLabel": "Recapitalization of redeemable convertible preferred stock from pre-closing stock repurchase"
       }
      }
     },
     "localname": "RecapitalizationCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r266",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r266",
      "r379",
      "r380",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r379"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Related party transaction, expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionPurchasesFromRelatedParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchases during the period (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Purchases from Related Party",
        "terseLabel": "Related party transaction, purchases from related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionPurchasesFromRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identify the stated interest rate per the agreement, for example, leasing and debt arrangements between related parties.",
        "label": "Related Party Transaction, Rate",
        "terseLabel": "Related party transaction, rate"
       }
      }
     },
     "localname": "RelatedPartyTransactionRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r266",
      "r379",
      "r383",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r377",
      "r378",
      "r380",
      "r384",
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related-Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of principal on term loan"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r104",
      "r432",
      "r454"
     ],
     "calculation": {
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of cash or cash equivalent items which are restricted as to withdrawal or usage.",
        "label": "Restricted Cash and Cash Equivalents [Axis]",
        "terseLabel": "Restricted Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r8",
      "r14",
      "r104",
      "r482"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash, noncurrent"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BorrowingArrangementsDetails",
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r234",
      "r314",
      "r456",
      "r473",
      "r478"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r116",
      "r117",
      "r119",
      "r121",
      "r127",
      "r130",
      "r193",
      "r311",
      "r312",
      "r313",
      "r325",
      "r326",
      "r469",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r158",
      "r159",
      "r164",
      "r169",
      "r170",
      "r174",
      "r175",
      "r177",
      "r247",
      "r248",
      "r417"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total revenue",
        "verboseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited",
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r106",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Sale of stock, consideration received on transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPIPEInvestmentDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPIPEInvestmentDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPIPEInvestmentDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPIPEInvestmentDetails",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred directly to consumer.",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "terseLabel": "Online"
       }
      }
     },
     "localname": "SalesChannelDirectlyToConsumerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "auth_ref": [
      "r256"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred through intermediary.",
        "label": "Sales Channel, Through Intermediary [Member]",
        "terseLabel": "Wholesale"
       }
      }
     },
     "localname": "SalesChannelThroughIntermediaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/AccruedLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r133",
      "r134",
      "r137",
      "r139",
      "r144"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails",
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r274",
      "r306",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r274",
      "r306",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date.",
        "label": "Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]",
        "terseLabel": "Schedule of Future Minimum Rental Payments for Operating Leases"
       }
      }
     },
     "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommitmentandContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r12",
      "r31",
      "r32",
      "r33"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory, Current"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r111",
      "r381",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r288",
      "r293",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r275",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails",
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails",
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Restricted Stock Unit, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r280",
      "r293",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Share-based Payment Arrangement, Option, Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r48",
      "r107",
      "r148",
      "r149",
      "r223",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails",
      "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r235",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of Stockholders' Equity Note, Warrants or Rights"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r336",
      "r337",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general, and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general, and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationSummaryofStockBasedCompensationExpenseforEmployeesandNonemployeesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series C preferred stock or outstanding series C preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C Preferred Stock",
        "verboseLabel": "Series C"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesDPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series D preferred stock or outstanding series D preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series D Preferred Stock [Member]",
        "terseLabel": "Series D"
       }
      }
     },
     "localname": "SeriesDPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r96"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails",
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)",
        "terseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails",
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails",
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-option equity instruments exercised by participants.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised",
        "negatedTerseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares under non-option equity instrument agreements that were either cancelled or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations",
        "negatedTerseLabel": "Forfeited and expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "auth_ref": [
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of non-option equity instruments granted to participants.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r281",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "terseLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Number of additional shares authorized (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Weighted Average Contractual Period (in\u00a0Years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable at the end of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable at the end of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of exercises during period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Forfeited and expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited and expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Award granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding balance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r282",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RelatedPartyTransactionsDetails",
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested and expected to vest at the end of the period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest at the end of the period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Vested and expected to vest at the end of the period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r273",
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsActivityDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantActivityDetails",
      "http://forhims.com/role/StockBasedCompensationVendorWarrantsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)",
        "verboseLabel": "Awards granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r105",
      "r275",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by range of option prices pertaining to options granted.",
        "label": "Exercise Price Range [Axis]",
        "terseLabel": "Exercise Price Range [Axis]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.",
        "label": "Exercise Price Range [Domain]",
        "terseLabel": "Exercise Price Range [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit",
        "terseLabel": "Share-based payments arrangement, option, exercise price range, lower range limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable",
        "terseLabel": "Shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": {
     "auth_ref": [
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding",
        "terseLabel": "Shares (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit",
        "terseLabel": "Share-based payments arrangement, option, exercise price range, upper range limit (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r272",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-based Payment Arrangement, Employee [Member]",
        "terseLabel": "Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Share Price",
        "terseLabel": "Share price (in dollars per share)"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsAdditionalInformationDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Awards vesting rights, percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r301",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsFairValueAssumptionsofPrivatePlacementWarrantsDetails",
      "http://forhims.com/role/StockBasedCompensationRSUsWeightedAverageFairValueAssumptionsDetails",
      "http://forhims.com/role/StockBasedCompensationWeightedAverageFairValueAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r309"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercisable at the end of the period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable at the end of the period (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options forfeited.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares",
        "negatedTerseLabel": "Forfeiture of unvested early exercised shares (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding balance (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Vested and expected to vested at the end of the period (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock, percent"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensation2017StockPlanand2020EquityIncentivePlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted Average Remaining Contractual Life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationExercisePriceRangeofOptionsOutstandingandExercisableDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r16",
      "r437",
      "r438",
      "r452"
     ],
     "calculation": {
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r20",
      "r21",
      "r22",
      "r107",
      "r109",
      "r133",
      "r134",
      "r135",
      "r137",
      "r139",
      "r148",
      "r149",
      "r150",
      "r192",
      "r227",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareAdditionalInformationDetails",
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails",
      "http://forhims.com/role/CommonStockPriortoMergerDetails",
      "http://forhims.com/role/CommonStockPublicWarrantTermsDetails",
      "http://forhims.com/role/CommonStockScheduleofWarrantsOutstandingDetails",
      "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/Cover",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r51",
      "r116",
      "r117",
      "r119",
      "r121",
      "r127",
      "r130",
      "r147",
      "r193",
      "r227",
      "r234",
      "r311",
      "r312",
      "r313",
      "r325",
      "r326",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r469",
      "r470",
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockMergerTransactionDetails",
      "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RecapitalizationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r116",
      "r117",
      "r119",
      "r147",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssued1": {
     "auth_ref": [
      "r101",
      "r102",
      "r103"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of stock issued in noncash financing activities.",
        "label": "Stock Issued",
        "terseLabel": "Expiration of Class A common stock redemption right"
       }
      }
     },
     "localname": "StockIssued1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r50",
      "r227",
      "r228",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "verboseLabel": "Conversion of convertible securities (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPriortoMergerDetails",
      "http://forhims.com/role/CommonStockSubsequenttoMergerDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r21",
      "r22",
      "r227",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of PIPE shares (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares (or other type of equity) forfeited during the period.",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited",
        "terseLabel": "Common stock, forfeited (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockSettlementofNonrecourseRelatedPartyPromissoryNotesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r21",
      "r22",
      "r227",
      "r234",
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Exercise of vested stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/StockBasedCompensationOptionActivityDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r51",
      "r227",
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of convertible securities"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r21",
      "r22",
      "r227",
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of PIPE shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r51",
      "r227",
      "r234"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of vested stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r21",
      "r22",
      "r227",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "terseLabel": "Stock repurchased and retired during period (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r21",
      "r22",
      "r227",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "negatedTerseLabel": "Pre-closing stock repurchase, net of exercise of vested options (in shares)",
        "terseLabel": "Pre-closing stock repurchase, net of exercise of vested options (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockAdditionalInformationDetails",
      "http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r21",
      "r22",
      "r227",
      "r234"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "negatedTerseLabel": "Pre-closing stock repurchase, net of exercise of vested options",
        "terseLabel": "Pre-closing stock repurchase, net of exercise of vested options"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPreClosingStockRepurchaseDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r22",
      "r26",
      "r27",
      "r109",
      "r179",
      "r192",
      "r362"
     ],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity (deficit):"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r108",
      "r234",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPIPEInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPIPEInvestmentDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RecapitalizationDetails",
      "http://forhims.com/role/RelatedPartyTransactionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CommonStockPIPEInvestmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofCashFlowsUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://forhims.com/role/AccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Tax payables"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/AccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Mezzanine equity:"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r13",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity, by Class of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Mezzanine equity, ending balance",
        "periodStartLabel": "Mezzanine equity, beginning balance",
        "terseLabel": "Total mezzanine equity"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference",
        "terseLabel": "Aggregate Liquidation Value",
        "verboseLabel": "Mezzanine equity, liquidation preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r13",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Mezzanine equity, par or stated value per share (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Mezzanine equity, shares authorized (in shares)",
        "verboseLabel": "Shares Authorized (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Shares Issued (in shares)",
        "verboseLabel": "Mezzanine equity, shares issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Mezzanine equity, ending balance (in shares)",
        "periodStartLabel": "Mezzanine equity, beginning balance (in shares)",
        "terseLabel": "Mezzanine equity, shares outstanding (in shares)",
        "verboseLabel": "Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Series D convertible preferred stock, net of issuance costs"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofMezzanineEquityandStockholdersEquityDeficitUnaudited"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r13",
      "r224"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Temporary Equity"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/RedeemableConvertiblePreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r188",
      "r189",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails",
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": {
     "auth_ref": [
      "r259",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).",
        "label": "US Government Agencies Debt Securities [Member]",
        "terseLabel": "Government bonds"
       }
      }
     },
     "localname": "USGovernmentAgenciesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/InvestmentsShorttermInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by the United States government.",
        "label": "US Government Debt Securities [Member]",
        "terseLabel": "Government bonds"
       }
      }
     },
     "localname": "USGovernmentDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityDisclosureTextBlock": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.",
        "label": "Variable Interest Entity Disclosure [Text Block]",
        "terseLabel": "Variable Interest Entities"
       }
      }
     },
     "localname": "VariableInterestEntityDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r336",
      "r337",
      "r341",
      "r342",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/VariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/StockBasedCompensationRSUsNarrativeDetails",
      "http://forhims.com/role/StockBasedCompensationStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareScheduleofExcludedAntidilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "calculation": {
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrants and rights outstanding",
        "verboseLabel": "Warrant liabilities"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedBalanceSheets",
      "http://forhims.com/role/RedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r132",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r131",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails",
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted average shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://forhims.com/role/BasicandDilutedNetLossperShareComputationofBasicandDilutedNetLossperShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "27",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e22044-107793"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=SL6284422-111562"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=SL116886442-113899"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4549-113899"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6228884-111685"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(Note 3)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121580752&loc=d3e38371-112697"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121549951&loc=d3e39927-112707"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41502-112717"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62557-112803"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.26(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121641442&loc=d3e19393-158473"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r493": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r494": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r495": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r496": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r497": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r498": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r499": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>99
<FILENAME>0001628280-21-010528-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-21-010528-xbrl.zip
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MZ2CMUOUK5]A#?=SM\3N?W=B<!MT;.Z>$M1$8\,:(Z,"#]<8IZX/)(4#0I[N
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M.!U_$(DJ)*0K'U4HCS\6%%-XQ3'0YSWVR# T%PQ-=4+2D"#'O 4NZ&@K4&R
MQ%(![BQAUD$L3+05&*E3LJBD[\J<=RPP[O"*9?UYSSNRK,\KZQ-9FAI2IHD"
M3.DT#,]0H V5P%CLN!3!"P.+@PX.%S53JWH''0^+3[RH,&YUSLZ:_3.?&H.D
MAD!)_.+:?=M&@:B]:73ZOJ0.0HMJ!W0WL48H^33&P(]>\VV[V?I_:_WNP-_,
MXK[:A\VVVYK<A0P&,X#!ARO%WSCZ0!O?CRGRA''&@%62 ZH0!<I'"P 99HE
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MX8&*^A) ;ISUS&#B]/W*]@Z.>IC;F#EJZ3F*X52EHRUPG = J2= IA'/7J/
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M'J?0_QPO_/W5NO/1_\NX+3"N'\6U_MB[_/HCWN,8,2(M<TF?>P:H1B;E$1"
MF.?0"&B\X[<K]8)W[XT_/W]R26:]RK+>#FUL'HNHOBTT%)#( 9'E; 1=K3G
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MO+\6%,2CQ(HH4E&((*;&.QG_AZ&&Q@1&#$(Y[++TW#X5=HE[MGEL,8S YAB
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M9KMF]7FSKUMYBNL+SF@;D^5]I,IN>ZNDR00J94":"Y!V)LT'@K1@'F+ /0J
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M_=5K;?^HFK051YH7"4TU.NW.M'>:<>DAN#0UF-UCJZ /&$1R1NLA1#M">FH
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ML33B%]FB=0N*H,>A>'P6QY)F:*V2^#_)&>;L"5ES8$!AU,P. =GJF0D"IL]
M"39",41 &CT$J,,$*.TT,,X'IDT0'NNR4XLD6?Z71_X?YFIF*F4J+7E'@^5C
M@JH?@V;C_)G[*)5'I )B&8R(FEEB U)5#-"*><"PML%B"R%"]QKGJX,JKTOL
M;QKHCY3Y.YH79(/[>;LB#3N8!&B#\@H0B06@6$L@-<8@$.0,@2Q26D:QSM*\
MLM+\[.?I6="?*;AV[:S=(6F#LQ80)R6@T;D&1C@(J-0&0HH]XWSH6^-%M47.
M I]=MTRE3*6EHE*5#]RS\GPFY7GM,#YP[+R'-CJ]* 6F?52>W%% /-;:".LL
M57<'IE].X%][)?&!/]<79W%EZ42^ZUNZ[QTXU]W^1>V\VSEK]GJ=[D6MW>G'
M.^KXBVVF3]2^-_NGHZ+B,N[UNFJ*<VI8IE*F4J92IM+24BG7 &8FR%3*5%H"
M+WH!(>B);*Y-]V70ZR>;OW?4V8S;EFZO6^]UT^VVM_1YLZ];!Z4G\#XY @?>
M^N:W-&CCREG(WO(\WO+AC5"SD(8ZACD0,&5R:HV $8P#0VAJJTV80W!M0[)'
M]]/-0IVA-U,I4VD9J?2\8>:L(%]405X+)T<::4T]!#!X#:@3!&AI+9!2<69]
M_!%<U13D:Z_N>M?I!M_L#[K^Y['DUU7<E8\U,Y4RE3*5,I66EDJY4F(U.L85
M!GZ1*3(T5W*SN,=:[S>&/G**+ P,\$BC(GL2:"8HT-0$;97S1NNU#2)@79 %
M=)JO(EHLF3@C^#I!?<G(]$I5;Z92IE*F4J92=:GTVI-(I_LZ'<9KQ$MOWVCP
M]%UWN[K=[Z5.3ULMW>O5-D<=GT9OY2S2? Z5J92IE*F4J;045'KB+-)G6F)F
MQI5@QI6D4L5*]6?.$/E4FK1CVSCGA,P35;[9"]]YK(5!'@A",:!<!: L0L!B
M$334"JO TQ"2*,T5R@K),IZ1.%,I4ZF*^O(YJO.SOGPV?7DMA])Z1YF."E(P
M@P U'@.%!03<! 4Y]TQP6CU]^=JS*'<FIG9?"Y).1U%S"F4^B<E4RE3*5,I4
M6@HJY13*IVXV3:!V6B#D8.I7")U1GFE!M,,>TVC4YV;3RVG<[U]O-DT$$8AB
M'$U[;@"E@0-)C01(PY0X2RFRJ)C'RT4=JYO3KU8'5%92ZE<.^E>22G,$6B(,
M&^*A-Q9YJI37Q!D6-.9!&F4LS6T0EQ26KY]16"^=M!0#S=(9A4,0*&L,0!(3
M:!%F0MEB)B$7N87PDLE[1N5,I4REY]>=4C&%#>2<48IE-''3<2_BRBLI"<G]
M]Y=6=UX[K_".2VX)!8XS&'6GDR!:2 H8X[T+4D%H5 5UYVM/_D[BHMNV.+"8
M.J@8G,>7>[Y[XKOU6ML7'8;[W7BCH<S;3J_?J^FV&WYHG!_>:FK3;#7[%SD=
M/)^O9RIE*F4J92HM!95R4^&5&*@Y[A)QUP''@4_.@#_PMLQ>:E[J_F3.4C[6
MF,$'.+QVK.$%PSCP &!T^@!%(1K_EGE@K4%(21BL<M$#('6I<!W3*C5_RW"_
M6*]_83,T[Q/EPJ__F21G;WXF21Z/S8QK.O;<*2,U 4%1#RCS$!AG&,!<4DJM
M,=*:*,E9@%=6@)^M%B?+]I/+]HU3+AETI)D#'#H$:! (2"%M)"3!&'**O%9K
M&PBK.F>/'O:593S[9)E*F4K+2*4JUN)D??GT^O)Z-W.%J8VN+> <1;_6< .4
MLQP@R(V0T#&'^4A?/GJ4?*[%>9*CK?>[[W<>,^IR:8_J<T)%IE*F4J92IM+2
M4BE7WCSUJ135@4IN(-7:T8"HT0@1C8/F!GNO?I;@O<#*F_CTQ5NYPF8>HWWO
M:+.?QA"-@EQ['XX#(T):+(%'V  JH0<:>0JL\I02& *6:FU#U!F$]<B)%<I(
MRR"_6-?\D<(]/HN:)<WTIOQFIWM&^;V8DE\C"%0.4< 4AX 2K8&D++K?RG+C
MH3$*Z^AT9[E=6;DE4$@D9?!"8HKB+U9&\.9&>>^HL?RY,L>S2#]4I(O_%VKY
MP\7^D3TFPB*.& 9.&P:HMP1H2A (+C@+71#0D*B3:5VI1\?1LF!GKRM3*5-I
M&:DTAY)TPGGIK F06FH,5UA%2S=XY0.7$N*L)*NO)#^/E.3EWO;FL0["6X,X
MH);HU!R" 64)!XQ;(YBB6-%H^ I6,:\UUU&-#YN\[K9!9] ?'CBE@1F3I56G
MG9;SW3PL(V<\9"IE*F4J92HM!Y5R==0KJ8[:BFN*?_)%.^=>,U*TR"/+15.+
ML/AWKI]462N%ME8 [X( 5$H")(4.B$A_S1ET)#5.0+2.&*DS7*5NSUD/+&O9
MU -%/#OU,XKXU6'6WL7^YC&DC%H-">"*($#3*PV] 8$ZY*WR'G*T@,.L+-G9
MPLM4RE3*5,I4>G%;9@$5,=F6J8(M,WU <7(L.84LNB: 0!F-&2H\,,0@$&1P
MD;;82D^J9<R\]D*8R:$TWWRO?S72NW.>*),K8O(9>*92IE*F4J;2<E I5\2L
MQ$G$3!4QQ9O[I:$R,F1</G.8RXC?O7[F8!#%4" '$ H24(8%4$Y8X'5@T@0.
ML55K&T34I7QT!Y@*X\A*"OK*H?U*4NEY>W'-GLAY/]SFF,EL<'N]\L%*IJ61
M&%"E!:#86R 9Y9%>J5&^BGI6PK4-6:6$SBS%&6LSE3*5JJ@1%W:VD#7B\VG$
MZ3('1P(FQG$@$8%1(U((C*0,$,ZP])&VBK&*:<1%EC@@=<L90E7."_[RO72@
M-BQE:%W4_(CM%W!NL+1GG_F$.E,I4RE3*5-I::F4*Q@R$V0J92HM@8N[L*!O
MD3ZWZ;X,>OTSW^[WCCJ;<=O2[77KO6ZZW?96F1^WDTS]*P=WZ/#^5:0+96]W
M+F]W[T;\UPB,+8G>+K=2 RIM (ISFT[>J'+2.Y8ZW[ \$FG)!#K#;J92IM+R
MQG^S<GP1Y3@="D:!&>48!U;''Y1*#"0U# 1#B2 $4P]%Q93C:\\H_U3.^J[Y
M'^>^W?.U9IH'WF[[4G*_-_NGPZG@.;4\'S1F*F4J92IE*BT%E7)J>6:"3*5,
MI27P@A<0(N[%QXVOYG:'KQ=5#_V!G=(=R![Q7![QYXEP<5S+MDT3!PU%G -N
M>/*(L0%&* <4Y-Y![[4G=FT#/=XESM*=,3A3*5-I&:GTO/'BK"DKHBD_3VE*
M9Z47'#M@L/. :H* D<P %>D-I0L>45$U3?G:6Z47"?7 Z)1/;#MG21 *T<CI
MQ/E0,E,I4RE3*5-I*:B4TXDS$V0J92HM@0>\@%CQS.U\9G&+B]X^A0NP->$!
M'/C_#)J]9M\?^NZWIO5E%6YTH3LG[>(J14%N=IKG<IH_W-*-PD"AJ([^<HA.
M,_,0&!7=9VQYT$H)1I5=VR"TCDF>-K!DF)"1.U,I4VD9(\Q9ORZO?KTVPM,+
M0C0U $O- 268 &TM!P(Z(:(=AHRF%=2OBTQJKG1_B_W^J>\6H>>N/XVRT?R6
M,ICC[SZG*^=SSDRE3*5,I4REI:!23E?.3)"IE*F4J92I=#>5WLP1R1"0<\@H
M\4%)RK'2G"M/+1:">NRTFC]7;A2W*-RNK4FO:[=PNO[L]'H-W]\/1_K'^TXW
M+7"SW^\VS:"O3<L?==[KKF_W<UABKK#$QW[1=G.R"0D1*&#!@$%* $ILB*^@
M!HH@**FS2 :SML%O3N[Z)0MV104[P^\R4&D>^%U\JG*&WY>"W^FHL%4,>8L4
MX AY0*6'0"KH %.&..$8AE17!WY?>Y)RE(A:*TI&3DK.YY*92IE*F4J92DM!
MI9R4G)D@4RE3*5,I4RE3:;FI-%?<7B$M)=6<*46A4)IQX334D'MJC;?S!(YF
M3D6,7O(XB)0C1',7LW^8BA Q"2DA&@(*+0+4! 44D19@1J5D FM'\-H&0W4*
M;]:SSQXERE)<72E>9/@W2_$SMZ0HI9A2BQPG'!"'+* V4" -(8!R#XMF_P;J
M:DGQ(A-_U?*%>G_7+=VVOJ9[:>+=GN[:TQI!]5H2L,<D! _=['*OWY*X0:XS
M,"U?&SW1\ /QP>]RPY<'Y.[$N%ZJ1.A=ASFDB:1*!ZU\O)XTT%-L$3'>$<6L
M/MZ]#=UV&^^F4>W2=SM.]TZO ]J1/SOO='7W8N<_@V;_HBB&Z.T/^KV^;J=]
MO<(XF#%N!HP[&>+;3K^QO4OV/QQ#R'7 ).H@BPV@3FF@+6< &Q,L\H93PJ]\
MC 5UWEF0-+WP0??3/>5,L'%;&<9+HL8_GH\+;NS/<L+I+2;C@[#T>L79C%"Z
MI;O=B[B%FV>1./V<)[ (;+VXPE:ZOWD<&=TY*P3 DC! /15 B>@$4JV<<<QX
MS&1UL+5B\)K-LX689U&[.^(I=2D'-'@AL0@"0F1,1!HH2#;/*@0A7R)T#,VS
M_:,3W/A^++Q0 H4('"RU#V8H "UH -QHS'1 '"E2'0BI$GYD\RR;9PLVSQZ&
MI=D\JPRV7DQA:^!8,BDA0 E6J8$*2.(Y<(PY%["'EE;(]:T8O%:H;/&)D7QY
M$.M6 U!CCKSTEF!'J%14:BTLIL)K!8TF=$8#\-Y3AVSV/=9S;(RC<FSOPS%7
MSGOJ-<"616CBT8>,)(0 ,D\UHSAHY-<VD$)U4IP^D Q/V?K+UM_3]EU\$)".
M!]1>@67JF7[::<7MZY6F7C;DYD7+BRFT)-0)RWT !J:1[)0Y("7C@$>83/T1
M*3)I<H#,()E!,H/DTYY@2,B]0-&7PHHJ80R#6!AMA U4$S'C"<;]QF;&ST>?
M4USK(JLPCHI-(D"M,H"2@($4! ,JM&8$H<!12'DNK(X1SRB:432CZ-/F#AK)
M@L$X".44%4PD:>2.LQ PE,K#NV'TCHKQ#)H+ ,WI'AR4!LF(=H"KZ)G3P!#0
M+#KJ@D$3N%;Q=?31!7Y\$7B&R@R5&2KO@$HFN/,\0B/UDAK!C8U6IW3*6ZH(
M%V@&J,RFYW.BZ'2AA',R,"4](,&ZE&)M@8I&)PA*$^OB'V7 :QL8XSI7-TW/
M#*492C.4+BK Z:-I*075VG$:()3!<D)H!%$OI5<X^^[5 -#I&I7 .7&!4H")
M#X#*B)TFNNN 4*B81P$R',U0K'"=\M7QW8LZEU^+=(CXKVM^V_A7_#%:^% "
M*%X7+$K)>:=7C$1XV_4MW6]^\[]];[K^Z4A")KXX?"(X_HHV<?&#_MU?F5BW
M]5&:NHN6<P1_)N@XK8E<$;'8C<F?I]W18L[UB0>FZ_57H$-<ZUO=^JXO>FN_
M3CW26;,]NK; \>;7'_W.!PSAR1ZPY(\(*YUN,?_B;>1*WTV?BFO2E5E+[;2;
ML/2_FC1^4!&M2/38*<%2$V(IASA":)!$L&.ZMG&4V#<5*FTE&&[W>__Z56],
MD_%JMS?^9;J_;MQ&XTG"Z>Y)I%T2.U98"X6 C)F[$,JX1RU]WO-O1R]^<\W>
M>4M?O&VVBR<MOO3;\%I#B6"W%'FE32C?'G/(.BRY9%B"-KSS\.WUXJUK(#-\
M3ZY+1.Y\&ZZCN[]ZSV7%.N?\05>]_SU"'_;-^];*UK%D2[)6OB[AW>]6:ZU5
MV]?GWP&Q3JE:DK56C5KWKY6HAV'62_  8W))ULK7H\^Q-&ME<C;9&I9F7[-1
ML2@5]:U1@6N6<I4=\-L=B:MG4K,\4VD_O\Q3B5N?ZL [[\\*(RK::,7"TNOW
MT<CSW:YWM<*AO?.I;U+RSCS7I=^@PC[=:NE>KV2%S?(/G;.S3KO\R\+V:B)L
M]HC,XB7=\7)'%\=X\:/=SO?KR=9+M27CP8D%SZ7IB6"W7?)?.4,Q;U2Y4=8.
MS@8MW?>NV)VBC_A(3L?-Q(N_E&UD:F]2(YD;8?:\?\4>;?O0M,U^WIUB=XXZ
M_:$$3H9Y_UG\I=0 9<BW]F:X;]-L]?_9^_>F-I)E71S^*@K.?L^9B5!Y==VK
M9G80P=B>65Z_#7AL9B;L?QQU!=E"8DO"&'_Z-ZNZ);4$V,@($% K8GF$+MW5
ME95//7FIS,OY$69/@A]=V-*NY3K=[/50GPI9UR-?GPT\@JFK#_W="E=Z!+-3
M%M8F+JP?(N&/<8[+\MRHY7F'7UU3];W[X3'?#WU=4F+O17#AV(914V4/ZS54
MV=O\<[K7G*K5#NK*2%-=4,&#]"QXK9G3C!@EE<M=A5+Z!=:8W.2@[A,IU]+_
M^!ZN]>[C+G]W\.9H]\6;CWL?_S[:);MD[_C/"L8%XX"QDKW><C;&_C][GW:/
MW_=VO_:/]OYX>;;W!WSK'[C_UW?D_8L_S]_#,^__ 7^3_\3=7GT*;?=M5>T=
M')Y_("$ZD!1!(:1B+=HS9$VHD#.\TM)5(0J<SJ&)+I>T*_C%_E W2L=X+#EK
M&Y^2=DWU_]&<M,U-.;LI[EU2ZOR'0&^EG+.G6E?ESD#P:PL$R8?*":6\I8A[
M1A$SUB-=$8QLM#CRB@3E70V"DCTU "QDZ+IDR!+""-&2I"/V+$H3J Z<N\KI
ME.Q8R- &X@">X\"G+T"&B+:<6.0-MH@QB9&R1*$HI1.6:R$K#CC0%41V,;UX
M2NIQ(T&A0H4*K07R"A7:) BD"Q#(3:6PU )5'HOZ;+VE1*#(* [<4668WMIF
M75Y53PS^-J]ZW(:7!KX5DN5IL-0P)U4 Z-'*RE2TPS/CO#"1\W60K,*J;NIB
MVGT^+7;T%]_;^<"QL-A&B12E "I2$>!5FB$2N+$$<Q>P!UZ%:5<IV:WTFDO#
M/8JBOS^B[(^84SU20O5C\';=<KV/]BCC'2);;P'9G';.<&&1BT8BIJE#1N&
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MLDQT)&!5(6]C0"Q2CXQ0#!&*@V-"5SP5!<>Z2_2-:X(_5 @M_+4 \$/)70P
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M)L,&\1;?:'WS-<S$T$_7QHM0_Q?^[I\FZ;3ALX;4 I8K@>5">2R3HN.8VW2
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M=1]/4)@17'0JWME7\OM^1@#R;>:_@U5P,AR'\3/@%VG?@O?ZY["@^OW.40_
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M=SY48,-7S%)$6"I98X1"VDF#N&342TQ]9&YKNWK&.+WHSIXNC>P[JC7RT@2
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MMA^7M/N\_O>I:OB4T.V]>/5U]^LAW3O[X*.K! FYTTM C#&"C%<:<<H\EY6
M6USP@6\D7SHX6HKM_YA!-K=PP(PZ,<EZ;#L+VM;C7$$.PR",LO,V\8.3EE7X
MUR"/($=NLB+MY.5N@'UE\O#'SL[K1V_RKS+_M9MJUXS<49W]0G'C/DO6P$RF
MM25[Q86MZ<.%DZ$;P+ZMK_@"+.)D/BY<M.JFF$#_-+'E(V#.O4'F@D Z@4/"
M $?#X]HLGR^D:PU_<F0FV>WVK/,\C":).+9]!]GR3@31S\)X8W@#/DY+:#8B
M^-6E]Y@MS)J/I@!$>MKL(9DMJM9"GL\2D,[A<6^2YV\'+/53=U33]?;HEF=D
M?#0\[<.D)J>,R3>%"WX\';BY7V8:6/C.W"1WV,7LFWK*TH>)%*=+G0<SZH1!
M&L/E8FL\9M<6RVH:MA &H.)!Q@#6!GZ-.3:&S17T*I&%J7/M^CH!HFV\0=T<
M=C(#<Y@_ _-P>-(;U$&A?A\LHC1S]:_2FFB4(EEVZ61W7C-F<II,W*1A"1$&
MV=.5Z.-T]433&\UO/S7UY@;I CIDH_&T7]]O>!)JEW7CY'9F?-2)_>'9>';Q
MR=$H! 2&;(J$@7B&'KYK3YNQ#">S\?2R)OM<4/3SS!"=WBP%J-S4\9D'?=I/
MGL;D:*J7?[(/4PPGN[7K.UUB';:Y\&/:-6Z9'"ZPV4()&TI(]CZ^JX 25L#Z
M#"$$2>XE8@Y[I'!PB 5--(<YUEXM4\(?QYQFN[G@_FXI;??;+O!:63_#ZQRP
M[.7X>(H"IRA,<I&G;?VHYX[@,AVXB$^!AK2D1G#!A"EM#W_]6]@>^\U?T]A!
MJ]93#6D-CK11,_1[QRGD-.-_XY7(S[-OV[>7NH-N(YK]%+-7Q=79JR41=0,3
M49,+LV2BWO>SW#03M?/3S(MV:5;JI:ZY[[K:EEUS!&.)23"5B$P:HFA0S,%&
MAKU1P!LVU*'Q>YMR=C+E'#=643:/.W/+&':CVIIM;9JP+?D6HVUB(#4MO<0U
MD0/-QV "PF!!7*T?+G[]_X,-TP^/'[?' KC\?%,?##MUQ&R\%$T'6V+<\E>W
M74.-OSJEXKE1S\[]0=>WFJYM#'=K8R@/.,G<=&92[,$XW:2QX5;C(HW5UL]?
MR(;Z(Q;Y+9L;?XW#?GP)#Y@$,WYB!L;%J-*K#UIC!=/GD(XAG?V5$5D;.+)*
M1.I,,%2QRRR,VBLQ2^E:S<Q(7TI>KI29M>0K&X6<*#1NN29FF;]A*K<FG6M\
M6M<F&#<^B!A36EO6[>/:>(%!#D<M'_ *SK#:K7D\! !J0\O58[#G[3$WMM1"
M3AR81Y]-_W0V:;V4H3P9CL[;[]?*[H9PR^GW<J"^23].PX2)KK^;?!>#E'+[
MS9]/H_NU<39_@"2'Q5!X^G*=+PIP^3GTAR>S1,9L@ U,/Z7X=L;#.&ER"\<I
MS+X[?VX+AA?\M!%)3C=:F+&/I_ZPGO;3DV'+&!REWZ4ACK)S<SP<9$99/W3^
MZH+;=I83"VL#?MW<"FX49C<>7WWKG)IQ;'Q(Z6:3TYPM/?<&U>G*/@FTO8D?
MF_..[Z5$WMH;O> [F]T)ELVPR;*:Y+7;C"9EJ^>;-OM!?:60K58;)F=I>[ML
MT&9A?,L9':NHW5D/[&@;&C4)_CLF[L/<5"[GQJ] T1IGYD,(F,Z'^[0=8A?W
MJ]T/Q'+.%3:(6^P0,YHA94)$E"G)I)7<!OD@@J0[4PA# &LH)^/[8-/&,891
M3U46]L;AJ ?V9LYJFIR.:C=:@W=)VQ-HSPX%' )T3G*>5DKC:ELK];YP;'J#
MM,.U+@4_[^<\JO23X:!AN1G<FT9<TUQ2V$D17/PX[UN-.@& WL9S?&NT"\_X
MC0'W8=^]9+SM8QEI4QOX;$R, Z!CBL*UOYW&!]P_!09#S4+R0,Z?6@BK-27=
ME.*<'<%IQNOS3=-T8W-Q*>0M+&_I#1&#&<U1H<180I/$?SH D0()@8]39E^]
M6%,N="($*2\Z^:#-EVYSIJFF<W4X)M&A43B"/3"%=M*I,F  3:!L84ML;80+
MX:7FK%C[*NG.W90E'4YRR#K1P1F#W$^W10>P]M!!.$X'*T;GG5>PG'JCS'_&
MH0[&YGT_#OLI9+5\YBPM2ICG<3/*\2PR-I]GH%@IT)O93TK5/ DN,5# _^1*
MGS6Q;?0G1;<^]WPB"N,4GDN\NI\(W.*=IT?"ZI\TKOEFSFJ-NT(*\]!C?QH_
M&X<+&CX3RD\-+_VYN7@CQ)E4+J,L*\KG)@&XAZ.1E[.9[RS!QT#C[M0WD(\=
MY$E-<SJ;TOF,[@]:!+(DKUU&S/[\P(FRC!*-5&0&,<4]4L3"G]8159%@%0^7
M.1+FQLS"QIO,[E/[,1OTPY0'GN/N"0'G6#L*GWOA[%GGU=(/$[  4.:\G/QM
M>'%V% ;SG(2\^Z1#.F"N#L^6L!>&4F<_9(P"B,S)%@E*X0=G.0-GZ !ELU^P
M3C7/INA%VO.M>YICV! SVN9[F.;\\%74I![B]-K=^MI@^<+ULH^BW_N43O]D
M4I22'V;F]_2"4_.O<;#X*ZX,7XG#O&&[83JSG/T4:5X7AYNGI)O(T>PA9_O;
M,*=039K,BG2?YF*U70S[URA<>KWY-C@;S4^FXV"PO>9L5/C2&T_&/S_K_'.;
M=TU!;IB;[-]*FU_&VS2S0">G>#M?AN/Z4&++Y53G[R;FVAI[XC*UM\,TTWLX
MR"/Y]K;9G1[\;"Y>>X'3_4!T]>^B<9/AZ+N77]Q$?TIC^ODB8UK/WKRX'2]Q
M[KHS1.?N"J[E(V:MBFNP_[A4=>TLL:$PN&!^SX$_MJ!E4\Z>W3O:P_T^Z,HI
MRBJ) /7!#(].(L!WC2J@+$8%FK;:NRP;6D2\?A%[#1(@!KDJ$-C0?86TYP9Q
M%V&CKY@A6FQM#X87SA9>/&SX703-[MWY)AZO'6^%+R:-?YP&^=7.S!PU*$3_
M!O[5/(.%Q2^R^+\^$$\C#I0C)76%&%85,E9I9+#&T=,*F^"66?QL.EN)#9F"
MCVO"$'N#^G3YX7#H&T^D.9N%0J;1NT1BA\XT3J*&+J ZRN(;?MP;>91*EIRG
M+-T(C#:3Q!2*.AJ>YO(!\\$ LYN>A*^9,+#NNK#$C' GMT3M],@$OF;H=;1K
M>I7\W=YX[K69Q87J%9PN#R03QEA_]3A,CH9^V>^2BKF$&M="JKH>?+<SAO&@
MXV&J4M%$YK[D ZWS>\.-FF#0].C^I0.>>8GR^=IA"CNET$\\S>G9*5Z78HA3
MUV:^]$+(#O"UEPADZ\XIJE9[FLY3Z:*Z)@),8VW]-"9$VQ3SI]E!NO!,LR=-
M9QU2\B%,8>L>M<?)G[K&$58_3#LL6ML64X/E66?_XD5FF9]I^9R-TH&*%,:,
M'9-]6).9:=?<,_GCZB,:Z=*M>.V"5\XL_\Z90;(M;,A^N6\3W)F3,@TG(!C,
MDI/]O^ZPFCI?H=3P3'7^20-_,3P;S/B0>'+0^-?7_8/=+WL?=[_ [^#UNP^,
M\>A,8"A4D2'FB$>VH@$1AROEHX@XZE1OX:I&%[!/]J?GS:^?3+;*8KEI7>JR
M6'YLL7QTU?X+1V'!P/]?D=V=#\PS&KA7J%*R2E%*BW14"JGHM*L8T83ZR]=*
M9]5ELLQ]5TQ-+VGH5Y%06=+0-V L)0V]I*%_/PW]>VGE%RK-5D%$$AV8,\Q[
MJX!6<<.Q3YU0N"#WGC)R^=R^250<./*;>7[?W?@ ;M<<;Q[K]]'P.*EMV@G_
MZ4V.GC=%+8N1OFBDO_M@A C.5 %Y[2AB%8W()%^LM941081HJ%M>\HI3$4$L
M5KO 2-0J1$JX(S@(0:B]D.-[[R539R&,<:Y$F-;])8?L6Y5I $\&WJ3\AN=#
M/T^1.!B>P)K]:6OG[?.MGSNB$MU9I;+-Z(0QU>J<5#I5@"9G:JH#XUL>\C<'
M. \VYH.7N9+M"0PVMRZN?3K 56?U:@'[Y_5HD\@&3?BJ-JR;X^?3Y)<Z4EN+
M"GY9A["F$;O)>1/.RU>US9O].JHU*V-8,^64HG5A,//M<SG5]5'Z3"_NC-]7
M^T68B(090RME-16L@HV1&4 :2E@TBE0N+L?L%^*$4SUMNP&/X8^FS-MPD$:=
MDXC&WRV!/"U5O)COW&2G3VN%U+5?\L&>DU8YC\'">]-+)M]@?=;8N*D_*_V9
M2H)<^H/N[(' /!Y.,_K'LPK;N7YWOZG3U%IQRP989V=672[5-!U/S"@#%MRW
M55SEXJFQNAA?BM'G;T_:LY-2(@:P<"Y4<OZ!HT'K6ZGD6BMUJ972'214O^B-
MS>'A".:S;N/00&ZV%@JQF!(+]T%BI8TW% DL+6(B-<CBSB'B'$QTY2GSYD$D
M5T_WU'88(B?BY(3,I$X_]0;U.IRDR '@QOCG7U8L85IG_<P<';G3%SQ@WYR,
MPR_3%[_ZWOBD;\Y_Z67T0_E'OS;&6^,=22Z5Y::PZ8;UQW-OP;.J]A@TO6F;
M.S<?/\L?+34FJS^3Y)FD5W]</<-7?O:MRV+\3&#]0Y?]]F?\E@9+KC>@[_3_
M7>K:=C_-'-6U>AI>WK1N]DSZQL]TE\Z4Y4>^8"-7[:/:!]EMNEN[35\FMVGF
M<3/7Z9)OX4G)_5K/5 OQ?I[J<M&FW7V%9UINY/H('K]:>/R5^Y0W'=177,BW
MT)_\^[MX57?N2._=H$%\:JJ9S9--[,=[S4FX?D/>E9__GOKQ7O/!5PA\5M9;
M;"*I5,#,DF H)]&"Z8N=X!4C*_8<_V;@\SO>RI=?&L-T)Z7\CH,_,%\VI6_O
MC]H83=_>W_M[']_!;P[)NX.]WM[!F_Z[CR_9WL'.^=X??W[=_^/5U[WCWX_>
M_[/7O]"W]Y^_R-['O]C^B_='N^05WOOC[][NP2&&\57O7^RR=Q_A:?_YO?^.
M@%W2JWOV[KZMSCYH+IR6." C*$?,1 $&B?=(:0\F"M4@4KFUS:NN4#=NV;NJ
M^MQV7_(EM+YV7_("@T\5!CFE1CB,"?6<5<1:R924C#I;<1&<6V=?\@*#MPZ#
M7V<P*!0A#C8Y)!F1B%4>8)"0B!A7%8\R"-CI@""J+B?LH<#@RNRU::G^8-CK
M/U/7[)4V"UGM:2\%Z@<-6)H2+G2HN%&:41RLHREOC6.+F9-5X6T/";#.6[P-
M-IQ (JV0K6),O4HBTH0H)&B0A,%J#X%O;>.NH#?&J\MAX5:9V=(MKW0T/'G]
M!B+BK:>&2V>9],129D-4'E>:.EW%0D@>E'[/"8F5FA,,J@V8#'89P#92UF)D
M)5&:4%;%JDKZS:G>(/U^] ZS@^$DUPK+FO"#C*^)25&88S\\31&NZ;B+1;FV
M"7HT"'_3\RD%X3<'X?>>MQA<I5D0,=A47<TB%F- FD8/QJ<C7E9<5HG!<=*E
M>,TFYQKTZV&XY@K2%J2]N\-=!6DW"FGG7)I2HJ,T#EE!*6(2$Z2P=RC*(*F4
M4LE@M[9IU:T$?31(FZGXOW(RU+J;*%V:!_O=O-:E/%B**:U\Y$8HP8CG"JP=
M1XQ4(!4:HMC0O+>4_=*DV396P&)*J0\Q'W%.R:33).U<N7'0KB%X=C2<E>)L
M)9TN)'FWTG.;I-QGG=]S.:AI0NIL -^]^259K/E$=:O/3\HI=F%:A'$A_[B=
M+]]*/*\3S"?9(FKRS^LZY5<EG$^'>=V,\R87?E0G(5\V1W4AZ.F8'F>-DN\>
MY%@0TO>3KN=-J,Z&J>A;WK/2<8^AA>>JZT[]TNK]_5/OYQH#9Q=(.> _]:9O
M7YZDW?GF /TP5Q+[]CASDP?32<W6T[J]=*3/.M-$U-ZX79-KL5QYF)7UNOPJ
MN9(%O!KGRK;V?''IU4W5F],8S>B6EUZ:DVY3=_\R24SGI3NM;9'[KX_GM?TO
M3N&%U;U0 V$ZW%K9KWBLI$5SJ4U2D;]A+Y?.SS,SK6?6:TK%^]#O32O2-6-L
M)<.W:X,X U/SPT.:/>&L>%Q=>W!ZW\NFHS76R?E)VO52 ]I.!&WRYKQ9;S-I
M#.TD%UAM&I]=>*"T@F>CR,^^#'K')_TPZR)PY>.LU"?DH4-.VGR6=H-C$%/J
M"GS5]-1[XR6[S#@7"G'34GO!N*.K5DPZ=-*9'H-/9SN ;)E^*DL]/;A17W-6
M0_);7TK%(1>*N8SR$DB%5RYL4]/ZA/WS?)'QU4NHFS;9=,(F_;>N5]E4[AM/
M.B?]T_QF3D?/]VZU,DASFA^^6:&K]#]J[CX[0S.KBP@_FM="P=7_;PHQR\>(
MGM3J/1A.*QI-#_HD0%\\2Q<75G@&\.EF"=^/,*?YC-&EYY,6.T=T4F7U&H/J
MI0M?..J=-&J3VC<.855L[4084"_+9+>YYA] ^T[&6^U:DPOW=L/1R7!:'C*1
MT;II:OLKLUZ0=?M(V''ZL$[R2?&3H_-QS_5,4UKR6S_.CQ\&AZGPTNSW]8DR
MMSRJ<>>GZ9SX85,K<W:KU,.EEU0R'?@:G([&Z;<)#M(SY)XM:2CIG#K\O#FR
MEK='8)'C7Y._*!UG!.7OIS.K:5=NZG/"!+Z>?F\KS<6<8:=C8&;^\=;/Z0?-
M1:\X5@9,(G4>@>^E$_8=U?F__P=L$OQKY^]IL\U7TXK>+YLY6MS_9@T]6WO<
M_(!;8N%-%_7<>[/NHI/ZQC3UD?+*:#/W:4%<&"ZLP7'#4T8)+I)4@S.I\A30
MLR4#9%9FJ5Y!5ZVQ/.O3"9K.S?CB!KQ$0W[-U&^QDFZ[X1I,T$DR =*$32NL
MU,P@%U%=K"O6- 8*)V"GPB G,^HQE4J^V_+M4GW3<=T99ZJRE]"G-/'YX\2S
MEHAGW>PEGYV]>+RQ78=]"O>_-J3W\\)0NFGC2-=.5;-R@_-1)@T)FR=YBP/-
MR56.FWT&K)O18;W[Y"ZOM5TW7B)JK9WE$?<A6SRS.=D@>#9SC5DNBG<" CPV
MN=W=3UNO:U.Z\WKVYA4HM/B]\QJ-\K.V%U^K3%]V#EUHD/3_EK#A"NBYS)JZ
M>QPZ,A?4(MUM"D^)DM7XM#P[>6)RU^+F_O]OO/!(#0!=G/QZ1FN2UIJ!&=]K
M T]=BMI-NT5F[%N>[O89Z-/QU!)L]5:'.4N_.C'NDSG,O95A]@_#()^PG2/'
M)0AV%6 N6Y4_#J!Y!?TZ1ZSOE;#Z9E&KIUB<2I7B5!LPEE*<JA2G^FYQJN\6
MFUHN3L6E--[ZBD?'L%.*1"ZH\]P&SQG15Y7Z>* AB]:NLTS.0;E.4P^,F7^L
MM6_6+*IFQ3&W VN<HHT[(3O6+A@'F2;?"DM>#TE^\&Z,=AQEUL=R*L<Y3:EC
M+#")=='?NFCRG L!GP,ND5GR]+>'J85I;5E?P3)/3WS=UG0R;\<Y];2'07;?
M9E]6W8HL.]UJOVZK9>K7QL2<_G[:>2,1TYK;HRE5K;EX<GC4RS83L7JTL& :
MOO.L\S95NZD;M 9DO$_UD.>^C8GYTM0N#CFFGGIWIC)0E_LELQ<__2ZW:.G6
M7VW&\XA-L8,EWIX:M^:J4DM=OF')]:?=UX;33VMW!UA/)^E[:>:/X)_L<TUS
M^[GV)C7.W23O&DQJ-\/4.V]FADJZ?VY%/HO!U&MR,=HR7F#!V170M+KSO5'J
M3E-[!U+!;!C90B2C73JK61$Y;E,WB9L*^\KXU5(4="F2-;MM'8'(O0VG;TWM
MVZLCJI=47WO[O$-9A5BU:475<CNO3LI/:=#XQ=0U]SP]<':>D5\WL=K:4]HN
M6ND*XQHG3\QYUID+GH+V?O^-(E^+$;C&.=M&U;F2SJ)S>67[SW5D9^94RZJ9
MQO)L5I1OANN]!K3GI=Y3@;QF[$UH.*,$?"& !7K9_=,3)DLB!S7GH=O%%()Y
M^\QY['A>#W'6>NN*^%;=4R$W2YW%CZ]XFJ904H)%F()95?U6OZG9P'/G]_-Y
MM[7%L>7F3KF>?J-OT\%^N\54<T>8]) T%HB"JT/C9CP>NMY">;EI)[.VDV(V
MA*81Y6*QIWJC7TY0:;F5YBMOVD%NNG N0;TI0G:2K^BR3I1K+[^],15HW^9.
M]+^9VG*:=Z)_O.3CEBO3O05C(N3Y;$_G?@:UG8$'(SM%O#Z'UZ >3>O)AYE?
MN<8Z=9\^4&*C5\(BSRN#&'$,614PLL(D<3"/Q:6])EM]&%-+E+28.\.3Q@&?
MVHQ,SE&KB?191HB\J8Q/:Q0$!/+#:5 P1=M@4=0M\M*U4OIN<KV_>?O7>.OG
MND7R<3#CT]$\Z2<;,G7'Z_EP:D*W.+QP?-(?GH>P.,Y\XWH4\_&E^V3/;M[U
M6JUJYA;7;WT#FOO69?3K[(;1! #YIZW?WNYN_=Q<&R4K(_?;'L*VU/QV&@SN
M#4Y.<_?GF=-Y;M^EP<X,NF%RNB;;IYOQL=L9]<:?4$R) RE=H9ZYIC=-CD2D
M-I=@)RT\9-UL)HQ"V^Y;]&\_/^J%V'GY);C3G'JQ'R-LF2-XIN<O]^&9,E2W
M-\8<QJVS'](FU)M/9S"C 1J>3CI);O5MLQ3:\Y<JB<'MS:@/I+UW?%J'9>JI
MNMAEN3$E74NG&Z:=\T5@V9B$,2A3GZ8+Y33;*/>[R2Z%:91V,?]HMB[F*Z&5
M?C1?!MG/7K.CU%DM/TCJA@Z7^1:H.:PI5S+JJ@)0(UYK(VG TCIJE"7Q4E!;
M[KSG3T=7=-Z['/!VYEOQ;^?SK[RN]^0=6.@^__-W_2"O\X3@)X:$>S">O:^[
M7_9>O**Y0<V?'Q16U%LID% @#Z:(1K:R23+1<Z&<U)7:VH[#TU'G'%;Y^$+C
MHL1"V\@R@Y1V/#KSV06..;JH2<LJG*Y6Z].R(K:U;Y$_MIK: AVVV5^>![+P
M\]1P9M0S,QYH'$#!YR8<>D'EEE(OYQJ= E/]E F<L1F W)XVEL;%#EX+$4SX
M?PR]!&#CQ'CA6N=U0^ +?:$> RVZG C^4Z^3SO_,;8C'\+!WWW>\F<CI/)Z7
M]N(+0$?2<9R]G0\D>.&TT,@K*A"CTB%EL444YK\*PKJHZ#>ZBW=FK&[<>3WJ
M?4[L"RBUJW,*_IGQJ)1S= H&M)N_]Y,=)K]=/KM00TR*$9RF8T_).,S96)C-
MTK'@AL< (AD+?T[PT+:RLZ.AQKY\]F &MO/S%LF\;BSGS/N>=7:^[\+N=NJ#
M"?D.+18)V_ L1;SQ=5\PV$V&S.$@U <DOM&*NFU;WZ@_] *TGDV=CBD"EAVW
MN?=Z?;*D09F9/[U.LID_ZV21-2=O<)UC 9M=OU<'@\S/3<@AC%Q*VIGV8#33
M!.K6G;+WQ?[<\# /5.NR+W5;&;G3%/[9!>9]UEN61'ZL:4)1Y\3T/$KN6'.2
M')H7VPD^!BB]?-_XGY#.%#V&Y[L7=\'_I..6H9[$I[U'7.Q8O?/!5L%(10W"
M7DG8)$)$J1(H$H$#&:8T&'RA>>W")E'[+L%VZN<93B?3IJUE 69<#4$)U #1
M/B>S>/K5!,W)_.S FG,A^W5'R4?M$F/M9QZ;O]<QAV ('\\;JB8\;LAE\A(/
M<_"H05! [GH<*?D74+#!Y"FAS8[G[YN3]7V3Y5?[/[-WUM@&L1L_1KIZ.K]K
MIL[T^O3/4EKB4I!TZAP>M0>WVH#2[/M>A TO)&IOP^0LN<V=&1_5EYU[99O4
MU]&\]U7MPVG?:735-)EQVR$]S4P[3IMHV@8O&]OM</G;A0< L7E#I->CX0!>
MUAQG7'CE99CQ\D.T A.N.-("V"4+,B EE$665!(;8X@C9CE#A]-HC7(6ZRHR
M:XSV%F/M"5'! ?2H#6N1<54S.5=CW8X'DQV4H-5*:W'I/-[=^M6@LW-ZF-@F
MJ;"JP6Z> W9I;['?AO"?SD];O^^\_6WKYZEG>.?M7_D2"---BX2_ &L%6'=R
MM_X^ K0X&XX^S:V5ADHWWM76=]_47;=K\$W[TN^)9O^=:?9N[=).G]UW7[)\
M".DXN9!S,H(B&Y>)L'GSUB3,IS5[G#OE-?NYGTM_M"S]EI%U/'^*<<I)AY=-
MP_=\M?/\,A&97"6BX\(HYYK,K]X^!IF4"<82@ +D0U1UX+\VP5VF';WF (H9
M#%)M@MJ.34DXA[U!SM.O,W9> )P=6WB!>3J*B'63<),,0>!LOO&$GZ3(R"3!
MW<6P[<)F7Q+.%Q>-+@GG&S"6DG!>$LZ_GW#^@PGDWZ6UFTGBZDQQV(.";V\R
MM:L6$/D\V7]3_*\]A+&7C-T<$LNGU5O;PO1,4VJN>&'+FH6#&LH\2?OHY=OF
M[$+Y)O59^=D>U1R7KQY%TNYWS(M7#4-^DM;%[\&.3LWH?-KB$XO&R #K8<EV
M$*@BF\9=:T=CYZ>ZA[)BY.=-X/N-EHUS&8E0X^O,-35UW=7IAD!:ES(+IP&<
M?NH7_"FD\]IU\D+.++4I"R1=(1/+5GY@K?])5&&<JI;UX'+)/YA+G:%A1/F0
MZ=:;_;_ **SS9YINQ\U833/:Q<&:#OPBY3@V)3EJ_],\W-$D32X\0\V&T[&4
M^DDSS<VIB)W^$,8[:BIKD*90Q[/._TR_6$<F6G&)E*F>MZ <%IGY'1ON//WB
M_Y^]=VUJ(UG6A?^*@KW/63,1E%?=+S/[)<(SV%Z>&(FQ!X]?^.*HJQ$6$EL2
MQO#K3U9WZ\8=(T"&VFL/!EVZJZLRG\S*RGQR6F=3.>F3 R4+>#FLLW'/?+#)
M!\I!N(5P7?TP]8G2[-#HNMW Z  >-@[G#KV^:V-0JV"].VB(2E)5#IV3"0ZF
M7V_.N.8LQ+5[#4JOV6M4G8?_..K-8$#/P8 ]S/'6ZFRQWLI6YJ/9D6<S]/FH
M6V>?UA'CG-0ZFIN#N3P?F/BY&IOI+%;)9LT95K[@=*[K[ 68 UB@3)-V>-B;
MK.%/3;K:[-DG55CU02+,49-S5&58-!9Q/>=X[4U$\+)+U(=SHW']$,.:.J>^
M[L]UH'=>1V;/4ATOYD&>3)XQ/TU6ROH<\ZA.R_HZ^7QSE#@_GR#BU4@6-:KR
M(/(N-=;)8/"),Q:_.YH['8AY(VRGFM"%C_AQ_7 Y VNR7$V!V,)1:9HZ?+-#
MTR?A!5QJ O\XZL?6-99O]:)F,\?\;56+7WOFT[#9,()_WOIS,)HSCXS*GW^9
MC_%4.Z^%3X)$7'CAQ[2JM;)55JI:H(/%!Y@F=OKZ27KUDU0QH>FCV+K.9B_V
MIFFN,[2NT.>BTKY\Z6$W'_RL3\L&9KEADQ1;.QKTJWUL55-Y=)@O:YL*T>CM
M:&*;IVI7-6NO@#2&J7YVA]4#U9:YLAI?;;<ZF$/P%ZKJ 4)TX]8HPE":"H_J
M_HW]GA$/#68)MCEAK8*[;([S15O50\\R!H[Z\ "]ZHPI3UR>@-&1WUNX504N
M=GY^*WO1 9M0&9G:7,PBS*9U;*<IR4T$-*OZ:/*PO6KQ:ABO\XP'U6%D$U:;
M/,F_)I;S(DQJO(HK+EA[5Q/S>>$U&M=@. LQCCP \&1RIBLVH?F8&+\JM6,.
M'*KRD^HZ)Q.O*I?5Y-7+*83=RN15%39G3TZK\]6<PCB7NC(=PZ5:7(O:WN"H
M%^K\POGSV0L*0LZ[R=4*OCP<PEZSCD5> GT&85ZOX7H^CLPFLI:GZ52L3PQ^
ME?G2Q%+/E#N.FC/I7- X4:S0K29RKH '1CT\JI*6&IZH3#HR7;;N#(W.B=]5
MXR>XNOGL;S(-RX<PK-BAI\.VH\.)%5]8_[E!+CHM.2M_@C_9(?B:\2(?2@\K
MNN)0ZU&5AG_DQU6R4YZPLP\Z)RY-^OE9Y*I4L:98J1JWCW,.=34/DQU<];V:
M[*[FMYOY;QEO%J:%8MC+S4U+_ALL7*X3GE"%329I2OHUF:*9#N3O@_)EW[!)
M&!CD<3;4:FE>02H$',V<Z*:D^'O<Z.JN9WSBN_N_Q95:ABLUG??K='+E @E_
M9RM2GPU5PYZ+!F79>UMO";=S-?PJ1!BZHTH':@]B,-'"29$D>"PU'(R:IP*U
M_)H!(VN=;<IAFF+*B02_F%^=)EPYFFI]_)8YDNK*EWJ?TI1Q3+BP>HNUF)6U
MS-O&G S:[&*'MMF9C>VW"7UI16-1.W4YIQUF\7.30FE[OMHKP1";_7A-19 A
MJ'\& -8O2[Z9IM3D6\[GN595!4?CS+3=9/_,DGQ&BU-Q;KM_NW,^BN=/#">N
MS7R9TB4;?)B/G-0UM\V_+@XQ\Z#N<C#9A!X>)NSP4+!;IU-5-/+PPK!B&_L\
M'!Q7Q;+U[7]:>_7F]UP3EQD48E-<6Z7%PK ;>I>YL/!<\>X%L8Q+EF/Q@<,
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M)]:SP:I_+6[PJ]SQ.:]\,8KQTXP0H/'4UQ>C#F=B2C]/[7U%2-P0J.8<AA;
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M%H+00A"Z4HR8A2!T,AVM0@Y:R$$+.6CA4+GA?AH'X;5V3+B4^V$0XY/R&LN
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M5J_ Q,!]0^RMGX$]>-1^ V'P.R#7*$_! &Y977AFY].49W;"5WTSUVJRZ#6
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M7&D-.L,O*.5WV<G<.0Y'.0@0Z\?_V@$F&UIGG=@-U2->##K4\S^U4-G^C@G
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MH?&^9*Z!Q@>3NLR6O%12)V*1YH$@;J)"SF*!;.[:'"W33H?<_^A'0F-% $[
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M1\/6_[5'QW^V_C<.AO##=D<'*ZV-GK\<?H_L8!_$*J^/RXN!X)_Z+&"*X6)
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M+"B."OS2 6J7/YZIHS;[G& U^G7<(WM!!7&J5QMG\H&'G?Q,>6CC[Q[8KQ&
M*O;F!U#>XXP;5;VC^OJ=WLQ%QN[167[LF4CZ0>Q=N%5^T$HZ>B7QM(KX?.?Q
M3W-8\69)N#9J$[7BU@;)$\8Z><D89U)%K:.ARX.*\Q9W>53Q #CGG>/PD]A,
M@;E)5+Y*QP5[7#_4K[H$=+[#VN_V-$TD&9H09MP@+B5#5D>6R]XZ:1EX,PF_
M>,DP6=%FL1G5;.;[Q5#UO =_6T-Z58+4;;C?W%*//XCAI!MK:5@0MDI&UDY&
M!P##YS%\S)[?#)'[!]!K^-?9A13']UD\MV&4?W7AO%],JMHPGO;YYK?-\R^\
M?0[CS#&^0(AE H$0 =>#%X' 3U:(QL M3XDJHEZT(JCA<18.,!N/U,'9G@'9
M6?M0%;Q8NAODHDZ4&%D=,5^(EO\^8R/L>"-5-@%@ @OB521VQAJ&SM!W^\.3
M0;EEZG=+H/"W3J^Z*\CL"3QN  <KA^:.1XM!]L$X6:\H5IVM!S8[Q=F'JAG'
M[W_\3(I+;T 7;S;.466RQR'!DM</XRW,X8_Q+W_"9!]W[=D?G5ZY:_G2GW64
MHXXCYN#C?'G_?,/J<!U6,V:5$Y$C:_7^J/K&==!MM03=YC)JZF-ZE1%RZ6&\
M>MMC@HE;?;,9;#/8ZPQ67NNRW]DS^"BV!NIK95\NSXZ[XIDN37<WUWG\*J#Z
M<R9@(<I:%:&NC>3,UN!F-EHS::P79N/V@O_XGG5,A"L5*'3X/M[\3.+Z#>HD
M/^ZIJER+Z^3J7^>1?ZFI&^=U%G>Q3NXLOT\VGY2_9G:@E+__#;RV$DS@R.63
MG9Q#<'E/RD9"&PE]?!)ZV^(*MYW=*^G5<N>JQ%Y_UKZ>*Y</+\ECUT3PP)26
MFFBN/=922N^YX#8ZJXBZGSSV:T63%F-)_\XK#-5OG:/.Z*E'+.M-+WG#RA>V
M<[C#=NAKFC>]P'C$YN?W1^VW[\YVW[[F6]L'AYN'F^?SFUYV/F^(K>W0:1^&
MPYWM'5)M</GR;??M#MY=__O+SO:^V'J[>0;/F5MNGXXWO<S'M38/X1J?-\YW
MZ*;86M^'<<*_;]\<P'>_;7W>H.VW\+S;7NP<P77*O, <''JQN?Z1M+?]7O("
M$^X\(H$)Q(,AR!(C\@\?K1;Y9V[XB!=+L[3&*UK/358_'A\WLOK89/7PXQ[7
M1B5' C*6*<0YL\@:0I!CCN+@G?*!9UGEBPGW<WDN/ZF@^:_=?X@:R:D*W#@B
M.>?1X!2PP@+[Z+B(ZH<5O+DE#(S7V&8B /.9+T][R^:#(<+99,LFM2)9%S2R
MRH*YT;XT(,&(2F6#Q49Q;UZ\9"N4W5?A\R?7E.@'LN!'BR!+ET9OQ1'N5#OB
MED"Q"!"_1#^3!X,//-WQ'97Q#'ND&2 '-RP" _ $&8^#I%&)8,*+EW+5T,?6
MRZ0Q_4_1],^$NQO3?RO=I=-:,!)CK;A$4<ML^C5'AN&$$N<F!16(3BF;?D(7
M4W0:T]^8_D=I^A<!HC']]PD?? (?SFK%'+QP1B/)91X$<E)AD$WE#36&1BNO
M8?H?NH?1XXLMWR):!Z:: .\*T3+%"?:6.!,UL9KPY(6B363YJ6K8V>71NIPE
M"?."-X]>G^VNO_[67M^@6]O=@_9;&-OZP<'.X0$\:YZSOY=$EC_N*>P K2E'
M446'N T2F:@H"H+"[RPFIG*7LU6Q9)__'2++CUI6F\CR(Y35PXT]S(*-A 4D
M8N2(4^F0-IK!GY2#O:&)AI@KN;!%:GJ'R'+36.(&U=*)%5(KD^"-< (N@_"$
M>P(P(KC#\L=52V^"QS]9Z:?!X^BM,1)<1A9Q1%Q1C2SU8%ND-LYAI4*V*&R%
MW5NKN*;_T\_U V]ES)L0\/,#@6D(6,CH?+0480H&FH/WEWO 442)45$*BJ5(
MN:0P;IH_-3:ZB?(^C'K.1'FQH$RXB)3&>:.<B,AZZI#R+.8%FLAL6> ENNG1
MV-CH)E;[C$!@&JN-1%)MX(4;GB@0=2.0BRD@S2P-*OD4&;V&C7[H#FS/(E9K
M)'61..]AUGE*07,=I'#4)HP#4ZF)U3Y1#6N_NB*S\GSWR];;C=/V^FN\M?X.
MQOGI8//MQC=X/K)Y_IKLT#='NY_;7[:V/RV-U<JH@#?3B# C&'%-#=(Q*"1!
M;I@'G64QUV1=Y4NJ)]PA5ONH9;6)U3Y"63W<V#.41)L,1=%K@3A.#!F7$N("
MC(NU,;>5R>56E_31>QQ9P,_>#[288H]S<J<EG#IL0@Q4$$K 4?<)I\?J!S:Q
MVKLJ_316RQE( /<.@00PQ"78%A.(0PP0WGBL@C:D)/J:.\=JFU9OC\(/O)4Q
M;V*USP\$9F.URB9B%%+:E9R=B'1>L-&1:1EQ<)S'%R_-*GF0]F^-C7X&-KJ)
MU=Y5/:>Q6FR,EY[8G.8 ZADE>'V4!Z05(Y3A:"VN-N.8^VI)W=CHQD8WL=I'
M  +36*TDD6,%^A\IZ#]/#FRTDPQ)XP*5@L,?YAHVNLFKO4VN(L'&"DVQT)Y;
MAD$]%1-@@1-1CM,F5OMD->S#Y?&O-OT;GO$U@^<2FX=_'[;?OL;MMQO?-M^^
M/MO\_.G+UOH[O/-YDVV]?;,D5KNS)YW 6E*.4A)Y<84+I(&UH:B T442.#$B
M+ZZ8)6WG[I)7^YAEM8G5/D)9/7RW)XW22CF'0O 8<<HITCQ&9+BFDE")O<\Y
MX&R5W6NPMDG:N8$CR##5)#'X/X>WH@WF40/Y)\(3HC%[K(Y@$ZR]J]9/@[5,
M>BJE5<@9G+=54X&<QQ1YRL!;"$Y$D]5T1>LFL?9Y.(*WLN9-L/;Y@< T6)M(
M9$9+>.&*2<2UX,A@J5'2T@J0$:Z"S(Z@DDUB;6.CFV#M@ZCG-%A+E>344H^L
M@Q\<*Y(WOX#OIYR,%N-D6+'10C0VNK'13;#V&8' -%@KG$DIIU& .PT@P'%"
M1@N%"#%6L^2XX:38:-$DUMYWL)8G9J)*5%O+N?7!**_ (E-#HDS$^B98^U0U
M[(J2I>W/.]_:;U_#/'PZV*0PSK>?#MJ?-SA<Y[R]O@O7/_BR<Q@.VN?+@K4?
M]ZQ/T4>I@$]S(-41K+8)(2$6@K"$@=N-$UAM,;.\<B_1VD<MK$VT]A$*Z^'&
MGL;*:<(%,D9R$%8CX3>><AC($(69H#1G@=,9%[!)K7U83U +:[1++%*1N)'1
M1*QPX")X'5Q4YG)/L G)/@'5GH9D Y&,,.Y ^33H8B(,V8@Q$C8)03SWG DP
M'*K)GGT>SMZM#'83D'U^$#"3/0NJ'K&EB!B9$">!(*>I10H()0B+9<27S!QE
MFNS9Q@PW4=?[T\&9%%E+N#(F(<L$1ISQO),9/#E'#+'8$Z8$?_%RT7=KC/ C
M5_2G;82;B.N/!8"9]%AN%!/1Y$[?&GSB7'8V)\KB0+@!8,#)J6*$]0]-C[V/
M!9&[++'69:?K)M$,L"GT3W++Z;'"_MKU[6W4)FK%K0V2)XQU\I(QSJ2*6D=#
M'^L";>.QWPTI9JL3!FY3L$2!GTYR?7L9D(F.(^"(0DFBK"0:/':R8NZM/.']
M:>437-]M(+&!Q,9[>H20./6>K L,!TJ1=\8AKEA$VCB,B%*:&L,2H:I (EE2
MK*.!Q+M=HU#.?XVR($^69>88ZO)U^<.3X:B3SFJ4>5E:^%Y<WKG.]WX<.BUT
M*Z89G=Y_^#B\^2@?W],M8&]YNK5NMY6?L+4_L "RH74\Z/0'K5&_-3J(K<TX
MV(^#UFD<Q-;PQ!U&/\J'K#_HQ*_Q*/9&K7YJV5:W\Y^33NB,SEKP,7QX>M#Q
M!ZU.SW=/ ESSM\[O+7@T\!M''=MM'8/>@(?<3PG&W-M?@>/YA)8[&<+XAD,0
MT2/7Z170;8&3"?A;-'>E!2.#<\O)0T#.^FYV"$"?X*NAY<[*N"DFJI7Q>+6U
MU6O];7LG=G &GZZTLFU8*><LC!DN4S]8:)UV1@?E+-_MPZ#V\V-.)V3U^<I#
MD04PE*T>7"\>'7?[9Q&NOA][X/YWNV>MKW$(+QV JG55P(,J'*/P,0AA.#;"
MF*"<-S*%!/:;7+MVXRF ZC#VKF>@UP:#;'"S6/YU-CWE'WN6/UH[M8-0?GR"
M1X!W^@\,NQ_(T[2]%];GMSZ_P^W/GXXVZ=]'N6-!>[T-X^L>[JYWX>]]W%[_
M<@[WY>W/NQ?7Y\^_B/:YWR/82R^T1<QH@CB-%#EBP;#&8+'3E"2+7[Q,_9-!
M*T>@AO-XOU+IRZ4\KE<HT!R/"Y2YQ)+A7FM.K#3,4^N<"2Y:;CS_3B;)1OO-
M]2)ABU+AKI**]UD9AB ;'H[:_3@A:>B)AKCN45*^[#FG#"5:(L&LSU5X#7+4
M:V2],,HF1XW-_2P62==_%^#(2'H5;-Q*)AK8> !A:,-XVN>;W]KK:Z=;ZYYL
MKNUYI;$DGB)X41CE#FI(LV212C)(A1-.EKYXV>_% AKSF-&R:01&)!O5L62
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M&! 2)9U >;B34=H7+_$J%VQ)08S1@:U,#7B]X%9Z #4+IFTJ3?U!9[^381O
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MX;^B8I][MEVER9Y]X^RBBMA.XM1!Q Y)"G^A9@NRA<0K"6/\Z]\QUUIJ$8U
M@("5>X\W(&EI-6,\XQF]4#AB&D'^+(VYGT8@C;E$RBI ">ZXR*PG@0(O#J;!
M@^IT>F=9$ NGJTHYY[CK3X5 O7)%_AR<P%[E58-_]H<MHKO_V'X1ULZ^WF8C
MI_-+WPT\^<+]NRH&,1-Z&&7GYSS,PA=O%D>HO-&B @!T8Q2RR(YYU@%X"12D
MGZ-?Y1_@?)ZO>YY#-&-'>TK;,T^9=<"+ZHGLP&<0@/OX2W3]JAZ!DC+6,_Y
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MX8TMVM0+ EJ/Y[[6V'!?4:V[ <0#\JI9$*C)U8I1 L^@A";)6FPDBB(&Q+W
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M.V\^P''1%=^0[:P;6W@X_^$!P&CLE(]]\MDYC+4W<2,4XC,HY)@3A J" I/
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M>L.I) 7GDC')F<;&286%#SC2&"(.<WN5KY](6(/:?8#:CS&H84-M"MH@G*Q
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M"LMB7E'3/ H?_M+O'8\BAKMI#@9KQ%L.\?@8\7+)IO,^(.L4\#UF-3*>*"3
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M!HUM>/'XN->MW@X_V,MQ'73$Q?Z%[<LF&4J\TE1S&87A41MMJ; LJBA4@>O
MPRF^"M?AQOFL@V= O0:Q.Z. GZ*W)^TA/*<?143C_7<P0-W#6)KM ?SE9SMH
M#VJ$!Q5L_0 2__& )9JBS2/7 .D1Y\P@0$A01JDM45P;D4>N];KQ@@8B>"@(
M7FBX?$]'4-V=DB&0H"GP_O=@L239(7RV$:M'U>CG)Y>%]\&$ZP8"]"G_5HM-
MB=SG0 R,\$GYO/K040]B$Q3*H2TDDY8L!$.B!6\,;W+!+E;5/0MX7NPX_&/[
MX#H,!QFQP'$8(^^+=!S 5OT27?\4N$^C]!/ 3EOO ;DS-9I8KV'L@Z'JG0[S
M,;+M*=T-^! QS1D"V"XH^I(.190@GQ@GS',<W5(-@LL2P3Y2KS"-E4-!J;F]
M0U% VVZJGO]N_U.^#ZT"J7;3G]&?]MM#L,IOP4#'\//Y2$ZJ-]8FJ<26K]^!
M%0IX$$)1@SR-"L&C4\AJRQ$6'@,A)#%2M;%%FHR3IEZPNVW&U7A[->D9J:LK
M_%20I"QR0)F^Q>YIW&SL@>@EV^XWCFW_*Q#,;[9S&K-QRC)YBZ\YLX,&>,<@
M0-D^G@[:W</B4#__N=/HG>2S1R?]ML]_/NZ%V&D69A4L9'Y3NW(I&@$^W2S/
M:^:$.FWKVAWP,8KO6<9%NIV&W,@S&BG(2.*WNZ$4^45I_1?N$V$@9(8S':GP
M2,1L60WQR#(OD&+*@%H0YDV6?KQY6;5ZY1.5PMOKMP_;7=N9DPWPHW/D$D0K
M$[>)9/G>8%B8KHOR/2?3S>Q7G/J1 %^A&".GK(![@/;C^..'[0+0-V+A$&>M
MRY\"@2SBIX5J.-LI3FAP%.-PL-GX\]0-X.VQ"V0Q9*MV'+,^50SSHBK<1C>S
M S2^,=7)]N!@?3!(P%ACXU7\?A*[@_BZ67B;B\X;)'H8RW.#,^F=Q(+.=DMZ
M# >!;P>./&A_ VWM#>#"GJ_US^)WU.L$<+R6?RKQ>^S[=L;D[-'"9^$!CY]4
MOI>W#2Y:P82/QH!IH1S(JI7PDZ2"$VY,\*-@$!T%@^Y$"@I^5T85WP$!Z![^
M =?>"V6T<>*4[J8I>CCA"C4G*-W4'ZW#@QB])-I$Y%C">1RG1H8)AA2QABAG
MG13T2DZP.!!YM1"F'/B>89_=@L<"2@Q..\.,??"701P..X7.WQI\)NA<HO:%
M<&<G@M\\!%=T*:M^1UF_7>#SYF+]PHT]!:I+L--*4(R,)11Q'PER6%#@NXD[
M[+'GGF8W^K*$YF7QS\9?)[WN&$1+%^J"K(TB+V,^NI#I+B-PPE,>F?&&A,2I
M=S8&91AU20*9"9A6-)+AY0/L-8V\N61QH)'*!Z(28R!/"22+88H<N$\H!*:=
MTP$K3_)0RTUVC6A5=#&[M^W4'D6&KP*U:_G<7/PG?W\6HW;WU):EIBN@02#&
M0'Q'J7M"9TM]'I<9_7?N@DMA]0(<W,BTDCIP[^ _*P2AGK D(S>^B*>T>M]B
MCBFL*C1B<6(<_&DGI"[^%X>\&!U\#$,X5CQK+#&$L"MC\G5HY/YIT'NV^_%
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MEQ4"O)4$[YST%H$LF#Q&0B$=)4<TI"020+G/[9\WMS0C8U(8F->;C?=VSO+
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MPDTB)5DB*:1B6R*Q]'+Z;'WZN@[Y,_(R8$E\!54\'-=-O"=@J0[\^:&LB(?
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MW=@+DP""1AO^83X/Z^)U+8@N'A69$R]Q*9-)C>"I-X24L42TI?G*BO?P\E_
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ME.7H1N>3P@!-)07!Z&9J2,?\FU'PL32N>&F8*TWJD# ^YPM&;[.T&I/JKL8
MKUI9K[P_H(FOU R DCT?207K5]96TG2>V$H\_2RL\Q/AGK\_9N<G7^S3BT^@
MV$5@R=AD:1B8S'-M,V*Q;4H66H$MXC#!LVC6T2)DZ$^$V[SA]*<QYWX42<>S
M?298'$IA<1!AVTVM2+*;ZH6[Z;_'Z7=@^N-0)*GK@R*6L3"9XWC@]T3,C**
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M%;\#=5(;P'8_]>KL&?%D3+W$F>UG UKXX[RG7Y]"'_("'<E2%%DLM1TU#OZ
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MN&A!2B&*P5@!S0\;HK)"COI<:,CLE9VJ^J+02ZL>46219-AP!:VJ$2;P;0M
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M\8#" :!/X<LM&:2U.W=EYZCHJH4WP/?R:H8=QUV#!WIVQ<3X]:[,R4XK\S'
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M,EIYVHJP\I\I)/#PT8T."3S'&_X56CAW]\K!>.V\*F"2='-D[)I7YW!VT8P
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M(@T[%G@].GIRI0*OFR=$FWCY0KW>73@J&SBO<[B"03#^"3+DULG?LO+]%>L
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M8'J0T4K5GH'(KQLMOMTQ+IF[?-<86"Q[HD>SMVUWPC+:B% (B-JHLVF-0B/
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M!SV1%IHISFS!C+=V;VE7/L@_PM*;,079 4-VD?/9"=0TOAV?Y8:20))X(OY
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M><6N.5&HN!4WG=:^/\2P"]*QW_ O[&ICD0@6UC1-C#<)9B+%#'V!N-:($%H
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M*-30W(2&RP:T^Q$L)9N"GN%XQQC?>_!5L #E:B1\R@8X**K%ZY7;&#!JB6;
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MX?2(L>#"M"81[AVR&KSIMGW@",= @^0@6"SP3,[),4VBI,/0BA,Y9BF\XGE
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M"";0VTZ$P-6N([GYT-9K0T>_Q%Q\(VBR*FYV'E(\#3&NUPCA\'QU105^!Q$
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M?X7F(D;/8?(/\/3/B3U72@T#6Y[$\.WW(_+<O(Q;STO7=R&;P;N%R@51HLD
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M1E%S%>$I5Q$>ITKZ%4 ?4XVN>#)C1D4PN-RZ0T9/2[!:!X:_EUF.2 (ANI%
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M=U@9CBU[@?XAK$RWBC? 114PM*KO';KX8-_07E1H)3!3&IDCPT_8ZH$Q(2[
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M2Z -KN)*81#P/1>^A %Z1V\NI7;8#['DF !LL&'WZJ5Z?*/5S5E=H<OJDR"
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MD:$,>ZX9L#9FR;%WLC*'1N*0M=E58P;'+D^-7'^DY2'W*?<NNDI6 $O(YNO
M*V&.N,O4<Q,>G$=EKFS7DW+:7E7:]2_%L$&M>]&56R[%E].M'^)KCCY>5L8>
MM.T],LXG7F,PYI3)?.>C>.Z%(\W)>F?<-513!Z]=0]]K7O<78<]C+HJT(U\I
MVI)>:I@$<I7(9A;D X?MR/  K#MJ.K^JYUM0<S*0*CQW;[,;W4HN:%[CSD>W
MGUF?);SE?]3S))>L^A];B%7$-XW*,X2%+4531OH7R7!F(6B8Y@VSDDYFL&%9
M'(K=-Y!6)=*_<!%.ZU^+ HNFU?Q*\23O\=F:\8@SHX33FXH=O]9G)R<"3]XR
M+[KDL"O::9$]0( HMFAP% 'LPNH=2OQF?7#Q2IZYY'SR0\E5WK"\]I_UF37F
M1>YI 1.GCO2@E5R)SWU:&>!+26KGO":9ZUVEN4)<J#I&$M*Q1T)Z1<P/Y,\?
M$K<W3S0S.%[4Z8AC0@9( L8,5]=SX,R,\)%G'^9HM"<9+TTG-JT=G#57(+D;
MO>]#Y84?%H >?10>LKN]Z3YDIC$Q4KI;LC.63U<[3:%T(9'WICY[4\_>3,O9
M&Z*KWO=@8"9RQ\59%SR)#J<O*#268?9$[HW=6CD!A[Z$G6"9.>\55"3T @<;
MTC^!N.5F5>H!^3A[_AO6P;'R;XX'T"GM#\YI6" =V0WAAO&SZUM\<W^I#A:.
MC,2/A(Y_6U(*J?".6KJB8-B8_?,9??Y_]/._E[L'C\CV7-;3&NXU,R9L1#<5
M%!-OFG87_DL$%2CGQ ZNEHFA^L!\P8@^N'^(H<+</=0YJQ<.EVTCYJ.(16CQ
M@/A?8%A0!CAFS^C86P;NMZKE^6CL91CAKCHGRG#6(4H)/MTELQACK#GP816N
M#MJJE?$%TS6($K"UBK2D+ F)6:^FVTX04>$!N;:-!X=W5K RCL[ T"D[GSQX
MY=[^ 5T5J4N.%B!NR&D2>O#!3$F\$)Q9,AA[3 \"0\:5B[]7<,>$K@FT/6@B
MN9A<U O6$Z/_<"Q%XM'BK.Y'QFX2%:>CH@=_D1S M:!<1Q];WU+Z C=QO7%\
MZ'> G(5J/=G;YU@@+#H::35)%!JFP?18TOB#VZU/LJS\U:FL? N>Y2Z6E?^(
MTSQZ/2Z?(S"PH762C@2F==%NQO (!NUG@SM2Z?,Y!A?-B\"(9LRS,-Z?T2-A
M^P@)NN91$0"HV+?$<(/7D;9;2M!;DJ0&FQH^UXC#GV6J@HSB5*(*TG%#K)4#
M[Z\3.&!]URF:DNQI<\AY8['P%<JSY"4U'.\%-^OUINQX0AYX]\I71JH.O7]A
M?51:;(FWL3O0%K8,CJH4"""1DG^;O?.M])H/.+<.#'"6&'B@S7'Q7M(AO:*P
M'M$)1CA$^2K-EWZ=T)'H G0)F%QW#+TN>#K"TS\8_^H#5@!G(6<L0M=+R6$M
M]7/2XT4Q8B0.HL-P/GEY9+?;+-@V9I^1.CBACP-N1&EJXV9N(OW2"4-[DLVT
MY/UX[X<Y#P%WM_=&X#=M^Q>YMI5[^H+])&\4. 5.*RZ-)J90[8F=<HA;$'O2
MB^6+=RA@!B-PCS?Z7T@(/.V_2JOMJ#7(GSB\4^R#3M^2)F3\+*$+_(@([CE(
M<9^%K2Y]= GI_2 QCP[467@44W\<&O9L28B+[F[7XWY*XX1MH]F%<ME>_/9+
MRR8B7*\B+A#I=EOP_[I2</#;FV3-JUA6$7$7AP$6D6C;$#"RB7)PBR6Y2Y\.
MEUU5C#,2LX6RRK,R1%"=6L6M?=(0\NFH&<;:\0D#\7Z[#W7.,Z:"S'+.EBEA
M,WK@O(6WQMLH''-P<T* "X?&6[+=9<65203NY0@&1ZN*BD3G# 9'L&E"M=#T
M=LR$'DY:AU,LJ2#[0B:>1 AOD-0.)Y_5,[GS=5EO-DO(C<_"OF&JG0A/NFQW
M_E[6D(7GBW7T01=$DL$.KNT"_?_35I5OS0&1@\>2W,!HA/.#C9?4B^0-J- G
MI/-,S9=L]R5]B?5/QW*B: <0IAEO-LS9%C\&8DX->SR:"6"'2Q)5U9FJCKA<
M&03LPHJ^V,?QB.4P>DR!SH#">8ER1AE[2VC(K*>96^456#D_F.4]_$83"H+-
MI&B/=&**8*3?;S]8>4;K_M/JLL9GK:$>+G#F,21O]B9K;W)5][CLP"F[J&=Q
M0=BK%HFI=4M<)6JH:1*Z/\96ZVA%%H=_#?O+?8>VY.<>9BCKX2"V ^<*,7IH
ME5Y/PG15J\/I*K8@].USL^VF%X)+P]G-T< ,_8R$N.:9TCNYNNHNY2T)AUZ]
M0 8T\E;J#DBSPU*0]]V3I_+.1RCOO.8=ZAJV<H)/66K9QH&-QQ$1*[24BJ?9
MI_YDI:4[K PO\V?J(HSB]&"##&+ QL1M%'#D^9" -X"_B)?9=G!49&L5CH3+
MW.WE<&WBZ/ T9*@C(H/]S%?DM? \5HF'=(#$[1 )=V0:OEP.E@JPNM&R, Y=
M&"T<'VPXI1HOV"=:7*Y<7R1RB+%HWXN @$2ISOZ;P)B'S(L+G!;S_SY6@(X'
MUN"QQL:"[ABK^M1_WY7K&KK?(NS>Y?#107.HYYR+AWYL#3V?O(9<!J+ESQ)8
MF2@-PI[+!(O0H3& 5.%WTV7=DS@RJR+X$GOEN*+XKYA1J>YCT/0PZ9R*W+LO
M&BKT4ME,SWW6+-FNZ>]$YK'M[%"FB=!>^^@GE&$-H$VA-UZ4\\DSV_.1<$6P
M4WALF520.1E9>SB>F"I0]378E!R:7EE0Q &2%"?[."EF)H%,4=ZW?M_,PAT:
MZLX@7,,#NLZ#1W#XMHT*=^I9Q0*%N$',[(A?5_I+>3I\?I,ZTA$K M22=P_
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MY*>VRWZ!WVD=LN/=C;&-(H\N!A7)FI)$S'4O,8^&3APWJ:9/,'6Q4TIRSUF
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M1#[0,G.!$U?!: WJ ME5T[X&Q'?53BF#Y^AS*')7LL(B!(?EAC-4TEF9!)\
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M$M%Z1954>=NFW(A[#@]^?!Z+H\>.":.(WS$<[_SD37<F!FA7]Y7;NI=54CD
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M:)Q)17HHDL>5HV,GO(C>=KS3(IH<O\XEG'7:%_9@ELKCR@D>T6?R!@U KM&
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M\TYG?\)GS9+9E!IIA8CUR,U;TW5+?<")R%=?U)2[XG [JOTIP7X\R=1MI8=
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M/)O*/#ZR3'XNQ/0MKO6PEM>@*CT%^_,T_-XV1]_*>WGI8.06I!^:D(<EWYJ
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MX -%R;8[+=B/O& 15239':?9M##B#L2XJ\9TEO W5E+P3F/+'0BG'.\MJ.L
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M90<WZ,OE*>O\,:>-!KQ/9VQTM@1;_/+%RQ\F+Q1(=YJICZZ20,E6BM@-T86
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M1L!]V13L77VG%FHMY-C$Z5HN?0F1E18\*V&Y"Z_T*CZ,' :CJUHDXB";$,P
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M@^TZ06"B.Q.J@>9&$>;&S_FPJ,)1Q%&4H"@R?@Q:+TY_CJKD?[_/B,&HO"M
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M#_C/!]69SAW[=L0C4O<TU$ G:5M)D"*5\_W"-M57>/*3D9 R5K0.#%Y-T@]
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MT=/79,9@,&4?'\$BQNZ,;-<:<; 2FYR+IV2I57"14.@E))+O,B)=Y^57@*<
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MGEMW%D5D!U;46#M5&.3+YL2V"D+&98SIY&JY<D+Z$(QW _V83,L]B.B3Q@N
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M:-9M_W+B TQ6[XZ6<_+)^^/1L_D<+_U\V77X0(QXEH&RJ GU,2%% R7.2D5
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M2**[)TLN/1EU[5+M83@#8"W^ ;A@-CJB,D-)$$&2X+(A,NBD@%HK5&KBE5T
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M:,3160EMLJ.0\\.2;@MU2'N5PR+=G8RYI]N[>;^\!(3QZP__#U!+ P04
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MXFQ4A,9$+5"=D['?IN9[^>-M%;^/<%LJ_,7E^&H\656#7F](8"UC3J")$FW
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M:3G3I*8;"O U;MTPHHHK9JQ"CTD$(IT"$@2C)%D% E<]W/B:7$7\"N')4>Q
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M,>:IC$0#Y0DX,\+T.]$X-O(G0_G'SXN*I__#)OOEY=Z:6KF5/5_E4/X,BS\
M)L7&G(],E/BN1X5T9J@.C=M=B#$0I00H89#??'LGJ$S^/1%_)_W)>="BO^W0
M>:ZWL(_H,I6P+%IS?RDYPB,M :ADGI3*M$0" Q)H3H09YWCRV6:]G1+W."R=
M.R;T9.C_J)C1X'[9$E9X>%YA9SM;'RNN2VK?V+$V.0-1*HC!1")DUN4NI2/.
MZEB2[V/FM@0MVEGW3:;T-%E_>G;4SB@Y6*K+&5Q,+Q'#?!4K>_7'!+^^&'_8
MS$M"LI$*3AB42'Q6%GT6G)=D6J*D&9-RN]9>94OF89!/AL>/2ML-$F@.?C]?
M?/HPGFTRO,;3-#)!\.P%[CO9E>;;@I'@C"(Q,.$R$U2'Q[58;\_@R7#ZM+IO
MD Y4KX.\S%(KSC+A1CJTI9(G(91>\HKZQ*W-^,LF)*XU@V.E'9V:NB?1^*ES
MFKXDY*&G6^I:+@_N'>5>2VY(R$&4*N*E!*VPQ# ?&,,O36Q2 >XFB%-E,IV(
M!MOYD8>JH\&=JPV63<G3'FA:%OBX#><T-3T.5\\=>AX@V_8:-UE[(WD@60-'
M>U(8XC-%:#EK18&"9$W,L&-H^H'Z'*T4O8](:Q\B=>13% 4\*]D6-[(O-H4C
MK V."T62EA;M,)5(B,D0D3F(H+/!K;:7Z[C7L,<WG(<H:'H4Z=:^+GT'T@VR
M&"G.$8A+3B.R%(C7*(72Y3!2I9C/_4[^[AWFR'5^&RJG!P<.D&SU ^3-%,M\
M-^7ELH(HE]S6GDBFT-.R61,*BEH=I07H><RU^_#SU.]0*58\$2VYFV^*0;HJ
M&A64]!&*ZX-(9+E-8[U))$6A99 1;*\RG;TRD+^,^C0M]<,%WT+[&Q+V@%'[
M)L*-\8]_]^! #6SK<(#X*M\NN DG@75*HY5I0>&2 IH2FZ,C/&L7\0\A?!\W
M_'%H\9X;!'65N(_4*BMO7?!@4]&7*V:\#\C@$-85,G2Y_131AC3:6J/[E,SM
MI;Y;(Q_WYL#!LI_6$%R#Y-+5QK I[QT1"%/)$F884M+*2"PWN*]G:4P0ULK4
MIK#,311/<XL=KI!39./<*8BOTYBD+6^SSYQ:QM1:3.HTD;D!7-DWN>98BFX0
MX&LR-R&RE 8X42EG(JE =RHH3A*5X(0T3M,F=^6_'?(^$&Q\Y-S=1[\-./OB
MZL/E]#/ TOE^]:%,:&-U\&R5T(XH7S+R!=7$&C0:5+149$J5:%/CZTY$C_#8
MO[G"IRVT5;T2\8X(ODIH!1*EL(3\[,.'&<3Q4HS+:KWSM\_>O%U/P?(D*"]U
M#60Y"&#6DA#!$^%HX +_\ZQ?1; Z>)XPW4ZEU>:UDKNOQ]YXF^:_ETK/)<I9
M_2;RO:.TN'?<?UI;MXQ%= 9<C(9%(P'W1,@\.V2.,#QF#G?<,KYWO)/?*?81
MA,Q*$^Z7-;L%)S[YDH;M4_9>"YJ:;&>GOU-\,(+E'W^'>:DGMLH?8R/MJ&;&
M*,)=*2/&K2+>Q$2LME91HT#H[0.LTXJQ8Q*/<&6OR]]J-QJ&,J#5)>5#<B%O
MSF6U2WV]IC=262:/3" T")2I+&X!*U73D@P^9^=]FV2,)K-YFOP^*2?:74F^
M'^Y?IY/%Q>7G6ZB5<^5^$;Z-Z."*'$AP$HCC(:,4M5&Q7V;)P1">#/V.J*D&
MM;[K)95+&K)FTA"&'R92,TH\%YY$SJT1(=/X_4+!XV#L:77_F&[QKOV4Y<7,
M^<OU;/XRF\[G(TIC#N@M$Y;03Y;!EF8;*%@:4DZ4AP2B25/.!G-YFL0^(1]:
M7=L]*"K4.:=_0-F.(#W["#/<A5Y\P@UIO+Z].?)HX&@>@6CJT+;W1A.;E",&
M<LJ@#%7I-'?7Z\WQ^ROQ2/CS:&[Z/HO_?3V>+TGPC_'B8OFAYSCO<8+55O<.
MJ3XOET-'&:5NLV!HHY53]B!$J:9-2:2QY",Z'4//?GKMP3X9HC]*[5>\ 3QL
M?G=L;/C=+WX!O_KQ[._^\AI&@J-#JTT@ EPHUS"*(9<-X=)H%8+7FC:N2=43
MZ7=>GTSO+6X$ET.#4@ 1TB_7LR]AQE4)E9LG"IN-)HU ,!LX5VB% ;H<7"?B
MP0O"I$ZY% [RL8U]OC?4)T/5(VESEW]V<%KBY?(SZV)5.Y+;-&!4GE+E."<0
M2Z/?TEPK6'"$,2-H*$VEQ794K4Z^8B]X3XYG#;2VRRU7+;<&9A_1.N[&^OMT
M\A'FQ: NXIF_FR[\Y<W?/Y_.%[]/%_\;%F\@3M]/EH75;KQ)(P"=0"V[!0(C
M,B9-G!.))- V".I,V*FG5S=/I^7LGARS'Q]G.HXV3E=I>#V!5]>+^<)/$NXP
MJZ)K(ZVC<?A.DZ2D0=N\W"+F0(FB,N++KB4/\221BWUG\N08?UHN=+"[7DYE
M[7?X2VO']8_*YQBZI5)DJAWQ(284N9/E>D@@H%GR4EK)VE3+/^XTG]Q[\8A9
MU/'2#"L^C$A6%?+'_UH;</&B2/E-^6ZDE;72.8W0 D*+,1,'Q4^-SOD<;:)^
MN]93=VCBWF&>#,$J2[R##(_L6&\K9-T1!(DR6@HR$J&#Q?DR1ZSF@IA8FJT9
M"*%12.&X\WPR%/\6>-3QWK0_*WQ@OINPS)<I+S>4EY/%;#R9C^-JDL;8F*+.
MA%N.7G4HK:MH=$132XW71F3>)!9RC,E]?T-.S9B.U^+@<\&]3*EW_M//,$&-
M+WY%)6WF]2K?<IR9B=8F;4E&T1))%1#O3"9,*\&4CURR)@?DU6;PY A^&MUW
ML/BTYW]?'(47?G;Y^<M;>[MD_4@ERD1PD3B;T7..GI64U]**QX3(<];"].N\
M>!2X3X;+CY0!'21_1!6"*=51>>5)AE+JV*1R\4Q8HL'AYF.I\KQ)>_FG6"%X
MD 5R$HT_E@K!MV^GZRS0[4Z>,%4J]:"WC6\?LT3@SW&-5>AX-PGEG5E9E+V(
M<&]9E'T4\JU4E.@SI^]E4?8OB[(75XY16N(017\K)$XA0*!&$9-@V?(:2'"L
M7$/0V2M7CGI.<YWWT9!WK[(HCXZ[^^CWJ&51N%$\!X][2_9E;P%5>JUG EG:
M#!YBLDVJ^)][692]%-Z[+,H^VFIP67D9(BZX_.)ZOJIVKJDWFBL" M\QR:4F
M(;%(K.!)B!"=\=L]HZK09P?)T[;RABFFP6W,6X V?0MZ0&IIJ'5@.HV=-5!;
M]^E^@*@;;#M=T)3EU*3,2<BE*;PJ]194D(3R9"$ZY#UODMET-.T_8*BT5_X^
M$FY_T?_K^O<[_+'9V3:EE*44PI9^71KQH666B;-&D)R$38)G&?6^]X]Z#'M\
M"V.PEOH6LAHFXF,64GM^/9OA7UMH6<P!H&2Y<8]HT5 JY0P=<2P;Z87D5FQ;
MH_L3HG/H,R;%<%$W]:)W 6\AM3GJ1"F"E$RC,T<%\1R=.6>%P9]3\*:)C=D?
MXK=+GL;J:&!9KJN0+'=.G*Z."=W\5/JC2"H3*:%[XBE77%,02C7IFG@#P]/V
M.PY51H/2&6LHZW>A#YB6OL8M-*?Q,@[63;>.!PBVP?9Q&Y12&KE*<;UC%C<T
MFBBQ3GBTH*ECP%3DL8E/<00M/^!-M%'R/O(\7H1]N63AJH8KWZO)%_M66:T4
M^DU"HE4KLY7$"96(429K9:,2\I@%'+LP'M\Z&*#-?L'PP:JHZ&J4UB#OQHNR
M%;Z<I/''<;KVE\L7(ON()FY,)-/23L*',F>TCX#CWN:7VUX?\Z!7;Y5.!$_3
M.*BCD(JEASH!E>H8;^!R*8_YQ?C#N^F+R6*\^+Q^:?I K=TD:T^,QV^D54&K
M]W&D@4HJ]V[:%S)S*B*T@$MO*M7"!2<NFDBR"$HKH9APZJS8<T\#K].29Q]-
M5";-\XLQY!>?(%Z7"N*O<AY'F*WW3&$HM=ED LHLRT5D=*9Q]U0Q2.< LG-]
M$K![$>0>',=M!M94=]/Z@F_5/JQ<MEE9[D"YEBH3%;(KI5.+T>X=3I!*Q2%X
MQ9LTQ;F%XFD:*\,54K'PVPZ8C=/= T[+:,86GA-FIQVFH;MT/4"\#=S>;5B@
M)/)8,Q)5R5UG2A,OO23,1TZ]C:4@[3>K[3[I7$V4O8]4:Y^._E_7$V"FB'T9
MO__J.G.F930LD\@83M!H0X)-FEA)?:+)1=_SW.NN$8X?@Q@D]VEMH=4^VMP"
M]>Z/Z:8MJ>!.I%A.73B"RMS\_^R]V7);N9(V^D1Y#N;ATN5R_:<BNLL.EWOO
M^*\8&!(VNV7135*UR_OI3X*4;(FBI+7(A<5%23<N347D\ '(1$Y$#QDL1G*I
MDE="NVXA[8=6>#Z:/$QH)QJJM%,L_:-&^LUJ=?5U6Y$T^(BE'FNV&+AT*,L[
MXY>"CRGE%##ZHAA+P2J'0DNCM<S:EP?&+_58_>3#F HZ'K!$( NSQD6E@B"=
M B&LXE8JR]N4T1Y/^LFF+NS39^USETCEGW#YE<^<9\IK1!">&3IFZ"NO,B.A
M*F^<SB7X-@5OS5B:8&KSL-@>;"[#L.AH-;;I$,'NXVSGJ/O'HKZ$7,S7WS_2
MI3M#7ZS-*H!5M4Z;DW_KE);@$BE$*R9DG-:(LMXLOLQ],3WTG*)8J@^G'^>K
M__EMB?C[Y1J7N%IO&#21A9B* LRI>@&%0XAT$'C%<TB*1<O:71,M.7O=%2?%
M2JL154,Q>',=_EK?T,G>WNYV1^SIS,%G56>[, E1UH9-&)%4$$TQIYFN?BQG
MKYOAI%AI,>IJL&?_S(T,HF3P?-,?U40(RC*H#?]UB4'QT"7(VA_T+[ SQE&0
M/HG&I]D90]6P918&M+?$@9:>MN%F:@6BXBPQ%YM8+<^L,T8O(#S:&:./0LZE
MJ4 7GEX[8_3OC-$+*V-T%SA$T><"8A:80^TC<,D9J&1<-5@*)%16!8,LZ-.8
MM),!;Z_.&)/#;A_]CMH9 VU$YCV"RSZ#RH4(4U: E%DQ-,%FT:2XZ+EWQNBE
M\,Z=,?IHZ\'WX+8AQ"V];]*:O+#U]\&CA?L_OD5@L ,C.S' 6%+4W&7T12N'
M/O#,>3!9:<6UE?J!&.#^A4X>[B-.G&"<_)],_H]*2H-3*H"0R2+74L7<Y&28
M2+COB*:=MX:;?%Q<7/RV6-9?DAGO,*D2@%E)1X+0%EQAD41@G)!%N1AVDR8F
MT8)[/SL3/*>'Q73#D3>'HF)*(;X'!_G$&(LKM04M)@[*)KJC!/=@M-+:6(9"
M-VF'.3@G9X3P 2'6?-!3'WQ,*5;WR+!Y3U:98+* <2$22]%"%#&!XW6PA(PI
MFB;3_!KP\@KZ"6"D152N_Y!7G9P+G"=@F^9^G,087-(@8LP8"Z:2VXP,><XC
M>QN"MJV&6P3'CA0B2:W@?'U%_)$#_N[O;_/M\/<?.V]64(=BR.VNW5"KOTS[
MS14$DX,++'G&_+2RBKIR]HKXR>%GP%+N=L:7(ZDF+A+82*A5FC&(ABXE[KTR
M/A26[3D:Y^.+]A_; 8X;V&P3-A?U1_<E[B4A/!*B,]\T:2:7D[!3AYMZG7ED
M6J9)#M[JRN 9G433> =H@IP).DK79D:-8-]X?L8J9SU")N)!246GJ9".CM10
MBA4ENM(FA65H3EXQ/RH6II2D>/\^VLE,OK&N/RSG":NE4VXLG>*TURZ#I%T-
MRA%.0Z'MG)73(086C6O<X'$L5E^WQ[30-$'7K2/'L^0,NFP=Q#H @ QP#=%Z
M#=XDD4MA*-0D9_QVY.^,=LI(4#W-SNJ%LTGE%'69>7R750S>IZ +&)MJ SM3
MP'L7 9VP=/[9(M-I7,#A>'S=5L=NJQ/A[126WE.LWAN6_"BWK-C:#I(!&HMU
MF+@%QXL X0L/3)4BS&F*I =E\W6#M=Y@[5 W06OPR8?81YD/Q20C(X/@E0&E
M,ND)C0)-!X]ESBHC)OFL<!37KSNPL>4X'B:G'3AXG$T38HZD$>O)6%9998@I
M%G!!9.YT]$)./:6M^R:;8I#A4>UX[8NP20.OY;_*LPR>10],)Y?KW#[')JF=
MX]@^HY-Q&J]/(Z)L@D?=K:?I1]ETCLL@:NE?J$>=%A&\%0%",)FC8\)/K -#
M/_Y>=\T$<-.@R>JQ;+[)>8.#</'K?%4KB3<&45RMER&M9[(X;D6RX+D7M>\*
MW?^F.$#M<Q!>H=:3-+T?Y>IU*YP,(_<W@#E9[[8G3<6/6)5+/W^[N-RP>A4N
M:MLN0<I 7:(GFU_13E<8*\N!0]$QH4;G@FD7ZAN7US/:+,.C=:A&<"-!K57@
MX@B6>]N>#TF"SQ"]TLX["%F3'9HYN:$J.V ^9%$<R\8VF?$^'1&\[L6S!V:K
M ,@1DGC8T'V8Y62#$T&2#>)J5F]PC.S=JCZ=@_6>S%[7+N]Z7%Y?-]WY0&W
MT,?./.+#-/$[\3*_7,W3MI79HWK!PB1*,O +MY'TPAQX4[N'!V9",=*Z>UOJ
MJ:'1S8D^H[UQG"<U:33<1[T]]:O"K6OT+M<S51)N)BN&DC+9LR6 MRQ!T-;*
MVDH!S21?%![D:+P],&T0MDOL.@)!$TR;?]KP?//Y\Q(_AS7N,*Y) 3R3 VCM
M9GZ,\N"DX: 9RYE%'0U.<NL<S/'KUCI1/&@(!$[;T[G+&)\9$GXVZ"'15Z!$
M-! 9$^!\9L+&D@QKUPRG"4NOFZ>U"W,,AB;=BCC0]>J+T)!RJ.UQN8-8;(#
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MT1A0RA";5M79Q8:5'*439K=?16OX[J?T%<DGT_M]4.LA0/WV0-9F4AOID^#
M)=GMRJJZ%ZV%9"5YH,GP>*_BY%','DK(BX3D*%J[CSAS[#/\VXNP6KTOUV]X
M[Y<?:^[PMLKY??F3=LB2=(>KM^'B O,OWV_>^J[_<#5SGLEHM003BJP-5Q($
MC :T0)T],YGK)HU]CJ3[Q6#T%'J^#U-[+$S???UVL?B.^"<N_R+C>;\P?V3
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M""H$I217/#>Q-!ZA:7S;]%B5W<M\&4;>37*F*FEO]Y(6<T@^. Z1;KO:WZV
M=U(!<SEYP;,HODD2P",T/1,H'"_O=O?!7=]I<_IQ.OR*(=,GYEH/H4EE+L4
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M1ZD[C9$PF"Z[8>0(132X-QXGTML<(BL*L-:$*B\+W9&Q$BES4#R&J)LX%2=
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M ?D^*'DJ?6<PI31PBCKDD4C&B:Q:UYX]IU-<17"^3O$R47@II*7_ONQ$GF/
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M7G8!52^==6A4=(# QX%"ML5ZS!JX"(8HLP$([!X(Z^1])<Y$Z9),,%D('%Q
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M%% X$HW=[3@>Z%;J>27S->.N9&T4(&7F 8OS!RNL!,5%*/M5LXACPFZ7G-^
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M) =;8#)*$<HCP[U,%<G3>I\L ]EQ2_]LJY6>I^??LK20;]9?5XM8((QXX,-
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MB023TD]@B$TE+D)]R#C&$/LH(2$CA(=H4:P+NK0]U=H?PHE -P.-]P[?FC$
MKX0#RZV\O<_1&RP5]R/$? 9]%@0024X@"Q()/8JESYCT1>#D<+H0RRF2CT9
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MF%/B02SUJ\NE)SCVA.<I)]X="/%)-O@5NN]'1->.@P?";&0FWDA9NV.OP Z
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M4KZ3'H_>.!T#=LF]0W*=%_;@L1V_Q&?C^<#$NUW[81C5KYZ,L R4$I"J4)D
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M:I'2JBS5MHQC@F)*B."0$Y) ) F#5"H*?24D(5$<">)45G-0Z>;&Q(UR8*V
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M'+,HC"%/S-F>AS1IQ4$(O40D"*,0"ZDFZ,'I)O7<V*\2WU ?W2C0U/0NMBH
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ML"C, ;[=@G,P@M,JL1EG/)8H@Q'T2E"+J=>"2D['?L\'0-I1\47PC,R?&]G
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MVMA#0<@@-E.A+4&*$?&B$#M5RCHQSMSX[-4ZR]9?3;WK5HB!8ZSI*4CM^&@
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MW$L@5^5B:7Y\J7:E%[PCEG[4><_\V.[8RW.Q-DU56DA<@08+4(,!-FB %AS
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MB)GG!XGO$R^)>W0%W!_'ZOV?OG/?5LRZU(+>3SS2)="6B.:O![!<4\>2] <
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MXT9_AL/Y3:QHP*%\LKZ!E_FM<UGGRCP\DM;YK!-F7NKDNB_/=>-%2@E!"&6
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M/G(4>NE3IF. WFL<]RWL4?#GA;B5;=/)SADV%^NZN-SN5#'GB;(J208R44(
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M;'Z\1>=<*(9C;0G&5L]J/"6(/I#;R\*<B_5-4Z?_>LGW>D%P"(M"( 9RO76
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MQ3<=4_!@OKX?#6/TGN/F/7\S6$B_6B-E)!HQ[1;Z8RA-'9#VR(SE96S1^#2
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M;F;$<0D:@4EB*YK_;=,YK7U^^6_&&/4K/Z?A\1=]]CJWKW>OA.*L3%F.E.B
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MK W0\\K[-#=/C#*J<7E>RV-3LN=*M^_[3+FKKLZ#C$6,"008"PE@GDF :8Y
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M4R-W+?55M%!R RUL?3"QUJ+7_[R*6"M]1&KQ[?L^&\R$&47[QS<P\S;0_GP
M[=<]:#O!H^M^:)T:1YLCY;N9M,'(HS>8-D?C5--IB[O=&.L3J;3O>7TGJHY
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MVQO2X#"T;O!J%X+4C_MI54DQ5WO?C\^5XN'FJ8V'=);(.$T1P2#.<*%XD@E
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M]URL;:]%'!J1.<Z8L1\XU 2,YB:N!8_^TJGPUVB^C(Z:PNWUA!OH!>?B0KX
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MC0&#1""!:)YSJYHW=L-/;1]UKOWN5=1J$.VIX*.[\=EY,=MOA4,[L"%@!72
M2"<WX,*W/#XKP03Z'@^A8];\>/ IKL4(FWV#WEC>J/_.-[KC97,L-HMAR129
M,0 +ID@.%PF@5&_F."<)+AGAI5$?))/!ID9IG:RU1^@J6FX%M2TQV(.O&5GY
M0BTP-6T!JUU#C:!-0]\!W!SJ!PX#XK=J8,]X(]<*'-;\;85 @WL<,^37XE9^
M6F\4,VUT>9*DS')2%*"@N2Y/0@N 2@$!YWD:DR+-N5UP]^'CIT802CKM@MG*
M9YG]?@B=&1.X Q+XVS_&0IDCJ\6<*0ND_6^0ZLRGX?":S7XXPKBYZR>U>Y.I
M?OHJ!X^P9@6R?FP3)+OSB[0H<"I9KKYI]6'#E$M 8";4MB=C1<F*.$;4^.S\
MY!!3^ZZ[O-WV$$A'K:@96XHZ6:9QH_PBJF^BLO"/G<;6P--Y,6*!/_Q6OFVR
M\]")D"DT%IZ^BR$:R3%G"Y6=ZZP7A5Y/U^D[QW-,]4I^X$?JO](Q=:T./;II
MS*%MLC8O24KB,@.<"0(@+ 0@"2\ @SR6A6Y9)ZT.PT^.,C7BNSD(AOPORZ2S
MDSB:F347HQ.8Y!KYKJ(.H! 9[[T8>$T7.SG0N*EA?;J^20/KO=C!SKGF__.\
MWM3-I1]6UUSMAQ3MD\4=F?//RYO&I;R?*GLOF)C7/NI[\=0T*)F5)(\9U#L=
MB!F .4D SI(29)RED.8\D8EY91X/ DV-2K:"&91J5'2S8O,Z$;8VKE[$6O^\
MMJT^Z&->#2RRD6<K-+7MM(D>5M%.GT@K%'U>1JU*^NQO/Z5_IU:TU6ODR;*P
M$4>>M)$LRG$FS\X.]8ATK]7J8YSQ;%R/J!Q8Q#Z?:[>4KJO-[%;*.1-55]H!
MLURM?QS(6)>(*2@&M"@Y2!-!LH3GF,=&)Z)OGCRUQ:T5SHSMWN+4O\9<I'W@
MQ:*5R^.QXEEM>RQ>=<^>M:O^=6SIOGWH*!_Z65VZ+_;\!4Z%"[@0W_677(?W
M7>]UMVS?L[S,"8X5+#31>UB4,("PS-5N5E >BS(7U+Q8^.!P4_M(=P(W\8__
MYW\E1?Q_K]L&,<V_^A,57# WL!^](AGX@S\&,>KP<T^4&<;0*CG>(Y:CY;CW
M8NHM-=T0F8$,\Z&GC)DH;JC14;ZWZ5T.'-S4$VK=D:=Z2'9,G&#&<98#D2'%
MOPC' .<< D%@AB0L80R-O(DV@TZ-C]O:2YWS^V135YO=OBGV!HP< -' O&P$
MI@L[FZ)JP=$!T!V)J2][9>WXVA*E7M8V?=9XW&VIW0&#V][KDCQ^LBGP7A/J
M#Z^[2]H>U75[X"^KY>W3KE#(YZ62KGXSU[MF->OKI4YWGS<51=:?ETVYD'\*
M77]8\.L749%OXM,?HF+SM;A3VHF9$ KBN$" 9ZE:,-(X!U@09<G')2NQ8&F*
M+?K\3$R[J:U,NX8MNAB%T,JHGW4#(;Y:+$BUU@7#&G>T52^AB<%NE+H_,9DG
MM.0V;>IKQ:-]</9[U4<?7J/]Z[;M[#5$=2@D:%!JBU9%>SA=17M(10JJ: \K
M[<KMZEIU>$4M8%&'6%1#]B._H39U$B8F^P3-EQ_^C;6L%#'1-Z*_.L74A!ZQ
M(L;45#]E?$Y62/O#&EW8;K68<WT65&>4Z/(B?\S7L[2$"8IS!&BJ+$XHF0 H
M@QR(!#&8XC2FB5&21]\@4[/Y]N6,.D&CW[2HAMOE7DB'CWA\ !78XG'"R.KD
M9PB$2P^!SCY_M/.@(0WWCX8&KW4+<#Q1-ON+V-S*!_+'3&"I"U''(*%%!B""
M%&#,&4@3+'B:I"++Q6RSVI!%_Z=O,)85 VQ'#/=V/^@Q=$F,O9K[B]7:,HNC
M#]Q^$O ,67 N.-N;0%F)H@[S4A)?G2FY[R],T@ NG\&2?<.-&C)IH/=QX*3)
M+:X]P^_4VY'&2=FY@VD:$PPQB'/*E E!8T!*@4!,8IPBF62(F8=#GAA@:N9#
MX__5,EY%6DK;'LE'\)EX9BX#);1SY @/IPJ*I]XKRW[1[@"-VB+:X,5QZ 9]
M6OGA!M!']XW<\_FTU&_;/)^YSLTF<M[6;2N97*_7S]_K#=Y:YZ'H$XF/\Y<Y
M%TM>]_(2E,),I+J[44%U\$T*$"L$2%G!%%&6:4FL$DB"2SPUBNUDC'@K9/0Z
M%PO#_@WCS;.9D3>IV1O%44[[W8ZT<SO24V['70FK:$_OJVC[3G2J>^XE-]HT
M^311PPL]JJ$[VAP<F\OC#6SON[L73^KS?-0E0+]5HI;F9O6LR\/4.35?U.?X
M<?6=S)<S6!8%C5$)&&*)LL2)! CE$F0TE2S&&:+$Z.38:M2IK1W[4D9:S.BW
M1E +WYXYY,/.OB! !M_Q6V-HY?NSQN129Z#Y@*-Y!ZTQV'<7VM]LQSM<S&<_
MBV]D4?LB7VN_-L8XHQFF(!%"%X7*%+M($>NXQK@H<Q2GU*BEW8EG3XU#:O':
MXFI6!P.G<.NGB O1"$P$-D 8,T"/RKOO?-U]Z&O!_O9M]?*?ZJ[F.U<_''_B
MIYXXRH?<HTKWN?9=XK:!;>T/?9CX=24WR@Q16\Z$0*)#Q6"JHXP93@&-N:Z\
M70A*$*(Q<6D%=6(HH[=S_-+8GY<Z=;C>2,R7T>^"KN<;$7'Q(A:KI_K7.L!K
MKBER21;@>2VB=:N1W;;R%/IF&T%7,,<**VZDB^2JBKX.06.]O>I1WN>&Z-0P
MHVYA>O0\WG3T76J_7-]H<JD$N5EQ,<-%@4N."H I%HH3RAP0W2B.R9P05K(,
M(J-TS.,'3VVAUK)%6KA(2V>^1A^ -;Q NT(0VDPWT]YJ83ZEZ@6K\L'C1EN2
M3RFQOQZ?_/LE435JV_]Y([ZOVUTAYVF:"9:"'-,"P)QE .4%!;+,*,U2)A!T
MB*HY'&1RG^*^G%$MJ,/.^RRDPQMM'T %WU<[8.0857,:!']1-4?/?X>HFM,:
MGHZJ.7.MBS=NO5$V;>T W-9?:$\LDT2JZ_5!3R'4JLL8 C@A!4""D"R)2\I2
M9.Y_.SO.U+[\>_$R[WK2W%5S93YVP;\[R6U\;^<!-O&V>8$M, ^8(.:YT((!
M,)<[V<X/,:);;5#/0T?:\.7VMOC'-J"@F=5/2_Y1'Q<2E,1I6BIFR.(,0-T_
M M$\ 5 011AI2H198M?9$:9&#)V0[=L=*3&CCWV'=H9 #AOL%\,3F "LD;&R
MX7NUO\"8/_W<T:SZ7K7VS?O^"YTC:;O: 6UII?I <*T(1%0O@JM-_$_/.K#_
M\WK]3)8ZCS,F4# H :$% 1!+"A#+2D @3V(!$REP9A,%8BW!U.C@9J\%W574
M]N]I2_U%5:M%[7Z2M1[1O%7$.BS7<J;,W'=!\0^^\=@5&;GJ"L,U41BZ!]@>
M](T*T><AZ%V"=]W@\QS2:RG$V(&^;AB="/]U?)!C(YGYFGS[5FEWOS)K;Z7N
MTK5\%@\Z$EQ7_Z^+_\]H67($20H03!4CYA@"+" &+(<%3(3DK+2*BS,:=6HL
M>"BTW@&T8ENVEC%"W(S9O.,8VGHZ!V'T6RUSF(835BAY[4!C-/"XK6ALL'C3
MD\;J9H<LA9;RMJ$1:9S@ATK1W*-X^'W5.6M8P5.9%T"6HE2[,<5#I$ %0 AR
M60B.A#0RSXQ'G!H1=5; 5N@Z*AU?1:W@D9+<(H3?"/1^/@H"96C+R@!%EXP(
M(S@M4B1\PSI2SL1%+ZE='H4-0KV)%48/&B_3PD:O@]0+JQO]VXVS!-,$IP4$
M9<$%@!)K?UDIM3N=0YK+1/W@RUR<&CD/F3B&5&*$\^5&XH3XV!TXKP;AV';@
M=,P_%ZOO0A;YHEM)W)%7_:C;S:.HVI^[@H4T32@K, ,\T?M.A B@:8Y!25F9
MB)*FHK0BDH'QIL8EM;A1*^-55$O<_=,RY7T(:3,J\8A?8#;IA2Y AV5#9'RR
MRM"0HQ*+H?['W&)ZFV/"J#)X^+-ZLM1!IDLU@Z]M1Z(C;XLL<DX+13&IT%M*
MC+3!@BB L$R27*""QD;M$FT'GAKA='+KU7<K^;:#EF46IRGX9M03 M+ '-2/
M9E"7ERU:7E,;3<<>-T/1$I$WB8:V][M1UL^KY3?UI7__*.CF03VB#:(30J(L
M4P052X@!3'(.<)D0!7U.*"]BE NKENZGAYD:'6DI@18STG)>15I2R]#$ 5S-
MN.=RM (SC1M0UJS2CX-/#CDSTJB,T:_M,3\,7.VSXL5,)"GBDB4@Q9F.4LXX
M("A)@,2I8)C'(I;R\C(54V.#^E"T+3W ]N3T45SBHHH0$R*"D^49=LGP=6W8
MNIVQMS;&9M"$+YTPA7H'9VV'_JL=N4%_#KMT8O[QN9HOOS614W5A@QEF92KB
M1*KW@:B]#$=(&0UY!@A)XC)-9,H%<4@M'!S8Z'L8/]'P3GT9;+%:*V&;4*:H
MVBIQ%2V;<GBB*W*L?FY;FJZ:XA"6-#,X.T6!,"%Y#)*"00"+I  HC07(),5Y
M1DE6F+67\3LM8_:6F=9\&*X /E$.O1C4H.X)&S72;F/6:X$]+@&FV'A=#08'
M'7=A,,7@S1IA?*-+7,6GV^LE_SBO!%-3V+I\(<DHC:$$.2ER  G25B126TP4
M)T+F!6(\-H^C.#'"U A'R5@7O.^DM#G4/P5@/V-X@24P0QPCXA3O< H:F_B&
M"R$:*Y[!].6QC%WHT;X_5N'4C2/&)O3(?1B+T'>A?8).4XNC]=[$*"\XPA1(
MM>L%4"84X"0M@$!EDDM2$I@8N>V/'SPUXNK*N%AYOMZ@U4]7EV 0F*5,U;=*
MM3FEZP49-@>/&RVQYI02^_DT)_\^C59K;8,,[3O_\MRL&3 M<E)FZAN6ZFN&
M-%4_)2F0O$0TA0Q*L[2;T22>'$WL!(S()MH\BDA7VU0[IZ<F64UW1VNR=MZY
M)=K;R3>PI:8VI:.X\D(V@MK37EU;ZS^UU^)]>XM=]'J,VB]LH'#OA]["O>:O
MR72;?IV=JK$;>;T5Y(=NSG46U] -M\X/[&"_''3CNM="I3![6&5%WN64T"SA
M$DI02H$ 3'/=NK6(ZY!#3!%,*31OA3$TVD3MAK:Q7U1+'/WO]&\PT[U@_G?V
MMR*W6!<&L398ZGTB&'IS,@R>BU=E$$6+E=$GFB.M:I>\DG9KD2DXO>O(X$/&
M6P-,]3G@;^.;W(XJ?R'5OT3=7.JK8,]5W2.MR6! 6#<@RJ2BW)0"6)(2$)QG
M("D1+@@JH,")S2'8V9&FQKD[0:.=I&XI(N?1-3O2\H)98)9U@\OZ!&L0"I\G
M5^<'&_7$:E#GXY.JX1L<:J"N7D1U397U1]C&I*[G_O43>D]KN:+?.LD\^2I/
M:GM);<^#YXU7W/.4&@?5/4]>X"<\YGK)[\5F7AV>K#;%-6:DQ&E>Y@F@4D(
MLT0  HL4E"A!C(DBR>*+8C'Z!I_:RO3U*!2#U_6WJT;\B#<1!*X.1:?9,5O&
M0F$>VLWW)DA#P]U*?ARPT4@?+F+#!+.0P1N]X[]K'(<),D,A'4;/<&,[70U1
MV>X;P6_(^E$-I/^C?2HO9*&]*:=_VVXE&8H+*K $!.4%@%!1(,H%!32G:0(A
MR[+"JM[9)<),C0VUD/476?^P)ZYC'L)%$V5&A&/!']J4<D?>F@=]0.:3%R^2
M9U2>]('<,6]Z>::#E_A:ROEBKL.1?Q%\SLCB[]7J^:G[^,JXP'E>%("EJ="N
M"L67>5P #)6EB*G(<6'DJA@>:FH<N!,V:J6-&G$M_)G]V!JXA+TA%IBVSH+E
MX@7N1\W"!>P-O9'\O_:OG)W7UPB/7I=O_Q/&\_<::7+@[#6[PX$_=6$0Q4;W
MHJT0._^S.08T<^N8/&)"WWDK:70LJHGSQQXZBT_=(X0C?>SGH/3TK1L"TONU
M#SUCO._=4)N#+][T'ONF&CLN:4(-VY6)Q,I0HB0'B2PS 'E" "U3M;=,N<!%
M+C@SJZ=Q?H@)VTB-F.9],\Y@V,^6?I 9SQ;J8GB]ML;H!^#2KAAGGCY:0XQ^
M[?9[80Q<Z5HW?UFSPS_GF\>;Y_5F]5U47]56:WWS2)9+I;5ND9K0G+*$$+4?
M8OI#+]6F",,"T+0@&"<\+855)KK)H%/[]#N9H]^5T%$G]554RQVU@ELUH[6:
M C.GD&]@@Y^C><#4H=*].4A^B]L;C#MR/7MS)-Z6L+>XUXV;/B]9)<A:?!3-
M?S\O3PWZ\YQ0Q8N;UYF,,<N0@$#"--=<A0&"D@#,<BH+B2B+C1KX.(X_-<;Z
M**2H]/%2Y5+ WA9\,X(*"&E@KNHDC_[2R?Y7W<GX'(5M5?#'6X[8^:0P6Q%&
M93-'?(Z)S?4Q+@E7^NA0M_@X=59X9CLW(UDA6"80P"F%:J^%,2 I*4"B-F Y
MS5 &R]P\@<I!@JGQ7-<C1:= L;T>1M'SD_KQ%U%]TQ]D6VE"3>1RK>92^W#8
M:KU9UX=/W^N+HM^)CF7?1(MN<EUSJ5SFU<!O%GJV E-H$P31R'\ZYN$JLO82
M>4+?)@4I\"R,E5(48C8L,X0N0+(_X\?EP2-F\%R@]V%&SB4/<C/*V[R>]</J
MZ_/3TV*NAI@)F>:LE (D19$"".,<X))3 !E'J2@+2 NK MXGQIC:HM.)J!,5
MUIV0=A;V*23-K.@+\0E,\_O0?!V$QMH,[E'>IZE[:IA1S=D>/8]-UKY+W;[R
MG\B\JNL1?9RO=?6N9_6"&)[PF3QB0F^K%K,ID17M">HUN-L&$9^O<.]XH[[+
M)IH?O]1&]SALNNZJ^0O9B+N%>A_T5_//QNCOPBU25K!$Y +$L5[+8D@!I3D%
MF2"0(9PQRLRW5_UC36Y-:Z2-MN)&G;P6UO< O :[''^@A5[HSN+E$@4T )S%
M!L4?@"-M11Q>/+N-AADBO5N*@4>,MWDPT^5@FV!XRZ7M-T[7!V@V(]?/F\=5
M-?]3\%^7ZMGUQJ6I":"D6JX_O+Y-3FVR&P51>X@<EB"E20%@1AC ">6 9'F1
MH#+G1%@Y]<.*.S5*'ZP4W2BU+?]QF(KME*@:^'TP,SZG,\NA?6I!)_B"CB0A
M<0_3QR2(Q._4_20D^N=[I@0==7(%[?XIYM\>-X)?OXB*?!,'\L^HFC^>%&JQ
MDD27N2,ZVZJ4H.3JMY 5ZD]H(F7N^O28VGIF5/R.KQ8+4JWUKYK#F^G4P>M]
M9TQ.@'Z(-V&4-6^TFGD=*E$+R]%2^F.\6Y,IL>?K'1NU\-[DW[4I5>8SF>%W
MK-?7*]Z_2Q4_DSD8L;:?D3@NOMQGNIBSSIVA4T7O!1??:WE:OUE&RQ2*0@+M
MO06P8 )@P4J0E2DA,BN*'!;F_MS!\:9F,#42;_UI5TV>]4YJ&P?E,-@FWEVO
M$(;V\ Z@Y^3G'8;1QM?K%<ZQ_+VN+Z6EU]<8FW[/[_!C1O3^&NMTZ $VO^U2
M+_"G[T^+U:L07T7UHNC]S,*RJ.=NWG2:9ZMO2^T9:*)7;G187NO\97$*,Y("
M(;-<-T0M =)Q)C$5)8&<$EIP-^>O1RFG1OF#+L&V*R!OZVZTP4%"F:K7WU?/
MVY[%SGY?GV^ K;OWG>;UO;V\%T_I!9[> )"'<?#Z%/2=_+H!L#[OS@TQF-OJ
M<OU"Y@O]G)]6=9+1KB2E;L2[^]>L++("HQ0!@<LZ>J, 5 H*2LRS)$8Y)HE1
M](;MP%-; W91378D;@RT&2^'@"\PU6K!]JK/*@+M= !R58$U\=$?P14?G[QH
M//:H5&>+R#%[6=]_L;E+JN5\^6VM&*\CR#G[\'I3)Z+<+,BZ,V7+F-*RI(#%
M,.W:],8<I!F*10PYRZ&K*6LFP=0HJE- ']YT*N@$A,:5>A75:EQ%]#5J-(EJ
M5:ZBSTNV>.8Z6^'A]U7SR^@7L7E<\8OM5L.IM+9)_4]0:'MS_+FYQ "UPS>0
M<6DHQ'L9CG88]1B%E@]R-/BT:_DCV8BVJR'#&<$BXT"2@@"(1 E(S'.@2%5D
M.2%9@:S8\^CY4^/&6KQ(R^=8@/08/T-SS1V5P(1D XB]%79:;:_&UM$0X]I4
MI_5[8SJ=N2Q,6.@UV\Q?YIO7FBT>Q!^;#TKD?\U*F @I. .XH$A]Z#(&%.,4
MH#@O(8<%Q\2J2K&;&%/C@T'_3Z>&WU#-,W-D:_^$0OZ]G6Z=!JUM$VDEHEJ+
M$2,J^V$<,U+RC"23BH#L1\LVLG'@::XM+10%ZQ>L.5#7XZV6^CR]K@-52DJ)
M9!F(2YD!&&<8$$$X0)C %*4)*G*CFGM&HTV-!MOPF9V03O6V^@$V)#=?L 7F
M,&O$')I+&"#AMYM$WX CMX\PT/UMOPB3FQR"89J.36IOUAX&=0F-!4MRF5,0
MDS0%4)2*,0J2@0+"."WBE"-NE)S?,\;4>&(KI458QAGT^NG $R:!26 K8'=,
MZ!*V<@8?BU"5RW$:*3SE#5Z>XE'Z >B-03ESZWAQ)_VR'\2:#%SJ6@OP14W\
MJGK]:;Z<KY59]O?5BJ^_B(T^=5R+ZD6L9[+,!(^Y(CD4J_\I( .D9*F.]TO3
M3!2DA%9E2 S&G!KS;46V+?8WC*Z98>09L\#,N)7V*NKDC6J!KZ(O3;VP3FB?
M9?R,$?);NF]XV)'+]1GC\+9$G_FM;G2SJSEQ*_=W?/=BH0LPUX$-]9Z0[L5#
MVU9(N6R0"7U& YZ2(,54_(#G\PN[4*)1/SX_Z!U_EYZ>ZOC)"KK991]\4:]K
M>_918)(5/$^!*!,,8%KF@$ N0<Q%+K!,&<56+I-S TW-%J@C67:"JB5-7>QX
MGG067$.F\P!98 YS1,N>MP:@\,I(Y\8:EVL&-'[#(D/7VS<P^479"=^?OW<]
MWEA<X$3!E9(BT9TP*<"I^B>6<2HS3EG"C7J\O7GRU!B@%<Z\2<DA3OW?]D7:
MA_9X-')Y;D1R4MM+^X\</G2TMB,G==GO-G+Z@C'[UM;N^(+'19YGJ:ZCH+Y5
M*1' 61$#S#D619Y(:1?0ZR[*U#[NG2913Q-5A_.1"V;+S!H89PX"4XP/^$?J
M8!OJ).8":7Z [K5]9S@>GNAPP%-'U]W*-HOOMKK72=5[6=9-TL6U5.QSH[9A
M\^4W'<TS2U I2YSK[DV%VO_D" ):JOT/3A#&.*<,)M#X ,A-AJEQYWX9F;9P
M#-$B1ZR1.>)*:(O#$<>9,3A<"H]W8)YL@H!O99?M&]U64:W$0>6+MO)\5"L2
MM9K4\7[A9\'B""O\;(QTQ!5L5NQ.Q"[#L_?$S/'1XYVH7:;[P8G;A8^ZJ++:
M?BV0^G_^H=9&-4(MP_J7U7+SN'A5 C#]4G\3,YA@FF$8@YSG"$ J8D"2'(,R
MA2PA3&90&D5R7R;&U!:D)K[YI9$YJFJAKZ+OC=AZB6KE=BHV93M%!LO2*,"/
M<FIQLF13,QVM)@TQJNEHE8GNQIT.I])= :?E'2IO^9X>UW)9CJ@:5KNR??I[
M%*MR1.!,K2G7I]E[@&]6R_5J,>?;]KDZ([0YPLB3/$XSE(,28PA@C(5:D0H.
MDI1DZO_T$5%JZ@X^/\S45IQ]2:-.5,O3H0%@A_W'?N *O8-Q0\K*M3P,Q*5^
MYIX11G,Z#VNY[X$VN/K"Y,+:9PE3Q#F2)<!9F@$(*0*TR"1@,<<I8TR4U*YD
MQ/[3I_;5[^?1.;B&#Y$S\_8ZXQ'XLS:'PCVA,)3G]7" ]TDF[/./GK[([6LU
MJD+S9;74FR?16!'KA]6&+/;_KD-/OJPV_T]L=C5J=D]J;KK=/(KJX9&T]2S7
MLZ)(2XYE#%B>"P +3@&&.0<("I*B(B4Y-#HG?G=-IL9"^_%B3ZUI3_8SZY8=
M"!%I+'[Q1U=88-7V,]#-6]5UF^A5;*)J"\551.J"5W:\]G[OF!F'_A!OSBC;
M]9YTS*W^W3;QT_:EZ9I@: C4=<U+<[_WTESWOS36*\"[3YC/U>;]E!EU97OW
M.3M>1=]?( ?/\#5CU7.]LU?8+^J0SYOGJE)?Z(RAE$DL.(AU%6:HEU("BQB@
M,E:;;JHVX=AHHSTPSM16NU;$IMVXA<>P!TD##ZT??$+;X(V040=1+::BZ490
M/UA9N$_]8#:2?]01.SO7YS BO;[-GMO'<UX.ZW#@G32XW#&Q?QOYWE]BGQY[
M1EM6WC)]^^^?5I44<_7O+\\Z1J\M4K">$9'#(LLD2#@D .K>>51B#(J4%U@4
ML:2\G"W%-^U7>;"H%#".^$9?&FZ^M#=*A/O:6FF?J[HFVG-G:0I2+5[5[J3I
M9\";=D/KN@M1\Z-AZZ&QWQ&S;<>4IGS\3<;9=B^T:_="3QU.M;KN[T?:7T5;
M_=4?:P3TN]1@X+$@P[B3YK6TPTBBCULD8MSY>%-N8N3A78))1#47ZYL[]28)
MM=#RNC?@4?MCPM,D2U@&&",9@&DF ,)9"K(\B9DL"X29>1"CP8!3VT0T(D<W
MT5;HJ);:I46W"=XF,2!^40S-[$, NA3%,$'2)GS#+Z)C!6HXOYJ681CFZ/0'
M7!@\9\30"G.M#H,H+.YSZ:Q%]([GZ%66!<XQY#E(2EUE@] 88)$( "E+:)FC
M1%#SIJ:G1I@:ZS8RNG#L2?P,2/525 *SZ!$@3OVO3B%CT_'J0H3&ZG%E^.I8
MMK3J4;Z_B=6I&T=L6]4C]V&CJKX++_"[^&UM>/N\66_(4I\M-6;P#"5<XC0F
MRCZE$D ..:!)3/59<<()CR5AI55=QA&$GAK;?A#?YDM=7#RB1/V!B0O]**'G
M/$]QKD,! $PH!1!C BA5<XZ+.%?_A3EA:-:D%WU:\A]SW@_%#S?WGVKY?I")
MM_">36@JI^\Z&^B4O*=]YT#S[#8;:;:\^\Q"RSV^PVRDF3CI+1MK;'^%]?<E
MJ3>"K;-.=P!K-%BOGYMNG^NC8NX,IBB+<0E2)'*UDT,84,$0D,J"S'6;HK0P
M.I0/(][43)3]QC@]1-;X/[8G 5L]HSU%+R_5?\&L&ZY@[S:7H=<J?],X>O'_
MRR<@=%. "R1\]V8!EZ-KTD3 PRB.J0_KM=A\(.Q?@N]ZX76%PO-8;6;R L29
M6@Y@D@N $LH *].2<4@(2ZW*Y_:,-35:KT55'*!EC>AJR2W9N0]6,ZKU!%9@
MWCS :2>GQSI;%GAX3:CH&6[<](IAO=\D6QC<8L<67,QG=<:5LF/5YT=TFQ/Q
MD6Q(%U-'"@9+0B%@&"( 2^WH0EB"@HFDX)QPR8P. H8&FAI/-+)&>\+J!")B
M%[ XB&X_8_C$+#!=N,)ES!:F6.RH8MUQQ5JPOWU;O?RG>D1#$^J'8W88?/PH
MU&"J9,<+QM>[F1 WJ^II59&-^*#6R3>K79P*F%+( >:*#Z#@,2 L08!2*DH*
MRP1AJT:-O:--C1ZVPKK8$/VXFED1WM *3 P[H+2@82T)(TQ\VA+] XYJ31CI
M?FQ/F-T4Z"QN?<[!UNZ0VJI&8OUYV50U^J?0M2($OWY15/=-='^_J^9,S)!D
MDF5Y"21"$,"48$!940)%1+PL8R)Y9I7;/:[X4Z.W3]LP9WT\PU>+!:G6NCA1
M<U3C^Z3&[ZO@Z<SFW29X J<W:]/(YRT(D7I/&ABNH@Z(J$5B>U548S'B24Z0
M.1SU3,>O!M,ZW0DR.];G/&&D<%LTOXB-KB1[5ZU>YESP#Z^_*ID^+V\5\Q)=
M+:EM0ZK6Z&T#&BH@2Q.2 (%CI$O<2T QH2 N(,)Y22D15KX\>Q&FMGAM18W(
M5E:[!<MA&LP6G;#@!EXX=)^LNNYU)[Y>)/ZB-5#D_]=H!_M.BR#]@-Q!],G<
M#E*,RK[N*!TSZ 5/<NV+O&+_>EPMU!WKYI#]RVHC=BV'=H>;."<%SO(4H%0J
MJ[_,F++Z\PQP*6)2%C!/\]BN1[+AR%/C/+6V?5<F7"V_;8]D4[ -[>H0$(8V
MB?=D_H\N($F+'>WDCGX+<^YK"Y??!LNF@X_<;-D2D[>-EVT?X"] 9]_*W#_P
M/=U!?I;!+"[BA $,8PD@E@*@0BKS#5/*LT1PGA:7!N78B30U:ANL!M25_.G4
MN3S<QG(.W4-LPLW,B$X$HTD9/7C&#=K0 3.64KU[D(P;BB:!,8Y/=B/J._7>
M/ZI1;^EB_JW)/,(IQGE")."$9P!JJY$*;4FB(D,QCDEJ=K!]?HBI$6DG8;3:
MBFA'E2=0-*.^R[ )3&5;6&Z'8;%FIO.:^V2:$Z.,RASGM3QF@IXK'5)7/Y%J
M>?N\V?5HJHGDU^5\FVV8R3)&B,9 4!RKKQQ10*", <F30D))1<*8<1[KX'!3
M^^*UP#J7(MIK8=9$NM9"6Z1R#B/=SP3^\0L=T-(/G4LZ[#"&%KFQ7K$<*5'6
M]76T2YPU1J8WBW;X*>.EU!IK=)!?:WZ7HTU5K9@0?/V3$O87LFEC!^XJ\=1U
M^]9M\1:+]:V\?B'SA;;G?EI57\E"[$(-9K!$4@$"%3?K2I$L)8"0+ $X9QPB
MM3NFS*KRLA>IIL;C.T5T&L.\+M-3*V-IOWF9,4.3;^QY"&TEMOI$^MN,=AI=
M17LZM:U!E59ZGNH^XSMEU%ZX4Q3(50762E6/AJ9/O+W:IEX$&]><]8GE&PO8
MZ\,=C.;_5O_3[+752/=??_WOQD_:FB!4%CR/"00L$RF FIEQ&I> EQF!>2+*
MF!CY(X>'FAK):F'_H_5;14K>2 D<M1);6'G]\!I8R=Y "\R(?7BYF,?]P%F8
MQMX ',DL=GKQ[&QB(TAZ[>'^)XQG"QMI<F 'F]WA,\AU.]KGI6YG-G\1=VK"
MUW>KQ9R]S@A!$B$I 2., $@*#G","T 0905*1!S''NK'],HP->JM=R8G0A)]
MA)GV3X;AT4U8B-_WK";ZK9$XT-&,.W3AXRS[Q9A L*013F81CV:/<LPUYGRN
MGTX6=V2N!K@A3_.F.<7W]G!G)I*$IV4.0<QEH>S*(@%(B@PDK,@2+M,82ZM(
MG>$AIT9R.XFC)R4RF"\CU@AMF8$\#+89J_F%,#")[:&GI=7AYJV\NM>/0?"3
M?5ZR,3Q>TY.'1QTW2]D8A3?)RN9W.NQBSS1"?YI7-=LUD=HSGJ%8EA("'K,2
M0,:I+G10 )HHPA%9FF:(&N]FC8:<&NNTTD9B*V?4%'JSV)F986VPM?6.8&#2
MJ>6-;F57VS.ZK9H>U#KQ98OG71@\+7:\WG$=:>?K!5^[G; 55+T[8K,GC;<S
MMM+L8(=L=Z=K@8E[\6VNP\.7FR_JE9A)E,:,I!Q G$$ DQ@#(M(4( @SDB8\
MH\CH9/[< %,CXK9"PD[(2$MI6T?B",1^SO4!36"&M43%H5S$:=4O+A-Q]-B1
MRT.<5NIM68@SUSG86P_BNTX5KUZ;>.I=\&N>%44IE6$E$RX 3%FN-W8,4)&5
MF82Q0,RH#$3O*%/[F.\%%^)['=!ZH[NF5)NY_OFH+8*%27 67@.KR@=H@3_S
MK8A=<H51,H4%3!;&D@^X1K*/CF'S9 ,-(=!K]IR]>3Q+9TC^ ^-F\&(',ORR
M6NH^U,^*:.[%0C>FNR/5YO5.B3E?KU=5G6[2G5R5:IM99J0$&'()("PR@+(R
M!@7*N: X9ZP4Q@1I,_+42'-/]J@5'M321SOQZZPKF^-6JZDP(--0  <F6'-L
M78YFK4"VH.)08(]$SQY>:#OB=L&KE\RM'C@>P;OH>4#Z3@]P+))V:O/\<?6=
MS)<S"O,<DYBIG:U4MK$NMHHT_\M4)*F((>>ET1[78*RID7WCVEGM7#NKUK43
M_=8(;,@_)C";'7=X F\4EZ,3;O;UTH81\5HMK6>X<6NE#>O]IE*:P2VNQ0X4
M/>G%ZE:^35NV+"]B]*P)O>Q;>>OJ[*>2\$/4#[%"R6^ZO<G (Z?:6V#Q-LW>
MYF:'?=9G+FHWUC]$-9=SUN2*BNIESG:ES$7"1%8B@!*&U1*;4D!(F8$B+;DH
M=6LF:I[@-3S>U);93N)H7^2HD]G"Q#> VF#WY!? P.S3CYW+/LD 1(O=D5\P
M1]H3.;Z0=OL@<V1Z=S\&CQEOSV.NT\%.Q^*V*?94O%\M%C^M*GW]+$[3&,(R
M 3!76R:8Y!)004J0DE0B!D4)A5&PQNB23VU1:/JT3ZF;WOXT&YJR4YR\T.;P
MF'WUHM\T"%&+0O"(WX S]^/TV-L7?@+1Q0'G9-QN>Z<$&'FU:ZO7[ G55R96
M"RQ;/A189"@N)(@ES0!,!0$XXP+P$A88P8*P5(ZR[#FK,+7US[7^]%3>B, K
MY"CS//VE<EO#_*#9[,"[$\8A]6XS.8FETUV+'V,-O7B6O"VFETOBX,2[5-K/
MRTTU7Z[G3+=,%+NL@ETYSUT5[JQ$&2M9"224:BV5G &L6Q2)$I$X+V(>)T;%
MT,<6?&HKZ/6W;Y7XIKOV;)6H>Z(:KIVCS[N!:W*BLSG*.OFA?YW\T*V3'WK7
MR:-7X2K:R\G:0\%DB7S?M\7"!SO1MV8D9^X[O#V>/,3O,&^]KN8QY1G/9_T.
M*!\XO]]C?#>_PE$4:GU<^GF]?A;\X[,2X5N38U.+\47\7O]E/4O30L8<4< %
MU]T-* .$9P(4+)$PB_,,8FCC&7 18FJ6B9:*J#>SCAA0\JKUYF/$]F+PG[8Q
M^&NMWU6T%'5XP;R[D:W6MH73G&;/;!<?>DX"VQ?'$>I7;4''1H6HT6';&*QE
M?J5(<X$'MO>!H\]=L),<H^YC+T'J>"=ZT;,\QEO^/%^*SQNAEH0T(3F"6084
M1Y8 Q@("BE,($IX4 @F&.#6*MC<;;FKLV!,]J&6.:J%]1%[N #>C.7\P!B:T
M"Q'T$X/Y!IC@89B[$=\_$O.-]D;!F&_O\GD"U!RI7S]O'E?5_$_!?UVJ)^ZU
M+:AKZ7QX/?2?:2OT^H_Y>B8R@DHI*9",)  6,@<XYR5($"QH'".9$WSY$<]%
M,DZ-R8[<[K6<T6]:4DOZ"C&?EQS0C#9+@8G298(\G8QX@3#\T<=E8D[@;,,+
MSF:'%WZ&>H?3B2^KNAJWX)](M=C*M_[RK$/OVGXWZUF<<\S++ 6RT%V^=)]R
M6B)EGR:0H"))RJPTJG(^GLB36P^TK)'8MIM6%MJRTR-:-8K5S<KK!N5KPP[E
M([X"(QQ1>)_8'^AP8JO[5=2\*EOUU=]J '2=(9O(R!'?C1$/)+R_(S_@4827
M=V7<\PBK:0MZ$F$FR8]S!F&%K-?3![N1'6R;V\VCJ!X>R7+KIOO\_8G,JSIE
M:_EYUT:D*0+;_.]>:](T112R&!!*(8 P1H"*,@>%X"R'$LH"FZ=672;+U*R1
M6AN@U0$[#_A.(8L%YL(Y,K JQD,^L+DP 'ITNXSVM+F*VK+6-N6MO<^/Q<H^
MWCR-M&2[S9>G!=</FKTKZ85#C+=$^L'B8.WS]$B7#7O/&=/-:KE1OU'CJI_6
M<_7$^A6_%R^BK@32UMN>_]E\CEDL((U1!A K!8 BRP$6"5'_E D6 DF$+7;E
MWN2:VF*W?^0N2+4$J^=-N\V.-JN(-=6WUWL9X#8;+'_3:;+#?I=)"KV-'CYQ
MW^D6'2AW%;7J1<?ZO<\4VFR$WV4JQ]KMCCJEEEM9[\#W[U?]#3?BIM0[1H<[
M3_^/MUN)U]5FIA^OEG5>/Z<^>:W/QDBN@RP2!DBBBSLCF>N2^PQ BK*XP!!G
MQ"@ X_P04UL?#Z1L @2L3BI[P.Q?TOQ %#J@PAX=8SX:!J#GE$_=O'?"I_YU
M?+K7\_11F&18NXX4#*[TU6)#5S[^WAS)Z3,X13RUGVHF<1&S0J: "O7%0RX$
MH'%2@AS&K"0HD3DUMZ5M1IX<&W0!1+_O HBJIJ=!M=4@>JH/S9]$U1C2]<D5
M7RT6I%KO?FMSB&4U60:6<J@I&"5\ZV1'B9WP;<B"$K]Q\H>"^=(.'A[@?O]&
M'@ZP>^CH,0"=?6./<P]\Y_X> WH.M_D8>H!+U;8EJP19BX^B^>_GY<<V)/]>
MO8FS A4RPV5=[Z  L(A+0$@B0)XE">>H8+@TRFHP&&MJ:T,GFUH)K X)!A U
MH'-_. 4F\$[0Z"^=J'^-/B^C+7+W7I&SJ<;F#<&Q*K%=@J1E/38C;/IKL?4_
M8L0Z;$:Z'-9@,[O%M3YL[UY?[^K5:W0K]_J0[/K$SSAF."Z*',0<IP *C(#:
MAU.0)BPK8%I"+JU2R"Z29FITO!-8V^O[263KK<R6P<87358_CX\^!9-P6^]-
MT'ZGG:_#$^10%]@#L'[K!5\BT,AUA#U@][:^L(^'NO:K4ZR^JO399AV?K$L=
MWZR>EYOJ]6;%Q0RQ$N$\(2 G+-96; QH690@Y8QGN4A95AIU<3<<;VK4V8@<
M'<BL<S]UR9!5%;621UITVQ9W_;CW<V0 - .SH \@';KB&<%S<9.\_E%&[IEG
MI/+;%GIFMSELDX^/8C[]P1YUY.".V3Z0]7P]RXE(,)0<D(0B9<*Q I"\U+7.
MXSC)\@2SW+RFD>&@4Z.;8[$CT<K=6FVUB4"UY!9[0],),-A>!X U,.^\0;03
M>=_H^A (48MM=P!D1]I_>T#8;A=N"57O=MST6>/MRRVU.]B@V][KP.;_K?Y'
M+15ME7^"LQ@RQ=D9$UPW1<UTOA<!+*<PY@G.,VA4T_7MHZ?&S%HX7=R)_<V"
M)P[!,N!79P@"L^A.>Y=V$8<P6)"B,QPC49_!2V%';2<5[B6PPSO&HZF3DAZ0
MT>DKW)R#]V*]J>9L(_@-63]^4?(]5U7MV%9V(4&Q!%+]5VU/F5#FHS(:4\PS
M 2GDE%CY_<X--#4ZVLD9,27HE4X2;46U\^2=1=;,2><#K^ 6X!:JFQJJ+\-0
M6?O4AG#PZ2X[.]:HGK AC8^=7(/7NS'#]0N9+W2#\I]6U5>R$!\%W>R<8]=,
MK0//=6/,OU>K]?K7926T=23XS^I?'X1<5>*!_#'+LQ1AFB< R3A3-)(D0/U3
M<4DL(2Z3F#,L9LNZ4BQ_,&<3+\(9?4JX^93>B!CNL]I)&VEQ;4\0_,R;&4F-
M-PWC,)J6?^]DX"K:*@B4L&"M5%2_VZD5U7I%1S-V%=%:MT@IYX\(O6+MDS7]
M"#8JQ7K%\IB/_3[<<X+3N;P)1$B1080 864!("$$T#B3(($<I0SBM+#8;SH(
M,#4S<#]E:3\_*7I^4C_^(JIOHMI6!MU49+DFK/;1U,5!([+D[45=%.<Z6LP)
MG2_FF_,)BGZFTF W''B" K.TP;EOX*2DP-E'_U9I1N^83!0J:VC:Z4&^\H#\
M)OR<*?BZ+:F/"EQ2F>0 DP(!F'$(**4<Q#3G+(E+IC82%Y2JGFJ?C%_$GW^2
MI:X+*FHY_^NBNM*6W;X]8!28ZH^K0P?IGC0 0\#BSN_3LGM WX$2S9[JV7]]
MINLYGZO':ANY[?]=IZSQ.$9"I@G@)<;:9< !3M(<%$Q9H9F,4YQG5A&'YT::
M&A=H\;9][-U*E9X%U8P0O$ 5VOJS0<D^A&\( :_A>6<'&S?T;DCG-V%U@S>X
MALQ=<Z[>E?6=VD21Q?\W?ZHCMK(R(8@P!B#G&8 0EH 6O 22Q+@0F4 0&ID&
M_<-,C0W:N*Y65%W<1@L;*6F=@N).(MO/"O[P"DP)KE YA+WU(7%QM-O)AX\<
MY-:GX-O8MMZKQRRF>[[+[S_J"GG72_[ICR>A3TD>5OI7>RT,FWIYLPS',(,E
M!@0Q13.<"D 80B#!J4QEF4+!C6CFO169&I$U<M<N,=%*KJO^Z )/$=E$FT>U
M]U%_4TOZ4[WY'+L(KX=7Q\3E]F.\$*&-M\N+L XTJ&_?-H5*U,$2/:SJ7Q\U
MZFW ^4'>L#$*_([[IOTX97_'>N-&*@CL;YK#E GV(-\/4#S8WRSX*2GL49X+
MVN;08<GIL>1WBBH>2=O20>=RZ=.Z>DMZ)Q2)+#<S+)(R)D4.4D%U]QR<  JY
M[NHN$.*"R5RFUMUS@H@Z-=NM$[@M-W-T&'JE+39F'1D7<*8-W5R3F+]13"W:
MO_#1;N&CIQ:^[>S?=;/?:-SXWJZBNX'9=^O6$W1BO#?M"2/M^+U[@J)^LH5/
MV!'=%J&Z*K&6J1*/2JSYB]#9>]^%CLWY(C:W\H'\<;>J:FDWFVI.GS<ZTN=A
M=4?JV-XTR7&,2*%>&5$"*!($$(T+P(J4HYRF29G&-BO-A?),;3FIU=%+R$Z?
M:*%4L5L_+IVDI,!"9%  R60&8*X/G3/*0<+*3""L; 7&9R^BHJL)3M.^7.-.
MU+Q6:=RI,EO/1X0_\*+=X'Z@2M3H$OU%:_-7W?NXCCE3*FE'=]4LZ7M::=]:
MHY>_==D3P#X7WTM%&G6%]83?\3+JZ[$.COIK_C_/;8'^A]6N[_T=F?//RYLF
M8.B@*TW7LZ;93<Y( DDJU!J)4D0:#J94$J#625@FI80\,6\-<Z$P4ULEM50Z
MD*ZIEK_7M*[M2-]UJ[-P75XZ708.[A$G(3 )[VFB'7D[72*MC"Z!UJISW/V+
M[SJ$-4J-.$,6#N(19VHD)^\(,V;GG/4$<:^#]=(QQG.2>D+CP-'IZYGVD2H?
MVW?Z04?]U\/>BR>URLXR&6>(\!P0S'7./H* R#('$@G(84P+R(T*U_<-,K6U
MJI,SV@D:-9*:!ZB<!70X/,4'3(%7$P>$K.)2AB"X("KE[*-'BTD94FX_(F7P
M6OL.%0_SC8YO^[SD\Y<Y?R:+.I8R24E)\Y@"4<8Z-3Y. <D0 Q(2R2CB+"9&
M@2)G1YC:1UX+J<W1G9C6_2E.0]G_A7L!*/#G[8"-57>*7OTO;4YQ^N&C]:;H
MU6V_-47_A6ZNWD_?GQ:K5R&^BNIESL3I@U.U@?X@ED+.-S\IR3M3HHUX;0V*
M64$AB0N1@#+)&8 R*P%AL  BID)@G# FJ8W3UYMD4^.1_:.FI_:HB>R<_E?;
MC:[^GII-[E6T(7]$M-'4SO?H;X+-O)#O,FTC'B)N#P?W9^S3WHS=MC.F=(P^
M#,R8M0O2.[H^G9'^A!O5+>D=TV,'I?\!W+B^[5C1ULF".16%**CN'U$"F" $
MD,0,Q(1 C'&9(V1U2'?P]*EQ;BN<Y1';(6!F_.<,0V .ZSK*#-97L^:DDQK[
MY)7# 4;EAI.Z'7_?IR\*:(]=+^I9F>NBW?>"K;XM=>6,)FGY1E=>^'F^%'7O
MLAF$*8_S- 5Y!E, ,\H SD4!"LPPY$G"$F14]3:0?%/C"8.57FO9!O+?="GA
M@E]%U]]U/>/H-ZU;TY_/,FW1]]1[M-?"3.C[6VT^YC*,#6>/^.B6G(6(T[/G
M[/%ULNH<AG%;-TXV)=L+3IZ5.,-", Y2RJ4V]SC :5D 6>0\9HD4,3(Z:C8=
M<&K,WM-/<K63VC[KRG@">(E3B/7A?H$1@.J?@,H$@C(I*"S3' F4V<5;^9R"
M<0*JOC;=[L.!;+;F^00N\"*V?6W_N7MMVXZ0>P+[6YQ,H?&YV@R..>KR88K
M\7I@?)]K"^'KO3C?;C_;;DTQ$83B!(,X%AC .,4 \[P J80RRV'.U(;>KFOP
M^<&F2>S7!T'YD=U^WPCC?FKQC=PHM'(&-)<:[$/HV?;P]8/BJ&U[;5]!A_:\
MPZ@,=^3M><;(37B'M7G;=]?@'J<>0B>+O#WL*EK6QOJL) 0A*C) 8$8!%&D"
M:)*E((.88($15V:=10^A_Y^[M^V1&T?21?\*@3W8.P,D9_5"B>393^6R/=<'
M;I>OVS.-17](\-5.;#FS-I7E;L^OOZ1>\CV5I))4R0>#<9?+DACQ4'H8$0Q&
M. TZ-;[M*AFNC^2> =FU1#VI!.K5^\9M*ASH. + D6GY4I7(&=@3&MQ'@M2K
MG5!P:$=K)W0[Q+[]A+RPNM)/R.U98_83\M+NJ)^0W[T!0R.?[1& >6Z3$0W*
MD"J;?T]29GQR7D+-4YFE)4:XO#TH4@\U-1:_Z%>"WVMY/6/7/1C?X))[(_=2
MSOA5T,+XX0=X1/? F]%>WO<^T-K)ZSZ\8X ]^':U_J;6;_Y4XGFS^*X>M%X(
MM>Z:DF68\+),H"BIADBG'/)2)U!+KB72)2DRIP3GJR--C3,:6<%66-!*ZV&*
M] +K8-*%@BLR45Q":HAGW0N9A\D6"KJ1[#3OE\W/*'-!H]<2ZWW >.:7BQX'
M-I?3#0,HLZE^\Z!K0E;5056".25%F0AF["S-"X@$,G86U3D4.DG+)"EQ1MW]
MYKZ1ID:9C:QUQ9A&VN/B,1Y$T(NP W>&PBTR=[:0/6C0"EK_N!=9"P69!W>&
M@FXD[AP.H1^)NL#22Z*]#QB/1%WT."!1IQL&D.BQY_NNZ6(G7SUO/JPV_Z4V
M]F#?7&*6RS)3,+.Q1U3R''*1:9@@0A1/RU)B]RY%3D-.C5;OFP;0B^69ID-/
M[(<U_SU8P@UU!X8-CF5DJCV)>(%.8F!$!D9F8(2N3P\'A].#?8/#.A(-AX#7
MCY"]D.IE9K<GC4?17IH=<+7?G<-"C!]6R]636C-;L*(I/M+F%FY;T4@N:28%
MA9DL[0X]PI D5$&4)UPAK71.2Y](X]41IT;934V?15O%1S7"_M6ST<]UG-VB
MC4'1BVT/[\FZK8+4BOO7*)V G-$)&8*\/NBHD4AG#(X#DNXW#J.:MVRQKAN3
MO5L^/6^J]^J[>LS::!"74JLRT;#,BP0BGN6049'!-"MSCJCBR.\(9L]84Z.7
M6K9__[>T3/XS\^.4/D#=V"003+%CDD;*KAMA(^@,U**"+,*A( =,0K)'WW"C
M\H:#WL>,X7++ %_R_SPOE2VTF25_K[=&EJI]J0E-TJ3 &M+"'OP3I(2<"@Z%
M0 7+DC1E;IG@O:-,C1^LG"#%,V!%!;6LP CKX=9<Q-/!,0R!4F1ZN #0D!V+
MBTAY^'PA$!O)S?-]M?Q<NFM ]'IQ%V\>SW&[)O^!KW;UXAOJ&=]5E=I4]];W
MLR6*"4XYSHQM9)D026G\,5UJ*#$J=)[3A&BO]HJG0TR- =MBMHUP@-6B#BAC
M>PBCFX%T&SB1B:_!I9%N!EKY A>-/:M[\#JPAZ.,7]KUK)9GJ[6>OW)X$;K_
M[YFMS3?T^*,MF:8%5A*7"&8L4="&Q2$1FD(N9$Y1CF52.$7(>\:8VN>]+;"V
ME7-P!;IC-/L_\D 81?[*_>$95'[N @ !JL\=/WGTXG,75#M7>^[2I<-6[[80
M<%TIC1>:B;)4D!*&S(>M,&1EJF"1%D6J"EP2[A5&W7OVU#[HKO[QD [(^Y"Y
M+=$#@8C\U3IBX+THG]$VY&J\__A1E^$S>AVOO^<N&5BJY* 1NFNYB;/=TR?P
MJK4][6+$T\_K'+1>P^$(XY9;.*O=2;6$\U<->_,:\W$;-WN]J,3CJGI>JSE'
M-GI%$IB7VB;T)X59*1"")-$%85ACDI#Y9K5ACV[KP\61O%:+[7@1]YKM&(.\
MNLM@NGW102"*_'%WWMTN!@YV<H;[T*]"$?*;OSS8J)__59V/F>#Z#0,[)XJO
M2C[; JEWR\U"+A[K_-9?E7A>+S8+5;WY4SP^2R5M>3U;HN5YT]9E></62[,B
M5A_5NJY/T1Q;(2DK1$HX+"@2$%')(<E*"FEB"QN+-"TSIY35..)-S5CMM+/I
MK?OZ@9V"H-,0V)<([.EH;^JTM-WTFF9\PPXB!7X+W"CPY>8V,F^^Q+3ZMTN,
M@G[0%HEA)1RW+6(4=$]:(<899<"VZ>#6P7?"F+A-Q?W?%INO]47WJV6UD'4V
MR&KYV;Q2U=?5HYSK,M.$910RI3.(4)X:*S7'D"N9HRS50DJG*,98 D]MM=F3
M'/QA1&^+20&Q+SW8=.+7]:;DZO&1K2O;J[>YW+'TU&@OA<,V\L2F.O;B<WO/
M^OT7Q2K>+D$'JH.M[A-[(3QVRR?V8HRT\3Z=%\1O2W_$V>K-#AA#CO$2#49$
M]2!G8<QQ!Q; 6"WKJ)L=Y?ZYVJR^J?7[!>.+Q\7F1[>3GTJF).8%)#K5$"7"
M[JP4"J9I)G6BI. D]2J%X3#HU.R*UUT!H[7ZKI;/GEU^G6!V<RA#@Q=YI>[$
M;8RQ3N 9V(H<(:_"!Z*@I3)<QAVW:(8'$B?E,WSN'1B7N\:/U26";+M>U*E@
MU;ME4S7Y-V4K?"AY]]VPY!?5-<KXN%X(94@,TR(I,ZB%,"3&M8)4E SFF6;6
ML<JSQ+/&[HC2^WS0XY3KK?6HP!>K@KK-C7J)MX%(C/.":_,I%^9M0%D)*57<
MN-DD105&/-5.'>HF_BZ,L3+^_2=]!1SCM].<V%'\:][K/E6 =_X3/^<_;?L&
M-PC8$]D-!C/0H0!:&'9-LFH@ L9_QY^]H,'A$<4?-W(\_KR<A)5?0(2;8LZ=
M"#L)/Z@_NDX3[2F*(B]RGF4I3'*<0,1* 1F6#$K%&)*82":&1(\=AI[:JF0$
M!)V$@X)W+G![Q64#@SABA/5LAYQ]@(><!/)#>E# ,S#B+Q"ZO(I\\+"C!V:.
M 427)[Y$*-!#TPM!/9\G1'*0KZQ1-J/3K$E+:0^:"_/CYY7]U5[KB:9<T9P7
M)!4DR:%*2VP6CH1!GLD<2L'*G"<:9<KKS--8@D]MV6GDKKN&J59RL%F![^;7
M@&W YJL"ROS;2M<_/M6FP_">-Z.]'H%\I1>8] DX2JY^TMZ[\V;OW;&_/NCH
M8U: &H81W:3 $S>JCQ1*]FDY2(%GQ-L["CW^P.VKM9*+S5LFZJ#TZ]4WMEC.
M9:%+F20"8H:4[<0A(*&EA*0H&<JP+'GBE9YY;I"IK3N-C* 3$OS>B.E;JOT<
MG([;4C>"%'L;RA<?_TVG'@"";C*=&V?<3:4>34\VD?JN'=BJ_##2TM7;?&T3
M Y5LV@CN]_TCG):$I0S2W)JVN620R5S5;1:-;5L(CKW:''N./S6F:.4<;G3Z
MXN_&'Q%1C4PM)\'L76'GMJ?E@>W6:A2PQ_HPY()V8?<48=P^[</P.>GD/O Q
MPTCNO=ILZBK"-7^V03!1\!P)8\D4PIY@$QC;34L&=9%R5E"><N[4RK%OD*G1
M52.C_9@:*?VXZBR,;H1T*SB16><8EPAUVOH0",D>9\<9E2+Z-#WF@=YK!YZ6
M/CJH8)RJA9BGM,!(">/&")Y E*+$>#!$0%H6N1 L%TIZA>3.CC*US[T6*D@J
MP7E0W;[]FZ&*_/&?'IV:@5K&@ ?3^R (>C[][$#C'E/OT_7DM'KOQ3>$^?GU
M: L_CK9LC\K>5=7SMR;TLHVXJ/6W=(Y4R0A.&"3*_($*G$-N6 5F1!-1()9R
M+;T#^U%$G1H5[6*P1KJ:DGXH0TA#0O1QIM8C*/_B$S;],/S>^?\]A6>[4+S5
M.7#(/>JT! ^RQY%V_+!Z5-3/!M+CCNA?&^_-<K/8_'B[>&S=V+G(RX2E&D/-
MA32V9I)!QI%Q-'%*,<U5*7.G$Q[G'CXY7J_E U; :QMIUX'KY^!;X8AM1KHC
MX57Q[I+*-Y2Z.WGD:#7N+BFS7]SNXC7#S,'7BF]VM4\\JVB=OWE";YT5<*_$
M3I2R6OT@A%P9+XPTZJK6K^WQBG3EZB&MR=2WI]6:K7\TE;S>F07+K&4V\[5S
MDN8BH[)@F$*AJ,TO4A3RG.=0("&UHJG,$'([?>,XHL\+/\Z)F5K()L&]#FHT
MQXEOKC_@ 'X_<40 -#*#;(4%;66^1MQ9"^XV*!(619^N9$'1'*LEV:VH>O8C
M<\:HOQG9]<>,V(G,6:?#-F3NMXU9M>;#:MED\[1B+<U*4;^(#MD]1[MEGY3=
M^#>_[PZ5/K-'Z\14\[QDE'#,88(2;CN.(,BQ8! G6%&1L2+A[AU')JWJU/P@
M]U35O315GQ#8]*<D:F&=J;U3HX3@;JJX8A"##63;)6@'VC8_]FX_/_;SV?S8
MDY2,+8!@#\$ZHN=8$77ZK\(H-8&F]D[_/-6$IO5NCU24:,S7)4XYHU$T^ D*
M(8TYDV%**(TJ<<C374TJV=WSYNMJO?B7DO]8FB?6[>,;?3X::JH.SA=_LEB\
M7RS5NXTRD*D"Y3FG%":,$X@D89!074)C31.>,IEDB5<CC#AB3LT</KLUN'_L
MLE%K=E2K -1:@=^M7J!6S+<J<9R7P&-S^$6G=L2-X4BS&NBT52C0XY^MNEG2
M"9RD"H6VV[FI8*,-"/]\4M\M>WY2@CTM-NQQ\:]:I-T.P&?UY^:50>R_YYP0
M@1F1L"")AB@79N$H: HQS74I<DFY*IQC,>[C3FTE.!;9PT/T -LA]! 'PLB,
MVPH-CJ4^V/*S@H-:<I^2$1[H>CC#<5 >R3-U0#N0$^@/4Z]'YO&X\=PC?QT/
M?)4!MP]S'#ZHS3VKOGY<K[XOI)*O?OS#+#COEF\72[84MH.7V"R^U\7QYTHD
M+"M$ <N"I!#9XR*<J]26O),<*RTS)GVZ'KD/[47K([1!,I(#840'3ZWL-B%0
M=W(#MA7<SW[WF LWFSP.PI%9WX)KI08?]\#]BY4<+)9_!5OAP=UUF+T-:G_$
M0AK)'J./:OCZHW)LS YXPL"$IX4=8"DK8S1_,^:RM8SG2DE"2B9A216&*%,9
MI-P069)0F5.6DRSQREP_-\C43,^MC#,@:BE!9<7T8Z2S:#HFC]V(4>S4L1T\
MC8#@UUYX_//&>O0/FC5V;IQQ<\9Z-#W)&.N[]M:.;#=XS*]^G/K,.Q< $Y'S
MM,@ASE+#'QSED.4%AFDN)$]106GBU.A[/)&GQD8W!<^&]F:+]CXX1D0G-<O3
MCH[6#;6 BR]_0^.VV-,0IYE;-*E?J,%;[%FXW/0M^L@#^PP_UB]Q6_GA1#Z[
MM;BLU-RXV *GE$!>VCKS*:&0:R9@BA4N!$5"(Z]#W&[#3FTA:3H0UZ9LRS9B
M/XM"-5)[]B9VFP WU@\/ZTLS]YLKF/HW,/:"*&@W8[>1QVUM[(7&29]CO[N'
M)/VRFCOM%U?WQ7SS<+>43;&*!_UJ90OUZ=>+M1)FTJNV+HI"15YBQB&A*3)<
MQ<U/N2XA0R@3I,Q*5B;NJ;C^ DR-M:P*=14GJT3;PO;-0YTPVP@,'C2H5;%7
M;97Q22@<,$L.^T:1L8]-;1;VAP[VMQWL=V=@?]B#?5 -\@'X^Z19QIV'L9(?
MA\U'J-S#X1CV9P0.>.Z(>7K#M3[,GKOA.7ZK3K7>S.]7STM#S$]LO?GQP;Q1
M=W\NJGFI4LIE4D"6T@(B13!D1"<PHYG$I,"(%4[E%R\-,+558U]&8(4$OULQ
M'6GI(HS]M!\"G,BT[HV+,T]<4[['%C6W[MFAYF_'-NC%9X_"!=<TZ[[UJ]<-
M;0ZZ#??6E2CF/,$<F0\7XD1B6TR(VZ*J!JR,Y((A7HK<K[+RT0#3^Y9W>S#_
M_F]IF?SGO_\;R=+T/\'](ZNJYE=W;1G5&3#8@^]U!9G_E?PM29)T!K(9+I*9
M^=G^OS8=T[*<E;0TOZ==;W*V#6,T5Y!L1G$^PZ2Y Y6S)"O,#:B[85&?$*S_
M<;7+6@:LLH;H+V:>OS:BY58"L_355[Y6HB;X@W]*9L \T*9!+[ZKQQ\'BOVS
M3[%TI]5Y+<@LQWA69OFAT#-WJ0^$>=LG3#FC*)WE178JR^S*N.=1\>WN>O2=
MN 4=;GG[HY/U;G=MUE1%FK7G@4.V:3VO?]B6K$=CC-Q^];R&IZU6+USG7]KG
M=>L4O%U4@CW^EV+KM^8WU5REJBA$6D*.C(>/;'E\QO(":D$Q*CG3FG#7"C\7
MQI@:>W=B@D9.8 4%M:3N!7\NP=G_A0<"*?9NNC\^7F6 KB!P0S6@2T\>K2C0
M%=7V:P-=NW3DBI$/726Q>F/$;N"]6V[6BV6U$#7UI'-BWAM%"FH<-FT<-JTU
MI$G.8)GQ@F1EC@U;C%(Q\JJH4R.</4DO-GL:J7KD]6EVW Z?Q.2-N)ER:Q.G
M/86-Q=2IW)A0$Z@>Z3PMDZ@>>5W:GZ-ZI#/JP:I'NH\X,#3 JJ]W2VG_8\_7
M&G_,GJRM(U4YIUHI*6".A(8H2W)(A;:=5U@ITR1ELO3*V[P\U-3XOTZ MFYF
M_<.>L%XA0 >('?W+(,#%]C2'8N;O;EZ%(ZCC>7FT<5W0JUJ?.*/7[QA:<?;^
M>;TV#_NDGE;KS6+YY=<-VQAG"N<\-PYI :7*)$04&<90:0%363!1*&UX@_A5
MGST_T-3XHJV_V@H+MM*"1ES?LK07T+WNJH;"+#)5#(5K0.W:?BQNKF-[X?$C
MU[3M5_*TONV5ZP<ZLKL=RJ.*H8R7,M/&WDYMLR-$<WL8F<.D$&6.4N.':K_T
M[0L#38T4NJR3JHF]/FWKA58WUPN]BKFC3Q@ R=@>W7[J3H0*EJY0!/6B+HTU
MK@]T1>,3#^;:]<-H8UL=_Q?%[,E:Z_C\MMA\_<=RQ2NU_MYX/$_/F^J3LIHM
M'A>UZV3^9EC,D)=MVU*]7S!>-Z;\.ULLWZ^JZMU2/#Y+>\BM:_,R5\8X40B7
MD)=Y!I$N<\@)TS#/C6&">8XH<S).1I=\:L1F)%P;E14P#*9MLXUF$\]\I<9A
M-0[MQO/@[7BO@!LM3G)B(_/LKFG*#.RI#?XP>H-]Q4&C.3A4?0:VRM?]JZH9
MV.H_ Q8!\!>+P5]!AX)]>3H<PM'XZ%,7<ET83_A1%YK1Y^1XY1I?@ %YWO=-
MI8F[+VM5"Y@E*6T35<M4\TRJ$F*D$42E/3]-B'&RTX2(O"A529UV?*^,,[5E
MII44;$6U&1TI]<@*[L&T?R4(B%3TJ-M9D(;D4/>@Y9$J'0:UD3*B?5\QOXSG
MZU#T)C;WW#Y>_O)U'0[2E!TN'^8F?%*/]IC-1YL4^=G8F)6M\K):UD%TB?,,
M\:PTA%@4AA^UAD3B J9$(,$E323Q*I/9,];4.+(5%=2R@CUA!VU4]('L9CH'
M@BXR:0Y&S=L>=< CI 79-]RH-I^#WL=6FLLMP[BCW4ZM/J_NQ/\\+];J[CM;
M/%JK[^UJ;<,:OUI#KRY_8ULJS952&"%)82YS!E'&D>&3)(<Y0ZQ$6:8XQ_.E
M^L*:!GZNM.(IAM/W0IOOY428>-_.1_.@K\;YKW-N%TO;9*+6RH]I?*?$C7UB
M(#P.(W62V[X=K>R@;J^VDW@&MMI O5K#RN@3CJ@&0A>2O'Q%&)70!N)S3')#
M'S/ H7ROJDJIAR>U9G:/Y[V-V'VL,]?,4)T<']3F07^RN2;<$(C]E?$V$UR4
MB8!I@HPU);&"-%$Y5)FF),V8DH6[MSE0B*F968T:,[#J% &/5I-9UU#'?(_@
MJ?N$EVICN;'>VF2=1AY^V-")<W!I1YB.R$39S<16!_"^F8E&#6#T %LRM;4,
M'S3X5*?WC3@3'N[R"#,RDB\=<6;\W.X;(>WUR8<^>SR'_4;M#[SY6Y\5LIF&
M0Z.0D_X@#YNO:OWY*VO[AU1_KS>GWBT;'8YZ@]3_^-JHL T7STN6(82,I8+R
M+(-(&9> \A+!LI!E+E.&"N)41V-RFDUM?:TE5#),3L140+ZI<\?$7XK861^W
MY_&?]N8"-3Y@8P#:9?DW&-G-R :E,VVYZDN A0KL=DEC-Q%YP?F/WW?D)92;
M0*N2%YQ3M^XF+RG@H(8H3VTPJLU+:G>KDC0K$T4T3+!MFY4)F_*C"\B)H$PK
MF2=YYM']Y.P@4UM!=V)NL^6\^G&<1]+!I0R 3_1H_Q::;?&C =NCES#R:E!R
M,U:C=2,YP2Q8]Y%>#*ZT&CE_[YA]17JE/VHBTG_M,._HW?*[F?[5^L>N&<D=
MK^IFAHX&9\\3)O35;J4\:#?4"1IPB\X!CI 64=]PH]HH#GH?6PTNMX1K;&9[
M="Z,.;+<F)^JA:RC$%T74)MRM7K>-%;&+BGY\WKQY8NU1]9*S44N!=:"P91+
M!%%BB_=F*8<$$Y2EE)0J<2^#&4G(Z=D131NJ]9&>MHU%IZG]<:?J#*A:6?/?
M1MTV*#YK#CZTYQXVC<[&^S)*W^3G1WUEG R>%W\1HAM,YUN1S<!.27!_^ Z\
M:=^!5M.M-]V86\VQC5;=&:@5GL!LW]Y;;LQ9?^%&="/-?I!>=J&F94CCNYO'
M?O$N>:'0<VFI%VRLD:OOU'_89N-&^$\VQE$9*87].K\H6W];IP5*("8V83OC
M":0HT[!0YG^24YY@KY-&4:2<FN51RUJ![XVT8%V+6^^PMP*/5'"G=V8]0OHO
M.5_3#\_7_P&MJN!3.]D?KT_V>!5V7"9C$L5U>@7].>KJN& =K*2.TV!!^[F^
M6[:TMFNTN W:8);GI-08%N9/B!AAD&I<0EJ:?RF%R!/NU*M[N A36PFVHH9N
MY=HW#6[,'A?<R+1]I;7K#O:=%E$B;L-!'*';:Y\44^CZZH"28_=7ER?=7&Z\
M:>_5%!R>"V)P4'D*D204(ETDD.&BA+G0:2I2P@JA!E8=WQ]G:GRV7WQ\=E3Y
MVT;"FM]XIKE<PMB-QP(@%YFL#@M7_]J6#(]8N?H<#I$*6!\,]5)UK,_IVU/.
M^NSE04L.&I):KW\8/FJRIX@L&2M) I7 $B*N$T@0T3 OS9^)+F0B_%H4N(PZ
M.>KHBNK5_>[53NX@%0B/$'>DCM XQB:22W4)9[:T;R=UZ*PN+Y1&*%=X-/ 4
M*A>>Q\*QB.&%FT-F'#MU)CWM2_KAN6G*]+#K4-&F1LV3G)=2IPRF5"80$<H@
M+U("DP(5:9DKK0HO2AM)[JF18J/@<--IK.GV"!9.:Q)'#!]Z-ZON;$&PIV+L
M9-QHDQ$_U3:\Z!-(I(TV'VYILO&&'[A\/?-J(1=L_>-AW6R<_:*,;+)Q\)7:
MJ]SWZL?IQ=UE=1/X.=8DS72!84&16:-DJ2'C3$*FF2A5*E51>/6Y#BG<Y!:B
MK;AFOKH3!XUZH!/<\-5!]UF[+7+NMNYZ\'NMJF?ECJ"O@..Z]4(3&WMQ>HDY
M]5^G(H ?=#$**=^X*TX$9$^6E1AC#%P[U-K6&OAHYEZMUTKN9[:7B!5:R0RR
M'&N(M%*0HD)#JF6"5)EB1KQVIGK&FARSUZ*"UYXLW .F(ZF&@2@V1[;H@*V<
MKL<J_(GN.B!!>:MGN'%IZ+K>)ZSB<,LPDOBLOCVMUH:!&O[I0B]WWVRGVKO-
M9KW@SQM+1I]7'YFM>S$GB<IXAB54.A<0Y11#)M($,E+R(I-%R:47=7A+,#5"
M^;RR=0:_J7_]BRT72]7F3/O1B_\TR+14E"'SFBO!("K*#'(M"T/CAKPS@G+)
MD_E3FU['UIL)3,:Q-/&FY)>CR9@!KKXLEK:2*^#,7"H\4\[\YP<13:G6!=0Y
MI1")PDR-8 ABB20F""<)(^W\O%G*R<Q.)\N8<Z.:7K\C38S;:AT5ZLAK^%;V
M;?+V=BNDD7\&]C6PA<D:'<*M[8/A"[GB^PLQJATP&*-CZV#X@P8Z%M;Z^+IZ
M-'=4S9#S@ABNHX4Q"K*$0X1*#HG4"*94$*I(ICAE\XU=*!W]B9,AO%;][4"Q
M5_UJ3\[_IR4T\!>I]$(L-KY[%V=@-<N$P!C#7##CILE$08Z+')8D(4KSO,Q4
MZ;_(WP;N>*OXJ]O6[#-X)J7 DI5F*<99;HTF"DEN7EA",1."22ZP]Z(< LWX
MJ^Z;&];8,T ZNKPW01/;TSWX=-NP7NQU\3(B05W=TU'&]7 O:GGBV%Z^\K:"
MP&V,S28UV1?^?E5MJCDS+(I24< RH1(BE0K("1(0$X9+35*"N?!Q7?L&FYJ7
MNJW/U[4MJ],4K;A 6'F'%?D]"S-1299S96!.F<T%37/(<Y5!11"CJ5(%Q^D-
M198'H_T"%97' ]V-D4.]L9&Y>1^W)OS820KN>W$;7!RY#Y 8E9#/CO<B98_[
M-+]4X[CWGF'$W?7@L:GJ2WG.%I89-WH*F&!B;&%E"(6AP@!<% JQI*!42A\7
MX]J TW0X'G=2STYBCK,Z&3*D3W)U5MQH)R36D:EG3]0:S3?]T5QOPG&%(B3I
M7!US5.)Q1>"8?)SO&T9 =T(\?WNN&U74A>]L6M!:?57+:O%=O5N*U3=E6X/5
M-7$_LS_G6&E&*>:0Y45F?',N()5Y"1.1(X$93E/L54'6<_RIV9=[XH-578U3
M["L 'HWL?MSC.R%N5!01YLC,M(]P4^_T0';0"-\V8YS5=;B-^61T"$=> \$+
MR66^(HQ*;0/Q.6:ZH8\96G;./M \9U?ZZ[/Z<_/**/;?<\GL>TDPI#D6$%$J
MH'D[C?.,$RY8*D6>>-6[Z!ML:I36?E!]7Y _H&XL%0JFR)2T0^B@E)\5%=2R
M!BWF=QV2L-7\>L8;N9S?=<U/Z_DYW./'%U(MYF^6&V-IW4EIWJ+JWOSXL/Z\
M^F,YERDIL*(9E)G=[6:&)D@J"R@DXYRG)"FP4V>9GC&FQ@Z-F*"5<P:LI#9!
MU,KJQA=]@/;31""8(K/#((2<><$!@QT=5!T?5$K\[<OJ^W^8NQLJ,#\<,T#?
MDT?Y\!U4Z[YWETN'F07;.MZO?FQ__'\7:FT>]/7'>_7=:&Z;1Q:$EB(U7WZ*
M2PZ1X 7DA4!04Y6)/$>*(:^#_V[#3HT,=MT#P%;8.GSPX>Z?@_IU.J+O9DV$
MQS0R<]P"Y_#&\D[H1.D*WS_RR[1T=T+C8C]VM[L'5!1^P]://[H36&T<NCUK
MU:9C:Y&E*6,8)ADI(%+&("%9P2$NBI)JD:3(+4'5;;BI,=%^19*N$HGM8:>L
M(D!UQRZW&U*K1AF/DJW79Z"?E<+C&MN.J:';GEC==AIHY1W2<> ZAAX%;(-B
M.5(IVBN8!JHAZXQ,;S78ZT\9KZZKLT8'%5K=[QK:PKW:K!=BTYY,^,=RL:D^
M_?J/]E7FBB8%8QH2S)D];%1"JFT6FY!4HS01)7%R#IU&FQH?&\$\X][]8+I9
M?,$@BDRM.SG;[[^6%/S%HO;7"&>.G' )V[:];\"1&[<[Z'[:NMWEIH$>YF+)
MEF+!'G<]IVJG)DDUXC1!4$@M(2+V7&*!,RC,+W'&":;2*^9\89RI,<56S+W.
M=L-\QPNX.CJ+MZ,5VSL< )2_5]@/0U W\,)0X_I]_?J>.'I7+K_ER/+]V5.V
M.4O3M"0Y%(P85BC2'%*290;/#)-",<JTEQ71,];4F*$]E'M_?"AWR!'F\^"6
MK$R%2#,HDXQ#E&0,<ID8WDUY(55:9I04\^]JS5<CP[L_9GR PP'JQK6!0(K,
MMY=>OVAGPGL!"7\F_/QP+W FO%?O\V?"^V\9$%_[N%X)I63UULC8Y7<^Z+UJ
MH<=M/N8XT8)K4<!,9LJX=V4!N= )1"C!0LJ<Y*D3,0\;?FI<W2D ["3OTKU7
MVN9#[=4*/N["Y1$\\I\BAX!<5. C$]06<RO\+E7\08/#4L/'*D3%W". %Q7[
MD0)ZP>? +](W&,+>R)__4\>+! [6^" R./PI [-LEYN%7#P^;Q;?U:]*/*_K
M?-XW?XK'9ZFDE<(FNSTW;^N#MFVB%LLOMHM'79JO.=,\+_)$E-K8IR)+*40D
MPY#()(%895254E!94*_<VQ!236TEVE<*5%NM@&K5:E8HL5/,+E*J56W7NW%X
M,=8P<^UF28\^@Y&7M(/)VRD$WAQ,WOWAY'5:V69+32W565OQ(6 *<$B@@R8&
M!Q%LW'3AD%B>)!$'??@PMG]XJIO^+;^\5ZQ2U=OGS?-:_;)8+KX]?^O.DKU^
M5N^6;\V'\U^&>ZHYX@EAG.4PR[#Q)A*"(2N(@EH+B5*5XTQG/M3N+\+4>-R\
M[\B/> ? [L:R<<&,3*E;X4$C_0PT\H-6@:Y@M?D'HP,PJY[5 M1JA.//X1"&
M),L!4HS*C,-1.J;!&YXT]"#KTEK0:R47F[=,V!-K/^SOWFV4L;<EEP42#$.9
MB10B)33D*2$PR72),).R1%Y1[-[1IL9D5C!KIS3B@DY>\'O]#[7(GEM=_6"[
MD5HP""/SUTWH#3BGZH!*V$.J?0..?$+50??3XZDN-P6+R!X5_9I398PFD2=0
M)K8!25EFT+9D@SA!TMA,>8JU4QZV^Y!38Y?+D=?-MB">3VU.#_!Q5F2BR!@L
MZF*/:9Y"1C&"6.FT$(B)DI9NVV=QX!]G%ZT3>WOVU+%HQU#4!T>U;T#RQ2+9
MQT4=@Z-Y<[SZ!E1?/$;MC&Z(J/0%H 9$HH^?]-+1YPN:.42<+]TYS ;_A:W_
M6]5%W':1C]T1W-(8X9+S'!:":HB01)!F4D*I$J9R8Y*3A/G8X+VC36V5W F[
M%U;T,[K[T74SNH-A%IF0S\+5-OT 4<XY.R$3TO#N'W!4P]M)]V/#V^VF@0%,
M6W[A@Q&>55^;(]5O_K3-HM0\I[G,<R5AFG-D[6T$>9$0: @D0T5*\B0I!Q2Y
MNSB@TS<Q?H6[5M2FY(MGE/(BMH[!R)N@&BGF6-=IZ4#J*K2T<E[>3O./*E[#
M(FCP\.)@X\8(K^E\$@J\>L/0@@AO_OR\9LMJ4;>(JROZSCF7PG8 @#2A*40)
M59#D",.,E9C;8MF8.IU"[!MD:K9%>^#_S9]@)REH1/6MB' &T7Y6"(539$(8
M M& D@B7,;BY)L*91X]<%.&R<J=5$7JN'681M#7V5\9=61J/]?7J&ULLYYFD
M(K5]S%5>F*\]M]: S4_124%0:OX0J5<5A+.C3.YS;TI+;J4$OS=R>L;PSR/J
M9@/<C%/LS]T;(N^EOQ>"D,O^^8%&7?)[=3U>[OLO'O;U_]V0B>WBMV&;YZI]
M4Q.%=<(R#;,ZG% R"2GA&LJ$JZ)$&&5IZO/MGQEC:E]^*R)H9!SXW9_#TNVK
MOQ&AR-^\+SC>7WR/^B&_]W/#C/JU]^AY_*WW73JX*N+:9@R\5LU_WRVW[L/S
MVC:%N*LJM:GF/&58%Y3!E!OO'TE>0LKKMFR(B[S@)$G1@#B X_ 3C0HT;N_C
M:OD%&CKZ!E@MK'<51:<)<*.,D'B.5ENQEA3\I9/YKS8G:1=1:.0&=_W8#JFS
MZ(-4X)*+3D./77W1!X\SA1B];A]JEZRJZN-ZI1>V,R3*=)9BB%*>0\0R8X\H
MKF B*2I3ZXP@[5,H?^_97G;("#7Q:]' 4RV;K_&Q \S5Z!@$0W1CPR+PL1^!
M 1;&B:YA+8O=XT>V*$[T.K4D3B\9&A;\S/Y\)\TGOM +46]M?WBN#P=CE+.<
M% SRE"80)7D"C9F00IIGJE1EILS7ZQ<;O##2U/R&-OIEZP4?B@L:>7VCA)<
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M2[4NS-N2(-N>!4.4EA021@QOY\3@+P6BRNMDM>.X4^/M?;&!W#;0:8ZT&36
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MB(8,S _'''#U\:-0@:N2'2,X7S]LN3\];G#4M_'3ZO'Q[6IM+9!Y0@M<8EI
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M.TW=<33?A,%#"!WC^L.!B4QDVP-85C3;-Z<K];X]T:GD]I36;,_3O+O>:V]
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MA"+*$@TIE10B5N:09Z* (DV)*+$0I7 Z%>PTVM18>MOON!88U!*#_Y7^K2C
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MB.9*IDK3G$.,$VX\,II!FC$-<2X%S83*E?#J/G-MP*FQXR_J7_]B2QNQ4+7
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M6D*T9[AQBXA>U_NDC*C#+0/YP_+1*U8I>;_Z9DOU- V._F!K^=EX9V;<7=<
MD1/*M*10TCRS?%) @IF$A=2(\5057'AE%'J,/3E^L:)#;F7O,EC G2U]_T4U
M%0-;!=S;7PR9$$?FB0-S;";R0/AZ_,J?G/Q!"TI6'L./2U[^N)R0V8!'!"6W
MW5OTZL?NDO8EJ^5X>*K/QW1-A:IWRX^U3UJ?/'BWW*P7RVHAZH-^\[S$)4])
M"CFW9=BM@<6DU%"E*BL5*Y&B?F781Q!Z:G2ZE0Y\KT^V&NM#=6H ^;RVON&0
M,BRCO  WL?"+3>N(]+VO\#Z'6]OR+,U;M6UK^%IQVT.^>Q462] H/P.[5Z96
M/3KS1YFH$9:,L')/8:V),A..BU2<L8>M;MNSYGM'BGY1S)XYEP_+3S;]PQ*G
MD7!1_6.YXI5:?V\2Y)Z>-^:?S228NVJ]=G7O949DF7 %RQ)KB)2BD,HLA2A3
M-$]Q@H5R.D(>4\BIK5Z[D@RS_8-VH-,3&-K;:@IJ56=@7UE0:PL.U?5;Z:*\
M#&XKVTM/<>25+,[LMN&4.$T88LY(R"4KBIRC+E$QD3Y>DJ*.-6P)^J V3:7G
M]ZNJVB8@?E[M=03\NGHTSZO:8VUWO-JLF=C,;1L*:I84J(2MRZPR :F6"32K
M#N:"%3DK"I]U9K D4UM,/CQ_L^=G5NO_[;< #)\*-Y8?!>#(5&YT &UY^+]8
M-?ZZ2X:VC2GVVX:VNFS/PX+?.WT"\O3-F(8DX^'"C,JX-V-V3*NW/S!D<*K9
M'[Q[WGQ=K1?_4O(?2_/$6HC&L?AH7NCJM-GU/YZ>U+K^Z?WBVV(SSUG*N$$7
M9FG*(!*$0T:T@"S!**/F!<B9UZ&WF,).C8'W0Q)/7=\:MA]Z7M7:S;8Q*O!4
M]WBOKYB!9ZM>\Q?P:!4,4HL@ZNMR2PAK_)?@I7<>'MKI[Y0"M5;@4S/]M6+-
M7T"M6NS05-@)B!^2"B3O!$)189%W"T$%'O.&M8L'$JW]C5UUV^#9;VKQY:M=
M:;\;4_B+^J1L;3+CVMROEO7*^\P>/ZOUMVR>,:R)8B44A9(02<H@)Y+#,L%)
MHG.>>AZRG(A>4UL1.[E!*SC82@[V1#=LIYN<2=L,P3>#;R+0^RR%+R_M_SVK
MYAX&,^#XOED( B^NTYG2X.OP!%0;?\F>@-)]J_N$Q'OQ/:A[]BB>F\*DGXRO
M]':UMMMI<\H2)'&60BUR6T>=*LAT6D!48*1*F5,IO1JX19=X:HMWG/T+V[!E
MJSWXW>H/6@ \4VOCOT*C;V/=_F+\E'M:@]Z)E]S<ZI^GB>YT71#Z9]WVZI^#
MB'M@5P;VK]9OEM9J];B0]2/?V,C?LBFSW6;K9AAI;="&7)<4(MN0CZ:V-TB:
M,AN/%2S+7:OS7QEK:FO0@;C&V-\3V+T8_S5\^VD^,&J1";H'L(#)SAZ8W%ID
M_]HPHQ75=]1WOXB^ZRW^I76:&F5W4IIWIVK_\WZQ5.D<,5G( I509<INX# *
MJ=(2JD2DG!4\Q<RYQL[%4:9&$VU9O5;$6?<#L,*ZGZ3H![:?)8+!%9D?!B/E
M59KG*A(WU.BY_.S1BO5<56^_:L_UBP>4[QF<9?IAM6P<_>94Z;MEM5G795"J
M?ZK*NOU+:3NOVW:(GU?V5WLG3H]" P?1A+E.:5Z2)(=Y03*(DI1 DBH.A2J0
MSDN18+<SH]-4;VJ$UVA3=_Q2K3XV$<661+0-:6TGVK8I;7/ZX::=Y&E.B4ME
MI<D)/:&5H(F[O^H_:/&J.VCQZMQ!"X,2;&#JNE3N 34#[4MJL (=6.#SJO[U
M;+_:P)FX_6&L_Z=^33W*6DU.>)_7=:1Z6O\WO+9^-;XF^U;T%A>;GM3C536;
MGNY'=NG$I1RVI51WI[.2KC<_['G@B@DK9-MAD9%29;(LH$"BA'8'"-(D8S#)
M,,.XX!P77EVW>T>;FKG8"@MJ:<&>N)ZM+=V@=MLV"09@9#OI!NR\MRB<, FY
MO= _X*A; TZZ'X?UW6X:&E][\TVMOQC2^OMZ]<?FJV5)MOPQ)YP3K(6 E"'#
M)")ED&!.H"ZYS!4B."^<&AY=&6=J'-)&CCI902,L:*7UC;"=A]8UQG8S8.-$
MV7RQ&A!CZT7BYBC;^:>/'&?K5?$TTM9_^<"T59M(\ZZJGI5\71>5:(YFUQN*
M>TDVVP0;:>219<E5!C7/<FA;V$)F: -JDDE"$:9)X9=@ZBO!Y.BC<XU6N@Y3
MF16UJNN$-6<B/)MX^$^(FU$2%>;8 9T:SD9XT$B_+7K1IFPTE[0Z;+W5@#T;
M!^,7-&O16XAQ\PN'8G22"3CX00-V'#I?3Q@_;_%=V7Q""[_Q];(DQ?5P]G?M
MEGJ9Z@*760HYX0E$-$'VE"XQ/U&F$D54CIRJ0?@//37>J\N^;\-,K0K REM'
M[ZT&[6=I?^<1Z?2;$(=@>3288QM;Y\!MZ^W?G4(\I&>!']8>$=]HF(\4C?7$
M/E!$=!!JO=%*OR>.%TD<I.E!E&_8$V[:DNYBA;M(8ALN/$D_;[+6]Y+0M[4%
M<)*QI& <8LXI1*S@D*7*+"4%27C."ZT*,6 [.8!H4UM@CJPY*^J@_;(0L^:U
M)3OR7(RXG3K@&%-;@WU/1Y?"$;'G<]#>Y<CS^@+[CD'F-_CN8$#<'7?V0HSX
M$KMR 9&ZL*,6<H1A(:OWBZ5ZT/=K)1>;M\PFKV]^_,+^M,VT7ZW6Z]4?]DP7
M,R^[^?V\+&1&J"@AS3DVJRV6D#)F_J"ZR%B)2I$[A;2'##ZU]=3*;H-4HI8>
MZ%;\&?C6* !XIP$0K0I^L2NOF7$+6\7"._*:V4'=" [>;J%N90=;X<']-:B]
M0U5#, L9I?(:?]0 U1!DCF-3@YXQC.F: N#FWKL_%]4\4VFJ;;]L3:2"*$LS
M2+G&D.2I8 663',O*CMX^M2XJA8.6.F,M6CD\]S&/T3.C6H&XQ&92]RA\&:*
MLRJ'I(+# 4;]UL_J=OPQG[]HY-+Z)\E&#YNO:OWY*VN3D:H/JV6SL7248U0W
MBWS--FI[!O#@F#CB2 @N85Y29/BB*"!50D*L"RRRDA9EXE\)9CKZ38VQ3E(F
MFXZH5GRP.UP\4K'^2*^4XU;CM*2>$)4': %PFM<+:I3 QL"T:Q"P1>I,+N_9
M%S-*-<^)O@F3Z#$02<4)U(![\?D-UKD@LI@CVQF7LYMWR20H([BP;SK&Y@_$
M,@X),C\5*2H$36F.=39?JB\V-_'S"+:#@\Q._$X;?C^1/'Y:D!S>PC7J3$=>
MRT--W$^S,%\Y>Q,C)6F$N9G$4NDB[\^Q[GD@'VP1\QG3O\1+&_KJ$D1*8;B6
M*)CFQ)Y%8012G4O(><E1F2I"N5.-AI,G3\W;:X5S+]5RB%,_^=ZD?62F[ +8
M84NNG-7VU@(KAP\=K9S*65WVBZ><OV!@B/C;:KU9_*OF@@?]=K%D2U'7-*PV
MU9QI43">2%AB>YZ#4@9)H30LS2>:98A0DJ9>$>.>P:;V@>[+:G=BI.(;L*BJ
M9R.S L**[!E2[D/:,<(<"+_8 ><CZ%Y;Z-YUT-WW0N<?@G; )&A$NF^\<0/4
M#IJ?Q*M=[AEZR-38!0M[M/6>55_GN<:(9IS 1-(4HI(9[N )@XICXP;*A$F<
M^)TJW7_\U-AB)QT01CS?,Z,'R+EQP7 \(G_]>U#<]T$QX CH.8W#GOD\&&'D
M0Y[GM#L]U7GVJALK#;?E'JU-7U=UK%XO*O&XLK_;=2Y$J2"L8)GYH+4Q!E*B
M(64%@4J@,B-Y+C7R,@:\1I_:][X7]]X3W],B\,/?C1:BH1J9-<X#6A\$V?][
MH\ILKY*NO<)XJ.OM+WZ/V__1!]<HY6Z=!'B9TK4^V%PL0^OUD '9^!_7*Z&4
MK-X:/<Z>!?N@-@_ZDWHRK_975JEJGO)"8%UJB+4MD$%)#FU%-\A*)E'"<Y4A
MI\298<-/C?HZ!8!]$7;]NG:'5^T7^;P\=Y)U!I9J8Z]<[]3SR.#VG[E^SHP_
M'Y%)<SL55OA+1UAGP/9H?-#@TTB@>Z3&1P5_I/3W\)/@E^8^&,/>5';_IXZ7
MKCY8XX.4].%/&>H?;]ABJ>0;MK9=0[H2VT*GI4IS#DFF&40,99 G6$.M=<[R
MA-!2.54'[1]F:HO(G3#?YG-3/NBUT@O1T]//!TU7W_E6C*+[T(V H),P8+C<
M#82P;O79D49VK_NT/76S>Z\>1@!OM%;"GC1M>N-^9G]^,N^_[1ZT6#Z;41Z>
M;)=J2T%S@91.BU3#4JK"D (W])"@$C*.*$<E1E)Z!<_<AYX:46PE!XNFR_2&
M_0G6-O5L?=0HQ:A@3_+ZT8C'G+A12QRD(]/-#N2VE;<1&UBY3[K1?+P"LC<+
M^>,5DID\1A^5K?Q1.6:P 4^X,8AX5U5J4]TM97\?&7/!?KBF;BOSWG#MNXTR
M1EE!=9XBG4-.$VY;DTG(,B:AR,H"9]S63OG_JSNV';=QZ_M^!8$"Q188=B6*
MNK %%D@F>0BPR!B9V19%'@S>-#'JL0:V)^G\?4E)EF5[)),R*2O[D#A>63P7
M\AR>.QGD9'0!W=1D8WOD5(5?:7N?GSYUXC,K\01?-::@1'7HP#$GF\#2TSDV
M:T?SA([(U>'^4)?4]^(O=0+@=?RI+FG;Z6]UNLC C.3%XVJAC$"ZVBK#L'C1
M2NIQ5BR562@W^PA(&!(:IA%2>H%AB*,401(2#F7$2!R@,"?<:FZEV;)3D_KW
M+T]/=/VJW:@M!, > [!#P3)9V(P)9L+9/6D]2]TSI/045;(CD]-<6K.5Q\V*
MM:+&27ZKW:^'2:K/<JL#[[-U\7TAI'C_^N=&BD^K3V6X0TM)?><N1>@<Y8G(
MI2 PHI&$6. 84O4?I&DLL0@"D;%TOBVV=&DFK<R7MI)8#0#^SI9V?>NL&/#K
MB\Y[7ZS^]MMSC87.B5_L, "T0<%.=%EPQ4Q\^:&U9Q&FR:RA!K,6<7_]LR8Y
M:( '[\Z3V5J2V5/,I32S6'U4B69/E6.I-N -(U>%U6&3=T(L] >ZW,?K-TV[
M+-WU-.,9@X0A'>50E[@LC064. ]DF@N2<:.F=:- .[4;WTD!;FOB?-W'6->(
M_?4O81+\\S^2KD>K$S/BO>&-<2H<]7W1O+Q2K"G2WN,,6DA/JQ+;ACV3*!8S
M OCGJ!:SH;VS<C&K12_05>P\;*P#MNZI2U^D'H]29L0W(O9!KI_0G'..9*SN
M[R)@ N(@HY#A.(-<,!0S1E)$K.+T5\!A:GJMA0)@=%E6A^A:Y]>A*FSD+6&A
MV*;+Z)](W?5/&&RH<7 ]TO1PK 6OPTOGNG%D-,;7F-?ATYMZ]$J@#-2N_)L4
M+TMYEY^] VRZ+@$/NE_K/(Z02 ),($E"IG5F BGAN?IG$H4!BF5*J97.= 79
MU#3A#K'2J6\@,3>](A-\+9&TC.&Z8[NA7KP&,WUKNW'Y:*^_7-/<J59R!MRX
MNL8U34\TB/,%ANF%?U.]4!DJ_J(545LUS45"6)XQ"?-0IS%CJA.:]6@W)%D0
MB(CS()HKO<4*4V'?MYS-D6\OZM%'5T$+EOL@NIWX[:5N(E%$@C2"",L08DDP
M)#SDD%*19CQ1M$V-AD:YINTHWL\:UC*_95U""XH]N ZI;*:W7-'.LRHZ(%L%
M:-N <J=33.CA4DWTKC>JY#?!_%B8&_W&4P2G4SOLNQBOA!YY]%GMJWIB=8 Q
MR[(401Z&Y8RA#-(XBB%+9:Z$$HT%2YP&;@8 .36)U6ZX/6B(N!=..@K#>.:/
M9ZEHPQKW,9(+:#=J:&0(G-.*B%Q :>M R"5K#9/TM\7ZN=!%,+JSTKU.R:RS
M-LL:.$8QB1EAZIZ(<HA3$4&6D P&09C)%&=((*LTR=[5IB9[&V !*U;"\@[>
M3U<S >J,6IXEX9Y097NN/:0>2@V-:.)2PO4O.*JH,L+]6.:8_<A.>.@Y\ ]K
MJB^:]Z]/K%C..<-4/<*49-#--FFJ[G94!I"P..1(ACRA1E;ER9NG)A1JX$ %
MG9E,."57__F_B B>S[HA_L;GNA/7_1G>[ [Q1O*_/Q;??U._J<ZO^G!\;$_?
M-\H1[41C=QR['QCH03L,X'Q^T<>Y=NNU#<$/B^6+>FR?.%$6630)54&.\@ E
M%*:4:ILLPI#0',$T5E89I:D0D9TWR E84SOT'^2J>%JL]!;^AZ63R V;#-U)
MHQ/?M^/I.#!?H=2$1 [<4$<%QEY2U]Q2V*DKRPUDXSJ]G%+SQ#WF]NT#VH/=
M+NEF<Y?7?KJ[=>FE^R*%?"KC\56Z[;M<2;#69-(YBD1$HBB$5"A+"PN,((V$
M@$DN))4Y$DEN%.D>#L+4Q&^=ETPUF.#'SAG-9-E?0+:&.>=%\__!ND$2J.>4
M(<U+"]NB7=4P]O6+ZG&8XMO>T_#K#E2[2-7=N@H+Z&:*#=5KKI5X#)R;/HP#
M%DW#O'-BI,9AGCABUSWL(F+V=A ;]N;QNHA=A/E!)['+WG2=<IT6)$<Z]V 0
M]YP&,F$!IS @N=#SG$+(TCR"F61ARM,DY\@^[=D_W%/3ABVP =V"[3>E U="
MWXGUQ^>FA@>(8KFDZXW^JIKY-'(IC^F^<!1-&I_;GM6LRWSG%O9OY#OO* !*
M$DRGTL>29U.J^3$%?5JQ+K?\<%T'9+O\ )/MK02YOBF,QT,8=1N4"JO-YJ72
MV9LR86[?]2+/4]U[+X4Q$PG$3""=>Y7 -,V8( 3E6$3&]IU_>*>F_KKR8L_-
MIJU'TSX<C*9MT <M_"T,E!&VBX$].:U-X%LK[OA_YXO_=:XT,&G3<I4M86'@
M3FMKC&0-^]\BCBSF\;C3:UZ/ ,9XMOAX-#TPW$=<=IB5_T$^%YO%=M>9[?7V
M9;U6<,P92A-$> 2C-%;7$4YTMKV>FBE%E)$T)&%HU2:S8YVI72-VCK)FZ(2H
MX&ZR[E_MC.4N\IH9MPZ(YEGMUA VO2-?;T -I#MS\0P57)IW74N-:HZ=P??8
M?#KW^#"YH$RF[W0K9TM:!4CJ##62)R1"/(8HRQG$(1-0_9S#C,1QE*4B0S&R
M$0MO+S,UJ3#[-/M8=[<R#Q:=H:29!+B</IX%0 T@:"#TD-S73P27Y[]CI5&/
M?S^VQZ?_S-,#YPC40PEF<EU>6UHC^N(@HP'AD(1(G7\A0ICE,8&!Q%&8);DN
M(;,:&]"UTM1$@.Y&R\M*ISHQH!RW\T>QJ1SI)?"6@P$ZB6PF&IR0SK-T:(:+
MS'8T\M3F]"PQG/;T[UQLW!;^YW ^Z=A_]@?#Q,7=^I&NZI&_M\I *98+41DM
M*S%3VVEGVC?C@.GR7GU3E398)K,Y66M")Z2-SPTXP*B4-FV<M&^SP0KLT?*2
MT^:4T"Y/GQO 1CVI3FEY?*K=OGR8!&@U=J_-C^989XG,J* IQ#(1$".:0<8H
MAP))FA,:""JL4HF[EYK:E:$&KUVP;YDFW$-6,VGIAEB>16 +R,9[X$6DG:>&
M2SG5L]JHPN<\UL<2Q> 7]H5!'U?;Q?;U_IM<+G68EZY>YRB)DCCG O(TBW7S
M)@YI'D<P)"A,@ASS*#+R,;[]^JF)@PI"4(((:AC-"X7>(%^_"+B<*+YM QMZ
M6!4.=:-]0?70&R\=K82H&Z%V'5'/4T-2'H9F97PNZN#%<6SC3!-GFC/"4D5W
MGJ8(8HQ#R)#@,"<LQ"A35P5JY%J\"O13$S:]#;UU"[\R%="FD_=U-H5)FL.$
M6>T[Z:&,8K_O3P5\OTL%?/]6M%L1 594. U\7]3_>P*;QR8A8L*;:*STB"MM
M)E=)$U?B8'\*Q=A C9A0<25Z'Z977 N("R>9UM/OR@6;^7=U8!"+ &4!3V&>
MIAG$)$\@B40( TH9#?,P3!,Q:$!ISZ)3N[ZT)U0VH X<&-I':S,OBFL*>KX5
MO$D\#V%9&[)XF;O9M^YUQFD:4*)S2J;);Z]3R?4ON=$Y]2OQ\7_/DJN/#X7^
MJKMO^&$A#R-!CH1(8<QIK%M&I3!#G,$H2W"FY)D,4KNAFE=%9VJBLL*FC!7)
M&A^P+8#.59EV'=B%N\I,=/\\>V444]%-U5AKRWUL;3G]];D1&E,M*7/#YRE5
MFEV(T4]5@.:&>Z[KTAQ!-<!WJZX/NF"\G%5;A7X_R%RNUPH$!?Q&#T'5L>+-
M=C,/\PPCH79@ED8,8AZ'D,61A#3'09ZG698$YFU%S->=FA8]AESK2U'##K9[
MX '7T%LXO2Q88>#K]$-@SZKGA+9W.=B!#5IP@UM_M+5P!?JA\4A./$>TMG.]
MV5.LUVEF\;KQW%WV.!XXJ@;\?)#<_ZYEI5J,/B^V=+G/"M*#?-7NT_E!"_4R
MNG=]Z:3 XF5;M1"YWQ;\OZ7Z>5@O'A_E^N%',1=(ICS'RG1C801Q$A*842P@
M$40BFJ.,<FRA(CR .#UM4B()UD=8WBCUL<-3?]PC>@-DB:KZNT*VMM1NP$;C
M"YXUPDH1E1B#[8_B(A/.XV8Q4F)7W@+>]5W%_6,$R_3.'?=O#[G_L>9^C6?=
MD^D&E*A6QA*HD;T!"MVK\]E*H5Z9WZ/IWBORW59C>V3)&>7N8^4Q[P$>*7=T
M9?"YTC!/\F?YXQWGQ4L)PFQ=J,7J!HJ;6;%<\-?JSWTI2X03$4E*8"(%T@W
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MW<;SWEAGY"A;-Z:GL:^>9[O.>YLI?ZA/O_^R^T;]H4/*O__R?U!+ P04
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M2D#(7.CD4Y#TK5V 7..CA$5<$;UYT1HD.%DNKK^SC9;O4M0?9+I1]JR%Y <
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M80/95)RFR@IMW,9@JM?@3+6LP4'@PD)2@?9NU#S8)H=KC] T&*>I'9BZTL@
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M#SZ1L8_>EB2*--)N]QKL!&U'47N897M6-8+MM?;<H#DR:((I*H(,-6/C:F&
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M>Q: ^7JPD&.":(D-'XKUTL6 XK!6-GL?WV^+SL& J2/Y#\"@W74#WI2?Q]-
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M=D3*4?A(8$D4;B>MP+%<3T&22\EH1<Y*BW76"?4G3X,\A8B7XT6:S!97<_Q
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MTR0^ ,R\3Y\P7TWP3=F?O[NHZ9B/ZV#EIV^WO[.9^WCQ>YCGE1<PLL5REVT
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M_@W.)[AX_OO=L]\L9^D_&_U$<W!:.&; 9$96UF&&R'P M)G"3FX3MYO&:7L
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MQ-A@^Y:Z2L>M%_AL.KVIAIMBW)4,B?!4B=/)!2N" ATK<;J>=:!)D(OC4;*
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M'[$3-"NJZ +FS:1[-B?V@G&[^J3&1&&:*\+N?,5:HC3YA/63(Y+M!WENFQN
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MPC01?[/ )%R!G,F<D,-F(00O0*28K<=(!J=93\F]5MJYZS$PE+8,R6XGUPZ
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MSF^-L;2,N6(+H+:!@EM3*,0@LZQ35-XC%N]W*6/8"5E/K*,C% TI]]GP0NC
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ML;;C WO,RQD+<2UD-"+N%O/EU=O)LGKE+Z=Y\FF2;\+URGW!Y'(HHC:S9D1
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M19E(DY@!>DM 9MSE(F,V:;.<_3'\-5A>C]5\I\+MV-*^/+R__7-V95W@A9M
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M6W#O;>(1DK)DLDHJ$(PT8 MRJ6P2/)V+/AX6T_57C'SN>G@<R$:>Z;I*DFC
ME/4XG+5=PE3MQ*R^]9!7TB4I/!;@):F:V5' ,U%G@%I-'Y48'LQ<WIX),R(1
M9QKG'7=&.3;3]T+.V$E@[=SP>CMSRY#B"TNE.,A*"E"!UVM&-& 8T]RK6'P0
M8ZG2@]6>:?#6I\X<AX4+5(Y[UF)C%M-=]+KJM?.E+@"Y3C)&!X(8!"K% DXJ
M<J"3*9PE$7G<K7?>^+2<:336IV*UQ-'?5^VNC)(NQ$*&21%S%,\*@JX>O N.
M>16*$J,Y?3O2,,X%VEGBO \=W0MTH\_D;L6L)X<6;_"+B2R=I^!:U*1$Q15X
MBF6!&>45<UXF-]J>N#L9X\1F/_3T9-"[P&WTCAF[,4LXXE;P G!5(&.X@$BN
M/["4(C,& \N[#2<:FY)Q0L(?JGI* %Z@MCYZ#[,3\V14+FN2>,EUPE4Q&:(6
M'@07@A5=M&.[=;'NC;)QXM ?VCPF0"]0NW>-+I KGHPO4!++H*QA9 2% )D,
MDT'$A-V?((US?_A#8T\#NK_M1>/3UDT['K.KDRI1@!(.P8>L(2@=3!1:1[?9
MSJBCZ\?^M/E"SX%/B+(+W$/O74\]R:8D$_<R,J#@7X'R-9 @0P:A%.\\,Z7(
MW1J>CT?#V;="[TGK6N#F M7K6<ZKUH_A^FMWM'LMSVPI-O J2^]!,64@QHC
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M:'@$EHMA.D@9])!WU$'AO/M5Y]4TY_.OCF=U#_BXZ]@32A8:.9!*2* X(R?
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M4$L! A0#%     @ (H*Q4BAR,S3Y/ , *-\> !$              ( !
M &AI;7,M,C R,3 S,S$N:'1M4$L! A0#%     @ (H*Q4JME>C/B&0  8T$!
M !$              ( !*#T# &AI;7,M,C R,3 S,S$N>'-D4$L! A0#%
M  @ (H*Q4B:F#SXV&0  9NP  !4              ( !.5<# &AI;7,M,C R
M,3 S,S%?8V%L+GAM;%!+ 0(4 Q0    ( "*"L5+-\9E%/Z8  !^J!P 5
M          "  :)P P!H:6US+3(P,C$P,S,Q7V1E9BYX;6Q02P$"% ,4
M"  B@K%2T9GD$/(I 0 .(0T %0              @ $4%P0 :&EM<RTR,#(Q
M,#,S,5]L86(N>&UL4$L! A0#%     @ (H*Q4JCL]T8VU0  ,1L* !4
M         ( !.4$% &AI;7,M,C R,3 S,S%?<')E+GAM;%!+ 0(4 Q0    (
M "*"L5*'T$@D40@  !XJ   ;              "  :(6!@!H:6US+3(P,C$P
M,S,Q>#$P<7AE>#,Q,2YH=&U02P$"% ,4    "  B@K%2C9?^:T0(  #?*0
M&P              @ $L'P8 :&EM<RTR,#(Q,#,S,7@Q,'%X97@S,3(N:'1M
M4$L! A0#%     @ (H*Q4JAV(G7)!   P14  !L              ( !J2<&
M &AI;7,M,C R,3 S,S%X,3!Q>&5X,S(Q+FAT;5!+ 0(4 Q0    ( "*"L5*#
MV;4_U00  $85   ;              "  :LL!@!H:6US+3(P,C$P,S,Q>#$P
A<7AE>#,R,BYH=&U02P4&      H "@"N @  N3$&

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
